PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Grabb, PA				Grabb, PA			Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: Technical case report	NEUROSURGERY			English	Article						brain injury; hydrocephalus; intraventricular hemorrhage; thrombolysis	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; CLOT LYSIS; POSTHEMORRHAGIC HYDROCEPHALUS; UROKINASE; PREVENTION; INFUSION; TRIAL	OBJECTIVE AND IMPORTANCE: Traumatic intraventricular hemorrhage (IVH) can result in association with acute obstructive hydrocephalus, repetitive malfunction of external ventricular drains (EVDs), and uncontrollable increased intracranial pressure. We report a case showing the safe and effective use of intraventricular recombinant-tissue plasminogen activator in a child with severe brain injury and acute hydrocephalus from IVH. CLINICAL PRESENTATION: A 15-year-old male patient presented to us after a motor vehicle accident with bilateral extensor posturing, intracerebral and IVH, and acute obstructive hydrocephalus. INTERVENTION: A right EVD was placed and functioned only transiently. A left EVD was placed and functioned only transiently. Because of the inability to maintain ventricular drainage, rising intracranial pressure, and worsening clinical status, 5 mg of recombinant-tissue plasminogen activator was injected through each EVD. Excellent EVD function was obtained quickly, with control of intracranial pressure and improvement in clinical status and without hemorrhagic complication. CONCLUSION: With obstructive hydrocephalus secondary to acute traumatic IVH that cannot be controlled with EVD because of recurrent obstruction from intraventricular blood, intraventricular recombinant-tissue plasminogen activator can be effective and safe, despite preexisting multiple hemorrhagic intracranial injuries.	Univ Alabama, Childrens Hosp, Div Neurosurg, Tuscaloosa, AL 35487 USA		Grabb, PA (corresponding author), Univ Alabama, Childrens Hosp, Div Neurosurg, ACC 400,1600 7th Ave, Tuscaloosa, AL 35487 USA.						AKDEMIR H, 1995, NEUROSURG REV, V18, P95, DOI 10.1007/BF00417665; BERRY K, 1994, AM J FOREN MED PATH, V15, P132, DOI 10.1097/00000433-199406000-00008; BRINKER T, 1992, NEUROSURGERY, V31, P306, DOI 10.1227/00006123-199208000-00016; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; FINDLAY JM, 1995, NEUROSURGERY, V37, P168, DOI 10.1227/00006123-199507000-00041; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; HUDGINS RJ, 1994, PEDIATR NEUROSURG, V20, P190, DOI 10.1159/000120786; Kajimoto Y, 1997, NEUROSURGERY, V40, P572, DOI 10.1097/00006123-199703000-00029; KIM CH, 1981, SURG NEUROL, V16, P415, DOI 10.1016/0090-3019(81)90233-0; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LITTLE JR, 1977, SURG NEUROL, V8, P143; Luciano R, 1997, CHILD NERV SYST, V13, P73, DOI 10.1007/s003810050045; MAYFRANK L, 1993, ACTA NEUROCHIR, V122, P32, DOI 10.1007/BF01446983; MULLER H, 1987, SURG NEUROL, V27, P398, DOI 10.1016/0090-3019(87)90021-8; PANG D, 1986, NEUROSURGERY, V19, P553, DOI 10.1227/00006123-198610000-00010; TODO T, 1991, J NEUROSURG, V74, P81, DOI 10.3171/jns.1991.74.1.0081; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444	19	21	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	OCT	1998	43	4					966	969		10.1097/00006123-199810000-00150			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	121MT	WOS:000076018200133	9766330				2022-02-06	
J	Kahabuka, FK; Willemsen, W; van't Hof, M; Ntabaye, MK; Burgersdijk, R; Frankenmolen, F; Plasschaert, A				Kahabuka, FK; Willemsen, W; van't Hof, M; Ntabaye, MK; Burgersdijk, R; Frankenmolen, F; Plasschaert, A			Initial treatment of traumatic dental injuries by dental practitioners	ENDODONTICS & DENTAL TRAUMATOLOGY			English	Article						dental education; dental injuries; dental trauma		The aim of this study was to investigate the nature of initial treatment provided by dental practitioners to children aged 1-17 years with various types of traumatic dental injuries at public dental clinics in Tanzania. Questionnaires on initial treatment were mailed to 188 practitioners and returned by 138 (73%). The reported treatments were analyzed in relation to the dental practitioners' qualifications and area of practice. Extraction of injured teeth was frequently reported for 64% of the injuries and prescription of antibiotics was reported by 67%, 48% and 46% of the practitioners for soft tissue injuries, concussion, and alveolar fracture respectively. Practitioners working at the Faculty of Dentistry were less involved in treating dental trauma than those at urban and rural clinics (P=0.001), while no significant association was found with the level of education of the practitioners. Equal proportions of practitioners, about one-third each, reported correct, unnecessary and wrong treatment options. The quality of the treatments provided could not be explained by background variables. It can be concluded that dental practitioners in Tanzania provide a lot of overtreatment for traumatic dental injuries. Therefore, it is suggested that efforts should be made to improve and standardize treatment methods in Tanzania.	Muhimbili Univ, Coll Hlth Sci, Fac Dent, Dar Es Salaam, Tanzania		Kahabuka, FK (corresponding author), Muhimbili Univ, Coll Hlth Sci, Fac Dent, POB 65014, Dar Es Salaam, Tanzania.		Kahabuka, Febronia/M-7080-2019				ANDREASEN JO, 1994, TXB COLOR ATLAS TRAU, P219; [Anonymous], 1995, Dent Clin North Am, V39, P221; Hamilton FA, 1997, BRIT DENT J, V182, P91, DOI 10.1038/sj.bdj.4809313; MCTIGUE DJ, 1994, PEDIAT DENT INFANCY, P209; RUSMAH M, 1990, AUST DENT J, V35, P430	5	21	22	0	2	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0109-2502			ENDOD DENT TRAUMATOL	Endod. Dent. Traumatol.	OCT	1998	14	5					206	209					4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	132QE	WOS:000076640400002	9855797				2022-02-06	
J	Cohen, JE; Eger, K; Montero, A; Israel, Z				Cohen, JE; Eger, K; Montero, A; Israel, Z			Rapid spontaneous resolution of acute subdural hematoma and HIV related cerebral atrophy: Case report	SURGICAL NEUROLOGY			English	Article						acute subdural hematoma; brain trauma; cerebral atrophy; HIV		BACKGROUND The natural history of a traumatic acute subdural hematoma is usually interrupted by its prompt surgical removal. Rapid spontaneous resolution within 48 hours, although infrequently reported, may be, underestimated and demonstrates a benign course of this condition. To our knowledge, this is the first case of rapid spontaneous resolution of an acute subdural hematoma in a patient with HIV encephalopathy and cerebral atrophy. METHODS AND RESULTS This 27-year-old man, an intravenous drug user with AIDS-related complex and HIV encephalopathy, suffered an acute subdural hematoma due to head injury in a car accident. The hematoma spontaneously resolved within 12 hours, resulting in a favorable outcome with nonoperative treatment. CONCLUSIONS AIDS related cerebral atrophy may not only have predisposed the patient to the development of an extracerebral collection, but may have also favorably influenced the spontaneous resolution of the hematoma. The mechanism of the hematoma resolution and the influence of HIV related cerebral atrophy is discussed. (C) 1998 by Elsevier Science Inc.	Hosp Emergencias Dr Clemente Alvarez, Dept Neurocirugia, Rosario, Santa Fe, Argentina; Univ Jena, Ausbildungsstandort, Klinikum Erfurt, Neurol Klin, Erfurt, Germany; Hosp Emergencias Dr Clemente Alvarez, Dept Immunodeficiencias, Rosario, Santa Fe, Argentina; Hadassah Univ Hosp, Dept Neurosurg, IL-91120 Jerusalem, Israel		Cohen, JE (corresponding author), Dorrego 851, RA-2000 Rosario, Santa Fe, Argentina.		Israel, Zvi/S-5814-2016	Israel, Zvi/0000-0002-0060-5769			AOKI N, 1990, ACTA NEUROCHIR, V103, P76, DOI 10.1007/BF01420196; CARDOSO ER, 1989, ACTA NEUROCHIR, V97, P40, DOI 10.1007/BF01577738; CHOKROVERTY S, 1968, DIS NERV SYST, V29, P704; CUATICO W, 1991, NEUROSURG SCI, V35, P139; DELAMONTE SM, 1987, NEUROLOGY, V37, P562, DOI 10.1212/WNL.37.4.562; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; Dymecki J, 1976, Neurol Neurochir Pol, V10, P497; FUJIOKA S, 1990, Neurologia Medico-Chirurgica, V30, P827, DOI 10.2176/nmc.30.827; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, MANAGEMENT HEAD INJU, P153; Joki Tatsuhiro, 1992, Neurological Surgery, V20, P915; KAUFMAN HH, 1986, NEUROSURGERY, V19, P446; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; MAKIYAMA Y, 1985, Nihon University Journal of Medicine, V27, P123; MCARTHUR JC, 1992, CLIN NEUROBIOLOGY, V2, P1312; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; PERLMUTTER I, 1961, JAMA-J AM MED ASSOC, V176, P212, DOI 10.1001/jama.1961.63040160001006; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; TEASDALE G, 1974, LANCET, V2, P81; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; [No title captured]	24	21	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	1998	50	3					241	244		10.1016/S0090-3019(97)00026-8			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	117AK	WOS:000075757400024	9736087				2022-02-06	
J	Ferrera, PC; Pauze, DR; Chan, L				Ferrera, PC; Pauze, DR; Chan, L			Sagittal sinus thrombosis after closed head injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						superior sagittal sinus; thrombosis; traumatic	CEREBRAL VENOUS THROMBOSIS; DURAL SINUS; COMPUTED-TOMOGRAPHY; VEIN-THROMBOSIS; DIAGNOSIS; MRI	Superior sagittal sinus thrombosis (SSST) is an unusual disorder, most often attributed to hematological abnormalities, oral contraceptive use, or association with the puerperium. Although SSST secondary to trauma has been reported, it still remains an extremely rare entity. Antemortem diagnosis of SSST is made by findings on computed tomographic scanning, cerebral angiography, or magnetic resonance imaging. Prognosis is variable and spontaneous resolution has been reported. Successful treatment options of spontaneous cases include systemic anticoagulation and thrombolytic therapy along with supportive measures. There are currently no guidelines for the management of SSST associated with traumatic brain injury. This report describes a case of SSST in a man who sustained a closed head injury. (Am J Emerg Med 1998;16:382-385. Copyright a 1998 by W.B. Saunders Company).	Albany Med Ctr, Dept Emergency Med A 139, Albany, NY 12208 USA		Ferrera, PC (corresponding author), Albany Med Ctr, Dept Emergency Med A 139, Albany, NY 12208 USA.						Bagley C, 1934, SURG GYNECOL OBSTET, V58, P498; BARNETT HJM, 1953, BRAIN, V76, P36, DOI 10.1093/brain/76.1.36; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; CARRIE AW, 1954, J NEUROSURG, V11, P173, DOI 10.3171/jns.1954.11.2.0173; CRIMMINS TJ, 1984, J NEUROSURG, V60, P179, DOI 10.3171/jns.1984.60.1.0179; DAVELLA D, 1984, J NEUROSURG, V61, P1129, DOI 10.3171/jns.1984.61.6.1129; DIROCCO C, 1981, ARCH NEUROL-CHICAGO, V38, P431, DOI 10.1001/archneur.1981.00510070065011; GETTELFINGER DM, 1977, ARCH NEUROL-CHICAGO, V34, P2, DOI 10.1001/archneur.1977.00500130022004; GOLDBERG AL, 1986, J COMPUT ASSIST TOMO, V10, P16, DOI 10.1097/00004728-198601000-00003; HANLEY DF, 1988, STROKE, V19, P903, DOI 10.1161/01.STR.19.7.903; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; HIGASHIDA R T, 1989, AJNR, V10, pS4; Holmes G, 1915, Br Med J, V2, P493; LAINE FJ, 1995, AM J ROENTGENOL, V164, P763, DOI 10.2214/ajr.164.3.7863913; MACCHI PJ, 1986, J COMPUT ASSIST TOMO, V10, P10, DOI 10.1097/00004728-198601000-00002; NUSSEL F, 1989, NEURORADIOLOGY, V31, P307; PERSSON L, 1990, NEUROSURGERY, V26, P117, DOI 10.1227/00006123-199001000-00016; PROVENZALE JM, 1994, J COMPUT ASSIST TOMO, V18, P719, DOI 10.1097/00004728-199409000-00007; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; SALVATI CA, 1990, HEADACHE, V30, P650, DOI 10.1111/j.1526-4610.1990.hed3010650.x; Satoh Hideki, 1993, Neurological Surgery, V21, P953; SCHELL CL, 1988, WESTERN J MED, V149, P304; STRINGER WL, 1983, NEUROSURGERY, V12, P95; TOVI F, 1991, J ORAL MAXIL SURG, V49, P303, DOI 10.1016/0278-2391(91)90227-D; TSAI FY, 1992, AM J NEURORADIOL, V13, P1137; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494; VOGL TJ, 1994, AM J ROENTGENOL, V162, P1191, DOI 10.2214/ajr.162.5.8166009; WANG PY, 1995, NEURORADIOLOGY, V37, P447; YEAKLEY JW, 1988, J NEUROSURG, V69, P867, DOI 10.3171/jns.1988.69.6.0867	29	21	21	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	JUL	1998	16	4					382	385		10.1016/S0735-6757(98)90134-6			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	101LH	WOS:000074870100014	9672457				2022-02-06	
J	Varney, NR; Bushnell, D				Varney, NR; Bushnell, D			NeuroSPECT findings in patients with posttraumatic anosmia: A quantitative analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED-HEAD-INJURY; TRAUMATIC BRAIN INJURY; SPECT	Objective: To investigate quantitative neuroSPECT findings, particularly from orbital frontal cortex, in patients rendered totally anosmic from head injury. Setting: Veterans Administration (VA) Medical Center. Subjects: Eighteen patients with head injury resulting in severe anosmia and five normal controls. Al 18 patients had sustained their head injuries at least 5 years prior to involvement in the study. Measures: Quantitative neuroSPECT (count density) from sagittal regions of interest (ROIs) ranging circumferentially from orbital frontal cortex to occipital pole. Results: Quantitative evaluation of neuroSPECT findings for anosmic patients as a group showed substantial orbital frontal hypoperfusion compared with controls, with 67% of individual anosmic patients showing orbital frontal hypoperfusion at a level two or more standard deviations below that of the worst control subject. By contrast, there were no between-group differences for five other ROIs (inferior frontal pole, superior frontal pole, posterior superior frontal lobe, the parasagittal region, and occipital pole), and individual abnormalities were infrequent in these areas. In addition, orbital frontal count was significantly correlated with ratings of outcome, the only ROI to have such a relationship Conclusions: Findings strongly suggest that posttraumatic anosmia and the neuropsychological deficits typically associated with posttraumatic anosmia are closely and specifically associated with hypoperfusion in orbital frontal cortex. The results also underscore the importance of posttraumatic anosmia as a clinical sign of orbital frontal damage, which is particularly important in patients with mild head injury who have normal computed tomography and magnetic resonance imaging scans.	Vet Adm Med Ctr, Psychol Serv 116B, Iowa City, IA 52246 USA; Univ Iowa, Coll Med, Dept Nucl Med, Iowa City, IA 52242 USA		Varney, NR (corresponding author), Vet Adm Med Ctr, Psychol Serv 116B, Iowa City, IA 52246 USA.			Bushnell, David/0000-0002-2768-396X			American Medical Association, 1993, GUID EV PERM IMP; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAY BG, 1992, J NUCL MED, V33, P52; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; Newberg AB, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199612000-00009; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; RICHARDSON ED, 1994, CLIN NEUROPSYCHOL, V8, P416, DOI 10.1080/13854049408402044; SUMNER D, 1976, HDB CLIN NEUROLOGY, V27; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Varney NR, 1996, ARCH CLIN NEUROPSYCH, V11, P345, DOI 10.1016/0887-6177(95)00015-1; VARNEY NR, 1989, IOWA COLLATERAL HEAD; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	17	21	21	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1998	13	3					63	72					10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZT046	WOS:000074042200006	9582179				2022-02-06	
J	Zhao, X; Newcomb, JK; Posmantur, RM; Wang, KKW; Pike, BR; Hayes, RL				Zhao, X; Newcomb, JK; Posmantur, RM; Wang, KKW; Pike, BR; Hayes, RL			pH dependency of mu-calpain and m-calpain activity assayed by casein zymography following traumatic brain injury in the rat	NEUROSCIENCE LETTERS			English	Article						calpain; traumatic brain injury; casein zymography; proteolysis	ACTIVATED NEUTRAL PROTEINASE; ENERGY PHOSPHATE-METABOLISM; MAGNETIC-RESONANCE; CALCIUM; FORMS	Studies employing casein zymographic assays analyzed the effects of varying pH (from pH 6.8 to pH 8.0) on changes in mu-calpain and m-calpain activity in naive, sham-injured and injured rat cortex 3 h following unilateral cortical impact injury. mu-Calpain activity following cortical impact injury was enhanced between pH values of 7.2 and 7.8, with pH 7.5 being optimal. m-Calpain activity was readily detected only between pH values of 7.2 and 7.4, with pH 7.3 producing the most prominent proteolytic activity. These observations suggest that strict control of pH is an important consideration in assessments of brain pH activation by casein zymography. Moreover, activation of different calpain isoforms, especially after traumatic brain injury, may be differentially influenced by smaller changes ir physiological pH than previously recognized. (C) 1998 Published by Elsevier Science Ireland Ltd.	Univ Texas, Hlth Sci Ctr, Vivian L Smith Ctr Neurol Res, Dept Neurosurg, Houston, TX 77030 USA; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Lab Neurobiochem, Dept Neurosci Therapeut, Ann Arbor, MI 48105 USA		Zhao, X (corresponding author), Univ Texas, Hlth Sci Ctr, Vivian L Smith Ctr Neurol Res, Dept Neurosurg, 6431 Fannin,Suite 7-154, Houston, TX 77030 USA.			Wang, Kevin/0000-0002-9343-6473			BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; DEROSBO NK, 1986, J NEUROCHEM, V47, P1007; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KMAPFL A, 1997, J NEUROTRAUM, V14, P121; MALIK MN, 1987, BIOCHIM BIOPHYS ACTA, V916, P135, DOI 10.1016/0167-4838(87)90220-2; MARMAROU A, 1992, J NEUROTRAUM, V9, P551; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; Michetti M, 1996, FEBS LETT, V392, P11, DOI 10.1016/0014-5793(96)00775-2; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NILSSON E, 1986, J NEUROCHEM, V47, P1086; NILSSON E, 1991, MOL CHEM NEUROPATHOL, V14, P99, DOI 10.1007/BF03159930; NILSSON P, 1993, J CEREB BLOOD FLOW M, V13, P185; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SAATMAN KE, 1996, J NEUROPATH EXP NEUR, V55, P852; SHAPIRA Y, 1989, Neurological Research, V11, P169; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; VITTO A, 1986, J NEUROCHEM, V47, P1039; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; YUEN PW, 1996, EXPERT OPIN INV DRUG, V5, P1291; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	36	21	21	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAY 8	1998	247	1					53	57		10.1016/S0304-3940(98)00219-5			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZP138	WOS:000073720200014	9637408				2022-02-06	
J	Tariq, M; Morais, C; Kishore, PN; Biary, N; Al Deeb, S; Al Moutaery, K				Tariq, M; Morais, C; Kishore, PN; Biary, N; Al Deeb, S; Al Moutaery, K			Neurological recovery in diabetic rats following spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						diabetes; electrophysiology; glutathione; oxidative stress; spinal cord injury; vitamin E	SOMATOSENSORY EVOKED-POTENTIALS; BLOOD-FLOW; LIPID-PEROXIDATION; EXTRACELLULAR CALCIUM; ALPHA-TOCOPHEROL; VITAMIN-E; METHYLPREDNISOLONE TREATMENT; CEREBRAL-ISCHEMIA; BIOCHEMICAL BASIS; SCIATIC-NERVE	This study was designed to assess the effect of spinal cord injury on neurobehavioral, electrophysiological, structural, and biochemical changes in normal and diabetic rats, Experimental diabetes was induced in Sprague-Dawley male rats (weighing 250-280 g) with streptozotocin (50 mg/kg IP). Eight weeks after the treatment with streptozotocin the animals were anaesthetized with chloral hydrate and laminectomy was performed at T 7-8 level leaving the dura intact. A compression plate (2.2 x 5.0 mm) loaded with a weight of 35 g was placed on the exposed spinal cord for 5 min, Postoperative neurological function was assessed using inclined plane test, modified Tarlov score, and vocal and sensory score daily for 10 days, Electrophysiological changes were assessed using somatosensory and corticomotor evoked-potentials, The animals were sacrificed at different time intervals and injured site of the spinal cord was analyzed for changes in vitamin E and glutathione levels (as markers of oxidative stress), Pathological changes in spinal cord were also studied using light microscopy, The data on neurobehavioral study clearly indicated that the compression of spinal cord produced highly significant neurological deficit and poor recovery in diabetic rats as compared to nondiabetic rats, Our histopathological and electrophysiological results also confirmed that diabetic animals are more susceptible to compressive spinal cord injury as compared to nondiabetic animals, A higher depletion of antioxidant defense markers (vitamin E and glutathione) was observed in diabetic rats as compared to nondiabetic rats, These results point toward the role of free radicals in poor recovery in diabetic rats following neurotrauma, Further studies are warranted to assess the neuroprotective potential of antioxidants to retard the secondary pathophysiological events following neurotrauma and to enhance the recovery.	Armed Forces Hosp, Dept Neurosurg, Riyadh 11159, Saudi Arabia; Armed Forces Hosp, Res Ctr, Riyadh 11159, Saudi Arabia		Tariq, M (corresponding author), Armed Forces Hosp, Dept Neurosurg, W-912,POB 7897, Riyadh 11159, Saudi Arabia.		Morais, Christudas/G-4412-2010; Morais, Christudas/G-3736-2016	Morais, Christudas/0000-0002-0862-418X			Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; ANDERSON DK, 1982, J NEUROSURG, V56, P106, DOI 10.3171/jns.1982.56.1.0106; ANDERSON DK, 1985, ANN EMERG MED, V14, P816, DOI 10.1016/S0196-0644(85)80064-0; ASBURY AK, 1988, NEW ENGL J MED, V319, P577, DOI 10.1056/NEJM198809013190909; BALENTINE JD, 1978, LAB INVEST, V39, P236; BALENTINE JD, 1985, NEUROLOGICAL SURG TR, P285; BASKIN DS, 1987, NEUROSURGERY, V20, P871, DOI 10.1227/00006123-198706000-00009; BLACK P, 1986, NEUROSURGERY, V19, P752, DOI 10.1227/00006123-198611000-00006; Braughler J M, 1985, Cent Nerv Syst Trauma, V2, P269; BRAUGHLER JM, 1983, J NEUROSURG, V59, P256, DOI 10.3171/jns.1983.59.2.0256; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; CALCUTT NA, 1991, J NEUROL SCI, V103, P116, DOI 10.1016/0022-510X(91)90294-H; CARSTEN RE, 1989, DIABETES, V38, P730, DOI 10.2337/diabetes.38.6.730; CLENDENON NR, 1978, J NEUROSURG, V49, P563, DOI 10.3171/jns.1978.49.4.0563; CRACCO J, 1984, ANN NEUROL, V15, P55, DOI 10.1002/ana.410150110; DELACRUZ JP, 1992, THROMB RES, V66, P277, DOI 10.1016/0049-3848(92)90278-I; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; DEMEPOULOS HB, 1980, ACTA PHYSL SCAND S, V492, P91; DEXTER DT, 1992, ANN NEUROL, V32, P591, DOI 10.1002/ana.410320420; DOLMAN CL, 1963, NEUROLOGY, V13, P135, DOI 10.1212/WNL.13.2.135; DYCK PJ, 1989, NEUROLOGY, V39, P111, DOI 10.1212/WNL.39.1.111; EKSTROM PAR, 1990, EXP NEUROL, V109, P200, DOI 10.1016/0014-4886(90)90074-3; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GREENBAUM D, 1964, BRAIN, V87, P201, DOI 10.1093/brain/87.2.201; GREENE DA, 1988, DIABETES, V37, P688, DOI 10.2337/diabetes.37.6.688; GREGERSEN G, 1968, J NEUROL NEUROSUR PS, V31, P175, DOI 10.1136/jnnp.31.2.175; Griggs DE, 1937, ARCH NEURO PSYCHIATR, V38, P564, DOI 10.1001/archneurpsyc.1937.02260210130009; GUPTA PR, 1981, NEUROLOGY, V31, P841, DOI 10.1212/WNL.31.7.841; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; HALL ED, 1987, P UPJOHN S OX FREE R, P92; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Hass W K, 1983, Neurol Clin, V1, P345; HOLTZ A, 1989, SURG NEUROL, V31, P350, DOI 10.1016/0090-3019(89)90066-9; HOLTZ A, 1990, NEUROSURGERY, V26, P952, DOI 10.1227/00006123-199006000-00005; HSU CY, 1985, J NEUROL SCI, V70, P275, DOI 10.1016/0022-510X(85)90169-8; HSU CY, 1986, J NEUROL SCI, V74, P289, DOI 10.1016/0022-510X(86)90114-0; HSU CY, 1988, J NEUROL SCI, V83, P55, DOI 10.1016/0022-510X(88)90019-6; IKATA T, 1989, SPINE, V14, P1096, DOI 10.1097/00007632-198910000-00012; ILDAN F, 1995, NEUROSURG REV, V18, P35, DOI 10.1007/BF00416476; JACOBS TP, 1987, STROKE, V18, P741, DOI 10.1161/01.STR.18.4.741; JONSSON HT, 1976, PROSTAGLANDINS, V11, P51, DOI 10.1016/0090-6980(76)90172-6; KAPPELLE AC, 1993, BRIT J PHARMACOL, V108, P780, DOI 10.1111/j.1476-5381.1993.tb12878.x; KARPEN CW, 1981, PROSTAGLANDINS, V22, P651, DOI 10.1016/0090-6980(81)90074-5; KIRSCH JR, 1979, STROKE, V10, P288, DOI 10.1161/01.STR.10.3.288; Kunisaki M, 1996, DIABETES, V45, pS117, DOI 10.2337/diab.45.3.S117; KURIHARA M, 1985, J NEUROSURG, V62, P743, DOI 10.3171/jns.1985.62.5.0743; LOW PA, 1991, DIABETES, V40, P873, DOI 10.2337/diabetes.40.7.873; LOWERY JM, 1990, DIABETES, V39, P1498, DOI 10.2337/diabetes.39.12.1498; MANGINO MJ, 1991, AM J PHYSIOL, V261, pF841, DOI 10.1152/ajprenal.1991.261.5.F841; MCCAY PB, 1989, ANN NY ACAD SCI, V570, P32; MILVY P, 1973, ANN NY ACAD SCI, V222, P1102, DOI 10.1111/j.1749-6632.1973.tb15327.x; MOORADIAN AD, 1988, ENDOCR REV, V9, P346, DOI 10.1210/edrv-9-3-346; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; NIELSEN ER, 1968, DIABETOLOGIA, V4, P34; NUKADA H, 1993, J NEUROL SCI, V119, P162, DOI 10.1016/0022-510X(93)90129-M; NUKADA H, 1986, DIABETES, V35, P1058, DOI 10.2337/diabetes.35.9.1058; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P467, DOI 10.1111/j.1600-0404.1988.tb03689.x; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P460, DOI 10.1111/j.1600-0404.1988.tb03688.x; OLSSON Y, 1968, PASTORAL REV GRAZIER'S REC, V3, P62; REDDY CC, 1982, LIFE SCI, V31, P571, DOI 10.1016/0024-3205(82)90486-6; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; RELKIN R, 1976, NEW YORK STATE J MED, V76, P281; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; RIVLIN AS, 1978, SURG NEUROL, V10, P39; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; SIEMKOWICZ E, 1978, ACTA NEUROL SCAND, V58, P1; SILBERBAUER K, 1979, NEW ENGL J MED, V300, P366; SLAGER UT, 1978, ARCH PATHOL LAB MED, V102, P467; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; SUBBIAH MTR, 1980, BIOCHEM MED METAB B, V23, P231, DOI 10.1016/0006-2944(80)90076-9; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; WALLACE MC, 1986, NEUROSURGERY, V18, P433; WOLTMAN HW, 1929, NEW ENGL J MED, V295, P1416; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667; Zochodne DW, 1996, DIABETES, V45, P627, DOI 10.2337/diabetes.45.5.627	85	21	23	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	1998	15	4					239	251		10.1089/neu.1998.15.239			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZF401	WOS:000072893800002	9555970				2022-02-06	
J	Hildebrandt, H; Zieger, A; Engel, A; Fritz, KW; Bussmann, B				Hildebrandt, H; Zieger, A; Engel, A; Fritz, KW; Bussmann, B			Differentiation of autonomic nervous activity in different stages of coma displayed by power spectrum analysis of heart rate variability	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Article						coma; autonomous nervous system; neuromonitoring; heart rate variability; spectral analysis	CARDIOVASCULAR CONTROL; PROBE	The analysis of heart rate (HR) variability offers a noninvasive method to investigate autonomic nervous system activity in comatose patients, We analyzed three components of the KR variability in a group of comatose patients: the low-frequency band (LF), representing mainly sympathetic influence, the mid-frequency band (MF), representing sympathetic and parasympathetic influence, and the high-frequency band (HF), representing the parasympathetic influence. A value for sympathovagal balance was defined as LF/HF and MF/HF ratio, Moreover, the skin conductance level (SCL) and the skin conductance resistance (SCR) variability were recorded, The patient group consisted of 22 patients with traumatic brain injuries. Coma depth was assessed by the Glacow Coma Scale and artifact-free HR, SCL, and SCR were measured 75 times in the patient group. The results documented a significant gain in sympathetic nervous system activity corresponding with the state of emerging from coma. This gain was most pronounced in the HF component of the HR and in the sympathovagal balance between LF/HF. The findings in SCL and SCR variability endorsed this result, It is concluded that emerging from coma is accompanied by an increasing influence of the sympathetic nervous system on HR control. This leads to a change in the sympathovagal balance, i.e., a reintegration of parasympathetic and sympathetic activity.	Univ Oldenburg, Programme Neuropsychol, D-26111 Oldenburg, Germany; Rehabil Unit, D-26111 Oldenburg, Germany; Nordwest Hosp Sanderbusch, Dept Anesthesiol, D-26452 Sande, Germany		Hildebrandt, H (corresponding author), Univ Oldenburg, Programme Neuropsychol, D-26111 Oldenburg, Germany.						AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ALCALAY M, 1991, NEUROSCI BIOBEHAV R, V15, P51, DOI 10.1016/S0149-7634(05)80091-0; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; BASAR E, 1985, INT J NEUROSCI, V26, P161; BESSER R, 1983, NEUROLOGIE PRAXIS KL, V1; DELETIS V, 1990, PHYS MED REHAB STATE, V4, P421; Freeman Edward, 1993, NEUROPSYCHOL REHABIL, V3, P139; Garcia A.L., 1994, NUMERICAL METHODS PH; GELSEMA AJ, 1985, PSYCHOPHYSIOLOGY CAR, P99; Hildebrandt H, 1996, EEG-EMG-Z ELEK ELEKT, V27, P126; JANIG W, 1987, PHYSL MENSCHEN, P349; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; LANGEWITZ W, 1991, HOMEOSTASIS HLTH DIS, V33, P23; LITSCHER G, 1994, EEG-EMG-Z ELEK ELEKT, V25, P200; LITSCHER G, 1994, MULTIVARIATE NICHT I; MIDDLETON HC, 1994, J PSYCHOPHARMACOL, V8, P1, DOI 10.1177/026988119400800101; MULDER G, 1981, PSYCHOPHYSIOLOGY, V18, P392, DOI 10.1111/j.1469-8986.1981.tb02470.x; MULDER LJM, 1992, BIOL PSYCHOL, V34, P205, DOI 10.1016/0301-0511(92)90016-N; PLUM F, 1993, ABNORMAL STATES BRAI, P29; PLUM F, 1974, DIAGNOSIS STUPOR COM; POECK K, 1992, NEUROLOGIE; Pruyn A. T. H., 1985, PSYCHOPHYSIOLOGY CAR, P365; TULEN JHM, 1994, PSYCHOPHARMACOLOGY, V114, P81, DOI 10.1007/BF02245447; VONCRAMON DY, 1984, UNKLARE BEWUSSTLOSIG, P3; ZHONG S, 1993, AM J PHYSIOL, V265, pR1026, DOI 10.1152/ajpregu.1993.265.5.R1026; ZIEGER A, 1997, FALLBUCH NEUROPSYCHO, P267; ZWIENER U, 1994, NEUROMONITORING ANAS, P17; [No title captured]	29	21	23	0	2	DR DIETRICH STEINKOPFF VERLAG	DARMSTADT	PLATZ DER DEUTSCHEN EINHEIT 25, D-64293 DARMSTADT, GERMANY	0940-1334			EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	FEB	1998	248	1					46	52		10.1007/s004060050016			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	ZF622	WOS:000072915500006	9561352				2022-02-06	
J	Moulton, RJ; Brown, JIM; Konasiewicz, SJ				Moulton, RJ; Brown, JIM; Konasiewicz, SJ			Monitoring severe head injury: a comparison of EEG and somatosensory evoked potentials	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							COMPRESSED SPECTRAL ARRAY; INTRACRANIAL-PRESSURE; PREDICTION; COMA	We report on our experience with long-term monitoring of the EEG power spectrum and somatosensory evoked potentials (SSEPs) in 103 patients with severe closed head injury (Glasgow Coma Scale - GCS less than or equal to 8). Patients were monitored for an average of 5 days post injury and monitoring was terminated when they died, regained consciousness or their intracranial physiologic parameters (primarily intracranial pressure - ICP) were stable for 2-3 days, Patients were treated according to a standard protocol that included mechanical ventilation, sedation, and neuromuscular blockade, At 7 of 9 twelve hour time intervals post injury, SSEPs were significantly (p < .05) different between outcome groups using the Glasgow Outcome Score collapsed to 3 categories. The percent slow (delta) activity in the EEG was not significantly different between outcome groups at any time point, post injury. The total power in the EEG power spectrum differed only at the last time epoch post injury (108 hr.). Based on the superior prognostic capabilities of the SSEP, we routinely base critical management decisions on SSEP values. We have not been able to rely on EEG parameters for these same decisions due to the lack of clear distinction between good and poor prognosis groups based on common EEG parameters.	St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1A6, Canada; Univ Toronto, Toronto, ON, Canada		Moulton, RJ (corresponding author), St Michaels Hosp, Div Neurosurg, 38 Shuter St, Toronto, ON M5B 1A6, Canada.						BICKFORD RG, 1977, DIDACTIC REV METHODS, P215; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Bruyn, 1975, HDB CLIN NEUROLOGY, V23, P317; GARCIALARREA L, 1992, J NEUROL NEUROSUR PS, V55, P792, DOI 10.1136/jnnp.55.9.792; HUTCHINSON DO, 1991, ELECTROEN CLIN NEURO, V78, P228, DOI 10.1016/0013-4694(91)90037-5; KARNAZE DS, 1982, NEUROLOGY, V32, P289, DOI 10.1212/WNL.32.3.289; KETY SS, 1945, AM J PHYSIOL, V143, P53, DOI 10.1152/ajplegacy.1945.143.1.53; KONASIEWICZ SJ, 1994, CAN J NEUROL SCI, V21, P219, DOI 10.1017/S0317167100041196; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; MOULTON R, 1991, J TRAUMA, V31, P676, DOI 10.1097/00005373-199105000-00012; MOULTON RJ, 1994, CAN J NEUROL SCI, V21, pS17, DOI 10.1017/S0084255900007567; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x	15	21	23	0	0	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	FEB	1998	25	1					S7	S11		10.1017/S031716710003465X			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YW720	WOS:000071965900018	9532290	Bronze			2022-02-06	
J	Turkstra, LS; Holland, AL				Turkstra, LS; Holland, AL			Assessment of syntax after adolescent brain injury: Effects of memory on test performance	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						adolescent; brain; injury; memory; language	CLOSED-HEAD-INJURY; SERIAL-ORDER MEMORY; WORKING-MEMORY; CHILDREN; CHILDHOOD; DISCOURSE; TUMORS; SKILLS	In this study, we investigated the influence of working memory load on performance of a task designed to measure receptive syntax ability Subjects were 6 brain-injured adolescents and 6 hospitalized control subjects matched for age, sex, and general ability Each subject was administered the Listening/Grammar subtest of the Test of Adolescent Language (TOAL-3) and a modified version of this subtest with identical syntax and fewer response choices [i.e., a reduced working memory processing and storage load). The syntactic structures tested on these tasks also were measured in spontaneous narratives. The brain-injured subjects' performance was significantly worse than that of controls on both versions of the syntax comprehension subtest. There was a significant group-by-task interaction, as brain-injured subjects' performance was significantly worse on the Listening/Grammar subtest than the modified subtest, whereas Control subjects' performance did not differ across the two tasks. In their spontaneous narratives, subjects in both groups produced the syntactic structures tested on the receptive syntax tasks, with no between-groups difference in syntax production. The results are discussed in terms of test validity and the impact of measurement methods on test performance in disordered groups.	Univ Arizona, Natl Ctr Neurogen Commun Disorders, Tucson, AZ 85721 USA		Turkstra, LS (corresponding author), Case Western Reserve Univ, Dept Commun Sci, 11206 Euclid Ave, Cleveland, OH 44106 USA.		Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P60DC001409] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-01409] Funding Source: Medline		Baddeley A. D., 1974, ADV RES THEOR, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; CASKEY WE, 1986, LANG SPEECH HEAR SER, V17, P307; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1991, NEUROPSYCHOLOGIA, V29, P829, DOI 10.1016/0028-3932(91)90050-I; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DENNIS M, 1992, NEUROPSYCHOLOGIA, V30, P257, DOI 10.1016/0028-3932(92)90004-6; Diller L, 1974, STUDIES COGNITION RE; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; GOLDMANRAKIC PS, 1988, BRAIN ORG MEMORY CEL; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Hammill D. D., 1994, TEST ADOLESCENT ADUL; JACOBSON MS, 1986, PEDIATRICS, V77, P236; JENNETT B, 1975, LANCET, V1, P480; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; LEVIN H, 1982, NEUROBEHAVIOR CONSEQ; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LIEBERMAN RJ, 1987, LANG SPEECH HEAR SER, V18, P250; LINEBARGER MC, 1983, COGNITION, V13, P391; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Newcomer P., 1988, TEST LANGUAGE DEV PR; Plante E, 1996, LANG SPEECH HEAR SER, V27, P99, DOI 10.1044/0161-1461.2702.99; RICHARDSON JTE, 1996, WORKING MEMORY HUMAN, P3; ROCHON E, 1994, BRAIN LANG, V46, P329, DOI 10.1006/brln.1994.1018; Sabers DL, 1996, LANG SPEECH HEAR SER, V27, P102, DOI 10.1044/0161-1461.2702.102; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Scott CherylM., 1988, LATER LANGUAGE DEV A, P49; SEMEL W, 1995, CLIN EVALUATION LANG; SHANKWEILER D, 1986, COGNITION, V24, P139, DOI 10.1016/0010-0277(86)90008-9; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; STEPHENS MI, 1985, TOP LANG DISORD, V5, P21, DOI 10.1097/00011363-198506000-00005; STINNETT TA, 1992, J PSYCHOEDUC ASSESS, V10, P161, DOI 10.1177/073428299201000209; Swanson H. L., 1995, SWANSON COGNITIVE PR; TURKSTRA L, 1997, EFFECT STIMULUS PRES; TURKSTRA L, 1997, WORKING MEMORY CELF; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Ylvisaker M., 1989, MILD MODERATE HEAD I, P203; [No title captured]	46	21	21	0	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1092-4388			J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	FEB	1998	41	1					137	149		10.1044/jslhr.4101.137			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	YW272	WOS:000071915700012	9493740				2022-02-06	
J	Castejon, OJ				Castejon, OJ			Electron microscopic analysis of cortical biopsies in patients with traumatic brain injuries and dysfunction of neurobehavioural system	JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY			English	Article						electron microscopy; neuron; neuroglial cells; brain trauma; neurobehavioural disorders	EDEMA; PATHOLOGY; DAMAGE; CAT	Cortical biopsies of eight patients with craniocerebral trauma complicated with subdural or epidural hematoma were examined with the transmission electron microscope. The patients showed posttraumatic neurobehavioural disorders and moderate or severe vasogenic brain edema. The capillary wall displayed increased vacuolar and vesicular endothelial transport, basement membrane thickening and vacuolization and swollen astrocytic end-feet. Pericapillary and parenchymatous hemorrhages were also observed. The extracellular space appeared considerably enlarged with presence of proteinaceous hematogenous edema fluid and fibrinous organization. Pyramidal and non-pyramidal neurons showed intracellular edema featured by irregular enlargement of rough endoplasmic reticulum, nuclear envelope and Golgi apparatus. The myelinated axons exhibited clear or black type axoplasmic degeneration, varicose fiber swelling, myelin sheath distortion, formation of myelin ovoids and increased amount of oligodendroglial ad-axonal layer. The dendrites also showed clear or dark and beaded shape degeneration. Synaptic degeneration was characterized by swollen and shrunken pre-and postsynaptic endings, clumping, enlargement and depletion of synaptic vesicles, synaptic membrane complex disassembly and detachment of glial ensheathment. Perivascular and perineuronal astrocytes appeared remarkably swollen. Phagocytic astrocytes were also found. Oligodendrocytes displayed hydropic and reactive changes. Reactive oligodendrocytes induced myelinolysis. The brain barrier dysfunction, the vasogenic and cytotoxic edema and the subsequent neuronal and neuroglial cell reactive and degeneration processes might represent the morphological substrate responsible for the post-traumatic neurobehavioural disorders.	Univ Zulia, Fac Med, Inst Invest Biol, Maracaibo 4011, Venezuela		Castejon, OJ (corresponding author), Univ Zulia, Fac Med, Inst Invest Biol, Apartado 526, Maracaibo 4011, Venezuela.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BAKAY L, 1965, CEREBRAL EDEMA, P12; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; BOWEN FP, 1968, ARCH NEUROL-CHICAGO, V19, P398, DOI 10.1001/archneur.1968.00480040064006; BRESNAHAN JC, 1996, SOC NEUR ABSTR, V2, P1185; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CASTEJON OJ, 1980, J NEUROPATH EXP NEUR, V39, P296, DOI 10.1097/00005072-198005000-00006; CASTEJON OJ, 1988, J SUBMICR CYTOL PATH, V20, P519; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P105; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P359; CASTEJON OJ, 1984, PATHOL RES PRACT, V179, P7, DOI 10.1016/S0344-0338(84)80054-0; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P601; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; CASTRO C, 1995, AGROCHIMICA, V39, P1; Choi Byung Ho, 1993, Yonsei Medical Journal, V34, P1; DANIEL DG, 1989, SCHIZOPHR RES, V2, P465, DOI 10.1016/0920-9964(89)90015-7; DICKSON LR, 1990, HOSP COMMUNITY PSYCH, V41, P290; DIEFENBACHER A, 1994, SCHWEIZ ARCH NEUROL, V5, P7; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FORMISANO R, 1991, ACTA NEUROCHIR, V109, P1, DOI 10.1007/BF01405688; Garcia J H, 1978, Adv Neurol, V20, P141; GILES GM, 1994, AM J OCCUP THER, V48, P247, DOI 10.5014/ajot.48.3.247; Hilton G, 1994, Orthop Nurs, V13, P25, DOI 10.1097/00006416-199407000-00006; HIRANO A, 1969, STRUCTURE FUNCTION N, V2, P69; ISACSON O, 1992, EXP NEUROL, V117, P151, DOI 10.1016/0014-4886(92)90123-8; Kimelberg Harold K., 1995, P919; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KIMELBERG HK, 1994, NEUROBIOLOGY CENTRAL, P193; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kryzhanovskii G. N., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P241; KUTKO II, 1988, ZH NEVROPATOL PSIKH, V88, P69; LAUTER H, 1991, ACTA PSYCHIAT SCAND, V83, P40, DOI 10.1111/j.1600-0447.1991.tb03108.x; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; LIM M, 1994, HUA HSI I KO TA SHUC, V25, P138; LOMBARDI G, 1993, J NEUROCHEM, V60, P1317, DOI 10.1111/j.1471-4159.1993.tb03292.x; LONG DM, 1966, J NEUROPATH EXP NEUR, V25, P373, DOI 10.1097/00005072-196607000-00003; LUSE SA, 1960, J NEUROSURG, V17, P439, DOI 10.3171/jns.1960.17.3.0439; MANZ HJ, 1974, HUM PATHOL, V5, P291, DOI 10.1016/S0046-8177(74)80113-9; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; Nillson P, 1963, CEREBR BLOOD FLOW ME, V13, P183; Norenberg M. D., 1996, Society for Neuroscience Abstracts, V22, P231; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; PERSSON LI, 1978, ACTA NEUROL SCAND, V57, P405; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; POVLISHOCK JT, 1980, CEREBRAL MICROVASCUL, V131, P227; PROMYALOV MSH, 1992, VORP MED KHIM, V37, P57; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SASAKI S, 1977, ACTA NEUROPATHOL, V40, P207, DOI 10.1007/BF00691955; Staub F, 1994, Anasthesiol Intensivmed Notfallmed Schmerzther, V29, P203, DOI 10.1055/s-2007-996719; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; TRANEL D, 1992, PSYCHIAT CLIN N AM, V15, P283; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; WILLMORE LJ, 1992, NEUROL CLIN, V10, P869, DOI 10.1016/S0733-8619(18)30184-1	59	21	21	0	2	NUOVA IMMAGINE EDITRICE	SIENA	VIA SAN QUIRICO 13, SIENA, 53100, ITALY	1122-9497			J SUBMICR CYTOL PATH	J. Submicrosc. Cytol. Pathol.	JAN	1998	30	1					145	156					12	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	ZC265	WOS:000072559500014	9530862				2022-02-06	
J	Clarke, KS				Clarke, KS			Epidemiology of athletic head injury	CLINICS IN SPORTS MEDICINE			English	Article								Although more common in collision sports, head injuries (for this article confined to cerebral neurotrauma) may occur in virtually any form of athletics. A few such injuries result in death, especially the second-impact syndrome and subdural hematoma. Tl-le more minor cerebral injuries, mostly concussions, have widespread misunderstanding in definition and severity. These misunderstandings in the field have contributed to a paucity of reliable epidemiological information about its actual frequency. The concerns accompanying cerebral insult a-re discussed. more than studied, but much can be gained in principle from the history of attention to concussions in football.	SLE Worldwide Inc, Risk Anal, Sun City, CA 92585 USA		Clarke, KS (corresponding author), SLE Worldwide Inc, Risk Anal, 27751 Calle Rabano, Sun City, CA 92585 USA.						BIASCA N, 1995, UNFALLCHIRURG, V98, P283; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Clarke K. S., 1977, P 2 NAT SPORTS SAF C, P41; CLARKE KS, 1979, MED SCI SPORT EXER, V11, P138; *COMM MED ASP SPOR, 1963, HEADS HELM TIPS ATHL, V5, P1; *CPSC DIR EP, 1990, CONSUMER PRODUCT SAF, V14, P7; Finvers KA, 1996, CLIN J SPORT MED, V6, P102, DOI 10.1097/00042752-199604000-00007; GERBERICH S, 1982, MINN MED         NOV, P691; Goldhaber Gerald M., 1993, Journal of Athletic Training, V28, P306; Henry P C, 1992, J Neurosci Nurs, V24, P311; MAROON JC, 1992, PHYSICIAN SPORTSMED, V20, P37, DOI 10.1080/00913847.1992.11710269; MUELLER F, 1996, ANN SURVEY FOOTBALL; SCHNEIDER R, 1965, CLIN NEUROSURG, V12, P226; *SUBC CLASS SPORTS, 1966, STAND NOM ATHL INJ, P20; 1962, JAMA, V180, P23	16	21	22	1	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	1998	17	1					1	+		10.1016/S0278-5919(05)70056-9			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YU153	WOS:000071687600002	9475966				2022-02-06	
J	Clarke, KS				Clarke, KS			Epidemiology of athletic neck injury	CLINICS IN SPORTS MEDICINE			English	Article							FOOTBALL	Neck injuries in sports are common, typically debilitating, and quite predictable in retrospect by mechanism of injury as to one of four natures-sprains/strains, fractures, brachial plexus pinches/stretches, and spinal cord injury.: Of these, the spinal cord injury, whether a concussion or contusion or physical disruption, is obviously the most severe and also, ironically, the best tracked because of its definition and notoriety when it is experienced. This article discusses the essence of what has been learned epidemiologically over recent decades since the advent of organized attention to spinal cord injuries among athletes.	SLE Worldwide Inc, Sun City, CA 92585 USA		Clarke, KS (corresponding author), SLE Worldwide Inc, 27751 Calle Rabano, Sun City, CA 92585 USA.						ADAMS J, 1993, NCAA FOOTBALL RULES; ALBRIGHT JP, 1976, JAMA-J AM MED ASSOC, V236, P1243, DOI 10.1001/jama.236.11.1243; *AM ALL HLTH PHYS, 1978, US TRAMP MIN PHYS ED; ASHARE A, 1996, AM HOCKEY MAGAZI JAN, P16; CHRISTENSEN C, 1983, 4 US GYMN SAF ASS; CLARKE K, 1979, MED SCI SPORTS EXERC, V10, P94; CLARKE K, 1983, SPORT RELATED PERMAN, P12; CLARKE K, 1980, SCI DIGEST       SUM, P16; CLARKE KS, 1966, J AMER MED ASSOC, V197, P894, DOI 10.1001/jama.197.11.894; CLARKE KS, 1979, MED SCI SPORT EXER, V11, P138; CLARKE KS, 1977, J SAFETY RES, V9, P140; Clarke KS, 1975, J SPORTS MED, V3, P292; *COMM ACC POIS PRE, 1997, TRAMP, P1; *COMM COMP SAF MED, 1978, US TRAMP DEV COMP SK, P2; *COMM MED ASP SPOR, 1963, HEADS HELM TIPS ATHL, V5, P1; *COMM MED ASP SPOR, 1963, SPEAR FOOTB TIPS ATH, V5, P1; Committee on Accident and Poison Prevention, 1981, PEDIATRICS, V67, P438; ELLIS WG, 1960, JAMA-J AM MED ASSOC, V174, P1673, DOI 10.1001/jama.1960.03030130001001; HAY J, 1974, SURVEY TRAMPOLINE IN, P27; HECK J, 1966, J ATHL TRAINING, V31, P31; MUELLER F, 1996, HUMAN KINETICS SPORT, V8, P114; MUELLER F, 1996, ANN SURVEY FOOTBALL; Nicely PG, 1978, AM J SPORTS MED, V6, P269; RAPP G, 1976, AM ORTH SOC SPORTS M; SCHIELDS C, 1978, PHYSICIAN SPORTSMED, V6, P71; SCHNEIDER R, 1965, CLIN NEUROSURG, V12, P226; Schneider RC., 1973, HEAD NECK INJURIES F; TATOR C H, 1986, Physician and Sportsmedicine, V14, P157; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; TORG JS, 1977, J AM COLL HEALTH ASS, V25, P224; TORG JS, 1984, PEDIATRICS, V74, P804; YOUNG J, 1980, SCI DIGEST       SUM, P45; Young JS, 1982, SPINAL CORD INJURY S, P1; 1962, JAMA, V180, P23	34	21	22	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	1998	17	1					83	+		10.1016/S0278-5919(05)70063-6			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YU153	WOS:000071687600009	9475973				2022-02-06	
J	AharonPeretz, J; Kliot, D; AmyelZvi, E; Tomer, R; Rakier, A; Feinsod, M				AharonPeretz, J; Kliot, D; AmyelZvi, E; Tomer, R; Rakier, A; Feinsod, M			Neurobehavioural consequences of closed head injury in the elderly	BRAIN INJURY			English	Article							TRAUMATIC COMA; ADULT; SCALE; AGE	The assessment of neurobehavioural outcome after head injury in older patients (> 60 year old) has met with difficulties, due to the obstacles in finding subjects who would constitute an appropriate control group. In the present study, survivors of closed head injury (CHI) of this age group were compared to two control groups: (I) orthopaedic patients (OF) who were injured in similar circumstances hut did not sustain head injury and (2) healthy, age-matched volunteers (HC). Compared with HC, CHI and OP were impaired on word fluency, memory and reasoning. No differences were found between CHI and the OF. These results may indicate that, rather than resulting only from the head injury brought about by falling, the cognitive decline may predate the injury and increase the risk of accidents in old age.	RAMBAM MED CTR,DEPT NEUROSURG,HAIFA,ISRAEL		AharonPeretz, J (corresponding author), RAMBAM MED CTR,COGNIT NEUROL UNIT,HAIFA,ISRAEL.		tomer, rachel/E-5747-2013				ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; *CENTR BUR STAT, 1991, STAT ABSTR ISR F 42; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1989, MILD MODERATE HEAD I, P153; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAZZUCCHI A, 1992, J NEUROL, V239, P256; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1974, WECHSLER MEMORY SCAL; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456	22	21	21	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1997	11	12					871	875					5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YG767	WOS:A1997YG76700003	9413621				2022-02-06	
J	Williams, JM				Williams, JM			The prediction of premorbid memory ability	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; WAIS-R; DEMOGRAPHIC-VARIABLES; IQ; SCALE; PERFORMANCE; DISCREPANCIES; INTELLIGENCE; EDUCATION; JUDGMENT	An estimation of premorbid memory ability is necessary for clinical judgments of memory status following brain injury of illness. This paper describes the nature of clinical reasoning about memory ability and intelligence. The analysis of these reasoning problems has progressed from the simple contrast of clinical versus actuarial models to a theory that integrates all such models as applications of reasoning under uncertainty. This is followed by the first empirical study of the estimation of premorbid memory ability from demographic variables. The results of this analysis clearly suggest that demographic variables predict memory scores at a low level (R = .45); this result stands in contrast to the higher predictive power of demographics when IQ is the criterion. Practical suggestions are then proposed for establishing an empirical basis for clinical judgments of premorbid memory ability. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.			Williams, JM (corresponding author), ALLEGHENY UNIV HLTH SCI,MAIL STOP 626,PHILADELPHIA,PA 19102, USA.						BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Cohen R. J., 1988, PSYCHOL TESTING; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P275, DOI 10.1111/j.2044-8260.1989.tb01377.x; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; DAWES RM, 1986, CLIN PSYCHOL REV, V6, P425, DOI 10.1016/0272-7358(86)90030-9; Dunn LM., 1981, PEABODY PICTURE VOCA; ELWOOD RW, 1991, CLIN NEUROPSYCHOL, V5, P329; ERICKSON RC, 1977, PSYCHOL BULL, V84, P1130, DOI 10.1037/0033-2909.84.6.1130; FIELDS FRJ, 1971, DIS NERV SYST, V32, P673; GOUVIER WD, 1983, CLIN NEUROPSYCHOLOGY, V5, P119; HALL JC, 1957, J CONSULT PSYCHOL, V21, P131, DOI DOI 10.1037/H0039695; HEILBRONNER RL, 1990, INT J CLIN NEUROPSYC, V12, P24; KAHNEMAN D, 1972, COGNITIVE PSYCHOL, V3, P430, DOI 10.1016/0010-0285(72)90016-3; KAREKEN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P147, DOI 10.1016/0887-6177(94)E0012-E; Kareken DA, 1994, PSYCHOL ASSESSMENT, V6, P83, DOI [10.1037/1040-3590.6.2.83, DOI 10.1037/1040-3590.6.2.83]; KARZMARK P, 1985, J CLIN EXP NEUROPSYC, V7, P412, DOI 10.1080/01688638508401273; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KLESGES RC, 1985, INT J CLIN NEUROPSYC, V7, P1; LARRABEE GJ, 1987, J CLIN EXP NEUROPSYC, V9, P456, DOI 10.1080/01688638708405065; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P351, DOI 10.1080/01688638408401227; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; MEEHL PE, 1954, CLIN VERSUS STATISTI; MEEHL PE, 1973, PSYCHODIAGNOSIS SELE; MORTENSEN EL, 1991, J CLIN EXP NEUROPSYC, V13, P361, DOI 10.1080/01688639108401050; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; OSCARBERMAN M, 1993, CLIN NEUROPSYCHOL, V7, P281, DOI 10.1080/13854049308401899; PRIFITERA A, 1985, J CONSULT CLIN PSYCH, V53, P564, DOI 10.1037/0022-006X.53.4.564; SOLOMON GS, 1986, J CLIN PSYCHOL, V42, P318, DOI 10.1002/1097-4679(198603)42:2<318::AID-JCLP2270420217>3.0.CO;2-3; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Tversky A, 1982, JUDGEMENT UNCERTAINT, P163, DOI 10.1017/cbo9780511809477.012; Wechsler, 1997, WECHSLER ADULT INTEL; Wedding D, 1991, Neuropsychol Rev, V2, P233, DOI 10.1007/BF01109046; Wedding D, 1989, Arch Clin Neuropsychol, V4, P233, DOI 10.1016/0887-6177(89)90016-4; Wilkinson, 1984, WIDE RANGE ACHIEVEME; WILLIAMS JM, 1992, MEMORY ASSESSMENT SC; WILLSHIRE D, 1991, J CLIN EXP NEUROPSYC, V13, P204, DOI 10.1080/01688639108401038; [No title captured], DOI DOI 10.1080/13854048808520093; [No title captured]	42	21	21	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	1997	12	8					745	756		10.1016/S0887-6177(97)00048-6			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YH876	WOS:A1997YH87600005	14590651	Bronze			2022-02-06	
J	Fugate, LP; Spacek, LA; Kresty, LA; Levy, CE; Johnson, JC; Mysiw, WJ				Fugate, LP; Spacek, LA; Kresty, LA; Levy, CE; Johnson, JC; Mysiw, WJ			Definition of agitation following traumatic brain injury .1. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED HEAD-INJURY; SCALE; ORIENTATION; PATIENT	Objective: To determine national patterns of defining agitation after traumatic brain injury (TBI) by physiatrists with expressed interest in treating TBI survivors. Design: A random sample of 70% of the members of the. Brain Injury Special Interest Group (SIG) of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) were surveyed by telephone. Results: The 129 members who responded yielded an 82% response rate. Respondents rated 18 characteristics from established rating scales on a 5-point scale according to each characteristic's relation to its clinical definition of agitation. Physical aggression, explosive anger, increased psychomotor activity, impulsivity, verbal aggression, disorganized thinking, perceptual disturbances, and reduced ability to maintain or appropriately shift attention were rated by at least 50% of the sample as very important or essential to agitation. Delirium, as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), has been proposed as a standard definition of agitation. The degree to which all characteristics from the 3rd revised edition of the DSM (DSM-IIIR), considered together, were perceived to relate to agitation predicted 24% of the degree to which the term ''delirium'' was perceived to relate to agitation (Canonical correlation r = .48, p = .0002). Physicians' ratings of individual delirium characteristics from the DSM-IIIR were examined to determine if a sufficient number were similarly ranked to fulfill the diagnostic criteria for delirium. A significant number of physicians rated diagnostic criteria for delirium in one direction, yet did not rank the term ''delirium'' accordingly (McNemar's p = .04). Conclusions: There is considerable variation among physiatrists in their rating of characteristics that define agitation. Many define agitation during the acute recovery phase as posttraumatic amnesia plus an excess of behavior such as aggression, disinhibition, and/or emotional lability. Less support was given to defining agitation by the DSM-IIIR or DSM-IV diagnostic criteria for delirium. Delirium appears related to, but is not sufficient for, a diagnosis of agitation. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	OHIO STATE UNIV,DEPT PREVENT MED,COLUMBUS,OH 43210; UNIV MISSOURI,MED INFORMAT GRP,COLUMBIA,MO		Fugate, LP (corresponding author), OHIO STATE UNIV,DEPT PHYS MED & REHABIL,1018 DODD HALL,480 W 9TH AVE,COLUMBUS,OH 43210, USA.		Mysiw, Walter/E-3724-2011; Levy, Carlos/AAN-7226-2020	Johnson, Jane/0000-0002-8825-5926	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32 HD07892-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD007892] Funding Source: NIH RePORTER		American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1996, RECOVERY TRAUMATIC B, P129; Dillman DA, 1978, MAIL TELEPHONE SURVE, V19; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MALKMUS D, 1980, REHABILITATION HEAD; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SANDEL ME, 1995, NEUROREHABILITATION, V5, P299, DOI 10.3233/NRE-1995-5404; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	18	21	21	1	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	1997	78	9					917	923		10.1016/S0003-9993(97)90050-2			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XV776	WOS:A1997XV77600001	9305261				2022-02-06	
J	Goodman, TA; Merkel, PA; Perlmutter, G; Doyle, MK; Krane, SM; Polisson, RP				Goodman, TA; Merkel, PA; Perlmutter, G; Doyle, MK; Krane, SM; Polisson, RP			Heterotopic ossification in the setting of neuromuscular blockade	ARTHRITIS AND RHEUMATISM			English	Article							BONE-FORMATION; MYOSITIS-OSSIFICANS; DISODIUM ETIDRONATE; PREVENTION; GROWTH; DIFFERENTIATION; INJURY	Objective, Heterotopic ossification (HO) is a disorder characterized by the formation of new bone in tissue that does not ossify under normal conditions, We report a series of 6 cases in which HO occurred in the setting of adult respiratory distress syndrome (ARDS). We wished to show that HO can occur after neuromuscular blockade and that these cases might provide additional evidence that HO is influenced by neural mechanisms, Methods, Cases of HO were selected from the consultation services at the Massachusetts General Hospital and the Brigham and Women's Hospital, Affected patients all had ARDS and had been treated vith a neuromuscular blocking agent. Patients with a history of stroke, burn, head trauma, spinal cord injury, or joint replacement were excluded from this study, Results. Heterotopic bone appeared around large joints in a pattern identical to that seen in patients with paralysis, traumatic brain injury, severe burns, or trauma, New bone formation was self-limited over a period of 1-2 years, Alkaline phosphatase and technetium bone scan were sensitive ways of detecting early disease and monitoring disease activity, Medical therapies had limited benefit, Surgical excision of mature new bone appeared to be the only definitive therapy. Conclusion. Neuromuscular blockade in the setting of ARDS appears to be an important risk factor for the development of HO, The similarity of these cases of HO occurring in patients with brain or spinal cord injury raises the possibility that neural mechanisms may be important in the pathogenesis of this disease. Whether the type of neuromuscular blocking agent and the duration of use are important determinants of disease severity remains to be determined.	BRIGHAM & WOMENS HOSP,BOSTON,MA 02115		Goodman, TA (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,ARTHRIT UNIT,BULFINCH 165,55 FRUIT ST,BOSTON,MA 02114, USA.						Brailsford J.F., 1948, RADIOLOGY BONES JOIN; BURING K, 1975, CLIN ORTHOP RELAT R, V110, P293; BUSCHBACHER R, 1992, AM J PHYS MED REHAB, V71, P86, DOI 10.1097/00002060-199204000-00005; BUSCHBACHER R, 1991, AM J PHYS MED REHAB, V70, P309; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; CLEMENTS NC, 1993, CHEST, V104, P1526, DOI 10.1378/chest.104.5.1526; COPE R, 1990, SOUTH MED J, V83, P1058, DOI 10.1097/00007611-199009000-00020; DEFLITCH CJ, 1993, RADIOLOGY, V188, P265, DOI 10.1148/radiology.188.1.8511309; EKELUND A, 1991, CLIN ORTHOP RELAT R, V263, P102; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; FINERMAN GAM, 1981, METAB BONE DIS RELAT, V3, P337, DOI 10.1016/0221-8747(81)90050-3; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V242, P169; GARLAND DE, 1983, CLIN ORTHOP RELAT R, V176, P197; GARLAND DE, 1991, CLIN ORTHOPAEDICS, V263, P13; GOLDBERG MA, 1977, ARCH INTERN MED, V137, P619, DOI 10.1001/archinte.137.5.619; JENSEN LL, 1988, AM J PHYS MED, V66, P351; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kjaersgaard-Andersen P., 1988, CLIN ORTHOP RELAT R, V234, P102; KJAERSGAARDANDE.P, 1991, CLIN ORTHOP RELAT R, V263, P78; LINDHOLM TS, 1987, SCAND J RHEUMATOL, V16, P33; MALONEY WJ, 1992, CLIN ORTHOPAEDICS, V280, P230; MICHELSSON JE, 1980, J BONE JOINT SURG AM, V62, P811, DOI 10.2106/00004623-198062050-00017; ORZEL JA, 1985, J NUCL MED, V26, P125; RIPAMONTI U, 1992, CRIT REV ORAL BIOL M, V3, P1, DOI 10.1177/10454411920030010101; ROSEN V, 1994, J BONE MINER RES, V9, P1759; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; SEEGENSCHMIEDT MH, 1993, RADIOLOGY, V188, P257, DOI 10.1148/radiology.188.1.8511308; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; STOVER SL, 1976, J BONE JOINT SURG AM, V58, P683, DOI 10.2106/00004623-197658050-00019; STOVER SL, 1991, CLIN ORTHOPAEDICS, V263, P71; SUZUKI Y, 1974, RADIOLOGY, V111, P663, DOI 10.1148/111.3.663; TANAKA T, 1977, RADIOLOGY, V123, P217, DOI 10.1148/123.1.217; URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220	35	21	21	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0004-3591			ARTHRITIS RHEUM	Arthritis Rheum.	SEP	1997	40	9					1619	1627		10.1002/art.1780400911			9	Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Rheumatology	XY539	WOS:A1997XY53900010	9324016				2022-02-06	
J	Rosenbluth, J; Schiff, R; Liang, WL; Menna, G; Young, W				Rosenbluth, J; Schiff, R; Liang, WL; Menna, G; Young, W			Xenotransplantation of transgenic oligodendrocyte-lineage cells into spinal cord-injured adult rats	EXPERIMENTAL NEUROLOGY			English	Article							TRANSPLANTED OLIGODENDROCYTES; SHIVERER MOUSE; REMYELINATION; AXONS; CAT; MIGRATION; LESION; TISSUE; BRAIN	Spinal cord trauma is associated not only with loss of nerve cells and fibers but also with damage to oligodendrocytes and demyelination. In order to assess the potential of transplanted oligodendrocyte-lineage cells to repair the demyelination that follows spinal cord injury, we have used donor glia derived from a transgenic mouse line containing the LacZ transgene under control of the myelin basic protein promoter (16). Glia derived from fetal or neonatal transgenic mice were injected into the spinal cords of immunosuppressed adult rats at the site of an experimental traumatic lesion 1-16 days after injury. Cells expressing LacZ were identified 15-18 days later in cryosections rostral and caudal to the transplant site, most conspicuously within white matter defects. Some of these cells within the dorsal columns gave rise to similar to 30- to 60-mu m processes, consistent with myelin segments, which are oriented parallel to the fiber tract. Glial transplantation may thus be a feasible means of replacing damaged host oligodendrocytes with donor oligodendrocyte-lineage cells capable of reforming myelin and potentially restoring function lost as a result of demyelination associated with spinal cord injury. (C) 1997 Academic Press.	NYU, SCH MED, RUSH INST REHABIL MED, DEPT PHYSIOL & NEUROSCI, NEW YORK, NY 10016 USA; NYU, SCH MED, DEPT NEUROSURG, NEW YORK, NY 10016 USA								BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BLAKEMORE WF, 1988, DEV NEUROSCI-BASEL, V10, P1, DOI 10.1159/000111949; BLAKEMORE WF, 1991, TRENDS NEUROSCI, V14, P323, DOI 10.1016/0166-2236(91)90155-N; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BLIGHT AR, 1983, NEUROSCIENCE, V10, P1471, DOI 10.1016/0306-4522(83)90128-8; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; BLIGHT AR, 1990, NEUROTRAUM, P87; BLIGHT AR, 1993, ADV NEUROL, V59, P91; CRANG AJ, 1991, GLIA, V4, P305, DOI 10.1002/glia.440040308; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; FRIEDRICH VL, 1993, J NEURAL TRANSP PLAS, V4, P139; GOUT O, 1988, NEUROSCI LETT, V87, P195, DOI 10.1016/0304-3940(88)90169-3; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; GUMPEL M, 1983, NEUROSCI LETT, V37, P307, DOI 10.1016/0304-3940(83)90449-4; HUANG PP, 1994, J NEUROTRAUM, V11, P547, DOI 10.1089/neu.1994.11.547; LACHAPELLE F, 1994, EUR J NEUROSCI, V6, P814, DOI 10.1111/j.1460-9568.1994.tb00992.x; REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302; ROSENBLUTH J, 1990, J NEUROCYTOL, V19, P718, DOI 10.1007/BF01188040; Rosenbluth J., 1996, P124, DOI 10.1017/CBO9780511570193.014; ROSENBLUTH J, 1995, J NEUROTRAUMA, V12, P972; ROSENBLUTH J, 1991, J NEUROCYTOL, V22, P967; Szuchet Sara, 1995, P23; TONTSCH U, 1994, P NATL ACAD SCI USA, V91, P11616, DOI 10.1073/pnas.91.24.11616; VIGNAIS L, 1993, INT J DEV NEUROSCI, V11, P603, DOI 10.1016/0736-5748(93)90049-J; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102	28	21	21	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	SEP	1997	147	1					172	182		10.1006/exnr.1997.6583			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XV981	WOS:A1997XV98100018	9294414				2022-02-06	
J	Castejon, OJ; Valero, C; Diaz, M				Castejon, OJ; Valero, C; Diaz, M			Light and electron microscope study of nerve cells in traumatic oedematous human cerebral cortex	BRAIN INJURY			English	Article							HUMAN-BRAIN EDEMA; PATHOLOGY; INJURY	The cerebral cortex of eight patients with complicated head and brain traumatic injuries has been examined with light and transmission electron microscopes. The neuronal and neuroglial cell bodies and their processes have been examined to study the changes induced by the brain injury and the associated vasogenic and cytotoxic, moderate or severe, brain oedema. Light microscopy study showed oedematous and ischaemic neurons and neuroglial cells in both moderate and severe oedema, and breakdown of the blood-brain barrier with perivascular and parenchymatous haemorrhagic loci. Astrocytes and oligodendrocytes exhibited oedematous and reactive changes. At the electron microscope level oedematous changes were found in intraneuronal and glial somatic compartment. Myelinated axons showed clear and dark degenerative features. Beaded dendrites and clear and dense synaptic degeneration were also found. The extracellular space appeared distended, with the presence of clear and electron-dense haematogenous oedema fluid and fibrinous organization. Phagocytosis of degenerated myelinated axons and synaptic endings by neuroglial cells and non-nervous invading cells were observed. The clinical evolution time of traumatic brain injuries was considered in relation to nerve cell degenerative features.	POLICIN MARACAIBO, MARACAIBO, VENEZUELA		Castejon, OJ (corresponding author), UNIV ZULIA, INST INVEST BIOL, FAC MED, APARTADO POSTAL NO 526, MARACAIBO 4011, VENEZUELA.						ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BAKAY L, 1965, CEREBRAL EDEMA, P1; Birbamer G, 1994, Acta Neurol (Napoli), V16, P114; BOWEN FP, 1968, ARCH NEUROL-CHICAGO, V19, P398, DOI 10.1001/archneur.1968.00480040064006; BRODKEY JA, 1995, J NEUROSURG, V82, P106, DOI 10.3171/jns.1995.82.1.0106; Cammermeyer J, 1972, STRUCTURE FUNCTION N, V6, P131; CASTEJON OJ, 1980, J NEUROPATH EXP NEUR, V39, P296, DOI 10.1097/00005072-198005000-00006; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P359; CASTEJON OJ, 1984, PATHOL RES PRACT, V179, P7, DOI 10.1016/S0344-0338(84)80054-0; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P601; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; CASTRO C, 1995, AGROCHIMICA, V39, P1; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Hardman J M, 1979, Adv Neurol, V22, P15; HIRANO A, 1969, STRUCTURE FUNCTION N, V11, P69; ISASSON O, 1992, EXPT NEUROLOGY, V177, P151; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kryzhanovskii G. N., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P241; KUSHI H, 1994, ACTA NEUROCHIR, P472; LIM M, 1994, HUA HSI I KO TA SHUC, V25, P138; LIM R, 1972, ARCH NEUROL-CHICAGO, V27, P314, DOI 10.1001/archneur.1972.00490160042006; LOMBARDI G, 1993, J NEUROCHEM, V60, P1317, DOI 10.1111/j.1471-4159.1993.tb03292.x; LONG DM, 1966, J NEUROPATH EXP NEUR, V25, P373, DOI 10.1097/00005072-196607000-00003; LUSE SA, 1960, J NEUROSURG, V17, P439, DOI 10.3171/jns.1960.17.3.0439; MANZ HJ, 1974, HUM PATHOL, V5, P291, DOI 10.1016/S0046-8177(74)80113-9; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; Nillson P, 1963, CEREBR BLOOD FLOW ME, V13, P183; Povlishock J T, 1980, Adv Exp Med Biol, V131, P227; Staub F, 1994, Anasthesiol Intensivmed Notfallmed Schmerzther, V29, P203, DOI 10.1055/s-2007-996719; Valsamis M P, 1994, Neurosurg Clin N Am, V5, P175; WAXMAN SG, 1988, CURRENT TISSUES NEUR, P3; WILLMORE LJ, 1992, NEUROL CLIN, V10, P869, DOI 10.1016/S0733-8619(18)30184-1	32	21	22	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	1997	11	5					363	388		10.1080/026990597123520			26	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WW455	WOS:A1997WW45500007	9146842				2022-02-06	
J	Suzuki, M; Nishina, M; Endo, M; Matsushita, K; Tetsuka, M; Shima, K; Okuyama, S				Suzuki, M; Nishina, M; Endo, M; Matsushita, K; Tetsuka, M; Shima, K; Okuyama, S			Decrease in cerebral free magnesium concentration following closed head injury and effects of VA-045 in rats	GENERAL PHARMACOLOGY			English	Article						closed head injury; free magnesium; VA-045; P-31-NMR; rat brain	FLUID-PERCUSSION MODEL; TRAUMATIC BRAIN INJURY; METABOLISM; TISSUES	1. We examined the alterations in cerebral free Mg2+ concentration in closed head in jury (CHI) in rats and the effects of VA-045, a novel apovincaminic acid derivative, on them with in vivo P-31-NMR. 2. Free Mg2+ decreased by about 30% within 20 min after head impact and, afterward, it gradually decreased further to reach about 60% of the control level after 3 hr. VA-045 inhibited the decrease. 3. In nonimpacted rats, VA-045 did not alter the free Mg2+ level. 4. The decrease in cerebral free Mg2+ following CHI may be a critical factor in the development of irreversible tissue injury, and VA-045 may prevent it. Copyright (C) 1997 Elsevier Science Inc.	SAITAMA MED SCH,DEPT MED ZOOL,MOROYAMA,SAITAMA 35004,JAPAN; NATL DEF MED COLL,DEPT NEUROSURG,TOKOROZAWA,SAITAMA 359,JAPAN; TAISHO PHARMACEUT CO LTD,MED RES LABS,OMIYA,SAITAMA 330,JAPAN		Suzuki, M (corresponding author), SAITAMA MED SCH,DEPT PHARMACOL,MOROYAMA,SAITAMA 35004,JAPAN.						DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GUPTA RK, 1984, ANNU REV BIOPHYS BIO, V13, P221; KAWASHIMA Y, 1993, J MED CHEM, V36, P815, DOI 10.1021/jm00059a004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; OKUYAMA S, 1993, LIFE SCI, V53, P273; PRICHARD JW, 1986, ANNU REV NEUROSCI, V9, P61; SEO Y, 1983, J BIOCHEM-TOKYO, V94, P729, DOI 10.1093/oxfordjournals.jbchem.a134413; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; VELOSO D, 1973, J BIOL CHEM, V248, P4811; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757	15	21	21	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0306-3623			GEN PHARMACOL	Gen. Pharmacol.	JAN	1997	28	1					119	121		10.1016/S0306-3623(96)00148-6			3	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	VZ130	WOS:A1997VZ13000019	9112087				2022-02-06	
J	Melot, C; Berre, C; Moraine, JJ; Kahn, RJ				Melot, C; Berre, C; Moraine, JJ; Kahn, RJ			Estimation of cerebral blood flow at bedside by continuous jugular thermodilution	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						nitrous oxide; cerebral blood flow; jugular blood flow; continuous thermodilution; cerebral vasoreactivity; carbon dioxide	TRAUMATIC BRAIN-LESIONS; ACUTE HEAD-INJURY; CARBON-DIOXIDE; COMATOSE PATIENTS; NITROUS-OXIDE; DOPPLER; VASOREACTIVITY; METABOLISM; VELOCITY; PRESSURE	The Kety-Schmidt technique can be regarded as the reference method for the measurement of cerebral blood flow (CBF). However, the method is somewhat cumbersome for routine use in the intensive care unit (ICU) at the bedside. The continuous thermodilution technique developed many years ago for the measurement of coronary sinus blood flow can be applied for the measurement of jugular blood now (JBF). However, the measurement of JBF by thermodilution has never been validated using the Kety-Schmidt reference method. We first validate the continuous thermodilution in vitro by comparison with a volumetric flow. The thermodilution method is accurate for flows between 50 and 900 ml min(-1) with a mean difference volumetric-thermodilution flow of -1 +/- 18 ml min(-1) (mean +/- SD), and precise with a coefficient of variability ranging between 1.21% and 2.50%. In vivo accuracy was assessed by comparing in 15 comatose patients CBF measured using the Kety-Schmidt (CBFKS) method and estimated from JBF measured by thermodilution (CBFTH) at four levels of arterial P(a)co(2) (25, 30, 35, and 40 mm Hg). The mean difference CBFKS - CBFTH is -0.9 +/- 3.6 ml min(-1) 100 g(-1). In vivo precision of the method was good, with a coefficient of variability of 4.1% in mean. We conclude that jugular continuous thermodilution technique is a reliable method for estimating CBF at the bedside. This technique allows repeated measurements jugular bulb blood sampling for brain metabolic studies.			Melot, C (corresponding author), ERASME UNIV HOSP,DEPT INTENS CARE,ROUTE LENNIK 808,B-1070 BRUSSELS,BELGIUM.		Moraine, Jean-Jacques/O-3364-2014	MELOT, Christian/0000-0002-6172-0330			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ALEXANDER SC, 1964, J APPL PHYSIOL, V19, P561, DOI 10.1152/jappl.1964.19.4.561; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; DEGUEVARA OL, 1987, J CHROMATOGR, V403, P350, DOI 10.1016/S0021-9673(00)96375-1; DOMINO KB, 1993, ANESTHESIOLOGY, V78, P91, DOI 10.1097/00000542-199301000-00014; Dumke PR, 1943, AM J PHYSIOL, V138, P0421, DOI 10.1152/ajplegacy.1943.138.3.421; Eckenhoff J E, 1966, Ann R Coll Surg Engl, V39, P67; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P497; EPSTEIN HM, 1970, ANESTHESIOLOGY, V32, P332, DOI 10.1097/00000542-197004000-00007; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; FRONEK A, 1960, CIRC RES, V8, P175, DOI 10.1161/01.RES.8.1.175; GANZ W, 1971, CIRCULATION, V44, P181, DOI 10.1161/01.CIR.44.2.181; JAKOBSEN M, 1989, J CEREBR BLOOD F MET, V9, P717, DOI 10.1038/jcbfm.1989.101; JENNETT B, 1975, LANCET, V1, P480; KETY SS, 1948, J BIOL CHEM, V173, P487; KETY SS, 1945, AM J PHYSIOL, V143, P53, DOI 10.1152/ajplegacy.1945.143.1.53; KETY SS, 1951, PHARMACOL REV, V3, P1; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KOZAM RL, 1970, J APPL PHYSIOL, V29, P593, DOI 10.1152/jappl.1970.29.5.593; LASSEN NA, 1965, CIRC RES, V26, P26; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MEYER JOHN S., 1963, TRANS AMER NEUROL ASSOC, V88, P78; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; POON CS, 1988, J APPL PHYSIOL, V64, P854, DOI 10.1152/jappl.1988.64.2.854; PROUGH DS, 1991, CRITICAL CARE STATE, P157; REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; SHARPLES PM, 1991, ARCH DIS CHILD, V66, P1326, DOI 10.1136/adc.66.11.1326; SHENKIN HA, 1948, ARCH NEURO PSYCHIATR, V60, P240, DOI 10.1001/archneurpsyc.1948.02310030021002; SIMONSON SG, 1995, CURR OPIN CRIT CARE, V1, P217; Spann W, 1965, Dtsch Z Gesamte Gerichtl Med, V56, P299, DOI 10.1007/BF00574453; SWENSON ER, 1994, AM J RESP CRIT CARE, V149, P1563, DOI 10.1164/ajrccm.149.6.8004314; TEASDALE G, 1974, LANCET, V2, P81; TOMINAGA S, 1976, STROKE, V7, P507, DOI 10.1161/01.STR.7.5.507; VANDERLINDEN J, 1991, J THORAC CARDIOV SUR, V102, P95; Waltz AG, 1970, STROKE, V1, P27, DOI 10.1161/01.STR.1.1.27; Wilson EM, 1970, STROKE, V1, P348, DOI 10.1161/01.STR.1.5.348; Wilson EM, 1972, STROKE, V3, P300, DOI 10.1161/01.STR.3.3.300; WINER BJ, 1971, STATISTICAL PRINCIPL, P514; YANG SP, 1995, J CEREBR BLOOD F MET, V15, P115, DOI 10.1038/jcbfm.1995.13; YOUNG WL, 1994, ANESTHESIA NEUROSURG, P17	49	21	21	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	1996	16	6					1263	1270		10.1097/00004647-199611000-00022			8	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	VP540	WOS:A1996VP54000022	8898700	Bronze			2022-02-06	
J	Barth, JT; Diamond, R; Errico, A				Barth, JT; Diamond, R; Errico, A			Mild head injury and post concussion syndrome: Does anyone really suffer?	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article; Proceedings Paper	Annual Spring Review Course and Meeting of the American-Medical-EEG-Association	FEB   24, 1996	CHARLESTON, SC	Amer Med EEG Assoc		concussion; mild head injury; mild traumatic brain injury; neuropsychological assessment; post concussion syndrome; psychosocial factors; recovery curves; shear-strain	BEHAVIORAL SEQUELAE; TOMOGRAPHY		UNIV VIRGINIA,DEPT PSYCHIAT MED,CHARLOTTESVILLE,VA 22901; HLTH S REHABIL HOSP,LARGO,FL								Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; GRONWALL D, 1974, LANCET, V2, P604; GRONWALL D, 1980, PSYCHOL EFFECTS CONC; Holbourn AHS, 1943, LANCET, V2, P438; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R. M., 1989, MILD HEAD INJURY, P176; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; SMITH RJ, HDB HUMAN BRAIN FUNC, V3; SYMONDS C, 1962, LANCET, V1, P1; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	23	21	21	0	1	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1996	27	4					183	186					4	Engineering, Biomedical; Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	XA211	WOS:A1996XA21100003	9465281				2022-02-06	
J	Clark, E				Clark, E			Children and adolescents with traumatic brain injury: Reintegration challenges in educational settings	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED-HEAD-INJURY; FOLLOW-UP; SEQUELAE; SEVERITY; DEFICITS; SCHOOL; COHORT	Changes in federal law have paved the way for students with traumatic brain injury (TBI) to receive special educational services. Although not all students with TBI need special education, many will need careful planning for reintegration into the classroom. The present article presents information about the range of services that need to be considered for these students and the problems that can affect students' academic and social functioning. Characteristics that distinguish this group of students from peers with special learning needs are highlighted and specific suggestions are made to help educators work more effectively with these students when they return to school. A case study is used to highlight the issues discussed.			Clark, E (corresponding author), UNIV UTAH,DEPT EDUC PSYCHOL,SCH PSYCHOL PROGRAM,327 MILTON BENNION HALL,SALT LAKE CITY,UT 84112, USA.						ANDERSON N, 1995, THESIS U UTAH SALT L; BAER R, 1992, ONE YEAR FOLLOW UP U; Begali V., 1992, HEAD INJURY CHILDREN; BIJUR PE, 1990, PEDIATRICS, V86, P337; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; CARNEY J, 1990, Pediatrician, V17, P222; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GOLDEN CJ, 1985, LURIANEBRASKA NEUROP; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KATSIYANNIS A, 1994, REM SPEC EDUC, V15, P319, DOI 10.1177/074193259401500507; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LANSER JB, 1988, HEADACHE, P176; LASH M, 1994, FAMILIES STUDENTS GE; Levin HS., 1982, NEUROBEHAVIORAL CONS; LONG CJ, 1992, HDB HEAD TRAUM A; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; MIRA MP, 1988, DIAGNOSTIQUE, V13, P174; MORGAN D, 1988, TEACHING BEHAV DISOR; MURPHY LL, 1994, TESTS PRINT, V4; PAPAS B, 1993, HEADLINES, V4, P2; Reitan R.M., 1993, HALSTEADREITAN NEURO; REYNOLDS CR, 1994, TESTS MEMORY LEARNIN; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; SAVAGE R, 1985, SURVEY TRAUMATICALLY; Savage R. C., 1994, ED DIMENSIONS ACQUIR; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SAVAGE RC, 1988, ED MANUAL WHAT ED NE; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; *USOE, 1993, GUID SERV STUD TRAUM; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; YLVISAKER M, 1989, J HEAD TRAUMA REHAB, V4, P51; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; ZASLER ND, 1991, NEUROREHABILITATION, V1, P29	51	21	21	0	4	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0022-2194			J LEARN DISABIL	J. Learn. Disabil.	SEP	1996	29	5					549	560		10.1177/002221949602900509			12	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	VJ057	WOS:A1996VJ05700009	8870524				2022-02-06	
J	Cornelius, CP; Altenmuller, E; Ehrenfeld, M				Cornelius, CP; Altenmuller, E; Ehrenfeld, M			The use of flash visual evoked potentials in the early diagnosis of suspected optic nerve lesions due to craniofacial trauma	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article							INJURY; FRACTURES	Craniofacial trauma encroaching on the orbital apex and optic canal can result in direct or indirect optic nerve lesions, leading to visual impairment or blindness, Early diagnosis of a visual loss and immediate therapy are generally considered crucial for a successful restoration of vision in indirect trauma. However, in comatose or sedated patients the assessment of optic nerve function by testing pupillary reactivity may be severely compromised or impossible because of tensely swollen eyelids, conjunctival oedema, concussion of the ciliary muscle or pharmacological effects, In the event that clinical ophthalmic examination, computer tomography or nuclear magnetic resonance scanning fail to clarify the state of the optic nerve, visual evoked potentials (VEPs) to flash stimulation appear to provide reliable information on function within the visual pathway, On this basis, treatment with corticosteroids and/or surgical decompression can be rapidly initiated, Our results in a preliminary patient series confirm the value of acutely monitored VEPs as an objective test of optic nerve function in cases of suspected optic nerve injury immediately after admission to the emergency care unit, The imaging techniques usually applied may be complemented by VEPs to show the functional significance of structural abnormalities found in the vicinity of the optic nerve.	UNIV TUBINGEN,DEPT NEUROL,D-72076 TUBINGEN,GERMANY		Cornelius, CP (corresponding author), UNIV TUBINGEN,KLIN KIEFER GESICHTSCHIRURG,DEPT MAXILLOFACIAL SURG,OSIANDERSTR 2-8,D-72076 TUBINGEN,GERMANY.						ALTENMULLER E, 1991, EEG-EMG-Z ELEK ELEKT, V22, P224; Altenmuller E, 1989, EVOZIERTE POTENTIALE, P279; BEHRENSBAUMANN W, 1979, KLIN MONATSBL AUGENH, V175, P584; BEUTHNER D, 1974, LARYNG RHINOL OTOL V, V53, P830; Brihaye J, 1981, CRANIAL NERVES; CELESIA GG, 1977, NEUROLOGY, V27, P637, DOI 10.1212/WNL.27.7.637; CLIFFORDJONES RE, 1980, J NEUROL SCI, V46, P239, DOI 10.1016/0022-510X(80)90082-9; Dumbach J, 1991, Fortschr Kiefer Gesichtschir, V36, P162; FEINSOD M, 1973, EUR NEUROL, V9, P56, DOI 10.1159/000114201; FEINSOD M, 1976, HEAD INJURIES, P95; Frenkel R E, 1987, Adv Ophthalmic Plast Reconstr Surg, V6, P71; FUKADO Y, 1981, CRANIAL NERVES, P125; HAMMER B, 1995, ORBITAL FRACTURES DI; HASSLER W, 1985, ACTA NEUROCHIR, V74, P87, DOI 10.1007/BF01418794; HOLT GR, 1983, OTOLARYNG HEAD NECK, V91, P276, DOI 10.1177/019459988309100313; KALLELA I, 1994, J CRANIO MAXILL SURG, V22, P220, DOI 10.1016/S1010-5182(05)80561-X; KLINE LB, 1984, NEUROSURGERY, V14, P756, DOI 10.1227/00006123-198406000-00021; LIPKIN AF, 1987, ARCH OTOLARYNGOL, V113, P81; MAHAPATRA AK, 1989, SURG NEUROL, V31, P339, DOI 10.1016/0090-3019(89)90064-5; NEUBAUER H, 1987, FORTSCHR KIEFER GESI, V32, P223; OBERTACKE U, 1986, UNFALLCHIRURG, V89, P132; ORD RA, 1981, BRIT J ORAL SURG, V19, P202, DOI 10.1016/0007-117X(81)90005-6; OSGUTHORPE JD, 1988, OTOLARYNG CLIN N AM, V21, P155; Perneczky A, 1993, ENDOSCOPIC ANATOMY N; RICE DH, 1993, ENDOSCOPIC PARANSAL; SAMII M, 1989, SURGERY SKULL BASE I; SCHRODER M, 1989, LARYNGO RHINO OTOL, V68, P534, DOI 10.1055/s-2007-998394; SHAKED A, 1982, ACTA NEUROCHIR, V62, P91, DOI 10.1007/BF01402214; SPOOR TC, 1990, AM J OPHTHALMOL, V110, P665, DOI 10.1016/S0002-9394(14)77065-5; STOLL W, 1988, J CRANIO MAXILL SURG, V16, P308, DOI 10.1016/S1010-5182(88)80068-4; WALSH FB, 1979, OCULAR TRAUMA; WIEGAND ME, 1989, ENDOSKOPISCHE CHIRUR; Wilhelm H., 1991, PUPILLENREAKTIONEN P; Zrenner E, 1989, PROG RETIN RES, V9, P427; [No title captured]	35	21	21	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF	0301-0503			J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	FEB	1996	24	1					1	11		10.1016/S1010-5182(96)80070-9			11	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	UE792	WOS:A1996UE79200001	8707935				2022-02-06	
J	Papaefthymiou, G; Oberbauer, R; Pendl, G				Papaefthymiou, G; Oberbauer, R; Pendl, G			Craniocerebral birth trauma caused by vacuum extraction: A case of growing skull fracture as a perinatal complication	CHILDS NERVOUS SYSTEM			English	Article						perinatal head trauma; growing skull fracture; head injury in infancy and childhood; vacuum extraction	CHILDREN	A case of growing skull fracture following birth trauma and caused by vacuum extraction is reported in order to emphasize the incidence of this peculiar head injury at the beginning of extrauterine life and to point out its relation to possible neuropsychological disturbances that may appear later in childhood. Delivery by vacuum extraction increases the incidence of perinatal injuries and consequently the incidence of neurological deficits in children. Neurosurgical repair is advocated as the appropriate treatment, with the aim not only of cosmetically correcting the lesion's typical subgaleal protuberance with cranioplasty, but also of performing a water-tight closure of the dura, enabling the cerebral cortex to ''fill in'' the intracerebral lesion. The surgical technique and gross pathology of the lesion are described together with radiological findings before and after surgery. Reports by other authors are reviewed in an attempt to identify the conditioning factors and pathological features of this traumatic injury to skull and brain in neonates and infants. The literature on cranial fractures associated with intracerebral lesions at this age shows a significant difference in recovery and outcome from that after similar lesions in older children.			Papaefthymiou, G (corresponding author), KARL FRANZENS UNIV GRAZ, UNIV KLIN NEUROCHIRURG, AUENBRUGGERPLATZ 29, A-8036 GRAZ, AUSTRIA.						ARSENI C, 1981, CHILD BRAIN, V8, P161; AVRAHAMI E, 1993, NEURORADIOLOGY, V35, P107, DOI 10.1007/BF00593964; BARKOVICH AJ, 1990, CONT NEUROIMAGING, V1, P64; Benaron D A, 1993, J Perinatol, V13, P228; Chiofalo N., 1986, HEAD INJURIES NEWBOR, P217; Choux M., 1986, HEAD INJURIES NEWBOR, P163; EBEN A, 1969, J NEUROSURG, V30, P446; HOPPEHIRSCH E, 1993, CRIT REV NEUROSURG, V3, P260; Hovind KH, 1986, HEAD INJURIES NEWBOR, P87; KINGSLEY D, 1978, J NEUROL NEUROSUR PS, V41, P312, DOI 10.1136/jnnp.41.4.312; LENDE RA, 1961, J NEUROSURG, V18, P479, DOI 10.3171/jns.1961.18.4.0479; RAIMONDI AJ, 1986, HEAD INJURIES NEWBOR, P141; RAMAMURTHI B, 1970, J NEUROSURG, V32, P427, DOI 10.3171/jns.1970.32.4.0427; Rifkinson-Mann Stephanie, 1993, Contemporary Neurosurgery, V15, P1; SCARFF TB, 1985, NEUROSURGERY, P1627; SCARFO GB, 1989, CHILD NERV SYST, V5, P163, DOI 10.1007/BF00272120; TANDON PN, 1987, ACTA NEUROCHIR, V88, P1, DOI 10.1007/BF01400508; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; Velardi F., 1986, HEAD INJURIES NEWBOR, P125	19	21	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	1996	12	2					117	120		10.1007/BF00819511			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	TW380	WOS:A1996TW38000017	8674080				2022-02-06	
J	Mesenge, C; Verrecchia, C; Allix, M; Boulu, RR; Plotkine, M				Mesenge, C; Verrecchia, C; Allix, M; Boulu, RR; Plotkine, M			Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors	JOURNAL OF NEUROTRAUMA			English	Article						head injury; L-NAME; nitric oxide; 7-nitro indazole; mice	FOCAL CEREBRAL-ISCHEMIA	This study investigates the effect of the NO synthase inhibitors, N-G-nitro L-arginine methyl ester (L-NAME) and 7-nitro indazole (7-NI), on the neurological deficit 24 h after a moderate closed head injury in mice. Low doses of L-NAME or 7-NI given soon after the injury significantly reduced the neurological deficit compared to the vehicle-treated group. L-Arginine (300 mg/kg) did not alter the neurological deficit, but reversed the protective effects of both L-NAME and 7-NI when given at the same time. Both L-NAME and 7-NI had dose-related effects. The neuroprotective effects of L-NAME and 7-NI occurred when the drugs were given 5, 30, or 60 min after brain injury, but not when treatment was begun 2 h after brain injury, suggesting a short therapeutic window for both drugs. These results suggest that NO synthesis by neuronal NO synthase plays an important role in the early neurotoxic cascade leading to neurological deficit following traumatic brain injury.			Mesenge, C (corresponding author), UNIV PARIS 05,PHARMACOL LAB,4 AVE OBSERV,F-75270 PARIS 06,FRANCE.		MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348			BABBEDGE RC, 1993, BRIT J PHARMACOL, V110, P225, DOI 10.1111/j.1476-5381.1993.tb13796.x; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BUISSON A, 1992, BRIT J PHARMACOL, V106, P766, DOI 10.1111/j.1476-5381.1992.tb14410.x; CARREAU A, 1994, EUR J PHARMACOL, V256, P241, DOI 10.1016/0014-2999(94)90549-5; DAWSON DA, 1994, CEREBROVAS BRAIN MET, V6, P299; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; Hall E.D., 1995, CENTRAL NERVOUS SYST, P213; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1994, NEUROCHEM RES, V19, P501, DOI 10.1007/BF00967330; IADECOLA C, 1994, J CEREBR BLOOD F MET, V14, P175, DOI 10.1038/jcbfm.1994.25; MACKENZIE GM, 1994, NEUROREPORT, V5, P1993, DOI 10.1097/00001756-199410000-00039; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123; ZHANG FY, 1995, J CEREBR BLOOD F MET, V15, P595, DOI 10.1038/jcbfm.1995.73	22	21	21	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1996	13	1					11	16		10.1089/neu.1996.13.11			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TW167	WOS:A1996TW16700002	8714858				2022-02-06	
J	KLONOFF, PS; LAGE, GA				KLONOFF, PS; LAGE, GA			SUICIDE IN PATIENTS WITH TRAUMATIC BRAIN INJURY - RISK AND PREVENTION	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						SUICIDE; TRAUMATIC BRAIN INJURY	HEAD-INJURY; IMPACT	Many patients sustaining traumatic brain injury (TBI) experience multiple deficits affecting cognition, personality, and physical independence. Often there is a dramatic and permanent change in work status, income, family life, support network, and quality of life. Clinical experience indicates that this can predispose patients to significant depressive reactions and increased risk of suicide. This article will describe clinical evaluation and treatment techniques that attempt to address suicide in TBI patients participating in an outpatient milieu-oriented rehabilitation program. Historical theories and research on suicide will be reviewed. Risk factors for TBI and their similarity to suicide will be explored. Preliminary clinical findings from a retrospective study of 111 TBI program participants will also be provided.			KLONOFF, PS (corresponding author), ST JOSEPHS HOSP,ADULT DAY HOSP NEUROL REHABIL,BARROW NEUROL INST,222 W THOMAS RD,PHOENIX,AZ 85013, USA.						BARRACLOUGH BM, 1987, ACTA PSYCHIAT SCAND, V76, P339, DOI 10.1111/j.1600-0447.1987.tb05616.x; Benson D.F., 1986, FRONTAL LOBES; BERMAN AL, 1991, ADOLESCENT SUICIDE A; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BOND MR, 1983, REHABILITATION HEAD; BOWLBY J, 1908, SECURE BASE; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN HN, 1987, COMPR PSYCHIAT, V28, P101, DOI 10.1016/0010-440X(87)90075-7; Farberow N. L., 1961, CRY HELP; GARLAND AF, 1993, AM PSYCHOL, V48, P169, DOI 10.1037/0003-066X.48.2.169; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; GOLDSTEIN LS, 1984, AM J PSYCHOTHER, V38, P392, DOI 10.1176/appi.psychotherapy.1984.38.3.392; HYDE MO, 1991, SUICIDE; Jourard Sidney M., 1971, TRANSPARENT SELF, V2nd; KLONOFF P, 1987, COMMUNITY REENTRY HE; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; KLONOFF PS, 1994, ANAL UNDERSTANDING P; Kohut H., 1972, PSYCHOANAL STUD C, V27, P360, DOI [DOI 10.1080/00797308.1972.11822721, 10.1080/00797308.1972.11822721]; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LITMAN RE, 1965, AM J PSYCHOTHER, V19, P570, DOI 10.1176/appi.psychotherapy.1965.19.4.570; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MACKENZIE TB, 1987, INT J PSYCHIAT MED, V17, P3; MALTSBERGER JT, 1986, SUICIDE RISK FORMULA; MARSHALL KA, 1980, SUICIDE LIFE-THREAT, V10, P29; Miller Alice.., 1990, YOUR OWN GOOD HIDDEN; NAUGLE RI, 1990, TRAUMATIC BRAIN INJU; OYEBODE F, 1986, BRIT J HOSP MED, V36, P104; Petzel S V, 1978, Adolesc Psychiatry, V6, P239; PIGATANO GP, 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; SADOWSKI C, 1993, J CONSULT CLIN PSYCH, V61, P121, DOI 10.1037/0022-006X.61.1.121; SCHNUR DB, 1985, J PSYCHIAT EDUC, V9, P127; SCHWABER EA, 1979, MAR STAFF PSYCH; SHAFFER D, 1988, J AM ACAD CHILD PSY, V27, P675, DOI 10.1097/00004583-198811000-00001; STEVENSON EK, 1972, DIS NERV SYST, V33, P112; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TABACKNICK ND, 1961, CRY HELP; TEFFT BM, 1977, ARCH GEN PSYCHIAT, V34, P1155; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WOLF E, 1988, SUICIDE; [No title captured]; [No title captured]	43	21	21	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1995	10	6					16	24		10.1097/00001199-199512000-00005			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ661	WOS:A1995TJ66100005					2022-02-06	
J	HIGH, WM; GORDON, WA; LEHMKUHL, LD; NEWTON, CN; VANDERGOOT, D; THOI, L; COURTNEY, L				HIGH, WM; GORDON, WA; LEHMKUHL, LD; NEWTON, CN; VANDERGOOT, D; THOI, L; COURTNEY, L			PRODUCTIVITY AND SERVICE UTILIZATION FOLLOWING TRAUMATIC BRAIN INJURY - RESULTS OF A SURVEY BY THE RSA REGIONAL TBI CENTERS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							REHABILITATION	Four regional TBI rehabilitation and prevention centers funded by the Rehabilitation Services Administration surveyed constituents concerning their participation in productive activities and the medical and rehabilitation services they had utilized within the preceding month. Analysis revealed that both productivity and service utilization were affected by geographical location, age at time of survey, educational level, gender, severity of injury, and time since injury. Persons who were most severely injured were more likely to be less productive and to utilize more services. The relationship between productivity and service utilization requires further systematic research.	INST REHABIL & RES,SW REG BRAIN INJURY REHABIL & PREVENT CTR,BRAIN INJURY RES CTR,HOUSTON,TX; MT SINAI SCH MED,DEPT PHYS MED & REHABIL,COMPREHENS REG TRAUMAT BRAIN INJURY REHABIL & PRE,NEW YORK,NY; CTR ESSENTIAL MANAGEMENT SERV,LONG ISL,NY		HIGH, WM (corresponding author), BAYLOR COLL MED,DEPT PHYS MED & REHABIL,HOUSTON,TX 77030, USA.						Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HANDLER B, 1993, AM REHABIL, V19, P29; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; LEHMKUHL LD, 1993, AM REHABIL, V19, P2; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MIKRUT SL, 1993, AM REHABIL, V19, P39; MURPHY L D, 1990, Brain Injury, V4, P95, DOI 10.3109/02699059009026153; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; SELLS J, 1993, AM REHABILITATION, V19, P6; SISK C, 1993, AM REHABIL, V19, P20; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1980, INT CLASS IMP DIS HA; YOUNG ME, 1993, AM REHABIL, V19, P33	22	21	21	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1995	10	4					64	80		10.1097/00001199-199508000-00007			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RN010	WOS:A1995RN01000007					2022-02-06	
J	REGAN, RF; PANTER, SS				REGAN, RF; PANTER, SS			TRAUMATIC NEURONAL INJURY IN CORTICAL CELL-CULTURE IS ATTENUATED BY 21-AMINOSTEROIDS	BRAIN RESEARCH			English	Article						CELL CULTURE; CEREBRAL CORTEX; EXCITOTOXICITY; FREE RADICAL; GLUTAMATE; HEAD TRAUMA; LIPID PEROXIDATION	SPINAL-CORD INJURY; INDUCED LIPID-PEROXIDATION; BRAIN INJURY; U74006F; ACID; METHYLPREDNISOLONE; ISCHEMIA; EDEMA; HEAD; RATS	The effect of the 21-aminosteroids U74500A and U74389F, alone and in combination with the NMDA receptor antagonist MK-801, on traumatic neuronal injury was quantitatively assessed in murine neocortical cell cultures. Consistent with prior observations, a mechanical insult to the culture monolayer resulted in widespread neuronal death over the following 24 h. Treatment with either U74500A or U74389F provided moderate protection, reducing neuronal death as measured by lactate dehydrogenase release by 25-50%. This effect was most consistent when these agents were preincubated for 2 h prior to injury. Combined treatment with a 21-aminosteroid plus the NMDA receptor antagonist MK-801 reduced injury more than either drug alone. Approximately 40% of the neuronal death occurring in the presence of MK-801 was blocked by concomitant treatment with 10 mu M U74500A or U74389F. These results suggest that free radicals may contribute to cell death in this in vitro model of traumatic neuronal injury.	UNIV CALIF SAN FRANCISCO,DEPT NEUROSURG,SAN FRANCISCO,CA 94143		REGAN, RF (corresponding author), THOMAS JEFFERSON UNIV,DIV EMERGENCY MED,1020 WALNUT ST,PHILADELPHIA,PA 19107, USA.						ANDERSON DK, 1988, J NEUROSURG, V69, P562, DOI 10.3171/jns.1988.69.4.0562; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; Dugan L. L., 1994, Society for Neuroscience Abstracts, V20, P1532; GOLDBERG M P, 1991, Neurology, V41, P390; HAGHIGHI SS, 1993, NEUROL RES, V15, P321; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; HALL ED, 1988, J NEUROSURG, V68, P462, DOI 10.3171/jns.1988.68.3.0462; HALL ED, 1982, J NEUROSURG, V57, P247, DOI 10.3171/jns.1982.57.2.0247; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Halliwell B., 1989, FREE RADICALS BIOL M, VSecond; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lynch J. J. Iii, 1992, Society for Neuroscience Abstracts, V18, P1453; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCKENNA R, 1991, ANAL BIOCHEM, V196, P443, DOI 10.1016/0003-2697(91)90492-C; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MURAD F, 1990, GOODMAN GILMANS PHAR, P774; PAZDERNIK TL, 1992, NEUROCHEM RES, V17, P11, DOI 10.1007/BF00966860; PIETRONIGRO DD, 1983, J NEUROCHEM, V41, P1072, DOI 10.1111/j.1471-4159.1983.tb09053.x; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Regan R. F., 1994, Society for Neuroscience Abstracts, V20, P192; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	33	21	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 5	1995	682	1-2					144	150		10.1016/0006-8993(95)00330-S			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RE222	WOS:A1995RE22200018	7552305				2022-02-06	
J	KISHI, Y; ROBINSON, RG; FORRESTER, AW				KISHI, Y; ROBINSON, RG; FORRESTER, AW			COMPARISON BETWEEN ACUTE AND DELAYED-ONSET MAJOR DEPRESSION AFTER SPINAL-CORD INJURY	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							TRAUMATIC BRAIN INJURY; STROKE PATIENTS; RAPHE NUCLEI; PROJECTIONS; STEM	Sixty patients with spinal cord injury were examined to assess major depression during the in-hospital period and at 3- and 6-month follow-up. Thirteen patients had depression during the initial in-hospital evaluation (acute onset depression) and eight had depression first diagnosed at either 3- or 6-month follow-up (delayed onset depression). Acute onset depression was related to the severity of impairment and premorbid history of psychiatric disorder, suggesting a psychological reaction to impairment or premorbid vulnerability as a possible mechanism for developing depression. Delayed onset depression was not related to severity of physical impairment but was associated with more rostral spinal injury, suggesting the possibility that neurophysiological response to injury more proximal to the brain may play a role in delayed onset depression. These data also suggest that the etiology and pathophysiology of these two types of depression may be different.	NIPPON MED COLL,DEPT NEUROPSYCHIAT,TOKYO,JAPAN; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205		KISHI, Y (corresponding author), UNIV IOWA,COLL MED,DEPT PSYCHIAT,200 HAWKINS DR,2887 JPP,IOWA CITY,IA 52242, USA.		Robinson, Robert/AAF-6191-2021; Kishi, Yasuhiro/T-4047-2019		NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 40355, MH 00163] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH040355] Funding Source: NIH RePORTER		BOWKER RM, 1983, BRAIN RES, V288, P33, DOI 10.1016/0006-8993(83)90079-3; Claus-Walker J, 1972, Paraplegia, V10, P142; CLAUSWALKER J, 1982, ARCH PHYS MED REHAB, V63, P628; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; CULPEPPERMORGAN JA, 1992, METABOLISM, V41, P578, DOI 10.1016/0026-0495(92)90048-F; DAVIDSON J, 1986, BRIT J PSYCHIAT, V148, P442, DOI 10.1192/bjp.148.4.442; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORRESTER AW, 1992, INT J PSYCHIAT MED, V22, P33, DOI 10.2190/CJ9D-32C2-8CM7-FT3D; FRANK RG, 1988, AM J PHYS MED REHAB, V67, P128, DOI 10.1097/00002060-198806000-00008; FRANK RG, 1985, AM J PSYCHIAT, V142, P252; FULLERTON DT, 1981, ARCH GEN PSYCHIAT, V38, P1361; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; HOLSTEGE JC, 1987, NEUROSCIENCE, V23, P809, DOI 10.1016/0306-4522(87)90160-6; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JUDD FK, 1989, BRIT J PSYCHIAT, V154, P668, DOI 10.1192/bjp.154.5.668; KAZAKOV VN, 1993, NEUROSCIENCE, V56, P157, DOI 10.1016/0306-4522(93)90570-6; KISHI Y, 1994, J NEUROPSYCH CLIN N, V6, P237; LEICHNETZ GR, 1978, NEUROSCI LETT, V8, P119, DOI 10.1016/0304-3940(78)90184-2; MCDANIEL JW, 1971, HORMONAL BEHAV, V2, P56; MORRIS PLP, 1990, INT J PSYCHIAT MED, V20, P349, DOI 10.2190/N8VU-6LWU-FLJN-XQKV; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; ROBINSON RG, 1981, BRAIN LANG, V14, P282, DOI 10.1016/0093-934X(81)90080-8; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; Starr L B, 1982, Soc Work Res Abstr, V18, P28; TOHYAMA M, 1979, BRAIN RES, V176, P215, DOI 10.1016/0006-8993(79)90980-6; TWIST DJ, 1992, AM J PHYS MED REHAB, V71, P156, DOI 10.1097/00002060-199206000-00006; Wing J. K., 1974, MEASUREMENT CLASSIFI; WOODRICH F, 1983, J REHABIL, V49, P26	32	21	21	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	MAY	1995	183	5					286	292		10.1097/00005053-199505000-00002			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	QY286	WOS:A1995QY28600002	7745381				2022-02-06	
J	GOLDSTEIN, FC; LEVIN, HS				GOLDSTEIN, FC; LEVIN, HS			NEUROBEHAVIORAL OUTCOME OF TRAUMATIC BRAIN INJURY IN OLDER ADULTS - INITIAL FINDINGS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						GERIATRICS; NEUROBEHAVIORAL OUTCOME; TRAUMATIC BRAIN INJURY	CLOSED HEAD-INJURY; ALZHEIMERS-DISEASE; ELDERLY PERSONS; RISK-FACTORS; FOLLOW-UP; COMMUNITY; RELATIVES; SURVIVAL; RECOVERY; DEMENTIA	This article examines the outcome of traumatic brain injury (TBI) in adults 50 years and older. The literature concerning prognostic variables such as age and severity of injury is reviewed in relation to mortality and morbidity. Research is then presented on the cognitive and behavioral sequelae identified by the authors in their two-center study. Findings on the early stages of recovery indicate that older adults display impairments in attention, memory, language, and executive processing. Moreover, family members observe changes involving cognition, mood, and social functioning. It is concluded that although TBI poses a significant problem for older adults, little systematic data have been collected focusing on their sequelae, recovery patterns, and rehabilitation needs. The neurobehavioral outcome of TBI in this subpopulation deserves extensive study because of injury and extra-injury differences such as pathophysiology, medical comorbidities, and psychosocial supports that differentiate these patients from young survivors.	UNIV MARYLAND,SCH MED,DIV NEUROL SURG,BALTIMORE,MD 21201		GOLDSTEIN, FC (corresponding author), EMORY UNIV,SCH MED,DEPT NEUROL,NEUROBEHAV PROGRAM,WESLEY WOODS GERIATR REHABI,ATLANTA,GA, USA.						ADAMS JH, 1982, J CLIN PATHOL, V33, P1132; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AMACHER AL, 1987, NEUROSURGERY, V20, P954; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BOLLOK I, 1983, NEUROPEPTIDES, V3, P263; BROOKS N, 1984, CLOSED HEAD INJURY P; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; DAVIS CS, 1988, J AM GERIATR SOC, V36, P225, DOI 10.1111/j.1532-5415.1988.tb01805.x; DELIS DC, 1988, COMMUNICATION; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; GOODMAN H, 1992, PHYSICAL MED REHABIL; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GRONWALL D, 1975, LANCET, V2, P995; Gustafson L, 1990, Adv Neurol, V51, P65; Hamsher K., 1989, MULTILINGUAL APHASIA; HANNAY HJ, 1988, CONTINUOUS RECOGNITI; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JENNETT B, 1975, LANCET, V1, P480; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; KRAUS JF, 1987, HEAD INJURY; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P667; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MAZZUCCHI A, 1992, J NEUROL, V239, P256; MILLER BL, 1991, NEUROLOGY, V41, P1374, DOI 10.1212/WNL.41.9.1374; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Ross A M, 1992, J Neurosci Nurs, V24, P88; ROY CW, 1986, INJURY, V17, P220, DOI 10.1016/0020-1383(86)90222-6; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; SCHWARTZ GE, 1983, PSYCHOL REP, V53, P479, DOI 10.2466/pr0.1983.53.2.479; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; VOLLMER DG, 1991, J NEUROSURG S, pS37; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; YSEVAGE JA, 1983, J PSYCHIAT RES, V17, P37	63	21	21	0	6	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1995	10	1					57	73		10.1097/00001199-199502000-00007			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QF163	WOS:A1995QF16300006					2022-02-06	
S	Myseros, JS; Bullock, R		Trembly, B; Slikker, W		Myseros, JS; Bullock, R			The rationale for glutamate antagonists in the treatment of traumatic brain injury	NEUROPROTECTIVE AGENTS: CLINICAL AND EXPERIMENTAL ASPECTS	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	2nd International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	JUL 31-AUG 03, 1994	LAKE GEORGE, NY	FDA, Natl Ctr Toxicol Res, Jefferson, Arkansas, Dept Vet Affairs Med Ctr, Togus, Maine			ACUTE SUBDURAL-HEMATOMA; CEREBRAL-ARTERY OCCLUSION; ISCHEMIC NEURONAL DAMAGE; RAT-BRAIN; GLUCOSE-UTILIZATION; BLOOD-FLOW; RECEPTORS; PATHOLOGY; BLOCKADE; RELEASE				Myseros, JS (corresponding author), DIV NEUROSURG,MCV STN,BOX 980631,RICHMOND,VA 23298, USA.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BECKER DP, 1989, J CEREB BLOOD FLO S1, V9, pS302; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; BULLOCK R, 1991, J CEREB BLOOD FLO S2, V11, pS109; BULLOCK R, 1990, VINKEN BRUYNS HDB CL, V24, P249; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; CHAPMAN A, 1990, EXCITATORY AMINO ACI, P265; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENTLEMAN D, 1981, LANCET, V2, P853; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; INGLIS FM, 1990, 8TH P INT S BRAIN OE, P277; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, J NEUROSURG, V76, P944; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; MELDRUM B, 1992, P OFFICIAL SATELLITE, P15; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; NEHLS DG, 1990, BRAIN RES, V511, P271, DOI 10.1016/0006-8993(90)90172-8; PINARD E, 1992, P OFFICIAL SATELLITE, P93; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; Smith D.H., 1991, J CEREB BLOOD FLO S2, V11, pS300; SMITH DH, 1990, SOC NEUR ABSTR, V2, P779; SMITH DH, 1990, FASEB J, V4, P773; SMITH JA, 1991, J MED ETHICS, V17, P167, DOI 10.1136/jme.17.3.167; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; TAKIZAWA S, 1991, J CEREBR BLOOD F MET, V11, P786, DOI 10.1038/jcbfm.1991.136; WALLACE MC, 1992, J NEUROSURG, V76, P127, DOI 10.3171/jns.1992.76.1.0127	44	21	21	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021	0077-8923		0-89766-945-2	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1995	765						262	271		10.1111/j.1749-6632.1995.tb16583.x			10	Neurosciences; Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	BE39D	WOS:A1995BE39D00022	7486612				2022-02-06	
J	SUN, FY; FADEN, AI				SUN, FY; FADEN, AI			N-METHYL-D-ASPARTATE RECEPTORS MEDIATE POSTTRAUMATIC INCREASES OF PROTEIN-KINASE-C IN RAT-BRAIN	BRAIN RESEARCH			English	Article						TRAUMATIC BRAIN INJURY; PROTEIN KINASE C; PHORBOL ESTER; NMDA RECEPTOR; MK-801; BRAIN	H-3 PHORBOL 12,13-DIBUTYRATE; EXCITATORY AMINO-ACIDS; SPINAL-CORD INJURY; FOREBRAIN ISCHEMIA; NEURONAL DAMAGE; AUTORADIOGRAPHIC ANALYSIS; BINDING; HIPPOCAMPUS; MK-801; ESTERS	Male Sprague-Dawley rats were subjected to traumatic brain injury (TBI) using a lateral fluid percussion-induced injury model. Effects of varying severities of TBI (mild = 1.1 +/- 0.1 atm; moderate = 2.2 +/- 0.2 atm; severe = 2.9 +/- 0.1 atm) on the levels of protein kinase C in rat cerebral cortex and hippocampus were investigated by quantitative autoradiography using [H-3]phorboldibutyrate ester ([H-3]PDBu) binding as a marker. Binding of [H-3]PDBu in the cerebral cortex and hippocampus was increased bilaterally following TBI, with changes related to injury severity. Significant increases were observed in hippocampus of injured animals, as compared to sham-operated controls, at 1 h after trauma. Maximum levels of binding in both cerebral cortex and hippocampus were reached by 3 h, with a return to control levels at 6 h and 72 h, respectively. Treatment with MK-801 (1 mg/kg, i.v.) administered 15 min before trauma prevented the injury-induced increase of [H-3]PDBu binding in hippocampus and cerebral cortex. These results demonstrate that TBI induces bilateral, time-dependent increases of protein kinase C in the hippocampus and cerebral cortex that are related to injury severity. Changes are mediated by actions at NMDA receptors, probably reflecting post-traumatic release of glutamate.	GEORGETOWN UNIV, MED CTR, SCH MED, DEPT NEUROL, WASHINGTON, DC 20007 USA; GEORGETOWN UNIV, SCH MED, DEPT PHARMACOL, WASHINGTON, DC 20007 USA						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027849] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01/NS27849] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR306634] Funding Source: Medline		ALBERS GW, 1989, ANN NEUROL, V25, P398, DOI 10.1002/ana.410250412; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BUCHAN A, 1990, J NEUROSCI, V10, P311; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; CARDELL M, 1990, NEUROSCI LETT, V119, P228, DOI 10.1016/0304-3940(90)90840-6; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; DAG KJE, 1993, EUR J PHARMACOL, V233, P95; DOMANSKAJANIK K, 1992, J NEUROCHEM, V58, P1432, DOI 10.1111/j.1471-4159.1992.tb11360.x; DRIEDGER PE, 1980, P NATL ACAD SCI-BIOL, V77, P567, DOI 10.1073/pnas.77.1.567; ETOH S, 1991, NEUROSCI LETT, V126, P119, DOI 10.1016/0304-3940(91)90533-Y; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; HARA H, 1990, J CEREBR BLOOD F MET, V10, P646, DOI 10.1038/jcbfm.1990.117; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HORSBURGH K, 1993, NEUROSCI LETT, V151, P166, DOI 10.1016/0304-3940(93)90012-A; HSU L, 1985, NEUROSCI LETT, V62, P283, DOI 10.1016/0304-3940(85)90369-6; JORGENSEN MB, 1989, NEUROSCI LETT, V103, P219, DOI 10.1016/0304-3940(89)90579-X; KACZMAREK LK, 1987, TRENDS NEUROSCI, V10, P30, DOI 10.1016/0166-2236(87)90122-6; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANEV H, 1992, FIDIA RES F S SERIES, V9, P103; MATTSON MP, 1991, EXP NEUROL, V112, P95, DOI 10.1016/0014-4886(91)90118-V; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCINTOSH TK, 1992, FIDIA RES F S SERIES, V9, P247; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; Montz H P, 1985, Brain Res, V355, P150; MURASE K, 1993, NEUROSCI LETT, V149, P229, DOI 10.1016/0304-3940(93)90778-J; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NISHIZUKA Y, 1991, PROG BRAIN RES, V89, P125; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ONODERA H, 1989, BRAIN RES, V481, P1, DOI 10.1016/0006-8993(89)90478-2; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PARENT A, 1993, BRAIN RES, V607, P23, DOI 10.1016/0006-8993(93)91485-B; SAITO N, 1988, J NEUROSCI, V8, P369; SHOYAB M, 1980, NATURE, V288, P451, DOI 10.1038/288451a0; SIMON W, 1992, CLASSICAL QUANT GRAV, V9, P241, DOI 10.1088/0264-9381/9/1/022; TANAKA K, 1992, EXP NEUROL, V117, P254, DOI 10.1016/0014-4886(92)90134-C; VACCARINO F, 1987, P NATL ACAD SCI USA, V84, P8707, DOI 10.1073/pnas.84.23.8707; VACCARINO FM, 1991, J NEUROCHEM, V57, P391, DOI 10.1111/j.1471-4159.1991.tb03765.x; WIELOCH T, 1991, J NEUROCHEM, V56, P1227, DOI 10.1111/j.1471-4159.1991.tb11415.x; WORLEY PF, 1986, J NEUROSCI, V6, P199; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; YOKOTA M, 1992, BRAIN RES, V587, P123, DOI 10.1016/0006-8993(92)91436-I	51	21	21	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 24	1994	661	1-2					63	69		10.1016/0006-8993(94)91181-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PM463	WOS:A1994PM46300009	7834386				2022-02-06	
J	YAMAKI, T; MURAKAMI, N; IWAMOTO, Y; YOSHINO, E; NAKAGAWA, Y; UEDA, S; HORIKAWA, J; TSUJII, T				YAMAKI, T; MURAKAMI, N; IWAMOTO, Y; YOSHINO, E; NAKAGAWA, Y; UEDA, S; HORIKAWA, J; TSUJII, T			A MODIFIED FLUID PERCUSSION DEVICE	JOURNAL OF NEUROTRAUMA			English	Article							DIFFUSE AXONAL INJURY; BRAIN INJURY; HEAD-INJURY; MODEL; RAT; CAT; CONCUSSION	This report examines a modified fluid percussion device with specific improvements made to address deficiencies found in previously reported devices. These improvements include the use of a cylindrical saline reservoir made of stainless steel, placement of the reservoir in a 15-degree head-up position for the easy release of air bubbles, placement of the fluid flushing outlet and the pressure transducer close to the piston on the same plane, with both perpendicular to the direction of the piston, an adjustable reservoir volume to vary the waveform of the pressure pulse, and a metallic central injury screw secured to the animal's skull over the exposed dura. Using this device, midline fluid percussion (MFP) and lateral fluid percussion (LFP) injuries were performed in 70 rats. Histopathologic findings included diffuse axonal injury in the MFP model and cortical contusion in the LFP model. Survival rate was 41.4% in MFP animals and 100% in LFM animals when the device settings were 178 mm(3) of the cylindrical reservoir and 50 degrees-60 degrees in height of the pendulum. Our results suggest that this modified fluid percussion device may offer significant improvements over previously reported fluid percussion models for use in experimental head injury.	SHIMADZU CO LTD,DIV TESTING & WEIGHING EQUIPMENT,KYOTO,JAPAN		YAMAKI, T (corresponding author), KYOTO PREFECTURAL UNIV MED,DEPT NEUROSURG,KAMIGYO KU,KYOTO 602,JAPAN.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; MASUZAWA H, 1976, Neurologia Medico-Chirurgica, V16, P77, DOI 10.2176/nmc.16pt1.77; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; SHAW NA, 1985, PHYSIOL BEHAV, V35, P637, DOI 10.1016/0031-9384(85)90154-4; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311	21	21	23	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1994	11	5					613	622		10.1089/neu.1994.11.613			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PR237	WOS:A1994PR23700013	7861452				2022-02-06	
J	GALE, SD; JOHNSON, SC; BIGLER, ED; BLATTER, DD				GALE, SD; JOHNSON, SC; BIGLER, ED; BLATTER, DD			TRAUMATIC BRAIN INJURY AND TEMPORAL HORN ENLARGEMENT - CORRELATES WITH TESTS OF INTELLIGENCE AND MEMORY	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						TRAUMATIC BRAIN INJURY; INTELLIGENCE TESTS; NEUROPSYCHOLOGICAL TESTS; VENTRICLE; BRAIN RATIOS	ABNORMALITIES; LOBE	Temporal horn volume, an indirect measure of hippocampal atrophy, based on postinjury magnetic resonance (MR) studies was calculated in a group of 61 traumatic brain injury (TBI) patients and 90 control subjects that were age- and gender-matched. Additionally, ventricle:brain ratios (VBRs), based on total ventricular volume corrected for head size, were calculated. Anatomic comparisons indicated that the ventricular system in TBI patients was significantly dilated. Enlargement of the temporal horns showed an inverse relationship to some neuropsychological test findings; however, the hypothesis that verbal memory tasks would relate specifically to the left temporal horn, and visual memory tasks to the right was not supported. Results are discussed in terms of the current conceptual framework of mesial temporal lobe damage in TBI and disruption of memory performance.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,PROVO,UT 84602; LDS HOSP,SALT LAKE CITY,UT								Amaral D. G., 1987, HDB PHYSL NERVOUS SY, VV, P211; BARTZOKIS G, 1993, MAGN RESON IMAGING, V11, P993, DOI 10.1016/0730-725X(93)90218-3; BEAURAIN J, 1994, MAGN RESON IMAGING, V12, P139, DOI 10.1016/0730-725X(94)92361-2; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; BLATTER DD, IN PRESS AM J NEUROR; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Evans RW., 1992, PROGNOSIS NEUROLOGIC, P97; FERGUSON GA, 1989, STATISTICAL ANAL PSY; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; NAIDICH TP, 1987, CRANIAL SPINAL MAGNE, P83; PRESS GA, 1989, NATURE, V341, P54, DOI 10.1038/341054a0; RAUSCH R, 1993, ARCH NEUROL-CHICAGO, V50, P812, DOI 10.1001/archneur.1993.00540080023008; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROBB RA, 1990, 3D IMAGING MED, P333; Roberts M, 1970, ATLAS HUMAN BRAIN SE; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; SQUIRE LR, 1987, HDB PHYSL 1, V5, P295; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED	23	21	21	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	JUL	1994	7	3					160	165					6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	PC765	WOS:A1994PC76500003					2022-02-06	
J	MOULTON, RJ; SHEDDEN, PM; TUCKER, WS; MULLER, PJ				MOULTON, RJ; SHEDDEN, PM; TUCKER, WS; MULLER, PJ			SOMATOSENSORY-EVOKED POTENTIAL MONITORING FOLLOWING SEVERE CLOSED-HEAD INJURY	CLINICAL AND INVESTIGATIVE MEDICINE			English	Article						HEAD INJURY; EVOKED POTENTIALS; CEREBRAL METABOLISM	INTRACRANIAL HYPERTENSION; BRAIN-FUNCTION; DYSFUNCTION; CONDUCTION; METABOLISM; TRAUMA; COMA	This paper describes the results of somatosensory evoked potential (SSEP) monitoring in 65 patients with severe head injury. Intracranial pressure (ICP) monitoring data were available for 63 patients, and arterial-jugular oxygen content (AVDO(2)) data for 52 patients. Eighty-nine percent of patients with no SSEP activity beyond 50 msec post-stimulus in either hemisphere died or were vegetative survivors (3 month Glasgow Outcome Score). All 17 patients with a good or moderate outcome had long latency cortical activity (i.e. greater than or equal to 70 msec post-stimulus) in both hemispheres. Among patients with absent activity in 1 hemisphere, 53% died and 47% were severely disabled (chi(2) = 40, P = 0.0000). In the latter group, age was a significant factor among patients who died or were severely disabled (p < 0.02). Forty-four of 65 patients had either clear-cut deterioration or improvement in SSEPs over the course of monitoring. There were no significant differences in peak ICP between patients with improving or deteriorating SSEPs. In contrast, those with deteriorating SSEPs had a significant drop in AVDO(2), compared with patients with improving SSEPs (p < 0.01). Long-term continuous monitoring of SSEPs shows that following severe injury, neurologic function may. undergo significant change in approximately two-thirds of patients. Furthermore, ICP does not appear to play a prominent role in neurologic deterioration. AVDO(2) measurements indicate that deterioration is more likely associated with perturbation of cerebral oxidative metabolism. SSEP monitoring following severe head injury has proven prognostic value, and is recommended for patients who must be pharmacologically paralyzed for ICP or ventilator management.			MOULTON, RJ (corresponding author), ST MICHAELS HOSP, DIV NEUROSURG, 38 SHUTER ST, TORONTO M5B 1A6, ON, CANADA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JENNETT B, 1975, LANCET, V1, P480; KONASIEWICZ SJ, IN PRESS CAN J NEURO; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOULTON R, 1991, J TRAUMA, V31, P676, DOI 10.1097/00005373-199105000-00012; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SHEDDEN P M, 1990, Pediatric Neurosurgery, V16, P203, DOI 10.1159/000120527; STRICH SJ, 1961, LANCET, V2, P443; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; YAMADA T, 1988, EVOKED POTENTIAL, P705	23	21	22	0	2	CANADIAN SOC CLINICAL INVESTIGATION	OTTAWA	CSCI HEAD OFFICE, 774 ECHO DRIVE, OTTAWA, ON K1S 5N8, CANADA	0147-958X	1488-2353		CLIN INVEST MED	Clin. Invest. Med.	JUN	1994	17	3					187	195					9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	NR184	WOS:A1994NR18400001	7923995				2022-02-06	
J	POLISSAR, NL; FAY, GC; JAFFE, KM; LIAO, S; MARTIN, KM; SHURTLEFF, HA; RIVARA, JB; WINN, HR				POLISSAR, NL; FAY, GC; JAFFE, KM; LIAO, S; MARTIN, KM; SHURTLEFF, HA; RIVARA, JB; WINN, HR			MILD PEDIATRIC TRAUMATIC BRAIN INJURY - ADJUSTING SIGNIFICANCE LEVELS FOR MULTIPLE COMPARISONS	BRAIN INJURY			English	Article							HEAD-INJURIES; SEVERITY; CHILDREN	The outcome following mild traumatic brain injury (TBI) is controversial. We addressed this topic in a study of neurobehavioural and 'real-world' functioning among 53 children with mild TBI and their matched controls, using statistical methods recently developed for multiple comparisons. Because the study involved calculation of 414 p-values, four methods of adjustment for multiple comparisons, including the Bonferroni method, were used to avoid 'false-positive' statistical significance. The additional three methods allowed greater insight into the data than provided by the standard Bonferroni adjustment. Results showed that at initial testing, three areas of 'real-world' functioning (eating, domestic and home/community living skills) had weak but statistically significant associations with mild injury. No other specific areas of neurobehavioural or 'real-world' functioning had plausible associations with the injury either initially, at 1 year, or when changes over the year were considered. However, the adjustment for multiple comparisons provided additional results. There were statistically significant associations of the injury with the entire domain of neurobehavioural variables both initially and at 1 year. These results suggest that the injury affects a spectrum of neurobehavioural skills weakly, rather than a single area substantially. The gain froin using multiple comparison methods is discussed.	CHILDENS HOSP & MED CTR,DEPT REHABIL MED,POB 5371,480 SAND POINT WAY NE,SEATTLE,WA 98105; UNIV WASHINGTON,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; STAT & EPIDEMIOL RES CORP,SEATTLE,WA; UNIV WASHINGTON,DEPT PSYCHIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT NEUROL SURG,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BEHAV SCI,SEATTLE,WA 98195; UNIV WASHINGTON,CHILDRENS HOSP & MED CTR,SCH SOCIAL WORK,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,CTR QUANTITAT SCI,SEATTLE,WA 98195					Shurtleff, Hillary/0000-0003-0959-2842	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR002299] Funding Source: Medline		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; Bruininks R. H., 1984, SCALES INDEPENDENT B; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Conover W.J., 1998, PRACTICAL NONPARAMET; DELIS DC, 1989, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Edelbrock C., 1986, MANUAL TEACHERS REPO; FAY GC, IN PRESS ARCH PHYSIC; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, IN PRESS ARCH PHYSIC; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Miller R. G., 1981, SIMULTANEOUS STAT IN; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; PRENTICE RL, 1984, BIOMETRICS, V40, P653, DOI 10.2307/2530908; REITMAN RM, 1974, CLIN NEUROPSYCHOLOGY; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Wechsler D., 1974, WECHSLER INTELLIGENC; Wilkinson, 1984, WIDE RANGE ACHIEVEME	21	21	21	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1994	8	3					249	263		10.3109/02699059409150977			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ND714	WOS:A1994ND71400006	8004083				2022-02-06	
J	MOSCATO, BS; TREVISAN, M; WILLER, BS				MOSCATO, BS; TREVISAN, M; WILLER, BS			THE PREVALENCE OF TRAUMATIC BRAIN INJURY AND COOCCURRING DISABILITIES IN A NATIONAL HOUSEHOLD SURVEY OF ADULTS	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							CLOSED HEAD-INJURY; HUMAN-MEMORY; EPIDEMIOLOGY; POPULATION; COMMUNITY; COUNTY	This original point prevalence study provides sociodemographic characteristics and Canadian household prevalence rates of adults (15 years and older) with disability who have survived a traumatic brain injury (TBI) and the type, number, and prevalence rates of co-occurring disabilities. This report is based on the Health and Activity Limitation Survey, a national survey conducted by Statistics Canada in 1986-87. The overall household prevalence rate of TBI is 62.31100,000 adults (95% confidence interval = 54.0,70.5). Gender-specific rates are 81.31100,000 males and 44.2/100,000 females, with a 1.8:1 male-to-female ratio. Rates are highest in the 45-64 age range, 3 times those in the 15-24 age group. Eighty-four percent of adults with TBI have co-occurring disabilities (median = 2), the most prevalent being limited mobility and agility.	SUNY BUFFALO,DEPT PSYCHIAT,BUFFALO,NY 14260		MOSCATO, BS (corresponding author), SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT SOCIAL & PREVENT MED,270 FARBER HALL,BUFFALO,NY 14214, USA.						ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; [Anonymous], 1980, INT CLASSIFICATION I; Bryden J, 1989, MODELS BRAIN INJURY, P17; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; DOLSON D, 1987, SUURVEY METHODOLOGY, V13, P93; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FURRIE AD, 1987, NATIONAL DATABASE DI; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KELLYHAYES M, 1992, AM J PUBLIC HEALTH, V82, P841, DOI 10.2105/AJPH.82.6.841; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1980, J NEUROSURG, V53, pS35; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1991, NEUROEPIDEMIOLOGY TR, P333; Kraus JF, 1987, HEAD INJURY, V2, P1; Last JM., 1988, DICT EPIDEMIOLOGY, V2; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MCDOWELL I, 1988, DISABILITY SCORE HLT; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; PARKINSON D, 1985, CAN J SURG, V28, P79; POPE AM, 1991, DISABIITY AM NATIONA; RICHARDSON JTE, 1985, COGNITIVE NEUROPSYCH, V2, P149, DOI 10.1080/02643298508252864; RICHARDSON JTE, 1984, COGN NEUROPSYCHOL, V1, P217, DOI 10.1080/02643298408252023; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P119; SELECKI BR, 1981, INJURIES HEAD SPINE; THEBERGE A, 1988, WEIGHTING HLTH ACTIV; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; WILLER B, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P18; 1990, 82602 STAT CAN CAT; 1991, 82615 STAT CAN CAT, V4; 1988, VITAL HLTH STATIS 13, V95; 1988, PROFILES URBAN RUR 1; 1989, HALS HOUSEHOLD DATA; 1989, STATISTICS CANADA DA; 1988, DISABILITY DATABASE	41	21	21	0	1	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	1994	6	2					134	142					9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	NJ963	WOS:A1994NJ96300005	8044034				2022-02-06	
J	VONBERENBERG, P; UNTERBERG, A; SCHNEIDER, GH; LANKSCH, WR				VONBERENBERG, P; UNTERBERG, A; SCHNEIDER, GH; LANKSCH, WR			TREATMENT OF TRAUMATIC BRAIN EDEMA BY MULTIPLE DOSES OF MANNITOL	ACTA NEUROCHIRURGICA			English	Article						CEREBRAL EDEMA; MANNITOL; COLD INJURY; RATS		Mannitol is frequently used to reduce elevated intracranial pressure often associated with brain edema. In cases of a damaged blood-brain barrier, however, mannitol might aggravate vasogenic cerebral edema, as has recently been stressed. The aim of this study was to investigate whether multiple doses of mannitol administered during development of vasogenic brain edema following a cryogenic cortical injury affect hemispheric swelling and edema. Sprague-Dawley rats were anesthetized with ketamine and xylazine. A cortical freezing lesion was applied to the right parietal region. A first series of eight rats received four doses of 20% mannitol (0.4 g/kg within 10 minutes) thirty minutes, 3, 6 and 9 hours after trauma. Twelve hours after cryogenic injury, the brains were removed for determination of hemispheric swelling and cerebral water content. Eight control rats were infused with saline only. In a second series nine rats received eight doses of 20% mannitol 30 minutes, 3, 6, 9, 12, 15, 18 and 21 hours after trauma. In this series, the brains were removed 24 hours after freezing. Again respective control animals were infused with saline only. Hemispheric swelling was 7.2 +/- 0.5% after four doses of mannitol compared to 7.6 +/- 0,5% in control animals (n.s.). Following eight doses of mannitol hemispheric swelling was 8.9 +/- 0.4% compared to 10.1 +/- 0.4% in control rats (p < 0.05). Accordingly, the water content of traumatized hemispheres was lower following repeated mannitol treatment (80.5 versus 80.8%). Water content in control hemispheres was not affected by mannitol. Taken together, these results indicate that multiple doses of mannitol do not aggravate total hemispheric swelling, nor global water content following induction of vasogenic edema. In contrast, repeated administration of mannitol reduces traumatic swelling, thus favouring repeated mannitol application even when the blood-brain barrier is defective.			VONBERENBERG, P (corresponding author), FREE UNIV BERLIN, RUDOLF VIRCHOW MED CTR, DEPT NEUROSURG, AUGUSTENBURGER PL 1, W-1000 BERLIN 33, GERMANY.						HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; KAUFMANNAM, 1992, J NEUROSURG, V77, P584; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Long DM, 1972, STEROIDS BRAIN EDEMA, P87; MACGOVERN GJ, 1984, CIRCULATION S1, V70, P191; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; PAPPIUS HM, 1965, ARCH NEUROL-CHICAGO, V13, P295; RICKELS E, ZENTRALBL NEUROCHIR, V54, P3; UNTERBERG A, 1990, ACT NEUR S, V51, P104	10	21	21	1	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			531	533					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600146	7976640				2022-02-06	
J	WHITEGBADEBO, D; HAMM, RJ				WHITEGBADEBO, D; HAMM, RJ			CHRONIC CORTICOSTERONE TREATMENT POTENTIATES DEFICITS FOLLOWING TRAUMATIC BRAIN INJURY IN RATS - IMPLICATIONS FOR AGING	JOURNAL OF NEUROTRAUMA			English	Article							ADRENOCORTICAL STRESS-RESPONSE; GLUCOCORTICOID TOXICITY; NEURONAL VULNERABILITY; AGE; HIPPOCAMPUS; BASAL; YOUNG	The present study examined the effect of chronic corticosterone exposure on motor and cognitive deficits following traumatic brain injury (TBI). Adults rats were treated with either corticosterone acetate (15 ug/ml) added to their drinking water or vehicle (0.5% alcohol) for 3 months. Following this 3-month treatment, corticosterone-treated rats (n = 8) and vehicle-treated rats (n = 10) were injured at a mild level of fluid percussion injury (1.7-1.8 atm). Additional corticosterone-treated (n = 8) and vehicle-treated rats (n = 8) were surgically prepared for injury but were not injured. Both motor (beam balance and beam walking) and cognitive (Morris water maze) performances were assessed following injury. Motor deficits were transiently enhanced following injury in rats treated with corticosterone. Rats treated with corticosterone were also slower in learning the Morris water maze than vehicle-treated rats. These findings demonstrate that elevated corticosterone levels potentiate the behavioral deficits observed after traumatic brain injury. Applied to aging research, these results suggest that the elevated basal levels of corticosterone present in aged animals may mediate the enhanced vulnerability of aged animals to traumatic brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,BOX 2018,RICHMOND,VA 23298						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER		DEKOSKY ST, 1984, NEUROENDOCRINOLOGY, V38, P33, DOI 10.1159/000123862; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; HAMM R J, 1991, Society for Neuroscience Abstracts, V17, P167; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; ISSA AM, 1990, J NEUROSCI, V10, P3247; KATAYAMA T, 1990, J NEUROSURG, V73, P899; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; MEANEY MJ, 1992, NEUROENDOCRINOLOGY, V55, P204, DOI 10.1159/000126116; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; SAPOLSKY R, 1985, J NEUROSCI, V5, P1221; SAPOLSKY RM, 1985, BRAIN RES, V359, P300, DOI 10.1016/0006-8993(85)91440-4; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1228; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; SCHEFF SW, 1980, EXP NEUROL, V68, P195, DOI 10.1016/0014-4886(80)90077-1; STEINBOK P, 1979, NEUROSURGERY, V5, P559, DOI 10.1227/00006123-197911000-00003; STEWART J, 1988, ENDOCRINOLOGY, V123, P1934, DOI 10.1210/endo-123-4-1934; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x	25	21	21	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FAL	1993	10	3					297	306		10.1089/neu.1993.10.297			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MC021	WOS:A1993MC02100006	8258842				2022-02-06	
J	LEVINE, MJ; VANHORN, KR; CURTIS, AB				LEVINE, MJ; VANHORN, KR; CURTIS, AB			DEVELOPMENTAL MODELS OF SOCIAL COGNITION IN ASSESSING PSYCHOSOCIAL ADJUSTMENTS IN HEAD-INJURY	BRAIN INJURY			English	Article								This study compared the levels of conceptual responses involved in the processing of two parameters of social cognition in a group of 40 adult patients with closed-head injury (CHI) and a group of 26 normal controls. The two parameters, interpersonal negotiation strategies (INS) and self understanding (self) were examined in the framework of Selman's model of social perspective taking and Damon and Hart's multidimensional model of self understanding. Differences among the components of the INS conflict dilemmas and aspects of self descriptions were observed in a structure interview. Results supported the hypothesis that the CHI group would respond at lower levels on the development measures of social cognition. The results of the present study are in agreement with the conclusions in the initial study. This study also extended the study of social cognition to the Tennessee Self Concept Scale and the Neurobehavioral Rating Scale, in addition to incorporating a control group. These studies support the view that psychosocial adjustment is a multidimensional construct and developmental social cognition methods appear to advance our understanding of this concept in CHI patients.	CENT MICHIGAN UNIV,DEPT PSYCHOL,MT PLEASANT,MI 48859; NEW ENGLAND REHABIL HOSP,WOBURN,MA								Damon W, 1988, SELF UNDERSTANDING C; DAMON W, 1988, UNPUB SCORING MANUAL; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; FITTS NH, 1972, RES MONOGRAPHY D WAL, V4; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; HOLOSKO MJ, 1989, J REHABIL, V2, P145; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; SELMAN RL, 1986, DEV PSYCHOL, V22, P450, DOI 10.1037/0012-1649.22.4.450; SELMAN RL, 1986, UNPUB INTERVIEW METH; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	17	21	21	0	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR-APR	1993	7	2					153	167		10.3109/02699059309008169			15	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KZ726	WOS:A1993KZ72600007	8453413				2022-02-06	
J	HELLER, L; KEREN, O; ALONI, R; DAVIDOFF, G				HELLER, L; KEREN, O; ALONI, R; DAVIDOFF, G			AN OPEN TRIAL OF VACUUM PENILE TUMESCENCE - CONSTRICTION THERAPY FOR NEUROLOGICAL IMPOTENCE	PARAPLEGIA			English	Article						MALE NEUROLOGICAL IMPOTENCE; VACUUM PENILE CONSTRICTION TUMESCENCE		Sexual dysfunction is a frequent result of traumatic and non traumatic neurological disorders, including spinal cord injury, stroke, traumatic brain injury and autonomic neuropathy (for example, as may be seen in patients with diabetes mellitus). Although many methods have been suggested for the treatment of some of these problems in male patients, most are invasive and have a substantial morbidity. This is the report of a pilot trial of vacuum tumescence constriction therapy for 30 patients with chronic neurological impotence. Seventeen of these patients, following sexual counselling and training, decided to purchase such a device. At follow up, a mean of 21 months, over 50% of those who had purchased the device were still actively using it. The frequency of coitus increased from 0.3/wk to 1.5/wk (t = -5.7; p < 0.00001). No significant morbidity was reported by patients. Vacuum tumescence constriction therapy shows promise as a noninvasive method for the treatment of neurological impotence.	LOEWENSTEIN HOSP & REHABIL CTR,CTR REHABIL,278 AHUZA,POB 3,RAANANA,ISRAEL									0	21	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0031-1758			PARAPLEGIA	Paraplegia	AUG	1992	30	8					550	553		10.1038/sc.1992.113			4	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	JU300	WOS:A1992JU30000003	1522995	Bronze			2022-02-06	
J	DRUDGE, OW; WILLIAMS, JM; KESSLER, M; GOMES, FB				DRUDGE, OW; WILLIAMS, JM; KESSLER, M; GOMES, FB			RECOVERY FROM SEVERE CLOSED HEAD-INJURIES - REPEAT TESTINGS WITH THE HALSTEAD-REITAN NEUROPSYCHOLOGICAL BATTERY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article									MED CTR HOSP VERMONT,BURLINGTON,VT 05401		DRUDGE, OW (corresponding author), UNIV VERMONT,BURLINGTON,VT 05405, USA.						BARNES GW, 1974, J NERV MENT DIS, V158, P50, DOI 10.1097/00005053-197401000-00007; BECKER B, 1977, J CLIN PSYCHOL, V47, P307; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOLL TJ, 1981, HDB CLIN NEUROPSYCHO; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; Klove H, 1972, Scand J Rehabil Med, V4, P55; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MATARAZZO JD, 1974, J NERV MENT DIS, V158, P37, DOI 10.1097/00005053-197401000-00006; MATARAZZO JD, 1976, J CLIN PSYCHOL, V32, P338, DOI 10.1002/1097-4679(197604)32:2<338::AID-JCLP2270320230>3.0.CO;2-O; Matthews CG, 1966, CORTEX, V2, P244; Reitan R, 1969, MANUAL ADM NEUROPSYC; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Wechsler D., 1955, MANUAL WECHSLER ADUL; WILLIAMS JM, 1981, 5TH ANN C REH BRAIN	21	21	21	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.		1984	40	1					259	265		10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C			7	Psychology, Clinical	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology	SH419	WOS:A1984SH41900048	6746939				2022-02-06	
J	SCHNITKER, MT				SCHNITKER, MT			A SYNDROME OF CEREBRAL CONCUSSION IN CHILDREN	JOURNAL OF PEDIATRICS			English	Article																	Beekman F, 1928, ANN SURG, V87, P355, DOI 10.1097/00000658-192803000-00002; BROCK S, 1942, J MT SINAI HOSP, V9, P349; CAMPBELL JB, IN PRESS J NEUROSURG; DANDY WE, 1946, B JOHNS HOPKINS HOSP, V79, P34; DAVISON C, 1945, ARCH NEURO PSYCHIATR, V54, P241, DOI 10.1001/archneurpsyc.1945.02300100013002; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Jefferson G, 1944, BRIT MED J, V1944, P1; KAHN E, COMMUNICATION; Penfield W, 1938, ARCH NEURO PSYCHIATR, V40, P417, DOI 10.1001/archneurpsyc.1938.02270090011001; Vance BM, 1927, ARCH SURG-CHICAGO, V14, P1023, DOI 10.1001/archsurg.1927.01130170071005	10	21	21	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.		1949	35	5					557	560		10.1016/S0022-3476(49)80138-7			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	UP117	WOS:A1949UP11700004	15393434				2022-02-06	
J	Linthicum, FH; Rand, CW				Linthicum, Fred H.; Rand, Carl W.			NEURO-OTOLOGICAL OBSERVATIONS IN CONCUSSION OF THE BRAIN	ARCHIVES OF OTOLARYNGOLOGY			English	Article																	AMBERG E, 1914, J MICHIGAN M SOC, V13, P84; Brunner H, 1925, MSCHR OHRENHEILK, V59, P697; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P763; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P922; Fletcher HA, 1922, J AMER MED ASSOC, V79, P529, DOI 10.1001/jama.1922.02640070017005; GOTTLIEB MJ, 1922, LARYNGOSCOPE, V32, P783; Greenacre P, 1917, B JOHNS HOPKINS HOSP, V28, P86; Grove WE, 1928, ARCHIV OTOLARYNGOL, V8, P249; HALSZ H, 1901, WIEN MED WCHNSCHR, V51, P1538; HOFMANN L, 1925, ANN MAL OREILLE LARY, V44, P1254; Hubby LM, 1927, ARCHIV OTOLARYNGOL, V6, P405; LINTHICUM FH, 1923, T PAC COAST OT SOC; MYGIND SH, 1918, ACTA OTO-LARYNGOL, V1, P513; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PASSOW KA, 1905, VERLETZUNGEN GEHOROR; RHESE, 1906, Z OHRENH, V52, P320; RISK EJE, 1890, BRIT MED J, V1, P234; SCHUSTER FB, 1927, SW MED, V11, P116; STENGER, 1909, ARCH OHRENHEILK, V79, P43; ZACHS MA, 1928, LARYNGOSCOPE, V38, P288	20	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0276-0673			ARCHIV OTOLARYNGOL	Arch. Otolaryngol.	JUN	1931	13	6					785	821					37	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	V06LR	WOS:000207195600001					2022-02-06	
J	Stokes, KA; Locke, D; Roberts, S; Henderson, L; Tucker, R; Ryan, D; Kemp, S				Stokes, Keith A.; Locke, Duncan; Roberts, Simon; Henderson, Lewis; Tucker, Ross; Ryan, Dean; Kemp, Simon			Does reducing the height of the tackle through law change in elite men's rugby union (The Championship, England) reduce the incidence of concussion? A controlled study in 126 games	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Objectives Most concussions in rugby union occur during tackles. We investigated whether legislation to lower maximum tackle height would change tackle behaviour, and reduce concussion incidence rate. Methods In an observational evaluation using a prospective cohort design, 12 elite men's teams played in two competitions during the 2018/2019 season. The Championship (90 games) retained standard Laws of Rugby for the tackle; the Championship Cup (36 games) used revised laws-the maximum tackle height was lowered from the line of the shoulders on the ball carrier to the line of the armpits. Videos of tackles were analysed for ball carrier and tackler behaviour. Injury data were collected using standardised methods. Results In the lowered tackle height setting, there was a significantly lower proportion of tackles; (1) in which ball carriers (rate ratio (RR) 0.83, 95% CI 0.79 to 0.86) and tacklers (RR 0.80, 95% CI 0.76 to 0.84) were upright, (2) in which the tackler's initial contact was to the ball carrier's head or neck (RR 0.70, 95% CI 0.58 to 0.84) and (3) in which initial contact was above the line of the ball carrier's armpit (RR 0.84, 95% CI 0.80 to 0.88). Concussion incidence rate did not differ between conditions (RR 1.31, 95% CI 0.85 to 2.01). Unexpectedly, compared with the standard tackle height setting, tacklers in the lowered tackle height setting were themselves concussed at a higher rate as measured by; (1) incidence (RR 1.90, 95% CI 1.05 to 3.45) and (2) concussions per 1000 tackles (2.09, 95% CI 1.15 to 3.80). Conclusions Legislating to lower the height of the tackle meant that tacklers made contact with the ball carrier's head and neck 30% less often. This did not influence concussion incidence rates. Tacklers in the lowered tackle height setting suffered more concussions than did tacklers in the standard tackle height setting.	[Stokes, Keith A.; Roberts, Simon] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Stokes, Keith A.; Locke, Duncan; Henderson, Lewis; Kemp, Simon] Rugby Football Union, Twickenham, England; [Locke, Duncan] Insight Anal, Bath, Avon, England; [Tucker, Ross] World Rugby Pty Ltd, Dublin, Ireland; [Ryan, Dean] Dragons Rugby, Newport, Gwent, Wales		Stokes, KA (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	k.stokes@bath.ac.uk	Stokes, Keith/C-2605-2009	Stokes, Keith/0000-0002-5049-2838; Kemp, Simon/0000-0002-3250-2713			Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Emery C, 2019, BR J SPORTS MED; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Rugby Football Union, ENGLAND PROFESSIONAL; Sterne, 2003, ESSENTIAL MED STAT; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; World Rugby, 2016, NEW MEASURES LIMIT C; World Rugby, HIA PROTOCOL; World Rugby, 2019, LAWS GAME	15	20	20	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2021	55	4					220	225		10.1136/bjsports-2020-101983			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QF2IW	WOS:000616724100010	31857335	Green Accepted, Green Submitted, Green Published	Y	N	2022-02-06	
J	Robba, C; Poole, D; McNett, M; Asehnoune, K; Bosel, J; Bruder, N; Chieregato, A; Cinotti, R; Duranteau, J; Einav, S; Ercole, A; Ferguson, N; Guerin, C; Siempos, II; Kurtz, P; Juffermans, NP; Mancebo, J; Mascia, L; McCredie, V; Nin, N; Oddo, M; Pelosi, P; Rabinstein, AA; Neto, AS; Seder, DB; Skrifvars, MB; Suarez, JI; Taccone, FS; van der Jagt, M; Citerio, G; Stevens, RD				Robba, Chiara; Poole, Daniele; McNett, Molly; Asehnoune, Karim; Boesel, Julian; Bruder, Nicolas; Chieregato, Arturo; Cinotti, Raphael; Duranteau, Jacques; Einav, Sharon; Ercole, Ari; Ferguson, Niall; Guerin, Claude; Siempos, Ilias I.; Kurtz, Pedro; Juffermans, Nicole P.; Mancebo, Jordi; Mascia, Luciana; McCredie, Victoria; Nin, Nicolas; Oddo, Mauro; Pelosi, Paolo; Rabinstein, Alejandro A.; Neto, Ary Serpa; Seder, David B.; Skrifvars, Markus B.; Suarez, Jose I.; Taccone, Fabio Silvio; van der Jagt, Mathieu; Citerio, Giuseppe; Stevens, Robert D.			Mechanical ventilation in patients with acute brain injury: recommendations of the European Society of Intensive Care Medicine consensus	INTENSIVE CARE MEDICINE			English	Article						Mechanical ventilation; Respiratory failure; ARDS; Traumatic brain injury; Acute stroke; Subarachnoid hemorrhage	RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; TIDAL VOLUMES; PREDICTION; OUTCOMES	Purpose To provide clinical practice recommendations and generate a research agenda on mechanical ventilation and respiratory support in patients with acute brain injury (ABI). Methods An international consensus panel was convened including 29 clinician-scientists in intensive care medicine with expertise in acute respiratory failure, neurointensive care, or both, and two non-voting methodologists. The panel was divided into seven subgroups, each addressing a predefined clinical practice domain relevant to patients admitted to the intensive care unit (ICU) with ABI, defined as acute traumatic brain or cerebrovascular injury. The panel conducted systematic searches and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method was used to evaluate evidence and formulate questions. A modified Delphi process was implemented with four rounds of voting in which panellists were asked to respond to questions (rounds 1-3) and then recommendation statements (final round). Strong recommendation, weak recommendation, or no recommendation were defined when > 85%, 75-85%, and < 75% of panellists, respectively, agreed with a statement. Results The GRADE rating was low, very low, or absent across domains. The consensus produced 36 statements (19 strong recommendations, 6 weak recommendations, 11 no recommendation) regarding airway management, non-invasive respiratory support, strategies for mechanical ventilation, rescue interventions for respiratory failure, ventilator liberation, and tracheostomy in brain-injured patients. Several knowledge gaps were identified to inform future research efforts. Conclusions This consensus provides guidance for the care of patients admitted to the ICU with ABI. Evidence was generally insufficient or lacking, and research is needed to demonstrate the feasibility, safety, and efficacy of different management approaches.	[Robba, Chiara; Pelosi, Paolo] San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Genoa, Italy; [Poole, Daniele] San Martino Hosp, Anesthesia & Intens Care Operat Unit, Belluno, Italy; [McNett, Molly] Ohio State Univ, Coll Nursing, Helene Fuld Hlth Trust Natl Inst EBP, Implementat Sci, Columbus, OH 43210 USA; [Asehnoune, Karim] Univ Hosp Nantes, Dept Anaesthesia & Crit Care, Hotel Dieu, Nantes, France; [Boesel, Julian] Univ Hosp Heidelberg, Dept Neurol, Heidelberg, Germany; [Boesel, Julian] Klinikum Kassel, Dept Neurol, Kassel, Germany; [Bruder, Nicolas] Aix Marseille Univ, CHU Timone, AP HM, Anesthesiol Intens Care Dept, Marseille, France; [Chieregato, Arturo] ASST Grande Osped Metropolitano Niguarda, Neurointens Care Unit, Milan, Italy; [Cinotti, Raphael] Univ Hosp Nantes, Dept Anaesthesia & Crit Care, Hop Guillaume & Rene Laennec, St Herblain, France; [Duranteau, Jacques] Paris Saclay Univ, Bicetre Hosp, AP HP, Dept Anesthesiol & Perioperat Intens Care Med, Paris, France; [Einav, Sharon] Shaare Zedek Med Ctr, Fac Med, Intens Care Unit, Jerusalem, Israel; [Einav, Sharon] Hebrew Univ Jerusalem, Jerusalem, Israel; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Ferguson, Niall; McCredie, Victoria] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Ferguson, Niall] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Guerin, Claude] Univ Lyon, Med Intens Reanimat, Hop Edouard Herriot, Lyon, France; [Guerin, Claude] INSERM, Creteil, France; [Siempos, Ilias I.] Natl & Kapodistrian Univ Athens, Evangelismos Hosp, Dept Crit Care Med & Pulm Serv 1, Med Sch, Athens, Greece; [Siempos, Ilias I.] New York Presbyterian Hosp, Weill Cornell Med, Weill Cornell Med Ctr, Div Pulm & Crit Care Med,Dept Med, New York, NY USA; [Kurtz, Pedro] Inst Estadual Cerebro Paulo Niemeyer, Dept Neurointens Care, Rio De Janeiro, Brazil; [Juffermans, Nicole P.] Olvg Hosp, Dept Intens Care Med, Amsterdam, Netherlands; [Juffermans, Nicole P.] Univ Amsterdam, Lab Expt Intens Care & Anesthesiol, Med Ctr, Amsterdam, Netherlands; [Mancebo, Jordi] Hosp Sant Pau, Serv Med Intens, Barcelona, Spain; [Mascia, Luciana] Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy; [Nin, Nicolas] Hosp Espanol, Dept Intens Care Med, Montevideo, Uruguay; [Oddo, Mauro] Univ Lausanne, Dept Intens Care Med, Ctr Hosp Univ Vaudois CHUV, Lausanne, Switzerland; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Rabinstein, Alejandro A.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Neto, Ary Serpa] Monash Univ, Australian & New Zealand Intens Care Res Ctr ANZI, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Neto, Ary Serpa] Hosp Israelita Alberto Einstein, Dept Crit Care Med, Sao Paulo, Brazil; [Seder, David B.] Maine Med Ctr, Neurosci Inst, Dept Crit Care Serv, 22 Bramhall St, Portland, ME 04102 USA; [Skrifvars, Markus B.] Univ Helsinki, Dept Emergency Care & Serv, HUS Helsinki, Haartmaninkatu 4, Helsinki 00029, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, HUS Helsinki, Haartmaninkatu 4, Helsinki 00029, Finland; [Suarez, Jose I.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 600 N Wolfe St,Phipps 455, Baltimore, MD 21287 USA; [Suarez, Jose I.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Suarez, Jose I.; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Taccone, Fabio Silvio] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care Med, Brussels, Belgium; [van der Jagt, Mathieu] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy		Stevens, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 600 N Wolfe St,Phipps 455, Baltimore, MD 21287 USA.	rstevens@jhmi.edu	Ercole, Ari/B-6288-2009; Serpa Neto, Ary/D-1927-2012; Ferguson, Niall/D-7619-2019; van der Jagt, Mathieu/G-1905-2017	Ercole, Ari/0000-0001-8350-8093; Serpa Neto, Ary/0000-0003-1520-9387; Ferguson, Niall/0000-0002-6213-5264; van der Jagt, Mathieu/0000-0003-2566-8325			Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; Asehnoune K, 2017, ANESTHESIOLOGY, V127, P338, DOI 10.1097/ALN.0000000000001725; Asehnoune K, 2017, INTENS CARE MED, V43, P957, DOI 10.1007/s00134-017-4764-6; Borsellino B, 2016, EXPERT REV RESP MED, V10, P1123, DOI 10.1080/17476348.2017.1235976; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171; Cavayas YA, 2021, PERFUSION-UK, V36, P161, DOI 10.1177/0267659120932705; Cinotti R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.08.16; Del Sorbo L, 2017, ANN AM THORAC SOC, V14, pS261, DOI 10.1513/AnnalsATS.201704-345OT; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Frisvold SK, 2019, INTENSIVE CARE MED; Gattinoni L, 2016, INTENS CARE MED, V42, P1567, DOI 10.1007/s00134-016-4505-2; Godet T, 2017, ANESTHESIOLOGY, V126, P104, DOI 10.1097/ALN.0000000000001379; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Huang DT, 2017, ANN AM THORAC SOC, V14, P124, DOI 10.1513/AnnalsATS.201608-629OT; Kienbaum P, 2008, ANESTH ANALG, V2018, P1; Laffey JG, 2016, INTENS CARE MED, V42, P1865, DOI 10.1007/s00134-016-4571-5; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Moss M, 2019, NEW ENGL J MED, V380, P1997, DOI 10.1056/NEJMoa1901686; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Quinones-Ossa GA, 2020, J NEUROSCI RURAL PRA, V11, P222, DOI 10.1055/s-0040-1709971; Robba C, 2020, INTENS CARE MED, V46, P983, DOI 10.1007/s00134-020-05935-5; Robba C, 2017, J TRAUMA ACUTE CARE, V82, P165, DOI 10.1097/TA.0000000000001276; Roquilly A, 2013, AM J RESP CRIT CARE, V188, P958, DOI 10.1164/rccm.201301-0116OC; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Silva PL, 2020, ANESTHESIOLOGY, V132, P949, DOI 10.1097/ALN.0000000000003222; Simonis FD, 2018, JAMA-J AM MED ASSOC, V320, P1872, DOI 10.1001/jama.2018.14280; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Pham T, 2019, ANESTHESIOLOGY, V130, P263, DOI 10.1097/ALN.0000000000002508	36	20	22	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	DEC	2020	46	12			SI		2397	2410		10.1007/s00134-020-06283-0		NOV 2020	14	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OZ3WD	WOS:000588595800002	33175276	Bronze, Green Accepted, Green Published, Green Submitted			2022-02-06	
J	Giromini, L; Barbosa, F; Coga, G; Azeredo, A; Viglione, DJ; Zennaro, A				Giromini, Luciano; Barbosa, Fernando; Coga, Giulia; Azeredo, Andreia; Viglione, Donald J.; Zennaro, Alessandro			Using the inventory of problems-29 (IOP-29) with the Test of Memory Malingering (TOMM) in symptom validity assessment: A study with a Portuguese sample of experimental feigners	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Brain Injury; depression; IOP-29; malingering; order; TOMM	STRUCTURED-INVENTORY; RETENTION TRIAL; RESPONSE BIAS; PERFORMANCE; INJURY; PAIN; VALIDATION; DISABILITY; BELIEFS; ISSUES	This study tested whether combining the Inventory of Problems - 29 (IOP-29) with the Test of Memory Malingering (TOMM) would increase sensitivity in the detection of experimentally feigned mental health problems, compared to using either test alone. Additionally, it also evaluated (a) the effects of administration order of these two tests and (b) the cultural and linguistic applicability of these tests to a European Portuguese population. The IOP-29 and TOMM were administered to a community sample of 100 nonclinical, adult volunteers from Portugal, with the instruction to feign mental health problems. Half were instructed to feign mild traumatic brain injury (mTBI) symptoms, half were instructed to feign major depression. Administration order had no effects on the tests' scores, and both measures produced excellent sensitivity values, ranging from .82 to .98 for the TOMM, and from .88 to 1.00 for the IOP-29, when using standard a priori cutoff scores. More importantly, combining the results of TOMM with those of IOP-29 notably increased sensitivity compared to using either test alone. This study thus supports the use of the IOP-29 together with the TOMM in multimethod symptom validity assessments and provides initial evidence that both tests can be used also in Portugal.	[Giromini, Luciano; Coga, Giulia; Zennaro, Alessandro] Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy; [Barbosa, Fernando; Azeredo, Andreia] Univ Porto, Fac Psychol & Educ Sci, Porto, Portugal; [Viglione, Donald J.] Alliant Int Univ San Diego, Calif Sch Profess Psychol, San Diego, CA USA		Giromini, L (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy.	luciano.giromini@unito.it	Giromini, Luciano/AAF-9386-2019; Barbosa, Fernando/L-3836-2014	Giromini, Luciano/0000-0002-9540-4803; Barbosa, Fernando/0000-0002-3310-5613			Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Booksh RL, 2007, ARCH CLIN NEUROPSYCH, V22, P87, DOI 10.1016/j.acn.2006.11.002; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brislin R.W., 1980, METHODOLOGY-EUR, V2, P389; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J.N., 2001, MINNESOTA MULTIPHASI; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cohen J., 2013, STAT POWER ANAL BEHA; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Derogatis L.R., 1994, SCL90 R ADM SCORING; Derogatis L.R., 1977, SCL 90 MANUAL I SCOR; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Geisinger K. F., 2003, HDB PSYCHOL, DOI [10.1002/0471264385.wei1005, DOI 10.1002/0471264385.WEI1005]; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; Giromini L, 2020, J PERS ASSESS, V102, P563, DOI 10.1080/00223891.2019.1566914; Giromini L, 2018, PSYCHOL INJ LAW, V11, P340, DOI 10.1007/s12207-018-9314-1; Gottfried E, 2016, ASSESSMENT, V23, P672, DOI 10.1177/1073191115599640; Gottfried ED, 2017, INT J FORENSIC MENT, V16, P197, DOI 10.1080/14999013.2017.1288667; Green P., 2004, MED SYMPTOM VALIDITY; Green P., 1996, WORD MEMORY TEST USE; Green R.L., 1991, MMPI 2 MMPI INTERPRE; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; IVERSON GL, 2001, J FORENSIC NEUROPSYC, V2, P19, DOI DOI 10.1300/J151v02n01_02; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Merten Thomas, 2013, Clínica y Salud, V24, P129, DOI 10.5093/cl2013a14; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; Mota M., 2008, PSIQUIATRIA PSICOLOG, V2, P23; Rainville J, 1997, SPINE, V22, P2016, DOI 10.1097/00007632-199709010-00016; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rey A, 1958, LEXAMEN CLINIQUE PSY; Rogers R., 2011, RES METHODS FORENSIC, P174; Rogers R., 2018, CLIN ASSESSMENT MALI; Rogers R., 2008, CLIN ASSESSMENT MALI; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Simoes M., 2012, ANAL PSICOL, V28, P209, DOI [10.14417/ap.269, DOI 10.14417/AP.269]; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Smith, 2005, SIMS STRUCTURED INVE; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Van de Vijver F, 1996, EUR PSYCHOL, V1, P89, DOI 10.1027/1016-9040.1.2.89; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Young G, 2014, INT LIBR ETH LAW NEW, V56, P1, DOI 10.1007/978-94-007-7899-3; Zakzanis K. K., 1998, NEUROPSYCHOLOGICAL D; Zhu JJ, 2000, CLIN NEUROPSYCHOL, V14, P461, DOI 10.1076/clin.14.4.461.7197	63	20	20	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 1	2020	27	6					504	516		10.1080/23279095.2019.1570929			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NR9QH	WOS:000571896700003	30773041				2022-02-06	
J	Gruen, DS; Guyette, FX; Brown, JB; Okonkwo, DO; Puccio, AM; Campwala, IK; Tessmer, MT; Daley, BJ; Miller, RS; Harbrecht, BG; Claridge, JA; Phelan, HA; Neal, MD; Zuckerbraun, BS; Yazer, MH; Billiar, TR; Sperry, JL				Gruen, Danielle S.; Guyette, Francis X.; Brown, Joshua B.; Okonkwo, David O.; Puccio, Ava M.; Campwala, Insiyah K.; Tessmer, Matthew T.; Daley, Brian J.; Miller, Richard S.; Harbrecht, Brian G.; Claridge, Jeffrey A.; Phelan, Herb A.; Neal, Matthew D.; Zuckerbraun, Brian S.; Yazer, Mark H.; Billiar, Timothy R.; Sperry, Jason L.			Association of Prehospital Plasma With Survival in Patients With Traumatic Brain Injury A Secondary Analysis of the PAMPer Cluster Randomized Clinical Trial	JAMA NETWORK OPEN			English	Article							OF-HOSPITAL HYPOTENSION; FRESH-FROZEN PLASMA; HEMORRHAGIC-SHOCK; RESUSCITATION; TRANSFUSION; MORTALITY; PLATELETS; OUTCOMES; RATIOS; MODEL	IMPORTANCE Prehospital plasma administration improves survival in injured patients at risk for hemorrhagic shock and transported by air ambulance. Traumatic brain injury (TBI) is a leading cause of death following trauma, but few early interventions improve outcomes. OBJECTIVE To assess the association between prehospital plasma and survival in patients with TBI. DESIGN, SETTING, AND PARTICIPANTS The Prehospital Air Medical Plasma (PAMPer) trial was a pragmatic, multicenter, phase 3, cluster randomized clinical trial involving injured patients who were at risk for hemorrhagic shock during air medical transport to a trauma center. The trial was conducted at 6 US sites with 9 level-I trauma centers (comprising 27 helicopter emergency services bases). The original trial analyzed 501 patients, including 230 patients who were randomized to receive plasma and 271 randomized to standard care resuscitation. This secondary analysis of a predefined subgroup included patients with TBI. Data analysis was performed from October 2019 to February 2020. INTERVENTIONS Patients were randomized to receive standard care fluid resuscitation or 2 units of thawed plasma. MAIN OUTCOMES AND MEASURES The primary outcome was mortality at 30 days. Patients with TBI were prespecified as a subgroup for secondary analysis and for measurement of markers of brain injury. The 30-day survival benefit of prehospital plasma in subgroups with and without TBI as diagnosed by computed tomography was characterized using Kaplan-Meier survival analysis and Cox proportional hazard regression. RESULTS In total, 166 patients had TBI (median [interquartile range] age, 43.00 [25.00-59.75] years; 125 men [75.3%]). When compared with the 92 patients who received standard care, the 74 patients with TBI who received prehospital plasma had improved 30-day survival even after adjustment for multiple confounders and assessment of the degree of brain injury with clinical variables and biomarkers (hazard ratio [HR], 0.55; 95% CI, 0.33-0.94; P = .03). Receipt of prehospital plasma was associated with improved survival among patients with TBI with a prehospital Glasgow Coma Scale score of less than 8 (HR, 0.56; 95% CI, 0.35-0.91) and those with polytrauma (HR, 0.50; 95% CI, 0.28-0.89). Patients with TBI transported from the scene of injury had improved survival following prehospital plasma administration (HR, 0.45; 95% CI, 0.26-0.80; P = .005), whereas patients who were transferred from an outside hospital showed no difference in survival for the plasma intervention (HR, 1.00; 95% CI, 0.33-3.00; P = .99). CONCLUSIONS AND RELEVANCE These findings are exploratory, but they suggest that receipt of prehospital plasma is associated with improved survival in patients with computed tomography-positive TBI. The prehospital setting may be a critical period to intervene in the care of patients with TBI. Future studies are needed to confirm the clinical benefits of early plasma resuscitation following TBI and concomitant polytrauma.	[Gruen, Danielle S.; Brown, Joshua B.; Campwala, Insiyah K.; Tessmer, Matthew T.; Neal, Matthew D.; Zuckerbraun, Brian S.; Billiar, Timothy R.; Sperry, Jason L.] Univ Pittsburgh, Dept Surg & Crit Care Med, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Gruen, Danielle S.; Brown, Joshua B.; Campwala, Insiyah K.; Tessmer, Matthew T.; Neal, Matthew D.; Zuckerbraun, Brian S.; Billiar, Timothy R.; Sperry, Jason L.] Pittsburgh Trauma Res Ctr, Pittsburgh, PA USA; [Guyette, Francis X.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Daley, Brian J.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Knoxville, TN USA; [Miller, Richard S.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA; [Harbrecht, Brian G.] Univ Louisville, Dept Surg, Louisville, KY 40292 USA; [Claridge, Jeffrey A.] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Phelan, Herb A.] Univ Texas Southwestern, Dept Surg, Dallas, TX USA; [Yazer, Mark H.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA		Sperry, JL (corresponding author), Univ Pittsburgh, Dept Surg & Crit Care Med, 200 Lothrop St, Pittsburgh, PA 15213 USA.	sperryjl@upmc.edu		Gruen, Danielle/0000-0003-1019-4390	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-2-0023]; NIH T32 Ruth L. Kirschstein Service FellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; University of PittsburghUniversity of Pittsburgh; Department of DefenseUnited States Department of Defense [1R35GM119526-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R35GM119526-01, R35]	The PAMPer study was supported by a grant (W81XWH-12-2-0023) from the US Army Medical Research and Materiel Command to Dr Sperry. Dr Gruenwas supported by an NIH T32 Ruth L. Kirschstein Service Fellowship. Dr Billiar was funded by an R35 grant from the NIH. Dr Harbrecht was funded by grants from the University of Pittsburgh and the Department of Defense. Dr Neal is supported by grant 1R35GM119526-01 from the NIH.	Anto VP, 2020, J TRAUMA ACUTE CARE, V88, P141, DOI 10.1097/TA.0000000000002530; Austin PC, 2017, INT STAT REV, V85, P185, DOI 10.1111/insr.12214; Barelli S, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00091; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brown JB, 2015, PREHOSP EMERG CARE, V19, P343, DOI 10.3109/10903127.2014.995851; Chang R, 2018, SHOCK, V49, P53, DOI 10.1097/SHK.0000000000000918; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Diebel LN, 2018, J TRAUMA ACUTE CARE, V84, P575, DOI 10.1097/TA.0000000000001791; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Etchill EW, 2017, CRIT CARE MED, V45, P1311, DOI 10.1097/CCM.0000000000002498; Fox EE, 2017, SHOCK, V47, P567, DOI 10.1097/SHK.0000000000000788; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Gruen DS, 2020, J TRAUMA ACUTE CARE, V89, P908, DOI 10.1097/TA.0000000000002816; Gruen DS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135350; Gruen DS, 2019, PAMPER TBI; Gurney JM, 2019, TRANSFUSION, V59, P1578, DOI 10.1111/trf.15243; Guyette FX, 2021, ANN SURG, V273, P358, DOI 10.1097/SLA.0000000000003324; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Harrell Jr F.E., 2019, RMS REGRESSION MODEL; Hernandez MC, 2017, J TRAUMA ACUTE CARE, V83, P398, DOI 10.1097/TA.0000000000001581; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Jokar TO, 2016, AM SURGEON, V82, P271; Kassambara A, 2018, SURVMINER DRAWING SU; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Pati S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192363; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Pusateri AE, 2020, JAMA SURG, V155, DOI 10.1001/jamasurg.2019.5085; R Core Team, 2017, R LANG ENV STAT COMP; Reitz KM, 2020, J TRAUMA ACUTE CARE, V88, P33, DOI 10.1097/TA.0000000000002485; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rodriguez EG, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0565-3; Shackelford SA, 2017, JAMA-J AM MED ASSOC, V318, P1581, DOI 10.1001/jama.2017.15097; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Therneau T., 2015, PACKAGE SURVIVAL ANA; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	46	20	20	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	OCT 15	2020	3	10							e2016869	10.1001/jamanetworkopen.2020.16869			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OI5DS	WOS:000583299600001	33057642	Green Published, gold			2022-02-06	
J	Allison, TA; Lin, PJ; Gass, JA; Chong, K; Prater, SJ; Escobar, MA; Hartman, HD				Allison, Teresa A.; Lin, Pei Jen; Gass, Jennifer A.; Chong, Kenneth; Prater, Samuel J.; Escobar, Miguel A.; Hartman, Heather D.			Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						anticoagulants; blood coagulation; hemostatics; therapeutic use; hemorrhage; prevention and control; hemorrhage; drug therapy; prothrombin complex concentrates	RIVAROXABAN; WARFARIN; EDOXABAN; DABIGATRAN; APIXABAN; MANAGEMENT	Objective: This study investigated the percentage of patients who achieved hemostasis with 4-factor prothrombin complex concentrate (4-factor PCC) 35 U/kg. The primary end point was to determine the effect of 4-factor PCC 35 U/kg on bleeding progression, assessed using computed tomography. Methods: This was a retrospective, observational, single-center study conducted in patients with a major bleed admitted to a level 1 trauma center from May 1, 2013, to June 15, 2015, who received 4-factor PCC 35 U/kg for reversal of a direct factor Xa inhibitor taken prior to admission. Results: Thirty-three patients were included in the study, with 31 patients in the final analysis. The mean (standard deviation) age was 73 (14.8) years; 54.5% of patients were female. Of the 33 patients, 13 presented with a traumatic brain injury, 9 with an aneurysmal subarachnoid hemorrhage, 8 with an intracerebral hemorrhage, 1 with a gastrointestinal bleed, 1 with a hematoma with active extravasation, and 1 with an intra-abdominal bleed. The most frequently used direct factor Xa inhibitor was rivaroxaban (81.8%). Overall, 83.8% of patients achieved hemostasis with 4-factor PCC 35 U/kg. Progression of hemorrhage was observed in 4 patients on repeat computed tomography scan and 1 patient had continued surgical bleeding. No thromboembolic events were reported. Conclusions: Low-dose, 4-factor PCC 35 U/kg appeared to produce hemostasis in a majority of the patients. This may be an effective dosing regimen for anticoagulant reversal of factor Xa inhibitors in clinically bleeding patients.	[Allison, Teresa A.; Lin, Pei Jen; Gass, Jennifer A.; Chong, Kenneth; Hartman, Heather D.] Mem Hermann Texas Med Ctr, Dept Pharm, Houston, TX 77030 USA; [Prater, Samuel J.; Escobar, Miguel A.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, McGovern Med Sch, Houston, TX 77030 USA		Hartman, HD (corresponding author), Mem Hermann Texas Med Ctr, Dept Pharm Serv, 6411 Fannin St, Houston, TX 77030 USA.	heather.hartman@memorialhermann.org	Gass, Jennifer/X-9446-2019	Gass, Jennifer/0000-0002-9113-4033			Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; [Anonymous], 2015, ELIQUIS; [Anonymous], 2014, XAR PACK INS; [Anonymous], 2015, PRAD PACK INS; [Anonymous], 2018, AND PACK INS; [Anonymous], 2014, KCENTR PACK INS; [Anonymous], 2015, SAVAYSA; [Anonymous], 2015, COUM PACK INS; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Herzog E, 2015, ANESTHESIOLOGY, V122, P387, DOI 10.1097/ALN.0000000000000520; Kalina U, 2008, INT J CLIN PRACT, V62, P1614, DOI 10.1111/j.1742-1241.2008.01859.x; Khorsand N, 2016, J THROMB HAEMOST, V14, P211, DOI 10.1111/jth.13148; Levi M, 2014, J THROMB HAEMOST, V12, P1428, DOI 10.1111/jth.12599; Majeed A, 2017, BLOOD, V130, P1706, DOI 10.1182/blood-2017-05-782060; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pezborn E, 2010, PATHOPHYSIOL HAEMO T, V37, pA10; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schulman S, 2018, THROMB HAEMOSTASIS, V118, P842, DOI 10.1055/s-0038-1636541; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Siegal DM, 2015, J THROMB THROMBOLYS, V39, P395, DOI 10.1007/s11239-015-1167-9; Zahir H, 2015, CIRCULATION, V131, P82, DOI 10.1161/CIRCULATIONAHA.114.013445	27	20	20	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	SEP	2020	35	9					903	908		10.1177/0885066618800657			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MT2PL	WOS:000554807700011	30244638				2022-02-06	
J	Early, AN; Gorman, AA; Van Eldik, LJ; Bachstetter, AD; Morganti, JM				Early, Alexandria N.; Gorman, Amy A.; Van Eldik, Linda J.; Bachstetter, Adam D.; Morganti, Josh M.			Effects of advanced age upon astrocyte-specific responses to acute traumatic brain injury in mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Astrocytes; TBI; Aging; Clasmatodendrosis; Neuroinflammation	CENTRAL-NERVOUS-SYSTEM; REACTIVE ASTROCYTES; ALZHEIMERS-DISEASE; COGNITIVE RECOVERY; ASTROGLIAL DEATH; CD44 EXPRESSION; HEAD TRAUMA; RISK-FACTOR; CLASMATODENDROSIS; PROTEIN	Background Older-age individuals are at the highest risk for disability from a traumatic brain injury (TBI). Astrocytes are the most numerous glia in the brain, necessary for brain function, yet there is little known about unique responses of astrocytes in the aged-brain following TBI. Methods Our approach examined astrocytes in young adult, 4-month-old, versus aged, 18-month-old mice, at 1, 3, and 7 days post-TBI. We selected these time points to span the critical period in the transition from acute injury to presumably irreversible tissue damage and disability. Two approaches were used to define the astrocyte contribution to TBI by age interaction: (1) tissue histology and morphological phenotyping, and (2) transcriptomics on enriched astrocytes from the injured brain. Results Aging was found to have a profound effect on the TBI-induced loss of astrocyte function needed for maintaining water transport and edema-namely, aquaporin-4. The aged brain also demonstrated a progressive exacerbation of astrogliosis as a function of time after injury. Moreover, clasmatodendrosis, an underrecognized astrogliopathy, was found to be significantly increased in the aged brain, but not in the young brain. As a function of TBI, we observed a transitory refraction in the number of these astrocytes, which rebounded by 7 days post-injury in the aged brain. Transcriptomic data demonstrated disproportionate changes in genes attributed to reactive astrocytes, inflammatory response, complement pathway, and synaptic support in aged mice following TBI compared to young mice. Additionally, our data highlight that TBI did not evoke a clear alignment with the previously defined "A1/A2" dichotomy of reactive astrogliosis. Conclusions Overall, our findings point toward a progressive phenotype of aged astrocytes following TBI that we hypothesize to be maladaptive, shedding new insights into potentially modifiable astrocyte-specific mechanisms that may underlie increased fragility of the aged brain to trauma.	[Early, Alexandria N.; Gorman, Amy A.; Van Eldik, Linda J.; Bachstetter, Adam D.; Morganti, Josh M.] Univ Kentucky, Sanders Brown Ctr Aging, Room 433,800 S Limestone St, Lexington, KY 40536 USA; [Early, Alexandria N.; Van Eldik, Linda J.; Bachstetter, Adam D.; Morganti, Josh M.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Van Eldik, Linda J.; Bachstetter, Adam D.; Morganti, Josh M.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Morganti, JM (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Room 433,800 S Limestone St, Lexington, KY 40536 USA.; Morganti, JM (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA.; Morganti, JM (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA.	josh.morganti@uky.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049	National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [R01NS103785, R00AG044445, UL1TR001998, R21AG058006]; National Institute on Aging, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01NS103785, R00AG044445, UL1TR001998, R21AG058006]	Funding This project was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences and National Institute on Aging, National Institutes of Health, through Grants R01NS103785 (ADB), R00AG044445 (ADB), UL1TR001998 pilot award (JMM), and R21AG058006 (JMM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Akiguchi I, 1997, STROKE, V28, P1423, DOI 10.1161/01.STR.28.7.1423; Allen NJ, 2017, NEURON, V96, P697, DOI 10.1016/j.neuron.2017.09.056; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Batiuk MY, 2017, J BIOL CHEM, V292, P8874, DOI 10.1074/jbc.M116.765313; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Chen AQ, 2016, BRAIN, V139, P242, DOI 10.1093/brain/awv328; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Domingues HS, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00071; Ferriero D. M., 2014, J BIOL METHODS, V1, DOI DOI 10.14440/JBM.2014.33; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frieler RA, 2015, BRAIN RES, V1624, P103, DOI 10.1016/j.brainres.2015.07.011; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Gabel S, 2016, MOL NEUROBIOL, V53, P5041, DOI 10.1007/s12035-015-9428-3; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kantzer CG, 2017, GLIA, V65, P990, DOI 10.1002/glia.23140; Kim DS, 2008, J COMP NEUROL, V511, P581, DOI 10.1002/cne.21851; Kim JH, 2017, GLIA, V65, P1471, DOI 10.1002/glia.23174; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lalo U, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001747; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Nielsen S, 1997, J NEUROSCI, V17, P171; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Pekny M, 2001, Prog Brain Res, V132, P23; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Penfield W, 1928, NEUROGLIA MICROGLIA; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Sahlas DJ, 2002, ANN NEUROL, V52, P378, DOI 10.1002/ana.10310; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Seifert G, 2013, EXP NEUROL, V244, P4, DOI 10.1016/j.expneurol.2011.08.024; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sorci Guglielmo, 2010, Italian Journal of Anatomy and Embryology, V115, P147; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Sosunov AA, 2013, J NEUROSCI, V33, P7439, DOI 10.1523/JNEUROSCI.4506-12.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tomimoto H, 1997, ACTA NEUROPATHOL, V94, P146, DOI 10.1007/s004010050686; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Villapol S, 2017, GLIA, V63, P1966; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeppenfeld DM, 2017, JAMA NEUROL, V74, P91, DOI 10.1001/jamaneurol.2016.4370	79	20	20	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	APR 14	2020	17	1							115	10.1186/s12974-020-01800-w			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	LG0ML	WOS:000527805600002	32290848	Green Published, Green Submitted, gold			2022-02-06	
J	Killgore, WDS; Vanuk, JR; Shane, BR; Weber, M; Bajaj, S				Killgore, William D. S.; Vanuk, John R.; Shane, Bradley R.; Weber, Mareen; Bajaj, Sahil			A randomized, double-blind, placebo-controlled trial of blue wavelength light exposure on sleep and recovery of brain structure, function, and cognition following mild traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						mTBI; Concussion; Light therapy; Blue light; Sleep; Circadian rhythm; Neuroimaging; DTI; VBM; Connectivity	DELAYED SLEEP; BRIGHT LIGHT; MELATONIN; DEPRIVATION; DISTURBANCE; WAKE; CONNECTIVITY; SENSITIVITY; DIFFUSION; THALAMUS	Sleep and circadian rhythms are among the most powerful but least understood contributors to cognitive performance and brain health. Here we capitalize on the circadian resetting effect of blue-wavelength light to phase shift the sleep patterns of adult patients (aged 18-48 years) recovering from mild traumatic brain injury (mTBI), with the aim of facilitating recovery of brain structure, connectivity, and cognitive performance. During a randomized, double-blind, placebo-controlled trial of 32 adults with a recent mTBI, we compared 6-weeks of daily 30-min pulses of blue light (peak lambda = 469 nm) each morning versus amber placebo light (peak lambda= 578 nm) on neurocognitive and neuroimaging outcomes, including gray matter volume (GMV), resting-state functional connectivity, directed connectivity using Granger causality, and white matter integrity using diffusion tensor imaging (DTI). Relative to placebo, morning blue light led to phase-advanced sleep timing, reduced daytime sleepiness, and improved executive functioning, and was associated with increased volume of the posterior thalamus (i.e., pulvinar), greater thalamo-cortical functional connectivity, and increased axonal integrity of these pathways. These findings provide insight into the contributions of the circadian and sleep systems in brain repair and lay the groundwork for interventions targeting the retinohypothalamic system to facilitate injury recovery.	[Killgore, William D. S.; Vanuk, John R.; Shane, Bradley R.; Weber, Mareen; Bajaj, Sahil] Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ 85721 USA		Killgore, WDS (corresponding author), Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ 85721 USA.	killgore@psychiatry.arizona.edu	; Bajaj, Sahil/C-6580-2016	Killgore, William/0000-0002-5328-0208; Bajaj, Sahil/0000-0003-0629-6036	U.S. Army Medical Research and Development Command [W81XWH-11-1-0056]	This study was funded by a grant from the U.S. Army Medical Research and Development Command (W81XWH-11-1-0056) to W. D. S.K.	Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Bajaj S, 2016, BRAIN CONNECT, V6, P652, DOI 10.1089/brain.2016.0422; Bajaj S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00616; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bellesi M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy034; Bellesi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36804; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P113, DOI 10.1097/HTR.0000000000000379; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Clark AL, 2018, J HEAD TRAUMA REHAB, V33, P382, DOI 10.1097/HTR.0000000000000377; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dai XJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00266; de Vivo L, 2017, SCIENCE, V355, P507, DOI 10.1126/science.aah5982; Dhamala M., 2013, ENCY COMPUTATIONAL N; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Figueiro MG, 2014, CLIN INTERV AGING, V9, P1527, DOI 10.2147/CIA.S68557; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Geerdink M, 2016, J BIOL RHYTHM, V31, P483, DOI 10.1177/0748730416657462; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HERSCOVITCH J, 1981, SLEEP, V4, P83, DOI 10.1093/sleep/4.1.83; Honma S, 2018, J PHYSIOL SCI, V68, P207, DOI 10.1007/s12576-018-0597-5; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x; Killgore WDS, 2007, SLEEP, V30, P345, DOI 10.1093/sleep/30.3.345; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lavie P, 2001, ANNU REV PSYCHOL, V52, P277, DOI 10.1146/annurev.psych.52.1.277; Liu CL, 2014, NEUROREPORT, V25, P320, DOI 10.1097/WNR.0000000000000091; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Monk T.H., 2005, CLIN SPORTS MED, V24, pxi; Munivenkatappa A, 2016, BRAIN INJURY, V30, P388, DOI 10.3109/02699052.2015.1089599; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raikes Adam C, 2018, Concussion, V3, pCNC57, DOI 10.2217/cnc-2018-0006; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Richardson C, 2018, SLEEP MED, V45, P114, DOI 10.1016/j.sleep.2018.02.001; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rosa JPP, 2018, CHRONOBIOL INT, V35, P1095, DOI 10.1080/07420528.2018.1459660; Sapede D, 2013, CURR TOP DEV BIOL, V106, P171, DOI 10.1016/B978-0-12-416021-7.00005-5; Saxvig IW, 2014, CHRONOBIOL INT, V31, P72, DOI 10.3109/07420528.2013.823200; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Tahkamo L, 2018, CHRONOBIOL INT, V36, P1; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Wu LM, 2018, J CLIN SLEEP MED, V14, P31, DOI 10.5664/jcsm.6874; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yeh E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060439; Yeh FC, 2016, NEUROIMAGE, V125, P162, DOI 10.1016/j.neuroimage.2015.10.053; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	72	20	21	6	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	FEB	2020	134								104679	10.1016/j.nbd.2019.104679			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KG3BV	WOS:000509818400045	31751607	hybrid, Green Published			2022-02-06	
J	Ye, XC; Hao, Q; Ma, WJ; Zhao, QC; Wang, WW; Yin, HH; Zhang, T; Wang, M; Zan, K; Yang, XX; Zhang, ZH; Shi, HJ; Zu, J; Raza, HK; Zhang, XL; Geng, DQ; Hu, JX; Cui, GY				Ye, Xin-Chun; Hao, Qi; Ma, Wei-Jing; Zhao, Qiu-Chen; Wang, Wei-Wei; Yin, Han-Han; Zhang, Tao; Wang, Miao; Zan, Kun; Yang, Xin-Xin; Zhang, Zuo-Hui; Shi, Hong-Juan; Zu, Jie; Raza, Hafiz Khuram; Zhang, Xue-Ling; Geng, De-Qin; Hu, Jin-Xia; Cui, Gui-Yun			Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Dectin-1; Syk; inflammation; ischemic stroke	TYROSINE KINASE SYK; BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTORS; NLRP3 INFLAMMASOME; BRAIN-INJURY; KAPPA-B; ACTIVATION; EXPRESSION; RECOGNITION; INHIBITION	Background Dendritic cell-associated C-type lectin-1 (Dectin-1) receptor has been reported to be involved in neuroinflammation in Alzheimer's disease and traumatic brain injury. The present study was designed to investigate the role of Dectin-1 and its downstream target spleen tyrosine kinase (Syk) in early brain injury after ischemic stroke using a focal cortex ischemic stroke model. Methods Adult male C57BL/6 J mice were subjected to a cerebral focal ischemia model of ischemic stroke. The neurological score, adhesive removal test, and foot-fault test were evaluated on days 1, 3, 5, and 7 after ischemic stroke. Dectin-1, Syk, phosphorylated (p)-Syk, tumor necrosis factor-alpha (TNF-alpha), and inducible nitric oxide synthase (iNOS) expression was analyzed via western blotting in ischemic brain tissue after ischemic stroke and in BV2 microglial cells subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) injury in vitro. The brain infarct volume and Iba1-positive cells were evaluated using Nissl's and immunofluorescence staining, respectively. The Dectin-1 antagonist laminarin (LAM) and a selective inhibitor of Syk phosphorylation (piceatannol; PIC) were used for the intervention. Results Dectin-1, Syk, and p-Syk expression was significantly enhanced on days 3, 5, and 7 and peaked on day 3 after ischemic stroke. The Dectin-1 antagonist LAM or Syk inhibitor PIC decreased the number of Iba1-positive cells and TNF-alpha and iNOS expression, decreased the brain infarct volume, and improved neurological functions on day 3 after ischemic stroke. In addition, the in vitro data revealed that Dectin-1, Syk, and p-Syk expression was increased following the 3-h OGD and 0, 3, and 6 h of reperfusion in BV2 microglial cells. LAM and PIC also decreased TNF-alpha and iNOS expression 3 h after OGD/R induction. Conclusion Dectin-1/Syk signaling plays a crucial role in inflammatory activation after ischemic stroke, and further investigation of Dectin-1/Syk signaling in stroke is warranted.	[Ye, Xin-Chun; Ma, Wei-Jing; Yin, Han-Han; Zhang, Tao; Wang, Miao; Zan, Kun; Yang, Xin-Xin; Zhang, Zuo-Hui; Shi, Hong-Juan; Zu, Jie; Raza, Hafiz Khuram; Geng, De-Qin; Hu, Jin-Xia; Cui, Gui-Yun] Xuzhou Med Univ, Inst Stroke Ctr, Xuzhou, Jiangsu, Peoples R China; [Ye, Xin-Chun; Ma, Wei-Jing; Yin, Han-Han; Zhang, Tao; Wang, Miao; Zan, Kun; Yang, Xin-Xin; Zhang, Zuo-Hui; Shi, Hong-Juan; Zu, Jie; Raza, Hafiz Khuram; Geng, De-Qin; Hu, Jin-Xia; Cui, Gui-Yun] Xuzhou Med Univ, Dept Neurol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Hao, Qi] Xuzhou Med Univ, Dept Neurol, Affiliated Hosp 2, Xuzhou, Jiangsu, Peoples R China; [Zhao, Qiu-Chen] Nanjing Univ, Drum Tower Hosp, Dept Neurol, Med Sch, Nanjing, Peoples R China; [Wang, Wei-Wei] Linyi Canc Hosp, Dept Rehabil Med, Linyi, Shandong, Peoples R China; [Zhang, Xue-Ling] Nanjing Drum Tower Hosp Grp, Dept Neurol, Suqian Peoples Hosp, Suqian, Jiangsu, Peoples R China		Ye, XC; Hu, JX; Cui, GY (corresponding author), Xuzhou Med Univ, Inst Stroke Ctr, Xuzhou, Jiangsu, Peoples R China.; Ye, XC; Hu, JX; Cui, GY (corresponding author), Xuzhou Med Univ, Dept Neurol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	xinchunye@xzhmu.edu.cn; jinxia0819@163.com; guiyuncui@foxmail.com	Raza, Hafiz Khuram/AAX-4308-2020; Zhang, Zuohui/AAQ-6728-2021	Raza, Hafiz Khuram/0000-0002-1748-7359; Zhang, Zuohui/0000-0002-8486-4767	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971134, 81571155, 81571210, 81771282]; National Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20191152, BK20150209, BL2014031]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [17KJB320017]; Jiangsu Provincial Medical Youth Talent [QNRC2016788]; Jiangsu Commission of Heath [LGY2019086]; Xuzhou Key Research and Development Program [KC18055, KC19131]; Xuzhou Innovation Capacity Building Program [KC19239]; Suqian Science and Technology Plan [S201714]; Summit of Six Top Talents Program of Jiangsu Province [2017-WSN-118]	The present study was supported by the National Natural Science Foundation of China (grant nos. 81971134 and 81571155 to Dr. Ye and grant nos. 81571210 and 81771282 to Dr. Cui), the National Natural Science Foundation of Jiangsu Province (grant nos. BK20191152, BK20150209 and BL2014031), the Natural Science Foundation of the Higher Education Institutions of Jiangsu Province (grant no. 17KJB320017), Jiangsu Provincial Medical Youth Talent (grant no. QNRC2016788), Jiangsu Commission of Heath (grant no. LGY2019086), Xuzhou Key Research and Development Program (grant nos. KC18055 and KC19131), Xuzhou Innovation Capacity Building Program (grant no. KC19239), Suqian Science and Technology Plan (grant no. S201714), and the Summit of Six Top Talents Program of Jiangsu Province (grant no. 2017-WSN-118).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Benakis C, 2010, BRAIN BEHAV IMMUN, V24, P800, DOI 10.1016/j.bbi.2009.11.001; Bertuzzi M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004413; Bhatia HS, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0615-6; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dhungana H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1010-7; Duta F, 2006, HISTOCHEM CELL BIOL, V126, P495, DOI 10.1007/s00418-006-0188-z; Eldahshan W, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104349; Friedrich V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-103; Frontera JA, 2012, J THROMB HAEMOST, V10, P711, DOI 10.1111/j.1538-7836.2012.04651.x; Gao L, 2017, INFLAMM RES, V66, P17, DOI 10.1007/s00011-016-0981-7; GEAHLEN RL, 1994, ADV EXP MED BIOL, V365, P103; Gensel JC, 2015, J NEUROSCI, V35, P9966, DOI 10.1523/JNEUROSCI.0337-15.2015; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Huang C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-129; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ishizuka F, 2013, INVEST OPHTH VIS SCI, V54, P5807, DOI 10.1167/iovs.13-11932; Jeong D, 2013, J ETHNOPHARMACOL, V146, P205, DOI 10.1016/j.jep.2012.12.034; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lech M, 2012, INT J MOL SCI, V13, P10113, DOI 10.3390/ijms130810113; Lugo-Villarino G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01123; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Pamuk ON, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3198; Pamuk ON, 2010, AM J PHYSIOL-GASTR L, V299, pG391, DOI 10.1152/ajpgi.00198.2010; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reid DM, 2004, J LEUKOCYTE BIOL, V76, P86, DOI 10.1189/jlb.0104031; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Seok Yang Woo, 2012, J Ethnopharmacol, V142, P287, DOI 10.1016/j.jep.2012.04.026; Shichita T, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07941.x; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Sun WK, 2012, EUR J CLIN MICROBIOL, V31, P2755, DOI 10.1007/s10096-012-1624-8; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang CS, 2009, GLIA, V57, P1091, DOI 10.1002/glia.20832; Ye XC, 2018, STROKE, V49, P165, DOI 10.1161/STROKEAHA.117.018115; Ye XC, 2017, EXP NEUROL, V292, P46, DOI 10.1016/j.expneurol.2017.03.002; Yin ZR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00065; Yoon JY, 2013, J ETHNOPHARMACOL, V148, P999, DOI 10.1016/j.jep.2013.05.030; Ystgaard MB, 2015, NEONATOLOGY, V108, P211, DOI 10.1159/000437247; Yu T, 2012, J ETHNOPHARMACOL, V139, P566, DOI 10.1016/j.jep.2011.11.051; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031	60	20	21	9	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 11	2020	17	1							17	10.1186/s12974-019-1693-z			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	KL9AE	WOS:000513708500003	31926564	Green Submitted, Green Published, gold			2022-02-06	
J	Miller, LE; Pinkerton, EK; Fabian, KC; Wu, LC; Espeland, MA; Lamond, LC; Miles, CM; Camarillo, DB; Stitzel, JD; Urban, JE				Miller, Logan E.; Pinkerton, Elizabeth K.; Fabian, Katie C.; Wu, Lyndia C.; Espeland, Mark A.; Lamond, Lindsey C.; Miles, Christopher M.; Camarillo, David B.; Stitzel, Joel D.; Urban, Jillian E.			Characterizing head impact exposure in youth female soccer with a custom-instrumented mouthpiece	RESEARCH IN SPORTS MEDICINE			English	Article						Subconcussive head impacts; head impact exposure; mouthpiece; instrumentation; women's soccer	STATES HIGH-SCHOOL; CONCUSSION INCIDENCE; BRAIN; EPIDEMIOLOGY; INJURIES; ACCELERATION; SPORTS	While many research efforts have focused on head impact exposure in professional soccer, there have been few studies characterizing exposure at the youth level. The aim of this study is to evaluate a new instrumentation approach and collect some of the first head impact exposure data for youth female soccer players. Athletes were instrumented with custom-fit mouthpieces that measure head impacts. Detailed video analysis was conducted to identify characteristics describing impact source (e.g., kick, header, throw). A total of 763 verified head impacts were collected over 23 practices and 8 games from 7 athletes. The median peak linear accelerations, rotational velocities, and rotational accelerations of all impacts were 9.4 g, 4.1 rad/s, and 689 rad/s(2), respectively. Pairwise comparisons resulted in statistically significant differences in kinematics by impact source. Headers following a kicked ball had the highest accelerations and velocity when compared to headers from thrown or another header.	[Miller, Logan E.; Pinkerton, Elizabeth K.; Fabian, Katie C.; Miles, Christopher M.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27106 USA; [Miller, Logan E.; Stitzel, Joel D.; Urban, Jillian E.] Wake Forest Univ, Sch Biomed Engn & Sci, Virginia Tech, Winston Salem, NC 27101 USA; [Wu, Lyndia C.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27106 USA; [Lamond, Lindsey C.] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC 27106 USA		Urban, JE (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27106 USA.	jurban@wakehealth.edu	Wu, Lyndia/AAQ-1106-2020	Wu, Lyndia/0000-0002-8236-032X			Abramowitz M., 1965, HDB MATH FUNCTIONS F, V55; [Anonymous], 2007, J2111 SAE; [Anonymous], 2016, IMPLEMENTATION GUIDE; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Cuff SC, 2019, RES SPORTS MED, V27, P11, DOI 10.1080/15438627.2018.1502186; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; FIFA Communications Division, 2007, FIFA DAT BIG COUNT 2, DOI 10.1177/0883073816634857; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Hood E. A., 2018, RES SPORTS MED, P1; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hunter LE, 2018, RES SPORTS MED, V26, P390, DOI 10.1080/15438627.2018.1492396; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Langhorst P., 2016, ENGAGE SPORTS; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Littell R.C., 1996, SAS SYSTEM MIXED MOD; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Miller LE, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039165; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Press J. N, 2016, CLIN J SPORT MED; Rowson S., 2012, HEAD ACCELERATION ME; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Self BP, 2006, ENG SPORT 6, V6, P81; Tyson A., 2017, LAB EVALUATION LOW C; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; U.S. Soccer Announces Recognize to Recover Player Health and Safety Program, 2015, US SOCCER ANNOUNCES; U.S. Soccer Provides Additional Information About Upcoming Player Safety Campaign, 2015, US SOCCER PROVIDES A; Walker L. B., 1973, SAE TECHNICAL PAPER; Wu L. C., 2016, ANN BIOMED ENG, P1; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153	46	20	20	2	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	JAN 2	2020	28	1					55	71		10.1080/15438627.2019.1590833			17	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KE9PZ	WOS:000508883700005	30880469				2022-02-06	
J	Alirezaei, Z; Pourhanifeh, MH; Borran, S; Nejati, M; Mirzaei, H; Hamblin, MR				Alirezaei, Zahra; Pourhanifeh, Mohammad Hossein; Borran, Sarina; Nejati, Majid; Mirzaei, Hamed; Hamblin, Michael R.			Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders	MOLECULAR NEUROBIOLOGY			English	Article						Neurofilament light chain; Biomarker; Neurodegenerative disorders; Magnetic resonance imaging; Diffusion tensor imaging	AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID BIOMARKERS; MARIE-TOOTH-DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; TRAUMATIC BRAIN-INJURY; WHITE-MATTER DAMAGE; MULTIPLE-SCLEROSIS; NEURODEGENERATIVE DISEASES; DIFFERENTIAL-DIAGNOSIS; PARKINSONS-DISEASE	The search for diagnostic and prognostic biomarkers for neurodegenerative conditions is of high importance, since these disorders may present difficulties in differential diagnosis. Biomarkers with high sensitivity and specificity are required. Neurofilament light chain (NfL) is a unique biomarker related to axonal damage and neural cell death, which is elevated in a number of neurological disorders, and can be detected in cerebrospinal fluid (CSF), as well as blood, serum, or plasma samples. Although the NfL concentration in CSF is higher than that in blood, blood measurement may be easier in practice due to its lesser invasiveness, reproducibility, and convenience. Many studies have investigated NfL in both CSF and serum/plasma as a potential biomarker of neurodegenerative disorders. Neuroimaging biomarkers can also potentially improve detection of CNS-related disorders at an early stage. Magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) are sensitive techniques to visualize neuroaxonal loss. Therefore, investigating the combination of NfL levels with indices extracted from MRI and DTI scans could potentially improve diagnosis of CNS-related disorders. This review summarizes the evidence for NfL being a reliable biomarker in the early detection and disease management in several CNS-related disorders. Moreover, we highlight the correlation between MRI and NfL and ask whether they can be combined.	[Alirezaei, Zahra] Isfahan Univ Med Sci, Sch Med, Dept Med Phys, Esfahan, Iran; [Pourhanifeh, Mohammad Hossein; Mirzaei, Hamed] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran; [Borran, Sarina] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran; [Nejati, Majid] Kashan Univ Med Sci, Anat Sci Res Ctr, Kashan, Iran; [Hamblin, Michael R.] Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, 40 Blossom St, Boston, MA 02114 USA		Mirzaei, H (corresponding author), Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran.; Hamblin, MR (corresponding author), Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, 40 Blossom St, Boston, MA 02114 USA.	zahra.alirezaei@gmail.com; mhph.lord.1996@gmail.com; Sarina.borran@sbmu.ac.ir; mnejatimt@gmail.com; mirzaei-h@kaums.ac.ir; HAMBLIN@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605; Pourhanifeh, Mohammad Hossein/0000-0002-6752-2765; mirzaei, hamed/0000-0002-9399-8281	National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875, R21AI121700] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R21 AI121700, R01 AI050875] Funding Source: Medline		Abdo WF, 2007, NEUROBIOL AGING, V28, P742, DOI 10.1016/j.neurobiolaging.2006.03.010; Abe A, 2009, J HUM GENET, V54, P94, DOI 10.1038/jhg.2008.13; Abu-Rumeileh S, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-017-0331-1; Acosta-Cabronero J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00266; Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Arrambide G, 2016, NEUROLOGY, V87, P1076, DOI 10.1212/WNL.0000000000003085; Baldaranov D, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00567; Barro C, 2018, BRAIN, V141, P2382, DOI 10.1093/brain/awy154; Bergman J, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000271; Burman J, 2014, ACTA NEUROL SCAND, V130, P81, DOI 10.1111/ane.12239; Burns A, 2011, DEMENT GERIATR COGN, V31, P158, DOI 10.1159/000324438; Byrne LM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7108; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Cai LS, 2018, NEUROPSYCH DIS TREAT, V14, P2241, DOI 10.2147/NDT.S173280; Califf RM, 2018, EXP BIOL MED, V243, P213, DOI 10.1177/1535370217750088; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Chitnis T, 2018, ANN CLIN TRANSL NEUR, V5, P1478, DOI 10.1002/acn3.638; Clement A, 2017, NEUROSCIENCE, V354, P101, DOI 10.1016/j.neuroscience.2017.04.030; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Constantinescu R, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00187; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P245, DOI 10.1016/j.parkreldis.2008.05.012; Cousins DA, 2012, CNS NEUROSCI THER, V18, P201, DOI 10.1111/j.1755-5949.2011.00280.x; de Jong D, 2007, J NEUROL NEUROSUR PS, V78, P936, DOI 10.1136/jnnp.2006.107326; De Marchis GM, 2018, EUR J NEUROL, V25, P562, DOI 10.1111/ene.13554; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Disanto G, 2016, J NEUROL NEUROSUR PS, V87, P126, DOI 10.1136/jnnp-2014-309690; Duering M, 2018, J STROKE, V20, P228, DOI 10.5853/jos.2017.02565; Feneberg E, 2018, NEUROLOGY, V90, pE22, DOI 10.1212/WNL.0000000000004761; Foerster BR, 2013, ACAD RADIOL, V20, P1099, DOI 10.1016/j.acra.2013.03.017; Fornari E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.014; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gaiani A, 2017, JAMA NEUROL, V74, P525, DOI 10.1001/jamaneurol.2016.5398; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gattringer T, 2017, NEUROLOGY, V89, P2108, DOI 10.1212/WNL.0000000000004645; Gille B., 2018, NEUROPATHOLOGY APPL, V45, P291; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Glass M, 2000, NEUROSCIENCE, V97, P505, DOI 10.1016/S0306-4522(00)00008-7; Goryunov D, 2008, J NEUROCHEM, V104, P1536, DOI 10.1111/j.1471-4159.2007.05103.x; Grossman M, 2014, JAMA NEUROL, V71, P442, DOI 10.1001/jamaneurol.2013.6064; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Haghighi S, 2004, ACTA NEUROL SCAND, V109, P97, DOI 10.1034/j.1600-0404.2003.00197.x; Hakansson I, 2017, EUR J NEUROL, V24, P703, DOI 10.1111/ene.13274; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Halliday GM, 2014, MOVEMENT DISORD, V29, P634, DOI 10.1002/mds.25857; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Henley SMD, 2005, CURR OPIN NEUROL, V18, P698, DOI 10.1097/01.wco.0000186842.51129.cb; Herbert MK, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00091; Herrmann W, 2011, CLIN CHEM LAB MED, V49, P435, DOI 10.1515/CCLM.2011.084; Hoy AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173982; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Huizinga R, 2008, TRENDS IMMUNOL, V29, P54, DOI 10.1016/j.it.2007.11.002; Huizinga R, 2007, J NEUROPATH EXP NEUR, V66, P295, DOI 10.1097/nen.0b013e318040ad5c; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Isgren A, 2017, BRAIN BEHAV IMMUN, V65, P195, DOI 10.1016/j.bbi.2017.05.002; Jakobsson J, 2014, NEUROPSYCHOPHARMACOL, V39, P2349, DOI 10.1038/npp.2014.81; Jeromin A, 2017, ADV NEUROBIOL, V15, P491, DOI 10.1007/978-3-319-57193-5_20; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Khalil M, 2016, NEUROLOGY, V87, P1068, DOI 10.1212/WNL.0000000000003107; Koikkalainen J, 2016, NEUROIMAGE-CLIN, V11, P435, DOI 10.1016/j.nicl.2016.02.019; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; Kuhle J, 2016, MULT SCLER J, V22, P1550, DOI 10.1177/1352458515623365; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Kuhle J, 2015, NEUROLOGY, V84, P1639, DOI 10.1212/WNL.0000000000001491; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Landqvist Waldo Maria, 2013, BMC Neurol, V13, P54, DOI 10.1186/1471-2377-13-54; Lewczuk P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0404-9; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Lin YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35766-w; Lista S, 2017, NEUROCHEM INT, V108, P355, DOI 10.1016/j.neuint.2017.05.010; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Magdalinou NK, 2017, PARKINSONISM RELAT D, V37, P65, DOI 10.1016/j.parkreldis.2017.01.016; Mahoney CJ, 2015, ANN NEUROL, V77, P33, DOI 10.1002/ana.24296; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; Masjuan J, 2006, NEUROLOGY, V66, P576, DOI 10.1212/01.wnl.0000198253.35119.83; Mattsson N, 2008, MOL MED REP, V1, P757, DOI 10.3892/mmr_00000025; Mattsson N, 2016, EMBO MOL MED, V8, P1184, DOI 10.15252/emmm.201606540; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Meeter LHH, 2018, NEUROLOGY, V90, pE1231, DOI 10.1212/WNL.0000000000005261; Mellgren A, 2007, NEUROLOGY, V69, P1536, DOI 10.1212/01.wnl.0000277635.05973.55; Menke RAL, 2015, ANN CLIN TRANSL NEUR, V2, P748, DOI 10.1002/acn3.212; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; Munemoto M, 2011, J CLIN NEUROSCI, V18, P478, DOI 10.1016/j.jocn.2010.07.141; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Niemela V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172762; Niikado Matias, 2018, J GERONTOL A-BIOL, V74, P442; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Norgren N, 2002, HYBRIDOMA HYBRIDOM, V21, P53, DOI 10.1089/15368590252917647; Novakova L, 2017, NEUROLOGY, V89, P2230, DOI 10.1212/WNL.0000000000004683; Novakova L, 2017, J NEUROCHEM, V141, P296, DOI 10.1111/jnc.13881; Novakova L, 2017, MULT SCLER J, V23, P62, DOI 10.1177/1352458516639384; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; Oeckl P, 2016, AMYOTROPH LAT SCL FR, V17, P404, DOI 10.3109/21678421.2016.1167913; Panman JL, 2017, ALZHEIMERS DEMENT, V13, P751, DOI [10.1016/j.jalz.2017.06.992, DOI 10.1016/J.JALZ.2017.06.992]; Perez-Olle R, 2002, J CELL SCI, V115, P4937, DOI 10.1242/jcs.00148; Perez-Olle R, 2004, HUM MOL GENET, V13, P2207, DOI 10.1093/hmg/ddh236; Petzold A, 2007, NEURODEGENER DIS, V4, P185, DOI 10.1159/000101843; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Petzold A, 2009, J NEUROL SCI, V279, P76, DOI 10.1016/j.jns.2008.12.037; Piehl F, 2018, MULT SCLER J, V24, P1046, DOI 10.1177/1352458517715132; Pijnenburg YAL, 2007, DEMENT GERIATR COGN, V23, P225, DOI 10.1159/000099473; Pijnenburg Yolande A L, 2015, Alzheimers Dement (Amst), V1, P505, DOI 10.1016/j.dadm.2015.11.001; Poesen K, 2017, NEUROLOGY, V88, P2302, DOI 10.1212/WNL.0000000000004029; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reiner A, 2011, INT REV NEUROBIOL, V98, P325, DOI [10.1016/B978-0-12-387003-2.00014-8, 10.1016/B978-0-12-381328-2.00014-6]; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rolstad S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127100; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Rossi D, 2018, J NEUROL, V265, P510, DOI 10.1007/s00415-017-8730-6; Rostgaard N, 2018, NEUROLOGY, V90, pE157, DOI 10.1212/WNL.0000000000004799; Sadaba MC, 2012, J NEUROIMMUNOL, V247, P86, DOI 10.1016/j.jneuroim.2012.03.020; Sako W, 2015, J NEUROL SCI, V352, P84, DOI 10.1016/j.jns.2015.03.041; Sandelius A, 2018, NEUROLOGY, V90, pE518, DOI 10.1212/WNL.0000000000004932; Saporta MA, 2013, NEUROL CLIN, V31, P597, DOI 10.1016/j.ncl.2013.01.009; Scherling CS, 2014, ANN NEUROL, V75, P116, DOI 10.1002/ana.24052; Schreiber S, 2018, J NEUROL, V265, P2633, DOI 10.1007/s00415-018-9043-0; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sharp AH, 1996, NEUROBIOL DIS, V3, P3, DOI 10.1006/nbdi.1996.0002; Silber E, 2002, NEUROLOGY, V58, P1372, DOI 10.1212/WNL.58.9.1372; Siller N, 2019, MULT SCLER J, V25, P678, DOI 10.1177/1352458518765666; Sjogren M, 2000, NEUROLOGY, V54, P1960, DOI 10.1212/WNL.54.10.1960; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; SOUSSAN L, 1994, MOL NEUROBIOL, V9, P83, DOI 10.1007/BF02816107; Soylu-Kucharz R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14179-1; Steinacker P, 2018, NEUROLOGY, V91, pE1390, DOI 10.1212/WNL.0000000000006318; Steinacker P, 2017, AMYOTROPH LAT SCL FR, V18, P112, DOI 10.1080/21678421.2016.1241279; Steinacker P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38737; Steinacker P, 2016, J NEUROL NEUROSUR PS, V87, P12, DOI 10.1136/jnnp-2015-311387; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stieltjes B, 2013, DIFFUSION TENSOR IMA; Stoessl AJ, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-5; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Sykova E, 2004, NEUROSCIENCE, V129, P861, DOI 10.1016/j.neuroscience.2004.06.077; Talja I, 2009, ANN NY ACAD SCI, V1173, P130, DOI 10.1111/j.1749-6632.2009.04624.x; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Thompson AGB, 2018, J NEUROL NEUROSUR PS, V89, P955, DOI 10.1136/jnnp-2017-317793; Tiedt S, 2018, NEUROLOGY, V91, pE1338, DOI 10.1212/WNL.0000000000006282; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tortelli R, 2015, EUR J NEUROL, V22, P215, DOI 10.1111/ene.12421; Tortelli R, 2012, EUR J NEUROL, V19, P1561, DOI 10.1111/j.1468-1331.2012.03777.x; Traenka C, 2015, CEREBROVASC DIS, V40, P222, DOI 10.1159/000440774; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Verde F, 2019, J NEUROL NEUROSUR PS, V90, P157, DOI 10.1136/jnnp-2018-318704; Villar LM, 2015, EUR J NEUROL, V22, P1169, DOI 10.1111/ene.12579; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Waldo ML, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-54; Wang J, 2012, COCHRANE DATABASE SY, V2; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Weydt P, 2016, ANN NEUROL, V79, P152, DOI 10.1002/ana.24552; Wild EJ, 2007, NEUROSCI LETT, V417, P231, DOI 10.1016/j.neulet.2007.02.053; Wilke C, 2016, J NEUROL NEUROSUR PS, V87, P1270, DOI 10.1136/jnnp-2015-312972; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Yarnall AJ, 2013, AGE AGEING, V42, P567, DOI 10.1093/ageing/aft085; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037; Zhai JB, 2007, HUM MOL GENET, V16, P3103, DOI 10.1093/hmg/ddm272; Zhang Yan, 2007, Zhonghua Yi Xue Za Zhi, V87, P2745; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071; Zhou WJ, 2017, NEUROSCI LETT, V650, P60, DOI 10.1016/j.neulet.2017.04.027; Zucchi E, 2018, J NEUROCHEM, V146, P631, DOI 10.1111/jnc.14542	182	20	20	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2020	57	1			SI		469	491		10.1007/s12035-019-01698-3			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV1HZ	WOS:000520176200040	31385229	Green Accepted			2022-02-06	
J	Bernini, A; Masoodi, M; Solari, D; Miroz, JP; Carteron, L; Christinat, N; Morelli, P; Beaumont, M; Abed-Maillard, S; Hartweg, M; Foltzer, F; Eckert, P; Cuenoud, B; Oddo, M				Bernini, Adriano; Masoodi, Mojgan; Solari, Daria; Miroz, John-Paul; Carteron, Laurent; Christinat, Nicolas; Morelli, Paola; Beaumont, Maurice; Abed-Maillard, Samia; Hartweg, Mickael; Foltzer, Fabien; Eckert, Philippe; Cuenoud, Bernard; Oddo, Mauro			Modulation of cerebral ketone metabolism following traumatic brain injury in humans	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article; Proceedings Paper	Journal-of-Cerebral-Blood-Flow-and-Metabolism (JCBFM) Symposium at International Symposium on Cerebral Blood Flow, Metabolism and Function (BRAIN)	JUL 07, 2019	Yokohama, JAPAN	Journal Cerebral Blood Flow & Metab		Traumatic brain injury; ketones; cerebral metabolism; glucose; nutrition	CORTICAL IMPACT INJURY; KETOGENIC DIET; BETA-HYDROXYBUTYRATE; LACTATE INCREASE; GLUCOSE; HYPERKETONEMIA; MICRODIALYSIS; OXYGEN; ACID	Adaptive metabolic response to injury includes the utilization of alternative energy substrates - such as ketone bodies (KB) - to protect the brain against further damage. Here, we examined cerebral ketone metabolism in patients with traumatic brain injury (TBI; n = 34 subjects) monitored with cerebral microdialysis to measure total brain interstitial tissue KB levels (acetoacetate and beta-hydroxybutyrate). Nutrition - from fasting vs. stable nutrition state - was associated with a significant decrease of brain KB (34.7 [10th-90th percentiles 10.7-189] mu mol/L vs. 13.1 [6.5-64.3] mu mol/L, p < 0.001) and blood KB (668 [168.4-3824.9] vs. 129.4 [82.6-1033.8] mu mol/L, p < 0.01). Blood KB correlated with brain KB (Spearman's rho 0.56, p = 0.0013). Continuous feeding with medium-chain triglycerides-enriched enteral nutrition did not increase blood KB, and provided a modest increase in blood and brain free medium chain fatty acids. Higher brain KB at the acute TBI phase correlated with age and brain lactate, pyruvate and glutamate, but not brain glucose. These novel findings suggest that nutritional ketosis was the main determinant of cerebral KB metabolism following TBI. Age and cerebral metabolic distress contributed to brain KB supporting the hypothesis that ketones might act as alternative energy substrates to glucose. Further studies testing KB supplementation after TBI are warranted.	[Bernini, Adriano; Solari, Daria; Miroz, John-Paul; Carteron, Laurent; Morelli, Paola; Abed-Maillard, Samia; Eckert, Philippe; Oddo, Mauro] CHUV Univ Hosp, Dept Intens Care Med, Neurosci Crit Care Res Grp, Lausanne, Switzerland; [Bernini, Adriano; Solari, Daria; Miroz, John-Paul; Carteron, Laurent; Morelli, Paola; Abed-Maillard, Samia; Eckert, Philippe; Oddo, Mauro] Fac Biol & Med, Rue Bugnon 46, CH-1011 Lausanne, Switzerland; [Masoodi, Mojgan; Christinat, Nicolas] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Beaumont, Maurice; Hartweg, Mickael; Foltzer, Fabien] Nestle Res Ctr, Clin Dev Unit, Lausanne, Switzerland; [Cuenoud, Bernard] Nestle Hlth Sci, Lausanne, Switzerland		Oddo, M (corresponding author), Fac Biol & Med, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.; Oddo, M (corresponding author), CHUV Univ Hosp, Dept Intens Care Med, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	mauro.oddo@chuv.ch	Abed-Maillard, Samia/AAI-1052-2021; Bernini, Adriano/AAR-7408-2020; MIROZ, John-Paul/AAR-7445-2020	Bernini, Adriano/0000-0003-0207-0064; Hartweg, Mickael/0000-0002-2228-9103			Al-Dorzi HM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1539-3; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Augustin K, 2018, LANCET NEUROL, V17, P84, DOI 10.1016/S1474-4422(17)30408-8; Bouteldja N, 2014, METABOLISM, V63, P1375, DOI 10.1016/j.metabol.2014.08.001; Brownlow ML, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00129; Casaer MP, 2015, LANCET DIABETES ENDO, V3, P734, DOI 10.1016/S2213-8587(15)00222-3; Chang P, 2016, BRAIN, V139, P431, DOI 10.1093/brain/awv325; Courchesne-Loyer A, 2017, J CEREBR BLOOD F MET, V37, P2485, DOI 10.1177/0271678X16669366; Cox PJ, 2016, CELL METAB, V24, P256, DOI 10.1016/j.cmet.2016.07.010; Croteau E, 2018, EXP GERONTOL, V107, P18, DOI 10.1016/j.exger.2017.07.004; Cunnane SC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00053; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Dienel GA, 2016, J CEREBR BLOOD F MET, V36, P1844, DOI 10.1177/0271678X16666552; Ghosh S, 2018, GLIA, V66, P1200, DOI 10.1002/glia.23271; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jiang LH, 2011, J CEREBR BLOOD F MET, V31, P2313, DOI 10.1038/jcbfm.2011.91; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; LONDON ED, 1986, J GERONTOL, V41, P599, DOI 10.1093/geronj/41.5.599; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19; Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Oddo M, 2018, INTENS CARE MED, V44, P1945, DOI 10.1007/s00134-017-5031-6; OWEN OE, 1974, METABOLISM, V23, P7, DOI 10.1016/0026-0495(74)90098-5; Pan JW, 2001, J NEUROCHEM, V79, P539, DOI 10.1046/j.1471-4159.2001.00575.x; Pan JW, 2000, J CEREBR BLOOD F MET, V20, P1502, DOI 10.1097/00004647-200010000-00012; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; Prins M, 2008, EPILEPSIA, V49, P111, DOI 10.1111/j.1528-1167.2008.01852.x; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Prins ML, 2012, EPILEPSY RES, V100, P218, DOI 10.1016/j.eplepsyres.2011.09.027; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Samala R, 2011, NEUROCHEM INT, V58, P5, DOI 10.1016/j.neuint.2010.10.011; Stubbs BJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00848; Svart M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190556; Valdebenito R, 2016, J CEREBR BLOOD F MET, V36, P1813, DOI 10.1177/0271678X15613955; White H, 2017, NEUROL RES, V39, P1, DOI 10.1080/01616412.2016.1251695; White H, 2013, INTENS CARE MED, V39, P727, DOI 10.1007/s00134-012-2790-y; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; Wolahan SM, 2017, NEUROCRIT CARE, V26, P239, DOI 10.1007/s12028-016-0313-3; Xu K, 2017, ADV EXP MED BIOL, V977, P205, DOI 10.1007/978-3-319-55231-6_28; Zhang YF, 2013, J CEREBR BLOOD F MET, V33, P1307, DOI 10.1038/jcbfm.2013.87	47	20	20	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2020	40	1					177	186		10.1177/0271678X18808947			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	JX2IE	WOS:000503564000015	30353770	Green Published, Bronze			2022-02-06	
J	Lempke, LB; Schmidt, JD; Lynall, RC				Lempke, Landon B.; Schmidt, Julianne D.; Lynall, Robert C.			Athletic Trainers' Concussion-Assessment and Concussion-Management Practices: An Update	JOURNAL OF ATHLETIC TRAINING			English	Article						sports medicine; mild traumatic brain injury; evaluation; diagnosis	FALSE DISCOVERY RATE; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONSENSUS STATEMENT; SPORT HELD; EPIDEMIOLOGY; RELIABILITY; SERVICES; ZURICH	Context: Athletic trainers (ATs) are often the first health care providers to conduct concussion assessments and carry out postinjury management. Best practices for concussion evaluation and management have changed rapidly in recent years, outdating previous reports of ATs' concussion practices. Objective: To examine ATs' current concussion-assessment and -management techniques. Design: Cross-sectional study. Setting: Web-based survey. Patients or Other Participants: A random convenience sample of 8777 ATs (response rate = 15.0% [n = 1307]; years certified = 15.0 +/- 10.6) from the National Athletic Trainers' Association membership. Main Outcome Measure(s): Survey Web links were emailed to prospective participants, with 2 follow-up e-mails sent by the National Athletic Trainers' Association. The survey collected demographic information, the number of concussions assessed, the concussion-recovery patterns, and the assessment and return-to-participation (RTP) decision-making methods used. Results: The ATs reported assessing a median of 12.0 (range = 0-218) concussions per year. A total of 95.3% (953/ 1000) ATs cited clinical examination as the most frequently used concussion-assessment tool, followed by symptom assessment 86.7%; 867/1000). A total of 52.7% (527/1000) ATs described a 3-domain minimum multidimensional concussion-assessment battery. Published RTP guidelines were the most common RTP decision-making tool (91.0%; 864/949), followed by clinical examination (88.2%; 837/949). The ATs with master's degrees were 1.36 times (95% confidence interval [Cl]= 1.02, 1.81) more likely to use a 3-domain concussion-assessment battery than ATs with only bachelor's degrees (chi(2) = 4.44, P= .05). Collegiate ATs were 2.12 (95% CI = 1.59, 2.84) and 1.63 (95% CI = 1.03, 2.59) times more likely to use a 3-domain concussion-assessment battery than high school and clinic-based ATs, respectively (chi(2) = 26.29, P < .001). Conclusions: Athletic trainers were using the clinical examination, standardized assessment tools, and a 3-domain concussion-assessment-battery approach more frequently in clinical practice than previously reported. However, despite practice improvements, nearly half of ATs were not using a 3-domain minimum concussion-assessment battery. Clinicians should strive to implement multidimensional concussion assessments in their practices to ensure optimal diagnosis and management.	[Lempke, Landon B.; Schmidt, Julianne D.; Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30606 USA		Lempke, LB (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Ramsey Student Ctr, 330 River Rd, Athens, GA 30606 USA.	lblempke@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], POS STAT SPORTS CONC; [Anonymous], SUGG GUID MAN CONC S; [Anonymous], DIAGN MAN SPORT REL; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Centers for Medicare & Medicaid Services, ICD 10; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ferrara Michael S., 2001, J Athl Train, V36, P145; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hankemeier DA, 2013, J ATHL TRAINING, V48, P394, DOI 10.4085/1062-6050-48.2.16; Harvey H, POLICY SURVEILLANCE; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; National Athletic Trainers' Association, 2018, NATA MEMB CLASS DIST; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Wallace J, 2018, ATHL TRAIN ED J, V13, P112; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	33	20	20	1	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2020	55	1					17	26		10.4085/1062-6050-322-18			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KC9BJ	WOS:000507465600004	31855075	Green Published, gold			2022-02-06	
J	Myer, GD; Foss, KB; Thomas, S; Galloway, R; DiCesare, CA; Dudley, J; Gadd, B; Leach, J; Smith, D; Gubanich, P; Meehan, WP; Altaye, M; Lavin, P; Yuan, WH				Myer, Gregory D.; Foss, Kim Barber; Thomas, Staci; Galloway, Ryan; DiCesare, Christopher A.; Dudley, Jonathan; Gadd, Brooke; Leach, James; Smith, David; Gubanich, Paul; Meehan, William P., III; Altaye, Mekibib; Lavin, Philip; Yuan, Weihong			Altered brain microstructure in association with repetitive subconcussive head impacts and the potential protective effect of jugular vein compression: a longitudinal study of female soccer athletes	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORTS-RELATED CONCUSSION; WHITE-MATTER DEVELOPMENT; DEFAULT MODE NETWORK; STATES HIGH-SCHOOL; DIFFUSION-TENSOR; SEX-DIFFERENCES; SPATIAL STATISTICS; CORPUS-CALLOSUM; INJURY; ADOLESCENCE	Purpose To (1) quantify white matter (WM) alterations in female high school athletes during a soccer season and characterise the potential for normalisation during the off-season rest period, (2) determine the association between WM alterations and exposure to repetitive subconcussive head impacts, and (3) evaluate the efficacy of a jugular vein compression collar to prevent WM alterations associated with head impact exposure. Methods Diffusion tensor imaging (DTI) data were prospectively collected from high school female soccer participants (14-18 years) at up to three time points over 9 months. Head impacts were monitored using accelerometers during all practices and games. Participants were assigned to a collar (n=24) or non-collar group (n=22). The Tract-Based Spatial Statistics approach was used in the analysis of within-group longitudinal change and between-group comparisons. Results DTI analyses revealed significant pre-season to post-season WM changes in the non-collar group in mean diffusivity (2.83%+/- 2.46%), axial diffusivity (2.58%+/- 2.34%) and radial diffusivity (3.52%+/- 2.60%), but there was no significant change in the collar group despite similar head impact exposure. Significant correlation was found between head impact exposure and pre-season to post-season DTI changes in the non-collar group. WM changes in the non-collar group partially resolved at 3 months off-season follow-up. Discussion Microstructural changes in WM occurred during a season of female high school soccer among athletes who did not wear the collar device. In comparison, there were no changes in players who wore the collar, suggesting a potential prophylactic effect of the collar device in preventing changes associated with repetitive head impacts. In those without collar use, the microstructural changes showed a reversal towards normal over time in the off-season follow-up period.	[Myer, Gregory D.; Foss, Kim Barber; Thomas, Staci; Galloway, Ryan; DiCesare, Christopher A.; Gadd, Brooke; Smith, David; Gubanich, Paul] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.] Duke Univ, Sch Med, Durham, NC USA; [Galloway, Ryan; Yuan, Weihong] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Dudley, Jonathan; Yuan, Weihong] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Lavin, Philip] Boston Biostat Res Fdn, Framingham, MA USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	greg.myer@cchmc.org	DiCesare, Christopher/ABH-9573-2020; DiCesare, Christopher/AAA-3327-2021; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Dudley, Jonathan/0000-0002-5189-9568	Heidt Family Foundation; Robert S Heidt Sr Wellington Foundation; Q30 Sports Sciences, LLC	The authors acknowledge funding support from The Heidt Family Foundation, Robert S Heidt Sr Wellington Foundation and Q30 Sports Sciences, LLC.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Kemp S, 2016, BRAIN INJURY, V30, P1068, DOI 10.3109/02699052.2016.1148776; Khodaee M, 2017, BR J SPORTS MED, V51; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; Leach J, 2018, VANC BC AM SOC NEUR; Leach JL, 2013, AM SOC NEUR ANN M; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Madhyastha T, 2014, HUM BRAIN MAPP, V35, P4544, DOI 10.1002/hbm.22493; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Markey KA, 2016, J PAIN RES, V9, P223, DOI 10.2147/JPR.S80824; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Seunarine KK, 2016, BRAIN CONNECT, V6, P37, DOI 10.1089/brain.2015.0340; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Smith D, 2018, FRONT PHYS, V6, DOI 10.3389/fphy.2018.00093; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Szeszko PR, 2003, NEUROREPORT, V14, P2469, DOI 10.1097/00001756-200312190-00035; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Vann Jones SA, 2014, BR J SPORTS MED, V48; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang YY, 2012, BRAIN RES, V1478, P1, DOI 10.1016/j.brainres.2012.08.038; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	70	20	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2019	53	24					1539	+		10.1136/bjsports-2018-099571			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JX6FI	WOS:000503828000009	30323056				2022-02-06	
J	Willer, BS; Haider, MN; Bezherano, I; Wilber, CG; Mannix, R; Kozlowski, K; Leddy, JJ				Willer, Barry S.; Haider, Mohammad N.; Bezherano, Itai; Wilber, Charles G.; Mannix, Rebekah; Kozlowski, Katherine; Leddy, John J.			Comparison of Rest to Aerobic Exercise and Placebo-like Treatment of Acute Sport-Related Concussion in Male and Female Adolescents	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Interagency Conference on TBI	JUN 12, 2018	Washington, DC			Adolescent; Brain concussion; Exercise; Exercise test; Post-concussion syndrome; Rehabilitation	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; GENDER-DIFFERENCES; HIGH-SCHOOL; RECOVERY; SYMPTOMS; RECOMMENDATIONS; RELIABILITY; RUMINATION; MEDICINE	Objective: To compare a sample of adolescents with sport-related concussion (SRC) who were prescribed rest with 2 arms of a randomized controlled trial comparing aerobic exercise with placebo-like stretching. We also compared sex differences across the 3 approaches to treatment. Design: Quasi-experimental trial. Setting: University concussion management clinics. Participants: Adolescent athletes (aged 13-18 years) presenting within 10 days of SRC (mean, 5 days after injury) received a recommendation for rest (rest group ERG], n=48, 15.4 +/- 1y, 25% female). Their outcomes were compared with matched samples of adolescents assigned to aerobic exercise (exercise group [EG], n=52, 15.3 +/- 2y, 46% female) or placebo-like stretching (placebo group [PG], n=51, 15.4 +/- 2y, 47% female) (N=151). Main Outcome Measures: The primary outcome was median days from injury to recovery. The secondary outcome was proportion classified as normal recovery (<30d) or delayed recovery (>= 30d). Results: The RG recovered in 16 days (interquartile range, 9.25-23.25d), which was significantly delayed (P=.020) compared with EG (13d; interquartile range, 10-18.5d). The PG recovered in 17 days (interquartile range, 13-23d). Four percent of the EG, 14% of the PG, and 13% of the RG had delayed recovery (P=.190). There was no difference in recovery time or delayed recovery between male participants and female participants across groups. Female participants prescribed rest experienced an increase in symptoms vs the other groups (P=.013). Conclusion: Relative rest and a placebo-like stretching program were very similar in days to recovery and symptom improvement pattern after SRC. Both conditions were less effective than subsymptom threshold aerobic exercise. Female adolescents appear to be susceptible to symptom increase when prescribed rest. (C) 2019 by the American Congress of Rehabilitation Medicine	[Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA; [Haider, Mohammad N.; Wilber, Charles G.; Leddy, John J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA; [Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, PhD Program Biomed Sci, Neurosci, Buffalo, NY USA; [Bezherano, Itai; Kozlowski, Katherine] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Nutr & Exercise Sci, Buffalo, NY USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA		Willer, BS (corresponding author), 3435 Main St,160 Farber Hall, Buffalo, NY 14214 USA.	bswiller@buffalo.edu	Mannix, Rebekah/AAD-8702-2020		National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [IR0INS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [ULITR001412]; State University of New York at Buffalo; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	Supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (award no. IR0INS094444) and the National Center for Advancing Translational Sciences of the National Institutes of Health (award no. ULITR001412) to the State University of New York at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bishop S, 2016, J CEREBR BLOOD F MET, V36, P292; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Du W., 2018, CLIN J SPORT MED, DOI 10.1097/JSM.0000000000000687; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gabrys RL, 2016, CLIN J SPORT MED; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Johnson DP, 2013, PERS INDIV DIFFER, V55, P367, DOI 10.1016/j.paid.2013.03.019; Kelly J, 2000, STANDARDIZED ASSESSM, P2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2018, CLIN J SPORT MED; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lempke L, 2019, J SPORT REHABIL, V28, P99, DOI 10.1123/jsr.2017-0217; Lohaus A, 2013, PSYCHOL HEALTH, V28, P1032, DOI 10.1080/08870446.2013.780606; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2009, BR J SPORTS MED S1, V43, pi85; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; OVERALL JE, 1967, PSYCHOL REP, V21, P70, DOI 10.2466/pr0.1967.21.1.70; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Serrador J, 2015, FASEB J, V29; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Suzuki T, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0061483; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	50	20	21	5	28	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2019	100	12					2267	2275		10.1016/j.apmr.2019.07.003			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	JW5QY	WOS:000503107600006	31377190	Green Accepted			2022-02-06	
J	Muraoka, S; Jedrychowski, MP; Tatebe, H; DeLeo, AM; Ikezu, S; Tokuda, T; Gygi, SP; Stern, RA; Ikezu, T				Muraoka, Satoshi; Jedrychowski, Mark P.; Tatebe, Harutsugu; DeLeo, Annina M.; Ikezu, Seiko; Tokuda, Takahiko; Gygi, Steven P.; Stern, Robert A.; Ikezu, Tsuneya			Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy	FRONTIERS IN NEUROSCIENCE			English	Article						chronic traumatic encephalopathy; cerebrospinal fluid; extracellular vesicles; microtubule-associated protein tau; proteome; tauopathy; football	EXOSOMAL TAU; PATHOLOGY; CLEAVAGE; DISEASE; FRAGMENTS; BETA; CELL	Chronic Traumatic Encephalopathy (CTE) is a tauopathy that affects individuals with a history of repetitive mild traumatic brain injury, such as American football players. Initial neuropathologic changes in CTE include perivascular deposition of phosphorylated microtubule-associated protein tau (p-tau) neurofibrillary tangles and other aggregates in neurons, astrocytes and cell processes in an irregular pattern often at the depths of the cortical sulci. In later stages, the p-tau depositions become widespread and is associated with neurodegeneration. Extracellular vesicles (EVs) are known to carry neuropathogenic molecules, most notably p-tau. We therefore examined the protein composition of EVs isolated from the cerebrospinal fluid (CSF) of former National Football League (NFL) players with cognitive and neuropsychiatric dysfunction, and an age-matched control group (CTRL) with no history of contact sports or traumatic brain injury. EVs were isolated from the CSF samples using an affinity purification kit. Total tau (t-tau) and tau phosphorylated on threonine(181) (p-tau(181)) in CSF-derived EVs from former NFL players and CTRL participants were measured by ultrasensitive immunoassay. The t-tau and p-tau(181) levels of CSF-derived EV were positively correlated with the t-tau and p-tau(181) levels of total CSF in former NFL players, respectively, but not in the CTRL group. 429 unique proteins were identified from CSF-derived EVs and quantified by TMT-10 plex method. The identified protein molecules were significantly enriched for the extracellular exosome molecules, Alzheimer's disease pathway and Age/Telomere Length ontology as determined by DAVID Gene Ontology analysis. Ingenuity pathway analysis of the differentially expressed EV proteins revealed enrichment of canonical liver/retinoid X receptor activation pathway. Upstream effect analysis predicted MAPT (tau) as an upstream regulator in former NFL players. These data will be useful for understanding the EV-mediated disease spread and development of novel EV biomarkers for CTE and related disorders.	[Muraoka, Satoshi; DeLeo, Annina M.; Ikezu, Seiko; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Jedrychowski, Mark P.; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Med Innovat & Translat Med Sci, Kyoto, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan; [Stern, Robert A.; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr,CTE Ctr, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg & Anat & Neurobiol, Boston, MA 02118 USA		Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.; Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr,CTE Ctr, Boston, MA 02118 USA.	tikezu@bu.edu	, Bob/ABA-8507-2020		Aethlon Medical, Inc.; Cure Alzheimer's Fund; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RF1AG054199, R56AG057469, R01NS078337, U01NS093334, P30AG13846]; AMED [17dk0207042s0101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM067945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56AG057469] Funding Source: NIH RePORTER	This work was in part funded by the Aethlon Medical, Inc. (TI), Cure Alzheimer's Fund (TI), NIH RF1AG054199 (TI), NIH R56AG057469 (TI), R01NS078337 (RS), U01NS093334 (RS), P30AG13846 (RS), and AMED 17dk0207042s0101 (TT).	Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Chen ZC, 2019, ALZHEIMERS DEMENT, V15, P487, DOI 10.1016/j.jalz.2018.09.010; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Cicognola C, 2019, ACTA NEUROPATHOL, V137, P279, DOI 10.1007/s00401-018-1948-2; Dayon L, 2019, J PROTEOME RES, V18, P1162, DOI 10.1021/acs.jproteome.8b00809; Deleo AM, 2018, J NEUROIMMUNE PHARM, V13, P292, DOI 10.1007/s11481-017-9768-z; Delpech JC, 2019, TRENDS NEUROSCI, V42, P361, DOI 10.1016/j.tins.2019.02.007; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Galasko DR, 2017, NAT REV NEUROL, V13, P131, DOI 10.1038/nrneurol.2017.11; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Lee J, 2016, CLIN CHIM ACTA, V462, P118, DOI 10.1016/j.cca.2016.09.001; Ling H, 2017, NEUROPATH APPL NEURO, V43, P467, DOI 10.1111/nan.12425; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moutinho M, 2017, J LIPID RES, V58, P1937, DOI 10.1194/jlr.R075556; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Nam KN, 2016, SCI REP-UK, V6, DOI 10.1038/srep24048; Paton D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067364; Paulo JA, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700326; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Quek C, 2017, BIOCHEM BIOPH RES CO, V483, P1178, DOI 10.1016/j.bbrc.2016.09.090; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tatebe H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0206-8; Wilhelmus MMM, 2009, BRAIN PATHOL, V19, P612, DOI 10.1111/j.1750-3639.2008.00197.x; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhao XH, 2016, NAT MED, V22, P1268, DOI 10.1038/nm.4199	47	20	20	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 9	2019	13								1059	10.3389/fnins.2019.01059			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO4UZ	WOS:000497576800001	31649498	Green Published, gold			2022-02-06	
J	Duma, C; Kopyov, O; Kopyov, A; Berman, M; Lander, E; Elam, M; Arata, M; Weiland, D; Cannell, R; Caraway, C; Berman, S; Scord, K; Stemler, L; Chung, K; Khoudari, S; McRory, R; Duma, C; Farmer, S; Bravo, A; Yassa, C; Sanathara, A; Singh, E; Rapaport, B				Duma, Christopher; Kopyov, Oleg; Kopyov, Alex; Berman, Mark; Lander, Elliot; Elam, Michael; Arata, Michael; Weiland, David; Cannell, Ruslana; Caraway, Chad; Berman, Sean; Scord, Kristin; Stemler, Lian; Chung, Karlyssa; Khoudari, Samuel; McRory, Rory; Duma, Chace; Farmer, Sawyer; Bravo, Anthony; Yassa, Christian; Sanathara, Ami; Singh, Elisa; Rapaport, Benjamin			Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients	MOLECULAR BIOLOGY REPORTS			English	Article						Intracerebroventricular; Stem cells; Autologous stem cells; ADSC; Neurodegenerative disease; Alzheimer's disease; ALS; Multiple sclerosis; Stromal vascular fraction	MESENCHYMAL STEM-CELLS; ALZHEIMERS-DISEASE; BONE-MARROW; MOUSE MODEL; MULTIPLE-SCLEROSIS; INTRANASAL DELIVERY; CONDITIONED MEDIUM; LIPOID MENINGITIS; OMMAYA RESERVOIR; TRANSPLANTATION	We have chosen to test the safety of human intracerebroventricular (ICV) brain injections of autologous non-genetically-modified adipose-derived stromal vascular fraction (ADSVF). In this IRB-approved trial, 24 patients received ICV ADSVF via an implanted reservoir between 5/22/14 and 5/22/17. Seven others were injected via their ventriculo-peritoneal shunts. Ten patients had Alzheimer's disease (AD), 6 had amyotrophic lateral sclerosis (ALS), 6 had progressive multiple sclerosis (MS-P), 6 had Parkinson's "Plus" (PD+), 1 had spinal cord injury, 1 had traumatic brain injury, and 1 had stroke. Median age was 74 (range 41-83). Injections were planned every 2-3 months. Thirty-one patients had 113 injections. Patients received SVF injection volumes of 3.5-20 cc (median:4 cc) containing 4.05 x 10(5) to 6.2 x 10(7) cells/cc, which contained an average of 8% hematopoietic and 7.5% adipose stem cells. Follow-up ranged from 0 to 36 months (median: 9.2 months). MRIs post injection(s) were unchanged, except for one AD patient whose hippocampal volume increased from < 5th percentile to 48th percentile -(NeuroQuant (R) volumetric MRI). Of the 10 AD patients, 8 were stable or improved in tests of cognition. Two showed improvement in P-tau and beta-amyloid levels. Of the 6 MS-P patients all are stable or improved. Four of 6 ALS patients died of disease progression. Twelve of 111 injections (11%) led to 1-4 days of transient meningismus, and mild temperature elevation, which resolved with acetaminophen and/or dexamethasone. Two (1.8% of injections) required hospitalization for these symptoms. One patient (0.9% of injections) had his reservoir removed and later replaced for presumed infection. In this Phase 1 safety trial, ADSVF was safely injected into the human brain ventricular system in patients with no other treatment options. Secondary endpoints of clinical improvement or stability were particularly promising in the AD and MS-P groups. These results will be submitted for a Phase 2 FDA-approved trial.	[Duma, Christopher; Kopyov, Oleg; Kopyov, Alex; Scord, Kristin; Stemler, Lian; Chung, Karlyssa; Khoudari, Samuel; McRory, Rory; Duma, Chace; Farmer, Sawyer; Bravo, Anthony; Yassa, Christian; Sanathara, Ami; Singh, Elisa; Rapaport, Benjamin] Brain & Spine Surg Orange Cty, Neurosurg, Newport Beach, CA 92660 USA; [Berman, Mark; Lander, Elliot; Elam, Michael; Arata, Michael; Berman, Sean] Cell Surg Network, Los Angeles, CA USA; [Weiland, David] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Cannell, Ruslana; Caraway, Chad] Univ Calif Irvine, Dept Neurobiol, Irvine, CA USA		Duma, C (corresponding author), Brain & Spine Surg Orange Cty, Neurosurg, Newport Beach, CA 92660 USA.	cduma@brainandspineoc.com; okopyov@cellavie.com; akopyov@cellavie.com; mark@cellsurgicalnetwork.com; elliot@cellsurgicalnetwork.com; info@michaelelammd.com; marata@drarata.com; djweilan@uci.edu; rcannell@uci.edu; ccaraway@uci.edu; sean@cellsurgicalnetwork.com; kscordpac@newportbeachdps.com; lstemler@stanford.edu; kchung@brainandspineoc.com; samuel.khoudari@hoag.org; rmccrory@brainandspineoc.com; chaceduma@ucsb.edu; shfarmer@ucsd.edu; aabravo@uci.edu; cyassa123@berkeley.edu; sanathaa@coyote.csusb.edu; elisa.singh@hoag.org; brapaport@brainandspineoc.com		Duma, Christopher/0000-0003-3943-2030			Abdallah AN, 2019, RES VET SCI, V125, P71, DOI 10.1016/j.rvsc.2019.05.016; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Al Jumah MA, 2012, INT J MOL SCI, V13, P9298, DOI 10.3390/ijms13079298; del Barrio JLA, 2017, CORNEA, V36, P952, DOI 10.1097/ICO.0000000000001228; Alonso A, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000164; Argibay B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40758; Baek W, 2012, J NEUROSURG SCI, V56, P261; Bagheri-Mohammadi S, 2019, MOL BIOL REP, V46, P4293, DOI 10.1007/s11033-019-04883-8; Berg J, 2015, STEM CELL REV REP, V11, P133, DOI 10.1007/s12015-014-9551-y; Berman M., 2017, AM J COSMETIC SURG, V34, P129, DOI [10.1177/0748806817691152, DOI 10.1177/0748806817691152]; Berman S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060112; Bonafede R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00080; Bonafede R, 2016, EXP CELL RES, V340, P150, DOI 10.1016/j.yexcr.2015.12.009; Bowles AC, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1099-3; Bowles AC, 2017, STEM CELLS, V35, P532, DOI 10.1002/stem.2516; Busser H, 2015, STEM CELLS DEV, V24, P2142, DOI 10.1089/scd.2015.0172; Chan TM, 2014, CELL TRANSPLANT, V23, P549, DOI 10.3727/096368914X678445; Chang KA, 2014, NEURODEGENER DIS, V13, P99, DOI 10.1159/000355261; Chang YH, 2016, CELL TRANSPLANT, V25, P937, DOI 10.3727/096368915X690288; Chernoff G, 2018, FACIAL PLAST SURG CL, V26, P487, DOI 10.1016/j.fsc.2018.06.009; Chi K, 2018, CELL TRANSPLANT, V27, P456, DOI 10.1177/0963689718757408; Chung JY, 2012, J NEUROL SCI, V317, P40, DOI 10.1016/j.jns.2012.02.035; Cobo M, 2013, CELL TRANSPLANT, V22, P839, DOI 10.3727/096368912X657404; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; D'Andrea MR, 2005, MED HYPOTHESES, V64, P458, DOI 10.1016/j.mehy.2004.08.024; Darlington PJ, 2011, EXPERT REV NEUROTHER, V11, P1295, DOI [10.1586/ern.11.113, 10.1586/ERN.11.113]; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Farinazzo A, 2015, CYTOTHERAPY, V17, P571, DOI 10.1016/j.jcyt.2015.01.005; Faustini M, 2010, TISSUE ENG PART C-ME, V16, P1515, DOI [10.1089/ten.tec.2010.0214, 10.1089/ten.TEC.2010.0214]; Fauzi AA, 2016, J STEM CELLS REGEN, V12, pP100; Fernandez O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195891; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forostyak S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00591; Forostyak S, 2014, STEM CELLS, V32, P3163, DOI 10.1002/stem.1812; Gentile P, 2012, STEM CELL TRANSL MED, V1, P230, DOI 10.5966/sctm.2011-0054; Ghorabi MT, 2017, CELL MOL BIOL, V63, P1, DOI 10.14715/cmb/2017.63.3.1; Giacoppo S, 2017, ARCH IMMUNOL THER EX, V65, P363, DOI 10.1007/s00005-017-0460-z; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Ha S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.051206; Habisch HJ, 2007, J NEURAL TRANSM, V114, P1395, DOI 10.1007/s00702-007-0748-y; Haddad-Mashadrizeh A, 2013, CYTOTHERAPY, V15, P951, DOI 10.1016/j.jcyt.2013.03.003; Hammadi AM, 2017, EXP CLIN TRANSPLANT, V15, P147, DOI 10.6002/ect.mesot2016.P26; Harach T, 2017, NEUROBIOL AGING, V51, P83, DOI 10.1016/j.neurobiolaging.2016.11.009; Hedayatpour A, 2013, CELL J, V15, P142; Higgins Joseph J, 2013, MLO Med Lab Obs, V45, P52; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hoyer C, 2016, J CLIN VIROL, V84, P82, DOI 10.1016/j.jcv.2016.10.006; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Hwang PH, 1996, LARYNGOSCOPE, V106, P1482, DOI 10.1097/00005537-199612000-00007; Iwasa SN, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4276927; Jiang YJ, 2011, EXPERT OPIN DRUG DEL, V8, P623, DOI 10.1517/17425247.2011.566267; Jozwiak S, 2010, CELL MED, V1, P71, DOI 10.3727/215517910X536618; Kantake M, 2017, REGEN MED, V12, P575, DOI 10.2217/rme-2017-0043; Katsuda Takeshi, 2015, Methods Mol Biol, V1212, P171, DOI 10.1007/7651_2014_98; Kilinc MO, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0183-8; Kim HW, 2018, CELL TRANSPLANT, V27, P814, DOI 10.1177/0963689718766324; Kim KS, 2014, CELL TRANSPLANT, V23, P1585, DOI 10.3727/096368913X673450; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045757; Knippenberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036857; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laso-Garcia F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202590; Lee M, 2018, BRAIN RES, V1691, P87, DOI 10.1016/j.brainres.2018.03.034; Lee M, 2016, BIOCHEM BIOPH RES CO, V479, P434, DOI 10.1016/j.bbrc.2016.09.069; Lehrer S, 2015, AM J ALZHEIMERS DIS, V30, P225, DOI 10.1177/1533317514545478; Li YH, 2015, EXP MOL PATHOL, V98, P145, DOI 10.1016/j.yexmp.2015.01.016; Liew LC, 2017, INT IMMUNOL, V29, P11, DOI 10.1093/intimm/dxx002; Liu DZ, 2012, TRANSL STROKE RES, V3, pS62, DOI 10.1007/s12975-012-0147-z; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; Lo Furno D, 2016, STEM CELLS DEV, V25, P1615, DOI 10.1089/scd.2016.0135; Luan Zuo, 2005, Zhonghua Er Ke Za Zhi, V43, P580; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Ma T, 2013, CELL TRANSPLANT, V22, pS113, DOI 10.3727/096368913X672181; Marconi S, 2013, NEUROSCIENCE, V248, P333, DOI 10.1016/j.neuroscience.2013.05.034; Marfia G, 2016, STEM CELLS DEV, V25, P1095, DOI 10.1089/scd.2015.0268; Matchynski-Franks JJ, 2016, CELL TRANSPLANT, V25, P687, DOI 10.3727/096368916X690818; Mazzini L, 2012, PROG BRAIN RES, V201, P333, DOI 10.1016/B978-0-444-59544-7.00016-0; Mazzini L, 2009, AMYOTROPH LATERAL SC, V10, P123, DOI 10.1080/17482960802572707; MCCARTHY M, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G1397; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Moon SM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/539051; Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140; Nasiri E, 2019, METAB BRAIN DIS, V34, P1131, DOI 10.1007/s11011-019-00421-4; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; OMMAYA AK, 1963, LANCET, V2, P983; Oppliger B, 2016, STEM CELLS DEV, V25, P1234, DOI 10.1089/scd.2016.0027; Peng LY, 2008, STEM CELLS DEV, V17, P761, DOI 10.1089/scd.2007.0217; Ra J-CK, 2017, J CLIN CASE REP, V7, P1040; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Ragerdi Kashani Iraj, 2012, Acta Med Iran, V50, P789; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reza-Zaldivar EE, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00317; Ricaurte JC, 2000, CLIN INFECT DIS, V30, P613, DOI 10.1086/313732; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Scherberich Arnaud, 2013, World J Stem Cells, V5, P1, DOI 10.4252/wjsc.v5.i1.1; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Shakhbazau A, 2016, CYTOTHERAPY, V18, P1245, DOI 10.1016/j.jcyt.2016.06.001; Shankle WR, 2009, ALZHEIMERS DEMENT, V5, P295, DOI 10.1016/j.jalz.2008.11.001; Siennicka K, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5762916; Simard PF, 2011, TRANSL STROKE RES, V2, P227, DOI 10.1007/s12975-011-0070-8; Smith OJ, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0505-8; Sowa Y, 2012, STEM CELLS DEV, V21, P1852, DOI 10.1089/scd.2011.0403; Staff NP, 2016, NEUROLOGY, V87, P2230, DOI 10.1212/WNL.0000000000003359; Stepien A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5302120; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; Sugaya K, 2006, PANMINERVA MED, V48, P87; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072926; Tang BL, 2017, REV NEUROSCIENCE, V28, P725, DOI 10.1515/revneuro-2017-0018; Wootla B, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/969657; Wu JH, 2016, CHINESE MED J-PEKING, V129, P1592, DOI 10.4103/0366-6999.184464; Yamazaki H, 2015, NEUROSCI LETT, V609, P53, DOI 10.1016/j.neulet.2015.10.023; Yan YF, 2014, NEURAL REGEN RES, V9, P798, DOI 10.4103/1673-5374.131596; Yang YF, 2016, CELL TRANSPLANT, V25, P1177, DOI 10.3727/096368915X688957; Yeh DC, 2015, CELL TRANSPLANT, V24, P487, DOI 10.3727/096368915X686940; Zack-Williams SDL, 2015, WORLD J STEM CELLS, V7, P51, DOI 10.4252/wjsc.v7.i1.51; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413; Zhou LH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44058; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	118	20	20	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	OCT	2019	46	5					5257	5272		10.1007/s11033-019-04983-5			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JL5SH	WOS:000495590600057	31327120	hybrid			2022-02-06	
J	Wartenberg, KE; Hwang, DY; Haeusler, KG; Muehlschlegel, S; Sakowitz, OW; Madzar, D; Hamer, HM; Rabinstein, AA; Greer, DM; Hemphill, JC; Meixensberger, J; Varelas, PN				Wartenberg, Katja E.; Hwang, David Y.; Haeusler, Karl Georg; Muehlschlegel, Susanne; Sakowitz, Oliver W.; Madzar, Dominik; Hamer, Hajo M.; Rabinstein, Alejandro A.; Greer, David M.; Hemphill, J. Claude, III; Meixensberger, Juergen; Varelas, Panayiotis N.			Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society	NEUROCRITICAL CARE			English	Article						Prognostication; Self-fulfilling prophecy; Outcome predictors; Comorbidities	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; HEMORRHAGE GRADING SCALE; CLINICAL-PREDICTION RULE; SHARED DECISION-MAKING; IN-HOSPITAL MORTALITY; ACUTE ISCHEMIC-STROKE; GLASGOW COMA SCALE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE	Background/Objective Prognostication is a routine part of the delivery of neurocritical care for most patients with acute neurocritical illnesses. Numerous prognostic models exist for many different conditions. However, there are concerns about significant gaps in knowledge regarding optimal methods of prognostication. Methods As part of the Arbeitstagung NeuroIntensivMedizin meeting in February 2018 in Wurzburg, Germany, a joint session on prognostication was held between the German NeuroIntensive Care Society and the Neurocritical Care Society. The purpose of this session was to provide presentations and open discussion regarding existing prognostic models for eight common neurocritical care conditions (aneurysmal subarachnoid hemorrhage, intracerebral hemorrhage, acute ischemic stroke, traumatic brain injury, traumatic spinal cord injury, status epilepticus, Guillain-Barre Syndrome, and global cerebral ischemia from cardiac arrest). The goal was to develop a qualitative gap analysis regarding prognostication that could help inform a future framework for clinical studies and guidelines. Results Prognostic models exist for all of the conditions presented. However, there are significant gaps in prognostication in each condition. Furthermore, several themes emerged that crossed across several or all diseases presented. Specifically, the self-fulfilling prophecy, lack of accounting for medical comorbidities, and absence of integration of in-hospital care parameters were identified as major gaps in most prognostic models. Conclusions Prognostication in neurocritical care is important, and current prognostic models are limited. This gap analysis provides a summary assessment of issues that could be addressed in future studies and evidence-based guidelines in order to improve the process of prognostication.	[Wartenberg, Katja E.] Univ Leipzig, Dept Neurol, Neurocrit Care & Stroke Unit, Liebigstr 20, D-04103 Leipzig, Germany; [Hwang, David Y.] Yale Sch Med, Dept Neurol, POB 208018, New Haven, CT 06520 USA; [Haeusler, Karl Georg] Univ Klinikum Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany; [Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Neurol Anesthesiol & Surg, 55 Lake Ave North, Worcester, MA 01655 USA; [Sakowitz, Oliver W.] RKH Klinikum Ludwigsburg, Neurosurg Ctr Ludwigsburg Heilbronn, Posilipostr 4, D-71640 Ludwigsburg, Germany; [Madzar, Dominik; Hamer, Hajo M.] Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany; [Rabinstein, Alejandro A.] Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA; [Greer, David M.] Boston Univ, Med Ctr, Dept Neurol, 72 East Concord St, Boston, MA 02118 USA; [Hemphill, J. Claude, III] Univ Calif San Francisco, Dept Neurol, 1001 Potrero Ave, San Francisco, CA 94110 USA; [Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, Liebigstr 20, D-04103 Leipzig, Germany; [Varelas, Panayiotis N.] Henry Ford Hosp, Dept Neurol & Neurosurg, 2799 W Grand Blvd Neurosurg K-11, Detroit, MI 48202 USA		Wartenberg, KE (corresponding author), Univ Leipzig, Dept Neurol, Neurocrit Care & Stroke Unit, Liebigstr 20, D-04103 Leipzig, Germany.	katja.wartenberg@medizin.uni-leipzig.de	Hwang, David/ABG-6957-2020; Hemphill, Claude/AAY-5630-2021; Hausler, Karl Georg/AAS-5962-2021	Hwang, David/0000-0002-2150-4289; Hemphill, Claude/0000-0003-4019-7525; Sakowitz, Oliver/0000-0003-3248-6335; Hamer, Hajo/0000-0003-1709-8617	National Institutes of Health/National Institute of Child Health and Human Development (NIH/NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971]; UMass Memorial Medical Group (Prize for Academic Collaboration and Excellence (PACE Prize)); DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [HR001117S0032WASH-FP-031]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS102574-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER	Susanne Muehlschlegel received Grant support from National Institutes of Health/National Institute of Child Health and Human Development (NIH/NICHD) Grant 5K23HD080971, UMass Memorial Medical Group (Prize for Academic Collaboration and Excellence (PACE Prize) and DARPA (HR001117S0032WASH-FP-031). David Greer received Grant support from National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) Grant (R01 NS102574-01A1).	[Anonymous], IMP PROGN CALC; [Anonymous], 2012, INJURY NCDE TB; Bar B, 2011, STROKE, V42, P2944, DOI 10.1161/STROKEAHA.111.617639; Belliveau T, 2016, ARCH PHYS MED REHAB, V97, P1663, DOI 10.1016/j.apmr.2016.04.014; Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Bruce SS, 2011, NEUROCRIT CARE, V15, P498, DOI 10.1007/s12028-011-9518-7; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Chu SY, 2016, SEMIN NEUROL, V36, P254, DOI 10.1055/s-0036-1581992; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; CRASH calculator, CRASH CALC; Cronberg T, 2013, RESUSCITATION, V84, P867, DOI 10.1016/j.resuscitation.2013.01.019; Degos V, 2012, STROKE, V43, P1253, DOI 10.1161/STROKEAHA.111.638197; Dengler NF, 2018, EUR J NEUROL, V25, P111, DOI 10.1111/ene.13471; Durand MC, 2006, LANCET NEUROL, V5, P1021, DOI 10.1016/S1474-4422(06)70603-2; Fagerlin A, 2005, MED DECIS MAKING, V25, P398, DOI 10.1177/0272989X05278931; Fahey M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0185402; Fallenius M, 2017, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-017-0448-z; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fonarow GC, 2014, STROKE, V45, P1589, DOI 10.1161/STR.0000000000000014; Gao Q, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1221-9; Garrett JS, 2013, NEUROCRIT CARE, V19, P329, DOI 10.1007/s12028-013-9926-y; Gonzalez-Cuevas M, 2016, EUR J NEUROL, V23, P1534, DOI 10.1111/ene.13073; Gotoh O, 1996, NEUROSURGERY, V39, P19, DOI 10.1097/00006123-199607000-00005; Greer DM, 2013, RESUSCITATION, V84, P1546, DOI 10.1016/j.resuscitation.2013.07.028; Griggs RC, 2012, NEUROLOGY, V79, P2293, DOI 10.1212/WNL.0b013e31827a3c0a; Gupta VP, 2017, WORLD NEUROSURG, V101, P577, DOI 10.1016/j.wneu.2017.02.082; Han JX, 2018, WORLD NEUROSURG, V109, pE601, DOI 10.1016/j.wneu.2017.10.039; Heeley E, 2015, INT J STROKE, V10, P1101, DOI 10.1111/ijs.12518; Hemphill JC, 2017, NEUROCRIT CARE, V26, P157, DOI 10.1007/s12028-017-0384-9; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hicks KE, 2017, SPINE J, V17, P1383, DOI 10.1016/j.spinee.2017.05.031; Hirai S, 1996, NEUROSURGERY, V39, P441, DOI 10.1097/00006123-199609000-00002; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Hwang BY, 2010, NEUROCRIT CARE, V13, P141, DOI 10.1007/s12028-010-9382-x; Hwang DY, 2016, NEUROLOGY, V86, P126, DOI 10.1212/WNL.0000000000002266; INGALL TJ, 1989, STROKE, V20, P718, DOI 10.1161/01.STR.20.6.718; Inoa V, 2014, CEREBROVASC DIS, V37, P251, DOI 10.1159/000358869; Jaja BNR, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5745; Jampathong N, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1032-5; Ji RJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13130; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Khan MW, 2017, NEUROL CLIN, V35, P825, DOI 10.1016/j.ncl.2017.06.014; Lagares A, 2005, ACTA NEUROCHIR, V147, P5, DOI 10.1007/s00701-004-0417-y; Lagares A, 2001, ACTA NEUROCHIR, V143, P665, DOI 10.1007/s007010170044; Lawn ND, 2001, ARCH NEUROL-CHICAGO, V58, P893, DOI 10.1001/archneur.58.6.893; Lee VH, 2014, NEUROCRIT CARE, V21, P14, DOI 10.1007/s12028-013-9952-9; Leitinger M, 2015, NEUROCRIT CARE, V22, P273, DOI 10.1007/s12028-014-0080-y; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas MB, 2017, CEREBROVASC DIS, V43, P110, DOI 10.1159/000452679; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; Mascitelli JR, 2020, NEUROSURGERY, V86, P101, DOI 10.1093/neuros/nyy600; Masotti L, 2017, ACTA NEUROL BELG, V117, P325, DOI 10.1007/s13760-016-0609-2; Masotti L, 2015, J STROKE CEREBROVASC, V24, P1100, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.013; Mattishent K, 2015, J CLIN NEUROL, V11, P339, DOI 10.3988/jcn.2015.11.4.339; Mikati AG, 2019, NEUROSURGERY, V85, pE872, DOI 10.1093/neuros/nyz127; Morgenstern LB, 2015, NEUROLOGY, V84, P1739, DOI 10.1212/WNL.0000000000001525; Moskowitz J, 2018, MDM POLICY PRACT, V3; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; Naval NS, 2014, J STROKE CEREBROVASC, V23, P902, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.035; Naval NS, 2013, J CRIT CARE, V28, P182, DOI 10.1016/j.jcrc.2012.05.008; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Pan K, 2017, J STROKE CEREBROVASC, V26, P2563, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.005; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Quinn TJ, 2017, NEUROLOGY, V89, P997, DOI 10.1212/WNL.0000000000004332; Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882; Reindl C, 2018, SEIZURE-EUR J EPILEP, V56, P92, DOI 10.1016/j.seizure.2018.01.024; Rossetti AO, 2006, NEUROLOGY, V66, P1736, DOI 10.1212/01.wnl.0000223352.71621.97; Rost NS, 2008, STROKE, V39, P2304, DOI 10.1161/STROKEAHA.107.512202; Ruiz-Sandoval JL, 2007, STROKE, V38, P1641, DOI 10.1161/STROKEAHA.106.478222; Safatli Diaa A, 2016, Surg Neurol Int, V7, pS510, DOI 10.4103/2152-7806.187493; Sano H, 2015, WORLD NEUROSURG, V83, P801, DOI 10.1016/j.wneu.2014.12.032; Satopaa J, 2017, J NEUROL SCI, V379, P103, DOI 10.1016/j.jns.2017.05.034; Sembill JA, 2017, NEUROLOGY, V89, P423, DOI 10.1212/WNL.0000000000004174; Soliman F, 2017, NEUROHOSPITALIST, V7, P169, DOI 10.1177/1941874417708128; Spatz ES, 2017, JAMA-J AM MED ASSOC, V317, P1309, DOI 10.1001/jama.2017.0616; Starke RM, 2009, J CLIN NEUROSCI, V16, P894, DOI 10.1016/j.jocn.2008.10.010; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strauss J, 2009, CRIT CARE MED, V37, P2436, DOI 10.1097/CCM.0b013e3181a0fdfc; Strbian D, 2012, NEUROLOGY, V78, P427, DOI 10.1212/WNL.0b013e318245d2a9; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Sutter R, 2014, NEUROLOGY, V82, P656, DOI 10.1212/WNL.0000000000000009; Sutter R, 2013, CRIT CARE MED, V41, pE475, DOI 10.1097/CCM.0b013e31829eca06; Takagi K, 1999, J NEUROSURG, V90, P680, DOI 10.3171/jns.1999.90.4.0680; Taylor CJ, 2011, NEUROCRIT CARE, V14, P341, DOI 10.1007/s12028-010-9377-7; Teale EA, 2012, CLIN REHABIL, V26, P771, DOI 10.1177/0269215511433068; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc; van Heuven AW, 2008, STROKE, V39, P1347, DOI 10.1161/STROKEAHA.107.498345; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; van Middendorp JJ, 2011, LANCET, V377, P1004, DOI 10.1016/S0140-6736(10)62276-3; Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407; Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Weimar C, 2006, J NEUROL NEUROSUR PS, V77, P601, DOI 10.1136/jnnp.2005.081117; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijdicks EFM, 2011, NEUROLOGY, V77, P84, DOI 10.1212/WNL.0b013e318220ac06; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P46, DOI 10.3171/2012.4.AOSPINE1246; Witsch J, 2016, ANN NEUROL, V80, P46, DOI 10.1002/ana.24675; Yogendrakumar V, 2018, CRIT CARE MED, V46, pE310, DOI 10.1097/CCM.0000000000002962; Zahuranec DB, 2016, NEUROLOGY, V86, P1864, DOI 10.1212/WNL.0000000000002676; Zeiler FA, 2017, NEUROCRIT CARE, V27, P381, DOI 10.1007/s12028-017-0396-5; Zis P, 2014, J STROKE CEREBROVASC, V23, P1928, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.006	114	20	20	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2019	31	2					231	244		10.1007/s12028-019-00769-6			14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JA0OX	WOS:000487511700001	31368059	Green Published, hybrid			2022-02-06	
J	Xiong, Y; Cao, FQ; Hu, LC; Yan, CC; Chen, L; Panayi, AC; Sun, Y; Zhou, W; Zhang, P; Wu, QP; Xue, H; Liu, MF; Liu, Y; Liu, J; Abududilibaier, A; Mi, BB; Liu, GH				Xiong, Yuan; Cao, Faqi; Hu, Liangcong; Yan, Chenchen; Chen, Lang; Panayi, Adriana C.; Sun, Yun; Zhou, Wu; Zhang, Peng; Wu, Qipeng; Xue, Hang; Liu, Mengfei; Liu, Yi; Liu, Jing; Abududilibaier, Abudula; Mi, Bobin; Liu, Guohui			miRNA-26a-5p Accelerates Healing via Downregulation of PTEN in Fracture Patients with Traumatic Brain Injury	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							MICE LACKING PTEN; OSTEOBLAST DIFFERENTIATION; STEM-CELLS; BONE-FORMATION; OSTEOGENIC DIFFERENTIATION; PROLIFERATION; REGENERATION; MICRORNA-34A; INHIBITION; EXPRESSION	Patients who sustain a traumatic brain injury (TBI) are known to have a significantly quicker fracture healing time than patients with isolated fractures, but the underlying mechanism has yet to be identified. In this study, we found that the upregulation of miRNA-26a-5p induced by TBI correlated with a decrease in phosphatase and tensin homolog (PTEN) in callus formation. In vitro, overexpressing miRNA-26a-5p inhibited PTEN expression and accelerated osteoblast differentiation, whereas silencing of miRNA-26a-5p inhibited osteoblast activity. Reduction of PTEN facilitated osteoblast differentiation via the PI3K/AKT signaling pathway. Through luciferase assays, we found evidence that PTEN is a miRNA-26a-5p target gene that negatively regulates the differentiation of osteoblasts. Moreover, the present study confirmed that preinjection of agomiR-26a-5p leads to increased bone formation. Collectively, these results indicate that miRNA-26a-5p overexpression may be a key factor governing the improved fracture healing observed in TBI patients after the downregulation of PTEN and PI3K/AKT signaling. Upregulation of miRNA-26a-5p may therefore be a promising therapeutic strategy for promoting fracture healing.	[Xiong, Yuan; Cao, Faqi; Hu, Liangcong; Yan, Chenchen; Chen, Lang; Zhou, Wu; Xue, Hang; Liu, Mengfei; Liu, Yi; Liu, Jing; Abududilibaier, Abudula; Mi, Bobin; Liu, Guohui] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Panayi, Adriana C.] Harvard Med Sch, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02215 USA; [Sun, Yun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430022, Hubei, Peoples R China; [Wu, Qipeng] Huazhong Univ Sci & Technol, Puai Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan 430030, Hubei, Peoples R China; [Zhang, Peng] Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou 215006, Peoples R China		Mi, BB; Liu, GH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	mi19882@163.com; liuguohui@hust.edu.cn	Xiong, Yuan/AAQ-3642-2021; Panayi, Adriana C./AAF-1817-2020; chou, wu/AAI-1145-2019	Panayi, Adriana C./0000-0003-4053-9855; Xiong, Yuan/0000-0003-1090-9288	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772345]; Healthy Commission Key Project of Hubei Province [WJ2019Z009]; Science and Technology Department of Hubei Province [2016CFB424]; Development Center for Medical Science and Technology, National Health and Family Planning Commission of the People's Republic of China [ZX-01-C2016024]	Our work was supported by the National Science Foundation of China (81772345), the Healthy Commission Key Project of Hubei Province (WJ2019Z009), the Science and Technology Department of Hubei Province (2016CFB424), and the Development Center for Medical Science and Technology, National Health and Family Planning Commission of the People's Republic of China (ZX-01-C2016024).	Arfat Y, 2018, MOL THER-NUCL ACIDS, V11, P323, DOI 10.1016/j.omtn.2017.11.009; Baek D, 2018, MOL THER-NUCL ACIDS, V13, P322, DOI 10.1016/j.omtn.2018.09.015; Balani DH, 2017, J CLIN INVEST, V127, P3333, DOI 10.1172/JCI91699; Bashash D, 2019, INT J BIOCHEM CELL B, V108, P7, DOI 10.1016/j.biocel.2019.01.005; Castellano L, 2017, NUCLEIC ACIDS RES, V45, P4401, DOI 10.1093/nar/gkx022; Chai C, 2018, CNS NEUROSCI THER, V24, P369, DOI 10.1111/cns.12785; Chen L, 2014, STEM CELLS, V32, P902, DOI 10.1002/stem.1615; Collins CJ, 2015, J BIOMECH, V48, P310, DOI 10.1016/j.jbiomech.2014.11.028; D'Abundo L, 2017, ONCOGENE, V36, P6617, DOI 10.1038/onc.2017.269; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Fan YS, 2018, MOLECULES, V23, DOI 10.3390/molecules23092306; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fushimi S, 2018, GENES CELLS, V23, P517, DOI 10.1111/gtc.12591; Hamada K, 2019, BIOL PHARM BULL, V42, P130, DOI 10.1248/bpb.b18-00801; Hu ZB, 2015, SCI REP-UK, V5, DOI 10.1038/srep18655; Huang YP, 2015, STEM CELLS, V33, P3481, DOI 10.1002/stem.2225; Kim KM, 2012, J BONE MINER RES, V27, P1669, DOI 10.1002/jbmr.1604; Klaw MC, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.34; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052; Liu H, 2014, J CELL PHYSIOL, V229, P1494, DOI 10.1002/jcp.24591; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Luo FT, 2018, MOL THER-NUCL ACIDS, V13, P291, DOI 10.1016/j.omtn.2018.09.012; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; Ma XK, 2018, ONCOTARGETS THER, V11, P8399, DOI 10.2147/OTT.S182573; Malentacchi F, 2019, ONCOL REP, V41, P1560, DOI 10.3892/or.2018.6939; Matsumoto Toshio, 2004, Nihon Rinsho, V62 Suppl 2, P37; Millis SZ, 2019, CANCER-AM CANCER SOC, V125, P1185, DOI 10.1002/cncr.31921; Moses C, 2019, MOL THER-NUCL ACIDS, V14, P287, DOI 10.1016/j.omtn.2018.12.003; Neirijnck Y, 2019, ENDOCRINOLOGY, V160, P387, DOI 10.1210/en.2018-00892; Paquet J, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.05.28; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Seeliger C, 2016, STEM CELLS DEV, V25, P1261, DOI 10.1089/scd.2016.0133; Su Y, 2019, BIOL PSYCHIAT, V85, P769, DOI 10.1016/j.biopsych.2018.12.008; Tian LJ, 2017, GENE, V627, P32, DOI 10.1016/j.gene.2017.06.002; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; van der Horst G, 2005, J BONE MINER RES, V20, P2233, DOI 10.1359/JBMR.050821; Walker CL, 2019, J NEUROTRAUM, V36, P2676, DOI 10.1089/neu.2018.6294; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Yang JL, 2017, MOL THER-NUCL ACIDS, V7, P278, DOI 10.1016/j.omtn.2017.04.010; Ye L, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0030-y; Yu B, 2012, J BONE MINER RES, V27, P2001, DOI 10.1002/jbmr.1663; Zha XL, 2018, J ORTHOP RES, V36, P417, DOI 10.1002/jor.23613; Zhang R, 2018, THER CLIN RISK MANAG, V14, P2315, DOI 10.2147/TCRM.S182325; Zhang XH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15037674; Zhang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10376	56	20	21	4	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 6	2019	17						223	234		10.1016/j.omtn.2019.06.001			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JA6XF	WOS:000487984400019	31272072	hybrid, Green Published			2022-02-06	
J	Boutte, AM; Thangavelu, B; LaValle, CR; Nemes, J; Gilsdorf, J; Shear, DA; Kamimori, GH				Boutte, Angela M.; Thangavelu, Bharani; LaValle, Christina R.; Nemes, Jeffrey; Gilsdorf, Janice; Shear, Deborah A.; Kamimori, Gary H.			Brain-related proteins as serum biomarkers of acute, subconcussive blast overpressure exposure: A cohort study of military personnel	PLOS ONE			English	Article							AUTOMATED NEUROBEHAVIORAL ASSESSMENT; NEUROFILAMENT LIGHT; SERVICE MEMBERS; INJURY; PLASMA; DUTY; TAU; PERFORMANCE; CONCUSSION; SYMPTOMS	Repeated exposure to blast overpressure remains a major cause of adverse health for military personnel who, as a consequence, are at a higher risk for neurodegenerative disease and suicide. Acute, early tracking of blast related effects holds the promise of rapid health assessment prior to onset of chronic problems. Current techniques used to determine blast-related effects rely upon reporting of symptomology similar to that of concussion and neurocognitive assessment relevant to operational decrement. Here, we describe the results of a cross sectional study with pared observations. The concentration of multiple TBI-related proteins was tested in serum collected within one hour of blast exposure as a quantitative and minimally invasive strategy to augment assessment of blast-exposure effects that are associated with concussion-like symptomology and reaction time decrements. We determined that median simple reaction time (SRT) was slowed in accordance with serum Nf-L, tau, A beta-40, and A beta-42 elevation after overpressure exposure. In contrast, median levels of serum GFAP decreased. Individual, inter-subject analysis revealed positive correlations between changes in Nf-L and GFAP, and in A beta-40 compared to A beta-42. The change in Nf-L was negatively associated with tau, A beta-40, and A beta-42. Participants reported experiencing headaches, dizziness and taking longer to think. Dizziness was associated with reaction time decrements, GFAP or NfL suppression, as well as A beta peptide elevation. UCH-L1 elevation had a weak association with mTBI/concussion history. Multiplexed serum biomarker quantitation, coupled with reaction time assessment and symptomology determined before and after blast exposure, may serve as a platform for tracking adverse effects in the absence of a head wound or diagnosed concussion. We propose further evaluation of serum biomarkers, which are often associated with TBI, in the context of acute operational blast exposures.	[Boutte, Angela M.; Thangavelu, Bharani; Gilsdorf, Janice; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD 20910 USA; [LaValle, Christina R.; Nemes, Jeffrey; Kamimori, Gary H.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		Boutte, AM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Branch, Silver Spring, MD 20910 USA.	angela.m.boutte.civ@mail.mil			Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3); Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award [W81XWH-16-2-0001]	This work was supported by the Combat Casualty Care Research Program, the U.S. Army Medical Research and Materiel Command Military Operational Medicine Research Program (Research Area Directorate 3), and Office of the Assistant Secretary of Defense for Health Affairs, Broad Agency Announcement Award No. W81XWH-16-2-0001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Bazarian JJ, 2018, LANCET NEUROL; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Britt TW, 2000, J APPL SOC PSYCHOL, V30, P1599, DOI 10.1111/j.1559-1816.2000.tb02457.x; Bu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13917; Cao R, 2019, JOURNAL OF NEUROTRAU; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Di Battista AP, 2016, PLOS ONE, V11; Dobrowolska JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089998; Fear NT, 2012, J EPIDEMIOL COMMUN H, V66, pA35, DOI 10.1136/jech-2012-201753.091; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Hanas JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215762; Haran FJ, 2016, APPL NEUROPSYCH-ADUL, V23, P411, DOI 10.1080/23279095.2016.1166111; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P1591, DOI 10.1001/archneurol.2012.18107; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kovacs GG, 2017, EUR J NEUROL, V24, P1326, DOI 10.1111/ene.13389; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mishra V, 2016, SCI REPORTS, V6; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Ono K, 2018, NEUROCHEM INT, V119, P57, DOI 10.1016/j.neuint.2017.08.010; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Puig KL, 2013, EXP GERONTOL, V48, P608, DOI 10.1016/j.exger.2012.07.009; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Song HL, 2019, J NEUROTRAUM, V36, P1591, DOI 10.1089/neu.2018.6114; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Tate CM, 2013, J NEUROTRAUM; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Wirsching A, 2018, J NEUROTRAUMA; Yang ZH, 2018, MOL NEUROBIOL, V55, P2174, DOI 10.1007/s12035-017-0424-7; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088	55	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221036	10.1371/journal.pone.0221036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	WOS:000485009500034	31408492	Green Submitted, Green Published, gold			2022-02-06	
J	Caldwell, JA; Knapik, JJ; Shing, TL; Kardouni, JR; Lieberman, HR				Caldwell, John A.; Knapik, Joseph J.; Shing, Tracie L.; Kardouni, Joseph R.; Lieberman, Harris R.			The association of insomnia and sleep apnea with deployment and combat exposure in the entire population of US army soldiers from 1997 to 2011: a retrospective cohort investigation	SLEEP			English	Article						posttraumatic stress disorder; traumatic brain injury; depression; anxiety; stress; mediation analysis; comorbidities	POSTTRAUMATIC-STRESS-DISORDER; GULF-WAR VETERANS; MEDIATION ANALYSIS; PSYCHIATRIC-DISORDERS; VIETNAM VETERANS; HEALTH-STATUS; PREVALENCE; IRAQ; COMORBIDITY; AFGHANISTAN	Since 2001, the United States has been engaged in the longest and most expensive overseas conflict in its history. Sleep disorders, especially insomnia and obstructive sleep apnea (OSA), are common in service members and appear related to deployment and combat exposure, but this has not been systematically examined. Therefore, the incidence of clinically diagnosed insomnia and OSA from 1997 to 2011 in the entire population of US Army soldiers was determined and associations of these disorders with deployment and combat exposure examined. This observational retrospective cohort study linked medical, demographic, deployment, and combat casualty data from all active duty US Army soldiers serving from 1997 to 2011 (n = 1 357 150). The mediating effects of multiple known comorbid conditions were considered. From 2003 to 2011, there were extraordinary increases in incidence of insomnia (652%) and OSA (600%). Factors increasing insomnia risk were deployment (risk ratio [RR] [deployed/not deployed] = 2.06; 95% confidence interval [CI], 2.04-2.08) and combat exposure (RR [exposed/not exposed] = 1.20; 95% CI, 1.19-1.22). Risk of OSA was increased by deployment (RR [deployed/not deployed] = 2.14; 95% CI, 2.11-2.17), but not combat exposure (RR [exposed/not exposed] = 1.00; 95% CI, 0.98-1.02). These relationships remained after accounting for other factors in multivariable analyses. A number of comorbid medical conditions such as posttraumatic stress disorder and traumatic brain injury mediated a portion of the association between the sleep disorders and deployment. It is essential to determine underlying mechanisms responsible for these very large increases in insomnia and OSA and introduce effective preventive measures.	[Caldwell, John A.; Shing, Tracie L.] Oak Ridge Inst Sci & Educ, Belcamp, MD USA; [Caldwell, John A.; Knapik, Joseph J.; Lieberman, Harris R.] US Army Res Inst Environm Med, Mil Nutr Div, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA; [Knapik, Joseph J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Shing, Tracie L.; Kardouni, Joseph R.] US Army Res Inst Environm Med, Mil Performance Div, Natick, MA USA		Lieberman, HR (corresponding author), US Army Res Inst Environm Med, Mil Nutr Div, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA.	harris.r.lieberman.civ@mail.mil			US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC)	The views, opinions, and/or findings contained in this report are those of the authors and should not be construed as official Department of the Army position, policy, or decision, unless so designated by other official documentation. Approved for public release; distribution is unlimited. This work was supported by the US Army Medical Research and Materiel Command (USAMRMC).	Armed Forces Health Surveillance Branch, 2010, MSMR, V17, P12; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Caldwell JA, 2017, J SLEEP RES, V26, P665, DOI 10.1111/jsr.12543; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Clark Leslie L, 2016, MSMR, V23, P9; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Dean AG, 2014, OPEN SOURCE EPIDEMIO; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2701; Dunn L, 2010, MSMR, V17, P8; Epidemiology Program Post-Deployment Health Group Office of Patient Care Services Veterans Health Administration Department of Veterans Affairs, 2017, ANAL VA HLTH CAR UT; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Foster SN, 2016, CURR PULMONOL REP, V5, P101, DOI 10.1007/s13665-016-0147-7; Harrison E, 2017, MIL MED, V182, P189, DOI 10.7205/MILMED-D-16-00078; Helfer Thomas M, 2011, MSMR, V18, P7; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hunt EJ, 2016, OCCUP MED; Institue of Medicine of the National Academies, 2006, SLEEP DISORDERS SLEE; Institute of Medicine, 2010, RET HOM IR AFGH PREL; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Knapik JJ, 2012, PUBLIC HEALTH, V126, P498, DOI 10.1016/j.puhe.2012.01.031; Krakow BJ, 2015, SLEEP MED REV, V24, P37, DOI 10.1016/j.smrv.2014.11.001; Lee-Chiong T., 2008, SLEEP MED ESSENTIALS; Lewis Paul E, 2014, MSMR, V21, P6; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Parish JM, 2009, CHEST, V135, P563, DOI 10.1378/chest.08-0934; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Sateia MJ, 2009, CHEST, V135, P1370, DOI 10.1378/chest.08-1834; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Seelig AD, 2016, SLEEP, V39, P1111, DOI 10.5665/sleep.5766; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Shattuck NL, 2013, SLEEP, V36, P159, DOI 10.5665/sleep.2356; Spiegelhalder K, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0364-5; Swinkels CM, 2013, SLEEP, V36, P1019, DOI 10.5665/sleep.2800; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213; Taylor MK, 2014, MIL MED, V179, P744, DOI 10.7205/MILMED-D-13-00551; Thorpy MJ, 2012, NEUROTHERAPEUTICS, V9, P687, DOI 10.1007/s13311-012-0145-6; Troxel WM, 2015, SLEEP MILITARY PROMO; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402; VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845	51	20	20	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	AUG	2019	42	8							zsz112	10.1093/sleep/zsz112			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JI3QV	WOS:000493383600014	31106808	Green Submitted, hybrid, Green Published			2022-02-06	
J	Lippert, T; Borlongan, CV				Lippert, Trenton; Borlongan, Cesario V.			Prophylactic treatment of hyperbaric oxygen treatment mitigates inflammatory response via mitochondria transfer	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						hyperbaric; mitochondria transfer; preconditioning; stroke; traumatic brain injury	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; BARRIER BREAKDOWN; CELL THERAPY; TNF-ALPHA; STROKE; APOPTOSIS; RAT; MECHANISMS; INHIBITION	Aims Hyperbaric oxygen therapy (HBOT) has been widely used as postinjury treatment; however, we investigate its ability to mitigate potential damage as a preconditioning option. Here, we tested the hypothesis that HBOT preconditioning mitigates cell death in primary rat neuronal cells (PRNCs) through the transfer of mitochondria from astrocytes. Methods Primary rat neuronal cells were subjected to a 90-minute HBOT treatment at 2.5 absolute atmospheres prior to either tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) injury to simulate the inflammation-plagued secondary cell death associated with stroke and traumatic brain injury (TBI). After incubation with TNF-alpha or LPS, the cell viability of each group was examined. Results There was a significant increase of cell viability accompanied by mitochondrial transfer in the injury groups that received HBOT preconditioning compared to the injury alone groups (44 +/- 5.2 vs 68 +/- 4.48, n = 20, P < 0.05). The transfer of mitochondria directly after HBOT treatment was visualized by capturing images in 5-minute intervals, which revealed that the robust transfer of mitochondria begins soon after HBOT and persisted throughout the treatment. Conclusion This study shows that HBOT preconditioning stands as a robust prophylactic treatment for sequestration of inflammation inherent in stroke and TBI, possibly facilitating the transfer of resilient mitochondria from astrocytes to inflammation-susceptible neuronal cells in mitigating cell death.	[Lippert, Trenton; Borlongan, Cesario V.] USF Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA; [Lippert, Trenton] Univ S Florida, Honors Coll, Tampa, FL USA		Borlongan, CV (corresponding author), USF Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu			Center for Scientific ReviewUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS102395]	Center for Scientific Review, Grant/Award Number: R01NS102395	Aliev G, 2004, MITOCHONDRION, V4, P649, DOI 10.1016/j.mito.2004.07.018; Andre-Levigne D, 2016, WOUND REPAIR REGEN, V24, P954, DOI 10.1111/wrr.12480; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Bhutani S, 2012, INDIAN J PLAST SURG, V45, P316, DOI 10.4103/0970-0358.101309; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Borlongan CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078490; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2000, FASEB J, V14, P1307, DOI 10.1096/fj.14.10.1307; Chen SY, 2011, UNDERSEA HYPERBAR M, V38, P375; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Dougherty JE, 2013, CRIT CARE NURS Q, V36, P299, DOI 10.1097/CNQ.0b013e318294ea41; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Gamdzyk M, 2016, BRAIN RES, V1648, P257, DOI 10.1016/j.brainres.2016.07.025; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Nguyen H, 2016, EXPERT REV NEUROTHER, V16, P915, DOI 10.1080/14737175.2016.1184086; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liu B, 2015, INT J BIOL SCI, V11, P353, DOI 10.7150/ijbs.9813; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Muriach M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/102158; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Newman MB, 2005, STEM CELLS DEV, V14, P29, DOI 10.1089/scd.2005.14.29; Okazawa H, 2014, Q J NUCL MED MOL IM, V58, P387; Ostrowski RP, 2008, NEUROBIOL DIS, V29, P1, DOI 10.1016/j.nbd.2007.07.020; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Saporta S, 1997, EXP NEUROL, V146, P299, DOI 10.1006/exnr.1997.6493; Selcuk CT, 2013, J BURN CARE RES, V34, pE237, DOI 10.1097/BCR.0b013e318270092e; Seule M, 2015, FACIAL PLAST SURG, V31, P325, DOI 10.1055/s-0035-1562884; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Soejima Y, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-9; Stoekenbroek RM, 2014, EUR J VASC ENDOVASC, V47, P647, DOI 10.1016/j.ejvs.2014.03.005; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Xia CF, 2004, HUM GENE THER, V15, P1243, DOI 10.1089/hum.2004.15.1243; Xing Pengcheng, 2018, Acta Cir. Bras., V33, P341, DOI 10.1590/s0102-865020180040000006; Yang L, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165187; Yang LM, 2015, BRAIN RES, V1627, P21, DOI 10.1016/j.brainres.2015.08.011; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Zhai WW, 2016, MED GAS RES, V6, P111, DOI 10.4103/2045-9912.184721; Zuo W, 2014, NEUROPHARMACOLOGY, V86, P103, DOI 10.1016/j.neuropharm.2014.07.002	54	20	20	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	AUG	2019	25	8					815	823		10.1111/cns.13124			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	IJ0XJ	WOS:000475623000002	30972972	Green Published, gold			2022-02-06	
J	Volovici, V; Steyerberg, EW; Cnossen, MC; Haitsma, IK; Dirven, CMF; Maas, AIR; Lingsma, HF				Volovici, Victor; Steyerberg, Ewout W.; Cnossen, Maryse C.; Haitsma, Iain K.; Dirven, Clemens M. F.; Maas, Andrew I. R.; Lingsma, Hester F.			Evolution of Evidence and Guideline Recommendations for the Medical Management of Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						BTF Guidelines; evidence base; guidelines for severe TBI; survival of recommendations	CLINICAL-PRACTICE GUIDELINES	Brain Trauma Foundation (BTF) Guidelines for medical management of severe traumatic brain injury (TBI) have become a global standard for the treatment of TBI patients. We aim to explore the evolution of the guidelines for the management of severe TBI. We reviewed the four editions of the BTF guidelines published over the past 20 years. The 1996 and 2000 editions were merged because of minimal differences, and are referred to as the 1996 edition. We described changes in topics and recommendations over time, and analyzed predictors of survival of recommendations with logistical regression. The guidelines contained 27 recommendations on 18 topics in 2016, 35 recommendations on 15 topics in 2007, and 22 recommendations on 10 topics in 1996. Substantial delays were found between the search for evidence and the guideline publication, ranging from 18 to 34 months. The overall body of evidence comprised 189 studies on 18 topics in 2016, compared with 156 studies on 15 topics in 2007 and 180 studies on 10 topics in 1996. Over time, a total of 175 studies were discarded from the evidence base following more rigorous grading of evidence. A total of 15/23 (65%) of the 1996/2000 recommendations were discarded over time. Out of 12 new recommendations introduced in the 2007 edition, 8 (66%) were discarded in 2016. Survival of recommendations varied between 33% and 100% for level I recommendations and between 11% and 31% for level II and III recommendations. No predictors of survival of recommendations were found. Substantial delays exist between literature search and publication, and survival rate of TBI guideline recommendations is poor. These factors may adversely affect currency and adherence to guidelines. The TBI community should take responsibility for improving the quality of the evidence base and ensuring that the translation of the evidence into guidelines supports clinicians in daily clinical practice.	[Volovici, Victor; Haitsma, Iain K.; Dirven, Clemens M. F.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Volovici, Victor; Steyerberg, Ewout W.; Cnossen, Maryse C.; Lingsma, Hester F.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Volovici, V (corresponding author), Erasmus MC Univ, Med Ctr, Erasmus MC Stroke Ctr, Dept Neurosurg & Med Decis Making, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	v.volovici@erasmusmc.nl	Volovici, Victor/AAZ-8901-2020; Maas, Andrew IR/C-5584-2013	Volovici, Victor/0000-0002-5798-5360; Maas, Andrew IR/0000-0003-1612-1264	European Union Framework 7 program - CENTER TBI [602150]	This work was supported by the European Union Framework 7 program (grant 602150) - CENTER TBI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Higgins J., 2008, COCHRANE HDB SYSTEMA; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V305, P1846, DOI 10.1001/jama.2011.597; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Laine C, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00011; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; Liu WM, 2018, NEUROSURG REV, V41, P55, DOI 10.1007/s10143-016-0742-7; Meyfroidt G, 2017, NEUROSURGERY, V81, pE1, DOI 10.1093/neuros/nyx144; Neuman MD, 2014, JAMA-J AM MED ASSOC, V311, P2092, DOI 10.1001/jama.2014.4949; Robin Graham M.M., 2011, CLIN PRACTICE GUIDEL; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; The Brain Trauma Foundation, 2000, METHODOLOGY J NEUROT, V17, P561; Thomas LH, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000349; Volovici V, 2019, WORLD NEUROSURG; Volovici V, 2017, NEUROSURGERY, V81, pE21, DOI 10.1093/neuros/nyx183; Yarascavitch BA, 2012, NEUROSURGERY, V71, P1131, DOI 10.1227/NEU.0b013e318271bc99	21	20	20	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2019	36	22					3183	3189		10.1089/neu.2019.6474		JUL 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JI6MG	WOS:000479787600001	31280663	Green Accepted, Bronze			2022-02-06	
J	Fraser, EE; Downing, MG; Biernacki, K; McKenzie, DP; Ponsford, JL				Fraser, Elinor E.; Downing, Marina G.; Biernacki, Kathryn; McKenzie, Dean P.; Ponsford, Jennie L.			Cognitive Reserve and Age Predict Cognitive Recovery after Mild to Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive recovery; cognitive reserve; traumatic brain injury	GLASGOW COMA SCALE; NEUROPSYCHOLOGICAL RECOVERY; MULTIPLE IMPUTATION; CLINICAL UTILITY; OLDER-ADULTS; HEAD-INJURY; FOLLOW-UP; MODERATE; IMPACT; TRAJECTORIES	The persistence of injury-related cognitive impairments can have devastating consequences for everyday function after traumatic brain injury (TBI). This longitudinal study examined the association of long-term cognitive recovery in 109 adults (71% male) experiencing complicated mild-to-severe TBI with age, pre-morbid intelligence (IQ), and injury severity measured by post-traumatic amnesia (PTA) duration. Participants' twice completed measures of pre-morbid IQ (National Adult Reading Test), attention (Digit Symbol Coding Test), memory (Rey Auditory Verbal Learning Test), and executive function (Trail Making Test Part-B) at a mean of 43.73 days post-TBI and again at a mean of 3.70 years (range 23-72 months) post-injury. A healthy control group comprising 63 adults (59% male) completed the measures once. At initial assessment, TBI participants performed significantly worse on all measures compared with the healthy control group. Within the TBI group, shorter PTA duration, younger age, and higher pre-morbid IQ were associated with better initial cognitive performance. Cognitive task performance improved significantly in the TBI group at follow-up between two to five years later but remained significantly below control group means. Notably, higher pre-morbid IQ and younger age were associated with greater cognitive recovery at follow-up, whereas PTA duration was not. These findings support the role of cognitive reserve and age in cognitive recovery after TBI and may inform prognostication and rehabilitation. Additional research is needed to elucidate the biological mechanisms of cognitive reserve in cognitive recovery after TBI.	[Fraser, Elinor E.; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Monash Epworth Rehabil Res Ctr, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Biernacki, Kathryn] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [McKenzie, Dean P.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ USA; [McKenzie, Dean P.] Epworth HealthCare, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632; Fraser, Elinor/0000-0001-5679-4362	Transport Accident Commission	This research was funded by the Transport Accident Commission. The authors also gratefully acknowledge the staff at the Monash-Epworth Rehabilitation Research Centre for their assistance with data collection.	[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; CALLAHAN CD, 1994, J CLIN PSYCHOL MED S, V1, P261, DOI 10.1007/BF01989627; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Crawford J. R., 1992, HDB NEUROPSYCHOLOGIC; de Guise E, 2017, BRAIN INJURY, V31, P1061, DOI 10.1080/02699052.2017.1297485; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2019, ARCH CLIN NEUROPSYCH, V34, P206, DOI 10.1093/arclin/acy035; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Harel O, 2009, J APPL STAT, V36, P1109, DOI 10.1080/02664760802553000; Haut MW, 2007, BRAIN IMAGING BEHAV, V1, P83, DOI 10.1007/s11682-007-9008-x; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Howell D. C., 2012, STAT METHODS PSYCHOL, V8 th; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kruskal W.H., 1960, TECHNOMETRICS, V2, P1, DOI DOI 10.2307/1266526; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Little R. J., 2019, STAT ANAL MISSING DA, V793; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Nelson H.E., 1982, NATL ADULT READING T; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Pollet TV, 2017, ADAPT HUM BEHAV PHYS, V3, P43, DOI 10.1007/s40750-016-0050-z; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1992, TRAIL MAKING TEST MA; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, pE17, DOI 10.1097/HTR.0000000000000290; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tabachnick B.G., 2013, USING MULTIVARIATE S; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553	89	20	20	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2019	36	19					2753	2761		10.1089/neu.2019.6430		JUN 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JB8IG	WOS:000472104100001	31017049				2022-02-06	
J	Killien, EY; Farris, RWD; Watson, RS; Dervan, LA; Zimmerman, JJ				Killien, Elizabeth Y.; Farris, Reid W. D.; Watson, R. Scott; Dervan, Leslie A.; Zimmerman, Jerry J.			Health-Related Quality of Life Among Survivors of Pediatric Sepsis	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						child; intensive care units; outcome assessment; quality of life; risk factors; sepsis	GENERIC CORE SCALES; TRAUMATIC BRAIN-INJURY; FUNCTIONAL OUTCOMES; CONSTRUCT-VALIDITY; ORGAN DYSFUNCTION; INFANT SCALES; SEPTIC SHOCK; CHILDREN; EPIDEMIOLOGY; RELIABILITY	Objectives: Mortality from pediatric sepsis has steadily declined over the past several decades; however, little is known about morbidity among survivors. We aimed to determine the prevalence of and risk factors for failure to recover to baseline health-related quality of life following community-acquired pediatric sepsis. Design: Retrospective cohort study. Setting: Seattle Children's Hospital. Patients: Children aged 1 month to 21 years admitted to the inpatient wards or ICUs from 2012 to 2015 who met 2005 consensus sepsis criteria within 4 hours of hospitalization and were enrolled in the hospital's Outcomes Assessment Program with baseline, admission, and post-discharge health-related quality of life data available. Interventions: None. Measurements and Main Results: We assessed health-related quality of life with the Pediatric Quality of Life Inventory for preadmission baseline, admission, and post-discharge (median, 31 d) status. We determined associations between patient and illness characteristics with failure to recover within 4.5 points of baseline at follow-up (the minimum clinically significant difference between two scores). Of 790 patients, 23.8% failed to recover to baseline health-related quality of life at follow-up. Factors associated with failure to recover were septic shock, older age, private insurance, complex chronic disease, immune compromise, CNS infection or bacteremia, ICU admission, and longer length of stay. On multivariable analysis controlling for time to follow-up, failure to recover was independently associated with septic shock (relative risk, 1.79; 95% CI, 1.24-2.58), older age (relative risk, 1.02/yr; 95% CI, 1.01-1.05), immune compromise (relative risk, 1.83; 95% CI, 1.40-2.40), and length of stay (relative risk, 1.03/d; 95% CI, 1.01-1.04). Conclusions: Nearly one-quarter of children surviving hospitalization for community-acquired sepsis experienced a clinically significant deterioration in health-related quality of life. We identify risk factors for poor outcomes following sepsis and highlight the need for ongoing evaluation and treatment by primary and specialty care providers for pediatric sepsis survivors after hospital discharge.	[Killien, Elizabeth Y.; Farris, Reid W. D.; Watson, R. Scott; Dervan, Leslie A.; Zimmerman, Jerry J.] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Killien, Elizabeth Y.] Harborview Injury Prevent Res Ctr, Seattle, WA 98104 USA; [Farris, Reid W. D.; Dervan, Leslie A.; Zimmerman, Jerry J.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA; [Watson, R. Scott] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; Seattle Childrens Hosp, Seattle, WA USA		Killien, EY (corresponding author), Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA.; Killien, EY (corresponding author), Harborview Injury Prevent Res Ctr, Seattle, WA 98104 USA.	elizabeth.killien@seattlechil-drens.org	Dervan, Leslie/ABH-4983-2020; /AAD-2116-2020	Dervan, Leslie/0000-0002-4521-354X; 	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER		Aspesberro F, 2016, PEDIATR CRIT CARE ME, V17, pE272, DOI 10.1097/PCC.0000000000000727; Aspesberro F, 2015, INTENS CARE MED, V41, P1235, DOI 10.1007/s00134-015-3780-7; Balamuth F, 2014, PEDIATR CRIT CARE ME, V15, P798, DOI 10.1097/PCC.0000000000000225; Bronner MB, 2009, PEDIATR CRIT CARE ME, V10, P636, DOI 10.1097/PCC.0b013e3181ae5c1a; Buysse CMP, 2008, CRIT CARE MED, V36, P596, DOI 10.1097/01.CCM.0000299740.65484.CA; Colville GA, 2013, PEDIATR CRIT CARE ME, V14, pE85, DOI 10.1097/PCC.0b013e3182712997; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Czaja AS, 2009, PEDIATRICS, V123, P849, DOI 10.1542/peds.2008-0856; de Souza DC, 2017, SHOCK, V47, P2, DOI 10.1097/SHK.0000000000000699; Desai AD, 2014, JAMA PEDIATR, V168, P1114, DOI 10.1001/jamapediatrics.2014.1600; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Edmond K, 2010, PEDIATR INFECT DIS J, V29, P1023, DOI 10.1097/INF.0b013e3181e598ea; Edwards JD, 2012, CRIT CARE MED, V40, P2196, DOI 10.1097/CCM.0b013e31824e68cf; Farris RWD, 2013, PEDIATR CRIT CARE ME, V14, P835, DOI 10.1097/PCC.0b013e3182a551c8; Gebara Bassam M, 2005, Pediatr Crit Care Med, V6, P500, DOI 10.1097/01.PCC.0000164344.07588.83; Gebara BM, 2005, PEDIATR CRIT CARE ME, V6, P501; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gupta S, 2016, CHEST, V150, P1251, DOI 10.1016/j.chest.2016.08.1460; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Kruse S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0168-2; Leteurtre S, 1999, MED DECIS MAKING, V19, P399, DOI 10.1177/0272989X9901900408; Limbers CA, 2009, ANN EPIDEMIOL, V19, P575, DOI 10.1016/j.annepidem.2009.04.004; Menon K, 2017, PEDIATR CRIT CARE ME, V18, pE146, DOI 10.1097/PCC.0000000000001078; Morrison Anne L, 2002, Pediatr Crit Care Med, V3, P1, DOI 10.1097/00130478-200201000-00001; Namachivayam P, 2012, PEDIATR CRIT CARE ME, V13, P520, DOI 10.1097/PCC.0b013e31824fb989; Nielsen KR, 2016, J INTENSIVE CARE MED, V31, P660, DOI 10.1177/0885066615571893; Phua J, 2013, CRIT CARE, V17, DOI 10.1186/cc12896; Polic B, 2013, EUR J PEDIATR, V172, P85, DOI 10.1007/s00431-012-1843-0; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Rabbitts JA, 2015, J PAIN, V16, P1334, DOI 10.1016/j.jpain.2015.09.005; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Ruth A, 2014, PEDIATR CRIT CARE ME, V15, P828, DOI 10.1097/PCC.0000000000000254; Simon TD, 2014, PEDIATRICS, V133, pE1647, DOI 10.1542/peds.2013-3875; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	39	20	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUN	2019	20	6					501	509		10.1097/PCC.0000000000001886			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	IQ4HF	WOS:000480711000007	30720672	Green Accepted			2022-02-06	
J	Papa, L; Zonfrillo, MR; Welch, RD; Lewis, LM; Braga, CF; Tan, CN; Ameli, NJ; Lopez, MA; Haeussler, CA; Giordano, DM; Giordano, PA; Ramirez, J; Mittal, MK				Papa, Linda; Zonfrillo, Mark R.; Welch, Robert D.; Lewis, Lawrence M.; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco A.; Haeussler, Crystal A.; Giordano, Diego Mendez; Giordano, Philip A.; Ramirez, Jose; Mittal, Manoj K.			Evaluating glial and neuronal blood biomarkers GFAP and UCH-L1 as gradients of brain injury in concussive, subconcussive and non-concussive trauma: a prospective cohort study	BMJ PAEDIATRICS OPEN			English	Article						biomarkers; concussion; mild traumatic brain injury; subconcussive; head trauma; trauma; children; paediatric; glial fibrillary acidic protein (GFAP); Ubiquitin C-terminal hydrolase (UCH-L1); blood test		ObjectivesTo evaluate the ability of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase (UCH-L1) to detect concussion in children and adult trauma patients with a normal mental status and assess biomarker concentrations over time as gradients of injury in concussive and non-concussive head and body trauma.DesignLarge prospective cohort study.SettingThree level I trauma centres in the USA.ParticipantsPaediatric and adult trauma patients of all ages, with and without head trauma, presenting with a normal mental status (Glasgow Coma Scale score of 15) within 4hours of injury. Rigorous screening for concussive symptoms was conducted. Of 3462 trauma patients screened, 751 were enrolled and 712 had biomarker data. Repeated blood sampling was conducted at 4, 8, 12, 16, 24, 36, 48, 60, 72, 84, 96, 108, 120, 132, 144, 156, 168 and 180hours postinjury in adults.Main outcomesDetection of concussion and gradients of injury in children versus adults by comparing three groups of patients: (1) those with concussion; (2) those with head trauma without overt signs of concussion (non-concussive head trauma controls) and (3) those with peripheral (body) trauma without head trauma or concussion (non-concussive body trauma controls).ResultsA total of 1904 samples from 712 trauma patients were analysed. Within 4hours of injury, there were incremental increases in levels of both GFAP and UCH-L1 from non-concussive body trauma (lowest), to mild elevations in non-concussive head trauma, to highest levels in patients with concussion. In concussion patients, GFAP concentrations were significantly higher compared with body trauma controls (p<0.001) and with head trauma controls (p<0.001) in both children and adults, after controlling for multiple comparisons. However, for UCH-L1, there were no significant differences between concussion patients and head trauma controls (p=0.894) and between body trauma and head trauma controls in children. The AUC for initial GFAP levels to detect concussion was 0.80 (0.73-0.87) in children and 0.76 (0.71-0.80) in adults. This differed significantly from UCH-L1 with AUCs of 0.62 (0.53-0.72) in children and 0.69 (0.64-0.74) in adults.ConclusionsIn a cohort of trauma patients with normal mental status, GFAP outperformed UCH-L1 in detecting concussion in both children and adults. Blood levels of GFAP and UCH-L1 showed incremental elevations across three injury groups: from non-concussive body trauma, to non-concussive head trauma, to concussion. However, UCH-L1 was expressed at much higher levels than GFAP in those with non-concussive trauma, particularly in children. Elevations in both biomarkers in patients with non-concussive head trauma may be reflective of a subconcussive brain injury. This will require further study.	[Papa, Linda; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco A.; Haeussler, Crystal A.; Giordano, Diego Mendez; Giordano, Philip A.] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA; [Welch, Robert D.] Wayne State Univ, Sch Med, Detroit, MI USA; [Lewis, Lawrence M.] Washington Univ, Div Emergency Med, St Louis, MO 63110 USA; [Braga, Carolina F.] Robert Wood Johnson Univ Hosp, Dept Family Med & Community Hlth, New Brunswick, NJ USA; [Ramirez, Jose] Arnold Palmer Hosp Children, Dept Pediat Emergency Med, Orlando, FL USA; [Mittal, Manoj K.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA		Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA.	lpstat@aol.com	Zonfrillo, Mark/H-9403-2017	Zonfrillo, Mark/0000-0002-0610-9563	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676]	This study was supported by Award Number R01NS057676 (LP, Principal Investigator) from the National Institute of Neurological Disorders and Stroke.	[Anonymous], 2018, FDA AUTH MARK 1 BLOO; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Reynolds BB., 2017, BRAIN IMAGING BEHAV; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	29	20	20	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2399-9772		BMJ PAEDIATR OPEN	BMJ Paediatr. Open	JUN	2019	3	1							e000473	10.1136/bmjpo-2019-000473			13	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	VK0TP	WOS:000655592900020	31531405	Green Published, gold			2022-02-06	
J	Romeu-Mejia, R; Giza, CC; Goldman, JT				Romeu-Mejia, Rafael; Giza, Christopher C.; Goldman, Joshua T.			Concussion Pathophysiology and Injury Biomechanics	CURRENT REVIEWS IN MUSCULOSKELETAL MEDICINE			English	Article						Concussion pathophysiology; Mild traumatic brain injury; Neurometabolic cascade; Biomechanical impact; Concussion threshold; Linear-rotational acceleration	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; CORTICAL IMPACT INJURY; LONG-TERM POTENTIATION; DIFFUSE AXONAL INJURY; SYNAPTIC PLASTICITY; BARRIER DISRUPTION; KETOGENIC DIET; CELL-DEATH; SPORTS	Purpose of ReviewThe concussion public health burden has increased alongside our knowledge of the pathophysiology of mild traumatic brain injury (mTBI). The purpose of this review is to summarize our current understanding of mTBI pathophysiology and biomechanics and how these underlying principles correlate with clinical manifestations of mTBI.Recent FindingsChanges in post-mTBI glutamate and GABA concentrations seem to be region-specific and time-dependent. Genetic variability may predict recovery and symptom severity while gender differences appear to be associated with the neuroinflammatory response and neuroplasticity. Ongoing biomechanical research has shown a growing body of evidence in support of an individual-specific threshold for mTBI that varies based on individual intrinsic factors.SummaryThe literature demonstrates a well-characterized timeframe for mTBI pathophysiologic changes in animal models while work in this area continues to grow in humans. Current human research shows that these underlying post-mTBI effects are multifactorial and may correlate with symptomatology and recovery. While wearable sensor technology has advanced biomechanical impact research, a definitive concussion threshold remains elusive.	[Romeu-Mejia, Rafael; Giza, Christopher C.; Goldman, Joshua T.] UCLA, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Romeu-Mejia, Rafael; Giza, Christopher C.] UCLA, Brain Injury Res Ctr, Los Angeles, CA USA; [Giza, Christopher C.] UCLA, Mattel Childrens Hosp, Dept Pediat Pediat Neurol, Los Angeles, CA USA; [Goldman, Joshua T.] UCLA, Dept Family Med, Div Sports Med, Los Angeles, CA 90095 USA; [Goldman, Joshua T.] UCLA, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Goldman, Joshua T.] UCLA, Dept Intercollegiate Athlet, Los Angeles, CA 90095 USA; [Goldman, Joshua T.] Orthoped Inst Children, Ctr Sports Med, Los Angeles, CA 90007 USA		Goldman, JT (corresponding author), UCLA, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA.; Goldman, JT (corresponding author), UCLA, Dept Family Med, Div Sports Med, Los Angeles, CA 90095 USA.; Goldman, JT (corresponding author), UCLA, Dept Orthoped Surg, Los Angeles, CA 90095 USA.; Goldman, JT (corresponding author), UCLA, Dept Intercollegiate Athlet, Los Angeles, CA 90095 USA.; Goldman, JT (corresponding author), Orthoped Inst Children, Ctr Sports Med, Los Angeles, CA 90007 USA.	jgoldman@mednet.ucla.edu					Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Belanger M, 2011, J NEUROCHEM, V116, P564, DOI 10.1111/j.1471-4159.2010.07135.x; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Caccese JB, 2017, SPORTS BIOMECH, V3141, P1; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choe MC, 2016, J CHILD NEUROL, V31, P109, DOI 10.1177/0883073815572685; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Fidan E, 2018, ASN NEURO, V10, DOI 10.1177/1759091418770543; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Gurkoff GG, 2017, NEW THER TRAUMA BRAI; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Institute NSS, 2017, INT CONS DIAGN MAN S, P1, DOI [10.1002/app.21943, DOI 10.1002/APP.21943]; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KALIMO H, 1981, J CEREBR BLOOD F MET, V1, P313, DOI 10.1038/jcbfm.1981.35; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Liu XX, 2017, J NEUROTRAUM, V34, P2445, DOI 10.1089/neu.2016.4823; Livingston WS, 2017, J NEUROTRAUM, V34, P853, DOI 10.1089/neu.2016.4479; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mc Fie S, 2018, J SPORT SCI, V36, P2226, DOI 10.1080/02640414.2018.1448570; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, ORTHOP J SPORTS MED, V4; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Monaghan KG, 2000, AM J MED GENET, V94, P120, DOI 10.1002/1096-8628(20000911)94:2<120::AID-AJMG4>3.0.CO;2-N; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Nahum AM, 1977, P 21 STAPP CAR CRASH; NIXON RA, 1993, BRAIN PATHOL, V3, P29, DOI 10.1111/j.1750-3639.1993.tb00723.x; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Ommaya AK, 1996, P 10 STAPP CAR CRASH, P314; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Prange M T, 2000, Stapp Car Crash J, V44, P205; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Spader HS, 2019, J NEUROSURG, V130, P1321, DOI 10.3171/2017.12.JNS171597; Steenerson K, 2017, NEUROL CLIN, V35, P403, DOI 10.1016/j.ncl.2017.03.011; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yasen AL, 2018, J NEUROPHYSIOL, V120, P1318, DOI 10.1152/jn.00896.2017; Yeung D, 2008, ACTA NEUROPATHOL, V115, P635, DOI 10.1007/s00401-008-0364-4; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	128	20	21	2	17	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1935-973X	1935-9748		CURR REV MUSCULOSKE	Curr. Rev. Musculoskelet. Med.	JUN	2019	12	2					105	116		10.1007/s12178-019-09536-8			12	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	IA8NP	WOS:000469815900006	30820754	Green Published			2022-02-06	
J	Hossain, I; Mohammadian, M; Takala, RSK; Tenovuo, O; Lagerstedt, L; Ala-Seppala, H; Frantzen, J; van Gils, M; Hutchinson, P; Katila, AJ; Maanpaa, HR; Menon, DK; Newcombe, VF; Tallus, J; Hrusovsky, K; Wilson, DH; Blennow, K; Sanchez, JC; Zetterberg, H; Posti, JP				Hossain, Iftakher; Mohammadian, Mehrbod; Takala, Riikka S. K.; Tenovuo, Olli; Lagerstedt, Linnea; Ala-Seppala, Henna; Frantzen, Janek; van Gils, Mark; Hutchinson, Peter; Katila, Ari J.; Maanpaa, Henna-Riikka; Menon, David K.; Newcombe, Virginia F.; Tallus, Jussi; Hrusovsky, Kevin; Wilson, David H.; Blennow, Kaj; Sanchez, Jean-Charles; Zetterberg, Henrik; Posti, Jussi P.			Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						GFAP; NF-L; outcome; traumatic brain injury	C-TERMINAL HYDROLASE-L1; HEAD-INJURY; CEREBROSPINAL-FLUID; SERUM; S100B; BIOMARKERS; BLOOD; DAMAGE; DIAGNOSIS; SEVERITY	The purpose of this study was to correlate the early levels of glial fibrillary acidic protein (GFAP) and neurofilament light protein (NF-L) with outcome in patients with mild traumatic brain injury (mTBI). A total of 107 patients with mTBI (Glasgow Coma Scale >= 13) who had blood samples for GFAP and NF-L available within 24 h of arrival were included. Patients with mTBI were divided into computed tomography (CT)-positive and CT-negative groups. Glasgow Outcome Scale-Extended (GOSE) was used to assess the outcome. Outcomes were defined as complete (GOSE 8) versus incomplete (GOSE <8), and favorable (GOSE 5-8) versus unfavorable (GOSE 1-4). GFAP and NF-L concentrations in blood were measured using ultrasensitive single molecule array technology. Patients with incomplete recovery had significantly higher levels of NF-L compared with those with complete recovery (p = 0.005). The levels of GFAP and NF-L were significantly higher in patients with unfavorable outcome than in patients with favorable outcome (p = 0.002 for GFAP and p < 0.001 for NF-L). For predicting favorable outcome, the area under the receiver operating characteristic curve for GFAP and NF-L was 0.755 and 0.826, respectively. In a multi-variate logistic regression model, the level of NF-L was still a significant predictor for complete recovery (odds ratio [OR] = 1.008; 95% confidence interval [CI], 1.000-1.016). Moreover, the level of NF-L was a significant predictor for complete recovery in CT-positive patients (OR = 1.009; 95% CI, 1.001-1.016). The early levels of GFAP and NF-L are significantly correlated with the outcome in patients with mTBI. The level of NF-L within 24 h from arrival has a significant predictive value in mTBI also in a multi-variate model.	[Hossain, Iftakher; Frantzen, Janek; Maanpaa, Henna-Riikka; Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Turku, Finland; [Hossain, Iftakher; Mohammadian, Mehrbod; Takala, Riikka S. K.; Tenovuo, Olli; Ala-Seppala, Henna; Katila, Ari J.; Maanpaa, Henna-Riikka; Tallus, Jussi; Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Tallus, Jussi] Turku Univ Hosp, Dept Radiol, Turku, Finland; [Hossain, Iftakher; Mohammadian, Mehrbod; Tenovuo, Olli; Ala-Seppala, Henna; Frantzen, Janek; Maanpaa, Henna-Riikka; Tallus, Jussi; Posti, Jussi P.] Univ Turku, Dept Neurol, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Univ Turku, Turku, Finland; [Lagerstedt, Linnea; Sanchez, Jean-Charles] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland; [van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Tampere, Finland; [Hutchinson, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England; [Menon, David K.; Newcombe, Virginia F.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Hrusovsky, Kevin; Wilson, David H.] Quanterix Corp, Lexington, MA USA; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, Queen Sq, London, England		Hossain, I (corresponding author), Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, POB 52, FI-20521 Turku, Finland.	ifthos@utu.fi	Posti, Jussi P./Y-2908-2019; Mohammadian, Mehrbod/AAH-1018-2019	Posti, Jussi P./0000-0002-5925-5193; Mohammadian, Mehrbod/0000-0002-6851-7511; Ala-Seppala, Henna/0000-0002-1577-3028; Newcombe, Virginia/0000-0001-6044-9035; Hossain, Iftakher/0000-0003-4836-1158; van Gils, Mark/0000-0002-0029-1771			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hainard A, 2013, TRANSLANT PROTEOMICS, V1, P57, DOI [10.1016/J.TRPROT.2013.04.003, DOI 10.1016/J.TRPROT.2013.04.003, 10.1016/j.trprot.2013.04.003]; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mercier E, 2018, J NEUROTRAUM, V35, P609, DOI 10.1089/neu.2017.5013; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Missler U, 1999, CLIN CHEM, V45, P138; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	47	20	21	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1551	1560		10.1089/neu.2018.5952			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900007	30489229	Green Submitted			2022-02-06	
J	Tigchelaar, S; Gupta, R; Shannon, CP; Streijger, F; Sinha, S; Flibotte, S; Rizzuto, MA; Street, J; Paquette, S; Ailon, T; Charest-Morin, R; Dea, N; Fisher, C; Dvorak, MF; Dhall, S; Mac-Thiong, JM; Parent, S; Bailey, C; Christie, S; Van Keuren-Jensen, K; Nislow, C; Kwon, BK				Tigchelaar, Seth; Gupta, Rishab; Shannon, Casey P.; Streijger, Femke; Sinha, Sunita; Flibotte, Stephane; Rizzuto, Michael A.; Street, John; Paquette, Scott; Ailon, Tamir; Charest-Morin, Raphaele; Dea, Nicolas; Fisher, Charles; Dvorak, Marcel F.; Dhall, Sanjay; Mac-Thiong, Jean-Marc; Parent, Stefan; Bailey, Christopher; Christie, Sean; Van Keuren-Jensen, Kendall; Nislow, Corey; Kwon, Brian K.			MicroRNA Biomarkers in Cerebrospinal Fluid and Serum Reflect Injury Severity in Human Acute Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; microRNA; next-generation sequencing; spinal cord injury	CLINICAL-TRIALS; BRAIN-INJURY; CIRCULATING MICRORNAS; BLOOD BIOMARKERS; PORCINE MODEL; RECOVERY; IDENTIFICATION; PREVALENCE; GENES; ROLES	Spinal cord injury (SCI) is a devastating condition with variability in injury mechanisms and neurologic recovery. Spinal cord impairment after SCI is measured and classified by a widely accepted standard neurological examination. In the very acute stages post-injury, however, this examination is extremely challenging (and often impossible) to conduct and has modest prognostic value in terms of neurological recovery. The lack of objective tools to classify injury severity and predict outcome is a barrier for clinical trials and thwarts development of therapies for those with SCI. Biological markers (biomarkers) represent a promising, complementary approach to these challenges because they represent an unbiased approach to classify injury severity and predict neurological outcome. Identification of a suitable panel of molecular biomarkers would comprise a fundamental shift in how patients with acute SCI are evaluated, stratified, and treated in clinical trials. MicroRNA are attractive biomarker candidates in neurological disorders for several reasons, including their stability in biological fluids, their conservation between humans and model mammals, and their tissue specificity. In this study, we used next-generation sequencing to identify microRNA associated with injury severity within the cerebrospinal fluid (CSF) and serum of human patients with acute SCI. The CSF and serum samples were obtained 1-5 days post-injury from 39 patients with acute SCI (24 American Spinal Injury Association Impairment Scale [AIS] A, 8 AIS B, 7 AIS C) and from five non-SCI controls. We identified a severity-dependent pattern of change in microRNA expression in CSF and identified a set of microRNA that are diagnostic of baseline AIS classification and prognostic of neurological outcome six months post-injury. The data presented here provide a comprehensive description of the CSF and serum microRNA expression changes that occur after acute human SCI. This data set reveals microRNA candidates that warrant further evaluation as biomarkers of injury severity after SCI and as key regulators in other neurological disorders.	[Tigchelaar, Seth; Gupta, Rishab; Streijger, Femke; Rizzuto, Michael A.; Dvorak, Marcel F.; Kwon, Brian K.] Univ British Columbia, ICORD, Vancouver, BC, Canada; [Shannon, Casey P.] Prevent Organ Failure Proof Ctr Excellence, Vancouver, BC, Canada; [Sinha, Sunita; Flibotte, Stephane; Nislow, Corey] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Street, John; Charest-Morin, Raphaele; Fisher, Charles; Dvorak, Marcel F.; Kwon, Brian K.] Univ British Columbia, Dept Orthoped, Div Spine, Vancouver, BC, Canada; [Paquette, Scott; Ailon, Tamir; Dea, Nicolas] Univ British Columbia, Div Neurosurg, Vancouver, BC, Canada; [Dhall, Sanjay] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Mac-Thiong, Jean-Marc] Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Parent, Stefan] Univ Montreal, Dept Surg, Chu St Justine, Montreal, PQ, Canada; [Bailey, Christopher] Victoria Hosp, Div Orthopaed Surg Schulich Med & Dent, London, ON, Canada; [Christie, Sean] Dalhousie Univ, Halifax Infirm, Div Neurosurg, Halifax, NS, Canada; [Van Keuren-Jensen, Kendall] Translat Genom, Phoenix, AZ USA		Kwon, BK (corresponding author), Blusson Spinal Cord Ctr, 6th Floor 818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca	Parent, Stefan/AAO-7492-2020; Bailey, Chris S/L-7522-2015	Parent, Stefan/0000-0002-4854-2816; Bailey, Chris S/0000-0001-5508-8415; Tigchelaar, Seth/0000-0002-2207-9034; Rizzuto, Michael/0000-0001-7743-4454; Christie, Sean/0000-0002-3540-6022; Shannon, Casey/0000-0002-5687-3156; Dvorak, Marcel/0000-0002-9404-8448	Brain Canada Foundation; GenomeBC; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; MITACS; VGH & UBC Hospital Foundation	The authors gratefully acknowledge the grant support of the Brain Canada Foundation, GenomeBC, Michael Smith Foundation for Health Research, MITACS, and the VGH & UBC Hospital Foundation. The authors also acknowledge the assistance of Allan Aludino and Leilani Reichl of the Vancouver Spine Research Program for support of the clinical trial, Daniel Rogers of the Rick Hansen Institute for managing the Canadian Multicentre CSF Monitoring and Biomaker (CAMPER) study, and Sara Assadian for managing the Brain Canada Multi-Investigator Research Initiative (MIRI). MFD is the Paetzold Chair in Spinal Cord Injury Research. BKK is the Canada Research Chair in Spinal Cord Injury and Dvorak Chair in Spine Trauma.	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Badhiwala JH, 2018, J NEUROTRAUM, V35, P1906, DOI 10.1089/neu.2018.5935; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Baran-Gale J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00352; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Boon H, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12622; Brennan FH, 2018, CURR OPIN NEUROL, V31, P334, DOI 10.1097/WCO.0000000000000550; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Dalkilic T, 2018, J NEUROTRAUM, V35, P435, DOI 10.1089/neu.2017.5357; Elizei SS, 2017, NEURAL REGEN RES, V12, P385, DOI 10.4103/1673-5374.202933; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Gong ZM, 2018, BIOCHEM BIOPH RES CO, V501, P501, DOI 10.1016/j.bbrc.2018.05.022; Hachisuka S, 2014, SPINAL CORD, V52, P596, DOI 10.1038/sc.2014.86; He Y, 2018, BIOSCI REP, V38; Jickling GC, 2011, NEUROTHERAPEUTICS, V8, P349, DOI 10.1007/s13311-011-0050-4; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Kim KT, 2018, J KOREAN NEUROSURG S, V61, P539, DOI 10.3340/jkns.2017.0276; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; Lee RS, 2012, J CLIN NEUROSCI, V19, P1338, DOI 10.1016/j.jocn.2012.02.015; Leshkowitz D, 2013, RNA, V19, P527, DOI 10.1261/rna.036475.112; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Li P, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1279051; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Marincola FM, 2011, J INTERN MED, V270, P123, DOI 10.1111/j.1365-2796.2011.02402.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Ning B, 2014, INT J BIOL SCI, V10, P997, DOI 10.7150/ijbs.9058; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Priebe M. M., 2007, ARCH PHYS MED REHA S, V88, pS84; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Shi ZJ, 2017, INT J NEUROSCI, V127, P1104, DOI 10.1080/00207454.2017.1323208; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Squair JW, 2018, ELIFE, V7, DOI 10.7554/eLife.39188; Streijger F, 2017, J NEUROTRAUM, V34, P2054, DOI 10.1089/neu.2016.4879; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Tigchelaar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01299-x; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Whiteley W, 2012, STROKE, V43, P86, DOI 10.1161/STROKEAHA.111.634089; Wu YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38718; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Yunta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034534; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	66	20	21	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 1	2019	36	15					2358	2371		10.1089/neu.2018.6256		MAY 2019	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IM5VD	WOS:000469288900001	30827169				2022-02-06	
J	Cryan, MT; Ross, AE				Cryan, Michael T.; Ross, Ashley E.			Scalene Waveform for Codetection of Guanosine and Adenosine Using Fast-Scan Cyclic Voltammetry	ANALYTICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; DOPAMINE RELEASE; SENSITIVITY; NUCLEOSIDES; INCREASES; SLICES; PURINE	Guanosine and adenosine are important neuromodulators in the brain and work in cooperation to mitigate the effects of stroke, traumatic injury, and other neurological events. Both purines can act on slow (minutes to hours) and rapid (milliseconds to seconds) time scales. A guanosine-adenosine interaction has been proposed in which guanosine modulates adenosine levels, and the two work together to control glutamate neurotransmission. Traditional methods to codetect purines, such as HPLC with microdialysis, are robust but lack the temporal resolution necessary to quantify release in real time. Fast-scan cyclic voltammetry (FSCV) has been used to detect guanosine and adenosine independently, but codetection has not been possible. Here, we developed a novel "scalene waveform" to codetect guanosine and adenosine with nanomolar limits of detection in real time with FSCV. The scalene waveform uses a slow rate (100 V/s) on the forward scan and the conventional rate (400 V/s) on the back scan; potentials go from -0.4 to 1.45 V and back to -0.4 V. The scan rates were optimized to increase the separation of the oxidative peaks for guanosine and adenosine. The temporal separation of the primary peaks was increased (4.6 +/- 0.1)-fold at the scalene waveform compared to the traditional waveform. Both exogenously applied guanosine and adenosine and endogenous transient release were detected at the scalene waveform in rat-brain slices. We show the first method for codetecting guanosine and adenosine using FSCV, which can be used to study the guanosine adenosine interaction and better understand their cooperative therapeutic effects.	[Cryan, Michael T.; Ross, Ashley E.] Univ Cincinnati, Dept Chem, 312 Coll Dr,404 Crosley Tower, Cincinnati, OH 45221 USA		Ross, AE (corresponding author), Univ Cincinnati, Dept Chem, 312 Coll Dr,404 Crosley Tower, Cincinnati, OH 45221 USA.	ashley.ross@uc.edu		Cryan, Michael/0000-0002-0635-8105; Ross, Ashley/0000-0003-2456-3636			Bath BD, 2000, ANAL CHEM, V72, P5994, DOI 10.1021/ac000849y; Bettio LEB, 2016, PURINERG SIGNAL, V12, P411, DOI 10.1007/s11302-016-9509-4; Cryan MT, 2019, ANALYST, V144, P249, DOI 10.1039/c8an01547c; de Mendonca A, 2000, BRAIN RES REV, V33, P258, DOI 10.1016/S0165-0173(00)00033-3; Di Liberto V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00158; Dobolyi A, 1998, NEUROCHEM INT, V32, P247, DOI 10.1016/S0197-0186(97)00090-9; Dobolyi A, 2000, NEUROCHEM INT, V37, P71, DOI 10.1016/S0197-0186(99)00162-X; DRAGUNOW M, 1988, TRENDS PHARMACOL SCI, V9, P193, DOI 10.1016/0165-6147(88)90079-X; Feng JDZ, 2000, THER DRUG MONIT, V22, P177, DOI 10.1097/00007691-200004000-00007; Hashemi P, 2009, ANAL CHEM, V81, P9462, DOI 10.1021/ac9018846; Hensley AL, 2018, ANAL CHEM, V90, P8642, DOI 10.1021/acs.analchem.8b01976; JACKSON BP, 1995, ANAL CHEM, V67, P1115, DOI 10.1021/ac00102a015; Jackson EK, 2014, J PHARMACOL EXP THER, V350, P719, DOI 10.1124/jpet.114.216978; John CE, 2007, FRONT NEUROENG, V1, P49; Keithley RB, 2011, ANAL CHEM, V83, P3563, DOI 10.1021/ac200143v; Lanznaster D, 2016, AGING DIS, V7, P657, DOI 10.14336/AD.2016.0208; Lee ST, 2018, ACS CHEM NEUROSCI, V9, P505, DOI 10.1021/acschemneuro.7b00280; Lim GN, 2019, ACS SENSORS, V4, P479, DOI 10.1021/acssensors.8b01504; Nguyen MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087165; Pajski ML, 2013, PURINERG SIGNAL, V9, P167, DOI 10.1007/s11302-012-9343-2; Pajski ML, 2010, ACS CHEM NEUROSCI, V1, P775, DOI 10.1021/cn100037d; Pyakurel P, 2016, ACS CHEM NEUROSCI, V7, P1112, DOI 10.1021/acschemneuro.6b00070; RATHBONE MP, 1991, NEUROREPORT, V2, P661, DOI 10.1097/00001756-199111000-00007; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Ross AE, 2015, J NEUROCHEM, V132, P51, DOI 10.1111/jnc.12946; Ross AE, 2014, ANAL CHEM, V86, P7486, DOI 10.1021/ac501229c; Ross AE, 2014, J NEUROCHEM, V130, P50, DOI 10.1111/jnc.12711; Ross AE, 2012, ANALYST, V137, P3045, DOI 10.1039/c2an35297d; Sanford AL, 2010, ANAL CHEM, V82, P5205, DOI 10.1021/ac100536s; Schmidt AC, 2014, ANAL CHEM, V86, P7806, DOI 10.1021/ac501725u; Spanos M, 2013, ACS CHEM NEUROSCI, V4, P782, DOI 10.1021/cn4000499; Strand AM, 2008, ANAL CHEM, V80, P3708, DOI 10.1021/ac8001275; Swamy BEK, 2007, ANAL CHEM, V79, P744, DOI 10.1021/ac061820i; WALLMANJOHANSSON A, 1994, LIFE SCI, V55, P721, DOI 10.1016/0024-3205(94)00680-6; Wang YX, 2012, J NEUROSCI METH, V208, P34, DOI 10.1016/j.jneumeth.2012.04.009; ZIMMERMAN JB, 1991, ANAL CHEM, V63, P24, DOI 10.1021/ac00001a005; 1988, TALANTA, V35, P911; 2008, NEUROSCI LETT, V431, P101, DOI DOI 10.1016/J.NEUTET.2007.11.072; 2002, CELL MOL NEUROBIOL, V22, P353	39	20	20	0	13	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	MAY 7	2019	91	9					5987	5993		10.1021/acs.analchem.9b00450			7	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	HX8FQ	WOS:000467642100072	30938508				2022-02-06	
J	Griemert, EV; Schwarzmaier, SM; Hummel, R; Golz, C; Yang, D; Neuhaus, W; Burek, M; Forster, CY; Petkovic, I; Trabold, R; Plesnila, N; Engelhard, K; Schafer, MK; Thal, SC				Griemert, Eva-Verena; Schwarzmaier, Susanne M.; Hummel, Regina; Goelz, Christina; Yang, Dong; Neuhaus, Winfried; Burek, Malgorzata; Foerster, Carola Y.; Petkovic, Ivan; Trabold, Raimund; Plesnila, Nikolaus; Engelhard, Kristin; Schaefer, Michael K.; Thal, Serge C.			Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury	ANNALS OF NEUROLOGY			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; GENE-EXPRESSION; PAI-1; COMPLEX; MICE; THROMBOGENESIS; NORMALIZATION; INACTIVATION; COAGULATION	Objective Plasminogen activator inhibitor-1 (PAI-1) is the key endogenous inhibitor of fibrinolysis, and enhances clot formation after injury. In traumatic brain injury, dysregulation of fibrinolysis may lead to sustained microthrombosis and accelerated lesion expansion. In the present study, we hypothesized that PAI-1 mediates post-traumatic malfunction of coagulation, with inhibition or genetic depletion of PAI-1 attenuating clot formation and lesion expansion after brain trauma. Methods We evaluated PAI-1 as a possible new target in a mouse controlled cortical impact (CCI) model of traumatic brain injury. We performed the pharmacological inhibition of PAI-1 with PAI-039 and stimulation by tranexamic acid, and we confirmed our results in PAI-1-deficient animals. Results PAI-1 mRNA was time-dependently upregulated, with a 305-fold peak 12 hours after CCI, which effectively counteracted the 2- to 3-fold increase in cerebral tissue-type/urokinase plasminogen activator expression. PAI-039 reduced brain lesion volume by 26% at 24 hours and 43% at 5 days after insult. This treatment also attenuated neuronal apoptosis and improved neurofunctional outcome. Moreover, intravital microscopy demonstrated reduced post-traumatic thrombus formation in the pericontusional cortical microvasculature. In PAI-1-deficient mice, the therapeutic effect of PAI-039 was absent. These mice also displayed 13% reduced brain damage compared with wild type. In contrast, inhibition of fibrinolysis with tranexamic acid increased lesion volume by 25% compared with vehicle. Interpretation This study identifies impaired fibrinolysis as a critical process in post-traumatic secondary brain damage and suggests that PAI-1 may be a central endogenous inhibitor of the fibrinolytic pathway, promoting a procoagulatory state and clot formation in the cerebral microvasculature. Ann Neurol 2019;85:667-680	[Griemert, Eva-Verena; Hummel, Regina; Goelz, Christina; Yang, Dong; Petkovic, Ivan; Engelhard, Kristin; Schaefer, Michael K.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Schwarzmaier, Susanne M.] Ludwig Maximilians Univ LMU Munich, Med Ctr, Dept Anesthesiol, Munich, Germany; [Neuhaus, Winfried] Austrian Inst Technol, Dept Hlth & Environm, Mol Diagnost, Vienna, Austria; [Burek, Malgorzata; Foerster, Carola Y.] Univ Wurzburg, Dept Anesthesia & Crit Care, Wurzburg, Germany; [Trabold, Raimund] Univ Munich, Med Ctr, Walter Brendel Ctr Expt Med, Inst Surg Res, Munich, Germany; [Plesnila, Nikolaus] Ludwig Maximilians Univ LMU Munich, Med Ctr, Inst Stroke & Dementia Res ISD, Munich, Germany; [Plesnila, Nikolaus] Munich Cluster Syst Neurol Synergy, Munich, Germany; [Schaefer, Michael K.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci, Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Burek, Malgorzata/AAF-3283-2021; Thal, Serge/D-6593-2011; Plesnila, Nikolaus/T-7522-2019; Schaefer, Michael K.E./S-1715-2019	Burek, Malgorzata/0000-0001-6148-2195; Thal, Serge/0000-0002-1222-8729; Schaefer, Michael K.E./0000-0001-6055-6244; Neuhaus, Winfried/0000-0002-6552-7183	Focus Program Translational Neurosciences of Johannes Gutenberg University; Advancement Program of the University Medical Center of the Johannes Gutenberg University Mainz	This work was supported by grants from the Focus Program Translational Neurosciences of Johannes Gutenberg University (S.C.T.) and Advancement Program of the University Medical Center of the Johannes Gutenberg University Mainz (E.-V.G.).	[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Beuth W, 1996, Neurol Neurochir Pol, V30, P427; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dietzmann K, 2000, PATHOL RES PRACT, V196, P15, DOI 10.1016/S0344-0338(00)80017-5; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; EMEIS JJ, 1992, ANN NY ACAD SCI, V667, P249, DOI 10.1111/j.1749-6632.1992.tb51622.x; EMEIS JJ, 1986, J EXP MED, V163, P1260, DOI 10.1084/jem.163.5.1260; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; FUJII S, 1991, CIRCULATION, V83, P645, DOI 10.1161/01.CIR.83.2.645; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giesen PLA, 2000, SEMIN THROMB HEMOST, V26, P379, DOI 10.1055/s-2000-8456; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Griemert EV, 2019, TRANSL STROKE RES, V10, P372, DOI 10.1007/s12975-018-0644-9; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Huber K, 2001, J THROMB THROMBOLYS, V11, P195, DOI 10.1023/A:1011952602122; Hultman K, 2010, J NEUROSCI RES, V88, P2441, DOI 10.1002/jnr.22412; Johansson L, 2000, STROKE, V31, P26, DOI 10.1161/01.STR.31.1.26; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Neuhaus W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136221; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nishida T, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0201-0; Rupin A, 2001, THROMB HAEMOSTASIS, V86, P1528, DOI 10.1055/s-0037-1616758; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Schucany WR, 2006, COMMUN STAT-THEOR M, V35, P2275, DOI 10.1080/03610920600853308; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; SIMPSON AJ, 1991, J CLIN PATHOL, V44, P139, DOI 10.1136/jcp.44.2.139; Smith LH, 2006, BLOOD, V107, P132, DOI 10.1182/blood-2005-07-2681; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Tuttolomondo A, 2009, ATHEROSCLEROSIS, V203, P503, DOI 10.1016/j.atherosclerosis.2008.06.030; VANDERPOLL T, 1991, J EXP MED, V174, P729, DOI 10.1084/jem.174.3.729; VANHINSBERGH VWM, 1988, BLOOD, V72, P1467; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xin HQ, 2013, NEUROSCI LETT, V542, P81, DOI 10.1016/j.neulet.2013.02.046; Yang D, 2009, J NEUROSCI, V29, P8669, DOI 10.1523/JNEUROSCI.1117-09.2009; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zhuang P, 2015, J CLIN NEUROSCI, V22, P1123, DOI 10.1016/j.jocn.2014.12.027	58	20	21	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	MAY	2019	85	5					667	680		10.1002/ana.25458			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HW2DH	WOS:000466492700006	30843275	hybrid, Green Published			2022-02-06	
J	Churchill, NW; Caverzasi, E; Graham, SJ; Hutchison, MG; Schweizer, TA				Churchill, Nathan W.; Caverzasi, Eduardo; Graham, Simon J.; Hutchison, Michael G.; Schweizer, Tom A.			White matter during concussion recovery: Comparing diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI)	HUMAN BRAIN MAPPING			English	Article						concussion; DTI; NODDI; white matter	TRAUMATIC BRAIN-INJURY; MICROSTRUCTURE; STABILITY; SPORT	Concussion pathophysiology in humans remains incompletely understood. Diffusion tensor imaging (DTI) has identified microstructural abnormalities in otherwise normal appearing brain tissue, using measures of fractional anisotropy (FA), axial diffusivity (AD), and radial diffusivity (RD). The results of prior DTI studies suggest that acute alterations in microstructure persist beyond medical clearance to return to play (RTP), but these measures lack specificity. To better understand the observed effects, this study combined DTI with neurite orientation dispersion and density imaging (NODDI), which employs a more sophisticated description of water diffusion in the brain. A total of 66 athletes were recruited, including 33 concussed athletes, scanned within 7 days after concussion and at RTP, along with 33 matched controls. Both univariate and multivariate methods identified DTI and NODDI parameters showing effects of concussion on white matter. Spatially extensive decreases in FA and increases in AD and RD were associated with reduced intra-neurite water volume, at both the symptomatic phase of injury and RTP, indicating that effects persist beyond medical clearance. Subsequent analyses also demonstrated that concussed athletes with higher symptom burden and a longer recovery time had greater reductions in FA and increased AD, RD, along with increased neurite dispersion. This study provides the first longitudinal evaluation of concussion from acute injury to RTP using combined DTI and NODDI, significantly enhancing our understanding of the effects of concussion on white matter microstructure.	[Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Caverzasi, Eduardo] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Graham, Simon J.] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Fac Med, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada		Churchill, NW (corresponding author), 209 Victoria St, Toronto, ON M5B 1M8, Canada.	nchurchill.research@gmail.com	Caverzasi, Eduardo/P-1707-2019		Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [RN294001-367456]; Canadian Institute for Military and Veterans Health [W7714-145967]; Siemens Canada Ltd.	Canadian Institutes of Health Research, Grant/Award Number: RN294001-367456; Canadian Institute for Military and Veterans Health, Grant/Award Number: W7714-145967; Siemens Canada Ltd.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bro R, 1996, J CHEMOMETR, V10, P47, DOI 10.1002/(SICI)1099-128X(199601)10:1<47::AID-CEM400>3.0.CO;2-C; Chang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123656; Churchill N, 2013, SPRINGER P MATH STAT, V56, P171, DOI 10.1007/978-1-4614-8283-3_11; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Grussu F, 2017, ANN CLIN TRANSL NEUR, V4, P663, DOI 10.1002/acn3.445; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2017, MAGN RESON MED, V78, P1767, DOI 10.1002/mrm.26575; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marmarou A., 2007, NEUROSURG FOCUS, V22, P1; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe V, 2009, BRIT J NEUROSURGERY, V21, P340; Owen JP, 2014, J NEUROSCI, V34, P6214, DOI 10.1523/JNEUROSCI.4495-13.2014; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	42	20	20	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	APR 15	2019	40	6					1908	1918		10.1002/hbm.24500			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	HO5SD	WOS:000460987100018	30585674	Green Published			2022-02-06	
J	Ventresca, M				Ventresca, Matt			The Curious Case of CTE: Mediating Materialities of Traumatic Brain Injury	COMMUNICATION & SPORT			English	Article						traumatic brain injury; concussion; chronic traumatic encephalopathy; media discourse; neuroscience	ENCEPHALOPATHY; CONCUSSION; FOOTBALL; MASCULINITY; SCIENCE; HEALTH	This article investigates how media discourses are sites for multiple "becomings" of chronic traumatic encephalopathy (CTE), a neurobiological condition associated with repetitive brain trauma. I explain that these discourses are contexts in which multiple actors (journalists, scientists, athletes, and sports organizations) struggle to represent the material complexities of CTE through competing ways of knowing. My analysis reveals two tensions underlying debates about sport-related traumatic brain injury. First, my examination reveals discursive clashes between emotionally charged representations of CTE as an urgent public health problem and commentary cautioning audiences about the scientific uncertainty surrounding CTE. I illuminate how, in the face of this uncertainty, scientific conclusiveness remains privileged as the basis for meaningful action to improve athletes' health. Second, inconsistencies across representations I examined illustrate how CTE defies a straightforward material-semiotic divide. These contradictions demonstrate how the materialities of CTE exceed the medico-scientific and lay discourses through which the condition is commonly known. I argue that such limitations should not enable stakeholders to overlook calls for drastic changes to how sports are played or deflect questions about how sports violence impacts athletes' lives. Instead, this level of uncertainty should accelerate (rather than delay) challenges to socially acceptable levels of sports violence.	[Ventresca, Matt] Georgia Inst Technol, Sch Hist & Sociol, Old Civil Engn Bldg,G17,221 Bobby Dodd Way, Atlanta, GA 30332 USA		Ventresca, M (corresponding author), Georgia Inst Technol, Sch Hist & Sociol, Old Civil Engn Bldg,G17,221 Bobby Dodd Way, Atlanta, GA 30332 USA.	matt.ventresca@gatech.edu		Ventresca, Matt/0000-0003-2863-5692			Abi- Rached Joelle M., 2013, NEURO NEW BRAIN SCI; Adelson E., 2017, YAHOO SPORTS    0606; Almasy S., 2015, JUDGE APPROVES NFL C; Altheide D. L., 2002, CREATING FEAR NEWS C; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; [Anonymous], 2016, GUARDIAN; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bachynski K. E., 2017, INJURY PREVENTION; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Branch J, 2015, BOY ICE LIFE DEATH D; Brennan Christine, 2016, US TODAY; Breslow J. M., 2015, PBS FRONTLINE; Brossard D, 2013, P NATL ACAD SCI USA, V110, P14096, DOI 10.1073/pnas.1212744110; Cabot J., 2017, MEDIA DISCOURSES CON; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Clarke AE, 2003, AM SOCIOL REV, V68, P161, DOI 10.2307/1519765; Concussion Legacy Foundation, 2016, WHAT IS CTE; de Jong IM, 2016, SCI ENG ETHICS, V22, P1107, DOI 10.1007/s11948-015-9684-7; Draper K., 2016, DEADSPIN        0720; Dumit J, 2004, PICTURING PERSONHOOD; Engber D, 2015, SLATE; Engber Daniel, 2012, SLATE; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; ESPN Staff, 2017, RES STUD CONF CTE FI; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Foucault M., 1990, HIST SEXUALITY VOLUM, V1; Frost S, 2011, FEM PHILOS COLLECT, P69, DOI 10.1007/978-1-4020-6835-5_4; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gartland Dan, 2017, SPORTS ILLUSTRATED; Goldberg DS, 2013, J LEGAL MED, V34, P157, DOI 10.1080/01947648.2013.800792; Golen J., 2016, APNEWS          1103; Haraway D.J., 1997, MODEST WITNESS 2 MIL; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Henne K., 2017, SPORT SCI TECHN SESS; Hull K, 2015, J SPORT SOC ISSUES, V39, P78, DOI 10.1177/0193723514558928; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Junod T., 2017, T BRADYS MOST DANGER; Kalter L., 2018, BOSTON HERALD; King S., 2005, QUALITATIVE METHODS, P21; Kirk M., 2013, LEAGUE DENIAL NFLS C; Klein J. Z., 2011, NY TIMES; Klimas J., 2011, POPULAR MECH; Kounang N., 2016, MORE ATHLETES PLEDGE; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Landesman P., 2015, CONCUSSION MOTION PI; Leonard P., 2016, NEW YORK DAILY NEWS; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Lomangino K., 2018, JOURNALISTS DROP BAL; Maese R., 2017, WASH POST; Malcolm D., 2017, SPORT MED HLTH MEDIC; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Markula P, 2011, QUALITATIVE RESEARCH FOR PHYSICAL CULTURE, P1, DOI 10.1057/9780230305632; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McIndoe S., 2017, GUARDIAN; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mirtle J, 2015, GLOBE MAIL; Morrison D.R., 2012, DSQ, V32, DOI 10.18061/dsq.v32i2.3189; Morrison DR, 2017, ROUTL RES SPORT CULT, P156; Oates T.P., 2017, FOOTBALL MANLINESS U; Omalu B., 2015, NY TIMES; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Payne M., 2017, WASH POST; Peters HP, 2013, P NATL ACAD SCI USA, V110, P14102, DOI 10.1073/pnas.1212745110; Pitts-Taylor V., 2016, BRAINS BODY NEUROSCI; Rabinow P., 1996, ESSAYS ANTHR REASON; Russo M., 2011, MINNESOTA STAR  0907; Shaver R., 2015, US TODAY; Smerconish, 2017, CNN             0810; Smith B., 2016, GLOBE MAIL; Starkman R., 2011, TORONTO STAR; Sullivan S., 2007, RACE EPISTEMOLOGIES; Thompson P., 2017, CHICAGO TRIBUNE; Thornton D., 2011, BRAIN CULTURE NEUROS; Waldby C., 2000, VISIBLE HUMAN PROJEC; Workewych AM, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117720057; Yasinkas P., 2017, SPORTING NEWS   0404	82	20	20	0	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	APR	2019	7	2					135	156		10.1177/2167479518761636			22	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	HM8ZS	WOS:000459773100001					2022-02-06	
J	Gobatto, ALN; Link, MA; Solla, DJ; Bassi, E; Tierno, PF; Paiva, W; Taccone, FS; Malbouisson, LM				Gobatto, Andre L. N.; Link, Milena A.; Solla, Davi J.; Bassi, Estevao; Tierno, Paulo F.; Paiva, Wellingson; Taccone, Fabio S.; Malbouisson, Luiz M.			Transfusion requirements after head trauma: a randomized feasibility controlled trial	CRITICAL CARE			English	Article						Transfusion; Traumatic brain injury; Anemia	BRAIN-INJURY; ANEMIA; VASOSPASM; STRATEGY; UPDATE	BackgroundAnemia is frequent among patients with traumatic brain injury (TBI) and is associated with an increased risk of poor outcome. The optimal hemoglobin concentration to trigger red blood cell (RBC) transfusion in patients with TBI is not clearly defined.MethodsAll eligible consecutive adult patients admitted to the intensive care unit (ICU) with moderate or severe TBI were randomized to a restrictive (hemoglobin transfusion threshold of 7g/dL), or a liberal (threshold 9g/dL) transfusion strategy. The transfusion strategy was continued for up to 14days or until ICU discharge. The primary outcome was the mean difference in hemoglobin between groups. Secondary outcomes included transfusion requirements, intracranial pressure management, cerebral hemodynamics, length of stay, mortality and 6-month neurological outcome.ResultsA total of 44 patients were randomized, 21 patients to the liberal group and 23 to the restrictive group. There were no baseline differences between the groups. The mean hemoglobin concentrations during the 14-day period were 8.41.0 and 9.31.3 (p<0.01) in the restrictive and liberal groups, respectively. Fewer RBC units were administered in the restrictive than in the liberal group (35 vs. 66, p=0.02). There was negative correlation (r=-0.265, p<0.01) between hemoglobin concentration and middle cerebral artery flow velocity as evaluated by transcranial Doppler ultrasound and the incidence of post-traumatic vasospasm was significantly lower in the liberal strategy group (4/21, 3% vs. 15/23, 65%; p<0.01). Hospital mortality was higher in the restrictive than in the liberal group (7/23 vs. 1/21; p=0.048) and the liberal group tended to have a better neurological status at 6months (p=0.06).Conclusions The trial reached feasibility criteria. The restrictive group had lower hemoglobin concentrations and received fewer RBC transfusions. Hospital mortality was lower and neurological status at 6 months favored the liberal group.Trial registration ClinicalTrials.gov, NCT02203292. Registered on 29 July 2014.	[Gobatto, Andre L. N.] Hosp Sao Rafael, Internal Med, Salvador, BA, Brazil; [Gobatto, Andre L. N.] Hosp Cidade, Intens Care Unit, Salvador, BA, Brazil; [Gobatto, Andre L. N.; Link, Milena A.; Malbouisson, Luiz M.] Univ Sao Paulo, Hosp Clin, Med Sch, Surg Intens Care Unit,Anesthesiol Div, Sao Paulo, Brazil; [Solla, Davi J.; Paiva, Wellingson] Univ Sao Paulo, Hosp Clin, Med Sch, Div Neurosurg, Sao Paulo, Brazil; [Bassi, Estevao; Tierno, Paulo F.; Malbouisson, Luiz M.] Univ Sao Paulo, Hosp Clin, Med Sch, Trauma Intens Care Unit,Surg Emergency Dept, Sao Paulo, Brazil; [Bassi, Estevao] Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil; [Taccone, Fabio S.] Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium		Malbouisson, LM (corresponding author), Univ Sao Paulo, Hosp Clin, Med Sch, Surg Intens Care Unit,Anesthesiol Div, Sao Paulo, Brazil.; Malbouisson, LM (corresponding author), Univ Sao Paulo, Hosp Clin, Med Sch, Trauma Intens Care Unit,Surg Emergency Dept, Sao Paulo, Brazil.	luiz.malbouisson@hc.fm.usp.br	Bassi, Estevao/AAN-5521-2020; Paiva, Wellingson S/G-5517-2013; Solla, Davi/E-6988-2013	Bassi, Estevao/0000-0002-3819-2699; Paiva, Wellingson S/0000-0002-5165-7040; Solla, Davi/0000-0002-5092-6595			Badenes R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1748-4; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Ferreira Cesar Biselli, 2015, Rev Bras Ter Intensiva, V27, P315, DOI 10.5935/0103-507X.20150055; Lagunju I, 2014, J CLIN ULTRASOUND, V42, P89, DOI 10.1002/jcu.22099; McIntyre L, 2004, J TRAUMA, V57, P563, DOI 10.1097/01.TA.0000136158.93864.54; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Perrein A, 2015, MINERVA ANESTESIOL, V81, P1219; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI [10.1016/j.jacc.2012.08.001, 10.1038/nrcardio.2012.122]; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	22	20	20	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	MAR 12	2019	23								89	10.1186/s13054-018-2273-9			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP0LQ	WOS:000461357900001	30871608	Green Published, gold			2022-02-06	
J	Tominaga, T; Shimada, R; Okada, Y; Kawamata, T; Kibayashi, K				Tominaga, Tadasuke; Shimada, Ryo; Okada, Yoshikazu; Kawamata, Takakazu; Kibayashi, Kazuhiko			Senescence-associated-beta-galactosidase staining following traumatic brain injury in the mouse cerebrum	PLOS ONE			English	Article							CELLULAR SENESCENCE; CYCLIN D1; EXPRESSION; INHIBITOR; INDUCTION; APOPTOSIS; CELLS; P16	Primary and secondary traumatic brain injury (TBI) can cause tissue damage by inducing cell death pathways including apoptosis, necroptosis, and autophagy. However, similar pathways can also lead to senescence. Senescent cells secrete senescence-associated secretory phenotype proteins following persistent DNA damage response signaling, leading to cell disorders. TBI initially activates the cell cycle followed by the subsequent triggering of senescence. This study aims to clarify how the mRNA and protein expression of different markers of cell cycle and senescence are modulated and switched over time after TBI. We performed senescence-associated-beta-galactosidase (SA-beta-gal) staining, immunohistochemical analysis, and real-time PCR to examine the time-dependent changes in expression levels of proteins and mRNA, related to cell cycle and cellular senescence markers, in the cerebrum during the initial 14 days after TBI using a mouse model of controlled cortical impact (CCI). Within the area adjacent to the cerebral contusion after TBI, the protein and/or mRNA expression levels of cell cycle markers were increased significantly until 4 days after injury and senescence markers were significantly increased at 4, 7, and 14 days after injury. Our findings suggested that TBI initially activated the cell cycle in neurons, astrocytes, and microglia within the area adjacent to the hemicerebrum contusion in TBI, whereas after 4 days, such cells could undergo senescence in a cell-type-dependent manner.	[Tominaga, Tadasuke; Kawamata, Takakazu] Tokyo Womens Med Univ, Sch Med, Dept Neurosurg, Tokyo, Japan; [Shimada, Ryo; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Tokyo, Japan; [Okada, Yoshikazu] St Lukes Int Hosp, Dept Neurosurg, Tokyo, Japan		Shimada, R (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Tokyo, Japan.	r_shimada@twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of Science KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP16K09220]	This work was supported by the Japan Society for the Promotion of Science KAKENHI, Grant Number JP16K09220. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2012, BIOCHEM BIOPH RES CO, V420, P605, DOI 10.1016/j.bbrc.2012.03.041; Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cao X, 2015, GENOM PROTEOM BIOINF, V13, P333, DOI 10.1016/j.gpb.2015.11.002; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Delou JMA, 2016, AN ACAD BRAS CIENC, V88, P2257, DOI 10.1590/0001-3765201620160127; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding Y, 2016, INT J BIOCHEM CELL B, V71, P72, DOI 10.1016/j.biocel.2015.12.010; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hwang CY, 2012, BIOCHEM BIOPH RES CO, V425, P94, DOI 10.1016/j.bbrc.2012.07.059; Ishikawa K, 2015, FEBS J, V282, P2540, DOI 10.1111/febs.13298; Johmura Y, 2014, MOL CELL, V55, P73, DOI 10.1016/j.molcel.2014.05.003; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Katano H, 2000, NEUROREPORT, V11, P2073, DOI 10.1097/00001756-200007140-00003; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kochanek PM, 2001, J NEUROTRAUM, V18, P73, DOI 10.1089/089771501750055785; Kozlova EN, 2002, GLIA, V37, P337, DOI 10.1002/glia.10045; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ohtani N., 2015, J CLIN EXPT MED, V253, P753; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Shimada R, 2017, LEGAL MED-TOKYO, V29, P29, DOI 10.1016/j.legalmed.2017.09.004; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shimada R, 2012, J CLIN NEUROSCI, V19, P447, DOI 10.1016/j.jocn.2011.06.033; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Tsukamoto A, 2015, EXP ANIM TOKYO, V64, P57, DOI 10.1538/expanim.14-0050; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029	38	20	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2019	14	3							e0213673	10.1371/journal.pone.0213673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6HL	WOS:000461030300058	30856215	Green Published, Green Submitted, gold			2022-02-06	
J	Xu, L; Xing, Q; Huang, TJ; Zhou, JK; Liu, TF; Cui, YB; Cheng, T; Wang, YP; Zhou, XK; Yang, B; Yang, GL; Zhang, JW; Zang, XX; Ma, SS; Guan, FX				Xu, Ling; Xing, Qu; Huang, Tuanjie; Zhou, Jiankang; Liu, Tengfei; Cui, Yuanbo; Cheng, Tian; Wang, Yaping; Zhou, Xinkui; Yang, Bo; Yang, Greta Luyuan; Zhang, Jiewen; Zang, Xingxing; Ma, Shanshan; Guan, Fangxia			HDAC1 Silence Promotes Neuroprotective Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Mouse Model of Traumatic Brain Injury via PI3K/AKT Pathway	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						histone deacetylase 1; human umbilical cord derived mesenchymal stem cells; traumatic brain injury; neuroprotection; PI3K/AKT	HIPPOCAMPAL NEUROGENESIS; MEMORY; REPAIR; PTEN; DISRUPTION; INHIBITORS; THERAPY; BARRIER; DISEASE; MICE	Stem cell transplantation is a promising therapy for traumatic brain injury (TBI), but low efficiency of survival and differentiation of transplanted stem cells limits its clinical application. Histone deacetylase 1 (HDAC1) plays important roles in self-renewal of stem cells as well as the recovery of brain disorders. However, little is known about the effects of HDAC1 on the survival and efficacy of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in vivo. In this study, our results showed that HDAC1 silence promoted hUC-MSCs engraftment in the hippocampus and increased the neuroprotective effects of hUC-MSCs in TBI mouse model, which was accompanied by improved neurological function, enhanced neurogenesis, decreased neural apoptosis, and reduced oxidative stress in the hippocampus. Further mechanistic studies revealed that the expressions of phosphorylated PTEN (p-PTEN), phosphorylated Akt (p-Akt), and phosphorylated GSK-3 beta (p-GSK-3 beta) were upregulated. Intriguingly, the neuroprotective effects of hUC-MSCs with HDAC1 silence on behavioral performance of TBI mice was markedly attenuated by LY294002, an inhibitor of the PI3K/AKT pathway. Taken together, our findings suggest that hUC-MSCs transplantation with HDAC1 silence may provide a potential strategy for treating TBI in the future.	[Xu, Ling; Xing, Qu; Huang, Tuanjie; Zhou, Jiankang; Liu, Tengfei; Cui, Yuanbo; Wang, Yaping; Zhou, Xinkui; Ma, Shanshan; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, Zhengzhou, Henan, Peoples R China; [Xu, Ling; Zhang, Jiewen; Guan, Fangxia] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Cui, Yuanbo] Zhengzhou Univ, Zhengzhou Cent Hosp, Translat Med Ctr, Zhengzhou, Henan, Peoples R China; [Cheng, Tian; Yang, Bo; Guan, Fangxia] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Yang, Greta Luyuan] Stuyvesant High Sch, New York, NY USA; [Zang, Xingxing] Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA		Ma, SS; Guan, FX (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou, Henan, Peoples R China.; Guan, FX (corresponding author), Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China.; Guan, FX (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	mashanshan84@163.com; guanfangxia@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1404313, 81601078, 81471306]; Innovative Research Team in Science and Technology of the University of Henan Province [15IRTSTHN022]; Plan for Scientific Innovation Talent of Henan Province [154200510008]; Key Research Project of Higher Education of Henan Province [17A310012]	This study was supported by the National Natural Science Foundation of China (U1404313, 81601078, 81471306), the Innovative Research Team in Science and Technology of the University of Henan Province (15IRTSTHN022), the Plan for Scientific Innovation Talent of Henan Province (154200510008), the Key Research Project of Higher Education of Henan Province (17A310012).	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Benito E, 2015, J CLIN INVEST, V125, P3572, DOI 10.1172/JCI79942; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Cai MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20004-0; Cerri S, 2015, STEM CELL TRANSL MED, V4, P1073, DOI 10.5966/sctm.2015-0023; Chen SB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1193-6; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cho Y, 2014, CURR OPIN NEUROBIOL, V27, P118, DOI 10.1016/j.conb.2014.03.008; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Cui YB, 2017, BEHAV BRAIN RES, V320, P291, DOI 10.1016/j.bbr.2016.12.021; Ganai SA, 2016, CURR NEUROPHARMACOL, V14, P55, DOI 10.2174/1570159X13666151021111609; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Jacob C, 2014, J NEUROSCI, V34, P6112, DOI 10.1523/JNEUROSCI.5212-13.2014; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Juliandi B, 2010, DEV GROWTH DIFFER, V52, P493, DOI 10.1111/j.1440-169X.2010.01175.x; Kang WC, 2016, KOREAN J PHYSIOL PHA, V20, P657, DOI 10.4196/kjpp.2016.20.6.657; Koh SH, 2008, BRAIN RES, V1229, P233, DOI 10.1016/j.brainres.2008.06.087; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Lebrun-Julien F, 2015, ASN NEURO, V7, DOI 10.1177/1759091415593066; Li DP, 2016, CELL MOL NEUROBIOL, V36, P1045, DOI 10.1007/s10571-015-0295-2; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Lv WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113262; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Park MJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0765-6; Qureshi IA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0506; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shein NA, 2011, MOL MED, V17, P448, DOI 10.2119/molmed.2011.00038; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032; Wang XX, 2016, MOL CELLS, V39, P418, DOI 10.14348/molcells.2016.2345; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Wen ZM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8678267; Xie ZH, 2016, CLIN EXP MED, V16, P89, DOI 10.1007/s10238-015-0375-0; Xu YA, 2012, J TISSUE ENG REGEN M, V6, P645, DOI 10.1002/term.468; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013	47	20	20	2	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JAN 4	2019	12								498	10.3389/fncel.2018.00498			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HG4LR	WOS:000454947500001	30662396	Green Published, gold			2022-02-06	
J	Kaufmann, CN; Orff, HJ; Moore, RC; Delano-Wood, L; Depp, CA; Schiehser, DM				Kaufmann, Christopher N.; Orff, Henry J.; Moore, Raeanne C.; Delano-Wood, Lisa; Depp, Colin A.; Schiehser, Dawn M.			Psychometric Characteristics of the Insomnia Severity Index in Veterans With History of Traumatic Brain Injury	BEHAVIORAL SLEEP MEDICINE			English	Article							1ST 2 YEARS; SLEEP DISTURBANCE; SYMPTOMS; INVENTORY; FATIGUE; UTILITY; IMPACT	Objective/Background: The Insomnia Severity Index (ISI) is a widely used self-report measure of insomnia symptoms. However, to date this measure has not been validated or well-characterized in veterans who have experienced traumatic brain injury (TBI). This study assessed the psychometric properties and convergent, divergent, construct, and discriminate validity of the ISI in veterans with a history of TBI. Participants: Eighty-three veterans with history of TBI were seen in the VA San Diego Healthcare System as part of a research protocol. Methods: Measures included the ISI, Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale, Neurobehavioral Symptom Inventory, Beck Depression Inventory-II, Beck Anxiety Inventory, and PTSD Checklist-Military Version. Results: The ISI demonstrated moderate to strong or excellent convergent and divergent validity. A principal component analysis indicated a single construct with excellent internal consistency (Cronbach's alpha = 0.92). In exploratory analyses, the ISI discriminated well between those with (73%) and without (27%) sleep disturbance based on the PSQI. Conclusions: Results from this study indicate validity of the ISI in assessing insomnia in veterans with history of TBI and suggest a cutoff score not dissimilar from non-TBI populations. Findings from this study can help inform clinical applicability of the ISI, as well as future studies of insomnia in TBI.	[Kaufmann, Christopher N.; Orff, Henry J.; Moore, Raeanne C.; Delano-Wood, Lisa; Depp, Colin A.; Schiehser, Dawn M.] Vet Adm San Diego Healthcare Syst, La Jolla, CA USA; [Kaufmann, Christopher N.; Moore, Raeanne C.; Delano-Wood, Lisa; Depp, Colin A.; Schiehser, Dawn M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Kaufmann, Christopher N.; Moore, Raeanne C.; Depp, Colin A.] Univ Calif San Diego, Stein Inst Res Aging, La Jolla, CA 92093 USA; [Orff, Henry J.; Delano-Wood, Lisa; Schiehser, Dawn M.] Vet Adm San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA		Schiehser, DM (corresponding author), Vet Adm San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	dschiehser@ucsd.edu	Moore, Raeanne/ABC-6648-2020; depp, colin a/D-1264-2009	Moore, Raeanne/0000-0002-7499-041X	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH107260, T32MH019934] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX001512, I01CX000842] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH019934, K23 MH107260] Funding Source: Medline; RRD VA [IK2 RX001512] Funding Source: Medline; CSRD VA [I01 CX000842] Funding Source: Medline		Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Jain A, 2014, ASIAN J PSYCHIATR, V8, P99, DOI 10.1016/j.ajp.2013.12.017; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Leyfer OT, 2006, J ANXIETY DISORD, V20, P444, DOI 10.1016/j.janxdis.2005.05.004; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Weathers F.W., 1991, PTSD CHECKLIST MILIT	23	20	21	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-2002	1540-2010		BEHAV SLEEP MED	Behav. Sleep Med.	JAN 2	2019	17	1					12	18		10.1080/15402002.2016.1266490			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	HD7YK	WOS:000452769900002	28098495	Green Accepted			2022-02-06	
J	Milders, M				Milders, Maarten			Relationship between social cognition and social behaviour following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; social behaviour; social outcome; social cognition	EMOTION PERCEPTION; HEAD-INJURY; FUNCTIONAL OUTCOMES; FACIAL EXPRESSION; RECOGNITION; IMPAIRMENTS; DEFICITS; MIND; SCHIZOPHRENIA; SATISFACTION	Objective: To present an overview of studies that investigated associations between social cognition functions (social cue perception, empathy, understanding intentions) and social behaviour or social outcome following traumatic brain injury (TBI). Methods: The literature search was conducted in the Medline, PsycInfo, Cochrane Library and Web of Science databases. Main criteria for selection were that the participants were adult persons with TBI, social cognition as well as social behaviour or social outcome post-TBI was assessed and correlations between social cognition and social behaviour or outcome were reported. Average correlations were calculated based on weighted summation of the correlations from the individual studies. Results: Of the 511 publications identified in the search, 13 were selected. Ten of these assessed emotion recognition, six assessed understanding of intentions and two assessed empathy. Average correlations between social cognition performance and post-injury social behaviour or outcome were significant for each of the three social cognition functions; poorer performance was associated with poorer outcome. Effect sizes varied from small to moderate (understanding intentions) to moderate (emotion recognition) to large (empathy). Conclusions: The associations were in line with models of social cognition and proposals that impairments in social cognition may underlie social behaviour difficulties and poor social outcome following TBI.	[Milders, Maarten] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands		Milders, M (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	m.v.milders@vu.nl					Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baguley I, 2006, J HEAD TRAUMA REHAB, V19, P314; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Borenstein M., 2009, INTRO META ANAL; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan PW, 1997, PSYCHIATRY, V60, P309, DOI 10.1080/00332747.1997.11024809; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2015, CURR OPIN PSYCHIATR, V28, P133, DOI 10.1097/YCO.0000000000000139; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Katsifaraki M, 2014, BRAIN INJURY, V28, P1389, DOI 10.3109/02699052.2014.919538; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Osborne-Crowley K, 2016, NEUROPSYCHOLOGY, V30, P820, DOI 10.1037/neu0000293; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	55	20	20	4	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		62	68		10.1080/02699052.2018.1531301			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400008	30325217	hybrid			2022-02-06	
J	Nicola, F; Marques, MR; Odorcyk, F; Petenuzzo, L; Aristimunha, D; Vizuete, A; Sanches, EF; Pereira, DP; Maurmann, N; Goncalves, CA; Pranke, P; Netto, CA				Nicola, Fabricio; Marques, Marilia Rossato; Odorcyk, Felipe; Petenuzzo, Leticia; Aristimunha, Dirceu; Vizuete, Adriana; Sanches, Eduardo Farias; Pereira, Daniela Pavulack; Maurmann, Natasha; Goncalves, Carlos-Alberto; Pranke, Patricia; Netto, Carlos Alexandre			Stem Cells from Human Exfoliated Deciduous Teeth Modulate Early Astrocyte Response after Spinal Cord Contusion	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Human dental pulp stem cells; Glial scar formation; Progenitor cells	RECTIFYING POTASSIUM CHANNELS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; DENTAL-PULP CELLS; REACTIVE ASTROCYTES; AXONAL REGENERATION; FUNCTIONAL RECOVERY; PROGENITOR CELLS; EXPRESSION; S100B	The transplantation of stem cells from human exfoliated deciduous teeth (SHED) has been studied as a possible treatment strategy for spinal cord injuries (SCIs) due to its potential for promoting tissue protection and functional recovery. The aim of the present study was to investigate the effects of the early transplantation of SHED on glial scar formation and astrocytic reaction after an experimental model of SCI. Wistar rats were spinalized using the NYU Impactor. Animals were randomly distributed into three groups: control (naive) (animal with no manipulation); SCI (receiving laminectomy followed by SCI and treated with vehicle), and SHED (SCI rat treated with intraspinal SHED transplantation, 1h after SCI). In vitro investigation demonstrated that SHED were able to express mesenchymal stem cells, vimentin and S100B markers, related with neural progenitor and glial cells, respectively. The acute SHED transplantation promoted functional recovery, measured as from the first week after spinal cord contusion by Basso, Beattie, and Bresnahan scale. Twenty-four and 48h after lesion, flow cytometry revealed a spinal cord vimentin(+) cells increment in the SHED group. The increase of vimentin(+) cells was confirmed by immunofluorescence. Moreover, the bioavailability of astrocytic proteins such as S100B and Kir4.1 shown to be increased in the spinal cord of SHED group, whereas there was a glial scar reduction, as indicated by ELISA and Western blot techniques. The presented results support that SHED act as a neuroprotector agent after transplantation, probably through paracrine signaling to reduce glial scar formation, inducing tissue plasticity and functional recovery.	[Nicola, Fabricio; Marques, Marilia Rossato; Odorcyk, Felipe] Univ Fed Rio Grande do Sul, Post Grad Program Neurosci, Porto Alegre, RS, Brazil; [Nicola, Fabricio; Marques, Marilia Rossato; Odorcyk, Felipe; Petenuzzo, Leticia; Aristimunha, Dirceu; Vizuete, Adriana; Sanches, Eduardo Farias; Goncalves, Carlos-Alberto; Netto, Carlos Alexandre] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, R Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil; [Pereira, Daniela Pavulack; Maurmann, Natasha; Pranke, Patricia] Univ Fed Rio Grande do Sul, Hematol & Stem Cell Lab, Porto Alegre, RS, Brazil; [Maurmann, Natasha; Pranke, Patricia] Univ Fed Rio Grande do Sul, Post Grad Program Physiol, Porto Alegre, RS, Brazil; [Pranke, Patricia] Stem Cell Res Inst, Porto Alegre, RS, Brazil		Nicola, F (corresponding author), Univ Fed Rio Grande do Sul, Post Grad Program Neurosci, Porto Alegre, RS, Brazil.; Nicola, F (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, R Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil.	fabricionicola@hotmail.com	Maurmann, Natasha/G-3113-2018	Maurmann, Natasha/0000-0001-5103-6394; Netto, Carlos Alexandre/0000-0002-0596-5667; Odorcyk, Felipe/0000-0003-2545-0668; Vizuete, Adriana/0000-0002-9299-7631	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Stem Cell Research Institute	This work was supported by funds from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Stem Cell Research Institute.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Baldwin SA, 1998, J NEUROTRAUM, V15, P1015, DOI 10.1089/neu.1998.15.1015; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Becker D, 2003, NEUROLOGIST, V9, P1, DOI 10.1097/01.nrl.0000038587.58012.05; Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Cerqueira SR, 2013, SMALL, V9, P738, DOI 10.1002/smll.201201888; Chen JQ, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.898190; Cunha JD, 2007, WOUND REPAIR REGEN, V15, P134, DOI 10.1111/j.1524-475X.2006.00194.x; de Almeida FM, 2011, J NEUROTRAUM, V28, P1939, DOI 10.1089/neu.2010.1317; De Berdt P, 2018, CELL MOL LIFE SCI, V75, P2843, DOI 10.1007/s00018-018-2764-5; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Ellis KM, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt419; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Heimfarth L, 2013, NEUROTOXICOLOGY, V34, P175, DOI 10.1016/j.neuro.2012.10.015; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lee SJ, 2010, EMERG MED J, V27, P209, DOI 10.1136/emj.2008.063743; Leite MC, 2008, J NEUROSCI METH, V169, P93, DOI 10.1016/j.jneumeth.2007.11.021; Luisi SB, 2007, J ENDODONT, V33, P833, DOI 10.1016/j.joen.2007.04.002; Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015; Maurmann N, 2017, BIOMED PHYS ENG EXPR, V3, DOI 10.1088/2057-1976/aa6308; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nesic O, 2010, NEUROSCIENCE, V168, P1019, DOI 10.1016/j.neuroscience.2010.01.037; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nicola FC, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165319; Nicola FD, 2017, BRAIN RES, V1663, P95, DOI 10.1016/j.brainres.2017.03.015; Obermair FJ, 2008, PHYSIOLOGY, V23, P296, DOI 10.1152/physiol.00017.2008; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Park DY, 2013, GLOB SPINE J, V3, P1, DOI 10.1055/s-0033-1337118; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rodrigues LP, 2012, BRAZ J MED BIOL RES, V45, P49, DOI 10.1590/S0100-879X2011007500162; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Seki T, 2007, J COMP NEUROL, V502, P275, DOI 10.1002/cne.21301; Sibille J, 2014, J PHYSIOL-LONDON, V592, P87, DOI 10.1113/jphysiol.2013.261735; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Taghipour Z, 2012, STEM CELLS DEV, V21, P1794, DOI 10.1089/scd.2011.0408; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tramontina F, 2007, J NEUROSCI METH, V162, P282, DOI 10.1016/j.jneumeth.2007.01.001; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Weeks J, 2004, LAB ANIMAL, V33, P35, DOI 10.1038/laban0304-35; Weis SN, 2012, MITOCHONDRION, V12, P271, DOI 10.1016/j.mito.2011.10.002; Wu D, 2017, MOL THER, V25, P2715, DOI 10.1016/j.ymthe.2017.08.011; Acasigua GAX, 2014, CURR STEM CELL RES T, V9, P330, DOI 10.2174/1574888X09666140228123911; Xu C, 2015, EXP NEUROL, V263, P172, DOI 10.1016/j.expneurol.2014.10.013; Yamamoto S, 2001, SPINAL CORD, V127, P115, DOI [10.1006/exnr.2001.7798, DOI 10.1006/EXNR.2001.7798]	60	20	21	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2019	56	1					748	760		10.1007/s12035-018-1127-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HH7VH	WOS:000455938600054	29796991				2022-02-06	
J	Silva, PHR; Spedo, CT; Baldassarini, CR; Benini, CD; Ferreira, DA; Barreira, AA; Leoni, RF				Silva, P. H. R.; Spedo, C. T.; Baldassarini, C. R.; Benini, C. D.; Ferreira, D. A.; Barreira, A. A.; Leoni, R. F.			Brain functional and effective connectivity underlying the information processing speed assessed by the Symbol Digit Modalities Test	NEUROIMAGE			English	Article						Information processing speed; Functional connectivity; Effective connectivity; Dynamic causal modeling	COGNITIVE IMPAIRMENT; FMRI; PERFORMANCE; RELIABILITY; ATTENTION; NETWORK	Delayed Information Processing Speed (IPS) often underlies attention deficits and is particularly evident in patients with traumatic brain injury, Parkinson's disease, depression, dementia, and multiple sclerosis. Therefore, it is of interest to determine the brain network that is responsible for such essential cognitive function to understand IPS deficits and to develop effective rehabilitation programs. We assessed brain functional connectivity and effective connectivity during the performance of an adapted version of the Symbol Digit Modalities Test. Using dynamic causal modeling, we focused on obtaining a network model for IPS function in healthy subjects. Sixteen right-handed volunteers (seven women, age: 29.7 +/- 5.0 years) were included in the study after giving written consent for participating. Functional magnetic resonance images were acquired in a 3T scanner. According to our results, two systems interact during the IPS task performance. One is formed by frontoparietal and fronto-occipital networks, related to the control of goal-directed (top-down) selection for stimuli and response, while the second is composed of the temporoparietal and inferior frontal cortices, which are associated with stimulus-driven attention in the brain. Additionally, the default-mode network showed a significant correlation with networks positively associated with the task, mainly those related to visual detection and processing, indicating its relevant role in functional integration involving IPS. Therefore, an IPS-related network was proposed through a methodology that may be useful for future studies considering other cognitive functions and tasks, clinical groups, and longitudinal assessments.	[Silva, P. H. R.; Leoni, R. F.] Univ Sao Paulo, FFCLRP, Dept Phys, Av Bandeirantes 3900, BR-14040901 Ribeirao Preto, SP, Brazil; [Spedo, C. T.; Baldassarini, C. R.; Benini, C. D.; Ferreira, D. A.; Barreira, A. A.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Neurosci & Behav Sci, Ribeirao Preto, SP, Brazil		Leoni, RF (corresponding author), Univ Sao Paulo, FFCLRP, Dept Phys, Av Bandeirantes 3900, BR-14040901 Ribeirao Preto, SP, Brazil.	leonirf@usp.br	Leoni, Renata Ferranti/J-3182-2012; da Silva, Pedro Henrique Rodrigues/AAR-8026-2020	Leoni, Renata Ferranti/0000-0002-4568-0746; da Silva, Pedro Henrique Rodrigues/0000-0002-0230-7474; Rossi Baldassarini, Caique/0000-0003-2362-9795	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.	Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Archibald CJ, 2004, BRAIN, V127, P1526, DOI 10.1093/brain/awh167; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benedict RHB, 2017, MULT SCLER J, V23, P721, DOI 10.1177/1352458517690821; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chiaravalloti ND, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00067; Chiaravalloti ND, 2013, J CLIN EXP NEUROPSYC, V35, P180, DOI 10.1080/13803395.2012.760537; Christodoulou C, 2003, NEUROLOGY, V60, P1793, DOI 10.1212/01.WNL.0000072264.75989.B8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; Feys P, 2017, MULT SCLER J, V23, P711, DOI 10.1177/1352458517690824; Fleisher AS, 2007, NEUROLOGY, V68, P1588, DOI 10.1212/01.wnl.0000258542.58725.4c; Forn C, 2013, BRAIN COGNITION, V82, P152, DOI 10.1016/j.bandc.2013.04.003; Forn C, 2013, EXP BRAIN RES, V225, P399, DOI 10.1007/s00221-012-3380-5; Forn C, 2009, NEUROSCI LETT, V456, P11, DOI 10.1016/j.neulet.2009.03.081; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Grefkes C, 2014, LANCET NEUROL, V13, P206, DOI 10.1016/S1474-4422(13)70264-3; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Huijbregts SCJ, 2004, NEUROLOGY, V63, P335, DOI 10.1212/01.WNL.0000129828.03714.90; Humphries C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00406; Kiran S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00316; Koster-Hale J, 2013, NEURON, V79, P836, DOI 10.1016/j.neuron.2013.08.020; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076; Laurienti PJ, 2002, NEUROIMAGE, V17, P751, DOI 10.1006/nimg.2002.1237; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Li Y, 2006, NANO TO MACRO 2006, P2; Maldjian J, 1994, HUM BRAIN MAPP, V63, P1; Marreiros AC, 2008, NEUROIMAGE, V39, P269, DOI 10.1016/j.neuroimage.2007.08.019; McDermott JH, 2008, CURR OPIN NEUROBIOL, V18, P452, DOI 10.1016/j.conb.2008.09.005; O'Brien CP, 2008, JAMA-J AM MED ASSOC, V300, P2054, DOI 10.1001/jama.2008.570; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PFEFFER RI, 1981, AM J EPIDEMIOL, V114, P515, DOI 10.1093/oxfordjournals.aje.a113217; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Poerio GL, 2017, SOC COGN AFFECT NEUR, V12, P1047, DOI 10.1093/scan/nsx041; Poggel DA, 2004, ACTA NEUROBIOL EXP, V64, P427; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rachakonda S., 2007, COMPUTER 554 0959 43, P304; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; Rao SM, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/975803; Rodrigues Ana Carolina, 2010, Dement. neuropsychol., V4, P277, DOI 10.1590/S1980-57642010DN40400005; Schoonheim MM, 2015, NEUROLOGY, V84, P776, DOI 10.1212/WNL.0000000000001285; Silva PHR, 2018, MULT SCLER RELAT DIS, V20, P136, DOI 10.1016/j.msard.2018.01.014; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Fittipaldi-Marquez MS, 2017, NEURODEGENER DIS, V17, P199, DOI 10.1159/000460252; STARKSTEIN SE, 1988, J NEUROL NEUROSUR PS, V51, P1259, DOI 10.1136/jnnp.51.10.1259; Tang R, 2015, BMC NEUROSCI, V16, pP247, DOI [10.1186/1471-2202-16-S1-P247, DOI 10.1186/1471-2202-16-S1-P247]; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Zanto TP, 2014, NEUROIMAGE, V84, P443, DOI 10.1016/j.neuroimage.2013.08.063	57	20	20	3	28	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN 1	2019	184						761	770		10.1016/j.neuroimage.2018.09.080			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GZ4RB	WOS:000449385000064	30292813	hybrid			2022-02-06	
J	Li, FY; Wang, XD; Deng, ZK; Zhang, XL; Gao, PF; Liu, HL				Li, Fayin; Wang, Xiaodong; Deng, Zhikui; Zhang, Xianlong; Gao, Pengfei; Liu, Hailin			Dexmedetomidine reduces oxidative stress and provides neuroprotection in a model of traumatic brain injury via the PGC-1 alpha signaling pathway	NEUROPEPTIDES			English	Article						Dexmedetomidine; Traumatic brain injury; PGC-1 alpha; Oxidative stress	ACUTE LUNG INJURY; RATS; EXPRESSION; MECHANISM; ANTIOXIDANTS; INVOLVEMENT; ACTIVATION	The protective effects of dexmedetomidine (DEX) mediated by reductions of oxidative stress, mitochondrial damage and disintegration have been demonstrated in many injury models. However, whether DEX has a beneficial effect on traumatic brain injury (TBI) remains unknown. In this study, the neuroprotective effect of DEX and its potential mechanism were assessed in a model of TBI. DEX treatment relieved encephala edema and neuron cell apoptosis and increased behavioral function. These protective effects were accompanied by upregulation of peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1 alpha) expression. These findings imply that DEX protects neurons following TBI, possibly by activating the PGC-1 alpha pathway. The data will help clarify the mechanisms responsible for the anti-apoptosis effect of DEX with possible involvement of the PGC-1 alpha pathway.	[Li, Fayin; Zhang, Xianlong; Gao, Pengfei; Liu, Hailin] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Anesthesiol, Huaian 223002, Jiangsu, Peoples R China; [Wang, Xiaodong] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Neurosurg, Huaian 223002, Jiangsu, Peoples R China; [Deng, Zhikui] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Cent Lab, Huaian 223002, Jiangsu, Peoples R China		Liu, HL (corresponding author), Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Anesthesiol, Huaian 223002, Jiangsu, Peoples R China.	huaianniuhailin@126.com					Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Butterfield DA, 2016, PROTEOM CLIN APPL, V10, P1191, DOI 10.1002/prca.201600003; Castillo LF, 2017, CELL SIGNAL, V34, P76, DOI 10.1016/j.cellsig.2017.03.003; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Di C. M. L., 2017, MINI-REV MED CHEM, V17, P95; Dobrovolny J, 2018, NEUROL SCI, V39, P989, DOI 10.1007/s10072-018-3398-y; Fan YW, 2012, BRAIN INJURY, V26, P1267, DOI 10.3109/02699052.2012.672789; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hu HY, 2017, AM J TRANSL RES, V9, P5245; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Li X, 2018, J CELL MOL MED, V22, P883, DOI 10.1111/jcmm.13313; Li X, 2016, AM J TRANSL RES, V8, P3558; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Liu YC, 2017, CELL MOL NEUROBIOL, V37, P879, DOI 10.1007/s10571-016-0425-5; Lu ZB, 2010, ANTIOXID REDOX SIGN, V13, P1011, DOI 10.1089/ars.2009.2940; Meng L, 2018, MOL IMMUNOL, V94, P7, DOI 10.1016/j.molimm.2017.12.008; Rasouri S, 2007, M S-MED SCI, V23, P840, DOI 10.1051/medsci/20072310840; Robinson A, 2014, AGING CELL, V13, P263, DOI 10.1111/acel.12183; Sabella S. A., 2018, BRAIN INJURY, P1; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Terry DP, 2018, CLIN NEUROPSYCHOL, V4, P1; Wu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23003-3; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yu LM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41337; Zhang H, 2017, BIOMED PHARMACOTHER, V90, P914, DOI 10.1016/j.biopha.2017.04.047; Zhang MH, 2018, MOL MED REP, V17, P8079, DOI 10.3892/mmr.2018.8898; Zhang W, 2017, EXP THER MED, V14, P973, DOI 10.3892/etm.2017.4623; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	34	20	23	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	DEC	2018	72						58	64		10.1016/j.npep.2018.10.004			7	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	HE0FT	WOS:000452942900007	30396595	hybrid			2022-02-06	
J	Bakhsheshian, J; Ding, L; Tang, A; Wen, T; Patel, A; Strickland, BA; Rennert, RC; Amer, A; Gruen, P; Giannotta, S; Mack, WJ; Attenello, FJ				Bakhsheshian, Joshua; Ding, Li; Tang, Austin; Wen, Timothy; Patel, Arati; Strickland, Ben A.; Rennert, Robert C.; Amer, Arun; Gruen, Peter; Giannotta, Steven; Mack, William J.; Attenello, Frank J.			Safety-Net Hospitals Have Higher Complication and Mortality Rates in the Neurosurgical Management of Traumatic Brain Injuries	WORLD NEUROSURGERY			English	Article						Complications; National Database; Quality improvement; Traumatic brain injury; Trauma	RACIAL DISPARITIES; CARE; SURGERY; OUTCOMES; FAILURE; RESCUE; GUIDELINES; BURDEN; HEALTH; VOLUME	BACKGROUND: Clinical outcomes in the surgical management of severe traumatic brain injury (TBI) have been shown to vary across different hospital institutions. The effect of the safety-net burden on postoperative mortality, complication rates, and failure to rescue rates is unclear. We evaluated the relationship of the safety-net burden with outcomes in the treatment of patients with severe TBI undergoing neurosurgery. METHODS: The hospitals were grouped according to their safety-net burden, defined as the proportion of Medicaid and uninsured patient charges for all hospitalizations during that time. Multivariate analyses were performed to examine significant associations with the degree of safety-net burden while controlling for potential confounders. RESULTS: Data from 20,989 encounters in 788 hospitals were included. Compared with low-burden hospitals (LBHs), high-burden hospitals (HBHs; odds ratio [OR], 1.48; 95% confidence interval [CI], 1.04-2.12; P= 0.03) had greater mortality rates. Major complications were more likely to occur at HBHs (OR, 1.44; 95% CI, 1.12-1.84; P< 0.01) compared with LBHs. The failure to rescue rates were similar among all safety-net burden hospital groups. Patients at HBHs also had an increased likelihood of an extended length of stay (OR, 1.92; 95% CI, 1.12-3.29; P = 0.02) and receiving a tracheostomy or gastrostomy (OR, 1.99; 95% CI, 1.36-2.89; P < 0.01) compared with patients at LBHs. CONCLUSIONS: The present study found that a greater hospital safety-net burden was independently associated with greater rates of mortality and major complications in the treatment of patients with severe TBI undergoing neurosurgery. Further research in evaluating the cause of disparities in mortality outcomes at high safety-burden hospitals is needed.	[Bakhsheshian, Joshua; Strickland, Ben A.; Rennert, Robert C.; Amer, Arun; Gruen, Peter; Giannotta, Steven; Mack, William J.; Attenello, Frank J.] Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90007 USA; [Ding, Li] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA; [Tang, Austin; Wen, Timothy; Patel, Arati] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA		Bakhsheshian, J (corresponding author), Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90007 USA.	joshuabakh@gmail.com	DING, LI/ABI-1989-2020; ding, li/AAN-2113-2020; Ding, Li/G-4031-2019	DING, LI/0000-0001-8565-430X; Ding, Li/0000-0001-8565-430X; Wen, Timothy/0000-0002-1749-3142; Bakhsheshian, Joshua/0000-0003-2983-6082	NIH SC CTSI KL2 Clinical and Translational Research Scholar AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	FJA was the recipient of the NIH SC CTSI KL2 Clinical and Translational Research Scholar Award.	Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Alali AS, 2017, J NEUROTRAUM, V34, P2760, DOI 10.1089/neu.2017.4997; Alali AS, 2017, NEUROSURGERY, V80, P534, DOI 10.1093/neuros/nyw098; Alban RF, 2010, AM SURGEON, V76, P1108; Altman S, 2000, AM HLTH CARE SAFETY; Bakhsheshian J, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16268; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dobson A, 2017, COMMONW FUND, V2017; Faigle R, 2016, JAMA NEUROL, V73, P1151, DOI 10.1001/jamaneurol.2016.1914; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hoehn RS, 2016, JAMA SURG, V151, P120, DOI 10.1001/jamasurg.2015.3209; Houchens R, 2005, FINAL REPORT CALCULA, P2002; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu N, 2004, J HEALTH CARE POOR U, V15, P618, DOI 10.1353/hpu.2004.0053; McCormick PJ, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0936-3; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reyes C, 2017, J AM COLL SURGEONS, V224, P301, DOI 10.1016/j.jamcollsurg.2016.11.010; Rosero EB, 2017, J VASC SURG, V66, P404, DOI 10.1016/j.jvs.2016.12.146; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Shermer CR, 2007, J TRAUMA, V63, P1268; Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wakeam E, 2014, JAMA SURG, V149, P229, DOI 10.1001/jamasurg.2013.3566; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	31	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2018	119						E284	E293		10.1016/j.wneu.2018.07.134			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GX7IO	WOS:000447941300035	30055361				2022-02-06	
J	Edlow, BL; Fins, JJ				Edlow, Brian L.; Fins, Joseph J.			Assessment of Covert Consciousness in the Intensive Care Unit: Clinical and Ethical Considerations	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						coma; consciousness; EEG; functional MRI; minimally conscious state; neuroethics; prognostication; traumatic brain injury; vegetative state	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; THALAMIC-STIMULATION; BEDSIDE DETECTION; DISORDERS; AWARENESS; WITHDRAWAL; DIAGNOSIS; RECOVERY; SCALE	Objective: To propose a practical ethical framework for how task-based functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) may be used in the intensive care unit (ICU) to identify covert consciousness in patients with acute severe traumatic brain injury (TBI). Methods: We present 2 clinical scenarios in which investigational task-based fMRI and EEG were performed in critically ill patients with acute severe TBI who appeared unconscious on the bedside behavioral assessment. From these cases, we consider the clinical and ethical challenges that emerge and suggest how to reconcile them. We also provide recommendations regarding communication with families about ICU patients with covert consciousness. Results: Covert consciousness was detected acutely in a patient who died in the ICU due to withdrawal of life-sustaining therapy, whereas covert consciousness was not detected in a patient who subsequently recovered consciousness, communication, and functional independence. These cases raise ethical challenges about how assessment of covert consciousness in the ICU might inform treatment decisions, prognostication, and perceptions about the benefits and burdens of ongoing care. Conclusions: Given that covert consciousness can be detected acutely in the ICU, we recommend that clinicians reconsider evaluative norms for ICU patients. As our clinical appreciation of covert consciousness evolves and its ethical import unfolds, we urge prognostic humility and transparency when clinicians communicate with families in the ICU about goals of care.	[Edlow, Brian L.] Harvard Med Sch, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Massachusetts Gen Hosp, Boston, MA USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Fins, Joseph J.] Weill Cornell Med Coll, Div Med Eth & Consortium Adv Study Brain Injury, New York, NY USA; [Fins, Joseph J.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Fins, Joseph J.] Yale Law Sch, Solomon Ctr Hlth Law & Policy, New Haven, CT USA		Edlow, BL (corresponding author), Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, 175 Cambridge St,Ste 300, Boston, MA 02114 USA.	bedlow@mgh.harvard.edu		Fins, Joseph/0000-0002-7221-0053	NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538]; Jerold B. Katz Foundation; James S. McDonnell Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538] Funding Source: NIH RePORTER	This work was supported by grants from the NIH National Institute of Neurological Disorders and Stroke (K23NS094538), Jerold B. Katz Foundation, and the James S. McDonnell Foundation.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Bodien YG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00688; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Chakraborty R, 2017, PALLIAT SUPPORT CARE, V15, P609, DOI 10.1017/S1478951516001061; Chatelle C, 2018, CLIN NEUROPHYSIOL, V129, P1519, DOI 10.1016/j.clinph.2018.04.747; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2014, NEUROIMAGE-CLIN, V4, P788, DOI 10.1016/j.nicl.2014.05.001; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Curley WH, 2018, BRAIN, V141, P1404, DOI 10.1093/brain/awy070; Curlin FA, 2008, AM J HOSP PALLIAT ME, V25, P112, DOI 10.1177/1049909107310141; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Detre JA, 2006, J MAGN RESON IMAGING, V23, P808, DOI 10.1002/jmri.20585; DONALDSON DI, 2001, FUNCTIONAL MRI INTRO; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; Fins JJ, 1997, KENNEDY INST ETHIC J, V7, P129, DOI 10.1353/ken.1997.0013; Fins JJ, 2015, OXFORD TXB PALLIATIV, P285; Fins JJ, 2015, RIGHTS COME MIND BRA; Fins JJ, 2016, REV MAKING MED KNOWL; Fins JJ, 2006, HASTINGS CENT REP, V36, P8, DOI 10.1353/hcr.2006.0094; Fins JJ, 2018, NEUROLOGY, V91, P471, DOI 10.1212/WNL.0000000000005927; Fins JJ, 2018, J HEAD TRAUMA REHAB, V33, P283, DOI 10.1097/HTR.0000000000000416; Fins JJ, 2018, CAMB Q HEALTHC ETHIC, V27, P163, DOI 10.1017/S0963180117000329; Fins JJ, 2012, ARCH NEUROL-CHICAGO, V69, P158, DOI 10.1001/archneurol.2011.1211; Fins JJ, 2009, PROG BRAIN RES, V177, P371, DOI 10.1016/S0079-6123(09)17726-9; FRIED TR, 1993, ARCH INTERN MED, V153, P722, DOI 10.1001/archinte.153.6.722; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Gosseries O, 2014, BRAIN INJURY, V28, P1141, DOI 10.3109/02699052.2014.920522; Hauger SL, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/145913; Henninger N, 2018, J TRAUMA ACUTE CARE, V84, P473, DOI 10.1097/TA.0000000000001733; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Kitzinger C, 2015, J MED ETHICS, V41, DOI 10.1136/medethics-2013-101799; KITZINGER J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI DOI 10.1111/1467-9566.12020; Kitzinger J, 2018, PALLIATIVE MED, V32, P1180, DOI 10.1177/0269216318766430; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Lewis LD, 2016, P NATL ACAD SCI USA, V113, pE6679, DOI 10.1073/pnas.1608117113; MacNeil SD, 2007, J MED ETHICS, V33, P549, DOI 10.1136/jme.2006.017129; Mangia AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099289; Monti MM, 2016, BRAIN STIMUL, V9, P940, DOI 10.1016/j.brs.2016.07.008; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pew Research Center, 2013, VIEWS END LIF MED TR; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; Richardson HS., 2012, MORAL ENTANGLEMENTS; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2015, NEUROREHAB NEURAL RE, V29, P308, DOI 10.1177/1545968314547767; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; TEASDALE G, 1974, LANCET, V2, P81; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Erp WS, 2014, EUR J NEUROL, V21, P1361, DOI 10.1111/ene.12483; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Weijer C, 2016, BRAIN, V139, P292, DOI 10.1093/brain/awv272; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091	86	20	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					424	434		10.1097/HTR.0000000000000448			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600018	30395042	Green Accepted			2022-02-06	
J	Lancaster, MA; Meier, TB; Olson, DV; McCrea, MA; Nelson, LD; Muftuler, LT				Lancaster, Melissa A.; Meier, Timothy B.; Olson, Daniel V.; McCrea, Michael A.; Nelson, Lindsay D.; Muftuler, L. Tugan			Chronic differences in white matter integrity following sport-related concussion as measured by diffusion MRI: 6-Month follow-up	HUMAN BRAIN MAPPING			English	Article						concussion management; concussion symptoms; diffusion kurtosis imaging; diffusion tensor imaging; mild traumatic brain injury; sport-related concussion	TRAUMATIC BRAIN-INJURY; GAUSSIAN WATER DIFFUSION; MILD HEAD-INJURY; FOOTBALL PLAYERS; HIGH-SCHOOL; CELL-DEATH; TENSOR; KURTOSIS; ANISOTROPY; IMPAIRMENT	Recent studies demonstrated evidence of physiological changes in the brain following sport-related concussion (SRC) that persisted beyond the point at which athletes achieved full symptom recovery. Diffusion MRI techniques have been used to study brain white matter (WM) changes following SRC; however, longitudinal studies that follow injured athletes from the acute to chronic stages of injury are sparse. The current study explores potential persisting effects of the injury, which serves as a follow-up to our previous work that reported WM changes in the acute and subacute phase of SRC recovery. Concussed high school and collegiate football players (n =17) and well-matched teammate controls (n = 20) were followed up at 6 months postinjury with diffusion tensor (DTI) and diffusion kurtosis imaging (DKI) as well as measures of self-reported symptoms, cognitive functioning, and balance. Results of tract-based spatial statistics (TBSS) analyses revealed continued widespread decreased mean and axial diffusivity compared to control subjects in 6-month follow-up scans. On the other hand, kurtosis metrics, which were significantly higher in concussed athletes in the acute phase, had normalized. WM tract regions-of-interest (ROIs) were created from significant clusters in the TBSS analysis, and linear mixed effects (LME) analyses were used to look at longitudinal changes in these ROIs over time. LME analyses revealed few timex group interactions indicating findings were relatively stable over time. In addition, acute concussion symptoms predicted diffusivity measures at 6 months postinjury. Findings indicate that DTI and DKI may be useful tools in assessing concussion severity, recovery, and possible long-term effects of concussion.	[Lancaster, Melissa A.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Lancaster, Melissa A.; Meier, Timothy B.; McCrea, Michael A.; Nelson, Lindsay D.; Muftuler, L. Tugan] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Olson, Daniel V.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Muftuler, L. Tugan] Med Coll Wisconsin, Ctr Imaging Res, Milwaukee, WI 53226 USA		Muftuler, LT (corresponding author), Med Coll Wisconsin, Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	lmuftuler@mcw.edu	Muftuler, L. Tugan/AAG-7539-2021	Muftuler, L. Tugan/0000-0002-6635-5678	Clinical and Translational Science Institute of Southeast Wisconsin [1UL1-RR031973]; NIH Clinical CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [8UL1TR000055]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); General ElectricGeneral Electric; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER	Clinical and Translational Science Institute of Southeast Wisconsin, Grant/Award Number: 1UL1-RR031973; NIH Clinical Center, Grant/Award Number: 8UL1TR000055; National Institutes of Health; National Center for Advancing Translational Sciences; General Electric; U.S. Army Medical Research and Materiel Command, Grant/Award Number: W81XWH-12-1-0004	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Coutu JP, 2014, NEUROBIOL AGING, V35, P1412, DOI 10.1016/j.neurobiolaging.2013.12.001; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gons RAR, 2013, NEUROLOGY, V81, P971, DOI 10.1212/WNL.0b013e3182a43e33; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Helmick K., 2006, DEFENSE VETERANS BRA; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Hutchinson EB, 2017, MAGN RESON MED, V78, P1767, DOI 10.1002/mrm.26575; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Johnson NF, 2012, NEUROIMAGE, V59, P1514, DOI 10.1016/j.neuroimage.2011.08.032; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murphy M., 2016, NEUROSURGERY S1, V63, P178, DOI [10. 1227/01. neu. 0000489768. 36395. 5a, DOI 10.1227/01.NEU.0000489768.36395.5A]; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Paydar A, 2014, AM J NEURORADIOL, V35, P808, DOI 10.3174/ajnr.A3764; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tseng BY, 2013, NEUROIMAGE, V82, P510, DOI 10.1016/j.neuroimage.2013.06.011; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	72	20	20	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	NOV	2018	39	11					4276	4289		10.1002/hbm.24245			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GW3TW	WOS:000446831900008	29964356	Green Published, Bronze, Green Accepted			2022-02-06	
J	Howard, L; Dumkrieger, G; Chong, CD; Ross, K; Berisha, V; Schwedt, TJ				Howard, Levi; Dumkrieger, Gina; Chong, Catherine D.; Ross, Katherine; Berisha, Visar; Schwedt, Todd J.			Symptoms of Autonomic Dysfunction Among Those With Persistent Posttraumatic Headache Attributed to Mild Traumatic Brain Injury: A Comparison to Migraine and Healthy Controls	HEADACHE			English	Article						posttraumatic headache; migraine; traumatic brain injury; autonomic dysfunction; orthostatic intolerance	NERVOUS-SYSTEM FUNCTION; US SOLDIERS; CONCUSSION; EXPLOSIONS; MODEL; PAIN	BackgroundObjectiveMost persistent posttraumatic headaches (PPTH) have a phenotype that meets diagnostic criteria for migraine or probable migraine. Although symptoms of autonomic dysfunction have been well described among those with migraine, the presence and relative severity of such symptoms among those with PPTH have yet to be reported. The objective of this study was to assess and compare symptoms of autonomic dysfunction among those with PPTH attributed to mild traumatic brain injury (mTBI) vs migraine vs healthy controls using Composite Autonomic Symptom Score 31 (COMPASS-31) questionnaire scores. MethodsResultsIndividuals with PPTH (n=56) (87.5% of whom had a migraine/probable migraine phenotype), migraine (n=30), and healthy controls (n=36) were prospectively assessed in this cross-sectional cohort study using the COMPASS-31 questionnaire. Total COMPASS-31 scores and individual domain scores (bladder, gastrointestinal, orthostatic intolerance, pupillomotor, secretomotor, vasomotor) were compared between subject groups. COMPASS-31 mean total weighted score was 37.2215.44 in the PPTH group, 27.15 +/- 14.37 in the migraine group, and 11.67 +/- 8.98 for healthy controls. COMPASS-31 mean weighted total scores were significantly higher in those with PPTH vs migraine (P=.014), for PPTH vs healthy controls (P=.001), and for migraine vs healthy controls (P=.001). Those with PPTH had numerically higher scores for all COMPASS-31 domains compared to those with migraine, and the domain scores were significantly higher for orthostatic intolerance (PPTH=4.80 +/- 2.47 vs migraine=3.33 +/- 2.31, P=.027) and bladder (PPTH=1.14 +/- 1.45 vs migraine=0.47 +/- 0.73, P=.020). Among individuals with PPTH, post hoc correlations indicated a positive association between number of total lifetime TBIs with total weighted COMPASS-31 scores (rho=0.32, P=.020), between years lived with headache and vasomotor domain subscores (rho=0.27; P=.044), and between headache frequency with vasomotor domain subscores (rho=0.27; P=.041). ConclusionsSymptoms of autonomic dysfunction were greatest among those with PPTH compared to migraine and healthy controls. Among individuals with PPTH, number of lifetime TBIs was associated with greater symptoms of autonomic dysfunction, while greater headache burden was associated with higher vasomotor domain autonomic dysfunction subscores, potentially indicating that PPTH patients with higher disease burden have an increased risk for having autonomic dysfunction. Symptoms of autonomic dysfunction should be ascertained during the clinical management of patients with PPTH and might be a characteristic that helps differentiate PPTH from migraine.	[Howard, Levi; Dumkrieger, Gina; Chong, Catherine D.; Schwedt, Todd J.] Mayo Clin, Phoenix, AZ USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Berisha, Visar] Arizona State Univ, Tempe, AZ USA		Schwedt, TJ (corresponding author), Mayo Clin, Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Schwedt.todd@mayo.edu		Dumkrieger, Gina/0000-0001-9519-5370; Berisha, Visar/0000-0001-8804-8874	Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program [W81XWH-15-1-0286]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0286. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; APPEL S, 1992, HEADACHE, V32, P10, DOI 10.1111/j.1526-4610.1992.hed3201010.x; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Cambron M, 2014, HEADACHE, V54, P655, DOI 10.1111/head.12139; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; Classification Committee of the International Headache Society, 2018, INT CLASS HEAD DIS, P1; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; CORTELLI P, 1991, HEADACHE, V31, P457, DOI 10.1111/j.1526-4610.1991.hed3107457.x; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Ettlin D., 2013, INT CLASSIFICATION H, P629; Ghodadra A, 2016, AM J NEURORADIOL, V37, P274, DOI 10.3174/ajnr.A4505; HAVANKAKANNIAINEN H, 1988, HEADACHE, V28, P465, DOI 10.1111/j.1526-4610.1988.hed2807465.x; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Kanjwal K, 2010, CARDIOL J, V17, P482; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2016, FRONT NEUROL, V13, P7; LasFountaine MF, 2017, INT J PSYCHOPHYSIOL; Lau MK, 2013, DTK DUNNET TUKEY KRA; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Matei D, 2015, EUR REV MED PHARMACO, V19, P3922; Miglis MG, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0671-y; Moye LS, 2017, J NEUROSCI RES, V95, P1347, DOI 10.1002/jnr.24001; Muller M, 2005, STROKE, V36, P1886, DOI 10.1161/01.STR.0000177886.94134.92; POGACNIK T, 1993, HEADACHE, V33, P545, DOI 10.1111/j.1526-4610.1993.hed3310545.x; Rabner J, 2016, CLIN AUTON RES, V26, P455, DOI 10.1007/s10286-016-0385-3; Rea NA, 2017, J NEUROL SCI, V377, P35, DOI 10.1016/j.jns.2017.03.032; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sarmento EM, 2007, HEADACHE, V47, P799; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Shechter A, 2002, NEUROLOGY, V58, P422, DOI 10.1212/WNL.58.3.422; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523; Team R.C, 2016, R LANG ENV STAT COMP; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Thijs RD, 2006, NEUROLOGY, V66, P1034, DOI 10.1212/01.wnl.0000204186.43597.66; Treister R, 2015, EUR J NEUROL, V22, P1124, DOI 10.1111/ene.12717; Truong JQ, 2018, J OPTOM, V11, P93, DOI 10.1016/j.optom.2016.12.005; Wang JW, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0973-4; Yakinci C, 1999, PEDIATR INT, V41, P529, DOI 10.1046/j.1442-200x.1999.01101.x	48	20	21	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	OCT	2018	58	9					1397	1407		10.1111/head.13396			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY8AZ	WOS:000448841600006	30156267	Bronze			2022-02-06	
J	Kinoshita, T; Hayashi, M; Yamakawa, K; Watanabe, A; Yoshimura, J; Hamasaki, T; Fujimi, S				Kinoshita, Takahiro; Hayashi, Motohisa; Yamakawa, Kazuma; Watanabe, Atsushi; Yoshimura, Jumpei; Hamasaki, Toshimitsu; Fujimi, Satoshi			Effect of the Hybrid Emergency Room System on Functional Outcome in Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Craniotomy; CT; Functional outcome; Traumatic brain injury; Trauma workflow	MULTISLICE COMPUTED-TOMOGRAPHY; ACUTE SUBDURAL-HEMATOMA; INTRACRANIAL HYPERTENSION; EXTERNAL VALIDATION; CT SCANNER; MANAGEMENT; PREDICTION; PROGNOSIS; MORTALITY; SURGERY	OBJECTIVE: The timely treatment of severe traumatic brain injury (TBI) is essential for limiting the effects of damage; however, there is no consensus regarding an effective method for early intervention. In August 2011, our hospital launched a novel trauma workflow using the hybrid emergency room (ER), consisting of an interventional radiology-computed tomography (CT) unit installed in the trauma resuscitation room to facilitate early interventions. The aim of this study was to evaluate effects of the hybrid ER system on functional outcomes in patients with severe TBI. METHODS: We conducted a retrospective historical control study of patients with severe TBI (Glasgow Coma Scale score <= 8) who received conventional treatment (August 2007-July 2011) or treatment in the hybrid ER (August 2011-July 2015). The primary end point was unfavorable outcome at 6 months after injury (death, vegetative state, or lower severe disability) as evaluated by the Glasgow Outcome Scale-Extended. Secondary end points included time from arrival to the start of CT examination and emergency intracranial operation. Potential confounders were adjusted with multivariable logistic regressions. RESULTS: Among 158 included patients, 88 were in the conventional group and 70 were in the hybrid ER group. After model adjustment, the hybrid ER group was significantly associated with a reduction in unfavorable outcomes. Times to CT examination and intracranial operation were significantly shorter in the hybrid ER group than that in the conventional group. CONCLUSIONS: The hybrid ER system is useful for realizing immediate CT examination and emergency surgery and improving functional outcomes in patients with severe TBI.	[Kinoshita, Takahiro; Hayashi, Motohisa; Yamakawa, Kazuma; Watanabe, Atsushi; Yoshimura, Jumpei; Fujimi, Satoshi] Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi Ku, Osaka, Japan; [Hamasaki, Toshimitsu] Natl Cerebral & Cardiovasc Ctr, Dept Data Sci, Suita, Osaka, Japan		Yamakawa, K (corresponding author), Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi Ku, Osaka, Japan.	k.yamakawa0911@gmail.com	Watanabe, Atsushi/AAU-8018-2020; Yamakawa, Kazuma/AAD-3436-2022; Hamasaki, Toshimitsu/N-3851-2015	Yamakawa, Kazuma/0000-0003-2999-4021; Hamasaki, Toshimitsu/0000-0002-4928-1160			American College of Surgeons Committee on Trauma, 2012, ATLS ADV TRAUM LIF S; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2017, SEV TBI; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Committee of the Japan Association of Traumatology, 2016, JAP ADV TRAUM EV CAR; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Harrison DA, 2015, J NEUROTRAUM, V32, P1522, DOI 10.1089/neu.2014.3628; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Huber-Wagner S, 2014, INJURY, V45, pS76, DOI 10.1016/j.injury.2014.08.022; Jin PHPFK, 2008, J TRAUMA, V64, P1320, DOI 10.1097/TA.0b013e318059b9ae; Kinoshita T, 2019, ANN SURG, V269, P370, DOI 10.1097/SLA.0000000000002527; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lee KL, 2009, INJURY, V40, P873, DOI 10.1016/j.injury.2008.12.001; Marcoux J, 2016, J NEUROSURG, V125, P642, DOI 10.3171/2015.6.JNS15175; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Saltzherr TP, 2012, BRIT J SURG, V99, P105, DOI 10.1002/bjs.7705; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wada D, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0484-3; Wada D, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-52; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; Weninger P, 2007, J TRAUMA, V62, P584, DOI 10.1097/01.ta.0000221797.46249.ee; Wulffeld S, 2017, ACTA ANAESTH SCAND, V61, P832, DOI 10.1111/aas.12927; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4	36	20	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2018	118						E792	E799		10.1016/j.wneu.2018.07.053			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GU1NY	WOS:000445032000103	30026142				2022-02-06	
J	Meletti, S; Lucchi, C; Monti, G; Giovannini, G; Bedin, R; Trenti, T; Rustichelli, C; Biagini, G				Meletti, Stefano; Lucchi, Chiara; Monti, Giulia; Giovannini, Giada; Bedin, Roberta; Trenti, Tommaso; Rustichelli, Cecilia; Biagini, Giuseppe			Low levels of progesterone and derivatives in cerebrospinal fluid of patients affected by status epilepticus	JOURNAL OF NEUROCHEMISTRY			English	Article						allopregnanolone; cerebrospinal fluid; liquid chromatography-electrospray tandem mass spectrometry (LC-MS/MS); progesterone; status epilepticus; gamma-aminobutyric acid type A (GABA(A)) receptor	REFRACTORY STATUS EPILEPTICUS; NEUROACTIVE STEROID-LEVELS; TRAUMATIC BRAIN-INJURY; PILOCARPINE MODEL; CLINICAL-TRIAL; EPILEPSY; ALLOPREGNANOLONE; NEUROSTEROIDS; BIOCHEMISTRY; INDUCTION	Neurosteroids such as allopregnanolone may play a role in epilepsy as positive modulators of inhibitory currents mediated by gamma-aminobutyric acid type A (GABA(A)) receptor. Indeed, these molecules have been consistently shown to be anticonvulsants in animal models, but their role is still unclear in patients. For this reason, we investigated neurosteroids in the cerebrospinal fluid (CSF) of patients with status epilepticus (SE) by liquid chromatography tandem-mass spectrometry. Patients were retrospectively identified within subjects who received a lumbar puncture in the 2007-2017 period. Seventy-three patients (median age 65, ranging from 13 to 94 years; 67% women) with SE were evaluated. Controls (n = 52, median age 53, ranging from 16 to 93 years; 65% women) were patients presenting with symptoms for which a lumbar puncture was required by clinical guidelines, and who were negative at the end of the diagnostic work-up. Progesterone was 64% lower in patients with SE (p < 0.001). With respect to progesterone, upstream pregnenolone sulfate and pregnenolone did not change. Instead, downstream 5 alpha-dihydroprogesterone, pregnanolone and allopregnanolone were, respectively, 49% (p < 0.001), 21% (p < 0.01) and 37% (p < 0.001) lower than in controls. Duration or type of SE, age and sex did not consistently affect CSF neurosteroid levels in the SE cohort. Instead, pregnenolone sulfate (Spearman's rho = 0.4335, p < 0.01), allopregnanolone (rho = 0.4121, p < 0.05) and pregnanolone (rho = 0.592, p < 0.001) levels significantly increased by aging in controls. We conclude that neurosteroidogenesis is defective in patients with SE.	[Meletti, Stefano; Lucchi, Chiara; Bedin, Roberta; Biagini, Giuseppe] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Meletti, Stefano; Lucchi, Chiara; Monti, Giulia; Giovannini, Giada; Biagini, Giuseppe] AOU Modena, Civil Hosp Baggiovara, Dept Neurosci, Modena, Italy; [Meletti, Stefano; Biagini, Giuseppe] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Modena, Italy; [Trenti, Tommaso] AUSL Modena, Dept Lab Med & Pathol Anat, Modena, Italy; [Rustichelli, Cecilia] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy		Biagini, G (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Via Campi 287, I-41125 Modena, Italy.	gbiagini@unimore.it	Biagini, Giuseppe/I-3227-2013; Trenti, Tommaso/K-8457-2016; Meletti, Stefano/O-3622-2015	Biagini, Giuseppe/0000-0002-7130-2511; Trenti, Tommaso/0000-0001-8093-4011; Meletti, Stefano/0000-0003-0334-539X	Ministry of Health of ItalyMinistry of Health, Italy [RF-2011-02350485]; Foundation 'Fondazione Cassa di Risparmio di Modena - FCRM'; Italian Ministry of HealthMinistry of Health, Italy	This study has been supported by Ministry of Health of Italy (RF-2011-02350485). The HPLC-ESI-TQ at the 'Centro Interdipartimentale Grandi Strumenti - CIGS' of the University of Modena and Reggio Emilia was granted by the Foundation 'Fondazione Cassa di Risparmio di Modena - FCRM'. C. Lucchi, G. Monti, G. Giovannini, R. Bedin and C. Rustichelli report no disclosures relevant to the manuscript. S. Meletti, T. Trenti, and G. Biagini received grant support from the Italian Ministry of Health.	Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Biagini G, 2009, EPILEPSIA, V50, P53, DOI 10.1111/j.1528-1167.2008.01971.x; Broomall E, 2014, ANN NEUROL, V76, P911, DOI 10.1002/ana.24295; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Gaspard N, 2015, NEUROLOGY, V85, P1604, DOI 10.1212/WNL.0000000000001940; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Herzog AG, 2012, NEUROLOGY, V78, P1959, DOI 10.1212/WNL.0b013e318259e1f9; Herzog AG, 2015, SEIZURE-EUR J EPILEP, V28, P18, DOI 10.1016/j.seizure.2015.02.024; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Melcangi RC, 2017, J STEROID BIOCHEM, V171, P229, DOI 10.1016/j.jsbmb.2017.04.003; Meletti S, 2017, EPILEPSIA, V58, pE16, DOI 10.1111/epi.13625; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Owen DR, 2017, BIOCHEM J, V474, P3985, DOI 10.1042/BCJ20170648; Ramanujam B, 2016, EPILEPTIC DISORD, V18, P101, DOI 10.1684/epd.2016.0792; Rogawski MA, 2013, EPILEPSIA, V54, P93, DOI 10.1111/epi.12289; Rosenthal ES, 2017, ANN NEUROL, V82, P342, DOI 10.1002/ana.25008; Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smeland OB, 2013, J CEREBR BLOOD F MET, V33, P1090, DOI 10.1038/jcbfm.2013.54; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Storbeck KH, 2015, J STEROID BIOCHEM, V151, P66, DOI 10.1016/j.jsbmb.2014.11.024; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vaitkevicius H, 2017, ANN CLIN TRANSL NEUR, V4, P411, DOI 10.1002/acn3.408; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wigginton JG, 2010, CRIT CARE MED, V38, pS620, DOI 10.1097/CCM.0b013e3181f243a9; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	32	20	20	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2018	147	2					275	284		10.1111/jnc.14550			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ5VX	WOS:000449499000010	30005125	Bronze			2022-02-06	
J	Raj, R; Bendel, S; Reinikainen, M; Hoppu, S; Laitio, R; Ala-Kokko, T; Curtze, S; Skrifvars, MB				Raj, R.; Bendel, S.; Reinikainen, M.; Hoppu, S.; Laitio, R.; Ala-Kokko, T.; Curtze, S.; Skrifvars, M. B.			Costs, outcome and cost-effectiveness of neurocritical care: a multi-center observational study	CRITICAL CARE			English	Article						Neurocritical care; neurointensive care; costs; cost-effectiveness; Traumatic brain injury; Intracerebral hemorrhage; Acute ischemic stroke; Subarachnoid hemorrhage; Finland; Outcome	STENT-RETRIEVER THROMBECTOMY; ACUTE ISCHEMIC-STROKE; INTENSIVE-CARE; BED NUMBERS; ENDOVASCULAR TREATMENT; MEDICINE; DISEASE; BURDEN; TRIAL; SCORE	Background: Neurocritical illness is a growing healthcare problem with profound socioeconomic effects. We assessed differences in healthcare costs and long-term outcome for different forms of neurocritical illnesses treated in the intensive care unit (ICU). Methods: We used the prospective Finnish Intensive Care Consortium database to identify all adult patients treated for traumatic brain injury (TBI), intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH) and acute ischemic stroke (AIS) at university hospital ICUs in Finland during 2003-2013. Outcome variables were one-year mortality and permanent disability. Total healthcare costs included the index university hospital costs, rehabilitation hospital costs and social security costs up to one year. All costs were converted to euros based on the 2013 currency rate. Results: In total 7044 patients were included (44% with TBI, 13% with ICH, 27% with SAH, 16% with AIS). In comparison to TBI, ICH was associated with the highest risk of death and permanent disability (OR 2.6, 95% CI 2.1-3.2 and OR 1.7, 95% CI 1.4-2.1), followed by AIS (OR 1.9, 95% CI 15-23 and OR 1.5, 95% CI 1.3-1.8) and SAH (OR 1.8, 95% CI 1.5-2.1 and OR 0. 8, 95% CI 0.6-0.9), after adjusting for severity of illness. SAH was associated with the highest mean total costs ((sic)51,906) followed by ICH ((sic)47,661), TBI ((sic)43,916) and AIS ((sic)39222). Cost per independent survivor was lower for TBI ((sic)58,497) and SAH ((sic)96,369) compared to AIS ((sic)104,374) and ICH ((sic)178,071). Conclusion: Neurocritical illnesses are costly and resource-demanding diseases associated with poor outcomes. Intensive care of patients with TBI or SAH more commonly result in independent survivors and is associated with lower total treatments costs compared to ICH and AIS.	[Raj, R.] Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland; [Raj, R.] Univ Helsinki, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland; [Bendel, S.] Kuopio Univ Hosp, Dept Intens Care, Kuopio, Finland; [Bendel, S.] Univ Eastern Finland, Kuopio, Finland; [Reinikainen, M.] North Karelia Cent Hosp, Dept Intens Care, Joensuu, Finland; [Hoppu, S.] Tampere Univ Hosp, Dept Intens Care, Tampere, Finland; [Hoppu, S.] Univ Tampere, Tampere, Finland; [Laitio, R.] Turku Univ Hosp, Dept Intens Care, Turku, Finland; [Laitio, R.] Univ Turku, Turku, Finland; [Ala-Kokko, T.] Oulu Univ Hosp, Dept Intens Care, Oulu, Finland; [Ala-Kokko, T.] Univ Oulu, Med Res Ctr, Res Grp Surg Anesthesiol & Intens Care, Oulu, Finland; [Curtze, S.] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland; [Curtze, S.; Skrifvars, M. B.] Univ Helsinki, Helsinki, Finland; [Skrifvars, M. B.] Helsinki Univ Hosp, Dept Anesthesia Intens Care & Pain Med, Helsinki, Finland; [Skrifvars, M. B.] Helsinki Univ Hosp, Dept Emergency Care & Serv, Helsinki, Finland		Raj, R (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland.; Raj, R (corresponding author), Univ Helsinki, Topeliuksenkatu 5,PB 266, Hus Helsinki 00029, Finland.	rahul.raj@hus.fi	Curtze, Sami/AAK-8595-2020; Raj, Rahul/K-7693-2012	Curtze, Sami/0000-0003-1545-8500; Raj, Rahul/0000-0003-4243-9591; Reinikainen, Matti/0000-0001-6878-3740	Helsinki University [H3702 73702705]; Helsinki University Hospital [VTR-TYH2014221]; Svenska Kulturfonden; Medicinska Understodsforeningen Liv and Halsa; Finska Lakaresallskapet; Maud Kuistilan Saatio; Eemil Aaltosen Saatio; Ella and Georg Ehrnroothin Saatio; Suomalais-Norjalainen Laaketieteen Saatio; Suomen Laaketieteen Saatio; Maire Taposen Saatio	This study was funded with grants from Helsinki University (3-year project grant: H3702 73702705) and Helsinki University Hospital (state funding: VTR-TYH2014221). RR has received personal research grants from Svenska Kulturfonden, Medicinska Understodsforeningen Liv and Halsa, Finska Lakaresallskapet, Maud Kuistilan Saatio, Eemil Aaltosen Saatio, Ella and Georg Ehrnroothin Saatio, Suomalais-Norjalainen Laaketieteen Saatio, Suomen Laaketieteen Saatio, and Maire Taposen Saatio. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achit H, 2017, STROKE, V48, P2843, DOI 10.1161/STROKEAHA.117.017856; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Carr BG, 2010, JAMA-J AM MED ASSOC, V303, P1371, DOI 10.1001/jama.2010.394; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; Efendijev I, 2016, ACTA ANAESTH SCAND, V60, P1415, DOI 10.1111/aas.12809; Fallenius M, 2017, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-017-0448-z; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Fernando SM, 2018, CRIT CARE MED, V1; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; GYLDMARK M, 1995, CRIT CARE MED, V23, P964; Halpern NA, 2004, CRIT CARE MED, V32, P1254, DOI 10.1097/01.CCM.0000128577.31689.4C; Halpern NA, 2016, CRIT CARE MED, V44, P1490, DOI 10.1097/CCM.0000000000001722; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Hemphill JC, 2015, STROKE; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kapiainen S., 2014, TERVEYDEN JA SOSIAAL, V3; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korja M, 2016, NEUROLOGY, V87, P1118, DOI 10.1212/WNL.0000000000003091; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Maud A, 2009, J NEUROSURG, V110, P880, DOI 10.3171/2008.8.JNS0858; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Raj R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2151-5; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Reinikainen M, 2007, ACTA ANAESTH SCAND, V51, P522, DOI 10.1111/j.1399-6576.2007.01274.x; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; REYNOLDS HN, 1988, JAMA-J AM MED ASSOC, V260, P3446, DOI 10.1001/jama.260.23.3446; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Shireman TI, 2017, STROKE, V48, P379, DOI 10.1161/STROKEAHA.116.014735; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wilby MJ, 2003, STROKE, V34, P2508, DOI 10.1161/01.STR.0000089922.94684.13	38	20	20	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	SEP 20	2018	22								225	10.1186/s13054-018-2151-5			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV1LP	WOS:000445839100001	30236140	Green Published, gold			2022-02-06	
J	St Ivany, A; Bullock, L; Schminkey, D; Wells, K; Sharps, P; Kools, S				St Ivany, Amanda; Bullock, Linda; Schminkey, Donna; Wells, Kristen; Sharps, Phyllis; Kools, Susan			Living in Fear and Prioritizing Safety: Exploring Women's Lives After Traumatic Brain Injury From Intimate Partner Violence	QUALITATIVE HEALTH RESEARCH			English	Article						domestic; abuse; violence against women; structural violence; brain injury; community and public health; qualitative; grounded theory; situational analysis; United States	ABUSED WOMEN; INTERSECTIONALITY; FRAMEWORK; OUTCOMES; HEALTH	There is increasing evidence that women are receiving a traumatic brain injury (TBI) during episodes of intimate partner violence (IPV), but little qualitative research exists around how surviving this experience impacts the lives of women. Primary and secondary data (N = 19) were used with a constructivist grounded theory approach to explore the lives of women aged 18 to 44 years, who were living with a TBI from IPV. Women described multiple aspects of living in fear that shaped their daily lives and ability to seek help and access resources. The central process of prioritizing safety emerged, with salient dimensions of maintaining a present orientation, exhibiting hyperprotection of children, invoking isolation as protection, and calculating risk of death. These findings add to the growing body of knowledge that women living with IPV are at high risk for receiving a TBI and are therefore a subgroup in need of more prevention and treatment resources.	[St Ivany, Amanda] Univ Virginia, Charlottesville, VA USA; [Bullock, Linda] Univ Virginia, Sch Nursing, Charlottesville, VA 22903 USA; [Schminkey, Donna] Univ Virginia, Sch Nursing, Acute & Specialty Care Dept, Charlottesville, VA 22903 USA; [Wells, Kristen] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Kools, Susan] Univ Virginia, Nursing, Charlottesville, VA USA; [St Ivany, Amanda] Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03766 USA; [Sharps, Phyllis] Johns Hopkins Univ, Nursing, Baltimore, MD USA; [Sharps, Phyllis] Johns Hopkins Univ, Community Programs & Initiat, Baltimore, MD USA		St Ivany, A (corresponding author), Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	Amanda.R.St.Ivany@dartmouth.edu	St Ivany, Amanda/AAC-6228-2019	Sharps, Phyllis/0000-0002-8508-5087	NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HP30036] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR009093] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR009093] Funding Source: NIH RePORTER		Anderson JC, 2015, J EMERG NURS, V41, P36, DOI 10.1016/j.jen.2014.01.015; Black M C., 2011, NATL INTIMATE PARTNE; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Collins PH, 2015, ANNU REV SOCIOL, V41, P1, DOI 10.1146/annurev-soc-073014-112142; Corbin J., 2009, DEV GROUNDED THEORY, P35; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [DOI 10.2307/1229039, 10.2307/1229039]; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; Dingwall, 2010, SAGE HDB QUALITATIVE, P174; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Ford-Gilboe M, 2011, FAMILY VIOLENCE NURS, P115; GALTUNG J, 1969, J PEACE RES, P167; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Kelly UA, 2011, ADV NURS SCI, V34, pE29, DOI 10.1097/ANS.0b013e3182272388; Kools S, 1996, QUAL HEALTH RES, V6, P312, DOI 10.1177/104973239600600302; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Nash JC, 2008, FEMINIST REV, P1, DOI 10.1057/fr.2008.4; Rich K, 2014, AFFILIA J WOM SOC WO, V29, P418, DOI 10.1177/0886109914522626; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sharps P, 2013, PEDIATRICS, V132, pS134, DOI 10.1542/peds.2013-1021L; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Strauss A., 1990, BASICS QUALITATIVE R, V15; Washburn R., 2017, SITUATIONAL ANAL GRO; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	27	20	20	0	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	SEP	2018	28	11			SI		1708	1718		10.1177/1049732318786705			11	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	GR2NN	WOS:000442412400003	30027811	Green Accepted			2022-02-06	
J	Gil-Jardine, C; Evrard, G; Al Joboory, S; Saint Jammes, JT; Masson, F; Ribereau-Gayon, R; Galinski, M; Salmi, LR; Revel, P; Regis, CA; Valdenaire, G; Lagarde, E				Gil-Jardine, Cedric; Evrard, Gregoire; Al Joboory, Samantha; Saint Jammes, Juliane Tortes; Masson, Francoise; Ribereau-Gayon, Regis; Galinski, Michel; Salmi, Louis-Rachid; Revel, Philippe; Regis, Cyril Alexandre; Valdenaire, Guillaume; Lagarde, Emmanuel			Emergency room intervention to prevent post concussion-like symptoms and post-traumatic stress disorder. A pilot randomized controlled study of a brief eye movement desensitization and reprocessing intervention versus reassurance or usual care	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; PREDICTORS; IMPAIRMENT; WORKPLACE; EXPOSURE; HEALTH; TRIAL; EMDR; PAIN	Up to 20% of patients presenting at an emergency room (ER) after a stressful event will for several months suffer from very diverse long-lasting symptoms and a potentially significant decline in quality of life, often described as post concussion-like symptoms (PCLS). The objectives of our randomized open-label single-center study were to assess the feasibility of psychologist-led interventions in the context of the ER and to compare the effect of eye movement desensitization and reprocessing (EMDR) with reassurance and usual care. Conducted in the ER of Bordeaux University Hospital, the study included patients with a high risk of PCLS randomized in three groups: a 15-min reassurance session, a 60-min session of EMDR, and usual care. Main outcomes were the proportion of interventions that could be carried out and the prevalence of PCSL and post-traumatic stress disorder (PTSD) three months after the ER visit. One hundred and thirty patients with a high risk of PCLS were randomized. No logistic problem or patient refusal was observed. In the EMDR, reassurance and control groups, proportions of patients with PCLS at three months were 18%, 37% and 65% and those with PTSD were 3%, 16% and 19% respectively. The risk ratio for PCLS adjusted for the type of event (injury, non-injury) for the comparison between EMDR and control was 0.36 [95% CI 0.20-0.66]. This is the first randomized controlled trial that shows that a short EMDR intervention is feasible and potentially effective in the context of the ER. The study was registered at ClinicalTrials.gov (NCT03194386).	[Gil-Jardine, Cedric; Evrard, Gregoire; Galinski, Michel; Revel, Philippe; Valdenaire, Guillaume] Univ Hosp Bordeaux, Pole Emergency Med, F-33000 Bordeaux, France; [Gil-Jardine, Cedric; Evrard, Gregoire; Masson, Francoise; Ribereau-Gayon, Regis; Galinski, Michel; Salmi, Louis-Rachid; Revel, Philippe; Valdenaire, Guillaume; Lagarde, Emmanuel] Bordeaux Populat Hlth Res Ctr, INSERM, ISPED, Injury Epidemiol Transport Occupat Team,U1219, F-33076 Bordeaux, France; [Ribereau-Gayon, Regis] Univ Hosp Bordeaux, Pole Med, F-33000 Bordeaux, France; [Al Joboory, Samantha; Saint Jammes, Juliane Tortes; Regis, Cyril Alexandre] Hosp Ctr Cadillac, CASPERTT, 31 Rue Cavailles, F-33310 Lormont, France; [Salmi, Louis-Rachid] Univ Hosp Bordeaux, Pole Publ Hlth, F-33000 Bordeaux, France; [Masson, Francoise] Univ Hosp Bordeaux, Pole Anesthesia & Intens Care, F-33000 Bordeaux, France		Gil-Jardine, C (corresponding author), Univ Hosp Bordeaux, Pellegrin Hosp, Emergency Dept, Pl Amelie Raba Leon, F-33000 Bordeaux, France.	cedric.gil-jardine@chu-bordeaux.fr	Jammes, Juliane Tortes saint/U-5420-2019; Regis, RIBEREAU-GAYON/U-5423-2019; VALDENAIRE, GUILLAUME/U-5426-2019; Lagarde, Emmanuel/F-7132-2013; Gil-Jardine, Cedric/T-5552-2019; Salmi, Louis-Rachid/T-1982-2019	Gil-Jardine, Cedric/0000-0001-5329-6405			Absolom K, 2007, BREAST, V16, P590, DOI 10.1016/j.breast.2007.05.001; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.5555/appi.books.9780890425596.x00pre, DOI 10.5555/APPI.BOOKS.9780890425596.X00PRE]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Carrasco V, 2003, ETUDES RESULTATS, V8; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Iyadurai L, 2018, MOL PSYCHIATR, V23, P674, DOI 10.1038/mp.2017.23; Jarero I, 2011, J EMDR PRACT RES, V5, P82, DOI 10.1891/1933-3196.5.3.82; Jeffries FW, 2013, BEHAV COGN PSYCHOTH, V41, P290, DOI 10.1017/S1352465812000793; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Manners JL, 2016, J NEUROTRAUM, V33, P1796, DOI 10.1089/neu.2015.4245; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Odeen M, 2013, J OCCUP REHABIL, V23, P209, DOI 10.1007/s10926-013-9451-z; Pincus T, 2013, PAIN, V154, P2407, DOI 10.1016/j.pain.2013.07.019; Price M, 2014, J CONSULT CLIN PSYCH, V82, P336, DOI 10.1037/a0035537; Quinn G., 2013, IMPLEMENTING EMDR EA; Rose SC, 2002, COCHRANE DB SYST REV, V2, DOI 10.1002/14651858.CD000560; Sack M, 2016, PSYCHOTHER PSYCHOSOM, V85, P357, DOI 10.1159/000447671; Samara OA, 2011, SAUDI J KIDNEY DIS T, V22, P515; Schmulson MJ, 2006, J PSYCHOSOM RES, V61, P461, DOI 10.1016/j.jpsychores.2006.02.011; Shapiro E., 2013, IMPLEMENTING EMDR EA; SHAPIRO F, 1989, J BEHAV THER EXP PSY, V20, P211, DOI 10.1016/0005-7916(89)90025-6; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Solomon SD, 1997, J CLIN PSYCHIAT, V58, P5; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Tarquinio C, 2016, ISSUES MENT HEALTH N, V37, P787, DOI 10.1080/01612840.2016.1224282; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; van den Hout M.A., 2012, J EXP PSYCHOPATHOL, V3, P724, DOI [10.5127/jep.028212, DOI 10.5127/JEP.028212]; Vuagnat A., 2013, PANORAMA ETABLISSEME, P11; World Health Organization, INT CLASS DIS	38	20	20	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	AUG	2018	103						229	236		10.1016/j.jpsychires.2018.05.024			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GM3LA	WOS:000438004900031	29894921				2022-02-06	
J	Register-Mihalik, JK; Williams, RM; Marshall, SW; Linnan, LA; Mihalik, JP; Guskiewicz, KM; McLeod, TCV				Register-Mihalik, Johna K.; Williams, Richelle M.; Marshall, Stephen W.; Linnan, Laura A.; Mihalik, Jason P.; Guskiewicz, Kevin M.; McLeod, Tamara C. Valovich			Demographic, Parental, and Personal Factors and Youth Athletes' Concussion-Related Knowledge and Beliefs	JOURNAL OF ATHLETIC TRAINING			English	Article						brain injury; sports; concussion education; theory of planned behavior; socioecological model	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; FOOTBALL PLAYERS; SOCIOECOLOGICAL FRAMEWORK; REPORTING BEHAVIORS; PHYSICAL-ACTIVITY; HEALTH-PROMOTION; SEX-DIFFERENCES; SOCCER PLAYERS; SOCIAL ECOLOGY	Context: Currently, significant attention is focused on improving care for patients with concussions through legislative mandates that include educational interventions. Few researchers have examined young athletes' concussion knowledge and the factors that may influence their knowledge. Objective: To use the socioecological model to examine demographic, parental, and personal factors associated with youth athletes' knowledge of concussion. Our ultimate goal is to inform the planning and implementation of youth sport concussion-related interventions. Design: Cross-sectional survey. Setting: Gymnasium and classroom. Patients or Other Participants: North Carolina and Arizona youth athletes (n = 225; age = 8 to 15 years) active in football, boys' or girls' soccer, boys' or girls' ice hockey, or boys' or girls' lacrosse in 2012-2013. Main Outcome Measure(s): Participants completed a validated, self-administered survey. The intention and belief measures were guided by the theory of planned behavior. Perceptions of concussion and intention to seek care were examined using descriptive statistics. Athletes' concussion knowledge was modeled using linear regressions and generalized estimating equations, with child demographic and personal factors and parental knowledge and attitudes about concussion as predictors. Results: Geography, sport, parental attitudes toward concussion, and athlete age were associated with athlete knowledge in the univariable analyses (P < .10). In the multivariable model, geographic location (North Carolina versus Arizona, mean difference [MD] = 2.2, 95% confidence interval [CI] = 1.1, 3.2), sport (girls' soccer versus girls' lacrosse, MD = 2.2, 95% CI = 0.7, 3.6), more favorable parental attitudes toward concussion (MD = 1.2 for a 2-standard deviation shift; 95% CI = 0.3, 2.1), and older age (>12 years, MD = 1.6; 95% CI = 0.5, 2.6) were associated with better knowledge about concussion. Conclusions: Geographic location, sport, parental attitudes about concussion, and athlete's age influenced athletes' concussion-related perceptions, indicating the need to address multiple levels of the socioecological model when targeting youth sport interventions. Parental interventions that translate to an improved culture of youth sport by improving youth athletes' perceptions and experiences are key areas for future work.	[Register-Mihalik, Johna K.; Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Marshall, Stephen W.] Univ N Carolina, Gillings Sch Global Publ Hlth, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Linnan, Laura A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Williams, Richelle M.] AT Still Univ, Dept Res Support, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA		Register-Mihalik, JK (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, CB 8700, Chapel Hill, NC 27599 USA.	johnakay@email.unc.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Williams, Richelle/0000-0003-4728-7443	National Operating Committee on Standards for Athletic Equipment; Injury Control Research Center award from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention [R49/CE002479]	Funding for this work was provided in part by a grant from the National Operating Committee on Standards for Athletic Equipment. The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the committee. The National Operating Committee on Standards for Athletic Equipment had no involvement in the study other than providing funding. No other interests were related to this work. Dr Marshall was partially supported by an Injury Control Research Center award (R49/CE002479) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.	Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bickell NA, 2012, J CLIN ONCOL, V30, P1791, DOI 10.1200/JCO.2011.38.7605; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Donaldson CD, 2016, PREV SCI, V17, P606, DOI 10.1007/s11121-016-0656-1; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Guo D, CLIN J SPORT MED; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kwon S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0383-9; LaBella C, 2014, JAMA-J AM MED ASSOC, V312, P739, DOI 10.1001/jama.2014.6668; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Myrdal CN, 2017, PHYSICIAN SPORTSMED, V45, P286, DOI 10.1080/00913847.2017.1345569; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schoeppe S, 2016, PEDIATR EXERC SCI, V28, P466, DOI 10.1123/pes.2015-0236; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; Stokols D, 1996, AM J HEALTH PROMOT, V10, P247, DOI 10.4278/0890-1171-10.4.247; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06	40	20	20	2	9	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2018	53	8					768	775		10.4085/1062-6050-223-17			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GW7OJ	WOS:000447157700008	30198745	gold, Green Published			2022-02-06	
J	Wardlaw, C; Hicks, AJ; Sherer, M; Ponsford, JL				Wardlaw, Carla; Hicks, Amelia J.; Sherer, Mark; Ponsford, Jennie L.			Psychological Resilience Is Associated With Participation Outcomes Following Mild to Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; TBI; resilience; participation; depression; anxiety	VERBAL-LEARNING TEST; QUALITY-OF-LIFE; 1ST 5 YEARS; PSYCHIATRIC-DISORDERS; COMMUNITY INTEGRATION; POSTTRAUMATIC AMNESIA; CLINICAL UTILITY; HOSPITAL ANXIETY; TBI-QOL; AXIS-I	Traumatic brain injury (TBI) causes physical and cognitive-behavioral impairments that reduce participation in employment, leisure, and social relationships. Demographic and injury-related factors account for a small proportion of variance in participation post-injury. Personal factors such as resilience may also impact outcomes. This study aimed to examine the association of resilience alongside demographic, injury-related, cognitive, emotional, and family factors with participation following TBI. It was hypothesized that resilience would make an independent contribution to participation outcomes after TBI. Participants included 245 individuals with mild-severe TBI [M-age = 44.41, SDage = 16.09; post traumatic amnesia (PTA) duration M 24.95 days, SD 45.99] who completed the Participation Assessment with Recombined Tools-Objective (PART-O), TBI Quality of Life Resilience scale, Family Assessment Device General Functioning Scale, Rey Auditory Verbal Learning Test, National Adult Reading Test, and Hospital Anxiety and Depression Scale an average 4.63 years post-injury (SD 3.02, R 0.5-13). Multiple regression analyses were used to examine predictors of PART-O scores as the participation measure. Variables in the model accounted for a significant 38% of the variability in participation outcomes, F-(13,F- 211) = 9.93, p < 0.05, R-2 = 0.38, adjusted R-2 = 0.34. Resilience was a significant predictor of higher participation, along with shorter PTA duration, more years since injury, higher education and IQ, and younger age. Mediation analyses revealed depression mediated the relationship between resilience and participation. As greater resilience may protect against depression and enhance participation this may be a focus of intervention.	[Wardlaw, Carla; Hicks, Amelia J.; Ponsford, Jennie L.] Monash Univ, Monash Epworth Rehabil Res Ctr, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Hicks, AJ (corresponding author), Monash Univ, Monash Epworth Rehabil Res Ctr, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.	amelia.hicks@monash.edu	Hicks, Amelia/AAQ-7743-2020	Hicks, Amelia/0000-0002-1152-0576	Institute for Safety, Compensation and Recovery Research	This work was supported by the Institute for Safety, Compensation and Recovery Research.	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN, P55; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bonanno GA, 2008, HEALTH PSYCHOL, V27, P659, DOI 10.1037/0278-6133.27.5.659; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CALLAHAN CD, 1994, J CLIN PSYCHOL MED S, V1, P261, DOI 10.1007/BF01989627; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cook RD, 1982, RESIDUALS INFLUENCE; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Erler K, 2016, ARCH PHYS MED REHAB, V97, pe16, DOI [10.1016/j.apmr.2016.09.042, DOI 10.1016/J.APMR.2016.09.042]; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; GEFFEN GM, 1994, ARCH CLIN NEUROPSYCH, V9, P303, DOI 10.1016/0887-6177(94)90018-3; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hayes A., 2016, PROCESS V2 16; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Jose P., 2013, DOING STAT MEDIATION; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2018, BRAIN INJURY, V32, P963, DOI 10.1080/02699052.2018.1468577; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; MacDonald RR, 2002, BRIT J MATH STAT PSY, V55, P193; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; Marwitz JH, 2018, ARCH PHYS MED REHAB, V99, P264, DOI 10.1016/j.apmr.2017.06.013; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; National Institute of Neurological Disorders and Stroke, 2017, COMM DAT EL TBI; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Parent MC, 2013, COUNS PSYCHOL, V41, P568, DOI 10.1177/0011000012445176; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Ridenour TA, 1999, FAM PROCESS, V38, P497, DOI 10.1111/j.1545-5300.1999.00497.x; Robottom BJ, 2012, PARKINSONISM RELAT D, V18, P174, DOI 10.1016/j.parkreldis.2011.09.021; Ruddle Jean Jean, 2011, SOCIAL CARE NEURODIS, V2, P200, DOI [10.1108/20420911111188452, DOI 10.1108/20420911111188452]; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Schipper K, 2011, BRAIN INJURY, V25, P832, DOI 10.3109/02699052.2011.589796; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schonberger M, 2007, PREDICTION EMPLOYMEN; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Senathi-Raja D, 2009, J REHABIL MED, V41, P666, DOI 10.2340/16501977-0396; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, pE17, DOI 10.1097/HTR.0000000000000290; Shin JI, 2012, ANN REHABIL MED-ARM, V36, P815, DOI 10.5535/arm.2012.36.6.815; Sigurdardottir S, 2014, BRAIN INJURY, V28, P1542, DOI 10.3109/02699052.2014.934285; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	109	20	20	0	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 16	2018	9								563	10.3389/fneur.2018.00563			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GN1KI	WOS:000438748300001	30061858	gold, Green Published			2022-02-06	
J	Bird, CW; Taylor, DH; Pinkowski, NJ; Chavez, GJ; Valenzuela, CF				Bird, Clark W.; Taylor, Devin H.; Pinkowski, Natalie J.; Chavez, G. Jill; Valenzuela, C. Fernando			Long-term Reductions in the Population of GABAergic Interneurons in the Mouse Hippocampus following Developmental Ethanol Exposure	NEUROSCIENCE			English	Article						interneuron; hippocampus; apoptosis; fetal; alcohol; development	PRENATAL ALCOHOL EXPOSURE; TRAUMATIC BRAIN-INJURY; SPECTRUM DISORDERS; DENTATE GYRUS; EXCITATORY ACTIONS; NEURONAL NETWORKS; FETAL; CHILDREN; GABA; MEMORY	Developmental exposure to ethanol leads to a constellation of cognitive and behavioral abnormalities known as Fetal Alcohol Spectrum Disorders (FASDs). Many cell types throughout the central nervous system are negatively impacted by gestational alcohol exposure, including inhibitory, GABAergic interneurons. Little evidence exists, however, describing the long-term impact of fetal alcohol exposure on survival of interneurons within the hippocampal formation, which is critical for learning and memory processes that are impaired in individuals with FASDs. Mice expressing Venus yellow fluorescent protein in inhibitory interneurons were exposed to vaporized ethanol during the third trimester equivalent of human gestation (postnatal days 2-9), and the longterm effects on interneuron numbers were measured using unbiased stereology at P90. In adulthood, interneuron populations were reduced in every hippocampal region examined. Moreover, we found that a single exposure to ethanol at P7 caused robust activation of apoptotic neurodegeneration of interneurons in the hilus, granule cell layer, CA1 and CA3 regions of the hippocampus. These studies demonstrate that developmental ethanol exposure has a long-term impact on hippocampal interneuron survivability, and may provide a mechanism partially explaining deficits in hippocampal function and hippocampus-dependent behaviors in those afflicted with FASDs. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Bird, Clark W.; Taylor, Devin H.; Pinkowski, Natalie J.; Chavez, G. Jill; Valenzuela, C. Fernando] Univ New Mexico, Sch Med, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA		Valenzuela, CF (corresponding author), Dept Neurosci, MSC08 4740,1 Univ New Mexico, Albuquerque, NM 87131 USA.	fvalenzuela@salud.unm.edu		Bird, Clark/0000-0001-7712-6531	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37-AA015614, P50-AA0022534]; UNM's Undergraduate Pipeline Network; University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50AA022534, R37AA015614] Funding Source: NIH RePORTER	Supported by NIH grants R37-AA015614 and P50-AA0022534 (CFV), as well as UNM's Undergraduate Pipeline Network (NJP). Unbiased stereology and fluorescence microscopy was carried out at the University of New Mexico & Cancer Center Fluorescence Microscopy Shared Resource, funded as detailed on: http://hsc.unm.edu/crtc/microscopy/acknowledgement.shtml. We thank Dr. Yuchio Yanagawa at the Department of Genetic and Behavioral Neuroscience at the Gunma University School of Medicine (Maebashi, Japan) for generously providing Venus-VGAT mice.	ANDRADE JP, 1992, HIPPOCAMPUS, V2, P65, DOI 10.1002/hipo.450020109; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; AUTTIRAMO I, 1991, NEUROPEDIATRICS, V22, P59, DOI 10.1055/s-2008-1071418; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Bering R, 1997, EXP BRAIN RES, V115, P423, DOI 10.1007/PL00005712; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.3.CO;2-K; Bird CW, 2017, BEHAV BRAIN RES, V320, P1, DOI 10.1016/j.bbr.2016.11.036; Cellot G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00136; Chasnoff IJ, 2010, J DEV BEHAV PEDIATR, V31, P192, DOI 10.1097/DBP.0b013e3181d5a4e2; Chi P, 2016, BEHAV BRAIN RES, V305, P1, DOI 10.1016/j.bbr.2015.12.040; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen J., 2013, STAT POWER ANAL BEHA; Cumming G, 2012, UNDERSTANDING NEW ST, P2012; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Erturk A, 2014, J NEUROSCI, V34, P1672, DOI 10.1523/JNEUROSCI.3121-13.2014; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Franklin KBJ, 2013, PAXINOS FRANKLINS MO; FREEDMAN R, 1993, J NEUROSCI, V13, P1965; Galindo R, 2005, J NEUROCHEM, V94, P1500, DOI 10.1111/j.1471-4159.2005.03294.x; Galindo R, 2006, ALCOHOL, V40, P111, DOI 10.1016/j.alcohol.2006.11.001; Gulyaeva NV, 2003, J NEUROSCI RES, V73, P853, DOI 10.1002/jnr.10730; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hamilton DA, 2003, BEHAV BRAIN RES, V143, P85, DOI 10.1016/S0166-4328(03)00028-7; Hamilton GF, 2011, BRAIN RES, V1412, P88, DOI 10.1016/j.brainres.2011.07.027; Hedges L.V., 1985, STAT METHODS META AN; Hellemans KGC, 2010, ALCOHOL CLIN EXP RES, V34, P633, DOI 10.1111/j.1530-0277.2009.01132.x; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; JOHANSEN FF, 1993, ACTA NEUROL SCAND, V88, P1; Kajimoto K, 2016, HIPPOCAMPUS, V26, P1078, DOI 10.1002/hipo.22588; Kajimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073788; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; Kodituwakku PW, 2007, NEUROSCI BIOBEHAV R, V31, P192, DOI 10.1016/j.neubiorev.2006.06.020; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Maccaferri G, 2003, TRENDS NEUROSCI, V26, P564, DOI 10.1016/j.tins.2003.08.002; Mattson SN, 2013, ALCOHOL CLIN EXP RES, V37, P517, DOI 10.1111/j.1530-0277.2012.01952.x; Mattson SN, 1996, ALCOHOL CLIN EXP RES, V20, P810, DOI 10.1111/j.1530-0277.1996.tb05256.x; Mattson SN, 1999, J INT NEUROPSYCH SOC, V5, P462, DOI 10.1017/S1355617799555082; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; Miguez HA, 2009, ACTA PSIQUIAT PSICOL, V55, P76; Miki T, 2000, HIPPOCAMPUS, V10, P284, DOI 10.1002/1098-1063(2000)10:3<284::AID-HIPO9>3.0.CO;2-K; Miller MW, 2006, NEUROSCIENCE, V138, P97, DOI 10.1016/j.neuroscience.2005.10.060; Moore DB, 1998, NEUROSCI LETT, V249, P25, DOI 10.1016/S0304-3940(98)00378-4; Moreno MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180873; Morton RA, 2014, JOVE-J VIS EXP, DOI 10.3791/51839; Muller Christina, 2014, Front Synaptic Neurosci, V6, P23, DOI 10.3389/fnsyn.2014.00023; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Thanh NX, 2014, J POPUL THER CLIN PH, V21, pE395; Nirgudkar P, 2016, NEUROSCI LETT, V632, P86, DOI 10.1016/j.neulet.2016.08.039; Noor S, 2017, BRAIN BEHAV IMMUN, V61, P80, DOI 10.1016/j.bbi.2016.12.016; Ogievetsky E, 2017, BIONANOSCIENCE, V7, P151, DOI 10.1007/s12668-016-0334-6; Ognjanovski N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15039; OLBRICH HG, 1985, ANAT EMBRYOL, V173, P105, DOI 10.1007/BF00707308; Olney JW, 2002, NEUROBIOL DIS, V9, P205, DOI 10.1006/nbdi.2001.0475; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Ribak CE, 2007, PROG BRAIN RES, V163, P155, DOI 10.1016/S0079-6123(07)63009-X; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Rodriguez CI, 2016, ALCOHOL CLIN EXP RES, V40, P2134, DOI 10.1111/acer.13175; Rodriguez CI, 2016, BEHAV BRAIN RES; Sadrian B, 2014, NEUROSCIENCE, V280, P204, DOI 10.1016/j.neuroscience.2014.09.008; Savanthrapadian S, 2014, J NEUROSCI, V34, P8197, DOI 10.1523/JNEUROSCI.5433-13.2014; Schiavone S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09202-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shetty AK, 2001, EXP NEUROL, V169, P276, DOI 10.1006/exnr.2001.7668; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; Simmons RW, 2010, ALCOHOL, V44, P371, DOI 10.1016/j.alcohol.2010.02.013; Smiley JF, 2015, ALCOHOL, V49, P571, DOI 10.1016/j.alcohol.2015.04.008; Staples MC, 2015, MOL CELL NEUROSCI, V65, P153, DOI 10.1016/j.mcn.2015.03.008; Stepanichev MY, 2005, NEUROSCIENCE, V136, P579, DOI 10.1016/j.neuroscience.2005.08.010; Topper LA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0382-9; Tunc-Ozcan E, 2017, MOL PSYCHIAT; Uecker A, 1998, AM J MENT RETARD, V103, P12, DOI 10.1352/0895-8017(1998)103<0012:SBNOMI>2.0.CO;2; Uecker A, 1996, NEUROPSYCHOLOGIA, V34, P209, DOI 10.1016/0028-3932(95)00096-8; Valeeva G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00020; Varaschin RK, 2010, J PHARMACOL EXP THER, V334, P191, DOI 10.1124/jpet.109.165027; Varlinskaya EI, 2014, BEHAV BRAIN RES, V261, P106, DOI 10.1016/j.bbr.2013.12.016; Viollet C, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00131; Wang Y, 2009, NEUROSCIENCE, V164, P1031, DOI 10.1016/j.neuroscience.2009.09.010; WEST JR, 1987, ALCOHOL DRUG RES, V7, P423; Wilson DA, 2011, ALCOHOL CLIN EXP RES, V35, P1974, DOI 10.1111/j.1530-0277.2011.01549.x; Wu JY, 1997, PEPTIDES, V18, P1131, DOI 10.1016/S0196-9781(97)00146-0	89	20	20	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 15	2018	383						60	73		10.1016/j.neuroscience.2018.05.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GI7RO	WOS:000434699900006	29753864	Green Accepted			2022-02-06	
J	Allen, RS; Motz, CT; Feola, A; Chesler, KC; Haider, R; Rao, SR; Skelton, LA; Fliesler, SJ; Pardue, MT				Allen, Rachael S.; Motz, Cara T.; Feola, Andrew; Chesler, Kyle C.; Haider, Raza; Rao, Sriganesh Ramachandra; Skelton, Lara A.; Fliesler, Steven J.; Pardue, Machelle T.			Long-Term Functional and Structural Consequences of Primary Blast Overpressure to the Eye	JOURNAL OF NEUROTRAUMA			English	Article						blast; electroretinogram; optomotor response; retina; visual function	TRAUMATIC BRAIN-INJURY; INDUCED OCULAR TRAUMA; FIBRILLARY ACIDIC PROTEIN; VISUAL FUNCTION; MOUSE MODEL; PROGESTERONE TREATMENT; RETINAL INJURY; DYSFUNCTION; ELECTRORETINOGRAM; DAMAGE	Acoustic blast overpressure (ABO) injury in military personnel and civilians is often accompanied by delayed visual deficits. However, most animal model studies dealing with blast-induced visual defects have focused on short-term (1 month) changes. Here, we evaluated long-term (8 months) retinal structure and function deficits in rats with ABO injury. Adult male Long-Evans rats were subjected to ABO from a single blast (approximately 190 dB SPL, approximate to 63kPa, @80 psi), generated by a shock tube device. Retinal function (electroretinography; ERG), visual function (optomotor response), retinal thickness (spectral domain-optical coherence tomography; SD-OCT), and spatial cognition/exploratory motor behavior (Y-maze) were measured at 2, 4, 6, and 8 months post-blast. Immunohistochemical analysis of glial fibrillary acidic protein (GFAP) in retinal sections was performed at 8 months post-blast. Electroretinogram a- and b-waves, oscillatory potentials, and flicker responses showed greater amplitudes with delayed implicit times in both eyes of blast-exposed animals, relative to controls. Contrast sensitivity (CS) was reduced in both eyes of blast-exposed animals, whereas spatial frequency (SF) was decreased only in ipsilateral eyes, relative to controls. Total retinal thickness was greater in both eyes of blast-exposed animals, relative to controls, due to increased thickness of several retinal layers. Age, but not blast exposure, altered Y-maze outcomes. GFAP was greatly increased in blast-exposed retinas. ABO exposure resulted in visual and retinal changes that persisted up to 8 months post-blast, mimicking some of the visual deficits observed in human blast-exposed patients, thereby making this a useful model to study mechanisms of injury and potential treatments.	[Allen, Rachael S.; Motz, Cara T.; Feola, Andrew; Haider, Raza; Pardue, Machelle T.] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Atlanta, GA USA; [Allen, Rachael S.; Feola, Andrew; Chesler, Kyle C.; Pardue, Machelle T.] Georgia Inst Technol, Biomed Engn, Atlanta, GA 30332 USA; [Rao, Sriganesh Ramachandra; Fliesler, Steven J.] SUNY Univ Buffalo, Ophthalmol Biochem & Neurosci Program, Buffalo, NY USA; [Skelton, Lara A.; Fliesler, Steven J.] VA Western NY Healthcare Syst, Res Serv, Buffalo, NY USA		Pardue, MT (corresponding author), Atlanta VA Ctr Visual & Neurocognit Rehabil, Res Serv Oph 151, 1670 Clairmont Rd, Decatur, GA 30033 USA.	machelle.pardue@bme.gatech.edu	Feola, Andrew/ABC-3476-2020; Fliesler, Steven J./AAE-9243-2020; Ramachandra Rao, Sriganesh/AAW-1354-2021	Feola, Andrew/0000-0002-7914-989X; Ramachandra Rao, Sriganesh/0000-0003-1029-1051	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 EY006360]; NCATS Clinical and Translational Science Award [1UL1 TR001358]; Department of Veterans Affairs (BLR&D Service Merit Award)US Department of Veterans Affairs [1I01 BX002439]; BLR&D Service Research Career Scientist Award; RR&D Service Research Career Scientist Award [C9257]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY006360] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK1RX002111, I01BX002439] Funding Source: NIH RePORTER	This work was supported, in part, by grants from the National Institutes of Health (NIH) (P30 EY006360 to Emory University [MTP], and NCATS Clinical and Translational Science Award 1UL1 TR001358 to the University at Buffalo [SJF]), and from the Department of Veterans Affairs (BLR&D Service Merit Award 1I01 BX002439 [SJF& BLR&D Service Research Career Scientist Award [SJF]; and RR&D Service Research Career Scientist Award [C9257; MTP]).	Allen RS, 2016, RESTOR NEUROL NEUROS, V34, P947, DOI 10.3233/RNN-160672; Allen RS, 2015, INVEST OPHTH VIS SCI, V56, P2880, DOI 10.1167/iovs.14-16070; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Balcer LJ, 2010, NEUROLOGY, V74, pS16, DOI 10.1212/WNL.0b013e3181dbb664; Behrend K, 2007, VISUAL NEUROSCI, V24, P787, DOI 10.1017/S0952523807070691; Bricker-Anthony C, 2017, OPTOMETRY VISION SCI, V94, P20, DOI 10.1097/OPX.0000000000000898; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Coe CD, 2010, OPTOMETRY VISION SCI, V87, P604, DOI 10.1097/OPX.0b013e3181e61bc0; Cunha-Vaz J, 2017, OPHTHALMOLOGICA, V237, P1, DOI 10.1159/000455809; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fernandez-Bueno I, 2017, INVEST OPHTH VIS SCI, V58, P4925, DOI 10.1167/iovs.17-21742; Emberti Gialloreti L, 2014, J AUTISM DEV DISORD, V44, P873, DOI 10.1007/s10803-013-1939-z; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guley N.M., 2016, THESIS; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Haan M, 2012, NEUROLOGY, V78, P942, DOI 10.1212/WNL.0b013e31824d9655; Hart S, 2013, INVEST OPHTH VIS SCI, V54; Hernandez-Ramirez E, 2017, CELL PHYSIOL BIOCHEM, V42, P2353, DOI 10.1159/000480007; HEYWOD CA, 1988, EXP BRAIN RES, V70, P513; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; JENKINS TCA, 1990, BRIT J OPHTHALMOL, V74, P681, DOI 10.1136/bjo.74.11.681; Jiang YD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-96; Jones K, 2016, J NEUROTRAUM, V33, P1194, DOI 10.1089/neu.2015.4022; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Kupenova P, 2008, VISION RES, V48, P882, DOI 10.1016/j.visres.2008.01.003; Lavoie J, 2014, PROG NEURO-PSYCHOPH, V48, P129, DOI 10.1016/j.pnpbp.2013.09.020; Lee JY, 2014, J PARKINSON DIS, V4, P197, DOI 10.3233/JPD-130306; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; MAURICE T, 1995, BEHAV PHARMACOL, V6, P167; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Moller A, 2003, VISUAL NEUROSCI, V20, P535, DOI 10.1017/S0952523803205071; Moore-Dotson JM, 2016, INVEST OPHTH VIS SCI, V57, P1418, DOI 10.1167/iovs.15-17999; Newman AJ, 2015, J NEUROSCI METH, V242, P82, DOI 10.1016/j.jneumeth.2015.01.009; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421; Polo V, 2017, EYE, V31, P1034, DOI 10.1038/eye.2017.23; POURCHO RG, 1983, J COMP NEUROL, V219, P25, DOI 10.1002/cne.902190104; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Sakai T, 2009, INVEST OPHTH VIS SCI, V50, P4402, DOI 10.1167/iovs.09-3458; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yin T.C., 2016, ENEURO, P3; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	78	20	20	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2104	2116		10.1089/neu.2017.5394		JUL 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000437229600001	29648979	Green Published			2022-02-06	
J	Lyons, DN; Vekaria, H; Macheda, T; Bakshi, V; Powell, DK; Gold, BT; Lin, AL; Sullivan, PG; Bachstetter, AD				Lyons, Danielle N.; Vekaria, Hemendra; Macheda, Teresa; Bakshi, Vikas; Powell, David K.; Gold, Brian T.; Lin, Ai-Ling; Sullivan, Patrick G.; Bachstetter, Adam D.			A Mild Traumatic Brain Injury in Mice Produces Lasting Deficits in Brain Metabolism	JOURNAL OF NEUROTRAUMA			English	Article						arterial spin labeling; biomarkers; concussion; magnetic resonance spectroscopy; mitochondria	CEREBRAL-BLOOD-FLOW; MITOCHONDRIAL BIOENERGETICS; MOUSE MODEL; SYNAPTIC MITOCHONDRIA; DAMAGE; DYSFUNCTION; CONCUSSION	Metabolic uncoupling has been well-characterized during the first minutes-to-days after a traumatic brain injury (TBI), yet mitochondrial bioenergetics during the weeks-to-months after a brain injury is poorly defined, particularly after a mild TBI. We hypothesized that a closed head injury (CHI) would be associated with deficits in mitochondrial bioenergetics at one month after the injury. A significant decrease in state-III (adenosine triphosphate production) and state-V (complex-I) driven mitochondrial respiration was found at one month post-injury in adult C57Bl/6J mice. Isolation of synaptic mitochondria demonstrated that the deficit in state-III and state-V was primarily neuronal. Injured mice had a temporally consistent deficit in memory recall at one month post-injury. Using proton magnetic resonance spectroscopy (H-1 MRS) at 7-Tesla, we found significant decreases in phosphocreatine, N-Acetylaspartic acid, and total choline. We also found regional variations in cerebral blood flow, including both hypo- and hyperperfusion, as measured by a pseudocontinuous arterial spin labeling MR sequence. Our results highlight a chronic deficit in mitochondrial bioenergetics associated with a CHI that may lead toward a novel approach for neurorestoration after a mild TBI. MRS provides a potential biomarker for assessing the efficacy of candidate treatments targeted at improving mitochondrial bioenergetics.	[Lyons, Danielle N.; Vekaria, Hemendra; Macheda, Teresa; Sullivan, Patrick G.; Bachstetter, Adam D.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Lyons, Danielle N.; Vekaria, Hemendra; Macheda, Teresa; Powell, David K.; Gold, Brian T.; Sullivan, Patrick G.; Bachstetter, Adam D.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Powell, David K.] Univ Kentucky, Dept Biomed Engn, Lexington, KY 40536 USA; [Bakshi, Vikas; Lin, Ai-Ling] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Bakshi, Vikas; Lin, Ai-Ling] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA		Bachstetter, AD (corresponding author), Univ Kentucky, Coll Med, 741 S Limestone St, Lexington, KY 40536 USA.	adam.bachstetter@uky.edu	Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235	Kentucky Spinal and Head Injury Trust trainee fellowship; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00 AG044445, P30 GM110787]; University of Kentucky; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [I01BX003405]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM110787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R00AG044445, R01AG054459] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	The corresponding author, Adam Bachstetter, PhD, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. DNL was supported in part by a Kentucky Spinal and Head Injury Trust trainee fellowship. Research reported in this publication was supported by National Institutes of Health under award numbers R00 AG044445 (ADB) and P30 GM110787 (ADB), and pilot grant funding from the University of Kentucky (ADB). This work was supported in part by a Merit Review Award # I01BX003405 to (PGS) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The content is solely the responsibility of the authors and does not represent the official views of the funding organizations.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; CDC, 2003, REP C MILD TRAUM BRA; Deelchand DK, 2015, MAGN RESON MED, V73, P1718, DOI 10.1002/mrm.25295; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Goyal MS, 2017, CELL METAB, V26, P353, DOI 10.1016/j.cmet.2017.07.010; Graaf R. A. d., 2007, IN VIVO NMR SPECTROS; Guo J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00213; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hong X, 2015, MAGN RESON IMAGING, V33, P1098, DOI 10.1016/j.mri.2015.06.010; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Oz G, 2010, J NEUROSCI, V30, P3831, DOI 10.1523/JNEUROSCI.5612-09.2010; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Parikh I, 2016, AGING-US, V8, P2814, DOI 10.18632/aging.101094; Peng SP, 2016, NEURAL REGEN RES, V11, P257, DOI 10.4103/1673-5374.177733; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sosunov SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120456; Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Warach SJ, 2016, STROKE, V47, P1389, DOI 10.1161/STROKEAHA.115.012364; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	59	20	21	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2435	2447		10.1089/neu.2018.5663		JUL 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437231600001	29808778	Green Published, hybrid			2022-02-06	
J	Erler, KS; Whiteneck, GG; Juengst, SB; Locascio, JJ; Bogner, JA; Kaminski, J; Giacino, JT				Erler, Kimberly S.; Whiteneck, Gale G.; Juengst, Shannon B.; Locascio, Joseph J.; Bogner, Jennifer A.; Kaminski, Jamie; Giacino, Joseph T.			Predicting the Trajectory of Participation After Traumatic Brain Injury: A Longitudinal Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; longitudinal studies; rehabilitation; social participation	QUALITY-OF-LIFE; 1ST 5 YEARS; COMMUNITY INTEGRATION; OUTCOMES; REHABILITATION; DEPRESSION; VALIDITY; SATISFACTION; HEALTH	Objective: To identify factors that predict trajectories of participation over the first 5 years after moderate to severe traumatic brain injury (TBI). Setting: TBI Model System Programs. Participants: Community-dwelling individuals with TBI, 16 years of age or older (n = 1947). Design: Secondary analysis of a prospective, nonrandomly sampled, longitudinal data registry. Main Measures: Participation Assessment with Recombined ToolsObjective (PART-O). Results: Age at injury and FIM Motor score predicted trajectory of participation over the first 5 years after moderate to severe TBI. Older age predicted generally worse participation overall as well as progressively worsening participation over time. Higher FIM Motor raised the predicted participation values, although it reduced the rate of improvement in participation scores over time. FIM Cognitive scores, race, depression, years of education, and living setting did not predict trajectory but did significantly influence participation consistently at all time points. Conclusion: The trajectories of participation over the first 5 years after TBI can be predicted by age at injury and FIM Motor scores. These findings may enhance the ability of rehabilitation professionals to identify individuals at risk for poor participation after TBI and develop targeted interventions for optimizing involvement in life activities.	[Erler, Kimberly S.; Kaminski, Jamie; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 1st Ave, Charlestown, MA 02129 USA; [Whiteneck, Gale G.] Craig Hosp, Res Dept, Englewood, CO USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA; [Locascio, Joseph J.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Erler, KS (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 1st Ave, Charlestown, MA 02129 USA.	kerler@partners.org	Juengst, Shannon B/AAC-5891-2019; Giacino, Joseph/AAF-1952-2021	Juengst, Shannon B/0000-0003-4709-545X; Giacino, Joseph/0000-0002-7916-9698	Harvard Catalyst; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL1 TR001102]; Harvard University; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0034, 90DP0039, 90DP0040, 90DP0041]	This work was conducted with support from Harvard Catalyst. The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.; This work was conducted with support from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; grant numbers 90DP0034, 90DP0039, 90DP0040, 90DP0041). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and endorsement by the Federal Government should not be assumed.	American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Juengst SB, 2014, AM J PHYS MED REHAB, V93, P1086, DOI 10.1097/PHM.0000000000000163; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Locascio JJ, 2011, DEMENT GER COGN D EX, V1, P330, DOI 10.1159/000330228; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; National Institute of Neurological Disorders and Stroke, 2016, NINDS COMM DAT EL HA; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; World Health Organization, 2007, INT CLASS FUNCT DIS	40	20	20	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					257	265		10.1097/HTR.0000000000000383			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900012	29385019				2022-02-06	
J	Irvine, KA; Clark, JD				Irvine, Karen-Amanda; Clark, J. David			Chronic Pain After Traumatic Brain Injury: Pathophysiology and Pain Mechanisms	PAIN MEDICINE			English	Article						Traumatic Brain Injury; Neuroinflammation; Chronic Pain; Descending Pain Modulation; Neurodegeneration; Epigenetics	POSTTRAUMATIC-STRESS-DISORDER; INFLAMMATION-MEDIATED NEURODEGENERATION; INTERLEUKIN-1 RECEPTOR ANTAGONIST; HISTONE H3 ACETYLATION; SPINAL-CORD-INJURY; HEAD-INJURY; NEUROPATHIC PAIN; PARKINSON DISEASE; EXTRACRANIAL INJURIES; CONCOMITANT INJURIES	Background. Traumatic brain injury refers to a broad range of neurological, cognitive, and emotional factors that result from the application of an external force to the head. Individuals recovering from traumatic brain injury will frequently experience acute and chronic pain. Objective. The objective of this paper is to discuss the pathophysiological changes resulting from traumatic brain injury and how these may be involved in the development and persistence of pain after injury. Methods. We based our review on articles retrieved from the MEDLINE database of references and abstracts on life sciences and biomedical topics (1966 to present) using the search engine PubMed United States National Library of Medicine). The published literature focused on traumatic brain injury and pain. Conclusions. This review presents evidence that pain is common after traumatic brain injury. However, while there are many potential mechanisms explaining this problem such as neuroinflammation, excitotoxicity, and axonal degeneration, we have no clear understanding of which of them contribute in individual patients. The authors highlight the priorities for research that will expand our knowledge and that may lead to the rational design of therapies that both reduce pain and provide optimal overall outcomes after traumatic brain injury.	[Irvine, Karen-Amanda; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, Palo Alto, CA 94304 USA; [Irvine, Karen-Amanda; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol Pain & Perioperat Med, Stanford, CA USA		Irvine, KA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	kairvine@stanford.edu			Department of Veterans AffairsUS Department of Veterans Affairs [RX001776]; Department of DefenseUnited States Department of Defense [MR130295]; Veterans AffairsUS Department of Veterans Affairs [I01RX001776] Funding Source: NIH RePORTER	This material is based on work supported by the Department of Veterans Affairs RX001776 and the Department of Defense, MR130295.	Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Alfano DP, 2006, BRAIN COGNITION, V60, P194; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; ARAKAWA S, 1995, LIFE SCI, V57, P1803, DOI 10.1016/0024-3205(95)02158-F; Bailey Zachary S, 2015, Biomed Sci Instrum, V51, P423; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bali KK, 2014, TRENDS MOL MED, V20, P437, DOI 10.1016/j.molmed.2014.05.006; Baltas I, 1998, J Neurosurg Sci, V42, P85; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Boccard SGJ, 2015, J CLIN NEUROSCI, V22, P1537, DOI 10.1016/j.jocn.2015.04.005; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Cole LJ, 2006, BRAIN, V129, P2957, DOI 10.1093/brain/awl228; Cole LJ, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.10.010; Conte A, 2013, NAT REV NEUROL, V9, P687, DOI 10.1038/nrneurol.2013.224; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cury RG, 2016, EUR J PAIN, V20, P151, DOI 10.1002/ejp.745; Defazio G, 2013, EUR J NEUROL, V20, P1517, DOI 10.1111/ene.12260; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Farber K, 2005, MOL CELL NEUROSCI, V29, P128, DOI 10.1016/j.mcn.2005.01.003; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; ffgen GB, 2014, J NEUROTRAUM, P1202; Frese A, 2006, CLIN J PAIN, V22, P252, DOI 10.1097/01.ajp.0000173020.10483.13; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gassner M, 2009, PAIN, V145, P204, DOI 10.1016/j.pain.2009.06.021; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hunsche S, 2013, STEREOT FUNCT NEUROS, V91, P328, DOI 10.1159/000350024; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Khan N, 2015, MOLECULES, V20, P10657, DOI 10.3390/molecules200610657; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kim SK, 2016, J CLIN INVEST, V126, P1983, DOI 10.1172/JCI82859; Kitisomprayoonkul Wasuwat, 2010, Journal of the Medical Association of Thailand, V93, P594; Klein RC, 2016, J NEUROSCI RES, V94, P579, DOI 10.1002/jnr.23702; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Krause T, 2012, J NEUROL NEUROSUR PS, V83, P776, DOI 10.1136/jnnp-2011-301936; Kumar A, 2015, CLIN J PAIN; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Liang DY, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-59; Liang DY, TBI INDUCED NOCICEPT; Liang LL, 2015, EPIGENOMICS-UK, V7, P235, DOI [10.2217/EPI.14.75, 10.2217/epi.14.75]; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loggia ML, 2015, BRAIN, V138, P604, DOI 10.1093/brain/awu377; Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Manners MT, 2015, FEBS OPEN BIO, V5, P733, DOI 10.1016/j.fob.2015.08.010; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Manresa JAB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100241; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Marmarou A, 2003, ACT NEUR S, V86, P7; Marques A, 2013, NEUROLOGY, V81, P633, DOI 10.1212/WNL.0b013e3182a08d00; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pertovaara A, 2013, EUR J PHARMACOL, V716, P2, DOI 10.1016/j.ejphar.2013.01.067; Petersen KK, 2016, PAIN, V157, P1400, DOI 10.1097/j.pain.0000000000000531; Pizza V, 2011, CNS NEUROL DISORD-DR, V10, P621, DOI 10.2174/187152711796235014; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rauh MJ, 2013, J REHABIL RES DEV, V50, P161, DOI 10.1682/JRRD.2011.11.0212; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Ruff Robert L, 2016, F1000Res, V5, DOI 10.12688/f1000research.9017.1; Ruscheweyh R, 2014, PAIN, V155, P1303, DOI 10.1016/j.pain.2014.04.006; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Segatore M, 1996, J Neurosci Nurs, V28, P28; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Tajerian M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055259; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vardeh D, 2016, J PAIN, V17, pT50, DOI 10.1016/j.jpain.2016.03.001; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willemen HLDM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-143; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yasuno F, 2014, BRAIN COGNITION, V84, P63, DOI 10.1016/j.bandc.2013.11.005; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhou YQ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0607-6; Zhu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091303	181	20	21	4	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	JUL	2018	19	7					1315	1333		10.1093/pm/pnx153			19	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	GT1XV	WOS:000444271900004	29025157	hybrid			2022-02-06	
J	Taylor, AJ; Kim, JH; Ress, D				Taylor, Amanda J.; Kim, Jung Hwan; Ress, David			Characterization of the hemodynamic response function across the majority of human cerebral cortex	NEUROIMAGE			English	Article						Cerebral hemodynamics; fMRI; Neurovascular coupling; Cerebral pathology; Multisensory stimulation	HUMAN VISUAL-CORTEX; SHORT STIMULUS-DURATION; SURFACE-BASED ANALYSIS; EVENT-RELATED FMRI; BLOOD-FLOW; OXYGEN-METABOLISM; BOLD RESPONSE; HUMAN BRAIN; NEGATIVE BOLD; DEFAULT-MODE	A brief (< 4 s) period of neural activation evokes a stereotypical sequence of vascular and metabolic events to create the hemodynamic response function (HRF) measured using functional magnetic resonance imaging (fMRI). Linear analysis of fMRI data requires that the HRF be treated as an impulse response, so the character and temporal stability of the HRF are critical issues. Here, a simple audiovisual stimulus combined with a fast-paced task was used to evoke a strong HRF across a majority, similar to 77%, of cortex during a single scanning session. High spatiotemporal resolution (2-mm voxels, 1.25-s acquisition time) was used to focus HRF measurements specifically on the gray matter for whole brain. The majority of activated cortex responds with positive HRFs, while similar to 27% responds with negative (inverted) HRFs. Spatial patterns of the HRF response amplitudes were found to be similar across subjects. Timing of the initial positive lobe of the HRF was relatively stable across the cortical surface with a mean of 6.1 +/- 0.6 s across subjects, yet small but significant timing variations were also evident in specific regions of cortex. The results provide guidance for linear analysis of fMRI data. More importantly, this method provides a means to quantify neurovascular function across most of the brain, with potential clinical utility for the diagnosis of brain pathologies such as traumatic brain injury.	[Taylor, Amanda J.; Kim, Jung Hwan; Ress, David] Baylor Coll Med, Dept Neurosci Core Adv MRI, Houston, TX 77030 USA		Ress, D (corresponding author), 1 Baylor Plaza S104N, Houston, TX 77030 USA.	ress@bcm.edu		Taylor, Amanda/0000-0002-0947-6297	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HL108143, R01NS095933, K25 HL131997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R21HL108143, K25HL131997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095933] Funding Source: NIH RePORTER	We thank Michael Beauchamp, Elizabeth Halfen, and John Magnotti for providing thoughtful comments and advice. This work was supported by NIH R21HL108143, NIH R01NS095933, and NIH K25 HL131997.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Bonakdarpour B, 2007, NEUROIMAGE, V36, P322, DOI 10.1016/j.neuroimage.2007.02.035; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Buxton RB, 2012, NEUROIMAGE, V62, P953, DOI 10.1016/j.neuroimage.2012.01.012; Carusone LM, 2002, AM J NEURORADIOL, V23, P1222; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis T. L., 1994, SMR 2 ANN M SAN FRAN, P435; Dilharreguy B, 2003, NEUROIMAGE, V19, P1820, DOI 10.1016/S1053-8119(03)00289-1; Drew PJ, 2011, P NATL ACAD SCI USA, V108, P8473, DOI 10.1073/pnas.1100428108; Drysdale PM, 2010, J THEOR BIOL, V265, P524, DOI 10.1016/j.jtbi.2010.05.026; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fransson P, 1999, MAGN RESON IMAGING, V17, P1, DOI 10.1016/S0730-725X(98)00163-5; Friman O, 2003, NEUROIMAGE, V19, P837, DOI 10.1016/S1053-8119(03)00077-6; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gonzalez-Castillo J, 2015, CEREB CORTEX, V25, P4667, DOI 10.1093/cercor/bhu148; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Griffeth VEM, 2011, NEUROIMAGE, V58, P198, DOI 10.1016/j.neuroimage.2011.05.077; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hernandez L, 2002, NEUROIMAGE, V17, P1018, DOI 10.1006/nimg.2001.1017; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hu XP, 2012, NEUROIMAGE, V62, P1103, DOI 10.1016/j.neuroimage.2012.03.005; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; Huppert TJ, 2007, J CEREBR BLOOD F MET, V27, P1262, DOI 10.1038/sj.jcbfm.9600435; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Khan R, 2011, GRAPH MODELS, V73, P313, DOI 10.1016/j.gmod.2010.11.002; Kim J. H., 2013, J CEREB BLOOD FLOW M; Kim JH, 2017, MAGN RESON IMAGING, V39, P53, DOI 10.1016/j.mri.2017.01.019; Kim JH, 2016, NEUROIMAGE, V124, P394, DOI 10.1016/j.neuroimage.2015.08.068; Koide M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/819340; Lin VL, 1999, J CEREBR BLOOD F MET, V19, P853, DOI 10.1097/00004647-199908000-00004; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Pfeuffer J, 2003, NEUROIMAGE, V18, P990, DOI 10.1016/S1053-8119(03)00035-1; Puckett AM, 2014, HUM BRAIN MAPP, V35, P5550, DOI 10.1002/hbm.22569; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ress David, 2009, Front Neuroenergetics, V1, P3, DOI 10.3389/neuro.14.003.2009; Ress D, 2007, NEUROIMAGE, V34, P74, DOI 10.1016/j.neuroimage.2006.08.020; Roc AC, 2006, STROKE, V37, P382, DOI 10.1161/01.STR.0000198807.31299.43; Rombouts SARB, 2005, NEUROIMAGE, V26, P1078, DOI 10.1016/j.neuroimage.2005.03.022; ROSTRUP E, 1995, NMR BIOMED, V8, P41, DOI 10.1002/nbm.1940080109; Scolari M, 2015, CURR OPIN BEHAV SCI, V1, P32, DOI 10.1016/j.cobeha.2014.08.003; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shmuel A., 2003, 9 ANN M ORG HUM BRAI; Siegel JS, 2015, J CEREB BLOOD FLOW M; Siero JCW, 2015, MAGN RESON MED, V73, P2283, DOI 10.1002/mrm.25349; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Steffener J, 2010, NEUROIMAGE, V49, P2113, DOI 10.1016/j.neuroimage.2009.11.014; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TURNER R, 1991, MAGNET RESON MED, V22, P159, DOI 10.1002/mrm.1910220117; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; Vazquez AL, 2008, NEUROIMAGE, V42, P49, DOI 10.1016/j.neuroimage.2008.04.024; Wade AR, 2002, NEURON, V36, P993, DOI 10.1016/S0896-6273(02)01138-8; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	79	20	20	2	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JUN	2018	173						322	331		10.1016/j.neuroimage.2018.02.061			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GD2XB	WOS:000430366000026	29501554	Bronze, Green Accepted			2022-02-06	
J	Salo, RA; Belevich, I; Manninen, E; Jokitalo, E; Grohn, O; Sierra, A				Salo, Raimo A.; Belevich, Ilya; Manninen, Eppu; Jokitalo, Eija; Grohn, Olli; Sierra, Alejandra			Quantification of anisotropy and orientation in 3D electron microscopy and diffusion tensor imaging in injured rat brain	NEUROIMAGE			English	Article							FOURIER-ANALYSIS; MRI; MICROSTRUCTURE; VALIDATION; LIGHT; WHITE; MATTER; TRACTOGRAPHY; DISPERSION	Diffusion tensor imaging (DTI) reveals microstructural features of grey and white matter non-invasively. The contrast produced by DTI, however, is not fully understood and requires further validation. We used serial block-face scanning electron microscopy (SBEM) to acquire tissue metrics, i.e., anisotropy and orientation, using three-dimensional Fourier transform-based (3D-FT) analysis, to correlate with fractional anisotropy and orientation in DTI. SBEM produces high-resolution 3D data at the mesoscopic scale with good contrast of cellular membranes. We analysed selected samples from cingulum, corpus callosum, and perilesional cortex of sham-operated and traumatic brain injury (TBI) rats. Principal orientations produced by DTI and 3D-FT in all samples were in good agreement. Anisotropy values showed similar patterns of change in corresponding DTI and 3D-FT parameters in sham-operated and TBI rats. While DTI and 3D-FT anisotropy values were similar in grey matter, 3D-FT anisotropy values were consistently lower than fractional anisotropy values from DTI in white matter. We also evaluated the effect of resolution in 3D-FT analysis. Despite small angular differences in grey matter samples, lower resolution datasets provided reliable results, allowing for analysis of larger fields of view. Overall, 3D SBEM allows for more sophisticated validation studies of diffusion imaging contrast from a tissue microstructural perspective.	[Salo, Raimo A.; Manninen, Eppu; Grohn, Olli; Sierra, Alejandra] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, POB 1627, FI-70211 Kuopio, Finland; [Belevich, Ilya; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, POB 56, FI-00014 Helsinki, Finland		Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, POB 1627, FI-70211 Kuopio, Finland.	alejandra.sierralopez@uef.fi	Jokitalo, Eija S/C-8375-2009	Jokitalo, Eija S/0000-0002-4159-6934; Manninen, Eppu/0000-0002-9353-6079; Salo, Raimo/0000-0003-3610-236X; Belevich, Ilya/0000-0003-2190-4909; Sierra Lopez, Alejandra/0000-0001-5399-2056	Academy of FinlandAcademy of FinlandEuropean Commission [275453, 298007]	This work was supported by the Academy of Finland (#275453 AS, #298007 OG), and Biocenter Finland and University of Helsinki (IB, EJ, and SBEM imaging). We would like to thank Maarit Pulkkinen for her help with the animal handling, Mervi Lindman and Antti Salminen for help preparing the samples for SBEM, and Dr. Jaakko Paasonen for video editing.	Aggarwal M, 2015, NEUROIMAGE, V105, P198, DOI 10.1016/j.neuroimage.2014.10.053; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Axer M., 2016, FRONT NEUROANAT, V10; Markus A, 2011, NEUROIMAGE, V54, P1091, DOI 10.1016/j.neuroimage.2010.08.075; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Budde MD, 2012, NEUROIMAGE, V63, P1, DOI 10.1016/j.neuroimage.2012.06.042; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chang EH, 2017, NEUROIMAGE, V147, P253, DOI 10.1016/j.neuroimage.2016.11.068; Chang EH, 2017, DATA BRIEF, V10, P438, DOI 10.1016/j.dib.2016.12.018; Chazotte B., 2011, COLD SPRING HARB PRO, V2011; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; Dauguet J, 2007, J NEUROSCI METH, V164, P191, DOI 10.1016/j.jneumeth.2007.04.017; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/NMETH.2476, 10.1038/nmeth.2476]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Jespersen SN, 2012, IEEE T MED IMAGING, V31, P16, DOI 10.1109/TMI.2011.2162099; Josso B, 2005, MECH SYST SIGNAL PR, V19, P1152, DOI 10.1016/j.ymssp.2004.07.005; Khan AR, 2015, NEUROIMAGE, V111, P192, DOI 10.1016/j.neuroimage.2015.01.061; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Lehto LJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3678; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Salo RA, 2017, NEUROIMAGE, V152, P221, DOI 10.1016/j.neuroimage.2017.03.003; Scherrer B, 2016, MAGN RESON MED, V76, P963, DOI 10.1002/mrm.25912; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang H, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.036003; Wang H, 2014, NEUROIMAGE, V100, P395, DOI 10.1016/j.neuroimage.2014.06.032; White NS, 2013, HUM BRAIN MAPP, V34, P327, DOI 10.1002/hbm.21454; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	47	20	21	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 15	2018	172						404	414		10.1016/j.neuroimage.2018.01.087			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GD2WK	WOS:000430364100032	29412154	hybrid, Green Accepted			2022-02-06	
J	Takayama, W; Endo, A; Koguchi, H; Sugimoto, M; Murata, K; Otomo, Y				Takayama, Wataru; Endo, Akira; Koguchi, Hazuki; Sugimoto, Momoko; Murata, Kiyoshi; Otomo, Yasuhiro			The impact of blood type O on mortality of severe trauma patients: a retrospective observational study	CRITICAL CARE			English	Article						ABO blood type; Bleeding; Trauma; Exsanguination; Von Willebrand factor	VON-WILLEBRAND-FACTOR; METAANALYSIS; DISEASE; HEMOSTASIS; SCORE	Background: Recent studies have implicated the differences in the ABO blood system as a potential risk for various diseases, including hemostatic disorders and hemorrhage. In this study, we evaluated the impact of the difference in the ABO blood type on mortality in patients with severe trauma. Methods: A retrospective observational study was conducted in two tertiary emergency critical care medical centers in Japan. Patients with trauma with an Injury Severity Score (ISS) > 15 were included. The association between the different blood types (type O versus other blood types) and the outcomes of all-cause mortality, cause-specific mortalities (exsanguination, traumatic brain injury, and others), ventilator-free days (VFD), and total transfusion volume were evaluated using univariate and multivariate competing-risk regression models. Moreover, the impact of blood type O on the outcomes was assessed using regression coefficients in the multivariate analysis adjusted for age, ISS, and the Revised Trauma Score (RTS). Results: A total of 901 patients were included in this study. The study population was divided based on the ABO blood type: type O, 284 (32%); type A, 285 (32%); type B, 209 (23%); and type AB, 123 (13%). Blood type O was associated with high mortality (28% in patients with blood type O versus 11% in patients with other blood types; p < 0.001). Moreover, this association was observed in a multivariate model (adjusted odds ratio = 2.86, 95% confidence interval 1.84-4.46; p < 0.001). The impact of blood type O on all-cause in-hospital mortality was comparable to 12 increases in the ISS, 1.5 decreases in the RTS, and 26 increases in age. Furthermore, blood type O was significantly associated with higher cause-specific mortalities and shorter VFD compared with the other blood types; however, a significant difference was not observed in the transfusion volume between the two groups. Conclusions: Blood type O was significantly associated with high mortality in severe trauma patients and might have a great impact on outcomes. Further studies elucidating the mechanism underlying this association are warranted to develop the appropriate intervention.	[Takayama, Wataru; Endo, Akira; Otomo, Yasuhiro] Tokyo Med & Dent Univ Hosp Med, Trauma & Acute Crit Care Med Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1130034, Japan; [Koguchi, Hazuki; Sugimoto, Momoko; Murata, Kiyoshi] Matsudo City Hosp, Shock Trauma & Emergency Med Ctr, 4005 Kamihongo, Matsudo, Chiba, Japan		Takayama, W (corresponding author), Tokyo Med & Dent Univ Hosp Med, Trauma & Acute Crit Care Med Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1130034, Japan.	tak2accm@tmd.ac.jp	Endo, Akira/AAL-8535-2021				[Anonymous], 1971, JAMA, V215, P277; Bayan K, 2009, DIGEST DIS SCI, V54, P1029, DOI 10.1007/s10620-008-0446-0; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chauleur C, 2008, J THROMB HAEMOST, V6, P2067, DOI 10.1111/j.1538-7836.2008.03168.x; Dentali F, 2013, SEMIN THROMB HEMOST, V39, P72, DOI 10.1055/s-0032-1329550; Dentali F, 2012, SEMIN THROMB HEMOST, V38, P535, DOI 10.1055/s-0032-1315758; GILL JC, 1987, BLOOD, V69, P1691; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Kruskall MS, 1997, TRANSFUS SCI, V18, P613, DOI 10.1016/S0955-3886(97)90148-X; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Mazzeffi M, 2017, INTENS CARE MED, V43, P275, DOI 10.1007/s00134-016-4568-0; Moeller A, 2001, TRANSFUSION, V41, P56, DOI 10.1046/j.1537-2995.2001.41010056.x; O'Donnell J, 2001, TRANSFUSION MED, V11, P343, DOI 10.1046/j.1365-3148.2001.00315.x; Reilly JP, 2015, CLIN J AM SOC NEPHRO, V10, P1911, DOI 10.2215/CJN.12201214; RUGGERI ZM, 1987, BLOOD, V70, P895; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Sun WJ, 2015, CANCER EPIDEMIOL, V39, P150, DOI 10.1016/j.canep.2014.12.006; Wu O, 2008, J THROMB HAEMOST, V6, P62	19	20	22	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	MAY 2	2018	22								100	10.1186/s13054-018-2022-0			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE6QK	WOS:000431353900001	29716619	Green Published, gold			2022-02-06	
J	Beaulieu-Bonneau, S; St-Onge, F; Blackburn, MC; Banville, A; Paradis-Giroux, AA; Ouellet, MC				Beaulieu-Bonneau, Simon; St-Onge, Frederic; Blackburn, Marie-Claude; Banville, Andree; Paradis-Giroux, Andree-Anne; Ouellet, Marie-Christine			Alcohol and Drug Use Before and During the First Year After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; drug; psychiatric disorders; rehabilitation; substance use; traumatic brain injury	SUBSTANCE-ABUSE; PSYCHIATRIC-DISORDERS; OUTCOMES; HISTORY; PREVALENCE; PATTERNS; MISUSE; RISK	Objectives: To compare individuals with mild and moderate/severe traumatic brain injury (TBI) on alcohol and drug use and substance use disorders before and in the first year post-TBI; to explore sociodemographic and injury-related variables associated with substance use disorders. Participants: A total of 225 adults hospitalized in a level I trauma center after TBI. Design: Observational cohort study with retrospective (pre-TBI) and prospective (4, 8, and 12 months post-TBI) assessments. Main measures:Mini International Neuropsychiatric Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Results: The percentage of participants using alcohol or drug declined shortly after the injury (4 months) but increased closer to preinjury levels by the end of the first year. Post-TBI alcohol use was higher after mild than moderate/severe TBI, but drug use was similar. About 11% of participants met criteria for a substance use disorder in the first year after TBI. Younger age, not being in a relationship, and suspected substance intoxication at the time of TBI were associated with the presence of a post-TBI substance use disorder. Conclusion: Individuals with milder injuries return to alcohol use earlier than those with more severe injuries. Given that substance use may alter recovery, preventive recommendations and systematic follow-ups are warranted regardless of injury severity and access to rehabilitation.	[Beaulieu-Bonneau, Simon; St-Onge, Frederic; Blackburn, Marie-Claude; Banville, Andree; Ouellet, Marie-Christine] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Beaulieu-Bonneau, Simon; St-Onge, Frederic; Paradis-Giroux, Andree-Anne; Ouellet, Marie-Christine] Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada		Beaulieu-Bonneau, S (corresponding author), Ctr Interdisciplinaire Rech Readaptat & Integrat, 525 Boul Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada.	simon.beaulieu-bonneau.1@ulaval.ca		Beaulieu-Bonneau, Simon/0000-0002-9544-5023; Ouellet, Marie-Christine/0000-0003-3477-1893	Fonds de Recherche du Quebec-Sante (FRQ-S) [16375]	This study was supported by a grant from the Fonds de Recherche du Quebec-Sante (FRQ-S; 16375).	Allen DN, 2009, APPL NEUROPSYCHOL, V16, P186, DOI 10.1080/09084280903098687; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 1997, REHAB PSYCHOL, V42, P13; Bryce S, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000091; Butt P, 2011, ALCOHOL HLTH CANADA; Cahalan D, 1969, AM DRINKING PRACTICE, P131; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Grant M., 1992, AUDIT ALCOHOL USE DI; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Leonard EA, 2016, J TRAUMA NURS, V23, P103, DOI 10.1097/JTN.0000000000000194; Ministere de la Sante et des Services Sociaux du Quebec Societe d'assurance Automobile du Quebec, 2005, OR MIN TRAUM CRAN CE; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pagulayan KF, 2016, J NEUROTRAUM, V33, P1390, DOI 10.1089/neu.2015.4071; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Ponsford J, 2012, J HEAD TRAUMA REHAB, V27, P342, DOI 10.1097/HTR.0b013e318265a576; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Statistics Canada, 2012, MENT HLTH PROF CAN C; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Vungkhanching M, 2007, J HEAD TRAUMA REHAB, V22, P167, DOI 10.1097/01.HTR.0000271117.19652.98; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397	48	20	20	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					E51	E60		10.1097/HTR.0000000000000341			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500006	28926484				2022-02-06	
J	Ganau, M; Lavinio, A; Prisco, L				Ganau, Mario; Lavinio, Andrea; Prisco, Lara			Delirium and agitation in traumatic brain injury patients: an update on pathological hypotheses and treatment options	MINERVA ANESTESIOLOGICA			English	Article						Traumatic brain injuries; Delirium; Psychomotor agitation	CRITICALLY-ILL PATIENTS; PLACEBO-CONTROLLED TRIAL; DYSFUNCTION; ATTENTION; PATHOPHYSIOLOGY; DEXMEDETOMIDINE; RECOMMENDATIONS; MANAGEMENT; CONFUSION; SYMPTOMS	Traumatic brain injury (TBI) is a global public health epidemic. It represents the principal cause of death and disability in individuals aged under 35 in the USA. In the subacute phase, severe TBI patients who recover consciousness go through a state of agitation and delirium. However, there is only limited research exploring the characteristics of post-traumatic delirium (PTD) although it is likely to be more frequent than in general Intensive Care Unit (ICU) patients. Evidence suggest the incidence of delirium in non-TBI ICU patients is up to 86%. The exact pathophysiological mechanisms underlying the development and progression of delirium in critically ill patients is still unclear. Many hypotheses have been proposed to play a role: neuroinflammation, neurotransmitter imbalance, structural and functional brain damage. TBI patients are at high risk of post-traumatic cognitive impairment, and up to two thirds of patients who survive TBI develop agitation and delirium which is associated with increased disability and long term cognitive impairment. Recommendation for the treatment of PTD in patients admitted to ICU are not clearly identified. Despite the high prevalence of PTD, the condition often goes misrecognized and attributed . primarily to the injury itself. There is increasing evidence that certain drugs such as antipsychotics can reduce the incidence and severity of delirium, whereas other drugs such as dexmedetomidine and remifentanil are associated with decreased risk of developing delirium in general ICU patients. However, there is a lack of high quality studies exploring treatment strategies for PTD in the acute setting.	[Ganau, Mario] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada; [Ganau, Mario] Univ Toronto, Toronto, ON, Canada; [Lavinio, Andrea] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Prisco, Lara] John Radcliffe Hosp, Neurosci Intens Care Unit, Headley Way, Oxford OX3 9DU, England		Prisco, L (corresponding author), John Radcliffe Hosp, Neurosci Intens Care Unit, Headley Way, Oxford OX3 9DU, England.	lara.prisco@ouh.nhs.uk	Ganau, Mario/AAY-7233-2020; Prisco, Lara/X-9310-2018; Prisco, Lara/I-9267-2019	Ganau, Mario/0000-0002-8676-1147; Prisco, Lara/0000-0001-6727-7870			Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Cerejeira J, 2010, ACTA NEUROPATHOL, V119, P737, DOI 10.1007/s00401-010-0674-1; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Deb S, 1999, AM J PSYCHIAT, V156, P374; Devlin JW, 2011, CRIT CARE, V15, DOI 10.1186/cc10450; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; FLEMINGER S, 2006, COCHRANE DB SYST REV, V18, DOI DOI 10.1002/14651858.CD003299.PUB2; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099; Hawkins KA, 2000, AGGRESS VIOLENT BEH, V5, P147, DOI 10.1016/S1359-1789(98)00033-0; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Hshieh TT, 2008, J GERONTOL A-BIOL, V63, P764, DOI 10.1093/gerona/63.7.764; Hughes CG, 2012, CURR OPIN CRIT CARE, V18, P518, DOI 10.1097/MCC.0b013e328357effa; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Maneewong J, 2017, NEUROPSYCH DIS TREAT, V13, DOI 10.2147/NDT.S128138; Mittal D, 2004, J CLIN PSYCHIAT, V65, P662; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naidech AM, 2016, NEUROCRIT CARE, V24, P397, DOI 10.1007/s12028-015-0210-1; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Page VJ, 2013, LANCET RESP MED, V1, P515, DOI 10.1016/S2213-2600(13)70166-8; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Prisco L, 2012, CRIT CARE, V16, DOI 10.1186/cc11891; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Syrmos N, 2013, CASE REP SURG, V2013, DOI 10.1155/2013/209750; Trzepacz P T, 2000, Semin Clin Neuropsychiatry, V5, P132; Trzepacz PT, 1999, DEMENT GERIATR COGN, V10, P330, DOI 10.1159/000017164; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vasilevskis EE, 2010, CHEST, V138, P1224, DOI 10.1378/chest.10-0466; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Zaal IJ, 2012, DRUGS, V72, P1457, DOI 10.2165/11635520-000000000-00000; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	49	20	21	1	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	MAY	2018	84	5					632	640		10.23736/S0375-9393.18.12294-2			9	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	GU4RZ	WOS:000445273100015	29479930	Green Submitted			2022-02-06	
J	Shang, JL; Cheng, Q; Duan, SJ; Li, L; Jia, LY				Shang, Jin-Lin; Cheng, Qing; Duan, Sheng-Jie; Li, Lu; Jia, Li-Ya			Cognitive improvement following ischemia/reperfusion injury induced by voluntary running-wheel exercise is associated with LncMALAT1-mediated apoptosis inhibition	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						ischemia; reperfusion; spontaneous running-wheel; MALAT1; learning and memory; apoptosis	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; SYNAPTIC PLASTICITY; ENDOTHELIAL-CELLS; NONCODING RNAS; FOCAL ISCHEMIA; EXPRESSION; MALAT1; GENE; RATS	Previous human and animal studies demonstrated that voluntary exercise may improve cognitive function and facilitate neuronal plasticity in ischemia/reperfusion (I/R) models. However, the possible underlying mechanisms remain to be elucidated. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long noncoding RNA (lncRNA), may be associated with the functions and dysfunctions of endothelial cells. The present study investigated whether spontaneous running-wheel (RW) exercise-induced MALAT1 expression changes may be associated with the cognitive improvement of mice following I/R injury. The expression of MALAT1 was evaluated using reverse transcription-quantitative polymerase chain reaction. Artificial MALAT1 and MALAT1 lentiviral mall interfering (siRNA) were used to alter MALAT1 expression levels in vivo. The Morris Water Maze test was performed to evaluate spatial learning and memory retention in the mice. Changes in the apoptotic rates of hippocampal neurons and levels of apoptosis-associated proteins were also detected. The data revealed that MALAT1 increased in the hippocampus of mice in the RW-treated I/R group and that this was associated with neurological, learning and memory improvement, reduced infarction volumes, decreased apoptosis and alterations to expression levels of apoptosis-associated proteins. Following RW training in I/R-injured mice, lentiviral MALAT1 siRNA conduction partially attenuated the protections induced by voluntary RW. However, exogenous MALAT1 treatment increased the protection. The current findings suggested that voluntary RW protected hippocampal neurons from I/R injury and promoted cognitive restoration, which was associated with lncRNA MALAT1-mediated apoptosis inhibition.	[Shang, Jin-Lin; Duan, Sheng-Jie; Li, Lu; Jia, Li-Ya] Changzhi Med Coll, Dept Neurol, Heji Hosp, 271 Taihang East St, Changzhi 046011, Shaanxi, Peoples R China; [Cheng, Qing] Changzhi People Hosp, Dept Geriatr, Changzhi 046011, Shaanxi, Peoples R China		Shang, JL (corresponding author), Changzhi Med Coll, Dept Neurol, Heji Hosp, 271 Taihang East St, Changzhi 046011, Shaanxi, Peoples R China.	jinlinshang139@126.com					Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dharap A, 2011, STROKE, V42, P1105, DOI 10.1161/STROKEAHA.110.598391; Durukan Aysan, 2010, Exp Transl Stroke Med, V2, P2, DOI 10.1186/2040-7378-2-2; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Joo SP, 2013, NEUROSCIENCE, V243, P149, DOI 10.1016/j.neuroscience.2013.03.062; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Kuete V, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0841-y; Lin XM, 2010, CHINESE MED J-PEKING, V123, P1833, DOI 10.3760/cma.j.issn.0366-6999.2010.14.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Miao W, 2016, MOL MED REP, V14, P2582, DOI 10.3892/mmr.2016.5576; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Moghimi M, 2016, IRAN J BASIC MED SCI, V19, P960; Niland Courtney N., 2012, Frontiers in Genetics, V3, P25, DOI 10.3389/fgene.2012.00025; Puthanveetil P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/jcmm.12576; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Thum T, 2014, CIRC RES, V114, P1366, DOI 10.1161/CIRCRESAHA.114.303896; Vaughan L, 2016, AGING NEUROPSYCHOL C, V23, P117, DOI 10.1080/13825585.2015.1058323; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Xin JW, 2017, EXP THER MED, V13, P1225, DOI 10.3892/etm.2017.4095; Xiong XX, 2013, NEUROCHEM INT, V62, P265, DOI 10.1016/j.neuint.2012.11.016; XiYang YB, 2016, MOL NEUROBIOL, V53, P955, DOI 10.1007/s12035-014-9048-3; Yan J, 2016, MOL CLIN ONCOL, V4, P100, DOI 10.3892/mco.2015.657; Zhang J, 2016, EXP NEUROL, V277, P162, DOI 10.1016/j.expneurol.2015.12.014; Zhang Q, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1085-4; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348	38	20	20	0	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2018	41	5					2715	2723		10.3892/ijmm.2018.3484			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GB5HU	WOS:000429095900027	29436629	hybrid, Green Published, Green Submitted			2022-02-06	
J	Tan, HP; Guo, Q; Hua, G; Chen, JX; Liang, JC				Tan, Hong-Ping; Guo, Qiang; Hua, Gang; Chen, Jun-Xi; Liang, Jun-Chao			Inhibition of endoplasmic reticulum stress alleviates secondary injury after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; endoplasmic reticulum stress; apoptosis; mitochondria; reactive oxygen species; unfolded protein response; secondary brain injury; salubrinal; neural regeneration	OXIDATIVE STRESS; ER STRESS; MITOCHONDRIAL DYSFUNCTION; INDUCED APOPTOSIS; NEURONAL INJURY; CELL-DEATH; DAMAGE; ACTIVATION; RATS; PROTECTS	Apoptosis after traumatic brain injury has been shown to be a major factor influencing prognosis and outcome. Endoplasmic reticulum stress may be involved in mitochondrial mediated neuronal apoptosis. Therefore, endoplasmic reticulum stress has become an important mechanism of secondary injury after traumatic brain injury. In this study, a rat model of traumatic brain injury was established by lateral fluid percussion injury. Fluorescence assays were used to measure reactive oxygen species content in the cerebral cortex. Western blot assays were used to determine expression of endoplasmic reticulum stress-related proteins. Hematoxylin-eosin staining was used to detect pathological changes in the cerebral cortex. Transmission electron microscopy was used to measure ultrastructural changes in the endoplasmic reticulum and mitochondria. Our results showed activation of the endoplasmic reticulum stress-related unfolded protein response. Meanwhile, both the endoplasmic reticulum stress response and mitochondrial apoptotic pathway were activated at different stages post-traumatic brain injury. Furthermore, pretreatment with the endoplasmic reticulum stress inhibitor, salubrinal (1 mg/kg), by intraperitoneal injection 30 minutes before injury significantly inhibited the endoplasmic reticulum stress response and reduced apoptosis. Moreover, salubrinal promoted recovery of mitochondrial function and inhibited activation of the mitochondrial apoptotic pathway post-traumatic brain injury. These results suggest that endoplasmic reticulum stress might be a key factor for secondary brain injury post-traumatic brain injury.	[Tan, Hong-Ping; Liang, Jun-Chao] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Tan, Hong-Ping; Guo, Qiang; Hua, Gang; Chen, Jun-Xi] Guangdong Sanjiu Brain Hosp, Dept Epilepsy Surg, Guangzhou, Guangdong, Peoples R China; [Tan, Hong-Ping; Liang, Jun-Chao] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China		Liang, JC (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.; Liang, JC (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.	liangjc_n@163.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Burton GJ, 2017, PLACENTA, V52, P146, DOI 10.1016/j.placenta.2016.04.001; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Choi JH, 2010, EXP MOL MED, V42, P811, DOI 10.3858/emm.2010.42.12.084; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Go BS, 2017, MOL NEUROBIOL, V54, P4041, DOI 10.1007/s12035-016-9969-0; Gulyaeva NV, 2015, J NEUROCHEM, V132, P263, DOI 10.1111/jnc.13016; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jin M, 2015, NEURAL REGEN RES, V10, P1830, DOI 10.4103/1673-5374.170313; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111083; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lopez-Hernandez B, 2015, BRIT J PHARMACOL, V172, P2838, DOI 10.1111/bph.13095; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; Matsuoka M, 2015, INT J MOL SCI, V16, P16275, DOI 10.3390/ijms160716275; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Placido AI, 2017, MOL NEUROBIOL, V54, P154, DOI 10.1007/s12035-015-9640-1; Raghubir R, 2011, METHOD ENZYMOL, V489, P259, DOI 10.1016/B978-0-12-385116-1.00015-7; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sophonnithiprasert T, 2017, ONCOL LETT, V13, P119, DOI 10.3892/ol.2016.5381; Sun GZ, 2016, NEURAL REGEN RES, V11, P1260, DOI 10.4103/1673-5374.189190; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Xue FX, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00049; Xue LX, 2017, NEURAL REGEN RES, V12, P779, DOI 10.4103/1673-5374.206649; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yi G, 2017, ONCOTARGET, V8, P40741, DOI 10.18632/oncotarget.16580; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; Zhang JC, 2015, SHOCK, V44, P65, DOI 10.1097/SHK.0000000000000367; Zhou XM, 2014, J NEUROSCI RES, V92, P714, DOI 10.1002/jnr.23359	39	20	20	0	7	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2018	13	5					827	836		10.4103/1673-5374.232477			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GI1LE	WOS:000434131200020	29863013	gold, Green Published			2022-02-06	
J	Carlson, SW; Saatman, KE				Carlson, Shaun W.; Saatman, Kathryn E.			Central Infusion of Insulin-Like Growth Factor-1 Increases Hippocampal Neurogenesis and Improves Neurobehavioral Function after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; hippocampus; IGF-1; neurogenesis; TBI	CONTROLLED CORTICAL IMPACT; DENTATE GYRUS; IGF-I; NEURONAL DIFFERENTIATION; GRANULE CELLS; ADULT RATS; MOUSE; MEMORY; AKT; PHOSPHORYLATION	Traumatic brain injury (TBI) produces neuronal dysfunction and cellular loss that can culminate in lasting impairments in cognitive and motor abilities. Therapeutic agents that promote repair and replenish neurons post-TBI hold promise in improving recovery of function. Insulin-like growth factor-1 (IGF-1) is a neurotrophic factor capable of mediating neuroprotective and neuroplasticity mechanisms. Targeted overexpression of IGF-1 enhances the generation of hippocampal newborn neurons in brain-injured mice; however, the translational neurogenic potential of exogenously administered IGF-1 post-TBI remains unknown. In a mouse model of controlled cortical impact, continuous intracerebroventricular infusion of recombinant human IGF-1 (hIGF) for 7 days, beginning 15 min post-injury, resulted in a dose-dependent increase in the number of immature neurons in the hippocampus. Infusion of 10 mu g/day of IGF-1 produced detectable levels of hIGF-1 in the cortex and hippocampus and a concomitant increase in protein kinase B activation in the hippocampus. Both motor function and cognition were improved over 7 days post-injury in IGF-1-treated cohorts. Vehicle-treated brain-injured mice showed reduced hippocampal immature neuron density relative to sham controls at 7 days post-injury. In contrast, the density of hippocampal immature neurons in brain-injured mice receiving acute onset IGF-1 infusion was significantly higher than in injured mice receiving vehicle and equivalent to that in sham-injured control mice. Importantly, the neurogenic effect of IGF-1 was maintained with as much as a 6-h delay in the initiation of infusion. These data suggest that central infusion of IGF-1 enhances the generation of immature neurons in the hippocampus, with a therapeutic window of at least 6h post-injury, and promotes neurobehavioral recovery post-TBI.	[Carlson, Shaun W.; Saatman, Kathryn E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B473 Biomed & Biol Res Bldg, Lexington, KY 40536 USA; [Carlson, Shaun W.] Univ Pittsburgh, Dept Neurol Surg, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B473 Biomed & Biol Res Bldg, Lexington, KY 40536 USA.	k.saatman@uky.edu		Carlson, Shaun/0000-0002-1413-5075	Kentucky Spinal Cord and Head Injury Research Trust [KSCHIRT 7-20, 14-12A]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS072302, P30 NS051220, F32 NS090748]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS090748] Funding Source: NIH RePORTER	This work was supported by Kentucky Spinal Cord and Head Injury Research Trust grants KSCHIRT 7-20 and 14-12A and National Institutes of Health grants R01 NS072302, P30 NS051220, and F32 NS090748. The authors thank Sindhu K. Madathil, PhD, and Jennifer Brelsfoard for their assistance in these experiments.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; ADAMO M, 1989, MOL NEUROBIOL, V3, P71, DOI 10.1007/BF02935589; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; BOZYCZKOCOYNE D, 1993, ANN NY ACAD SCI, V692, P311; Brooker GJF, 2000, J NEUROSCI RES, V59, P332, DOI 10.1002/(SICI)1097-4547(20000201)59:3<332::AID-JNR6>3.0.CO;2-2; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; Busiguina S, 2000, NEUROBIOL DIS, V7, P657, DOI 10.1006/nbdi.2000.0311; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; CLEMMONS DR, 1993, ANN NY ACAD SCI, V692, P10; CONTRERAS PC, 1995, J PHARMACOL EXP THER, V274, P1443; Craig MM, 2015, BEHAV NEUROSCI, V129, P643, DOI 10.1037/bne0000081; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Escartin C, 2004, NEUROREPORT, V15, P2251, DOI 10.1097/00001756-200410050-00022; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; GLUCKMAN PD, 1993, ANN NY ACAD SCI, V692, P138; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Guan J, 1996, NEUROREPORT, V7, P632, DOI 10.1097/00001756-199601310-00061; Guan J, 2001, J CEREBR BLOOD F MET, V21, P493, DOI 10.1097/00004647-200105000-00003; Guan J, 2000, BRAIN RES, V859, P286, DOI 10.1016/S0006-8993(00)01988-0; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hatton J, 2006, J NEUROSURG, V105, P843, DOI 10.3171/jns.2006.105.6.843; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McCurdy RD, 2005, EUR J NEUROSCI, V22, P1581, DOI 10.1111/j.1460-9568.2005.04355.x; Mir S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03641-9; Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188; Nagaraja Tavarekere N, 2005, Cerebrospinal Fluid Res, V2, P5, DOI 10.1186/1743-8454-2-5; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Pardridge W.M, 1991, PEPTIDE DRUG DELIVER; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Perez-Martin M, 2003, EUR J NEUROSCI, V18, P923, DOI 10.1046/j.1460-9568.2003.02830.x; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rubovitch V, 2011, NEUROCHEM INT, V58, P443, DOI 10.1016/j.neuint.2011.01.009; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; RUDICK RA, 1982, J NEUROSCI METH, V6, P253, DOI 10.1016/0165-0270(82)90088-7; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SARA VR, 1988, PROG BRAIN RES, V73, P87; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Song Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32095; Stewart-Wallace AM, 1939, BRAIN, V62, P426, DOI 10.1093/brain/62.4.426; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Suto T, 2014, PAIN, V155, P1935, DOI 10.1016/j.pain.2014.05.014; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160, DOI 10.1002/jlb.67.2.160; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang J, 2007, J NEUROSCI RES, V85, P1618, DOI 10.1002/jnr.21289; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	96	20	21	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1467	1480		10.1089/neu.2017.5374		APR 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000430445900001	29455576	Green Published			2022-02-06	
J	Herman, P; Stein, A; Gibbs, K; Korsunsky, I; Gregersen, P; Bloom, O				Herman, Paige; Stein, Adam; Gibbs, Katie; Korsunsky, Ilya; Gregersen, Peter; Bloom, Ona			Persons with Chronic Spinal Cord Injury Have Decreased Natural Killer Cell and Increased Toll-Like Receptor/Inflammatory Gene Expression	JOURNAL OF NEUROTRAUMA			English	Article						genomics; human studies; inflammation; spinal cord injury	ELEVATED CIRCULATING LEVELS; MIGRATION INHIBITORY FACTOR; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; SYSTEMIC INFLAMMATION; IMMUNE SUPPRESSION; INNATE IMMUNITY; NK CELLS; DEFICIENCY; BIOMARKERS	Infections are the leading cause of death for individuals with traumatic spinal cord injury (SCI). Along with increased infection rates, inflammation is often also observed in persons with chronic SCI. Together, immunological changes post-SCI are also poised to impede neurological recovery and mediate common medical consequences of SCI, including atherogenesis and neuropathic pain. The molecular mechanisms contributing to increased infection susceptibility and inflammation in persons living with SCI are poorly understood. Here, we used tools of functional genomics to perform a pilot study to compare whole-blood gene expression in individuals with chronic SCI (1 year from initial injury; N=31) and uninjured individuals (N=26). We identified 1815 differentially expressed genes in all SCI participants and 2226 differentially expressed genes in persons with SCI rostral to thoracic level 5, compared to uninjured participants. This included marked downregulation of natural killer cell genes and upregulation of the proinflammatory Toll-like receptor signaling pathway. These data provide novel mechanistic insights into the causes underlying the symptoms of immune dysfunction in individuals living with SCI.	[Herman, Paige; Gibbs, Katie; Bloom, Ona] Northwell Hlth, Feinstein Inst Med Res, Hempstead, NY USA; [Stein, Adam; Gibbs, Katie; Bloom, Ona] Northwell Hlth, Zucker Sch Med, Dept Phys Med & Rehabil, Hempstead, NY USA; [Korsunsky, Ilya; Gregersen, Peter] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Gregersen, Peter; Bloom, Ona] Northwell Hlth, Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA; [Herman, Paige] SUNY Downstate Sch Med, Brooklyn, NY USA; [Korsunsky, Ilya] Harvard Med Sch, Broad Inst, Brigham & Womens Hosp, Dept Med, Cambridge, MA USA		Bloom, O (corresponding author), Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Phys Med & Rehabil Mol Med, Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	obloom@northwell.edu		BLOOM, ONA/0000-0002-8340-2392	Craig H. Neilsen Foundation; NY State Empire Clinical Research Program; NY State Spinal Cord Injury Research Board; Northwell Health	We thank the participants for enabling this study. We thank Cassandra Pond for outstanding technical assistance. Support was provided by the Craig H. Neilsen Foundation, the NY State Empire Clinical Research Program (grants to O.B.), the NY State Spinal Cord Injury Research Board (grants to OB), and Northwell Health.	Adib-Conquy M, 2014, IMMUNOL CELL BIOL, V92, P256, DOI 10.1038/icb.2013.99; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Bank M, 2015, ARCH PHYS MED REHAB, V96, P633, DOI 10.1016/j.apmr.2014.10.021; Bauman W A, 2000, Phys Med Rehabil Clin N Am, V11, P109; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bauman WA, 1999, SPINAL CORD, V37, P601, DOI 10.1038/sj.sc.3100911; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Campagnolo DI, 2008, SPINAL CORD, V46, P477, DOI 10.1038/sc.2008.4; CAMPAGNOLO DI, 1994, AM J PHYS MED REHAB, V73, P387, DOI 10.1097/00002060-199411000-00003; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Church JS, 2016, J NEUROSCI, V36, P6352, DOI 10.1523/JNEUROSCI.0353-16.2016; Darwiche SS, 2013, J TRAUMA ACUTE CARE, V74, P1454, DOI 10.1097/TA.0b013e3182905ed2; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; Didangelos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21607; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Frost F, 2005, ARCH PHYS MED REHAB, V86, P312, DOI 10.1016/j.apmr.2004.02.009; Gao M, 2011, SHOCK, V36, P228, DOI 10.1097/SHK.0b013e318225b29a; Garshick E, 2011, PM&R, V3, P433, DOI 10.1016/j.pmrj.2011.02.003; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kigerl KA, 2018, BRAIN BEHAV IMMUN, V72, P22, DOI 10.1016/j.bbi.2017.11.018; Kigerl KA, 2009, CURR TOP MICROBIOL, V336, P121, DOI 10.1007/978-3-642-00549-7_7; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Kopp MA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-168; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Leicht CA, 2013, EXERC IMMUNOL REV, V19, P144; Li P, 2015, SCI REP-UK, V5, DOI 10.1038/srep10229; Li XQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-62; Lustig A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01027; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; NASH MS, 1994, MED SCI SPORT EXER, V26, P164, DOI 10.1249/00005768-199402000-00006; National Spinal Cord Injury Statistical Center, 2017, FACTS FIG GLANC; National Spinal Cord Injury Statistical Center, 2016, COMPL PUBL VERS; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Papatheodorou A, 2017, J NEUROTRAUM, V34, P746, DOI 10.1089/neu.2016.4596; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Pruss H, 2017, NAT NEUROSCI, V20, P1549, DOI 10.1038/nn.4643; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Sabharwal L, 2014, J BIOCHEM, V156, P299, DOI 10.1093/jb/mvu057; Saltzman JW, 2013, J NEUROTRAUM, V30, P434, DOI 10.1089/neu.2012.2501; Satzer D, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0212-0; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Segal JL, 1997, ARCH PHYS MED REHAB, V78, P44, DOI 10.1016/S0003-9993(97)90008-3; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Souza-Fonseca-Guimaraes F, 2012, CRIT CARE, V16, DOI 10.1186/cc11838; Stein A, 2013, ARCH PHYS MED REHAB, V94, P1498, DOI 10.1016/j.apmr.2013.04.004; Stirling DP, 2014, BRAIN, V137, P707, DOI 10.1093/brain/awt341; Stivers NS, 2017, EXP NEUROL, V294, P1, DOI 10.1016/j.expneurol.2017.04.012; Streijger F, 2017, J NEUROTRAUM, V34, P2054, DOI 10.1089/neu.2016.4879; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Yuan ZQ, 2016, CELL SIGNAL, V28, P158, DOI 10.1016/j.cellsig.2015.12.013; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013; Zimmer P, 2017, EXERC IMMUNOL REV, V23, P66	72	20	20	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	15					1819	1829		10.1089/neu.2017.5519		APR 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GL8IW	WOS:000429203100001	29310515	Green Published, Bronze			2022-02-06	
J	Chung, S; Fieremans, E; Wang, XY; Kucukboyaci, NE; Morton, CJ; Babb, J; Amorapanth, P; Foo, FYA; Novikov, DS; Flanagan, SR; Rath, JF; Lui, YW				Chung, Sohae; Fieremans, Els; Wang, Xiuyuan; Kucukboyaci, Nuri E.; Morton, Charles J.; Babb, James; Amorapanth, Prin; Foo, Farng-Yang A.; Novikov, Dmitry S.; Flanagan, Steven R.; Rath, Joseph F.; Lui, Yvonne W.			White Matter Tract Integrity: An Indicator of Axonal Pathology after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion; kurtosis; mild traumatic brain injury; MRI; white matter tract integrity	DIFFUSION TENSOR; CORPUS-CALLOSUM; KURTOSIS; CONCUSSION; METRICS; QUANTIFICATION; DEMYELINATION; PREDICTORS; MRI	We seek to elucidate the underlying pathophysiology of injury sustained after mild traumatic brain injury (mTBI) using multi-shell diffusion magnetic resonance imaging, deriving compartment-specific white matter tract integrity (WMTI) metrics. WMTI allows a more biophysical interpretation of white matter (WM) changes by describing microstructural characteristics in both intra- and extra-axonal environments. Thirty-two patients with mTBI within 30 days of injury and 21 age- and sex-matched controls were imaged on a 3 Tesla magnetic resonance scanner. Multi-shell diffusion acquisition was performed with five b-values (250-2500sec/mm(2)) along 6-60 diffusion encoding directions. Tract-based spatial statistics (TBSS) was used with family-wise error (FWE) correction for multiple comparisons. TBSS results demonstrated focally lower intra-axonal diffusivity (D-axon) in mTBI patients in the splenium of the corpus callosum (sCC; p < 0.05, FWE-corrected). The area under the curve value for D-axon was 0.76 with a low sensitivity of 46.9% but 100% specificity. These results indicate that D-axon may be a useful imaging biomarker highly specific for mTBI-related WM injury. The observed decrease in D-axon suggests restriction of the diffusion along the axons occurring shortly after injury.	[Chung, Sohae; Fieremans, Els; Wang, Xiuyuan; Morton, Charles J.; Babb, James; Novikov, Dmitry S.; Lui, Yvonne W.] NYU, Sch Med, Ctr Adv Imaging Innovat & Res, Dept Radiol, New York, NY 10016 USA; [Chung, Sohae; Fieremans, Els; Wang, Xiuyuan; Morton, Charles J.; Babb, James; Novikov, Dmitry S.; Lui, Yvonne W.] NYU, Sch Med, Bernard & Irene Schwartz Ctr Biomed Imaging, Dept Radiol, New York, NY USA; [Kucukboyaci, Nuri E.; Amorapanth, Prin; Flanagan, Steven R.; Rath, Joseph F.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Foo, Farng-Yang A.] New York Univ Langone Hlth, Dept Neurol, New York, NY USA		Lui, YW (corresponding author), NYU, Sch Med, Ctr Adv Imaging Innovat & Res, Dept Radiol, New York, NY 10016 USA.	yvonne.lui@nyumc.org	Chung, Sohae/S-9249-2019; Rath, Joseph F./C-4823-2008	Rath, Joseph F./0000-0003-2933-6299; Amorapanth, Prin/0000-0002-4260-7826; Flanagan, Steven/0000-0001-9005-5897; Babb, James/0000-0003-1798-1186; Novikov, Dmitry/0000-0002-4213-3050; Fieremans, Els/0000-0002-1384-8591; Foo, Farng-Yang/0000-0002-5167-9442	National Institutes of Health (NIH), National Institute for Neurological Disorders and Stroke (NINDS) [R01 NS039135-11, R21 NS090349]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051] Funding Source: NIH RePORTER	This work is supported in part by grant funding from the National Institutes of Health (NIH): R01 NS039135-11 and R21 NS090349, National Institute for Neurological Disorders and Stroke (NINDS). This work is also performed under the rubric of the Center for Advanced Imaging Innovation and Research (CAI<SUP>2</SUP>R, www.cai2r.net), a National Institute of Biomedical Imaging and Bioengineering Biomedical Technology Resource Center (NIH P41 EB017183).	Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Centers for Disease Control and Prevention and National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Collier Q, 2015, MAGN RESON MED, V73, P2174, DOI 10.1002/mrm.25351; de Kouchkovsky I, 2016, J NEUROL, V263, P1146, DOI 10.1007/s00415-016-8118-z; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2015, NEUROIMAGE, V118, P334, DOI 10.1016/j.neuroimage.2015.05.061; Guan XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117707; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Reisert M, 2017, NEUROIMAGE, V147, P964, DOI 10.1016/j.neuroimage.2016.09.058; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	42	20	21	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	8					1015	1020		10.1089/neu.2017.5320			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0DM	WOS:000429447100004	29239261	Green Published			2022-02-06	
J	Dressler, D; Bhidayasiri, R; Bohlega, S; Chana, P; Chien, HF; Chung, TM; Colosimo, C; Ebke, M; Fedoroff, K; Frank, B; Kaji, R; Kanovsky, P; Kocer, S; Micheli, F; Orlova, O; Paus, S; Pirtosek, Z; Relja, M; Rosales, RL; Sagastegui-Rodriguez, JA; Schoenle, PW; Shahidi, GA; Timerbaeva, S; Walter, U; Saberi, FA				Dressler, Dirk; Bhidayasiri, Roongroj; Bohlega, Saeed; Chana, Pedro; Chien, Hsin Fen; Chung, Tae Mo; Colosimo, Carlo; Ebke, Markus; Fedoroff, Klemens; Frank, Bernd; Kaji, Ryuji; Kanovsky, Petr; Kocer, Serdar; Micheli, Federico; Orlova, Olga; Paus, Sebastian; Pirtosek, Zvezdan; Relja, Maja; Rosales, Raymond L.; Alberto Sagastegui-Rodriguez, Jose; Schoenle, Paul W.; Shahidi, Gholam Ali; Timerbaeva, Sofia; Walter, Uwe; Saberi, Fereshte Adib			Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy	JOURNAL OF NEUROLOGY			English	Article						Spasticity; Rigidity; Dystonia; Spasms; Contractures; Treatment; Botulinum toxin therapy	LIMB SPASTICITY	Spasticity is a symptom occurring in many neurological conditions including stroke, multiple sclerosis, hypoxic brain damage, traumatic brain injury, tumours and heredodegenerative diseases. It affects large numbers of patients and may cause major disability. So far, spasticity has merely been described as part of the upper motor neurone syndrome or defined in a narrowed neurophysiological sense. This consensus organised by IAB-Interdisciplinary Working Group Movement Disorders wants to provide a brief and practical new definition of spasticity-for the first time-based on its various forms of muscle hyperactivity as described in the current movement disorders terminology. We propose the following new definition system: Spasticity describes involuntary muscle hyperactivity in the presence of central paresis. The involuntary muscle hyperactivity can consist of various forms of muscle hyperactivity: spasticity sensu strictu describes involuntary muscle hyperactivity triggered by rapid passive joint movements, rigidity involuntary muscle hyperactivity triggered by slow passive joint movements, dystonia spontaneous involuntary muscle hyperactivity and spasms complex involuntary movements usually triggered by sensory or acoustic stimuli. Spasticity can be described by a documentation system grouped along clinical picture (axis 1), aetiology (axis 2), localisation (axis 3) and additional central nervous system deficits (axis 4). Our new definition allows distinction of spasticity components accessible to BT therapy and those inaccessible. The documentation sheet presented provides essential information for planning of BT therapy.	[Dressler, Dirk] Hannover Med Sch, Dept Neurol, Movement Disorders Sect, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Bhidayasiri, Roongroj] King Chulalongkorn Mem Hosp, Chulalongkorn Ctr Excellence Parkinsons Dis & Rel, Bangkok, Thailand; [Bohlega, Saeed] King Faisal Specialist Hosp & Res Ctr, Dept Neurol, Riyyad, Saudi Arabia; [Chana, Pedro] Univ Santiago de Chile, Dept Neurol, Santiago, Chile; [Chien, Hsin Fen] Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil; [Chung, Tae Mo] Univ Sao Paulo, Sao Paulo, Brazil; [Colosimo, Carlo] Azienda Osped Santa Maria Terni, Terni, Italy; [Ebke, Markus] Median Klin Bad Salzuflen, Bad Salzuflen, Germany; [Fedoroff, Klemens] Gailtal Klin, Hermagor, Austria; [Frank, Bernd] Helios Klin Leezen, Leezen, Germany; [Kaji, Ryuji] Univ Tokushima, Dept Neurol, Tokushima, Japan; [Kanovsky, Petr] Palacky Univ, Dept Neurol, Olomouc, Czech Republic; [Kocer, Serdar] Hop Jura, Ctr Reeducat & Med Phys, Porrentruy, Switzerland; [Micheli, Federico] Univ Buenos Aires, Hosp Clin Jose de San Martin, Dept Neurol, Buenos Aires, DF, Argentina; [Orlova, Olga] Clin Cecil Plus, Moscow, Russia; [Paus, Sebastian] Rhein Friedrich Wilhelms Univ, Dept Neurol, Bonn, Germany; [Pirtosek, Zvezdan] Univ Ljubljana, Dept Neurol, Med Ctr, Ljubljana, Slovenia; [Relja, Maja] Univ Zagreb, Dept Neurol, Zagreb, Croatia; [Rosales, Raymond L.] Univ Santo Tomas Hosp, Dept Neurol, Manila, Philippines; [Alberto Sagastegui-Rodriguez, Jose] Univ Monterrey, Dept Neurol, Monterrey, Nueva Leon, Mexico; [Schoenle, Paul W.] Maternus Klin Rehabil, Bad Oeynhausen, Germany; [Shahidi, Gholam Ali] Iran Univ Med Sci, Rasoul E Akram Hosp, Dept Neurol, Movement Disorders Clin, Tehran, Iran; [Timerbaeva, Sofia] Minist Hlth & Social Dev Russian Federat, Fed State Hosp Treatment & Rehabil, Moscow, Russia; [Walter, Uwe] Rostock Univ, Dept Neurol, Rostock, Germany; [Saberi, Fereshte Adib] IAB Interdisciplinary Working Grp Movement Disord, Hamburg, Germany		Dressler, D (corresponding author), Hannover Med Sch, Dept Neurol, Movement Disorders Sect, Carl Neuberg Str 1, D-30625 Hannover, Germany.	dressler.dirk@mh-hannover.de	Pirtosek, Zvezdan/AAB-4729-2020; Kocer, Serdar/AAG-2708-2019; Chana, Pedro/ABG-9944-2020; Colosimo, Carlo/AAY-8552-2020; Walter, Uwe/O-4591-2017; Fheodoroff, Klemens/H-6406-2013	Pirtosek, Zvezdan/0000-0002-5495-944X; Chana, Pedro/0000-0001-9946-3299; Colosimo, Carlo/0000-0002-2216-3973; Walter, Uwe/0000-0002-6280-785X; Fheodoroff, Klemens/0000-0002-6508-5055; Shahidi, Gholam Ali/0000-0002-3889-4973	Newton Fund UK; Thailand research fundThailand Research Fund (TRF); Ratchadapisek sompot faculty grant; CU-CLUSTER fund of Chulalongkorn University; Ipsen PharmaIpsen; Merz Pharmaceuticals; AllerganAbbVieAllergan; Merz Pharma	Dressler D: DD received honoraria for services provided to Allergan, Ipsen, Merz, Desitin, Syntaxin, Abbvie, Medtronic, St Jude, Boston Scientific, Almirall, Bayer, Sun, Teva, UCB, IAB-Interdisciplinary Working Group for Movement Disorders. He is shareholder of Allergan and holds patents on botulinum toxin and botulinum toxin therapy. Bhidayasiri R: No conflict of interest to report. Stock Ownership in medically related fields: None. Consultancies: Ipsen Pharmaceuticals. Advisory Boards: Britannia Pharmaceuticals. Honoraria to speak: Novartis, BL Hua, Abbott. Partnerships: None. Grants: Newton Fund UK, Thailand research fund, Ratchadapisek sompot faculty grant and CU-CLUSTER fund of Chulalongkorn University. Intellectual Property Rights: Parkinson's disease laser cane, Tremor analysis algorithm, Nocturnal monitoring device (NIGHT-Recorder). Expert Testimony: None. Employment: Chulalongkorn University. Royalties: Blackwell-Wiley, Humana Publications. Others: None. Bohlega S: Nothing to declare. Chana P: Nothing to declare. Chien S: Nothing to declare. Chung TM: Honoraria from Ipsen, Allergan and Merz to lecture in Symposium, Training Couses and Advisory Board participation. Participation in clinical research from Ipsen. No research funding and no financial interest in Botulinum Toxin. Colosimo C: Consultancies with Zambon, Sunovion, Ipsen and Bial. Royalties from Cambridge University Press and Oxford University Press. Ebke M: Nothing to declare. Fedoroff K: Nothing to declare. Frank B: Nothing to declare. Kaji R: Nothing to declare. Kanovsky P: Nothing to declare. Kocer S: Nothing to declare. Micheli F: Nothing to declare. Orlova O: OO is scientific consultant for Ipsen, Allergan, Merz and Microgen. PausS: SP received research grants and lecturer fees from Ipsen Pharma and Merz Pharmaceuticals. Member of the Advisory Boards of Ipsen Pharma and Merz Pharmaceuticals. Pirtosek Z: Nothing to declare. Relja M: Northing to declare. Rosales RL: RR received advisory, research and travel grants from Ipsen Pharma and lecture and travel grants from Allergan and Merz Pharma. Sagastequi A: AS received honoraria for lecturing from Allergan and Ipsen. Schoenle PW: Nothing to declare. Shahidi G: Nothing to declare. Timerbaeva S: Nothing to declare. Walter U: UW received speaker honoraria and travel reimbursement from Merz Pharma, Ipsen Pharma, Allergan, Bristol-Myers Squibb, Daiichi Sankyo, Bayer Vital and Pfizer, and a research grant from Merz Pharma. Adib Saberi F: FAS received reimbursement from Abbot, Abbvie, Almirall, Allergan, Bayer, Desitin, Dynamed, Hempel GesundheitsPartner, Ipsen, Johnson & Johnson, Licher, Meda, Medtronic, Merz, Orion, PTZ Nawrath, Sensomotorik & Rehabilitation Hellmuth & Thiel, Sintetica, Sporlastic, Sun, Teva, Tricumed, TRS Med, UCB.	Barnes MP, 2008, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY: CLINICAL MANAGEMENT AND NEUROPHYSIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511544866.002; Brashear A, 2016, SPASTICITY: DIAGNOSIS AND MANAGEMENT, SECOND EDITION, P3; Dressler D, 2015, J NEURAL TRANSM, V122, P1573, DOI 10.1007/s00702-015-1425-1; Dressler D, 2000, BOTULINUM TOXIN THER; Dressler D, 2018, TREATMENT D IN PRESS; Dressler D, 2014, J NEURAL TRANSM, V121, P367, DOI 10.1007/s00702-013-1108-8; Dressler D, 2012, CURR OPIN MICROBIOL, V15, P325, DOI 10.1016/j.mib.2012.05.012; Egen-Lappe V, 2013, INT J GEN MED, V6, P135, DOI 10.2147/IJGM.S36030; Gracies JM, 2018, MUSCLE NERVE, V57, P245, DOI 10.1002/mus.25721; Horn LJ, 2016, SPASTICITY: DIAGNOSIS AND MANAGEMENT, SECOND EDITION, P111; Keating GM, 2017, DRUGS, V77, P563, DOI 10.1007/s40265-017-0720-6; Lance J.W., 1980, SPASTICITY DISORDERE, P485; McGuire JR, 2016, SPASTICITY: DIAGNOSIS AND MANAGEMENT, SECOND EDITION, P5; Nalysnyk L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-118; Nathan P W, 1965, J Neurol Sci, V2, P7, DOI 10.1016/0022-510X(65)90060-2; Puligopu AK, 2011, J PEDIATR NEUROSCI, V6, P118, DOI 10.4103/1817-1745.85730; Rosales RL, 2017, BOTULINUM TOXIN THER; Santamato A, 2016, NEUROPSYCH DIS TREAT, V12, DOI 10.2147/NDT.S86978; Sheean Geoffrey, 2003, Expert Rev Neurother, V3, P773, DOI 10.1586/14737175.3.6.773; Sherman SJ, 2000, J NEUROL SCI, V175, P145, DOI 10.1016/S0022-510X(00)00299-9; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; Wissel J, 2017, NEUROLOGY, V88, P1321, DOI 10.1212/WNL.0000000000003789	22	20	24	0	21	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	APR	2018	265	4					856	862		10.1007/s00415-018-8759-1			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB3AV	WOS:000428928200013	29423615				2022-02-06	
J	Wang, P; Lin, CW; Wu, SY; Huang, KL; Wang, Y; Bao, XM; Zhang, F; Huang, ZH; Teng, HL				Wang, Peng; Lin, Chaowei; Wu, Shiyang; Huang, Kelun; Wang, Yu; Bao, Xiaomei; Zhang, Fan; Huang, Zhihui; Teng, Honglin			Inhibition of Autophagy is Involved in the Protective Effects of Ginsenoside Rb1 on Spinal Cord Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Ginsenoside Rb1; Autophagy; Apoptosis	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; UP-REGULATION; CELL-DEATH; MEDIATED AUTOPHAGY; BECLIN 1; APOPTOSIS; NEURONS; RATS; PHOSPHORYLATION	Spinal cord injury (SCI) is a devastating neurological disorder. Autophagy is induced and plays a crucial role in SCI. Ginsenoside Rb1 (Rb1), one of the major active components extracted from Panax Ginseng CA Meyer, has exhibited neuroprotective effects in various neurodegenerative diseases. However, it remains unknown whether autophagy is involved in the neuroprotection of Rb1 on SCI. In this study, we examined the regulation of autophagy following Rb1 treatment and its involvement in the Rb1-induced neuroprotection in SCI and in vitro injury model. Firstly, we found that Rb1 treatment decreased the loss of motor neurons and promoted function recovery in the SCI model. Furthermore, we found that Rb1 treatment inhibited autophagy in neurons, and suppressed neuronal apoptosis and autophagic cell death in the SCI model. Finally, in the in vitro injury model, Rb1 treatment increased the viability of PC12 cells and suppressed apoptosis by inhibiting excessive autophagy, whereas stimulation of autophagy by rapamycin abolished the anti-apoptosis effect of Rb1. Taken together, these findings suggest that the inhibition of autophagy is involved in the neuroprotective effects of Rb1 on SCI.	[Wang, Peng; Lin, Chaowei; Wu, Shiyang; Huang, Kelun; Wang, Yu; Teng, Honglin] Wenzhou Med Univ, Dept Spine Surg, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Peng; Wu, Shiyang; Bao, Xiaomei; Zhang, Fan; Huang, Zhihui] Wenzhou Med Univ, Inst Neurosci, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Peng; Wu, Shiyang; Bao, Xiaomei; Zhang, Fan; Huang, Zhihui] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China		Teng, HL (corresponding author), Wenzhou Med Univ, Dept Spine Surg, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China.; Huang, ZH (corresponding author), Wenzhou Med Univ, Inst Neurosci, Wenzhou 325035, Zhejiang, Peoples R China.; Huang, ZH (corresponding author), Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China.	hzhzju021@163.com; honlinten@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571190, 81371350, 31671071]; Foundation of Zhejiang Educational Committee [Y201636785]	This work was supported by National Natural Science Foundation of China (81571190, 81371350, 31671071), and Foundation of Zhejiang Educational Committee (Y201636785).	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Bisicchia E, 2017, MOL NEUROBIOL, V54, P4896, DOI 10.1007/s12035-016-0031-z; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Chen BY, 2015, NEUROCHEM RES, V40, P531, DOI 10.1007/s11064-014-1498-5; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Chen W, 2016, CELL MOL NEUROBIOL, V36, P1057, DOI 10.1007/s10571-015-0299-y; Cheong CU, 2016, MOLECULES, V21, DOI 10.3390/molecules21070898; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Guo ZS, 2014, J NEUROSCI RES, V92, P1295, DOI 10.1002/jnr.23400; Huang F, 2015, MOL MED REP, V11, P3565, DOI 10.3892/mmr.2015.3162; ISAAC L, 1995, SURG NEUROL, V43, P484, DOI 10.1016/0090-3019(95)80094-W; Jang M, 2016, J PAIN, V17, P282, DOI 10.1016/j.jpain.2015.10.007; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, AUTOPHAGY, V5, P390, DOI 10.4161/auto.5.3.7724; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim SO, 2010, CELL MOL NEUROBIOL, V30, P857, DOI 10.1007/s10571-010-9513-0; Lee MJ, 2016, MOL NEUROBIOL, V53, P1977, DOI 10.1007/s12035-015-9131-4; Lee MS, 2009, J ALZHEIMERS DIS, V18, P339, DOI 10.3233/JAD-2009-1149; Lepine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Lim JH, 1997, NEUROSCI RES, V28, P191, DOI 10.1016/S0168-0102(97)00041-2; Lin CW, 2016, NEUROSCI BULL, V32, P137, DOI 10.1007/s12264-016-0017-x; Luo TF, 2014, INT J MOL SCI, V15, P15426, DOI 10.3390/ijms150915426; Malagelada C, 2006, J NEUROSCI, V26, P9996, DOI 10.1523/JNEUROSCI.3292-06.2006; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Seo JY, 2015, SPINE, V40, P883, DOI 10.1097/BRS.0000000000000845; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Sirbulescu RF, 2010, NEUROSCIENCE, V171, P599, DOI 10.1016/j.neuroscience.2010.09.002; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Wang Z, 2008, CARDIOVASC DRUG THER, V22, P443, DOI 10.1007/s10557-008-6129-4; Xue JF, 2006, BRAIN RES, V1106, P91, DOI 10.1016/j.brainres.2006.05.106; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284; Zhou KL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020466	47	20	22	0	13	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2018	38	3					679	690		10.1007/s10571-017-0527-8			12	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FY3IZ	WOS:000426713900010	28762191				2022-02-06	
J	Streijger, F; So, K; Manouchehri, N; Gheorghe, A; Okon, EB; Chan, RM; Ng, B; Shortt, K; Sekhon, MS; Griesdale, DE; Kwon, BK				Streijger, Femke; So, Kitty; Manouchehri, Neda; Gheorghe, Ana; Okon, Elena B.; Chan, Ryan M.; Ng, Benjamin; Shortt, Katelyn; Sekhon, Mypinder S.; Griesdale, Donald E.; Kwon, Brian K.			A Direct Comparison between Norepinephrine and Phenylephrine for Augmenting Spinal Cord Perfusion in a Porcine Model of Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; compression; MAP; microdialysis; oxygenation; porcine model; spinal cord injury; vasopressor support	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE OXYGENATION; CEREBRAL-BLOOD-FLOW; PRESSURE AUGMENTATION; CORTICAL PERFUSION; DOPAMINE; HEMORRHAGE; MANAGEMENT; SWINE; VALUES	Current clinical guidelines recommend elevating the mean arterial blood pressure (MAP) to increase spinal cord perfusion in patients with acute spinal cord injury (SCI). This is typically achieved with vasopressors such as norepinephrine (NE) and phenylephrine (PE). These drugs differ in their pharmacological properties and potentially have different effects on spinal cord blood flow (SCBF), oxygenation (PO2), and downstream metabolism after injury. Using a porcine model of thoracic SCI, we evaluated how these vasopressors influenced intraparenchymal SCBF, PO2, hydrostatic pressure, and metabolism within the spinal cord adjacent to the injury site. Yorkshire pigs underwent a contusion/compression SCI at T10 and were randomized to receive either NE or PE for MAP elevation of 20 mm Hg, or no MAP augmentation. Prior to injury, a combined SCBF/PO2 sensor, a pressure sensor, and a microdialysis probe were inserted into the spinal cord adjacent to T10 at two locations: a "proximal" site and a "distal" site, 2 mm and 22 mm from the SCI, respectively. At the proximal site, NE and PE resulted in little improvement in SCBF during cord compression. Following decompression, NE resulted in increased SCBF and PO2, whereas decreased levels were observed for PE. However, both NE and PE were associated with a gradual decrease in the lactate to pyruvate (L/P) ratio after decompression. PE was associated with greater hemorrhage through the injury site than that in control animals. Combined, our results suggest that NE promotes better restoration of blood flow and oxygenation than PE in the traumatically injured spinal cord, thus providing a physiological rationale for selecting NE over PE in the hemodynamic management of acute SCI.	[Streijger, Femke; So, Kitty; Manouchehri, Neda; Gheorghe, Ana; Okon, Elena B.; Chan, Ryan M.; Ng, Benjamin; Shortt, Katelyn; Kwon, Brian K.] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Sekhon, Mypinder S.] Univ British Columbia, Vancouver Gen Hosp, Div Crit Care Med, Dept Med, Vancouver, BC, Canada; [Griesdale, Donald E.] Univ British Columbia, Dept Anesthesiol, Vancouver, BC, Canada; [Kwon, Brian K.] Univ British Columbia, Vancouver Spine Surg Inst, Dept Orthopaed, Vancouver, BC, Canada		Kwon, BK (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Orthopaed, Blusson Spinal Cord Ctr, 818 West 10th Ave,6th Floor, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca		Okon, Elena/0000-0001-8568-5771	Wings for Life Spinal Cord Foundation; United States Department of Defense Spinal Cord Injury Research Program; Canada Research Chairs programCanada Research Chairs; VGH & UBC Hospital Foundation	The authors gratefully acknowledge the funding support of the Wings for Life Spinal Cord Foundation, and also the United States Department of Defense Spinal Cord Injury Research Program. Dr. Kwon acknowledges the support of the Canada Research Chairs program and the VGH & UBC Hospital Foundation. The authors also recognize the tremendous support, commitment, and expertise of the staff at the UBC Center for Comparative Medicine (CCM) where these long and complex experiments were performed. These include Dr. Ian Welch (Director), Gordon Gray (Facilities Manager), the clinical veterinarians Dr. Cathy Schuppli, Dr. Shelly McErlane, Dr. Laura Mobrey, Dr. Tamara Godbey, and Dr. Po-Yan Chen, and the amazing team of veterinarian technicians, including Micky Burgess, Kate Cooper, Shanna Dumontier, Kris Gillespie, Rhonda Hildebrandt, Mark Huang, Nicole Jackson, Tina Jorgensen, Stephanie Laprise, Ava McHugh, Kayla Reich, and Belinda To.	Bangash MN, 2012, BRIT J PHARMACOL, V165, P2015, DOI 10.1111/j.1476-5381.2011.01588.x; Brassard P, 2010, J APPL PHYSIOL, V108, P1472, DOI 10.1152/japplphysiol.01206.2009; Catapano JS, 2016, WORLD NEUROSURG, V96, P72, DOI 10.1016/j.wneu.2016.08.053; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Friess SH, 2015, J NEUROTRAUM, V32, P237, DOI 10.1089/neu.2014.3468; Friess SH, 2012, CRIT CARE MED, V40, P2400, DOI 10.1097/CCM.0b013e31825333e6; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Gianotti GC, 2014, ACTA SCI VET, V42; GODDARD J, 1980, J PEDIATR-US, V96, P1057, DOI 10.1016/S0022-3476(80)80641-X; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; KOYAMA K, 1990, PEDIATR NEUROL, V6, P87, DOI 10.1016/0887-8994(90)90039-4; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Lee JHT, 2013, J NEUROTRAUM, V30, P142, DOI 10.1089/neu.2012.2386; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Martirosyan NL, 2011, J NEUROSURG-SPINE, V15, P238, DOI 10.3171/2011.4.SPINE10543; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; Muzevich KM, 2009, NEUROCRIT CARE, V11, P112, DOI 10.1007/s12028-009-9214-z; Nissen P, 2010, NEUROCRIT CARE, V12, P17, DOI 10.1007/s12028-009-9313-x; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Roy B, 2017, CEREBROVASC DIS, V43, P266, DOI 10.1159/000458536; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Schomberg DT, 2017, J NEUROTRAUM, V34, P541, DOI 10.1089/neu.2016.4567; Schomberg DT, 2016, TOXICOL PATHOL, V44, P299, DOI 10.1177/0192623315618292; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Soubeyrand M, 2014, EUR SPINE J, V23, P658, DOI 10.1007/s00586-013-3086-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Strauch JT, 2007, ANN THORAC SURG, V83, P2130, DOI 10.1016/j.athoracsur.2007.01.060; Streijger F, 2016, J NEUROTRAUM, V33, P2217, DOI 10.1089/neu.2016.4456; SWINDLE M. MICHAEL, 2015, SWINE LAB SURG ANEST; Tark BE, 2014, J STROKE CEREBROVASC, V23, P2296, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.018; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; WEI EP, 1975, STROKE, V6, P654, DOI 10.1161/01.STR.6.6.654; Yue J.K., 2017, J NEUROSURG SCI, DOI [10.23736/S0390-561617.04003-6, DOI 10.23736/S0390-561617.04003-6]	47	20	20	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	12					1345	1357		10.1089/neu.2017.5285		MAR 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GJ4ID	WOS:000428574900001	29338544				2022-02-06	
J	Stolp, HB; Ball, G; So, PW; Tournier, JD; Jones, M; Thornton, C; Edwards, AD				Stolp, H. B.; Ball, G.; So, P. -W.; Tournier, J. -D.; Jones, M.; Thornton, C.; Edwards, A. D.			Voxel-wise comparisons of cellular microstructure and diffusion-MRI in mouse hippocampus using 3D Bridging of Optically-clear histology with Neuroimaging Data (3D-BOND)	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; SPHERICAL DECONVOLUTION; DTI MEASURES; TISSUE; RECONSTRUCTION; MICROSCOPY; REGISTRATION; TRACTOGRAPHY; VALIDATION	A key challenge in medical imaging is determining a precise correspondence between image properties and tissue microstructure. This comparison is hindered by disparate scales and resolutions between medical imaging and histology. We present a new technique, 3D Bridging of Optically-clear histology with Neuroimaging Data (3D-BOND), for registering medical images with 3D histology to overcome these limitations. Ex vivo 120 x 120 x 200 mu m resolution diffusion-MRI (dMRI) data was acquired at 7 T from adult C57Bl/6 mouse hippocampus. Tissue was then optically cleared using CLARITY and stained with cellular markers and confocal microscopy used to produce high-resolution images of the 3D-tissue microstructure. For each sample, a dense array of hippocampal landmarks was used to drive registration between upsampled dMRI data and the corresponding confocal images. The cell population in each MRI voxel was determined within hippocampal subregions and compared to MRI-derived metrics. 3D-BOND provided robust voxel-wise, cellular correlates of dMRI data. CA1 pyramidal and dentate gyrus granular layers had significantly different mean diffusivity (p > 0.001), which was related to microstructural features. Overall, mean and radial diffusivity correlated with cell and axon density and fractional anisotropy with astrocyte density, while apparent fibre density correlated negatively with axon density. Astrocytes, axons and blood vessels correlated to tensor orientation.	[Stolp, H. B.; Ball, G.; Tournier, J. -D.; Jones, M.; Thornton, C.; Edwards, A. D.] St Thomas Hosp, Kings Coll London, Sch Biomed Engn & Imaging Sci, Ctr Developing Brain, London SE1 7EH, England; [So, P. -W.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Maurice Wohl Clin Neurosci Inst, Dept Neuroimaging, London SE5 9NU, England; [Ball, G.] Murdoch Childrens Res Inst, Dev Imaging, Clin Sci, Melbourne, Vic 3052, Australia; [Stolp, H. B.] Royal Vet Coll, Dept Comparat Biomed Sci, London NW1 0TU, England		Thornton, C (corresponding author), St Thomas Hosp, Kings Coll London, Sch Biomed Engn & Imaging Sci, Ctr Developing Brain, London SE1 7EH, England.	claire.thornton@kcl.ac.uk	Thornton, Claire/AAF-7481-2019; So, Po-Wah/AAJ-5501-2020	Thornton, Claire/0000-0001-7676-3272; So, Po-Wah/0000-0003-3449-8532; Edwards, Anthony David/0000-0003-4801-7066; Ball, Gareth/0000-0003-3509-1435; Tournier, Jacques-Donald/0000-0001-5591-7383	Department of Perinatal Imaging and Health; King's Health Partners Research & Development Challenge Fund; Medical Research Council, United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre Award to Guy's & St Thomas' NHS Foundation Trust; King's College London and King's College Hospital NHS Foundation Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_16048, MC_PC_15031, MR/K006355/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K006355/1, MC_PC_16048, MC_PC_15031] Funding Source: researchfish	We gratefully acknowledge the support of the Department of Perinatal Imaging and Health, in particular Henrik Hagberg, Pierre Gressens, Jo Hajnal, Paul Aljabar and Serena Counsell for their thoughtful comments and discussions. Financial support for this work was provided by King's Health Partners Research & Development Challenge Fund and the Medical Research Council, United Kingdom. We thank the British Heart Foundation for supporting the 7T MRI scanner (Preclinical Imaging Unit, King's College London) used in this study. In addition, the authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre Award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Aggarwal M, 2014, MAGN RESON MED, V72, P829, DOI 10.1002/mrm.24956; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bruce IP, 2017, NEUROIMAGE, V159, P46, DOI 10.1016/j.neuroimage.2017.07.035; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chang EH, 2017, NEUROIMAGE, V147, P253, DOI 10.1016/j.neuroimage.2016.11.068; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Errico C, 2015, NATURE, V527, P499, DOI 10.1038/nature16066; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feng L, 2017, BRAIN STRUCT FUNCT, V222, P4131, DOI 10.1007/s00429-017-1463-6; Goubran M, 2016, HUM BRAIN MAPP, V37, P1103, DOI 10.1002/hbm.23090; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hutchinson E. B., 2017, J NEUROSCI RES; Jacobs MA, 1999, MED PHYS, V26, P1568, DOI 10.1118/1.598671; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Khan A. U., 2015, QUAL QUANT, V2015, P1, DOI [DOI 10.1109/SPICES.2015.7091527, DOI 10.1016/J.IJHCS.2015.07.001]; Labate A, 2015, EPILEPSIA, V56, P1109, DOI 10.1111/epi.13027; Lee SP, 1999, MAGNET RESON MED, V42, P919, DOI 10.1002/(SICI)1522-2594(199911)42:5<919::AID-MRM12>3.0.CO;2-8; Mandl RCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00817; Manjon J. V., 2010, INT J BIOMED IMAGING, V2010, DOI DOI 10.1155/2010/425891; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Manjon JV, 2012, MED IMAGE ANAL, V16, P18, DOI 10.1016/j.media.2011.04.003; Mollink J, 2017, NEUROIMAGE; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Seehaus A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00098; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Silva AC, 1997, MAGNET RESON MED, V38, P232, DOI 10.1002/mrm.1910380211; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Trojsi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119045; Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023; Wu D, 2016, NEUROIMAGE, V125, P84, DOI 10.1016/j.neuroimage.2015.10.051; Xu G, 2014, CEREB CORTEX, V24, P579, DOI 10.1093/cercor/bhs330; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zhang B, 2014, CNS NEUROSCI THER, V20, P3, DOI 10.1111/cns.12166; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	46	20	20	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 5	2018	8								4011	10.1038/s41598-018-22295-9			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0ZI	WOS:000426540800044	29507311	gold, Green Published, Green Accepted			2022-02-06	
J	Clark, MD; Varangis, EML; Champagne, AA; Giovanello, KS; Shi, F; Kerr, ZY; Smith, JK; Guskiewicz, KM				Clark, Michael D.; Varangis, Eleanna M. L.; Champagne, Allen A.; Giovanello, Kelly S.; Shi, Feng; Kerr, Zachary Y.; Smith, J. Keith; Guskiewicz, Kevin M.			Effects of Career Duration, Concussion History, and Playing Position on White Matter Microstructure and Functional Neural Recruitment in Former College and Professional Football Athletes	RADIOLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; SUBCONCUSSIVE HEAD TRAUMA; LIFE COGNITIVE IMPAIRMENT; LEAGUE PLAYERS; RECURRENT CONCUSSION; BRAIN-FUNCTION; OLDER-ADULTS; NFL PLAYERS; DEPRESSION; ASSOCIATION	Purpose: To better understand the relationship between exposure to concussive and subconcussive head impacts, white matter integrity, and functional task-related neural activity in former U.S. football athletes. Materials and Methods: Between 2011 and 2013, 61 cognitively unimpaired former collegiate and professional football players (age range, 52-65 years) provided informed consent to participate in this cross-sectional study. Participants were stratified across three crossed factors: career duration, concussion history, and primary playing position. Fractional anisotropy (FA) and blood oxygen level-dependent (BOLD) percent signal change (PSC) were measured with diffusion-weighted and task-related functional magnetic resonance imaging, respectively. Analyses of variance of FA and BOLD PSC were used to determine main or interaction effects of the three factors. Results: A significant interaction between career duration and concussion history was observed; former college players with more than three concussions had lower FA in a broadly distributed area of white matter compared with those with zero to one concussion (t29 = 2.774; adjusted P =.037), and the opposite was observed for former professional players (t29 = 3.883; adjusted P =.001). A separate interaction between concussion history and position was observed: Nonspeed players with more than three concussions had lower FA in frontal white matter compared with those with zero to one concussion (t25 = 3.861; adjusted P =.002). Analysis of working memory-task BOLD PSC revealed a similar interaction between concussion history and position (all adjusted P<.004). Overall, former players with lower FA tended to have lower BOLD PSC across three levels of a working memory task. Conclusion: Career duration and primary playing position seem to modify the effects of concussion history on white matter structure and neural recruitment. The differences in brain structure and function were observed in the absence of clinical impairment, which suggested that multimodal imaging may provide early markers of onset of traumatic neurodegenerative disease. (C) RSNA, 2017	[Clark, Michael D.; Kerr, Zachary Y.; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA; [Varangis, Eleanna M. L.; Giovanello, Kelly S.] Univ North Carolina Chapel Hill, Dept Psychol & Neurosci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA; [Smith, J. Keith] Univ North Carolina Chapel Hill, Dept Radiol, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA; [Champagne, Allen A.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Shi, Feng] Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA		Guskiewicz, KM (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 209 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu	Smith, J Keith/AAD-3968-2021	Smith, J Keith/0000-0001-7588-3520; Varangis, Eleanna/0000-0002-2688-2297; Clark, Michael/0000-0002-5019-0290	National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS090816]; National Football League Charities; National Football League Players' Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS090816] Funding Source: NIH RePORTER	M.D.C. supported by National Institute of Neurologic Disorders and Stroke (F30NS090816). Study supported by the National Football League Charities and the National Football League Players' Association.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hakun JG, 2015, NEUROPSYCHOLOGIA, V71, P225, DOI 10.1016/j.neuropsychologia.2015.04.008; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; O'Conaill CR, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9106-9; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Wechsler D., 1997, TECHNICAL MANUAL WEC; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	38	20	20	0	17	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	MAR	2018	286	3					975	985		10.1148/radiol.2017170539			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	FW8LC	WOS:000425583200027	29087238	Green Published, Bronze			2022-02-06	
J	Lippa, SM; Brickell, TA; Bailie, JM; French, LM; Kennedy, JE; Lange, RT				Lippa, Sara M.; Brickell, Tracey A.; Bailie, Jason M.; French, Louis M.; Kennedy, Jan E.; Lange, Rael T.			Postconcussion Symptom Reporting After Mild Traumatic Brain Injury in Female Service Members: Impact of Gender, Posttraumatic Stress Disorder, Severity of Injury, and Associated Bodily Injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						female; gender; mild traumatic brain injury; military; postconcussion symptoms; posttraumatic stress disorder; symptom reporting	IRAQI FREEDOM; OEF/OIF VETERANS; COMBAT STRESS; POLYTRAUMA; BLAST; AFGHANISTAN; PERSISTENT; DEPLOYMENT; TBI; CONCUSSION	Objective: Examine effects of diagnostically relevant posttraumatic stress disorder (PTSD) symptoms, mild traumatic brain injury (TBI) severity, and associated bodily injury severity on postconcussion symptom reporting in female service members (SM) compared with a matched sample of male SM. Setting: Six US military medical treatment facilities. Participants: A total of 158 SM (79 females, 79males) evaluated within 30months aftermild TBI. Men and women were matched by age, days postinjury, PTSD symptom status, mild TBI severity, and bodily injury severity. All passed a measure of symptom validity. Design: Compare reported postconcussion symptoms for men and women stratified by PTSD diagnostic symptoms (present/absent), mild TBI severity (alteration of consciousness/loss of consciousness), and bodily injury severity (mild/moderate-severe). Main Measures: Neurobehavioral Symptom Inventory, PTSD Checklist, Abbreviated Injury Scale. Results: Overall postconcussion symptom reporting increased with PTSD but did not significantly differ based on severity of mild TBI or associated bodily injury. Females reported more somatosensory and/or vestibular symptoms than males under some circumstances. Females in the PTSD-Present group, Alteration of Consciousness Only group, and Moderate-Severe Bodily Injury group reported more somatosensory symptoms than males in those groups. Females in the Alteration of Consciousness Only group and Minor Bodily Injury group reported more vestibular symptoms than males in those groups. Conclusion: Diagnostically relevant PTSD symptoms, mild TBI severity, and bodily injury severity differentially impact somatosensory and vestibular postconcussion symptom reporting for male and female SM after mild TBI. Controlling for PTSD and symptom validity resulted in fewer gender-based differences in postconcussive symptoms than previously demonstrated in the literature.	[Lippa, Sara M.; Brickell, Tracey A.; Bailie, Jason M.; French, Louis M.; Kennedy, Jan E.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lippa, Sara M.; Brickell, Tracey A.; French, Louis M.; Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, Oceanside, CA USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Kennedy, Jan E.] San Antonio Mil Med Ctr, San Antonio, TX USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 19 Room 6003,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	saralippa@gmail.com	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This material is based upon work supported by the Defense and Veterans Brain Injury Center. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position, policy, or decision unless so designated by other official documentation.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andreski P, 1998, PSYCHIAT RES, V79, P131, DOI 10.1016/S0165-1781(98)00026-2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense Manpower Data Center, 2016, TABL ACT DUT FEM RAN; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2011, NATO SCI PEACE SEC, V86, P171, DOI 10.3233/978-1-60750-797-0-171; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Secretary of Defense, IMPL GUID FULL INT W; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	51	20	20	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					101	112		10.1097/HTR.0000000000000353			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200011	29084103				2022-02-06	
J	Nicol, LSC; Thornton, P; Hatcher, JP; Glover, CP; Webster, CI; Burrell, M; Hammett, K; Jones, CA; Sleeman, MA; Billinton, A; Chessell, I				Nicol, Louise S. C.; Thornton, Peter; Hatcher, Jon P.; Glover, Colin P.; Webster, Carl I.; Burrell, Matthew; Hammett, Kessia; Jones, Clare A.; Sleeman, Matthew A.; Billinton, Andrew; Chessell, Iain			Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain	PAIN			English	Article						Granulocyte-macrophage colony-stimulating factor; Neuropathic pain; Inflammation; Microglia; Astrocyte; Blood-brain barrier; Cytokine	GM-CSF RECEPTOR; PERIPHERAL-NERVE INJURY; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; MICROGLIAL ACTIVATION; SPINAL-CORD; EXPRESSION; CYTOKINES; MECHANISMS; INTERLEUKIN-1-BETA	With less than 50% of patients responding to the current standard of care and poor efficacy and selectivity of current treatments, neuropathic pain continues to be an area of considerable unmet medical need. Biological therapeutics such as monoclonal antibodies (mAbs) provide better intrinsic selectivity; however, delivery to the central nervous system (CNS) remains a challenge. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is well described in inflammation-induced pain, and early-phase clinical trials evaluating its antagonism have exemplified its importance as a peripheral pain target. Here, we investigate the role of this cytokine in a murine model of traumatic nerve injury and show that deletion of the GM-CSF receptor or treatment with an antagonizing mAb alleviates pain. We also demonstrate enhanced analgesic efficacy using an engineered construct that has greater capacity to penetrate the CNS. Despite observing GM-CSF receptor expression in microglia and astrocytes, the gliosis response in the dorsal horn was not altered in nerve injured knockout mice compared with wild-type littermate controls as evaluated by ionized calcium binding adapter molecule 1 (Iba1) and glial fibrillary acidic protein, respectively. Functional analysis of glial cells revealed that pretreatment with GM-CSF potentiated lipopolysaccharide-induced release of proinflammatory cytokines. In summary, our data indicate that GM-CSF is a proinflammatory cytokine that contributes to nociceptive signalling through driving spinal glial cell secretion of proinflammatory mediators. In addition, we report a successful approach to accessing CNS pain targets, providing promise for central compartment delivery of analgesics.	[Nicol, Louise S. C.; Glover, Colin P.; Jones, Clare A.; Sleeman, Matthew A.] MedImmune, Resp Inflammat & Autoimmun Res, Cambridge, England; [Thornton, Peter; Hatcher, Jon P.; Billinton, Andrew; Chessell, Iain] AstraZeneca, IMED, Neurosci, Cambridge, England; [Webster, Carl I.; Burrell, Matthew] MedImmune, Antibody Discovery & Prot Engn, Cambridge, England; [Hammett, Kessia] Kings Coll London, Wolfson Ctr Age Related Dis, London, England		Nicol, LSC (corresponding author), MedImmune Ltd, Res & Dev, Cambridge CB21 6GH, England.	nicoll@medimmune.com			MedImmuneAstraZenecaMedimmune	The authors thank all the staff of MedImmune's Biological Services unit for their invaluable help and technical assistance in performing the surgeries. All work described in this article was funded by MedImmune.	ALVAROGRACIA JM, 1991, J IMMUNOL, V146, P3365; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Backonja MM, 2008, J NEUROIMMUNOL, V195, P157, DOI 10.1016/j.jneuroim.2008.01.005; BALDWIN GC, 1993, BLOOD, V82, P3279; BERENBAUM F, 1994, EUR CYTOKINE NETW, V5, P43; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; Cook AD, 2001, ARTHRITIS RES, V3, P293, DOI 10.1186/ar318; Cook AD, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4037; Cook AD, 2013, ANN RHEUM DIS, V72, P265, DOI 10.1136/annrheumdis-2012-201703; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Dame JB, 1999, PEDIATR RES, V46, P358, DOI 10.1203/00006450-199910000-00002; Daramola O, 2014, BIOTECHNOL PROGR, V30, P132, DOI 10.1002/btpr.1809; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Fleetwood AJ, 2005, CRIT REV IMMUNOL, V25, P405, DOI 10.1615/CritRevImmunol.v25.i5.50; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; Greven DEA, 2015, ANN RHEUM DIS, V74, P1924, DOI 10.1136/annrheumdis-2014-205234; Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton JA, 2017, NAT REV DRUG DISCOV, V16, P53, DOI 10.1038/nrd.2016.231; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hansen RR, 2013, EUR J PHARMACOL, V716, P120, DOI 10.1016/j.ejphar.2013.03.023; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Lanfranconi S, 2011, J CELL MOL MED, V15, P1645, DOI 10.1111/j.1582-4934.2009.00987.x; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Mirski R, 2003, J NEUROIMMUNOL, V140, P88, DOI 10.1016/S0165-5728(03)00179-6; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Ni Mingwei, 2010, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1217s43; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; SAWADA M, 1993, NEUROSCI LETT, V160, P131, DOI 10.1016/0304-3940(93)90396-3; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schroeder GD, 2017, SPINE J, V17, P129, DOI 10.1016/j.spinee.2016.08.006; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Weber KT, 2015, IMMUNOL RES, V63, P170, DOI 10.1007/s12026-015-8709-2; Webster CI, 2017, PAIN, V158, P660, DOI 10.1097/j.pain.0000000000000810; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wright HL, 2012, RHEUMATOLOGY, V51, P451, DOI 10.1093/rheumatology/ker338; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617	56	20	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	MAR	2018	159	3					550	559		10.1097/j.pain.0000000000001130			10	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	GB3ZN	WOS:000428999500017	29351125	Green Published			2022-02-06	
J	Kovacs, G; Sowers, N				Kovacs, George; Sowers, Nicholas			Airway Management in Trauma	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Airway; Trauma; Airway management	RAPID-SEQUENCE INTUBATION; CERVICAL-SPINE INJURY; ADVANCED LIFE-SUPPORT; NATIONAL AUDIT PROJECT; DIFFICULT AIRWAY; TRACHEAL INTUBATION; ENDOTRACHEAL INTUBATION; EMERGENCY-DEPARTMENT; MAJOR TRAUMA; CARDIOVASCULAR COLLAPSE	Airway management in the trauma patient presents numerous unique challenges beyond placement of an endotracheal tube, and outcomes are dependent on the provider's ability to anticipate difficulty. Airway management strategies for the care of the patient with polytrauma are reviewed, with specific considerations for those presenting with traumatic brain injury, suspected c-spine injury, the contaminated airway, the agitated trauma patient, maxillofacial trauma, and the traumatized airway. An approach to airway management that considers the potential anatomic and physiologic challenges in caring for these patients with complicated trauma is presented.	[Kovacs, George; Sowers, Nicholas] Dalhousie Univ, Div Med Educ, Dept Emergency Med, 3rd Floor,HI Site,Suite 355,Room 364D, Halifax, NS B3H 3A7, Canada; [Kovacs, George] Dalhousie Univ, Div Med Educ, Dept Anaesthesia, 3rd Floor,HI Site,Suite 355,Room 364D, Halifax, NS B3H 3A7, Canada; [Kovacs, George] Dalhousie Univ, Div Med Educ, Dept Med Neurosci, 3rd Floor,HI Site,Suite 355,Room 364D, Halifax, NS B3H 3A7, Canada; [Kovacs, George; Sowers, Nicholas] QEII Hlth Sci Ctr, Charles V Keating Trauma & Emergency Ctr, 1799 Robie St, Halifax, NS B3H 3G1, Canada		Kovacs, G (corresponding author), QEII Hlth Sci Ctr, Charles V Keating Trauma & Emergency Ctr, 1799 Robie St, Halifax, NS B3H 3G1, Canada.	gkovacs@dal.ca					Algie CM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011656.pub2; APRAHAMIAN C, 1984, ANN EMERG MED, V13, P584, DOI 10.1016/S0196-0644(84)80278-4; Bathory I, 2009, ANAESTHESIA, V64, P1337, DOI 10.1111/j.1365-2044.2009.06075.x; Bodily JB, 2015, ANN EMERG MED, P1; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; Bowman-Howard M., 2000, HDB DIFFICULT AIRWAY, P199; Brainard C, 2015, JEMS, V40, P32; Brainard Criss, 2015, JEMS, V40, P26; Brindley PG, 2017, CAN J ANAESTH; Brown CA, 2015, ANN EMERG MED, V65, P363, DOI 10.1016/j.annemergmed.2014.10.036; Choudhary D. K., 2015, J PLANT GROWTH REGUL, P1; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Conroy MJ, 2014, AM J EMERG MED, V32, P541, DOI 10.1016/j.ajem.2014.02.006; Cook TM, 2011, BRIT J ANAESTH, V106, P632, DOI 10.1093/bja/aer059; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; Cowley R A, 1975, Md State Med J, V24, P37; Crosby Edward T, 2007, Anesthesiol Clin, V25, P511, DOI 10.1016/j.anclin.2007.05.001; Crosby ET, 2006, ANESTHESIOLOGY, V104, P1293, DOI 10.1097/00000542-200606000-00026; Driver BE, 2017, ANN EMERG MED, V69, P1, DOI 10.1016/j.annemergmed.2016.06.018; Dronen S, 1999, ACAD EMERG MED, V6, P1, DOI 10.1111/j.1553-2712.1999.tb00084.x; DuCanto J, 2017, WEST J EMERG MED, V18, DOI [10.5811/WESTJEM.2016.9.30891, 10.5811/westjem.2016.9.30891]; Duggan LV, 2015, ANAESTHESIA, V70, P769, DOI 10.1111/anae.13163; Dugganh LV, 2016, BRIT J ANAESTH, V117, P28, DOI 10.1093/bja/aew192; Dupanovic M, 2010, CURR OPIN ANAESTHESI; Durga P, 2014, INDIAN J ANAESTH, V58, P684, DOI 10.4103/0019-5049.147132; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Ehrenfeld JM, 2012, ANESTH ANALG, V115, P95, DOI 10.1213/ANE.0b013e31822dac35; Farmer J, 1998, J SPINAL DISORD, V11, P192; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Gebremedhn EG, 2014, WORLD J EMERG MED, V5, P279, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.007; GOLD CR, 1987, ANN EMERG MED, V16, P797, DOI 10.1016/S0196-0644(87)80578-4; Green RS, 2012, CAN J EMERG MED, V14, P74, DOI 10.2310/8000.2012.110548; Green RS, 2015, J CRIT CARE; Gu Y, 2016, CAN J ANAESTH, V63; Hamaekers AE, 2011, ANAESTHESIA, V66, P65, DOI 10.1111/j.1365-2044.2011.06936.x; Hardy G, 2016, EMERG MED J, V33, P439, DOI 10.1136/emermed-2016-205871.2; Heffner AC, 2013, RESUSCITATION, V84, P1500, DOI 10.1016/j.resuscitation.2013.07.022; Heffner AC, 2012, J CRIT CARE, V27, P587, DOI 10.1016/j.jcrc.2012.04.022; Heffner AC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.011; Higgs A, 2016, BR J ANAESTH; Hindman BJ, 2016, J NEUROSURG-SPINE, V25, P545, DOI 10.3171/2016.3.SPINE1640; Hindman BJ, 2015, ANESTHESIOLOGY, V123, P1042, DOI 10.1097/ALN.0000000000000830; Horton CL, 2014, J EMERG MED, V46, P814, DOI 10.1016/j.jemermed.2013.11.085; HUTCHISON I, 1990, BRIT MED J, V301, P595, DOI 10.1136/bmj.301.6752.595; Jain U, 2016, ANESTHESIOLOGY, V124, P199, DOI 10.1097/ALN.0000000000000903; Jose Anson, 2016, J Emerg Trauma Shock, V9, P73, DOI 10.4103/0974-2700.179456; Kerslake D, 2015, RESUSCITATION, V89, P20, DOI 10.1016/j.resuscitation.2015.01.005; Kill C, 2013, J EMERG MED, V44, P750, DOI 10.1016/j.jemermed.2012.07.080; Kleine-Brueggeney M, 2016, BRIT J ANAESTH, V116, P670, DOI 10.1093/bja/aew058; Kovacs G, 2016, LIGHTS CAMERA ACTION; Krausz Amir A, 2009, World J Emerg Surg, V4, P21, DOI 10.1186/1749-7922-4-21; Kummer C, 2007, INJURY, V38, P27, DOI 10.1016/j.injury.2006.09.002; Kwan I, 2001, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858; Lai WH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060528; Langvad S, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-43; Lapinsky SE, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0964-z; Law JA, 2013, CAN J ANESTH, V60, P1089, DOI 10.1007/s12630-013-0019-3; Law JA, 2013, CAN J ANESTH, V60, P1119, DOI 10.1007/s12630-013-0020-x; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Leeuwenburg T, 2015, CRIT CARE HORIZONS, V1, P1; LeGrand SA, 2007, ANESTHESIOLOGY, V107, P884, DOI 10.1097/01.anes.0000291461.62404.46; Levitan R, 2013, PHARM PREHOSPITAL RE; Levitan R., 2015, ACEP NOW; Lockwood DNJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1136; Mace SE, 2008, EMERG MED CLIN N AM, V26, P1043, DOI 10.1016/j.emc.2008.10.002; Manoach S, 2007, ANN EMERG MED, V50, P236, DOI 10.1016/j.annemergmed.2007.01.009; Marshall SD, 2016, ACAD EMERG MED, V23, P1074, DOI 10.1111/acem.13037; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Mercer SJ, 2016, BRIT J ANAESTH, V117, P49, DOI 10.1093/bja/aew193; Michailidou M, 2015, WORLD J SURG, V39, P782, DOI 10.1007/s00268-014-2845-z; Mihara R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806243; Miller M, 2016, ANN EMERG MED, V68, P181, DOI 10.1016/j.annemergmed.2016.03.041; Miraflor E, 2011, J SURG RES, V170, P286, DOI 10.1016/j.jss.2011.03.044; Mosier JM, 2017, INTENS CARE MED, V43, P226, DOI 10.1007/s00134-016-4426-0; Mosier JM, 2015, WEST J EMERG MED, V16, P1109, DOI 10.5811/westjem.2015.8.27467; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Murphy M, 2005, CAN J ANAESTH, V52, P231, DOI 10.1007/BF03016055; Nimmagadda U, 2017, ANESTH ANALG, V124, P507, DOI 10.1213/ANE.0000000000001589; Norris A, 2016, BRIT J ANAESTH, V117, P148, DOI 10.1093/bja/aew122; Norskov AK, 2016, BRIT J ANAESTH, V116, P680, DOI 10.1093/bja/aew057; Ohchi F, 2016, AM J EMERG MED; Oteir AO, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041080; Perbet S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0975-9; Petrosoniak A, 2013, CURR OPIN ANESTHESIO, V26, P699, DOI 10.1097/ACO.0000000000000007; Pieters BMA, 2016, ANAESTHESIA, V71, P556, DOI 10.1111/anae.13413; Pracy JP, 2016, BRIT J ANAESTH, V117, P426, DOI 10.1093/bja/aew221; Rogers FB, 2015, INJURY, V46, P525, DOI 10.1016/j.injury.2014.08.043; Sakles JC, 2017, ACAD EMERG MED, V38, P42; Sakles JC, 2016, ACAD EMERG MED, V23, P703, DOI 10.1111/acem.12931; Salem MR, 2013, ANESTH ANALG, V116, P264, DOI 10.1213/ANE.0b013e31827696fa; Salem MR, 2017, ANESTHESIOLOGY, V9, P378; Sirian R, 2009, BJA EDUC, V9, P105, DOI 10.1093/bjaceaccp/mkp018; Sise MJ, 2009, J TRAUMA, V66, P32, DOI 10.1097/TA.0b013e318191bb0c; Smith KA, 2015, ACAD EMERG MED, V22, P989, DOI 10.1111/acem.12717; Sowers N, 2016, J EMERG MED, V50, P315, DOI 10.1016/j.jemermed.2015.10.010; Spaite DW, 2017, ANN EMERG MED; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Suppan L, 2016, BRIT J ANAESTH, V116, P27, DOI 10.1093/bja/aev205; Teoh WH, 2016, BRIT J ANAESTH, V117, P1, DOI 10.1093/bja/aew148; Thiboutot F, 2009, CAN J ANAESTH, V56, P412, DOI 10.1007/s12630-009-9089-7; Thompson WL, 2009, CAN J EMERG MED, V11, P14; Tobias JD, 2014, SAUDI J ANAESTH, V8, P153, DOI 10.4103/1658-354X.130672; Tran DTT, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub3; Trivedi S, 2015, J CRIT CARE, V30; Upchurch CP, 2017, ANN EMERG MED, V69, P24, DOI 10.1016/j.annemergmed.2016.08.009; Vannucci A, 2016, MINERVA ANESTESIOL, V82, P69; Vu M, 2011, AIRWAY MANAGEMENT EM, P299; Wang HE, 2014, EMERG MED J, V31, P186, DOI 10.1136/emermed-2012-202101; Weingart SD, 2015, ANN EMERG MED, V65, P349, DOI 10.1016/j.annemergmed.2014.09.025; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Welch JL, 2016, ANN EMERG MED; Wilson MH, 2016, RESUSCITATION, V105, P52, DOI 10.1016/j.resuscitation.2016.05.007; Wong DT, 2017, CAN J ANAESTH; Woodall N, 2011, ANAESTHESIA, V66, P27, DOI 10.1111/j.1365-2044.2011.06931.x; Yentis SM, 2002, ANAESTHESIA, V57, P105, DOI 10.1046/j.0003-2409.2001.02515.x; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y	118	20	24	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2018	36	1					61	+		10.1016/j.emc.2017.08.006			25	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FQ8TD	WOS:000418635200006	29132582	hybrid			2022-02-06	
J	Pieracci, FM; Agarwal, S; Doben, A; Shiroff, A; Lottenberg, L; Whitbeck, SA; White, TW				Pieracci, Fredric M.; Agarwal, Suresh; Doben, Andrew; Shiroff, Adam; Lottenberg, Larwence; Whitbeck, Sarah Ann; White, Thomas W.			Indications for surgical stabilization of rib fractures in patients without flail chest: surveyed opinions of members of the Chest Wall Injury Society	INTERNATIONAL ORTHOPAEDICS			English	Article						Rib fractures; Survey; Surgical stabilization of rib fractures	INTERNAL-FIXATION; OPEN REDUCTION; POLYTRAUMA PATIENTS; MANAGEMENT; OUTCOMES; TRAUMA; METAANALYSIS; DISABILITY; BENEFIT; REPAIR	Purpose There are currently no evidence-based indications for surgical stabilization of rib fractures (SSRF) in patients without flail chest. The purpose of this survey was to identify patients for whom there is relative equipoise (operative vs. non-operative) in order to assist in designing a randomized clinical trial. Methods Members of the Chest Wall Injury Society were sent an online survey, in which 18 patient scenarios were presented. The baseline patient had >= three displaced, contiguous fractures and had no other contraindications for surgery. This default scenario was then varied based upon patient age, degree of traumatic brain injury (TBI), fracture series location, and number of abnormal pulmonary physiologic variables (oxygen requirement, respiratory rate, incentive spirometry ability, cough, and numeric pain score). Results Thirty respondents provided a total of 540 answers. Overall, the majority of responses were in favor of SSRF (n = 413, 84.1%). Furthermore, the vast majority of responses indicated that some degree of pulmonary compromise was necessary to recommend SSRF (n = 44, 90.4%), with >= two abnormal parameters being the most common threshold (n = 156, 31.8%). Decision to recommend SSRF varied significantly by number of abnormal clinical variables, age, and degree of TBI, but not by fracture series location. Patients aged 85 years old and those with moderate TBI were the least likely to be recommended for SSRF, regardless of abnormal pulmonary physiologic variables. The most appropriate cutoff for equipoise appeared to be a patient aged 21-79 years old, with no or mild TBI, >= two abnormal pulmonary parameters, and regardless of fracture location (44.8% consensus for SSRF). Conclusion SSRF was recommended for most patients with non-flail, displaced rib fractures. However, this recommendation was contingent upon patient age, degree of TBI, and pulmonary clinical status. Results of this survey may be used to inform inclusion criteria for a future randomized, clinical trial.	[Pieracci, Fredric M.] Denver Hlth Med Ctr, Denver, CO 80204 USA; [Agarwal, Suresh] Duke Univ, Sch Med, Durham, NC USA; [Doben, Andrew] Baystate Med Ctr, Springfield, MA USA; [Shiroff, Adam] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Lottenberg, Larwence] St Marys Hosp, W Palm Beach, FL USA; [Whitbeck, Sarah Ann; White, Thomas W.] Intermt Med Ctr, Salt Lake City, UT USA		Pieracci, FM (corresponding author), Denver Hlth Med Ctr, Denver, CO 80204 USA.	Fredric.pieracci@dhha.org					Bhatnagar A, 2012, J AM COLL SURGEONS, V215, P201, DOI 10.1016/j.jamcollsurg.2012.02.023; Bottlang M, 2010, EUR J TRAUMA EMERG S, V36, P417, DOI 10.1007/s00068-010-0047-4; Coughlin TA, 2016, BONE JOINT J, V98B, P1119, DOI 10.1302/0301-620X.98B8.37282; DeFreest L, 2016, AM J SURG, V211, P761, DOI 10.1016/j.amjsurg.2015.11.014; Dehghan N, 2014, J TRAUMA ACUTE CARE, V76, P462, DOI 10.1097/TA.0000000000000086; Doben AR, 2017, AM J SURG, V213, P1189, DOI 10.1016/j.amjsurg.2016.07.029; Doben AR, 2014, J CRIT CARE, V29, P139, DOI 10.1016/j.jcrc.2013.08.003; Drummond MF, 2015, METHODS EC EVALUATIO; Farquhar J, 2016, CAN J SURG, V59, P299, DOI 10.1503/cjs.000515; Granetzny Andreas, 2005, Interact Cardiovasc Thorac Surg, V4, P583, DOI 10.1510/icvts.2005.111807; Hasenboehler EA, 2011, J TRAUMA, V71, P494, DOI 10.1097/TA.0b013e3182255d30; Kane ED, 2017, 47 ANN M W TRAUM ASS; Kasotakis G, 2017, J TRAUMA ACUTE CARE, V82, P618, DOI [10.1097/TA.0000000000001350, 10.1097/TA.0000000000001389]; Lafferty PM, 2011, J BONE JOINT SURG AM, V93A, P97, DOI 10.2106/JBJS.I.00696; LANDERCASPER J, 1984, J TRAUMA, V24, P410, DOI 10.1097/00005373-198405000-00007; Leinicke JA, 2013, ANN SURG, V258, P914, DOI 10.1097/SLA.0b013e3182895bb0; Majercik S, 2014, AM J SURG, V208, P88, DOI 10.1016/j.amjsurg.2013.08.051; Marasco S, 2014, J TRAUMA ACUTE CARE, V77, P452, DOI 10.1097/TA.0000000000000375; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; Mayberry JC, 2009, AM SURGEON, V75, P389; Mayberry JC, 2009, J TRAUMA, V66, P875, DOI 10.1097/TA.0b013e318190c3d3; Pieracci Fredric M, 2015, Trauma Case Rep, V1, P39, DOI 10.1016/j.tcr.2015.10.001; Pieracci FM, 2017, INJURY, V48, P307, DOI 10.1016/j.injury.2016.11.026; Pieracci FM, 2016, J TRAUMA ACUTE CARE, V80, P187, DOI 10.1097/TA.0000000000000925; Pieracci FM, 2015, J TRAUMA ACUTE CARE, V78, P883, DOI 10.1097/TA.0000000000000581; Slobogean GP, 2013, J AM COLL SURGEONS, V216, P302, DOI 10.1016/j.jamcollsurg.2012.10.010; Tanaka H, 2002, J TRAUMA, V52, P727, DOI 10.1097/00005373-200204000-00020; Tyburski JG, 1999, J TRAUMA, V46, P833, DOI 10.1097/00005373-199905000-00011	28	20	21	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	FEB	2018	42	2					401	408		10.1007/s00264-017-3612-1			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	FU2WV	WOS:000423711600024	28852836				2022-02-06	
J	Salehi, A; Jullienne, A; Baghchechi, M; Hamer, M; Walsworth, M; Donovan, V; Tang, JP; Zhang, JH; Pearce, WJ; Obenaus, A				Salehi, Arjang; Jullienne, Amandine; Baghchechi, Mohsen; Hamer, Mary; Walsworth, Mark; Donovan, Virginia; Tang, Jiping; Zhang, John H.; Pearce, William J.; Obenaus, Andre			Up-regulation of Wnt/beta-catenin expression is accompanied with vascular repair after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Angiogenesis; brain recovery; brain trauma; regeneration and recovery; vascular biology	ENDOTHELIAL GROWTH-FACTOR; BETA-CATENIN; PROGENITOR CELLS; CHRONIC HYPOXIA; ANGIOGENESIS; BARRIER; VEGF; MOUSE; RAT; PATHWAY	Recent data suggest that repairing the cerebral vasculature after traumatic brain injury (TBI) may help to improve functional recovery. The Wnt/beta-catenin signaling pathway promotes blood vessel formation during vascular development, but its role in vascular repair after TBI remains elusive. In this study, we examined how the cerebral vasculature responds to TBI and the role of Wnt/beta-catenin signaling in vascular repair. We induced a moderate controlled cortical impact in adult mice and performed vessel painting to visualize the vascular alterations in the brain. Brain tissue around the injury site was assessed for beta-catenin and vascular markers. A Wnt transgenic mouse line was utilized to evaluate Wnt gene expression. We report that TBI results in vascular loss followed by increases in vascular structure at seven days post injury (dpi). Immature, non-perfusing vessels were evident in the tissue around the injury site. beta-catenin protein expression was significantly reduced in the injury site at 7 dpi. However, there was an increase in beta-catenin expression in perilesional vessels at 1 and 7 dpi. Similarly, we found increased number of Wnt-GFP-positive vessels after TBI. Our findings suggest that Wnt/beta-catenin expression contributes to the vascular repair process after TBI.	[Salehi, Arjang; Obenaus, Andre] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Salehi, Arjang; Jullienne, Amandine; Baghchechi, Mohsen; Hamer, Mary; Walsworth, Mark; Donovan, Virginia; Obenaus, Andre] Loma Linda Univ, Dept Pediat, Coleman Pavil,Room A-1120,11175 Campus St, Loma Linda, CA 92354 USA; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Tang, Jiping; Zhang, John H.; Pearce, William J.] Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92354 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA 92354 USA; [Pearce, William J.] Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92354 USA		Obenaus, A (corresponding author), Loma Linda Univ, Dept Pediat, Coleman Pavil,Room A-1120,11175 Campus St, Loma Linda, CA 92354 USA.	aobenaus@llu.edu	Jullienne, Amandine/H-3081-2019	Jullienne, Amandine/0000-0001-9458-055X; , Andre/0000-0003-0081-6950; Pearce, William/0000-0002-5331-5677; Zhang, John H./0000-0002-4319-4285	NIH Program Project grant from National Institute of Neurological Disorders and Stroke [1P01NS082184]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD083132] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: NIH Program Project grant from National Institute of Neurological Disorders and Stroke (1P01NS082184, Project 3).	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corada M, 2014, ARTERIOSCL THROM VAS, V34, P2372, DOI 10.1161/ATVBAHA.114.303218; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Easwaran V, 2003, CANCER RES, V63, P3145; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gong DS, 2012, BRAIN INJURY, V26, P291, DOI 10.3109/02699052.2011.648710; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hughes S, 2014, METHODS MOL BIOL, V1135, P127, DOI 10.1007/978-1-4939-0320-7_12; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Lange C, 2016, EMBO J, V35, P924, DOI 10.15252/embj.201592372; Lengfeld JE, 2017, P NATL ACAD SCI USA, V114, pE1168, DOI 10.1073/pnas.1609905114; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lim RG, 2017, CELL REP, V19, P1365, DOI 10.1016/j.celrep.2017.04.021; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO;2-7; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Walchli T, 2015, NAT PROTOC, V10, P53, DOI 10.1038/nprot.2015.002; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Ward NL, 2007, J APPL PHYSIOL, V102, P1927, DOI 10.1152/japplphysiol.00909.2006; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Xu K, 2006, J APPL PHYSIOL, V100, P725, DOI 10.1152/japplphysiol.00940.2005; Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3; Zhang L, 2013, INT J MOL MED, V32, P867, DOI 10.3892/ijmm.2013.1456; Zhang YM, 2016, ACUPUNCT MED, V34, P48, DOI 10.1136/acupmed-2014-010742; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	58	20	20	2	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2018	38	2					274	289		10.1177/0271678X17744124			16	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FU7VJ	WOS:000424060500008	29160735	Green Published, Bronze			2022-02-06	
J	Trevena-Peters, J; McKay, A; Spitz, G; Suda, R; Renison, B; Ponsford, J				Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Suda, Rachel; Renison, Belinda; Ponsford, Jennie			Efficacy of Activities of Daily Living Retraining During Posttraumatic Amnesia: A Randomized Controlled Trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Activities of daily living; Brain injuries; traumatic; Occupational therapy; Neuropsychology; Rehabilitation	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; EARLY REHABILITATION; AGITATION; MEMORY; SCALE; ORIENTATION; RECOVERY; DURATION; MODERATE	Objective: To assess the efficacy of activities of daily living (ADL) retraining during posttraumatic amnesia (PTA) compared with ADL retraining commencing after emergence from PTA. Design: Randomized controlled trial. Setting: Inpatient rehabilitation center. Participants: Participants with severe TBI (N=104), admitted to rehabilitation and remaining in PTA for >7 days, were randomized to receive either treatment as usual (TAU) with daily ADL retraining (treatment), or TAU alone (physiotherapy and/or necessary speech therapy) during PTA. Interventions: ADL retraining was manualized, followed errorless and procedural learning principles, and included individualized goals. Both groups received occupational therapy as usual after PTA. Main Outcome Measures: Primary outcome was the FIM completed at admission, PTA emergence, discharge, and 2-month follow-up. Secondary outcomes included length of rehabilitation inpatient stay, PTA duration, Agitated Behavior Scale scores, and Community Integration Questionnaire (CIQ) scores at follow-up. Groups did not significantly differ in baseline characteristics. Results: On the primary outcome, FIM total change, random effects regression revealed a significant interaction of group and time (P<.01). The treatment group had greater improvement in FIM scores from baseline to PTA emergence, which was maintained at discharge, but not at follow-up. Twenty-seven percent more of the treatment group reliably changed on FIM scores at PTA emergence. Group differences in length of stay, PTA duration, agitation, and CIQ scores were not significant; however, TAU trended toward longer length of stay and PTA duration. Conclusions: Individuals in PTA can benefit from skill retraining. (C) 2017 by the American Congress of Rehabilitation Medicine	[Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Spitz, Gershon; Renison, Belinda; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [McKay, Adam; Suda, Rachel] Epworth HealthCare, Richmond, Vic, Australia		Trevena-Peters, J (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia.; Trevena-Peters, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia.; Trevena-Peters, J (corresponding author), Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia.	jessica.trevena-peters@monash.edu	Spitz, Gershon/H-7755-2014; McKay, Adam/M-6003-2017	Spitz, Gershon/0000-0002-7810-1480; McKay, Adam/0000-0002-0479-7681	Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research [N-13-089]; Epworth Research Institute Grant; William Buckland Foundation Grant	Supported by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research (grant no: N-13-089); a Epworth Research Institute Grant; and a William Buckland Foundation Grant.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GILES GM, 1993, BRAIN INJURY REHABIL; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Langhorn L, 2015, J NEUROSCI NURS, V47, pE2, DOI 10.1097/JNN.0000000000000106; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; Legg LA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003585.pub2; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Rebeiro K L, 1999, Can J Occup Ther, V66, P14; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Symonds CP, 1943, LANCET, V1, P7; TERRACE HS, 1963, SCIENCE, V140, P318, DOI 10.1126/science.140.3564.318; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Watanabe TK, 1998, BRAIN INJURY, V12, P81; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006	49	20	20	1	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2					329	337		10.1016/j.apmr.2017.08.486			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YX	WOS:000424069800015	28947165				2022-02-06	
J	de Rooij, R; Kuhl, E				de Rooij, Rijk; Kuhl, Ellen			Microtubule Polymerization and Cross-Link Dynamics Explain Axonal Stiffness and Damage	BIOPHYSICAL JOURNAL			English	Article							SELF-ASSEMBLY KINETICS; FORCE GENERATION; TAU PROTEINS; STRAIN-RATE; ELONGATION; INJURY; MODEL; NEURONS; STRETCH; BRAIN	Axonal damage is a critical indicator for traumatic effects of physical impact to the brain. However, the precise mechanisms of axonal damage are still unclear. Here, we establish a mechanistic and highly dynamic model of the axon to explore the evolution of damage in response to physical forces. Our axon model consists of a bundle of dynamically polymerizing and depolymerizing microtubules connected by dynamically detaching and reattaching cross-links. Although the probability of cross-link attachment depends exclusively on thermal fluctuations, the probability of detachment increases in the presence of physical forces. We systematically probe the landscape of axonal stretch and stretch rate and characterize the overall axonal force, stiffness, and damage as a direct result of the interplay between microtubule and cross-link dynamics. Our simulations reveal that slow loading is dominated by cross-link dynamics, a net reduction of cross-links, and a gradual accumulation of damage, whereas fast loading is dominated by cross-link deformations, a rapid increase in stretch, and an immediate risk of rupture. Microtubule polymerization and depolymerization decrease the overall axonal stiffness, but do not affect the evolution of damage at timescales relevant to axonal failure. Our study explains different failure mechanisms in the axon as emergent properties of microtubule polymerization, cross-link dynamics, and physical forces. We anticipate that our model will provide insight into causal relations by which molecular mechanisms determine the timeline and severity of axon damage after a physical impact to the brain.	[de Rooij, Rijk; Kuhl, Ellen] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA		Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X	Stanford Graduate FellowshipStanford University; Bio-X IIP seed grant Molecular Mechanisms of Chronic Traumatic Encephalopathy; National Science Foundation grant Understanding Neurodegeneration across the Scales [CMMI 1727268]; Humboldt Research AwardAlexander von Humboldt Foundation	This study was supported by the Stanford Graduate Fellowship to R.d.R. and by the Bio-X IIP seed grant Molecular Mechanisms of Chronic Traumatic Encephalopathy, the National Science Foundation grant Understanding Neurodegeneration across the Scales (CMMI 1727268), and the Humboldt Research Award to E.K.	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Ahmed W. W., 2012, FUNDAMENTALS FRONTIE; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Castle BT, 2017, MOL BIOL CELL, V28, P1238, DOI 10.1091/mbc.E16-08-0567; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; de Rooij R, 2017, COMPUT MECH, V59, P523, DOI 10.1007/s00466-016-1359-y; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Franze K, 2013, ANNU REV BIOMED ENG, V15, P227, DOI 10.1146/annurev-bioeng-071811-150045; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Garcia-Grajales JA, 2017, COMPUT METHOD APPL M, V314, P147, DOI 10.1016/j.cma.2016.07.032; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goriely A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.138001; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; HAAK RA, 1976, J PHYSIOL-LONDON, V263, P115, DOI 10.1113/jphysiol.1976.sp011624; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Holland MA, 2015, ANN BIOMED ENG, V43, P1640, DOI 10.1007/s10439-015-1312-9; Igaev M, 2014, BIOPHYS J, V107, P2567, DOI 10.1016/j.bpj.2014.09.016; Jakobs M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00441; Kasas S, 2004, BIOL CELL, V96, P697, DOI 10.1016/j.biolcel.2004.09.002; King S, 2012, DYNEINS: STRUCTURE, BIOLOGY AND DISEASE, pXIII; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Krieg M, 2017, ELIFE, V6, DOI [10.7554/eLife.20172, 10.7554/elife.20172]; LAMOUREUX P, 1989, NATURE, V340, P156, DOI 10.1038/340159a0; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Lemaitre J., 1992, COURSE DAMAGE MECH; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; O'Toole M, 2015, BIOPHYS J, V108, P1027, DOI 10.1016/j.bpj.2015.01.021; Pannese E., 2015, NEUROCYTOLOGY FINE S; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Prahl LS, 2014, METHOD ENZYMOL, V540, P35, DOI 10.1016/B978-0-12-397924-7.00003-0; Recho P, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032410; Roossien DH, 2014, J CELL SCI, V127, P3593, DOI 10.1242/jcs.152611; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Soheilypour M, 2015, BIOPHYS J, V108, P1718, DOI 10.1016/j.bpj.2015.01.030; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; van den Bedem H, 2015, BIOPHYS J, V109, P2215, DOI 10.1016/j.bpj.2015.10.020; Vemu A, 2016, J BIOL CHEM, V291, P12907, DOI 10.1074/jbc.C116.731133; Voelzmann A, 2016, BRAIN RES BULL, V126, P226, DOI 10.1016/j.brainresbull.2016.08.006; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yogev S, 2016, NEURON, V92, P449, DOI 10.1016/j.neuron.2016.09.036; YU WQ, 1994, J NEUROSCI, V14, P2818; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	65	20	20	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	JAN 9	2018	114	1					201	212		10.1016/j.bpj.2017.11.010			12	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	FS2FZ	WOS:000419595500021	29320687	Green Published, Bronze			2022-02-06	
J	Ramirez, BJ; Gupta, V				Ramirez, B. J.; Gupta, V.			Evaluation of novel temperature-stable viscoelastic polyurea foams as helmet liner materials	MATERIALS & DESIGN			English	Article						Viscoelastic foams; Polyurea; Football helmets; Impact mitigation; Strain rate sensitivity	GLASS COMPOSITE JOINTS; HIGH-STRAIN RATES; DYNAMIC TENSILE-STRENGTH; PROFESSIONAL FOOTBALL; PRESSURE-SENSITIVITY; CONSTITUTIVE MODEL; POLYMERIC FOAMS; BEHAVIOR; DEFORMATION; CONCUSSION	Viscoelastic polyurea foams with densities of 98, 170, and 230 kg/m(3) were manufactured and integrated into helmet shells and tested using the NOCSAE and FMVSS 218 standards for football and motorcycle helmets, respectively. For football helmet testing, a Riddell Revolution helmet shell was used. The helmets with a foam liner thickness of 28 mm were dropped using a NOCSAE medium headform (4.9 kg) from heights ranging from 0.305 to 1.524 m. All impact tests were done on the crown of the helmet and dropped on a 12.7 mm modular elastomer programmer pad. Use of PU98 foam resulted in a reduction of 22% in peak g's and 25% in Severity Index and Head Injury Criteria values when compared to helmets with the original VN600 foams under ambient conditions. These tests were repeated under varying temperatures along with a reduced liner thickness of 22.2 mm. In these tests, PU98 foam reduced the peak g's by 18% at 23 degrees C, 26% at - 15 degrees C, and 20%, at 50 degrees C when compared to VN600 helmets. The FMVSS motorcycle helmet tests demonstrated the success of using an additional layer of polyurea foam liner on top of the existing expanded polystyrene liner in reducing the peak g's by 17%. (C) 2017 Elsevier Ltd. All rights reserved.	[Ramirez, B. J.; Gupta, V.] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA		Ramirez, BJ; Gupta, V (corresponding author), Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA.	bjramirez@ucla.edu; vgupta@ucla.edu			Office of Naval ResearchOffice of Naval Research [N0008]	This work was supported by the Office of Naval Research under grant number N0008 for which we are grateful to Dr. Roshdy Barsoum of the agency.	Amini MR, 2010, MECH MATER, V42, P628, DOI 10.1016/j.mechmat.2009.09.008; Amini MR, 2010, INT J IMPACT ENG, V37, P82, DOI 10.1016/j.ijimpeng.2009.04.002; Amirkhizi AV, 2006, PHILOS MAG, V86, P5847, DOI 10.1080/14786430600833198; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Choi T, 2012, MACROMOLECULES, V45, P3581, DOI 10.1021/ma300128d; Fragiadakis D, 2010, POLYMER, V51, P178, DOI 10.1016/j.polymer.2009.11.028; Gadd C. W., 1966, 660793 SAE, P164; Gibson L. J., 1999, CELLULAR SOLIDS STRU; Grujicic M, 2010, MAT SCI ENG A-STRUCT, V527, P7741, DOI 10.1016/j.msea.2010.08.042; Gupta V, 2014, EXP MECH, V54, P1133, DOI 10.1007/s11340-014-9854-6; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; He Y, 2014, J MATER SCI, V49, P7339, DOI 10.1007/s10853-014-8458-y; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Holzworth K, 2013, POLYMER, V54, P3079, DOI 10.1016/j.polymer.2013.03.067; Jain A, 2013, J ADHES SCI TECHNOL, V27, P403, DOI 10.1080/01694243.2012.705545; Jain A, 2012, MECH MATER, V46, P16, DOI 10.1016/j.mechmat.2011.11.003; Jeong KY, 2012, J MECH SCI TECHNOL, V26, P2033, DOI 10.1007/s12206-012-0509-1; Jia Z., 2014, C P SOC EXPT MECH SE, V2, P17; Jiao T, 2007, AIP CONF PROC, V955, P707, DOI 10.1063/1.2833212; Jiao T, 2009, AIP CONF PROC, V1195, P1229; Kim H, 2012, MECH MATER, V45, P10, DOI 10.1016/j.mechmat.2011.08.017; Lindholm US., 1974, J CELL PLAST, V10, P127, DOI DOI 10.1177/0021955X7401000306; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Mills NJ, 2007, POLYMER FOAMS HANDBOOK: ENGINEERING AND BIOMECHANICS APPLICATIONS AND DESIGN GUIDE, P1; Moss W. C., 2011, LLNLSR464951; National Operating Committee on Standards for Athletic Equipment, 1998, 00298M03 NOCSAE; National Operating Committee on Standards for Athletic Equipment, 2004, 00104M05 NOCSAE; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ramirez BJ, 2017, J APPL PHYS, V121, DOI 10.1063/1.4985280; Roland CM, 2007, POLYMER, V48, P574, DOI 10.1016/j.polymer.2006.11.051; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; RUSCH KC, 1970, J APPL POLYM SCI, V14, P1433, DOI 10.1002/app.1970.070140603; RUSCH KC, 1969, J APPL POLYM SCI, V13, P2297, DOI 10.1002/app.1969.070131106; Sarva SS, 2007, POLYMER, V48, P2208, DOI 10.1016/j.polymer.2007.02.058; Shariatmadari MR, 2012, MATER DESIGN, V37, P543, DOI 10.1016/j.matdes.2011.10.045; Shim J, 2009, INT J IMPACT ENG, V36, P1116, DOI 10.1016/j.ijimpeng.2008.12.010; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Yi J, 2006, POLYMER, V47, P319, DOI 10.1016/j.polymer.2005.10.107; Youssef G, 2012, J MATER RES, V27, P494, DOI 10.1557/jmr.2011.405; Zhang J, 1997, J ENG MATER-T ASME, V119, P284, DOI 10.1115/1.2812258	44	20	21	3	69	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	JAN 5	2018	137						298	304		10.1016/j.matdes.2017.10.037			7	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	FM0PO	WOS:000414669500029					2022-02-06	
J	Filho, IT				Filho, Ivo Torres			Hemorrhagic Shock and the Microvasculature	COMPREHENSIVE PHYSIOLOGY			English	Article							NEAR-INFRARED SPECTROSCOPY; BODY NEGATIVE-PRESSURE; FRESH-FROZEN PLASMA; RED-BLOOD-CELLS; ENDOTHELIAL GLYCOCALYX DEGRADATION; HEMOGLOBIN OXYGEN-SATURATION; TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; HYPERTONIC SALINE RESUSCITATION; INDUCED VASCULAR HYPOREACTIVITY	The microvasculature plays a central role in the pathophysiology of hemorrhagic shock and is also involved in arguably all therapeutic attempts to reverse or minimize the adverse consequences of shock. Microvascular studies specific to hemorrhagic shock were reviewed and broadly grouped depending on whether data were obtained on animal or human subjects. Dedicated sections were assigned to microcirculatory changes in specific organs, and major categories of pathophysiological alterations and mechanisms such as oxygen distribution, ischemia, inflammation, glycocalyx changes, vasomotion, endothelial dysfunction, and coagulopathy as well as biomarkers and some therapeutic strategies. Innovative experimental methods were also reviewed for quantitative microcirculatory assessment as it pertains to changes during hemorrhagic shock. The text and figures include representative quantitative microvascular data obtained in various organs and tissues such as skin, muscle, lung, liver, brain, heart, kidney, pancreas, intestines, and mesentery from various species including mice, rats, hamsters, sheep, swine, bats, and humans. Based on reviewed findings, a new integrative conceptual model is presented that includes about 100 systemic and local factors linked to microvessels in hemorrhagic shock. The combination of systemic measures with the understanding of these processes at the microvascular level is fundamental to further develop targeted and personalized interventions that will reduce tissue injury, organ dysfunction, and ultimately mortality due to hemorrhagic shock. Published 2018.	[Filho, Ivo Torres] US Army, Inst Surg Res, JBSA, Ft Sam Houston, TX 78234 USA		Filho, IT (corresponding author), US Army, Inst Surg Res, JBSA, Ft Sam Houston, TX 78234 USA.	ivo.p.torresfilho.civ@mail.mil		Torres Filho, Ivo/0000-0003-1797-519X	US Army Medical Research Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Brazilian National Council for Scientific and Technological DevelopmentConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Pew Charitable Trusts; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; US Department of DefenseUnited States Department of Defense	The opinions or assertions contained herein are the private views of the author and not to be construed as official or as reflecting the views of the Department of the Army or the US Department of Defense. This study was supported by the US Army Medical Research Materiel Command. The experimental studies by the author were conducted in compliance with the Animal Welfare Act, the implementing Animal Welfare Regulations, and the principles of the Guide for the Care and Use of Laboratory Animals, using protocols approved by the Institutional Animal Care and Use Committee of the respective institutions, including the US Army ISR. The author thanks the wisdom, support, and collaboration of various colleagues, technicians, and students, mainly at the State and Federal Universities of Rio de Janeiro, University of Washington, University of Arizona, University of California, San Diego, Virginia Commonwealth University, and US Army Institute of Surgical Research. The support from the Brazilian National Council for Scientific and Technological Development, the Pew Charitable Trusts, National Institutes of Health, and the US Department of Defense is also acknowledged. The author declares no competing financial interests although has intellectual property on the use of resonance Raman spectroscopy for tissue oxygenation monitoring.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; ACHAKRI H, 1995, J VASC RES, V32, P237, DOI 10.1159/000159098; Adolphs J, 2003, ANESTHESIOLOGY, V99, P685, DOI 10.1097/00000542-200309000-00025; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aksu U, 2012, RESUSCITATION, V83, P767, DOI 10.1016/j.resuscitation.2011.11.022; ALTURA BM, 1976, EUR J PHARMACOL, V37, P155, DOI 10.1016/0014-2999(76)90018-2; ALTURA BM, 1976, J PHARMACOL EXP THER, V198, P187; AMUNDSON B, 1980, ACTA PHYSIOL SCAND, V108, P147, DOI 10.1111/j.1748-1716.1980.tb06512.x; AMUNDSON B, 1982, SCAND J PLAST RECONS, P16; AMUNDSON B, 1980, ACTA PHYSIOL SCAND, V108, P139, DOI 10.1111/j.1748-1716.1980.tb06511.x; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Audonnet-Blaise S, 2006, RESUSCITATION, V70, P124, DOI 10.1016/j.resuscitation.2005.11.014; Ba ZF, 2005, AM J PHYSIOL-GASTR L, V288, pG860, DOI 10.1152/ajpgi.00437.2004; BADONNEL MC, 1983, J NEUROPATH EXP NEUR, V42, P561, DOI 10.1097/00005072-198309000-00008; BADR KF, 1988, NEW ENGL J MED, V319, P623; BAEZ S, 1964, Int Anesthesiol Clin, V2, P365, DOI 10.1097/00004311-196402000-00012; BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0; Balaz D, 2016, UNDERSEA HYPERBAR M, V43, P123; Ban KC, 2015, SHOCK, V44, P452, DOI 10.1097/SHK.0000000000000452; Baron BJ, 2004, J TRAUMA, V57, P69, DOI 10.1097/01.TA.0000090754.94232.2C; BARROSOARANDA J, 1988, CIRC RES, V63, P437, DOI 10.1161/01.RES.63.2.437; BarrosoAranda J, 1995, J CARDIOVASC PHARM, V25, pS23, DOI 10.1097/00005344-199500252-00006; BARROSOARANDA J, 1989, AM J PHYSIOL, V257, pH846, DOI 10.1152/ajpheart.1989.257.3.H846; Bartlett AH, 2007, MOL CELLS, V24, P153; Bauer C, 2004, SHOCK, V21, P165, DOI 10.1097/01.shk.0000107442.26299.fb; Bauer I, 1998, HEPATOLOGY, V27, P829, DOI 10.1002/hep.510270327; Becker BF, 2011, NUCLEOS NUCLEOT NUCL, V30, P1161, DOI 10.1080/15257770.2011.605089; Becker BF, 2015, BRIT J CLIN PHARMACO, V80, P389, DOI 10.1111/bcp.12629; BEHRMAN SW, 1991, J TRAUMA, V31, P589, DOI 10.1097/00005373-199105000-00001; Beilman GJ, 1999, SHOCK, V12, P196, DOI 10.1097/00024382-199909000-00005; Belizaire RM, 2012, J AM COLL SURGEONS, V214, P648, DOI 10.1016/j.jamcollsurg.2011.12.032; BELLAMY RF, 1984, CIRC SHOCK, V14, P113; BENNETT HS, 1959, AM J PHYSIOL, V196, P381, DOI 10.1152/ajplegacy.1959.196.2.381; Bertuglia S, 1997, MICROVASC RES, V54, P233, DOI 10.1006/mvre.1997.2042; Bezemer R, 2010, MED BIOL ENG COMPUT, V48, P1233, DOI 10.1007/s11517-010-0698-7; Bezemer R, 2010, OPT EXPRESS, V18, P15054, DOI 10.1364/OE.18.015054; Bhattacharjee H, 2011, SHOCK, V35, P590, DOI 10.1097/SHK.0b013e3182150e80; BICHER HI, 1971, J PHYSIOL-LONDON, V217, P689, DOI 10.1113/jphysiol.1971.sp009594; Bjerkvig CK, 2016, TRANSFUSION, V56, pS182, DOI 10.1111/trf.13500; BLAHITKA J, 1977, CIRC SHOCK, V4, P79; Bliemel C, 2014, J TRAUMA ACUTE CARE, V76, P366, DOI [10.1097/TA.0000000000000088, 10.1097/TA.0b013e3182aafd7a]; BOHLEN HG, 1976, MICROVASC RES, V11, P103, DOI 10.1016/0026-2862(76)90081-9; Bojic S, 2015, TOHOKU J EXP MED, V237, P103, DOI 10.1620/tjem.237.103; Boldt J, 2010, INTENS CARE MED, V36, P1299, DOI 10.1007/s00134-010-1912-7; BORGSTROM P, 1992, CIRC SHOCK, V36, P57; BORGSTROM P, 1990, AM J PHYSIOL, V259, pH190, DOI 10.1152/ajpheart.1990.259.1.H190; Bougle A, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-1; BOUSKELA E, 1989, BRAZ J MED BIOL RES, V22, P259; BOUSKELA E, 1979, AM J PHYSIOL, V237, pH59, DOI 10.1152/ajpheart.1979.237.1.H59; BOUSKELA E, 1989, MICROVASC RES, V37, P339, DOI 10.1016/0026-2862(89)90051-4; BOUSKELA E, 1990, ACTA PHYSIOL SCAND, V140, P85, DOI 10.1111/j.1748-1716.1990.tb08978.x; Branemark P-I, 2006, J Tissue Viability, V16, P16; Branemark PI, 1968, MICROCIRCULATION REL, P161; BREDENBERG CE, 1980, ANN SURG, V192, P86, DOI 10.1097/00000658-198007000-00015; Breithaupt-Faloppa AC, 2013, SHOCK, V40, P203, DOI 10.1097/SHK.0b013e3182a01e24; Breslin JW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003336; BREZIS M, 1994, AM J PHYSIOL-RENAL, V267, pF1063, DOI 10.1152/ajprenal.1994.267.6.F1063; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Brookes ZLS, 2002, BRIT J ANAESTH, V88, P255, DOI 10.1093/bja/88.2.255; Bruegger D, 2005, AM J PHYSIOL-HEART C, V289, pH1993, DOI 10.1152/ajpheart.00218.2005; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2014, J TRAUMA ACUTE CARE, V76, P19; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Cabrales P, 2005, SHOCK, V24, P66, DOI 10.1097/01.shk.0000167111.80753.ef; Cabrales P, 2005, SHOCK, V23, P549, DOI 10.1097/01.shk.0000164187.38741.19; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH363, DOI 10.1152/ajpheart.01039.2003; Cabrales P, 2008, RESUSCITATION, V77, P379, DOI 10.1016/j.resuscitation.2008.01.008; Cabrales P, 2007, RESUSCITATION, V72, P306, DOI 10.1016/j.resuscitation.2006.06.021; Cabrales P, 2009, RESUSCITATION, V80, P1431, DOI 10.1016/j.resuscitation.2009.09.005; Cabrales P, 2009, RESUSCITATION, V80, P707, DOI 10.1016/j.resuscitation.2009.03.001; Cabrates P, 2007, RESUSCITATION, V75, P124, DOI 10.1016/j.resuscitation.2007.03.010; Cardenas JC, 2014, CURR OPIN HEMATOL, V21, P404, DOI 10.1097/MOH.0000000000000063; Carpentier P, 1981, CAPILLAROSCOPIE PERI; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; Chambers R, 1944, AM J ANAT, V75, P173, DOI 10.1002/aja.1000750204; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chappell D, 2007, ANESTHESIOLOGY, V107, P776, DOI 10.1097/01.anes.0000286984.39328.96; Chappell D, 2014, EUR J ANAESTH, V31, P474, DOI 10.1097/EJA.0000000000000085; Chappell D, 2011, ANESTHESIOLOGY, V115, P483, DOI 10.1097/ALN.0b013e3182289988; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chappell D, 2009, CARDIOVASC RES, V83, P388, DOI 10.1093/cvr/cvp097; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Chelazzi C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0741-z; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Chen CW, 1997, ACTA PHYSIOL SCAND, V161, P281, DOI 10.1046/j.1365-201X.1997.00216.x; Chen CW, 1999, SHOCK, V12, P69, DOI 10.1097/00024382-199907000-00010; Chen HZ, 2005, J SURG RES, V123, P235, DOI 10.1016/j.jss.2004.08.025; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Cheung AT, 2006, CLIN HEMORHEOL MICRO, V34, P325; CHIEN S, 1967, PHYSIOL REV, V47, P214, DOI 10.1152/physrev.1967.47.2.214; Chignalia AZ, 2016, SHOCK, V45, P338, DOI 10.1097/SHK.0000000000000513; Childs EW, 2008, AM J PHYSIOL-HEART C, V294, pH2285, DOI 10.1152/ajpheart.01361.2007; Childs EW, 2008, SHOCK, V29, P636, DOI 10.1097/SHK.0b013e318157f524; Childs EW, 2007, AM J PHYSIOL-HEART C, V292, pH3179, DOI 10.1152/ajpheart.01337.2006; Childs EW, 2010, SHOCK, V34, P229, DOI 10.1097/SHK.0b013e3181d75b50; Childs EW, 2005, J TRAUMA, V58, P271, DOI 10.1097/01.TA.0000119203.24601.7E; Childs EW, 2002, SHOCK, V18, P423, DOI 10.1097/00024382-200211000-00006; Choi JY, 2012, SHOCK, V38, P635, DOI 10.1097/SHK.0b013e318273299f; Chong SP, 2015, BIOMED OPT EXPRESS, V6, P1429, DOI 10.1364/BOE.6.001429; Clavijo JA, 2008, MED SCI MONITOR, V14, pBR175; Coffey JC, 2016, LANCET GASTROENTEROL, V1, P238, DOI 10.1016/S2468-1253(16)30026-7; COLANTUONI A, 1985, MICROVASC RES, V30, P133, DOI 10.1016/0026-2862(85)90045-7; COLANTUONI A, 1994, INT J MICROCIRC, V14, P151, DOI 10.1159/000178823; Convertino VA, 2013, J APPL PHYSIOL, V115, P1196, DOI 10.1152/japplphysiol.00668.2013; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Cooper ES, 2009, J TRAUMA, V66, P1365, DOI 10.1097/TA.0b013e3181919e43; Coyan GN, 2014, SHOCK, V42, P518, DOI 10.1097/SHK.0000000000000241; Crimi E, 2012, J CRIT CARE, V27, P108, DOI 10.1016/j.jcrc.2011.06.001; Crookes BA, 2005, J TRAUMA, V58, P806, DOI 10.1097/01.TA.0000158269.68409.1C; CRYER HM, 1985, J SURG RES, V39, P59, DOI 10.1016/0022-4804(85)90162-3; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; Czabanka M, 2007, CURR VASC PHARMACOL, V5, P266, DOI 10.2174/157016107782023389; Davenport RA, 2016, CURR OPIN ANESTHESIO, V29, P212, DOI 10.1097/ACO.0000000000000295; Davis M. J., 2011, COMPREHENSIVE PHYSL, P161, DOI [10.1002/cphy.cp020406, DOI 10.1002/CPHY.CP020406]; DAVIS MJ, 1985, AM J PHYSIOL, V248, pH143, DOI 10.1152/ajpheart.1985.248.1.H143; DAVIS MJ, 1987, MICROVASC RES, V34, P223, DOI 10.1016/0026-2862(87)90055-0; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2004, AM HEART J, V147, P91, DOI 10.1016/j.ahj.2003.07.006; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; De Backer D, 2014, BEST PRAC RES-CL ANA, V28, P441, DOI 10.1016/j.bpa.2014.09.005; de Carvalho H, 1999, SHOCK, V12, P75, DOI 10.1097/00024382-199907000-00011; Deb S, 1999, J TRAUMA, V46, P582, DOI 10.1097/00005373-199904000-00005; Deitch EA, 2014, CRIT CARE MED, V42, pE200, DOI 10.1097/CCM.0000000000000119; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; DeLano FA, 2014, SHOCK, V41, P55, DOI 10.1097/SHK.0000000000000048; DeLano FA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005046; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; DEMLING RH, 1980, SURGERY, V87, P552; DEMLING RH, 1980, CIRC SHOCK, V7, P149; DEMLING RH, 1980, J TRAUMA, V20, P856, DOI 10.1097/00005373-198010000-00006; Deng XY, 2016, SHOCK, V45, P50, DOI 10.1097/SHK.0000000000000458; deWerra I, 1997, CRIT CARE MED, V25, P607, DOI 10.1097/00003246-199704000-00009; Driessen B, 2007, CRIT CARE MED, V35, P2101, DOI 10.1097/01.CCM.0000277040.31978.3D; DRUCKER WR, 1975, ANN SURG, V181, P698, DOI 10.1097/00000658-197505000-00026; Dubin A, 2009, INTENS CARE MED, V35, P556, DOI 10.1007/s00134-008-1385-0; DULING BR, 1981, AM J PHYSIOL, V241, pH108, DOI 10.1152/ajpheart.1981.241.1.H108; Dunphy I, 2002, ANAL BIOCHEM, V310, P191, DOI 10.1016/S0003-2697(02)00384-6; Duret J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0854-4; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Ekelund U, 1996, ACTA PHYSIOL SCAND, V157, P471, DOI 10.1046/j.1365-201X.1996.516275000.x; Ekelund U, 1998, ACTA PHYSIOL SCAND, V164, P285; ELLIS CG, 1990, AM J PHYSIOL, V258, pH1216, DOI 10.1152/ajpheart.1990.258.4.H1216; ERNI D, 1995, EUR J ANAESTH, V12, P423; Essayagh S, 2005, THROMB HAEMOSTASIS, V94, P853, DOI 10.1160/TH04-12-0786; Estrada AD, 2008, OPT LETT, V33, P1038, DOI 10.1364/OL.33.001038; FABER JE, 1982, AM J PHYSIOL, V243, pH837, DOI 10.1152/ajpheart.1982.243.6.H837; Fang XS, 2006, CRIT CARE MED, V34, pS447, DOI 10.1097/01.CCM.0000246011.86907.3A; Fellahi JL, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.05.004; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Fruchterman TM, 1998, SHOCK, V10, P417, DOI 10.1097/00024382-199812000-00007; Fulop A, 2013, EUR SURG RES, V50, P57, DOI 10.1159/000348808; Gagnon L, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00082; Geppert A, 2002, CRIT CARE MED, V30, P1987, DOI 10.1097/00003246-200209000-00007; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Goering J, 2016, SHOCK, V45, P33, DOI 10.1097/SHK.0000000000000477; Golub AS, 1997, BIOPHYS J, V73, P452, DOI 10.1016/S0006-3495(97)78084-6; Gomez H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135032; Gong WF, 2011, J TRAUMA, V71, P275, DOI 10.1097/TA.0b013e318226eb51; GORBUNOVA NA, 1991, GEMATOL TRANSFUZIOL, V36, P3; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; GRAY SD, 1972, J TRAUM, V12, P147, DOI 10.1097/00005373-197202000-00008; GROSSLIGHT K, 1985, ANESTHESIOLOGY, V63, P533, DOI 10.1097/00000542-198511000-00011; Gruartmoner G, 2015, CURR OPIN CRIT CARE, V21, P276, DOI 10.1097/MCC.0000000000000220; Gulati A, 2016, CURR VASC PHARMACOL, V14, P187, DOI 10.2174/1570161114666151202210221; GUNNARSSON U, 1994, SHOCK, V2, P60, DOI 10.1097/00024382-199407000-00012; Gustafsson U, 1995, INT J MICROCIRC, V15, P163, DOI 10.1159/000178971; GUSTAFSSON U, 1991, MICROVASC RES, V42, P224, DOI 10.1016/0026-2862(91)90090-X; Gutierrez G, 2004, CRIT CARE, V8, P373, DOI 10.1186/cc2851; Hahnenkamp K, 2002, ANESTH ANALG, V94, P1441, DOI 10.1097/00000539-200206000-00011; HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025; Haljamae H, 1984, Am J Emerg Med, V2, P100, DOI 10.1016/0735-6757(84)90117-7; HARRIS PD, 1970, AM J PHYSIOL, V218, P560, DOI 10.1152/ajplegacy.1970.218.2.560; Harrois A, 2013, CRIT CARE MED, V41, pE376, DOI 10.1097/CCM.0b013e318292388d; Haugaa H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0903-z; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Helling TS, 2005, J AM COLL SURGEONS, V201, P774, DOI 10.1016/j.jamcollsurg.2005.05.035; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; HERSHEY SG, 1950, ANESTHESIOLOGY, V11, P145, DOI 10.1097/00000542-195003000-00001; Hierholzer C, 2001, ARCH ORTHOP TRAUM SU, V121, P219, DOI 10.1007/s004020000211; Hildebrand F, 2006, J LEUKOCYTE BIOL, V79, P1173, DOI 10.1189/jlb.0106029; HILLEN GP, 1971, AM J SURG, V122, P639, DOI 10.1016/0002-9610(71)90292-3; Hinojosa-Laborde C, 2014, J APPL PHYSIOL, V116, P406, DOI 10.1152/japplphysiol.00640.2013; Hiratsuka M, 2009, INFLAMM RES, V58, P463, DOI 10.1007/s00011-009-0011-0; Hofmann-Kiefer KF, 2009, EUR J MED RES, V14, P526; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holcomb JB, 2011, ANN SURG, V254, P201, DOI 10.1097/SLA.0b013e318226483d; Holcroft JW, 1999, J TRAUMA, V46, P588; Horstick G, 2002, CRIT CARE MED, V30, P851, DOI 10.1097/00003246-200204000-00023; Hu Y, 2014, J TRAUMA ACUTE CARE, V76, P394, DOI 10.1097/TA.0b013e3182aa2d98; Hubbard W, 2015, J SURG RES, V193, P355, DOI 10.1016/j.jss.2014.06.047; HUGUET C, 1978, ARCH SURG-CHICAGO, V113, P1448; Hungerer S, 2006, ARTIF CELL BLOOD SUB, V34, P455, DOI 10.1080/10731190600769008; HUTCHINS PM, 1973, MICROVASC RES, V5, P131, DOI 10.1016/0026-2862(73)90064-2; Hyttel-Sorensen S, 2014, J CLIN MONIT COMPUT, V28, P149, DOI 10.1007/s10877-013-9507-9; Ince C, 2016, J APPL PHYSIOL, V120, P226, DOI 10.1152/japplphysiol.00298.2015; Ince C, 2015, CRIT CARE, V19, DOI 10.1186/cc14726; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; INTAGLIETTA M, 1991, BLOOD VESSELS, V28, P1; INTAGLIETTA M, 1972, J APPL PHYSIOL, V32, P546, DOI 10.1152/jappl.1972.32.4.546; INTAGLIETTA M, 1971, IEEE T BIO-MED ENG, VBM18, P376, DOI 10.1109/TBME.1971.4502869; INTAGLIETTA M, 1976, MED PROG TECHNOL, V4, P55; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Ivanov KP, 2006, B EXP BIOL MED+, V141, P666, DOI 10.1007/s10517-006-0247-4; Japee SA, 2005, MICROCIRCULATION, V12, P489, DOI 10.1080/10739680591003332; Japee SA, 2004, MICROCIRCULATION, V11, P39, DOI 10.1080/10739680490266171; Jia JM, 2017, NAT METHODS, V14, P160, DOI [10.1038/NMETH.4105, 10.1038/nmeth.4105]; Jiang H, 2014, SHOCK, V42, P271, DOI 10.1097/SHK.0000000000000212; Jin XH, 1998, J APPL PHYSIOL, V85, P2360, DOI 10.1152/jappl.1998.85.6.2360; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johnson BD, 2014, J APPL PHYSIOL, V117, P131, DOI 10.1152/japplphysiol.00070.2014; JOHNSON PC, 1973, MICROVASC RES, V5, P292, DOI 10.1016/0026-2862(73)90040-X; Jones T.W., 1852, PHILOS T R SOC LOND, V142, P131, DOI [10.1098/rstl.1852.0011, DOI 10.1098/RSTL.1852.0011]; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; Kamoun WS, 2010, NAT METHODS, V7, P655, DOI [10.1038/NMETH.1475, 10.1038/nmeth.1475]; Edul VSK, 2012, CRIT CARE MED, V40, P1443, DOI 10.1097/CCM.0b013e31823dae59; Kara A, 2016, CURR OPIN CRIT CARE, V22, P444, DOI 10.1097/MCC.0000000000000335; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kerger H, 1996, AM J PHYSIOL-HEART C, V270, pH827, DOI 10.1152/ajpheart.1996.270.3.H827; Kerger H, 1997, ANESTHESIOLOGY, V86, P372, DOI 10.1097/00000542-199702000-00012; Kerger H, 1999, AM J PHYSIOL-HEART C, V276, pH2035, DOI 10.1152/ajpheart.1999.276.6.H2035; KERGER H, 1995, AM J PHYSIOL-HEART C, V268, pH802, DOI 10.1152/ajpheart.1995.268.2.H802; Kerger H, 1997, AM J PHYSIOL-HEART C, V272, pH525, DOI 10.1152/ajpheart.1997.272.1.H525; Kheirbek T, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-65; KITAJIMA T, 1995, DIGESTION, V56, P111, DOI 10.1159/000201230; KOO A, 1977, MICROVASC RES, V13, P315, DOI 10.1016/0026-2862(77)90097-8; Korzonek-Szlacheta I, 2007, PHARMACOL REP, V59, P98; Kottke MA, 2016, SHOCK, V46, P20, DOI 10.1097/SHK.0000000000000666; Koury J, 2004, SHOCK, V22, P270, DOI 10.1097/01.shk.0000135256.67441.3f; Kovach A G, 1988, Prog Clin Biol Res, V264, P147; KOVACH AGB, 1979, ACTA PHYSIOL HUNG, V54, P333; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; KOZIOL JM, 1988, J TRAUMA, V28, P10; Krejci V, 2000, BRIT J ANAESTH, V84, P468, DOI 10.1093/oxfordjournals.bja.a013472; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; Kubulus D, 2008, SHOCK, V29, P583, DOI 10.1097/SHK.0b013e318157e526; Kubulus D, 2009, SHOCK, V32, P179, DOI 10.1097/SHK.0b013e318199352b; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lapi D, 2008, J VASC RES, V45, P89, DOI 10.1159/000109818; LAZARUS HM, 1984, CIRC SHOCK, V13, P171; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; LEE RE, 1949, AM J PHYSIOL, V157, P259, DOI 10.1152/ajplegacy.1949.157.2.259; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Legrand M, 2010, ANESTHESIOLOGY, V112, P119, DOI 10.1097/ALN.0b013e3181c4a5e2; Leong B, 2011, RESUSCITATION, V82, P937, DOI 10.1016/j.resuscitation.2011.03.018; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Li RR, 2015, CRIT CARE MED, V43, pE567, DOI 10.1097/CCM.0000000000001203; Li T, 2011, J CARDIOVASC PHARM, V57, P656, DOI 10.1097/FJC.0b013e318215e21d; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Lima R, 2012, SHOCK, V38, P493, DOI 10.1097/SHK.0b013e31826b64e5; LINDBOM L, 1985, INT J MICROCIRC, V4, P19; Lipowsky HH, 2011, AM J PHYSIOL-HEART C, V301, pH2235, DOI 10.1152/ajpheart.00803.2011; Liu HZ, 2015, FRONT BIOSCI-LANDMRK, V20, P927, DOI 10.2741/4347; Liu Jie, 2000, Chin J Traumatol, V3, P39; Liu LM, 2005, J SURG RES, V125, P128, DOI 10.1016/j.jss.2004.12.008; Lomas-Neira JL, 2016, SHOCK, V45, P157, DOI 10.1097/SHK.0000000000000499; Lomas-Niera JL, 2005, SHOCK, V24, P33, DOI 10.1097/01.shk.0000191411.48719.ab; LONGNECKER DE, 1982, ANESTHESIOLOGY, V57, P177, DOI 10.1097/00000542-198209000-00006; LONGNECKER DE, 1980, FED PROC, V39, P1580; Looney MR, 2014, ANNU REV PHYSIOL, V76, P431, DOI 10.1146/annurev-physiol-021113-170331; Lu HZ, 2014, J SURG RES, V187, P262, DOI 10.1016/j.jss.2013.10.015; Lu XG, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-80; Lubbers DW, 1997, KIDNEY INT, V51, P372, DOI 10.1038/ki.1997.49; LUFT JH, 1966, FED PROC, V25, P1773; Luo ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116076; Maier M, 2003, SHOCK, V19, P457, DOI 10.1097/01.shk.0000056961.48384.f2; Maier S, 2009, J TRAUMA, V66, P337, DOI 10.1097/TA.0b013e31817dac66; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Marki A, 2015, J LEUKOCYTE BIOL, V98, P503, DOI 10.1189/jlb.3MR0115-011R; Martini J, 2013, CRIT CARE MED, V41, pE301, DOI 10.1097/CCM.0b013e31828a4520; Martini J, 2008, CRIT CARE, V12, DOI 10.1186/cc6874; Massey MJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1213-9; Matheson PJ, 2005, MICROSURG, V25, P247, DOI 10.1002/micr.20120; Matsuki T, 2000, MICROCIRCULATION, V7, P411, DOI 10.1038/sj.mn.7300128; MAZZONI MC, 1989, CIRC SHOCK, V29, P27; MAZZONI MC, 1994, INT J MICROCIRC, V14, P144, DOI 10.1159/000178822; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; MAZZONI MC, 1992, J APPL PHYSIOL, V73, P1467, DOI 10.1152/jappl.1992.73.4.1467; MAZZONI MC, 1994, AM J PHYSIOL-HEART C, V267, pH1928, DOI 10.1152/ajpheart.1994.267.5.H1928; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MELLANDER S, 1963, CIRC RES, V13, P105, DOI 10.1161/01.RES.13.2.105; MELLANDER S, 1987, ACTA PHYSIOL SCAND, V129, P325, DOI 10.1111/j.1748-1716.1987.tb08076.x; METZGER H, 1984, ADV EXP MED BIOL, V180, P599; MEYER JU, 1988, MICROVASC RES, V35, P193, DOI 10.1016/0026-2862(88)90062-3; Mik EG, 2004, J APPL PHYSIOL, V97, P1962, DOI 10.1152/japplphysiol.01399.2003; Miyabe M, 2002, ANESTH ANALG, V94, P296, DOI 10.1097/00000539-200202000-00012; Moochhala S, 2009, FRONT BIOSCI-LANDMRK, V14, P4631, DOI 10.2741/3555; Motaharinia J, 2015, DARU, V23, DOI 10.1186/s40199-015-0130-9; Moy AJ, 2011, MICROVASC RES, V82, P199, DOI 10.1016/j.mvr.2011.07.004; Muir WW, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/864237; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Myburgh JA, 2013, NEW ENGL J MED, V369, P2462, DOI 10.1056/NEJMc1313345; MYERS BD, 1986, NEW ENGL J MED, V314, P97; NAGAKAWA B, 1976, SURG GYNECOL OBSTET, V142, P871; Nassour I, 2015, SHOCK, V43, P166, DOI 10.1097/SHK.0000000000000264; Naumann DN, 2016, SHOCK, V46, P609, DOI 10.1097/SHK.0000000000000687; Naumann DN, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0113-4; NERLICH M, 1983, CIRC SHOCK, V10, P179; NICOLL PA, 1946, ANN NY ACAD SCI, V46, P697, DOI 10.1111/j.1749-6632.1946.tb31698.x; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; NYSTROM SHM, 1968, ACTA NEUROPATHOL, V10, P209, DOI 10.1007/BF00687724; Ortiz D, 2014, AM J EMERG MED, V32, P248, DOI 10.1016/j.ajem.2013.11.045; Ostrowski SR, 2017, J TRAUMA ACUTE CARE, V82, P293, DOI 10.1097/TA.0000000000001304; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Paes-da-Silva F, 2003, SHOCK, V19, P55, DOI 10.1097/00024382-200301000-00011; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Pajk W, 2002, AM J PHYSIOL-HEART C, V283, pH2511, DOI 10.1152/ajpheart.00222.2002; Palagyi P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/847152; Pannen BHJ, 1998, J CLIN INVEST, V102, P1220, DOI 10.1172/JCI3428; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Paxian M, 2004, AM J PHYSIOL-GASTR L, V286, pG37, DOI 10.1152/ajpgi.00041.2003; Paxian M, 2003, FASEB J, V17, P993, DOI 10.1096/fj.02-0624com; Paxian M, 2003, SHOCK, V20, P449, DOI 10.1097/01.shk.0000090601.26659.87; Paxian M, 2003, ANESTHESIOLOGY, V98, P1391, DOI 10.1097/00000542-200306000-00014; Paxian M, 2001, SHOCK, V15, P438, DOI 10.1097/00024382-200115060-00005; Peiniger S, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-78; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Pennings FA, 2004, STROKE, V35, P1284, DOI 10.1161/01.STR.0000126039.91400.cb; Perez-Barcena J, 2015, J NEUROL SCI, V353, P38, DOI 10.1016/j.jns.2015.03.044; Peruski AM, 2014, AM J VET RES, V75, P77, DOI 10.2460/ajvr.75.1.77; Peruski AM, 2011, AM J VET RES, V72, P438, DOI 10.2460/ajvr.72.4.438; PINSKY MR, 1993, CHEST, V103, P565, DOI 10.1378/chest.103.2.565; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Potter DR, 2015, J TRAUMA ACUTE CARE, V78, pS7, DOI 10.1097/TA.0000000000000630; Pries A. R., 2006, V176, P1; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; PRIES AR, 1995, AM J PHYSIOL-HEART C, V269, pH1713, DOI 10.1152/ajpheart.1995.269.5.H1713; Prince JM, 2006, J AM COLL SURGEONS, V202, P407, DOI 10.1016/j.jamcollsurg.2005.11.021; PROCTOR HJ, 1979, J TRAUMA, V19, P682, DOI 10.1097/00005373-197909000-00009; Pruefer D, 2003, ANN THORAC SURG, V75, P210, DOI 10.1016/S0003-4975(02)03932-2; Puyana JC, 1999, J TRAUMA, V46, P9, DOI 10.1097/00005373-199901000-00003; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Rajnik M, 2002, SHOCK, V17, P322, DOI 10.1097/00024382-200204000-00015; RANA MW, 1992, J TRAUMA, V32, P420, DOI 10.1097/00005373-199204000-00003; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reitsma S, 2011, THROMB HAEMOSTASIS, V106, P939, DOI 10.1160/TH11-02-0133; Rhee CJ, 2012, J APPL PHYSIOL, V113, P307, DOI 10.1152/japplphysiol.00024.2012; Rickards CA, 2015, COMPR PHYSIOL, V5, P1585, DOI 10.1002/cphy.c140058; Rickards CA, 2015, J APPL PHYSIOL, V119, P677, DOI 10.1152/japplphysiol.00127.2015; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Rixen D, 2001, SHOCK, V16, P239, DOI 10.1097/00024382-200116030-00012; Roesner JP, 2006, INTENS CARE MED, V32, P1649, DOI 10.1007/s00134-006-0335-y; ROMANUS M, 1978, SCAND J PLAST RECONS, V12, P181, DOI 10.3109/02844317809012993; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Rowland MR, 2014, SURGERY, V156, P861, DOI 10.1016/j.surg.2014.06.019; RUMSEY WL, 1988, SCIENCE, V241, P1649, DOI 10.1126/science.3420417; RUSH BF, 1989, ANN SURG, V210, P342, DOI 10.1097/00000658-198909000-00010; RUSSELL DH, 1995, SHOCK, V4, P50, DOI 10.1097/00024382-199507000-00008; Sailhamer EA, 2010, CYTOKINE, V49, P303, DOI 10.1016/j.cyto.2009.11.013; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Sakai H, 1999, AM J PHYSIOL-HEART C, V276, pH563, DOI 10.1152/ajpheart.1999.276.2.H563; Sakai H, 2009, SHOCK, V31, P507, DOI 10.1097/SHK.0b013e318188f83d; Vazquez BYS, 2009, BIORHEOLOGY, V46, P167, DOI 10.3233/BIR-2009-0539; Samarska IV, 2009, ANESTHESIOLOGY, V111, P600, DOI 10.1097/ALN.0b013e3181b31c8e; Sarelius IH, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.985954; Sawant DA, 2014, J PHYSIOL BIOCHEM, V70, P971, DOI 10.1007/s13105-014-0366-8; Sawant DA, 2014, J CARDIOVASC TRANSL, V7, P711, DOI 10.1007/s12265-014-9589-x; Sawant DA, 2011, J TRAUMA, V70, P481, DOI 10.1097/TA.0b013e31820b3ed7; Scalia R, 1999, J EXP MED, V189, P931, DOI 10.1084/jem.189.6.931; SCALIA SV, 1992, J TRAUMA, V33, P321, DOI 10.1097/00005373-199208000-00024; Schmid-Schonbein Geert W, 2011, Bol Soc Port Hemorreol Microcirc, V26, P6; Schmid-Schonbein GW, 2005, MICROCIRCULATION, V12, P71, DOI 10.1080/10739680590896009; Schmid-Schonbein GW, 2001, BIORHEOLOGY, V38, P185; SCHMIDSCHONBEIN GW, 1990, BIORHEOLOGY, V27, P859; Schumacher J, 2006, BRIT J ANAESTH, V96, P437, DOI 10.1093/bja/ael030; Schumacher J, 2003, SHOCK, V20, P565, DOI 10.1097/01.shk.0000093540.78705.71; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; SCHYWALSKY M, 1990, ADV EXP MED BIOL, V277, P697; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; SEYDE WC, 1984, ANESTHESIOLOGY, V61, P686, DOI 10.1097/00000542-198412000-00010; Shen Q, 2017, PHYSL REP, V2; Shinohara H, 1996, HEPATOLOGY, V23, P137, DOI 10.1002/hep.510230119; Shires GT, 2005, AM J SURG, V189, P85, DOI 10.1016/j.amjsurg.2004.06.040; SHORR E, 1948, ANN NY ACAD SCI, V49, P571, DOI 10.1111/j.1749-6632.1948.tb30953.x; Sielenkamper AW, 2000, ANESTHESIOLOGY, V93, P844, DOI 10.1097/00000542-200009000-00036; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Simoes C, 2002, J CARDIOVASC PHARM, V39, P340, DOI 10.1097/00005344-200203000-00004; Sinaasappel M, 1999, J PHYSIOL-LONDON, V514, P245, DOI 10.1111/j.1469-7793.1999.245af.x; SLAAF DW, 1988, AM J PHYSIOL, V255, pH1240, DOI 10.1152/ajpheart.1988.255.5.H1240; SLAAF DW, 1987, INT J MICROCIRC, V6, P391; SMITH M, 1986, J TRAUMA, V26, P217, DOI 10.1097/00005373-198603000-00002; Soller BR, 2012, J TRAUMA ACUTE CARE, V73, pS106, DOI 10.1097/TA.0b013e318260a928; Song D, 1998, ADV EXP MED BIOL, V454, P173; Sordi R, 2015, MOL MED, V21, P563, DOI 10.2119/molmed.2015.00049; Sordia T, 2004, CLIN HEMORHEOL MICRO, V30, P461; Stern S, 2009, SHOCK, V31, P64, DOI 10.1097/SHK.0b013e3181778dc3; STEVENS PM, 1965, AM J CARDIOL, V16, P506, DOI 10.1016/0002-9149(65)90027-5; Stringham JR, 2014, J TRAUMA ACUTE CARE, V76, P1214, DOI 10.1097/TA.0000000000000231; Styp-Rekowska B, 2007, MICROCIRCULATION, V14, P207, DOI 10.1080/10739680601139302; Sun NN, 2014, ACAD RADIOL, V21, P175, DOI 10.1016/j.acra.2013.11.017; Szabo A, 2004, SHOCK, V21, P320, DOI 10.1097/00024382-200404000-00006; SZABO C, 1994, SHOCK, V2, P145, DOI 10.1097/00024382-199408000-00011; Szopinski J, 2011, J TRAUMA, V71, P1779, DOI 10.1097/TA.0b013e31823a05b5; Tachon G, 2014, CRIT CARE MED, V42, P1433, DOI 10.1097/CCM.0000000000000223; Takasu A, 1999, CRIT CARE MED, V27, P1557, DOI 10.1097/00003246-199908000-00025; Tanaka S, 2017, CRIT CARE MED, V45, pE154, DOI 10.1097/CCM.0000000000002064; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; Tharakan B, 2012, SHOCK, V37, P306, DOI 10.1097/SHK.0b013e318240b564; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Torres IP, 2017, J THROMB HAEMOST, V15, P163, DOI 10.1111/jth.13556; Torres Filho IP, 2009, FASEB J, V23, P950; Torres I, 2016, J SURG RES, V201, P425, DOI 10.1016/j.jss.2015.12.001; Filho IT, 2013, MICROVASC RES, V85, P128, DOI 10.1016/j.mvr.2012.11.005; Torres IP, 2008, J APPL PHYSIOL, V104, P1809, DOI 10.1152/japplphysiol.00025.2008; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; Torres IP, 2005, AM J PHYSIOL-HEART C, V289, pH488, DOI 10.1152/ajpheart.01171.2004; TORRES IP, 1994, P NATL ACAD SCI USA, V91, P2081, DOI 10.1073/pnas.91.6.2081; TORRES IP, 1993, AM J PHYSIOL, V265, pH1434; Torres IP, 1996, MICROVASC RES, V51, P202; Torres IP, 2001, SHOCK, V15, P353, DOI 10.1097/00024382-200115050-00004; Torres IP, 2001, LIFE SCI, V68, P1057; TORRES IP, 1994, INT J MICROCIRC, V14, P3; TORRES IP, 1989, AM J PHYSIOL, V257, pH1647; Torres LN, 2008, MICROVASC RES, V75, P217, DOI 10.1016/j.mvr.2007.07.003; Torres LN, 2014, J TRAUMA ACUTE CARE, V77, P716, DOI 10.1097/TA.0000000000000448; Torres LN, 2013, J TRAUMA ACUTE CARE, V75, P759, DOI 10.1097/TA.0b013e3182a92514; TSAI AG, 1993, INT J MICROCIRC, V12, P75; Tsai AG, 2004, TRANSFUSION, V44, P1626, DOI 10.1111/j.0041-1132.2004.04128.x; Tsai AG, 2004, EXPERT OPIN BIOL TH, V4, P1147, DOI 10.1517/14712598.4.7.1147; Tsai AG, 2001, BIORHEOLOGY, V38, P229; Tsai AG, 2010, TRANSFUS APHER SCI, V43, P69, DOI 10.1016/j.transci.2010.05.011; Tsukada K, 2004, J APPL PHYSIOL, V96, P1561, DOI 10.1152/japplphysiol.00764.2003; Turek Z, 2009, SEMIN CARDIOTHORAC V, V13, P249, DOI 10.1177/1089253209353134; Uhl E, 2003, NEUROSURGERY, V52, P1307, DOI 10.1227/01.NEU.0000065154.04824.9E; Vajda K, 2004, EUR SURG RES, V36, P338, DOI 10.1159/000081640; Vajda K, 2004, MICROCIRCULATION, V11, P307, DOI 10.1080/10739680490437469; Vallet B, 2011, ANESTH ANALG, V112, P258, DOI 10.1213/ANE.0b013e3182066299; van Bommel J, 1998, ADV EXP MED BIOL, V454, P189; van Bommel J, 2001, TRANSFUSION, V41, P1515, DOI 10.1046/j.1537-2995.2001.41121515.x; van Golen RF, 2012, FREE RADICAL BIO MED, V52, P1382, DOI 10.1016/j.freeradbiomed.2012.01.013; van Iterson M, 2003, J TRAUMA, V55, P1111, DOI 10.1097/01.TA.0000101391.58216.DD; van Iterson M, 1998, J LAB CLIN MED, V132, P421; van Iterson M, 2012, TRANSFUSION, V52, P1552, DOI 10.1111/j.1537-2995.2011.03471.x; van Meurs M, 2008, SHOCK, V29, P291, DOI 10.1097/shk.0b013e318145a7c1; van Meurs M, 2011, ANESTHESIOLOGY, V115, P474, DOI 10.1097/ALN.0b013e318229a640; van Meurs M, 2009, AM J PHYSIOL-RENAL, V297, pF272, DOI 10.1152/ajprenal.00137.2009; VANDERKLEIJ AJ, 1983, SURGERY, V93, P518; VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476; Vazquez BYS, 2008, BBA-PROTEINS PROTEOM, V1784, P1421, DOI 10.1016/j.bbapap.2008.04.020; Vazquez BYS, 2011, CRIT CARE MED, V39, P1461, DOI 10.1097/CCM.0b013e3182120cdb; VEDDER NB, 1988, J CLIN INVEST, V81, P939, DOI 10.1172/JCI113407; Villela NR, 2011, J TRAUMA, V71, P418, DOI 10.1097/TA.0b013e3181fa2630; Villela NR, 2009, CURR OPIN ANESTHESIO, V22, P163, DOI 10.1097/ACO.0b013e328328d304; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; Vollmar B, 1998, ADV EXP MED BIOL, V454, P95; VOLLMAR B, 1994, AM J PHYSIOL-HEART C, V267, pH1936; Vollmar B, 1997, MICROVASC RES, V54, P164, DOI 10.1006/mvre.1997.2028; Vollmar B, 1996, CRIT CARE MED, V24, P445, DOI 10.1097/00003246-199603000-00014; Vollmer C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/589606; VRIELINK HHEO, 1990, AM J PHYSIOL, V258, pH29, DOI 10.1152/ajpheart.1990.258.1.H29; VRIELINK HHEO, 1989, PFLUG ARCH EUR J PHY, V414, P571, DOI 10.1007/BF00580993; Wan Z, 2010, CRIT CARE MED, V38, P928, DOI 10.1097/CCM.0b013e3181cd100c; Wandall-Frostholm C, 2015, BRIT J PHARMACOL, V172, P4493, DOI 10.1111/bph.13234; Wang B, 2015, SHOCK, V44, P234, DOI 10.1097/SHK.0000000000000408; WANG P, 1993, AM J PHYSIOL, V265, pH973, DOI 10.1152/ajpheart.1993.265.3.H973; WANG P, 1992, CAN J PHYSIOL PHARM, V70, P349, DOI 10.1139/y92-044; WANG P, 1990, CIRC SHOCK, V32, P307; WANG P, 1992, AM J PHYSIOL, V262, pG92, DOI 10.1152/ajpgi.1992.262.1.G92; WANG P, 1991, J SURG RES, V50, P368, DOI 10.1016/0022-4804(91)90205-Z; WANG P, 1990, AM J PHYSIOL, V259, pR645, DOI 10.1152/ajpregu.1990.259.3.R645; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Wang XM, 2012, AM J PHYSIOL-REG I, V302, pR805, DOI 10.1152/ajpregu.00350.2011; Wanner GA, 2000, CRIT CARE MED, V28, P950, DOI 10.1097/00003246-200004000-00007; WARD BJ, 1993, CARDIOVASC RES, V27, P384, DOI 10.1093/cvr/27.3.384; Ward KR, 2010, RESUSCITATION, V81, P987, DOI 10.1016/j.resuscitation.2010.03.027; Ward KR, 2006, CRIT CARE MED, V34, P792, DOI 10.1097/01.CCM.0000201898.43135.3F; Ward KR, 2006, RESUSCITATION, V68, P27, DOI 10.1016/j.resuscitation.2005.06.022; Waschke KF, 2004, J TRAUMA, V56, P591, DOI 10.1097/01.TA.0000075335.35705.E2; Waschke KF, 1996, INTENS CARE MED, V22, P1026, DOI 10.1007/s001340050208; WAYLAND H, 1967, J APPL PHYSIOL, V22, P333, DOI 10.1152/jappl.1967.22.2.333; WEIL MH, 1979, ANESTH ANALG, V58, P124; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wettstein R, 2004, SHOCK, V21, P235, DOI 10.1097/01.shk.0000114301.36496.ea; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; WHALEN WJ, 1967, J APPL PHYSIOL, V23, P798, DOI 10.1152/jappl.1967.23.5.798; White NJ, 2015, J THROMB HAEMOST, V13, P978, DOI 10.1111/jth.12919; Whitehouse T, 2006, AM J PHYSIOL-RENAL, V291, pF647, DOI 10.1152/ajprenal.00475.2005; Wichmann MW, 1998, CRIT CARE MED, V26, P1372, DOI 10.1097/00003246-199808000-00024; Zakaria ER, 2007, SURGERY, V142, P487, DOI 10.1016/j.surg.2007.08.007; Zakaria ER, 2006, SURGERY, V140, P579, DOI 10.1016/j.surg.2006.05.015; Zakaria ER, 2005, J TRAUMA, V58, P499, DOI 10.1097/01.TA.0000152892.24841.54; WIEDERHIELM CA, 1979, MICROVASC RES, V18, P124, DOI 10.1016/0026-2862(79)90022-0; WIEDERHIELM CA, 1964, AM J PHYSIOL, V207, P173, DOI 10.1152/ajplegacy.1964.207.1.173; Wilson DF, 2013, ADV EXP MED BIOL, V789, P51, DOI 10.1007/978-1-4614-7411-1_8; Winslow RM, 2004, ARTIF ORGANS, V28, P800, DOI 10.1111/j.1525-1594.2004.07392.x; WU CH, 1989, INT J MICROCIRC, V8, P303; Wu CY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1135-y; Wu CY, 2015, MICROVASC RES, V101, P55, DOI 10.1016/j.mvr.2015.06.003; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Xu JF, 2013, SHOCK, V39, P361, DOI 10.1097/SHK.0b013e31828936aa; Xu J, 2012, CARDIOVASC RES, V96, P308, DOI 10.1093/cvr/cvs254; Xu J, 2010, J TRAUMA, V69, P1274, DOI 10.1097/TA.0b013e3181d74abe; Yada-Langui MM, 2004, EXP BIOL MED, V229, P684, DOI 10.1177/153537020422900713; YAMASHITA M, 1977, CAN ANAESTH SOC J, V24, P695, DOI 10.1007/BF03006712; Yang GM, 2013, J TRAUMA ACUTE CARE, V74, P1033, DOI 10.1097/TA.0b013e31828586a2; Yang YM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23494; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596; Zaets SB, 2011, J SURG RES, V166, pE135, DOI 10.1016/j.jss.2010.12.001; Zakaria ER, 2007, SHOCK, V27, P436, DOI 10.1097/01.shk.0000245017.86117.4e; Zakaria ER, 2005, SURGERY, V138, P195, DOI 10.1016/j.surg.2005.06.009; Zhang GQ, 2010, AM J PHYSIOL-HEART C, V299, pH1494, DOI 10.1152/ajpheart.00462.2010; Zhang HY, 2011, J SURG RES, V171, P218, DOI 10.1016/j.jss.2010.01.024; ZHAO KS, 1985, MICROVASC RES, V30, P143, DOI 10.1016/0026-2862(85)90046-9; ZHAO KS, 1987, MICROVASC RES, V34, P84, DOI 10.1016/0026-2862(87)90081-1; Zhao KS, 2002, SHOCK, V18, P189, DOI 10.1097/00024382-200208000-00017; Zhao KS, 2000, CLIN HEMORHEOL MICRO, V23, P259; Zhu Y, 2013, J SURG RES, V184, P951, DOI 10.1016/j.jss.2013.03.039; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005; Zweifach Benjamin W., 1995, Microcirculation (New York), V2, P245, DOI 10.3109/10739689509146770; ZWEIFACH BW, 1957, J EXP MED, V106, P403, DOI 10.1084/jem.106.3.403; Zweifach BW, 1944, AM J PHYSIOL, V142, P80, DOI 10.1152/ajplegacy.1944.142.1.80; ZWEIFACH BW, 1974, ANESTHESIOLOGY, V41, P157, DOI 10.1097/00000542-197408000-00006; ZWEIFACH BW, 1957, J EXP MED, V106, P385, DOI 10.1084/jem.106.3.385; ZWEIFACH BW, 1952, ANN NY ACAD SCI, V55, P370, DOI 10.1111/j.1749-6632.1952.tb26553.x; ZWEIFACH BW, 1949, SURG GYNECOL OBSTET, V89, P469; ZWEIFACH BW, 1948, ANN NY ACAD SCI, V49, P553, DOI 10.1111/j.1749-6632.1948.tb30952.x; ZWEIFACH BW, 1945, SURGERY, V18, P48; Zweifach BW, 1944, ANN SURG, V120, P232, DOI 10.1097/00000658-194408000-00011	537	20	24	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2040-4603			COMPR PHYSIOL	Compr. Physiol.	JAN	2018	8	1					61	101		10.1002/cphy.c170006			41	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	GB0VC	WOS:000428766500003	29357125				2022-02-06	
J	Gill, J; Mustapic, M; Diaz-Arrastia, R; Lange, R; Gulyani, S; Diehl, T; Motamedi, V; Osier, N; Stern, RA; Kapogiannis, D				Gill, Jessica; Mustapic, Maja; Diaz-Arrastia, Ramon; Lange, Rael; Gulyani, Seema; Diehl, Tom; Motamedi, Vida; Osier, Nicole; Stern, Robert A.; Kapogiannis, Dimitrios			Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel	BRAIN INJURY			English	Article						Exosomes; post-traumatic stress disorder; tau; traumatic brain injury (TBI); inflammation	TRAUMATIC BRAIN-INJURY; PRECLINICAL ALZHEIMERS-DISEASE; POSTTRAUMATIC-STRESS-DISORDER; EXTRACELLULAR VESICLES; BLOOD EXOSOMES; IN-VIVO; ENCEPHALOPATHY; PTSD; PROTEINS; INVENTORY	Objective: Identify biomarkers in peripheral blood that relate to chronic post-concussive and behavioural symptoms following traumatic brain injuries (TBIs) to ultimately improve clinical management. Research design: We compared military personnel with mild TBIs (mTBIs) (n = 42) to those without TBIs (n = 22) in concentrations of tau, amyloid-beta (A beta 42) and cytokines (tumour necrosis factor alpha (TNF alpha, interleukin (IL)-6 and -10) in neuronal-derived exosomes from the peripheral blood. We utilized nanosight technology coupled with ultra-sensitivity immunoassay methods. We also examined the impact of post-concussive and behavioural symptoms including depression and post-traumatic stress disorder (PTSD) on these neuronal-derived markers. Results: We report that concentrations of exosomal tau (F-1,F- (62) = 10.50), A beta 42 (F-1,F- (61) = 5.32) and IL-10 (F-1,F-59 = 4.32) were elevated in the mTBI group compared to the controls. Within the mTBI group, regression models show that post-concussive symptoms were most related to exosomal tau elevations, whereas exosomal IL-10 levels were related to PTSD symptoms. Conclusions: These findings suggest that chronic post-concussive symptoms following an mTBI relate to altered exosomal activity, and that greater tau pathology may underlie chronic post-concussive symptoms that develop following mTBIs. It also suggests that central inflammatory activity contributes to PTSD symptoms following an mTBI, providing necessary insights into the role of inflammation in chronic PTSD symptoms.	[Gill, Jessica; Motamedi, Vida; Osier, Nicole] NINR, Tissue Injury Branch, NIH, Bethesda, MD 20892 USA; [Mustapic, Maja; Gulyani, Seema; Diehl, Tom; Kapogiannis, Dimitrios] NIA, Aging, NIH, Baltimore, MD 21224 USA; [Diaz-Arrastia, Ramon] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Lange, Rael] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Stern, Robert A.] Boston Univ, Neurosurg & Anat & Neurobiol, Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA		Gill, J (corresponding author), NIH, Intramural Res Program, Bldg 10, Bethesda, MD 20892 USA.	gillj@mail.nih.gov	, Bob/ABA-8507-2020; Gill, Gill M/Q-2020-2017; Kapogiannis, Dimitrios/AAW-4934-2020; Mustapic, Maja/AAV-3212-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; 	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Institute of Nursing Research, Intramural Research Program; National Institute on Aging, Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)	This work was supported by the The Center for Neuroscience and Regenerative Medicine; National Institute of Nursing Research, Intramural Research Program; and National Institute on Aging, Intramural Research Program.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Armstrong RA, 2016, NEUROPATHOL APPL NEU, V2, P185; Baker S, 2016, J ALZHEIMERS DIS, V54, P1207, DOI 10.3233/JAD-160371; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bersani FS, 2016, BRAIN BEHAV IMMUN, V52, P153, DOI 10.1016/j.bbi.2015.10.015; Bogoslovsky T, 2016, J NEUROTRAUM, V5, P70; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Ebenezer PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160923; Falker C, 2016, J NEUROCHEM, V137, P88, DOI 10.1111/jnc.13514; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Gatson JW, 2016, J NEUROSURG, V124, P1646, DOI 10.3171/2015.6.JNS15639; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Hamlett ED, 2018, FREE RADICAL BIO MED, V114, P110, DOI 10.1016/j.freeradbiomed.2017.08.028; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Jin Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2783-2; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Mac Donald CL, 2016, J NEUROTRAUM, V22, P23; Mac Donald CL, 2016, J NEUROTRAUM, V4, P12; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Nie H, 2014, PROG NEURO-PSYCHOPH, V51, P16, DOI 10.1016/j.pnpbp.2014.01.002; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Saenz-Cuesta M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00050; Saman S, 2014, J ALZHEIMERS DIS, V40, pS47, DOI 10.3233/JAD-132135; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tucker Phebe, 2010, Am J Disaster Med, V5, P113; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	60	20	20	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1359	1366		10.1080/02699052.2018.1471738			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000007		Green Accepted			2022-02-06	
J	Lupu, T; Elbaum, T; Wagner, M; Braw, Y				Lupu, T.; Elbaum, T.; Wagner, M.; Braw, Y.			Enhanced detection of feigned cognitive impairment using per item response time measurements in the Word Memory Test	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Malingering; performance validity test (PVT); response time; simulation; Word Memory Test (WMT)	SYMPTOM VALIDITY TEST; TRAUMATIC BRAIN-INJURY; PERFORMANCE VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; DEFICITS; INFORMATION; DISABILITY; SIMULATION; FRAMEWORK; CLAIMANTS	Response time (RT) is a less obvious outcome measure than conventional accuracy measures used in performance validity tests (PVTs). It is also under less conscious control and is affected by cognitive processes associated with deception. Studies that assessed the utility of RT for the detection of feigned cognitive impairment are however numbered. Moreover, RT variability was not assessed in a clinically used PVT. In the current study, we assessed the utility of RT measures for the detection of feigned cognitive impairment in the Word Memory Test (WMT). Healthy participants (N=90) were randomly assigned to a simulation or control condition and their per-item RTs were recorded while they performed the WMT's immediate recognition (IR) subtest. Simulators had longer mean RTs and larger RT variance than controls. Combining RT measures and the IR-subtest's accuracy score enabled a highly accurate detection of simulators. Moreover, the combined scale demonstrated incremental value (though slight) in predicting group membership beyond the use of the accuracy score as the sole PVT measure. The findings tentatively point toward the usefulness of RT measures to enhance the detection of feigned cognitive impairment. Further studies are needed, however, in order to explore the utility of these measures in clinical settings.	[Lupu, T.; Elbaum, T.; Wagner, M.; Braw, Y.] Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel		Braw, Y (corresponding author), Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel.	yoramb@ariel.ac.il	Wagner, Michael/AAX-3472-2021; Braw, Yoram/AAE-1669-2019	Wagner, Michael/0000-0002-8448-7906; Elbaum, Tomer/0000-0002-4455-6153			Allen LM, 1999, SEVERE TBI SAMPLE PE; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Boone K.B., 2013, CLIN PRACTICE FORENS; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Castiel M, 2012, NEUROPSYCHOL REHABIL, V22, P734, DOI 10.1080/09602011.2012.686884; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Cohen J., 2013, STAT POWER ANAL BEHA; Colangelo A, 2016, ARCH PHYS MED REHAB, V97, P714, DOI 10.1016/j.apmr.2015.12.019; Dandachi-FitzGerald B, 2013, J EXP PSYCHOPATHOL, V4, P46, DOI 10.5127/jep.025511; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Faust D, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P1, DOI 10.1007/978-1-4614-0442-2_1; Fine S, 2016, J BUS PSYCHOL, V31, P51, DOI 10.1007/s10869-015-9398-5; Fox J., 2016, APPL REGRESSION ANAL, V3; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Green P., 2003, GREENS WORD MEMORY T; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 1996, WORD MEMORY TEST USE; Green P., 1999, PERFORMANCE NEUROLOG; Green P, 2016, APPL NEUROPSYCH-CHIL, V5, P25, DOI 10.1080/21622965.2014.935378; Green P, 2015, APPL NEUROPSYCH-ADUL, V22, P293, DOI 10.1080/23279095.2014.925903; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Hegedish O, 2013, EUR J PSYCHOL ASSESS, V29, P253, DOI 10.1027/1015-5759/a000154; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Kertzman S, 2006, ISRAEL J PSYCHIAT, V43, P112; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Myers R. H., 2000, CLASSICAL MODERN REG; Nitch S. R., 2007, ASSESSMENT FEIGNED C, P78; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Rogers R., 2011, RES METHODS FORENSIC, P174; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Vendemia JMC, 2005, AM J PSYCHOL, V118, P413; Walczyk JJ, 2005, PERS PSYCHOL, V58, P141, DOI 10.1111/j.1744-6570.2005.00484.x; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x	50	20	20	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	6					532	542		10.1080/23279095.2017.1341410			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GO1LC	WOS:000439712000006	28696772				2022-02-06	
J	McNally, KA; Patrick, KE; LaFleur, JE; Dykstra, JB; Monahan, K; Hoskinson, KR				McNally, Kelly A.; Patrick, Kristina E.; LaFleur, Jacob E.; Dykstra, Jana B.; Monahan, Kerry; Hoskinson, Kristen R.			Brief cognitive behavioral intervention for children and adolescents with persistent post-concussive symptoms: A pilot study	CHILD NEUROPSYCHOLOGY			English	Article						Concussion; Traumatic brain injury; Post-concussion syndrome; Pediatric; Rehabilitation	MILD HEAD-INJURY; TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; REHABILITATION; SPORT; EXPECTATION; PREDICTORS; RECOVERY; ETIOLOGY; OUTCOMES	This study aims to evaluate the efficacy of a brief cognitive behavioral intervention program for children and adolescents experiencing persistent post-concussion symptoms. A total of 31 patients aged 10 to 18 years participated in the intervention. The median time since injury at treatment onset was 95days though the range was large (23-720days). Treatment was on average four sessions in duration. Sessions included concussion education, activity scheduling, sleep hygiene relaxation training, and cognitive restructuring. Outcomes were measured using symptom reports on the Sports Concussion Assessment Tool - Third Edition (SCAT-3) and parent-reported quality of life on the Pediatric Quality of Life Inventory (PedsQL). Mixed-effects models revealed that symptom reports did not decrease prior to the initiation of this treatment, though significant symptom improvement occurred following treatment. Quality of life scores significantly improved across domains, with the largest gains made in the emotional and school domains. Participant characteristics including age, sex, maternal education, and previous mental health problems were not found to be significantly related to treatment outcomes. Contrary to predictions, length of time since injury was not related to symptom changes. The primary limitation of this study is that it lacks randomization and an experimental control group. The results suggest that brief cognitive behavioral intervention may be a promising treatment for children and adolescents experiencing persistent post-concussive symptoms and warrants further investigation.	[McNally, Kelly A.; Patrick, Kristina E.; Dykstra, Jana B.; Monahan, Kerry] Nationwide Childrens Hosp, Sect Pediat Psychol & Neuropsychol, Columbus, OH USA; [McNally, Kelly A.; Hoskinson, Kristen R.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [LaFleur, Jacob E.; Hoskinson, Kristen R.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA		McNally, KA (corresponding author), Nationwide Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43205 USA.	kelly.mcnally@nationwidechildrens.org	Hoskinson, Kristen/AAL-9162-2020	Hoskinson, Kristen/0000-0003-4044-9753; McNally, Kelly/0000-0001-9278-9413			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; [Anonymous], 2015, R LANG ENV STAT COMP; Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bates D., 2015, LINEAR MIXED EFFECTS; Beck J.S., 2011, COGNITIVE BEHAV THER, V2nd ed; BIJUR PE, 1990, PEDIATRICS, V86, P337; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Ferguson RJ, 1996, SOURCEBOOK PSYCHOL T, P615; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schreurs KMG, 2011, BEHAV RES THER, V49, P908, DOI 10.1016/j.brat.2011.09.004; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varvogli L., 2011, HLTH SCI J, V5, P74, DOI DOI 10.1080/02699930302287; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	39	20	20	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	3					396	412		10.1080/09297049.2017.1280143			17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FY5UB	WOS:000426900000007	28125932				2022-02-06	
J	Rauch, SAM; Simon, NM; Kim, HM; Acierno, R; King, AP; Norman, SB; Venners, MR; Porter, K; Phan, KL; Tuerk, PW; Allard, C; Liberzon, I; Rothbaum, BO; Martis, B; Stein, MB; Hoge, CW				Rauch, Sheila A. M.; Simon, Naomi M.; Kim, H. Myra; Acierno, Ron; King, Anthony P.; Norman, Sonya B.; Venners, Margaret R.; Porter, Katherine; Phan, K. Luan; Tuerk, Peter W.; Allard, Carolyn; Liberzon, Israel; Rothbaum, Barbara O.; Martis, Brian; Stein, Murray B.; Hoge, Charles W.			Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial)	CONTEMPORARY CLINICAL TRIALS			English	Article						Randomized controlled trial; Posttraumatic stress disorder; Biomarkers; Mechanisms; Methods	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; SOCIAL ANXIETY DISORDER; ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; PSYCHOMETRIC PROPERTIES; EMOTION REGULATION; NEURAL PREDICTORS; SOMATIC SYMPTOMS	Increased emphasis on mechanisms of treatment effectiveness, biomarker predictors, and objective indicators of treatment response has sparked interest in integrated, translational treatment outcomes trials. The PROlonGed ExpoSure and Sertraline Trial (PROGrESS) is one such randomized controlled trial (RCT) focused on a key question in clinical management of posttraumatic stress disorder (PTSD) - the comparative and combined effectiveness of medication and psychotherapy. PROGrESS employs a state of the art trial design to examine psychotherapy and medication effects across three conditions: 1) Prolonged Exposure (PE) plus pill placebo, 2) Sertraline (SERT) plus Enhanced Medication Management (EMM), and 3) Combined treatment (PE/SERT). Innovative measures will capture potential biomarker predictors and indicators of treatment response within and across these three treatment conditions in Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) service members and veterans with PTSD. Assessments include clinician-rated measures, self-report outcome measures, saliva for salivary cortisol and cortisol response to awakening at six assessment points, blood at baseline and week 24 for genetic and genomic analysis, as well as resting state connectivity and emotion processing and regulation using functional Magnetic Resonance Imaging (fMRI) paradigms in a subsample of veterans. Accordingly, the current study is designed to provide pragmatic clinical direction for the delivery of PTSD treatment through its primary outcomes in an effectiveness design, and will also provide informative results to elucidate underlying mechanisms and biomarkers involved in PTSD treatment response.	[Rauch, Sheila A. M.] Atlanta VA Med Ctr, 1670 Clairmont Rd, Atlanta, GA 30033 USA; [Rauch, Sheila A. M.; Rothbaum, Barbara O.] Emory Univ, Sch Med, 12 Execut Pk,3rd Floor, Atlanta, GA 30029 USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Dept Psychiat, One Bowdoin Sq,6th Floor, Boston, MA 02114 USA; [Simon, Naomi M.] NYU, Med Sch, Dept Psychiat, One Pk Ave,8th Floor, New York, NY 10016 USA; [Kim, H. Myra; King, Anthony P.; Venners, Margaret R.; Porter, Katherine; Liberzon, Israel; Martis, Brian] VA Ann Arbor Healthcare Syst, 2215 Fuller Rd, Ann Arbor, MI 48105 USA; [Kim, H. Myra] Univ Michigan, Consulting Stat Comp & Analyt Res, 3550 Rackham,950 E Washington St, Ann Arbor, MI 48109 USA; [King, Anthony P.; Porter, Katherine; Liberzon, Israel; Martis, Brian] Univ Michigan, Dept Psychiat, 4250 Plymouth Rd, Ann Arbor, MI 48109 USA; [Acierno, Ron; Tuerk, Peter W.] Ralph H Johnson VA Med Ctr, 109 Bee St, Charleston, SC 29401 USA; [Acierno, Ron] Med Univ South Carolina, Coll Nursing, Jonathan Lucas St, Charleston, SC 29425 USA; [Tuerk, Peter W.] Med Univ South Carolina, Dept Psychiat, 67 President St, Charleston, SC 29425 USA; [Allard, Carolyn; Stein, Murray B.] VA San Diego Healthcare Syst, 3350 Villa La Jolla Dr, San Diego, CA 92161 USA; [Norman, Sonya B.] Natl Ctr PTSD, 215 N Main St, White River Jct, VT 05009 USA; [Norman, Sonya B.] VA Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,MC116B, San Diego, CA 92161 USA; [Norman, Sonya B.; Allard, Carolyn; Stein, Murray B.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92037 USA; [Allard, Carolyn] Solara Mental Hlth San Diego, San Diego, CA USA; [Phan, K. Luan] Univ Illinois, Dept Psychiat, 1747 W Roosevelt Rd, Chicago, IL 60608 USA; [Phan, K. Luan] Jesse Brown VA Med Ctr, 820 S Damen Ave, Chicago, IL 60612 USA; [Hoge, Charles W.] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Rauch, SAM (corresponding author), Emory Univ, Sch Med, 12 Execut Pk,3rd Floor, Atlanta, GA 30329 USA.	sheila.a.m.rauch@emory.edu	Rauch, Sheila A.M./K-4450-2015; Allard, Carolyn B./B-3521-2013; , Anthony/AAG-9308-2019	Allard, Carolyn B./0000-0002-7803-2243; King, Anthony/0000-0002-0764-9625; Liberzon, Israel/0000-0002-4990-556X	U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC) [W81XWH-11-1-0073]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433] Funding Source: NIH RePORTER	This work was supported by the U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command (MRMC; Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy, and Their Combination in OEF/OIF Combat Veterans with PTSD); (Award #W81XWH-11-1-0073; PI: Rauch); the National Center for Advancing Translational Sciences of the National Institutes of Health (Award #UL1TR000433). This material is the result of work supported with resources and the use of facilities at Massachusetts General Hospital, the VA Ann Arbor Healthcare System, Ralph H. Johnson VA Medical Center, and VA San Diego Healthcare System. The views expressed in this article presentation are solely those of the author(s) and do not reflect an endorsement by or the official policy of the Department of Veterans Affairs, Department of Defense, or the U.S. Government, or the official views of the National Institutes of Health.	Adkins JW, 2008, J ANXIETY DISORD, V22, P1393, DOI 10.1016/j.janxdis.2008.02.002; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Association A. P., 2017, CLIN PRACT GUID TREA; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Breen MS, 2015, MOL PSYCHIATR, V20, P1538, DOI 10.1038/mp.2015.9; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Burns B., 1996, SUBSTANCE ABUSE OUTC; Chen AC, 2010, NEUROIMAGE, V51, P930, DOI 10.1016/j.neuroimage.2010.02.044; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Cisler JM, 2016, PSYCHOL MED, V46, P3013, DOI 10.1017/S0033291716001847; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Duncan LE, 2017, MOL PSYCHIAT; Ekman P., 1976, PICTURES FACIAL AFFE; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Foa EB, 2004, J CONSULT CLIN PSYCH, V72, P879, DOI 10.1037/0022-006X.72.5.879; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Gur RC, 2002, NEUROIMAGE, V16, P651, DOI 10.1006/nimg.2002.1097; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Hosmer D, 1989, APPL LOGISTIC REGRES; Jacobson N.S., 1992, CLIN SIGNIFICANCE ST, P631; Jayawickreme N, 2014, DEPRESS ANXIETY, V31, P412, DOI 10.1002/da.22225; King AP, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00154; Klumpp H, 2017, NEUROIMAGE-CLIN, V15, P25, DOI 10.1016/j.nicl.2017.04.006; Klumpp H, 2017, PROG NEURO-PSYCHOPH, V75, P106, DOI 10.1016/j.pnpbp.2017.01.010; Klumpp H, 2013, PROG NEURO-PSYCHOPH, V45, P83, DOI 10.1016/j.pnpbp.2013.05.004; Klumpp H, 2012, BIOL PSYCHOL, V89, P273, DOI 10.1016/j.biopsycho.2011.10.010; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lang M.M., 1997, INT AFFECTIVE PICTUR; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; Ma ST, 2017, COGN AFFECT BEHAV NE, V17, P437, DOI 10.3758/s13415-016-0489-1; MacNamara A, 2016, NEUROPSYCHOPHARMACOL, V41, P611, DOI 10.1038/npp.2015.190; Marciniak M, 2004, DEPRESS ANXIETY, V19, P112, DOI 10.1002/da.10131; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Rauch SAM, 2015, DEPRESS ANXIETY, V32, P204, DOI 10.1002/da.22331; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Schneier FR, 2012, AM J PSYCHIAT, V169, P80, DOI 10.1176/appi.ajp.2011.11020321; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sripada RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00672; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; VA/DOD, 2017, VET AFF DEP DEF CLIN; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002	59	20	20	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2018	64						128	138		10.1016/j.cct.2017.10.013			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	FU1ZE	WOS:000423647200017	29081351				2022-02-06	
J	Samadi-Dooki, A; Voyiadjis, GZ; Stout, RW				Samadi-Dooki, Aref; Voyiadjis, George Z.; Stout, Rhett W.			A combined experimental, modeling, and computational approach to interpret the viscoelastic response of the white matter brain tissue during indentation	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Monotonic indentation; Traumatic brain injury; Rate dependent behavior; Finite element modeling	MECHANICAL-PROPERTIES; IN-VIVO; STIFFNESS; DISEASE; STRAIN; TESTS	Viscoelastic properties of the white matter brain tissue are systematically studied in this paper utilizing indentation experiments, mathematical modeling, and finite element simulation. It is first demonstrated that the internal stiffness of the instrument needs to be thoroughly obtained and incorporated in the analysis as its contribution to the recorded mechanical response is significant for experiments on very compliant materials. The flat-punch monotonic indentation is then performed indirectly on sagittal plane slices with pushing a large rigid coverslip into the sample surface. The recorded load and displacement data are used for calibrating different viscoelastic models and presenting numerical values for the model elements. Consequently, the accuracy of the findings based on the theoretical models is investigated by performing finite element simulations which suggest a considerable substrate effect that causes violation of the semi-infinite half-space assumption in modeling of the material behavior. Accordingly, correction factors for adjusting the viscoelastic constants are obtained and presented. Since the Maxwell model shows a superior capability in rendering the mechanical response of the brain, an extension of this model to Multimode Maxwell viscoelastic solid is proposed for modeling the tissue behavior under a more complex load-hold-unload indentation cycle that shows acceptable agreement with experimental observations.	[Samadi-Dooki, Aref; Voyiadjis, George Z.] Louisiana State Univ, Computat Solid Mech Lab, Dept Civil & Environm Engn, Baton Rouge, LA 70803 USA; [Stout, Rhett W.] Louisiana State Univ, Sch Vet Med, Pathobiol Sci Dept, Baton Rouge, LA 70803 USA		Voyiadjis, GZ (corresponding author), Louisiana State Univ, Computat Solid Mech Lab, Dept Civil & Environm Engn, Baton Rouge, LA 70803 USA.	asamad3@lsu.edu; voyiadjis@eng.lsu.edu; rstout1@lsu.edu	Voyiadjis, George Zino/R-1476-2018	Voyiadjis, George Zino/0000-0002-7965-6592; Samadi-Dooki, Aref/0000-0001-5927-9016			Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bayly PV, 2014, J MECH BEHAV BIOMED, V29, P568, DOI 10.1016/j.jmbbm.2013.02.018; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen FQ, 2015, ANN BIOMED ENG, V43, P2903, DOI 10.1007/s10439-015-1350-3; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Feng Y, 2017, J MECH BEHAV BIOMED, V71, P407, DOI 10.1016/j.jmbbm.2017.04.008; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kuhl E, 2016, NAT PHYS, V12, P533, DOI 10.1038/nphys3641; LAUN HM, 1978, RHEOL ACTA, V17, P1, DOI 10.1007/BF01567859; Liu KF, 2009, J MECH BEHAV BIOMED, V2, P355, DOI 10.1016/j.jmbbm.2008.12.001; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Ram YM, 2004, Z ANGEW MATH MECH, V84, P807, DOI 10.1002/zamm.200310137; Samadi-Dooki A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036486; Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI [DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4]; Stewart DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177561; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Tallinen T, 2016, NAT PHYS, V12, P588, DOI [10.1038/NPHYS3632, 10.1038/nphys3632]; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040	38	20	20	2	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2018	77						24	33		10.1016/j.jmbbm.2017.08.037			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FQ4EC	WOS:000418309500003	28888930				2022-02-06	
J	Sharp, AL; Huang, BZ; Tang, T; Shen, E; Melnick, ER; Venkatesh, AK; Kanter, MH; Gould, MK				Sharp, Adam L.; Huang, Brian Z.; Tang, Tania; Shen, Ernest; Melnick, Edward R.; Venkatesh, Arjun K.; Kanter, Michael H.; Gould, Michael K.			Implementation of the Canadian CT Head Rule and Its Association With Use of Computed Tomography Among Patients With Head Injury	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL DECISION-SUPPORT; INTERRUPTED TIME-SERIES; ADULTS; CARE	Study objective: Approximately 1 in 3 computed tomography (CT) scans performed for head injury may be avoidable. We evaluate the association of implementation of the Canadian CT Head Rule on head CT imaging in community emergency departments (EDs). Methods: We conducted an interrupted time-series analysis of encounters from January 2014 to December 2015 in 13 Southern California EDs. Adult health plan members with a trauma diagnosis and Glasgow Coma Scale score at ED triage were included. A multicomponent intervention included clinical leadership endorsement, physician education, and integrated clinical decision support. The primary outcome was the proportion of patients receiving a head CT. The unit of analysis was ED encounter, and we compared CT use pre- and postintervention with generalized estimating equations segmented logistic regression, with physician as a clustering variable. Secondary analysis described the yield of identified head injuries pre- and postintervention. Results: Included were 44,947 encounters (28,751 preintervention and 16,196 postintervention), resulting in 14,633 (32.6%) head CTs (9,758 preintervention and 4,875 postintervention), with an absolute 5.3% (95% confidence interval [CI] 2.5% to 8.1%) reduction in CT use postintervention. Adjusted pre-post comparison showed a trend in decreasing odds of imaging (odds ratio 0.98; 95% CI 0.96 to 0.99). All but one ED reduced CTs postintervention (0.3% to 8.7%, one ED 0.3% increase), but no interaction between the intervention and study site over time existed (P=.34). After the intervention, diagnostic yield of CT-identified intracranial injuries increased by 2.3% (95% CI 1.5% to 3.1%). Conclusion: A multicomponent implementation of the Canadian CT Head Rule was associated with a modest reduction in CT use and an increased diagnostic yield of head CTs for adult trauma encounters in community EDs.	[Sharp, Adam L.; Huang, Brian Z.; Tang, Tania; Shen, Ernest; Gould, Michael K.] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Sharp, Adam L.] Kaiser Permanente Southern Calif, Los Angeles Med Ctr, Dept Emergency Med, Los Angeles, CA 90027 USA; [Melnick, Edward R.; Venkatesh, Arjun K.] Yale Univ, Dept Emergency Med, New Haven, CT USA; [Kanter, Michael H.] Southern Calif Permanente Med Grp, Pasadena, CA USA		Sharp, AL (corresponding author), Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.; Sharp, AL (corresponding author), Kaiser Permanente Southern Calif, Los Angeles Med Ctr, Dept Emergency Med, Los Angeles, CA 90027 USA.	adam.l.sharp@kp.org	kanter, michael howard/W-2753-2019	Huang, Brian/0000-0001-8645-5142	Kaiser Permanente Southern California Care Improvement Research Team; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS021271]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS021271] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. Internal funding from the Kaiser Permanente Southern California Care Improvement Research Team supported this project. Dr. Melnick is supported, in part, by grant K08HS021271 from the Agency for Healthcare Research and Quality.	ABIM Foundation, 2014, AM COLL EM PHYS CHOO; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Barrett MSC, 2015, METHODS SERIES REPOR; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Cawood TJ, 2009, EUR J ENDOCRINOL, V161, P513, DOI 10.1530/EJE-09-0234; Fretheim A, 2015, J CLIN EPIDEMIOL, V68, P324, DOI 10.1016/j.jclinepi.2014.10.003; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Korley FK, 2013, ACAD EMERG MED, V20, P463, DOI 10.1111/acem.12136; Lang ES, 2007, ANN EMERG MED, V49, P355, DOI 10.1016/j.annemergmed.2006.08.022; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Mitchell J, 2005, SEMIN ULTRASOUND CT, V26, P37, DOI 10.1053/j.sult.2004.10.004; Pape UJ, 2013, J ROY SOC MED, V106, P124, DOI 10.1258/jrsm.2012.110319; Parma C, 2014, AM SURGEON, V80, P664; Rivara FP, 2015, JAMA-J AM MED ASSOC, V314, P2629, DOI 10.1001/jama.2015.17298; Rogers RL, 2015, AM J EMERG MED, V33, P1505, DOI 10.1016/j.ajem.2015.07.039; Rosenberg A, 2015, JAMA INTERN MED, V175, P1913, DOI 10.1001/jamainternmed.2015.5441; Schriger DL, 2001, ANN EMERG MED, V37, P75, DOI 10.1067/mem.2001.111570; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Sharp AL, 2014, J EMERG MED, V47, P333, DOI 10.1016/j.jemermed.2014.04.017; Sierzenski PR, 2014, ANN EMERG MED, V63, P25, DOI 10.1016/j.annemergmed.2013.08.027; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taljaard M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-77; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	27	20	20	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JAN	2018	71	1					54	63		10.1016/j.annemergmed.2017.06.022			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FS6UH	WOS:000419933100016	28739290	Green Accepted			2022-02-06	
J	Wang, X; Lan, YL; Xing, JS; Lan, XQ; Wang, LT; Zhang, B				Wang, Xun; Lan, Yu-Long; Xing, Jin-Shan; Lan, Xiao-Qiang; Wang, Li-Tao; Zhang, Bo			Alantolactone plays neuroprotective roles in traumatic brain injury in rats via anti-inflammatory, anti-oxidative and anti-apoptosis pathways	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Alantolactone; traumatic brain injury; inflammation; apoptosis	NF-KAPPA-B; CLOSED-HEAD INJURY; OXIDATIVE STRESS; INFLAMMATION; EXPRESSION; PATHOPHYSIOLOGY; PROGESTERONE; NEURONS; TARGETS; IMPACT	Traumatic brain injury (TBI) is a common disease associated with a high rate of morbidity and mortality. Secondary brain injury following TBI triggers pathological, physiological, and biological reactions that lead to neurological dysfunctions. Alantolactone (ATL) is a well-known Chinese medicine that possesses strong anti-inflammatory properties, but its role in TBI remains poorly understood. The objective of this study was to evaluate the protective effect of ATL in a rat model of controlled cortical impact (CCI). We observed the neurological scores, brain water content, oxidative stress, neuroinflammation and apoptosis by performing an enzyme-linked immunosorbent assay, western blotting, quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR), immunohistochemical (IHC) staining and other methods after CCI. The neurological scores, brain water content, levels of oxidative stress and inflammatory cytokines, and apoptosis index were markedly decreased following the ATL treatment in rats after TBI. Moreover, the antioxidant and anti-inflammatory effects of ATL in TBI may be partially mediated by inhibition of the NF-kappa B pathway and suppression of Cyclooxygenase 2 (COX-2). In addition, ATL attenuated TBI-induced neuronal apoptosis by suppressing the cytochrome c/caspase-dependent apoptotic pathway. Thus, ATL could exert neuroprotection in rats in a TBI model. Importantly, ATL has great potential in the clinical treatment of TBI.	[Wang, Xun; Lan, Yu-Long; Xing, Jin-Shan; Lan, Xiao-Qiang; Zhang, Bo] Dalian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Dalian 116023, Peoples R China; [Wang, Xun; Wang, Li-Tao] Dalian Med Univ, Nondirectly Affiliated Hosp, Dept Neurosurg, Peoples Hosp Dalian 3, Dalian 116033, Peoples R China; [Wang, Xun; Lan, Yu-Long; Xing, Jin-Shan] Dalian Med Univ, Dept Pharm, Dalian 116044, Peoples R China; [Lan, Yu-Long] Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China		Zhang, B (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Dalian 116023, Peoples R China.	zhangbodlykdx@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372714, 81672480]; Liaoning Provincial Natural Science Foundation of China [201602244]; Distinguished Professor Project of Liaoning Province; Special Grant for Translational Medicine, Dalian Medical University [2015002]; Traditional Chinese Medicine Foundation of Dalian [17Z1007]	This work is supported by grants from National Natural Science Foundation of China (Nos. 81372714, 81672480), Liaoning Provincial Natural Science Foundation of China (No. 201602244), Distinguished Professor Project of Liaoning Province, Special Grant for Translational Medicine, Dalian Medical University (No. 2015002), Traditional Chinese Medicine Foundation of Dalian (17Z1007).	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chung MH, 2014, MUTAT RES-FUND MOL M, V768, P74, DOI [10.1016/j.mrfmmm.2014.04.003, 1]; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dixon DJ, 2017, PHYS MED REH CLIN N, V28, P215; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hasegawa Y, 2015, TRANSL STROKE RES, V6, P458, DOI 10.1007/s12975-015-0423-9; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jung KT, 2014, KOREAN J PAIN, V27, P365, DOI 10.3344/kjp.2014.27.4.365; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Khalaj L, 2013, BRAIN RES, V1527, P117, DOI 10.1016/j.brainres.2013.06.041; Khan M, 2012, IUBMB LIFE, V64, P783, DOI 10.1002/iub.1068; Kim HN, 2014, CANCER LETT, V351, P41, DOI 10.1016/j.canlet.2014.03.037; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee JY, 2016, BIOPHARM DRUG DISPOS, V37, P156, DOI 10.1002/bdd.2005; Lehmann GL, 2004, CURR NEUROVASC RES, V1, P293, DOI 10.2174/1567202043362081; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo Chun, 2002, Chin J Traumatol, V5, P299; Luo Chun, 1999, Chin J Traumatol, V2, P101; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Seifert HA, 2014, TRANSL STROKE RES, V5, P543, DOI 10.1007/s12975-014-0349-7; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Wang D, 2012, MOLECULES, V17, P9803, DOI 10.3390/molecules17089803; Wang QS, 2005, NEUROCHEM RES, V30, P1387, DOI 10.1007/s11064-005-8391-1; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Wang X, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0563-8; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Xiong XY, 2014, TRANSL STROKE RES, V5, P429, DOI 10.1007/s12975-013-0317-7; Yang Shu-Yuan, 2004, Chin J Traumatol, V7, P159; Yang Xiao-feng, 2005, Chin J Traumatol, V8, P96; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	54	20	21	1	8	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2018	10	2					368	380					13	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FW3NJ	WOS:000425214200003	29511431				2022-02-06	
J	McLeod, TCV; Wagner, AJ; Bacon, CEW				McLeod, Tamara C. Valovich; Wagner, Alyssa J.; Bacon, Cailee E. Welch			Lived Experiences of Adolescent Athletes Following Sport-Related Concussion	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; emotional; quality of life; symptoms	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; CLINICAL-OUTCOMES ASSESSMENT; HIGH-SCHOOL; ACADEMIC ACCOMMODATIONS; CONSENSUS STATEMENT; DISABLEMENT MODELS; TRAINING PRACTICE; FOOTBALL PLAYERS; CHILDREN	Background: Previous studies have identified the effect of sport-related concussion on health-related quality of life through the use of patient-reported outcome measures. However, there has been little research exploring the underlying mechanisms that influence these perceptions of health-related quality of life among adolescent athletes who have sustained a sport-related concussion. Purpose: To explore the psychosocial aspects of concussion among adolescent athletes. Study Design: Case series; Level of evidence, 4. Methods: A total of 12 interscholastic athletes (4 girls, 8 boys; mean SD age, 15.7 1.7 years; grade level, 10.2 +/- 1.4) were interviewed via a semistructured interview protocol between 15 and 30 days postinjury. Data analysis was guided by the consensual qualitative research tradition. Themes and categories emerged through consensus by a 3-person research team, and bias was minimized through the use of multiple-analyst triangulation. Results: Participants identified numerous postconcussion symptoms that resulted in increasing difficulty with emotions (eg, irritable, easily frustrated), roles at school (eg, concentration difficulties, fatigue), and roles in their social environment (eg, letting the team down, not being able to contribute to sport). As a result, participants expressed how they tried to minimize or mask symptoms to decrease the potential of being viewed differently by their peers. Conclusion: Adolescent athletes perceived a significant effect of sport-related concussion on numerous areas of psychosocial and emotional health and well-being. Anticipatory guidancewith education regarding the possible signs and symptoms, risk factors, and recovery expectations following a concussionis important to include in postinjury management. A better understanding of sport-related concussion and expected recovery could help to improve perceptions of this injury among interscholastic athletes. Additionally, best practices should be identified to assist health care professionals and school personnel in the development of temporary adjustments or formal academic adjustment policies in the secondary school setting, therefore ensuring that the patients receive the support that they need to maintain their roles as students.	[McLeod, Tamara C. Valovich; Wagner, Alyssa J.; Bacon, Cailee E. Welch] AT Still Univ, Postprofess Athlet Training Program, Mesa, AZ USA; [McLeod, Tamara C. Valovich; Bacon, Cailee E. Welch] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA		McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722	National Operating Committee on Standards for Athletic Equipment	One or more of the authors has declared the following potential conflict of interest or source of funding: This project was funded by the National Operating Committee on Standards for Athletic Equipment.	Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, pe333; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Di Battista A, 2015, BRAIN INJURY, V29, P573, DOI 10.3109/02699052.2014.989905; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Halstead ME, BRIT J SPORT MED, DOI [10. 1136/bjsports-2016-096674 ., DOI 10.1136/BJSP0RTS-2016-096674]; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Nagi SZ., 1965, SOCIOLOGY REHABILITA, P100; Neal TL, 2015, J ATHL TRAINING, V50, P231, DOI 10.4085/1062-6050-50.3.03; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Valier AR, 2016, ARCH PHYS MED REHAB, V97, P1202, DOI 10.1016/j.apmr.2015.11.015; Valovich McLeod TC, 2015, J ATHL TRAINING, V50, pS115; Valovich McLeod TC, 2017, J ATHL TRAINING, V52, P262; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; Vassilyadi M, 2014, PEDIATR NEUROSURG, V50, P196, DOI 10.1159/000431232; Ware J.E., 2008, USERS MANUAL SF 36V2; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Welch Bacon CE, INT J ATHL THER TRAI, DOI [10. 1123/ijatt. 2017-0043 ., DOI 10.1123/IJATT.2017-0043]; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; World Health Organisation, 2002, COMM LANG FUNCT DIS; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	61	20	20	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC 11	2017	5	12							2325967117745033	10.1177/2325967117745033			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FP6RW	WOS:000417754500001	29276716	Green Published, gold			2022-02-06	
J	Kramer, T; Grob, T; Menzel, L; Hirnet, T; Griemert, E; Radyushkin, K; Thal, SC; Methner, A; Schaefer, MKE				Kraemer, Tobias; Grob, Theresa; Menzel, Lutz; Hirnet, Tobias; Griemert, Eva; Radyushkin, Konstantin; Thal, Serge C.; Methner, Axel; Schaefer, Michael K. E.			Dimethyl fumarate treatment after traumatic brain injury prevents depletion of antioxidative brain glutathione and confers neuroprotection	JOURNAL OF NEUROCHEMISTRY			English	Article						fumaric acid ester derivatives; glutathione; oxidative stress; therapy; traumatic brain injury	REMITTING MULTIPLE-SCLEROSIS; CONTROLLED CORTICAL IMPACT; OXIDATIVE STRESS; IN-VITRO; CEREBRAL-ISCHEMIA; SYNAPTIC PROTEINS; DOUBLE-BLIND; ACID ESTERS; TIME-COURSE; NRF2	Dimethyl fumarate (DMF) is an immunomodulatory compound to treat multiple sclerosis and psoriasis with neuroprotective potential. Its mechanism of action involves activation of the antioxidant pathway regulator Nuclear factor erythroid 2-related factor 2 thereby increasing synthesis of the cellular antioxidant glutathione (GSH). The objective of this study was to investigate whether post-traumatic DMF treatment is beneficial after experimental traumatic brain injury (TBI). Adult C57Bl/6 mice were subjected to controlled cortical impact followed by oral administration of DMF (80mg/kg body weight) or vehicle at 3, 24, 48, and 72h after the inflicted TBI. At 4 days after lesion (dal), DMF-treated mice displayed less neurological deficits than vehicle-treated mice and reduced histopathological brain damage. At the same time, the TBI-evoked depletion of brain GSH was prevented by DMF treatment. However, nuclear factor erythroid 2-related factor 2 target gene mRNA expression involved in antioxidant and detoxifying pathways was increased in both treatment groups at 4 dal. Blood brain barrier leakage, as assessed by immunoglobulin G extravasation, inflammatory marker mRNA expression, and CD45(+) leukocyte infiltration into the perilesional brain tissue was induced by TBI but not significantly altered by DMF treatment. Collectively, our data demonstrate that post-traumatic DMF treatment improves neurological outcome and reduces brain tissue loss in a clinically relevant model of TBI. Our findings suggest that DMF treatment confers neuroprotection after TBI via preservation of brain GSH levels rather than by modulating neuroinflammation.	[Kraemer, Tobias; Grob, Theresa; Menzel, Lutz; Hirnet, Tobias; Griemert, Eva; Thal, Serge C.; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mouse Behav Unit, Mainz, Germany; [Radyushkin, Konstantin; Thal, Serge C.; Methner, Axel; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany; [Methner, Axel] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, Mainz, Germany		Schaefer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.; Schaefer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci FTN, Langenbeckstr 1, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Thal, Serge/D-6593-2011; Schaefer, Michael K.E./S-1715-2019	Thal, Serge/0000-0002-1222-8729; Schaefer, Michael K.E./0000-0001-6055-6244; Menzel, Lutz/0000-0002-3816-6255; Kramer, Tobias/0000-0001-6900-3486			Abbas K, 2011, FREE RADICAL BIO MED, V51, P107, DOI 10.1016/j.freeradbiomed.2011.03.039; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahuja M, 2016, J NEUROSCI, V36, P6332, DOI 10.1523/JNEUROSCI.0426-16.2016; Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Arnold P, 2014, CLIN PHARMACOL-ADV A, V6, P35, DOI 10.2147/CPAA.S35033; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brennan MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120254; Clausen BH, 2017, EXP NEUROL, V295, P144, DOI 10.1016/j.expneurol.2017.06.011; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cordaro M., 2016, J NEUROTRAUMA, DOI 10.1089/neu.2016.4678<original-structure ref=info:doi/10.1089/neu.2016.4678></original-structure>; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Du LN, 2016, J NEUROTRAUM, V33, P1913, DOI 10.1089/neu.2015.4342; Dubey D, 2015, EXPERT REV NEUROTHER, V15, P339, DOI 10.1586/14737175.2015.1025755; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Graber DJ, 2012, J NEUROIMMUNE PHARM, V7, P266, DOI 10.1007/s11481-011-9338-8; Gruenbaum S. E., 2016, CNS DRUGS, V23, P23; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; HELD KD, 1988, RADIAT RES, V115, P495, DOI 10.2307/3577299; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Iniaghe LO, 2015, NEUROBIOL DIS, V82, P349, DOI 10.1016/j.nbd.2015.07.001; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kunze R, 2015, EXP NEUROL, V266, P99, DOI 10.1016/j.expneurol.2015.02.022; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Lin RH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0733-1; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu YZ, 2015, J NEUROSURG, V123, P915, DOI 10.3171/2014.11.JNS132348; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Methner A, 2013, NAT REV NEUROL, V9, P72, DOI 10.1038/nrneurol.2012.277; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; NAVARI RM, 1978, MICROVASC RES, V16, P304, DOI 10.1016/0026-2862(78)90064-X; Nelson KC, 1999, INVEST OPHTH VIS SCI, V40, P1927; NIEBOER C, 1990, DERMATOLOGICA, V181, P33, DOI 10.1159/000247856; Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Palle P, 2016, LAB ANIM-UK, V50, P427, DOI 10.1177/0023677216675008; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Penning TM, 2017, CHEM RES TOXICOL, V30, P162, DOI 10.1021/acs.chemrestox.6b00319; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P1766, DOI 10.1089/ars.2013.5745; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Ruggieri S, 2014, THER CLIN RISK MANAG, V10, P229, DOI 10.2147/TCRM.S53285; Salmen A, 2014, EXP NEUROL, V262, P52, DOI 10.1016/j.expneurol.2014.02.015; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schulze-Topphoff U, 2016, P NATL ACAD SCI USA, V113, P4777, DOI 10.1073/pnas.1603907113; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yao Y, 2016, TRANSL STROKE RES, V7, P535, DOI 10.1007/s12975-016-0496-0; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003	75	20	21	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2017	143	5					523	533		10.1111/jnc.14220			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FN0OG	WOS:000415677200005	28921587	Bronze			2022-02-06	
J	O'Connor, S; Warrington, G; McGoldrick, A; Cullen, S				O'Connor, Siobhan; Warrington, Giles; McGoldrick, Adrian; Cullen, SarahJane			Epidemiology of Injury Due to Race-Day Jockey Falls in Professional Flat and Jump Horse Racing in Ireland, 2011-2015	JOURNAL OF ATHLETIC TRAINING			English	Article						National Hunt; injury incidence; injury rate; high-risk sport; concussions; head injury; fractures; bone	GREAT-BRITAIN; BONE HEALTH; AUSTRALIA; INDUSTRY; CONSENSUS; FRANCE	Context: Professional horse racing is considered a high-risk sport, yet the last analysis of fall and injury incidence in this sport in Ireland was completed between 1999 and 2006. Objective: To provide an updated analysis of the fall and injury incidence in professional flat and jump horse racing in Ireland from 2011 through 2015, compare it with the previous analysis, and detail the specific types and locations of injuries. Design: Descriptive epidemiology study. Setting: A medical doctor recorded all injuries that occurred at every official flat and jump race meeting for the 2011 through 2015 seasons using standardized injury-report forms. Main Outcome Measure(s): Injury and fall rates and their 95% confidence intervals (CIs) were reported for flat and jump racing. Incidence rate ratios and 95% CIs were calculated between flat and jump racing, between the 1999-2006 analysis and the current results, and between 2011 and 2015. The distribution of injuries for type and location of injury was reported. Results: Compared with flat racing, jump racing had significantly more falls per 1000 rides (49.5 versus 3.8), injuries per 1000 rides (10.1 versus 1.4), and injuries per 1000 meetings 776.0 versus 94.1). However, the rate of injuries per 1000 falls was significantly higher in flat racing (352.8 versus 203.8). An increase in injuries per 1000 falls between 2011 and 2015 was found in flat racing (P = .005). Since the previous analysis, a significant increase in injuries per 1000 rides and falls was noted in jump racing. Soft tissue injuries were predominant in flat and jump racing (61.54% and 68.80%, respectively), with fractures the second most common injury (15.38% and 18.06%, respectively). Concussions were more prevalent from flat-racing falls (incidence rate ratio = 0.30; 95% CI = 0.15, 0.61). The lower limb was the most frequent location of injury (32.89%) in flat racing; however, in jump racing, upper limb injuries (34.97%) were predominant. Conclusions: An update on professional flat-and jumpracing fall and injury epidemiology is provided. Further research to identify risk factors for injury, design and investigate the feasibility of injury-prevention strategies, and document their effects on fall and injury incidence is required.	[O'Connor, Siobhan] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Warrington, Giles] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland; [McGoldrick, Adrian] Turf Club, Curragh, Kildare, Ireland; [Cullen, SarahJane] Waterford Inst Technol, Dept Hlth Sport & Exercise Sci, Waterford, Ireland		O'Connor, S (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland.	siobhan.oconnor@dcu.ie	O'Connor, Siobhan/Q-8568-2018	O'Connor, Siobhan/0000-0002-2001-0746; Warrington, Giles/0000-0001-6473-3607	Irish Turf Club	This research was supported by the Irish Turf Club. We acknowledge the support of the Turf Club medical officers who gathered the valuable data at the various race meetings.	Bolwell C, 2014, COMP EXERC PHYSIOL, V10, P49, DOI 10.3920/CEP13036; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Cowley S, 2007, BRIT J SPORT MED, V41, P639, DOI 10.1136/bjsm.2006.032888; Curry BA, 2016, OCCUP MED-OXFORD, V66, P222, DOI 10.1093/occmed/kqv150; Hitchens P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000142; Hitchens P, 2011, ACCIDENT ANAL PREV, V43, P840, DOI 10.1016/j.aap.2010.11.003; Hitchens PL, 2016, EQUINE VET J, V48, P50, DOI 10.1111/evj.12392; Hitchens PL, 2015, INJURY PREV, V21, P109, DOI 10.1136/injuryprev-2014-041223; Hitchens PL, 2012, INJURY PREV, V18, P385, DOI 10.1136/injuryprev-2011-040255; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; Hitchens PL, 2010, OCCUP ENVIRON MED, V67, P693, DOI 10.1136/oem.2009.050567; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Turner M, 2012, BRIT J SPORT MED, V46, P704, DOI 10.1136/bjsports-2011-090312; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571; Waller AE, 2000, JAMA-J AM MED ASSOC, V283, P1326, DOI 10.1001/jama.283.10.1326; Warrington G, 2009, J SPORT SCI, V27, P543, DOI 10.1080/02640410802702863; Wilson G, 2013, INT J SPORTS MED, V34, P453, DOI 10.1055/s-0032-1321898; Wilson G, 2014, SPORTS MED, V44, P785, DOI 10.1007/s40279-014-0169-7; Zasa M, 2016, SPORTS ORTHOP TRAUMA, V32, P289	22	20	21	1	9	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2017	52	12					1140	1146		10.4085/1062-6050-52.12.17			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FR9BQ	WOS:000419368900007	29154693	Green Published, Bronze			2022-02-06	
J	Sen, N				Sen, Nilkantha			An insight into the vision impairment following traumatic brain injury	NEUROCHEMISTRY INTERNATIONAL			English	Article							RETINAL GANGLION-CELLS; OCULOMOTOR NERVE PALSY; MINOR HEAD TRAUMA; OPTIC-NERVE; COMPUTED-TOMOGRAPHY; AXONAL INJURY; DAMAGE; NEUROPROTECTION; NEUROPATHY; MORTALITY	Traumatic brain injury (TBI) is one of the major cause of morbidity and mortality and it affects more than 1.7 million Americans each year. Depending on its location and severity, TBI leads to structural and functional damage in several parts of the brain such as cranial nerves, optic nerve tract or other circuitry involved in vision, and occipital lobe. As a result, the function associated with vision processing and perception are significantly affected and cause blurred vision, double vision, decreased peripheral vision and blindness. In this mini-review, we will focus the recent progress made to understand the pathology and underlying cellular/molecular mechanisms involved in the impairment of the integrity of visual systems following TBI. (C) 2017 Elsevier Ltd. All rights reserved.	[Sen, Nilkantha] Augusta Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA 2018, Augusta, GA 30907 USA		Sen, N (corresponding author), Augusta Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA 2018, Augusta, GA 30907 USA.	nsen@augusta.edu	Sen, Nilkantha/AAW-9788-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1EY025622, RO1NS094516]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094516] Funding Source: NIH RePORTER	N.S is supported by funding from NIH (RO1EY025622 and RO1NS094516).	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; ANDERSON RL, 1982, OPHTHALMOLOGY, V89, P445; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; BROOKS AMV, 1984, BRIT J OPHTHALMOL, V68, P838, DOI 10.1136/bjo.68.11.838; BUDENZ DL, 1994, OPHTHALMOLOGY, V101, P559; Caesar R, 2003, EYE, V17, P661, DOI 10.1038/sj.eye.6700420; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; De Leeuw M, 2015, J FORENSIC LEG MED, V36, P43, DOI 10.1016/j.jflm.2015.08.009; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; DOMINGO Z, 1993, BRIT J NEUROSURG, V7, P141, DOI 10.3109/02688699309103470; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Gauguet Jean-Marc, 2008, Radiol Case Rep, V3, P124, DOI 10.2484/rcr.v3i1.124; Giacci MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104565; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hassan A, 2002, CLIN EXP OPHTHALMOL, V30, P273, DOI 10.1046/j.1442-9071.2002.00534.x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; KEANE JR, 1992, NEUROL CLIN, V10, P849, DOI 10.1016/S0733-8619(18)30183-X; Kim E, 2013, J KOREAN NEUROSURG S, V54, P434, DOI 10.3340/jkns.2013.54.5.434; KROHEL GB, 1979, AM J OPHTHALMOL, V88, P254, DOI 10.1016/0002-9394(79)90474-4; Lee Bruce, 2005, NeuroRx, V2, P372; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Levin Leonard A, 2004, Ophthalmol Clin North Am, V17, P455, DOI 10.1016/j.ohc.2004.05.008; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Ma M, 2012, J NEUROTRAUM, V29, P2555, DOI 10.1089/neu.2012.2473; Magharious Mark M, 2011, J Vis Exp, DOI 10.3791/2241; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Masquere P, 2013, CRIT CARE, V17, DOI 10.1186/cc12728; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; McCann J D, 1994, Curr Opin Ophthalmol, V5, P3, DOI 10.1097/00055735-199412000-00002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moreau F, 2013, CEREBROVASC DIS EXTR, V3, P130, DOI 10.1159/000355024; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Sawhney R, 2003, EYE, V17, P667, DOI 10.1038/sj.eye.6700411; Schumann P, 2013, CRANIOMAX TRAUM REC, V6, P75, DOI 10.1055/s-0033-1343783; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Simon GJB, 2006, J NEUROTRAUM, V23, P1072, DOI 10.1089/neu.2006.23.1072; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Sulaiman AM, 2011, J NEUROTRAUM, V28, P383, DOI 10.1089/neu.2010.1707; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; WALSH FRANK B., 1966, INVEST OPHTHALMOL, V5, P433; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; WARNER JEA, 1995, INT OPHTHALMOL CLIN, V35, P57, DOI 10.1097/00004397-199503510-00007; Warner N, 2010, CURR OPIN OPHTHALMOL, V21, P459, DOI 10.1097/ICU.0b013e32833f00c9; Young A. M., 2016, PEDIAT RES	62	20	20	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	DEC	2017	111				SI		103	107		10.1016/j.neuint.2017.01.019			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FR3OS	WOS:000418976600011	28163060	Green Accepted			2022-02-06	
J	Chen, SL; Smielewski, P; Czosnyka, M; Papadopoulos, MC; Saadoun, S				Chen, Suliang; Smielewski, Peter; Czosnyka, Marek; Papadopoulos, Marios C.; Saadoun, Samira			Continuous Monitoring and Visualization of Optimum Spinal Cord Perfusion Pressure in Patients with Acute Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; blood pressure; critical care; spinal cord injuries; vasopressor agents	TRAUMATIC BRAIN-INJURY; INTRASPINAL PRESSURE; INTRATHECAL PRESSURE; MICRODIALYSIS; PROFILE	The optimum spinal cord perfusion pressure (SCPP) after traumatic spinal cord injury (TSCI) is unknown. Here, we describe techniques to compute and display the optimum SCPP in real time. We recruited adults within 72 h of severe TSCI (American Spinal Injuries Association [ASIA] grades A-C). A pressure probe and a microdialysis catheter were placed on the injured cord. SCPP was computed as mean arterial pressure (MAP) minus intraspinal pressure (ISP), spinal pressure reactivity index (sPRx) as the running ISP/MAP correlation coefficient, and continuous optimum SCPP (cSCPP(opt)) as the SCPP that minimizes sPRx in a moving 4-h window. In 45 patients, we monitored ISP and blood pressure. In 14 patients, we also monitored injury site metabolism. cSCPP(opt) could be computed 45% of the time. Mean cSCPP(opt) varied by up to 60 mm Hg between patients. Each patient's cSCPP(opt) varied with time (standard deviation 10-20 mm Hg). Color-coded maps showing the sPRx/SCPP curve evolution enhanced visualization of cSCPP(opt). Periods when SCPP approximate to cSCPP(opt) were associated with low injury site glucose, high pyruvate, and high lactate. Mean SCPP deviation from cSCPP(opt) correlated with worse neurological outcome at 9-12 months: ASIA grade improved in 30% of patients with < 5mm Hg deviation, 10% of patients with 5-15 mm Hg deviation, and no one with > 15 mm Hg deviation. We conclude that real-time computation and visualization of cSCPP(opt) after TSCI are feasible. cSCPP(opt) appears to enhance glucose utilization at the injury site and varies widely between and within patients. Our data suggest that targeting cSCPP(opt) after TSCI might improve neurological outcome.	[Chen, Suliang; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, London SW17 0RE, England; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, London SW17 0RE, England.	ssaadoun@sgul.ac.uk		Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176	Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI	This research was supported by grants awarded to MCP and SS from Wings for Life Spinal Cord Research Foundation and to MCP from the Neurosciences Research Foundation (Fletcher Fund). We thank the neurosurgeons at St. George's Hospital, King's College Hospital, and Hurstwood Park Neurological Centre as well as the spinal orthopaedic surgeons at St. George's Hospital who helped recruit patients. The neuroanaesthetic, neurointensive care, and operating theatre staff at St. George's Hospital helped with data collection.	Aries MJH, 2016, CRIT CARE MED, V44, pE996, DOI 10.1097/CCM.0000000000001816; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Chen S., 2016, J NEUROCHEM; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Cozzens JW, 2013, NEUROSURGERY, V72, P2, DOI 10.1227/NEU.0b013e3182772981; Depreitere B, 2016, ACTA NEUROCHIR SUPPL, V122, P245, DOI 10.1007/978-3-319-22533-3_49; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; McKinley W, 2006, J SPINAL CORD MED, V29, P501, DOI 10.1080/10790268.2006.11753899; Papadopoulos MC, 2015, NEUROSURGERY, V77, pE500, DOI 10.1227/NEU.0000000000000862; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Ploumis A, 2010, SPINAL CORD, V48, P356, DOI 10.1038/sc.2009.150; Readdy WJ, 2015, J NEUROSURG-SPINE, P1; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038	29	20	21	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2017	34	21					2941	2949		10.1089/neu.2017.4982			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FK6VJ	WOS:000413643000001	28351230	Green Accepted			2022-02-06	
J	Marini, A; Zettin, M; Bencich, E; Bosco, FM; Galetto, V				Marini, Andrea; Zettin, Marina; Bencich, Erica; Bosco, Francesca Marina; Galetto, Valentina			Severity effects on discourse production after TBI	JOURNAL OF NEUROLINGUISTICS			English	Article						Traumatic brain injury; TBI severity; Narrative analysis; Language	TRAUMATIC BRAIN-INJURY; NARRATIVE LANGUAGE; HEAD-INJURY; MULTILEVEL APPROACH; EXECUTIVE FUNCTIONS; STORY NARRATIVES; CONNECTED SPEECH; MILD; ADULTS; DEFICITS	Persons with traumatic brain injury (TBI) often experience macrolinguistic (i.e., pragmatic and discourse) difficulties. However, it is still not clear whether these difficulties are related to their cognitive impairments and little research has investigated communication abilities across the severity spectrum of TBI. This study compared the cognitive profile and narrative performance of persons with mild-to-moderate TBI, individuals with severe TBI and healthy control participants by adopting a multilevel procedure for discourse analysis. The results showed both severity-dependent and severity-independent effects on the participants' cognitive and narrative skills. A series of correlational analyses and two Principal Component Analyses confirmed the articulated nature of their narrative impairments and the complex interplay between cognitive and discourse difficulties in both groups of patients. The results from this study suggest that trauma severity influences the gravity of some of the symptoms observed in persons with TBI. At the same time, however, they highlight the cognitive nature of their narrative difficulties. (C) 2017 Elsevier Ltd. All rights reserved.	[Marini, Andrea] Univ Udine, Dipartimento Lingue & Letterature Comunicaz Forma, Via Margreth 3, I-33100 Udine, Italy; [Marini, Andrea] Claudiana Landesfachhsch Gesundheitsberufe, Lorenz Bohler Str 13, I-39100 Bolzano, Italy; [Bencich, Erica] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Zettin, Marina; Galetto, Valentina] Ctr Puzzle, Turin, Italy; [Zettin, Marina; Bosco, Francesca Marina; Galetto, Valentina] Univ Torino, Dipartimento Psicol, Turin, Italy		Marini, A (corresponding author), Univ Udine, Dipartimento Lingue & Letterature Comunicaz Forma, Via Margreth 3, I-33100 Udine, Italy.	andrea.marini@uniud.it	Marini, Andrea/A-1206-2012; bosco, francesca marina/B-6746-2013	Marini, Andrea/0000-0002-6058-3864; bosco, francesca marina/0000-0001-6101-8587			Andreetta S, 2015, APHASIOLOGY, V29, P705, DOI 10.1080/02687038.2014.979394; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Barker MS, 2017, BRAIN LANG, V168, P23, DOI 10.1016/j.bandl.2017.01.004; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Carlesimo GA, 1997, CORTEX, V33, P155, DOI 10.1016/S0010-9452(97)80011-1; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Coelho C, 2012, NEUROPSYCHOLOGIA, V50, P3564, DOI 10.1016/j.neuropsychologia.2012.09.005; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Gernsbacher M.A, 1990, LANGUAGE COMPREHENSI; Gernsbacher Morton Ann, 1999, Discourse Stud, V1, P355, DOI 10.1177/1461445699001003004; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Green S. B., 2008, USING SASS WINDOW MA; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HUBER W, 1982, BRAIN LANG, V16, P1, DOI 10.1016/0093-934X(82)90069-4; Indefrey P., 2000, NEW COGNITIVE NEUROS, P845; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kertesz A., 1982, W APHASIA BATTERY; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Levelt W.J.M., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Luzzatti C., 1991, AACHENER APHASIE TES; Marini A, 2005, BRAIN LANG, V93, P46, DOI 10.1016/j.bandl.2004.08.002; Marini A, 2011, APHASIOLOGY, V25, P1372, DOI 10.1080/02687038.2011.584690; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2012, J COGNITIVE NEUROSCI, V24, P2211, DOI 10.1162/jocn_a_00283; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Raven JC, 1938, PROGRESSIVE MATRICES; Reitan RM, 1992, TRAIL MAKING TEST; Rey A, 1958, LEXAMEN CLINIQUE PSY; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sherratt S, 2007, APHASIOLOGY, V21, P375, DOI 10.1080/02687030600911435; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Soldatovic-Stajic B, 2014, EUR REV MED PHARMACO, V18, P1632; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wright HH, 2012, APHASIOLOGY, V26, P656, DOI 10.1080/02687038.2012.676855; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; Zimmermann N, 2015, BRAIN INJURY, V29, P1071, DOI 10.3109/02699052.2015.1015613	72	20	20	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	NOV	2017	44						91	106		10.1016/j.jneuroling.2017.03.005			16	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	FH8BZ	WOS:000411418100006					2022-02-06	
J	Schwartz, JA; Connolly, EJ; Brauer, JR				Schwartz, Joseph A.; Connolly, Eric J.; Brauer, Jonathan R.			Head Injuries and Changes in Delinquency from Adolescence to Emerging Adulthood: The Importance of Self-control as a Mediating Influence	JOURNAL OF RESEARCH IN CRIME AND DELINQUENCY			English	Article						head injuries; self-control; delinquency; desistance; adolescence	TRAUMATIC BRAIN-INJURY; DECISION-MAKING; PREFRONTAL CORTEX; PARENTAL SOCIALIZATION; ANTISOCIAL-BEHAVIOR; GENETIC INFLUENCES; EXECUTIVE FUNCTION; SENSATION SEEKING; METAANALYSIS; IMPULSIVITY	Objectives: The current study examines whether head injuries suffered earlier in the life course are associated with subsequent changes in self-control and delinquency. Methods: Latent growth curve models and path analysis are used to analyze the developmental trajectories of self-control and delinquency as well as the potential associations between head injury, self-control, and delinquency among a sample of youth offenders from the pathways to desistance study. Results: The results revealed significant associations between head injuries and short-term changes in self-control and subsequent increases in aggressive delinquency. Indirect pathway models revealed that lower levels of self-control significantly mediated the association between head injuries and starting levels in aggressive delinquency. The association between head injuries and changes in aggressive delinquency was also significantly mediated by self-control, but the association was negative, indicating that youth who previously suffered head injuries desisted from aggressive delinquency at a slightly faster rate than their noninjured peers. Additional analyses revealed that, despite accelerated rates of decline, injured youth engaged in significantly higher levels of aggressive delinquency throughout the entire observation period. Conclusion: Head injuries represent one environmental factor that may influence delinquent behaviors through their influence on biological and developmental processes.	[Schwartz, Joseph A.] Univ Nebraska, Sch Criminol & Criminal Justice, 218 CPACS,6001 Dodge St, Omaha, NE 68182 USA; [Connolly, Eric J.] Penn State Univ, Dept Criminal Justice, Abington, PA USA; [Connolly, Eric J.] Sam Houston State Univ, Coll Criminal Justice, Huntsville, TX 77340 USA; [Brauer, Jonathan R.] Indiana Univ, Dept Criminal Justice, Bloomington, IN USA		Schwartz, JA (corresponding author), Univ Nebraska, Sch Criminol & Criminal Justice, 218 CPACS,6001 Dodge St, Omaha, NE 68182 USA.	jaschwartz@unomaha.edu		Connolly, Eric/0000-0003-4714-6739			Acock AC, 2005, J MARRIAGE FAM, V67, P1012, DOI 10.1111/j.1741-3737.2005.00191.x; Batts S, 2009, BEHAV SCI LAW, V27, P261, DOI 10.1002/bsl.857; Beaver KM, 2007, CRIM JUSTICE BEHAV, V34, P1345, DOI 10.1177/0093854807302049; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Behnken MP, 2015, ROUT INT HANDB, P418; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; Blokland AAJ, 2005, CRIMINOLOGY, V43, P919, DOI 10.1111/j.1745-9125.2005.00029.x; Boisvert D, 2013, CRIM JUSTICE BEHAV, V40, P80, DOI 10.1177/0093854812453129; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Brown CH, 2008, DRUG ALCOHOL DEPEN, V95, pS74, DOI 10.1016/j.drugalcdep.2007.11.013; Brown J., 2015, DENVER POST; Burt CH, 2014, CRIMINOLOGY, V52, P450, DOI 10.1111/1745-9125.12045; Burt CH, 2006, CRIMINOLOGY, V44, P353, DOI 10.1111/j.1745-9125.2006.00052.x; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cristofori I, 2016, J NEUROSCI, V36, P2757, DOI 10.1523/JNEUROSCI.2975-15.2016; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; DeLisi M., 2015, NURTURE VERSUS BIOSO, P172; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Forth A. E., 2003, HARE PSYCHOPATHY CHE; Foster SL, 1995, PSYCHOL ASSESSMENT, V7, P248, DOI 10.1037/1040-3590.7.3.248; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Gibson CL, 2010, J RES CRIME DELINQ, V47, P31, DOI 10.1177/0022427809348903; Glenn AL, 2010, BIOL PSYCHIAT, V67, P52, DOI 10.1016/j.biopsych.2009.06.018; Gottfredson M. R., 1990, GEN THEORY CRIME; Grant JE, 2014, CNS SPECTRUMS, V19, P21, DOI 10.1017/S109285291300028X; Harden KP, 2012, DEVELOPMENTAL SCI, V15, P150, DOI 10.1111/j.1467-7687.2011.01115.x; Harden KP, 2011, DEV PSYCHOL, V47, P739, DOI 10.1037/a0023279; Hay C., 2016, SELF CONTROL CRIME L; Hay C, 2006, CRIMINOLOGY, V44, P739, DOI 10.1111/j.1745-9125.2006.00062.x; Hirschi T, 2004, HDB SELF REGULATION, P537; HOLLINGSHEAD AB, 1971, SOC FORCES, V49, P563, DOI 10.2307/2576737; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUIZINGA D, 1991, J CRIM LAW CRIM, V82, P83, DOI 10.2307/1143790; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; Konicar L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09426; Loughran TA, 2011, CRIMINOLOGY, V49, P1029, DOI 10.1111/j.1745-9125.2011.00251.x; Meier MH, 2008, J ABNORM PSYCHOL, V117, P377, DOI 10.1037/0021-843X.117.2.377; Meijers J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00043; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Monahan KC, 2013, DEV PSYCHOPATHOL, V25, P1093, DOI 10.1017/S0954579413000394; Mulvey E. P, 2012, ICPSR29961V2; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Niv S, 2012, BEHAV GENET, V42, P378, DOI 10.1007/s10519-011-9518-6; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Perron B. E., 2015, INT HDB BIOSOCIAL CR; Polito MZ, 2010, J AM ACAD NURSE PRAC, V22, P504, DOI 10.1111/j.1745-7599.2010.00540.x; Pratt TC, 2004, J RES CRIME DELINQ, V41, P219, DOI 10.1177/0022427803260270; Pratt TC, 2014, CRIMINOLOGY, V52, P87, DOI 10.1111/1745-9125.12030; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sariaslan A, 2016, JAMA PSYCHIAT, V73, P796, DOI 10.1001/jamapsychiatry.2016.1349; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Schug RA, 2010, J NERV MENT DIS, V198, P870, DOI 10.1097/NMD.0b013e3181fe7280; Schwartz JA, 2015, INTELLIGENCE, V51, P109, DOI 10.1016/j.intell.2015.06.001; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Steinberg L, 1996, LAW HUMAN BEHAV, V20, P249, DOI 10.1007/BF01499023; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Ttofi MM, 2016, J CRIM JUST, V45, P4, DOI 10.1016/j.jcrimjus.2016.02.003; Turner MG, 2005, J CRIM JUST, V33, P327, DOI 10.1016/j.jcrimjus.2005.04.003; Vazsonyi AT, 2017, J CRIM JUST, V48, P48, DOI 10.1016/j.jcrimjus.2016.10.001; Walters GD, 2014, AGGRESSIVE BEHAV, V40, P238, DOI 10.1002/ab.21514; Wechsler D., 2011, WECHSLER ABBREVIATED; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wiesner M, 2007, CRIMINOLOGY, V45, P835, DOI 10.1111/j.1745-9125.2007.00099.x; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yancey JR, 2013, J CRIM JUST, V41, P309, DOI 10.1016/j.jcrimjus.2013.06.002; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	85	20	20	0	22	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-4278	1552-731X		J RES CRIME DELINQ	J. Res. Crime Delinq.	NOV	2017	54	6					869	901		10.1177/0022427817710287			33	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	FJ5UQ	WOS:000412818900005					2022-02-06	
J	Jiang, WW; Wang, QH; Liao, YJ; Peng, P; Xu, M; Yin, LX				Jiang, Wan-Wei; Wang, Qing-Hui; Liao, Ya-Jing; Peng, Pai; Xu, Min; Yin, Li-Xin			Effects of dexmedetomidine on TNF-alpha and interleukin-2 in serum of rats with severe craniocerebral injury	BMC ANESTHESIOLOGY			English	Article						Dexmedetomidine; Severe craniocerebral injury; TNF-alpha; Il-2	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; ISCHEMIA-REPERFUSION; HEAD-INJURY; CELLS; NEUROPROTECTION; ANESTHESIA; IMPACT; DAMAGE; IL-6	Background: Dexmedetomidine is a highly selective adrenergic receptor agonist, which has a dose-dependent sedative hypnotic effect. Furthermore, it also has pharmacological properties, and the ability to inhibit sympathetic activity and improve cardiovascular stability during an operation. However, its protective effect on patients with severe craniocerebral injury in the perioperative period remains unclear. Method: Eighty adult male SD rats were used and divided into two groups (n = 40, each group): dexmedetomidine injury group (experimental group), and sodium chloride injury group (control group). Models of severe craniocerebral injury were established in these two groups using the modified Feeney's free-fall method. As soon as the establishment of models was succeed, rat in the experimental group received 1 mu g of dexmedetomidine (0.1 ml), while each rat in the control group was given 0.1 ml of 0.9% sodium chloride. Blood was sampled from an incision at the femoral vein to detect TNF-alpha and IL-2 levels at 1, 12, 24,36,48 and 72 h after establishing the model in the two groups. Results: After severe craniocerebral injury, TNF-alpha levels of rats were lower in every stage and at different degrees in the experimental group than in the control group (P < 0.05), while IL-2 levels were lower in the experimental group to different extents (P < 0.05). Conclusion: Dexmedetomidine protects the brain of rats with severe craniocerebral injury by reducing the release of inflammatory mediators.	[Jiang, Wan-Wei; Wang, Qing-Hui; Liao, Ya-Jing; Peng, Pai; Xu, Min; Yin, Li-Xin] Dalian Univ, Affiliated Zhongshan Hosp, Dept Anesthesiol 2, 6 Jiefang St, Dalian 116001, Peoples R China		Jiang, WW (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dept Anesthesiol 2, 6 Jiefang St, Dalian 116001, Peoples R China.	wanweijdoc@163.com					Aleksandrova E V, 2014, Zh Vopr Neirokhir Im N N Burdenko, V78, P53; Alipour E, 2016, J SOLID STATE ELECTR, V20, P1645, DOI 10.1007/s10008-016-3168-9; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cakir M, 2015, RENAL FAILURE, V37, P704, DOI 10.3109/0886022X.2015.1011550; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; De Los Rios JA, 2009, NEUROCIRUGIA, V20, P433; Farag E, 2012, CURR PHARM DESIGN, V18, P6257, DOI 10.2174/138161212803832272; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Foley K, 2009, MED HYPOTHESES, V72, P150, DOI 10.1016/j.mehy.2008.08.024; Inoue S, 2016, SHOCK, V45, P63; Lee JS, 2009, ARCH ORTHOP TRAUM SU, V129, P711, DOI 10.1007/s00402-008-0632-8; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mengel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00675; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Riha H, 2012, PHYSIOL RES, V61, P63, DOI 10.33549/physiolres.932224; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sanders RD, 2009, CRIT CARE CLIN, V25, P551, DOI 10.1016/j.ccc.2009.05.001; Sato K, 2010, ACTA ANAESTH SCAND, V54, P377, DOI 10.1111/j.1399-6576.2009.02139.x; Shi QQ, 2012, SAUDI MED J, V33, P375; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Tang XP, 2008, NEURAL REGEN RES, V3, P867; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang H, 2016, HYPERTENSION, V68, P114, DOI 10.1161/HYPERTENSIONAHA.116.07084; Wang QH, 2000, J TRAUMA SURG, V22, P24; Wu XJ, 2013, J TRAUMA ACUTE CARE, V74, P524, DOI 10.1097/TA.0b013e31827d5de3; Zhang XB, 2014, INFLAMMATION, V37, P942, DOI 10.1007/s10753-014-9814-4; Zhang XY, 2012, ANESTHESIOLOGY, V116, P1035, DOI 10.1097/ALN.0b013e3182503964	33	20	27	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	SEP 20	2017	17								130	10.1186/s12871-017-0410-7			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	FH7QB	WOS:000411384200001	28931374	Green Published, gold			2022-02-06	
J	Haber, M; Hutchinson, EB; Sadeghi, N; Cheng, WH; Namjoshi, D; Cripton, P; Irfanoglu, MO; Wellington, C; Diaz-Arrastia, R; Pierpaoli, C				Haber, M.; Hutchinson, E. B.; Sadeghi, N.; Cheng, W. H.; Namjoshi, D.; Cripton, P.; Irfanoglu, M. O.; Wellington, C.; Diaz-Arrastia, R.; Pierpaoli, C.			Defining an Analytic Framework to Evaluate Quantitative MRI Markers of Traumatic Axonal Injury: Preliminary Results in a Mouse Closed Head Injury Model	ENEURO			English	Article						CHIMERA; diffuse axonal injury; diffusion tensor imaging; glia; immunohistochemistry; mouse	COMMON DATA ELEMENTS; BRAIN-INJURY; DIFFEOMORPHIC REGISTRATION; DIFFUSION; DISEASE; DAMAGE; ACCELERATION; MECHANISMS; ANISOTROPY; PATHOLOGY	Diffuse axonal injury (DAI) is a hallmark of traumatic brain injury (TBI) pathology. Recently, the Closed Head Injury Model of Engineered Rotational Acceleration (CHIMERA) was developed to generate an experimental model of DAI in a mouse. The characterization of DAI using diffusion tensor magnetic resonance imaging (MRI; diffusion tensor imaging, DTI) may provide a useful set of outcome measures for preclinical and clinical studies. The objective of this study was to identify the complex neurobiological underpinnings of DTI features following DAI using a comprehensive and quantitative evaluation of DTI and histopathology in the CHIMERA mouse model. A consistent neuroanatomical pattern of pathology in specific white matter tracts was identified across ex vivo DTI maps and photomicrographs of histology. These observations were confirmed by voxelwise and regional analysis of DTI maps, demonstrating reduced fractional anisotropy (FA) in distinct regions such as the optic tract. Similar regions were identified by quantitative histology and exhibited axonal damage as well as robust gliosis. Additional analysis using a machine-learning algorithm was performed to identify regions and metrics important for injury classification in a manner free from potential user bias. This analysis found that diffusion metrics were able to identify injured brains almost with the same degree of accuracy as the histology metrics. Good agreement between regions detected as abnormal by histology and MRI was also found. The findings of this work elucidate the complexity of cellular changes that give rise to imaging abnormalities and provide a comprehensive and quantitative evaluation of the relative importance of DTI and histological measures to detect brain injury.	[Haber, M.; Diaz-Arrastia, R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Hutchinson, E. B.; Sadeghi, N.; Irfanoglu, M. O.; Pierpaoli, C.] Natl Inst Biomed Imaging & Bioengn, Quantitat Med Imaging Sect, NIH, Bethesda, MD USA; [Hutchinson, E. B.; Sadeghi, N.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Quantitat Imaging & Tissue Sci, NIH, Bethesda, MD USA; [Cheng, W. H.; Namjoshi, D.; Wellington, C.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Pathol & Lab Med, Vancouver, BC, Canada; [Cripton, P.] Univ British Columbia, Int Collaborat Repair Discoveries, Mech Engn, Vancouver, BC, Canada; [Hutchinson, E. B.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA		Haber, M (corresponding author), Univ Penn, 51 N 39th St,Mutch Room 417, Philadelphia, PA 19104 USA.	Margalit.haber@uphs.upenn.edu	Pierpaoli, Carlo/E-1672-2011; Cripton, Peter Alec/AAC-8268-2020	Pierpaoli, Carlo/0000-0001-8558-4428; Cripton, Peter Alec/0000-0002-5067-0833; Hutchinson, Elizabeth/0000-0002-3374-5469; Cheng, Wai Hang/0000-0002-3408-9184	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Weston Brain Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [ZIAEB000089] Funding Source: NIH RePORTER	This work was supported by the Department of Defense in the Center for Neuroscience and Regenerative Medicine. T.C., D.N., P.C., and C.L.W. are supported by operating grants from the Canadian Institutes of Health Research and the Weston Brain Institute.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Centers for Disease Control and Prevention (CDC), 2017, RAT TBI REL EM DEP V RAT TBI REL EM DEP V; Chen ZQ, 2008, NEUROL RES, V30, P720, DOI 10.1179/174313208X297968; Chiang SR, 2016, EPILEPSY RES, V120, P37, DOI 10.1016/j.eplepsyres.2015.12.002; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kacar K, 2011, AM J NEURORADIOL, V32, P2098, DOI 10.3174/ajnr.A2864; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Loane C, 2016, MOVEMENT DISORD, V31, P1020, DOI 10.1002/mds.26606; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Melah KE, 2016, J ALZHEIMERS DIS, V50, P873, DOI 10.3233/JAD-150897; Nagae LM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00017; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pierpaoli C, 2010, ISMRM 18 ANN M; R Core Team, 2016, R LANG ENV STAT COMP; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sener S, 2016, NEUROSURGERY, V79, P786, DOI 10.1227/NEU.0000000000001325; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Skinner NP, 2015, NMR BIOMED, V28, P1489, DOI 10.1002/nbm.3405; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yang M, 2017, BRAIN TOPOGR, V30, P249, DOI 10.1007/s10548-016-0503-5; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y	50	20	20	0	1	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2017	4	5							0164-17.2017	10.1523/ENEURO.0164-17.2017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG8JW	WOS:000410678100004	28966972	gold, Green Published			2022-02-06	
J	Hansen, B; Khan, AR; Shemesh, N; Lund, TE; Sangill, R; Eskildsen, SF; Ostergaard, L; Jespersen, SN				Hansen, Brian; Khan, Ahmad R.; Shemesh, Noam; Lund, Torben E.; Sangill, Ryan; Eskildsen, Simon F.; Ostergaard, Leif; Jespersen, Sune N.			White matter biomarkers from fast protocols using axially symmetric diffusion kurtosis imaging	NMR IN BIOMEDICINE			English	Article						biophysics; diffusion; kurtosis; MRI; white matter; WMTI	MAGNETIC-RESONANCE MICROSCOPY; NON-GAUSSIAN DIFFUSION; TRAUMATIC BRAIN-INJURY; TRACT INTEGRITY; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; TENSOR MICROSCOPY; NERVOUS-TISSUE; METRICS; TIME	White matter tract integrity (WMTI) can characterize brain microstructure in areas with highly aligned fiber bundles. Several WMTI biomarkers have now been validated against microscopy and provided promising results in studies of brain development and aging, as well as in a number of brain disorders. Currently, WMTI is mostly used in dedicated animal studies and clinical studies of slowly progressing diseases, and has not yet emerged as a routine clinical tool. To this end, a less data intensive experimental method would be beneficial by enabling high resolution validation studies, and ease clinical applications by speeding up data acquisition compared with typical diffusion kurtosis imaging (DKI) protocols utilized as part of WMTI imaging. Here, we evaluate WMTI based on recently introduced axially symmetric DKI, which has lower data demand than conventional DKI. We compare WMTI parameters derived from conventional DKI with those calculated analytically from axially symmetric DKI. We employ numerical simulations, as well as data from fixed rat spinal cord (one sample) and in vivo human (three subjects) and rat brain (four animals). Our analysis shows that analytical WMTI based on axially symmetric DKI with sparse data sets (19 images) produces WMTI metrics that correlate strongly with estimates based on traditional DKI data sets (60 images or more). We demonstrate the preclinical potential of the proposed WMTI technique in in vivo rat brain (300m isotropic resolution with whole brain coverage in a 1h acquisition). WMTI parameter estimates are subject to a duality leading to two solution branches dependent on a sign choice, which is currently debated. Results from both of these branches are presented and discussed throughout our analysis. The proposed fast WMTI approach may be useful for preclinical research and e.g. clinical evaluation of patients with traumatic white matter injuries or symptoms of neurovascular or neuroinflammatory disorders.	[Hansen, Brian; Khan, Ahmad R.; Lund, Torben E.; Sangill, Ryan; Eskildsen, Simon F.; Ostergaard, Leif; Jespersen, Sune N.] Aarhus Univ, Dept Clin Med, CFIN, Aarhus, Denmark; [Hansen, Brian; Khan, Ahmad R.; Lund, Torben E.; Sangill, Ryan; Eskildsen, Simon F.; Ostergaard, Leif; Jespersen, Sune N.] Aarhus Univ, Dept Clin Med, MINDLab, Aarhus, Denmark; [Shemesh, Noam] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Jespersen, Sune N.] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark		Hansen, B (corresponding author), Aarhus Univ, Dept Clin Med, CFIN, Aarhus, Denmark.; Hansen, B (corresponding author), Aarhus Univ, Dept Clin Med, MINDLab, Aarhus, Denmark.	brian@cfin.au.dk	Ostergaard, Lars/AAA-3020-2020; Ostergaard, Leif/A-9281-2008; Lund, Torben E/B-1919-2008; Eskildsen, Simon/K-3934-2019; Khan, Ahmad Raza/L-1461-2019; Jespersen, Sune Norhoj/B-1914-2008	Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Leif/0000-0003-2930-6997; Lund, Torben E/0000-0002-9002-4676; Eskildsen, Simon/0000-0003-4242-9158; Khan, Ahmad Raza/0000-0002-7396-3073; Jespersen, Sune Norhoj/0000-0003-3146-4329; Shemesh, Noam/0000-0001-6681-5876; Ostergaard, Lars/0000-0002-7619-605X	Danish Ministry of Science, Technology and Innovation's University Investment Grant [0601-01354B]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01EB012874-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB012874] Funding Source: NIH RePORTER	Danish Ministry of Science, Technology and Innovation's University Investment Grant, Grant/Award Number: 0601-01354B; NIH, Grant/Award Number: 1R01EB012874-01	BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Chuhutin A, 2016, ISMRM 24 ANN M EXH S; Chuhutin A, 2015, P 23 ANN M ISMRM BER, P2833; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; de Kouchkovsky I, 2016, J NEUROL, V263, P1146, DOI 10.1007/s00415-016-8118-z; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Flint JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18095; Flint JJ, 2012, NEUROIMAGE, V60, P1404, DOI 10.1016/j.neuroimage.2012.01.050; Flint JJ, 2010, NEUROIMAGE, V52, P556, DOI 10.1016/j.neuroimage.2010.04.031; Flint JJ, 2009, NEUROIMAGE, V46, P1037, DOI 10.1016/j.neuroimage.2009.03.009; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Gong NJ, 2014, NEUROBIOL AGING, V35, P2203, DOI 10.1016/j.neurobiolaging.2014.03.011; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hansen B, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.72; Hansen B, 2016, NEUROIMAGE, V142, P371, DOI 10.1016/j.neuroimage.2016.08.022; Hansen B, 2016, MAGN RESON MED, V76, P1455, DOI 10.1002/mrm.26055; Hansen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23999; Hansen B, 2014, MAGN RESON MED, V71, P2250, DOI 10.1002/mrm.25090; Hansen B, 2011, NEUROIMAGE, V57, P1458, DOI 10.1016/j.neuroimage.2011.04.052; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Hardin RH, 1996, DISCRETE COMPUT GEOM, V15, P429, DOI 10.1007/BF02711518; Hui ES, 2015, NEUROIMAGE, V120, P371, DOI 10.1016/j.neuroimage.2015.07.013; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3689; Jensen JH, 2014, NMR BIOMED, V27, P363, DOI [10.1002/nbm.3094, 10.1002/nbm.3030]; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2012, NMR BIOMED, V25, P813, DOI 10.1002/nbm.1808; Jespersen SN, 2012, IEEE T MED IMAGING, V31, P16, DOI 10.1109/TMI.2011.2162099; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kelma ND, 2016, NEUROIMAGE, V124, P612, DOI 10.1016/j.neuroimage.2015.09.028; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Lee CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11147; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Novikov DS, ARXIV1609091441PHYSI; Ong HH, 2010, NEUROIMAGE, V51, P1360, DOI 10.1016/j.neuroimage.2010.03.063; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Paydar A, 2014, AM J NEURORADIOL, V35, P808, DOI 10.3174/ajnr.A3764; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Pyatigorskaya N, 2014, MAGN RESON MED, V72, P492, DOI 10.1002/mrm.24921; Reisert M, 2017, NEUROIMAGE, V147, P964, DOI 10.1016/j.neuroimage.2016.09.058; Ronen I, 2014, BRAIN STRUCT FUNCT, V219, P1773, DOI 10.1007/s00429-013-0600-0; SCHOENIGER JS, 1994, J MAGN RESON SER B, V103, P261, DOI 10.1006/jmrb.1994.1039; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; Skinner NP, 2017, MAGN RESON MED, V77, P1639, DOI 10.1002/mrm.26243; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Westin CF, 1999, LECT NOTES COMPUT SC, V1679, P441; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084	70	20	20	0	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	SEP	2017	30	9							e3741	10.1002/nbm.3741			17	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	FD6QV	WOS:000407653900007	28543843	Green Accepted, Green Submitted			2022-02-06	
J	Liu, SJ; Shen, Y; Shultz, SR; Nguyen, A; Hovens, C; Adlard, PA; Bush, AI; Chan, JX; Kwan, P; O'Brien, TJ; Jones, NC				Liu, Shijie; Shen, Yu; Shultz, Sandy R.; Anne Nguyen; Hovens, Christopher; Adlard, Paul A.; Bush, Ashley I.; Chan, Jianxiong; Kwan, Patrick; O'Brien, Terence J.; Jones, Nigel C.			Accelerated kindling epileptogenesis in Tg4510 tau transgenic mice, but not in tau knockout mice	EPILEPSIA			English	Article						rTg4510; Tau; Animal model; Amygdala kindling; Epileptogenesis	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MOUSE MODEL; HYPERPHOSPHORYLATED TAU; EPILEPSY; SEIZURES; HYPEREXCITABILITY; REDUCTION; DEMENTIA	The biologic processes underlying epileptogenesis following a brain insult are not fully understood, but several lines of evidence suggest that hyperphosphorylation of tau may be an important factor in these processes. To provide further insight into the causal relationship between tau and epileptogenesis, this study applied amygdala kindling to rTg4510 mice that, concurrent with other pathologies, overexpress phosphorylated tau, tau knockout mice, or their respective wild-type controls. Mice were electrically stimulated twice daily, 5 days per week for 3 weeks. Electroencephalography was recorded to measure the primary afterdischarge duration, and the behavioral progression of kindling-induced seizures was assessed. rTg4510 mice (n = 10) had increased primary afterdischarge durations (p < 0.001), and significantly more rapid progression of kindling (p < 0.001), compared with wild-type mice (n = 10). Tau knockout mice (n = 7), however, did not differ from their wild-type counterparts (n = 8) on any of the seizure outcomes. These results suggest that Tg4510 mice are more vulnerable to epileptogenesis, but that the presence of tau itself is not necessary for kindling epileptogenesis to occur.	[Liu, Shijie; Shen, Yu; Shultz, Sandy R.; Chan, Jianxiong; Kwan, Patrick; O'Brien, Terence J.; Jones, Nigel C.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic, Australia; [Anne Nguyen; Hovens, Christopher] Univ Melbourne, Dept Surg, Royal Melbourne Hosp, Parkville, Vic, Australia; [Adlard, Paul A.; Bush, Ashley I.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Kwan, Patrick; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia		Jones, NC (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne Brain Ctr, Parkville, Vic 3052, Australia.	ncjones@unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; Bush, Ashley I/A-1186-2007; O'Brien, Terence/L-8102-2013; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Hovens, Christopher/0000-0002-0610-1289; O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439	Australian Research Council (ARC) Future FellowshipsAustralian Research Council [FT120100030, FT13100100]; Victorian Government's Operational Infrastructure Support Program; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1006077]	PAA (FT120100030) and NCJ (FT13100100) are supported by Australian Research Council (ARC) Future Fellowships. We gratefully acknowledge the support of the Victorian Government's Operational Infrastructure Support Program, and the National Health and Medical Research Council (NHMRC) (project grant APP1006077).	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Chan JX, 2015, EPILEPSIA, V56, pe73, DOI 10.1111/epi.12993; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Friedman D, 2012, CNS NEUROSCI THER, V18, P285, DOI 10.1111/j.1755-5949.2011.00251.x; Garcia-Cabrero AM, 2013, NEUROBIOL DIS, V58, P200, DOI 10.1016/j.nbd.2013.06.005; Gheyara AL, 2014, ANN NEUROL, V76, P443, DOI 10.1002/ana.24230; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jones NC, 2012, NEUROBIOL DIS, V45, P897, DOI 10.1016/j.nbd.2011.12.005; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209	17	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	SEP	2017	58	9					E136	E141		10.1111/epi.13847			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF9LT	WOS:000409338700003	28710841	Bronze, Green Submitted			2022-02-06	
J	Ryan, NP; Catroppa, C; Beare, R; Silk, TJ; Hearps, SJ; Beauchamp, MH; Yeates, KO; Anderson, VA				Ryan, Nicholas P.; Catroppa, Cathy; Beare, Richard; Silk, Timothy J.; Hearps, Stephen J.; Beauchamp, Miriam H.; Yeates, Keith O.; Anderson, Vicki A.			Uncovering the neuroanatomical correlates of cognitive, affective and conative theory of mind in paediatric traumatic brain injury: a neural systems perspective	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						childhood; brain injuries; Theory of Mind; social cognition; magnetic resonance imaging	SOCIAL COGNITION; MIRROR NEURON; EXECUTIVE FUNCTIONS; FRONTAL-CORTEX; CHILDREN; NETWORK; CONNECTIVITY; CHILDHOOD; MODERATE; OUTCOMES	Deficits in theory of mind (ToM) are common after neurological insult acquired in the first and second decade of life, however the contribution of large-scale neural networks to ToM deficits in children with brain injury is unclear. Using paediatric traumatic brain injury (TBI) as a model, this study investigated the sub-acute effect of paediatric traumatic brain injury on grey-matter volume of three large-scale, domain-general brain networks (the Default Mode Network, DMN; the Central Executive Network, CEN; and the Salience Network, SN), as well as two domain-specific neural networks implicated in social-affective processes (the Cerebro-Cerebellar Mentalizing Network, CCMN and the Mirror Neuron/Empathy Network, MNEN). We also evaluated prospective structure-function relationships between these large-scale neural networks and cognitive, affective and conative ToM. 3D T1- weighted magnetic resonance imaging sequences were acquired sub-acutely in 137 children [TBI: n = 103; typically developing (TD) children: n = 34]. All children were assessed on measures of ToM at 24-months post-injury. Children with severe TBI showed sub-acute volumetric reductions in the CCMN, SN, MNEN, CEN and DMN, as well as reduced grey-matter volumes of several hub regions of these neural networks. Volumetric reductions in the CCMN and several of its hub regions, including the cerebellum, predicted poorer cognitive ToM. In contrast, poorer affective and conative ToM were predicted by volumetric reductions in the SN and MNEN, respectively. Overall, results suggest that cognitive, affective and conative ToM may be prospectively predicted by individual differences in structure of different neural systems-the CCMN, SN and MNEN, respectively. The prospective relationship between cerebellar volume and cognitive ToM outcomes is a novel finding in our paediatric brain injury sample and suggests that the cerebellum may play a role in the neural networks important for ToM. These findings are discussed in relation to neurocognitive models of ToM. We conclude that detection of sub-acute volumetric abnormalities of large-scale neural networks and their hub regions may aid in the early identification of children at risk for chronic social-cognitive impairment.	[Ryan, Nicholas P.; Catroppa, Cathy; Hearps, Stephen J.; Anderson, Vicki A.] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Parkville, Vic 3052, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Parkville, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia; [Beare, Richard; Silk, Timothy J.] Murdoch Childrens Res Inst, Dev Imaging, Parkville, Vic, Australia; [Silk, Timothy J.; Anderson, Vicki A.] Univ Melbourne, Dept Pediat, Parkville, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB, Canada		Ryan, NP (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021; Hearps, Stephen/L-6853-2016; Silk, Tim/K-4295-2019; Ryan, Nicholas/K-5445-2019; Yeates, Keith/AAJ-4223-2020	Catroppa, Cathy/0000-0002-9750-0436; Ryan, Nicholas/0000-0002-0878-8889; Yeates, Keith/0000-0001-7680-2892; Beare, Richard/0000-0002-7530-5664; Hearps, Stephen/0000-0003-2984-1172; Silk, Tim/0000-0002-7290-512X	Victoria Neurotrauma Initiative, Australia [CO6E1]; Victorian Government Operational Infrastructure Support Program; Australian Postgraduate AwardAustralian Government; MCRI PhD scholarship; NHMRC Moving Ahead Centre for Research Excellence in Brain Injury Recovery Seed GrantNational Health and Medical Research Council of Australia; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	This work was supported by a grant from the Victoria Neurotrauma Initiative, Australia (No. CO6E1); the Victorian Government Operational Infrastructure Support Program; an Australian Postgraduate Award, MCRI PhD scholarship, and NHMRC Moving Ahead Centre for Research Excellence in Brain Injury Recovery Seed Grant to NR; and an NHMRC Senior Practitioner Fellowship to VA.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Ahmed RM, 2016, J NEUROL NEUROSUR PS, V87, P1234, DOI 10.1136/jnnp-2014-308350; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Backhausen LL, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00558; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2011, BRAIN INJURY, V25, P950, DOI 10.3109/02699052.2011.589791; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2007, SOC COGN AFFECT NEUR, V2, P130, DOI 10.1093/scan/nsm009; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Corradini A, 2013, CONSCIOUS COGN, V22, P1152, DOI 10.1016/j.concog.2013.03.003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Decety J, 2003, NEUROPSYCHOLOGIA, V41, P127, DOI 10.1016/S0028-3932(02)00143-4; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman AI, 2009, MIND LANG, V24, P235, DOI 10.1111/j.1468-0017.2008.01361.x; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Herbet G, 2013, CORTEX, V49, P2711, DOI 10.1016/j.cortex.2013.08.003; Iacobini M., 2008, MIRRORING PEOPLE SCI; IACOBONI M, 2008, MIRRORING PEOPLE; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kao HW, 2012, EUR RADIOL, V22, P1397, DOI 10.1007/s00330-012-2387-4; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mitchell JP, 2005, NEUROIMAGE, V28, P757, DOI 10.1016/j.neuroimage.2005.03.011; Molenberghs P, 2016, NEUROSCI BIOBEHAV R, V65, P276, DOI 10.1016/j.neubiorev.2016.03.020; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Saxe R, 2009, PHILOS STUD, V144, P447, DOI 10.1007/s11098-009-9353-2; Saxe RR, 2009, CHILD DEV, V80, P1197, DOI 10.1111/j.1467-8624.2009.01325.x; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schmitgen MM, 2016, NEUROIMAGE, V129, P450, DOI 10.1016/j.neuroimage.2016.01.029; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shaw P, 2004, BRAIN, V127, P1535, DOI 10.1093/brain/awh168; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Sodian B, 2011, CHILD DEV PERSPECT, V5, P39, DOI 10.1111/j.1750-8606.2010.00152.x; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Stewart E, 2016, NEUROPSYCHOL REV, V26, P3, DOI 10.1007/s11065-015-9313-x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Taylor H. G., 2010, PEDIAT TRAUMATIC BRA, P145; TEASDALE G, 1974, LANCET, V2, P81; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Van Overwalle F, 2015, HUM BRAIN MAPP, V36, P5137, DOI 10.1002/hbm.23002; Van Overwalle F, 2016, NEUROIMAGE, V124, P248, DOI 10.1016/j.neuroimage.2015.09.001; Van Overwalle F, 2015, SOC NEUROSCI-UK, V10, P337, DOI 10.1080/17470919.2015.1005666; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wolfe KR, 2013, CHILD NEUROPSYCHOL, V19, P370, DOI 10.1080/09297049.2012.669470; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Young L, 2010, NEUROPSYCHOLOGIA, V48, P2658, DOI 10.1016/j.neuropsychologia.2010.05.012; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010	104	20	21	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	SEP	2017	12	9					1414	1427		10.1093/scan/nsx066			14	Neurosciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FJ3QI	WOS:000412646400005	28505355	Green Published, gold			2022-02-06	
J	Wang, CX; Hu, ZY; Zou, Y; Xiang, MJ; Jiang, YT; Botchway, BOA; Huo, X; Du, XX; Fang, MR				Wang, Changxing; Hu, Zhiying; Zou, Yang; Xiang, Mingjun; Jiang, Yuting; Botchway, Benson O. A.; Huo, Xue; Du, Xiaoxue; Fang, Marong			The post-therapeutic effect of rapamycin in mild traumatic brain-injured rats ensuing in the upregulation of autophagy and mitophagy	CELL BIOLOGY INTERNATIONAL			English	Article						apoptosis; brain system; mitochondria; neurodegeneration	OXIDATIVE STRESS; RODENT MODEL; PARKIN; MITOCHONDRIA; PINK1; PROMOTES; COMPLEX	Mild traumatic brain injury (mTBI), common in juveniles, has been reported to be caused by sports-related concussion. Many young children may suffer from post-concussion syndrome. mTBI, in early stages of life, could play a part in neuron apoptosis and degeneration, cognitive and motor coordination impairment, as well as dementia. Our study was aimed at further investigating the post-therapeutic efficacy of rapamycin in the recuperation of mTBI while at the same time investigating the metamorphosis in both autophagy and mitophagy in mTBI. We created a weight-drop rat mTBI model with the administration of rapamycin at 4h after every mTBI. Behavioral tests of beam walking and open field task indicated the expected improvement of cognitive and motor coordination functions. Both Western blot and immunofluorescence examinations revealed increased Beclin-1 and PINK1 in the treated rats as well as reduction of caspase-3 and cytochrome C (Cyt C). More so, the TUNEL staining evidenced curtailment of apoptotic cells following treatment with rapamycin. The upregulation of Beclin-1 and PINK1 and the downregulation of caspase-3 and Cyt C extrapolate that rapamycin plays neuroprotective as well as anti-apoptotic role via interposition of both autophagy and mitophagy.	[Wang, Changxing; Zou, Yang] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China; [Hu, Zhiying] Hangzhou Red Cross Hosp, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China; [Xiang, Mingjun; Jiang, Yuting; Botchway, Benson O. A.; Huo, Xue; Du, Xiaoxue; Fang, Marong] Zhejiang Univ, Sch Med, Inst Neurosci, Hangzhou 310058, Zhejiang, Peoples R China		Fang, MR (corresponding author), Zhejiang Univ, Sch Med, Inst Neurosci, Hangzhou 310058, Zhejiang, Peoples R China.	fangmaro@zju.edu.cn	Botchway, Benson/ABD-3436-2021	Botchway, Benson/0000-0001-9732-7904; , Marong/0000-0002-6636-4347; Hu, Zhiying/0000-0003-2084-1010	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371493, 81671138]; Traditional Chinese Medicine Science and Technology planning project of Zhejiang province [2017ZA062]	The authors wish to thank Sanhua Fang, from the Core Facilities of Zhejiang University Institute of Neuroscience, for his technical assistance in this project. The work was supported by the National Natural Science Foundation of China (No. 81371493 and No. 81671138), and Traditional Chinese Medicine Science and Technology planning project of Zhejiang province (No. 2017ZA062).	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Caron AM, 2015, NAT SCI SLEEP, V7, P63, DOI 10.2147/NSS.S82888; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jemmerson R, 2005, ANTIOXID REDOX SIGN, V7, P1158, DOI 10.1089/ars.2005.7.1158; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Khandelwal PJ, 2011, HUM MOL GENET, V20, P2091, DOI 10.1093/hmg/ddr091; Koch JC, 2016, EXP EYE RES, V144, P81, DOI 10.1016/j.exer.2015.08.016; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Martinez-Vicente M, 2010, NAT NEUROSCI, V20, P172; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Perez-Polo JR, 2016, J NEUROSCI RES, V94, P27, DOI 10.1002/jnr.23617; Pignataro G, 2011, CURR OPIN PHARMACOL, V11, P378, DOI 10.1016/j.coph.2011.05.003; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; Sepe S, 2014, NEUROBIOL AGING, V35, P96, DOI 10.1016/j.neurobiolaging.2013.07.001; Sigmond T, 2008, METHOD ENZYMOL, V451, P467, DOI 10.1016/S0076-6879(08)03228-X; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Vega GE, 2013, OXID MED CELL LONGEV, V2013, P93; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang Y, 2015, MEDIAT INFLAMM, V2015	38	20	22	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	SEP	2017	41	9					1039	1047		10.1002/cbin.10820			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FD6QX	WOS:000407654100011	28685977				2022-02-06	
J	Stokum, JA; Keledjian, K; Hayman, E; Karimy, JK; Pampori, A; Imran, Z; Woo, SK; Gerzanich, V; Simard, JM				Stokum, Jesse A.; Keledjian, Kaspar; Hayman, Erik; Karimy, Jason K.; Pampori, Adam; Imran, Ziyan; Woo, Seung Kyoon; Gerzanich, Volodymyr; Simard, J. Marc			Glibenclamide pretreatment protects against chronic memory dysfunction and glial activation in rat cranial blast traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Blast-TBI; Glibenclamide; Memory dysfunction; Glial activation; Blood-brain barrier	SULFONYLUREA RECEPTOR 1; K-ATP-CHANNELS; CEREBRAL-ARTERIES; OXIDATIVE STRESS; DENTATE GYRUS; RODENT MODEL; MOUSE MODEL; TIME-COURSE; INFLAMMATION; GLYBURIDE	Blast traumatic brain injury (bTBI) affects both military and civilian populations, and often results in chronic deficits in cognition and memory. Chronic glial activation after bTBI has been linked with cognitive decline. Pharmacological inhibition of sulfonylurea receptor 1 (SUR1) with glibenclamide was shown previously to reduce glial activation and improve cognition in contusive models of CNS trauma, but has not been examined in bTBI. We postulated that glibenclamide would reduce chronic glial activation and improve long-term memory function after bTBI. Using a rat direct cranial model of bTBI (dc-bTBI), we evaluated the efficacy of two glibenclamide treatment paradigms: glibenclamide prophylaxis (pre-treatment), and treatment with glibenclamide starting after dc-bTBI (post-treatment). Our results show that dc-bTBI caused hippocampal astrocyte and microglial/macrophage activation that was associated with hippocampal memory dysfunction (rapid place learning paradigm) at 28 days, and that glibenclamide pre-treatment, but not post-treatment, effectively protected against glial activation and memory dysfunction. We also report that a brief transient time-window of blood brain barrier (BBB) disruption occurs after dc-bTBI, and we speculate that glibenclamide, which is mostly protein bound and does not normally traverse the intact BBB, can undergo CNS delivery only during this brief transient opening of the BBB. Together, our findings indicate that prophylactic glibenclamide treatment may help to protect against chronic cognitive sequelae of bTBI in warfighters and other at-risk populations.	[Stokum, Jesse A.; Keledjian, Kaspar; Hayman, Erik; Karimy, Jason K.; Pampori, Adam; Imran, Ziyan; Woo, Seung Kyoon; Gerzanich, Volodymyr] Univ Maryland, Sch Med, Dept Neurosurg, MSTF, 10 S Pine St,Room 634B, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, MSTF, 10 S Pine St,Room 634B, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, MSTF, 10 S Pine St,Room 634B, Baltimore, MD 21201 USA		Stokum, JA (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, MSTF, 10 S Pine St,Room 634B, Baltimore, MD 21201 USA.	jesse.stokum@som.umaryland.edu			Veterans AdministrationUS Department of Veterans Affairs [5I01BX001629]	Funding for this study was provided in part by a grant to JMS from the Veterans Administration (5I01BX001629).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adebiyi A, 2011, AM J PHYSIOL-HEART C, V301, pH1360, DOI 10.1152/ajpheart.00406.2011; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bast T, 2009, PLOS BIOL, V7, P730, DOI 10.1371/journal.pbio.1000089; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cemak I, 2011, NEUROBIOL DIS, V41, P538; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gopalakrishnan M, 2000, BRIT J PHARMACOL, V129, P1323, DOI 10.1038/sj.bjp.0703181; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Heron-Milhavet L, 2004, MOL CELL NEUROSCI, V25, P585, DOI 10.1016/j.mcn.2003.10.012; Hosier H, 2015, J NEUROTRAUM, V32, P1633, DOI 10.1089/neu.2015.3892; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Ishizaki E, 2009, J PHYSIOL-LONDON, V587, P2233, DOI 10.1113/jphysiol.2009.169003; Jansen-Olesen I, 2005, EUR J PHARMACOL, V523, P109, DOI 10.1016/j.ejphar.2005.08.028; JONSSON A, 1994, DIABETES CARE, V17, P142, DOI 10.2337/diacare.17.2.142; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Kwon MS, 2015, INT J MOL SCI, V16, P5028, DOI 10.3390/ijms16035028; Lahmann C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134476; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lee JW, 2009, LEARN MEMORY, V16, P530, DOI 10.1101/lm.1483709; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Martin Y., 2010, PROT EXCHANGE, V10; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McHugh T.J., SCIENCE, V317; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Mutalik S, 2004, J PHARM SCI-US, V93, P1577, DOI 10.1002/jps.20058; NADAL A, 1995, P NATL ACAD SCI USA, V92, P1426, DOI 10.1073/pnas.92.5.1426; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OLSEN KM, 1995, J CLIN PHARMACOL, V35, P739, DOI 10.1002/j.1552-4604.1995.tb04115.x; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Rawson RA, 1943, AM J PHYSIOL, V138, P0708, DOI 10.1152/ajplegacy.1943.138.5.708; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rosenfeld JV, 2005, MED J AUSTRALIA, V183, P567, DOI 10.5694/j.1326-5377.2005.tb00036.x; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RYDBERG T, 1994, DIABETES CARE, V17, P1026, DOI 10.2337/diacare.17.9.1026; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Sheth KN, 2014, STROKE, V45, P281, DOI 10.1161/STROKEAHA.113.003352; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Simard J.M., 2017, BEHAV BRAIN RES, V333, P43; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Sola D, 2015, ARCH MED SCI, V11, P840, DOI 10.5114/aoms.2015.53304; Sun HS, 2015, EXP NEUROL, V263, P161, DOI 10.1016/j.expneurol.2014.10.003; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Whishaw IQ, 1996, HIPPOCAMPUS, V6, P513, DOI 10.1002/(SICI)1098-1063(1996)6:5<513::AID-HIPO4>3.0.CO;2-J; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhuo JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136151; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	94	20	21	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	AUG 30	2017	333						43	53		10.1016/j.bbr.2017.06.038			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FE5ZK	WOS:000408289600006	28662892				2022-02-06	
J	Zhang, DF; Xue, Q; Chen, JG; Dong, Y; Hou, LJ; Jiang, Y; Wang, JY				Zhang, Danfeng; Xue, Qiang; Chen, Jigang; Dong, Yan; Hou, Lijun; Jiang, Ying; Wang, Junyu			Decompressive craniectomy in the management of intracranial hypertension after traumatic brain injury: a systematic review and meta-analysis	SCIENTIFIC REPORTS			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; METABOLISM; DISABILITY; CHILDREN; TRIAL; ICP	We aim to perform a systematic review and meta-analysis to examine the prognostic value of decompressive craniectomy (DC) in patients with traumatic intracranial hypertension. PubMed, EMBASE, Cochrane Controlled Trials Register, Web of Science, http://clinicaltrials.gov/were searched for eligible studies. Ten studies were included in the systematic review, with four randomized controlled trials involved in the meta-analysis, where compared with medical therapies, DC could significantly reduce mortality rate [risk ratio (RR), 0.59; 95% confidence interval (CI), 0.47-0.74, P < 0.001], lower intracranial pressure (ICP) [mean difference (MD), -2.12 mmHg; 95% CI, -2.81 to -1.43, P < 0.001], decrease the length of ICU stay (MD, -4.63 days; 95% CI, -6.62 to -2.65, P < 0.001) and hospital stay (MD, -14.39 days; 95% CI, -26.00 to -2.78, P = 0.02), but increase complications rate (RR, 1.94; 95% CI, 1.31-2.87, P < 0.001). No significant difference was detected for Glasgow Outcome Scale at six months (RR, 0.85; 95% CI, 0.61-1.18, P = 0.33), while in subgroup analysis, early DC would possibly result in improved prognosis (P = 0.04). Results from observational studies supported pooled results except prolonged length of ICU and hospital stay. Conclusively, DC seemed to effectively lower ICP, reduce mortality rate but increase complications rate, while its benefit on functional outcomes was not statistically significant.	[Zhang, Danfeng; Xue, Qiang; Chen, Jigang; Dong, Yan; Hou, Lijun; Jiang, Ying; Wang, Junyu] Changzheng Hosp, Dept Neurosurg, Shanghai Neurosurg Inst, Shanghai, Peoples R China		Hou, LJ; Jiang, Y; Wang, JY (corresponding author), Changzheng Hosp, Dept Neurosurg, Shanghai Neurosurg Inst, Shanghai, Peoples R China.	smmulijunhou@163.com; yiyijijiji@gmail.com; junyuwang2016@126.com					Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cotte J, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grindlinger GA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3251-9; Harscher S, 2006, ACTA NEUROCHIR, V148, P31, DOI 10.1007/s00701-005-0617-0; Higgins J. P., 2010, COCHRANE HDB SYSTEMA, V2011, pS38; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Marmarou A, 2005, ACT NEUR S, V95, P149; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733	31	20	20	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 18	2017	7								8800	10.1038/s41598-017-08959-y			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE1LP	WOS:000407980000054	28821777	Green Published, gold			2022-02-06	
J	Abdul-Muneer, PM; Long, M; Conte, AA; Santhakumar, V; Pfister, BJ				Abdul-Muneer, P. M.; Long, Mathew; Conte, Adriano Andrea; Santhakumar, Vijayalakshmi; Pfister, Bryan J.			High Ca2+ Influx During Traumatic Brain Injury Leads to Caspase-1-Dependent Neuroinflammation and Cell Death	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Neuronal stretch injury; Fluid percussion injury; Ca2+ influx; Caspase-1; IL-1 beta; Neuroinflammation; Apoptosis	MITOCHONDRIAL PERMEABILITY TRANSITION; MATRIX METALLOPROTEINASES; AXONAL INJURY; CEREBROSPINAL-FLUID; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; SODIUM-CHANNELS; STRETCH INJURY; APOPTOSIS; MECHANISMS	We investigated the hypothesis that high Ca2+ influx during traumatic brain injury induces the activation of the caspase-1 enzyme, which triggers neuroinflammation and cell apoptosis in a cell culture model of neuronal stretch injury and an in vivo model of fluid percussion injury (FPI). We first established that stretch injury causes a rapid increase in the intracellular Ca2+ level, which activates interleukin-converting enzyme caspase-1. The increase in the intracellular Ca2+ level and subsequent caspase-1 activation culminates into neuroinflammation via the maturation of IL-1 beta. Further, we analyzed caspase-1-mediated apoptosis by TUNEL staining and PARP western blotting. The voltage-gated sodium channel blocker, tetrodotoxin, mitigated the stretch injury-induced neuroinflammation and subsequent apoptosis by blocking Ca2+ influx during the injury. The effect of tetrodotoxin was similar to the caspase-1 inhibitor, zYVAD-fmk, in neuronal culture. To validate the in vitro results, we demonstrated an increase in caspase-1 activity, neuroinflammation and neurodegeneration in fluid percussion-injured animals. Our data suggest that neuronal injury/traumatic brain injury (TBI) can induce a high influx of Ca2+ to the cells that cause neuroinflammation and cell death by activating caspase-1, IL-1 beta, and intrinsic apoptotic pathways. We conclude that excess IL-1 beta production and cell death may contribute to neuronal dysfunction and cognitive impairment associated with TBI.	[Abdul-Muneer, P. M.; Long, Mathew; Conte, Adriano Andrea; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Abdul-Muneer, P. M.] JFK Med Ctr, Neurosci Inst, Edison, NJ 08820 USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA		Abdul-Muneer, PM; Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.; Abdul-Muneer, PM (corresponding author), JFK Med Ctr, Neurosci Inst, Edison, NJ 08820 USA.	pmamuneer@gmail.com; bryan.j.pfister@njit.edu	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187; Abdul-Muneer, P. M/0000-0001-8231-4385	New Jersey Commission on Brain Injury Research [CBIR11PJT003]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	This work was funded by New Jersey Commission on Brain Injury Research no. CBIR11PJT003 to Bryan J. Pfister and Vijayalakshmi Santhakumar and NIH/NINDS R01NS069861 to Vijayalakshmi Santhakumar. The authors gratefully acknowledge Mr. Brian Swenson, Dept of Biomedical Engineering, NJIT for the technical support in calibrating strain.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; [Anonymous], 2015, MOL NEUROBIOL; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Byrne AM, 1999, HEPATOLOGY, V29, P1523, DOI 10.1002/hep.510290521; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; FAN L, 1995, MOL BRAIN RES, V30, P125; Faul M, 2010, TRAUMATIC BRAIN INJU; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Hans VHJ, 1999, NEUROREPORT, V10, P409; Haorah J, 2008, GLIA, V56, P78, DOI 10.1002/glia.20596; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Montal M, 1998, BBA-BIOENERGETICS, V1366, P113, DOI 10.1016/S0005-2728(98)00124-8; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Siesjo BK, 1999, J CEREBR BLOOD F MET, V19, P19, DOI 10.1097/00004647-199901000-00002; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Soares HD, 1995, J NEUROSCI, V15, P8223; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WINSTON FK, 1989, J APPL PHYSIOL, V67, P397, DOI 10.1152/jappl.1989.67.1.397; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	59	20	21	1	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2017	54	6					3964	3975		10.1007/s12035-016-9949-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA8QN	WOS:000405710900004	27289225				2022-02-06	
J	Helwig, K; Seeger, F; Holschermann, H; Lischke, V; Gerriets, T; Niessner, M; Foerch, C				Helwig, Kirsten; Seeger, Florian; Hoelschermann, Hans; Lischke, Volker; Gerriets, Tibo; Niessner, Marion; Foerch, Christian			Elevated Serum Glial Fibrillary Acidic Protein (GFAP) is Associated with Poor Functional Outcome After Cardiopulmonary Resuscitation	NEUROCRITICAL CARE			English	Article						Cardiac arrest; GFAP; NSE; Outcome; Biomarker	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; C-TERMINAL HYDROLASE-L1; CARDIAC-ARREST; INTRACEREBRAL HEMORRHAGE; ACUTE STROKE; THERAPEUTIC HYPOTHERMIA; COMPUTED-TOMOGRAPHY; COMATOSE SURVIVORS; ISCHEMIC-STROKE	Background The neurological prognosis of patients after cardiopulmonary resuscitation (CPR) is difficult to assess. GFAP is an astrocytic intermediate filament protein released into bloodstream in case of cell death. We performed a prospective study aiming to compare the predictive potential of GFAP after resuscitation to the more widely used biomarker neuron-specific enolase (NSE). Methods One hundred patients were included at 48 h (tolerance interval +/- 12 h) after cardiac arrest. A serum sample was collected immediately after study inclusion. We determined serum levels of GFAP and NSE by means of immunoassays. Primary outcome was the modified Glasgow outcome scale at 4 weeks. Values below four were considered as a poor functional outcome. Results Median GFAP levels in poor outcome (n = 61) and good outcome (n = 39) patients were 0.03 mu g/L (interquartile range 0.01-0.07 mu g/L) and 0.02 mu g/L (0.01-0.03 mu g/L; p = 0.014), respectively. GFAPrevealed a sensitivity of 60.7% and a specificity of 66.7% to predict a poor functional outcome. All patients having a GFAP level > 0.08 mu g/L had a poor functional outcome. For NSE, sensitivity was 44.3% and specificity was 100.0% for predicting a poor outcome. Multivariate regression analysis revealed GFAP, NSE, and the Karnofsky index to be independent predictors of outcome. Conclusions The release patterns of GFAP and NSE after CPR show differences. GFAP levels above 0.08 mu g/L were associated with a poor outcome in all cases, and patients with strongly elevated values (> 3 mu g/L) consistently had severe brain damage on brain imaging. Both biomarkers independently contribute to outcome prediction after CPR.	[Helwig, Kirsten; Foerch, Christian] Goethe Univ, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany; [Seeger, Florian] Goethe Univ, Dept Cardiol, Frankfurt, Germany; [Hoelschermann, Hans] Hochtaunus Kliniken, Dept Cardiol, Bad Homburg, Germany; [Lischke, Volker] Hochtaunus Kliniken, Dept Anesthesiol, Bad Homburg, Germany; [Gerriets, Tibo] Justus Liebig Univ, Dept Neurol, Giessen, Germany; [Gerriets, Tibo] Gesundheitszentrum Wetterau, Dept Neurol, Friedberg, Germany; [Niessner, Marion] Roche Diagnost, Penzberg, Germany		Foerch, C (corresponding author), Goethe Univ, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	foerch@em.uni-frankfurt.de					Ben-Hamouda N, 2014, CHEST, V146, P1375, DOI 10.1378/chest.14-0523; Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Conlon N, 2008, BRIT J ANAESTH, V100, P219, DOI 10.1093/bja/aem372; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Fogel W, 1997, CRIT CARE MED, V25, P1133, DOI 10.1097/00003246-199707000-00012; Geocadin RG, 2006, NEUROLOGY, V67, P105, DOI 10.1212/01.wnl.0000223335.86166.b4; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Horn J, 2014, CURR OPIN CRIT CARE, V20, P280, DOI 10.1097/MCC.0000000000000085; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Koenig MA, 2014, CRIT CARE CLIN, V30, P765, DOI 10.1016/j.ccc.2014.06.007; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Missler U, 1999, CLIN CHEM, V45, P138; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Rana OR, 2012, CLIN RES CARDIOL, V101, P533, DOI 10.1007/s00392-012-0423-7; Reisinger J, 2007, EUR HEART J, V28, P52, DOI 10.1093/eurheartj/ehl316; Sandroni C, 2013, RESUSCITATION, V84, P1324, DOI 10.1016/j.resuscitation.2013.06.020; Scolletta S, 2012, EXPERT REV CLIN PHAR, V5, P687, DOI [10.1586/ecp.12.64, 10.1586/ECP.12.64]; Steffen IG, 2010, CRIT CARE, V14, DOI 10.1186/cc8975; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x	31	20	21	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2017	27	1					68	74		10.1007/s12028-016-0371-6			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FB7GX	WOS:000406310200010	28054291				2022-02-06	
J	Abreu, V; Vaz, R; Rebelo, V; Rosas, MJ; Chamadoira, C; Gillies, MJ; Aziz, TZ; Pereira, EAC				Abreu, Vasco; Vaz, Rui; Rebelo, Virginia; Rosas, Maria Jose; Chamadoira, Clara; Gillies, Martin J.; Aziz, Tipu Z.; Pereira, Erlick A. C.			Thalamic Deep Brain Stimulation for Neuropathic Pain: Efficacy at Three Years' Follow-Up	NEUROMODULATION			English	Article						Amputation; brachial plexus injury; Brief Pain Inventory; deep brain stimulation; neuropathic pain; SF-36; ventral posterolateral thalamus; visual analog scale; University of Washington Neuropathic Pain Score	MOTOR CORTEX STIMULATION; ROOT ENTRY ZONE; BRACHIAL-PLEXUS AVULSION; CHRONIC NONCANCER PAIN; LONG-TERM OUTCOMES; INTRACTABLE PAIN; SPINAL-CORD; ELECTRICAL-STIMULATION; PRIMARY-CARE; NEUROSTIMULATION	ObjectChronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a serious burden to society. Deep Brain Stimulation (DBS) is already established for movement disorders and also used to treat some off-label conditions. However, DBS for the treatment of chronic, drug refractory, neuropathic pain, has shown variable outcomes with few studies performed in the last decade. Thus, this procedure has consensus approval in parts of Europe but not the USA. This study prospectively evaluated the efficacy at three years of DBS for neuropathic pain. MethodsSixteen consecutive patients received 36 months post-surgical follow-up in a single-center. Six had phantom limb pain after amputation and ten deafferentation pain after brachial plexus injury, all due to traumas. To evaluate the efficacy of DBS, patient-reported outcome measures were collated before and after surgery, using a visual analog scale (VAS) score, University of Washington Neuropathic Pain Score (UWNPS), Brief Pain Inventory (BPI), and 36-Item Short-Form Health Survey (SF-36). ResultsContralateral, ventroposterolateral sensory thalamic DBS was performed in sixteen patients with chronic neuropathic pain over 29 months. A postoperative trial of externalized DBS failed in one patient with brachial plexus injury. Fifteen patients proceeded to implantation but one patient with phantom limb pain after amputation was lost for follow-up after 12 months. No surgical complications or stimulation side effects were noted. After 36 months, mean pain relief was sustained, and the median (and interquartile range) of the improvement of VAS score was 52.8% (45.4%) (p=0.00021), UWNPS was 30.7% (49.2%) (p=0.0590), BPI was 55.0% (32.0%) (p=0.00737), and SF-36 was 16.3% (30.3%) (p=0.4754). ConclusionsDBS demonstrated efficacy at three years for chronic neuropathic pain after traumatic amputation and brachial plexus injury, with benefits sustained across all pain outcomes measures and slightly greater improvement in phantom limb pain.	[Abreu, Vasco; Vaz, Rui; Chamadoira, Clara] Univ Porto, Fac Med, Oporto, Portugal; [Vaz, Rui; Chamadoira, Clara; Aziz, Tipu Z.; Pereira, Erlick A. C.] Hosp Sao Joao, Dept Neurocirugia, Oporto, Portugal; [Vaz, Rui; Rosas, Maria Jose] Ctr Neurosci CUF Porto, Oporto, Portugal; [Rebelo, Virginia] Hosp Sao Joao, Dept Psicol, Oporto, Portugal; [Rosas, Maria Jose] Hosp Sao Joao, Dept Neurol, Oporto, Portugal; [Gillies, Martin J.; Aziz, Tipu Z.] Oxford Univ Hosp, Dept Neurosurg, Oxford, England; [Gillies, Martin J.; Aziz, Tipu Z.] Oxford Univ Hosp, Nuffield Dept Surg, Oxford, England; [Pereira, Erlick A. C.] St Georges Univ London, Acad Neurosurg Unit, London, England		Abreu, V (corresponding author), Univ Porto, Fac Med Neurosurg, P-4200319 Oporto, Portugal.	vrlsa1993@gmail.com	Pereira, Erlick/AAB-5335-2020	Pereira, Erlick/0000-0003-0452-4023; Vaz, Rui/0000-0001-7527-8187; Sousa Abreu, Vasco/0000-0001-8942-275X; Gillies, Martin/0000-0002-4391-713X	Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-SGCL12-Gillies] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CL-2013-13-001] Funding Source: researchfish		Aichaoui F, 2011, PAIN, V152, P1923, DOI 10.1016/j.pain.2011.03.037; Ali M, 2011, NEUROSURGERY, V68, P1252, DOI 10.1227/NEU.0b013e31820c04a9; Ashburn MA, 1999, LANCET, V353, P1865, DOI 10.1016/S0140-6736(99)04088-X; Boccard SGJ, 2013, NEUROSURGERY, V72, P221, DOI 10.1227/NEU.0b013e31827b97d6; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Coffey RJ, 2001, PAIN MED, V2, P183, DOI 10.1046/j.1526-4637.2001.01029.x; Coffey RJ, 2006, J NEUROSURG, V105, P175, DOI 10.3171/jns.2006.105.2.175; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; FRIEDMAN AH, 1988, NEUROSURGERY, V22, P369, DOI 10.1227/00006123-198802000-00016; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Green AL, 2006, CEPHALALGIA, V26, P561, DOI 10.1111/j.1468-2982.2005.01068.x; Green AL, 2004, NEUROMODULATION, V7, P76, DOI 10.1111/j.1094-7159.2004.04010.x; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Gybels J.M., 1989, PHYSL PATHOLOGICAL M, V11; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; Heath R., 1954, STUDIES SCHIZOPHRENI; HOSOBUCHI Y, 1977, SCIENCE, V197, P183, DOI 10.1126/science.301658; HOSOBUCHI Y, 1973, ARCH NEUROL-CHICAGO, V29, P158, DOI 10.1001/archneur.1973.00490270040005; HOSOBUCHI Y, 1986, J NEUROSURG, V64, P543, DOI 10.3171/jns.1986.64.4.0543; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Katayama Y, 2001, STEREOT FUNCT NEUROS, V77, P183, DOI 10.1159/000064618; Katayama Y, 2001, STEREOT FUNCT NEUROS, V77, P159, DOI 10.1159/000064593; Kim J, 2015, J KOREAN NEUROSURG S, V57, P6, DOI 10.3340/jkns.2015.57.1.6; Ko AL, 2016, J NEUROSURG, V124, P1470, DOI 10.3171/2015.2.JNS142572; Konrad P, 2014, NEUROSURG CLIN N AM, V25, P699, DOI 10.1016/j.nec.2014.07.010; Kreitler S, 2007, PAIN CLIN UPDATES, V15, P1; Kumar K, 1997, NEUROSURGERY, V40, P736, DOI 10.1097/00006123-199704000-00015; Lefaucheur JP, 2009, BRAIN, V132, P1463, DOI 10.1093/brain/awp035; LEVY RM, 1987, NEUROSURGERY, V21, P885, DOI 10.1227/00006123-198712000-00017; Levy RM, 2003, NEUROSURG CLIN N AM, V14, P389, DOI 10.1016/S1042-3680(03)00036-6; Levy R, 2010, PAIN PHYSICIAN, V13, P157; Marchand S, 2003, PAIN, V105, P481, DOI 10.1016/S0304-3959(03)00265-3; MARK VH, 1965, POSTGRAD MED, V37, P563, DOI 10.1080/00325481.1965.11695514; Mazars G, 1979, ADV PAIN RES THER, V3, P541; NARAKAS A, 1978, CLIN ORTHOP RELAT R, P71; Nizard J, 2012, DISCOV MED, V14, P237; Owen SLF, 2006, PAIN, V120, P202, DOI 10.1016/j.pain.2005.09.035; Papuc E, 2013, ANN AGR ENV MED, P14; PARRY CBW, 1984, NEUROSURGERY, V15, P960; Pereira EAC, 2011, NEUROSTIMULATION TRE, V1, P187; Pereira EAC, 2007, EXPERT REV MED DEVIC, V4, P591, DOI 10.1586/17434440.4.5.591; Pereira EAC, 2014, NEUROTHERAPEUTICS, V11, P496, DOI 10.1007/s13311-014-0278-x; Pereira EAC, 2009, NEUROMODULATION, VOLS 1 AND 2, P499, DOI 10.1016/B978-0-12-374248-3.00039-2; Rasche Dirk, 2006, Neurosurg Focus, V21, pE8; Richardson D E, 1977, Neurosurgery, V1, P199; Rokyta R, 2012, PHYSIOL RES, V61, pS23, DOI 10.33549/physiolres.932392; Sachs AJ, 2014, NEUROMODULATION, V17, P303, DOI 10.1111/ner.12181; Sindou M, 2001, PAIN, V92, P159, DOI 10.1016/S0304-3959(00)00487-5; Sindou MP, 2005, J NEUROSURG, V102, P1018, DOI 10.3171/jns.2005.102.6.1018; Son BC, 2014, STEREOT FUNCT NEUROS, V92, P218, DOI 10.1159/000362933; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Viswanathan A, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.6.FOCUS13236; Wilkinson HA, 1999, NEUROSURGERY, V45, P1129, DOI 10.1097/00006123-199911000-00023; WYNNPARRY CB, 1980, PAIN, V9, P41, DOI 10.1016/0304-3959(80)90027-5; Yamamoto T, 2006, STEREOT FUNCT NEUROS, V84, P180, DOI 10.1159/000094958; Young RF, 1997, NEUROSURGICAL MANAGE, P283	58	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	JUL	2017	20	5					504	513		10.1111/ner.12620			10	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	EZ7AC	WOS:000404870500015	28631870	Green Submitted			2022-02-06	
J	Khalili, H; Paydar, S; Safari, R; Arasteh, P; Niakan, A; Foroughi, AA				Khalili, Hosseinali; Paydar, Shahram; Safari, Rasool; Arasteh, Peyman; Niakan, Amin; Foroughi, Amin Abolhasani			Experience with Traumatic Brain Injury: Is Early Tracheostomy Associated with Better Prognosis?	WORLD NEUROSURGERY			English	Article						Brain injury; Outcome; Prognosis; Tracheostomy; Trauma	SEVERE HEAD-INJURY; MECHANICAL VENTILATION; IMPACT	OBJECTIVE: In this study we compared the effects of early tracheostomy (ET) versus late tracheostomy on traumatic brain injury (TBI)-related outcomes and prognosis. PATIENTS AND METHODS: Data on 152 TBI patients with a Glasgow Coma Scale (GCS) score of <= 8, admitted to Rajaee Hospital between March 1, 2014 and August 23, 2015, were collected. Rajaee Hospital is the main referral trauma center in southern Iran and is affiliated with Shiraz University of Medical Sciences. Patients who had tracheostomy before or at the sixth day of their admission were considered as ET, and those who had tracheostomy after the sixth day of admission were considered as late tracheostomy. RESULTS: Patients with ET had a significantly lower hospital stay (46.4 vs. 38.6 days; P = 0.048) and intensive care unit stay (34.9 vs. 26.7 days; P = 0.003). Mortality rates were not significantly different between the 2 groups (P > 0.99). Although not statistically significant, favorable outcomes (Glasgow Outcome Scale >4) were higher and ventilator-associated pneumonia rates were lower among the ET group (P = 0.346 and P = 492, respectively). Multivariate analysis showed that ET significantly improves 6-month prognosis (Glasgow Outcome Scale >4) (odds ratio = 2.535; 95% confidence interval: 1.030-6.237). Higher age was inversely associated with favorable prognosis (odds ratio = -0.958; confidence interval: 0.936-0.981). Glasgow Coma Scale and Rotterdam score did not show any effect on 6-month prognosis. CONCLUSION: Despite previous concern regarding increased mortality rates among patients who undergo ET, performing a tracheostomy for patients with severe TBI <6 days after their hospital admission, in addition to decreasing hospital and intensive care unit stays, will improve patient prognosis.	[Khalili, Hosseinali] Shiraz Univ Med Sci, Shiraz Trauma Res Ctr, Dept Neurosurg, Shiraz, Iran; [Paydar, Shahram; Arasteh, Peyman] Shiraz Univ Med Sci, Trauma Res Ctr, Shahid Rajaee Trauma Hosp, Shiraz, Iran; [Safari, Rasool] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran; [Niakan, Amin] Shiraz Univ Med Sci, Dept Neurosurg, Shiraz, Iran; [Foroughi, Amin Abolhasani] Shiraz Univ Med Sci, Med Imaging Res Ctr, Dept Radiol, Nemazee Hosp, Shiraz, Iran; [Arasteh, Peyman] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran		Arasteh, P (corresponding author), Shiraz Univ Med Sci, Trauma Res Ctr, Shahid Rajaee Trauma Hosp, Shiraz, Iran.; Arasteh, P (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	peyman.arasteh@yahoo.com	Khalili, Hosseinali/I-1087-2016; Foroughi, Amin Abolhasani/G-5474-2015; paydar, shahram/U-3074-2018; niakan, amin/A-6818-2019	Khalili, Hosseinali/0000-0002-3390-4212; Foroughi, Amin Abolhasani/0000-0001-6565-5014; paydar, shahram/0000-0002-6980-2576; niakan, amin/0000-0003-2644-8543; Arasteh, Peyman/0000-0001-6499-9093; Safari, Rasool/0000-0002-3333-0896			Agrawal Amit, 2009, J Emerg Trauma Shock, V2, P56, DOI 10.4103/0974-2700.44687; Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; DAMELIO LF, 1994, AM SURGEON, V60, P180; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Durbin Charles G Jr, 2005, Respir Care, V50, P483; Durbin CG, 2010, RESP CARE, V55, P76; Gurkin MA, 2002, AM SURGEON, V68, P324; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Hyde GA, 2015, INJURY, V46, P110, DOI 10.1016/j.injury.2014.08.049; Jalalvandi F, 2016, GLOBAL J HLTH SCI, V8, P139; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Moller MG, 2005, AM J SURG, V189, P293, DOI 10.1016/j.amjsurg.2005.01.002; Paydar Shahram, 2014, Bull Emerg Trauma, V2, P136; Pinheiro BD, 2010, J BRAS PNEUMOL, V36, P84, DOI 10.1590/S1806-37132010000100014; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saboori M, 2009, J ISFAHAN MED SCH, V27, P211; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Wang F, 2011, CHEST, V140, P1456, DOI 10.1378/chest.11-2024; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	25	20	22	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2017	103						88	93		10.1016/j.wneu.2017.02.060			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA5JR	WOS:000405479900013	28254541				2022-02-06	
J	Gao, WW; Li, F; Zhou, ZW; Xu, X; Wu, YG; Zhou, S; Yin, DP; Sun, DD; Xiong, JH; Jiang, RC; Zhang, JN				Gao, Weiwei; Li, Fei; Zhou, Ziwei; Xu, Xin; Wu, Yingang; Zhou, Shuai; Yin, Dongpei; Sun, Dongdong; Xiong, Jianhua; Jiang, Rongcai; Zhang, Jianning			IL-2/Anti-IL-2 Complex Attenuates Inflammation and BBB Disruption in Mice Subjected to Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; IL-2/anti-IL-2; regulatory T cells; microglia; inflammation; blood-brain barrier	REGULATORY T-CELLS; CONTROLLED CORTICAL IMPACT; INTRACEREBRAL HEMORRHAGE; CEREBRAL-ISCHEMIA; IMMUNE-SYSTEM; SPINAL-CORD; TGF-BETA; MICROGLIA; STROKE; ACTIVATION	Traumatic brain injury (TBI) induces the excessive inflammation and disruption of blood-brain barrier, both of which are partially mediated by the activation of microglia and release of inflammatory cytokines. Previous reports showed that administration of regulatory T cells (Tregs) could suppress inflammation and promote neurological function recovery, and that the IL-2/anti-IL-2 complex (IL-2C) could increase the number of Tregs. Thus, we hypothesized that IL-2C-mediated expansion of Tregs would be beneficial in mice subjected to TBI. In this study, mice received an intraperitoneal injection of IL-2C for three consecutive days. We observed that IL-2C dose-dependently increased Tregs without affecting the populations of CD4, CD8, or natural killer cells. IL-2C could improve the neurological recovery and reduce brain edema, tissue loss, neutrophils infiltration, and tight junction proteins degradation. Furthermore, this complex could also reduce the expression of CD16/32, IL-1 beta, or TNF-alpha, and elevate the expression of CD206, arginase 1, or TGF-beta. These results suggest that IL-2C could be a potential therapeutic method to alleviate excessive inflammation and maintain blood vessel stability after TBI.	[Gao, Weiwei; Li, Fei; Zhou, Ziwei; Xu, Xin; Wu, Yingang; Zhou, Shuai; Yin, Dongpei; Sun, Dongdong; Xiong, Jianhua; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Key Lab Postneurotrauma Neurorepair & Regenerat C, Dept Neurosurg,Minist Educ & Tianjin City, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Key Lab Postneurotrauma Neurorepair & Regenerat C, Dept Neurosurg,Minist Educ & Tianjin City, Tianjin, Peoples R China.	jianningzhang@hotmail.com		Dongpei, Yin/0000-0003-2572-3689; Xu, Xin/0000-0003-3395-9923	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271361, 81330029]; Natural Science Foundations of TianjinNatural Science Foundation of Tianjin [13JCZDJC30800, 15JCYBJC50500]	This work was supported by the National Natural Science Foundation of China (Grants 81271361 and 81330029) and the Natural Science Foundations of Tianjin (Grant 13JCZDJC30800 and 15JCYBJC50500).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li PY, 2013, STROKE, V44, P3509, DOI 10.1161/STROKEAHA.113.002637; Liesz A, 2013, J NEUROSCI, V33, P17350, DOI 10.1523/JNEUROSCI.4901-12.2013; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin J, 2010, J LIPID RES, V51, P1208, DOI 10.1194/jlr.D000497; Liu RL, 2010, EUR J IMMUNOL, V40, P1577, DOI 10.1002/eji.200939792; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maeda Toshihiko, 2013, Nihon Rinsho, V71, P789; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Nico B, 2012, CURR DRUG METAB, V13, P50, DOI 10.2174/138920012798356970; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Dinh TN, 2012, CIRCULATION, V126, P1256, DOI 10.1161/CIRCULATIONAHA.112.099044; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang Z, 2014, INT IMMUNOPHARMACOL, V22, P522, DOI 10.1016/j.intimp.2014.06.037; Yu YH, 2016, MOL MED REP, V14, P5556, DOI 10.3892/mmr.2016.5954; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	48	20	20	1	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 30	2017	8								281	10.3389/fneur.2017.00281			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EZ1YD	WOS:000404505800001	28713327	Green Published, gold			2022-02-06	
J	Schwerin, SC; Hutchinson, EB; Radomski, KL; Ngalula, KP; Pierpaoli, CM; Juliano, SL				Schwerin, Susan C.; Hutchinson, Elizabeth B.; Radomski, Kryslaine L.; Ngalula, Kapinga P.; Pierpaoli, Carlo M.; Juliano, Sharon L.			Establishing the ferret as a gyrencephalic animal model of traumatic brain injury: Optimization of controlled cortical impact procedures	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Surgery; Behavior; Immunohistochemistry; Landmarks; Microglia; Astrocytes; MRI; Craniotomy; TBI; CCI; Temporalis; Antibiotics; Reproducibility; White matter; Cognitive; Motor; Impairment; Acute; Chronic; Inflammation	MOUSE MODEL; MRI; NEURODEGENERATION; ABNORMALITIES; INFLAMMATION; IMPAIRMENT; ESTROGEN; BEHAVIOR; DEFICIT; FEMALE	Background: Although rodent TBI studies provide valuable information regarding the effects of injury and recovery, an animal model with neuroanatomical characteristics closer to humans may provide a more meaningful basis for clinical translation. The ferret has a high white/gray matter ratio, gyrencephalic neocortex, and ventral hippocampal location. Furthermore, ferrets are amenable to behavioral training, have a body size compatible with pre-clinical MRI, and are cost-effective. New methods: We optimized the surgical procedure for controlled cortical impact (CCI) using 9 adult male ferrets. We used subject-specific brain/skull morphometric data from anatomical MRIs to overcome across-subject variability for lesion placement. We also reflected the temporalis muscle, closed the craniotomy, and used antibiotics. We then gathered MRI, behavioral, and immunohistochemical data from 6 additional animals using the optimized surgical protocol: 1 control, 3 mild, and 1 severely injured animals (surviving one week) and 1 moderately injured animal surviving sixteen weeks. Results: The optimized surgical protocol resulted in consistent injury placement. Astrocytic reactivity increased with injury severity showing progressively greater numbers of astrocytes within the white matter. The density and morphological changes of microglia amplified with injury severity or time after injury. Motor and cognitive impairments scaled with injury severity. Comparison with existing method(s): The optimized surgical methods differ from those used in the rodent, and are integral to success using a ferret model. Conclusions: We optimized ferret CCI surgery for consistent injury placement. The ferret is an excellent animal model to investigate pathophysiological and behavioral changes associated with TBI. Published by Elsevier B.V.	[Schwerin, Susan C.; Radomski, Kryslaine L.; Ngalula, Kapinga P.; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,Bldg B, Bethesda, MD 20814 USA; [Hutchinson, Elizabeth B.; Pierpaoli, Carlo M.] NICHD, NIH, 13 South Dr,Bldg 13, Bethesda, MD 20892 USA; [Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Program Neurosci, 4301 Jones Bridge Rd,Bldg B, Bethesda, MD 20814 USA		Schwerin, SC (corresponding author), USUHS APG, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	susan.schwerin.ctr@usuhs.edu; elizabeth.hutchinson@nih.gov; kryslaine.radomski.ctr@usuhs.edu; kabaselepatricia@gmail.com; cp1a@nih.gov; sharon.juliano@usuhs.edu	Juliano, Sharon/AAO-1030-2020; Pierpaoli, Carlo/E-1672-2011	Pierpaoli, Carlo/0000-0001-8558-4428; Schwerin, Susan/0000-0001-5435-2448; Radomski, Kryslaine/0000-0001-9624-623X; Hutchinson, Elizabeth/0000-0002-3374-5469	Congressionally Directed Medical Research Programs CDMRPUnited States Department of Defense [W81XWH-13-2-0019, W81XWH-13-2-0018]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [ZIAEB000089] Funding Source: NIH RePORTER	This research was supported by the Congressionally Directed Medical Research Programs CDMRP) (award numbersW81XWH-13-2-0019 and W81XWH-13-2-0018). The authors thank the Center for Neuroscience and Regenerative Medicine (CNRM) for core facility support enabling this work, specifically the translational imaging facility with Asamoah Bosomtwi and Alexandru Korotcov. The authors also thank the Laboratory of Animal Medicine staff for assistance during the surgery and care of the animals: Dennis Aguilar, Kayln Alloway, Cassie Barnett, Andrew Brown, Marla Brunell, Amanda Christy, Clayton Gerrian, Althea Jamerson, Branden Maxwell, Herlyth Pemberton, Stephen Petroski, David Smith, and Robert Wolfe. We also thank Branden Maxwell for document editing.	ATKINSON CS, 1989, STROKE, V20, P1085, DOI 10.1161/01.STR.20.8.1085; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bakthavatchalu V, 2016, VET PATHOL, V53, P349, DOI 10.1177/0300985815623621; Ball RS, 2006, ILAR J, V47, P348, DOI 10.1093/ilar.47.4.348; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Cabot E B, 1990, J Invest Surg, V3, P177, DOI 10.3109/08941939009140347; Christensson M, 2005, NEUROREPORT, V16, P1319, DOI 10.1097/01.wnr.0000175614.93312.53; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobbins HD, 2007, J NEUROSCI METH, V161, P101, DOI 10.1016/j.jneumeth.2006.10.013; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Empie K, 2015, INT J DEV NEUROSCI, V45, P2, DOI 10.1016/j.ijdevneu.2015.06.005; Esquenazi A., 2017, PM&R, P30030, DOI [10.1016/j.2016.12.010, DOI 10.1016/j.2016.12.010]; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Fox J. G., 1988, BIOL DIFERRET; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gold JR, 2015, BEHAV NEUROSCI, V129, P473, DOI 10.1037/bne0000065; HADDAD R, 1976, DEV PSYCHOBIOL, V9, P311, DOI 10.1002/dev.420090403; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; He T, 2002, LAB ANIM-UK, V36, P86, DOI 10.1258/0023677021911795; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hutchinson EB, 2017, NEUROIMAGE, V152, P575, DOI 10.1016/j.neuroimage.2017.03.009; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Keiser NW, 2011, CURR OPIN PULM MED, V17, P478, DOI 10.1097/MCP.0b013e32834b14c9; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kou ZH, 2015, CELL RES, V25, P1372, DOI 10.1038/cr.2015.130; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; LAWES INC, 1987, J ANAT, V154, P157; Lesniak A, 2016, NEUROPHARMACOLOGY, V101, P506, DOI 10.1016/j.neuropharm.2015.10.014; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; McLaughlin DF, 1998, SOMATOSENS MOT RES, V15, P253, DOI 10.1080/08990229870673; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Noctor SC, 1997, J COMP NEUROL, V387, P179; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Oh DY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00080; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Peng X, 2014, NAT BIOTECHNOL, V32, P1250, DOI 10.1038/nbt.3079; Poluch S, 2015, CEREB CORTEX, V25, P346, DOI 10.1093/cercor/bht232; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; RABE A, 1985, LAB ANIM SCI, V35, P256; Rafaels K., 2016, INT REA COUNC BIOM I; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Robbins T. W., 1993, METHODS ASSESSING AT, P13; Rodriguiz R.M., 2006, ANIMAL MODELCOGNIT; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sawada K, 2013, NEUROIMAGE, V83, P294, DOI 10.1016/j.neuroimage.2013.06.024; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sun X., 2014, GENETIC ENG FERRET B, V3; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YUSHKEVICH PA, 2006, NEUROIMAGE; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhou ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23568	77	20	20	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUN 15	2017	285						82	96		10.1016/j.jneumeth.2017.05.010			15	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EY5CS	WOS:000403995400009	28499842	Green Accepted			2022-02-06	
J	Treble-Barna, A; Wade, SL; Martin, LJ; Pilipenko, V; Yeates, KO; Taylor, HG; Kurowski, BG				Treble-Barna, Amery; Wade, Shari L.; Martin, Lisa J.; Pilipenko, Valentina; Yeates, Keith Owen; Taylor, H. Gerry; Kurowski, Brad G.			Influence of Dopamine-Related Genes on Neurobehavioral Recovery after Traumatic Brain Injury during Early Childhood	JOURNAL OF NEUROTRAUMA			English	Article						behavior; genetic factors; neurotransmitters; pediatric brain injury; TBI	DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CATECHOL-O-METHYLTRANSFERASE; D2 RECEPTOR-BINDING; AGE-RELATED-CHANGES; EXECUTIVE FUNCTION; WORKING-MEMORY; SIGNIFICANT ASSOCIATION; COGNITIVE PERFORMANCE; FUNCTIONAL OUTCOMES	The present study examined the association of dopamine-related genes with short-and long-term neurobehavioral recovery, as well as neurobehavioral recovery trajectories over time, in children who had sustained early childhood traumatic brain injuries (TBI) relative to children who had sustained orthopedic injuries (OI). Participants were recruited from a prospective, longitudinal study evaluating outcomes of children who sustained a TBI (n = 68) or OI (n = 72) between the ages of 3 and 7 years. Parents completed ratings of child executive function and behavior at the immediate post-acute period (0-3 months after injury); 6, 12, and 18 months after injury; and an average of 3.5 and 7 years after injury. Thirty-two single nucleotide polymorphisms (SNPs) in dopamine-related genes (dopamine receptor D2 [DRD2], solute carrier family 6 member 3 [SLC6A3], solute carrier family 18 member A2 [SLC18A2], catechol-o-methyltransferase [COMT], and ankyrin repeat and kinase domain containing 1 [ANKK1]) were examined in association with short-and long-term executive function and behavioral adjustment, as well as their trajectories over time. After controlling for premorbid child functioning, genetic variation within the SLC6A3 (rs464049 and rs460000) gene was differentially associated with neurobehavioral recovery trajectories over time following TBI relative to OI, with rs464049 surviving multiple testing corrections. In addition, genetic variation within the ANKK1 (rs1800497 and rs2734849) and SLC6A3 (rs464049, rs460000, and rs1042098) genes was differentially associated with short-and long-term neurobehavioral recovery following TBI, with rs460000 and rs464049 surviving multiple testing corrections. The findings provide preliminary evidence that genetic variation in genes involved in DRD2 expression and density (ANKK1) and dopamine transport (SLC6A3) plays a role in neurobehavioral recovery following pediatric TBI.	[Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Div Phys Med & Rehabil, Pittsburgh, PA USA; [Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Martin, Lisa J.; Pilipenko, Valentina] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Martin, Lisa/E-2425-2016; Yeates, Keith/AAJ-4223-2020	Martin, Lisa/0000-0001-8702-9946; Yeates, Keith/0000-0001-7680-2892	Rehabilitation Medicine Scientist Training Program (RMSTP) [K-12 HD001097-16]; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1, R01 HD42729]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]	Funding for this study was supported in part by the Rehabilitation Medicine Scientist Training Program (RMSTP) K-12 HD001097-16, National Institute for Child Health and Human Development K23HD074683-01A1, R01 HD42729, and Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Albrecht B, 2014, J CHILD PSYCHOL PSYC, V55, P914, DOI 10.1111/jcpp.12212; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BANNON MJ, 1983, PHARMACOL REV, V35, P53; Barnett JH, 2009, AM J PSYCHIAT, V166, P909, DOI 10.1176/appi.ajp.2009.08081251; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Benes FM, 2001, DEV COGN NEUROSCI, P79; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Brehmer Y, 2009, NEUROSCI LETT, V467, P117, DOI 10.1016/j.neulet.2009.10.018; Brocki K, 2009, NEUROSCIENCE, V164, P241, DOI 10.1016/j.neuroscience.2009.01.029; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Conley YP, 2011, PM&R, V3, pS52, DOI 10.1016/j.pmrj.2011.04.004; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; Diamond A, 2011, PROG BRAIN RES, V189, P319, DOI 10.1016/B978-0-444-53884-0.00032-4; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fasano C, 2008, EUR J NEUROSCI, V28, P1480, DOI 10.1111/j.1460-9568.2008.06450.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2008, NEUROCHEM RES, V33, P1940, DOI 10.1007/s11064-008-9693-x; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Hawi Z, 2015, MOL PSYCHIATR, V20, P289, DOI 10.1038/mp.2014.183; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; Huang WH, 2009, NEUROPSYCHOPHARMACOL, V34, P319, DOI 10.1038/npp.2008.37; Jeong SH, 2015, PSYCHIAT GENET, V25, P119, DOI 10.1097/YPG.0000000000000086; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Karabanov A, 2010, P NATL ACAD SCI USA, V107, P7574, DOI 10.1073/pnas.0911805107; Klingberg T, 2014, TRENDS COGN SCI, V18, P573, DOI 10.1016/j.tics.2014.06.007; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000162; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Luciana M, 2012, DEV PSYCHOL, V48, P844, DOI 10.1037/a0027432; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Markos S.M., 2016, J HEAD TRAUMA REHABI; Matthys W, 2013, DEV PSYCHOPATHOL, V25, P193, DOI 10.1017/S0954579412000272; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Myrga J.M., 2015, J HEAD TRAUMA REHAB, V31, pE15; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Narbad M.E., 2016, J HEAD TRAUMA REHABI; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Rieck M, 2012, PHARMACOGENOMICS, V13, P1701, DOI [10.2217/PGS.12.149, 10.2217/pgs.12.149]; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rosema S, 2015, J NEUROTRAUM, V32, P976, DOI 10.1089/neu.2014.3567; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; SEEMAN P, 1987, SYNAPSE, V1, P399, DOI 10.1002/syn.890010503; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shang CY, 2014, INT J NEUROPSYCHOPH, V17, P9, DOI 10.1017/S1461145713000783; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Smith HJ, 2013, DEVELOPMENTAL SCI, V16, P515, DOI 10.1111/desc.12046; Smith HJ, 2012, CHILD DEV, V83, P1932, DOI 10.1111/j.1467-8624.2012.01818.x; Soderqvist S, 2014, J COGNITIVE NEUROSCI, V26, P54, DOI 10.1162/jocn_a_00478; Soderqvist S, 2012, DEV PSYCHOL, V48, P836, DOI 10.1037/a0026179; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; TEASDALE G, 1974, LANCET, V2, P81; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Treble-Barna A., NEUROPSYCHO IN PRESS; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1	87	20	21	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2017	34	11					1919	1931		10.1089/neu.2016.4840			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EV4KD	WOS:000401727500002	28323555	Green Published			2022-02-06	
J	Zhao, ZA; Zhao, Y; Ning, YL; Yang, N; Peng, Y; Li, P; Chen, XY; Liu, D; Wang, H; Chen, X; Bai, W; Chen, JF; Zhou, YG				Zhao, Z-A; Zhao, Y.; Ning, Y-L; Yang, N.; Peng, Y.; Li, P.; Chen, X-Y; Liu, D.; Wang, H.; Chen, X.; Bai, W.; Chen, J-F; Zhou, Y-G			Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation	TRANSLATIONAL PSYCHIATRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DEPENDENT PROTEIN-KINASE; MICROTUBULE INTERACTIONS; MILITARY PERSONNEL; ALZHEIMERS-DISEASE; PATTERN COMPLETION; IN-VIVO; PHOSPHORYLATION; CAFFEINE; MEMORY	Tau is a microtubule-associated protein, and the oligomeric and hyperphosphorylated forms of tau are increased significantly after neurotrauma and considered important factors in mediating cognitive dysfunction. Blockade of adenosine A(2A) receptors, either by caffeine or gene knockout (KO), alleviates cognitive dysfunction after traumatic brain injury (TBI). We postulated that A(2A)R activation exacerbates cognitive impairment via promoting tau hyperphosphorylation. Using a mouse model of moderate controlled cortical impact, we showed that TBI induced hyperphosphorylated tau (p-tau) in the hippocampal dentate gyrus and spatial memory deficiency in the Morris water maze test at 7 days and 4 weeks after TBI. Importantly, pharmacological blockade (A(2A)R antagonist ZM241385 or non-selective adenosine receptor antagonist caffeine) or genetic inactivation of A(2A)Rs reduced the level of tau phosphorylation at Ser404 and alleviated spatial memory dysfunction. The A(2A)R control of p-tau is further supported by the observations that a KO of A(2A)R decreased the activity of the tau phosphorylation kinases, glycogen synthase kinase-3 beta (GSK-3 beta) and protein kinase A (PKA) after TBI, and by that CGS21680 (A(2A)R agonist) exacerbated okadaic acid-induced tau hyperphosphorylation in cultured primary hippocampal neurons. Lastly, CGS21680-induced neuronal tau hyperphosphorylation and axonal injury were effectively alleviated by individual treatments with ZM241385 (A2AR antagonist), H89 (PKA antagonist) and SB216763 (GSK-3 beta antagonist), or by the combined treatment with H89 and SB216763. Our findings suggest a novel mechanism whereby A(2A)R activation triggers cognitive dysfunction by increasing the phosphorylation level of tau protein after TBI and suggest a promising therapeutic and prophylactic strategy by targeting aberrant A(2A)R signaling via tau phosphorylation.	[Zhao, Z-A; Zhao, Y.; Ning, Y-L; Yang, N.; Peng, Y.; Li, P.; Chen, X-Y; Liu, D.; Chen, X.; Bai, W.; Zhou, Y-G] Third Mil Med Univ, Res Inst Surg, State Key Lab Trauma Burn & Combined Injury, Mol Biol Ctr, Chongqing 400042, Peoples R China; [Zhao, Z-A; Zhao, Y.; Ning, Y-L; Yang, N.; Peng, Y.; Li, P.; Chen, X-Y; Liu, D.; Wang, H.; Chen, X.; Bai, W.; Zhou, Y-G] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Wang, H.] Third Mil Med Univ, Res Inst Surg, Dept Neurosurg, Chongqing, Peoples R China; [Chen, J-F] Boston Univ, Sch Med, Dept Neurol & Pharmacol, Boston, MA 02118 USA		Zhou, YG (corresponding author), Third Mil Med Univ, Res Inst Surg, State Key Lab Trauma Burn & Combined Injury, Mol Biol Ctr, Chongqing 400042, Peoples R China.; Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China.	yuanguo.zhou@gmail.com	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471109, 81201461]	This work was supported by the National Natural Science Foundation of China (Nos. 81471109 and 81201461).	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Batalha VL, 2013, MOL PSYCHIATR, V18, P320, DOI 10.1038/mp.2012.8; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009; Canas PM, 2009, NEUROBIOL AGING, V30, P1877, DOI 10.1016/j.neurobiolaging.2008.01.003; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2014, INT REV NEUROBIOL, V119, P1, DOI 10.1016/B978-0-12-801022-8.00001-5; CHERN YJ, 1995, MOL PHARMACOL, V48, P1; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cunha GMA, 2006, NEUROSCIENCE, V141, P1775, DOI 10.1016/j.neuroscience.2006.05.024; Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Duarte JMN, 2006, NEUROCHEM INT, V48, P144, DOI 10.1016/j.neuint.2005.08.008; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gelber RP, 2011, J ALZHEIMERS DIS, V23, P607, DOI 10.3233/JAD-2010-101428; Giralt A, 2011, HUM MOL GENET, V20, P4232, DOI 10.1093/hmg/ddr351; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gruart A, 2012, J NEUROSCI, V32, P17431, DOI 10.1523/JNEUROSCI.4339-12.2012; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170; Kaster MP, 2015, P NATL ACAD SCI USA, V112, P7833, DOI 10.1073/pnas.1423088112; Laurent C, 2016, MOL PSYCHIATR, V21, P97, DOI 10.1038/mp.2014.151; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li WZ, 2009, INT CON DISTR COMP S, P215, DOI 10.1109/ICDCS.2009.23; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lopes LV, 1999, J NEUROCHEM, V73, P1733, DOI 10.1046/j.1471-4159.1999.731733.x; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; Moradi AR, 2012, BEHAV RES THER, V50, P435, DOI 10.1016/j.brat.2012.03.009; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Ning YL, 2015, CHIN J TRAUMATOL, V18, P204, DOI 10.1016/j.cjtee.2015.10.003; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; van Boxtel MPJ, 2003, PHARMACOL BIOCHEM BE, V75, P921, DOI 10.1016/S0091-3057(03)00171-0; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Whittington RA, 2013, PROG NEURO-PSYCHOPH, V47, P147, DOI 10.1016/j.pnpbp.2013.03.004; Xu L, 2015, BBA-MOL BASIS DIS, V1852, P1298, DOI 10.1016/j.bbadis.2015.03.009; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103; Zhao Zi-Ai, 2014, Sheng Li Ke Xue Jin Zhan, V45, P213; Zhou SJ, 2009, BRAIN RES, V1303, P74, DOI 10.1016/j.brainres.2009.09.082	66	20	21	3	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	MAY 9	2017	7								e1123	10.1038/tp.2017.98			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	EW2MY	WOS:000402331900006	28485728	gold, Green Published			2022-02-06	
J	Lavoie, S; Sechrist, S; Quach, N; Ehsanian, R; Duong, T; Gotlib, IH; Isaac, L				Lavoie, Sarah; Sechrist, Samantha; Quach, Nhung; Ehsanian, Reza; Duong, Thao; Gotlib, Ian H.; Isaac, Linda			Depression in Men and Women One Year Following Traumatic Brain Injury (TBI): A TBI Model Systems Study	FRONTIERS IN PSYCHOLOGY			English	Article						depression; mood; traumatic brain injury; concussion; gender	MAJOR DEPRESSION; SEX-DIFFERENCES; FUNCTIONAL CONNECTIVITY; GENDER-DIFFERENCES; PREVALENCE; HEALTH; DISORDERS; SEVERITY; HYPOPITUITARISM; EPIDEMIOLOGY	In the general population, females experience depression at significantly higher rates than males. Individuals with traumatic brain injury (TBI) are at substantially greater risk for depression compared to the overall population. Treatment of, and recovery from, TBI can be hindered by depression; comorbid TBI and depression can lead to adverse outcomes and negatively affect multiple aspects of individuals' lives. Gender differences in depression following TBI are not well understood, and relevant empirical findings have been mixed. Utilizing the Patient Health Questionnaire-9 (PHQ-9) 1 year after TBI, we examined whether women would experience more severe depressive symptoms, and would endorse higher levels of depression within each category of depression severity, than would men. Interestingly, and contrary to our hypothesis, men and women reported mild depression at equal rates; PHQ-9 total scores were slightly lower in women than in men. Men and women did not differ significantly in any PHQ-9 depression severity category. Item analyses, yielded significant gender differences on the following items: greater concentration difficulties (cognitive problems) in men and more sleep disturbances (psychosomatic issues) in women per uncorrected two-sample Z-test for proportions analyses; however, these results were not significant after the family-wise Bonferroni correction. Our results indicate that, in contrast to the general population, mild depression in persons with moderate to severe TBI may not be gender-specific. These findings underscore the need for early identification, active screening, and depression treatment equally for men and women to improve emotional well-being, promote recovery, and enhance quality of life following TBI.	[Lavoie, Sarah; Sechrist, Samantha; Quach, Nhung; Ehsanian, Reza; Duong, Thao; Isaac, Linda] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Ehsanian, Reza] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Duong, Thao; Isaac, Linda] Stanford Univ, Dept Phys Med & Rehabil, Stanford, CA 94305 USA; [Gotlib, Ian H.] Stanford Univ, Dept Psychol, Stanford, CA USA		Isaac, L (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA.; Isaac, L (corresponding author), Stanford Univ, Dept Phys Med & Rehabil, Stanford, CA 94305 USA.	linda.Isaac@hhs.sccgov.org			National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department of Health and Human Services [H133A11006]	This work was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department of Health and Human Services (Grant # H133A11006) to the SCVMC Rehabilitation Research Center Director and Principal Investigator, LI.	Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Alexandrino-Silva C, 2013, J AFFECT DISORDERS, V147, P355, DOI 10.1016/j.jad.2012.11.041; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Brandel MG, 2017, J NEUROTRAUM, V34, P1005, DOI 10.1089/neu.2016.4504; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Foland-Ross LC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00489; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Guillamondegui OD., 2011, TRAUMATIC BRAIN INJU; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kircanski K, 2012, WIRES COGN SCI, V3, P301, DOI 10.1002/wcs.1177; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; Model Systems Knowledge Translation Center, 2016, NAT DAT STAT CTR TRA; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; National Alliance on Mental Illness, 2016, DEPRESSION; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverstein B, 2013, SOC PSYCH PSYCH EPID, V48, P257, DOI 10.1007/s00127-012-0540-7; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; WEISSMAN MM, 1984, J AFFECT DISORDERS, V7, P179, DOI 10.1016/0165-0327(84)90039-9; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	58	20	21	1	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 5	2017	8								634	10.3389/fpsyg.2017.00634			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EU7AG	WOS:000401186500001	28529492	Green Published, gold			2022-02-06	
J	Han, K; Davis, RA; Chapman, SB; Krawczyk, DC				Han, Kihwan; Davis, Rebecca A.; Chapman, Sandra B.; Krawczyk, Daniel C.			Strategy-based reasoning training modulates cortical thickness and resting-state functional connectivity in adults with chronic traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						functional connectivity; magnetic resonance imaging; morphometry; plasticity; rehabilitation; traumatic brain injury	HUMAN CEREBRAL-CORTEX; SURFACE-BASED ANALYSIS; WORKING-MEMORY; GRAY-MATTER; STRUCTURAL PLASTICITY; PHYSICAL-ACTIVITY; MOTOR CORTEX; DEFAULT MODE; HEAD MOTION; NETWORK	Introduction: Prior studies have demonstrated training-induced changes in the healthy adult brain. Yet, it remains unclear how the injured brain responds to cognitive training months-to-years after injury. Methods: Sixty individuals with chronic traumatic brain injury (TBI) were randomized into either strategy-based (N = 31) or knowledge-based (N = 29) training for 8 weeks. We measured cortical thickness and resting-state functional connectivity (rsFC) before training, immediately posttraining, and 3 months posttraining. Results: Relative to the knowledge-based training group, the cortical thickness of the strategy-based training group showed diverse temporal patterns of changes over multiple brain regions (p(vertex) < .05, p(cluster) < .05): (1) increases followed by decreases, (2) monotonic increases, and (3) monotonic decreases. However, network-based statistics (NBS) analysis of rsFC among these regions revealed that the strategy-based training group induced only monotonic increases in connectivity, relative to the knowledge-based training group (vertical bar Z vertical bar > 1.96, p(NBS) < 0.05). Complementing the rsFC results, the strategy-based training group yielded monotonic improvement in scores for the trail-making test (p < .05). Analyses of brain-behavior relationships revealed that improvement in trail-making scores were associated with training-induced changes in cortical thickness (p(vertex) < .05, p(cluster) < .05) and rsFC (p(vertex) < .05, p(cluster) < .005) within the strategy-based training group. Conclusions: These findings suggest that training-induced brain plasticity continues through chronic phases of TBI and that brain connectivity and cortical thickness may serve as markers of plasticity.	[Han, Kihwan; Davis, Rebecca A.; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Dallas, TX USA; [Krawczyk, Daniel C.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA		Han, K (corresponding author), Ctr BrainHlth, Sch Behav & Brain Sci, Dallas, TX 75234 USA.	kihwan.han98@gmail.com	Han, Kihwan/I-1984-2019	Han, Kihwan/0000-0002-4574-7306	Department of DefenseUnited States Department of Defense [W81XWH-11-2-0194, W81XWH-11-2-0195]; Meadows Foundation; Friends of BrainHealth Distinguished New Scientist Award	This work was supported by the Department of Defense (W81XWH-11-2-0194 to D.C.K. and W81XWH-11-2-0195 to S.B.C.), the Meadows Foundation to D.C.K. and S.B.C., and the Friends of BrainHealth Distinguished New Scientist Award to K.H.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Aleman-Gomez Y, 2013, J NEUROSCI, V33, P15004, DOI 10.1523/JNEUROSCI.1459-13.2013; Alonso-Ortiz E, 2015, MAGN RESON MED, V73, P70, DOI 10.1002/mrm.25198; Alosco ML, 2015, J INT NEUROPSYCH SOC, V21, P851, DOI 10.1017/S1355617715000697; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Baldwin G, 2015, C TRAUM BRAIN INJ US; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Best JR, 2015, J INT NEUROPSYCH SOC, V21, P745, DOI 10.1017/S1355617715000673; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; Binder D., 2008, BRAIN HLTH WORKSHOP; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BLACK JE, 1987, NEUROSCI LETT, V83, P351, DOI 10.1016/0304-3940(87)90113-3; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Giglio L, 2016, RADIOLOGY, V280, P202, DOI 10.1148/radiol.2016150710; Delis D. C., 2001, D KEFS EXECUTIVE FUN; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fan YT, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00546; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guerra-Carrillo B, 2014, NEUROSCIENTIST, V20, P522, DOI 10.1177/1073858414524442; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; Joo JWJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0903-6; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kochunov P, 2008, HUM BRAIN MAPP, V29, P36, DOI 10.1002/hbm.20369; Kolb B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00377; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Kwok V, 2011, P NATL ACAD SCI USA, V108, P6686, DOI 10.1073/pnas.1103217108; Landi SM, 2011, J NEUROSCI, V31, P11808, DOI 10.1523/JNEUROSCI.2253-11.2011; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mackey AP, 2013, J NEUROSCI, V33, P4796, DOI 10.1523/JNEUROSCI.4141-12.2013; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McEwen SC, 2015, J INT NEUROPSYCH SOC, V21, P868, DOI 10.1017/S1355617715000983; Metzler-Baddeley C, 2016, NEUROIMAGE, V130, P48, DOI 10.1016/j.neuroimage.2016.01.007; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reiter K, 2015, J INT NEUROPSYCH SOC, V21, P757, DOI 10.1017/S135561771500079X; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Saad ZS, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1510; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schmidt-Wilcke T, 2010, NEUROIMAGE, V51, P1234, DOI 10.1016/j.neuroimage.2010.03.042; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; SIREVAAG AM, 1988, DEV BRAIN RES, V43, P299, DOI 10.1016/0165-3806(88)90107-1; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P3646, DOI 10.1002/hbm.22427; Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023175; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; TEASDALE G, 1974, LANCET, V2, P81; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Thaler NS, 2013, ARCH CLIN NEUROPSYCH, V28, P798, DOI 10.1093/arclin/act080; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Thurman DJ., 1995, GUIDELINES SURVEILLA; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Valkanova V, 2014, INT PSYCHOGERIATR, V26, P891, DOI 10.1017/S1041610213002482; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varkuti B, 2013, NEUROREHAB NEURAL RE, V27, P53, DOI 10.1177/1545968312445910; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Ventura-Campos N, 2013, J NEUROSCI, V33, P9295, DOI 10.1523/JNEUROSCI.4655-12.2013; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warren DE, 2014, P NATL ACAD SCI USA, V111, P14247, DOI 10.1073/pnas.1322173111; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 2011, WECHSLER ABBREVIATED; WechslerD, 2001, WECHSLER TEST ADULT; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhou IY, 2014, NEUROIMAGE, V84, P1, DOI 10.1016/j.neuroimage.2013.08.037; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	144	20	20	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	MAY	2017	7	5							e00687	10.1002/brb3.687			27	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EY2EJ	WOS:000403780900020	28523229	Green Published, gold			2022-02-06	
J	Hanley, D; Prichep, LS; Bazarian, J; Huff, JS; Naunheim, R; Garrett, J; Jones, EB; Wright, DW; O'Neill, J; Badjatia, N; Gandhi, D; Curley, KC; Chiacchierini, R; O'Neil, B; Hack, DC				Hanley, Daniel; Prichep, Leslie S.; Bazarian, Jeffrey; Huff, J. Stephen; Naunheim, Rosanne; Garrett, John; Jones, Elizabeth B.; Wright, David W.; O'Neill, John; Badjatia, Neeraj; Gandhi, Dheeraj; Curley, Kenneth C.; Chiacchierini, Richard; O'Neil, Brian; Hack, Dallas C.			Emergency Department Triage of Traumatic Head Injury Using a Brain Electrical Activity Biomarker: A Multisite Prospective Observational Validation Trial	ACADEMIC EMERGENCY MEDICINE			English	Article							SPORT-RELATED CONCUSSION; COMPUTED-TOMOGRAPHY; UNITED-STATES; DECISION RULES; CT; IDENTIFICATION; PERFORMANCE; HEMATOMAS; VISITS	Objectives: A brain electrical activity biomarker for identifying traumatic brain injury (TBI) in emergency department (ED) patients presenting with high Glasgow Coma Scale (GCS) after sustaining a head injury has shown promise for objective, rapid triage. The main objective of this study was to prospectively evaluate the efficacy of an automated classification algorithm to determine the likelihood of being computed tomography (CT) positive, in high-functioning TBI patients in the acute state. Methods: Adult patients admitted to the ED for evaluation within 72 hours of sustaining a closed head injury with GCS 12 to 15 were candidates for study. A total of 720 patients (18-85 years) meeting inclusion/exclusion criteria were enrolled in this observational, prospective validation trial, at 11 U.S. EDs. GCS was 15 in 97%, with the first and third quartiles being 15 (interquartile range = 0) in the study population at the time of the evaluation. Standard clinical evaluations were conducted and 5 to 10 minutes of electroencephalogram (EEG) was acquired from frontal and frontal-temporal scalp locations. Using an a priori derived EEG-based classification algorithm developed on an independent population and applied to this validation population prospectively, the likelihood of each subject being CT+ was determined, and performance metrics were computed relative to adjudicated CT findings. Results: Sensitivity of the binary classifier (likely CT+ or CT-) was 92.3% (95% confidence interval [CI] = 87.8%-95.5%) for detection of any intracranial injury visible on CT (CT+), with specificity of 51.6% (95% CI = 48.1%-55.1%) and negative predictive value (NPV) of 96.0% (95% CI = 93.2%- 97.9%). Using ternary classification (likely CT+, equivocal, likely CT-) demonstrated enhanced sensitivity to traumatic hematomas (>= 1 mL of blood), 98.6% (95% CI = 92.6%-100.0%), and NPV of 98.2% (95% CI = 95.5%-99.5%). Conclusion: Using an EEG-based biomarker high accuracy of predicting the likelihood of being CT+ was obtained, with high NPV and sensitivity to any traumatic bleeding and to hematomas. Specificity was significantly higher than standard CT decision rules. The short time to acquire results and the ease of use in the ED environment suggests that EEG-based classifier algorithms have potential to impact triage and clinical management of head-injured patients.	[Hanley, Daniel] Johns Hopkins Med Inst, Brain Injury Outcomes, Baltimore, MD 21205 USA; [Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Prichep, Leslie S.] BrainScope Co Inc, Bethesda, MD 20814 USA; [Bazarian, Jeffrey] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Huff, J. Stephen] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Naunheim, Rosanne] Washington Univ, Barnes Jewish Med Ctr, St Louis, MO USA; [Garrett, John] Baylor Univ, Med Ctr, Dallas, TX USA; [Jones, Elizabeth B.] Univ Texas Houston, Mem Hermann Hosp, Houston, TX USA; [Wright, David W.] Emory Univ, Sch Med, Atlanta, GA USA; [Wright, David W.] Grady Mem Hosp, Atlanta, GA USA; [O'Neill, John] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; [Badjatia, Neeraj] Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Gandhi, Dheeraj] Univ Maryland, Dept Radiol, Baltimore, MD 21201 USA; [Curley, Kenneth C.] Iatrikos Res & Dev Strategies LLC, Tampa, FL USA; [Curley, Kenneth C.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Chiacchierini, Richard] RP Chiacchierini Consulting LLC, Gaithersburg, MD USA; [O'Neil, Brian] Detroit Receiving Hosp & Univ Hlth Ctr, Detroit, MI USA; [Hack, Dallas C.] Brain Hlth, Harpers Ferry, WV USA		Prichep, LS (corresponding author), NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA.; Prichep, LS (corresponding author), BrainScope Co Inc, Bethesda, MD 20814 USA.	leslie.prichep@nyumc.org	Badjatia, Neeraj/AAS-4855-2021	Badjatia, Neeraj/0000-0003-1509-9034; Hanley, Daniel/0000-0002-9536-4258	U.S. ArmyUnited States Department of Defense [W81XWH-14-C-1405]; BrainScope Co., Inc.; BIOS	This study was funded in part by a research contract from U.S. Army, contract W81XWH-14-C-1405, entitled, "Validation of Point-of-Care TBI Detection System for Head Injured Patients." Data acquisition for this study was supported by research grants from BrainScope Co., Inc., to the clinical sites.; JB, JSH, RN, JG, EBJ, DWW, JO, NB, and BO were all principal investigators at clinical data acquisition sites (University of Rochester Medical Center, Rochester, NY; University of Virginia Health System, Charlottesville, VA; Washington University Barnes Jewish Medical Center, St. Louis, MO; Baylor University Medical Center, Dallas, TX; University of Texas Memorial Hermann Hospital, Houston, TX; Emory University School of Medicine and Grady Memorial Hospital, Atlanta, GA; Allegheny General Hospital, Pittsburgh, PA; R Adams Cowley Shock Trauma Center, Baltimore, MD; Detroit Receiving Hospital, Detroit, MI, respectively), whose institutions received research contracts from BrainScope Company, Inc., to support subject recruitment, consenting and data acquisition. DH led the Brain Injury Outcomes (BIOS) Division of Johns Hopkins, the independent CRC for the trial. He is a member of the Medical Advisory Board of BrainScope Co., Inc., but receives no financial remuneration for this activity. DG served as an independent CT adjudicator, is associate professor and director of interventional neuroradiology at the University of Maryland, and receives salary from BIOS. LSP is employed by BrainScope as the chief scientific officer and is a professor at NYU School of Medicine. LSP holds potential financial interest through patented technology licensed by BrainScope from NYU School of Medicine. DCH currently serves as a consultant to BrainScope Co., Inc., who at the time the study was conducted was coordinator of the Brain Health/Fitness Research Program at the U.S. Army Medical Research and Materiel Command. KCC currently serves as a consultant to BrainScope Co., Inc., who at the time the study was conducted was the Neurotrauma Research Portfolio Manager for Combat Casualty Care Research Program and Defense Health Program at the U.S. Army Medical Research and Materiel Command. RPC served as the independent consulting statistician to BrainScope Co., Inc., for this study.	ACEP, 2013, BMJ QUAL SAF S; [Anonymous], 2014, MIL MED; [Anonymous], 2015, C TRAUM BRAIN INJ US; Ayaz SI, 2015, AM J EMERG MED, V33, P493, DOI 10.1016/j.ajem.2014.11.015; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kerber KA, 2010, AM J EMERG MED, V28, P1030, DOI 10.1016/j.ajem.2009.06.007; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Linton O, 2011, J AM COLL RADIOL, V8, P325, DOI 10.1016/j.jacr.2010.09.004; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; Melnick ER, 2015, JT COMM J QUAL PATIE, V41, P313, DOI 10.1016/S1553-7250(15)41041-4; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Newman-Toker DE, 2013, JAMA-J AM MED ASSOC, V310, P1237, DOI 10.1001/jama.2013.278019; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Prichep LS, 2015, J NEUROTRAUM, V32, P17, DOI 10.1089/neu.2014.3365; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tibshirani R., 1996, J R STAT SOC B	29	20	20	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2017	24	5					617	627		10.1111/acem.13175			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	EU6SY	WOS:000401165800009	28177169	Bronze			2022-02-06	
J	Giorgi-Coll, S; Amaral, AI; Hutchinson, PJA; Kotter, MR; Carpenter, KLH				Giorgi-Coll, Susan; Amaral, Ana I.; Hutchinson, Peter J. A.; Kotter, Mark R.; Carpenter, Keri L. H.			Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ENERGY-METABOLISM; MICRODIALYSIS; MECHANISMS; ASTROCYTES; CHEMISTRY; RISK	Mitochondrial dysfunction, the inability to efficiently utilise metabolic fuels and oxygen, contributes to pathological changes following traumatic spinal cord or traumatic brain injury (TBI). In the present study, we tested the hypothesis that succinate supplementation can improve cellular energy state under metabolically stressed conditions in a robust, reductionist in vitro model of mitochondrial dysfunction in which primary mixed glial cultures (astrocytes, microglia and oligodendrocytes) were exposed to the mitochondrial complex I inhibitor rotenone. Cellular response was determined by measuring intracellular ATP, extracellular metabolites (glucose, lactate, pyruvate), and oxygen consumption rate (OCR). Rotenone produced no significant changes in glial ATP levels. However, it induced metabolic deficits as evidenced by lactate/pyruvate ratio (LPR) elevation (a clinically-established biomarker for poor outcome in TBI) and decrease in OCR. Succinate addition partially ameliorated these metabolic deficits. We conclude that succinate can improve glial oxidative metabolism, consistent our previous findings in TBI patients' brains. The mixed glial cellular model may be useful in developing therapeutic strategies for conditions involving mitochondrial dysfunction, such as TBI.	[Giorgi-Coll, Susan; Hutchinson, Peter J. A.; Kotter, Mark R.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Amaral, Ana I.; Kotter, Mark R.] Univ Cambridge, Anne McLaren Lab, Wellcome Trust MRC Cambridge Stem Cell Inst, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England; [Amaral, Ana I.; Kotter, Mark R.] Univ Cambridge, Dept Clin Neurosci, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England		Giorgi-Coll, S; Kotter, MR; Carpenter, KLH (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Kotter, MR (corresponding author), Univ Cambridge, Anne McLaren Lab, Wellcome Trust MRC Cambridge Stem Cell Inst, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England.; Kotter, MR (corresponding author), Univ Cambridge, Dept Clin Neurosci, West Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England.	sv377@cam.ac.uk; mrk25@cam.ac.uk; klc1000@wbic.cam.ac.uk		Carpenter, Keri/0000-0001-8236-7727	UK Multiple Sclerosis Society; Qatar Foundation; core funding from the Wellcome Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [CS-2015-15-023, NIHR-RP-R3-12-013] Funding Source: researchfish	This work was supported by grants from the UK Multiple Sclerosis Society and from Qatar Foundation. The work was further supported by core funding from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. Authors' support: AIA - UK Multiple Sclerosis Society; SGC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); PJAH - National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge. MRK - National Institute for Health Research Clinician Scientist Award. The authors also acknowledge Mr Matthew Stovell (Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge) for fruitful discussions. We also acknowledge Dr Tony Vidal's lab (Institute of Metabolic Science, University of Cambridge) for the access to the XF24 Flux Analyser and, in particular, Dr Sergio Rodriguez-Cuenca for the technical support and fruitful discussions regarding the implementation of the OCR-based assays. We also thank Nicholas Howe (Agilent Technologies UK Ltd) for advice on analysis of data acquired on the Seahorse Flux Analyser.	Amaral AI, 2016, GLIA, V64, P21, DOI 10.1002/glia.22900; Berg J.M, 2002, BIOCHEMISTRY-US; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529; Falkowska A, 2015, INT J MOL SCI, V16, P25959, DOI 10.3390/ijms161125939; Ferreira FL, 2000, HORM METAB RES, V32, P335, DOI 10.1055/s-2007-978647; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hertz L, 2015, METAB BRAIN DIS, V30, P317, DOI 10.1007/s11011-014-9536-1; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; Okon EB, 2013, J NEUROTRAUM, V30, P1564, DOI 10.1089/neu.2013.2956; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Protti A, 2006, CRITICAL CARE, V10, P1, DOI DOI 10.1186/CC5014; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	27	20	20	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 21	2017	7								1003	10.1038/s41598-017-01149-w			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET0SD	WOS:000399972900002	28432362	gold, Green Published			2022-02-06	
J	Hellstrom, T; Kaufmann, T; Andelic, N; Soberg, HL; Sigurdardottir, S; Helseth, E; Andreassen, OA; Westlye, LT				Hellstrom, Torgeir; Kaufmann, Tobias; Andelic, Nada; Soberg, Helene L.; Sigurdardottir, Solrun; Helseth, Eirik; Andreassen, Ole A.; Westlye, Lars T.			Predicting Outcome 12 Months after Mild Traumatic Brain injury in Patients admitted to a neurosurgery service	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; cortical thickness; volumetric analysis; prediction; outcome	POST-CONCUSSION SYMPTOMS; HUMAN CEREBRAL-CORTEX; CENTER-TASK-FORCE; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; DIFFUSE AXONAL INJURY; SPINAL-CORD-INJURY; HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; RISK-FACTORS	Objective: Accurate outcome prediction models for patients with mild traumatic brain injury (MTBI) are key for prognostic assessment and clinical decision-making. Using multivariate machine learning, we tested the unique and added predictive value of (1) magnetic resonance imaging (MRI)-based brain morphometric and volumetric characterization at 4-week postinjury and (2) demographic, preinjury, injury-related, and postinjury variables on 12-month outcomes, including global functioning level, postconcussion symptoms, and mental health in patients with MTBI. Methods: A prospective, cohort study of patients (n = 147) aged 16-65 years with a 12-month follow-up. T1-weighted 3 T MRI data were processed in FreeSurfer, yielding accurate cortical reconstructions for surface-based analyses of cortical thickness, area, and volume, and brain segmentation for subcortical and global brain volumes. The 12-month outcome was defined as a composite score using a principal component analysis including the Glasgow Outcome Scale Extended, Rivermead Postconcussion Questionnaire, and Patient Health Questionnaire-9. Using leave-one-out cross-validation and permutation testing, we tested and compared three prediction models: (1) MRI model, (2) clinical model, and (3) MRI and clinical combined. Results: We found a strong correlation between observed and predicted outcomes for the clinical model (r = 0.55, p < 0.001). The MRI model performed at the chance level (r = 0.03, p = 0.80) and the combined model (r = 0.45, p < 0.002) were slightly weaker than the clinical model. Univariate correlation analyses revealed the strongest association with outcome for postinjury factors of posttraumatic stress (Posttraumatic Symptom Scale-10, r = 0.61), psychological distress (Hospital Anxiety and Depression Scale, r = 0.52), and widespread pain (r = 0.43) assessed at 8 weeks. Conclusion: We found no added predictive value of MRI-based measures of brain cortical morphometry and subcortical volumes over and above demographic and clinical features.	[Hellstrom, Torgeir; Andelic, Nada; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Hellstrom, Torgeir; Helseth, Eirik] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Kaufmann, Tobias; Andreassen, Ole A.; Westlye, Lars T.] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Norwegian Ctr Mental Disorder Res NORMENT, Div Mental Hlth & Addict, Oslo, Norway; [Andelic, Nada] Univ Oslo, Fac Med, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Inst Hlth & Soc, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway		Hellstrom, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Hellstrom, T (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	torgehel@uio.no	Hellstrom, Torgeir/AAW-4301-2021; Hellstrom, Torgeir/AAY-6043-2021; Andreassen, Ole A./AAY-7531-2020; Helseth, Eirik/AAH-2466-2020; Kaufmann, Tobias/M-8972-2017	Hellstrom, Torgeir/0000-0003-0831-3274; Kaufmann, Tobias/0000-0002-4003-1018; Westlye, Lars T./0000-0001-8644-956X; Andelic, Nada/0000-0002-3719-4406	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; South-Eastern Norway Regional Health Authority [2014097]	The authors thank all the patients who took time to participate in the study. We also thank radiograph Anne-Hilde Farstad for practical MRI assistance and the Department of Physical Medicine and Rehabilitation, Oslo University Hospital for institutional and financial support. The research was funded by the South-Eastern Norway Regional Health Authority (2014097).	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chang FH, 2012, ARCH PHYS MED REHAB, V93, P2264, DOI 10.1016/j.apmr.2012.06.008; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Constantino MJ, 2011, J CLIN PSYCHOL, V67, P184, DOI 10.1002/jclp.20754; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hart T, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000210; Hellstrom T, 2016, BRAIN INJURY, V30, P1683, DOI 10.1080/02699052.2016.1199905; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; TEASDALE G, 1974, LANCET, V2, P81; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zeller B, 2013, J CLIN ONCOL, V31, P2078, DOI 10.1200/JCO.2012.47.4031; Zhou GY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14329; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	77	20	21	2	11	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 10	2017	8								125	10.3389/fneur.2017.00125			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ER5GF	WOS:000398829000001	28443058	gold, Green Published			2022-02-06	
J	Ferguson, S; Mouzon, B; Paris, D; Aponte, D; Abdullah, L; Stewart, W; Mullan, M; Crawford, F				Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Aponte, Destinee; Abdullah, Laila; Stewart, William; Mullan, Michael; Crawford, Fiona			Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; inflammation; therapeutic approaches for the treatment of CNS injury; traumatic brain injury	MICROGLIAL ACTIVATION; CLINICAL-TRIALS; MOUSE MODEL; HEAD-INJURY; INFLAMMATION; RECOVERY; NERVE	Traumatic brain injury (TBI) has chronic and long-term consequences for which there are currently no approved pharmacological treatments. We have previously characterized the chronic neurobehavioral and pathological sequelae of a mouse model of repetitive mild TBI (r-mTBI) through to 2 years post-TBI. Despite the mild nature of the initial insult, secondary injury processes are initiated that involve neuroinflammatory and neurodegenerative pathways persisting and progressing for weeks and months post-injury and providing a potential window of opportunity for therapeutic intervention. In this study we examined the efficacy of a novel anti-inflammatory compound, anatabine, in modifying outcome after TBI. Our model of r-mTBI involves a series of five mild impacts (midline impact at 5 m/sec, 1mm strike depth, 200 msec dwell time) with an interval of 48 h. Anatabine treatment was administered starting 30 min after injury and was delivered continuously through drinking water. At 6 months after TBI, anatabine treatment improved spatial memory in injured mice. Nine months after TBI, a cohort of mice was euthanized for pathological analysis that revealed reductions in astroglial (glial fibrillary acid protein, GFAP) and microglial (ionized calcium-binding adapter molecule 1, IBA1) responses in treated, injured animals. Treatments for the remaining mice were then crossed-over to assess the effects of late treatment administration and the effects of treatment termination. Nine months following crossover the remaining mice showed no effect of injury on their spatial memory, and whereas pathological analysis showed improvements in mice that had received delayed treatment, corpus callosum IBA1 increased in post-crossover placebo r-mTBI mice. These data demonstrate efficacy of both early and late initiation of treatment with anatabine in improving long term behavioral and pathology outcomes after mild TBI. Future studies will characterize the treatment window, the time course of treatment needed, and the dose needed to achieve therapeutic levels of anatabine in humans after injury.	[Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Aponte, Destinee; Abdullah, Laila; Mullan, Michael; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Stewart, William] Queen Elizabeth Glasgow Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Mullan, Michael] Rock Creek Pharmaceut, Sarasota, FL USA; [Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL USA		Ferguson, S (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	sferguson@rfdn.org		Stewart, William/0000-0003-2199-2582	Roskamp Foundation; VA Career Scientist Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS094003]; DODUnited States Department of Defense [PT110785]; NHS Research Scotland Career Researcher Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS038104] Funding Source: NIH RePORTER	This study was paid for by the Roskamp Foundation. Dr. Fiona Crawford holds a VA Career Scientist Award. Dr. William Stewart is supported by NIH grants NS038104 and NS094003, DOD grant PT110785, and by a NHS Research Scotland Career Researcher Fellowship.	Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gry, 2003, NICOTINE ALKALOIDS S; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Thompson Hilaire J, 2005, Evid Based Nurs, V8, P51, DOI 10.1136/ebn.8.2.51; Thurman D, 2001, EPIDEMIOLOGY EC HEAD, V327, P347; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32	32	20	20	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1676	1691		10.1089/neu.2016.4636			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500019	27889957	Green Accepted, Green Published			2022-02-06	
J	Fu, F; Qin, Z; Xu, C; Chen, XY; Li, RX; Wang, LN; Peng, DW; Sun, HT; Tu, Y; Chen, C; Zhang, S; Zhao, ML; Li, XH				Fu, Feng; Qin, Zhe; Xu, Chao; Chen, Xu-yi; Li, Rui-xin; Wang, Li-na; Peng, Ding-wei; Sun, Hong-tao; Tu, Yue; Chen, Chong; Zhang, Sai; Zhao, Ming-liang; Li, Xiao-hong			Magnetic resonance imaging-three-dimensional printing technology fabricates customized scaffolds for brain tissue engineering	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; three-dimensional printing; traumatic brain injury; tissue engineering; scaffolds; magnetic resonance imaging; collagen; chitosan; mimics; neural regeneration	COLLAGEN SCAFFOLDS; INJURY; REGENERATION; DIFFERENTIATION; TRANSPLANTATION; NEUROGENESIS; CONSEQUENCES; MECHANISMS; GROWTH; CELLS	Conventional fabrication methods lack the ability to control both macro- and micro-structures of generated scaffolds. Three-dimensional printing is a solid free-form fabrication method that provides novel ways to create customized scaffolds with high precision and accuracy. In this study, an electrically controlled cortical impactor was used to induce randomized brain tissue defects. The overall shape of scaffolds was designed using rat-specific anatomical data obtained from magnetic resonance imaging, and the internal structure was created by computer-aided design. As the result of limitations arising from insufficient resolution of the manufacturing process, we magnified the size of the cavity model prototype five-fold to successfully fabricate customized collagen-chitosan scaffolds using three-dimensional printing. Results demonstrated that scaffolds have three-dimensional porous structures, high porosity, highly specific surface areas, pore connectivity and good internal characteristics. Neural stem cells co-cultured with scaffolds showed good viability, indicating good biocompatibility and biodegradability. This technique may be a promising new strategy for regenerating complex damaged brain tissues, and helps pave the way toward personalized medicine.	[Fu, Feng; Xu, Chao; Chen, Xu-yi; Wang, Li-na; Peng, Ding-wei; Sun, Hong-tao; Tu, Yue; Chen, Chong; Zhang, Sai; Zhao, Ming-liang; Li, Xiao-hong] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China; [Fu, Feng; Xu, Chao; Chen, Xu-yi; Wang, Li-na; Peng, Ding-wei; Sun, Hong-tao; Tu, Yue; Chen, Chong; Zhang, Sai; Zhao, Ming-liang; Li, Xiao-hong] Key Lab Neurotrauma Repair Tianjin, Tianjin, Peoples R China; [Qin, Zhe] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Tianjin, Peoples R China; [Li, Rui-xin] Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China		Zhao, ML; Li, XH (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China.; Zhao, ML; Li, XH (corresponding author), Key Lab Neurotrauma Repair Tianjin, Tianjin, Peoples R China.	physolar@sohu.com; lixiaohong12@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301050, 81401067, 81271392, 81471275, 81541034]; Natural Science Foundation of Tianjin City of ChinaNatural Science Foundation of Tianjin [14JCQNJC10200, 15JCQNJC11100, 16JCYBJC27600]	This work was supported by the National Natural Science Foundation of China, No. 81301050, 81401067, 81271392, 81471275, 81541034; the Natural Science Foundation of Tianjin City of China, No. 14JCQNJC10200, 15JCQNJC11100, 16JCYBJC27600.	Ahu A-Y, 2016, BIOFABRICATION, V8; Ajioka I, 2015, TISSUE ENG PT A, V21, P193, DOI [10.1089/ten.tea.2014.0080, 10.1089/ten.TEA.2014.0080]; Alvarez Z, 2014, BIOMATERIALS, V35, P4769, DOI 10.1016/j.biomaterials.2014.02.051; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Chimene D, 2016, ANN BIOMED ENG, V44, P2090, DOI 10.1007/s10439-016-1638-y; Crozier A, 2016, ANN BIOMED ENG, V44, P58, DOI 10.1007/s10439-015-1474-5; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Domingos M, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045004; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Eagle KS, 1995, J COMP NEUROL, V363, P377, DOI 10.1002/cne.903630304; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guan YX, 2015, INT J CLIN EXP MED, V8, P14308; Haghbayan H, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0184-x; Hsieh FY, 2015, BIOMATERIALS, V71, P48, DOI 10.1016/j.biomaterials.2015.08.028; Huang KF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/672409; Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040; Jardini AL, 2014, J CRANIO MAXILL SURG, V42, P1877, DOI 10.1016/j.jcms.2014.07.006; Jiao Qian, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1318; Johnson BN, 2015, ADV FUNCT MATER, V25, P6205, DOI 10.1002/adfm.201501760; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kikinis R, 2011, IEEE ENG MED BIO, P6982, DOI 10.1109/IEMBS.2011.6091765; Klein GT, 2013, WORLD NEUROSURG, V80, P233, DOI 10.1016/j.wneu.2013.07.009; Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057; Lee JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045003; Lee SJ, 2017, IEEE T BIO-MED ENG, V64, P408, DOI 10.1109/TBME.2016.2558493; Leung GKK, 2012, METHOD ENZYMOL, V508, P177, DOI 10.1016/B978-0-12-391860-4.00009-4; Mahmoud AA, 2016, EUR J PHARM SCI, V83, P155, DOI 10.1016/j.ejps.2015.12.026; Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011; Maravelakis E., 2008, Journal of Medical Engineering & Technology, V32, P115, DOI 10.1080/03091900600700749; Marro A, 2016, CURR PROBL DIAGN RAD, V45, P2, DOI 10.1067/j.cpradiol.2015.07.009; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Monsell F, 2014, STRATEG TRAUMA LIMB, V9, P45, DOI 10.1007/s11751-014-0188-9; Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571; Otto IA, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/3/032001; Park JH, 2017, ANN BIOMED ENG, V45, P180, DOI 10.1007/s10439-016-1611-9; Patra S, 2016, CELL BIOCHEM BIOPHYS, V74, P93, DOI 10.1007/s12013-016-0730-0; Radenkovic D, 2016, MED HYPOTHESES, V87, P30, DOI 10.1016/j.mehy.2015.12.017; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Spater T, 2016, J BIOMED MATER RES B, DOI [10.1002/jbm.b.33813:n/a-n/a, DOI 10.1002/JBM.B.33813:N/A-N/A]; Suri S, 2011, BIOMED MICRODEVICES, V13, P983, DOI 10.1007/s10544-011-9568-9; Tian LL, 2015, REGEN BIOMATER, V2, P31, DOI 10.1093/rb/rbu017; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Ventola C Lee, 2014, P T, V39, P704; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Wust S, 2015, J BIOMED MATER RES A, V103, P2558, DOI 10.1002/jbm.a.35393; Xu XH, 2014, STROKE, V45, P3433, DOI 10.1161/STROKEAHA.114.007095; Yan F, 2015, NEURAL REGEN RES, V10, P1421, DOI 10.4103/1673-5374.163466; Yang P, 2016, ZHONGGUO ZUZHI GONGC, V20, P7773; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Zeng W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101300; Zhang Wei-guo, 2006, Zhonghua Yi Xue Za Zhi, V86, P1065; Zhang XY, 2015, CELL BIOCHEM BIOPHYS, V72, P777, DOI 10.1007/s12013-015-0531-x	57	20	21	6	22	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2017	12	4					614	622		10.4103/1673-5374.205101			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EU3HO	WOS:000400920000025	28553343	gold, Green Published			2022-02-06	
J	Lim, SW; Sung, KC; Shiue, YL; Wang, CC; Chio, CC; Kuo, JR				Lim, Sher-Wei; Sung, Kuan-Chin; Shiue, Yow-Ling; Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung			Hyperbaric Oxygen Effects on Depression-Like Behavior and Neuroinflammation in Traumatic Brain Injury Rats	WORLD NEUROSURGERY			English	Article						Depression-like behavior; Fluid percussion injury; Forced swim; Hippocampus; Microglia; Tumor necrosis factor-alpha	LATERAL FLUID-PERCUSSION; NECROSIS-FACTOR-ALPHA; FORCED-SWIMMING TEST; MICROGLIAL ACTIVATION; MODEL; HIPPOCAMPUS; SEROTONIN; THERAPY; ANGIOGENESIS; STIMULATION	OBJECTIVE: The aim of this study was to determine whether hyperbaric oxygen (HBO) therapy causes attenuation of traumatic brain injury (TBI)-induced depressionlike behavior and its associated anti-neuroinflammatory effects after fluid percussion injury. METHODS: Anesthetized male Sprague-Dawley rats were divided into 3 groups: sham operation plus normobaric air (NBA) (21% oxygen at 1 absolute atmosphere [ATA]), TBI plus NBA, and TBI plus HBO (100% oxygen at 2.0 ATA). HBO was applied immediately for 60 min/d after TBI for 3 days. Depression-like behavior was tested by a forced swimming test, motor function was tested by an inclined plane test, and infarction volume was tested by triphenyltetrazolium chloride (TTC) staining on days 4, 8, and 15. Neuronal apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling assay), microglial (marker OX42) activation, and tumor necrosis factor (TNF)-alpha expression in microglia in the hippocampus CA3 were measured by immunofluorescence methods. RESULTS: Compared with the TBI controls, without significant changes in TTC staining or in the motor function test, TBI-induced depression-like behavior was significantly attenuated by HBO therapy by day 15 after TBI. Simultaneously, TBI-induced neuronal apoptosis, microglial (marker OX42) activation, and TNF-alpha expression in the microglia in the hippocampus CA3 were significantly reduced by HBO. CONCLUSIONS: Our results suggest that HBO treatment may ameliorate TBI-induced depression-like behavior in rats by attenuating neuroinflammation, representing one possible mechanism by which depression-like behavior recovery might occur. We also recommend HBO as a potential treatment for TBI-induced depression-like behavior if early intervention is possible.	[Lim, Sher-Wei; Shiue, Yow-Ling] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Lim, Sher-Wei] Chi Mei Med Ctr, Dept Neurosurg, Chiali, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Sung, Kuan-Chin; Wang, Che-Chuan; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com			Chi-Mei Medical Center [NSC-102-2314-B-384 -004-MY1, CHM10217]	The research was funded by CHM10217 and NSC-102-2314-B-384 -004-MY1 grants from Chi-Mei Medical Center.	Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Basso AM, 2005, NEUROPSYCHOPHARMACOL, V30, P1257, DOI 10.1038/sj.npp.1300677; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Cao H, 2013, EXP THER MED, V5, P1609, DOI 10.3892/etm.2013.1043; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Dong Y, 2015, J PHYS THER SCI, V27, P1295, DOI 10.1589/jpts.27.1295; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Jorge R, 2002, NEUROREHABILITATION, V17, P311; Kaster MP, 2012, NEUROPHARMACOLOGY, V62, P419, DOI 10.1016/j.neuropharm.2011.08.018; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu S, 2015, EXP BRAIN RES, V233, P3359, DOI 10.1007/s00221-015-4405-7; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; MARTIN P, 1990, PSYCHOPHARMACOLOGY, V101, P403, DOI 10.1007/BF02244061; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MELTZER HY, 1990, ANN NY ACAD SCI, V600, P486, DOI 10.1111/j.1749-6632.1990.tb16904.x; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nemoto EM, 2007, NEUROL RES, V29, P116, DOI 10.1179/016164107X174138; Nielsen CK, 2000, BEHAV BRAIN RES, V107, P21; PORSOLT RD, 1979, EUR J PHARMACOL, V57, P201, DOI 10.1016/0014-2999(79)90366-2; Sumen-Secgin G, 2005, METHOD FIND EXP CLIN, V27, P471, DOI 10.1358/mf.2005.27.7.896829; Tai PA, 2010, J NEUROTRAUM, V27, P1121, DOI 10.1089/neu.2009.1162; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; van Heesch F, 2013, BEHAV BRAIN RES, V253, P191, DOI 10.1016/j.bbr.2013.07.038; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang CC, 2016, FORMOS J SURG, V49, P101, DOI 10.1016/j.fjs.2015.12.003; Wang CC, 2013, J SURG RES, V185, P753, DOI 10.1016/j.jss.2013.07.002; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang Y, 1997, J NEUROSCI, V17, P4341; [尤志珺 YOU Zhi-jun], 2009, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V31, P667; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	42	20	22	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2017	100						128	137		10.1016/j.wneu.2016.12.118			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7BT	WOS:000401930000016	28065873				2022-02-06	
J	Song, Y; Han, GX; Chen, L; Zhai, YZ; Dong, J; Chen, W; Li, TS; Zhu, HY				Song, Y.; Han, G. -X.; Chen, L.; Zhai, Y. -Z.; Dong, J.; Chen, W.; Li, T. -S.; Zhu, H. -Y.			The role of the hippocampus and the function of calcitonin gene-related peptide in the mechanism of traumatic brain injury accelerating fracture-healing	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Hippocampus; Fracture-healing; Traumatic brain injury; Calcitonin gene-related peptide	BLOOD-BRAIN; CEREBROSPINAL-FLUID; MOUSE MODEL; RAT; ISCHEMIA; BARRIER; IMMUNOREACTIVITY; POLYPEPTIDE; REPERFUSION; OSTEOBLASTS	OBJECTIVE: This research attempts to identify the part the hippocampus plays in accelerated fracture-healing after traumatic brain injury as well as to test functions of calcitonin gene-related peptide (CGRP) during this process. MATERIALS AND METHODS: Experiments were carried out on Male Sprague-Dawley rats that were split into four groups at random: TBI-fracture group, fracture-only group, TBI-only group, and control group. In the first week, blood specimen would be drawn from rats among the groups except those of the control group at threetime points (24, 72 and 168 hours) post-damage. These rats would be assessed from the neurological perspective based on their grades of performance in a sequence of tests 24 hours before and 12 hours after brain injury. Blood samples were also taken from the control group 24 hours before the injury, and whole brain tissues in the injured groups were harvested at 72 and 168 hours post-injury. We compared the serum CGRP concentration, the distribution of CGRP, the CGRP expression, and the expression of CGRP in the hippocampus, the expression of CGRP in the hippocampus, the expression of CGRP in the hippocampus, and the expression of CGRP in the brain by immunohistochemistry, Western blotting, RT-Of CGRP RNA expression levels. RESULTS: Neurological examinations suggested that the functions of the cerebral cortex, cerebellum, and brain stem showed significant differences pre-and post-injury (p < 0.001). ELISA analysis indicated a great density of CGRP in TBI-fracture group at different time points. Furthermore, in the TBI-fracture group, CGRP in both hippocampus and the whole brain showed a noticeable augment in RT-PCR and western blot analysis at 72 and 168 h post-injury, and only in this group, immunohistochemistry analysis indicated that CGRP was present in the hippocampus at 168 hours post-injury. CONCLUSIONS: We observed that the hippo-campus and CGRP were responsible for quick bone-healing mechanisms. We suggest a role for the hippocampus in accelerated fracture healing. CGRP expression, as determined by IHC, cannot be observed in other groups, indicating that the hippocampus may be the specific component of the brain that responds to "big stress".	[Song, Y.; Han, G. -X.; Chen, L.; Zhai, Y. -Z.; Dong, J.; Chen, W.; Li, T. -S.; Zhu, H. -Y.] Gen Hosp Chinese PLA, Dept Emergency, Beijing, Peoples R China		Zhu, HY (corresponding author), Gen Hosp Chinese PLA, Dept Emergency, Beijing, Peoples R China.	zhuhy301@aliyun.com			National Natural Science Research Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81670467]; Beijing Scientific & Technologic Supernova Supportive Project [15111000030000/XXJH2015B100]; Youth Project of National Natural fund [81400648]; Beijing Natural Science FundBeijing Natural Science Foundation [7152136]; Youth Culture Project of Chinese PLA [13QNP171]; Surface Project of Hainan Province Natural Fund [20158315]; Clinical Science Fund of PLA General Hospital [2015FC-ZHCG-2007, 2012FC-TSYS-4028]	This study was supported by the National Natural Science Research Foundation of China (No: 81670467), Beijing Scientific & Technologic Supernova Supportive Project (No: 15111000030000/XXJH2015B100), Youth Project of National Natural fund (No: 81400648), the Beijing Natural Science Fund (No: 7152136), Youth Culture Project of Chinese PLA (No: 13QNP171), Surface Project of Hainan Province Natural Fund (No: 20158315), and Clinical Science Fund of PLA General Hospital (No: 2015FC-ZHCG-2007, 2012FC-TSYS-4028).	Akopian A, 2000, PEPTIDES, V21, P559, DOI 10.1016/S0196-9781(00)00185-6; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; Arrieta-Cruz I, 2007, EXP NEUROL, V205, P449, DOI 10.1016/j.expneurol.2007.03.005; Beggs S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-74; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Bucinskaite V, 1998, NEUROPEPTIDES, V32, P179, DOI 10.1016/S0143-4179(98)90035-X; Bulloch K, 1998, EXP NEUROL, V150, P195, DOI 10.1006/exnr.1997.6765; Cornish J, 1999, J BONE MINER RES, V14, P1302, DOI 10.1359/jbmr.1999.14.8.1302; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Edvinsson L, 2008, BRIT J PHARMACOL, V155, P967, DOI 10.1038/bjp.2008.346; Edvinsson Lars, 2002, ScientificWorldJournal, V2, P1484; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Harada N, 2009, TRANSL RES, V154, P90, DOI 10.1016/j.trsl.2009.05.001; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; Liu XD, 2011, NEUROSCI LETT, V494, P10, DOI 10.1016/j.neulet.2011.02.036; Ma W, 2003, NEUROSCIENCE, V120, P677, DOI 10.1016/S0306-4522(03)00159-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Shih C, 1997, CLIN ORTHOP RELAT R, P335; Sobanska K, 2016, EUR REV MED PHARMACO, V20, P166; Somogyvari-Vigh A, 2000, REGUL PEPTIDES, V91, P89, DOI 10.1016/S0167-0115(00)00123-3; Sun Bao-liang, 2010, Front Biosci (Elite Ed), V2, P1502; Toth CC, 2009, J NEUROPATH EXP NEUR, V68, P326, DOI 10.1097/NEN.0b013e31819ac71b; Trinkl A, 2006, EUR J NEUROSCI, V24, P520, DOI 10.1111/j.1460-9568.2006.04920.x; Vignery A, 1996, BONE, V18, P331, DOI 10.1016/8756-3282(96)00017-8; Vrettos T, 2016, EUR REV MED PHARMACO, V20, P620; Yang CS, 2004, ANAL CHEM, V76, P4465, DOI 10.1021/ac035491v; Zhi XL, 2016, EUR REV MED PHARMACO, V20, P2156; Ziporen L, 1997, J CLIN INVEST, V100, P613, DOI 10.1172/JCI119572	31	20	21	1	8	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	APR	2017	21	7					1522	1531					10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	ET0CS	WOS:000399929900013	28429354				2022-02-06	
J	Zhao, W; Ji, SB				Zhao, Wei; Ji, Songbai			Brain strain uncertainty due to shape variation in and simplification of head angular velocity profiles	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Head impact; Head angular motion; Brain strains; Pre-computation	FINITE-ELEMENT-ANALYSIS; INJURY PREDICTORS; AMERICAN FOOTBALL; CONTACT SPORTS; IMPACT; RESPONSES; ACCELERATION; MODEL; CONCUSSION; KINEMATICS	Head angular velocity, instead of acceleration, is more predictive of brain strains. Surprisingly, no study exists that investigates how shape variation in angular velocity profiles affects brain strains, beyond characteristics such as peak magnitude and impulse duration. In this study, we evaluated brain strain uncertainty due to variation in angular velocity profiles and further compared with that resulting from simplifying the profiles into idealized shapes. To do so, we used reconstructed head impacts from American National Football League for shape extraction and simulated head uniaxial coronal rotations from onset to full stop. The velocity profiles were scaled to maintain an identical peak velocity magnitude and duration in order to isolate the shape for investigation. Element-wise peak maximum principal strains from 44 selected impacts were obtained. We found that the shape of angular velocity profile could significantly affect brain strain magnitude (e.g., percentage difference of 4.29-17.89 % in the whole brain relative to the group average, with cumulative strain damage measure (CSDM) uncertainty range of 23.9 %) but not pattern (correlation coefficient of 0.94-0.99). Strain differences resulting from simplifying angular velocity profiles into idealized shapes were largely within the range due to shape variation, in both percentage difference and CSDM (signed difference of 3.91 % on average, with a typical range of 0-6 %). These findings provide important insight into the uncertainty or confidence in the performance of kinematics-based injury metrics. More importantly, they suggest the feasibility to simplify head angular velocity profiles into idealized shapes, at least within the confinements of the profiles evaluated, to enable real-time strain estimation via pre-computation in the future.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01605 USA; [Ji, Songbai] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01605 USA.; Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	sji@wpi.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R01NS092853] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781. The authors are grateful to the National Football League (NFL) Committee on Mild Traumatic Brain Injury (MTBI) and Biokinetics and Associates Ltd. for providing the reconstructed head impact kinematics data. In addition, the authors thank Dr. Richard M. Greenwald and Mr. Jonathan Beckwith at Simbex, LLC, for their help.	Abaqus, 2016, AB ONL DOC; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Nahum A, 1977, 770922 SAE; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Ogden, 1984, NONLINEAR ELASTIC DE; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; The CDC NI H DoD and VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2015, IRCOBI C LYON FRANC, P208; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhao W, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0091; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0	41	20	20	2	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	APR	2017	16	2					449	461		10.1007/s10237-016-0829-7			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	EQ5HF	WOS:000398112800006	27644441	Green Accepted			2022-02-06	
J	Vodret, S; Bortolussi, G; Jasprova, J; Vitek, L; Muro, AF				Vodret, Simone; Bortolussi, Giulia; Jasprova, Jana; Vitek, Libor; Muro, Andres F.			Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1(-/-) mouse model	JOURNAL OF NEUROINFLAMMATION			English	Article						Ugt1a1; Crigler-Najjar syndrome; Astrocytes; Microglia; Oxidative stress; Autophagy; Apoptosis; ER stress	TRAUMATIC BRAIN-INJURY; UNCONJUGATED BILIRUBIN; OXIDATIVE STRESS; CELL-DEATH; GUNN RAT; GLIAL-CELLS; MOLECULAR-MECHANISMS; MACROPHAGE SUBSETS; NERVE-CELL; NEUROTOXICITY	Background: Severe hyperbilirubinemia is toxic during central nervous system development. Prolonged and uncontrolled high levels of unconjugated bilirubin lead to bilirubin- induced neurological damage and eventually death by kernicterus. Bilirubin neurotoxicity is characterized by a wide array of neurological deficits, including irreversible abnormalities in motor, sensitive and cognitive functions, due to bilirubin accumulation in the brain. Despite the abundant literature documenting the in vitro and in vivo toxic effects of bilirubin, it is unclear which molecular and cellular events actually characterize bilirubin-induced neurodegeneration in vivo. Methods: We used a mouse model of neonatal hyperbilirubinemia to temporally and spatially define the response of the developing cerebellum to the bilirubin insult. Results: We showed that the exposure of developing cerebellum to sustained bilirubin levels induces the activation of oxidative stress, ER stress and inflammatory markers at the early stages of the disease onset. In particular, we identified TNFa and NFK beta as key mediators of bilirubin- induced inflammatory response. Moreover, we reported that M1 type microglia is increasingly activated during disease progression. Failure to counteract this overwhelming stress condition resulted in the induction of the apoptotic pathway and the generation of the glial scar. Finally, bilirubin induced the autophagy pathway in the stages preceding death of the animals. Conclusions: This study demonstrates that inflammation is a key contributor to bilirubin damage that cooperates with ER stress in the onset of neurotoxicity. Pharmacological modulation of the inflammatory pathway may be a potential intervention target to ameliorate neonatal lethality in Ugt1(-/-) mice.	[Vodret, Simone; Bortolussi, Giulia; Muro, Andres F.] ICGEB, Padriciano 99, I-34149 Trieste, Italy; [Jasprova, Jana; Vitek, Libor] Charles Univ Prague, Inst Med Biochem & Lab Med, Fac Med 1, Prague 12000, Czech Republic; [Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague 12000, Czech Republic		Bortolussi, G; Muro, AF (corresponding author), ICGEB, Padriciano 99, I-34149 Trieste, Italy.	giulia.bortolussi@icgeb.org; muro@icgeb.org	Muro, Andres F/K-3156-2016; vodret, simone/AAA-6348-2019; Jasprova, Jana/H-7839-2017; Vitek, Libor/A-2645-2008	Muro, Andres F/0000-0002-9628-0494; vodret, simone/0000-0003-1627-4404; Jasprova, Jana/0000-0002-0579-0895; Vitek, Libor/0000-0002-5318-0151; Bortolussi, Giulia/0000-0001-9470-0902	TelethonFondazione Telethon [GGP10051]; Friuli-Venezia Giulia Regional; Beneficentia Stiftung; AXA Research; Czech Ministry of HealthMinistry of Health, Czech Republic [RVO VFN64165]; Czech Ministry of EducationMinistry of Education, Youth & Sports - Czech Republic [KONTAKT LH15097]	This work was supported by Telethon (GGP10051), by Friuli-Venezia Giulia Regional Grant and by Beneficentia Stiftung to A. F. Muro (ICGEB), by AXA Research Fund to G. Bortolussi (ICGEB), and by the Czech Ministry of Health (RVO VFN64165) and Czech Ministry of Education (KONTAKT LH15097) to L. Vitek.	Alirezaei M, 2011, EUR J NEUROSCI, V33, P197, DOI 10.1111/j.1460-9568.2010.07500.x; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Barateiro A, 2016, MOL PHARMACOL, V89, P84, DOI 10.1124/mol.115.098228; Barateiro A, 2012, NEUROMOL MED, V14, P285, DOI 10.1007/s12017-012-8187-9; Bhutani VK, 2013, J CLIN NEONATOL, V2, P61, DOI 10.4103/2249-4847.116402; Bockor L, 2016, HUM MOL GENET; Bortolussi G, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.113; Bortolussi G, 2014, DIS MODEL MECH, V7, P1057, DOI 10.1242/dmm.016535; Bortolussi G, 2012, FASEB J, V26, P1052, DOI 10.1096/fj.11-195461; Brites D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00088; Brites D, 2011, SEMIN PERINATOL, V35, P114, DOI 10.1053/j.semperi.2011.02.004; Brito MA, 2004, BRAIN RES, V1026, P33, DOI 10.1016/j.brainres.2004.07.063; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brito MA, 2008, NEUROBIOL DIS, V29, P30, DOI 10.1016/j.nbd.2007.07.023; Calligaris R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-543; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Daood MJ, 2012, PEDIATR RES, V72, P455, DOI 10.1038/pr.2012.111; Falcao AS, 2007, NEUROSCIENCE, V144, P878, DOI 10.1016/j.neuroscience.2006.10.026; Falcao AS, 2007, J NEUROSCI RES, V85, P1229, DOI 10.1002/jnr.21227; Falcao AS, 2006, ACTA NEUROPATHOL, V112, P95, DOI 10.1007/s00401-006-0078-4; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Fernandes A, 2004, J NEUROIMMUNOL, V153, P64, DOI 10.1016/j.jneuroim.2004.04.007; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Fernandes A, 2009, CURR PHARM DESIGN, V15, P2915, DOI 10.2174/138161209789058165; Fernandes A, 2009, DEV NEUROBIOL, V69, P568, DOI 10.1002/dneu.20727; Fischer R, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/610813; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Gazzin S, 2012, PEDIATR RES, V71, P653, DOI 10.1038/pr.2012.23; Geiger AS, 2007, NEONATOLOGY, V92, P219, DOI 10.1159/000103740; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Giraudi PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029078; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gordo AC, 2006, J NEUROSCI RES, V84, P194, DOI 10.1002/jnr.20857; Greco C, 2016, NEONATOLOGY, V110, P172, DOI 10.1159/000445708; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Johnson LH, 2002, J PEDIATR-US, V140, P396, DOI 10.1067/mpd.2002.123098; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Lin SZ, 2005, EUR J NEUROSCI, V22, P21, DOI 10.1111/j.1460-9568.2005.04182.x; Lin SZ, 2003, NEUROSCI LETT, V353, P209, DOI 10.1016/j.neulet.2003.09.053; Maisels MJ, 2004, PEDIATRICS, V114, P297; MIKOSHIBA K, 1980, J NEUROCHEM, V35, P1309, DOI 10.1111/j.1471-4159.1980.tb09003.x; NOTTER MFD, 1986, EXP NEUROL, V94, P670, DOI 10.1016/0014-4886(86)90246-3; Oakes GH, 2010, J BIOCHEM MOL TOXIC, V24, P73, DOI 10.1002/jbt.20313; Oakes GH, 2005, J BIOCHEM MOL TOXIC, V19, P244, DOI 10.1002/jbt.20086; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Palmela I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00022; Qaisiya M, 2016, ARCH TOXICOL; Qaisiya M, 2014, CELL SIGNAL, V26, P512, DOI 10.1016/j.cellsig.2013.11.029; Reichman NE, 2015, ANN EPIDEMIOL, V25, P126, DOI 10.1016/j.annepidem.2014.10.016; Rice AC, 2011, BRAIN RES, V1368, P290, DOI 10.1016/j.brainres.2010.10.052; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Schreuder AB, 2013, LIVER INT, V33, P1557, DOI 10.1111/liv.12219; SCHUTTA HS, 1967, J NEUROPATH EXP NEUR, V26, P377, DOI 10.1097/00005072-196707000-00003; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; Silva SL, 2012, NEUROPHARMACOLOGY, V62, P2398, DOI 10.1016/j.neuropharm.2012.02.002; Stoeckius M, 2012, J BIOL CHEM, V287, P15418, DOI 10.1074/jbc.M111.266510; Tell G, 2009, CURR PHARM DESIGN, V15, P2908, DOI 10.2174/138161209789058174; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vaz AR, 2011, MOL CELL NEUROSCI, V48, P82, DOI 10.1016/j.mcn.2011.06.008; Vodret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16203; Watchko JF, 2006, NEUROMOL MED, V8, P513, DOI 10.1385/NMM:8:4:513; Watchko JF, 2013, NEW ENGL J MED, V369, P2021, DOI 10.1056/NEJMra1308124; Whitney ER, 2008, J NEUROSCI METH, V168, P42, DOI 10.1016/j.jneumeth.2007.09.009; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yueh MF, 2014, J BIOL CHEM, V289, P4699, DOI 10.1074/jbc.M113.518613; Zhang YH, 2008, BIOCHEM BIOPH RES CO, V377, P1205, DOI 10.1016/j.bbrc.2008.10.151	71	20	21	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAR 24	2017	14								64	10.1186/s12974-017-0838-1			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EP9BO	WOS:000397668900001	28340583	gold, Green Published			2022-02-06	
J	Chandra, N; Sundaramurthy, A; Gupta, RK				Chandra, Namas; Sundaramurthy, Aravind; Gupta, Raj K.			Validation of Laboratory Animal and Surrogate Human Models in Primary Blast Injury Studies	MILITARY MEDICINE			English	Article							SHOCK; TBI	Blast-induced neurotrauma has affected more than 300,000 service members. It is important to understand the effect of single and repeated shock-blast wave exposures on the neuropsychological behavior of soldiers, to offer them better protection, diagnostics, and treatment. Preclinical animal models and helmet design studies on human surrogate models have relied on the use of compression gas-driven shock tubes. Traditional shock tubes are so simple that if not carefully designed and operated, the test results can easily introduce detrimental artifacts clouding the conclusions. In this work, we present live-fire test results of an instrumented human surrogate head-neck model and compare with the data obtained in a carefully designed shock tube. We present various features incorporated in the shock tube design that led to better fidelity between live-fire and laboratory shock-blast conditions. The effect of specimen placement, choice of driver gas, pressure and volume of driver, end-plate conditions, and measurement techniques all determine the successful replication of live-fire loading conditions. These parameters become more important when conducting animal testing as the totality of loading will dictate the injury severity and type which ultimately will determine the mechanisms of blast-induced neurotrauma and hence their prevention and treatment strategies.	[Chandra, Namas; Sundaramurthy, Aravind] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, 111 Lock St, Newark, NJ 07102 USA; [Gupta, Raj K.] US Army Med Res & Mat Command, DOD Blast Injury Res Program Coordinating Off, HQ, 504 Scott St, Ft Detrick, MD 21792 USA		Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med, 111 Lock St, Newark, NJ 07102 USA.		Sundaramurthy, Aravind/O-2047-2019	Sundaramurthy, Aravind/0000-0002-0359-8680	U.S. Army Research office [W911NF-08-1-0483]	NC acknowledges the financial support provided by the U.S. Army Research office with contract number W911NF-08-1-0483 and laboratory members for some of the laboratory shock field data.	Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Fomin NA, 2010, J ENG PHYS THERMOPH+, V83, P1118, DOI 10.1007/s10891-010-0437-9; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Hyde, 1991, CONVENTIONAL WEAPONS; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Tanielian T.L., 2008, INVISIBLE WOUNDS WAR, V1; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wortman JD, 1982, DTIC DOCUMENT	14	20	21	1	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			105	113		10.7205/MILMED-D-16-00144			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6VN	WOS:000398947100018	28291460	Bronze			2022-02-06	
J	Chen, T; Yu, Y; Tang, LJ; Kong, L; Zhang, CH; Chu, HY; Yin, LW; Ma, HY				Chen, Tao; Yu, Yan; Tang, Liu-jiu; Kong, Li; Zhang, Cheng-hong; Chu, Hai-ying; Yin, Liang-wei; Ma, Hai-ying			Neural stem cells over-expressing brain-derived neurotrophic factor promote neuronal survival and cytoskeletal protein expression in traumatic brain injury sites	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain-derived neurotrophic factor; neural stem cells; transfect; differentiation; traumatic brain injury; cytoskeleton; neurofilament; microtubule-associated proteins; calmodulin; Wnt/beta-catenin; neural regeneration	FUNCTIONAL RECOVERY; SPINAL-CORD; RAT MODEL; STEM/PROGENITOR CELLS; SYNAPTIC PROTEIN; TRANSPLANTATION; DIFFERENTIATION; GROWTH; REGENERATION; CALMODULIN	Cytoskeletal proteins are involved in neuronal survival. Brain-derived neurotrophic factor can increase expression of cytoskeletal proteins during regeneration after axonal injury. However, the effect of neural stem cells genetically modified by brain-derived neurotrophic factor transplantation on neuronal survival in the injury site still remains unclear. To examine this, we established a rat model of traumatic brain injury by controlled cortical impact. At 72 hours after injury, 2 x 10(7) cells/mL neural stem cells overexpressing brain-derived neurotrophic factor or naive neural stem cells (3 mL) were injected into the injured cortex. At 1-3 weeks after transplantation, expression of neurofilament 200, microtubule-associated protein 2, actin, calmodulin, and beta-catenin were remarkably increased in the injury sites. These findings confirm that brain-derived neurotrophic factor-transfected neural stem cells contribute to neuronal survival, growth, and differentiation in the injury sites. The underlying mechanisms may be associated with increased expression of cytoskeletal proteins and the Wnt/beta-catenin signaling pathway.	[Chen, Tao] Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian, Liaoning Provin, Peoples R China; [Yu, Yan; Tang, Liu-jiu; Kong, Li; Zhang, Cheng-hong; Chu, Hai-ying; Ma, Hai-ying] Dalian Med Univ, Dept Histol & Embryol, Dalian, Liaoning Provin, Peoples R China; [Yin, Liang-wei] Dalian Cent Hosp, Dept Oncol, Dalian, Liaoning Provin, Peoples R China		Ma, HY (corresponding author), Dalian Med Univ, Dept Histol & Embryol, Dalian, Liaoning Provin, Peoples R China.; Yin, LW (corresponding author), Dalian Cent Hosp, Dept Oncol, Dalian, Liaoning Provin, Peoples R China.	Lwyin2008@163.com; hyma20060602@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31300812, 31371218]	This research was supported by grants from the National Natural Science Foundation of China, No. 31300812 and No. 31371218.	Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Castorina A, 2015, NEURAL REGEN RES, V10, P850, DOI 10.4103/1673-5374.158352; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chung S, 2016, INT J MOL MED, V37, P1170, DOI 10.3892/ijmm.2016.2532; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103; Difato F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00183; Fauza DO, 2008, SURGERY, V144, P367, DOI 10.1016/j.surg.2008.05.009; Galvin JE, 2000, EXP NEUROL, V165, P77, DOI 10.1006/exnr.2000.7461; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Huh JW, 2002, EXP NEUROL, V175, P198, DOI 10.1006/exnr.2002.7880; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KITAMURA Y, 1995, EUR J PHARM-MOLEC PH, V289, P299, DOI 10.1016/0922-4106(95)90107-8; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lee IS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0035-6; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levinson H, 2004, WOUND REPAIR REGEN, V12, P505, DOI 10.1111/j.1067-1927.2004.012502.x; Lin W, 2016, ASIA PAC J CLIN TRIA, V1, P170; Liu WG, 2011, NEUROL RES, V33, P686, DOI 10.1179/1743132810Y.0000000031; Lou YL, 2016, ZHONGGUO ZUZHI GONGC, V20, P1474; Lv XM, 2016, NEURAL REGEN RES, V11, P652, DOI 10.4103/1673-5374.180753; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Ma XH, 2010, CRYOBIOLOGY, V60, P184, DOI 10.1016/j.cryobiol.2009.10.013; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meng XT, 2008, CELL BIOL INT, V32, P1546, DOI 10.1016/j.cellbi.2008.09.001; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Ortega F, 2013, NAT CELL BIOL, V15, P602, DOI 10.1038/ncb2736; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Santamaria S, 2015, NEURAL REGEN RES, V10, P1574, DOI 10.4103/1673-5374.165266; Schaloske RH, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-13; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shetty AK, 1995, J COMP NEUROL, V363, P581, DOI 10.1002/cne.903630406; Shetty AK, 2013, INT J DEV NEUROSCI, V31, P646, DOI 10.1016/j.ijdevneu.2013.05.006; Wang LJ, 2014, ACTA NEUROCHIR, V156, P1409, DOI 10.1007/s00701-014-2089-6; Yang JW, 2015, NEUROPEPTIDES, V54, P35, DOI 10.1016/j.npep.2015.08.005; Yao Y, 2016, NEURAL REGEN RES, V11, P1456, DOI 10.4103/1673-5374.191220; Ye LJ, 2016, NEURAL REGEN RES, V11, P1464, DOI 10.4103/1673-5374.191221; Yu B, 2011, INT J MOL MED, V28, P739, DOI 10.3892/ijmm.2011.734; Yuan LL, 2015, NEURAL REGEN RES, V10, P1516, DOI 10.4103/1673-5374.165526	47	20	22	1	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2017	12	3					433	439		10.4103/1673-5374.202947			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	ES8GC	WOS:000399792000024	28469658	gold, Green Published			2022-02-06	
J	Farrell, K; Joshi, J; Kothapalli, CR				Farrell, Kurt; Joshi, Jyotsna; Kothapalli, Chandrasekhar R.			Injectable uncrosslinked biomimetic hydrogels as candidate scaffolds for neural stem cell delivery	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						neural stem cells; hydrogels; rheology; uncrosslinked; differentiation; injectability; axonal outgrowth; extracellular matrix	HYALURONIC-ACID HYDROGELS; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; NEURONAL DIFFERENTIATION; IN-VITRO; RETINOIC ACID; COLLAGEN GELS; SPINAL-CORD; STEM/PROGENITOR CELLS; MECHANICAL-PROPERTIES	Mammalian central nervous system has a limited ability for self-repair under diseased or injury conditions. Repair strategies focused on exogenously delivering autologous neural stem cells (NSCs) to replace lost neuronal populations and axonal pathways in situ, and promote endogenous repair mechanisms are gaining traction. Successful outcomes are contingent on selecting an appropriate delivery vehicle for injecting cells that promotes cell retention and survival, elicits differentiation to desired lineages, and enhances axonal outgrowth upon integration into the host tissue. Hydrogels made of varying compositions of collagen, laminin, hyaluronic acid (HA), and chondroitin sulfate proteoglycan (CSPG) were developed, with no external crosslinking agents, to mimic the native extracellular matrix composition. The physical (porosity, pore-size, gel integrity, swelling ratio, and enzymatic degradation), mechanical (viscosity, storage and loss moduli, Young's modulus, creep, and stress-relaxation), and biological (cell survival, differentiation, neurite outgrowth, and integrin expression) characteristics of these hydrogels were assessed. These hydrogels exhibited excellent injectability, retained gel integrity, and matched the mechanical moduli of native brain tissue, possibly due to natural collagen fibril polymerization and physical-crosslinking between HA molecules and collagen fibrils. Depending on the composition, these hydrogels promoted cell survival, neural differentiation, and neurite outgrowth, as evident from immunostaining and western blots. These cellular outcomes were facilitated by cellular binding via (6), (1), and CD44 surface integrins to these hydrogels. Results attest to the utility of uncrosslinked, ECM-mimicking hydrogels to deliver NSCs for tissue engineering and regenerative medicine applications. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 790-805, 2017.	[Farrell, Kurt; Joshi, Jyotsna; Kothapalli, Chandrasekhar R.] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA		Kothapalli, CR (corresponding author), Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.	c.kothapalli@csuohio.edu			Cellular and molecular medicine fellowship (CMMS); CSU	Contract grant sponsors: Cellular and molecular medicine fellowship (CMMS), dissertation research awards (DRA), CSU, Startup funds, Faculty Research Development Grant from CSU	Akita J, 2002, BRAIN RES, V954, P286, DOI 10.1016/S0006-8993(02)03356-5; Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1080/10601329908951195; Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; BAXTER E, 1971, ANN RHEUM DIS, V30, P419, DOI 10.1136/ard.30.4.419; Bergstrom T, 2014, BBA-GEN SUBJECTS, V1840, P2526, DOI 10.1016/j.bbagen.2014.01.021; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358; Cacciatore I, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/240146; Cesaretti M, 2003, CARBOHYD POLYM, V54, P59, DOI 10.1016/S0144-8617(03)00144-9; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Christie VB, 2010, J NEUROSCI METH, V193, P239, DOI 10.1016/j.jneumeth.2010.08.022; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Farrell K, 2012, J REGENERATIVE MED, V1, P2, DOI [10.4172/23259620, DOI 10.4172/23259620]; Farrell K, 2017, J BIOMED MATER RES A, V105, P790, DOI 10.1002/jbm.a.35956; Fedoroff S, 2001, PROTOCOLS NEURAL CEL, p[xxii, 362]; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042; Kothapalli CR, 2005, ACTA BIOMATER, V1, P653, DOI 10.1016/j.actbio.2005.06.005; Krebs J, 2005, SPINE, V30, pE118, DOI 10.1097/01.brs.0000154670.49227.65; Kulbatski I, 2009, J HISTOCHEM CYTOCHEM, V57, P405, DOI 10.1369/jhc.2008.951814; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lai GL, 2008, INT J BIOL MACROMOL, V42, P285, DOI 10.1016/j.ijbiomac.2007.12.010; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Liang Y, 2013, BIOMATERIALS, V34, P5521, DOI 10.1016/j.biomaterials.2013.03.095; Liu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117709; Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831; Lopez-Garcia MDC, 2010, BIO-MED MATER ENG, V20, P361, DOI 10.3233/BME-2010-0649; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Ma FK, 2014, BIOMACROMOLECULES, V15, P1062, DOI 10.1021/bm500062n; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Mao YW, 2005, J CELL BIOL, V170, P305, DOI 10.1083/jcb.200505061; Moretti Morgana, 2014, Front Biosci (Elite Ed), V6, P341; Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002; Muraoka M, 1996, J BIOCHEM-TOKYO, V119, P167; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X; Oliveira SM, 2008, J BIOMED MATER RES B, V87B, P49, DOI 10.1002/jbm.b.31066; Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70; Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Scatena R, 2007, EXPERT OPIN INV DRUG, V16, P59, DOI 10.1517/13543784.16.1.59; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Sharif-Kashani P, 2011, J BIOMECH, V44, P419, DOI 10.1016/j.jbiomech.2010.10.002; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Simmers P, 2015, TISSUE ENG PT A, V21, P1455, DOI [10.1089/ten.tea.2014.0363, 10.1089/ten.TEA.2014.0363]; Siriwardane ML, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015012; Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]; Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Tunesi M, 2013, INT J ARTIF ORGANS, V36, P762, DOI 10.5301/ijao.5000282; Volpi N, 2014, NAT PROTOC, V9, P541, DOI 10.1038/nprot.2014.026; Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033; Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3; Watanabe K, 2007, RESTOR NEUROL NEUROS, V25, P109; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4	78	20	20	1	68	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	MAR	2017	105	3					790	805		10.1002/jbm.a.35956			16	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EK5HO	WOS:000393957700011	27798959				2022-02-06	
J	Ide, K; Uematsu, S; Tetsuhara, K; Yoshimura, S; Kato, T; Kobayashi, T				Ide, Kentaro; Uematsu, Satoko; Tetsuhara, Kenichi; Yoshimura, Satoshi; Kato, Takahiro; Kobayashi, Tohru			External Validation of the PECARN Head Trauma Prediction Rules in Japan	ACADEMIC EMERGENCY MEDICINE			English	Article							DECISION RULE; CHILDREN; INJURY	ObjectivesThe Pediatric Emergency Care Applied Research Network (PECARN) head trauma prediction rules are used to assist computed tomography (CT) decision-making for children with minor head trauma. Although the PECARN rules have been validated in North America and Europe, they have not yet been validated in Asia. In Japan, there are no clinical decision rules for children with minor head trauma. The rate of head CT for children with minor head trauma in Japan is high since CT is widely accessible across the country. The objective of this study was to evaluate the diagnostic accuracy of the PECARN rules for identifying clinically important traumatic brain injuries (ciTBI) in children with minor head trauma in Japan. MethodsWe conducted a retrospective cohort study at a tertiary care pediatric hospital in Japan (30,000 patients/year). We enrolled all children younger than 18 years with minor head trauma (Glasgow Coma Scale 14) who presented to the emergency department within 24 hours of their injury between January and December 2013. We retrospectively classified the children into three risk categories according to the PECARN rules. The PECARN rules were considered negative when children were classified into the very-low-risk category. The primary outcome was considered positive when a child had ciTBI defined as head injury resulting in death, neurosurgery, intubation for>24 hours, or hospital admission 2 nights with evidence of TBI on CT. ResultsAmong 2,208 children included in the study, 24 (1.1%) had ciTBI. Sensitivities and specificities of the PECARN rules to predict ciTBI were 85.7% (12/14; 95% confidence interval [CI]= 57.2 to 98.2) and 73.5% (572/778; 95% CI= 70.3 to 76.6), respectively, for children<2 years old, and 100% (10/10; 95% CI= 58.7 to 100) and 73.5% (1033/1406; 95% CI= 71.0 to 75.7) for children 2 years old, respectively. There were 10 cases of physically abused children<2 years old, and six (60%) of them had ciTBI. Also, two cases of physically abused children with ciTBI were classified as very low risk. If we did not include physically abused children, the sensitivity of the PECARN rule for children<2 years old improved from 85.7% to 100% (8/8). ConclusionsThe PECARN rules were less sensitive for physically abused children, although the rules showed excellent applicability for the cohort without physical abuse. Thoughtful consideration may be needed for cases of nonaccidental trauma. Further prospective studies are required to verify the applicability of the PECARN rules for children with minor head trauma in Japan.	[Ide, Kentaro] Natl Ctr Child Hlth & Dev, Div Crit Care Med, Tokyo, Japan; [Uematsu, Satoko; Tetsuhara, Kenichi; Kato, Takahiro] Natl Ctr Child Hlth & Dev, Div Pediat Emergency & Transport Serv, Tokyo, Japan; [Yoshimura, Satoshi] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Tokyo, Japan; [Kobayashi, Tohru] Natl Ctr Child Hlth & Dev, Ctr Clin Res & Dev, Div Clin Res Planning, Dept Dev Strategy, Tokyo, Japan; [Ide, Kentaro] Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada; [Ide, Kentaro] SickKids Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada		Ide, K (corresponding author), Natl Ctr Child Hlth & Dev, Div Crit Care Med, Tokyo, Japan.; Ide, K (corresponding author), Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada.; Ide, K (corresponding author), SickKids Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada.	ide-k@ncchd.go.jp	Tetsuhara, Kenichi/AAD-2776-2019	Tetsuhara, Kenichi/0000-0001-6473-0326	Foundation for Growth Science [26-44]; Japanese Foundation for Pediatric Research; Marumo Science Research Foundation for Emergency Medicine	This work was supported in part by grants from the Foundation for Growth Science (26-44), the Japanese Foundation for Pediatric Research, and the Marumo Science Research Foundation for Emergency Medicine.	Bergman DA, 1999, PEDIATRICS, V104, P1407; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V10, P92; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Kemp AM, 2014, ARCH DIS CHILD, V99, P108, DOI 10.1136/archdischild-2013-304339; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Ono K, 2011, HEALTH PHYS, V100, P491, DOI 10.1097/HP.0b013e3181f497ef; Ozaki M, 2010, JPN J NEUROSURG TOKY, V19, P474; Pierce MC, 2010, PEDIATRICS, V125, P67, DOI 10.1542/peds.2008-3632; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983	15	20	20	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAR	2017	24	3					308	314		10.1111/acem.13129			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EP7LL	WOS:000397559200004	27862642	Bronze			2022-02-06	
J	Janickova, H; Rosborough, K; Al-Onaizi, M; Kljakic, O; Guzman, MS; Gros, R; Prado, MAM; Prado, VF				Janickova, Helena; Rosborough, Kaie; Al-Onaizi, Mohammed; Kljakic, Ornela; Guzman, Monica S.; Gros, Robert; Prado, Marco A. M.; Prado, Vania F.			Deletion of the vesicular acetylcholine transporter from pedunculopontine/laterodorsal tegmental neurons modifies gait	JOURNAL OF NEUROCHEMISTRY			English	Article						acetylcholine; balance; gait; motor disease; Parkinson's disease; pedunculopontine	PROGRESSIVE SUPRANUCLEAR PALSY; M5 MUSCARINIC RECEPTORS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD CONTUSION; PARKINSONS-DISEASE; CHOLINERGIC NEURONS; NUCLEUS-ACCUMBENS; MESOPONTINE TEGMENTUM; EXCITOTOXIC LESIONS; SUBTHALAMIC NUCLEUS	Postural instability and gait disturbances, common disabilities in the elderly and frequently present in Parkinson's disease (PD), have been suggested to be related to dysfunctional cholinergic signaling in the brainstem. We investigated how long-term loss of cholinergic signaling from mesopontine nuclei influence motor behaviors. We selectively eliminated the vesicular acetylcholine transporter (VAChT) in pedunculopontine and laterodorsal tegmental nuclei cholinergic neurons to generate mice with selective mesopontine cholinergic deficiency (VAChT(En1-Cre-flox/flox)). VAChT(En1-Cre-flox/flox) mice did not show any gross health or neuromuscular abnormality on metabolic cages, wire-hang and grip-force tests. Young VAChT(En1-Cre-flox/flox) mice (2-5months-old) presented motor learning/coordination deficits on the rotarod; moved slower, and had smaller steps on the catwalk, but showed no difference in locomotor activity on the open field. Old VAChT(En1-Creflox/flox) mice (13-16months-old) showed more pronounced motor learning/balance deficits on the rotarod, and more pronounced balance deficits on the catwalk. Furthermore, old mutants moved faster than controls, but with similar step length. Additionally, old VAChT-deficient mice were hyperactive. These results suggest that dysfunction of cholinergic neurons from mesopontine nuclei, which is commonly seen in PD, has causal roles in motor functions. Prevention of mesopontine cholinergic failure may help to prevent/improve postural instability and falls in PD patients.	[Janickova, Helena; Rosborough, Kaie; Al-Onaizi, Mohammed; Kljakic, Ornela; Guzman, Monica S.; Gros, Robert; Prado, Marco A. M.; Prado, Vania F.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON N6A 5B7, Canada; [Rosborough, Kaie; Al-Onaizi, Mohammed; Kljakic, Ornela; Guzman, Monica S.; Prado, Marco A. M.; Prado, Vania F.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Gros, Robert; Prado, Marco A. M.; Prado, Vania F.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada		Prado, MAM; Prado, VF (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON N6A 5B7, Canada.	mprado@robarts.ca; vprado@robarts.ca	Gros, Robert/A-3010-2009; Gros, Robert/AAV-2237-2020; Prado, Marco Antonio Maximo/K-7638-2013; Janickova, Helena/Q-7211-2017; Prado, Vania Ferreira/K-7630-2013	Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Janickova, Helena/0000-0003-0310-7893; Prado, Vania Ferreira/0000-0003-4994-6393; Kljakic, Ornela/0000-0003-3668-9391	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 126000, MOP 89919]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [402524-2013]; Brain Canada; Canadian Foundation for InnovationCanada Foundation for Innovation; Ontario research fund; Kuwait University; Heart and Stroke FoundationHeart & Stroke Foundation of Canada	The authors declare no competing financial interests. We thank Sanda Raulic, Jue Fan, and Matthew Cowan for animal care and technical support. Work supported by Canadian Institute of Health Research (MOP 126000 and MOP 89919), NSERC (402524-2013), Brain Canada, Canadian Foundation for Innovation, and Ontario research fund (M.A.M.P. and V.F.P.). M.A.A-O and M.S.G received support from Kuwait University and The Heart and Stroke Foundation respectively. The authors have no conflict of interest to declare.	Al-Onaizi M. A., 2016, CEREB CORTEX; Alderson HL, 2003, NEUROSCIENCE, V118, P311, DOI 10.1016/S0306-4522(03)00152-0; Baiguera C, 2012, BRAIN, V135, P2750, DOI 10.1093/brain/aws193; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Bohnen NI, 2013, MOVEMENT DISORD, V28, P1492, DOI 10.1002/mds.25534; Bohnen NI, 2012, J CEREBR BLOOD F MET, V32, P1609, DOI 10.1038/jcbfm.2012.60; Bohnen NI, 2009, NEUROLOGY, V73, P256, DOI 10.1212/WNL.0b013e3181b0bd3d; Bolivar VJ, 2009, NEUROBIOL LEARN MEM, V92, P206, DOI 10.1016/j.nlm.2009.02.002; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Chung KA, 2010, NEUROLOGY, V75, P1263, DOI 10.1212/WNL.0b013e3181f6128c; Clarke NP, 1997, NEUROSCIENCE, V81, P371, DOI 10.1016/S0306-4522(97)00247-9; Clements J R, 1991, Adv Exp Med Biol, V295, P127; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; Cyr M, 2015, BEHAV BRAIN RES, V278, P107, DOI 10.1016/j.bbr.2014.09.021; de Castro BM, 2009, GENES BRAIN BEHAV, V8, P23, DOI 10.1111/j.1601-183X.2008.00439.x; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Fernandez Hubert H, 2012, Cleve Clin J Med, V79 Suppl 2, pS14, DOI 10.3949/ccjm.79.s2a.03; Forster GL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0001.2002; Gangarossa G, 2016, NEUROBIOL DIS, V87, P69, DOI 10.1016/j.nbd.2015.12.010; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Grabli D, 2013, J NEUROSCI, V33, P11986, DOI 10.1523/JNEUROSCI.1568-13.2013; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Guzman MS, 2013, J NEUROCHEM, V124, P658, DOI 10.1111/jnc.12128; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hernandez-Chan NG, 2011, BEHAV BRAIN RES, V225, P482, DOI 10.1016/j.bbr.2011.08.007; HIRSCH EC, 1987, P NATL ACAD SCI USA, V84, P5976, DOI 10.1073/pnas.84.16.5976; Honey CR, 2016, CAN J NEUROL SCI, V2016, P1; INGLIS WL, 1994, NEUROSCIENCE, V62, P51, DOI 10.1016/0306-4522(94)90314-X; Jaarsma D, 1997, PROG BRAIN RES, V114, P67; JELLINGER K, 1988, J NEUROL NEUROSUR PS, V51, P540, DOI 10.1136/jnnp.51.4.540; Jia HG, 2003, BRAIN RES, V992, P205, DOI 10.1016/j.brainres.2003.08.062; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimmel RA, 2000, GENE DEV, V14, P1377; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; KNUTSSON E, 1972, BRAIN, V95, P475, DOI 10.1093/brain/95.3.475; Kojima J, 1997, NEUROSCI LETT, V226, P111, DOI 10.1016/S0304-3940(97)00254-1; Kolisnyk B, 2016, CEREB CORTEX; Kolisnyk B, 2013, J NEUROSCI, V33, P14908, DOI 10.1523/JNEUROSCI.1933-13.2013; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Kucinski A, 2015, BEHAV BRAIN RES, V282, P155, DOI 10.1016/j.bbr.2015.01.012; Lambert CS, 2015, BEHAV BRAIN RES, V291, P342, DOI 10.1016/j.bbr.2015.05.056; LAVOIE B, 1994, J COMP NEUROL, V344, P190, DOI 10.1002/cne.903440203; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; Liu Y, 2013, BEHAV BRAIN RES, V257, P166, DOI 10.1016/j.bbr.2013.10.007; MacLaren DAA, 2014, EUR J NEUROSCI, V40, P3224, DOI 10.1111/ejn.12666; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martins-Silva C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017611; Martyn AC, 2012, P NATL ACAD SCI USA, V109, P17651, DOI 10.1073/pnas.1215381109; Maskos U, 2008, BRIT J PHARMACOL, V153, pS438, DOI 10.1038/bjp.2008.5; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Munro-Davies LE, 1999, EXP BRAIN RES, V129, P511, DOI 10.1007/s002210050921; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Oakman SA, 1999, NEUROSCIENCE, V94, P529, DOI 10.1016/S0306-4522(99)00307-3; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Patel JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2144; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Perlman, 2000, Curr Treat Options Neurol, V2, P215, DOI 10.1007/s11940-000-0004-3; Pienaar IS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0044-5; Plaha P, 2005, NEUROREPORT, V16, P1883, DOI 10.1097/01.wnr.0000187637.20771.a0; Prado VF, 2013, BIOCHEM J, V450, P265, DOI 10.1042/BJ20121662; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Prado VF, 2002, CELL MOL NEUROBIOL, V22, P565, DOI 10.1023/A:1021884319363; Sakae DY, 2015, MOL PSYCHIATR, V20, P1448, DOI 10.1038/mp.2015.104; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; SKINNER RD, 1984, BRAIN RES, V323, P385, DOI 10.1016/0006-8993(84)90319-6; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346; Steidl S, 2015, BEHAV BRAIN RES, V287, P82, DOI 10.1016/j.bbr.2015.02.049; Steidl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084412; Steiniger B, 2004, BEHAV BRAIN RES, V151, P17, DOI 10.1016/j.bbr.2003.08.001; SWERDLOW NR, 1987, BRAIN RES, V412, P233, DOI 10.1016/0006-8993(87)91129-2; Thomsen M, 2011, EXP CLIN PSYCHOPHARM, V19, P321, DOI 10.1037/a0024798; Visser Jasper E., 2005, Neural Plasticity, V12, P161, DOI 10.1155/NP.2005.161; Vlamings R, 2007, NEUROSCIENCE, V148, P815, DOI 10.1016/j.neuroscience.2007.06.043; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Wang XH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-142; Wang YG, 2008, J CEREBR BLOOD F MET, V28, P1936, DOI 10.1038/jcbfm.2008.82; Wecker L, 2013, NEUROPHARMACOLOGY, V73, P75, DOI 10.1016/j.neuropharm.2013.05.016; Wenning GK, 1999, MOVEMENT DISORD, V14, P947, DOI 10.1002/1531-8257(199911)14:6<947::AID-MDS1006>3.0.CO;2-O; Westin JE, 2012, BEHAV BRAIN RES, V226, P519, DOI 10.1016/j.bbr.2011.10.006; Whitley E, 2002, CRIT CARE, V6, P335; Wilcox RA, 2011, J NEUROL NEUROSUR PS, V82, P1256, DOI 10.1136/jnnp.2010.213462; Winn P, 2006, J NEUROL SCI, V248, P234, DOI 10.1016/j.jns.2006.05.036; WOOLF NJ, 1990, BRAIN RES, V520, P55, DOI 10.1016/0006-8993(90)91691-9; Yeomans J, 2001, LIFE SCI, V68, P2449, DOI 10.1016/S0024-3205(01)01038-4; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zesiewicz TA, 2012, NEUROLOGY, V78, P545, DOI 10.1212/WNL.0b013e318247cc7a; ZWEIG RM, 1989, ANN NEUROL, V26, P41, DOI 10.1002/ana.410260106	91	20	20	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2017	140	5					787	798		10.1111/jnc.13910			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EM8OX	WOS:000395571900010	27889925	Bronze			2022-02-06	
J	Lund-Johansen, M; Laeke, T; Tirsit, A; Munie, T; Abebe, M; Sahlu, A; Biluts, H; Wester, K				Lund-Johansen, Morten; Laeke, Tsegazeab; Tirsit, Abenezer; Munie, Tadios; Abebe, Mersha; Sahlu, Abat; Biluts, Hagos; Wester, Knut			An Ethiopian Training Program in Neurosurgery with Norwegian Support	WORLD NEUROSURGERY			English	Article						Education; Neurosurgery; Sub-Sahara; Training	HEAD CIRCUMFERENCE; DATA-COLLECTION; GLOBAL SURGERY; NEUROTRAUMA; SITUATION; EDUCATION; TRAUMA; HEALTH	After a 4-year planning period, a joint Ethiopian/Norwegian training program in neurosurgery was started in June 2006. The collaborating partners were Addis Ababa University; Department of Surgery, Tikur Anbessa Specialized Hospital; University of Bergen; Haukeland University Hospital; and Myungsung Christian Medical Center, a Korean missionary hospital in Addis Ababa, Ethiopia. A memorandum of understanding was signed at dean/chief executive officer levels. Although other initiatives have been involved in supporting neurosurgery in Addis Ababa during the same period, this institutionally founded program has been the main external contributor to neurosurgical capacity building through the education of 21 Ethiopian neurosurgeons, and in supporting a sustainable environment for neurosurgical training within a network of 5 centers in Addis Ababa. This article gives an account of the strategies underlying the program planning, the history of the program, and on the experience gained by it. Finally, ethical problems and challenges encountered in the program are discussed.	[Lund-Johansen, Morten; Wester, Knut] Univ Bergen, Dept Clin Med K1, Bergen, Norway; [Lund-Johansen, Morten; Wester, Knut] Haukeland Hosp, Dept Neurosurg, Bergen, Norway; [Laeke, Tsegazeab; Tirsit, Abenezer; Munie, Tadios; Abebe, Mersha; Sahlu, Abat; Biluts, Hagos] Univ Addis Ababa, Tikur Anbessa Specialized Hosp, Dept Surg, Addis Ababa, Ethiopia		Lund-Johansen, M (corresponding author), Univ Bergen, Dept Clin Med K1, Bergen, Norway.; Lund-Johansen, M (corresponding author), Haukeland Hosp, Dept Neurosurg, Bergen, Norway.	mljo@helse-bergen.no					Amare EB, 2015, WORLD NEUROSURG, V84, P1566, DOI 10.1016/j.wneu.2015.08.045; Bagan M, 2010, WORLD NEUROSURG, V73, P289, DOI 10.1016/j.wneu.2010.03.007; Bernstein M, 2004, CAN J SURG, V47, P170; Carlson L, 2015, WORLD J SURG, V39, P813, DOI 10.1007/s00268-014-2938-8; El Khamlichi A, 2001, NEUROSURGERY, V48, P1344, DOI 10.1097/00006123-200106000-00034; Eriksen AA, 2016, WORLD NEUROSURG, V91, P592, DOI 10.1016/j.wneu.2016.04.132; Idowu OE, 2014, INJURY, V45, P1717, DOI 10.1016/j.injury.2014.05.028; Lavy C, 2011, WORLD J SURG, V35, P262, DOI 10.1007/s00268-010-0885-6; Lehre MA, 2015, J NEUROSURG-SPINE, V23, P772, DOI 10.3171/2015.3.SPINE141282; Meara JG, 2015, SURGERY, V157, P834, DOI 10.1016/j.surg.2015.02.009; Mefire AC, 2010, S AFR J SURG, V48, P90; Mitchell KB, 2013, CAN J SURG, V56, P199, DOI 10.1503/cjs.028911; O'Flynn E, 2016, WORLD J SURG, V40, P2620, DOI 10.1007/s00268-016-3601-3; Peter Noel Aaron, 2015, Lancet, V385 Suppl 2, pS43, DOI 10.1016/S0140-6736(15)60838-8; Prinja S, 2015, ESSENTIAL SURG DIS C, V1, P317; Sahlu A, 2016, J NEUROSCI RURAL PRA, V7, P143, DOI 10.4103/0976-3147.165357; Sahlu A, 2016, ACTA NEUROCHIR, V158, P611, DOI 10.1007/s00701-016-2710-y; Shawar YR, 2015, LANCET GLOB HEALTH, V3, pE487, DOI 10.1016/S2214-109X(15)00098-4; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Wall LL, 2006, INT UROGYNECOL J, V17, P559, DOI 10.1007/s00192-005-0056-8	20	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2017	99						403	408		10.1016/j.wneu.2016.12.051			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EP2CH	WOS:000397190100057	28017754				2022-02-06	
J	White, ER; Pinar, C; Bostrom, CA; Meconi, A; Christie, BR				White, Emily R.; Pinar, Cristina; Bostrom, Crystal A.; Meconi, Alicia; Christie, Brian R.			Mild Traumatic Brain Injury Produces Long-Lasting Deficits in Synaptic Plasticity in the Female Juvenile Hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						gender; hippocampus; long-term potentiation; mTBI; synaptic plasticity	GABA(A) RECEPTOR ACTIVATION; DENDRITIC SPINE DENSITY; FLUID PERCUSSION INJURY; CLOSED-HEAD INJURY; DENTATE GYRUS; TERM POTENTIATION; ADULT HIPPOCAMPUS; GONADAL-STEROIDS; SEX-DIFFERENCES; COGNITIVE DEFICITS	Mild traumatic brain injury (mTBI) is becoming recognized as a significant concern in modern society. In particular, youth is being increasingly seen as a vulnerable time period for mTBI, as this is the final developmental period for the brain and typically involves robust synaptic reorganization and axonal myelination. Another issue that is being hotly debated is whether mTBI differentially impacts the male and female brain. To examine the impact of mTBI in the juvenile brain, we measured hippocampal synaptic plasticity using a closed-head mTBI model in male and female Long-Evans rats (25-28 days of age) at either 1h, 1 day, 7 days, or 28 days post-injury. In female rats, the dentate gyrus (DG) region ipsilateral to the impact showed a significant reduction in long-term potentiation (LTP) at 1 day, which persisted to 28 days following injury. In male rats, the deficit in LTP was maximal in the CA1 and DG subfields ipsilateral to the impact site 7 days post-injury; however, these deficits did not persist to 28 days post-injury. These data indicate that mTBI can produce more immediate and persistent impairments in synaptic plasticity in the female brain.	[White, Emily R.; Pinar, Cristina; Bostrom, Crystal A.; Meconi, Alicia; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [White, Emily R.; Pinar, Cristina; Bostrom, Crystal A.; Meconi, Alicia; Christie, Brian R.] Univ Victoria, Neurosci Grad Program, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada; [Christie, Brian R.] Univ British Columbia, Program Neurosci, Vancouver, BC, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada		Christie, BR (corresponding author), Univ Victoria, Med Sci Bldg,POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160	Agusti Pedro i Pons Foundation scholarship (Spain); Natural Sciences and Engineering Research Council (NSERC) Discovery grantNatural Sciences and Engineering Research Council of Canada (NSERC) [FRN 103103]; Canadian Institutes of Health Research (CIHR) awardCanadian Institutes of Health Research (CIHR) [FRN 125888]; Canadian Foundation for Innovation (CFI)/British Development Knowledge Development Fund (BCKDF)	The authors acknowledge assistance from Jessica DeVries, Jennifer Graham, and Christine Fontaine in this work. C.P. is a recipient of an Agusti Pedro i Pons Foundation scholarship (Spain). Funding to B.R.C. was provided by a Natural Sciences and Engineering Research Council (NSERC) Discovery grant (FRN 103103); a Canadian Institutes of Health Research (CIHR) award (FRN 125888); and Canadian Foundation for Innovation (CFI)/British Development Knowledge Development Fund (BCKDF).	Adelson PD, 1998, ACT NEUR S, V71, P104; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; ALLEN LS, 1990, J COMP NEUROL, V302, P697, DOI 10.1002/cne.903020402; ALLEN LS, 1989, J NEUROSCI, V9, P497; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; ANDERSEN P, 1969, ACTA PHYSIOL SCAND, V76, pA4; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BAYER SA, 1980, J COMP NEUROL, V190, P115, DOI 10.1002/cne.901900108; Brake WG, 2001, ENDOCRINOLOGY, V142, P1284, DOI 10.1210/en.142.3.1284; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Fester L, 2015, BRAIN RES, V1621, P162, DOI 10.1016/j.brainres.2014.10.033; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gengenbach Marianne S, 2007, CONSERVATIVE MANAGEM; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GOULD E, 1990, J NEUROSCI, V10, P1286; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hilton GD, 2003, NEUROSCIENCE, V116, P383, DOI 10.1016/S0306-4522(02)00716-9; HINE RJ, 1974, Z ANAT ENTWICKLUNGS, V144, P173, DOI 10.1007/BF00519773; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Isgor C, 1998, HORM BEHAV, V34, P183, DOI 10.1006/hbeh.1998.1477; Isgor C, 2003, J NEUROBIOL, V55, P179, DOI 10.1002/neu.10200; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kohn D. F., 2002, Laboratory animal medicine, P121; Kramar Eniko A, 2009, Mol Cell Pharmacol, V1, P258; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Long JA, 1920, ANA REC, V18, P244; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MADEIRA MD, 1995, PROG NEUROBIOL, V45, P275, DOI 10.1016/0301-0082(94)00052-J; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Nunez JL, 2003, EXP NEUROL, V181, P258, DOI 10.1016/S0014-4886(03)00053-0; Nunez JL, 2003, EXP NEUROL, V181, P270, DOI 10.1016/S0014-4886(03)00051-7; Ooishi Y, 2012, J STEROID BIOCHEM, V131, P37, DOI 10.1016/j.jsbmb.2011.10.004; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rabinowicz T, 1999, J CHILD NEUROL, V14, P98, DOI 10.1177/088307389901400207; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; ROOF RL, 1992, BRAIN RES, V572, P310, DOI 10.1016/0006-8993(92)90491-Q; ROOF RL, 1993, BRAIN RES, V610, P148, DOI 10.1016/0006-8993(93)91228-K; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Sickmann HM, 2014, HIPPOCAMPUS, V24, P54, DOI 10.1002/hipo.22203; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Spencer JL, 2008, FRONT NEUROENDOCRIN, V29, P219, DOI 10.1016/j.yfrne.2007.08.006; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Team R. C., 2012, R LANG ENV STAT COMP; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Titterness AK, 2012, HIPPOCAMPUS, V22, P69, DOI 10.1002/hipo.20849; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; WINSON J, 1977, SCIENCE, V196, P1223, DOI 10.1126/science.193192; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; WONG M, 1992, J NEUROSCI, V12, P3217, DOI 10.1523/JNEUROSCI.12-08-03217.1992; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Woolley CS, 1999, CURR OPIN NEUROBIOL, V9, P349, DOI 10.1016/S0959-4388(99)80051-8; Yamashita Shin, 2011, Kurume Medical Journal, V58, P47; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 1997, TRAUMATIC BRAIN INJU; Ylvisaker M., 2002, FORGET IT SOURCES TH, P147; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; [No title captured]	108	20	20	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1111	1123		10.1089/neu.2016.4638			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200015	27735217				2022-02-06	
J	Mossberg, KA; Durham, WJ; Zgaljardic, DJ; Gilkison, CR; Danesi, CP; Sheffield-Moore, M; Masel, BE; Urban, RJ				Mossberg, Kurt A.; Durham, William J.; Zgaljardic, Dennis J.; Gilkison, Charles R.; Danesi, Christopher P.; Sheffield-Moore, Melinda; Masel, Brent E.; Urban, Randall J.			Functional Changes after Recombinant Human Growth Hormone Replacement in Patients with Chronic Traumatic Brain Injury and Abnormal Growth Hormone Secretion	JOURNAL OF NEUROTRAUMA			English	Article						cognitive; growth hormone; physical; TBI	GH-DEFICIENT ADULTS; QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; AEROBIC CAPACITY; MUSCLE STRENGTH; FATIGUE; EXERCISE; THERAPY; HYPOPITUITARISM; PERFORMANCE	We explored the effects of recombinant human growth hormone (rhGH) replacement on physical and cognitive functioning in subjects with a moderate-to-severe traumatic brain injury (TBI) with abnormal growth hormone (GH) secretion. Fifteen individuals who sustained a TBI at least 12 months prior to study enrollment were identified as having abnormal GH secretion by glucagon stimulation testing (maximum GH response less than 8 ng/mL). Peak cardiorespiratory capacity, body composition, and muscle force testing were assessed at baseline and one year after rhGH replacement. Additionally, standardized neuropsychological tests that assess memory, processing speed, and cognitive flexibility, as well as self-report inventories related to depression and fatigue, were administered at baseline and 1 year after rhGH replacement. Comparison tests were performed with proper post hoc analyses. All analyses were carried out at alpha < 0.05. Peak O-2 consumption, peak oxygen pulse (estimate of cardiac stroke volume), and peak ventilation all significantly increased (p < 0.05). Maximal isometric and isokinetic force production were not altered. Skeletal muscle fatigue did not change but the perceptual rating of fatigue was reduced by similar to 25% (p = 0.06). Cognitive performance did not change significantly over time, whereas self-reported symptoms related to depression and fatigue significantly improved. The observed changes suggest that rhGH replacement has a positive impact on cardiorespiratory fitness and a positive impact on perceptual fatigue in survivors of TBI with altered GH secretion.	[Mossberg, Kurt A.; Durham, William J.; Zgaljardic, Dennis J.; Gilkison, Charles R.; Danesi, Christopher P.; Sheffield-Moore, Melinda; Masel, Brent E.; Urban, Randall J.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Zgaljardic, Dennis J.; Masel, Brent E.] Transit Learning Ctr, Galveston, TX USA		Mossberg, KA (corresponding author), Univ Texas Med Branch, Dept Phys Therapy, 301 Univ Blvd, Galveston, TX 77555 USA.	kmossber@utmb.edu	Sheffield-Moore, Melinda/A-9794-2016	Sheffield-Moore, Melinda/0000-0001-6579-4655	Moody Endowment; Pfizer, Inc.Pfizer; Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001439] Funding Source: NIH RePORTER	This work was partially funded by the generous support of the Moody Endowment and Pfizer, Inc. Recombinant growth hormone was supplied by Pfizer, Inc. This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1TR001439) from the National Center for Advancing Translational Sciences, National Institutes of Health.	Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Amann M, 2010, J APPL PHYSIOL, V109, P966, DOI 10.1152/japplphysiol.00462.2010; Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; Astrand PO, 2003, TXB WORK PHYSL PHYSL; BALKE B, 1959, U S Armed Forces Med J, V10, P675; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Benedict RHB, 2001, J NEUROPSYCH CLIN N, V13, P70, DOI 10.1176/appi.neuropsych.13.1.70; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cuocolo A, 1996, EUR J NUCL MED, V23, P390, DOI 10.1007/BF01247366; Delis D.C., 2000, CALIFORNIA VERBAL LE; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Gotherstrom G, 2005, CLIN ENDOCRINOL, V62, P105, DOI 10.1111/j.1365-2265.2004.02181.x; Gullestad L, 1998, GROWTH HORM IGF RES, V8, P377, DOI 10.1016/S1096-6374(98)80307-9; Hampson DB, 2001, SPORTS MED, V31, P935, DOI 10.2165/00007256-200131130-00004; Hartman ML, 2008, J CLIN ENDOCR METAB, V93, P125, DOI 10.1210/jc.2007-1430; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Janssen YJH, 1999, J CLIN ENDOCR METAB, V84, P279, DOI 10.1210/jc.84.1.279; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P2877, DOI 10.1210/jc.82.9.2877; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lafortuna CL, 2014, J CLIN ENDOCR METAB, V99, P1816, DOI 10.1210/jc.2013-3607; Li GL, 2008, J CLIN ENDOCR METAB, V93, P1379, DOI 10.1210/jc.2007-2021; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jcem.77.6.8263155; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2008, J CLIN ENDOCR METAB, V93, P2581, DOI 10.1210/jc.2008-0368; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; NASS R, 1995, J CLIN ENDOCR METAB, V80, P552, DOI 10.1210/jc.80.2.552; Nyberg F, 2013, NAT REV ENDOCRINOL, V9, P357, DOI 10.1038/nrendo.2013.78; Nystrom Henrik C, 2005, BMC Physiol, V5, P17, DOI 10.1186/1472-6793-5-17; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Robergs R. A., 2004, AM J PHYSIOL-REG I, V56, pR502; RUTHERFORD OM, 1995, CLIN SCI, V88, P67, DOI 10.1042/cs0880067; Schnieders J, 2012, J HEAD TRAUMA REHAB, V27, P404, DOI 10.1097/HTR.0b013e3182306341; Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203; Short KR, 2008, J CLIN ENDOCR METAB, V93, P597, DOI 10.1210/jc.2007-1814; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Thompson W R, 2010, ACSMS GUIDELINES EXE; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; WHITEHEAD HM, 1992, CLIN ENDOCRINOL, V36, P45, DOI 10.1111/j.1365-2265.1992.tb02901.x; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; WILSON J T L, 1990, Brain Injury, V4, P349; Woodhouse LJ, 2006, ENDOCR REV, V27, P287, DOI 10.1210/er.2004-0022; Woodhouse LJ, 1999, J CLIN ENDOCR METAB, V84, P4570, DOI 10.1210/jc.84.12.4570; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242	55	20	20	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					845	852		10.1089/neu.2016.4552			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200011	27627580	Green Published			2022-02-06	
J	Urban, KJ; Riggs, L; Wells, GD; Keightley, M; Chen, JK; Ptito, A; Fait, P; Taha, T; Sinopoli, KJ				Urban, Karolina J.; Riggs, Lily; Wells, Greg D.; Keightley, Michelle; Chen, Jen-Kai; Ptito, Alain; Fait, Philippe; Taha, Tim; Sinopoli, Katia J.			Cortical Thickness Changes and Their Relationship to Dual-Task Performance following Mild Traumatic Brain Injury in Youth	JOURNAL OF NEUROTRAUMA			English	Article						concussion; cortical thickness; dual-task paradigm; mTBI; working memory	CHILDREN; CONCUSSION; MODERATE; MEMORY; MRI; REGISTRATION; CORTEX; SPORT; MAP	Mild traumatic brain injury (mTBI) is common in youth, especially in those who participate in sport. Recent investigations from our group have shown that asymptomatic children and adolescents with mTBI continue to exhibit alterations in neural activity and cognitive performance compared with those without a history of mTBI. This is an intriguing finding, given that current return-to-learn and return-to-play protocols rely predominately on subjective symptom reports, which may not be sensitive enough to detect subtle injury-related changes. As a result, youth may be at greater risk for re-injury and long-term consequences if they are cleared for activity while their brains continue to be compromised. It is currently unknown whether mTBI also affects brain microstructure in the developing brain, particularly cortical thickness, and whether such changes are also related to cognitive performance. The present study examined cortical thickness in 13 asymptomatic youth (10-14 years old) who had sustained an mTBI 3-8 months prior to testing compared with 14 age-matched typically developing controls. Cortical thickness was also examined in relation to working memory performance during single and dual task paradigms. The results show that youth who had sustained an mTBI had thinner cortices in the left dorsolateral prefrontal region and right anterior and posterior inferior parietal lobes. Additionally, cortical thinning was associated with slower reaction time during the dual-task condition in the injured youth only. The results also point to a possible relationship between functional and structural alterations as a result of mTBI in youth, and lend evidence for neural changes beyond symptom resolution.	[Urban, Karolina J.; Riggs, Lily; Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Urban, Karolina J.; Keightley, Michelle] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada; [Wells, Greg D.; Taha, Tim] Univ Toronto, Dept Kinesiol & Phys Educ, Toronto, ON, Canada; [Wells, Greg D.] Hosp Sick Children, Dept Physiol & Expt Med, Toronto, ON, Canada; [Sinopoli, Katia J.] Hosp Sick Children, Dept Psychol, Div Neurol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Res Grp Neuromusculoskeletal Dysfunct GRAN, Trois Rivieres, PQ, Canada		Sinopoli, KJ (corresponding author), Hosp Sick Children, Dept Psychol, Div Neurol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	katia.sinopoli@sickkids.ca	Sinopoli, Katia/AAO-7803-2020	Urban, Karolina/0000-0003-1301-7891	Ontario Neurotrauma Foundation [ONF 2009-ABI-IMAGING-750]; Rita G. Rudel Early Career Award	This project was funded by the Ontario Neurotrauma Foundation (ONF 2009-ABI-IMAGING-750) awarded to Drs. Keightley and Wells, and the Rita G. Rudel Early Career Award awarded to Dr. Sinopoli. We thank Dr. Elysa Widjaja (staff neuroradiologist, Hospital for Sick Children) for reviewing the clinical MRI scans, and Nick Reed, Sam Liu, and Sabrina Agnihotri for their assistance in the development of the imaging protocols.	Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Baker S, 2014, BRAIN INJURY, V28, P686; Boucher M, 2009, MED IMAGE ANAL, V13, P203, DOI 10.1016/j.media.2008.09.001; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Cocosco CA, 2003, MED IMAGE ANAL, V7, P513, DOI 10.1016/S1361-8415(03)00037-9; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Croteau-Chonka EC, 2016, NEUROIMAGE, V125, P413, DOI 10.1016/j.neuroimage.2015.10.038; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Einarson D., 2006, HUMAN BRAIN MAPPING; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hartikainen P, 2012, J ALZHEIMERS DIS, V30, P857, DOI 10.3233/JAD-2012-112060; Jaeggi SM, 2007, COGN AFFECT BEHAV NE, V7, P75, DOI 10.3758/CABN.7.2.75; Jonkman LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129380; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Levan A, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000040; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Mutlu AK, 2013, NEUROIMAGE, V82, P200, DOI 10.1016/j.neuroimage.2013.05.076; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; PARENT A, 1995, HUMAN NEUROANATOMY; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Richter J, 2015, PSYCHIAT RES-NEUROIM, V234, P15, DOI 10.1016/j.pscychresns.2015.06.011; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sun D, 2009, SCHIZOPHR RES, V108, P85, DOI 10.1016/j.schres.2008.11.026; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	65	20	20	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					816	823		10.1089/neu.2016.4502			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200008	27629883				2022-02-06	
J	Doherty, C; Zhao, L; Ryan, J; Komaba, Y; Inomata, A; Caulfield, B				Doherty, Cailbhe; Zhao, Liang; Ryan, John; Komaba, Yusuke; Inomata, Akihiro; Caulfield, Brian			Quantification of postural control deficits in patients with recent concussion: An inertial-sensor based approach	CLINICAL BIOMECHANICS			English	Article						Brain concussion [MeSH]; Biomechanics [MeSH]; Kinetics [MeSH]; Postural balance [MeSH]	ERROR SCORING SYSTEM; GAIT BALANCE CONTROL; MILD HEAD-INJURY; HEALTHY-YOUNG; RECOVERY; ADULTS; ACCELEROMETER; ADOLESCENTS; STATEMENT; SPORT	Background: The aim of this study was to quantify postural control ability in a group with concussion compared with a healthy control group. Method: Fifteen concussion patients (4 females, 11 males) and a group of fifteen age-and sex-matched controls were recruited. Participants were tested during the performance of the three stance variants (bilateral, tandem and unilateral) of the balance error scoring system standing on a force place, while wearing an inertial measurement unit placed at the posterior aspect of the sacrum. Findings: The area of postural sway was computed using the force-plate and the '95% ellipsoid volume of sway' was computed from the accelerometer data. Concussed patients exhibited increased sway area (1513 mm(2) [95% CI: 935 to 2091 mm(2)] vs 646 mm(2) [95% CI: 519 to 772 mm(2)]; p = 0.02) and sway volume (9.46 m(3) S-6 [95% CI: 8.02 to 19.94 m3 s(-6)] vs 2.68 m(3) s(-6) [95% CI: 1.81 to 3.55 m(3) s(-6)]; p = 0.01) in the bilateral stance position of the balance error scoring system. The sway volume metric also had excellent accuracy in identifying task 'errors' (tandem stance: 91% accuracy [95% CI: 85-96%], p < 0.001; unilateral stance: 91% accuracy [95% CI: 86-96%], p < 0.001). Interpretation: Individuals with concussion display increased postural sway during bilateral stance. The sway volume that was calculated from the accelerometer data not only differentiated a group with concussion from a healthy control group, but successfully identified when task errors had occurred. This may be of value in the development of a pitch-side assessment system for concussion. (C) 2017 Elsevier Ltd. All rights reserved.	[Doherty, Cailbhe; Zhao, Liang; Caulfield, Brian] Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland; [Ryan, John] St Vincents Univ Hosp, Dublin, Ireland; [Komaba, Yusuke; Inomata, Akihiro] Fujitsu Labs Ltd, Tokyo, Japan		Doherty, C; Zhao, L (corresponding author), Univ Coll Dublin, Insight Ctr Data Analyt, Dublin, Ireland.	Cailbhe.doherty@insight-centre.org; liang.zhao@insight-centre.org		Doherty, Cailbhe/0000-0002-5284-856X; Caulfield, Brian/0000-0003-0290-9587	Fujitsu Laboratories Ltd., Japan, KIDUKU project	This study was supported by Fujitsu Laboratories Ltd., Japan as part of the KIDUKU project. We have no conflicts of interest to declare.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Doherty C, 2016, AM J SPORT MED, V44, P995, DOI 10.1177/0363546516628870; Downey Daniel J, 2007, Curr Sports Med Rep, V6, P328; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Johnston W., 2017, CONCUSSION IN PRESS; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mayagoitia RE, 2002, GAIT POSTURE, V16, P55, DOI 10.1016/S0966-6362(01)00199-0; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI 10.1002/9780470549148; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	32	20	20	1	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	FEB	2017	42						79	84		10.1016/j.clinbiomech.2017.01.007			6	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	EM9AP	WOS:000395603500012	28110244	Green Submitted			2022-02-06	
J	Hearps, SJC; Takagi, M; Babl, FE; Bressan, S; Truss, K; Davis, GA; Godfrey, C; Clarke, C; Doyle, M; Rausa, V; Dunne, K; Anderson, V				Hearps, Stephen J. C.; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Truss, Katherine; Davis, Gavin A.; Godfrey, Celia; Clarke, Cathriona; Doyle, Melissa; Rausa, Vanessa; Dunne, Kevin; Anderson, Vicki			Validation of a Score to Determine Time to Postconcussive Recovery	PEDIATRICS			English	Article							POST-CONCUSSIVE SYMPTOMS; TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; HIGH-SCHOOL; CHILDREN; PREDICTORS; EPIDEMIOLOGY; DURATION; SPORT	BACKGROUND: A reliable, developmentally appropriate and standardized method for assessing postconcussive symptoms (PCS) is essential to accurately determine recovery postconcussion and to effectively manage return to normal activities. The aim of this study was to develop an evidence-based, psychometrically validated approach to determining clinically useful cutoff scores by using a commonly administered PCS measure. METHODS: The current study was a prospective, longitudinal observational study conducted between July 2013 and November of 2015 at a statewide tertiary pediatric hospital. Participants were 120 children (5-18 years of age) presenting to the emergency department with a concussion within 48 hours of injury. PCS were assessed by using the Postconcussion Symptom Inventory (PCSI), acutely, 1 to 4 days postinjury and 2 weeks postinjury. Using comprehensive clinical assessment as gold standard, we assessed the clinical cutoff discrimination ability of PCSI at 2 weeks postinjury by using published approaches, and then varying each approach to optimize their discrimination ability. RESULTS: Existing and potential clinical cutoff scores were explored in predicting delayed recovery. Receiver operating characteristic curve results returned acceptable discrimination and sensitivity when PCSI items increased in severity from preinjury by 1 or more. Compared with a published cutoff score being 3+ items with increased severity, the current study suggests a more stringent cutoff requirement of 2+ is better able to accurately classify symptomatic children. CONCLUSIONS: This study provides the first validated index (2+ items, 1+ severity) of concussion recovery for children and youth. Further studies in more varied samples are needed to establish the effectiveness of this method.	[Hearps, Stephen J. C.; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Truss, Katherine; Davis, Gavin A.; Godfrey, Celia; Clarke, Cathriona; Doyle, Melissa; Rausa, Vanessa; Dunne, Kevin; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Takagi, Michael; Truss, Katherine; Doyle, Melissa; Rausa, Vanessa; Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Dunne, Kevin; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy		Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Med Res, Level 4 West,50 Flemington Rd, Parkville, Vic 3012, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Takagi, Michael/0000-0003-2903-7598; Hearps, Stephen/0000-0003-2984-1172; Visser, Melissa/0000-0002-5313-3347	Royal Children's Hospital Research Foundation; Victorian Government Operational Infrastructure Scheme; Australian National Health and Medical Research Council (NHMRC) Development grantNational Health and Medical Research Council of Australia; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	This study was funded by the Royal Children's Hospital Research Foundation and the Victorian Government Operational Infrastructure Scheme. Mr Hearps was funded by an Australian National Health and Medical Research Council (NHMRC) Development grant, Dr Babl was funded by the Royal Children's Hospital Research Foundation, and Dr Anderson by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	26	20	20	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	FEB	2017	139	2							e20162003	10.1542/peds.2016-2003			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	EJ2JC	WOS:000393035100024	28138006	Bronze, Green Published			2022-02-06	
J	Pruitt, P; Penn, J; Peak, D; Borczuk, P				Pruitt, Peter; Penn, Joshua; Peak, David; Borczuk, Pierre			Identifying patients with mild traumatic intracranial hemorrhage at low risk of decompensation who are safe for ED observation	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	National Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 12-15, 2015	San Diego, CA	Soc Acad Emergency Med		Traumatic intracranial hemorrhage; Subarachnoid hemorrhage; Subdural hematoma; Intraparenchymal hemorrhage; Observation medicine	DEPARTMENT OBSERVATION UNIT; MINOR HEAD-INJURY; BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; ADULT PATIENTS; MANAGEMENT; ADMISSION; PROTOCOL; CARE	Background: Patients with traumatic intracranial hemorrhage and mild traumatic brain injury (mTIH) receive broadly variable care which often includes transfer to a trauma center, neurosurgery consultation and ICU admission. However, there may be a low risk cohort of patients who can be managed without utilizing such significant resources. Objective: Describe mTIH patients who are at low risk of clinical or radiographic decompensation and can be safely managed in an ED observation unit (EDOU). Methods: Retrospective evaluation of patients age >= 16, GCS >= 13 with ICH on CT. Primary outcomes included clinical/neurologic deterioration, CT worsening or need for neurosurgery. Results: 1185 consecutive patients were studied. 814 were admitted and 371 observed patients (OP) were monitored in the EDOU or discharged from the ED after a period of observation. None of the OP deteriorated clinically. 299 OP (81%) had a single lesion on CT; 72 had mixed lesions. 120 patients had isolated subarachnoid hemorrhage (iSAH) and they did uniformly well. Of the 119 OP who had subdural hematoma (SDH), 6 had worsening CT scans and 3 underwent burr hole drainage procedures as inpatients due to persistent SDH without new deficit. Of the 39 OP who had cerebral contusions, 3 had worsening CT scans and one required NSG admission. No patient returned to the ED with a complication. Follow-up was obtained on 81% of OP. 2 patients with SDH required burr hole procedure >2 weeks after discharge. Conclusions: Patients with mTIH, particularly those with iSAH, have very low rates of clinical or radiographic deterioration and may be safe for monitoring in an emergency department observation unit. (C) 2016 Elsevier Inc. All rights reserved.	[Pruitt, Peter] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL USA; [Penn, Joshua] Winchester Hosp, Dept Emergency Med, Winchester, MA USA; [Peak, David; Borczuk, Pierre] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA; [Peak, David; Borczuk, Pierre] Harvard Med Sch, Boston, MA USA		Pruitt, P (corresponding author), 211 East Ontario St,Suite 200, Chicago, IL 60611 USA.	peter.pruitt@northwestern.edu			Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [(AHRQ)T[HYPHEN]32 HS 000078]	Dr Pruitt is a National Research Service Award postdoctoral fellow supported by Agency for Healthcare Research and Quality (AHRQ)T[HYPHEN]32 HS 000078 (PI: Jane L. Holl, MD, MPH). AHRQ was not involved in the design or execution of this research.	Baugh CW, 2011, HEALTH CARE MANAGE R, V36, P28, DOI 10.1097/HMR.0b013e3181f3c035; CONRAD L, 1985, Journal of Emergency Medicine, V2, P325, DOI 10.1016/0736-4679(85)90285-9; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holly J, 2012, AM J EMERG MED, V30, P1402, DOI 10.1016/j.ajem.2011.10.012; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Ross Michael A, 2012, Crit Pathw Cardiol, V11, P128; Rydman RJ, 1998, MED CARE, V36, P599, DOI 10.1097/00005650-199804000-00015; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Welch RD, 2001, EMERG MED CLIN N AM, V19, P137, DOI 10.1016/S0733-8627(05)70172-3; Wu C, 2015, WEST J EMERG MED, V16, P707, DOI 10.5811/westjem.2015.7.27458	18	20	20	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2017	35	2					255	259		10.1016/j.ajem.2016.10.064			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	EL9FE	WOS:000394924600011	27838043				2022-02-06	
J	Surguchov, A; Surgucheva, I; Sharma, M; Sharma, R; Singh, V				Surguchov, Andrei; Surgucheva, Irina; Sharma, Mukut; Sharma, Ram; Singh, Vikas			Pore-Forming Proteins as Mediators of Novel Epigenetic Mechanism of Epilepsy	FRONTIERS IN NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; ALPHA-SYNUCLEIN EXPRESSION; PARKINSONS-DISEASE; DNA METHYLATION; ION CHANNELS; ALZHEIMERS-DISEASE; STEFIN-B; EPILEPTOGENESIS; GENETICS	Epilepsy is a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures. In the last two decades, numerous gene defects underlying different forms of epilepsy have been identified with most of these genes encoding ion channel proteins. Despite these developments, the etiology of majority of non-familial epilepsies has no known associated genetic mutations and cannot be explained by defects in identified ion channels alone. We hypothesize that de novo formation of ion channels by naturally unfolded proteins (NUPs) increases neuronal excitability. Altered ionic homeostasis may initiate/contribute to cellular cascades related to epileptogenesis in susceptible individuals. Here, we consider two small proteins, namely, alpha-synuclein and stefin B, as prototypical candidates to illustrate the underlying mechanism(s). Previous work points to an association between epilepsy and a-synuclein or stefin B, but the mechanism(s) underlying such association remains elusive. We review the evidence to link the structure-function of these proteins with disease processes. Epigenetic mechanisms unrelated to altered DNA sequence(s) that may affect epileptogenesis include transcriptional or posttranscriptional regulation. Such epigenetic mechanisms or their combination(s) enhance the levels of these proteins and as a result the ability to form annular structures, which upon incorporation into membrane form novel ion channels and disturb intracellular ion homeostasis. Alternative epigenetic mechanisms may change amyloidogenic proteins by posttranslational modifications, thereby increasing their propensity to form channels. Further research elucidating the details about the formation of ion channels through these mechanisms and their role in epileptogenesis may define new molecular targets and guide the development of new drug targets.	[Surguchov, Andrei; Surgucheva, Irina; Singh, Vikas] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Sharma, Mukut; Sharma, Ram; Singh, Vikas] Kansas City Vet Adm, Med Ctr, Kansas City, KS USA; [Sharma, Mukut] Midwest Biomed Res Fdn, Kansas City, MO USA		Surguchov, A (corresponding author), Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA.	asurguchov@kumc.edu			VA Merit ReviewUS Department of Veterans Affairs [1I01BX000361]; Glaucoma Foundation [QB42308]; Midwest Biomedical Research Foundation (MBRF); KC VA Medical Research Center, Kansas City, MO, USA	Some of the work by AS and IS cited in this manuscript was conducted at the Kansas City VA Medical Center, Kansas City, MO, USA, with support from VA Merit Review grants 1I01BX000361 and the Glaucoma Foundation grant QB42308. MS is supported, in part, by the Midwest Biomedical Research Foundation (MBRF), KC VA Medical Research Center, Kansas City, MO, USA, and as co-investigator for NIDDK 1RO1 DK107490.	Anderluh G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00085; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Aranda S, 2016, MOL CELL BIOL, V36, P2432, DOI 10.1128/MCB.00328-16; Boison D, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00026; Born HA, 2015, NEUROSCIENCE, V286, P251, DOI 10.1016/j.neuroscience.2014.11.051; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Costa C, 2016, NEUROBIOL AGING, V48, P161, DOI 10.1016/j.neurobiolaging.2016.08.025; Cunliffe VT, 2015, SEIZURE-EUR J EPILEP, V24, P44, DOI 10.1016/j.seizure.2014.09.018; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; England MJ, 2012, EPILEPSY SPECTRUM PR, P19; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Ghanizadeh A, 2015, IRAN J CHILD NEUROL, V9, P99; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Graves TD, 2006, QJM-INT J MED, V99, P201, DOI 10.1093/qjmed/hcl021; Henshall DC, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022731; Hildebrand MS, 2013, J MED GENET, V50, P271, DOI 10.1136/jmedgenet-2012-101448; Hirose S, 2002, BRAIN DEV-JPN, V24, P211, DOI 10.1016/S0387-7604(02)00056-6; Hoffman-Zacharska D, 2013, PARKINSONISM RELAT D, V19, P1057, DOI 10.1016/j.parkreldis.2013.07.011; Horiuchi H, 2005, GENET TEST, V9, P328, DOI 10.1089/gte.2005.9.328; Hu R, 2015, SEIZURE-EUR J EPILEP, V27, P6, DOI 10.1016/j.seizure.2015.02.007; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Kagan BL, 2010, ADV EXP MED BIOL, V677, P150; Kobow K, 2013, ACTA NEUROPATHOL, V126, P741, DOI 10.1007/s00401-013-1168-8; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Kobow K, 2009, J NEUROPATH EXP NEUR, V68, P356, DOI 10.1097/NEN.0b013e31819ba737; Kos J, 2009, ATLAS GENET CYTOGENE, V13, P155, DOI [10.4267/2042/44486, DOI 10.4267/2042/44486]; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li AQ, 2010, BRAIN PATHOL, V20, P1077, DOI 10.1111/j.1750-3639.2010.00414.x; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loscher W, 2010, EPILEPSIA, V51, P89, DOI 10.1111/j.1528-1167.2009.02183.x; Lubin FD, 2012, EPILEPSY CURR, V12, P105, DOI 10.5698/1535-7511-12.3.105; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; McCormack AL, 2009, CURR PROTEIN PEPT SC, V10, P476, DOI 10.2174/138920309789351912; Meldrum B, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01343.x; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Miller-Delaney SFC, 2015, BRAIN, V138, P616, DOI 10.1093/brain/awu373; Mulley JC, 2003, CURR OPIN NEUROL, V16, P171, DOI 10.1097/00019052-200304000-00009; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Myers CT, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0214-7; Nicita F, 2012, SEIZURE-EUR J EPILEP, V21, P3, DOI 10.1016/j.seizure.2011.08.007; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Pandolfo M, 2011, SEMIN NEUROL, V31, P506, DOI 10.1055/s-0031-1299789; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Polajnar M, 2014, BBA-MOL CELL RES, V1843, P2089, DOI 10.1016/j.bbamcr.2014.05.018; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Puschmann A, 2009, PARKINSONISM RELAT D, V15, P390, DOI 10.1016/j.parkreldis.2008.08.002; Qureshi IA, 2010, NEUROBIOL DIS, V39, P53, DOI 10.1016/j.nbd.2010.02.005; Rabzelj S, 2008, FEBS J, V275, P2455, DOI 10.1111/j.1742-4658.2008.06390.x; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rostovtseva TK, 2015, J BIOL CHEM, V290, P18467, DOI 10.1074/jbc.M115.641746; Ruzza P, 2014, ACS CHEM NEUROSCI, V5, P30, DOI 10.1021/cn400149k; Salahuddin P, 2016, EUR J MED CHEM, V114, P41, DOI 10.1016/j.ejmech.2016.02.065; Sima XT, 2014, MOL MED REP, V9, P1242, DOI 10.3892/mmr.2014.1977; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C., 2013, J NEUROL TRANSL NEUR, V1, P1010; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Striano P, 2016, PHARMACOL RES, V107, P426, DOI 10.1016/j.phrs.2016.04.006; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Surguchov A, 2015, INT REV CEL MOL BIO, V320, P103, DOI 10.1016/bs.ircmb.2015.07.007; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Waszkielewicz AM, 2013, CURR MED CHEM, V20, P1241; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Williams-Karnesky RL, 2013, J CLIN INVEST, V123, P3552, DOI 10.1172/JCI65636; Yang JW, 2006, AMINO ACIDS, V30, P477, DOI 10.1007/s00726-005-0281-y; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061; Zhu Q, 2012, J MOL NEUROSCI, V46, P420, DOI 10.1007/s12031-011-9602-7	82	20	20	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 18	2017	8								3	10.3389/fneur.2017.00003			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EH9HE	WOS:000392081600001	28149289	Green Published, gold			2022-02-06	
J	Kucera, KL; Yau, RK; Register-Mihalik, J; Marshall, SW; Thomas, LC; Wolf, S; Cantu, RC; Mueller, FO; Guskiewicz, KM				Kucera, Kristen L.; Yau, Rebecca K.; Register-Mihalik, Johna; Marshall, Stephen W.; Thomas, Leah C.; Wolf, Susanne; Cantu, Robert C.; Mueller, Frederick O.; Guskiewicz, Kevin M.			Traumatic Brain and Spinal Cord Fatalities Among High School and College Football Players - United States, 2005-2014	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article							AMERICAN FOOTBALL; INJURIES; SPORTS; HEAD		[Kucera, Kristen L.; Yau, Rebecca K.; Thomas, Leah C.; Wolf, Susanne; Mueller, Frederick O.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Natl Ctr Catastroph Sport Injury Res, Chapel Hill, NC 27514 USA; [Yau, Rebecca K.; Marshall, Stephen W.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Register-Mihalik, Johna; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Cantu, Robert C.] Emerson Hosp, Concord, MA USA; [Cantu, Robert C.] Boston Univ, Boston, MA 02215 USA		Kucera, KL (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Natl Ctr Catastroph Sport Injury Res, Chapel Hill, NC 27514 USA.	kkucera@email.unc.edu			American Football Coaches Association; National Athletic Trainers' Association; National Collegiate Athletic Association; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; American Medical Society for Sports Medicine	Julie Gilchrist, MD, National Center for Injury Prevention and Control, CDC; R. Dawn Comstock, PhD, Douglas J. Casa, PhD, Tom P. Dompier, PhD, Jonathan A. Drezner, MD, Zackary Y. Kerr, PhD, David Klossner, PhD, Rebecca L. Stearns, PhD, Consortium for Catastrophic Injury Monitoring in Sport. The National Center for Catastrophic Sport Injury Research is funded by the following organizations: the American Football Coaches Association, the National Athletic Trainers' Association, the National Collegiate Athletic Association, the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, and the American Medical Society for Sports Medicine.	Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Cantu RC, 2009, BRIT J SPORT MED, V43, P981, DOI 10.1136/bjsm.2009.067728; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; HADDON W, 1973, J TRAUMA, V13, P321, DOI 10.1097/00005373-197304000-00011; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; MUELLER FO, 1987, CLIN SPORT MED, V6, P185; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03	10	20	20	2	11	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	JAN 6	2017	65	52					1465	1469					5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	EH6UF	WOS:000391908700002	28056008	Bronze			2022-02-06	
J	Chien, DK; Hwang, HF; Lin, MR				Chien, Ding-Kuo; Hwang, Hei-Fen; Lin, Mau-Roung			Injury severity measures for predicting return-to-work after a traumatic brain injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Traumatic brain injury; Employment; Return-to-work; Injury severity; AIS; ISS	GLASGOW-OUTCOME-SCALE; COMA SCALE; COMMUNITY INTEGRATION; COGNITIVE STATUS; EMPLOYMENT; IMPACT; SCORE; REHABILITATION; INDIVIDUALS; MORTALITY	This study compared the ability of five injury severity measures, namely the Abbreviated Injury Scale to the Head (AIS-H), Glasgow Coma Scale (GCS), Glasgow Outcome Scale (GOS), Extended Glasgow Outcome Scale (GOSE), and Injury Severity Score (ISS), to predict return-to-work after a traumatic brain injury (TBI). Furthermore, factors potentially associated with return-to-work were investigated. In total, 207 individuals aged <= 65 years newly diagnosed with a TBI and employed at the time of injury were recruited and followed-up for 1 year by telephone every 3 months. A bivariate proportional hazards model analysis revealed that all five injury severity measures were significantly associated with return-to-work after a TBI. The AIS-H and non-head ISS explained 23.8% of the variation in the duration of returning to work from discharge after hospitalization for a TBI; similarly, the GCS, GOS, GOSE, and ISS respectively accounted for 4.7%, 21.4%,12.9%, and 48.4% of the variation. A multivariable analysis revealed that individuals with higher injury severity as measured by the ISS (hazard ratio [HR], 0.94; 95% confidence interval [CI], 0.92-0.97), a lack of autonomy in transportation (HR, 2.55; 95% CI, 1.23-5.32), cognitive impairment (HR, 0.47; 95% CI, 0.28-0.79), and depression (HR, 0.97; 95% CI, 0.95-0.99) were significantly less likely to be employed after a TBI. In conclusion, of the five injury severity measures, the ISS may be the most capable measure of predicting return-to-work after a TBI. In addition to injury severity, autonomy in transportation, cognitive function, and the depressive status may also influence the employment status during the first year after a TBI. (C) 2016 Elsevier Ltd. All rights reserved.	[Chien, Ding-Kuo; Lin, Mau-Roung] Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan; [Chien, Ding-Kuo] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chien, Ding-Kuo] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Hwang, Hei-Fen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Lin, Mau-Roung] Taipei Med Univ, Coll Nursing, Masters Program Long Term Care, Taipei, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	mrlin@tmu.edu.tw			Ministry of Technology and Science, Taiwan [MOST103-2314-B-038-012, MOST104-2627-M-038-001]; National Health Research Institutes, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX104-10317PI]	This work was funded by the Ministry of Technology and Science (MOST103-2314-B-038-012 and MOST104-2627-M-038-001) and the National Health Research Institutes (NHRI-EX104-10317PI), Taiwan.	[Anonymous], 2000, J Neurotrauma, V17, P563; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Chen Y.C., 1997, CHIN J PUBLIC HLTH, V16, P119; Chien C P, 1985, Seishin Shinkeigaku Zasshi, V87, P335; Chiu W. T., 1996, NEUROTRAUMA, P905; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; COX DR, 1972, J R STAT SOC B, V34, P187; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Des Plain I. L., 1990, ABBREVIATED INJURY S; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fleming J, 1999, BRAIN INJURY, V13, P417; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; KENT JT, 1988, BIOMETRIKA, V75, P525, DOI 10.2307/2336603; Knopman DS, 2010, NEUROEPIDEMIOLOGY, V34, P34, DOI 10.1159/000255464; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Yu DSF, 2004, RES NURS HEALTH, V27, P135, DOI 10.1002/nur.20008	47	20	21	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2017	98						101	107		10.1016/j.aap.2016.09.025			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	EG3SR	WOS:000390965500011	27716491				2022-02-06	
J	Johansson, B; Wentzel, AP; Andrell, P; Ronnback, L; Mannheimer, C				Johansson, B.; Wentzel, A. -P.; Andrell, P.; Ronnback, L.; Mannheimer, C.			Long-term treatment with methylphenidate for fatigue after traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cognition; mental fatigue; methylphenidate; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; MENTAL FATIGUE; DOUBLE-BLIND; ATTENTION DEFICITS; HEAD-INJURY; VITAL SIGNS; SAFETY; ADULTS; MILD; REHABILITATION	Objectives - Traumatic brain injury (TBI) may cause long-lasting post-concussive symptoms, such as mental fatigue and concentration difficulties, and this may become the main hindrance for returning to work and studies. There is currently no effective treatment for longlasting mental fatigue. In this hypothesis generating study, the long-term effects of methylphenidate on mental fatigue, cognitive function, and safety were assessed. Materials & methods - Thirty participants who suffered from long-term post-concussion symptoms after a mild TBI or moderate TBI and who had reported positive effects with methylphenidate during an initial phase of this follow-up study were treated with methylphenidate for a further six months. Results - After six-month follow-up, effects on Mental Fatigue Scale (MFS), depression, anxiety, and cognitive function (processing speed, attention, working memory) were significantly improved compared to baseline data (P < 0.001, respectively). Heart rate was significantly increased (P = 0.01), while blood pressure was not changed. Conclusions - Individuals suffering from prolonged symptoms after TBI reported reduced mental fatigue and improved cognitive functions with long-term methylphenidate treatment. It is suggested that methylphenidate can be a treatment option for long-term mental fatigue and cognitive impairment after a TBI, but further randomized control research is warranted.	[Johansson, B.; Ronnback, L.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden; [Wentzel, A. -P.; Andrell, P.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Multidisciplinary Pain Ctr, Gothenburg, Sweden; [Wentzel, A. -P.; Mannheimer, C.] Kungalv Hosp, Multidisciplinary Pain Ctr, Gothenburg, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Dubbsgatan 14,1tr, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142; Johansson, Birgitta/0000-0002-8942-5771	Health & Medical Care Committee of the Region, Vastra Gotaland	The study was funded by grants from The Health & Medical Care Committee of the Region, Vastra Gotaland. Silva Litrop, Mona Roos, Lena Stiller, and Christina Wikman-Lundbom (Head of Department) are acknowledged for clinical support at the Kungalv Hospital.	Adler LA, 2009, J CLIN PSYCHOPHARM, V29, P239, DOI 10.1097/JCP.0b013e3181a390ce; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; ASBERG M, 1978, ACTA PSYCHIAT SCAND, V271, P527; Godfrey J, 2009, J PSYCHOPHARMACOL, V23, P194, DOI 10.1177/0269881108089809; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Johansson B., 2012, BRAIN INJURY FUNCTIO, V1, P3, DOI [10.5772/27042, DOI 10.5772/27042]; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Ripley DL, 2014, BRAIN INJURY, V28, P1514, DOI 10.3109/02699052.2014.919530; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Ronnback L, 2012, LONG LASTING MENTAL; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 2003, WECHSLER ADULT INTEL; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369	32	20	20	0	24	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JAN	2017	135	1					100	107		10.1111/ane.12587			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE2NM	WOS:000389421400010	26991608				2022-02-06	
J	King, D; Hume, P; Gissane, C; Clark, T				King, Doug; Hume, Patria; Gissane, Conor; Clark, Trevor			Head impacts in a junior rugby league team measured with a wireless head impact sensor: an exploratory analysis	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						injury; linear; rotational; impact; rugby union; wireless head impact sensor; trauma	KING-DEVICK TEST; COLLEGIATE FOOTBALL PLAYERS; SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; VISUAL SCREENING TOOL; HIGH-SCHOOL FOOTBALL; EXPOSURE; BIOMECHANICS; STATISTICS; MAGNITUDE	OBJECTIVE The aim of this study was to investigate the frequency, magnitude, and distribution of head impacts sustained by players in a junior rugby league over a season of matches. METHODS The authors performed a prospective cohort analysis of impact magnitude, frequency, and distribution on data collected with instrumented XPatches worn behind the ear of players in an "under-11" junior rugby league team (players under 11 years old). RESULTS A total of 1977 impacts were recorded. Over the course of the study, players sustained an average of 116 impacts (average of 13 impacts per player per match). The measured linear acceleration ranged from 10g to 123g (mean 22g, median 16g, and 95th percentile 57g). The rotational acceleration ranged from 89 rad/sec(2) to 22,928 rad/sec(2) (mean 4041 rad/sec(2), median 2773 rad/sec(2), and 95th percentile 11,384 rad/sec(2)). CONCLUSIONS The level of impact severity based on the magnitude of impacts for linear and rotational accelerations recorded was similar to the impacts reported in studies of American junior and high school football, collegiate football, and youth ice hockey players, but the players in the rugby league cohort were younger, had less body mass, and played at a slower speed than the American players. Junior rugby league players are required to tackle the player to the ground and use a different tackle technique than that used in American football, likely increasing the rotational accelerations recorded at the head.	[King, Doug; Hume, Patria] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Fac Hlth & Environm Sci, Auckland, New Zealand; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, Middx, England; [Clark, Trevor] Australian Coll Phys Educ, Fac Sport Performance, Sydney Olympic Pk, NSW, Australia		King, D (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt 5040, New Zealand.	doug.king@clear.net.nz	Hume, Patria Anne/P-1084-2017; Gissane, Conor/I-3661-2019; Hume, Patria/AAN-5514-2021	Hume, Patria Anne/0000-0003-1847-8128; Gissane, Conor/0000-0003-4677-3853; Hume, Patria/0000-0003-1847-8128; Clark, Dr Trevor/0000-0002-2853-0068			ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gabbett T, 2008, J SCI MED SPORT, V11, P585, DOI 10.1016/j.jsams.2007.07.004; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, THESIS, P341; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Krause LM, 2015, J SCI MED SPORT, V18, P358, DOI 10.1016/j.jsams.2014.05.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lennon A, 2015, THESIS, P44; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Vopat LM, 2015, IOC MANUAL OF EMERGENCY SPORTS MEDICINE, P205; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	51	20	20	1	16	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2017	19	1					13	23		10.3171/2016.7.PEDS1684			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EG0LS	WOS:000390724900003	27791705	Bronze			2022-02-06	
J	Marin, JR; Weaver, MD; Mannix, RC				Marin, Jennifer R.; Weaver, Matthew D.; Mannix, Rebekah C.			Burden of USA hospital charges for traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; charges; nationwide emergency department sample	EMERGENCY-DEPARTMENT VISITS; HEALTH-CARE; ECONOMIC BURDEN; UNITED-STATES; HEAD-INJURY; OUTCOMES; COST; MANAGEMENT; BLUNT	Objectives: This study sought to estimate charges associated with USA hospital visits for traumatic brain injury (TBI), compare charges from 2006-2010 and evaluate factors associated with higher charges. Methods: The Nationwide Emergency Department Sample database, 2006-2010, was used to estimate charges for emergency department visits and inpatient hospital stays associated with TBI and trends in charges over time were compared. Multivariable linear regression was used to evaluate factors associated with visit charges. Results: In 2010, there were $21.4 billion (95% confidence interval (CI) = $17.7-$25.2 billion) in charges for TBI-related admissions, an increase of 22% from 2006. Charges for ED visits resulting in discharge or transfer were $8.2 billion (95% CI = $7.4-$8.9 billion), an increase of 94% from 2006. The proportion of charges for TBI-related visits was disproportionately higher than the proportion of visits for TBI across all years of the study (p < 0.001). Patient age and gender, West region, trauma, centre status, non-paediatric hospital designation, metropolitan location and hospital ownership were independently associated with higher charges. Conclusions: There was a substantial charge burden from TBI-related hospital visits and charges increased disproportionately to visit volume. There are patient and hospital factors independently associated with higher charges. These findings, as well as methods to, reduce the charge burden and charge disparities, deserve further study.	[Marin, Jennifer R.] Univ Pittsburgh, Sch Med, Dept Pediat, 4401 Penn Ave,AOB Suite 2400, Pittsburgh, PA 15224 USA; [Marin, Jennifer R.] Univ Pittsburgh, Sch Med, Dept Emergency Med, 4401 Penn Ave,AOB Suite 2400, Pittsburgh, PA 15224 USA; [Weaver, Matthew D.] Harvard Med Sch, Dept Med, Div Sleep Med, Boston, MA USA; [Mannix, Rebekah C.] Childrens Hosp Boston, Div Emergency Med, Boston, MA USA		Marin, JR (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, 4401 Penn Ave,AOB Suite 2400, Pittsburgh, PA 15224 USA.; Marin, JR (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, 4401 Penn Ave,AOB Suite 2400, Pittsburgh, PA 15224 USA.	jennifer.marin@chp.edu	Mannix, Rebekah/AAD-8702-2020	Marin, Jennifer/0000-0003-3090-664X	National Institutes of Health, National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL109068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL109068] Funding Source: NIH RePORTER	The first author received grant support from the National Institutes of Health, National Heart Lung and Blood Institute (K12HL109068). The first author has consulted in the last 12 months for SmartAnalyst, Inc, for research relating to traumatic brain injury. The remaining authors report no conflicts of interest.	Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clark DE., ICDPIC STATA MODULE; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Gaynor M, 2003, RAND J ECON, V34, P764, DOI 10.2307/1593787; Hsia RY, 2008, ANN EMERG MED, V51, P265, DOI 10.1016/j.annemergmed.2007.08.009; Hsia RY, 2014, ANN EMERG MED, V64, P120, DOI 10.1016/j.annemergmed.2014.03.006; Hsia RY, 2012, ARCH INTERN MED, V172, P818, DOI 10.1001/archinternmed.2012.1173; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Ingram DD, 2014, VITAL HLTH STAT, V2, P1; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Melnick G, 2007, J HEALTH ECON, V26, P400, DOI 10.1016/j.jhealeco.2006.10.002; Obirieze AC, 2012, J TRAUMA ACUTE CARE, V73, P516, DOI 10.1097/TA.0b013e31825132a0; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Rubin D.B., 1987, MULTIPLE IMPUTATION; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Sears JM, 2014, INJURY, V45, P16, DOI 10.1016/j.injury.2012.12.024; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yong P, 2010, HEALTHCARE IMPERATIV; Zwanziger J, 2006, HEALTH AFFAIR, V25, P197, DOI 10.1377/hlthaff.25.1.197	35	20	20	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					24	31		10.1080/02699052.2016.1217351			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600004	27830939	Green Accepted			2022-02-06	
S	Menon, DK; Ercole, A		Wijdicks, EFM; Kramer, AH		Menon, D. K.; Ercole, A.			Critical care management of traumatic brain injury	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							SEVERE HEAD-INJURY; GLASGOW COMA SCALE; CEREBRAL PERFUSION-PRESSURE; FIBRILLARY ACIDIC PROTEIN; APPARENT DIFFUSION-COEFFICIENT; CORTICAL SPREADING DEPRESSION; MILD THERAPEUTIC HYPOTHERMIA; BLOOD-CELL TRANSFUSION; QUALITY-OF-LIFE; INTRACRANIAL-PRESSURE	Traumatic brain injury (TBI) is a growing global problem, which is responsible for a substantial burden of disability and death, and which generates substantial healthcare costs. High-quality intensive care can save lives and improve the quality of outcome. TBI is extremely heterogeneous in terms of clinical presentation, pathophysiology, and outcome. Current approaches to the critical care management of TBI are not underpinned by high-quality evidence, and many of the current therapies in use have not shown benefit in randomized control trials. However, observational studies have informed the development of authoritative international guidelines, and the use of multimodality monitoring may facilitate rational approaches to optimizing acute physiology, allowing clinicians to optimize the balance between benefit and risk from these interventions in individual patients. Such approaches, along with the emerging impact of advanced neuroimaging, genomics, and protein biomarkers, could lead to the development of precision medicine approaches to the intensive care management of TBI.	[Menon, D. K.; Ercole, A.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Menon, D. K.; Ercole, A.] Addenbrookes Hosp, Neurosci Trauma Crit Care Unit, Cambridge, England		Menon, DK (corresponding author), Addenbrookes Hosp, Box 93, Cambridge CB2 2QQ, England.	dkm13@cam.ac.uk	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093			Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Agrawal D, 2016, NEUROL INDIA, V64, P62, DOI 10.4103/0028-3886.173649; Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Altmeyer W, 2016, MAGN RESON IMAGING C, V24, P305, DOI 10.1016/j.mric.2015.11.011; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Blumbergs PC, 2008, GREENFIELDS NEUROPAT; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brain Trauma Foundation, 2016, C NEUR SURG; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown GC, 2000, ACTA PHYSIOL SCAND, V168, P667, DOI 10.1046/j.1365-201x.2000.00718.x; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carlson AP, 2012, J NEUROIMAGING, V22, P408, DOI 10.1111/j.1552-6569.2011.00621.x; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen S, 2015, EXP NEUROL, V272, P4, DOI 10.1016/j.expneurol.2015.03.007; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dengler B, 2015, J CRIT CARE, V30, P823, DOI 10.1016/j.jcrc.2015.03.027; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Ding K., 2016, TRANSLATIONAL RES TR; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; EuroSafe, 2013, INJ EUR UN REP INJ S; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2010, TRAUMATIC BRAIN INJU; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P624; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Gupta AK, 1997, ANESTH ANALG, V85, P817, DOI 10.1097/00000539-199710000-00018; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Harrison DA, 2015, J NEUROTRAUM, V32, P1522, DOI 10.1089/neu.2014.3628; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; Hinzman JM, 2016, J NEUROTRAUMA; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ICNARC, 2015, ANN QUAL REP 2013 14; Inaba K, 2015, J TRAUMA ACUTE CARE, V78, P1220, DOI 10.1097/TA.0000000000000536; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Karabinis A, 2004, CRIT CARE, V8, pR268, DOI 10.1186/cc2896; Kasprowicz M, 2016, BRIT J NEUROSURG, V30, P211, DOI 10.3109/02688697.2016.1161173; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2013, J CLIN NEUROSCI, V20, P1697, DOI 10.1016/j.jocn.2013.02.021; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Krajcova A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1112-5; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Krishnamurthy K, 2015, CELLULAR MOL MECH SE; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kucinski T, 2002, STROKE, V33, P1786, DOI 10.1161/01.STR.0000019125.80118.99; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Leal-Noval SR, 2016, NEUROCRIT CARE, V24, P371, DOI 10.1007/s12028-015-0220-z; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Levy M, 2005, NEUROREHABILITATION, V20, P279; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Li M, 2015, MEDICINE, V94; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Miller MP, 2014, AM J EMERG MED, V32, P375, DOI 10.1016/j.ajem.2013.11.044; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munoz-Bendix C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1088-1; Mura E, 2014, CURR PHARM DESIGN, V20, P4121; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; National Research Council Committee for the Update of the Guide for the C Use of Laboratory A, 2011, NAT AC COLL REP FUND; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Nyam TTE, 2017, NEUROCRIT C IN PRESS; O'Boynick CP, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1473; O'Leary R, 2016, NEW ENGL J MED, V374, P1383, DOI 10.1056/NEJMc1600339; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Pajoumand M, 2016, J TRAUMA ACUTE CARE, V81, P345, DOI 10.1097/TA.0000000000001069; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pape HC, 2009, J AM ACAD ORTHOP SUR, V17, P541, DOI 10.5435/00124635-200909000-00001; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Price L, 2015, BLOOD BRAIN BARRIER; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Puljula J, 2016, ANN SURG, V263, P1235, DOI 10.1097/SLA.0000000000001392; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; REILLY PL, 1975, LANCET, V2, P375; Riker RR, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-0025-5; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Ryu JH, 2013, NEUROCRIT CARE, V19, P222, DOI 10.1007/s12028-013-9824-3; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sanchez-Izquierdo-Riera JA, 1998, ANESTH ANALG, V86, P1219, DOI 10.1097/00000539-199806000-00016; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Saxena M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub3; Schaible EV, 2013, CURR OPIN ANESTHESIO, V26, P529, DOI 10.1097/01.aco.0000432519.16586.6b; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Shafer A, 1998, CRIT CARE MED, V26, P947, DOI 10.1097/00003246-199805000-00034; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sharshar T, 2014, INTENS CARE MED, V40, P484, DOI 10.1007/s00134-014-3214-y; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Steiner LA, 2005, ACTA NEUROCHIR, V147, P477, DOI 10.1007/s00701-005-0510-x; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stevens RD, 2014, CURR OPIN CRIT CARE, V20, P168, DOI 10.1097/MCC.0000000000000069; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P507; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Vallier HA, 2013, J ORTHOP TRAUMA, V27, P543, DOI 10.1097/BOT.0b013e31829efda1; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2016, JAMA NEUROL, V73, P504, DOI 10.1001/jamaneurol.2016.0251; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wafaisade A, 2010, EMERG MED J, V27, P934, DOI 10.1136/emj.2009.088484; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC; Xu J., 2016, BIOPROCESS PLANT VIT, V1, P1, DOI [10.1007/978-3-319-32004-5_14-1, DOI 10.1007/978-3-319-32004-5_14-1, 10.1007/978-3-319-32004-5.]; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	335	20	20	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						239	274		10.1016/B978-0-444-63600-3.00014-3			36	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500016	28187802	Green Submitted			2022-02-06	
J	Ozay, R; Turkoglu, E; Gurer, B; Dolgun, H; Evirgen, O; Erguder, BI; Hayirli, N; Gurses, L; Sekerci, Z; Yilmaz, ER				Ozay, Rafet; Turkoglu, Erhan; Gurer, Bora; Dolgun, Habibullah; Evirgen, Oya; Erguder, Berrin Imge; Hayirli, Nazli; Gurses, Levent; Sekerci, Zeki; Yilmaz, Erdal Resit			Does Decorin Protect Neuronal Tissue via Its Antioxidant and Antiinflammatory Activity from Traumatic Brain Injury? An Experimental Study	WORLD NEUROSURGERY			English	Article						Antioxidants; Apoptosis; Decorin; Methylprednisolone; Neuroprotection; Traumatic brain injury	GROWTH-FACTOR-BETA; SPINAL-CORD; OXIDATIVE STRESS; LIPID-PEROXIDATION; TGF-BETA; BLOOD; EXPRESSION; SYSTEM; DAMAGE; METHYLPREDNISOLONE	BACKGROUND: The development of secondary brain injury via oxidative stress after traumatic brain injury (TBI) is well known. Decorin (DC) inactivates transforming growth factor beta 1, complement system, and tumor necrosis factor alpha, which are related to oxidative stress and apoptosis. Consequently, the aim of the present study was to evaluate the role of DC on TBI. METHODS: A total of 24 male rats were used and divided into 4 groups as follows; control, trauma, DC, and methylprednisolone (MP). The trauma, DC, and MP groups were subjected to closed-head contusive weight-drop injuries. Rats received treatment with intraperitoneal saline, DC, or MP, respectively. All the animals were killed at the 24th hour after trauma and brain tissues were extracted. The oxidant/antioxidant parameters (malondialdehyde, glutathione peroxidase, superoxide dismutase, and NO) and caspase 3 in the cerebral tissue were analyzed, and histomorphologic evaluation of the cerebral tissue was performed. RESULTS: Levels of malondialdehyde, NO, and activity of caspase 3 were significantly reduced, and in addition glutathione peroxidase and superoxide dismutase levels were increased in the DC and MP groups compared with the trauma group. The pathology scores and the percentage of degenerated neurons were statistically lower in the DC and MP groups than in the trauma group. CONCLUSIONS: The results of the present study showed that DC inactivates transforming growth factor beta 1 and protects the brain tissue and neuronal cells after TBI.	[Ozay, Rafet; Turkoglu, Erhan; Dolgun, Habibullah; Gurses, Levent; Sekerci, Zeki; Yilmaz, Erdal Resit] Minist Hlth Diskapi Yildirim Beyazit Training & R, Neurosurg Clin, Ankara, Turkey; [Gurer, Bora] Minist Hlth Fatih Sultan Mehmet Training & Res Ho, Neurosurg Clin, Istanbul, Turkey; [Evirgen, Oya; Hayirli, Nazli] Ankara Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey; [Erguder, Berrin Imge] Ankara Univ, Fac Med, Dept Biochem, Ankara, Turkey		Ozay, R (corresponding author), Minist Hlth Diskapi Yildirim Beyazit Training & R, Neurosurg Clin, Ankara, Turkey.	rftozay@hotmail.com	Ozyol, Nazli Hayirli/ABG-6396-2021; Erguder, Imge/AAZ-5673-2020; Evirgen, Oya/AAH-7582-2020; Turkoglu, Erhan/AAB-6395-2020; Dolgun, Habibullah/AAL-6610-2021; dolgun, habibullah/AAF-6745-2021; Hayirli Ozyol, Nazli/ABG-6379-2021; Gurer, Bora/K-1177-2012	Evirgen, Oya/0000-0001-6456-1083; Dolgun, Habibullah/0000-0002-1513-2044; Gurer, Bora/0000-0003-1500-6184; /0000-0003-0628-9223			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alan C, 2011, ARCH MED SCI, V7, P211, DOI 10.5114/aoms.2011.22069; Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00269; ANDERSON DK, 1982, J NEUROSURG, V56, P106, DOI 10.3171/jns.1982.56.1.0106; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bae James J, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P9; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Basarslan SK, 2015, ULUS TRAVMA ACIL CER, V21, P235, DOI 10.5505/tjtes.2015.66502; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Durak I, 2001, ACTA ANAESTH SCAND, V45, P119, DOI 10.1034/j.1399-6576.2001.450118.x; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Hall ED, 1997, J NEUROSCI METH, V76, P115, DOI 10.1016/S0165-0270(97)00089-7; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jortner BS, 2006, NEUROTOXICOLOGY, V27, P628, DOI 10.1016/j.neuro.2006.03.002; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kappler J, 1998, BRAIN RES, V793, P328, DOI 10.1016/S0006-8993(98)00260-1; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Liu RM, 2015, REDOX BIOL, V6, P565, DOI 10.1016/j.redox.2015.09.009; Logan A, 1999, EXP NEUROL, V159, P504, DOI 10.1006/exnr.1999.7180; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P381, DOI 10.1007/978-3-211-85578-2_73; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mecollari V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00328; Minor KH, 2011, BRAIN, V134, P1140, DOI 10.1093/brain/awq304; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nichols NR, 2005, BRAIN RES REV, V48, P287, DOI 10.1016/j.brainresrev.2004.12.019; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; SUN Y, 1988, CLIN CHEM, V34, P497; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3	57	20	22	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						407	415		10.1016/j.wneu.2016.09.115			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400055	27744073				2022-02-06	
J	Peeters, W; Majdan, M; Brazinova, A; Nieboer, D; Maas, AIR				Peeters, Wouter; Majdan, Marek; Brazinova, Alexandra; Nieboer, Daan; Maas, Andrew I. R.			Changing Epidemiological Patterns in Traumatic Brain Injury: A Longitudinal Hospital-Based Study in Belgium	NEUROEPIDEMIOLOGY			English	Article						Traumatic brain injury; Head injury; Epidemiology; Incidence; Mortality; Belgium; Longitudinal study	TRENDS; MORTALITY; ADULTS; FALLS	Background: Various reports have suggested that epidemiological patterns of Traumatic Brain Injury (TBI) are changing in high-income countries, but the evidence to support this is often indirect and only a few longitudinal studies exist. We aimed to explore epidemiological patterns of TBI in Belgium over a 10-year period. Methods: A retrospective analysis of Minimum Hospital Data provided by Statistics Belgium was performed for the period 2003-2012. ICD-9 classification was used to identify TBI and to differentiate subtypes. The annual incidence of hospital admissions and in-hospital mortality rates were calculated and further differentiated for age, gender and cause of injury. Results: The age-adjusted incidence of hospital admissions decreased by 3.6% per year. An increase in the number of elderly patients with TBI and a decrease in the younger age groups were found. Falls now represent the main cause of TBI. A mortality rate of 6.5 per 100,000 population per year was found and did not change significantly over time. Conclusions: This longitudinal study confirms that epidemiological patterns in TBI are changing: overall incidence is steadily decreasing, but in el-derly patients, the incidence is increasing. Falls are the leading cause, occurring most frequently in elderly patients. These changes are relevant for prevention. (C) 2017 S. Karger AG, Basel	[Peeters, Wouter; Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Wilrijkstraat 10, BE-2650 Edegem, Belgium; [Majdan, Marek; Brazinova, Alexandra] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava, Slovakia; [Nieboer, Daan] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands		Peeters, W (corresponding author), Antwerp Univ Hosp, Dept Neurosurg, Wilrijkstraat 10, BE-2650 Edegem, Belgium.	dr.peeters.w@gmail.com	Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X; Peeters, Wouter/0000-0001-7783-1425	European Union Seventh Framework Programme (FP7) [602150]	This study was conducted within the project: Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 602150.	Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dias C, 2014, ACTA MEDICA PORT, V27, P349, DOI 10.20344/amp.4892; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Milos V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-40; Nishtala PS, 2014, PHARMACOEPIDEM DR S, V23, P753, DOI 10.1002/pds.3624; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Sung KC, 2015, J NEUROTRAUM, V32, P1078, DOI 10.1089/neu.2014.3509; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1995, GUIDELINES FRO SURVE; U.S. Department of Health and Human Services, 1997, INT CLASS DIS 9 REV	25	20	20	4	10	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2017	48	1-2					63	70		10.1159/000471877			8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	EX6OP	WOS:000403361900009	28448968				2022-02-06	
J	Poff, AM; Kernagis, D; D'Agostino, DP				Poff, Angela M.; Kernagis, Dawn; D'Agostino, Dominic P.			Hyperbaric Environment: Oxygen and Cellular Damage versus Protection	COMPREHENSIVE PHYSIOLOGY			English	Article							GROWTH-FACTOR EXPRESSION; TRAUMATIC BRAIN-INJURY; LOW-CARBOHYDRATE DIET; ACUTE LUNG INJURY; LIPID-PEROXIDATION; OXIDATIVE STRESS; KETOGENIC DIET; NITRIC-OXIDE; DNA-DAMAGE; ISCHEMIC TOLERANCE	The elevation of tissue pO(2) induced by hyperbaric oxygen (HBO) is a physiological stimulus that elicits a variety of cellular responses. These effects are largely mediated by, or in response to, an increase in the production of reactive oxygen and nitrogen species (RONS). The major consequences of elevated RONS include increased oxidative stress and enhanced antioxidant capacity, and modulation of redox-sensitive cell signaling pathways. Interestingly, these phenomena underlie both the therapeutic and potentially toxic effects of HBO. Emerging evidence indicates that supporting mitochondrial health is a potential method of enhancing the therapeutic efficacy of, and preventing oxygen toxicity during, HBO. This review will focus on the cellular consequences of HBO, and explore how these processes mediate a delicate balance of cellular protection versus damage. (C) 2017 American Physiological Society.	[Poff, Angela M.; D'Agostino, Dominic P.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Kernagis, Dawn; D'Agostino, Dominic P.] Inst Human & Machine Cognit, Pensacola, FL 32502 USA		D'Agostino, DP (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.; D'Agostino, DP (corresponding author), Inst Human & Machine Cognit, Pensacola, FL 32502 USA.	ddagosti@health.usf.edu					Abe M, 2012, JPN J RADIOL, V30, P340, DOI 10.1007/s11604-011-0046-3; Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Pereira ALA, 2014, ACTA CIR BRAS, V29, P771, DOI 10.1590/S0102-86502014001900001; Allen BW, 2009, J APPL PHYSIOL, V106, P662, DOI 10.1152/japplphysiol.91109.2008; Alleva R, 2005, BIOCHEM BIOPH RES CO, V333, P404, DOI 10.1016/j.bbrc.2005.05.119; Almzaiel AJ, 2013, LIFE SCI, V93, P125, DOI 10.1016/j.lfs.2013.06.003; Arieli Y, 2014, RESP PHYSIOL NEUROBI, V197, P29, DOI 10.1016/j.resp.2014.03.006; Asano T, 2007, CIRC J, V71, P405, DOI 10.1253/circj.71.405; Baynosa RC, 2013, J SURG RES, V183, P355, DOI 10.1016/j.jss.2013.01.004; Baynosa RC, 2012, UNDERSEA HYPERBAR M, V39, P857; Bellance N, 2009, FRONT BIOSCI-LANDMRK, V14, P4015, DOI 10.2741/3509; Benson RM, 2003, CLIN EXP IMMUNOL, V134, P57, DOI 10.1046/j.1365-2249.2003.02248.x; Bert P., 1943, BAROMETRIC PRESSURE; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bhutani S, 2012, INDIAN J PLAST SURG, V45, P316, DOI 10.4103/0970-0358.101309; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bitterman N, 1997, BRAIN RES, V761, P146, DOI 10.1016/S0006-8993(97)00442-3; BOADI WY, 1991, PHARMACOL TOXICOL, V68, P77, DOI 10.1111/j.1600-0773.1991.tb02039.x; Brady LW., 2008, PRINCIPLES PRACTICE, V5th; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; BUTLER FK, 1986, UNDERSEA BIOMED RES, V13, P91; Butler FK, 2004, UNDERSEA HYPERBAR M, V31, P3; CALDWELL PR, 1966, J APPL PHYSIOL, V21, P1477, DOI 10.1152/jappl.1966.21.5.1477; Cameron L, 2012, POSTGRAD MED J, V88, P684, DOI 10.1136/postgradmedj-2012-130809; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P259; Chavko M, 1996, FREE RADICAL BIO MED, V20, P973, DOI 10.1016/0891-5849(95)02181-7; Chen LF, 2014, J FORMOS MED ASSOC, V113, P620, DOI 10.1016/j.jfma.2014.03.012; Chen SJ, 2007, CLIN BIOCHEM, V40, P30, DOI 10.1016/j.clinbiochem.2006.07.007; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Claireaux A E, 1975, J Clin Pathol Suppl (R Coll Pathol), V9, P75; CLARK JM, 1971, PHARMACOL REV, V23, P37; COMROE JH, 1945, JAMA-J AM MED ASSOC, V128, P710, DOI 10.1001/jama.1945.02860270012004; CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721; CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123; D'agostino DP, 2009, NEUROSCIENCE, V159, P1011, DOI 10.1016/j.neuroscience.2009.01.062; D'Agostino DP, 2013, AM J PHYSIOL-REG I, V304, pR829, DOI 10.1152/ajpregu.00506.2012; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Daruwalla J, 2006, WORLD J SURG, V30, P2112, DOI 10.1007/s00268-006-0190-6; DAVIES KJA, 1987, J BIOL CHEM, V262, P8220; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Dean JB, 2010, J APPL PHYSIOL, V108, P1786, DOI 10.1152/japplphysiol.01337.2009; Dean JB, 2003, J APPL PHYSIOL, V95, P883, DOI 10.1152/japplphysiol.00920.2002; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Demchenko IT, 2005, J CEREBR BLOOD F MET, V25, P1288, DOI 10.1038/sj.jcbfm.9600110; Demchenko IT, 2007, AM J PHYSIOL-LUNG C, V293, pL229, DOI 10.1152/ajplung.00450.2006; Demchenko IT, 2013, J APPL PHYSIOL, V115, P819, DOI 10.1152/japplphysiol.00625.2013; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dennog C, 1999, MUTAT RES-FUND MOL M, V428, P83, DOI 10.1016/S1383-5742(99)00034-4; Dennog C, 1996, MUTAGENESIS, V11, P605, DOI 10.1093/mutage/11.6.605; DIRKS RC, 1982, BRAIN RES, V248, P355, DOI 10.1016/0006-8993(82)90594-7; DONALD K W, 1947, Br Med J, V1, ppassim; Elayan IM, 2000, J NEUROPHYSIOL, V83, P2022, DOI 10.1152/jn.2000.83.4.2022; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Feldmeier J, 2003, UNDERSEA HYPERBAR M, V30, P1; Fenech M, 1999, MUTAT RES-FUND MOL M, V428, P271, DOI 10.1016/S1383-5742(99)00053-8; Fildissis G, 2004, EUR CYTOKINE NETW, V15, P217; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; FREEMAN BA, 1982, LAB INVEST, V47, P412; GABB G, 1987, CHEST, V92, P1074, DOI 10.1378/chest.92.6.1074; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Garcia AJ, 2010, J APPL PHYSIOL, V109, P804, DOI 10.1152/japplphysiol.91429.2008; GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Godman CA, 2010, ANN NY ACAD SCI, V1197, P178, DOI 10.1111/j.1749-6632.2009.05393.x; Groesbeck DK, 2006, DEV MED CHILD NEUROL, V48, P978, DOI 10.1111/j.1469-8749.2006.tb01269.x; Gu GJ, 2008, J APPL PHYSIOL, V104, P1185, DOI 10.1152/japplphysiol.00323.2007; Gurdol F, 2010, PHYSIOL RES, V59, P423, DOI 10.33549/physiolres.931702; Heyboer M, 2014, STEM CELL RES, V12, P638, DOI 10.1016/j.scr.2014.02.005; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Hite AH, 2011, NUTR CLIN PRACT, V26, P300, DOI 10.1177/0884533611405791; Hodgson JC, 2006, VET IMMUNOL IMMUNOP, V112, P12, DOI 10.1016/j.vetimm.2006.03.008; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hu Q, 2014, STROKE, V45, P1807, DOI 10.1161/STROKEAHA.114.005116; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Jadhav V, 2007, SURG NEUROL, V67, P15, DOI 10.1016/j.surneu.2006.07.014; Jadhav V, 2010, ACTA NEUROCHIR SUPPL, V106, P217, DOI 10.1007/978-3-211-98811-4_40; JAMIESON D, 1989, FREE RADICAL BIO MED, V7, P87, DOI 10.1016/0891-5849(89)90103-2; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Jasani B, 2013, NEW ENGL J MED, V368, P1161, DOI 10.1056/NEJMc1301021; JERRETT SA, 1973, AEROSPACE MED, V44, P40; Jyonouchi H, 1998, AM J RESP CELL MOL, V19, P426, DOI 10.1165/ajrcmb.19.3.2862m; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang Thomas S, 2004, Arch Facial Plast Surg, V6, P31, DOI 10.1001/archfaci.6.1.31; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kazzaz JA, 1996, J BIOL CHEM, V271, P15182, DOI 10.1074/jbc.271.25.15182; KERR JS, 1987, AM REV RESPIR DIS, V135, P1334; Kesl S, 2014, FASEB J S, V28, P734; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kim HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109297; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; KISTLER GS, 1967, J CELL BIOL, V32, P605, DOI 10.1083/jcb.32.3.605; Korhonen K, 2000, ANN CHIR GYNAECOL, V89, P7; KOVACHICH GB, 1980, J NEUROCHEM, V35, P1449, DOI 10.1111/j.1471-4159.1980.tb09022.x; Kutlay M, 2008, NEUROSURGERY, V62, P540, DOI [10.1227/01.NEU.0000186012.95462.E5, 10.1227/01.neu.0000316257.21478.5b]; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; Lahat N, 1995, CLIN EXP IMMUNOL, V102, P655; Lambertsen CJ, 1978, HDB PHYSL 3, P232; Leach RM, 1998, BRIT MED J, V317, P1140; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Lee PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL175, DOI 10.1152/ajplung.2000.279.1.L175; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li HF, 2013, IRAN J PEDIATR, V23, P613; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Lin SK, 2002, BIOCHEM BIOPH RES CO, V296, P710, DOI 10.1016/S0006-291X(02)00924-5; Liu W, 2009, UNDERSEA HYPERBAR M, V36, P155; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luongo C, 1998, CRIT CARE MED, V26, P1972, DOI 10.1097/00003246-199812000-00022; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482; Maltepe E, 2009, PEDIATR RES, V65, P261, DOI 10.1203/PDR.0b013e31818fc83f; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Massey PR, 2012, J SURG RES, V177, P146, DOI 10.1016/j.jss.2012.03.016; Matott MP, 2014, NEUROSCIENCE, V270, P98, DOI 10.1016/j.neuroscience.2014.03.017; Matsunami T, 2010, PHYSIOL RES, V59, P97, DOI 10.33549/physiolres.931711; Matsunami T, 2010, INT J CLIN EXP PATHO, V3, P177; Medan D, 2005, J CELL PHYSIOL, V203, P78, DOI 10.1002/jcp.20201; Mehta JL, 1999, CARDIOVASC RES, V43, P291, DOI 10.1016/S0008-6363(99)00132-7; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Milovanova TN, 2008, MOL CELL BIOL, V28, P6248, DOI 10.1128/MCB.00795-08; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Mulkey DK, 2003, J APPL PHYSIOL, V95, P910, DOI 10.1152/japplphysiol.00864.2002; Muralidharan Vijayaragavan, 2007, HPB (Oxford), V9, P174, DOI 10.1080/13651820601175926; NARKOWICZ CK, 1993, FREE RADICAL RES COM, V19, P71, DOI 10.3109/10715769309056501; Netea MG, 2015, CELL METAB, V21, P513, DOI 10.1016/j.cmet.2015.03.012; Neuman TS., 2008, PHYSL MED HYPERBARIC; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; NISHIKI K, 1976, BIOCHEM J, V160, P343, DOI 10.1042/bj1600343; NOaA A, 2011, SCI DIV STAND SAF MA; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Olshyk VN, 2014, CHEM PHYS LIPIDS, V177, P1, DOI 10.1016/j.chemphyslip.2013.10.010; Ostrowski RP, 2008, NEUROBIOL DIS, V29, P1, DOI 10.1016/j.nbd.2007.07.020; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pagano A, 2003, ANN NY ACAD SCI, V1010, P405, DOI 10.1196/annals.1299.074; Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Pasupathy S, 2005, ARCH SURG-CHICAGO, V140, P405, DOI 10.1001/archsurg.140.4.405; PASUPATHY S, 2005, ARCH SURG-CHICAGO, V140, P410; Patel D, 2003, J INDIAN ACAD CLIN M, V4, P234; Peng ZY, 2008, BRAIN RES, V1212, P71, DOI 10.1016/j.brainres.2008.03.027; Pesa, 2011, HBO THER SOFT TISS R; Pilla R, 2013, J APPL PHYSIOL, V114, P1009, DOI 10.1152/japplphysiol.01326.2012; Poff AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127407; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Portakal O, 2000, CLIN BIOCHEM, V33, P279, DOI 10.1016/S0009-9120(00)00067-9; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Romashko J, 2003, FREE RADICAL BIO MED, V35, P978, DOI 10.1016/S0891-5849(03)00494-5; Rothfuss A, 1998, CARCINOGENESIS, V19, P1913, DOI 10.1093/carcin/19.11.1913; SAITO K, 1991, CLIN EXP IMMUNOL, V86, P322; Schroedl C, 2002, LUNC CELL MOL PHYSL, V283, P31; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shaikh Nissar, 2009, J Emerg Trauma Shock, V2, P180, DOI 10.4103/0974-2700.55330; Sharman MJ, 2004, CLIN SCI, V107, P365, DOI 10.1042/CS20040111; Shaw JJ, 2014, SURG INFECT, V15, P328, DOI 10.1089/sur.2012.135; Sheikh AY, 2000, ARCH SURG-CHICAGO, V135, P1293, DOI 10.1001/archsurg.135.11.1293; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Shyu KG, 2008, LIFE SCI, V83, P65, DOI 10.1016/j.lfs.2008.05.005; Smith J L, 1899, J Physiol, V24, P19; Soejima Y, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-9; Song Xiao-Yu, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P1275; Speit G, 2000, CARCINOGENESIS, V21, P1795, DOI 10.1093/carcin/21.10.1795; Speit G, 2002, MUTAT RES-REV MUTAT, V512, P111, DOI 10.1016/S1383-5742(02)00045-5; Speit G, 1998, MUTAGENESIS, V13, P85, DOI 10.1093/mutage/13.1.85; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Sun L, 2008, STROKE, V39, P1000, DOI 10.1161/STROKEAHA.107.490599; Sunkari VG, 2015, WOUND REPAIR REGEN, V23, P98, DOI 10.1111/wrr.12253; Thom S, 2008, INT SOC STEM CELL RE, V453, P62; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Thom SR., 1989, J INTENSIVE CARE MED, V4, P58, DOI [10.1177/088506668900400204, DOI 10.1177/088506668900400204]; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Thomson L, 2014, PAEDIATR RESPIR REV, V15, P120, DOI 10.1016/j.prrv.2014.03.003; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Torres-Gonzalez Moises, 2008, J Atheroscler Thromb, V15, P235; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tyurina YY, 2010, AM J PHYSIOL-LUNG C, V299, pL73, DOI 10.1152/ajplung.00035.2010; Undersea and Hyperbaric Medicine Society (UHMS), IND HYP OX THER; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wada K, 2001, NEUROSURGERY, V49, P160; Wada K, 1996, BRAIN RES, V740, P15; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang Y, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-18; Weaver LK, 2001, CHEST, V120, P1407, DOI 10.1378/chest.120.4.1407; Weaver LK, 2014, UHMS HYPERBARIC OXYG; Weih M, 1999, STROKE, V30, P1851, DOI 10.1161/01.STR.30.9.1851; Weisz G, 1997, J CLIN IMMUNOL, V17, P154, DOI 10.1023/A:1027378532003; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; WOLFF SP, 1986, TRENDS BIOCHEM SCI, V11, P27, DOI 10.1016/0968-0004(86)90228-8; Wood C D, 1970, J La State Med Soc, V122, P219; Wright CJ, 2009, PEDIATR RES, V66, P3, DOI 10.1203/PDR.0b013e3181a2c184; Xu XF, 2009, OXID MED CELL LONGEV, V2, P7, DOI 10.4161/oxim.2.1.7697; Yang Y, 2014, NEUROSCI LETT, V563, P38, DOI 10.1016/j.neulet.2014.01.002; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Yee M, 2006, AM J PHYSIOL-LUNG C, V291, pL1101, DOI 10.1152/ajplung.00126.2006; Yin XS, 2015, J CARDIOVASC PHARM T, V20, P428, DOI 10.1177/1074248414568196; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu SL, 2015, IRAN J BASIC MED SCI, V18, P98; Yurkova IL, 2012, RUSS CHEM REV+, V81, P175, DOI 10.1070/RC2012v081n02ABEH004205; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53; Zhang QX, 2014, J INVEST DERMATOL, V134, P237, DOI 10.1038/jid.2013.301; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	221	20	23	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2040-4603			COMPR PHYSIOL	Compr. Physiol.	JAN	2017	7	1					213	234		10.1002/cphy.c150032			22	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	EK8PQ	WOS:000394186300008	28135004				2022-02-06	
J	Poulin, V; Korner-Bitensky, N; Bherer, L; Lussier, M; Dawson, DR				Poulin, Valerie; Korner-Bitensky, Nicol; Bherer, Louis; Lussier, Maxime; Dawson, Deirdre R.			Comparison of two cognitive interventions for adults experiencing executive dysfunction post-stroke: a pilot study	DISABILITY AND REHABILITATION			English	Article						Cognitive rehabilitation; computerised training; executive function; strategy training; stroke	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; ACUTE STROKE; WORKING-MEMORY; REHABILITATION; PERFORMANCE; FEASIBILITY; MANAGEMENT; DEFICITS; PROGRAM	Purpose This pilot partially randomised controlled trial compared the feasibility and preliminary efficacy of two promising interventions for persons with executive dysfunction post-stroke: (1) occupation-based strategy training using an adapted version of the Cognitive Orientation to daily Occupational Performance (CO-OP) approach; and (2) Computer-based EF training (COMPUTER training). Method Participants received 16h of either CO-OP or COMPUTER training. We assessed feasibility and acceptability of each intervention, and change in intervention outcomes at baseline, post-intervention and one-month follow-up. Performance and satisfaction with performance in self-selected everyday life goals were measured by the participant and the significant other-rated Canadian Occupational Performance Measure (COPM). Other intervention outcomes included changes in EF impairment, participation in daily life and self-efficacy. Results Six participants received CO-OP and five received COMPUTER training: one in each group discontinued the intervention for medical reasons unrelated to the intervention. The remaining nine participants completed all 16 sessions. Participants expressed high levels of satisfaction with both interventions. Both treatment groups showed large improvements in self and significant other-rated performance and satisfaction with performance on their goals immediately post-intervention and at follow-up (CO-OP: effect sizes (ES)=1.6-3.5; COMPUTER: ES=0.9-4.0), with statistically significant within-group differences in CO-OP (p<0.05). The COMPUTER group also showed large improvements in some areas of EF impairment targeted by the computerised tasks (ES=0.9-1.6); the CO-OP group demonstrated large improvements in self-efficacy for performing everyday activities (ES=1.5). Conclusions Our findings provide preliminary evidence supporting the feasibility of using both CO-OP and COMPUTER training with patients with executive dysfunction post-stroke.	[Poulin, Valerie] Univ Quebec Trois Rivieres, Dept Occupat Therapy, CP 500,3351 Boul Forges, Trois Rivieres, PQ G9A 5H7, Canada; [Poulin, Valerie] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Korner-Bitensky, Nicol] McGill Univ, Sch Phys & Occupat Therapy, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Bherer, Louis] Concordia Univ, Dept Psychol, Montreal, PQ, Canada; [Bherer, Louis] Concordia Univ, PERFORM Ctr, Montreal, PQ, Canada; [Lussier, Maxime] Univ Quebec, Dept Psychol, Montreal, PQ, Canada; [Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Dawson, Deirdre R.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Dawson, Deirdre R.] Baycrest, Rotman Res Inst, Toronto, ON, Canada		Poulin, V (corresponding author), Univ Quebec Trois Rivieres, Dept Occupat Therapy, CP 500,3351 Boul Forges, Trois Rivieres, PQ G9A 5H7, Canada.	valerie.poulin@uqtr.ca	Dawson, Deirdre/I-8882-2014	Dawson, Deirdre/0000-0001-7517-6121	Richard and Edith Strauss Canada Foundation; Fonds de recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec; Canadian Stroke Network; Canadian Research Chair programCanada Research Chairs	This study was carried out with financial support from the Richard and Edith Strauss Canada Foundation. Valerie Poulin was also supported by a PhD fellowship award from the Fonds de recherche du Quebec - Sante at the time of the study. Nicol Korner-Bitensky was supported by the Canadian Stroke Network. Louis Bherer was supported by the Canadian Research Chair program. The authors report no declarations of interest.	Anderson PJ, 2010, STUD NEUROPSYCHOL NE, P3; Army Individual Test Battery, 1944, MAN DIR SCOR; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; Dawson D, 2014, CLIN REHABIL, V28, P118, DOI 10.1177/0269215513492541; Dawson DR, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-306; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Delis DC., 2001, DELIS KAPLAN EXECUTI; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Figueiredo S, 2013, DISABIL REHABIL, V35, P968, DOI 10.3109/09638288.2012.717580; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fougeyrollas P, 2002, LIFE HABITS MEASURE; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Glass, 1976, ED RES, V5, P3, DOI [10.2307/1174772ISSN0536-1036, 10.3102/0013189x005010003, DOI 10.3102/0013189X005010003]; Godefroy O, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P369, DOI 10.1017/CBO9780511544880.020; Honda Tetsumi, 1999, Top Stroke Rehabil, V6, P15, DOI 10.1310/CN46-B2WU-NGVN-37YJ; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; Levack WMM, 2006, DISABIL REHABIL, V28, P741, DOI 10.1080/09638280500265961; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Lussier M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00129; Lyrette J, 2009, THESIS; Machin D., 2009, SAMPLE SIZE TABLES C; Man DWK, 2006, NEUROREHABILITATION, V21, P205; Mandich, 2004, ENABLING OCCUPATION; McDowd JM, 2003, J GERONTOL B-PSYCHOL, V58, pP45, DOI 10.1093/geronb/58.1.P45; McEwen S, 2015, NEUROREHAB NEURAL RE, V29, P526, DOI 10.1177/1545968314558602; McEwen SE, 2010, NEUROPSYCHOL REHABIL, V20, P541, DOI 10.1080/09602011003638194; McEwen SE, 2009, BRAIN INJURY, V23, P1041, DOI 10.3109/02699050903421107; National Institute for Health Research Evaluation Trials and Studies Coordinating Centre, 2015, EV TRIALS STUD GLOSS; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Pollock N., 2005, CANADIAN OCCUPATIONA; Poulin V, 2012, TOP STROKE REHABIL, V19, P158, DOI 10.1310/tsr1902-158; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Rand D, 2010, NEUROREHAB NEURAL RE, V24, P722, DOI 10.1177/1545968310368684; Rand D, 2009, AM J OCCUP THER, V63, P535, DOI 10.5014/ajot.63.5.535; Riepe MW, 2004, DEMENT GERIATR COGN, V17, P49, DOI 10.1159/000074082; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI 10.4135/9781412984997; SCHOENFELD D, 1980, INT J RADIAT ONCOL, V6, P371, DOI 10.1016/0360-3016(80)90153-4; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Skidmore E. R., 2014, NEUROREHABILITATION, V29, P668; Skidmore ER, 2015, PM&R, V7, P562, DOI 10.1016/j.pmrj.2014.12.010; Skidmore ER, 2014, CLIN REHABIL, V28, P378, DOI 10.1177/0269215513502799; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D. T., 2009, REHABILITATION EXECU, P3; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Torkia C, 2012, CAN STROK C 2012 SEP, pe27; Uniform Data System for Medical Rehabilitation, 1996, GUID UN DAT SET MED; Wechsler D., 2008, WECHSLER ADULT INTEL; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wressle E., 1999, SCAND J OCCUP THER, V6, P84, DOI [DOI 10.1080/110381299443771, 10.1080/110381299443771]; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015	60	20	23	0	33	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	1					1	13		10.3109/09638288.2015.1123303			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EC9WG	WOS:000388494400001	26750772				2022-02-06	
J	Ricciardi, MC; Bokkers, RPH; Butman, JA; Hammoud, DA; Pham, DL; Warach, S; Latour, LL				Ricciardi, Maria Chiara; Bokkers, Reinoud P. H.; Butman, John A.; Hammoud, Dima A.; Pham, Dzung L.; Warach, Steven; Latour, Lawrence L.			Trauma-Specific Brain Abnormalities in Suspected Mild Traumatic Brain Injury Patients Identified in the First 48 Hours after Injury: A Blinded Magnetic Resonance Imaging Comparative Study Including Suspected Acute Minor Stroke Patients	JOURNAL OF NEUROTRAUMA			English	Article						CT scanning; MRI; TBI	DIFFUSE AXONAL INJURY; CT; LESIONS	We assessed the utility of a brief MRI protocol, appropriate for the acute setting, to detect acute traumatic brain injury (TBI) in patients with suspected mild TBI (mTBI) and distinguish traumatic from nontraumatic brain injury by comparing trauma with nontrauma patients. Twenty-two patients with suspected mTBI were included in this exploratory study over a period of 9 months. Median time from injury to MR scanning was 5.4 h (interquartile range 3.6-15.3). To determine the specificity of certain findings for TBI, 61 patients presenting with suspected minor acute stroke were included as a comparative group using the same MRI methods. A selected series of MRI sequences (diffusion-weighted imaging, fluid attenuated inversion recovery [FLAIR], and T2* weighted) were independently evaluated by two neuroradiologists blinded to clinical diagnosis, for presence of specific findings. In a separate session, all cases in which at least one MRI sequence above was positive were classified as TBI, stroke, or indeterminate. Intracranial MRI abnormalities were observed in 47 (57%) of the 83 studied patients. Based on findings on MRI, 12 (55%) of 22 suspected mTBI patients were classified as having traumatic injury. Nine (47%) of the 19 suspected mTBI patients with a negative CT had findings on MRI. Abnormalities on MRI consistent with trauma were observed most frequently on postcontrast FLAIR (83%) and T2*-weighted (58%) sequences. We demonstrated the ability of a fast MRI protocol to identify trauma-related abnormalities not seen on CT, and differentiate acute trauma from nonspecific chronic disease in a blinded cohort of mTBI patients.	[Ricciardi, Maria Chiara; Latour, Lawrence L.] Natl Inst Neurol Disorders & Stroke, Stroke Diagnost & Therapeut Sect, Bethesda, MD USA; [Butman, John A.] NIH, Dept Diagnost Radiol, Bethesda, MD USA; [Hammoud, Dima A.] NIH, Ctr Clin, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Ricciardi, Maria Chiara; Butman, John A.; Pham, Dzung L.; Latour, Lawrence L.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Bokkers, Reinoud P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Warach, Steven] Univ Texas Austin, Stroke Inst, Seton Dell Med Sch, Austin, TX 78712 USA		Latour, LL (corresponding author), Natl Inst Neurol Disorders & Stroke, NIH, 10 Ctr Dr,Bldg 10,Room B1D733, Bethesda, MD 20892 USA.	LatourL@ninds.nih.gov	Latour, Larry/AAH-5663-2021; Butman, John A/A-2694-2008; Pham, Dzung/AAR-8263-2020; Butman, John/J-2780-2013; Bokkers, Reinoud P H/ABD-2928-2020; Hammoud, Dima A/C-2286-2015; Warach, Steven/R-5074-2019	Latour, Larry/0000-0001-6160-5263; Butman, John/0000-0002-1547-9195; Bokkers, Reinoud P H/0000-0001-6130-7311; Hammoud, Dima/0000-0001-7406-7871	Intramural Research Program at NINDS; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Dutch Heart FoundationNetherlands Heart Foundation [2013T047]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003043, ZIANS003120, ZICNS003044] Funding Source: NIH RePORTER	We are grateful to the patients and their families without whom this research would not be possible. We wish to acknowledge the staff at Suburban Hospital, and the Investigators of the Center for Neuroscience and Regenerative Medicine THINC Study. Support for this work included funding from the Intramural Research Program at NINDS and the Department of Defense in the Center for Neuroscience and Regenerative Medicine. R. P. H. Bokkers receives support from the Dutch Heart Foundation (Grant 2013T047). The contents of this article are solely the responsibility of the authors and do not represent the official views of the Department of Defense or the Center for Neuroscience and Regenerative Medicine.	Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M, 2010, TRAUMATIC BRAIN INJU; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim S.C., 2014, PLOS ONE, V16, P9; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	27	20	20	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					23	30		10.1089/neu.2015.4338			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100004	27215444	Green Published, Green Submitted			2022-02-06	
J	Tardif, PA; Moore, L; Boutin, A; Dufresne, P; Omar, M; Bourgeois, G; Bonaventure, PL; Kuimi, BLB; Turgeon, AF				Tardif, Pier-Alexandre; Moore, Lynne; Boutin, Amelie; Dufresne, Philippe; Omar, Madiba; Bourgeois, Gilles; Bonaventure, Paule Lessard; Kuimi, Brice Lionel Batomen; Turgeon, Alexis F.			Hospital length of stay following admission for traumatic brain injury in a Canadian integrated trauma system: A retrospective multicenter cohort study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Acute care; Determinants; Intensive care; Length of stay; Traumatic brain injury	MULTIPLE IMPUTATION; CARE-UNIT; LEVEL I; MISSING DATA; OUTCOMES; COSTS; MORTALITY; IMPROVES; IMPLEMENTATION; REIMBURSEMENT	Background: Traumatic brain injury (TBI) is the leading cause of disability in children and young adults and costs CAD$3 billion annually in Canada. Stakeholders have expressed the urgent need to obtain information on resource use for TBI to improve the quality and efficiency of acute care in this patient population. We aimed to assess the components and determinants of hospital and ICU LOS for TBI admissions. Methods: We performed a retrospective multicenter cohort study on 11,199 adults admitted for TBI between 2007 and 2012 in an inclusive Canadian trauma system. Our primary outcome measure was index hospital LOS (admission to the hospital with the highest designation level). Index LOS was compared to total LOS (all consecutive admissions related to the injury). Expected LOS was calculated by matching TBI admissions to all-diagnosis hospital admissions by age, gender, and year of admission. LOS determinants were identified using multilevel linear regression. Results: Geometric mean total LOS was 1 day longer than geometric mean index LOS (12.6 versus 11.7 days). Observed index and ICU LOS were respectively 4.2 days and 2.5 days longer than that expected according to all-diagnosis admissions. The six most important determinants of LOS were discharge destination, severity of concomitant injuries, extracranial complications, GCS, TBI severity, and mechanical ventilation, accounting for 80% of explained variation. Conclusions: Results of this multicenter retrospective cohort study suggest that hospital and ICU LOS for TBI admissions are 56% and 119% longer than expected according to all-diagnosis admissions, respectively. In addition, hospital LOS is underestimated when only the index visit is considered and is largely influenced by discharge destination and extracranial complications, suggesting that improvements could be achieved with better discharge planning and interventions targeting prevention of in-hospital complications. This study highlights the importance of considering TBI patients as a distinct population when allocating resources or planning quality improvement interventions. (C) 2016 Elsevier Ltd. All rights reserved.	[Tardif, Pier-Alexandre; Moore, Lynne; Boutin, Amelie; Dufresne, Philippe; Omar, Madiba; Bonaventure, Paule Lessard; Kuimi, Brice Lionel Batomen; Turgeon, Alexis F.] Univ Laval, Trauma Emergency Crit Care Med, Populat Hlth & Optimal Hlth Practices Res Unit, CHU Quebec,Res Ctr, Quebec City, PQ, Canada; [Tardif, Pier-Alexandre; Moore, Lynne; Boutin, Amelie; Dufresne, Philippe; Omar, Madiba] Univ Laval, Dept Social & Preventat Med, Quebec City, PQ, Canada; [Bourgeois, Gilles] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada; [Bonaventure, Paule Lessard] Univ Laval, Div Neurosurg, Dept Neurol Sci, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval, Div Crit Care Med, Dept Anesthesiol, Quebec City, PQ, Canada		Tardif, PA (corresponding author), Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, CHU Quebec,Res Ctr,Hop Enfant Jesus, 1401,18eme Rue,Local H-012a, Quebec City, PQ G1J 1Z4, Canada.	pier-alexandre.tardif.1@ulaval.ca; lynne.moore@fmed.ulaval.ca; amelie.boutin.2@ulaval.ca; philippe.dufresne.3@ulaval.ca; madiba.omar.1@ulaval.ca; gillesbourgeois1954@gmail.com; paule.lessard.bonaventure@gmail.com; brice-lionel.batomen-kuimi.1@ulaval.ca; alexis.Turgeon@fmed.ulaval.ca	Kuimi, Brice Lionel Batomen/AAF-3970-2020	Kuimi, Brice Lionel Batomen/0000-0002-5772-120X; Tardif, Pier-Alexandre/0000-0003-3003-2399; Boutin, Amelie/0000-0003-1907-2920	Canadian Institutes of Health Research (CIHR) New Investigator AwardCanadian Institutes of Health Research (CIHR) [110996]; CIHR Best and Banting PhD Training Award; CIHR Masters Training AwardCanadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR) New Investigator Award (LM and AFT) and research grant (LM; #110996); CIHR Best and Banting PhD Training Award (AB) and CIHR Masters Training Award (PLB). None of the funders had any role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. The authors declare no conflicts of interest.	Alkhoury F, 2011, AM SURGEON, V77, P277; American College of Surgeons Committee on Trauma, 2012, NAT TRAUM DAT BANK 2; [Anonymous], 2006, I CANADIEN INFORM SA; Arthur M, 2009, J RURAL HEALTH, V25, P182, DOI 10.1111/j.1748-0361.2009.00215.x; Bodanapally UK, 2013, INJURY, V44, P75, DOI 10.1016/j.injury.2011.10.037; Bodner TE, 2008, STRUCT EQU MODELING, V15, P651, DOI 10.1080/10705510802339072; Brehaut JC, 2005, ACAD EMERG MED, V12, P948, DOI 10.1197/j.aem.2005.04.024; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Caminiti C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-14; Cohen J., 2013, STAT POWER ANAL BEHA; Conforti DA, 2004, AUSTRALAS J AGEING, V23, P189, DOI 10.1111/j.1741-6612.2004.00048.x; Daly L, 2000, INTERPRETATION USES; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; de Jongh MAC, 2011, J TRAUMA, V71, pE102, DOI 10.1097/TA.0b013e31820e351f; Dutton RP, 2003, J TRAUMA, V55, P913, DOI 10.1097/01.TA.0000093395.34097.56; Eastman AB, 2006, J TRAUMA, V60, P535; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fakhry SM, 2010, J AM COLL SURGEONS, V210, P817, DOI 10.1016/j.jamcollsurg.2010.01.030; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2010, TRAUMATIC BRAIN INJU; Frederickson TA, 2013, J INTENSIVE CARE MED, V28, P58, DOI 10.1177/0885066611432420; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Hassan M, 2010, INT J PHARM HEALTHC, V4, P324, DOI 10.1108/17506121011095182; Jarrett Letha Ann, 2009, J Trauma Nurs, V16, P68, DOI 10.1097/JTN.0b013e3181ac91c1; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; KALB PE, 1989, JAMA-J AM MED ASSOC, V261, P2389, DOI 10.1001/jama.261.16.2389; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Kuimi BLB, 2015, INJURY, V46, P595, DOI 10.1016/j.injury.2015.01.006; Legorreta A P, 1993, J Assoc Acad Minor Phys, V4, P52; Liberman M, 2004, J TRAUMA, V56, P1330, DOI 10.1097/01.TA.0000071297.76727.8B; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; Mains C, 2009, J TRAUMA, V66, P1315, DOI 10.1097/TA.0b013e31819d96d8; McDonagh MS, 2000, HEALTH POLICY, V53, P157, DOI 10.1016/S0168-8510(00)00092-0; Miller Finkelstein ECP, INCIDENCE EC BURDEN; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore L, 2014, ANN SURG, V260, P179, DOI 10.1097/SLA.0000000000000624; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Nickrenz L, 2010, ETHOS, V38; O'Keefe GE, 1999, J TRAUMA, V46, P473, DOI 10.1097/00005373-199903000-00023; Omar M, 2016, J TRAUMA ACUTE UNPUB; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robinson BRH, 2008, J TRAUMA, V65, P517, DOI 10.1097/TA.0b013e318181b8f6; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rotondo MF, 2010, J AM COLL SURGEONS, V210, P821; Ruffieux C, 2000, CASEMIX Q, V2, P1; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schulman J, 2006, J PERINATOL, V26, P243, DOI 10.1038/sj.jp.7211478; SCHWAB CW, 1988, J TRAUMA, V28, P939, DOI 10.1097/00005373-198807000-00006; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; SHWARTZ M, 2003, RISK ADJUSTMENT MEAS; SIEGEL JH, 1994, J TRAUMA, V37, P928, DOI 10.1097/00005373-199412000-00010; Solberg BCJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6903; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Yeung Jacky T, 2013, J Emerg Trauma Shock, V6, P189, DOI 10.4103/0974-2700.115337; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028	61	20	21	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2017	48	1					94	100		10.1016/j.injury.2016.10.042			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EF7YF	WOS:000390544600017	27839794				2022-02-06	
J	Vahidinia, Z; Alipour, N; Atlasi, MA; Naderian, H; Beyer, C; Tameh, AA				Vahidinia, Zeinab; Alipour, Nasim; Atlasi, Mohammad Ali; Naderian, Homayoun; Beyer, Cordian; Tameh, Abolfazl Azami			Gonadal steroids block the calpain-1-dependent intrinsic pathway of apoptosis in an experimental rat stroke model	NEUROLOGICAL RESEARCH			English	Article						Estrogen; Progesterone; Apoptosis; tMCAO; Calpain-1	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; INDUCED CELL-DEATH; ARTERY OCCLUSION; NEURONAL DEATH; NEUROPROTECTION; ESTROGEN; CALPAIN; PROGESTERONE; MECHANISMS	Objectives: Apoptosis plays an important role in the progression of the ischemic penumbra after reperfusion. Estrogen and progesterone have neuroprotective effects against ischemic brain damage, however the exact mechanisms of neuroprotection and signaling pathways is not completely understood. In this study, we investigated the possible regulatory effects of a combined steroid treatment on extrinsic and intrinsic apoptotic signaling pathways after cerebral ischemia. Methods: Adult male Wistar rats were subjected to transient middle cerebral artery occlusion (tMCAO) using an intraluminal filament technique for 1h followed by 23h reperfusion. Estrogen and progesterone were immediately injected after tMCAO subcutaneously. Sensorimotor functional tests and the infarct volume were evaluated 24h after ischemia. Protein expression of calpain-1 and Fas receptor (FasR), key members of intrinsic and extrinsic apoptosis, were determined in the penumbra region of the ischemic brain using western blot analysis, immunohistochemistry, and TUNEL staining. Results: Neurological deficits and infarct volume were significantly reduced following hormone therapy. Calpain-1 up-regulation and caspase-3 activation were apparent 24h after ischemia in the peri-infarct area of the cerebral cortex. Steroid hormone treatment reduced infarct pathology and attenuated the induction of both proteases. FasR protein levels were not affected by ischemia and hormone application. Conclusion: We conclude that a combined steroid treatment inhibits ischemia-induced neuronal apoptosis through the regulation of intrinsic pathways.	[Vahidinia, Zeinab; Alipour, Nasim; Atlasi, Mohammad Ali; Naderian, Homayoun; Tameh, Abolfazl Azami] Kashan Univ Med Sci, Anat Sci Res Ctr, Kashan, Iran; [Beyer, Cordian] Rhein Westfal TH Aachen, Fac Med, Inst Neuroanat, Aachen, Germany; [Tameh, Abolfazl Azami] Kashan Univ Med Sci, Sch Med, Dept Anat, Kashan, Iran		Tameh, AA (corresponding author), Kashan Univ Med Sci, Anat Sci Res Ctr, Kashan, Iran.; Tameh, AA (corresponding author), Kashan Univ Med Sci, Sch Med, Dept Anat, Kashan, Iran.	aazami@kaums.ac.ir	Naderian, Homayoun/H-2265-2017; Atlasi, Mohammad Ali/H-1786-2017; Azami Tameh, Abolfazl/G-8213-2017	Naderian, Homayoun/0000-0001-9427-5168; Atlasi, Mohammad Ali/0000-0002-5058-9111; Azami Tameh, Abolfazl/0000-0002-5359-3298	Kashan University of Medical Sciences [92159]	This work was supported by Kashan University of Medical Sciences [grant number 92159].	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Arnold S, 2009, J NEUROCHEM, V110, P1, DOI 10.1111/j.1471-4159.2009.06133.x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; BARTUS RT, 1995, J CEREBR BLOOD F MET, V15, P969, DOI 10.1038/jcbfm.1995.123; Becher B, 1998, TRENDS NEUROSCI, V21, P114, DOI 10.1016/S0166-2236(97)01180-6; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Cimarosti H, 2006, NEUROCHEM RES, V31, P483, DOI 10.1007/s11064-006-9043-9; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Daniel PT, 2000, LEUKEMIA, V14, P2035, DOI 10.1038/sj.leu.2401940; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fujimoto S, 2004, NEUROSCI RES, V50, P179, DOI 10.1016/j.neures.2004.06.013; Gao G, 2000, J CELL BIOCHEM, V80, P53; Garcia J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-414; Garcia-Segura LM, 2009, FRONT NEUROENDOCRIN, V30, pV, DOI 10.1016/j.yfrne.2009.04.006; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Gutierrez-Fernandez M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0406-3; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kim YJ, 2000, J NEUROCHEM, V74, P2490, DOI 10.1046/j.1471-4159.2000.0742490.x; Lammerding L, 2016, NEUROENDOCRINOLOGY, V103, P460, DOI 10.1159/000439435; Li YG, 2013, CHINESE MED J-PEKING, V126, P4088, DOI 10.3760/cma.j.issn.0366-6999.20130800; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lorenz L, 2009, J NEUROENDOCRINOL, V21, P841, DOI 10.1111/j.1365-2826.2009.01903.x; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nilsen J, 2002, BRAIN RES, V930, P216, DOI 10.1016/S0006-8993(02)02254-0; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ouyang CH, 2007, NEUROSCI LETT, V420, P174, DOI 10.1016/j.neulet.2007.05.004; Rami A, 2003, NEUROBIOL DIS, V13, P75, DOI 10.1016/S0969-9961(03)00018-4; Ryang YM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-113; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; Sribnick EA, 2007, NEUROCHEM RES, V32, P2210, DOI 10.1007/s11064-007-9433-7; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stupka N, 2001, J APPL PHYSIOL, V91, P1828, DOI 10.1152/jappl.2001.91.4.1828; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Tameh AA, 2013, ANN ANAT, V195, P415, DOI 10.1016/j.aanat.2013.03.004; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Ulbrich C, 2012, J STEROID BIOCHEM, V131, P10, DOI 10.1016/j.jsbmb.2012.01.007; Vakili A, 2014, BRAIN RES, V1548, P56, DOI 10.1016/j.brainres.2013.12.019; Wang Y, 2007, LIFE SCI, V80, P2067, DOI 10.1016/j.lfs.2007.03.010; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745	60	20	23	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2017	39	1					54	64		10.1080/01616412.2016.1250459			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EF6HF	WOS:000390431000009	27832728				2022-02-06	
J	Alluri, H; Grimsley, M; Shaji, CA; Varghese, KP; Zhang, SYL; Peddaboina, C; Robinson, B; Beeram, MR; Huang, JH; Tharakan, B				Alluri, Himakarnika; Grimsley, Marcene; Shaji, Chinchusha Anasooya; Varghese, Kevin Paul; Zhang, Shenyuan L.; Peddaboina, Chander; Robinson, Bobby; Beeram, Madhava R.; Huang, Jason H.; Tharakan, Binu			Attenuation of Blood-Brain Barrier Breakdown and Hyperpermeability by Calpain Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; INJURY; PERMEABILITY; MATRIX-METALLOPROTEINASE-9; CLEAVAGE; EDEMA; DYSFUNCTION; MODULATION; INDUCTION	Blood-brain barrier (BBB) breakdown and the associated microvascular hyperpermeability followed by brain edema are hallmark features of several brain pathologies, including traumatic brain injuries (TBI). Recent studies indicate that pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) that is upregulated following traumatic injuries also promotes BBB dysfunction and hyperpermeability, but the underlying mechanisms are not clearly known. The objective of this study was to determine the role of calpains in mediating BBB dysfunction and hyperpermeability and to test the effect of calpain inhibition on theBBBfollowing traumatic insults to the brain. In these studies, rat brain microvascular endothelial cell monolayers exposed to calpain inhibitors (calpain inhibitor III and calpastatin) or transfected with calpain-1 siRNA demonstrated attenuation of IL-1 beta-induced monolayer hyperpermeability. Calpain inhibition led to protection against IL-1 beta-induced loss of zonula occludens-1 (ZO-1) at the tight junctions and alterations in F-actin cytoskeletal assembly. IL-1 beta treatment had no effect on ZO-1 gene (tjp1) or protein expression. Calpain inhibition via calpain inhibitor III and calpastatin decreased IL-1 beta-induced calpain activity significantly (p < 0.05). IL-1 beta had no detectable effect on intracellular calcium mobilization or endothelial cell viability. Furthermore, calpain inhibition preserved BBB integrity/permeability in a mouse controlled cortical impact model of TBI when studied using Evans blue assay and intravital microscopy. These studies demonstrate that calpain-1 acts as a mediator of IL-1 beta-induced loss of BBB integrity and permeability by altering tight junction integrity, promoting the displacement of ZO-1, and disorganization of cytoskeletal assembly. IL-1 beta-mediated alterations in permeability are neither due to the changes in ZO-1 expression nor cell viability. Calpain inhibition has beneficial effects against TBI-induced BBB hyperpermeability.	[Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Peddaboina, Chander; Robinson, Bobby; Tharakan, Binu] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA; [Huang, Jason H.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Neurosurg,Coll Med, Temple, TX 76504 USA; [Beeram, Madhava R.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Pediat,Coll Med, Temple, TX 76504 USA; [Grimsley, Marcene] Texas Biosci Inst, Temple, TX 76502 USA; [Varghese, Kevin Paul] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Zhang, Shenyuan L.] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76504 USA		Tharakan, B (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.	btharakan@medicine.tamhsc.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	Baylor Scott and White Health Academic Operations Research funds	This work was supported by Baylor Scott and White Health Academic Operations Research funds (to B. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alluri H, 2014, MICROCIRCULATION, V21, P187, DOI 10.1111/micc.12110; Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Blamire AM, 2000, J NEUROSCI, V20, P8153; Bralic M, 2012, COLLEGIUM ANTROPOL, V36, P1319; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Chakraborti S, 2012, INDIAN J BIOCHEM BIO, V49, P316; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Elali A, 2011, STROKE, V42, P3238, DOI 10.1161/STROKEAHA.111.615559; Fei B, 2013, BBA-MOL CELL RES, V1833, P2153, DOI 10.1016/j.bbamcr.2013.05.010; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Jeong SY, 2013, P NATL ACAD SCI USA, V110, pE4007, DOI 10.1073/pnas.1316852110; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kotecki M, 2010, MICROVASC RES, V80, P339, DOI 10.1016/j.mvr.2010.07.012; Loot AE, 2013, J CARDIOVASC PHARM, V61, P528, DOI 10.1097/FJC.0b013e31828d0fa3; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; Mayhan WG, 2001, MICROCIRCULATION, V8, P89, DOI 10.1038/sj.mn.7300154; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; Prangsaengtong O, 2012, HUM CELL, V25, P36, DOI 10.1007/s13577-012-0042-7; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samantaray S, 2015, MOL NEUROBIOL, V52, P1054, DOI 10.1007/s12035-015-9255-6; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Toba S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01224; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Yuan S. Y., 2010, C SERIES INTEGRATED, P39; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492	49	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26958	26969		10.1074/jbc.M116.735365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	WOS:000391576300002	27875293	hybrid, Green Published			2022-02-06	
J	Brady, RD; Shultz, SR; Sun, MJ; Romano, T; van der Poel, C; Wright, DK; Wark, JD; O'Brien, TJ; Grills, BL; McDonald, SJ				Brady, Rhys D.; Shultz, Sandy R.; Sun, Mujun; Romano, Tania; van der Poel, Chris; Wright, David K.; Wark, John D.; O'Brien, Terence J.; Grills, Brian L.; McDonald, Stuart J.			Experimental Traumatic Brain Injury Induces Bone Loss in Rats	JOURNAL OF NEUROTRAUMA			English	Article						bone homeostasis; femur; fluid percussion injury; bone loss; traumatic brain injury	MINERAL DENSITY; HEAD-INJURY; GROWTH-HORMONE; LEUKOCYTE MOBILIZATION; FRACTURE; FLUID; NEUROINFLAMMATION; MODEL; DYSFUNCTION; DESTRUCTION	Few studies have investigated the influence of traumatic brain injury (TBI) on bone homeostasis; however, pathophysiological mechanisms involved in TBI have potential to be detrimental to bone. The current study assessed the effect of experimental TBI in rats on the quantity and quality of two different weight-bearing bones, the femur and humerus. Rats were randomly assigned into either sham or lateral fluid percussion injury (FPI) groups. Open-field testing to assess locomotion was conducted at 1, 4, and 12 weeks post-injury, with the rats killed at 1 and 12 weeks post-injury. Bones were analyzed using peripheral quantitative computed tomography (pQCT), histomorphometric analysis, and three-point bending. pQCT analysis revealed that at 1 and 12 weeks post-injury, the distal metaphyseal region of femora from FPI rats had reduced cortical content (10% decrease at 1 week, 8% decrease at 12 weeks; p < 0.01) and cortical thickness (10% decrease at 1 week, 11% decrease at 12 weeks p < 0.001). There was also a 23% reduction in trabecular bone volume ratio at 1 week post-injury and a 27% reduction at 12 weeks post-injury in FPI rats compared to sham (p < 0.001). There were no differences in bone quantity and mechanical properties of the femoral midshaft between sham and TBI animals. There were no differences in locomotor outcomes, which suggested that post-TBI changes in bone were not attributed to immobility. Taken together, these findings indicate that this rat model of TBI was detrimental to bone and suggests a link between TBI and altered bone remodeling.	[Brady, Rhys D.; Romano, Tania; van der Poel, Chris; Grills, Brian L.; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Shultz, Sandy R.; Sun, Mujun; Wark, John D.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Wright, David K.] Univ Melbourne, Anat & Neurosci, Parkville, Vic, Australia; [Wright, David K.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia		McDonald, SJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Hlth Sci 2, Bundoora, Vic 3086, Australia.	stuart.mcdonald@latrobe.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179; Wright, David/0000-0002-7535-8651; Sun, Mujun/0000-0002-9923-9913	NHMRC of AustraliaNational Health and Medical Research Council of Australia	Funding for this project was provided by the NHMRC of Australia.	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brady RD, 2014, J ORTHOP RES, V32, P1277, DOI 10.1002/jor.22686; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Ciucci T, 2015, GUT, V64, P1072, DOI 10.1136/gutjnl-2014-306947; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Grills BL, 1997, J ORTHOPAED RES, V15, P235, DOI 10.1002/jor.1100150212; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; HOLMES SJ, 1994, J CLIN ENDOCR METAB, V78, P669, DOI 10.1210/jc.78.3.669; Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Lin HL, 2015, ACTA NEUROL SCAND, V131, P158, DOI 10.1111/ane.12301; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; McDonald SJ, 2011, J ORTHOP RES, V29, P740, DOI 10.1002/jor.21302; MUNDY GR, 1991, J PERIODONTAL RES, V26, P213, DOI 10.1111/j.1600-0765.1991.tb01647.x; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Oppl B, 2014, J BONE MINER RES, V29, P1096, DOI 10.1002/jbmr.2122; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Romano T, 2014, REPROD FERT DEVELOP, V26, P385, DOI 10.1071/RD12378; Romano T, 2010, BONE, V47, P1054, DOI 10.1016/j.bone.2010.08.020; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith EM, 2009, ARCH PHYS MED REHAB, V90, P1127, DOI 10.1016/j.apmr.2008.09.578; Szulc P, 2009, OSTEOPOROSIS INT, V20, P1281, DOI 10.1007/s00198-009-0994-y; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	53	20	22	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2154	2160		10.1089/neu.2014.3836			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800011	25686841				2022-02-06	
J	Gu, XC; Zhang, XB; Hu, B; Zi, Y; Li, M				Gu, Xiao-chuan; Zhang, Xiao-Bin; Hu, Bing; Zi, Ying; Li, Ming			Neuropeptide Y accelerates post-fracture bone healing by promoting osteogenesis of mesenchymal stem cells	NEUROPEPTIDES			English	Article						NRY; MSCs; Fracture; Bone healing	TIBIAL SHAFT FRACTURE; KNOCKOUT MICE; OSTEOBLAST DIFFERENTIATION; ENERGY HOMEOSTASIS; RAT-BRAIN; RECEPTORS; NPY; EXPRESSION; INSIGHTS; LEPTIN	Fracture repair is a complex yet well orchestrated regenerative process involving numerous signaling and cell types including osteoblasts. Here we showed that NPY, a neurotransmitter with regulatory functions in bone homeostasis, may contribute to the post-fracture bone healing in patients with traumatic brain injury-fracture combined injuries. Our results suggested NPY levels were increased in patients with the combined injuries, accomplished by arising of bone healing markers, such as ALP, OC, PICP and ICTP, than in those with simple fractures, and NPY have direct actions on MSCs to promote their osteogenic differentiation. Our results provided clinical evidences for NPY participating in the bone healing process in a nonhypothalamic manner, most probably by directly promoting osteogenesis of mesenchymal stem cells. (C) 2016 Published by Elsevier Ltd.	[Gu, Xiao-chuan; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [Zhang, Xiao-Bin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Emergency Med, Shanghai, Peoples R China; [Hu, Bing] Shanghai Minhang Dist Hosp Tradit Chinese Med, Dept Med Oncol, Shanghai, Peoples R China; [Zi, Ying] 463rd Hosp PLA, Dept Emergency, Shenyang 110042, Peoples R China		Li, M (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China.; Zi, Y (corresponding author), 463rd Hosp PLA, Dept Emergency, Shenyang 110042, Peoples R China.	ziying008@hotmail.com; limingch@21cn.com			Natural Science Foundation Project of Liaoning, China [201602762]	This work was supported by Natural Science Foundation Project of Liaoning, China (201602762).	Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baht GS, 2014, J ORTHOP RES, V32, P581, DOI 10.1002/jor.22562; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Bowles SA, 1996, ANN CLIN BIOCHEM, V33, P196, DOI 10.1177/000456329603300304; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; DUMONT Y, 1990, EUR J PHARMACOL, V191, P501, DOI 10.1016/0014-2999(90)94189-5; Einhorn T. A., 1998, CLIN ORTHOP RELAT R, V355, P57; Franquinho F, 2010, FEBS J, V277, P3664, DOI 10.1111/j.1742-4658.2010.07774.x; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JOERRING S, 1992, ARCH ORTHOP TRAUM SU, V111, P265, DOI 10.1007/BF00571521; JOERRING S, 1994, ARCH ORTHOP TRAUM SU, V113, P334, DOI 10.1007/BF00426183; Knoch H G, 1973, Zentralbl Chir, V98, P505; Lee NJ, 2015, MOL METAB, V4, P164, DOI 10.1016/j.molmet.2014.12.010; Lee NJ, 2009, NEUROPEPTIDES, V43, P457, DOI 10.1016/j.npep.2009.08.006; Liao KH, 2016, J CHIN MED ASSOC, V79, P58, DOI 10.1016/j.jcma.2015.10.002; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Nunes AF, 2010, FEBS J, V277, P263, DOI 10.1111/j.1742-4658.2009.07482.x; OBRANT KJ, 1990, CLIN ORTHOP RELAT R, P300; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reichelt A, 1967, Hefte Unfallheilkd, V91, P250; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shi YC, 2012, BONE, V50, P430, DOI 10.1016/j.bone.2011.10.001; Sousa C. P., 2015, AN ACAD BRAS CIENC; Stoffel K, 2007, CLIN CHEM, V53, P131, DOI 10.1373/clinchem.2006.076976; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Veitch SW, 2006, OSTEOPOROSIS INT, V17, P364, DOI 10.1007/s00198-005-2025-y; Victoria G, 2009, INDIAN J ORTHOP, V43, P117, DOI 10.4103/0019-5413.50844; Zengin A, 2010, TRENDS ENDOCRIN MET, V21, P411, DOI 10.1016/j.tem.2010.02.004	39	20	22	2	14	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	DEC	2016	60						61	66		10.1016/j.npep.2016.09.005			6	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	EE2FJ	WOS:000389398800009	27720230				2022-02-06	
J	Nagakannan, P; Iqbal, MA; Yeung, A; Thliveris, JA; Rastegar, M; Ghavami, S; Eftekharpour, E				Nagakannan, Pandian; Iqbal, Mohamed Ariff; Yeung, Albert; Thliveris, James A.; Rastegar, Mojgan; Ghavami, Saeid; Eftekharpour, Eftekhar			Perturbation of redox balance after thioredoxin reductase deficiency interrupts autophagy-lysosomal degradation pathway and enhances cell death in nutritionally stressed SH-SY5Y cells	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Neurodegenerative disease; Redox Regulation; Lysosome; Autophagy-Apotosis Interplay; Ubiquitination; Proteasome	AURANOFIN INDUCES APOPTOSIS; SPINAL-CORD-INJURY; OXIDATIVE STRESS; GLUTATHIONE; INHIBITION; ANTIOXIDANTS; MITOCHONDRIA; MODULATION; ACTIVATION; EXPRESSION	Oxidative damage and aggregation of cellular proteins is a hallmark of neuronal cell death after neurotrauma and chronic neurodegenerative conditions. Autophagy and ubiquitin protease system are involved in degradation of protein aggregates, and interruption of their function is linked to apoptotic cell death in these diseases. Oxidative modification of cysteine groups in key molecular proteins has been linked to modification of cellular systems and cell death in these conditions. Glutathione and thioredoxin systems provide reducing protons that can effectively reverse protein modifications and promote cell survival. The central role of Thioredoxin in inhibition of apoptosis is well identified. Additionally, its involvement in initiation of autophagy has been suggested recently. We therefore aimed to investigate the involvement of Thioredoxin system in autophagy-apoptosis processes. A model of serum deprivation in SH-SY5Y was used that is associated with autophagy and apoptosis. Using pharmacological and RNA-editing technology we show that Thioredoxin reductase deficiency in this model enhances oxidative stress and interrupts the early protective autophagy and promotes apoptosis. This was associated with decreased protein-degradation in lysosomes due to altered lysosomal acidification and accumulation of autophagosomes as well as impairment in proteasome pathway. We further confirmed that the extent of oxidative stress is a determining factor in autophagy-apoptosis interplay, as upregulation of cellular reducing capacity by N-acetylcysteine prevented impairment in autophagy and proteasome systems thus promoted cell viability. Our study provides evidence that excessive oxidative stress inhibits protein degradation systems and affects the final stages of autophagy by inhibiting autolysosome maturation: a novel mechanistic link between protein aggregation and conversion of autophagy to apoptosis that can be applicable to neurodegenerative diseases.	[Nagakannan, Pandian; Iqbal, Mohamed Ariff; Yeung, Albert; Eftekharpour, Eftekhar] Univ Manitoba, Rady Fac Hlth Sci, Dept Physiol & Pathophysiol, Spinal Cord Res Ctr, Winnipeg, MB, Canada; [Rastegar, Mojgan] Univ Manitoba, Rady Fac Hlth Sci, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Thliveris, James A.; Ghavami, Saeid] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Nagakannan, Pandian; Iqbal, Mohamed Ariff; Yeung, Albert; Rastegar, Mojgan; Eftekharpour, Eftekhar] Univ Manitoba, Rady Fac Hlth Sci, Regenerat Med Program, Winnipeg, MB, Canada		Eftekharpour, E (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Spinal Cord Res Ctr, 631 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.		Ghavami, Saeid/Q-8918-2016; Rastegar, Mojgan/T-9394-2019	Rastegar, Mojgan/0000-0003-3619-6116; Pandian, Nagakannan/0000-0002-6791-0661; Iqbal, Mohamed Ariff/0000-0002-5094-0717; Ghavami, Saeid/0000-0001-5948-508X; Eftekharpour, Eftekhar/0000-0002-2849-3754			Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Andoh T, 2002, ANN NY ACAD SCI, V962, P1, DOI 10.1111/j.1749-6632.2002.tb04051.x; Arodin L, 2014, FREE RADICAL BIO MED, V73, P328, DOI 10.1016/j.freeradbiomed.2014.05.011; Bai J, 2007, ANTIOXID REDOX SIGN, V9, P603, DOI 10.1089/ars.2006.1513; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Bar-Am O, 2005, FASEB J, V19, P1899, DOI 10.1096/fj.05-3794fje; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Cabet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137009; Cernotta N, 2011, MOL BIOL CELL, V22, P278, DOI 10.1091/mbc.E10-07-0616; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Cox AG, 2008, BIOCHEM PHARMACOL, V76, P1097, DOI 10.1016/j.bcp.2008.08.021; Desideri E, 2012, AUTOPHAGY, V8, P1769, DOI 10.4161/auto.22037; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Eftekharpour E, 2000, GLIA, V31, P241, DOI 10.1002/1098-1136(200009)31:3<241::AID-GLIA50>3.0.CO;2-9; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ghavami S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.36; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gu Z, 2005, CELL DEATH DIFFER, V12, P1202, DOI 10.1038/sj.cdd.4401705; Haga S, 2014, ANTIOXID REDOX SIGN, V21, P2515, DOI 10.1089/ars.2013.5391; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hintze KJ, 2003, J NUTR, V133, P2721, DOI 10.1093/jn/133.9.2721; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kiermayer C, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002153; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Levonen AL, 2014, FREE RADICAL BIO MED, V71, P196, DOI 10.1016/j.freeradbiomed.2014.03.025; Li L, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/467245; Lin YX, 2015, MOL PHARMACEUT, V12, P2869, DOI 10.1021/acs.molpharmaceut.5b00060; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu ZH, 2013, NEURAL REGEN RES, V8, P3275, DOI 10.3969/j.issn.1673-5374.2013.35.002; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Lu J., 2007, P NATL ACAD SCI US, V104; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Marzano C, 2007, FREE RADICAL BIO MED, V42, P872, DOI 10.1016/j.freeradbiomed.2006.12.021; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; Perez-Perez ME, 2014, AUTOPHAGY, V10, P1953, DOI 10.4161/auto.34396; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shao FY, 2015, ONCOTARGET, V6, P30939, DOI 10.18632/oncotarget.5132; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Walter C, 2016, NEUROPHARMACOLOGY; [王增林 Wang Zenglin], 2014, [油气地质与采收率, Petroleum Geology and Recovery Efficiency], V21, P5; Xu HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063232; You BR, 2015, MOL MED REP, V11, P1428, DOI 10.3892/mmr.2014.2830; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zhou KL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17130	61	20	20	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC	2016	101						53	70		10.1016/j.freeradbiomed.2016.09.026			18	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	EG0DN	WOS:000390701300006	27693380				2022-02-06	
J	Patino, P; Parada, E; Farre-Alins, V; Molz, S; Cacabelos, R; Marco-Contelles, J; Lopez, MG; Tasca, CI; Ramos, E; Romero, A; Egea, J				Patino, Paloma; Parada, Esther; Farre-Alins, Victor; Molz, Simone; Cacabelos, Ramon; Marco-Contelles, Jose; Lopez, Manuela G.; Tasca, Carla I.; Ramos, Eva; Romero, Alejandro; Egea, Javier			Melatonin protects against oxygen and glucose deprivation by decreasing extracellular glutamate and Nox-derived ROS in rat hippocampal slices	NEUROTOXICOLOGY			English	Article						Melatonin; Cerebral ischemia; Glutamate Neurotoxicity; OGD-reoxygenation; Rat hippocampal slices	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; CELL-DEATH; SUPEROXIDE-PRODUCTION; REACTIVE OXYGEN; NADPH OXIDASE; NEURONS; STROKE; MICE	Therapeutic interventions on pathological processes involved in the ischemic cascade, such as oxidative stress, neuroinflammation, excitotoxicity and/or apoptosis, are of urgent need for stroke treatment. Melatonin regulates a large number of physiological actions and its beneficial properties have been reported. The aim of this study was to investigate whether melatonin mediates neuroprotection in rat hippocampal slices subjected to oxygen-glucose-deprivation (OGD) and glutamate excitotoxicity. Thus, we describe here that melatonin significantly reduced the amount of lactate dehydrogenase released in the OGD-treated slices, reverted neuronal injury caused by OGD-reoxygenation in CAl and CA3 hippocampal regions, restored the reduction of GSH content of the hippocampal slices induced by OGD, and diminished the oxidative stress produced in the reoxygenation period. Furthermore, melatonin afforded maximum protection against glutamate-induced toxicity and reversed the glutamate released almost basal levels, at 10 and 30 mu M concentration, respectively. Consequently, we propose that melatonin might strongly and positively influence the outcome of brain ischemia/reperfusion. (C) 2016 Elsevier B.V. All rights reserved.	[Patino, Paloma] La Paz Univ Hosp, Paediat Unit, Paseo Castellana 261, Madrid 28046, Spain; [Parada, Esther; Farre-Alins, Victor; Lopez, Manuela G.; Egea, Javier] Hosp Univ Princesa, Inst Invest Sanitaria, Serv Farmacol Clin, Madrid, Spain; [Parada, Esther; Farre-Alins, Victor; Lopez, Manuela G.; Egea, Javier] Univ Autonoma Madrid, Inst Teofilo Hernando, C Arzobispo Morcillo 4, E-28049 Madrid, Spain; [Parada, Esther; Farre-Alins, Victor; Lopez, Manuela G.; Egea, Javier] Univ Autonoma Madrid, Dept Pharmacol, C Arzobispo Morcillo 4, E-28049 Madrid, Spain; [Farre-Alins, Victor] Contestado Univ, Sch Pharm, BR-89460000 Canoinhas, SC, Brazil; [Cacabelos, Ramon; Tasca, Carla I.] Inst CNS Disorders & Genom Med, EuroEspes Biomed Res Ctr, La Corunna 15166, Spain; [Cacabelos, Ramon] Camilo Jose Cela Univ, Chair Genom Med, Madrid, Spain; [Marco-Contelles, Jose] Inst Gen Organ Chem CSIC, Lab Med Chem, Juan Cierva 3, Madrid 28006, Spain; [Tasca, Carla I.] Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil; [Ramos, Eva; Romero, Alejandro] Univ Complutense Madrid, Fac Vet Med, Dept Toxicol & Pharmacol, E-28040 Madrid, Spain		Egea, J (corresponding author), Hosp Univ Princesa, Inst Invest Sanitaria, Serv Farmacol Clin, Madrid, Spain.; Romero, A (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Toxicol & Farmacol, Avda Puerta de Hierro S-N, E-28040 Madrid, Spain.	manarome@ucm.es; javier.egea@inv.uam.es	Egea, Javier/X-7281-2019; Lopez, Manuela G/D-2164-2015; Ramos, Eva/A-8275-2018; Tasca, Carla Ines/AAB-8287-2019; Romero, Alejandro/A-8282-2018; Romero, Alejandro/N-9686-2019	Egea, Javier/0000-0003-4704-3019; Lopez, Manuela G/0000-0003-4461-8788; Tasca, Carla Ines/0000-0002-3414-6150; Romero, Alejandro/0000-0001-5483-4973; Romero, Alejandro/0000-0001-5483-4973; RAMOS ALONSO, EVA/0000-0001-5791-0687; FARRE ALINS, VICTOR/0000-0002-6908-1705	IS Carlos III, Programa Miguel Servet [CP14/00008]; IS Carlos III research contract under Miguel Servet Program; Spanish Ministry of Economy and CompetenceSpanish Government [SAF2015-63935-R]	This work was supported by a grant from IS Carlos III, Programa Miguel Servet (CP14/00008) and IS Carlos III research contract under Miguel Servet Program to JE. MGL has a grant from Spanish Ministry of Economy and Competence Ref. SAF2015-63935-R.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; Andersen LPH, 2016, CLIN DRUG INVEST, V36, P169, DOI 10.1007/s40261-015-0368-5; Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Buendia I, 2015, NEUROPHARMACOLOGY, V99, P187, DOI 10.1016/j.neuropharm.2015.07.014; CHIANG G L, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P643; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Egea J, 2014, NEUROSCIENCE, V267, P11, DOI 10.1016/j.neuroscience.2014.02.025; Egea J, 2012, NEUROPHARMACOLOGY, V62, P1082, DOI 10.1016/j.neuropharm.2011.10.022; El-Denshary E. S., 2002, J PINEAL RES, V33, P87; FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A; Fiorina P, 1996, LANCET, V347, P692, DOI 10.1016/S0140-6736(96)91246-5; He Z, 2014, CELL MOL NEUROBIOL, V34, P539, DOI 10.1007/s10571-014-0037-x; Jefferies H, 2003, ANZ J SURG, V73, P517, DOI 10.1046/j.1445-1433.2003.02682.x; Juan WS, 2014, J PINEAL RES, V56, P213, DOI 10.1111/jpi.12114; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Koh PO, 2008, J PINEAL RES, V45, P199, DOI 10.1111/j.1600-079X.2008.00577.x; Koh PO, 2008, J PINEAL RES, V44, P101, DOI 10.1111/j.1600-079X.2007.00495.x; Koh PO, 2012, J PINEAL RES, V53, P358, DOI 10.1111/j.1600-079X.2012.01005.x; Koh PO, 2012, J PINEAL RES, V52, P57, DOI 10.1111/j.1600-079X.2011.00918.x; Kumar VSS, 2014, CURR MED CHEM, V21, P2065, DOI 10.2174/0929867321666131228204246; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lezoualch F, 1996, NEUROREPORT, V7, P2071, DOI 10.1097/00001756-199609020-00003; Li HY, 2014, J PINEAL RES, V57, P110, DOI 10.1111/jpi.12148; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Lorrio S, 2013, NEUROPHARMACOLOGY, V67, P403, DOI 10.1016/j.neuropharm.2012.12.001; Manev H, 1996, FASEB J, V10, P1546, DOI 10.1096/fasebj.10.13.8940301; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Molz S, 2008, BRAIN RES, V1231, P113, DOI 10.1016/j.brainres.2008.07.009; Molz S, 2008, NEUROCHEM RES, V33, P27, DOI 10.1007/s11064-007-9402-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishio N, 2013, NEUROSCIENCE, V247, P201, DOI 10.1016/j.neuroscience.2013.05.023; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Parada E, 2014, J PINEAL RES, V56, P204, DOI 10.1111/jpi.12113; Perez EL, 2012, NEUROBIOL DIS, V47, P331, DOI 10.1016/j.nbd.2012.05.010; Reiter RJ, 1997, ANN NY ACAD SCI, V825, P70, DOI 10.1111/j.1749-6632.1997.tb48415.x; Romero A, 2013, CNS NEUROSCI THER, V19, P285, DOI 10.1111/cns.12073; Schousboe A, 2003, NEUROCHEM RES, V28, P347, DOI 10.1023/A:1022397704922; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; Uchida K, 2004, J PINEAL RES, V37, P215, DOI 10.1111/j.1600-079X.2004.00159.x; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Weimar Christian, 2006, Expert Rev Neurother, V6, P185, DOI 10.1586/14737175.6.2.185; Yang Y, 2015, J PINEAL RES, V58, P61, DOI 10.1111/jpi.12193; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006	56	20	23	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	DEC	2016	57						61	68		10.1016/j.neuro.2016.09.002			8	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	EE3NT	WOS:000389497000008	27620136				2022-02-06	
J	Skovira, JW; Wu, JF; Matyas, JJ; Kumar, A; Hanscom, M; Kabadi, SV; Fang, R; Faden, AI				Skovira, Jacob W.; Wu, Junfang; Matyas, Jessica J.; Kumar, Alok; Hanscom, Marie; Kabadi, Shruti V.; Fang, Raymond; Faden, Alan I.			Cell cycle inhibition reduces inflammatory responses, neuronal loss, and cognitive deficits induced by hypobaria exposure following traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Inflammation; Neuronal cell death; Aeromedical evacuation; Hypobaria	SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; PROVIDES NEUROPROTECTION; AEROMEDICAL EVACUATION; THERAPEUTIC TARGET; DEPENDENT KINASES; SCAR FORMATION; CDK INHIBITOR; CNS INJURY	Background: Traumatic brain injury (TBI) patients in military settings can be exposed to prolonged periods of hypobaria (HB) during aeromedical evacuation. Hypobaric exposure, even with supplemental oxygen to prevent hypoxia, worsens outcome after experimental TBI, in part by increasing neuroinflammation. Cell cycle activation (CCA) after TBI has been implicated as a mechanism contributing to both post-traumatic cell death and neuroinflammation. Here, we examined whether hypobaric exposure in rats subjected to TBI increases CCA and microglial activation in the brain, as compared to TBI alone, and to evaluate the ability of a cyclin-dependent kinase (CDK) inhibitor (CR8) to reduce such changes and improve behavioral outcomes. Methods: Adult male Sprague Dawley rats were subjected to fluid percussion-induced injury, and HB exposure was performed at 6 h after TBI. Western blot and immunohistochemistry (IHC) were used to assess cell cycle-related protein expression and inflammation at 1 and 30 days after injury. CR8 was administered intraperitoneally at 3 h post-injury; chronic functional recovery and histological changes were assessed. Results: Post-traumatic hypobaric exposure increased upregulation of cell cycle-related proteins (cyclin D1, proliferating cell nuclear antigen, and CDK4) and microglial/macrophage activation in the ipsilateral cortex at day 1 post-injury as compared to TBI alone. Increased immunoreactivity of cell cycle proteins, as well as numbers of Iba-1(+) and GFAP(+) cells in both the ipsilateral cortex and hippocampus were found at day 30 post-injury. TBI/HB significantly increased the numbers of NADPH oxidase 2 (gp91(phox)) enzyme-expressing cells that were co-localized with Iba-1(+). Each of these changes was significantly reduced by the administration of CR8. Unbiased stereological assessment showed significantly decreased numbers of microglia displaying the highly activated phenotype in the ipsilateral cortex of TBI/HB/CR8 rats compared with TBI/HB/Veh rats. Moreover, treatment with this CDK inhibitor also significantly improved spatial and retention memory and reduced lesion volume and hippocampal neuronal cell loss. Conclusions: HB exposure following TBI increases CCA, neuroinflammation, and associated neuronal cell loss. These changes and post-traumatic cognitive deficits are reduced by CDK inhibition; such drugs may therefore serve to protect TBI patients requiring aeromedical evacuation.	[Skovira, Jacob W.; Wu, Junfang; Matyas, Jessica J.; Kumar, Alok; Hanscom, Marie; Kabadi, Shruti V.; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Skovira, Jacob W.; Wu, Junfang; Matyas, Jessica J.; Kumar, Alok; Hanscom, Marie; Kabadi, Shruti V.; Faden, Alan I.] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Skovira, Jacob W.] US Army Med Res Inst Chem Def, Div Res, Pharmacol Branch, Aberdeen, MD 21010 USA; [Fang, Raymond] Univ Maryland, Sch Med, Program Trauma, Ctr Sustainment Trauma & Readiness Skills C STARS, Baltimore, MD 21201 USA		Wu, JF (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.; Wu, JF (corresponding author), Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA.	jwu@anes.umm.edu; afaden@anes.umm.edu		Hanscom, Marie/0000-0001-8308-135X; Faden, Alan I./0000-0003-0128-2348	711 HPW/XPT [FA8650-11-2-6D04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007698] Funding Source: NIH RePORTER	This study was supported by the 711 HPW/XPT under Cooperative Agreement number FA8650-11-2-6D04. The funder had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arendt T, 2012, MOL NEUROBIOL, V46, P125, DOI 10.1007/s12035-012-8262-0; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Dardiotis E, 2012, BRAIN INJURY PATHOGE, P2446, DOI [10.4161/cc.29420, DOI 10.4161/CC.29420]; Defense and Veteran Brain Injury Center, 2016, DOD TBI WORLDW NUMB; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Fang R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1043; Faul M, 2010, TRAUMATIC BRAIN INJU; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Kim H, 2016, PSYCHIAT INVEST, V13, P127, DOI 10.4306/pi.2016.13.1.127; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Reno J, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1023; Sanphui P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078842; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Seward ME, 2013, J CELL SCI, V126, P1278, DOI 10.1242/jcs.1125880; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Wu J, 2014, CELL CYCLE, V13, P15; Wu JF, 2016, PAIN, V157, P488, DOI 10.1097/j.pain.0000000000000393; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Wu JF, 2012, CELL CYCLE, V11, P1782, DOI 10.4161/cc.20153	43	20	20	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	DEC 1	2016	13								299	10.1186/s12974-016-0769-2			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EG0IF	WOS:000390714500001	27903275	Green Published, gold			2022-02-06	
J	Ye, F; Li, XY; Li, F; Li, JX; Chang, W; Yuan, J; Chen, J				Ye, Fang; Li, Xiaoyi; Li, Fen; Li, Jianxin; Chang, Wei; Yuan, Jing; Chen, Jun			Cyclosporin A protects against Lead neurotoxicity through inhibiting mitochondrial permeability transition pore opening in nerve cells	NEUROTOXICOLOGY			English	Article						Pb; Neurotoxicity; CyPD; MPTP; CSA; ROS	INDUCED OXIDATIVE STRESS; TRAUMATIC BRAIN-INJURY; CYCLOPHILIN-D; INDUCED APOPTOSIS; SH-SY5Y CELLS; DEATH; TRANSLOCATION; AUTOPHAGY; EXPOSURE; HIPPOCAMPUS	Mitochondria play a key role in the process of lead (Pb)-induced impairment in nervous system. To further clarify the underlying mechanism of Pb neurotoxicity, this study was designed to investigate the role of mitochondrial permeability transition (MPT) and cyclophilin D (CyPD), a component of MPT pore (MPTP), in Pb-induced mitochondrial apoptosis in nerve cells. In SH-SY5Y and PC12 cells, Cyclosporin A (CSA), a special inhibitor of CyPD, could alleviate cell death, lactate dehydrogenase (LDH) leakage and adenosine 5 triphosphate (ATP) decrease caused by PbAc. In the following experiments, we found PbAc increased the protein level of CyPD and induced MPT pore (MPTP) opening. When cells were pretreated with CSA to inhibit MPTP opening, the Pb-induced impairment of mitochondrial morphology (swelling and rupture) and the loss of mitochondria were attenuated. In addition, CSA obviously ameliorated the Pb-induced damage of mitochondrial function, such as reactive oxygen species (ROS) boost and mitochondrial membrane potential (MMP) collapse, as well as the release of cytochrome C (Cyto C) and apoptosis-inducing factor (AIF) from mitochondria. These beneficial effects could finally result in cell survival under Pb-exposure conditions. Furthermore, scavenging ROS also significantly abrogated MPTP opening and attenuated Pb neurotoxicity. Therefore, we found that MPT played an important role in Pb-induced mitochondrial damage and, ultimately, cell death. Our results provided a potential strategy for inhibiting PbAc neurotoxicity. However, due to the high Pb concentrations used in this study further investigations at Pb concentrations closer to human exposure are needed to verify the results. (C) 2016 Elsevier B.V. All rights reserved.	[Ye, Fang; Li, Fen; Yuan, Jing; Chen, Jun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan, Peoples R China; [Ye, Fang; Yuan, Jing; Chen, Jun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan, Peoples R China; [Li, Xiaoyi] Huazhong Univ Sci & Technol, Dept Immunol, Tongji Med Coll, Wuhan, Peoples R China; [Li, Fen] Dis Control & Prevent Ctr Xiqing, Tianjin, Peoples R China; [Li, Jianxin] Xiaonan Matern & Child Hlth Hosp, Dept Internal Med, Xiaogan, Peoples R China; [Chang, Wei] Wuhan Univ Sci & Technol, Dept Publ Hlth, Coll Med, Wuhan, Peoples R China		Chen, J (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan, Peoples R China.	chen-jun@hust.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273019, 81072265]	This work was supported by the National Natural Science Foundation of China (Grant NO. 81273019 and 81072265).	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baranowska-Bosiacka I, 2013, TOXICOLOGY, V303, P187, DOI 10.1016/j.tox.2012.10.027; Baranowska-Bosiacka I, 2011, TOXICOLOGY, V280, P24, DOI 10.1016/j.tox.2010.11.004; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Bustos PL, 2015, PARASITOLOGY, V142, P1024, DOI 10.1017/S0031182015000232; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chao SL, 2007, J BIOCHEM MOL TOXIC, V21, P265, DOI 10.1002/jbt.20191; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Garza A, 2006, MED SCI MONITOR, V12, pRA57; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; He LH, 2000, J BIOL CHEM, V275, P12175, DOI 10.1074/jbc.275.16.12175; Izzo V, 2016, TRENDS CELL BIOL, V26, P655, DOI 10.1016/j.tcb.2016.04.006; Katoh H, 2002, CIRCULATION, V105, P2666, DOI 10.1161/01.CIR.0000016831.41648.04; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lee J, 2010, J INT MED RES, V38, P1561, DOI 10.1177/147323001003800501; Li CC, 2014, NEUROTOXICOL TERATOL, V46, P1, DOI 10.1016/j.ntt.2014.08.007; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Linard D, 2009, ARCH BIOCHEM BIOPHYS, V491, P39, DOI 10.1016/j.abb.2009.09.002; Liu CM, 2012, TOXICOL APPL PHARM, V258, P330, DOI 10.1016/j.taap.2011.11.015; Liu G, 2016, ARCH TOXICOL, V90, P1193, DOI 10.1007/s00204-015-1547-0; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Marchlewicz M, 2004, CHEMOSPHERE, V57, P1553, DOI 10.1016/j.chemosphere.2004.08.102; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005; Matas J, 2009, J MOL CELL CARDIOL, V46, P420, DOI 10.1016/j.yjmcc.2008.10.020; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Patrick L, 2006, ALTERN MED REV, V11, P114; Patrick L, 2006, ALTERN MED REV, V11, P2; Prins JM, 2010, TOXICOL SCI, V113, P169, DOI 10.1093/toxsci/kfp249; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Sun XY, 1999, TOXICOL APPL PHARM, V156, P40, DOI 10.1006/taap.1999.8622; Toman J, 2011, J BIOENERG BIOMEMBR, V43, P3, DOI 10.1007/s10863-011-9337-8; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Verma SK, 2005, BASIC CLIN PHARMACOL, V96, P475, DOI 10.1111/j.1742-7843.2005.pto_96611.x; Xu J, 2006, TOXICOL LETT, V166, P160, DOI 10.1016/j.toxlet.2006.06.643; Ye F, 2015, FOOD CHEM TOXICOL, V86, P191, DOI 10.1016/j.fct.2015.10.009; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	47	20	21	3	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	DEC	2016	57						203	213		10.1016/j.neuro.2016.10.004			11	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	EE3NT	WOS:000389497000024	27725305				2022-02-06	
J	Goodrich, JA; Kim, JH; Situ, R; Taylor, W; Westmoreland, T; Du, F; Parks, S; Ling, G; Hwang, JY; Rapuano, A; Bandak, FA; de Lanerolle, NC				Goodrich, James A.; Kim, Jung H.; Situ, Robert; Taylor, Wesley; Westmoreland, Ted; Du, Fu; Parks, Steven; Ling, Geoffrey; Hwang, Jung Y.; Rapuano, Amedeo; Bandak, Faris A.; de lanerolle, Nihal C.			Neuronal and glial changes in the brain resulting from explosive blast in an experimental model	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; TEMPORAL-LOBE; AXONAL INJURY; EXPOSURE; SPECTROSCOPY; DENSITY; RATS	Mild traumatic brain injury (mTBI) is the signature injury in warfighters exposed to explosive blasts. The pathology underlying mTBI is poorly understood, as this condition is rarely fatal and thus postmortem brains are difficult to obtain for neuropathological studies. Here we report on studies of an experimental model with a gyrencephalic brain that is exposed to single and multiple explosive blast pressure waves. To determine injuries to the brain resulting from the primary blast, experimental conditions were controlled to eliminate any secondary or tertiary injury from blasts. We found small but significant levels of neuronal loss in the hippocampus, a brain area that is important for cognitive functions. Furthermore, neuronal loss increased with multiple blasts and the degree of neuronal injury worsened with time post-blast. This is consistent with our findings in the blast-exposed human brain based on magnetic resonance spectroscopic imaging. The studies on this experimental model thus confirm what has been presumed to be the case with the warfighter, namely that exposure to multiple blasts causes increased brain injury. Additionally, as in other studies of both explosive blast as well as closed head mTBI, we found astrocyte activation. Activated microglia were also prominent in white matter tracts, particularly in animals exposed to multiple blasts and at long post-blast intervals, even though injured axons (i.e. beta-APP positive) were not found in these areas. Microglial activation appears to be a delayed response, though whether they may contribute to inflammation related injury mechanism at even longer post-blast times than we tested here, remains to be explored. Petechial hemorrhages or other gross signs of vascular injury were not observed in our study. These findings confirm the development of neuropathological changes due to blast exposure. The activation of astrocytes and microglia, cell types potentially involved in inflammatory processes, suggest an important area for future study.	[Goodrich, James A.] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT USA; [Kim, Jung H.; Hwang, Jung Y.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Situ, Robert; Rapuano, Amedeo; de lanerolle, Nihal C.] Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA; [Taylor, Wesley; Westmoreland, Ted] Adv Med Training, Mckinney, TX USA; [Du, Fu] FD NeuroTechnol Inc, Ellicott City, MD USA; [Parks, Steven] ORA Inc, Fredericksburg, VA USA; [Ling, Geoffrey; Bandak, Faris A.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Bandak, Faris A.] Integrated Serv Grp Inc, Potomac, MD USA		de Lanerolle, NC (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	nihal.delanerolle@yale.edu			Defense Advanced Research Projects Agency "PREVENT" Research Program	This work was supported by a contract from Defense Advanced Research Projects Agency "PREVENT" Research Program. The views, opinions, and/or findings contained in this study are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the Defense Advanced Research Projects Agency or the Department of Defense.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; DAM AM, 1979, NEUROPATH APPL NEURO, V5, P249, DOI 10.1111/j.1365-2990.1979.tb00624.x; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; Hetherington H, 2015, Handb Clin Neurol, V127, P309, DOI 10.1016/B978-0-444-52892-6.00020-9; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KIM JH, 1990, ACTA NEUROPATHOL, V80, P41, DOI 10.1007/BF00294220; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	32	20	20	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	NOV 24	2016	4								124	10.1186/s40478-016-0395-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED0EI	WOS:000388515400002	27884214	Green Published, gold			2022-02-06	
J	Wilde, EA; Li, XQ; Hunter, JV; Narayana, PA; Hasan, K; Biekman, B; Swank, P; Robertson, C; Miller, E; McCauley, SR; Chu, ZD; Faber, J; McCarthy, J; Levin, HS				Wilde, Elisabeth A.; Li, Xiaoqi; Hunter, Jill V.; Narayana, Ponnada A.; Hasan, Khader; Biekman, Brian; Swank, Paul; Robertson, Claudia; Miller, Emmy; McCauley, Stephen R.; Chu, Zili David; Faber, Jessica; McCarthy, James; Levin, Harvey S.			Loss of Consciousness Is Related to White Matter Injury in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; loss of consciousness; mild traumatic brain injury	DIFFUSE AXONAL INJURY; IDENTIFICATION TEST AUDIT; TENSOR IMAGING FINDINGS; ABUSE SCREENING-TEST; PRACTICAL SCALE; ABNORMALITIES; ASSOCIATION; VALIDATION; CONCUSSION; ANISOTROPY	To study the relation of loss of consciousness (LOC) to white matter integrity after mild traumatic brain injury (mTBI), we acquired diffusion tensor imaging (DTI) at 3 Tesla in 79 participants with mTBI and normal computed tomography (age 18 to 50 years) whom we imaged after a mean post-injury interval of 25.9 h (standard deviation = 12.3) and at 3 months. For comparison, 64 participants with orthopedic injury (OI) underwent DTI at similar intervals. Quantitative tractography was used to measure fractional anisotropy (FA) and mean diffusivity (MD) in the left and right uncinate fasciculus (UF), left and right inferior frontal occipital fasciculus (IFOF), and the genu of the corpus callosum. Generalized estimating equation models assessed the association between LOC and both MD and FA across time after mTBI and compared their DTI metrics with the OI group. LOC was significantly related to MD in UF and IFOF (p values ranged from p < 0.0001 to 0.0270) and to FA in left UF (p = 0.0104) and right UF (p = 0.0404). Between-group differences in MD were significant for left UF, left and right IFOF, and the genu of the corpus callosum on initial DTI, but not at 3 months post-injury, and these differences were specific to the mTBI subgroup with LOC. Groups did not differ in FA at either occasion. Early DTI may provide a biomarker for mTBI with LOC, even in patients whose consciousness recovers by arrival in the emergency department. MD better differentiates mTBI from OI than FA on early DTI, but this is specific to mTBI with LOC. DTI findings support a continuum of white matter injury in early mTBI.	[Wilde, Elisabeth A.; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Li, Xiaoqi; Biekman, Brian; Faber, Jessica] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hunter, Jill V.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Chu, Zili David] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Narayana, Ponnada A.; Hasan, Khader; McCarthy, James] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Swank, Paul] Univ Texas Sch Publ Hlth, Houston, TX USA; [Miller, Emmy] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA		Levin, HS (corresponding author), Baylor Coll Med, One Baylor Plaza BCM637, Houston, TX 77030 USA.	hlevin@bcm.edu	Hasan, Khader M./ABB-5767-2020		Department of DefenseUnited States Department of Defense [W81XWH-08-2-0133, PT074693P2]	This work was supported by the Congressionally Directed Medical Research Program by the Department of Defense (W81XWH-08-2-0133, PT074693P2). The funding source had no role in the interpretation of data, writing of this paper, or in the decision to submit for publication. The contents of this paper are solely the responsibility of the authors and do not represent the official views of the Department of Defense. The authors wish to thank James Montier and English Pratts, Baylor College of Medicine, for their assistance in the preparation of this manuscript. We also are indebted to the research staff in the Mission Connect consortium and to the patients who participated in the project.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bohn M.J., VALIDITY DRUG ABUSE; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chaim TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110199; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hayes J.P., 2015, NAT REV NEUROL, V11, P247; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaya A, 2008, J INT MED RES, V36, P9, DOI 10.1177/147323000803600102; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Martino J, 2014, CLIN ANAT, V27, P563, DOI 10.1002/ca.22321; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; TEASDALE G, 1974, LANCET, V2, P81; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	50	20	20	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2016	33	22					2000	2010		10.1089/neu.2015.4212			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EC4OL	WOS:000388112300003	26801471				2022-02-06	
J	Chen, H; Chan, YL; Nguyen, LT; Mao, YL; de Rosa, A; Beh, IT; Chee, C; Oliver, B; Herok, G; Saad, S; Gorrie, C				Chen, Hui; Chan, Yik Lung; Nguyen, Long The; Mao, Yilin; de Rosa, Alicia; Beh, Ing Tsyr; Chee, Candice; Oliver, Brian; Herok, George; Saad, Sonia; Gorrie, Catherine			Moderate traumatic brain injury is linked to acute behaviour deficits and long term mitochondrial alterations	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						behavioural studies; immunohistochemistry; mitochondria; mitophagy; oxidative stress; rat brain; trauma	OXIDATIVE STRESS; NEURONAL AUTOPHAGY; CEREBRAL-ISCHEMIA; IN-VITRO; DYSFUNCTION; DISEASE; INFLAMMATION; METABOLISM; HEMORRHAGE; MITOPHAGY	Traumatic brain injury (TBI) remains one of the leading causes of death and disability worldwide. Mild TBI may lead to neuropsychiatric sequelae, including memory loss and motor impairment. Mitochondrial dysfunction and oxidative stress have a contributory role in several neurological disorders; however, their association with mitophagy in mild TBI is unclear. TBI was induced in female Sprague Dawley (SD) rats using a New York University Impactor (10 g, impactor head 2.5 mm diameter, weight drop 50 mm) and compared to sham surgery controls. The novel object recognition and error ladder tests were performed at 24 hours and for 6 weeks post injury, and the brains were examined histologically to confirm the extent of injury. Mitochondria manganese superoxide dismutase (MnSOD) and the oxidative phosphorylation (OXPHOS) complexes I-V (CI-CV), as well as mitophagy markers, dynamin related protein 1 (DRP-1), LC3A/B and PTEN-induced putative kinase 1 (PINK-1), were measured in the penumbra by western blot. At 24 hours sham rats performed as expected on a novel object recognition test while TBI rats showed cognitive deficits at the early time points. TBI rats also showed more early motor deficits on a horizontal ladder, compared with the sham rats. MnSOD, OXPHOS CI, CIII and CV protein levels were significantly lower in the TBI group at 24 hours. DRP-1, LC3A/B I and II, and PINK-1 were increased at 6 weeks suggesting abnormal mitophagy. Moderate TBI caused immediate cognitive and mild motor functional deficits in the rats that did not persist. Reduced antioxidative capacity and possibly compromised mitochondrial function may affect the long term functional recovery.	[Chen, Hui; Chan, Yik Lung; Nguyen, Long The; Mao, Yilin; de Rosa, Alicia; Beh, Ing Tsyr; Chee, Candice; Oliver, Brian; Herok, George; Saad, Sonia; Gorrie, Catherine] Univ Technol Sydney, Fac Sci, Sch Life Sci, Broadway, NSW, Australia; [Nguyen, Long The; Saad, Sonia] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia; [Beh, Ing Tsyr; Chee, Candice] Singapore Polytech, Sch Chem Life Sci, Singapore, Singapore		Chen, H; Gorrie, C (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, Broadway, NSW, Australia.	hui.chen-1@uts.edu.au; catherine.gorrie@uts.edu.au	Nguyen, Long/AAH-2433-2021; Chen, Hui/R-6137-2019; Oliver, Brian/E-7939-2010; Gorrie, Catherine/S-6591-2019; Chen, Hui/D-2005-2014	Chen, Hui/0000-0001-6883-3752; Oliver, Brian/0000-0002-7122-9262; Chen, Hui/0000-0001-6883-3752; Saad, Sonia/0000-0001-8067-8046; Chan, Yik Lung/0000-0002-9605-4200; Mao, Yilin/0000-0002-3573-6486; Gorrie, Catherine/0000-0001-5934-2492	Faculty of Science, University of Technology Sydney	Faculty of Science, University of Technology Sydney	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Amadoro G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00018; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bertolin G, 2013, AUTOPHAGY, V9, P1801, DOI 10.4161/auto.25884; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Gabryel B, 2012, PHARMACOL REP, V64, P1; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jahani-Asl A, 2011, J BIOL CHEM, V286, P4772, DOI 10.1074/jbc.M110.167155; Knoferl MW, 2002, ANN SURG, V235, P105, DOI 10.1097/00000658-200201000-00014; Knoferl MW, 2001, AM J PHYSIOL-CELL PH, V281, pC1131, DOI 10.1152/ajpcell.2001.281.4.C1131; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McDonald RPA, 1999, NEUROREPORT, V10, P1875, DOI 10.1097/00001756-199906230-00014; Metz GA, 2009, J VIS EXP; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; Nguyen LT, 2015, AM J PHYSIOL-RENAL, V308, pF689, DOI 10.1152/ajprenal.00417.2014; O'Carroll SJ, 2013, NEUROSCI RES, V75, P256, DOI 10.1016/j.neures.2013.01.004; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Owens K, 2013, TRANSL STROKE RES, V4, P618, DOI 10.1007/s12975-013-0278-x; Park J, 2013, J NEUROCHEM, V127, P221, DOI 10.1111/jnc.12361; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Wager K, 2013, AUTOPHAGY, V9, P1693, DOI 10.4161/auto.25082; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang WJ, 2015, NEUROCHEM INT, V80, P33, DOI 10.1016/j.neuint.2014.11.003; Yano M, 1998, J BIOL CHEM, V273, P26844, DOI 10.1074/jbc.273.41.26844; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132	61	20	21	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	NOV	2016	43	11					1107	1114		10.1111/1440-1681.12650			8	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	EC7HI	WOS:000388307400011	27557565	Green Accepted			2022-02-06	
J	Kurowski, BG; Wade, SL; Dexheimer, JW; Dyas, J; Zhang, NH; Babcock, L				Kurowski, Brad G.; Wade, Shari L.; Dexheimer, Judith W.; Dyas, Jenna; Zhang, Nanhua; Babcock, Lynn			Feasibility and Potential Benefits of a Web-Based Intervention Delivered Acutely After Mild Traumatic Brain Injury in Adolescents: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescents; concussion; intervention; mild traumatic brain injury; Web-based	COGNITIVE-BEHAVIORAL THERAPY; SPORT-RELATED CONCUSSION; PROBLEM-SOLVING THERAPY; POSTCONCUSSION SYNDROME; EXECUTIVE DYSFUNCTION; RANDOMIZED-TRIAL; CHILDREN; SYMPTOMS; RECOVERY; EFFICACY	Background: There is a paucity of evidence-based interventions for mild traumatic brain injury (mTBI). Objective: To evaluate the feasibility and potential benefits of an interactive, Web-based intervention for mTBI. Setting: Emergency department and outpatient settings. Participants: Of the 21 adolescents aged 11 to 18 years with mTBI recruited from November 2013 to June 2014 within 96 hours of injury, 13 completed the program. Design: Prospective, open pilot. Intervention: The Web-based Self-Management Activity-restriction and Relaxation Training (SMART) program incorporates anticipatory guidance and psychoeducation, self-management and pacing of cognitive and physical activities, and cognitive-behavioral principles for early management of mTBI in adolescents. Main Measures: Primary: Daily Post-Concussion Symptom Scale (PCSS). Secondary: Daily self-reported ratings of activities and satisfaction survey. Results: Average time from injury to baseline testing was 14.0 (standard deviation = 16.7) hours. Baseline PCSS was 23.6 (range: 0-46), and daily activity was 1.8 (range: 0-5.75) hours. Repeated-measures, generalized linear mixed-effects model analysis demonstrated a significant decrease of PCSS at a rate of 2.0 points per day that stabilized after about 2 weeks. Daily activities, screen time, and physical activity increased by 0.06 (standard error [SE] = 0.04, P = .09), 0.04 (SE = 0.02, P = .15), and 0.03 (SE = 0.02, P = .05) hours per day, respectively, over the 4-week follow-up. Satisfaction was rated highly by parents and youth. Conclusions: Self-Management Activity-restriction and Relaxation Training is feasible and reported to be helpful and enjoyable by participants. Future research will need to determine the comparative benefits of SMART and ideal target population.	[Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Dexheimer, Judith W.; Dyas, Jenna; Babcock, Lynn] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Emergency Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Dexheimer, Judith W.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biomed Informat, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org		Babcock, Lynn/0000-0002-2658-6893; Zhang, Nanhua/0000-0001-5796-3404	Ohio Department of Public Safety; Cincinnati Children's Research Foundation Place Outcomes Grant; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER	Funding for this study was supported in part by the Ohio Department of Public Safety, Cincinnati Children's Research Foundation Place Outcomes Grant, National Institute for Child Health and Human Development K23HD074683-01A1, and Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; CASEY R, 1987, PEDIATRICS, V80, P159; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Dexheimer JW, 2014, PED AC SOC ANN C VAN; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; ImPACT Applications Inc, 2011, IMM POSTC ASS TEST I; Institute of Medicine and National Research Council Committee on Sports Related Concussion in Youth, 2014, SPORTS RELATED CONCU; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lukens E.P., 2004, BRIEF TREATMENT CRIS, V4, P205, DOI [DOI 10.1093/BRIEF-TREATMENT/MHH019, https://doi.org/10.1093/brief-treatment/mhh019]; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2013, NAT REV NEUROL, V9, P361, DOI 10.1038/nrneurol.2013.88; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vidal PG, 2012, PEDIATR ANN, V41, pE186, DOI 10.3928/00904481-20120827-10; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	49	20	20	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					369	378		10.1097/HTR.0000000000000180			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800008	26360000	Green Accepted			2022-02-06	
J	Tlustos, SJ; Kirkwood, MW; Taylor, HG; Stancin, T; Brown, TM; Wade, SL				Tlustos, Sarah J.; Kirkwood, Michael W.; Taylor, H. Gerry; Stancin, Terry; Brown, Tanya M.; Wade, Shari L.			A Randomized Problem-Solving Trial for Adolescent Brain Injury: Changes in Social Competence	REHABILITATION PSYCHOLOGY			English	Article						social adjustment; traumatic brain injury; closed head injury; adolescence	EXECUTIVE FUNCTION DEFICITS; BEHAVIOR RATING INVENTORY; CHILDHOOD HEAD-INJURY; COMPLICATED MILD; NEUROSCIENCE PERSPECTIVE; ACADEMIC-ACHIEVEMENT; FUNCTIONAL OUTCOMES; EMOTION PERCEPTION; CLINICAL-TRIAL; CHILDREN	Purpose/Objective: Traumatic brain injury (TBI) in adolescence has well documented effects on social competence. Few studies have examined the effects of behavioral interventions on social competence or identified factors associated with changes in social competence after injury. Research Method/Design: Adolescents with moderate to severe TBI ages 12-17 years were randomized within 6 months of injury to either a problem solving and communication (CAPS) group that received online counseling (n = 65) or an Internet resources comparison (IRC) group (n = 67) for a comparative effectiveness trial. Parent-report measures of social competence (Child Behavior Checklist, CBCL; Home and Community Social Behavior Scales, HCSBS; Behavioral and Emotional Rating Scale, BERS-2) were administered at baseline (preintervention) and approximately 6 months later. Analyses examined these measures in relation to treatment group, TBI severity, and age. Regression analyses were also conducted to examine baseline measures of cognition as predictors of social competence after TBI. Results: CAPS had a more positive effect than the comparison condition on the HCSBS and BERS-2 for younger teens with moderate TBI and older teens with severe TBI. More parent-rated executive dysfunction at baseline was related to both lower concurrent levels of social competence and less positive gains in competence over time, whereas higher baseline IQ predicted greater gains in competence. Conclusions/Implications: CAPS may be effective for improving social competence for teens after TBI, with benefits dependent on the teen's age and injury severity. Parent-rated executive dysfunction, moreover, has utility in predicting both lower concurrent levels of social competence and subsequent postinjury gains in competence.	[Tlustos, Sarah J.; Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, 13123 East 16th Ave,B285, Aurora, CO 80045 USA; [Tlustos, Sarah J.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Boulder, CO 80309 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp, Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Brown, Tanya M.] Mayo Coll Med, Dept Psychol, Rochester, MI USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Medicine, Cincinnati, OH 45221 USA		Tlustos, SJ (corresponding author), Childrens Hosp Colorado, Dept Phys Med & Rehabil, 13123 East 16th Ave,B285, Aurora, CO 80045 USA.	sarah.tlustos@childrenscolorado.org	Stancin, Terry/L-7993-2019		National Institutes of Health from the National Institute of Mental Health [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; National Institute of Disability and Rehabilitation Research, Department of Education [H133B090010]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by a National Institutes of Health Grant R01-MH073764 from the National Institute of Mental Health, a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program, and by Grant H133B090010, to Dr. Shari L. Wade, from the National Institute of Disability and Rehabilitation Research, Department of Education. The authors acknowledge the contributions of Mary Ann Toth, Kendra McMullen, Robert Blaha, Elizabeth Hagesfeld, Michelle Jacobs, Daniel Maier, and Nina Fox in data collection and entry, Amy Cassedy in data management, and John Stullenberger in website support. The authors also acknowledge the contributions of the therapists JoAnne Carey, PsyD, Britt Nielsen, PsyD, and Brad Jackson, PhD.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Bedell GM, 2011, ARCH PHYS MED REHAB, V92, P765, DOI 10.1016/j.apmr.2010.12.029; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Centers for Disease Control and Prevention, 2010, YOUTH RISK BEH SURV; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chen XY, 1997, DEV PSYCHOL, V33, P518, DOI 10.1037/0012-1649.33.3.518; Clark C, 2002, J CHILD PSYCHOL PSYC, V43, P785, DOI 10.1111/1469-7610.00084; D'Zurilla TJ., 2004, SOCIAL PROBLEM SOLVI, P11, DOI [10.1037/10805-001, DOI 10.1037/10805-001]; DeRosier ME, 2010, READ WRIT Q, V27, P25, DOI 10.1080/10573569.2011.532710; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; EPSTEIN MH, 2002, THE JOURNAL OF BEHAV, V29, P208, DOI DOI 10.1007/BF02287707; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Guy SC, 2004, BRIEF SR BEHAV RATIN; Hessler DM, 2010, J ADOLESCENCE, V33, P241, DOI 10.1016/j.adolescence.2009.04.007; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Merrell KM., 2002, HOME COMMUNITY SOCIA; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; Parker J., 2006, DEV PSYCHOPATHOL RIS, V2, P419, DOI DOI 10.1002/9780470939383.CH12; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Redpath SJ, 2004, BRAIN INJURY, V18, P861, DOI 10.1080/02699050410001671838; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rockhill CM, 2009, J ADOLESCENCE, V32, P535, DOI 10.1016/j.adolescence.2008.06.011; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; TEASDALE G, 1974, LANCET, V2, P81; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; TURKSTRA LS, 2001, THE JOURNAL OF HEAD, V16, P469, DOI DOI 10.1097/00001199-200110000-00006; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; WADE SL, 2006, THE JOURNAL OF HEAD, V21, P57, DOI DOI 10.1097/00001199-200601000-00006; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	76	20	20	0	19	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2016	61	4					347	357		10.1037/rep0000098			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	EC3BK	WOS:000387999200001	27831729	Bronze, Green Accepted			2022-02-06	
J	Wang, T; Zhu, M; He, ZZ				Wang, Tao; Zhu, Mang; He, Zhong-Zheng			Low-Molecular-Weight Fucoidan Attenuates Mitochondrial Dysfunction and Improves Neurological Outcome After Traumatic Brain Injury in Aged Mice: Involvement of Sirt3	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Fucoidan; TBI; Mitochondrial dysfunction; Sirt3; Aging	OXIDATIVE STRESS; CLINICAL-TRIALS; EPIDEMIOLOGY; THERAPIES; MODEL	Traumatic brain injury (TBI) is a leading cause of death and long-term disability. Fucoidan, a sulfated polysaccharide extracted from brown algae, possesses potent anti-oxidative and anti-inflammatory effects. Considering TBI happens frequently in adults, especially in aged individuals, we herein sought to define the protective effects of low-molecular-weight fucoidan (LMWF) in the aged mice. 16- to 18-month-old mice administered with LMWF (1-50 mg/kg) or vehicle were subjected to TBI using a controlled cortical impact (CCI) model. LMWF at the doses of 10 and 50 mg/kg significantly reduced both cortical and hippocampal lesion volume. This protection was associated with reduced neuronal apoptosis, as evidenced by TUNEL staining. Importantly, LMWF was effective even when administered up to 4 h after TBI. Treatment with LMWF improved long-term neurobehavioral outcomes, including sensorimotor function, and hippocampus-associated spatial learning and memory. In addition, LMWF significantly suppressed protein carbonyl, lipid peroxidation, reactive oxygen species (ROS) generation, as well as mitochondrial dysfunction, which was evidenced by mitochondrial cytochrome c release and collapse of mitochondrial membrane potential (MMP). To evaluate the underlying molecular mechanisms, the expression of sirtuin 3 (Sirt3) was detected by RT-PCR and Western blot. The results showed that TBI significantly increased the expression of Sirt3, which was further elevated by LMWF treatment. Knockdown of Sirt3 using intracerebroventricular injection of small interfering RNA (siRNA) partially prevented the therapeutic effects of LMWF. Collectively, these findings demonstrated that LMWF exerts neuroprotection against TBI in the aged brain, which may be associated with the attenuation of mitochondrial dysfunction through Sirt3 activation.	[Wang, Tao; Zhu, Mang; He, Zhong-Zheng] Xi An Jiao Tong Univ, Dept Neurosurg, Xian Cent Hosp, Xian 710032, Shaanxi, Peoples R China		Wang, T (corresponding author), Xi An Jiao Tong Univ, Dept Neurosurg, Xian Cent Hosp, Xian 710032, Shaanxi, Peoples R China.	wangtao_zxyy@126.com					Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barker-Collo Suzanne, 2008, N Z Med J, V121, pU2903; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Berteau O, 2003, GLYCOBIOLOGY, V13, p29R, DOI 10.1093/glycob/cwg058; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Chen JJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/658925; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dai SH, 2014, INT J MOL SCI, V15, P14591, DOI 10.3390/ijms150814591; Dai SH, 2014, INT J MOL MED, V34, P1159, DOI 10.3892/ijmm.2014.1876; Fitton JH, 2011, MAR DRUGS, V9, P1731, DOI 10.3390/md9101731; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Hu W, 2014, NEUROCHEM INT, V79, P57, DOI 10.1016/j.neuint.2014.10.005; Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Veena CK, 2008, EUR J PHARMACOL, V579, P330, DOI 10.1016/j.ejphar.2007.09.044; Ye RD, 2011, NEUROPHARMACOLOGY, V61, P815, DOI 10.1016/j.neuropharm.2011.05.029; Yu XF, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/420929; Zheng SL, 2015, EXP NEUROL, V272, P160, DOI 10.1016/j.expneurol.2015.03.012	40	20	23	1	25	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2016	36	8					1257	1268		10.1007/s10571-015-0323-2			12	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DY5VX	WOS:000385173600004	26743530				2022-02-06	
J	Wang, XX; Sekine, Y; Byrne, AB; Cafferty, WBJ; Hammarlund, M; Strittmatter, SM				Wang, Xingxing; Sekine, Yuichi; Byrne, Alexandra B.; Cafferty, William B. J.; Hammarlund, Marc; Strittmatter, Stephen M.			Inhibition of Poly-ADP-Ribosylation Fails to Increase Axonal Regeneration or Improve Functional Recovery after Adult Mammalian CNS Injury	ENEURO			English	Article						axon regeneration; optic nerve regeneration; PARP; poly (ADP-ribose); spinal cord injury	FC DECOY PROTEIN; SPINAL-CORD; LOCOMOTION; GROWTH; PTEN; PARP	After traumatic damage of the brain or spinal cord, many surviving neurons are disconnected, and recovery of function is limited by poor axon regeneration. Recent data have suggested that poly ADP-ribosylation plays a role in limiting axonal regrowth such that inhibition of poly (ADP-ribose) polymerase (PARP) may have therapeutic efficacy for neurological recovery after trauma. Here, we tested systemic administration of the PARP inhibitor, veliparib, and showed effective suppression of PARylation in the mouse CNS. After optic nerve crush injury or dorsal hemisection of the thoracic spinal cord in mice, treatment with veliparib at doses with pharmacodynamic action had no benefit for axonal regeneration or functional recovery. We considered whether PARP gene family specificity might play a role. In vitro mouse cerebral cortex axon regeneration experiments revealed that short hairpin RNA (shRNA)-mediated suppression of PARP1 promoted axonal regeneration, whereas suppression of other PARP isoforms either had no effect or decreased regeneration. Therefore, we examined recovery from neurological trauma in mice lacking PARP1. No increase of axonal regeneration was observed in Parp1-/-mice after optic nerve crush injury or dorsal hemisection of the thoracic spinal cord, and there was no improvement in motor function recovery. Thus, comprehensive in vivo analysis reveals no indication that clinical PARP inhibitors will on their own provide benefit for recovery from CNS trauma.	[Wang, Xingxing; Sekine, Yuichi; Byrne, Alexandra B.; Hammarlund, Marc; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA; [Wang, Xingxing; Sekine, Yuichi; Byrne, Alexandra B.; Hammarlund, Marc; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA; [Wang, Xingxing; Sekine, Yuichi; Cafferty, William B. J.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA; [Byrne, Alexandra B.; Hammarlund, Marc] Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA		Strittmatter, SM (corresponding author), Yale Univ, Program Cellular Neurosci Neurodegenerat & Repair, Sch Med, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Sekine, Yuichi/S-8813-2019; Strittmatter, Stephen/F-5739-2011	Sekine, Yuichi/0000-0002-2861-603X; Strittmatter, Stephen/0000-0001-8188-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Falk Medical Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094219, R01NS098817, R35NS097283] Funding Source: NIH RePORTER	This work was supported by grants from NIH and Falk Medical Research Trust to S.M.S.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Brochier C, 2015, P NATL ACAD SCI USA, V112, P15220, DOI 10.1073/pnas.1509754112; Byrne AB, 2016, ELIFE, V5, DOI 10.7554/eLife.12734; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fink KL, 2015, J NEUROSCI, V35, P15403, DOI 10.1523/JNEUROSCI.3165-15.2015; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Geoffroy CG, 2015, J NEUROSCI, V35, P6413, DOI 10.1523/JNEUROSCI.4013-14.2015; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang XX, 2006, ANN NEUROL, V60, P540, DOI 10.1002/ana.20953; Wang XX, 2015, INVEST OPHTH VIS SCI, V56, P1357, DOI 10.1167/iovs.14-15472; Wang XX, 2014, J NEUROTRAUM, V31, P1955, DOI 10.1089/neu.2014.3355; Wang XX, 2012, EXP NEUROL, V237, P55, DOI 10.1016/j.expneurol.2012.06.009; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zou YX, 2015, J NEUROSCI, V35, P10429, DOI 10.1523/JNEUROSCI.1718-15.2015	25	20	20	0	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	NOV-DEC	2016	3	6							0270-16.2016	10.1523/ENEURO.0270-16.2016			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EH7CQ	WOS:000391930900021	28032120	gold, Green Published			2022-02-06	
J	Zhang, GX; Zhang, F; Zhang, T; Gu, JB; Li, CM; Sun, YW; Yu, P; Zhang, ZJ; Wang, YQ				Zhang, Gaoxiao; Zhang, Fen; Zhang, Tao; Gu, Jianbo; Li, Cuimei; Sun, Yewei; Yu, Pei; Zhang, Zaijun; Wang, Yuqiang			Tetramethylpyrazine Nitrone Improves Neurobehavioral Functions and Confers Neuroprotection on Rats with Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Neuroprotection; Oxidative stress; Apoptosis; Nrf-2; HO-1	CELL-DEATH; NEURONS; PROTEIN; STROKE; ACTIVATION; EXPRESSION; TRANSIENT; BIOMARKER; ISCHEMIA; PATHWAY	Oxidative stress is one of the major secondary injury mechanisms after traumatic brain injury (TBI). 2-[[(1,1-Dimethylethyl)oxidoimino]-methyl]-3,5,6-trimethylpyrazine (TBN), a derivative of the clinically used anti-stroke drug tetramethylpyrazine armed with a powerful free radical-scavenging nitrone moiety, has been demonstrated promising therapeutic efficacy in ischemic stroke and Parkinson's models. The present study aims to investigate the effects of TBN on behavioral function and neuroprotection in rats subjected to TBI. TBN (90 mg/kg) was administered twice daily for 7 days by intravenous injection following TBI. TBN improved neuronal behavior functions after brain injury, including rotarod test and adhesive paper removal test. Compared with the TBI model group, TBN treatment significantly protected NeuN-positive neurons, while decreased glial fibrillary acidic protein (GFAP)-positive cells. The number of 4-hydroxynonenal (4-HNE)-positive and 8-hydroxy-2'-deoxyguanosine (8-OHdG)-positive cells around the damaged area after TBI were significantly decreased in the TBN treatment group. In addition, TBN effectively reversed the altered expression of Bcl-2, Bax and caspase 3, and the down-regulation of nuclear factor erythroid-derived 2-like 2 (Nrf-2) and hemeoxygenase-1 (HO-1) proteins expression stimulated by TBI. In conclusion, TBN improves neurobehavioral functions and protects neurons against TBI. This protective effect may be achieved by anti-neuronal apoptosis, alleviating oxidative stress damage and up-regulating Nrf-2 and HO-1 expression.	[Zhang, Gaoxiao; Zhang, Fen; Zhang, Tao; Gu, Jianbo; Li, Cuimei; Sun, Yewei; Yu, Pei; Zhang, Zaijun; Wang, Yuqiang] Jinan Univ, Coll Pharm, Inst New Drug Res, Huangpu Rd, Guangzhou 510632, Guangdong, Peoples R China; [Zhang, Gaoxiao; Zhang, Fen; Zhang, Tao; Gu, Jianbo; Li, Cuimei; Sun, Yewei; Yu, Pei; Zhang, Zaijun; Wang, Yuqiang] Jinan Univ, Coll Pharm, Guangzhou Key Lab Innovat Chem Drug Res Cardiocer, Guangzhou 510632, Guangdong, Peoples R China		Zhang, ZJ (corresponding author), Jinan Univ, Coll Pharm, Inst New Drug Res, Huangpu Rd, Guangzhou 510632, Guangdong, Peoples R China.; Zhang, ZJ (corresponding author), Jinan Univ, Coll Pharm, Guangzhou Key Lab Innovat Chem Drug Res Cardiocer, Guangzhou 510632, Guangdong, Peoples R China.	zaijunzhang@163.com		Zhang, Zai-jun/0000-0002-0690-1673	Science and Technology Project of Guangdong [2015B020232011, 2013A022100030, 2016A020217013, 2015A030313317]; Key Laboratory Project of Guangzhou [151800010]	This work is supported by grants from the Science and Technology Project of Guangdong (2015B020232011 to YW, 2013A022100030 and 2016A020217013 to PY, 2015A030313317 to ZZ), and the Key Laboratory Project of Guangzhou (151800010 to YW).	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bembea MM, 2011, PEDIATR CRIT CARE ME, V12, P572, DOI 10.1097/PCC.0b013e3181fe3ec7; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; CHAN PH, 1985, PROG BRAIN RES, V63, P227; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Emami P, 2016, J NEUROSURG, P1; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Guo BJ, 2014, BIOL PHARM BULL, V37, P274, DOI 10.1248/bpb.b13-00743; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Lee EJ, 2005, J PINEAL RES, V38, P42, DOI 10.1111/j.1600-079X.2004.00173.x; Lian TT, 2015, INT J MOL SCI, V16, P13427, DOI 10.3390/ijms160613427; Loncarevic-Vasiljkovic N, 2016, NEUROCHEM INT, V96, P69, DOI 10.1016/j.neuint.2016.02.017; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Ren ZQ, 2012, J ETHNOPHARMACOL, V144, P555, DOI 10.1016/j.jep.2012.09.037; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sun YW, 2008, BIOORGAN MED CHEM, V16, P8868, DOI 10.1016/j.bmc.2008.08.075; Sun YW, 2012, J NEUROSCI RES, V90, P1662, DOI 10.1002/jnr.23034; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	35	20	22	0	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2016	41	11					2948	2957		10.1007/s11064-016-2013-y			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EB5DG	WOS:000387393000012	27452038				2022-02-06	
J	Yu, W; Parakramaweera, R; Teng, S; Gowda, M; Sharad, Y; Thakker-Varia, S; Alder, J; Sesti, F				Yu, Wei; Parakramaweera, Randika; Teng, Shavonne; Gowda, Manasa; Sharad, Yashsavi; Thakker-Varia, Smita; Alder, Janet; Sesti, Federico			Oxidation of KCNB1 Potassium Channels Causes Neurotoxicity and Cognitive Impairment in a Mouse Model of Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						aging; dasatinib; Kv2.1; oxidative stress; ROS; Src kinases	KV2.1 K+ CHANNEL; CONTROLLED CORTICAL IMPACT; SRC KINASE-ACTIVITY; NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; HIPPOCAMPAL; RAT; EXCITABILITY; DASATINIB; ACTIVATION	The delayed rectifier potassium (K+) channel KCNB1 (Kv2.1), which conducts a major somatodendritic current in cortex and hippocampus, is known to undergo oxidation in the brain, but whether this can cause neurodegeneration and cognitive impairment is not known. Here, we used transgenic mice harboring human KCNB1 wild-type (Tg-WT) or a nonoxidable C73A mutant (Tg-C73A) in cortex and hippocampus to determine whether oxidizedKCNB1channels affect brain function. Animals were subjected to moderate traumatic brain injury (TBI), a condition characterized by extensive oxidative stress. Dasatinib, a Food and Drug Administration-approved inhibitor of Src tyrosine kinases, was used to impinge on the proapoptotic signaling pathway activated by oxidized KCNB1 channels. Thus, typical lesions of brain injury, namely, inflammation (astrocytosis), neurodegeneration, and cell death, were markedly reduced in Tg-C73A and dasatinib-treated non-Tg animals. Accordingly, Tg-C73A mice and non-Tg mice treated with dasatinib exhibited improved behavioral outcomes in motor (rotarod) and cognitive (Morris water maze) assays compared to controls. Moreover, the activity of Src kinases, along with oxidative stress, were significantly diminished in Tg-C73A brains. Together, these data demonstrate that oxidation of KCNB1 channels is a contributing mechanism to cellular and behavioral deficits in vertebrates and suggest a new therapeutic approach to TBI.	[Yu, Wei; Parakramaweera, Randika; Teng, Shavonne; Gowda, Manasa; Sharad, Yashsavi; Thakker-Varia, Smita; Alder, Janet; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West, Piscataway, NJ 08854 USA		Sesti, F (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West, Piscataway, NJ 08854 USA.	federico.sesti@rutgers.edu			National Science FoundationNational Science Foundation (NSF) [1456675]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS096619-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG060919] Funding Source: NIH RePORTER	This work was supported by National Science Foundation Grant 1456675 and NIH Grant 1R21NS096619-01 to F.S. The thy1.2 cassette was a kind gift from Dr. Pico Caroni. We thank Drs. Madura and Chen for help with the Zeiss Axio Imager and Shuang Liu for critical reading of this manuscript. We thank Nick Scurato for helping with the genotyping.	Agarwal S, 2012, MOL CANCER THER, V11, P2183, DOI 10.1158/1535-7163.MCT-12-0552; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; BARNES CA, 1987, J COMP NEUROL, V259, P549, DOI 10.1002/cne.902590405; BARNES CA, 1994, TRENDS NEUROSCI, V17, P13, DOI 10.1016/0166-2236(94)90029-9; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Cai SQ, 2009, NAT NEUROSCI, V12, P611, DOI 10.1038/nn.2291; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Chico LK, 2009, NAT REV DRUG DISCOV, V8, P892, DOI 10.1038/nrd2999; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Fox PD, 2013, J NEUROSCI, V33, P1259, DOI 10.1523/JNEUROSCI.3008-12.2013; Frazzini V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.18; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hasima Noor, 2012, Int J Biochem Mol Biol, V3, P328; Hettiarachchi NT, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.529; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hille B., 2001, IONIC CHANNELS EXCIT, VThird; JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Katsumata R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046185; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Konig H, 2008, CANCER RES, V68, P9624, DOI 10.1158/0008-5472.CAN-08-1131; LANDFIELD PW, 1986, J NEUROPHYSIOL, V56, P797, DOI 10.1152/jn.1986.56.3.797; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Liu H, 2013, MOL CELL NEUROSCI, V57, P73, DOI 10.1016/j.mcn.2013.10.008; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Murakoshi H, 1999, J NEUROSCI, V19, P1728; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Papatheodoropoulos C, 1996, EUR J NEUROSCI, V8, P510, DOI 10.1111/j.1460-9568.1996.tb01235.x; Patel R, 2016, BRAIN RES, V1639, P174, DOI 10.1016/j.brainres.2016.02.046; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Rojas P, 2008, J NEUROSCI, V28, P757, DOI 10.1523/JNEUROSCI.3825-07.2008; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sensi SL, 2008, EXP GERONTOL, V43, P488, DOI 10.1016/j.exger.2007.10.018; Sesti Federico, 2014, World J Biol Chem, V5, P85, DOI 10.4331/wjbc.v5.i2.85; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Thakker-Varia S, 2001, J NEUROSCI, V21, P6782, DOI 10.1523/JNEUROSCI.21-17-06782.2001; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zhou TT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.119	74	20	20	0	4	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 26	2016	36	43					11084	11096		10.1523/JNEUROSCI.2273-16.2016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EG4WX	WOS:000391045800015	27798188	Green Published, Bronze			2022-02-06	
J	Itsekson-Hayosh, Z; Shavit-Stein, E; Katzav, A; Rubovitch, V; Maggio, N; Chapman, J; Harnof, S; Pick, CG				Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Katzav, Aviva; Rubovitch, Vardit; Maggio, Nicola; Chapman, Joab; Harnof, Sagi; Pick, Chaim G.			Minimal Traumatic Brain Injury in Mice: Protease-Activated Receptor 1 and Thrombin-Related Changes	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; mTBI; PAR-1; thrombin	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FLUID PERCUSSION INJURY; LONG-TERM POTENTIATION; INTRACEREBRAL HEMORRHAGE; COGNITIVE DEFICITS; MESSENGER-RNA; SERINE PROTEASES; NERVOUS-SYSTEM; UP-REGULATION; TIME-COURSE	Minimal traumatic brain injury (mTBI) is partially defined by the existence of retrograde amnesia and is associated with microscopic bleeds containing activated coagulation factors. In a previous study, we have found that mTBI immediately releases thrombin-like activity in the brain, which induces amnesia by activating protease-activated receptor 1 (PAR-1) and blocking long-term potentiation (LTP). In the present study, we assessed the effects of mTBI on thrombin and PAR-1 levels in the brain using the same model. After the immediate elevation, thrombin activity returned to baseline 1h post-trauma and increased again 72h later (42% relative to control; p<0.005). These changes were associated with a significant increase in PAR-1 levels 24 (17%; p<0.05) and 72h (20%; p<0.05) post-trauma. Interestingly, the late elevation in thrombin-like activity was also associated with elevation of the major central nervous system thrombin inhibitor, protease nexin-1, 72h post-mTBI (10%; p<0.005). When thrombin was injected into brain ventricles, an increased sensitivity to seizure-like activity was detected at 72h post-mTBI. The results are compatible with astrocyte activation post-mTBI resulting in increased thrombin secretion, PAR-1 expression, and seizure sensitivity.	[Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Chapman, Joab] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, Tel Aviv, Israel; [Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Katzav, Aviva; Maggio, Nicola; Chapman, Joab] Chaim Sheba Med Ctr, Dept Neurol, Tel Hashomer, Israel; [Itsekson-Hayosh, Zeev; Shavit-Stein, Efrat; Katzav, Aviva; Maggio, Nicola; Chapman, Joab] Chaim Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Tel Hashomer, Israel; [Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, Tel Aviv, Israel; [Harnof, Sagi] Chaim Sheba Med Ctr, Dept Neurosurg, IL-52621 Tel Hashomer, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Robert & Martha Harden Chair Mental & Neurol Dis, Tel Aviv, Israel; [Maggio, Nicola] Tel Aviv Univ, Dept Neurol, Sackler Fac Med, Tel Aviv, Israel; [Maggio, Nicola; Chapman, Joab; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Harnof, S (corresponding author), Chaim Sheba Med Ctr, Dept Neurosurg, IL-52621 Tel Hashomer, Israel.	sagi.harnof@sheba.health.gov.il	Chapman, Joab/E-4598-2010				Akahoshi N, 2011, EPILEPSY BEHAV, V22, P659, DOI 10.1016/j.yebeh.2011.09.002; Aronovich R, 2005, IMMUNOBIOLOGY, V210, P781, DOI 10.1016/j.imbio.2005.10.010; Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270; Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013; Beilin O, 2007, NEUROREPORT, V18, P581, DOI 10.1097/WNR.0b013e328091c1e6; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Chapman J, 2013, SEMIN THROMB HEMOST, V39, P876, DOI 10.1055/s-0033-1357482; CHOI BH, 1990, AM J PATHOL, V137, P741; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio Raimondo, 2005, Epilepsy Curr, V5, P244, DOI 10.1111/j.1535-7511.2005.00077.x; de Lanerolle NC, 2005, EPILEPSY BEHAV, V7, P190, DOI 10.1016/j.yebeh.2005.06.003; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Fan YY, 2005, J SURG RES, V129, P196, DOI 10.1016/j.jss.2005.07.041; Feinsod M, 2012, WORLD NEUROSURG, V78, P371, DOI 10.1016/j.wneu.2011.12.007; Friedmann I, 2001, J NEUROIMMUNOL, V121, P12, DOI 10.1016/S0165-5728(01)00397-6; Friedmann I, 2001, J NEUROCHEM, V76, P641, DOI 10.1046/j.1471-4159.2001.00001.x; Friedmann I, 1999, FASEB J, V13, P533, DOI 10.1096/fasebj.13.3.533; Hamilton N, 2010, GLIA, V58, P66, DOI 10.1002/glia.20902; Han KS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-32; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Laskowski A, 2007, NEUROSCI LETT, V415, P17, DOI 10.1016/j.neulet.2006.12.050; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Pompili E, 2004, MOL BRAIN RES, V122, P93, DOI 10.1016/j.molbrainres.2003.12.001; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ribeiro MD, 2006, EXP NEUROL, V198, P199, DOI 10.1016/j.expneurol.2005.11.017; Riek-Burchardt M, 2002, NEUROSCI LETT, V329, P181, DOI 10.1016/S0304-3940(02)00645-6; Rohatgi T, 2004, J NEUROSCI RES, V75, P273, DOI 10.1002/jnr.10847; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Shavit E, 2011, J NEUROCHEM, V119, P460, DOI 10.1111/j.1471-4159.2011.07436.x; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Thevenet J, 2009, J NEUROCHEM, V111, P828, DOI 10.1111/j.1471-4159.2009.06369.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; Wu H, 2010, NEUROCHEM INT, V57, P248, DOI 10.1016/j.neuint.2010.06.002; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; Zheng GQ, 2009, NEUROSCI LETT, V459, P62, DOI 10.1016/j.neulet.2009.05.007; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	64	20	20	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1848	1854		10.1089/neu.2015.4146			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300005	26537880				2022-02-06	
J	Aries, MJH; Wesselink, R; Elting, JWJ; Donnelly, J; Czosnyka, M; Ercole, A; Maurits, NM; Smielewski, P				Aries, Marcel J. H.; Wesselink, Robin; Elting, Jan Willem J.; Donnelly, Joseph; Czosnyka, Marek; Ercole, Ari; Maurits, Natasha M.; Smielewski, Peter			Enhanced Visualization of Optimal Cerebral Perfusion Pressure Over Time to Support Clinical Decision Making	CRITICAL CARE MEDICINE			English	Article						cerebral autoregulation; cerebral perfusion pressure management; traumatic brain injury		Objective: Cerebrovascular reactivity can provide a continuously updated individualized target for management of cerebral perfusion pressure, termed optimal cerebral perfusion pressure. The objective of this project was to find a way of improving the optimal cerebral perfusion pressure methodology by introducing a new visualization method. Data Sources: Four severe traumatic brain injury patients with intracranial pressure monitoring. Data Extraction: Data were collected and preprocessed using ICM+ software. Data Synthesis: Sequential optimal cerebral perfusion pressure curves were used to create a color-coded maps of autoregulation - cerebral perfusion pressure relationship evolution over time. Conclusions: The visualization method addresses some of the main drawbacks of the original methodology and might bring the potential for its clinical application closer.	[Aries, Marcel J. H.; Wesselink, Robin] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, Groningen, Netherlands; [Aries, Marcel J. H.; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Grp, Cambridge, England; [Wesselink, Robin] Univ Twente, Dept Tech Med, Enschede, Netherlands; [Elting, Jan Willem J.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Dept Anaesthesia, Cambridge, England; [Maurits, Natasha M.] Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands		Aries, MJH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, Groningen, Netherlands.; Aries, MJH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Grp, Cambridge, England.	m.j.h.aries@umcg.nl	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Ercole, Ari/B-6288-2009	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Ercole, Ari/0000-0001-8350-8093; Maurits, Natasha/0000-0001-6231-7044; Smielewski, Peter/0000-0001-5096-3938; Wesselink, Robin/0000-0001-5671-2531	Dutch Society of Intensive Care; Woolf Fisher Trust, New Zealand (study scholarship); Cambridge Enterprise, United Kingdom; Radboud University Nijmegen; European UnionEuropean Commission; Princess Beatrix Foundation, The NetherlandsNetherlands Government	Dr. Aries received an unrestricted grant from the Dutch Society of Intensive Care. Dr. Donnelly received funding from Woolf Fisher Trust, New Zealand (study scholarship). Dr. Czosnyka disclosed other support (Integra Life sciences Speakers Bureau - payment (sic)1,500) and received funding from Cambridge Enterprise, United Kingdom. He has a financial interest in a part of the licensing fee. Dr. Maurits received funding from Radboud University Nijmegen. Her institution received funding from the European Union and from the Princess Beatrix Foundation, The Netherlands. Dr. Smielewski disclosed other support (he has a financial interest in the part of the licensing fees of the software, ICM+, used in data collection and partial analysis for this project). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	8	20	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2016	44	10					E996	E999		10.1097/CCM.0000000000001816			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VC9PN	WOS:000435244200011	27270178	Green Accepted			2022-02-06	
J	Fisher, JAN; Huang, S; Ye, MJ; Nabili, M; Wilent, WB; Krauthamer, V; Myers, MR; Welle, CG				Fisher, Jonathan A. N.; Huang, Stanley; Ye, Meijun; Nabili, Marjan; Wilent, W. Bryan; Krauthamer, Victor; Myers, Matthew R.; Welle, Cristin G.			Real-Time Detection and Monitoring of Acute Brain Injury Utilizing Evoked Electroencephalographic Potentials	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Animal models; biomarkers; focused ultrasound; somatosensory evoked potentials (SSEPs); traumatic brain injury (TBI)	INTENSITY FOCUSED ULTRASOUND; CLOSED-HEAD-INJURY; TRANSCALLOSAL INHIBITION; APPROXIMATE ENTROPY; SPREADING DEPRESSION; SPECTRAL-ANALYSIS; NETWORK ACTIVITY; GOLDEN HOUR; IN-VIVO; EEG	Rapid detection and diagnosis of a traumatic brain injury (TBI) can significantly improve the prognosis for recovery. Helmet-mounted sensors that detect impact severity based on measurements of acceleration or pressure show promise for aiding triage and transport decisions in active, field environments such as professional sports or military combat. The detected signals, however, report on the mechanics of an impact rather than directly indicating the presence and severity of an injury. We explored the use of cortical somatosensory evoked electroencephalographic potentials (SSEPs) to detect and track, in real-time, neural electrophysiological abnormalities within the first hour following head injury in an animal model. To study the immediate electrophysiological effects of injury in vivo, we developed an experimental paradigm involving focused ultrasound that permits continuous, real-time measurements and minimizes mechanical artifact. Injury was associated with a dramatic reduction of amplitude over the damaged hemisphere directly after the injury. The amplitude systematically improved over time but remained significantly decreased at one hour, compared with baseline. In contrast, at one hour there was a concomitant enhancement of the cortical SSEP amplitude evoked from the uninjured hemisphere. Analysis of the inter-trial electroencephalogram (EEG) also revealed significant changes in low-frequency components and an increase in EEG entropy up to 30 minutes after injury, likely reflecting altered EEG reactivity to somatosensory stimuli. Injury-induced alterations in SSEPs were also observed using noninvasive epidermal electrodes, demonstrating viability of practical implementation. These results suggest cortical SSEPs recorded at just a few locations by head-mounted sensors and associated multiparametric analyses could potentially be used to rapidly detect and monitor brain injury in settings that normally present significant levels of mechanical and electrical noise.	[Fisher, Jonathan A. N.; Huang, Stanley; Ye, Meijun; Nabili, Marjan; Krauthamer, Victor; Myers, Matthew R.; Welle, Cristin G.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Fisher, Jonathan A. N.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Wilent, W. Bryan] Sentient Med Syst, Hunt Halley, MD 20131 USA		Welle, CG (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	jonathan_fisher@nymc.edu; Stanley.huang@fda.hhs.gov; meijun.ye@fda.hhs.gov; marjan.nabili@fda.hhs.gov; bwilent@gmail.com; victor.krauthamer@fda.hhs.gov; matthew.myers@fda.hhs.gov; cristin.welle@ucdenver.edu			FDA Medical Countermeasures Initiative [274]; New York Medical College	The work of C. G. Welle was supported by FDA Medical Countermeasures Initiative 274. The work of J. A. N. Fisher was supported by the New York Medical College. (Corresponding author: Cristin G. Welle.)	BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bein B, 2006, BEST PRACT RES-CLIN, V20, P101, DOI 10.1016/j.bpa.2005.07.009; Bezerianos A, 2003, ANN BIOMED ENG, V31, P221, DOI 10.1114/1.1541013; Brodie SM, 2014, J NEUROPHYSIOL, V112, P1470, DOI 10.1152/jn.00074.2014; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chen J, 2012, ELECTROPHYSIOLOGICAL; CHILDERS DG, 1987, CRIT REV BIOMED ENG, V14, P185; Coutin-Churchman P, 2003, CLIN NEUROPHYSIOL, V114, P2294, DOI 10.1016/S1388-2457(03)00228-1; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; He XF, 2015, PHYSIOL BEHAV, V151, P502, DOI 10.1016/j.physbeh.2015.08.026; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knuth T., 2005, GUIDELINES FIELD MAN; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kumar V, 2015, J ULTRAS MED, V34, P1351, DOI 10.7863/ultra.34.8.1351; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; McCabe JT, 2014, ULTRASOUND MED BIOL, V40, P965, DOI 10.1016/j.ultrasmedbio.2013.11.023; McCahery JA, 2010, PRIVATE COMPANY LAW REFORM: INTERNATIONAL AND EUROPEAN PERSPECTIVES, P1, DOI 10.1007/978-90-6704-477-6_1; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Misic B, 2016, J NEUROSCI, V36, P419, DOI 10.1523/JNEUROSCI.1506-15.2016; Mitra P, 2007, OBSERVED BRAIN DYNAM; Monteforte M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.268104; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P142, DOI 10.1016/S0013-4694(97)00117-X; Ouckama R, 2011, J BIOMECH, V44, P904, DOI 10.1016/j.jbiomech.2010.11.035; Paxinos G., 2004, MOUSE BRAIN STEREOTA; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Prichep L. S., 2013, Field deployable concussion assessment device, Patent No. [U. S. 8478394 B2, 8478394]; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SAKATANI K, 1990, STROKE, V21, P124, DOI 10.1161/01.STR.21.1.124; Sawant-Pokam P. M., 2016, CEREB CORTEX N Y N 1; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Steward W., 1999, Helmet system including at least three accelerometers and mass memory and method for recording in real-time orthogonal acceleration data of a head, Patent No. [U. S. 5,978,972, 5978972]; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Takechi U, 2014, CLIN NEUROPHYSIOL, V125, P2055, DOI 10.1016/j.clinph.2014.01.034; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Tong S, 2002, PHYSICA A, V305, P619, DOI 10.1016/S0378-4371(01)00621-5; Tong SB, 2003, PHYS LETT A, V314, P354, DOI 10.1016/S0375-9601(03)00949-6; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Wahab R., 2010, J ACOUST SOC AM, V127, P1789; Wallace D, 2012, J MIL VETERANS HEALT, V20, P10; WALSER H, 1986, J NEUROL, V233, P34, DOI 10.1007/BF00313989; Wang J., 2015, P NIH IEEE 2015 STRA; Wu D, 2010, NEUROSCI LETT, V485, P157, DOI 10.1016/j.neulet.2010.08.086	76	20	20	0	18	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	SEP	2016	24	9					1003	1012		10.1109/TNSRE.2016.2529663			10	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Rehabilitation	DX2QZ	WOS:000384217100009	26955039				2022-02-06	
J	Merchant-Borna, K; Lee, H; Wang, D; Bogner, V; van Griensven, M; Gill, J; Bazarian, JJ				Merchant-Borna, Kian; Lee, Hyunhwa; Wang, Dan; Bogner, Viktoria; van Griensven, Martijn; Gill, Jessica; Bazarian, Jeffrey J.			Genome-Wide Changes in Peripheral Gene Expression following Sports-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						gene network; IPA; longitudinal study; mild traumatic brain injury; mTBI; PBMC; sports-related concussion	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; BLOOD MONONUCLEAR-CELLS; ACTIVATION; IMMUNITY; INNATE; INTERLEUKIN-12; PROFILES; CYTOKINE; IMPACT	We conducted a prospective study to identify genome-wide changes in peripheral gene expression before and after sportsrelated concussion (SRC). A total of 253 collegiate contact athletes underwent collection of peripheral blood mononuclear cells (PBMCs) before the sport season (baseline). Sixteen athletes who subsequently developed an SRC, along with 16 non-concussed teammate controls, underwent repeat collection of PBMCs within 6 h of injury (acutely). Concussed athletes underwent additional sample collection at 7 days post-injury (sub-acutely). Messenger RNA (mRNA) expression at baseline was compared with mRNA expression acutely and sub-acutely post-SRC. To estimate the contribution of physical exertion to gene changes, baseline samples from athletes who subsequently developed an SRC were compared with samples from uninjured teammate controls collected at the acute time-point. Clinical outcome was determined by changes in post-concussive symptoms, postural stability, and cognition from baseline to the sub-acute time-point. SRC athletes had significant changes in mRNA expression at both the acute and sub-acute time-points. There were no significant expression changes among controls. Acute transcriptional changes centered on interleukins 6 and 12, toll-like receptor 4, and NF-kappa B. Sub-acute gene expression changes centered on NF-kappa B, follicle stimulating hormone, chorionic gonadotropin, and protein kinase catalytic subunit. All SRC athletes were clinically back to baseline by Day 7. In conclusion, acute post-SRC transcriptional changes reflect regulation of the innate immune response and the transition to adaptive immunity. By 7 days, transcriptional activity is centered on regulating the hypothalamic-pituitary-adrenal axis. Future efforts to compare expressional changes in fully recovered athletes with those who do not recover from SRC could suggest putative targets for therapeutic intervention.	[Merchant-Borna, Kian; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Lee, Hyunhwa] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA; [Wang, Dan; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Bogner, Viktoria] Univ Munich, Munich, Germany; [van Griensven, Martijn] Tech Univ Munich, Klinikum Rechts Isar, Dept Trauma Surg, Munich, Germany		Bazarian, JJ (corresponding author), Univ Rochester, Sch Med & Dent, 265 Elmwood Ave, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu	van Griensven, Martijn/F-5808-2012; Gill, Gill M/Q-2020-2017	van Griensven, Martijn/0000-0001-5104-9881; Lee, Hyunhwa/0000-0002-5625-3141	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24 HD064754] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD064754] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000033] Funding Source: NIH RePORTER		Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; De Boever P, 2014, GENOMICS, V103, P31, DOI 10.1016/j.ygeno.2013.11.006; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Glatt SJ, 2013, AM J MED GENET B, V162B, P313, DOI 10.1002/ajmg.b.32167; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kanof M E, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0703s00; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McIntosh LJ, 1996, NEUROTOXICOLOGY, V17, P873; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Segman RH, 2005, MOL PSYCHIATR, V10, P514, DOI [10.1038/sj.mp.4001654, 10.1038/sj.mp.4001636]; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Zhao W, 2013, J ALZHEIMERS DIS, V34, P417, DOI 10.3233/JAD-121894	54	20	21	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1576	1585		10.1089/neu.2015.4191			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300003	27035221	Green Published			2022-02-06	
J	Wolfe, PL; Lehockey, KA				Wolfe, Penny L.; Lehockey, Katie A.			Neuropsychological Assessment of Driving Capacity	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Disability; handicaps; Elderly; geriatrics; aging; Head injury; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MINI-MENTAL-STATE; MONTREAL COGNITIVE ASSESSMENT; CLOSED-HEAD-INJURY; OLDER DRIVERS; DIVIDED ATTENTION; AWARENESS QUESTIONNAIRE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; HUNTINGTON DISEASE	Clinicians are increasingly requested to make determinations regarding patients' driving capacity in the context of neurological injury/conditions and a growing cohort of older drivers. The capability to drive safely involves a number of cognitive, physical, and sensorimotor abilities that may be impacted by injury, illness, or substances that influence alertness. Neuropsychological measures are an important component of a multidisciplinary approach for evaluation of driving capacity. Clinicians should become familiar with measures that have the best predictive validity so they may incorporate a patient's neurocognitive strengths and weaknesses in decisions about driving ability.	[Wolfe, Penny L.; Lehockey, Katie A.] MedStar Natl Rehabil Hosp, 102 Irving St NW, Washington, DC 20010 USA		Wolfe, PL (corresponding author), MedStar Natl Rehabil Hosp, 102 Irving St NW, Washington, DC 20010 USA.	penny.wolfe@medstar.net					Adler G, 2005, J SAFETY RES, V36, P399, DOI 10.1016/j.jsr.2005.07.005; Akinwuntan AE, 2006, NEUROREHAB NEURAL RE, V20, P417, DOI 10.1177/1545968306287157; Akinwuntan AE, 2013, TOP STROKE REHABIL, V20, P87, DOI 10.1310/tsr2001-87; Aksan N, 2015, ACCIDENT ANAL PREV, V75, P236, DOI 10.1016/j.aap.2014.12.007; Al Banna M, 2016, J NEUROL NEUROSUR PS, V87, P161, DOI 10.1136/jnnp-2015-310305; American Bar Association Commission on Law and Aging & American Psychological Association, 2008, ASS OLD AD DIM CAP H, P91; Amick MM, 2007, ARCH CLIN NEUROPSYCH, V22, P957, DOI 10.1016/j.acn.2007.07.004; [Anonymous], 2015, C TRAUM BRAIN INJ US; Anstey KJ, 2012, ACCIDENT ANAL PREV, V45, P766, DOI 10.1016/j.aap.2011.10.006; Asimakopulos J, 2012, AUST OCCUP THER J, V59, P402, DOI 10.1111/j.1440-1630.2011.00963.x; Ball K., 1998, USEFUL FIELD OF VIEW; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bowers AR, 2013, ACCIDENT ANAL PREV, V59, P537, DOI 10.1016/j.aap.2013.06.037; Brouwer W H, 1994, Disabil Rehabil, V16, P149; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Colarusso R.P., 2003, MOTOR FREE VISUAL PE; Crizzle AM, 2012, ACCIDENT ANAL PREV, V49, P287, DOI 10.1016/j.aap.2012.02.003; Cuenen A, 2015, ACCIDENT ANAL PREV, V77, P12, DOI 10.1016/j.aap.2015.01.011; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Devos H, 2014, NEUROLOGY, V82, P956, DOI 10.1212/WNL.0000000000000220; Devos H, 2012, NEUROLOGY, V79, P1975, DOI 10.1212/WNL.0b013e3182735d11; Dobbs B. M., 2005, MED CONDITIONS DRIVI; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FINKELMAN JM, 1977, J APPL PSYCHOL, V62, P713, DOI 10.1037/0021-9010.62.6.713; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fleming JM, 1996, BRAIN INJURY, V10, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox GK, 1997, J AM GERIATR SOC, V45, P949, DOI 10.1111/j.1532-5415.1997.tb02965.x; Galski T, 2009, HANDBOOK FOR THE ASSESSMENT OF DRIVING CAPACITY, P187, DOI 10.1016/B978-0-12-631255-3.00010-2; Gfeller JD, 1996, J CLIN PSYCHOL, V52, P191, DOI 10.1002/(SICI)1097-4679(199603)52:2<191::AID-JCLP10>3.0.CO;2-F; GOLPER LAC, 1980, ARCH PHYS MED REHAB, V61, P34; Gorman AA, 2009, NEUROPSYCHOL REV, V19, P186, DOI 10.1007/s11065-009-9095-0; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Hartje W, 1991, NEUROPSYCHOL REHABIL, V3, P161; Hollis AM, 2015, J AM GERIATR SOC, V63, P988, DOI 10.1111/jgs.13384; Hooper H., 1958, HOOPER VISUAL ORG TE; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; Joseph PG, 2014, J AM GERIATR SOC, V62, P1419, DOI 10.1111/jgs.12936; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Kay LG, 2009, DISABIL REHABIL, V31, P1074, DOI 10.1080/09638280802509553; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Lundqvist A., 2011, SCIRES, V2, P615, DOI [10.4236/psych.2011.26094, DOI 10.4236/PSYCH.2011.26094]; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Mackenzie C, 2003, APHASIOLOGY, V17, P107, DOI 10.1080/729255215; Mathias JL, 2009, INT PSYCHOGERIATR, V21, P637, DOI 10.1017/S1041610209009119; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Mazer BL, 2001, AM J OCCUP THER, V55, P552, DOI 10.5014/ajot.55.5.552; McInerney K, 2016, J INT NEUROPSYCH SOC, V22, P332, DOI 10.1017/S1355617715001253; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; McKenna P., 2009, ROOKWOOD DRIVING BAT; McKenna P, 2007, J NEUROPSYCHOL, V1, P85, DOI 10.1348/174866407X180837; Mizenko AJ, 2014, OLDER AM DRIVERS TRA; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Motta K, 2014, J SAFETY RES, V49, P33, DOI 10.1016/j.jsr.2014.02.005; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Highway Traffic Safety Administration, 2015, TRAFF SAF FACTS 2014; National Highway Traffic Safety Administration, 2012, TRAFF SAF FACTS 2012; National Highway Traffic Safety Administration, 2016, CLEAR OLD ROAD US SA; National Highway Traffic Safety Administration and American Medical Association, 2010, PHYS GUIDE ASSESSING; Neavyn MJ, 2014, J MED TOXICOL, V10, P269, DOI 10.1007/s13181-014-0393-4; Nouri F M, 1987, Int Disabil Stud, V9, P110; NOURI FM, 1994, STROKE DRIVER SCREEN; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Oswanski MF, 2007, AM J PHYS MED REHAB, V86, P190, DOI 10.1097/PHM.0b013e31802b7de5; Owens DA, 2007, HUM FACTORS, V49, P1115, DOI 10.1518/001872007X249974; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rapoport MJ, 2013, ACCIDENT ANAL PREV, V61, P288, DOI 10.1016/j.aap.2013.03.030; Regan MA, 2011, ACCIDENT ANAL PREV, V43, P1771, DOI 10.1016/j.aap.2011.04.008; Reger M. A., 2004, NEUROPSYCHOLOGY, P85; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis Maria T, 2014, Curr Phys Med Rehabil Rep, V2, P176; Schultheis MT, 2009, HANDBOOK FOR THE ASSESSMENT OF DRIVING CAPACITY, P117, DOI 10.1016/B978-0-12-631255-3.00007-2; Schultheis MT, 2010, ARCH PHYS MED REHAB, V91, P465, DOI 10.1016/j.apmr.2009.09.026; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sivan AB., 1992, BENTON VISUAL RETENT; Smith A., 1982, SYMBOL DIGIT MODALIT; Stern R., 1999, BOSTON QUALITATIVE S; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stolwyk RJ, 2006, J CLIN EXP NEUROPSYC, V28, P898, DOI 10.1080/13803390591000909; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vaughan L, 2015, J AM GERIATR SOC, V63, P1774, DOI 10.1111/jgs.13634; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Vrkljan BH, 2011, CAN J OCCUP THER, V78, P80, DOI 10.2182/cjot.2011.78.2.3; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Wolfe P. L., 2012, CIVIL CAPACITIES CLI, P121; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P577, DOI 10.1167/iovs.08-2506; Yale Steven H, 2003, Clin Med Res, V1, P177; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Zuin D, 2002, EUR J NEUROL, V9, P29, DOI 10.1046/j.1468-1331.2002.00296.x	105	20	20	1	15	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2016	31	6					517	529		10.1093/arclin/acw050			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DZ7AU	WOS:000386016000005	27474026	Bronze			2022-02-06	
J	Yang, LY; Huang, CC; Chiu, WT; Huang, LT; Lo, WC; Wang, JY				Yang, Ling-Yu; Huang, Chao-Ching; Chiu, Wen-Ta; Huang, Li-Tung; Lo, Wei-Cheng; Wang, Jia-Yi			Association of traumatic brain injury in childhood and attention-deficit/hyperactivity disorder: a population-based study	PEDIATRIC RESEARCH			English	Article							DEFICIT-HYPERACTIVITY DISORDER; OF-THE-LITERATURE; HEAD-INJURY; YOUNG-ADULTS; CHILDREN; ADHD; ADOLESCENTS; COHORT; RISK; PREDICTORS	BACKGROUND: We evaluated the risk of attention-deficit hyperactivity disorder (ADHD) following childhood traumatic brain injury (TBI). METHODS: Using Taiwan's National Health Insurance Research Database, we included 10,416 newly diagnosed TBI children (aged <= 2 y) between 2001 and 2002 and 41,664 children without TBI, who were frequency matched by sex, age, and year of the index medical service with each TBI child, as controls. Children who had been diagnosed with ADHD prior to their medical service index were excluded. Each individual was followed for 9 y to identify ADHD diagnosis. We also compared the ADHD risk in children who were treated for fractures but not TBI as sensitivity analysis. RESULTS: During the 9-y follow-up Period, children with TBI had a higher ADHD risk (adjusted hazard ratio (AHR) = 1.32, 95% confidence interval (CI) = 1.19, 1.45) than did those without TBI. Furthermore, children with mild and severe TBI had higher AHRs for ADHD than did those without TBI (AHR = 1.30; 95% CI = 1.10, 1.53; and AHR = 1.37; 95% CI = 1.22, 1.55). However, no significant association was observed between fractures and ADHD. CONCLUSION: TBI in childhood is associated with a greater likelihood of developing ADHD.	[Yang, Ling-Yu; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Chao-Ching] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan; [Huang, Chao-Ching] Coll Med, Tainan, Taiwan; [Huang, Chao-Ching] Taipei Med Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Huang, Li-Tung] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Huang, Li-Tung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lo, Wei-Cheng] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351; Huang, Chao-Ching/0000-0003-2799-7181	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST-104-2320-B-038-057-MY3, MOST-104-2923-B-038-001- MY3]	This study was supported in part by a grant from the Ministry of Science and Technology (MOST-104-2320-B-038-057-MY3 and MOST-104-2923-B-038-001- MY3 to JY Wang), Taiwan.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barkley RA, 1997, J DEV BEHAV PEDIATR, V18, P271; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Chen MH, 2015, BIPOLAR DISORD, V17, P315, DOI 10.1111/bdi.12266; Chou IC, 2014, DEV MED CHILD NEUROL, V56, P1111, DOI 10.1111/dmcn.12501; Chou PH, 2013, EUR CHILD ADOLES PSY, V22, P301, DOI 10.1007/s00787-012-0369-3; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; Fischer M, 2007, ACCIDENT ANAL PREV, V39, P94, DOI 10.1016/j.aap.2006.06.008; Glascoe F P, 2000, Pediatr Rev, V21, P272, DOI 10.1542/pir.21-8-272; Glascoe FP, 2000, PEDIAT REV, V21; Halmoy A, 2012, BIOL PSYCHIAT, V71, P474, DOI 10.1016/j.biopsych.2011.11.013; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Konrad KN, 2000, BRAIN INJURY, V14, P859; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Olazagasti MAR, 2013, J AM ACAD CHILD PSY, V52, P153, DOI 10.1016/j.jaac.2012.11.012; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Robison LM, 2004, INT CLIN PSYCHOPHARM, V19, P17, DOI 10.1097/00004850-200401000-00003; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shank LK, 2010, REHABIL PSYCHOL, V55, P188, DOI 10.1037/a0019601; Shyu CS, 2012, J MICROBIOL IMMUNOL, V45, P237, DOI 10.1016/j.jmii.2011.11.008; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Thomas CR, 2004, BURNS, V30, P221, DOI 10.1016/j.burns.2003.10.013; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	38	20	20	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	SEP	2016	80	3					356	362		10.1038/pr.2016.85			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DV0HI	WOS:000382598200005	27064246	Bronze			2022-02-06	
J	Jackson, CE; Green, JD; Bovin, MJ; Vasterling, JJ; Holowka, DW; Ranganathan, G; Rosen, RC; Keane, TM; Marx, BP				Jackson, Colleen E.; Green, Jonathan D.; Bovin, Michelle J.; Vasterling, Jennifer J.; Holowka, Darren W.; Ranganathan, Gayatri; Rosen, Raymond C.; Keane, Terence M.; Marx, Brian P.			Mild Traumatic Brain Injury, PTSD, and Psychosocial Functioning Among Male and Female US OEF/OIF Veterans	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ENDURING FREEDOM; NATIONAL-GUARD; HEALTH; AFGHANISTAN; IRAQ; ASSOCIATION; IMPAIRMENT; DISABILITY; OUTCOMES	This study examined the unique and combined relationship between mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) with psychosocial functioning in a cohort of 1,312 U.S. male and female veterans of Operations Enduring Freedom (OEF) and Iraqi Freedom (OIF) enrolled in the Veterans After-Discharge Longitudinal Registry (Project VALOR). We assessed mTBI with structured screening questions reflective of current TBI classification standards and PTSD via the SCID-IV PTSD module; all other variables were assessed by self-report questionnaires. We identified significant diagnostic group differences in psychosocial functioning for both sexes. Individuals with PTSD, with or without a history of mTBI, reported significantly worse psychosocial functioning than individuals with mTBI alone or neither mTBI nor PTSD (males, (2)(p) = .11, p < .001; females, (2)(p) = .14, p < .001), even after adjusting for demographics and severity of chronic pain. The results suggested that veterans experiencing PTSD, regardless of whether they had a history of mTBI, were at increased risk for long-term psychosocial impairment. Further research examining possible benefits from improved access to resources and treatment to address these needs would be valuable. Resumen Este estudio examino la relacion unica y combinada entre la lesion cerebral traumatica leve (LCTL) y trastorno por estres postraumatico (TEPT) con el funcionamiento psicosocial en una cohorte de 1.312 hombres y mujeres veteranos de las operaciones Enduring Freedom (OEF) y Libertad Iraqui (OIF) inscritos en el Registro Longitudinal de Veteranos despues de descargos (Proyecto VALOR). Se evaluo LCTL con preguntas de screening estructuradas que reflejan los criterios de clasificacion de LCT actual y trastorno por estres postraumatico a traves del modulo de TEPT SCID-IV; todas las demas variables se evaluaron mediante cuestionarios de auto-reporte. Se identificaron diferencias significativas entre los grupos de diagnostico en el funcionamiento psicosocial para ambos sexos, de tal manera que las personas con trastorno de estres postraumatico, con o sin historial de LCTL, reportaron significativamente peor funcionamiento psicosocial en comparacion con los individuos con LCTL solo o los que no tenian LCTL ni trastorno por estres postraumatico (hombres, 2 p = 0,11, p <0,001; mujeres, 2 p = 0,14, p <0,001), incluso despues de ajustar las variables demograficas y la severidad del dolor cronico. Los resultados sugieren que los veteranos que experimentan trastorno por estres postraumatico, independientemente de si tenian un historial de LCTL, estaban en mayor riesgo de deterioro psicosocial a largo plazo. Futuras investigaciones que examinen los posibles beneficios de un acceso mejorado a los recursos y el tratamiento para dirigir estas necesidades serian valiosas.	[Jackson, Colleen E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Jackson, Colleen E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Jackson, Colleen E.; Green, Jonathan D.; Bovin, Michelle J.; Vasterling, Jennifer J.; Holowka, Darren W.; Keane, Terence M.; Marx, Brian P.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Green, Jonathan D.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Bovin, Michelle J.; Vasterling, Jennifer J.; Holowka, Darren W.; Keane, Terence M.; Marx, Brian P.] VA Boston Healthcare Syst, Behav Sci Div, Natl Ctr PTSD, Boston, MA USA; [Ranganathan, Gayatri; Rosen, Raymond C.] New England Res Inst, 9 Galen St, Watertown, MA 02172 USA		Marx, BP (corresponding author), VA Boston Healthcare Syst 116B 4, Natl Ctr PTSD, Behav Sci Div, 150 South Huntington Ave, Boston, MA 02130 USA.	brian.marx@va.gov	Marx, Brian/AAK-5072-2020; Keane, Terence/I-8253-2014	Jackson, Colleen/0000-0002-9927-2684; Bovin, Michelle/0000-0002-3296-4360; Keane, Terence/0000-0002-0482-3149			Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Association AP., 2000, DIAGNOSTIC STAT MANU; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bergman S, 2005, DISABIL REHABIL, V27, P675, DOI 10.1080/09638280400009030; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Evans VC, 2014, J CLIN PSYCHIAT, V75, P1359, DOI 10.4088/JCP.13r08939; Fang SC, 2015, J WOMENS HEALTH, V24, P1038, DOI 10.1089/jwh.2014.5096; Goldberg J, 2014, QUAL LIFE RES, V23, P1579, DOI 10.1007/s11136-013-0585-4; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holowka D. W., 2012, OXFORD HDB TRAUMATIC, P315; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marx B. P., 2013, DEV VALIDATION PTSD; Marx B. P., 2009, 25 ANN M INT SOC TRA; Marx BP, 2015, PSYCHIAT SERV, V66, P1312, DOI 10.1176/appi.ps.201400400; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Raggi A, 2012, J HEADACHE PAIN, V13, P595, DOI 10.1007/s10194-012-0482-1; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Rosen RC, 2012, INT J METH PSYCH RES, V21, P5, DOI 10.1002/mpr.355; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Shea MT, 2010, J TRAUMA STRESS, V23, P100, DOI 10.1002/jts.20497; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; U.S. Department of Veterans Affairs, 2010, VHA DIR 2010 012 SCR; U.S. Department of Veterans Affairs, 2015, AN VA HLTH CARE UT O; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	39	20	20	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2016	29	4					309	316		10.1002/jts.22110			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	DW2MW	WOS:000383477500004	27405050				2022-02-06	
J	Liu, F; Chen, MR; Liu, J; Zou, Y; Wang, TY; Zuo, YX; Wang, TH				Liu, Fei; Chen, Mei-Rong; Liu, Jia; Zou, Yu; Wang, Ting-Yong; Zuo, Yun-Xia; Wang, Ting-Hua			Propofol administration improves neurological function associated with inhibition of pro-inflammatory cytokines in adult rats after traumatic brain injury	NEUROPEPTIDES			English	Article						Traumatic brain injury; Neuroprotection; Propofol; Pro-inflammatory cytokine	CEREBRAL-ISCHEMIA; EXPRESSION; EPIDEMIOLOGY; CELLS; PATHOPHYSIOLOGY; PHARMACOLOGY; EDEMA	Background: Neurological deficits following traumatic brain injury (TBI) result in dramatic impacts on the survivors, but the effect of propofol and associated mechanism are waiting to be determined. Methods: Adult male Sprague-Dawley rats were randomly assigned into Sham, TBI, TBI + Intralipid and TBI + Propofol group. Modified Feeney method was adopted to generate TBI model from free hammer fall injury, and animals in TBI + Propofol group were immediately treated with propofol administration for 2 hours after TBI, rats after TBI without propofol treatment was used as injury control, intralipid as vehicle in propofol was injected in TBI + intralipid group. Then, neurological severity scores (NSS) were evaluated at 1, 3, 7 and 14 days. Moreover, the expressions of IL-1 beta, IL-6 and TNF-alpha mRNA and protein were examined using quantitative real time-polymerase chain reaction and Western blot, immunohistochemical staining was used to localize cytokines. Results: The NSS increased greatly in the rats induced by TBI, while propofol could effectively decreased NSS, confirming the neuroprotective effect of propofol. Moreover, the mRNA expressions of IL-1 beta, IL-6 and TNF-alpha, at 1, 3, 7 days after operation (dpo), were significantly augmented in the injured cortex, compared with sham one. But there was no difference between TBI and TBI + Intralipid group, but markedly decreased after propofol treatment. Additionally, the protein level of IL-1 beta, IL-6 and TNF-alpha in four groups determined by Western blot and immunohistochemistry showed the similar change with mRNA expression. Conclusion: Propofol treatment could elicit a robust neuroprotective response, resulting in significant neurological function improvement for TBI rats, which was independent with intralipid. The underlying molecular mechanism may be partially associated with an inhibition of pro-inflammatory cytoldnes. (C) 2016 Elsevier Ltd. All rights reserved.	[Liu, Fei; Zuo, Yun-Xia] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan Provinc, Peoples R China; [Chen, Mei-Rong; Liu, Jia; Zou, Yu; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Kunming 650031, Peoples R China; [Wang, Ting-Hua] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Peoples R China		Zuo, YX (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan Provinc, Peoples R China.; Wang, TH (corresponding author), Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Peoples R China.	zuoyunxiahx@qq.com; tinghua_neuron@263.net					Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chui J, 2014, CAN J ANESTH, V61, P347, DOI 10.1007/s12630-014-0118-9; Cordaro M., 2014, J NEUROTRAUMA; Cuthbert J.P., 2014, J HEAD TRAUMA REHABI; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; FULTON B, 1995, DRUGS, V50, P636, DOI 10.2165/00003495-199550040-00006; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; He BL, 2013, NEUROPEPTIDES, V47, P1, DOI 10.1016/j.npep.2012.06.001; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kotani Y, 2008, CNS NEUROSCI THER, V14, P95, DOI 10.1111/j.1527-3458.2008.00043.x; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Shi SS, 2014, NEUROCHEM RES, V39, P793, DOI 10.1007/s11064-014-1272-8; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Xi HJ, 2011, BRAIN RES, V1410, P24, DOI 10.1016/j.brainres.2011.06.060; Yisarakun W, 2015, NEUROPEPTIDES, V51, P9, DOI 10.1016/j.npep.2015.03.008; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082729; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	31	20	21	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	AUG	2016	58						1	6		10.1016/j.npep.2016.03.004			6	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	DU7SI	WOS:000382414500001	27045803				2022-02-06	
J	Birchley, G; Jones, K; Huxtable, R; Dixon, J; Kitzinger, J; Clare, L				Birchley, Giles; Jones, Kerry; Huxtable, Richard; Dixon, Jeremy; Kitzinger, Jenny; Clare, Linda			Dying well with reduced agency: a scoping review and thematic synthesis of the decision-making process in dementia, traumatic brain injury and frailty	BMC MEDICAL ETHICS			English	Article						End-of-life; Good Death; Mental capacity; Decision-making; Scoping review; Thematic synthesis; Frailty; Dementia; Traumatic brain injury	END-OF-LIFE; NURSING-HOME RESIDENTS; LONG-TERM-CARE; COGNITIVE IMPAIRMENT; QUALITATIVE RESEARCH; ADVANCE DIRECTIVES; OLDER-ADULTS; GOOD DEATH; PEOPLE; FAMILY	Background: In most Anglophone nations, policy and law increasingly foster an autonomy-based model, raising issues for large numbers of people who fail to fit the paradigm, and indicating problems in translating practical and theoretical understandings of 'good death' to policy. Three exemplar populations are frail older people, people with dementia and people with severe traumatic brain injury. We hypothesise that these groups face some over-lapping challenges in securing good end-of-life care linked to their limited agency. To better understand these challenges, we conducted a scoping review and thematic synthesis. Methods: To capture a range of literature, we followed established scoping review methods. We then used thematic synthesis to describe the broad themes emerging from this literature. Results: Initial searches generated 22,375 references, and screening yielded 49, highly heterogeneous, studies that met inclusion criteria, encompassing 12 countries and a variety of settings. The thematic synthesis identified three themes: the first concerned the processes of end-of-life decision-making, highlighting the ambiguity of the dominant shared decision-making process, wherein decisions are determined by families or doctors, sometimes explicitly marginalising the antecedent decisions of patients. Despite this marginalisation, however, the patient does play a role both as a social presence and as an active agent, by whose actions the decisions of those with authority are influenced. The second theme examined the tension between predominant notions of a good death as 'natural' and the drive to medicalise death through the lens of the experiences and actions of those faced with the actuality of death. The final theme considered the concept of antecedent end-of-life decision-making (in all its forms), its influence on policy and decision-making, and some caveats that arise from the studies. Conclusions: Together these three themes indicate a number of directions for future research, which are likely to be applicable to other conditions that result in reduced agency. Above all, this review emphasises the need for new concepts and fresh approaches to end of life decision-making that address the needs of the growing population of frail older people, people with dementia and those with severe traumatic brain injury.	[Birchley, Giles; Huxtable, Richard] Univ Bristol, Ctr Eth Med, Bristol, Avon, England; [Jones, Kerry] Open Univ, Fac Hlth & Social Care, Milton Keynes, Bucks, England; [Dixon, Jeremy] Univ Bath, Dept Social & Policy Sci, Bath, Avon, England; [Kitzinger, Jenny] Cardiff Univ, Coma & Disorders Consciousness Res Ctr, Cardiff, S Glam, Wales; [Clare, Linda] Univ Exeter, REACH Ctr Res Ageing & Cognit Hlth, Exeter, Devon, England		Birchley, G (corresponding author), Univ Bristol, Ctr Eth Med, Bristol, Avon, England.	giles.birchley@bristol.ac.uk	Jones, K/AAD-6630-2019	Clare, Linda/0000-0003-3989-5318; Jones, Kerry/0000-0003-2756-8029; Dixon, Jeremy/0000-0003-0656-5646; Birchley, Giles/0000-0002-2973-2163	GW4 Building Communities Programme (Accelerator Fund) [GW4- 81-PA]	This work was funded through a GW4 Building Communities Programme (Accelerator Fund) Grant no: GW4- 81-PA.	Abarshi EA, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578052; Allen RS, 2003, GERONTOLOGIST, V43, P309, DOI 10.1093/geront/43.3.309; Anquinet L, 2013, J AM GERIATR SOC, V61, P1768, DOI 10.1111/jgs.12447; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Ayalon L, 2012, INT PSYCHOGERIATR, V24, P1798, DOI 10.1017/S1041610212000877; Bagshaw SM, 2013, CURR OPIN CRIT CARE, V19, P496, DOI 10.1097/MCC.0b013e328364d570; Baker A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625175; Barclay S, 2014, BRIT J GEN PRACT, V64, pE576, DOI 10.3399/bjgp14X681397; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Basic D, 2015, J AGING HEALTH, V27, P670, DOI 10.1177/0898264314558202; Birchley G, 2014, HEALTH CARE ANAL, V22, P203, DOI 10.1007/s10728-013-0267-y; Black BS, 2009, J AGING HEALTH, V21, P627, DOI 10.1177/0898264309333316; Bosek Marcia Sue DeWolf, 2003, JONAS Healthc Law Ethics Regul, V5, P34, DOI 10.1097/00128488-200306000-00006; Bottrell MM, 2001, GERIATR NURS, V22, P313, DOI 10.1067/mgn.2001.120994; Brazil K, 2012, SCAND J CARING SCI, V26, P513, DOI 10.1111/j.1471-6712.2011.00956.x; Cavalieri Thomas A., 2002, Journal of the American Osteopathic Association, V102, P541; Chan HYL, 2011, J CLIN NURS, V20, P1454, DOI 10.1111/j.1365-2702.2010.03670.x; Chan HYL, 2010, J CLIN NURS, V19, P3073, DOI 10.1111/j.1365-2702.2010.03353.x; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Cigolle CT, 2009, J AM GERIATR SOC, V57, P830, DOI 10.1111/j.1532-5415.2009.02225.x; De Jong JD, 2009, J PALLIAT CARE, V25, P61, DOI 10.1177/082585970902500107; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Demertzi A, 2014, BRAIN INJURY, V28, P1209, DOI 10.3109/02699052.2014.920526; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Dening KH, 2012, BMJ SUPPORT PALLIAT, V2, P103, DOI 10.1136/bmjspcare-2011-000178; Department of Health (UK), 2008, END OF LIFE CARE STR; Di Giulio P, 2008, J PALLIAT MED, V11, P1023, DOI 10.1089/jpm.2008.0020; Doron I., 2014, LAW ETHICS DEMENTIA, P15; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Evans WG, 2006, J PALLIAT MED, V9, P100, DOI 10.1089/jpm.2006.9.100; Ferrucci L, 2003, CRIT REV ONCOL HEMAT, V46, P127, DOI 10.1016/S1040-8428(02)00177-4; Forbes S, 2000, J NURS SCHOLARSHIP, V32, P251, DOI 10.1111/j.1547-5069.2000.00251.x; Fried TR, 1997, J AM GERIATR SOC, V45, P265, DOI 10.1111/j.1532-5415.1997.tb00938.x; Gawande A., 2014, WELLCOME SERIES; Good MJD, 2004, SOC SCI MED, V58, P939, DOI 10.1016/j.socscimed.2003.10.043; Hallam E, 1999, BEYOND THE BODY DEAT; Haller IV, 2007, J PALLIAT MED, V10, P400, DOI 10.1089/jpm.2006.0129; Herring J., 2014, THE LAW AND ETHICS O, P301; Hick G, 2010, PHYSIOLOGICAL RESILI, P89; Hofstede G., 2001, CULTURES CONSEQUENCE; Jox RJ, 2015, ARCH PHYS MED REHAB, V96, P323, DOI 10.1016/j.apmr.2014.09.030; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Kitzinger C, 2015, J MED ETHICS, V41, DOI 10.1136/medethics-2013-101799; Kitzinger J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI 10.1111/1467-9566.12020; Lamberg JL, 2005, J AM GERIATR SOC, V53, P1396, DOI 10.1111/j.1532-5415.2005.53426.x; Lavrijsen J, 2005, BRAIN INJURY, V19, P67, DOI 10.1080/02699050410001720013; Livingston G, 2013, INT PSYCHOGERIATR, V25, P1849, DOI 10.1017/S1041610213001221; Livingston G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4184; McDermott C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653589; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; Mor Vincent, 2005, J Palliat Med, V8, P58, DOI 10.1089/jpm.2005.8.58; Munthe C, 2012, HEALTH CARE ANAL, V20, P231, DOI 10.1007/s10728-011-0183-y; Nakanishi M, 2009, ARCH GERONTOL GERIAT, V48, P296, DOI 10.1016/j.archger.2008.02.009; NatCen Social Research, 2013, BRITISH SOCIAL ATTIT; Office for National Statistics, 2015, NATIONAL POPULATION; Parsons C, 2014, INT J GERIATR PSYCH, V29, P281, DOI 10.1002/gps.4006; PIJNENBORG L, 1995, ARCH INTERN MED, V155, P286, DOI 10.1001/archinte.155.3.286; Pollack KM, 2010, HEALTH POLICY, V96, P57, DOI 10.1016/j.healthpol.2010.01.004; Potkins D, 2000, INT J GERIATR PSYCH, V15, P1005, DOI 10.1002/1099-1166(200011)15:11<1005::AID-GPS223>3.0.CO;2-0; Prince M., 2014, DEMENTIA UK UPDATE 2; Reinhardt JP, 2014, J SOC WORK END-LIFE, V10, P112, DOI 10.1080/15524256.2014.906371; Rich BA, 2004, WIEN KLIN WOCHENSCHR, V116, P420, DOI 10.1007/BF03040929; Robinson L, 2013, PALLIATIVE MED, V27, P401, DOI 10.1177/0269216312465651; Rockwood K, 2006, J AM GERIATR SOC, V54, P975, DOI 10.1111/j.1532-5415.2006.00738.x; Rodrigue C, 2013, NEUROETHICS-NETH, V6, P25, DOI 10.1007/s12152-011-9142-4; Rurup ML, 2006, PATIENT EDUC COUNS, V61, P372, DOI 10.1016/j.pec.2005.04.016; Sampson EL, 2011, PALLIATIVE MED, V25, P197, DOI 10.1177/0269216310391691; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Schlosser M., 2015, THE STANFORD ENCYCLO; Sloane PD, 2008, GERONTOLOGIST, V48, P741, DOI 10.1093/geront/48.6.741; Solloway Michele, 2005, J Palliat Med, V8, P789, DOI 10.1089/jpm.2005.8.789; Soskis CW, 1997, SOC WORK HEALTH CARE, V25, P107, DOI 10.1300/J010v25n01_11; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Triplett P, 2008, J AGING HEALTH, V20, P583, DOI 10.1177/0898264308317822; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; van der Steen JT, 2005, ALZ DIS ASSOC DIS, V19, P148, DOI 10.1097/01.wad.0000175525.99104.b7; Vandervoort A, 2014, J PAIN SYMPTOM MANAG, V47, P245, DOI 10.1016/j.jpainsymman.2013.03.009	78	20	20	2	28	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6939			BMC MED ETHICS	BMC Med. Ethics	JUL 27	2016	17								46	10.1186/s12910-016-0129-x			15	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	DS7UC	WOS:000380987400001	27461340	Green Accepted, Green Published, gold			2022-02-06	
J	Reyes-Mendoza, J; Morales, T				Reyes-Mendoza, Julio; Morales, Teresa			POST-TREATMENT WITH PROLACTIN PROTECTS HIPPOCAMPAL CA1 NEURONS OF THE OVARIECTOMIZED FEMALE RAT AGAINST KAINIC ACID-INDUCED NEURODEGENERATION	NEUROSCIENCE			English	Article						hippocampus; excitotoxicity; prolactin; females; memory; neurogenesis	ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; INDUCED EXPRESSION; MOLECULAR-MECHANISMS; OBJECT RECOGNITION; DORSAL HIPPOCAMPUS; GLIAL RESPONSES; DENTATE GYRUS; NEUROGENESIS	Kainic acid (KA) is a glutamate agonist widely used in studies of neurodegeneration due to its ability to induce excitotoxic damage in the rodent brain. Previously, we reported that pre-treatment with prolactin (PRL) prevents the neuron loss induced by KA administration in CA1, CA3 and CA4 of the hippocampus of the female rat. Here, we investigated if PRL has a neuroprotective effect in the dorsal hippocampus when it is administered after KA. For this, 100 ng of KA or 0.9% saline was administered intracere-broventricularly (ICV) to ovariectomized female rats. One hour later, they received subcutaneous PRL (103 mu g/day for 7 days) or saline through an osmotic minipump. Also, to determine the hippocampal neurogenesis rate, the rats were administered bromodeoxyuridine along with the PRL treatment. Immunostaining for NeuN revealed that neuronal loss is lower in the CA1 of PRL-treated rats compared with the untreated group, but PRL did not confer any protection in the CA3 and CA4 subfields. Furthermore, PRL prevented the KA-induced cognitive deficit measured as a better performance in the novel object recognition test. The PRL treatment did not modify the neurogenesis rate. These data indicate that post-treatment with PRL confers differential neuroprotection against KA-induced neuronal loss in hippocampal subfield CA1, which correlates with a more mild cognitive deficit compared with the untreated control group. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Reyes-Mendoza, Julio; Morales, Teresa] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Celular & Mol, Queretaro 76230, Qro, Mexico		Morales, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Blvd Juriquilla 3001, Queretaro 76230, Qro, Mexico.	marter@unam.mx	Morales, Teresa/I-2941-2019	Morales, Teresa/0000-0003-1539-2070	UNAM-DGAPA-PAPIITPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IN202812, 202315]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [128090, 298998]	This study was supported by funds from UNAM-DGAPA-PAPIIT IN202812 and 202315, and CONACYT 128090 grants. We thank Dr. Dorothy Pless for grammatical review, and Nydia Hernandez (digital imaging), Eugenia Ramos, and Martin Garcia, and Alejandra Castilla (Animal Care) for technical assistance. JRM received CONACYT scholarship No. 298998 as part of his master studies (Maestria en Ciencias Neurobiologia, UNAM).	Alipanahzadeh H, 2014, CELL J, V16, P315; Arnold E, 2014, J NEUROSCI, V34, P1868, DOI 10.1523/JNEUROSCI.2452-13.2014; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; BOLZAN AD, 1995, EXP GERONTOL, V30, P169, DOI 10.1016/0531-5565(94)00053-0; Bolzan AD, 1997, EXP GERONTOL, V32, P297, DOI 10.1016/S0531-5565(96)00101-5; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; Chen ZG, 2005, J NEUROBIOL, V62, P207, DOI 10.1002/neu.20099; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; de Lima MN, 2005, EXP GERONTOL, V40, P506, DOI 10.1016/j.exger.2005.03.004; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; DEVITO WJ, 1995, J CELL BIOCHEM, V57, P290, DOI 10.1002/jcb.240570213; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Franssen RA, 2012, BRAIN RES, V1454, P80, DOI 10.1016/j.brainres.2012.03.028; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Frye CA, 2011, DEV NEUROBIOL, V71, P142, DOI 10.1002/dneu.20832; Goldhar AS, 2005, MOL CELL ENDOCRINOL, V232, P9, DOI 10.1016/j.mce.2005.01.005; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Kinoshita Y, 2012, EPILEPSIA, V53, P125, DOI 10.1111/j.1528-1167.2012.03483.x; Kochendoerfer SK, 2003, J ENDOCRINOL, V178, P265, DOI 10.1677/joe.0.1780265; LEFF M, 1996, ENDOCRINOLOGY, V144, P2102; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Mala G, 2014, PLOS ONE, V9; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Moderscheim TAE, 2007, NEUROSCIENCE, V145, P963, DOI 10.1016/j.neuroscience.2006.12.053; Morales T, 2014, NEUROSCIENCE, V258, P211, DOI 10.1016/j.neuroscience.2013.11.015; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NADLER JV, 1980, J COMP NEUROL, V192, P333, DOI 10.1002/cne.901920209; Olney J W, 1986, Adv Neurol, V44, P857; Palomero-Gallagher N, 2003, J COMP NEUROL, V459, P468, DOI 10.1002/cne.10638; Panegyres PK, 1998, J NEUROL SCI, V154, P123, DOI 10.1016/S0022-510X(97)00214-1; Pearson JN, 2014, EPILEPSY RES, V108, P1032, DOI 10.1016/j.eplepsyres.2014.04.003; Ploszaj T, 1998, APOPTOSIS, V3, P295, DOI 10.1023/A:1009669427662; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SIGNORELLA AP, 1984, ANAL BIOCHEM, V136, P372, DOI 10.1016/0003-2697(84)90232-X; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Sugino N, 1998, BIOL REPROD, V59, P599, DOI 10.1095/biolreprod59.3.599; Swanson L.W., 1998, BRAIN MAPS STRUCTURE, V2; Tan DX, 1998, J NEUROSCI RES, V54, P382, DOI 10.1002/(SICI)1097-4547(19981101)54:3<382::AID-JNR9>3.0.CO;2-Y; Tejadilla D, 2010, NEUROSCIENCE, V169, P1178, DOI 10.1016/j.neuroscience.2010.05.074; Too CKL, 1998, MOL CELL ENDOCRINOL, V137, P187, DOI 10.1016/S0303-7207(97)00240-2; Torner L, 2013, BEHAV BRAIN RES, V252, P32, DOI 10.1016/j.bbr.2013.05.031; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; Vanoye-Carlo A, 2008, HORM BEHAV, V53, P112, DOI 10.1016/j.yhbeh.2007.09.004; Veliskova J, 2000, EPILEPSIA, V41, pS30, DOI 10.1111/j.1528-1157.2000.tb01553.x; Walker TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044371; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zhang XM, 2011, CURR NEUROPHARMACOL, V9, P388, DOI 10.2174/157015911795596540; ZHENG XY, 2010, J BIOMED BIOTECHNOL, V2011, P1	60	20	20	1	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 22	2016	328						58	68		10.1016/j.neuroscience.2016.04.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM5JP	WOS:000376385100007	27126559				2022-02-06	
J	Fiorin, FD; Ferreira, APD; Ribeiro, LR; Silva, LFA; de Castro, MRT; da Silva, LRH; da Silveira, MEP; Zemolin, APP; Dobrachinski, F; de Oliveira, SM; Franco, JL; Soares, FA; Furian, AF; Oliveira, MS; Fighera, MR; Royes, LFF				Fiorin, Fernando da Silva; de Oliveira Ferreira, Ana P.; Ribeiro, Leandro R.; Silva, Luiz F. A.; de Castro, Mauro R. T.; da Silva, Luis R. H.; da Silveira, Mauro E. P.; Zemolin, Ana P. P.; Dobrachinski, Fernando; de Oliveira, Sara Marchesan; Franco, Jeferson L.; Soares, Felix A.; Furian, Ana F.; Oliveira, Mauro S.; Fighera, Michele R.; Freire Royes, Luiz F.			The Impact of Previous Physical Training on Redox Signaling after Traumatic Brain Injury in Rats: A Behavioral and Neurochemical Approach	JOURNAL OF NEUROTRAUMA			English	Article						cognition; fluid percussion injury; oxidative stress; physical exercise; spontaneous epileptiform events	CONTROLLED CORTICAL IMPACT; HEAT-SHOCK-PROTEIN; GLUTAMATE TRANSPORTERS; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; POSTTRAUMATIC EPILEPSY; VOLUNTARY EXERCISE; TIME-COURSE; MECHANISMS; ANTIOXIDANT	Throughout the world, traumatic brain injury (TBI) is one of the major causes of disability, which can include deficits in motor function and memory, as well as acquired epilepsy. Although some studies have shown the beneficial effects of physical exercise after TBI, the prophylactic effects are poorly understood. In the current study, we demonstrated that TBI induced by fluid percussion injury (FPI) in adult male Wistar rats caused early motor impairment (24 h), learning deficit (15 days), spontaneous epileptiform events (SEE), and hilar cell loss in the hippocampus (35 days) after TBI. The hippocampal alterations in the redox status, which were characterized by dichlorofluorescein diacetate oxidation and superoxide dismutase (SOD) activity inhibition, led to the impairment of protein function (Na+, K+-adenosine triphosphatase [ATPase] activity inhibition) and glutamate uptake inhibition 24 h after neuronal injury. The molecular adaptations elicited by previous swim training protected against the glutamate uptake inhibition, oxidative stress, and inhibition of selected targets for free radicals (e.g., Na+, K+-ATPase) 24 h after neuronal injury. Our data indicate that this protocol of exercise protected against FPI-induced motor impairment, learning deficits, and SEE. In addition, the enhancement of the hippocampal phosphorylated nuclear factor erythroid 2-related factor (P-Nrf2)/Nrf2, heat shock protein 70, and brain-derived neurotrophic factor immune content in the trained injured rats suggests that protein expression modulation associated with an antioxidant defense elicited by previous physical exercise can prevent toxicity induced by TBI, which is characterized by cell loss in the dentate gyrus hilus at 35 days after TBI. Therefore, this report suggests that previous physical exercise can decrease lesion progression in this model of brain damage.	[Fiorin, Fernando da Silva; de Oliveira Ferreira, Ana P.; Ribeiro, Leandro R.; Silva, Luiz F. A.; de Castro, Mauro R. T.; da Silva, Luis R. H.; da Silveira, Mauro E. P.; Fighera, Michele R.; Freire Royes, Luiz F.] Univ Fed Santa Maria, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil; [Zemolin, Ana P. P.; Dobrachinski, Fernando; de Oliveira, Sara Marchesan; Franco, Jeferson L.; Soares, Felix A.; Fighera, Michele R.; Freire Royes, Luiz F.] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol, Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil; [Furian, Ana F.; Oliveira, Mauro S.; Fighera, Michele R.; Freire Royes, Luiz F.] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97105900 Santa Maria, RS, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecn Desportivas, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Fighera, Michele R/J-9576-2014; Franco, Jeferson Luis/F-7797-2012; da Silva Fiorin, Fernando/AAQ-9472-2021; Soares, Felix/AAE-6251-2020; Oliveira, Mauro Schneider/G-3437-2012; Soares, Felix AA/K-7611-2012; Dobrachinski, Fernando/C-4316-2014	Franco, Jeferson Luis/0000-0002-3874-8618; da Silva Fiorin, Fernando/0000-0002-6517-7160; Soares, Felix/0000-0002-6453-7902; Oliveira, Mauro Schneider/0000-0002-5381-1208; Soares, Felix AA/0000-0002-6453-7902; Dobrachinski, Fernando/0000-0002-3948-1273; Fighera, Michele/0000-0002-3111-7530; Ribeiro, Leandro/0000-0002-8442-4075; oliveira, sara/0000-0003-2960-5284; Almeida Silva, Luiz Fernando/0000-0002-7621-4836			Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ansari MN, 2008, INDIAN J EXP BIOL, V46, P521; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Asghar M, 2007, AM J PHYSIOL-RENAL, V293, pF914, DOI 10.1152/ajprenal.00272.2007; Ashman TA, 2006, MT SINAI J MED, V73, P999; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Chuang De-Maw, 2004, Critical Reviews in Neurobiology, V16, P83, DOI 10.1615/CritRevNeurobiol.v16.i12.90; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; de Oliveira CV, 2015, PHYSIOL BEHAV, V143, P142, DOI 10.1016/j.physbeh.2015.03.004; DeKosky ST, 2004, J NEUROTRAUM, V21, P491, DOI 10.1089/089771504774129838; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Fiske CH, 1925, J BIOL CHEM, V66, P375; Franco JL, 2010, TOXICOL SCI, V113, P150, DOI 10.1093/toxsci/kfp245; Frizzo MED, 2002, CELL MOL NEUROBIOL, V22, P353; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Gonzalez-Lima F, 2004, LEARN MEMORY, V11, P633, DOI 10.1101/lm.82404; Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hong Y, 2010, J INT MED RES, V38, P1893, DOI 10.1177/147323001003800602; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; INIGUEZ C, 1985, J NEUROSCI METH, V13, P77, DOI 10.1016/0165-0270(85)90045-7; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Kelly S, 2002, ANN NEUROL, V52, P160, DOI 10.1002/ana.10264; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Liu X, 2010, NEUROSCI LETT, V476, P99, DOI 10.1016/j.neulet.2010.04.011; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marquezi ML, 2003, INT J SPORT NUTR EXE, V13, P65, DOI 10.1123/ijsnem.13.1.65; McColl E, 2003, QUAL LIFE RES, V12, P217; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meeusen R, 2014, SPORTS MED, V44, P47, DOI 10.1007/s40279-014-0150-5; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Packer L, 2007, FREE RADICAL RES, V41, P951, DOI 10.1080/10715760701490975; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Roach JT, 2004, BRAIN RES, V1015, P161, DOI 10.1016/j.brainres.2004.05.004; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scharfman HE, 2014, ADV EXP MED BIOL, V813, P133, DOI 10.1007/978-94-017-8914-1_11; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Szabo Z, 2010, BRAIN RES, V1341, P25, DOI 10.1016/j.brainres.2009.01.035; Toth Z, 1997, J NEUROSCI, V17, P8106; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	99	20	20	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1317	1330		10.1089/neu.2015.4068			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100004	26651029				2022-02-06	
J	Blumenfeld, RS; Winsell, JC; Hicks, JW; Small, SL				Blumenfeld, Robert S.; Winsell, Jessica C.; Hicks, James W.; Small, Steven L.			The Epidemiology of Sports-Related Head Injury and Concussion in Water Polo	FRONTIERS IN NEUROLOGY			English	Article						concussion; brain injury; sports-related head injury; epidemiology; survey; mild TBI; contact sports	DIAGNOSIS; SYMPTOMS	Purpose: Water polo is a sport with a high degree of physicality and aggressive play. Unlike most contact sports, epidemiological data on the incidence or prevalence of head trauma in water polo have not been gathered, reported, or made publicly available. The purpose of this study was to begin a systematic characterization of the risks of head impact and concussion in men and women who play water polo at various levels. Design: We sent an electronic survey to the 44,000+ members of USA Water Polo, asking questions about concussions, head impacts, and symptoms commonly associated with prior concussion. From over 1500 complete responses, we report summary information on the prevalence of concussions and major head impacts in water polo. Results: We found that 36% of respondents report sustaining a concussion while playing water polo, with an average of two concussions reported. The prevalence and number of concussions reported varied across positions, levels, and gender. Most strikingly, we found that goalies are at significantly higher risk for concussion, report a significantly more concussions, and appear to experience a qualitatively different type of head impact compared to other positions. Additionally, we found that competition level, gender, and field position are robust predictors of concussion risk. Conclusion: Our findings demonstrate that concussions are not uncommon in water polo players. We conclude that there is need for systematic concussion reporting in water polo and suggest that understanding the risk factors of concussion in water polo will require fully considering differences in the head impact exposure between different field positions, competition levels, sexes, and differences in exposure between competition and practice.	[Blumenfeld, Robert S.] Calif State Polytech Univ Pomona, Dept Psychol & Sociol, Pomona, CA 91768 USA; [Blumenfeld, Robert S.; Winsell, Jessica C.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Small, Steven L.] Univ Calif Irvine, Brain Circuits Lab, Biol Sci 3, Irvine, CA USA		Small, SL (corresponding author), Univ Calif Irvine, Brain Circuits Lab, Biol Sci 3, Irvine, CA USA.	small@uci.edu		Small, Steven/0000-0002-5293-6172	University of California Irvine (UC Irvine) School of Medicine	Financial support for the study was provided by the University of California Irvine (UC Irvine) School of Medicine. Logistical support was provided by USA Water Polo, which graciously sent our survey out to its entire constituency, and by the UC Irvine Department of Intercollegiate Athletics, which has consistently provided our sports neurology program with access, advice, and hands-on assistance. Thanks to Manali Khadilkar for helping to implement the survey. Finally, we are particularly grateful to Maria Corrada-Bravo, Sc.D., who read over the manuscript and provided invaluable advice on epidemiology and biostatistics.	Bell L., 2014, SELF REPORTED CONCUS; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Harmon KG, 2012, BRIT J SPORT MED, V46, P158, DOI 10.1136/bjsports-2012-090999; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Parsons J, 2014, 2014 15 NCAA SPORTS; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667	14	20	20	0	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 24	2016	7								98	10.3389/fneur.2016.00098			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP5OR	WOS:000378547400001	27445965	Green Published, gold			2022-02-06	
J	Wu, G; Liu, ZY				Wu, Gang; Liu, Zongying			Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Mediates Neuroprotection in Traumatic Brain Injury at Least in Part by Inactivating Microglia	MEDICAL SCIENCE MONITOR			English	Article						Brain Injuries; Microglia; NF-E2-Related Factor 2	TRANSCRIPTION FACTOR NRF2; ACTIVATION; INFLAMMATION; MICE; PROTECTION; PHENOTYPE; SYSTEM; RAT	Background: Microglial activation has been reported to be involved in traumatic brain injury (TBI). Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a significant role in protecting against TBI-induced secondary brain injury. However, the exact mechanism is not clearly understood. The present study aimed to explore whether Nrf2 protects against TBI partly by regulating microglia function. Material/Methods: Microglia cells were isolated from C57BL/6 mouse brains (postnatal day 1-3). The expression of Nrf2 was suppressed by transfection with Nrf2-specific small interfering RNA (siRNA), and overexpressed by transfections with pcDNA3.1-Nrf2. The expression of Nrf2 was confirmed by real-time PCR and Western blotting. After transfection, cell viability, phagocytic ability, and the expression of pro-inflammatory cytokines (tumor necrosis factor (TNF)-alpha and interleukin (IL)-6) were determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) colorimetric assay, phagocytosis assay, and enzyme-linked immunosorbent assay (ELISA), respectively. Results: mRNA and protein expression levels of Nrf2 were significantly reduced by transfection with Nrf2-specific siRNA (both P<0.05) but were elevated by transfection with pcDNA3.1-Nrf2 (both P<0.01). The cell viability, phagocytic ability, and the expression of TNF-alpha and IL-6 were all significantly reduced by overexpression of Nrf2 but were significantly increased by silencing of Nrf2 compared with the control group. Conclusions: Our results suggest that Nrf2 protects against TBI, at least part by regulating microglia function.	[Wu, Gang] Binzhou Peoples Hosp, Dept Neurol, Binzhou, Shandong, Peoples R China; [Liu, Zongying] Peoples Hosp Pingyi Cty, Dept Clin Lab, Linyi, Shandong, Peoples R China		Wu, G (corresponding author), Binzhou Peoples Hosp, Dept Neurol, Binzhou, Shandong, Peoples R China.	wugang2425@126.com					Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jin W, 2009, J SURG RES, V157, P251, DOI 10.1016/j.jss.2008.08.003; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Koh K, 2011, J NEUROIMMUNOL, V233, P160, DOI 10.1016/j.jneuroim.2011.01.004; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kraft AD, 2006, J NEUROCHEM, V98, P1852, DOI 10.1111/j.1471-4159.2006.04019.x; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nagamoto-Combs K, 2010, J NEUROSCI, V30, P9641, DOI 10.1523/JNEUROSCI.0828-10.2010; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	35	20	20	0	4	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JUN 23	2016	22						2161	2166		10.12659/MSM.896568			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DQ0HS	WOS:000378880500001	27336674	Green Published			2022-02-06	
J	Hammond, FM; Alexander, DN; Cutler, AJ; D'Amico, S; Doody, RS; Sauve, W; Zorowitz, RD; Davis, CS; Shin, P; Ledon, F; Yonan, C; Formella, AE; Siffert, J				Hammond, Flora M.; Alexander, David N.; Cutler, Andrew J.; D'Amico, Stephen; Doody, Rachelle S.; Sauve, William; Zorowitz, Richard D.; Davis, Charles S.; Shin, Paul; Ledon, Fred; Yonan, Charles; Formella, Andrea E.; Siffert, Joao			PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury	BMC NEUROLOGY			English	Article						Dextromethorphan; Quinidine; Pseudobulbar affect; Dementia; Brain injuries; Stroke; Neuropsychiatric symptoms; Center for neurologic study-lability scale	EMOTIONAL EXPRESSION DISORDER; MULTIPLE-SCLEROSIS; DEPRESSION; LABILITY; TRIAL	Background: Phase 3 trials supporting dextromethorphan/quinidine (DM/Q) use as a treatment for pseudobulbar affect (PBA) were conducted in patients with amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). The PRISM II study provides additional DM/Q experience with PBA secondary to dementia, stroke, or traumatic brain injury (TBI). Methods: Participants in this open-label, multicenter, 90-day trial received DM/Q 20/10 mg twice daily. The primary outcome was the Center for Neurologic Study-Lability Scale (CNS-LS), assessing change in PBA episode frequency and severity. The CNS-LS final visit score was compared to baseline (primary analysis) and to the response in a previously conducted placebo-controlled trial with DM/Q in patients with ALS or MS. Secondary outcomes included change in PBA episode count and Clinical Global Impression of Change with respect to PBA as rated by a clinician (CGI-C) and by the patient or caregiver (PGI-C). Results: The study enrolled 367 participants with PBA secondary to dementia, stroke, or TBI. Mean (standard deviation [SD]) CNS-LS score improved significantly from 20.4 (4.4) at baseline to 12.8 (5.0) at Day 90/Final Visit (change, -7.7 [6.1]; P < .001, 95 % CI: -8.4, -7.0). This magnitude of improvement was consistent with DM/Q improvement in the earlier phase-3, placebo-controlled trial (mean [95 % CI] change from baseline, -8.2 [-9.4, -7.0]) and numerically exceeds the improvement seen with placebo in that study (-5.7 [-6.8, -4.7]). Reduction in PBA episode count was 72.3 % at Day 90/Final Visit compared with baseline (P < .001). Scores on CGI-C and PGI-C showed that 76.6 and 72.4 % of participants, respectively, were "much" or "very much" improved with respect to PBA. The most frequently occurring adverse events (AEs) were diarrhea (5.4 %), headache (4.1 %), urinary tract infection (2.7 %), and dizziness (2.5 %); 9.8 % had AEs that led to discontinuation. Serious AEs were reported in 6.3 %; however, none were considered treatment related. Conclusions: DM/Q was shown to be an effective and well-tolerated treatment for PBA secondary to dementia, stroke, or TBI. The magnitude of PBA improvement was similar to that reported in patients with PBA secondary to ALS or MS, and the adverse event profile was consistent with the known safety profile of DM/Q.	[Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Alexander, David N.] Univ Calif Los Angeles, Los Angeles, CA USA; [Cutler, Andrew J.] Florida Clin Res Ctr LLC, Bradenton, FL USA; [D'Amico, Stephen] Cornerstone Med Grp, Franklin, TN USA; [Doody, Rachelle S.] Baylor Coll Med, Houston, TX 77030 USA; [Sauve, William] TMS NeuroHlth Ctrs, Richmond, VA USA; [Zorowitz, Richard D.] MedStar Natl Rehabil Network, Washington, DC USA; [Davis, Charles S.] CSD Biostat Inc, Tucson, AZ USA; [Shin, Paul; Ledon, Fred; Yonan, Charles; Formella, Andrea E.; Siffert, Joao] Avanir Pharmaceut Inc, Aliso Viejo, CA USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com	Group, Prescott Medical Communications/AAE-7494-2019; Formella, Andrea/AAE-4073-2020	Formella, Andrea/0000-0003-2737-7898; Zorowitz, Richard/0000-0001-8938-786X	Avanir Pharmaceuticals, Inc.	This study and medical writing and editing services were funded by Avanir Pharmaceuticals, Inc.	Avanir Pharmaceuticals Inc, 2015, NUED PRESCR INF; Brooks BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072232; Brooks BR, 2004, NEUROLOGY, V63, P1364; CODD EE, 1995, J PHARMACOL EXP THER, V274, P1263; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Doody R. S., 2015, CNS SPECTRUMS, P1; Engelman W, 2014, NEUROPSYCH DIS TREAT, V10, P1903, DOI 10.2147/NDT.S63304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hammond F, 2015, 33 ANN S NAT NEUR SO; Hernandez SC, 2000, J PHARMACOL EXP THER, V293, P962; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Pattee GL, 2014, CURR MED RES OPIN, V30, P2255, DOI 10.1185/03007995.2014.940040; Pioro EP, 2011, DRUGS, V71, P1193, DOI 10.2165/11591450-000000000-00000; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Smith RA, 2004, MULT SCLER J, V10, P679, DOI 10.1191/1352458504ms1106oa; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Werling LL, 2007, EXP NEUROL, V207, P248, DOI 10.1016/j.expneurol.2007.06.013; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; Zorowitz RD, 2015, 92 ANN C AM C REH ME	31	20	20	0	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	JUN 9	2016	16								89	10.1186/s12883-016-0609-0			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO2DW	WOS:000377590900001	27276999	Green Published, gold			2022-02-06	
J	Cheng, TA; Bell, JM; Haileyesus, T; Gilchrist, J; Sugerman, DE; Coronado, VG				Cheng, Tabitha A.; Bell, Jeneita M.; Haileyesus, Tadesse; Gilchrist, Julie; Sugerman, David E.; Coronado, Victor G.			Nonfatal Playground-Related Traumatic Brain Injuries Among Children, 2001-2013	PEDIATRICS			English	Article							UNITED-STATES; EQUIPMENT; PROGRAM; SPORTS; TRENDS; NEISS	OBJECTIVE: To describe the circumstances, characteristics, and trends of emergency department (ED) visits for nonfatal, playground-related traumatic brain injury (TBI) among persons aged <= 14 years. METHODS: The National Electronic Injury Surveillance System-All Injury Program from January 1, 2001, through December 31, 2013, was examined. US Census bridged-race population estimates were used as the denominator to compute rates per 100000 population. SAS and Joinpoint linear weighted regression analyses were used to analyze the best-fitting join-point and the annual modeled rate change. These models were used to indicate the magnitude and direction of rate trends for each segment or period. RESULTS: During the study period, an annual average of 21101 persons aged <= 14 years were treated in EDs for playground-related TBI. The ED visit rate for boys was 39.7 per 100000 and 53.5 for persons aged 5-9 years. Overall, 95.6% were treated and released, 33.5% occurred at places of recreation or sports, and 32.5% occurred at school. Monkey bars or playground gyms (28.3%) and swings (28.1%) were the most frequently associated with TBI, but equipment involvement varied by age group. The annual rate of TBI ED visits increased significantly from 2005 to 2013 (P < .05). CONCLUSIONS: Playgrounds remain an important location of injury risk to children. Strategies to reduce the incidence and severity of playground-related TBIs are needed. These may include improved adult supervision, methods to reduce child risk behavior, regular equipment maintenance, and improvements in playground surfaces and environments.	[Cheng, Tabitha A.; Bell, Jeneita M.; Gilchrist, Julie; Sugerman, David E.; Coronado, Victor G.] Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA USA; [Cheng, Tabitha A.] Ctr Dis Control & Prevent, CDC Experience Appl Epidemiol Fellowship, Div Sci Educ & Profess Dev, Natl Ctr Injury Prevent, Atlanta, GA USA; [Haileyesus, Tadesse] Ctr Dis Control & Prevent, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent, Atlanta, GA USA		Cheng, TA (corresponding author), UCLA Emergency Med, 924 Westwood Blvd,Ste 300, Los Angeles, CA 90095 USA.	tacheng@mednet.ucla.edu			External Medical Affairs, Pfizer Inc.Pfizer	The CDC Experience is a 1-year fellowship in applied epidemiology at the Centers for Disease Control and Prevention made possible by a public/private partnership supported by a grant to the Centers for Disease Control and Prevention Foundation from External Medical Affairs, Pfizer Inc.	American Society for Testing and Materials International, F148711 ASTM; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; [Anonymous], F129299 ASTM; [Anonymous], 2015, NEISS NAT EL INJ SUR; Centers for Disease Control and Prevention, HEADS UP CONC; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Frost J., 2004, DEV BENEFITS PLAYGRO; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; ILLINGWORTH C, 1975, BRIT MED J, V4, P332, DOI 10.1136/bmj.4.5992.332; Loder RT, 2008, J PEDIATR SURG, V43, P691, DOI 10.1016/j.jpedsurg.2007.12.061; Mack MG, 1997, INJURY PREV, V3, P100; Morrongiello BA, 2013, LIFESTYLE MEDICINE, 2ND EDITION, P1473; Morrongiello BA, 2015, PREV SCI, V16, P61, DOI 10.1007/s11121-014-0484-0; National Center for Health Statistics, US CENS POP BRIDG RA; Norton C, 2004, ARCH DIS CHILD, V89, P103, DOI 10.1136/adc.2002.013045; Phelan KJ, 2001, AMBUL PEDIATR, V1, P227, DOI 10.1367/1539-4409(2001)001<0227:TAPOPI>2.0.CO;2; Rivara FP, 2011, PEDIATRICS, V128; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; RIVERS RPA, 1978, COMMUNITY HEALTH, V9, P178; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; U. S. Consumer Product Safety Commission, 2016, NEISS NAT EL INJ SUR; US Consumer Product Safety Commission, 2015, PUBL PLAYGR SAF HDB; US Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_	27	20	20	1	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2016	137	6							e20152721	10.1542/peds.2015-2721			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DP5EZ	WOS:000378520100011	27244845	Green Accepted			2022-02-06	
J	Fontana, ACK; Fox, DP; Zoubroulis, A; Mortensen, OV; Raghupathi, R				Fontana, Andreia Cristina Karklin; Fox, Douglas P.; Zoubroulis, Argie; Mortensen, Ole Valente; Raghupathi, Ramesh			Neuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat	JOURNAL OF NEUROTRAUMA			English	Article						EAAT2; GLT-1; glutamate uptake; MS-153; neuroprotection; traumatic brain injury	AMINO-ACID TRANSPORTER-2; ALCOHOL-PREFERRING RATS; BEHAVIORAL SENSITIZATION; EXTRACELLULAR GLUTAMATE; NUCLEUS-ACCUMBENS; NMDA RECEPTOR; UP-REGULATION; EXPRESSION; MECHANISMS; RELEASE	Traumatic brain injury (TBI) in humans and in animals leads to an acute and sustained increase in tissue glutamate concentrations within the brain, triggering glutamate-mediated excitotoxicity. Excitatory amino acid transporters (EAATs) are responsible for maintaining extracellular central nervous system glutamate concentrations below neurotoxic levels. Our results demonstrate that as early as 5min and up to 2h following brain trauma in brain-injured rats, the activity (V-max) of EAAT2 in the cortex and the hippocampus was significantly decreased, compared with sham-injured animals. The affinity for glutamate (K-M) and the expression of glutamate transporter 1 (GLT-1) and glutamate aspartate transporter (GLAST) were not altered by the injury. Administration of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153), a GLT-1 activator, beginning immediately after injury and continuing for 24h, significantly decreased neurodegeneration, loss of microtubule-associated protein 2 and NeuN (+) immunoreactivities, and attenuated calpain activation in both the cortex and the hippocampus at 24h after the injury; the reduction in neurodegeneration remained evident up to 14 days post-injury. In synaptosomal uptake assays, MS-153 up-regulated GLT-1 activity in the naive rat brain but did not reverse the reduced activity of GLT-1 in traumatically-injured brains. This study demonstrates that administration of MS-153 in the acute post-traumatic period provides acute and long-term neuroprotection for TBI and suggests that the neuroprotective effects of MS-153 are related to mechanisms other than GLT-1 activation, such as the inhibition of voltage-gated calcium channels.	[Fontana, Andreia Cristina Karklin; Zoubroulis, Argie; Mortensen, Ole Valente] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, 245 N 15th St, Philadelphia, PA 19102 USA; [Fox, Douglas P.; Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19102 USA		Fontana, ACK (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, 245 N 15th St, Philadelphia, PA 19102 USA.	andreia.mortensen@drexelmed.edu	Mortensen, Andreia/AAR-2177-2020; Raghupathi, Ramesh/AAX-5538-2021	Mortensen, Andreia/0000-0002-4791-8746; Mortensen, Ole Valente/0000-0002-3487-8239	DUCOM [001564-002]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS065017-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065017] Funding Source: NIH RePORTER	The study was supported by DUCOM Tobacco Settlement grant 001564-002 to A.C.K.F. and NIH 5R01NS065017-03 to R.R.	Aal-Aaboda M, 2015, J NEUROSCI RES, V93, P930, DOI 10.1002/jnr.23554; Abekawa T, 2002, BRAIN RES, V926, P176, DOI 10.1016/S0006-8993(01)03164-X; Abekawa T, 2002, PSYCHOPHARMACOLOGY, V160, P122, DOI 10.1007/s00213-001-0958-1; Alhaddad H, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00366; Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Amin B, 2012, NEUROSCIENCE, V224, P15, DOI 10.1016/j.neuroscience.2012.07.058; Aslan A, 2009, PHARMACOL RES, V59, P120, DOI 10.1016/j.phrs.2008.10.003; Azbill RD, 2000, BRAIN RES, V871, P175, DOI 10.1016/S0006-8993(00)02430-6; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Berry JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061177; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; Brothers HM, 2013, J NEUROIMMUNE PHARM, V8, P1098, DOI 10.1007/s11481-013-9476-2; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Castillo MR, 1998, NEUROSCIENCE, V86, P1133, DOI 10.1016/S0306-4522(98)00070-0; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; Conrad KL, 2010, NEUROSCIENCE, V169, P182, DOI 10.1016/j.neuroscience.2010.04.056; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dunlop J, 2006, CURR OPIN PHARMACOL, V6, P103, DOI 10.1016/j.coph.2005.09.004; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fontana ACK, 2003, BRIT J PHARMACOL, V139, P1297, DOI 10.1038/sj.bjp.0705352; Frizzo ME, 2005, CELL MOL NEUROBIOL, V25, P913, DOI 10.1007/s10571-005-4939-5; Frizzo MES, 2001, NEUROREPORT, V12, P879, DOI 10.1097/00001756-200103260-00051; Gegelashvili G, 2000, NEUROCHEM INT, V37, P163, DOI 10.1016/S0197-0186(00)00019-X; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Ikematsu K, 2002, FORENSIC SCI INT, V130, P83, DOI 10.1016/S0379-0738(02)00344-4; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jabaudon D, 2000, P NATL ACAD SCI USA, V97, P5610, DOI 10.1073/pnas.97.10.5610; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawazura H, 1997, JPN J PHARMACOL, V73, P317, DOI 10.1254/jjp.73.317; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Li XB, 2004, EUR J PHARMACOL, V505, P145, DOI 10.1016/j.ejphar.2004.10.041; Li Y, 2011, NEUROPHARMACOLOGY, V60, P1168, DOI 10.1016/j.neuropharm.2010.10.016; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Liu SY, 2008, BIOCHEM BIOPH RES CO, V366, P520, DOI 10.1016/j.bbrc.2007.11.179; Maas AIR, 2000, CNS DRUGS, V13, P139, DOI 10.2165/00023210-200013020-00007; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; Nakagawa T, 2005, BEHAV BRAIN RES, V156, P233, DOI 10.1016/j.bbr.2004.05.029; Nakagawa T, 2001, EUR J PHARMACOL, V419, P39, DOI 10.1016/S0014-2999(01)00965-7; Nicholson KJ, 2014, J NEUROSCI RES, V92, P116, DOI 10.1002/jnr.23295; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nishida A, 2004, BIOL PHARM BULL, V27, P817, DOI 10.1248/bpb.27.817; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pan Xiang-dong, 2011, Zhejiang Da Xue Xue Bao Yi Xue Ban, V40, P522; Phillis JW, 1996, BRAIN RES, V730, P150; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramos KM, 2010, NEUROSCIENCE, V169, P1888, DOI 10.1016/j.neuroscience.2010.06.014; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rasmussen BA, 2011, AMINO ACIDS, V40, P761, DOI 10.1007/s00726-010-0589-0; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimada F, 1999, EUR J PHARMACOL, V386, P263, DOI 10.1016/S0014-2999(99)00735-9; Suchak SK, 2003, J NEUROCHEM, V84, P522, DOI 10.1046/j.1471-4159.2003.01553.x; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; Uenishi H, 1999, ANN NY ACAD SCI, V890, P385, DOI 10.1111/j.1749-6632.1999.tb08018.x; Umemura K, 1996, STROKE, V27, P1624, DOI 10.1161/01.STR.27.9.1624; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vetiska S., 2014, HDB NEUROTOXICITY, P1381; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamamoto T, 1999, ACT NEUR S, V75, P17; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	88	20	20	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1073	1083		10.1089/neu.2015.4079			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600011	26200170	Green Submitted, Green Published			2022-02-06	
J	Jimenez, N; Symons, RG; Wang, J; Ebel, BH; Vavilala, MS; Buchwald, D; Temkin, N; Jaffe, KM; Rivara, FP				Jimenez, Nathalia; Symons, Rebecca G.; Wang, Jin; Ebel, Beth H.; Vavilala, Monica S.; Buchwald, Dedra; Temkin, Nancy; Jaffe, Kenneth M.; Rivara, Frederick P.			Outpatient Rehabilitation for Medicaid-Insured Children Hospitalized With Traumatic Brain Injury	PEDIATRICS			English	Article							OUTCOMES; INSURANCE; CARE; AVAILABILITY; STATES	OBJECTIVES: To describe the prevalence of postdischarge outpatient rehabilitation among Medicaid-insured children hospitalized with a traumatic brain injury (TBI) and to identify factors associated with receipt of services. METHODS: Retrospective cohort of children <21 years, hospitalized for a TBI between 2007 and 2012, from a national Medicaid claims database. Outcome measures were receipt of outpatient rehabilitation (physical, occupational, or speech therapies or physician visits to a rehabilitation provider) 1 and 3 years after discharge. Multivariable regression analyses determined the association of demographic variables, injury severity, and receipt of inpatient services with receipt of outpatient rehabilitation at 1 and 3 years. The mean number of services was compared between racial/ethnic groups. RESULTS: Among 9361 children, only 29% received any type of outpatient rehabilitation therapy during the first year after injury, although 62% sustained a moderate to severe TBI. The proportion of children receiving outpatient therapies declined to 12% in the second and third years. The most important predictor of receipt of outpatient rehabilitation was receipt of inpatient therapies or consultation with a rehabilitation physician during acute care. Compared with children of other racial/ethnic groups, Hispanic children had lower rates of receipt of outpatient speech therapy. CONCLUSIONS: Hospitalized children who received inpatient assessment of rehabilitation needs were more likely to continue outpatient rehabilitation care. Hispanic children with TBI were less likely than non-Hispanics to receive speech therapy. Interventions to increase inpatient rehabilitation during acute care might increase outpatient rehabilitation and improve outcomes for all children.	[Jimenez, Nathalia; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Jimenez, Nathalia; Symons, Rebecca G.; Wang, Jin; Ebel, Beth H.; Vavilala, Monica S.; Jaffe, Kenneth M.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Ebel, Beth H.; Vavilala, Monica S.; Jaffe, Kenneth M.; Rivara, Frederick P.] Univ Washington, Pediat, Seattle, WA 98195 USA; [Ebel, Beth H.; Rivara, Frederick P.] Univ Washington, Epidemiol, Seattle, WA 98195 USA; [Buchwald, Dedra] Univ Washington, Ctr Clin & Epidemiol Res, Seattle, WA 98195 USA; [Temkin, Nancy; Jaffe, Kenneth M.] Univ Washington, Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Biostat, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Rehabil Med, Seattle, WA 98195 USA		Jimenez, N (corresponding author), Dept Anesthesiol & Pain Med, Box 9824,4800 Sand Point Way NE, Seattle, WA 98105 USA.	nathalia.jimenez@seattlechildrens.org		Jimenez, Nathalia/0000-0002-6785-8330	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD078453-01]; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention grant [R49 CE 001021]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development (grant 1K23HD078453-01 to Dr Jimenez) and National Center for Injury Prevention and Control, Centers for Disease Control and Prevention grant R49 CE 001021. Funded by the National Institutes of Health (NIH).	Adams PF, 2013, VITAL HLTH STAT SERI, V10; Bennett TD, ARCH PHYS MED REHABI; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, ARCH PHYS MED REHABI; Decker SL, 2015, HEALTH SERV RES, V50, P1508, DOI 10.1111/1475-6773.12288; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Fairbrother G, 2011, ACAD PEDIATR, V11, P318, DOI 10.1016/j.acap.2011.05.004; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Hahn DR, 2009, STAT SOFTWARE COMPON; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Sommers BD, 2005, HEALTH SERV RES, V40, P59, DOI 10.1111/j.1475-6773.2005.00342.x; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	22	20	20	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2016	137	6							e20153500	10.1542/peds.2015-3500			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DP5EZ	WOS:000378520100022	27244850	Green Accepted, Green Published			2022-02-06	
J	Kleffelgaard, I; Soberg, HL; Bruusgaard, KA; Tamber, AL; Langhammer, B				Kleffelgaard, Ingerid; Soberg, Helene Lundgaard; Bruusgaard, Kari A.; Tamber, Anne L.; Langhammer, Birgitta			Vestibular Rehabilitation After Traumatic Brain Injury: Case Series	PHYSICAL THERAPY			English	Article							POST-CONCUSSION SYMPTOMS; POSTTRAUMATIC VERTIGO; LEVEL MOBILITY; DIZZINESS; DISORDERS	Background and Purpose. There has been an increasing focus on vestibular rehabilitation (VR) after traumatic brain injury (TBI) in recent years. However, detailed descriptions of the content of and patient responses to VR after TBI are limited. The purposes of this case series are (1) to describe a modified, group-based VR intervention and (2) to examine changes in self-reported and performance-based outcome measures. Case Description. Two women and 2 men (aged 24-45 years) with mild TBI, dizziness, and balance problems participated in an 8-week intervention consisting of group sessions with guidance, individually modified VR exercises, a home exercise program, and an exercise diary. Self-reported and performance-based outcome measures were applied to assess the impact of dizziness and balance problems on functions related to activity and participation. Outcomes. The intervention caused no adverse effects. Three of the 4 patients reported reduced self-perceived disability because of dizziness, diminished frequency and severity of dizziness, improved health-related quality of life, reduced psychological distress, and improved performance-based balance. The change scores exceeded the minimal detectable change, indicating a clinically significant change or improvement in the direction of age-related norms. The fourth patient did not change or improve in most outcome measures. Discussion. A modified, group-based VR intervention was safe and appeared to be viable and beneficial when addressing dizziness and balance problems after TBI. However, concurrent physical and psychological symptoms, other neurological deficits, and musculoskeletal problems might influence the course of central nervous system compensation and recovery. The present case series may be useful for tailoring VR interventions to patients with TBI. Future randomized controlled trials are warranted to evaluate the short- and longterm effects of VR after TBI.	[Kleffelgaard, Ingerid; Soberg, Helene Lundgaard] Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4956, N-0424 Oslo, Oslo, Norway; [Kleffelgaard, Ingerid; Soberg, Helene Lundgaard; Bruusgaard, Kari A.; Tamber, Anne L.; Langhammer, Birgitta] Oslo & Akershus Univ Coll, Fac Hlth Sci, Inst Physiotherapy, Oslo, Norway		Kleffelgaard, I (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4956, N-0424 Oslo, Oslo, Norway.; Kleffelgaard, I (corresponding author), Oslo & Akershus Univ Coll, Fac Hlth Sci, Inst Physiotherapy, Oslo, Norway.	ingerid.kleffelgard@hioa.no	Langhammer, Birgitta/P-1765-2019	Langhammer, Birgitta/0000-0002-9639-0570			Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Hassett LM, 2008, COCHRANE DB SYST REV, V2, P1; Herdman SJ, 2014, VESTIBULAR REHABILIT; Kleffelgaard I, 2013, PHYS THER, V93, P900, DOI 10.2522/ptj.20120381; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; Peterson MD, 2010, J HEAD TRAUMA REHAB, V25, P193, DOI 10.1097/HTR.0b013e3181dc82fa; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Shumway-Cook A, 2007, VESTIBULAR REHABILIT, P444; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; Tamber AL, 2014, EUR J PHYSIOTHER, V16, P93, DOI 10.3109/21679169.2014.886721; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; von SN, 2010, J NEUROTRAUM, V27, P1167; von SN, 2010, J NEUROTRAUM, V27, P1157; Wilhelmsen K, 2008, BMC EAR NOSE THROAT, V8, DOI 10.1186/1472-6815-8-2; Yardley L, 2004, ANN INTERN MED, V141, P598, DOI 10.7326/0003-4819-141-8-200410190-00007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	20	21	1	18	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUN	2016	96	6					839	849		10.2522/ptj.20150095			11	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	DN1CT	WOS:000376804600011	26586860	Bronze, Green Published			2022-02-06	
J	Shields, C; Ownsworth, T; O'Donovan, A; Fleming, J				Shields, Cassandra; Ownsworth, Tamara; O'Donovan, Analise; Fleming, Jennifer			A transdiagnostic investigation of emotional distress after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Emotional distress; Transdiagnostic perspective; Emotional dysregulation	COGNITIVE-BEHAVIOR THERAPY; SELF-FOCUSED ATTENTION; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; POSTTRAUMATIC GROWTH; MULTIPLE IMPUTATION; UNIFIED TREATMENT; VERBAL FLUENCY; DEPRESSION	Emotional distress after traumatic brain injury (TBI) often presents as a range of neurobehavioural and emotional reactions rather than distinct disorders. This study adopted a transdiagnostic approach with the aim of identifying psychological processes common to depression, anxiety and global distress after TBI. Fifty participants with TBI (aged 19-66 years, 12-65 months post-injury) completed measures of threat appraisals and avoidance behaviour (Appraisal of Threat and Avoidance Questionnaire), self-discrepancy (Head Injury Semantic Differential Scale III), emotion dysregulation (Difficulties in Emotion Regulation Scale), worry (Penn State Worry Questionnaire), negative self-focused attention (Self-Focus Sentence Completion) and emotional distress (Depression Anxiety Stress Scales and Brief Symptom Inventory). Significant correlations were found among the proposed transdiagnostic variables (rs=.29-.82, p<.05). A principal components analysis revealed two underlying factors: (1) Threats to Self, and (2) Emotion Dysregulation. Only the Emotion Dysregulation factor accounted for significant unique variance in levels of depression, anxiety and global distress (sr(2)=.12-.17). Such findings indicate the need for interventions to target difficulties in identifying and regulating emotions after TBI to facilitate emotional adjustment.	[Shields, Cassandra; Ownsworth, Tamara; O'Donovan, Analise] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Shields, Cassandra; Ownsworth, Tamara; O'Donovan, Analise] Griffith Univ, Griffith Hlth Inst, Mt Gravatt, Qld 4122, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia		Shields, C (corresponding author), Logan Clin Psychol, 77 Wembley Rd, Logan Cent, Qld 4114, Australia.	cassandra.shields76@gmail.com	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094			A.B.o. Statistics, 2007, NAT SURV MENT HLTH W; Aldao A, 2010, BEHAV RES THER, V48, P974, DOI 10.1016/j.brat.2010.06.002; American Psychiatric Association, 2004, DIAGN STAT MAN MENT; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 1996, CLIN REHABILITATION; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Army Individual Test Battery, 1944, MAN DIR SCOR; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Ashworth F, 2011, BRAIN IMPAIR, V12, P128, DOI 10.1375/brim.12.2.128; Barlow, 2008, CLIN HDB PSYCHOL DIS, P216; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Beck R, 2003, J PSYCHOPATHOL BEHAV, V25, P251, DOI 10.1023/A:1025899029040; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Benton A., 1976, MULTILINGUAL APHASIA; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brown TA, 2009, PSYCHOL ASSESSMENT, V21, P256, DOI 10.1037/a0016608; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P542; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; CARVER CS, 1987, J PERS, V55, P525, DOI 10.1111/j.1467-6494.1987.tb00449.x; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; de Jong-Meyer R, 2009, PERS INDIV DIFFER, V46, P547, DOI 10.1016/j.paid.2008.12.010; Derogatis L., 1975, SCL 90 R REVISED VER; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Dozois DJA, 2009, J COGN PSYCHOTHER, V23, P44, DOI 10.1891/0889-8391.23.1.44; Duval TS., 1972, THEORY OBJECTIVE SEL; Ehring T, 2008, INT J COGN THER, V1, P192, DOI 10.1680/ijct.2008.1.3.192; Endler N. S., 1989, SELF REALIZATION SUC, P151; EXNER JE, 1973, J PERS ASSESS, V37, P437, DOI 10.1080/00223891.1973.10119902; Falquez R, 2014, FRONT BEHAV NEUROSCI, V8, P1, DOI 10.3389/fnbeh.2014.00165; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Folkman S., 1984, STRESS; Gilbert, 2010, COMPASSION FOCUSED T; Gillis MM, 1995, PSYCHOL ASSESSMENT, V7, P450, DOI 10.1037/1040-3590.7.4.450; Goldstein K., 1939, CONCEPTION ORGANISM; Goldstein K, 1943, PSYCHOSOM MED, V5, P376, DOI 10.1097/00006842-194310000-00007; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Green JD, 2003, BRIT J SOC PSYCHOL, V42, P147, DOI 10.1348/014466603763276171; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Gross JJ., 2007, HDB EMOTION REGULATI; Hair JF., 2006, MULTIVARIATE DATA AN, V6; Hair JF, 1998, MULTIVARIATE DATA AN, V5; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hayes S. C., 2012, ACCEPTANCE COMMITMEN, V2nd; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Linehan MM., 1993, SKILLS TRAINING MANU, V1st edn; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Mansell, 2004, COGNITIVE BEHAV PROC; Mansell W, 2009, J COGN PSYCHOTHER, V23, P6, DOI 10.1891/0889-8391.23.1.6; Mansell W, 2008, INT J COGN THER, V1, P181, DOI 10.1680/ijct.2008.1.3.181; McDonald S., 2014, UNDERSTANDING TRAUMA, P133; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Nolen-Hoeksema S, 2011, PERSPECT PSYCHOL SCI, V6, P589, DOI 10.1177/1745691611419672; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Randolphs C., 1998, REPEATABLE BATTERY A; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Robinson John P., 1991, MEASURES PERSONALITY; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Salas CE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00242; Salas CE, 2013, NEUROPSYCHOL REHABIL, V23, P467, DOI 10.1080/09602011.2013.784709; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; Schulz KF, 2011, INT J SURG, V9, P672, DOI [10.7326/0003-4819-152-11-201006010-00232, 10.1016/j.ijsu.2011.09.004]; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shields C., 2013, NEURODISABILITY PSYC, V1, P39; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Sinharay S, 2001, PSYCHOL METHODS, V6, P317, DOI 10.1037//1082-989X.6.4.317; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tate RL, 2010, COMPENDIUM TESTS SCA; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Trosper SE, 2009, CLIN CHILD FAM PSYCH, V12, P234, DOI 10.1007/s10567-009-0043-6; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Tyerman A., 1997, HEAD INJURY SEMANTIC, VIII; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Waldron B, 2013, NEUROPSYCHOL REHABIL, V23, P64, DOI 10.1080/09602011.2012.724196; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029; Woodruff-Borden J, 2001, BEHAV COGN PSYCHOTH, V29, P169, DOI 10.1017/S1352465801002041	134	20	20	0	30	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 3	2016	26	3					410	445		10.1080/09602011.2015.1037772			36	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DG2RO	WOS:000371915600005	25918948	Green Accepted			2022-02-06	
J	Agrawal, D; Raghavendran, K; Schaubel, DE; Mishra, MC; Rajajee, V				Agrawal, Deepak; Raghavendran, Krishnan; Schaubel, Douglas E.; Mishra, Mahesh C.; Rajajee, Venkatakrishna			A Propensity Score Analysis of the Impact of Invasive Intracranial Pressure Monitoring on Outcomes after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						developing countries; Glasgow Outcome Scale; intracranial pressure; traumatic brain injury	ROAD-TRAFFIC INJURIES; DECOMPRESSIVE CRANIECTOMY; MORTALITY; EPIDEMIOLOGY; BURDEN; TRIAL	Although a recent clinical trial (BEST TRIP) demonstrated no improvement in outcomes with invasive intracranial pressure (ICP) monitoring (ICPM) following severe traumatic brain injury (TBI), its generalizability has been called into question. In several global settings ICPM is not the standard of care and is used at the discretion of the attending neurosurgeon. Our objective was to determine the impact of ICPM on mortality and 6-month functional outcomes following severe TBI. The setting was a referral trauma center with 36 intensive care unit (ICU) beds and 300-600 TBI admissions per year. During a 2-year period data were prospectively entered into a severe TBI registry. Patients with severe TBI aged >12 years meeting Brain Trauma Foundation (BTF) criteria for ICPM were included in the study. Outcomes of interest were in-hospital mortality and poor 6-month functional outcome defined as Glasgow Outcome Scale (GOS) score of 3 or lower. A propensity score based analysis incorporating known predictors of outcome in TBI was utilized to examine the impact of ICPM on outcomes. Of 1345 patients meeting study criteria 497 (37%) underwent ICPM. In-hospital mortality was 35% (471/1345). Of 454 patients for whom 6-month outcome was available, 161 (35%) suffered a poor functional outcome. Following propensity score analysis ICPM use was associated with an 8% (p = 0.002) decrease in mortality but no significant effect (p = 0.2) on functional outcome. The use of ICPM following severe TBI was associated with decreased in-hospital mortality. Further clinical trials of ICPM in TBI may be warranted.	[Agrawal, Deepak] All India Inst Med Sci, JPN Apex Trauma Ctr, Ansari Nagar, India; [Agrawal, Deepak] All India Inst Med Sci, Neurosci Ctr, Ansari Nagar, India; [Mishra, Mahesh C.] All India Inst Med Sci, Dept Surg Disciplines, Ansari Nagar, India; [Raghavendran, Krishnan] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Schaubel, Douglas E.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, Ann Arbor, MI USA		Rajajee, V (corresponding author), Univ Michigan, Dept Neurosurg, Taubman Hlth Care Ctr 3552, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; Rajajee, V (corresponding author), Univ Michigan, Dept Neurol, Taubman Hlth Care Ctr 3552, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	vrajajee@yahoo.com	/AAG-3032-2021	/0000-0002-5499-0746; Rajajee, Venkatakrishna/0000-0002-7183-8324			Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dandona R, 2008, INJURY PREV, V14, P354, DOI 10.1136/ip.2008.019620; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a	20	20	21	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					853	858		10.1089/neu.2015.4015			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800007	26414629	Green Submitted			2022-02-06	
J	Burns, TC; Awad, AJ; Li, MD; Grant, GA				Burns, Terry C.; Awad, Ahmed J.; Li, Matthew D.; Grant, Gerald A.			Radiation-induced brain injury: low-hanging fruit for neuroregeneration	NEUROSURGICAL FOCUS			English	Article						radiation; brain injury; neuroregeneration; oligodendrocyte progenitor cell; transplantation; myelination; neurogenesis	OLIGODENDROCYTE PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT HIPPOCAMPAL NEUROGENESIS; MESENCHYMAL STEM-CELLS; SYNAPTIC PLASTICITY; IN-VIVO; GENE-EXPRESSION; MOUSE MODELS; IRRADIATION; TRANSPLANTATION	Brain radiation is a fundamental tool in neurooncology to improve local tumor control, but it leads to profound and progressive impairments in cognitive function. Increased attention to quality of life in neurooncology has accelerated efforts to understand and ameliorate radiation-induced cognitive sequelae. Such progress has coincided with a new understanding of the role of CNS progenitor cell populations in normal cognition and in their potential utility for the treatment of neurological diseases. The irradiated brain exhibits a host of biochemical and cellular derangements, including loss of endogenous neurogenesis, demyelination, and ablation of endogenous oligodendrocyte progenitor cells. These changes, in combination with a state of chronic neuroinflammation, underlie impairments in memory, attention, executive function, and acquisition of motor and language skills. Animal models of radiation-induced brain injury have demonstrated a robust capacity of both neural stem cells and oligodendrocyte progenitor cells to restore cognitive function after brain irradiation, likely through a combination of cell replacement and trophic effects. Oligodendrocyte progenitor cells exhibit a remarkable capacity to migrate, integrate, and functionally remyelinate damaged white matter tracts in a variety of preclinical models. The authors here critically address the opportunities and challenges in translating regenerative cell therapies from rodents to humans. Although valiant attempts to translate neuroprotective therapies in recent decades have almost uniformly failed, the authors make the case that harnessing human radiation-induced brain injury as a scientific tool represents a unique opportunity to both successfully translate a neuroregenerative therapy and to acquire tools to facilitate future restorative therapies for human traumatic and degenerative diseases of the central nervous system.	[Burns, Terry C.; Grant, Gerald A.] Stanford Univ, Dept Neurosurg, 300 Pasteur Dr, Stanford, CA 94305 USA; [Burns, Terry C.; Grant, Gerald A.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Awad, Ahmed J.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Awad, Ahmed J.] An Najah Natl Univ, Fac Med & Hlth Sci, Nablus, Palestine; [Li, Matthew D.] Stanford Univ, Sch Med, Stanford, CA 94305 USA		Burns, TC (corresponding author), Stanford Univ, Dept Neurosurg, 300 Pasteur Dr, Stanford, CA 94305 USA.	tcburns@stanford.edu		Terry, Burns/0000-0001-7633-3045	California Institute of Regenerative MedicineCalifornia Institute for Regenerative Medicine	Dr. Burns has received research funding from the California Institute of Regenerative Medicine, which had no direct role in the research design or preparation of this manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Acharya MM, 2011, CANCER RES, V71, P4834, DOI 10.1158/0008-5472.CAN-11-0027; Acharya MM, 2009, P NATL ACAD SCI USA, V106, P19150, DOI 10.1073/pnas.0909293106; Bellinzona M, 1996, NEUROSCI LETT, V208, P163, DOI 10.1016/0304-3940(96)12572-6; Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Blakemore WF, 2008, J NEUROL SCI, V265, P43, DOI 10.1016/j.jns.2007.08.004; Brown PD, 2013, NEURO-ONCOLOGY, V15, P1429, DOI 10.1093/neuonc/not114; Brown PD, 2015, J CLIN ONCOL S, V33, pLBA4; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Burns TC, 2015, EUR J PHARMACOL, V759, P90, DOI 10.1016/j.ejphar.2015.03.041; Burns TC, 2015, EUR J PHARMACOL, V759, P101, DOI 10.1016/j.ejphar.2015.03.021; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Coderre JA, 2006, RADIAT RES, V166, P495, DOI 10.1667/RR3597.1; Combs SE, 2013, ACTA ONCOL, V52, P147, DOI 10.3109/0284186X.2012.692882; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Doucette T, 2011, NEOPLASIA, V13, P716, DOI 10.1593/neo.101680; Eaton ML, 2015, CURR TOP BEHAV NEURO, V19, P297, DOI 10.1007/7854_2014_337; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; FRANKLIN RJM, 1995, GLIA, V13, P39, DOI 10.1002/glia.440130105; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Higgins SC, 2015, ANTICANCER RES, V35, P77; Hinks GL, 2001, NEUROPATH APPL NEURO, V27, P59, DOI 10.1046/j.0305-1846.2001.00303.x; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; Hyrien O, 2010, CANCER RES, V70, P10051, DOI 10.1158/0008-5472.CAN-10-1400; Irvine KA, 2007, EUR J NEUROSCI, V25, P417, DOI 10.1111/j.1460-9568.2007.05313.x; Ishii A, 2009, P NATL ACAD SCI USA, V106, P14605, DOI 10.1073/pnas.0905936106; Ji JF, 2014, STEM CELL TRANSL MED, V3, P356, DOI 10.5966/sctm.2013-0135; Kempf SJ, 2015, J PROTEOME RES, V14, P4674, DOI 10.1021/acs.jproteome.5b00564; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Kohutek ZA, 2015, J NEURO-ONCOL, V125, P149, DOI 10.1007/s11060-015-1881-3; Leach JK, 2001, CANCER RES, V61, P3894; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Leoni G, 2014, J ANAT, V224, P216, DOI 10.1111/joa.12141; Leten C, 2014, STEM CELLS, V32, P2833, DOI 10.1002/stem.1819; Li MD, 2015, GLIA, V63, P754, DOI 10.1002/glia.22782; Li Q, 2014, CLIN CANCER RES, V20, P2375, DOI 10.1158/1078-0432.CCR-13-1415; Nigro A, 2012, J MOL CELL BIOL, V4, P423, DOI 10.1093/jmcb/mjs046; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; Machida M, 2010, RADIAT RES, V174, P618, DOI 10.1667/RR1988.1; Madany M, 2015, ADV EXP MED BIOL, V853, P139, DOI 10.1007/978-3-319-16537-0_8; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Merchant TE, 2014, INT J RADIAT ONCOL, V90, P554, DOI 10.1016/j.ijrobp.2014.06.058; Merchant TE, 2009, J CLIN ONCOL, V27, P3691, DOI 10.1200/JCO.2008.21.2738; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Meyers CA, 2000, INT J RADIAT ONCOL, V46, P51, DOI 10.1016/S0360-3016(99)00376-4; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Niranjan A, 2007, J NEUROSURG, V107, P383, DOI 10.3171/JNS-07/08/0383; Okada S, 2001, NEUROPATHOLOGY, V21, P247, DOI 10.1046/j.1440-1789.2001.00408.x; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Pan WY, 2015, CLIN CHEM, V61, P514, DOI 10.1373/clinchem.2014.235457; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Penderis J, 2003, BRAIN, V126, P1382, DOI 10.1093/brain/awg126; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Purger D., 2015, NEUROPHARMACOLOGY; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rapp SR, 2015, J CLIN ONCOL, V33, P1653, DOI 10.1200/JCO.2014.58.4508; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rosi S, 2008, CANCER RES, V68, P9763, DOI 10.1158/0008-5472.CAN-08-1861; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Scott CT, 2014, STEM CELL TRANSL MED, V3, P1398, DOI 10.5966/sctm.2014-0147; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silver DJ, 2016, NEURO-ONCOLOGY, V18, P153, DOI 10.1093/neuonc/nov157; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stock K, 2012, NAT MED, V18, P1232, DOI 10.1038/nm.2827; Sypecka J, 2014, MOL NEUROBIOL, V49, P685, DOI 10.1007/s12035-013-8549-9; Szerlip N, 2011, J NEURO-ONCOL, V103, P111, DOI 10.1007/s11060-010-0358-7; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Vlkolinsky R, 2008, RADIAT RES, V169, P523, DOI 10.1667/RR1228.1; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wang YX, 2015, P NATL ACAD SCI USA, V112, P9704, DOI 10.1073/pnas.1511694112; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Wong-Goodrich SJE, 2010, CANCER RES, V70, P9329, DOI 10.1158/0008-5472.CAN-10-1854; Xu LY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0087-0; YAMAGUCHI N, 1991, J NEUROSURG, V74, P625, DOI 10.3171/jns.1991.74.4.0625; Yazlovitskaya EM, 2006, CANCER RES, V66, P11179, DOI 10.1158/0008-5472.CAN-06-2740; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Zachrisson O, 2011, J PARKINSON DIS, V1, P49, DOI 10.3233/JPD-2011-0003; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	99	20	21	1	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2016	40	5							E3	10.3171/2016.2.FOCUS161			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK7PX	WOS:000375119300002	27132524	gold			2022-02-06	
J	Leeper, CM; Nasr, I; McKenna, C; Berger, RP; Gaines, BA				Leeper, Christine M.; Nasr, Isam; McKenna, Christine; Berger, Rachel P.; Gaines, Barbara A.			Elevated admission international normalized ratio strongly predicts mortality in victims of abusive head trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Abusive head trauma; international normalized ratio; acute traumatic coagulopathy; mortality	BRAIN-INJURY; RAPID THROMBELASTOGRAPHY; BLEEDING DISORDERS; EARLY COAGULOPATHY; YOUNG-CHILDREN; ORGAN FAILURE; INFANTS; SHOCK; DEFINITION; OUTCOMES	BACKGROUND: Victims of abusive head trauma have poor outcomes compared with other injured children. There is often a delay in diagnosis because these young patients are unable to communicate with health care providers. These critically injured patients would benefit from early identification and therapy. METHODS: We performed a retrospective review of our single hospital trauma registry from 2005 to 2014. All Level 1 pediatric (age 0-17 years) trauma patients who sustained abusive head trauma were included. Exclusion criteria included no admission coagulation studies, prehospital product transfusion, preexisting coagulation disorder, or death upon arrival. Primary outcome was mortality; secondary outcomes were early blood transfusion and neurosurgical intervention. Univariate analysis included Fisher's exact and Wilcoxon rank-sum testing; we then performed logistic regression modeling and calculated adjusted odds ratios (AORs) to control for known predictors of poor outcome including hypotension, hypothermia, acidosis, Injury Severity Score (ISS), and head Abbreviated Injury Scale (AIS) score. RESULTS: In 101 total subjects, 35% (n = 35) had international normalized ratio (INR) of 1.3 or greater at admission. On univariate analysis, patients with coagulation dysregulation were more likely to have hypothermia, hypotension, acidosis, high ISS, and low Glasgow Coma Scale (GCS) score (all p < 0.05). Therewas no difference in age, anemia, and incidence of polytrauma. Overallmortalitywas 24.8% (n = 25), which varied significantly based at admission INR (60% INR = 1.3 vs. 6% INR > 1.3, p < 0.001). Patients with elevated INR were also more likely to have early packed red blood cell transfusion (p = 0.003) and neurosurgical intervention (p = 0.011). In logistic regression analysis, admission INR was the strongest independent predictor of mortality, with increased odds of 3.65 (p = 0.045). AOR after controlling specifically for hypotension, hypothermia, and acidosis was 6.25 (p = 0.006), and after controlling for head AIS score and admission GCS score, the AOR was 5.27 (p = 0.007). CONCLUSION: Admission INR of 1.3 or greater strongly predicts mortality in abusive head trauma. These patients should be targeted for early aggressive interventions and monitoring with the goal of improving patient outcomes. Further study is warranted to investigate potential therapeutic targets in trauma-induced coagulation dysregulation. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Leeper, Christine M.; McKenna, Christine; Berger, Rachel P.; Gaines, Barbara A.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Leeper, Christine M.] Univ Pittsburgh, Dept Surg, Div Gen Surg & Trauma, Dept Surg, Pittsburgh, PA 15224 USA; [Nasr, Isam] Johns Hopkins Univ Hosp, Div Pediat Surg, Baltimore, MD 21287 USA		Gaines, BA (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, UPMC, 7th Floor,Fac Pavilion,One Childrens Hosp Dr, Pittsburgh, PA 15224 USA.	Barbara.Gaines@chp.edu					Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Anderst JD, 2013, PEDIATRICS, V131, pE1314, DOI 10.1542/peds.2013-0195; Attard C, 2013, J THROMB HAEMOST, V11, P1850, DOI 10.1111/jth.12372; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brousseau TJ, 2005, J EMERG MED, V29, P283, DOI 10.1016/j.jemermed.2005.02.009; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Eswald MB, 2010, TXB PEDIAT EMERGENCY, V6; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Frith D, 2010, SURG-J R COLL SURG E, V8, P159, DOI 10.1016/j.surge.2009.10.022; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Gonzalez E, 2014, SCAND J SURG, V103, P89, DOI 10.1177/1457496914531927; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jackson J, 2012, CHILD ABUSE NEGLECT, V36, P127, DOI 10.1016/j.chiabu.2011.09.009; Janus J, 2010, AM FAM PHYSICIAN, V81, P1462; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kleinman ME, 2010, PEDIATRICS, V126, pE1361, DOI 10.1542/peds.2010-2972D; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V78, P516, DOI 10.1097/TA.0000000000000545; Lecky FE, 2010, DAMAGE CONTROL MANAGEMENT IN THE POLYTRAUMA PATIENT, P13, DOI 10.1007/978-0-387-89508-6_2; Lind K, 2015, CHILD ABUSE NEGL; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Matschke J, 2015, INT J LEGAL MED, V129, P105, DOI 10.1007/s00414-014-1060-7; Miller TR, 2014, PEDIATRICS, V134, pE1545, DOI 10.1542/peds.2014-1385; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Ravichandiran N, 2010, PEDIATRICS, V125, P60, DOI 10.1542/peds.2008-3794; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Stewart CL, 2013, J PEDIATR SURG, V48, P2106, DOI 10.1016/j.jpedsurg.2013.05.009; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	50	20	20	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2016	80	5					711	716		10.1097/TA.0000000000000954			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	DM9ZB	WOS:000376723100005	27100929				2022-02-06	
J	Moran, LM; Babikian, T; Del Piero, L; Ellis, MU; Kernan, CL; Newman, N; Giza, CC; Mink, R; Johnson, J; Babbitt, C; Asarnow, R				Moran, Lisa M.; Babikian, Talin; Del Piero, Larissa; Ellis, Monica U.; Kernan, Claudia L.; Newman, Nina; Giza, Christopher C.; Mink, Richard; Johnson, Jeffrey; Babbitt, Christopher; Asarnow, Robert			The UCLA study of Predictors of Cognitive Functioning Following Moderate/Severe Pediatric Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Cognitive Symptoms; Longitudinal Studies; Neuropsychological Tests; Psychometrics; Children; Adolescents; Brain Injury	OF-THE-LITERATURE; YOUNG-CHILDREN; UNITED-STATES; RECOVERY; OUTCOMES; TERM; VARIABLES; SEVERITY; AGE	Objectives: Following pediatric moderate-to-severe traumatic brain injury (msTBI), few predictors have been identified that can reliably identify which individuals are at risk for long-term cognitive difficulties. This study sought to determine the relative contribution of detailed descriptors of injury severity as well as demographic and psychosocial factors to long-term cognitive outcomes after pediatric msTBI. Methods: Participants included 8- to 19-year-olds, 46 with msTBI and 53 uninjured healthy controls (HC). Assessments were conducted in the post-acute and chronic stages of recovery. Medical record review provided details regarding acute injury severity. Parents also completed a measure of premorbid functioning and behavioral problems. The outcome of interest was four neurocognitive measures sensitive to msTBI combined to create an index of cognitive performance. Results: Results indicated that none of the detailed descriptors of acute injury severity predicted cognitive performance. Only the occurrence of injury, parental education, and premorbid academic competence predicted post-acute cognitive functioning. Long-term cognitive outcomes were best predicted by post-acute cognitive functioning. Conclusions: The findings suggest that premorbid factors influence cognitive outcomes nearly as much as the occurrence of a msTBI. Furthermore, of youth with msTBI who initially recover to a level of moderate disability or better, a brief cognitive battery administered within several months after injury can best predict which individuals will experience poor long-term cognitive outcomes and require additional services.	[Moran, Lisa M.; Babikian, Talin; Ellis, Monica U.; Kernan, Claudia L.; Newman, Nina; Asarnow, Robert] Univ Calif Los Angeles, Dept Psychiat & Biobehav Hlth, Los Angeles, CA USA; [Babikian, Talin; Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Del Piero, Larissa] Univ Southern Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Ellis, Monica U.] Fuller Theol Seminary, Dept Psychol, Pasadena, CA 91101 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA USA; [Giza, Christopher C.] Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA USA; [Mink, Richard; Johnson, Jeffrey] Los Angeles Cty, Dept Pediat, Los Angeles, CA USA; [Mink, Richard] Harbor Univ Calif, Los Angeles, CA USA; [Johnson, Jeffrey] Univ Southern Calif, Med Ctr, Los Angeles, CA USA; [Babbitt, Christopher] Miller Childrens Hosp, Dept Pediat, Long Beach, CA USA; [Asarnow, Robert] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Asarnow, Robert] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Babikian, T (corresponding author), Univ Calif Los Angeles, Div Child & Adolescent Psychiat, 760 Westwood Plaza, Los Angeles, CA 90095 USA.	tbabikian@mednet.ucla.edu		Del Piero, Larissa/0000-0002-4407-5472	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504] Funding Source: NIH RePORTER	No competing financial interests exist. The authors declare no conflict of interest. This work was supported by grant R01 HD061504 from the National Institute of Child Health and Human Development to Robert Asarnow, Ph.D.	Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Howard I., 2005, ETHN DIS S5, V15; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	27	20	20	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2016	22	5					512	519		10.1017/S1355617716000175			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	DU8SJ	WOS:000382484300003	27019212				2022-02-06	
J	Shen, YF; Yu, WH; Dong, XQ; Du, Q; Yang, DB; Wu, GQ; Zhang, ZY; Wang, H; Jiang, L				Shen, Yong-Feng; Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Yang, Ding-Bo; Wu, Gang-Qun; Zhang, Zu-Yong; Wang, Hao; Jiang, Li			The change of plasma galectin-3 concentrations after traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Galectin-3; Acute traumatic coagulopathy; Progressive hemorrhagic injury; Posttraumatic cerebral infarction; Mortality	POSTTRAUMATIC CEREBRAL INFARCTION; RISK-FACTORS; HEAD TRAUMA; COAGULOPATHY; HEMORRHAGE; MICROGLIA; MODERATE; PATHOPHYSIOLOGY; INFLAMMATION; PROGRESSION	Background: Galectin-3 plays a significant role in microglia activation. Its increased circulating concentration has been associated with some inflammatory diseases. In-hospital major adverse events (IMAEs), including acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction, have high prevalence and are strong predictors of mortality after severe traumatic brain injury (STBI). The present study was designed to investigate the relationships between plasma galectin-3 concentrations and trauma severity, in-hospital mortality and IMAEs following STBI. Methods: Plasma galectin-3 concentrations of 100 STBI patients and 100 controls were determined. Diagnosis of progressive hemorrhagic injury and posttraumatic cerebral infarction was made on the follow-up computerized tomography scan. Acute traumatic coagulopathy was defined based on coagulation test. Results: Plasma galectin-3 concentrations were significantly higher in patients as compared to controls and also associated highly with Glasgow Coma Scale scores and plasma C-reactive protein concentrations. Galectin-3 emerged as an independent predictor for in-hospital mortality and IMAEs. Areas under receiver operating characteristic curve of plasma galectin-3 concentrations were similar to those of Glasgow Coma Scale scores for prediction of in-hospital morality and IMAEs. Conclusions: Plasma galectin-3 concentrations have close relation to inflammation, trauma severity and clinical outcome, suggesting that galectin-3 should have the potential to be a good prognostic biomarker after STBI. (C) 2016 Elsevier B.V. All rights reserved.	[Shen, Yong-Feng; Yang, Ding-Bo] Tumor Hosp Hangzhou City, Dept Neurosurg, 34 Yanguan Lane, Hangzhou 310002, Zhejiang, Peoples R China; [Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Wang, Hao; Jiang, Li] Nanjing Med Univ, Hangzhou Hosp, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Wu, Gang-Qun] Tonglu TCM Hosp, Dept Neurosurg, 25 Guangchang Rd, Tonglu 311500, Peoples R China; [Zhang, Zu-Yong] Hangzhou Hosp Tradit Chinese Med, Dept Neurosurg, 453 Tiyuchang Rd, Hangzhou 310007, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Hosp, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxghyy@163.com			Zhejiang Province Medical and Health Project [2014KYA177, 2016RCB016]; Hangzhou Medical Research Fund Project [2014Z06]	The authors thank all staffs in the Department of Neurosurgery, The Hangzhou First People's Hospital (Hangzhou, China) for their technical support. This study was supported financially by the Zhejiang Province Medical and Health Project (No. 2014KYA177, 2016RCB016) and the Hangzhou Medical Research Fund Project (No. 2014Z06).	Ahmed H, 2015, CLIN MED INSIGHTS-ON, V9, P113, DOI 10.4137/CMO.S29462; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Arad U, 2015, CYTOKINE, V73, P30, DOI 10.1016/j.cyto.2015.01.016; Boza-Serrano A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0156-0; Burguillos MA, 2015, CELL REP, V10, P1626, DOI 10.1016/j.celrep.2015.02.012; Chen Hung-Lin, 2014, Adv Neurobiol, V9, P517, DOI 10.1007/978-1-4939-1154-7_24; Chiariotti L, 1999, BIOCHIMIE, V81, P381, DOI 10.1016/S0300-9084(99)80085-6; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; de Oliveira FL, 2015, EXP BIOL MED, V240, P1019, DOI 10.1177/1535370215593826; Doverhag C, 2010, NEUROBIOL DIS, V38, P36, DOI 10.1016/j.nbd.2009.12.024; Edsfeldt A, 2016, CEREBROVASC DIS, V41, P199, DOI 10.1159/000443022; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Koca SS, 2014, CLIN RHEUMATOL, V33, P215, DOI 10.1007/s10067-013-2346-8; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012; Latronico N, 2009, J TRAUMA, V66, P1745, DOI 10.1097/TA.0b013e3181a56c8b; Li LC, 2014, J PHARMACOL EXP THER, V351, P336, DOI 10.1124/jpet.114.218370; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Nielsen C. T., 2014, SCI MED, V1; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Peacock William Frank, 2014, Crit Pathw Cardiol, V13, P73, DOI 10.1097/HPC.0000000000000012; Piper SE, 2016, INT J CARDIOL, V207, P279, DOI 10.1016/j.ijcard.2016.01.179; Satoh K, 2011, NEUROSCI LETT, V504, P199, DOI 10.1016/j.neulet.2011.09.015; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Shin T, 2013, ACTA HISTOCHEM, V115, P407, DOI 10.1016/j.acthis.2012.11.010; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Walther M, 2000, J NEUROSCI RES, V61, P430, DOI 10.1002/1097-4547(20000815)61:4<430::AID-JNR9>3.0.CO;2-3; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zhang WL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001993; Zhou JY, 2010, J PROTEOME RES, V9, P5133, DOI 10.1021/pr100409r	40	20	20	2	146	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	MAY 1	2016	456						75	80		10.1016/j.cca.2016.02.029			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	DL0YG	WOS:000375357900014	26944570				2022-02-06	
J	Shin, MS; Park, HK; Kim, TW; Ji, ES; Lee, JM; Choi, HS; Kim, MY; Kim, YP				Shin, Mal Soon; Park, Hun Kyung; Kim, Tae Woon; Ji, Eun Sang; Lee, Jae Min; Choi, Han Sung; Kim, Mi Ye; Kim, Young Pyo			Neuroprotective Effects of Bone Marrow Stromal Cell Transplantation in Combination With Treadmill Exercise Following Traumatic Brain Injury	INTERNATIONAL NEUROUROLOGY JOURNAL			English	Article						Brain Injuries; Mesenchymal Stromal Cells; Exercise Test; Neurogenesis; Apoptosis	STEM-CELLS; APOPTOSIS; NEUROGENESIS; HIPPOCAMPUS; RAT; MITOCHONDRIA; PLASTICITY; RECOVERY; MODEL; LTP	Purpose: Traumatic brain injury (TBI) causes cognitive impairments, motor deficits, and neuropsychiatric/behavioral deficits problems. Transplantation of bone marrow stromal cells (BMSCs) facilitates functional recovery from brain insults. Treadmill exercise increases neurogenesis and inhibits apoptosis. In this study, we investigated the effects of BMSC transplantation in combination with treadmill exercise on memory function, by evaluating its effect on neurogenesis and apoptosis in the hippocampus following TBI. Methods: TBI was induced using an electromagnetic-controlled cortical impact device. BMSCs were transplanted into both sides of traumatic scar region 1 week after TBI induction. One week after transplantation of BMSCs, the rats in the exercise groups were trained to run on a treadmill for 30 minutes once daily for 28 days. Step-down avoidance task and radial 8-arm maze test were conducted. Levels of 5-bromo-2'-deoxyuridine and caspase-3 were evaluated using immunohistochemistry. Western blot was used to evaluate the expression of brain-derived neurotrophic factor (BDNF), tyrosine kinase B (TrkB), total-extracellular signal-regulated kinase 1 and 2 (t-ERK1/2), phosphorylated-ERK1/2 (p-ERK1/2), Bcl-2, and Bax. Results: TBI deteriorated memory function, suppressed neurogenesis, and accelerated apoptosis in the hippocampus. Treadmill exercise and BMSC transplantation independently improved memory function by increasing neurogenesis with suppression of apoptosis through the BDNF-ERK pathway in the TBI-induced rats. Combination of BMSC transplantation with treadmill exercise showed additional enhancement of neurogenesis and suppression of apoptosis in the hippocampus. Conclusions: The present study shows that treadmill exercise may aid the therapeutic effect of BMSC transplantation on TBI in rats.	[Shin, Mal Soon] Korea Univ, Sch Global Sport Studies, Sejong, South Korea; [Park, Hun Kyung; Kim, Tae Woon; Ji, Eun Sang; Lee, Jae Min] Kyung Hee Univ, Dept Physiol, Coll Med, Seoul, South Korea; [Choi, Han Sung] Kyung Hee Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Kim, Mi Ye; Kim, Young Pyo] Jeju Natl Univ, Dept Kinesiol, Coll Nat Sci, 102 Jejudaehak Ro, Jeju 63243, South Korea		Kim, YP (corresponding author), Jeju Natl Univ, Dept Kinesiol, Coll Nat Sci, 102 Jejudaehak Ro, Jeju 63243, South Korea.	kimyp@jejunu.ac.kr			Korea Institute of Sport Science, Seoul Olympic Sports Promotion Foundation [KISS-14-A05005]	This work was done with the sports promotion fund from Korea Institute of Sport Science, Seoul Olympic Sports Promotion Foundation (KISS-14-A05005).	Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Chae CH, 2009, NEUROCHEM INT, V55, P208, DOI 10.1016/j.neuint.2009.02.024; Cho YS, 2015, MOL MED REP, V12, P1796, DOI 10.3892/mmr.2015.3612; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219; Ji ES, 2015, J EXERC REHABIL, V11, P133, DOI 10.12965/jer.150212; Jiang YF, 2011, NEUROL RES, V33, P331, DOI 10.1179/016164110X12816242542571; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim K, 2015, J EXERC REHABIL, V11, P296, DOI 10.12965/jer.150264; Kim SE, 2013, NEUROSCI LETT, V538, P54, DOI 10.1016/j.neulet.2013.01.039; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Neirinckx V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0202-2; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Song HW, 2011, LIFE SCI, V89, P439, DOI 10.1016/j.lfs.2011.07.003; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052	26	20	22	1	12	KOREAN CONTINENCE SOC	YEONGOTONG-GU	DEPT UROLOGY, AJOU UNIV COLL MEDICINE, SAN 5 WONCHEN-DONG, YEONGOTONG-GU, SUWON 443-721, SOUTH KOREA	2093-4777	2093-6931		INT NEUROUROL J	Int. Neurourol. J.	MAY	2016	20			1			S49	S56		10.5213/inj.1632616.308			8	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	DN3ZN	WOS:000377002900008	27230460	Green Published, Green Submitted, gold			2022-02-06	
J	Wu, LM; Tanenbaum, ML; Dijkers, MPJM; Amidi, A; Hall, SJ; Penedo, FJ; Diefenbach, MA				Wu, Lisa M.; Tanenbaum, Molly L.; Dijkers, Marcel P. J. M.; Amidi, Ali; Hall, Simon J.; Penedo, Frank J.; Diefenbach, Michael A.			Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study	SOCIAL SCIENCE & MEDICINE			English	Article						Prostate cancer; Oncology; Cognitive functioning; Neurobehavioral functioning; Androgen deprivation therapy; Attributions; Quality of life	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; STEM-CELL TRANSPLANT; MEN; IMPAIRMENT; APATHY; CHEMOTHERAPY; METAANALYSIS; MANAGEMENT; CIRCUITS	BACKGROUND: Few studies have investigated prostate cancer patients' experiences of cognitive functioning or neurobehavioral symptoms (i.e., behavioral changes associated with neurological dysfunction) following androgen deprivation therapy (ADT). METHODS: Semi-structured interviews conducted from the US by phone and in-person were used to explore and characterize the: 1) experience of cognitive and neurobehavioral functioning in non metastatic prostate cancer patients undergoing ADT (n = 19) compared with patients who had not undergone ADT (n = 20); 2) perceived causes of cognitive and neurobehavioral symptoms; 3) impact of these symptoms on quality of life; and 4) strategies used to cope with or compensate for these symptoms. Neuropsychological performance was assessed to characterize the sample. RESULTS: Overall, ADT patients experienced marginally more cognitive problems than non-ADT (nADT) patients even though there were no significant differences between groups in neuropsychological performance. ADT patients also experienced more declines in prospective memory and multi-tasking than nADT patients. Significant proportions of participants in both groups also experienced retrospective memory, attention and concentration, and information processing difficulties. With respect to neurobehavioral symptoms, more ADT patients experienced emotional lability and impulsivity (both aspects of disinhibition) than nADT patients. Among the causes to which participants attributed declines, both groups attributed them primarily to aging. A majority of ADT patients also attributed declines to ADT. For both groups, increased cognitive and neurobehavioral symptoms negatively impacted quality of life, and most participants developed strategies to ameliorate these problems. CONCLUSION: ADT patients are more vulnerable to experiencing specific cognitive and neurobehavioral symptoms than nADT patients. This study highlights the importance of capturing: a) cognitive symptoms not easily detected using neuropsychological tests; b) neurobehavioral symptoms that can be confused with psychological symptoms, and c) causal beliefs that may affect how people cope with these symptoms. Effective interventions are needed to assist prostate cancer patients in managing these symptoms. (C) 2016 Elsevier Ltd. All rights reserved.	[Wu, Lisa M.; Penedo, Frank J.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, 633 North St Clair,Suite 19-073, Chicago, IL 60611 USA; [Tanenbaum, Molly L.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Dijkers, Marcel P. J. M.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Amidi, Ali] Aarhus Univ Hosp, Dept Oncol, Unit Psychooncol & Hlth Psychol, Aarhus C, Denmark; [Amidi, Ali] Aarhus Univ Hosp, Dept Psychol & Behav Sci, Aarhus C, Denmark; [Amidi, Ali] Aarhus Univ, Aarhus C, Denmark; [Diefenbach, Michael A.] Northwell Hlth, Dept Med, Great Neck, NY USA; [Diefenbach, Michael A.] Northwell Hlth, Dept Urol, Great Neck, NY USA		Wu, LM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, 633 North St Clair,Suite 19-073, Chicago, IL 60611 USA.	lisa.wu1@northwestern.edu; mollyt@stanford.edu; Marcel.Dijkers@mountsinai.org; ali@psy.au.dk; Shall12@Northwell.edu; fpenedo@northwestern.edu; MDiefenbach@Northwell.edu	; Wu, Lisa/P-1202-2018	Tanenbaum, Molly/0000-0003-4222-4224; Wu, Lisa/0000-0003-2241-9905; Dijkers, Marcel/0000-0002-8362-5596; Amidi, Ali/0000-0003-2921-9797	National Cancer Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5R03CA165827-02, 7K07CA184145-02]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R03CA165827, K07CA184145, P30CA060553] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers #5R03CA165827-02 and #7K07CA184145-02. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also thank Krista Herbert, M.A. for her assistance with data management.	Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Baddeley A., 2009, MEMORY; Batrinos ML, 2012, INT J ENDOCRINOL MET, V10, P563, DOI 10.5812/ijem.3661; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Butler C, 2005, J NEUROL NEUROSUR PS, V76, pI31, DOI 10.1136/jnnp.2004.060459; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Cherner MM, 2009, PSYCHO-ONCOLOGY, V18, P237, DOI 10.1002/pon.1401; Cherrier MM, 2015, AM J ALZHEIMERS DIS, V30, P421, DOI 10.1177/1533317514556874; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dauncey MJ, 2014, EUR J CLIN NUTR, V68, P1179, DOI 10.1038/ejcn.2014.173; DAVIDSON JM, 1983, J CLIN ENDOCR METAB, V57, P71, DOI 10.1210/jcem-57-1-71; Garcia JGD, 2007, SOC SCI MED, V64, P2223, DOI 10.1016/j.socscimed.2007.02.001; Diefenbach M. A., 2008, HDB EMOTIONS, P645; Donovan KA, 2015, CANCER-AM CANCER SOC, V121, P4286, DOI 10.1002/cncr.29672; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Glaser B., 1967, DISCOVERY GROUNDED T; Gomella LG, 2007, BJU INT, V99, P25, DOI 10.1111/j.1464-410X.2007.06598.x; Gonzalez B. D., 2015, J CLIN ONCOL OFF J A, DOI JC0.2014.60.1963[pii]; Gualtieri C.T., 2004, 32 INT NEUR SOC ANN; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Jansen CE, 2007, ONCOL NURS FORUM, V34, P997, DOI 10.1188/07.ONF.997-1005; Joly F, 2006, J UROLOGY, V176, P2443, DOI 10.1016/j.juro.2006.07.151; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Kryscio RJ, 2014, NEUROLOGY, V83, P1359, DOI 10.1212/WNL.0000000000000856; Kumar Ravi J, 2005, Rev Urol, V7 Suppl 5, pS37; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Larner A. J., 2010, DICT NEUROLOGICAL SI; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maggio M, 2006, J ANDROL, V27, P725, DOI 10.2164/jandrol.106.000141; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mandelblatt JS, 2013, SEMIN ONCOL, V40, P709, DOI 10.1053/j.seminoncol.2013.09.006; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McGinty HL, 2014, SUPPORT CARE CANCER, V22, P2271, DOI 10.1007/s00520-014-2285-1; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Ollendick TH, 2003, ENCY CLIN CHILD PEDI; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Richards L., 2005, HANDLING QUALITATIVE; Salman H, 2012, BIOMED PHARMACOTHER, V66, P330, DOI 10.1016/j.biopha.2012.03.004; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Singh J, 2010, CLIN INTERV AGING, V5, P187; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; VERMEULEN A, 1991, J CLIN ENDOCR METAB, V73, P221, DOI 10.1210/jcem-73-2-221; Voerman B, 2006, J PSYCHOSOC ONCOL, V24, P49, DOI 10.1300/J077v24n02_04; Von Ah D, 2014, CLIN J ONCOL NURS, V18, P17, DOI 10.1188/14.CJON.S3.17-25; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; WechslerD, 2001, WECHSLER TEST ADULT; Wefel JS, 2015, CA-CANCER J CLIN, V65, P123, DOI 10.3322/caac.21258; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Wu LM, 2014, PSYCHO-ONCOLOGY, V23, P1406, DOI 10.1002/pon.3554; Wu LM, 2013, UROL ONCOL-SEMIN ORI, V31, P1533, DOI 10.1016/j.urolonc.2012.07.003; Wu LM, 2012, PSYCHO-ONCOLOGY, V21, P1175, DOI 10.1002/pon.2012; Yang J, 2015, EUR J CANCER CARE, V24, P198, DOI 10.1111/ecc.12299	60	20	20	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	MAY	2016	156						80	89		10.1016/j.socscimed.2016.03.016			10	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	DL3ET	WOS:000375517700010	27019142	Green Accepted, Green Submitted			2022-02-06	
J	Lossi, L; Cocito, C; Alasia, S; Merighi, A				Lossi, Laura; Cocito, Carolina; Alasia, Silvia; Merighi, Adalberto			Ex vivo imaging of active caspase 3 by a FRET-based molecular probe demonstrates the cellular dynamics and localization of the protease in cerebellar granule cells and its regulation by the apoptosis-inhibiting protein survivin	MOLECULAR NEURODEGENERATION			English	Article						Neurons; Caspase 3; Survivin; Apoptosis; FRET; Biolistic transfection; Cerebellum; Organotypic cultures; Live imaging; Confocal microscopy	RESONANCE ENERGY-TRANSFER; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; NEURONAL APOPTOSIS; FLUORESCENT PEPTIDE; MAMMALIAN CNS; DEATH; ACTIVATION; MECHANISMS; IDENTIFICATION	Background: Apoptosis takes place in naturally occurring neuronal death, but also in aging, neurodegenerative disorders, and traumatic brain injuries. Caspase 3 (Casp3) is the most important effector protease in apoptosis: being inactive inside the cell, it undergoes enzymatic cleavage and - hence - activation once the apoptotic cascade is triggered. Immunological techniques with antibodies against cleaved Casp3 (cCasp3) or assays with colorimetric/fluorogenic substrates are commonly in use, but they do not allow to directly follow the dynamics of activation in alive neurons that may be committed to die. Results: By combined biolistic transfection, confocal microscopy, and fluorescence resonance energy transfer (FRET), we have implemented a methodology to dynamically monitor Casp3 activation in organotypic cerebellar slices from postnatal mice. After transfection with pSCAT3 FRET probes, we measured the ratio of the emissions of the donor/acceptor pair (ECFPem/Venus(em)) in fixed or alive cultures. In so doing, we i. discriminated the cellular compartment(s) of enzyme activation (nucleus, perikaryon, neurites); ii. demonstrated that Casp3 was constitutively active in the granule cells; iii. followed the fluctuations of ECFPem/Venusem, and its response to 25 mM KCl depolarization, or to increased intracellular Ca++ after NMDA (1 mM), kainic acid (1 mM), or A23187 (100-200 mu M). The specificity of the active pSCAT3-DEVD probe was confirmed with RNA interference and after inhibition of Casp3 with Ac-DEVD-CMK (100 mu M), as both sets of experiments brought ECFPem/Venus(em) to the values recorded with the control probe pSCAT3-DEVG. After double-transfection with pSCAT3-DEVD + pHcRed1-C1-survivin, we also showed a 44-56 % reduction of basal Casp3 activity in cells overexpressing survivin, a protein-member of the family of apoptosis inhibitors, with augmented survival (2.82 folds). Survivin-rescued cells were sensitive to 5 mM H2O2 oxidative stress but died without intervention of Casp3. Conclusions: This ex vivo FRET-based methodology provides quantitative information on the functional and histological dynamics of Casp3 activation in individual neurons at a cell level resolution. Not only it can be combined with experimental manipulation of the apoptotic machinery inside the cell, but offers several advantages over existing protocols for monitoring apoptosis in live mammalian neurons, and has potential to be transferred in vivo. Due to the pivotal role of Casp3 in apoptosis, our approach is relevant for a better comprehension of molecular neurodegeneration in the normal and pathological brain.	[Lossi, Laura; Cocito, Carolina; Alasia, Silvia; Merighi, Adalberto] Univ Turin, Dept Vet Sci, Largo Paolo Braccini 2, I-10095 Grugliasco, TO, Italy		Merighi, A (corresponding author), Univ Turin, Dept Vet Sci, Largo Paolo Braccini 2, I-10095 Grugliasco, TO, Italy.	adalberto.merighi@unito.it	Merighi, Adalberto/AAE-1308-2020	Merighi, Adalberto/0000-0002-1140-3556; Cocito, Carolina/0000-0003-2325-5244	University of Turin	We are greatly indebted to Prof. Masayuki Miura for kindly providing us with the SCAT3-DEVD and SCAT3-DEVG probes and for useful comments and suggestions about this work. We also wish to thank Dr. Rachel Altura for her kind gift of the HcRed1-C1-survivin plasmid. This work was supported by local grants from the University of Turin.	Adams JM, 2002, CURR OPIN CELL BIOL, V14, P715, DOI 10.1016/S0955-0674(02)00381-2; Alasia S., 2015, IMMUNOCYTOCHEMISTRY, P329; Alasia S, 2015, METHODS MOL BIOL, V1254, P99, DOI 10.1007/978-1-4939-2152-2_8; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Altieri DC, 2003, ADV CANCER RES, V88, P31, DOI 10.1016/S0065-230X(03)88303-3; Altman J, 1997, DEV CEREBELLAR SYSTE; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Barnett EM, 2009, P NATL ACAD SCI USA, V106, P9391, DOI 10.1073/pnas.0812884106; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Bickler PE, 2004, NEUROSCIENCE, V127, P673, DOI 10.1016/j.neuroscience.2004.05.035; Blatt NB, 2001, BIOORGAN MED CHEM, V9, P1371, DOI 10.1016/S0968-0896(01)00041-4; Bullok K, 2005, J MED CHEM, V48, P5404, DOI 10.1021/jm050008p; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; D'Amelio M, 2012, TRENDS NEUROSCI, V35, P700, DOI 10.1016/j.tins.2012.06.004; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hamburger Viktor, 1990, NATURALLY OCCURRING, P126; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Jolivel V, 2014, J MOL NEUROSCI, V54, P451, DOI 10.1007/s12031-014-0325-4; Juan TSC, 1997, GENOMICS, V40, P86, DOI 10.1006/geno.1996.4548; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Koike-Kuroda Y, 2010, TOXICOL IN VITRO, V24, P2012, DOI 10.1016/j.tiv.2010.07.022; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kuranaga E, 2011, DEVELOPMENT, V138, P1493, DOI 10.1242/dev.058958; Lakowicz JR, 1999, J BIOMOL SCREEN, V4, P355, DOI 10.1177/108705719900400610; Liu Y, 2012, J CONTROL RELEASE, V163, P203, DOI 10.1016/j.jconrel.2012.09.001; Lo SC, 2015, J NEUROSCI, V35, P2118, DOI 10.1523/JNEUROSCI.3280-14.2015; Lossi L, 2004, J MOL HISTOL, V35, P621; Lossi L, 2004, J NEUROBIOL, V60, P437, DOI 10.1002/neu.20032; Lossi L, 2003, PROG NEUROBIOL, V69, P287, DOI 10.1016/S0301-0082(03)00051-0; Lossi L, 2002, NEUROSCIENCE, V112, P509, DOI 10.1016/S0306-4522(02)00112-4; Lossi L., 2002, CELLULAR MOL METHODS, P235; Lossi L, 2015, METHODS MOL BIOL, V1254, P1, DOI 10.1007/978-1-4939-2152-2_1; Lossi L, 2009, DEV NEUROBIOL, V69, P855, DOI 10.1002/dneu.20744; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Marzban H, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00450; Maxwell D, 2009, BIOCONJUGATE CHEM, V20, P702, DOI 10.1021/bc800516n; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Pasti L, 1997, J NEUROSCI, V17, P7817; Pelet S, 2006, MICROSC RES TECHNIQ, V69, P861, DOI 10.1002/jemt.20361; Rao L, 1997, CURR OPIN GENET DEV, V7, P52, DOI 10.1016/S0959-437X(97)80109-8; Smolewski P, 2011, CURR MOL MED, V11, P633, DOI 10.2174/156652411797536723; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Takemoto K, 2007, P NATL ACAD SCI USA, V104, P13367, DOI 10.1073/pnas.0702733104; Tanaka M, 2000, DEV BRAIN RES, V121, P223, DOI 10.1016/S0165-3806(00)00041-9; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Verdaguer E, 2002, BRIT J PHARMACOL, V135, P1297, DOI 10.1038/sj.bjp.0704581; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang JY, 2014, DEV CELL, V28, P670, DOI 10.1016/j.devcel.2014.02.009; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wu YX, 2006, CANCER LETT, V235, P239, DOI 10.1016/j.canlet.2005.04.036; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057; Yang JH, 2013, BIOMETALS, V26, P43, DOI 10.1007/s10534-012-9593-z; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; YUAN JY, 1995, CURR OPIN CELL BIOL, V7, P211, DOI 10.1016/0955-0674(95)80030-1; Zadran S, 2012, APPL MICROBIOL BIOT, V96, P895, DOI 10.1007/s00253-012-4449-6	61	20	21	0	28	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1750-1326			MOL NEURODEGENER	Mol. Neurodegener.	APR 28	2016	11								34	10.1186/s13024-016-0101-8			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK7LS	WOS:000375107400001	27122136	Green Published, gold			2022-02-06	
J	Ong, QX; Guo, SL; Duan, LT; Zhang, K; Collier, EA; Cui, BX				Ong, Qunxiang; Guo, Shunling; Duan, Liting; Zhang, Kai; Collier, Eleanor Ann; Cui, Bianxiao			The Timing of Raf/ERK and AKT Activation in Protecting PC12 Cells against Oxidative Stress	PLOS ONE			English	Article							OPTOGENETIC CONTROL; ISCHEMIC-INJURY; BRAIN-INJURY; OXYGEN; MECHANISMS; DYNAMICS; TIME; REQUIREMENT; EXPRESSION; INDUCTION	Acute brain injuries such as ischemic stroke or traumatic brain injury often cause massive neural death and irreversible brain damage with grave consequences. Previous studies have established that a key participant in the events leading to neural death is the excessive production of reactive oxygen species. Protecting neuronal cells by activating their endogenous defense mechanisms is an attractive treatment strategy for acute brain injuries. In this work, we investigate how the precise timing of the Raf/ERK and the AKT pathway activation affects their protective effects against oxidative stress. For this purpose, we employed optogenetic systems that use light to precisely and reversibly activate either the Raf/ERK or the AKT pathway. We find that preconditioning activation of the Raf/ERK or the AKT pathway immediately before oxidant exposure provides significant protection to cells. Notably, a 15-minute transient activation of the Raf/ERK pathway is able to protect PC12 cells against oxidant strike that is applied 12 hours later, while the transient activation of the AKT pathway fails to protect PC12 cells in such a scenario. On the other hand, if the pathways are activated after the oxidative insult, i.e. postconditioning, the AKT pathway conveys greater protective effect than the Raf/ERK pathway. We find that postconditioning AKT activation has an optimal delay period of 2 hours. When the AKT pathway is activated 30min after the oxidative insult, it exhibits very little protective effect. Therefore, the precise timing of the pathway activation is crucial in determining its protective effect against oxidative injury. The optogenetic platform, with its precise temporal control and its ability to activate specific pathways, is ideal for the mechanistic dissection of intracellular pathways in protection against oxidative stress.	[Ong, Qunxiang; Guo, Shunling; Duan, Liting; Collier, Eleanor Ann; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Zhang, Kai] Univ Illinois, Sch Mol & Cellular Biol, Dept Biochem, Urbana, IL 61801 USA		Cui, BX (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bcui@stanford.edu	Zhang, Kai/ABD-1498-2021	Zhang, Kai/0000-0002-6687-4558	US National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2-NS082125]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [DP2NS082125] Funding Source: NIH RePORTER	This work was supported by US National Institute of Health (www.nih.gov) DP2-NS082125 to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHULAIFI AM, 1993, CARDIOSCIENCE, V4, P163; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi YS, 2007, EXP MOL MED, V39, P556, DOI 10.1038/emm.2007.61; Cohen MV, 2015, BRIT J PHARMACOL, V172, P1913, DOI 10.1111/bph.12903; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Dijkmans TF, 2008, J NEUROCHEM, V105, P2388, DOI 10.1111/j.1471-4159.2008.05338.x; Duan LT, 2015, CHEM BIOL, V22, P671, DOI 10.1016/j.chembiol.2015.04.014; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FOOTE CS, 1968, ACCOUNTS CHEM RES, V1, P104, DOI 10.1021/ar50004a002; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jiang H, 2005, J MOL NEUROSCI, V25, P133, DOI 10.1385/JMN:25:2:133; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Katsura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14589; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim SY, 2011, ONCOL REP, V26, P1561, DOI 10.3892/or.2011.1439; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kokona D, 2015, EXP EYE RES, V136, P45, DOI 10.1016/j.exer.2015.05.007; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marinho HS, 2013, METHOD ENZYMOL, V526, P159, DOI 10.1016/B978-0-12-405883-5.00010-7; Martin KR, 2002, HUM EXP TOXICOL, V21, P71, DOI 10.1191/0960327102ht213oa; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Moreira JBN, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0444-x; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Neumann JT, 2015, J CEREBR BLOOD F MET, V35, P121, DOI 10.1038/jcbfm.2014.185; Noh MY, 2013, MOL NEUROBIOL, V47, P757, DOI 10.1007/s12035-012-8382-6; Ong Q, 2015, OPTOGENETIC CO UNPUB; Ong QX, 2015, ACS CHEM NEUROSCI, V6, P130, DOI 10.1021/cn500288n; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; SACK S, 1993, CARDIOVASC RES, V27, P551, DOI 10.1093/cvr/27.4.551; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Schulz R, 2001, CARDIOVASC RES, V52, P181, DOI 10.1016/S0008-6363(01)00384-4; Shahzad T, 2013, J MOL CELL CARDIOL, V58, P209, DOI 10.1016/j.yjmcc.2013.01.003; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; STEEVES G, 1994, ANN NY ACAD SCI, V723, P116, DOI 10.1111/j.1749-6632.1994.tb36721.x; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wauson EM, 2013, BIOCHEMISTRY-US, V52, P5164, DOI 10.1021/bi4007644; Wegener S, 2004, STROKE, V35, P616, DOI 10.1161/01.STR.0000115767.17923.6A; Weitzman M, 2014, CURR OPIN CELL BIOL, V30, P112, DOI 10.1016/j.ceb.2014.08.004; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YOUNGMAN RJ, 1981, FEBS LETT, V129, P265, DOI 10.1016/0014-5793(81)80180-9; Zhang K, 2015, TRENDS BIOTECHNOL, V33, P92, DOI 10.1016/j.tibtech.2014.11.007; Zhang KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098215; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	61	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153487	10.1371/journal.pone.0153487			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	WOS:000374291800022	27082641	gold, Green Published, Green Submitted			2022-02-06	
J	Ellis, MJ; McDonald, PJ; Cordingley, D; Mansouri, B; Essig, M; Ritchie, L				Ellis, Michael J.; McDonald, Patrick J.; Cordingley, Dean; Mansouri, Behzad; Essig, Marco; Ritchie, Lesley			Retirement-from-sport considerations following pediatric sports-related concussion: case illustrations and institutional approach	NEUROSURGICAL FOCUS			English	Article						concussion; traumatic brain injury; neuropsychology; neuroimaging; return to play; retirement	CHRONIC TRAUMATIC ENCEPHALOPATHY; SPINAL-CORD-INJURY; SELF-REPORTED CONCUSSIONS; ARACHNOID CYST SECONDARY; CERVICAL-SPINE; OPTIC NEUROPATHY; RADIOGRAPHIC ABNORMALITY; RECURRENT CONCUSSION; HEAD-INJURY; POSTCONCUSSION SYNDROME	The decision to advise an athlete to retire from sports following sports-related concussion ( SRC) remains a persistent challenge for physicians. In the absence of strong empirical evidence to support recommendations, clinical decision making must be individualized and should involve a multidisciplinary team of experts in concussion and traumatic brain injury. Although previous authors have advocated for a more conservative approach to these issues in child and adolescent athletes, there are few reports outlining considerations for this process among this unique population. Here, the authors use multiple case illustrations to discuss 3 subgroups of clinical considerations for sports retirement among pediatric SRC patients including the following: those with structural brain abnormalities identified on neuroimaging, those presenting with focal neurological deficits and abnormalities on physical examination, and those in whom the cumulative or prolonged effects of concussion are suspected or demonstrated. The authors' evolving multidisciplinary institutional approach to return-to-play and retirement decision making in pediatric SRC is also presented.	[Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Essig, Marco] Univ Manitoba, Dept Diagnost Radiol, Winnipeg, MB, Canada; [Mansouri, Behzad] Univ Manitoba, Dept Neurol & Neuroophthalmol, Winnipeg, MB, Canada; [Ritchie, Lesley] Univ Manitoba, Dept Clin Hlth Psychol, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Neurosurg Sect, Winnipeg, MB, Canada; [Ellis, Michael J.; Cordingley, Dean; Mansouri, Behzad; Essig, Marco; Ritchie, Lesley] Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; McDonald, Patrick J.] Childrens Hosp, Res Inst Manitoba, 840 Sherbrook St, Winnipeg, MB R3A 1S1, Canada; [Ellis, Michael J.; McDonald, Patrick J.; Cordingley, Dean; Mansouri, Behzad; Essig, Marco; Ritchie, Lesley] Canada North Concuss Network, Winnipeg, MB, Canada; [McDonald, Patrick J.] British Columbia Childrens Hosp, Div Neurosurg, Vancouver, BC V6H 3V4, Canada; [McDonald, Patrick J.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada		Ellis, MJ (corresponding author), Pan Am Clin, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		essig, marco/0000-0002-7964-2297			Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464; Allen CR, 2002, CLIN SPORT MED, V21, P15, DOI 10.1016/S0278-5919(03)00054-1; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; BAILES JE, 1991, NEUROSURGERY, V29, P491, DOI 10.1227/00006123-199110000-00001; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Blount JP, 2004, NEUROSURGERY, V54, P1190, DOI 10.1227/01.NEU.0000119236.08000.49; Bondurant CP, 1995, PEDIATR NEUROSURG, V23, P254, DOI 10.1159/000120968; Bosch PP, 2002, SPINE, V27, P2788, DOI 10.1097/00007632-200212150-00009; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cantu RC, 1998, CLIN SPORT MED, V17, P137, DOI 10.1016/S0278-5919(05)70068-5; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cantu RC, 2013, CURR SPORT MED REP, V12, P14, DOI 10.1249/JSR.0b013e31827dc1fb; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; CANTU RV, 1994, J NEUROSURG, V80, P592; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Cook MW, 1996, ARCH OTOLARYNGOL, V122, P389; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cress M, 2013, NEUROSURGERY, V72, P716, DOI 10.1227/NEU.0b013e318285b3a4; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Davis G, 2010, BRIT J SPORT MED, V44, P1139, DOI 10.1136/bjsm.2008.048215; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; Demetriades AK, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005710; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis M.J., 2014, CURR RES CONCUSSION, V1, P33; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Ellis MJ, 2015, CURR SPORT MED REP, V14, P20, DOI 10.1249/JSR.0000000000000108; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ford RL, 2012, J AAPOS, V16, P413, DOI 10.1016/j.jaapos.2012.04.009; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00141; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldenberg-Cohen N, 2004, J AAPOS, V8, P20, DOI 10.1016/j.jaapos.2003.08.009; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Kawanishi A, 1999, NEUROL MED-CHIR, V39, P231, DOI 10.2176/nmc.39.231; Kelly JP, 1997, NEUROLOGY, V48, P581; Kepler CK, 2012, CLIN SPORT MED, V31, P499, DOI 10.1016/j.csm.2012.03.005; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kestle JRW, 2003, NEUROL CLIN, V21, P883, DOI 10.1016/S0733-8619(03)00016-1; KODSI SR, 1992, AM J OPHTHALMOL, V114, P568, DOI 10.1016/S0002-9394(14)74484-8; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; MAHAPATRA AK, 1993, PEDIATR NEUROSURG, V19, P34, DOI 10.1159/000120698; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2015, CLIN J SPORT MED, V25, P133, DOI 10.1097/JSM.0000000000000107; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; OSENBACH RK, 1992, NEUROSURGERY, V30, P385, DOI 10.1227/00006123-199203000-00012; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pang D, 2004, NEUROSURGERY, V55, P1325, DOI 10.1227/01.NEU.0000143030.85589.E6; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; Paulus S, 2014, PHYS MED REH CLIN N, V25, P723, DOI 10.1016/j.pmr.2014.06.005; POLLACK IF, 1988, J NEUROSURG, V69, P177, DOI 10.3171/jns.1988.69.2.0177; Prabhu VC, 2002, NEUROSURGERY, V50, P195; RICHARDS BW, 1992, AM J OPHTHALMOL, V113, P489, DOI 10.1016/S0002-9394(14)74718-X; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; Ritchie LJ, 2015, CURR RES CONCUSSION, V2, P8; Saigal R, 2014, WORLD NEUROSURG, V82, P485, DOI 10.1016/j.wneu.2014.06.043; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tator CH, 2014, BRIT J SPORT MED, V48, P81, DOI 10.1136/bjsports-2013-093040; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tempel ZJ, 2015, NEUROSURGERY, V77, P23, DOI 10.1227/NEU.0000000000000728; THORNDIKE A, 1952, NEW ENGL J MED, V247, P554, DOI 10.1056/NEJM195210092471504; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Torg JS, 2009, SPORTS HEALTH, V1, P376, DOI 10.1177/1941738109343161; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Torg JS, 1997, PHYSICIAN SPORTSMED, V25, P60, DOI 10.3810/psm.1997.07.1487; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Torg JS, 1997, CLIN J SPORT MED, V7, P273, DOI 10.1097/00042752-199710000-00005; Torg JS, 1997, CLIN SPORT MED, V16, P501, DOI 10.1016/S0278-5919(05)70037-5; Tsuzuki N, 2003, NEUROSURGERY, V53, P242, DOI 10.1227/01.NEU.0000072303.16102.E1; Tubbs RS, 2011, CHILD NERV SYST, V27, P1927, DOI 10.1007/s00381-011-1457-2; WHITE AA, 1975, CLIN ORTHOP RELAT R, P85, DOI 10.1097/00003086-197506000-00011; Wippold FJ, 2008, AM J NEURORADIOL, V29, P1998; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zuckerman SL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12257	115	20	20	0	18	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4							E8	10.3171/2016.1.FOCUS15600			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500003	27032925	gold			2022-02-06	
J	Fogerson, SM; van Brummen, AJ; Busch, DJ; Allen, SR; Roychaudhuri, R; Banks, SML; Klarner, FG; Schrader, T; Bitan, G; Morgan, JR				Fogerson, Stephanie M.; van Brummen, Alexandra J.; Busch, David J.; Allen, Scott R.; Roychaudhuri, Robin; Banks, Susan M. L.; Klaerner, Frank-Gerrit; Schrader, Thomas; Bitan, Gal; Morgan, Jennifer R.			Reducing synuclein accumulation improves neuronal survival after spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						CLR01; Lamprey; Molecular tweezer; Neurodegeneration; Parkinson's disease; Synaptotagmin	TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; AXON REGENERATION; IN-VIVO; PATHOLOGY; DEMENTIA; REPAIR; BETA; NEURODEGENERATION	Spinal cord injury causes neuronal death, limiting subsequent regeneration and recovery. Thus, there is a need to develop strategies for improving neuronal survival after injury. Relative to our understanding of axon regeneration, comparatively little is known about the mechanisms that promote the survival of damaged neurons. To address this, we took advantage of lamprey giant reticulospinal neurons whose large size permits detailed examination of post-injury molecular responses at the level of individual, identified cells. We report here that spinal cord injury caused a select subset of giant reticulospinal neurons to accumulate synuclein, a synaptic veside-associated protein best known for its atypical aggregation and causal role in neurodegeneration in Parkinson's and other diseases. Post-injury synuclein accumulation took the form of punctate aggregates throughout the somata and occurred selectively in dying neurons, but not in those that survived. In contrast, another synaptic vesicle protein, synaptotagmin, did not accumulate in response to injury. We further show that the post-injury synuclein accumulation was greatly attenuated after single dose application of either the "molecular tweezer" inhibitor, CLR01, or a translation-blocking synuclein morpholino. Consequently, reduction of synuclein accumulation not only improved neuronal survival, but also increased the number of axons in the spinal cord proximal and distal to the lesion. This study is the first to reveal that reducing synuclein accumulation is a novel strategy for improving neuronal survival after spinal cord injury. (C) 2016 Elsevier Inc. All rights reserved.	[Fogerson, Stephanie M.; van Brummen, Alexandra J.; Allen, Scott R.; Banks, Susan M. L.; Morgan, Jennifer R.] Marine Biol Lab, Eugene Bell Ctr Regenerat Biol & Tissue Engn, 7 MBL St, Woods Hole, MA 02543 USA; [van Brummen, Alexandra J.; Busch, David J.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Roychaudhuri, Robin; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Klaerner, Frank-Gerrit; Schrader, Thomas] Univ Duisburg Essen, Inst Organ Chem, D-45117 Essen, Germany; [Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Bitan, Gal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Fogerson, Stephanie M.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Busch, David J.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Roychaudhuri, Robin] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA		Morgan, JR (corresponding author), Marine Biol Lab, Eugene Bell Ctr Regenerat Biol & Tissue Engn, 7 MBL St, Woods Hole, MA 02543 USA.	jmorgan@mbl.edu	Bitan, Gal/U-2204-2019	Bitan, Gal/0000-0001-7046-3754; Roychaudhuri, Robin/0000-0003-3851-4181	Morton Cure Paralysis Fund; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS078165]; Parkinson's Disease Foundation [PDF-SFW-1214]; University of California-Los Angeles Jim Easton Consortium; Team Parkinson/Parkinson Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078165] Funding Source: NIH RePORTER	This work was supported by research grants from the Morton Cure Paralysis Fund and the NIH (RO1 NS078165 to JRM), a Parkinson's Disease Foundation summer student fellowship (PDF-SFW-1214 to AJVB), University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development (GB), and Team Parkinson/Parkinson Alliance (GB). The authors would like to thank Michele Nsianya and the 2013 Brown-MBL NeuroPracticum Course students for the technical assistance with immunofluorescence experiments, and Paul Oliphint for the histological image of the lamprey spinal cord.	Acharya S, 2014, J BIOL CHEM, V289, P10727, DOI 10.1074/jbc.M113.524520; Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289; Barreiro-Iglesias Anton, 2012, Enzyme Res, V2012, P835731, DOI 10.1155/2012/835731; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Beyer K, 2008, CURR MED CHEM, V15, P2748, DOI 10.2174/092986708786242868; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Bloom OE, 2011, MOL CELL NEUROSCI, V48, P339, DOI 10.1016/j.mcn.2011.04.003; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Busch DJ, 2014, MOL BIOL CELL, V25, P3926, DOI 10.1091/mbc.E14-02-0708; Busch DJ, 2012, J COMP NEUROL, V520, P1751, DOI 10.1002/cne.23011; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Ferrucci Michela, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS180, DOI 10.1016/j.parkreldis.2008.04.025; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Giorgi FS, 2006, J NEURAL TRANSM-SUPP, P105; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Hu JL, 2013, J NEUROSCI METH, V220, P92, DOI 10.1016/j.jneumeth.2013.08.016; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Jin LQ, 2009, J COMP NEUROL, V515, P295, DOI 10.1002/cne.22057; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Lau BYB, 2013, EXP NEUROL, V250, P31, DOI 10.1016/j.expneurol.2013.09.004; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lulla A., 2016, NEUROTOXICITY UNPUB; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Oliphint PA, 2010, J COMP NEUROL, V518, P2854, DOI 10.1002/cne.22368; Prabhudesai S, 2012, NEUROTHERAPEUTICS, V9, P464, DOI 10.1007/s13311-012-0105-1; ROVAINEN CM, 1967, J NEUROPHYSIOL, V30, P1000, DOI 10.1152/jn.1967.30.5.1000; Roychaudhuri R, 2014, J MOL BIOL, V426, P2422, DOI 10.1016/j.jmb.2014.04.004; Sakurai M, 2009, J CEREBR BLOOD F MET, V29, P752, DOI 10.1038/jcbfm.2008.167; Shifman MI, 2008, J COMP NEUROL, V510, P269, DOI 10.1002/cne.21789; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Viscomi M. T., 2014, MOL NEUROBIOL; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Wang Y.C., 2016, APOPTOSIS; Williams RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118918; YIN HS, 1983, J NEUROSCI, V3, P1135; Zhang GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137670	50	20	20	0	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2016	278						105	115		10.1016/j.expneurol.2016.02.004			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH3EX	WOS:000372671400011	26854933	Green Accepted, Green Published			2022-02-06	
J	Ryan, NP; Catroppa, C; Beare, R; Silk, TJ; Crossley, L; Beauchamp, MH; Yeates, KO; Anderson, VA				Ryan, Nicholas P.; Catroppa, Cathy; Beare, Richard; Silk, Timothy J.; Crossley, Louise; Beauchamp, Miriam H.; Yeates, Keith Owen; Anderson, Vicki A.			Theory of mind mediates the prospective relationship between abnormal social brain network morphology and chronic behavior problems after pediatric traumatic brain injury	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						childhood; brain injuries; social cognition; theory of mind; magnetic resonance imaging	SUPERIOR TEMPORAL SULCUS; YOUNG-ADULT SURVIVORS; NEURAL BASIS; EXTERNALIZING BEHAVIOR; CORPUS-CALLOSUM; CHILDREN; MODERATE; PREDICTORS; OUTCOMES; PREVALENCE	Childhood and adolescence coincide with rapid maturation and synaptic reorganization of distributed neural networks that underlie complex cognitive-affective behaviors. These regions, referred to collectively as the 'social brain network' (SBN) are commonly vulnerable to disruption from pediatric traumatic brain injury (TBI); however, the mechanisms that link morphological changes in the SBN to behavior problems in this population remain unclear. In 98 children and adolescents with mild to severe TBI, we acquired 3D T1-weighted MRIs at 2-8 weeks post-injury. For comparison, 33 typically developing controls of similar age, sex and education were scanned. All participants were assessed on measures of Theory of Mind (ToM) at 6 months post-injury and parents provided ratings of behavior problems at 24-months post-injury. Severe TBI was associated with volumetric reductions in the overall SBN package, as well as regional gray matter structural change in multiple component regions of the SBN. When compared with TD controls and children with milder injuries, the severe TBI group had significantly poorer ToM, which was associated with more frequent behavior problems and abnormal SBN morphology. Mediation analysis indicated that impaired theory of mind mediated the prospective relationship between abnormal SBN morphology and more frequent chronic behavior problems. Our findings suggest that sub-acute alterations in SBN morphology indirectly contribute to long-term behavior problems via their influence on ToM. Volumetric change in the SBN and its putative hub regions may represent useful imaging biomarkers for prediction of post-acute social cognitive impairment, which may in turn elevate risk for chronic behavior problems.	[Ryan, Nicholas P.; Catroppa, Cathy; Silk, Timothy J.; Crossley, Louise; Anderson, Vicki A.] Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Beare, Richard] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Radiol, Melbourne, Vic, Australia; Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Hotchkiss, Inst Brain, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen] Univ Calgary, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada		Ryan, NP (corresponding author), Murdoch Childrens Res Inst, Child Neuropsychol, Flemington Rd, Parkville, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au	Yeates, Keith/AAJ-4223-2020; Ryan, Nicholas/K-5445-2019; Silk, Tim/K-4295-2019; Catroppa, Cathy/AAX-9458-2021	Ryan, Nicholas/0000-0002-0878-8889; Catroppa, Cathy/0000-0002-9750-0436; Beare, Richard/0000-0002-7530-5664; Silk, Tim/0000-0002-7290-512X; Yeates, Keith/0000-0001-7680-2892	Victorian Neurotrauma Initiative, Australia [CO6E1]; Victorian Government Operational Infrastructure Support Program; Australian Postgraduate AwardAustralian Government; MCRI; National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Brain Injury Recovery Seed GrantNational Health and Medical Research Council of Australia; NHMRCNational Health and Medical Research Council of Australia	This work was supported by a grant from the Victorian Neurotrauma Initiative (No. CO6E1), Australia; the Victorian Government Operational Infrastructure Support Program; an Australian Postgraduate Award, MCRI PhD scholarship, and National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Brain Injury Recovery Seed Grant to N.R.; and an NHMRC Senior Practitioner Fellowship to V.A. The funding bodies did not play a role in the design of the study, collection, analysis and interpretation of the data, or writing of the article.	Achenbach TM, 2001, ASEBA SCH AGE FORMS; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2011, BRAIN INJURY, V25, P950, DOI 10.3109/02699052.2011.589791; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Hayes, 2018, INTRO MEDIATION MODE; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Herbet G, 2013, CORTEX, V49, P2711, DOI 10.1016/j.cortex.2013.08.003; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kenny D.T., 2007, NSW CRIME JUSTICE B, V107, P1; Lahnakoski JM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00233; Lavin C., 2013, FRONT NEUROSCI, V7, P1; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Shin JE, 2015, PROG NEURO-PSYCHOPH, V58, P81, DOI 10.1016/j.pnpbp.2014.12.006; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Sodian B, 2011, CHILD DEV PERSPECT, V5, P39, DOI 10.1111/j.1750-8606.2010.00152.x; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; TEASDALE G, 1974, LANCET, V2, P81; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	83	20	20	0	20	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	APR	2016	11	4					683	692		10.1093/scan/nsw007			10	Neurosciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DJ5DT	WOS:000374227700016	26796967	Green Submitted, Green Published, hybrid			2022-02-06	
J	Vogel, EW; Effgen, GB; Patel, TP; Meaney, DF; Bass, CR; Morrison, B				Vogel, Edward W., III; Effgen, Gwen B.; Patel, Tapan P.; Meaney, David F.; Bass, Cameron R. Dale; Morrison, Barclay, III			Isolated Primary Blast Inhibits Long-Term Potentiation in Organotypic Hippocampal Slice Cultures	JOURNAL OF NEUROTRAUMA			English	Article						brain; electrophysiology; in vitro; learning; neuron	TRAUMATIC BRAIN-INJURY; PAIRED-PULSE FACILITATION; FLUID PERCUSSION INJURY; IN-VITRO MODEL; AREA CA1; SYNAPTIC-TRANSMISSION; CELL-DEATH; RAT MODEL; MECHANISMS; CALCIUM	Over the last 13 years, traumatic brain injury (TBI) has affected over 230,000 U.S. service members through the conflicts in Iraq and Afghanistan, mostly as a result of exposure to blast events. Blast-induced TBI (bTBI) is multi-phasic, with the penetrating and inertia-driven phases having been extensively studied. The effects of primary blast injury, caused by the shockwave interacting with the brain, remain unclear. Earlier in vivo studies in mice and rats have reported mixed results for primary blast effects on behavior and memory. Using a previously developed shock tube and in vitro sample receiver, we investigated the effect of isolated primary blast on the electrophysiological function of rat organotypic hippocampal slice cultures (OHSC). We found that pure primary blast exposure inhibited long-term potentiation (LTP), the electrophysiological correlate of memory, with a threshold between 9 and 39 kPa center dot ms impulse. This deficit occurred well below a previously identified threshold for cell death (184 kPa center dot ms), supporting our previously published finding that primary blast can cause changes in brain function in the absence of cell death. Other functional measures such as spontaneous activity, network synchronization, stimulus-response curves, and paired-pulse ratios (PPRs) were less affected by primary blast exposure, as compared with LTP. This is the first study to identify a tissue-level tolerance threshold for electrophysiological changes in neuronal function to isolated primary blast.	[Vogel, Edward W., III; Effgen, Gwen B.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA; [Patel, Tapan P.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bass, Cameron R. Dale] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122; Patel, Tapan/0000-0001-8959-6645	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS088176] Funding Source: Medline		Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Commins S, 1998, NEUROREPORT, V9, P4109, DOI 10.1097/00001756-199812210-00019; Compte A, 2006, NEUROSCIENCE, V139, P135, DOI 10.1016/j.neuroscience.2005.06.011; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DISCENNA PG, 1994, HIPPOCAMPUS, V4, P569, DOI 10.1002/hipo.450040506; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DVBIC, 2015, DEP DEF NUMB TRAUM B; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fueta Y, 1998, BRAIN RES, V779, P324, DOI 10.1016/S0006-8993(97)01214-6; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Huang M., 2015, PSYCHONEUROENDOCRINO; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; JOY RM, 1993, BRAIN RES, V604, P273, DOI 10.1016/0006-8993(93)90379-2; Kang W. H., 2015, BIOMECH MODEL MECHAN, P1; Kang WH, 2015, J NEUROTRAUM, V32, P1011, DOI 10.1089/neu.2014.3667; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Keyes DC, 2005, MED RESPONSE TERRORI; Li XL, 2007, J NEUROPHYSIOL, V98, P3341, DOI 10.1152/jn.00977.2007; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maugineanu DG, 2000, BRAIN RES BULL, V51, P69, DOI 10.1016/S0361-9230(99)00209-9; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Patel TP, 2015, J NEUROSCI METH, V243, P26, DOI 10.1016/j.jneumeth.2015.01.020; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; SCHULZ PE, 1995, J PHYSIOLOGY-PARIS, V89, P3, DOI 10.1016/0928-4257(96)80546-8; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; STANFORD IM, 1995, EUR J PHARMACOL, V277, P229, DOI 10.1016/0014-2999(95)00083-W; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Swant J, 2006, LEARN MEMORY, V13, P161, DOI 10.1101/lm.63806; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wallis RA, 1995, EUR J PHARMACOL, V294, P475, DOI 10.1016/0014-2999(95)00568-4; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; WU LG, 1994, J NEUROSCI, V14, P645; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	72	20	20	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					652	661		10.1089/neu.2015.4045			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700004	26414012	Green Published			2022-02-06	
J	Wilde, EA; Hunter, JV; Li, XQ; Amador, C; Hanten, G; Newsome, MR; Wu, TC; McCauley, SR; Vogt, GS; Chu, ZD; Biekman, B; Levin, HS				Wilde, Elisabeth A.; Hunter, Jill V.; Li, Xiaoqi; Amador, Cristian; Hanten, Gerri; Newsome, Mary R.; Wu, Trevor C.; McCauley, Stephen R.; Vogt, Gregory S.; Chu, Zili David; Biekman, Brian; Levin, Harvey S.			Chronic Effects of Boxing: Diffusion Tensor Imaging and Cognitive Findings	JOURNAL OF NEUROTRAUMA			English	Article						boxing; chronic effects; cognition; imaging	TRAUMATIC BRAIN-INJURY; PROFESSIONAL BOXERS; WHITE-MATTER; MEMORY; STRIATUM; SPECTRUM; DISEASE; AMATEUR; DAMAGE; MRI	We used magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) to evaluate the effects of boxing on brain structure and cognition in 10 boxers (8 retired, 2 active; mean age = 45.7 years; standard deviation [SD] = 9.71) and 9 participants (mean age = 43.44; SD = 9.11) in noncombative sports. Evans Index (maximum width of the anterior horns of the lateral ventricles/maximal width of the internal diameter of the skull) was significantly larger in the boxers (F = 4.52; p = 0.050; Cohen's f = 0.531). Word list recall was impaired in the boxers (F-(1,F-14) = 10.70; p = 0.006; f = 0.84), whereas implicit memory measured by faster reaction time (RT) to a repeating sequence of numbers than to a random sequence was preserved (t = 2.52; p < 0.04). Fractional anisotropy (FA) and the apparent diffusion coefficient (ADC) measured by tractography did not significantly differ between groups. However, DTI metrics were significantly correlated with declarative memory (e.g., left ventral striatum ADC with delayed recall, r = -0.74; p = 0.02) and with RT to the repeating number sequence (r = 0.70; p = 0.04) in the boxers. Years of boxing had the most consistent, negative correlations with FA, ranging from -0.65 for the right ventral striatum to -0.92 for the right cerebral peduncle. Years of boxing was negatively related to the number of words consistently recalled over trials (r = -0.74; p = 0.02), delayed recall (r = -0.83; p = 0.003), and serial RT (r = 0.66; p = 0.05). We conclude that microstructural integrity of white matter tracts is related to declarative memory and response speed in boxers and to the extent of boxing exposure. Implications for chronic traumatic encephalopathy are discussed.	[Wilde, Elisabeth A.; Newsome, Mary R.; McCauley, Stephen R.; Vogt, Gregory S.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Rehabil Res & Dev, Houston, TX USA; [Wilde, Elisabeth A.; Hunter, Jill V.; Li, Xiaoqi; Hanten, Gerri; Newsome, Mary R.; McCauley, Stephen R.; Chu, Zili David; Biekman, Brian; Levin, Harvey S.] Baylor Coll Med, One Baylor Plaza,BCM637, Houston, TX 77030 USA; [Amador, Cristian] Rice Univ, Houston, TX USA; [Wu, Trevor C.] Mercy Hlth St Marys, Hauenstein Neurosci, Grand Rapids, MI USA		Levin, HS (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM637, Houston, TX 77030 USA.	hlevin@bcm.edu		Vogt, Gregory/0000-0001-8259-5885	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R21-NS086714, 5P01-NS056202] Funding Source: Medline; RRD VA [I21 RX001608] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS086714, P01NS056202] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I21RX001608] Funding Source: NIH RePORTER		Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Gobel EW, 2013, NEUROPSYCHOLOGY, V27, P314, DOI 10.1037/a0032305; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mattfeld AT, 2015, HIPPOCAMPUS, V25, P900, DOI 10.1002/hipo.22411; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Unterharnscheidt F, 2003, BOXING MED ASPECTS; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	32	20	20	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					672	680		10.1089/neu.2015.4035			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700006	26414735	Green Published			2022-02-06	
J	Sacco, K; Galetto, V; Dimitri, D; Geda, E; Perotti, F; Zettin, M; Geminiani, GC				Sacco, Katiuscia; Galetto, Valentina; Dimitri, Danilo; Geda, Elisabetta; Perotti, Francesca; Zettin, Marina; Geminiani, Giuliano C.			Concomitant Use of Transcranial Direct Current Stimulation and Computer-Assisted Training for the Rehabilitation of Attention in Traumatic Brain Injured Patients: Behavioral and Neuroimaging Results	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						transcranial direct current stimulation (tDCS); cognitive rehabilitation; attention; traumatic brain injury (TB!); functional magnetic resonance imaging (fMRI); cerebral plasticity	DORSOLATERAL PREFRONTAL CORTEX; DIVIDED ATTENTION; COGNITIVE REHABILITATION; TDCS; DRIVERS; MEMORY; QUESTION; EVENTS; HEALTH	Divided attention (DA), the ability to distribute cognitive resources among two or more simultaneous tasks, may be severely compromised after traumatic brain injury (TBI), resulting in problems with numerous activities involved with daily living. So far, no research has investigated whether the use of non-invasive brain stimulation associated with neuropsychological rehabilitation might contribute to the recovery of such cognitive function. The main purpose of this study was to assess the effectiveness of 10 transcranial direct current stimulation (tDCS) sessions combined with computer-assisted training; it also intended to explore the neural modifications induced by the treatment. Thirty-two patients with severe TBI participated in the study: 16 were part of the experimental group, and 16 part of the control group. The treatment included 20' of tDCS, administered twice a day for 5 days. The electrodes were placed on the dorsolateral prefrontal cortex. Their location varied across patients and it depended on each participant's specific area of damage. The control group received sham tDCS. After each tDCS session, the patient received computer-assisted cognitive training on DA for 40'. The results showed that the experimental group significantly improved in DA performance between pre- and post-treatment, showing faster reaction times (RTs), and fewer omissions. No improvement was detected between the baseline assessment (i.e., 1 month before treatment) and the pre-training assessment, or within the control group. Functional magnetic resonance imaging (fMRI) data, obtained on the experimental group during a DA task, showed post-treatment lower cerebral activations in the right superior temporal gyrus (BA 42), right and left middle frontal gyrus (BA 6), right postcentral gyrus (BA 3) and left inferior frontal gyrus (BA 9). We interpreted such neural changes as normalization of previously abnormal hyperactivations.	[Sacco, Katiuscia; Galetto, Valentina; Dimitri, Danilo; Geda, Elisabetta; Perotti, Francesca; Zettin, Marina; Geminiani, Giuliano C.] Univ Turin, Imaging & Cerebral Plast Res Grp, Dept Psychol, Turin, Italy; [Sacco, Katiuscia; Geminiani, Giuliano C.] Univ Turin, Neurosci Inst Turin, Turin, Italy; [Galetto, Valentina; Dimitri, Danilo; Zettin, Marina] Ctr Puzzle, Turin, Italy		Galetto, V (corresponding author), Univ Turin, Imaging & Cerebral Plast Res Grp, Dept Psychol, Turin, Italy.; Galetto, V (corresponding author), Ctr Puzzle, Turin, Italy.	valentinagaletto@virgilio.it			ex WO	This research has been supported by local research funds (ex WO managed by University of Turin, Department of Psychology, year 2014, and by the Brain Imaging Group Association. The authors are grateful to the patients who participated in the research, and to the reviewers. A special thanks goes to our radiology technician, Dumitru Scafesi, for his courtesy and kindness.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bikson M, 2010, CLIN NEUROPHYSIOL, V121, P1976, DOI 10.1016/j.clinph.2010.05.020; Bikson M, 2012, NEUROMODULATION, V15, P306, DOI 10.1111/j.1525-1403.2012.00481.x; Brouwer W, 2001, BRAIN COGNITION, V46, P54, DOI 10.1016/S0278-2626(01)80033-6; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clark VP, 2014, NEUROIMAGE, V85, P889, DOI 10.1016/j.neuroimage.2013.08.071; Collette F, 2005, COGNITIVE BRAIN RES, V24, P237, DOI 10.1016/j.cogbrainres.2005.01.023; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; De Luca R, 2014, DISABIL HEALTH J, V7, P356, DOI 10.1016/j.dhjo.2014.04.003; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Jackson ML, 2011, BRAIN IMAGING BEHAV, V5, P97, DOI 10.1007/s11682-011-9115-6; Johnson JA, 2005, CEREB CORTEX, V15, P1609, DOI 10.1093/cercor/bhi039; Johnson JA, 2007, J COGNITIVE NEUROSCI, V19, P907, DOI 10.1162/jocn.2007.19.6.907; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Klingberg T, 2000, PROG BRAIN RES, V126, P95; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Loose R, 2003, HUM BRAIN MAPP, V18, P249, DOI 10.1002/hbm.10082; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Masson M, 2013, BRAIN INJURY, V27, P538, DOI 10.3109/02699052.2013.766926; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Montani V, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00409; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Park SH, 2013, J KOREAN NEUROSURG S, V54, P484, DOI 10.3340/jkns.2013.54.6.484; PONSFORD A, 1991, Radiography Today, V57, P10; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Scelzo E, 2011, EUR PSYCHIAT, V26; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shin YI, 2015, NEUROPSYCHOLOGIA, V69, P154, DOI 10.1016/j.neuropsychologia.2015.02.002; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Tachibana A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-26; Toyokura Minoru, 2012, Tokai J Exp Clin Med, V37, P19; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wagner M, 2006, J PSYCHIATR RES, V40, P315, DOI 10.1016/j.jpsychires.2005.06.001; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	53	20	21	1	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAR 31	2016	10								57	10.3389/fnbeh.2016.00057			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DH8IF	WOS:000373036000001	27065823	Green Published, gold			2022-02-06	
J	Yoon, KJ; Lee, YT; Chae, SW; Park, CR; Kim, DY				Yoon, Kyung Jae; Lee, Yong-Taek; Chae, Seoung Wan; Park, Chae Ri; Kim, Dae Yul			Effects of anodal transcranial direct current stimulation (tDCS) on behavioral and spatial memory during the early stage of traumatic brain injury in the rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Direct current stimulation; tDCS; Neuromodulation; Traumatic brain injury; TBI; BDNF; Memory	NONINVASIVE CORTICAL STIMULATION; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN MOTOR CORTEX; VOLUNTARY EXERCISE; DC-STIMULATION; UP-REGULATION; EXCITABILITY; PLASTICITY; NEURONS; MODEL	Transcranial direct current stimulation (tDCS) is a noninvasive technique to modulate the neural membrane potential. Its effects in the early stage of traumatic brain injury (TBI) have rarely been investigated. This study assessed the effects of anodal tDCS on behavioral and spatial memory in a rat model of traumatic brain injury. Thirty six rats underwent lateral fluid percussion and were then randomly assigned to one of three groups: control (n = 12), five-day tDCS over peri-lesional cortex at one (1W, n = 12), or two (2W, n = 12) weeks post injury. The Barnes maze (BM) and Rotarod (RR) tests were evaluated in a blind manner on day 1, week 3 and week 5 post-injury. After three weeks, both the 1W and 2W groups showed significant improvements in the BM ratio (P < 0.05), whereas only group 2W obtained a significant improvement in the RR ratio compared with the control group (P < 0.05). However, there were no significant differences between any of the groups at five weeks after TBI. Immunohistochemistry revealed that only group 2W had a significantly higher brain derived neurotrophic factor (BDNF) expression in the peri-lesional cortex, which was significantly correlated with the improvement of the Rotarod test at 3-week post-injury. However, BDNF expression in the ipsilesional hippocampus was not significantly different among the three groups. Group 1W tended to have increased choline/creatine ratios, as measured by magnetic resonance spectroscopy in the peri-lesional cortex, than the control group (P = 0.051). Neither regimen aggravated the lesion volume or brain edema measured by MRI. These beneficial effects were not observed with either regimen at five weeks post-injury. In conclusions, anodal tDCS ameliorated behavioral and spatial memory function in the early phase after TBI when it is delivered two weeks post-injury. Earlier stimulation (one week post-injury) improves spatial memory only. However, the beneficial effects did not persist after cessation of the anodal stimulation. (C) 2016 Elsevier B.V. All rights reserved.	[Yoon, Kyung Jae; Lee, Yong-Taek] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Seoul, South Korea; [Yoon, Kyung Jae; Lee, Yong-Taek] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Regenerat & Neurosci Lab, Med Res Inst, Seoul, South Korea; [Chae, Seoung Wan] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Pathol, Seoul, South Korea; [Park, Chae Ri] Univ Ulsan, Coll Med, Asan Inst Life Sci, Ulsan, South Korea; [Kim, Dae Yul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Asanbyeongwon Gil 86, Seoul 138736, South Korea		Kim, DY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Asanbyeongwon Gil 86, Seoul 138736, South Korea.	kysmart@amc.seoul.kr	Yoon, Kyung Jae/ABB-3785-2021		Asan Institute for Life Science, Seoul, Korea [2009-454]; Kangbuk Samsung HospitalSamsung; Samsung Biomedical Research InstituteSamsung [SMX1132351]	This study was supported and funded by the Asan Institute for Life Science, Seoul, Korea (Task No.: 2009-454) and by Medical Research Funds from the Kangbuk Samsung Hospital and a grant from the Samsung Biomedical Research Institute [#SMX1132351].	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; de Berker AO, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00613; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Floel A, 2012, NEUROBIOL AGING, V33, P1682, DOI 10.1016/j.neurobiolaging.2011.05.007; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GARTSIDE IB, 1968, NATURE, V220, P382, DOI 10.1038/220382a0; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; ISLAM N, 1995, EXP NEUROL, V133, P25, DOI 10.1006/exnr.1995.1004; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Jiang T, 2012, NEUROSCIENCE, V226, P421, DOI 10.1016/j.neuroscience.2012.09.035; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Merzagora AC, 2010, NEUROIMAGE, V49, P2304, DOI 10.1016/j.neuroimage.2009.10.044; MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Yoon KJ, 2012, BRAIN RES, V1452, P61, DOI 10.1016/j.brainres.2012.02.062	37	20	20	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2016	362						314	320		10.1016/j.jns.2016.02.005			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH1PW	WOS:000372558400062	26944170				2022-02-06	
J	Cobb, BR; Zadnik, AM; Rowson, S				Cobb, Bryan R.; Zadnik, Abigail M.; Rowson, Steven			Comparative analysis of helmeted impact response of Hybrid III and National Operating Committee on Standards for Athletic Equipment headforms	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Concussion; brain injury; helmet testing; biomechanics; linear acceleration; rotational acceleration	ICE HOCKEY HELMETS; HEAD IMPACT; PROFESSIONAL FOOTBALL; BIOMECHANICAL PERFORMANCE; BRAIN-INJURY; CONCUSSION; ACCELERATION; EXPOSURE; KINEMATICS; RISK	As advanced helmet testing methodologies are developed, the effect headform selection may have on the biomechanical impact response must be considered. This study sought to assess response differences between two of the most commonly used headforms, the Hybrid III and National Operating Committee on Standards for Athletic Equipment headforms, through a series of helmeted impact tests. A total of 180 pendulum impact tests were conducted with three impactor velocities and six impact locations. Test condition-specific significant differences were found between the two headforms for peak linear and angular accelerations (=0.05), although differences tended to be small. On average, the National Operating Committee on Standards for Athletic Equipment headform experienced higher peak linear (3.7 +/- 7.8%) and angular (12.0 +/- 21.6%) accelerations, with some of the largest differences associated with impacts to the facemask. Without the facemask impacts, the average differences in linear (1.8 +/- 6.0%) and angular (9.6 +/- 15.9%) acceleration would be lower. No significant differences were found in coefficient of variation values for linear (Hybrid III: 2.6 +/- 2.3%, National Operating Committee on Standards for Athletic Equipment: 2.0 +/- 1.4%) or angular (Hybrid III: 4.9 +/- 4.0%; National Operating Committee on Standards for Athletic Equipment: 5.2 +/- 5.8%) acceleration. These data have application toward development and validation of future helmet evaluation protocols and standards.	[Cobb, Bryan R.; Zadnik, Abigail M.; Rowson, Steven] Virginia Tech, Ctr Injury Biomech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA		Cobb, BR (corresponding author), Virginia Tech, Ctr Injury Biomech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	cobb84@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596			Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Gadd C, 1966, 660793 SAE; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hardy, 2003, P INT RES C BIOM IMP; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hirsch AE, 1970, 700899 SAE; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; MacAlister Anna, 2014, Biomed Sci Instrum, V50, P242; McLeod D. G., 1974, 741193 SAE; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2006, STAND LIN IMP TEST M; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NOCSAE, 2011, STAND PERF SPEC NEWL; NOCSAE (National Operating Committee on Standards for Athletic Equipment), 2011, STAND TEST METH EQ U; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; Ouckama R, 2012, P I MECH ENG P-J SPO, V226, P185, DOI 10.1177/1754337111435625; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, J NEUROSURG, V119, P805, DOI 10.3171/2013.3.JNS121735; Rowson S, 2013, P I MECH ENG P-J SPO, V227, P12, DOI 10.1177/1754337112442620; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Versace J., 1971, 710881 SAE; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	45	20	20	0	10	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	MAR	2016	230	1			SI		50	60		10.1177/1754337115599133			11	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	DG8AN	WOS:000372304900007					2022-02-06	
J	Fang, F; Hallmarker, U; James, S; Ingre, C; Michaelsson, K; Ahlbom, A; Feychting, M				Fang, Fang; Hallmarker, Ulf; James, Stefan; Ingre, Caroline; Michaelsson, Karl; Ahlbom, Anders; Feychting, Maria			Amyotrophic lateral sclerosis among cross-country skiers in Sweden	EUROPEAN JOURNAL OF EPIDEMIOLOGY			English	Article						Amyotrophic lateral sclerosis; Cross-country ski; Physical activity; Longitudinal study	CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL PLAYERS; MOTOR-NEURON DISEASE; GULF-WAR VETERANS; BRAIN-INJURY; PHYSICAL-ACTIVITY; INCREASED RISK; HEAD-INJURY; ALS; MORTALITY	A highly increased risk of amyotrophic lateral sclerosis (ALS) has been suggested among professional athletes. We aimed to examine whether long distance cross-country skiers have also a higher risk of ALS and whether the increased risk was modified by skiing performance. We followed 212,246 cross-country skiers in the Swedish Vasaloppet cohort and a random selection of 508,176 general Swedes not participating in the Vasaloppet during 1989-2010. The associations between cross-country skiing as well as skiing performance (i.e., type of race, finishing time and number of races) and the consequent risk of ALS were estimated through hazard ratios (HRs) derived from Cox model. During the study, 39 cases of ALS were ascertained among the skiers. The fastest skiers (100-150 % of winner time) had more than fourfold risk of ALS (HR 4.31, 95 % confidence interval [CI] 1.78-10.4), as compared to skiers that finished at > 180 % of winner time. Skiers who participated > 4 races during this period had also a higher risk (HR 3.13, 95 % CI 1.37-7.17) than those participated only one race. When compared to the non-skiers, the fastest skiers still had a higher risk (HR 2.08, 95 % CI 1.12-3.84), as skiers who had > 4 races (HR 1.88, 95 % CI 1.05-3.35), but those finishing at > 180 % of winner time had a lower risk (HR 0.46, 95 % CI 0.24-0.87). In conclusion, long distance cross-country skiing is associated with a higher risk of ALS, but only among the best skiers; recreational skiers appear to have a largely reduced risk.	[Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden; [Hallmarker, Ulf] Mora Hosp, Dept Internal Med, Mora, Sweden; [Hallmarker, Ulf; James, Stefan] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Hallmarker, Ulf; James, Stefan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Ingre, Caroline] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Ingre, Caroline] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Michaelsson, Karl] Uppsala Univ, Sect Orthoped, Dept Surg Sci, Uppsala, Sweden; [Ahlbom, Anders; Feychting, Maria] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden		Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	fang.fang@ki.se	James, Stefan K/J-4554-2014; Hallmarker, Ulf/ABC-5527-2020; Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217; Ingre, Caroline/0000-0001-5327-7204	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Society for Medical Research; Karolinska InstitutetKarolinska Institutet	This study was supported by the Swedish Research Council, the Swedish Society for Medical Research and the Karolinska Institutet.	Abel EL, 2007, PERCEPT MOTOR SKILL, V104, P1251, DOI 10.2466/PMS.104.4.1251-1254; Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; Bassini A, 2014, BIOCHEM BIOPH RES CO, V445, P708, DOI 10.1016/j.bbrc.2013.12.137; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Carlsson Sofia, 2007, Lakartidningen, V104, P670; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2002, J CLIN EPIDEMIOL, V55, P723, DOI 10.1016/S0895-4356(02)00409-2; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P205, DOI 10.1080/17482960902721634; del Aguila MA, 2003, NEUROLOGY, V60, P813, DOI 10.1212/01.WNL.0000049472.47709.3B; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029749; Farahmand BY, 2003, J INTERN MED, V253, P276, DOI 10.1046/j.1365-2796.2003.01122.x; FELMUS MT, 1976, NEUROLOGY, V26, P167, DOI 10.1212/WNL.26.2.167; GRANIERI E, 1988, NEUROLOGY, V38, P1604, DOI 10.1212/WNL.38.10.1604; GREGOIRE N, 1991, REV NEUROL-FRANCE, V147, P706; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Huisman MHB, 2013, J NEUROL NEUROSUR PS, V84, P976, DOI 10.1136/jnnp-2012-304724; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; ROELOFSIVERSON RA, 1984, NEUROLOGY, V34, P393, DOI 10.1212/WNL.34.3.393; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9	31	20	21	2	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0393-2990	1573-7284		EUR J EPIDEMIOL	Eur. J. Epidemiol.	MAR	2016	31	3					247	253		10.1007/s10654-015-0077-7			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	DI6WX	WOS:000373642000004	26220522				2022-02-06	
J	Haran, HP; Bressan, S; Oakley, E; Davis, GA; Anderson, V; Babl, FE				Haran, Harini P.; Bressan, Silvia; Oakley, Ed; Davis, Gavin A.; Anderson, Vicki; Babl, Franz E.			On-field management and return-to-play in sports-related concussion in children: Are children managed appropriately?	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Traumatic brain injury; Head injury; Sport; Child; Return to play	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; RECOVERY; FOOTBALL; STATEMENT	Objectives: On-field management and return-to-play guidelines aim to ensure the identification and appropriate management of the concussed athlete. Compliance with current guidelines in many settings is unknown. We assessed whether key components of current concussion guidelines are being followed in child athletes. Design: Prospective observational study. Methods: Data were collected from children (5-18 years) presenting to a paediatric emergency department with sport-related concussion via researcher-administered surveys in the emergency department and during a follow up phone call. On hospital discharge all patients received a return to sports fact sheet based on the International Concussion in Sports Group. Results: Ninety-three had sustained a concussion (mean age 12.7 (+/- 0.27) years, 83% male). Sports played included Australian Football (47%), soccer (12%), rugby (9%) basketball (8%), other (25%). 82% participated in organised sports. Concussive signs or symptoms included loss of consciousness (41%), disorientation (36%), vomiting (23%), amnesia (30%), headache (60%). For concussive injury in organised sports (n = 76), overall 42% were not managed according to recommended guidelines: 19% were not immediately removed from play, 29% were allowed to return to play on the same day and 27% were not assessed by qualified personnel. 93% of parents and 96% of patients were unaware of concussionor return-to-play guidelines from their organisations. Overall, 72% were compliant with provided return-to-play guidelines. Conclusions: Many children with sports related-concussion are not formally assessed on-field and continue to play. On-field concussion management and return to play practices are often suboptimal. Awareness and education of coaches, teachers, parents and children need to be improved. (C) 2015 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Haran, Harini P.; Bressan, Silvia; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp Melbourne, Emergency Dept, Melbourne, Vic, Australia; [Haran, Harini P.; Bressan, Silvia; Oakley, Ed; Davis, Gavin A.; Anderson, Vicki; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Haran, Harini P.] Monash Univ, Clayton, Vic, Australia; [Bressan, Silvia] Univ Padua, I-35100 Padua, Italy; [Oakley, Ed; Davis, Gavin A.; Anderson, Vicki; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia		Babl, FE (corresponding author), Royal Childrens Hosp Melbourne, Emergency Dept, Melbourne, Vic, Australia.; Babl, FE (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Babl, FE (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia.	Franz.babl@rch.org.au			Victorian Government Infrastructure Support programme; Royal Children's Hospital Foundation, Melbourne, Australia [2014-400]	The authors declare that there are no competing interests and no grants associated with the research contained within this manuscript. We acknowledge the support of the families involved in the study, the assistance of medical and nursing staff and Ms. Amanda Williams, emergency research coordinator, Murdoch Children's Research Institute, Melbourne, Australia. This study was supported by the Victorian Government Infrastructure Support programme and the Royal Children's Hospital Foundation (2014-400), Melbourne, Australia.	AFL Research Board AFL Medical Officer's Association, GUID MAN CONC AUSTR; Australian Bureau of Statistics, 2009, 49010 AUSTR BUR STAT; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; International Rugby Board, IRB CONC GUID; Kelly JP, 1997, NEUROLOGY, V48, P581; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Royal Children's Hospital Melbourne Australia, HEAD INJ RET SPORT; Royal Children's Hospital Melbourne Australia, HEAD INJ GEN ADV; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; White PE, 2013, BR J SPORTS MED; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	24	20	20	1	18	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2016	19	3					194	199		10.1016/j.jsams.2015.02.009			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DF6DH	WOS:000371445600002	25772997	Bronze			2022-02-06	
J	Palmer, CP; Metheny, HE; Elkind, JA; Cohen, AS				Palmer, Christopher P.; Metheny, Hannah E.; Elkind, Jaclynn A.; Cohen, Akiva S.			Diminished amygdala activation and behavioral threat response following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; mTBI; Amygdala; Cued fear; Threat response; Voltage-sensitive dye; Lateral fluid percussion; LFPI	IN-VITRO; ANIMAL-MODELS; FEAR; HIPPOCAMPUS; EMOTION; NETWORK; SLICES; STATES; MOUSE	Each year, approximately 3.8 million people suffer mild to moderate traumatic brain injuries (mTBI) that result in an array of neuropsychological symptoms and disorders. Despite these alarming statistics, the neurological bases of these persistent, debilitating neuropsychological symptoms are currently poorly understood. In this study we examined the effects of mTBI on the amygdala, a brain structure known to be critically involved in the processing of emotional stimuli. Seven days after lateral fluid percussion injury (LFPI), mice underwent a series of physiological and behavioral experiments to assess amygdala function. Brain-injured mice exhibited a decreased threat response in a cued fear conditioning paradigm, congruent with a decrease in amygdala excitability determined with basolateral amygdala (BLA) field excitatory post-synaptic potentials together with voltage-sensitive dye imaging (VSD). Furthermore, beyond exposing a general decrease in the excitability of the primary input of the amygdala, the lateral amygdala (LA), VSD also revealed a decrease in the relative strength or activation of inter nuclear amygdala circuit projections after LFPI. Thus, not only does activation of the LA require increased stimulation, but the proportion of this activation that is propagated to the primary output of the amygdala, the central amygdala, is also diminished following LFPI. Intracellular recordings revealed no changes in the intrinsic properties of BLA pyramidal neurons after LFPI. This data suggests that mild to moderate TBI has prominent effects on amygdala function and provides a potential neurological substrate for many of the neuropsychological symptoms suffered by TBI patients. (C) 2016 Elsevier Inc. All rights reserved.	[Palmer, Christopher P.] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, 3451 Walnut St, Philadelphia, PA 19104 USA; [Metheny, Hannah E.; Elkind, Jaclynn A.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Dept Anesthesiol, Crit Care Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, 3451 Walnut St, Philadelphia, PA 19104 USA		Cohen, AS (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Rm 816H,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 HD059288, RO1 NS069629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER	This work was supported in part by NIH grants R37 HD059288 and RO1 NS069629. The authors would like to thank Drs. Gordon Barr and Colin Smith for critiquing and earlier version of this manuscript.	Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Avrabos C, 2013, J NEUROSCI, V33, P16262, DOI 10.1523/JNEUROSCI.2397-13.2013; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bourgeois EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108686; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; LEUNG LS, 1995, BRAIN RES, V697, P262; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McAllister T.W, 1992, NAT NEUROSCI; Newton JR, 2004, NAT NEUROSCI, V7, P968, DOI 10.1038/nn1306; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tominaga T, 2000, J NEUROSCI METH, V102, P11, DOI 10.1016/S0165-0270(00)00270-3; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	39	20	20	1	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2016	277						215	226		10.1016/j.expneurol.2016.01.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF2ST	WOS:000371194800022	26791254	Green Accepted			2022-02-06	
J	Ploetz, DM; Mazur-Mosiewicz, A; Kirkwood, MW; Sherman, EMS; Brooks, BL				Ploetz, Danielle M.; Mazur-Mosiewicz, Anya; Kirkwood, Michael W.; Sherman, Elisabeth M. S.; Brooks, Brian L.			Performance on the Test of Memory Malingering in children with neurological conditions	CHILD NEUROPSYCHOLOGY			English	Article						Performance validity; Symptom Validity; Effort Testing; Children; Adolescents; Malingering	SYMPTOM VALIDITY TEST; PEDIATRIC SAMPLE; TOMM; ADOLESCENTS	Despite increasing interest in the use of performance validity tests with youth, relatively little is known about how children and adolescents with neurological diagnoses perform on these measures. The purpose of this study was to examine performance on the Test of Memory Malingering (TOMM) in a general pediatric neurologic sample. Data were obtained from 266 consecutive patients (mean age=13.0, SD=3.7, range=5-18) referred for a neuropsychological assessment in a tertiary care pediatric hospital. As part of a broader neuropsychological battery, patients were administered the TOMM. In this sample, 94% of children passed the TOMM. Pass rate was 87% for 5-7year-olds but was 90% for all other ages. Children with a history of stroke had the lowest pass rate (86%), with other diagnostic groups scoring 90%, including epilepsy, traumatic brain injury, and hydrocephalus. Lower TOMM performance was related to slower processing speed and weaker memory performance. The results support using the TOMM with children and adolescents who have neurological diagnoses. Caution may still be warranted when interpreting scores in those who are younger and/or who have more significant cognitive difficulty.	[Ploetz, Danielle M.; Mazur-Mosiewicz, Anya; Sherman, Elisabeth M. S.; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Dept Neurosci, Brain Injury Program, Calgary, AB T3B 6A8, Canada; [Ploetz, Danielle M.; Mazur-Mosiewicz, Anya; Sherman, Elisabeth M. S.; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Rehabil Program, Calgary, AB T3B 6A8, Canada; [Mazur-Mosiewicz, Anya] Chicago Sch Profess Psychol, Clin Psychol Doctoral Program, Chicago, IL USA; [Kirkwood, Michael W.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Sherman, Elisabeth M. S.] Copeman Healthcare Ctr, Calgary, AB, Canada; [Sherman, Elisabeth M. S.; Brooks, Brian L.] Univ Calgary, Dept Paediat, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Sherman, Elisabeth M. S.; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Res Inst, Behav & Dev Brain Program, Calgary, AB T3B 6A8, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Dept Neurosci, Brain Injury Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca					Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2011, ARCH CLIN NEUROPSYCH, V26, P306, DOI 10.1093/arclin/acr030; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Cox, 1997, MANUAL COMPUTERIZED; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 1994, CALIFORNIA VERBAL LE; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2003, MANUAL WORD MEMORY T; Green P., 2004, MANUAL GREENS MED SY; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Gunn D, 2010, CHILD NEUROPSYCHOL, V16, P105, DOI 10.1080/09297040903352564; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; IVERSON GL, 1998, 21 ITEM TEST RES MAN; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Loughan AR, 2014, APPL NEUROPSYCH-CHIL, V3, P26, DOI 10.1080/21622965.2012.670584; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Martin R. C., 1995, ARCH CLIN NEUROPSYCH, V10, P364, DOI [10.1093/arclin/10.4.364, DOI 10.1093/ARCLIN/10.4.364]; Perna RB, 2013, CHILD NEUROPSYCHOL, V19, P438, DOI 10.1080/09297049.2012.731500; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rienstra A, 2010, ARCH CLIN NEUROPSYCH, V25, P371, DOI 10.1093/arclin/acq035; Schmand B., 2004, AMSTERDAM SHORT TERM; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 2004, WECHSLER PRESCHOOL P, V3rd	41	20	20	0	38	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	FEB 17	2016	22	2					133	142		10.1080/09297049.2014.986446			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CW2GV	WOS:000364810400001	25495184				2022-02-06	
J	Chung, MG; O'Brien, NF				Chung, Melissa G.; O'Brien, Nicole F.			Prevalence of Early Posttraumatic Seizures in Children With Moderate to Severe Traumatic Brain Injury Despite Levetiracetam Prophylaxis	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						antiepileptics; children; head injury; levetiracetam seizures; traumatic brain injury	ABUSIVE HEAD TRAUMA; CLINICAL PREDICTORS; UNITED-STATES; PHENYTOIN; TRIAL; PREVENTION	Objectives: To evaluate the prevalence of early seizures after levetiracetam prophylaxis in children with moderate to severe traumatic brain injury. Design: Prospective observational study. Setting: Level 1 pediatric trauma center. Patients: We enrolled 34 patients between the ages of 0-18 years with moderate to severe traumatic brain injury admitted to the PICU at a level 1 trauma center who received levetiracetam for early posttraumatic seizure prophylaxis. Measurements and Main Results: Primary outcome was the prevalence of early posttraumatic seizures that were defined as clinical seizures within 7 days of injury. In 6 of 34 patients (17%), clinical seizures developed despite levetiracetam prophylaxis. An additional two patients had nonconvulsive seizures. This prevalence is similar to that reported in the literature in this patient population who do not receive seizure prophylaxis (20-53%) and is higher than that in patients who receive phenytoin prophylaxis (2-15%). Patients with early posttraumatic seizures were younger (median age, 4 mo) (p < 0.001) and more likely to have suffered from abusive head trauma (p < 0.0004). Conclusions: Early clinical posttraumatic seizures occurred frequently in children with moderate to severe traumatic brain injury despite seizure prophylaxis with levetiracetam. Younger children and those with abusive head trauma were at increased risk of seizures. Further studies are needed to evaluate the efficacy of levetiracetam before it is routinely used for seizure prophylaxis in these children, particularly in young children and those who have suffered from abusive head trauma.	[Chung, Melissa G.; O'Brien, Nicole F.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Div Crit Care Med, Columbus, OH 43210 USA; [Chung, Melissa G.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Neurol Sect, Columbus, OH 43210 USA		Chung, MG (corresponding author), Neurol Sect, 700 Childrens Dr, Columbus, OH 43205 USA.						Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Caballero G Christina, 2013, Hosp Pharm, V48, P757, DOI 10.1310/hpj4809-757; [Centers for Disease Control and Prevention National Center for Injury Prevention and Control], 2010, WEB BAS INJ STAT QUE; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; Greiner MV, 2012, CHILD NERV SYST, V28, P889, DOI 10.1007/s00381-012-1714-z; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Knoblich O E, 1980, Neurosurg Rev, V3, P243, DOI 10.1007/BF01650029; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Pearl PL, 2013, EPILEPSIA, V54, pe135, DOI 10.1111/epi.12326; POSNER JB, 1969, ARCH NEUROL-CHICAGO, V20, P388, DOI 10.1001/archneur.1969.00480100064010; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	32	20	21	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2016	17	2					150	156		10.1097/PCC.0000000000000588			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	DD1HW	WOS:000369672900007	26669640				2022-02-06	
J	Morecraft, RJ; Ge, J; Stilwell-Morecraft, KS; McNeal, DW; Hynes, SM; Pizzimenti, MA; Rotella, DL; Darling, WG				Morecraft, R. J.; Ge, J.; Stilwell-Morecraft, K. S.; McNeal, D. W.; Hynes, S. M.; Pizzimenti, M. A.; Rotella, D. L.; Darling, W. G.			Frontal and frontoparietal injury differentially affect the ipsilateral corticospinal projection from the nonlesioned hemisphere in monkey (Macaca mulatta)	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						pyramidal tract; frontal lobe; parietal lobe; corticofugal; neurosurgical resection; plasticity; spinal cord; motor recovery; hand movements	PRIMARY MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; CERVICAL-SPINAL-CORD; SELECTIVE MUSCLE ACTIVATION; TRAUMATIC BRAIN-INJURY; RHESUS-MONKEY; SUPPLEMENTARY MOTOR; STROKE PATIENTS; NONHUMAN-PRIMATES; MACAQUE MONKEY	Upper extremity hemiplegia is a common consequence of unilateral cortical stroke. Understanding the role of the unaffected cerebral hemisphere in the motor recovery process has been encouraged, in part, by the presence of ipsilateral corticospinal projections (iCSP). We examined the neuroplastic response of the iCSP from the contralesional primary motor cortex (cM1) hand/arm area to spinal levels C5-T1 after spontaneous long-term recovery from isolated frontal lobe injury and isolated frontoparietal injury. High-resolution tract tracing, stereological, and behavioral methodologies were applied. Recovery from frontal motor injury resulted in enhanced numbers of terminal labeled boutons in the iCSP from cM1 compared with controls. Increases occurred in lamina VIII and the adjacent ventral sectors of lamina VII, which are involved in axial/proximal limb sensorimotor processing. Larger frontal lobe lesions were associated with greater numbers of terminal boutons than smaller frontal lobe lesions. In contrast, frontoparietal injury blocked this response; total bouton number was similar to controls, demonstrating that disruption of somatosensory input to one hemisphere has a suppressive effect on the iCSP from the nonlesioned hemisphere. However, compared with controls, elevated bouton numbers occurred in lamina VIII, at the expense of lamina VII bouton labeling. Lamina IX boutons were also elevated in two frontoparietal lesion cases with extensive cortical injury. Because laminae VIII and IX collectively harbor axial, proximal, and distal motoneurons, therapeutic intervention targeting the ipsilateral corticospinal linkage from cM1 may promote proximal, and possibly distal, upper-limb motor recovery following frontal and frontoparietal injury. J. Comp. Neurol. 524:380-407, 2016. (c) 2015 Wiley Periodicals, Inc.	[Morecraft, R. J.; Ge, J.; Stilwell-Morecraft, K. S.; McNeal, D. W.] Univ S Dakota, Sanford Sch Med, Lab Neurol Sci, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Hynes, S. M.; Pizzimenti, M. A.; Rotella, D. L.; Darling, W. G.] Univ Iowa, Motor Control Labs, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA; [Pizzimenti, M. A.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA		Morecraft, RJ (corresponding author), Univ S Dakota, Sanford Sch Med, Lab Neurol Sci, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	rmorecra@usd.edu		Pizzimenti, Marc A/0000-0002-1309-6633	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 046367]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS046367, R01NS046367] Funding Source: NIH RePORTER	Grant sponsor: National Institutes of Health; Grant number: NS 046367.	AIZAWA H, 1990, EXP BRAIN RES, V82, P219; Alagona G, 2001, STROKE, V32, P1304, DOI 10.1161/01.STR.32.6.1304; ARMAND J, 1982, PROG BRAIN RES, V57, P329, DOI 10.1016/S0079-6123(08)64136-9; Armand J, 1997, J NEUROSCI, V17, P251, DOI 10.1523/JNEUROSCI.17-01-00251.1997; Baker SN, 2015, PROG BRAIN RES, V218, P389, DOI 10.1016/bs.pbr.2014.12.010; Belhaj-Saif A, 2000, J NEUROPHYSIOL, V83, P3147, DOI 10.1152/jn.2000.83.5.3147; Bonin G.Von, 1947, NEOCORTEX MACACA MUL; Bradnam LV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00184; Bradnam LV, 2010, J NEUROPHYSIOL, V104, P2594, DOI 10.1152/jn.00365.2010; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Carey JR, 2006, RESTOR NEUROL NEUROS, V24, P191; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; CHENEY PD, 1991, PROG BRAIN RES, V87, P213; Chiken S, 2001, NEUROSCI LETT, V307, P143, DOI 10.1016/S0304-3940(01)01918-8; Darling WG, 2013, EXP BRAIN RES, V228, P9, DOI 10.1007/s00221-013-3533-1; Darling WG, 2011, J INTEGR NEUROSCI, V10, P353, DOI 10.1142/S0219635211002737; Darling WG, 2010, EXP BRAIN RES, V202, P529, DOI 10.1007/s00221-010-2157-y; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; Darling WG, 2006, J NEUROSCI METH, V154, P38, DOI 10.1016/j.jneumeth.2005.11.013; Davare M, 2007, CEREB CORTEX, V17, P353, DOI 10.1093/cercor/bhj152; DENNYBROWN D, 1950, J NERV MENT DIS, V112, P1; Dhamoon MS, 2012, STROKE, V43, P2180, DOI 10.1161/STROKEAHA.112.658922; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; GODSCHALK M, 1995, NEUROSCI RES, V23, P269, DOI 10.1016/0168-0102(95)00950-7; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Guthrie L, 1918, Proc R Soc Med, V11, P21; Hendricks, 2007, STEREOLOGY BIOL RES; Holstege G, 1988, Rev Oculomot Res, V2, P431; Hoyer EH, 2011, RESTOR NEUROL NEUROS, V29, P395, DOI 10.3233/RNN-2011-0611; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Jang SH, 2004, NEUROREPORT, V15, P395, DOI 10.1097/00001756-200403010-00002; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; JENNY AB, 1983, J NEUROSCI, V3, P567; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Kennard MA, 1940, J NEUROPHYSIOL, V3, P248; Kermadi I, 1998, SOMATOSENS MOT RES, V15, P287, DOI 10.1080/08990229870709; Kuypers H., 1981, HDB PHYSL, VVol II, P567; KUYPERS HGJ, 1970, BRAIN RES, V24, P29, DOI 10.1016/0006-8993(70)90272-6; KUYPERS HGJM, 1982, PROG BRAIN RES, V57, P381, DOI 10.1016/S0079-6123(08)64138-2; Lassek AM, 1954, PYRAMIDAL TRACT ITS, P88; Lemon, 1993, CORTICOSPINAL FUNCTI; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; LEMON RN, 1993, EXP PHYSIOL, V78, P263, DOI 10.1113/expphysiol.1993.sp003686; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lotze M, 2012, NEUROREHAB NEURAL RE, V26, P594, DOI 10.1177/1545968311427706; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; MATELLI M, 1985, BEHAV BRAIN RES, V18, P125, DOI 10.1016/0166-4328(85)90068-3; MATSUSHITA M, 1979, J COMP NEUROL, V184, P63, DOI 10.1002/cne.901840105; McCambridge AB, 2011, J NEUROPHYSIOL, V105, P2937, DOI 10.1152/jn.00171.2011; McNeal DW, 2010, J COMP NEUROL, V518, P586, DOI 10.1002/cne.22218; Misawa S, 2008, EUR J NEUROL, V15, P706, DOI 10.1111/j.1468-1331.2008.02168.x; MOLENAAR I, 1978, BRAIN RES, V158, P203, DOI 10.1016/0006-8993(78)90016-1; MOLENAAR I, 1974, BRAIN RES, V78, P239, DOI 10.1016/0006-8993(74)90549-6; MOLENAAR I, 1978, BRAIN RES, V152, P429, DOI 10.1016/0006-8993(78)91102-2; Montgomery LR, 2013, EXP BRAIN RES, V230, P153, DOI 10.1007/s00221-013-3639-5; Morecraft RJ, 2015, J COMP NEUROL, V523, P669, DOI 10.1002/cne.23703; Morecraft RJ, 2012, BRAIN RES BULL, V87, P457, DOI 10.1016/j.brainresbull.2011.12.005; Morecraft RJ, 2004, J COMP NEUROL, V469, P37, DOI 10.1002/cne.10980; MORECRAFT RJ, 1992, J COMP NEUROL, V322, P471, DOI 10.1002/cne.903220403; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Morecraft RJ, 2014, DIFFUSION MRI QUANTI, P359, DOI [10.1016/B978-0-12-396460-1.00017-2, DOI 10.1016/B978-0-12-396460-1.00017-2]; Morecraft RJ, 2007, J COMP NEUROL, V504, P149, DOI 10.1002/cne.21438; Morecraft RJ, 2007, J COMP NEUROL, V500, P134, DOI 10.1002/cne.21165; Morecraft RJ, 2013, J COMP NEUROL, V521, P4205, DOI 10.1002/cne.23410; Morishita T, 2011, BRAIN RES, V1371, P65, DOI 10.1016/j.brainres.2010.11.049; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Netz J, 1997, BRAIN, V120, P1579, DOI 10.1093/brain/120.9.1579; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; PANDYA DN, 1982, J COMP NEUROL, V204, P196, DOI 10.1002/cne.902040208; Pizzimenti MA, 2007, J NEUROPHYSIOL, V98, P1015, DOI 10.1152/jn.00354.2007; Plow EB, 2015, NEUROSCIENTIST, V21, P225, DOI 10.1177/1073858414537381; PREUSS TM, 1991, J COMP NEUROL, V310, P429, DOI 10.1002/cne.903100402; RASMUSSEN D, 1992, STROKE, V23, P506, DOI 10.1161/01.STR.23.4.506; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reed AF, 1940, J COMP NEUROL, V72, P187, DOI 10.1002/cne.900720107; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Schaechter JD, 2002, NEUROREHAB NEURAL RE, V16, P326, DOI 10.1177/154596830201600403; Schieber Marc H, 2007, Handb Clin Neurol, V82, P15, DOI 10.1016/S0072-9752(07)80005-4; Schwerin S, 2008, EXP BRAIN RES, V185, P509, DOI 10.1007/s00221-007-1169-8; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Sonde L, 2000, CLIN REHABIL, V14, P14, DOI 10.1191/026921500673534278; Soteropoulos DS, 2011, J NEUROSCI, V31, P11208, DOI 10.1523/JNEUROSCI.0257-11.2011; SPRAGUE JM, 1948, AM J ANAT, V82, P1, DOI 10.1002/aja.1000820102; STERLING PETER, 1967, BRAIN RES, V4, P16, DOI 10.1016/0006-8993(67)90145-X; STERLING PETER, 1968, BRAIN RES, V7, P419, DOI 10.1016/0006-8993(68)90008-5; Stinear CM, 2014, CURR OPIN NEUROL, V27, P624, DOI 10.1097/WCO.0000000000000153; Takei T, 2013, J NEUROSCI, V33, P8850, DOI 10.1523/JNEUROSCI.4032-12.2013; Takei T, 2010, J NEUROSCI, V30, P17041, DOI 10.1523/JNEUROSCI.4297-10.2010; TANJI J, 1988, J NEUROPHYSIOL, V60, P325, DOI 10.1152/jn.1988.60.1.325; Thorsen AM, 2005, STROKE, V36, P297, DOI 10.1161/01.STR.0000152288.42701.a6; Turton A, 1996, ELECTROMYOGR MOTOR C, V101, P316, DOI 10.1016/0924-980X(96)95560-5; Uehara K, 2011, NEUROSCI LETT, V488, P22, DOI 10.1016/j.neulet.2010.10.073; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Werhahn KJ, 2003, ANN NEUROL, V54, P464, DOI 10.1002/ana.10686; West MJ., 2012, BASIC STEREOLOGY BIO, P843; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238; Yoo K M, 1998, J Stroke Cerebrovasc Dis, V7, P344, DOI 10.1016/S1052-3057(98)80053-0; Young Brittany M, 2014, Front Neuroeng, V7, P26, DOI 10.3389/fneng.2014.00026; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115	105	20	21	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	FEB 1	2016	524	2					380	407		10.1002/cne.23861			28	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	CY7QV	WOS:000366604700010	26224429	Green Accepted			2022-02-06	
J	Ahuja, P; Cantrelle, FX; Huvent, I; Hanoulle, X; Lopez, J; Smet, C; Wieruszeski, JM; Landrieu, I; Lippens, G				Ahuja, Puneet; Cantrelle, Francois-Xavier; Huvent, Isabelle; Hanoulle, Xavier; Lopez, Juan; Smet, Caroline; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, G.			Proline Conformation in a Functional Tau Fragment	JOURNAL OF MOLECULAR BIOLOGY			English	Article						Tau protein; proline conformation; cis/trans isomerisation; exchange spectroscopy; nuclear magnetic resonance spectroscopy	NUCLEAR-MAGNETIC-RESONANCE; CIS-TRANS ISOMERIZATION; I PROCOLLAGEN INCELLULO; TRIPLE-HELIX; PROLYL ISOMERIZATION; PROTEIN; PHOSPHORYLATION; PEPTIDE; ASSIGNMENT; SPECTROSCOPY	The conformational state of distinct prolines can determine the folding of a protein but equally other biological processes when coupled to a conformation-sensitive secondary reaction. For the neuronal tau protein, the importance of proline conformation is underscored by its interaction with different prolyl cis/trans isomerases. The proline conformation would gain even further importance after phosphorylation of the preceding residue by various proline-directed kinases. A number of molecular diseases including Alzheimer's disease and traumatic brain injury were thereby recently qualified as "cistauosis", as they would imply a cis conformation for the pThr231-Pro232 prolyl bond. We here investigate by NMR spectroscopy the conformation of all prolines in a functional Tau fragment, Tau[208-324]. Although we can detect and identify some minor conformers in the cis form, we show that all prolines are for over 90% in the trans conformation. Phosphorylation by CDK2/CycA3, which notably leads to complete modification of the Thr231 residue, does not change this conclusion. Our data hence disagree with the notion that specific prolyl bonds in tau would adopt preferentially the cis conformation. (C) 2015 Elsevier Ltd. All rights reserved.	[Ahuja, Puneet; Cantrelle, Francois-Xavier; Huvent, Isabelle; Hanoulle, Xavier; Lopez, Juan; Smet, Caroline; Wieruszeski, Jean-Michel; Landrieu, Isabelle; Lippens, G.] Univ Lille, CNRS, UMR8576, F-59658 Villeneuve Dascq, France		Lippens, G (corresponding author), Univ Lille, CNRS, UMR8576, F-59658 Villeneuve Dascq, France.	Guy.Lippens@univ-lille1.fr	Smet-Nocca, Caroline/U-3427-2019; Hanoulle, Xavier/AAK-7236-2021; Landrieu, Isabelle/AAF-8495-2019; Smet-Nocca, Caroline/G-2868-2012	Smet-Nocca, Caroline/0000-0002-9793-0882; Hanoulle, Xavier/0000-0002-3755-2680; Landrieu, Isabelle/0000-0002-4883-2637; Smet-Nocca, Caroline/0000-0002-9793-0882; Lippens, Guy/0000-0002-8236-0901; Huvent, Isabelle/0000-0002-7241-0290; cantrelle, francois-xavier/0000-0002-3413-5443; lopez, juan/0000-0002-5390-6610	Complix (Ghent, Belgium); Region Nord-Pas de CalaisRegion Hauts-de-FranceEuropean Commission; CNRSCentre National de la Recherche Scientifique (CNRS)European Commission; Pasteur Institute of Lille; European Community (FEDER)European Commission; French Research MinistryMinistry of Research, France; University of Sciences and Technologies of Lille I; TGE RMN THC (France) [FR-3050]; Laboratory of Excellence, Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease	P.A. was supported by a grant from Complix (Ghent, Belgium). The NMR facilities were funded by the Region Nord-Pas de Calais, CNRS, Pasteur Institute of Lille, European Community (FEDER), French Research Ministry and the University of Sciences and Technologies of Lille I. We acknowledge support from the TGE RMN THC (FR-3050, France). This study was supported by the Laboratory of Excellence, Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's disease.	Amniai L, 2011, BIOCHEM BIOPH RES CO, V412, P743, DOI 10.1016/j.bbrc.2011.08.046; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Bibow S, 2011, J AM CHEM SOC, V133, P15842, DOI 10.1021/ja205836j; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; DORMAN DE, 1973, J ORG CHEM, V38, P2379, DOI 10.1021/jo00953a021; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fauquant C, 2011, J BIOL CHEM, V286, P33358, DOI 10.1074/jbc.M111.223545; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; HANGER DP, 2011, INT J ALZHEIMERS DIS, V2011, P1; HOWARTH OW, 1978, PROG NUCL MAG RES SP, V12, P1, DOI 10.1016/0079-6565(78)80001-6; Huvent I, 2014, BIOCHEM BIOPH RES CO, V445, P299, DOI 10.1016/j.bbrc.2014.01.161; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Kanelis V, 2000, J BIOMOL NMR, V16, P253, DOI 10.1023/A:1008355012528; KERN D, 1995, BIOCHEMISTRY-US, V34, P13594, DOI 10.1021/bi00041a039; Kimura T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00065; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Lee KK, 2008, J PHYS CHEM B, V112, P16782, DOI 10.1021/jp803285x; Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419; LIN LN, 1983, BIOCHEMISTRY-US, V22, P559, DOI 10.1021/bi00272a006; Lu PJ, 1999, NATURE, V399, P784; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Peterson DW, 2010, P NATL ACAD SCI USA, V107, P2884, DOI 10.1073/pnas.0912718107; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Sibille N, 2012, PROTEINS, V80, P454, DOI 10.1002/prot.23210; SIEMION IZ, 1975, ANGEW CHEM INT EDIT, V14, P702, DOI 10.1002/anie.197507021; Smet C, 2005, FEBS LETT, V579, P4159, DOI 10.1016/j.febslet.2005.06.048; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Tomlinson JH, 2012, J BIOMOL NMR, V52, P57, DOI 10.1007/s10858-011-9583-4; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; WANG AC, 1995, J BIOMOL NMR, V5, P376; Weiwad M, 2004, J MOL BIOL, V339, P635, DOI 10.1016/j.jmb.2004.02.021; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Wieruszeski JM, 2006, J MAGN RESON, V181, P199, DOI 10.1016/j.jmr.2006.04.007; WISHART DS, 1995, J BIOMOL NMR, V5, P332, DOI 10.1007/BF00211764; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(05)00083-3	58	20	20	0	19	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836	1089-8638		J MOL BIOL	J. Mol. Biol.	JAN 16	2016	428	1					79	91		10.1016/j.jmb.2015.11.023			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE5NC	WOS:000370676700008	26655856				2022-02-06	
J	Chapple, LAS; Chapman, MJ; Lange, K; Deane, AM; Heyland, DK				Chapple, Lee-anne S.; Chapman, Marianne J.; Lange, Kylie; Deane, Adam M.; Heyland, Daren K.			Nutrition support practices in critically ill head-injured patients: a global perspective	CRITICAL CARE			English	Article						Nutrition support; Nutritional status; Head injury; Head trauma; Traumatic brain injury; Critical illness	TRAUMATIC BRAIN-INJURY; ENTERAL NUTRITION; CRITICAL ILLNESS; MODERATE; THERAPY; REQUIREMENTS; GUIDELINES; MANAGEMENT; PROVISION; DELIVERY	Background: Critical illness following head injury is associated with a hypermetabolic state but there are insufficient epidemiological data describing acute nutrition delivery to this group of patients. Furthermore, there is little information describing relationships between nutrition and clinical outcomes in this population. Methods: We undertook an analysis of observational data, collected prospectively as part of International Nutrition Surveys 2007-2013, and extracted data obtained from critically ill patients with head trauma. Our objective was to describe global nutrition support practices in the first 12 days of hospital admission after head trauma, and to explore relationships between energy and protein intake and clinical outcomes. Data are presented as mean (SD), median (IQR), or percentages. Results: Data for 1045 patients from 341 ICUs were analyzed. The age of patients was 44.5 (19.7) years, 78 % were male, and median ICU length of stay was 13.1 (IQR 7.9-21.6) days. Most patients (94 %) were enterally fed but received only 58 % of estimated energy and 53 % of estimated protein requirements. Patients from an ICU with a feeding protocol had greater energy and protein intakes (p < 0.001, 0.002 respectively) and were more likely to survive (OR 0.65; 95 % CI 0.42-0.99; p = 0.043) than those without. Energy or protein intakes were not associated with mortality. However, a greater energy and protein deficit was associated with longer times until discharge alive from both ICU and hospital (all p < 0.001). Conclusion: Nutritional deficits are commonplace in critically ill head-injured patients and these deficits are associated with a delay to discharge alive.	[Chapple, Lee-anne S.; Chapman, Marianne J.; Deane, Adam M.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA 5000, Australia; [Chapman, Marianne J.; Deane, Adam M.] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia; [Lange, Kylie] Univ Adelaide, Discipline Med, Adelaide, SA 5000, Australia; [Heyland, Daren K.] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON K7L 2V7, Canada; [Heyland, Daren K.] Queens Univ, Kingston, ON, Canada		Heyland, DK (corresponding author), Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON K7L 2V7, Canada.	dkh2@queensu.ca	Chapple, Lee-anne/AAN-7751-2021; Deane, Adam/AAF-7370-2020	Deane, Adam/0000-0002-7620-5577; Chapple, Lee-anne S/0000-0002-9818-2484	NestleNestle SA; Abbott Nutritional Inc; GlaxoSmithKlineGlaxoSmithKline; Baxter; GSKGlaxoSmithKline; Theravance	DKH has received honorarium and research grant money from Nestle, Abbott Nutritional Inc, GlaxoSmithKline, and Baxter. AMD and MJC have received unrestricted grants from GSK and Theravance for investigator-led studies and have also received research support in kind from Fresenius Kabi. The authors declare that while the results of this analysis may support the use of particular strategies to improve nutrition support practices, they do not promote specific products or drugs.	Adam S, 1997, INTENS CARE MED, V23, P261, DOI 10.1007/s001340050326; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Alhashemi HH, 2010, NEUROSCIENCES, V15, P231; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Brooke MM, 1989, J NEUROL REHABIL, V3, P27; Cartwright Martina M, 2004, Crit Care Nurs Clin North Am, V16, P467, DOI 10.1016/S0899-5885(04)00070-X; Chapman MJ, 2011, GASTROENTEROL CLIN N, V40, P725, DOI 10.1016/j.gtc.2011.09.003; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Czapran A, 2015, BURNS, V41, P510, DOI 10.1016/j.burns.2014.09.013; De Beaux I, 2001, ANAESTH INTENS CARE, V29, P619, DOI 10.1177/0310057X0102900611; De Jonghe B, 2001, CRIT CARE MED, V29, P8, DOI 10.1097/00003246-200101000-00002; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Genton L, 2011, INT J VITAM NUTR RES, V81, P143, DOI 10.1024/0300-9831/a000058; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Heyland DK, 2011, CRIT CARE MED, V39, P2619, DOI 10.1097/CCM.0b013e318226641d; Heyland DK, 2010, CRIT CARE, V14, DOI 10.1186/cc8991; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Jacobs DG, 2004, J TRAUMA, V57, P660, DOI 10.1097/01.TA.0000135348.48525.A0; Kar P, 2016, JPEN-PARENTER ENTER, V40, P1050, DOI 10.1177/0148607115588333; Kim H, 2010, ASIAN NURS RES, V4, P102, DOI 10.1016/S1976-1317(10)60010-2; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Matters K, 2014, AUSTRALAS J NEUROSCI, V24, P42; Morgan Laurie M, 2004, Nutr Clin Pract, V19, P511, DOI 10.1177/0115426504019005511; Nicolo M, 2016, JPEN-PARENTER ENTER, V40, P45, DOI 10.1177/0148607115583675; Peake SL, 2014, AM J CLIN NUTR, V100, P616, DOI 10.3945/ajcn.114.086322; Reid C, 2006, J HUM NUTR DIET, V19, P13, DOI 10.1111/j.1365-277X.2006.00661.x; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; Sheean PM, 2012, J ACAD NUTR DIET, V112, P1073, DOI 10.1016/j.jand.2012.02.007; Soguel L, 2012, CRIT CARE MED, V40, P412, DOI 10.1097/CCM.0b013e31822f0ad7; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Tian F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0902-0; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wolkewitz M, 2009, INTENS CARE MED, V35, P826, DOI 10.1007/s00134-009-1423-6	40	20	25	1	20	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JAN 7	2016	20								6	10.1186/s13054-015-1177-1			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4XW	WOS:000367807100001	26738550	gold, Green Published			2022-02-06	
J	Azman, KF; Zakaria, R; Aziz, CBA; Othman, Z				Azman, Khairunnuur Fairuz; Zakaria, Rahimah; Aziz, Che Badariah Abdul; Othman, Zahiruddin			Tualang Honey Attenuates Noise Stress-Induced Memory Deficits in Aged Rats	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							NERVE GROWTH-FACTOR; RADICAL SCAVENGING ACTIVITY; TRAUMATIC BRAIN-INJURY; ANTIOXIDANT CAPACITY; COGNITIVE FUNCTION; OXIDATIVE STRESS; SPATIAL MEMORY; RECOGNITION MEMORY; MESSENGER-RNA; DNA-DAMAGE	Ageing and stress exposure may lead to memory impairment while oxidative stress is thought to be one of the underlying mechanisms involved. This study aimed to investigate the potential protective effects of Tualang honey supplementation on memory performance in aged rats exposed to noise stress. Tualang honey supplementation was given orally, 200 mg/kg body weight for 28 days. Rats in the stress group were subjected to loud noise, 100 dB(A), 4 hours daily for 14 days. All rats were subjected to novel object recognition test for evaluation of memory performance. It was observed that the rats subjected to noise stress exhibited significantly lower memory performance and higher oxidative stress as evident by elevated malondialdehyde and protein carbonyl levels and reduction of antioxidant enzymes activities compared to the nonstressed rats. Tualang honey supplementation was able to improve memory performance, decrease oxidative stress levels, increase brain-derived neurotrophic factor (BDNF) concentration, decrease acetylcholinesterase activity, and enhance neuronal proliferation in the medial prefrontal cortex (mPFC) and hippocampus. In conclusion, Tualang honey protects against memory decline due to stress exposure and/or ageing via enhancement of mPFC and hippocampal morphology possibly secondary to reduction in brain oxidative stress and/or upregulation of BDNF concentration and cholinergic system.	[Azman, Khairunnuur Fairuz; Zakaria, Rahimah; Aziz, Che Badariah Abdul] Univ Sains Malaysia, Sch Med Sci, Dept Physiol, Kota Baharu 16150, Kelantan, Malaysia; [Othman, Zahiruddin] Univ Sains Malaysia, Sch Med Sci, Dept Psychiat, Kota Baharu 16150, Kelantan, Malaysia		Zakaria, R (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Physiol, Kota Baharu 16150, Kelantan, Malaysia.	rahimah@usm.my	Othman, Zahiruddin/E-3914-2012; Azman, Khairunnuur F/A-2041-2014; Azman, Khairunnuur/AAY-6094-2020; Zakaria, Rahimah/C-8660-2016	Othman, Zahiruddin/0000-0002-9070-2078; Azman, Khairunnuur F/0000-0003-2735-0177; Azman, Khairunnuur/0000-0003-2735-0177; Zakaria, Rahimah/0000-0002-2459-3213; Abdul Aziz, Che Badariah/0000-0003-0102-1594	Universiti Sains MalaysiaUniversiti Sains Malaysia [304/PPSP/61313056]; School of Medical Sciences USM; Ministry of Education MalaysiaMinistry of Education, Malaysia	This project was supported by short-term grant of Universiti Sains Malaysia (304/PPSP/61313056). The financial supports from School of Medical Sciences USM and Ministry of Education Malaysia for RLKA fellowship and SLAB scholarship to Ms. Khairunnuur Fairuz Azman are gratefully acknowledged.	Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Al-Himyari FA, 2009, ALZHEIMERS DEMENT, V5, pP247, DOI DOI 10.1016/J.JALZ.2009.04.248; Al-Mamary M, 2002, NUTR RES, V22, P1041, DOI 10.1016/S0271-5317(02)00406-2; Al-Rahbi B., 2014, International Journal of Applied Research in Natural Products, V7, P28; Al-Rahbi B, 2014, ACTA HISTOCHEM, V116, P79, DOI 10.1016/j.acthis.2013.05.004; Al-Rahbi B, 2014, SCI WORLD J, DOI 10.1155/2014/310821; Al-Waili Noori S., 2003, Journal of Medicinal Food, V6, P135, DOI 10.1089/109662003322233549; Aljadi AM, 2004, FOOD CHEM, V85, P513, DOI 10.1016/S0308-8146(02)00596-4; Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; ARMSTRONG DM, 1993, NEUROBIOL AGING, V14, P457, DOI 10.1016/0197-4580(93)90104-J; Azman KF, 2015, NOISE HEALTH, V17, P83, DOI 10.4103/1463-1741.153388; Backman C, 1996, J NEUROSCI, V16, P5437; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Beretta G, 2007, PLANTA MED, V73, P1182, DOI 10.1055/s-2007-981598; Chen CZ, 2011, J OCCUP HEALTH, V53, P157, DOI 10.1539/joh.L10125; Cheng L, 2011, PHYSIOL BEHAV, V104, P981, DOI 10.1016/j.physbeh.2011.06.018; Chepulis LM, 2009, PHYSIOL BEHAV, V97, P359, DOI 10.1016/j.physbeh.2009.03.001; Cotman CW, 2002, NEUROBIOL AGING, V23, P809, DOI 10.1016/S0197-4580(02)00073-8; Dias CP, 2007, NEUROSCIENCE, V146, P1719, DOI 10.1016/j.neuroscience.2007.03.018; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Erejuwa OO, 2010, ANN ENDOCRINOL-PARIS, V71, P291, DOI 10.1016/j.ando.2010.03.003; Erejuwa OO, 2011, INT J MOL SCI, V12, P829, DOI 10.3390/ijms12010829; Fahnestock M, 2012, NEUROBIOL AGING, V33, P546, DOI 10.1016/j.neurobiolaging.2010.03.019; Ferreira ICFR, 2009, FOOD CHEM, V114, P1438, DOI 10.1016/j.foodchem.2008.11.028; FISCHER W, 1991, J NEUROSCI, V11, P1889; Fu Z, 2010, ENDOCRINOLOGY, V151, P3026, DOI 10.1210/en.2009-1294; Fukui K, 2001, ANN NY ACAD SCI, V928, P168; Gheldof N, 2003, J AGR FOOD CHEM, V51, P1500, DOI 10.1021/jf025897t; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; Granholm AC, 2000, EXPERT OPIN INV DRUG, V9, P685, DOI 10.1517/13543784.9.4.685; Gustilo MC, 1999, J COMP NEUROL, V405, P491, DOI 10.1002/(SICI)1096-9861(19990322)405:4<491::AID-CNE4>3.0.CO;2-N; Haider Saida, 2012, Sci Pharm, V80, P1001, DOI 10.3797/scipharm.1207-15; Hwang SL, 2009, J AGR FOOD CHEM, V57, P2576, DOI 10.1021/jf8033607; Ilhan A, 2004, CLIN CHIM ACTA, V340, P153, DOI 10.1016/j.cccn.2003.10.012; Jama JW, 1996, AM J EPIDEMIOL, V144, P275, DOI 10.1093/oxfordjournals.aje.a008922; Jhoo JH, 2004, BEHAV BRAIN RES, V155, P185, DOI 10.1016/j.bbr.2004.04.012; Kishore RK, 2011, NUTR RES, V31, P322, DOI 10.1016/j.nutres.2011.03.001; Lee JS, 2014, J ETHNOPHARMACOL, V153, P782, DOI 10.1016/j.jep.2014.03.048; Lenzi P, 2003, ENVIRON HEALTH PERSP, V111, P467, DOI 10.1289/ehp.5847; LEVIMONTALCINI R, 1987, BIOSCIENCE REP, V7, P681, DOI 10.1007/BF01116861; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Manikandan S, 2005, BIOL PHARM BULL, V28, P2327, DOI 10.1248/bpb.28.2327; Manikandan S, 2006, NEUROSCI LETT, V399, P17, DOI 10.1016/j.neulet.2006.01.037; Marghitas LA, 2009, FOOD CHEM, V112, P863, DOI 10.1016/j.foodchem.2008.06.055; MEANEY MJ, 1995, EXP GERONTOL, V30, P229, DOI 10.1016/0531-5565(94)00065-B; Mohamed M, 2010, AFR J TRADIT COMPLEM, V7, P59; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Nibuya M, 1999, NEUROSCI LETT, V267, P81, DOI 10.1016/S0304-3940(99)00335-3; Othman Z, 2011, MENOPAUSE, V18, P1219, DOI 10.1097/gme.0b013e31821e2044; Ozarowski M, 2013, FITOTERAPIA, V91, P261, DOI 10.1016/j.fitote.2013.09.012; Pachauri SD, 2013, BEHAV PHARMACOL, V24, P307, DOI 10.1097/FBP.0b013e3283637a51; Perez E, 2006, J MED FOOD, V9, P510, DOI 10.1089/jmf.2006.9.510; QUIRION R, 1995, J NEUROSCI, V15, P1455; Rainey-Smith S, 2008, NEUROSCI LETT, V438, P29, DOI 10.1016/j.neulet.2008.04.056; Ravindran R, 2005, J PHARMACOL SCI, V98, P354, DOI 10.1254/jphs.FP0050127; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7; Sapolsky RM, 2002, SCI AGING KNOWLEDGE, V2002, P21; Sharifabad M. H., 2008, IRAN J BASIC MED SCI, V11, P37; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Srikumar R, 2006, MOL CELL BIOCHEM, V283, P67, DOI 10.1007/s11010-006-2271-0; Wang PS, 1997, J FORMOS MED ASSOC, V96, P792; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wengreen HJ, 2007, J NUTR HEALTH AGING, V11, P230; WILSON MM, 1980, BRAIN RES, V197, P433, DOI 10.1016/0006-8993(80)91128-2; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Zaid SSM, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-82	71	20	20	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2016	2016								1549158	10.1155/2016/1549158			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DM1AT	WOS:000376078100001	27119005	Green Published, Green Submitted, gold, Green Accepted			2022-02-06	
J	Block, CK; West, SE; Goldin, Y				Block, Cady K.; West, Sarah E.; Goldin, Yelena			Misconceptions and Misattributions About Traumatic Brain Injury: An Integrated Conceptual Framework	PM&R			English	Article							MILD HEAD-INJURY; GOOD OLD DAYS; POSTCONCUSSION-SYNDROME; SYMPTOM REPORT; INFORMATIONAL CASCADES; COMMON MISCONCEPTIONS; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; CONCUSSION; KNOWLEDGE	The objective of the present narrative review was to provide a conceptual framework to address common misconceptions in the field of traumatic brain injury (TBI) and enhance clinical and research practices. This framework is based on review of the literature on TBI knowledge and beliefs. The comprehensive search of the literature included seminal and current texts as well as relevant articles on TBI knowledge and education, misconceptions, and misattributions. Reviewed materials ranged from 1970 to 2013 and were obtained from PubMed and PubMed Central online research databases. Research findings from the reviewed literature were integrated with existing social and cognitive psychological concepts to develop a framework that includes: (1) the identification antecedents of TBI-related misconceptions and misattribution; (2) understanding of how inaccurate beliefs form and persist as the result of pre-and postinjury cognitive operations such as informational cascades and attribution biases; and (3) a discussion of ways in which these beliefs can result in consequences in all domains of a survivor's life, including physical and mental health, stigma, and discrimination. This framework is intended to serve as a first stage of development of a model that will improve treatment endeavors and service delivery to individuals with TBI and their families.	[Block, Cady K.] Mem Hermann, TIRR, Houston, TX 77030 USA; [West, Sarah E.; Goldin, Yelena] JKF Johnson Rehabil Inst, Edison, NJ USA		Block, CK (corresponding author), Mem Hermann, TIRR, 1333 Moursund Ave, Houston, TX 77030 USA.	cady.block@memorialhermann.org	Block, Cady/I-3078-2014	Block, Cady/0000-0001-7168-6116			Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson LR, 1997, AM ECON REV, V87, P847; AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; Baron R.A., 2003, BEHAV ORG UNDERSTAND; Baxendale S, 2004, BMJ-BRIT MED J, V329, P1480, DOI 10.1136/bmj.329.7480.1480; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Browndyke JN, 1997, ANN M NAT AC NEUR LA; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; Deidan C, 2002, STUD NEUROPSYCHOL DE, P281; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Finch C., 2012, INJURY RES THEORIES, P619; Fraas MR, 2007, DISABIL REHABIL, V29, P1449, DOI 10.1080/09638280601102311; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Gouvier W Drew, 2002, Appl Neuropsychol, V9, P48, DOI 10.1207/S15324826AN0901_6; GOUVIER WD, 1991, REHABIL PSYCHOL, V36, P121, DOI 10.1037/0090-5550.36.2.121; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Heider F., 1958, PSYCHOL INTERPERSONA; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jackson H, 2001, NEUROREHABILITATION, V16, P27; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Kempe CB, 2013, CLIN NEUROPSYCHOL, V27, P762, DOI 10.1080/13854046.2013.795245; Kozak G S, 1989, J Emerg Nurs, V15, P18; Kuran T, 1999, STANFORD LAW REV, V51, P683, DOI 10.2307/1229439; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; Linden MA, 2010, BRAIN INJURY, V24, P642, DOI 10.3109/02699051003601689; Linden MA, 2005, BRAIN INJURY, V19, P1011, DOI 10.1080/02699050500110314; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; McClure J, 2011, J HEAD TRAUMA REHAB, V26, P392, DOI 10.1097/HTR.0b013e3181f8fd34; McClure J, 2009, BRAIN IMPAIR, V10, P180, DOI 10.1375/brim.10.2.180; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Miller P, 2004, DISABILISM TACKLE TA; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; MORROW KA, 1992, J COUNS DEV, V70, P571, DOI 10.1002/j.1556-6676.1992.tb01663.x; Noonan BM, 2004, J COUNS PSYCHOL, V51, P68, DOI 10.1037/0022-0167.51.1.68; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Obsorn C., 2000, MY HEAD DOCTORS OWN; Ono MY, 2011, BRAIN INJURY, V25, P237, DOI 10.3109/02699052.2010.541893; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Pavalko EK, 2003, J HEALTH SOC BEHAV, V44, P18, DOI 10.2307/1519813; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; REID JC, 1994, HEALTH COMMUN, V6, P327, DOI 10.1207/s15327027hc0604_7; Risher P, 2000, 11681 HARR INT INC B; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; RYAN GA, 1992, WORLD J SURG, V16, P398, DOI 10.1007/BF02104438; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; *US DEP HHS, HEADS FACTS PHYS MIL; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Wei HG, 2000, ACAD EMERG MED, V7, P710, DOI 10.1111/j.1553-2712.2000.tb02052.x; WEINER B, 1980, J PERS SOC PSYCHOL, V39, P186, DOI 10.1037/0022-3514.39.2.186; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Widjicks EFM, 2006, J NEUROL NEUROSUR PS, V78, P644; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Woodruff L, 2008, INSTANT FAMILYS JOUR; [No title captured]	91	20	20	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	JAN	2016	8	1					58	+		10.1016/j.pmrj.2015.05.022			15	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DB1KQ	WOS:000368267500008	26054960				2022-02-06	
J	Cossette, I; Gagne, ME; Ouellet, MC; Fait, P; Gagnon, I; Sirois, K; Blanchet, S; Le Sage, N; McFadyen, BJ				Cossette, Isabelle; Gagne, Marie-Eve; Ouellet, Marie-Christine; Fait, Philippe; Gagnon, Isabelle; Sirois, Katia; Blanchet, Sophie; Le Sage, Natalie; McFadyen, Bradford J.			Executive dysfunction following a mild traumatic brain injury revealed in early adolescence with locomotor-cognitive dual-tasks	BRAIN INJURY			English	Article						Executive functioning; gait; locomotion; concussion; adolescent	STABILITY FOLLOWING CONCUSSION; SPORT-RELATED CONCUSSION; GAIT BALANCE CONTROL; POSTURAL CONTROL; HEAD-INJURY; CHILDREN; CHILDHOOD; PERFORMANCE; MANAGEMENT; ATTENTION	Objective: To compare gait parameters between children in early adolescence (EA) with and without a mild traumatic brain injury (mTBI) during dual-task walking (DTW). Methods: Children in EA with mTBI (n = 14; six girls) were compared to those without (n = 13; five girls) while walking in different combinations of obstacle avoidance and cognitive dual-tasks. Gait speed and fluidity and their related dual-task costs (DTC) were analysed along with foot clearance and proximity to the obstacle. Results: No group effects were found for gait speed, proximity or clearance, but were found for fluidity DTC, specifically during the dual Stroop task and when crossing the deeper obstacle. There were also group differences for fluidity during the planning of obstacle avoidance for the narrow obstacle combined with the verbal fluency task and the deep obstacle with no cognitive task. Finally, gait fluidity showed group differences across unobstructed dual-task situations. Conclusions: Gait fluidity may be a more sensitive variable than gait speed for revealing executive dysfunction following mTBI in EA. Assessing DTW in level walking also seems to show a potential to reveal executive dysfunctions in this age group. These results provide direction for future research on clinical assessment using DTW post-mTBI in adolescents.	[Cossette, Isabelle; Gagne, Marie-Eve; Ouellet, Marie-Christine; Sirois, Katia; McFadyen, Bradford J.] CIUSSS CN, CIRRIS, 525 Hamel, Quebec City, PQ G1M 2S8, Canada; [Cossette, Isabelle; McFadyen, Bradford J.] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ, Canada; [Gagne, Marie-Eve; Ouellet, Marie-Christine; Sirois, Katia] Univ Laval, Fac Social Sci, Sch Psychol, Quebec City, PQ, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada; [Fait, Philippe] Univ Montreal, Res Ctr Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ, Canada; [Blanchet, Sophie] Univ Paris 05, Inst Psychol, Paris, France; [Le Sage, Natalie] Univ Quebec, Hop Enfants Jesus, Trauma Res Unit, Ctr Hosp, Quebec City, PQ, Canada		McFadyen, BJ (corresponding author), CIUSSS CN, CIRRIS, 525 Hamel, Quebec City, PQ G1M 2S8, Canada.	brad.mcfadyen@fmed.ulaval.ca	Le Sage, Natalie/G-7063-2016	Le Sage, Natalie/0000-0003-4762-8156; Ouellet, Marie-Christine/0000-0003-3477-1893; McFadyen, Bradford/0000-0003-1992-4927; Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [CBI-127052]	The authors report no conflicts of interest. This project was funded by the Canadian Institutes for Health Research (CBI-127052).	Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Boonyong S, 2012, GAIT POSTURE, V35, P428, DOI 10.1016/j.gaitpost.2011.11.002; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gagnon I, 2001, J HEAD TRAUMA REHAB, V16, P595, DOI 10.1097/00001199-200112000-00007; George PS, 1993, EXEMPLARY MIDDLE SCH; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hurd TL., 2005, NURTURING CHILDREN Y; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korkman M, 2013, CHILD NEUROPSYCHOL, V19, P516, DOI 10.1080/09297049.2012.705822; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Malina RM., 2004, GROWTH MATURATION PH, V2nd ed; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McFadyen B.J., 2015, NEUROPSYCHOL REHABIL, P1; McFadyen BJ, 2001, GAIT POSTURE, V13, P7, DOI 10.1016/S0966-6362(00)00090-4; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Pickett William, 2004, Chronic Dis Can, V25, P32; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Young people's health - a challenge for society, 1986, WHO TECH REP SER, V731, P11	51	20	20	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1648	1655		10.1080/02699052.2016.1200143			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800019	27740859				2022-02-06	
J	King, JB; Lopez-Larson, MP; Yurgelun-Todd, DA				King, Jace B.; Lopez-Larson, Melissa P.; Yurgelun-Todd, Deborah A.			Mean cortical curvature reflects cytoarchitecture restructuring in mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Mean cortical curvature; Mild traumatic brain injury; Cerebral atrophy	HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; VOLUME; THICKNESS; ATROPHY; GYRIFICATION; SEGMENTATION; CONNECTIVITY; DIFFUSION; MILITARY	In the United States alone, the number of persons living with the enduring consequences of traumatic brain injuries is estimated to be between 3.2 and 5 million. This number does not include individuals serving in the United States military or seeking care at Veterans Affairs hospitals. The importance of understanding the neurobiological consequences of mild traumatic brain injury (mTBI) has increased with the return of veterans from conflicts overseas, many of who have suffered this type of brain injury. However, identifying the neuroanatomical regions most affected by mTBI continues to prove challenging. The aim of this study was to assess the use of mean cortical curvature as a potential indicator of progressive tissue loss in a cross-sectional sample of 54 veterans with mTBI compared to 31 controls evaluated with MRI. It was hypothesized that mean cortical curvature would be increased in veterans with mTBI, relative to controls, due in part to cortical restructuring related to tissue volume loss. Mean cortical curvature was assessed in 60 bilateral regions (31 sulcal, 29 gyral). Of the 120 regions investigated, nearly 50% demonstrated significantly increased mean cortical curvature in mTBI relative to controls with 25% remaining significant following multiple comparison correction (all, pFDR < .05). These differences were most prominent in deep gray matter regions of the cortex. Additionally, significant relationships were found between mean cortical curvature and gray and white matter volumes (all, p < .05). These findings suggest potentially unique patterns of atrophy by region and indicate that changes in brain microstructure due to mTBI are sensitive to measures of mean curvature. (C) 2016 The Authors. Published by Elsevier Inc.	[King, Jace B.] Univ Utah, Dept Radiol, 30 North 1900 East 1A071, Salt Lake City, UT 84132 USA; [King, Jace B.; Yurgelun-Todd, Deborah A.] Univ Utah, Interdept Program Neurosci, 20 South 2030 East,390A BPRB, Salt Lake City, UT 84112 USA; [King, Jace B.; Lopez-Larson, Melissa P.; Yurgelun-Todd, Deborah A.] Univ Utah, Diagnost Neuroimaging, 383 Colorow Dr, Salt Lake City, UT 84108 USA; [Lopez-Larson, Melissa P.; Yurgelun-Todd, Deborah A.] Univ Utah, Dept Psychiat, 501 Chipeta Way, Salt Lake City, UT 84108 USA; [Yurgelun-Todd, Deborah A.] VA VISN 19 Mental Illness Res Educ & Clin Ctr MIR, George E Whalen Dept, Vet Affairs Med Ctr, 500 Foothill Dr, Salt Lake City, UT 84148 USA		King, JB (corresponding author), Univ Utah, Dept Radiol, 30 North 1900 East 1A071, Salt Lake City, UT 84132 USA.; King, JB (corresponding author), Univ Utah, Imaging & Neurosci Ctr, 729 Arapeen Dr, Salt Lake City, UT 84108 USA.	jace.king@hsc.utah.edu; melissa.lopez-larson@hsc.utah.edu; deborah.yurgelun-todd@hsc.utah.edu		King, Jace/0000-0002-0206-0475	Department of Veterans Affairs Salt Lake City Mental Illness Research, Education & Clinical Center (MIRECC) [5I01CX000253-02]; Veterans AffairsUS Department of Veterans Affairs [I01CX000253] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs Salt Lake City Mental Illness Research, Education & Clinical Center (MIRECC), Merit Review 5I01CX000253-02 (PI Yurgelun-Todd). The authors would like to thank Elliott Bueler, Margaret Legaretta, PhD, and Erin McGlade, PhD for their contributions to this work including, but not limited to, subject recruitment and study management. We would also like to thank Jeffrey S. Anderson, MD, PhD for his feedback and assistance with methods, proof reading, and editing and Kagan R. Breitenbach for his assistance in figure creation.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P32; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Deppe M, 2014, NEUROIMAGE-CLIN, V6, P475, DOI 10.1016/j.nicl.2014.02.012; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; First M.B., 1996, STRUCTURED CLIN INTE; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Guadalupe T, 2015, CORTEX, V62, P41, DOI 10.1016/j.cortex.2014.07.015; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Lopez-Larson MP, 2012, PSYCHIAT RES-NEUROIM, V204, P32, DOI 10.1016/j.pscychresns.2012.09.009; Luders E, 2006, NEUROIMAGE, V29, P1224, DOI 10.1016/j.neuroimage.2005.08.049; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Operto G, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P422, DOI 10.1109/ISBI.2012.6235574; Osborn A.G., 2010, DIAGNOSTIC IMAGING; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pienaar R, 2008, INT J IMAG SYST TECH, V18, P42, DOI 10.1002/ima.20138; Ronan L, 2012, NEUROIMAGE, V63, P611, DOI 10.1016/j.neuroimage.2012.06.034; Ronan L, 2011, EPILEPSIA, V52, P28, DOI 10.1111/j.1528-1167.2010.02895.x; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Wang JQ, 2014, MED BIOL ENG COMPUT, V52, P331, DOI 10.1007/s11517-013-1131-9; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	58	20	21	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	11						81	89		10.1016/j.nicl.2016.01.003			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DQ9BD	WOS:000379504500012	26909332	gold, Green Published			2022-02-06	
J	Liu, KY; Khan, H; Geng, XK; Zhang, J; Ding, YC				Liu, Kaiyin; Khan, Hajra; Geng, Xiaokun; Zhang, Jun; Ding, Yuchuan			Pharmacological hypothermia: a potential for future stroke therapy?	NEUROLOGICAL RESEARCH			English	Article						Hypothermia; Ischemia-reperfusion injury	FOCAL CEREBRAL-ISCHEMIA; DRUG-INDUCED HYPOTHERMIA; OLIGODENDROCYTE PRECURSOR CELLS; CANNABINOID RECEPTOR AGONIST; TRAUMATIC BRAIN-INJURY; RAT MODEL; PROVIDES NEUROPROTECTION; BODY-TEMPERATURE; INFARCT SIZE; WIN 55,212-2	Mild physical hypothermia after stroke has been associated with positive outcomes. Despite the well-studied beneficial effects of hypothermia in the treatment of stroke, lack of precise temperature control, intolerance for the patient, and immunosuppression are some of the reasons which limit its clinical translation. Pharmacologically induced hypothermia has been explored as a possible treatment option following stroke in animal models. Currently, there are eight classes of pharmacological agents/agonists with hypothermic effects affecting a multitude of systems including cannabinoid, opioid, transient receptor potential vanilloid 1 (TRPV1), neurotensin, thyroxine derivatives, dopamine, gas, and adenosine derivatives. Interestingly, drugs in the TRPV1, neurotensin, and thyroxine families have been shown to have effects in thermoregulatory control in decreasing the compensatory hypothermic response during cooling. This review will briefly present drugs in the eight classes by summarizing their proposed mechanisms of action as well as side effects. Reported thermoregulatory effects of the drugs will also be presented. This review offers the opinion that these agents may be useful in combination therapies with physical hypothermia to achieve faster and more stable temperature control in hypothermia.	[Liu, Kaiyin; Khan, Hajra; Geng, Xiaokun; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI USA; [Geng, Xiaokun; Ding, Yuchuan] Capital Med Univ, Beijing Luhe Hosp, Dept Neurol, 82 Xinhua South Rd, Beijing 101149, Peoples R China; [Zhang, Jun] Capital Med Univ, Xuanwu Hosp, China Amer Inst Neurosci, Beijing, Peoples R China		Geng, XK (corresponding author), Capital Med Univ, Beijing Luhe Hosp, Dept Neurol, 82 Xinhua South Rd, Beijing 101149, Peoples R China.	xgeng@med.wayne.edu			American Heart AssociationAmerican Heart Association [14GRNT20460246]; US Department of Veterans Affairs Rehabilitation RD ServiceUS Department of Veterans Affairs [I01RX-001964-01]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501141]; Talent Training Program of Beijing Ministry of Organization [2013D008011000002]; Veterans AffairsUS Department of Veterans Affairs [I01RX001964] Funding Source: NIH RePORTER	This work was supported in part by American Heart Association Grant-in-Aid [grant number 14GRNT20460246], Merit Review Award [grant number I01RX-001964-01] from the US Department of Veterans Affairs Rehabilitation R&D Service, National Natural Science Foundation of China [grant number 81501141]; Talent Training Program of Beijing Ministry of Organization [grant number 2013D008011000002].	ADLER MW, 1988, ANNU REV PHARMACOL, V28, P429, DOI 10.1146/annurev.pa.28.040188.002241; Amantea D, 2007, FEBS J, V274, P4464, DOI 10.1111/j.1742-4658.2007.05975.x; American Heart Association, 2015, WEB BAS INT GUID CAR; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; [Anonymous], 2012, INC PREV 2012 CHART; Baena RC, 1997, NEUROLOGY, V48, P768, DOI 10.1212/WNL.48.3.768; Baker AK, 2002, J PHARMACOL EXP THER, V302, P1253, DOI 10.1124/jpet.102.037655; Benamar K, 2002, J PHARMACOL EXP THER, V303, P375, DOI 10.1124/jpet.102.036269; Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Berganza CJ, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-18; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Bonfils PK, 2006, NEUROCHEM INT, V49, P508, DOI 10.1016/j.neuint.2006.03.015; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; Cao ZJ, 2014, AM J PHYSIOL-REG I, V306, pR149, DOI 10.1152/ajpregu.00329.2013; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Chanda S, 2005, REGUL TOXICOL PHARM, V43, P66, DOI 10.1016/j.yrtph.2005.06.003; Chi OZ, 2012, PHARMACOLOGY, V89, P333, DOI 10.1159/000338755; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; COLBOC O, 1980, J PHARM PHARMACOL, V32, P624, DOI 10.1111/j.2042-7158.1980.tb13018.x; COLERIDGE HM, 1964, J PHYSIOL-LONDON, V170, P272, DOI 10.1113/jphysiol.1964.sp007330; Costa ACS, 2005, J NEUROSCI, V25, P7801, DOI 10.1523/JNEUROSCI.1699-05.2005; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Diaz M, 2010, ANESTH PROG, V57, p:; Diaz Marcos, 2010, Anesth Prog, V57, P25, DOI 10.2344/0003-3006-57.1.25; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doyle KP, 2007, STROKE, V38, P2569, DOI 10.1161/STROKEAHA.106.480277; Drabek T, 2008, RESUSCITATION, V77, P220, DOI 10.1016/j.resuscitation.2007.11.020; England TJ, 2015, J CEREBR BLOOD F MET, V35, P348, DOI 10.1038/jcbfm.2014.218; Feketa VV, 2013, AM J PHYSIOL-REG I, V305, pR1040, DOI 10.1152/ajpregu.00296.2013; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Fosgerau K, 2010, BMC CARDIOVASC DISOR, V10; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Glushakova Olena Y, 2016, Brain Circ, V2, P28, DOI 10.4103/2394-8108.178546; Gonzalez-Ibarra FP, 2011, FRONT NEUROL, V2; Goossens J, 2014, CURR NEUROPHARMACOL, V12, P399, DOI 10.2174/1570159X12666140424233036; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Gullapalli S, 2002, PHARMACOL BIOCHEM BE, V72, P93, DOI 10.1016/S0091-3057(01)00726-2; Guluma KZ, 2010, RESUSCITATION, V81, P1642, DOI 10.1016/j.resuscitation.2010.08.003; Hampson AJ, 2001, EUR J NEUROSCI, V13, P1529, DOI 10.1046/j.0953-816x.2001.01536.x; Hart ME, 2006, J MED CHEM, V49, P1101, DOI 10.1021/jm0505718; Hayakawa K, 2007, LIFE SCI, V80, P1466, DOI 10.1016/j.lfs.2007.01.014; Hillard CJ, 2008, CURR PHARM DESIGN, V14, P2347, DOI 10.2174/138161208785740054; Hoesch RE, 2007, NEUROLOGIST, V13, P331, DOI 10.1097/NRL.0b013e318154bb79; Ianculescu AG, 2010, MOL BIOSYST, V6, P1338, DOI 10.1039/b926583j; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; Jinka TR, 2015, ACS CHEM NEUROSCI, V6, P899, DOI 10.1021/acschemneuro.5b00056; Johansen FF, 2013, PATHOBIOLOGY, V81, P42, DOI 10.1159/000352026; Johansen Flemming Fryd, 2003, J Stroke Cerebrovasc Dis, V12, P97; Joseph C, 2012, J CEREBR BLOOD F MET, V32, P1632, DOI 10.1038/jcbfm.2012.65; Kao TK, 2008, NEUROCHEM INT, V52, P1256, DOI 10.1016/j.neuint.2008.01.007; Katz LM, 2012, THER HYPOTHERMIA TEM, V2, P61, DOI 10.1089/ther.2012.0011; Katz LM, 2001, ACAD EMERG MED, V8, P1115, DOI 10.1111/j.1553-2712.2001.tb01126.x; Kim J., 2015, BRAIN CIRC, V1, P14, DOI [10.4103/2394-8108.164997, DOI 10.4103/2394-8108.164997]; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Koronowski Kevin B, 2015, Brain Circ, V1, P69; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Kuric E, 2014, J NEUROIMMUNOL, V269, P94, DOI 10.1016/j.jneuroim.2014.02.009; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Leker RR, 2003, STROKE, V34, P2000, DOI 10.1161/01.STR.0000079817.68944.1E; Lin HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00029; Liu SM, 2015, NEUROL RES, V37, P454, DOI 10.1179/1743132815Y.0000000031; LIU XH, 1995, J NEUROL SCI, V129, P9, DOI 10.1016/0022-510X(94)00239-K; MACHIDA R, 1993, BIOL PHARM BULL, V16, P43; Marinelli S, 2002, J PHYSL, V543, P31; Martini WZ, 2009, J TRAUMA, V67, P202, DOI 10.1097/TA.0b013e3181a602a7; MELLER E, 1989, LIFE SCI, V44, P1019, DOI 10.1016/0024-3205(89)90553-5; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Mozaffarian D, 2015, CIRCULATION, V131, P434, DOI 10.1161/CIR.0000000000000157; Muthian S, 2004, NEUROSCIENCE, V129, P743, DOI 10.1016/j.neuroscience.2004.08.044; Muzzi M, 2013, J CEREBR BLOOD F MET, V33, P171, DOI 10.1038/jcbfm.2012.181; Muzzi M, 2012, J CEREBR BLOOD F MET, V32, P978, DOI 10.1038/jcbfm.2012.36; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Nunez E, 2008, NEUROSCIENCE, V151, P104, DOI 10.1016/j.neuroscience.2007.10.029; O'Neil RG, 2003, NEWS PHYSIOL SCI, V18, P226, DOI 10.1152/nips.01468.2003; O'Neill MJ, 1998, EUR J PHARMACOL, V352, P37, DOI 10.1016/S0014-2999(98)00333-1; Pan Y, 2007, EXP NEUROL, V205, P587, DOI 10.1016/j.expneurol.2007.03.023; Pan Y, 2011, NEUROSCI LETT, V497, P144, DOI 10.1016/j.neulet.2011.04.048; Panas HN, 2010, J NEUROSCI RES, V88, P1962, DOI 10.1002/jnr.22367; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Rawls Scott M, 2011, Front Biosci (Schol Ed), V3, P822; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Rittiner JE, 2012, J BIOL CHEM, V287, P5301, DOI 10.1074/jbc.M111.291666; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Sherman AL, 2014, PHYS MED REH CLIN N, V25, P519, DOI 10.1016/j.pmr.2014.04.003; Shimizu I, 2005, J PHARMACOL EXP THER, V314, P1378, DOI 10.1124/jpet.105.084277; Shirakawa H, 2008, BIOCHEM BIOPH RES CO, V377, P1211, DOI 10.1016/j.bbrc.2008.10.152; Sigg DC, 2002, AM J PHYSIOL-HEART C, V282, pH1953, DOI 10.1152/ajpheart.01045.2001; Sun J, 2013, ACTA PHARMACOL SIN, V34, P119, DOI 10.1038/aps.2012.141; Sun J, 2013, BRAIN RES, V1491, P225, DOI 10.1016/j.brainres.2012.11.006; Suzuki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040889; Suzuki N, 2012, BRAIN RES, V1430, P93, DOI 10.1016/j.brainres.2011.10.044; Swoap SJ, 2007, AM J PHYSIOL-REG I, V293, pR468, DOI 10.1152/ajpregu.00888.2006; Tansey EA, 2015, ADV PHYSIOL EDUC, V39, P139, DOI 10.1152/advan.00126.2014; Tao ZY, 2011, AM J TRANSL RES, V3, P351; Torup L, 2003, NEUROSCI LETT, V351, P173, DOI 10.1016/j.neulet.2003.08.008; Tyler BM, 1999, NEUROPHARMACOLOGY, V38, P1027, DOI 10.1016/S0028-3908(99)00011-8; Tyler-McMahon BM, 2000, REGUL PEPTIDES, V93, P125, DOI 10.1016/S0167-0115(00)00183-X; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Xu XS, 2011, STROKE, V42, P3245, DOI 10.1161/STROKEAHA.111.618306; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371; ZARRINDAST MR, 1989, ARCH INT PHARMACOD T, V298, P38; Zhang F, 2009, J CEREBR BLOOD F MET, V29, P1022, DOI 10.1038/jcbfm.2009.28; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zhang M, 2008, NEUROSCIENCE, V152, P753, DOI 10.1016/j.neuroscience.2008.01.022; Zhang M, 2013, J CEREB BLOOD FLOW M, V33; Zhang MJ, 2013, CNS NEUROL DISORD-DR, V12, P371, DOI 10.2174/1871527311312030010; Zhang Y, 2015, STROKE, V46, P2637, DOI 10.1161/STROKEAHA.115.009792; Zhang ZA, 2003, ANESTH ANALG, V97, P1776, DOI 10.1213/01.ANE.0000087800.56290.2E; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	130	20	21	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	6			SI		478	490		10.1080/01616412.2016.1187826			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO9ZH	WOS:000378146300002	27320243				2022-02-06	
J	Schumacher, R; Walder, B; Delhumeau, C; Muri, RM				Schumacher, Rahel; Walder, Bernhard; Delhumeau, Cecile; Muri, Rene M.			Predictors of inpatient (neuro)rehabilitation after acute care of severe traumatic brain injury: An epidemiological study	BRAIN INJURY			English	Article						Traumatic brain injury; clinical pathway; predictors; inpatient rehabilitation; neurorehabilitation	GLASGOW COMA SCALE; HEAD-INJURY; PARIS-TBI; REHABILITATION; DISCHARGE; MODERATE; OUTCOMES; ADULTS; VOLUME; AGE	Objective: To describe the discharge destination of patients with severe traumatic brain injury (sTBI) after acute care. To identify predictors associated with inpatient rehabilitation (vs discharge home) and to identify predictors associated with neurorehabilitation (vs general rehabilitation).Methods: A national, multi-centre, prospective study with adult survivors after sTBI (abbreviated injury scale head score > 3). Univariate and multivariate logistic regression models included patient characteristics, pre-injury conditions, initial neuro-physiological assessment, trauma mechanisms, severity of TBI and pre-hospital conditions to find predictors of discharge destination.Results: Out of the 566 included patients, 341 (60%) were referred to inpatient rehabilitation, thereof 249 (73%) to neurorehabilitation; 225 (40%) were discharged home or to a nursing home. Lower scores on the Glasgow Coma Scale at admission/at 14 days, higher injury severity scores and older age were predictors for inpatient rehabilitation. Younger age and male gender were predictors for neurorehabilitation.Conclusions: Patients' pathways after acute care are not only determined by the severity of their brain injury, but also by their overall injury severity and socio-biological factors. More than half of the patients after sTBI are not discharged to specialized inpatient neurorehabilitation and, therefore, efforts should be taken to optimize post-acute care.	[Schumacher, Rahel; Muri, Rene M.] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol,Div Cognit & Restorat Neurol, Bern, Switzerland; [Schumacher, Rahel; Muri, Rene M.] Univ Bern, Univ Hosp Bern, Inselspital, Percept & Eye Movement Lab,Dept Neurol, Bern, Switzerland; [Schumacher, Rahel; Muri, Rene M.] Univ Bern, Univ Hosp Bern, Inselspital, Percept & Eye Movement Lab,Dept Clin Res, Bern, Switzerland; [Walder, Bernhard; Delhumeau, Cecile] Univ Hosp Geneva, Dept Intens Care & Clin Pharmacol, Div Anaesthesiol, Geneva, Switzerland; [Muri, Rene M.] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland		Schumacher, R (corresponding author), Univ Hosp Bern, Inselspital, Div Cognit & Restorat Neurol, Dept Neurol, Freiburgstr, CH-3010 Bern, Switzerland.	rahel.schumacher@dkf.unibe.ch	Muri, Rene/E-9320-2012	Muri, Rene/0000-0001-6990-4188; Schumacher, Rahel/0000-0001-7500-7491			Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Graham JE, 2013, MED CARE, V51, P404, DOI 10.1097/MLR.0b013e318286e3c8; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kool B, 2012, NEUROEPIDEMIOLOGY, V38, P179, DOI 10.1159/000337261; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tillou A, 2014, JAMA SURG, V149, P83, DOI 10.1001/jamasurg.2013.4244; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	25	20	20	1	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1186	1193		10.1080/02699052.2016.1183821			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300003	27389772				2022-02-06	
J	Shen, Q; Yin, Y; Xia, QJ; Lin, N; Wang, YC; Liu, J; Wang, HP; Lim, A; Wang, TH				Shen, Qin; Yin, Yong; Xia, Qing-Jie; Lin, Na; Wang, You-Cui; Liu, Jia; Wang, Hang-Ping; Lim, Apiradee; Wang, Ting-Hua			Bone Marrow Stromal Cells Promote Neuronal Restoration in Rats with Traumatic Brain Injury: Involvement of GDNF Regulating BAD and BAX Signaling	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Bone marrow stromal cells; Traumatic brain injury; Glial cell-line derived neurotrophic factor; BAX; BAD	MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; SCHWANN-CELLS; IN-VIVO; TRANSPLANTATION; BCL-2; APOPTOSIS; SURVIVAL; GENE; EXPRESSION	Background/Aims: To investigate the effects of bone marrow stromal cells (BMSCs) and underlying mechanisms in traumatic brain injury (TBI). Methods: Cultured BMSCs from green fluorescent protein-transgenic mice were isolated and confirmed. Cultured BMSCs were immediately transplanted into the regions surrounding the injured-brain site to test their function in rat models of TBI. Neurological function was evaluated by a modified neurological severity score on the day before, and on days 7 and 14 after transplantation. After 2 weeks of BMSC transplantation, the brain tissue was harvested and analyzed by microarray assay. And the coronal brain sections were determined by immunohistochemistry with mouse anti-growth-associated protein-43 kDa (anti-GAP-43) and anti-synaptophysin to test the effects of transplanted cells on the axonal regeneration in the host brain. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and Western blot were used to detect the apoptosis and expression of BAX and BAD. Results: Microarray analysis showed that BMSCs expressed growth factors such as glial cell-line derived neurotrophic factor (GDNF). The cells migrated around the injury sites in rats with TBI. BMSC grafts resulted in an increased number of GAP-43-immunopositive fibers and synaptophysin-positive varicosity, with suppressed apoptosis. Furthermore, BMSC transplantation significantly downregulated the expression of BAX and BAD signaling. Moreover, cultured BMSC transplantation significantly improved rat neurological function and survival. Conclusion: Transplanted BMSCs could survive and improve neuronal behavior in rats with TBI. Mechanisms of neuroprotection and regeneration were involved, which could be associated with the GDNF regulating the apoptosis signals through BAX and BAD. (C) 2016 The Author(s) Published by S. Karger AG, Basel	[Shen, Qin; Lin, Na; Liu, Jia; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Fac Basic Med, Kunming 650031, Peoples R China; [Yin, Yong] Kunming Med Univ, Affiliated Hosp 4, Dept Rehabil, Kunming 650031, Peoples R China; [Xia, Qing-Jie; Wang, You-Cui; Wang, Ting-Hua] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Inst Neurobiol Dis, Chengdu 610064, Peoples R China; [Xia, Qing-Jie; Wang, You-Cui; Wang, Ting-Hua] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Wang, Hang-Ping; Wang, Ting-Hua] Yun Nan Normal Univ, Sch Sports, Kunming, Peoples R China; [Lim, Apiradee] Prince Songkla Univ, Fac Sci & Technol, Pattani Campus, Hat Yai 646400, Thailand		Wang, TH (corresponding author), Kunming Med Univ, Inst Neurosci, Fac Basic Med, Kunming 650031, Peoples R China.; Lim, A (corresponding author), Prince Songkla Univ, Fac Sci & Technol, Pattani Campus, Hat Yai 646400, Thailand.	api_45@hotmail.com; tinghuawang263@sina.com			Natural Science Fund of Yunnan ProvinceNatural Science Foundation of Yunnan Province [2010ZC109]; China Nation Science Foundation [81271358, 81070991, 81260191]; Key Natural Science Fund of Yunnan Province [2012ZC107]	This study was supported by the Natural Science Fund of Yunnan Province (No. 2010ZC109) by a grant from the China Nation Science Foundation (No. 81271358, 81070991, and 81260191) and the Key Natural Science Fund of Yunnan Province (No. 2012ZC107).	Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Bader AM, 2014, CELL PHYSIOL BIOCHEM, V34, P646, DOI 10.1159/000363030; Ban DX, 2011, REGEN MED, V6, P707, DOI [10.2217/RME.11.32, 10.2217/rme.11.32]; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Chadbunchachai Witaya, 2012, J Med Assoc Thai, V95 Suppl 7, pS274; Chang YQ, 2014, CELL PHYSIOL BIOCHEM, V34, P703, DOI 10.1159/000363035; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Ding P, 2014, AM J TRANSL RES, V6, P224; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gu WD, 2012, NEUROL RES, V34, P172, DOI 10.1179/1743132811Y.0000000068; Gu WD, 2010, NEUROPATHOLOGY, V30, P205, DOI 10.1111/j.1440-1789.2009.01063.x; Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; Jiang YF, 2011, NEUROL RES, V33, P331, DOI 10.1179/016164110X12816242542571; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KORSMEYER SJ, 1992, BLOOD, V80, P879; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Lukashyk SP, 2014, J CLIN TRANSL HEPATO, V2, P217, DOI 10.14218/JCTH.2014.00027; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Naghdi Majid, 2009, Iranian Biomedical Journal, V13, P117; Nojiri Yukiko, 2008, J Med Dent Sci, V55, P121; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sandner B, 2016, CELL TRANSPLANT, V25, P125, DOI 10.3727/096368915X687679; SCHADEN H, 1994, J NEUROBIOL, V25, P1570, DOI 10.1002/neu.480251209; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shichinohe H, 2015, NEUROREHAB NEURAL RE, V29, P80, DOI 10.1177/1545968314525856; Shintani A, 2007, BRAIN RES, V1186, P48, DOI 10.1016/j.brainres.2007.09.086; Sun Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1331, DOI 10.1159/000430300; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang L, 2015, CELL PHYSIOL BIOCHEM, V37, P2171, DOI 10.1159/000438574	45	20	23	1	16	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2016	38	2					748	762		10.1159/000443031			15	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	DF1ER	WOS:000371082300025	26871686	gold			2022-02-06	
J	Tepe, V; Yarnell, A; Nindl, BC; Van Arsdale, S; Deuster, PA				Tepe, Victoria; Yarnell, Angela; Nindl, Bradley C.; Van Arsdale, Stephanie; Deuster, Patricia A.			Women in Combat: Summary of Findings and a Way Ahead	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; GENDER-DIFFERENCES; UNINTENDED PREGNANCY; MILITARY PERSONNEL; IRON-DEFICIENCY; MENTAL-HEALTH; RISK-FACTORS; US MILITARY; DEPLOYMENT	The Women in Combat Symposium was held at the Defense Health Headquarters April 29 to May 1, 2014, cohosted by the Office of the Assistant Secretary of Defense for Health Affairs and the Consortium for Health and Military Performance. The conference was a call to renew and extend research investment and policy commitment to recognize operational scenarios, requirements, health priorities, and combat-related injury exposures uniquely relevant to the performance and well-being of female Service members. Symposium participants worked in groups to identify knowledge and capability gaps critical to the successful integration, health, and performance of female Service members in combat roles and to develop recommendations for researchers and policy makers to address gaps in three specific areas of concern: Leadership and Peer Behavior, Operational Performance, and Health and Well-Being. Consensus findings are summarized as 20 research gaps and accompanying recommendations. Each represents an opportunity to advance health and performance outcomes and to leverage female Service members' strengths and capacities to the general benefit of all Service members and their families.	[Tepe, Victoria] Dept Def Hearing Ctr Excellence HCE, 2200 Bergquist Dr, Jbsa Lackland, TX 78236 USA; [Yarnell, Angela] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci Res, Silver Spring, MD 20910 USA; [Nindl, Bradley C.] US Army, Inst Publ Hlth, Publ Hlth Command, Aberdeen Proving Ground, MD 21010 USA; [Van Arsdale, Stephanie; Deuster, Patricia A.] Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Dept Mil & Emergency Med, Bethesda, MD 20814 USA		Tepe, V (corresponding author), Dept Def Hearing Ctr Excellence HCE, 2200 Bergquist Dr, Jbsa Lackland, TX 78236 USA.		Deuster, Patricia A/G-3838-2015	Deuster, Patricia A/0000-0002-7895-0888	CHAMP; APHC; DCoE; Office of the Assistant Secretary of Defense for Research and Engineering	We would like to thank Health Affairs for their support in hosting the Women in Combat Symposium. We are grateful to CHAMP, and APHC, DCoE, and the Office of the Assistant Secretary of Defense for Research and Engineering for their support. A special thanks to our keynote speakers, Dr. David J. Smith, DASD/HA, and Ms. Juliet Beyler, Director of Officer and Enlisted Personnel Management. Additional thanks to the anonymous reviewers for their contributions to this manuscript.	Adler A. B., 2006, MILITARY LIFE PSYCHO, V2, P213; Albright TS, 2005, MIL MED, V170, P735, DOI 10.7205/MILMED.170.9.735; Bell NS, 2000, AM J PREV MED, V18, P141, DOI 10.1016/S0749-3797(99)00173-7; Booth-Kewley S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-130; BORSAYTRINDLE LA, 1991, MIL MED, V156, P82, DOI 10.1093/milmed/156.2.82; Bowles SV, 2010, MIL MED, V175, P382, DOI 10.7205/MILMED-D-10-00099; Castro, 2011, DEPLOYMENT PSYCHOL E, P69, DOI DOI 10.1037/12300-003; Chen GL, 2002, J APPL PSYCHOL, V87, P549, DOI 10.1037//0021-9010.87.3.549; Christopher MLA, 2007, MIL MED, V172, P9, DOI 10.7205/MILMED.172.1.9; Deuster PA, 1997, MIL MED, V162, P649, DOI 10.1093/milmed/162.10.649; Dutra L, 2011, J TRAUMA DISSOCIATIO, V12, P25, DOI 10.1080/15299732.2010.496141; Erdman J., 2011, NUTR TRAUMATIC BRAIN; Friedl KE, 2008, MED SCI SPORT EXER, V40, pS609, DOI 10.1249/MSS.0b013e3181892d53; Friedl KE, 2005, J WOMENS HEALTH, V14, P764, DOI 10.1089/jwh.2005.14.764; Grindlay K, 2013, OBSTET GYNECOL, V121, P241, DOI 10.1097/AOG.0b013e31827c616e; HawleyBowland C, 1996, WOMEN HEALTH ISS, V6, P353; Hill D W, 1993, Br J Sports Med, V27, P45; Holt K, 2011, MIL MED, V176, P1056, DOI 10.7205/MILMED-D-11-00012; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Jonas W.B., 2010, MIL MED, V175, P6, DOI [DOI 10.7205/MILMED-D-10-00280, 10.7205/MILMED-D-10-00280]; Kelley ML, 2002, MIL PSYCHOL, V14, P199, DOI 10.1207/S15327876MP1403_2; Kelley ML., 1994, MIL PSYCHOL, V6, P125, DOI [10.1207/s15327876mp0602_4, DOI 10.1207/S15327876MP0602_4]; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; KING N, 1993, J AM COLL NUTR, V12, P344, DOI 10.1080/07315724.1993.10718320; Knapik J, 2005, J STRENGTH COND RES, V19, P246; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1011, DOI 10.1097/00005768-200106000-00022; LeardMann CA, 2013, WOMEN HEALTH ISS, V23, pE215, DOI 10.1016/j.whi.2013.05.002; Lindberg LD, 2011, CONTRACEPTION, V84, P249, DOI 10.1016/j.contraception.2011.01.017; Lipari RN, 2006, 2007002 DEF MANP DAT; Lowe NK, 2003, MIL MED, V168, P569, DOI 10.1093/milmed/168.7.569; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; Maguen S, 2008, MIL MED, V173, P1; McClung JP, 2014, J TRACE ELEM MED BIO, V28, P388, DOI 10.1016/j.jtemb.2014.06.022; McClung JP, 2013, ANNU REV NUTR, V33, P271, DOI 10.1146/annurev-nutr-071812-161205; Millegan J, 2015, J TRAUMA STRESS, V28, P298, DOI 10.1002/jts.22028; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Moore J, 1996, WOMEN HEALTH ISS, V6, P374; Morgan BJ, 2011, MIL MED, V176, P976, DOI 10.7205/MILMED-D-10-00433; Murdoch M, 2007, MIL MED, V172, P718, DOI 10.7205/MILMED.172.7.718; Naclerio A., 2011, CONCERNS WOMEN CURRE; Nindl BC, 2000, J APPL PHYSIOL, V88, P2251, DOI 10.1152/jappl.2000.88.6.2251; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Reynolds KL, 2001, J STRENGTH COND RES, V15, P136; Ritchie EC, 2001, MIL MED, V166, P1033, DOI 10.1093/milmed/166.12.1033; Rona RJ, 2007, INT J EPIDEMIOL, V36, P319, DOI 10.1093/ije/dyl273; Rundell JR, 2006, GEN HOSP PSYCHIAT, V28, P352, DOI 10.1016/j.genhosppsych.2006.04.006; Schumm WR, 2001, PSYCHOL REP, V89, P153, DOI 10.2466/PR0.89.5.153-165; Segal MW, 2015, MIL BEHAV HLTH, P1; Shaffer RA, 1999, MIL MED, V164, P17, DOI 10.1093/milmed/164.1.17; Steele N, 2013, UROL NURS, V33, P78; Steele Nancy, 2013, Urol Nurs, V33, P61; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Swan SC, 2008, VIOLENCE VICTIMS, V23, P301, DOI 10.1891/0886-6708.23.3.301; Taft CT, 2007, J FAM PSYCHOL, V21, P270, DOI 10.1037/0893-3200.21.2.270; Tepe V, 2015, WOMEN AT WAR; Turner JB, 2007, J TRAUMA STRESS, V20, P643, DOI 10.1002/jts.20245; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Vogt DS, 2005, J TRAUMA STRESS, V18, P271; Wardell D W, 2001, J Am Acad Nurse Pract, V13, P187; Wilson C, 2010, NURS CLIN N AM, V45, P95, DOI 10.1016/j.cnur.2010.02.005; Yanovich R, 2011, J STRENGTH COND RES, V25, P3412, DOI 10.1519/JSC.0b013e318215f779	65	20	20	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2016	181			1			109	118		10.7205/MILMED-D-15-00409			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI3NW	WOS:000373406400016	26741909	Bronze			2022-02-06	
J	Alhilali, LM; Delic, JA; Gumus, S; Fakhran, S				Alhilali, Lea M.; Delic, Joseph A.; Gumus, Serter; Fakhran, Saeed			Evaluation of White Matter Injury Patterns Underlying Neuropsychiatric Symptoms after Mild Traumatic Brain Injury	RADIOLOGY			English	Article							MAJOR DEPRESSION; CLINICAL-OUTCOMES; HEAD-INJURY; CONCUSSION; SEQUELAE; PLAYERS; STIMULATION; ASSOCIATION; DYSFUNCTION; AGGRESSION	Purpose: To determine if a central axonal injury underlies neuropsychiatric symptoms after mild traumatic brain injury (mTBI) by using tract-based spatial statistics analysis of diffusion-tensor images. Materials and Methods: The institutional review board approved this study, with waiver of informed consent. Diffusion-tensor imaging and serial neurocognitive testing with the Immediate Post-Concussion Assessment and Cognitive Testing evaluation were performed in 45 patients with mTBI (38 with irritability, 32 with depression, and 18 with anxiety). Control subjects consisted of 29 patients with mTBI without neuropsychiatric symptoms. Fractional anisotropy and diffusivity maps were analyzed by using tract-based spatial statistics with a multivariate general linear model. Diffusion-tensor imaging findings were correlated with symptom severity, neurocognitive test scores, and time to recovery with the Pearson correlation coefficient. Results: Compared with control subjects, patients with mTBI and depression had decreased fractional anisotropy in the superior longitudinal fasciculus (P = .006), white matter around the nucleus accumbens (P = .03), and anterior limb of the internal capsule (P = .02). Patients with anxiety had diminished fractional anisotropy in the vermis (P = .04). No regions of significantly decreased fractional anisotropy were seen in patients with irritability relative to control subjects. Injury in the region of the nucleus accumbens inversely correlated with recovery time in patients with depression (r = 20.480, P = .005). Conclusion: Unique white matter injury patterns were seen for two major posttraumatic neuropsychiatric symptoms. Injury to the cerebellar vermis in patients with mTBI and anxiety may indicate underlying dysfunction in primitive fear conditioning circuits in the cerebellum. Involvement of the nucleus accumbens in depression after mTBI may suggest an underlying dysfunctional reward circuit that affects the prognosis in these patients. (C) RSNA, 2015	[Alhilali, Lea M.; Delic, Joseph A.; Gumus, Serter; Fakhran, Saeed] Univ Pittsburgh, UPMC Presbyterian Hosp, Med Ctr, Dept Radiol,Div Neuroradiol, 200 Lothrop St,Presby South Tower,3rd Floor,Suite, Pittsburgh, PA 15213 USA		Alhilali, LM (corresponding author), Univ Pittsburgh, UPMC Presbyterian Hosp, Med Ctr, Dept Radiol,Div Neuroradiol, 200 Lothrop St,Presby South Tower,3rd Floor,Suite, Pittsburgh, PA 15213 USA.	alhilalilm@upmc.edu					Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Borek LL, 2001, BRAIN INJURY, V15, P65, DOI 10.1080/02699050150209147; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fletcher JM, 2008, HEALTH ECON, V17, P1215, DOI 10.1002/hec.1319; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall GBC, 2014, EUR ARCH PSY CLIN N, V264, P187, DOI 10.1007/s00406-013-0437-9; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Millet B, 2014, EUR NEUROPSYCHOPHARM, V24, P1229, DOI 10.1016/j.euroneuro.2014.05.006; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Saluja G, 2004, ARCH PEDIAT ADOL MED, V158, P760, DOI 10.1001/archpedi.158.8.760; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374	35	20	22	0	7	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	DEC	2015	277	3					793	800		10.1148/radiol.2015142974			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DC9EY	WOS:000369525100019	26079380	Bronze			2022-02-06	
J	Arrey, EN; Kerr, ML; Fletcher, S; Cox, CS; Sandberg, DI				Arrey, Eliel N.; Kerr, Marcia L.; Fletcher, Stephen; Cox, Charles S., Jr.; Sandberg, David I.			Linear nondisplaced skull fractures in children: who should be observed or admitted?	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						nondisplaced; linear skull fracture; pediatric head trauma	TRAUMATIC BRAIN-INJURY; MINOR HEAD TRAUMA; POSTCONCUSSIVE SYMPTOMS; UNITED-STATES; MANAGEMENT; GUIDELINES	OBJECT In this study the authors reviewed clinical management and outcomes in a large series of children with isolated linear nondisplaced skull fractures (NDSFs). Factors associated with hospitalization of these patients and costs of management were also reviewed. METHODS After institutional review board approval, the authors retrospectively reviewed clinical records and imaging studies for patients between the ages of 0 and 16 years who were evaluated for NDSFs at a single children's hospital between January 2009 and December 2013. Patients were excluded if the fracture was open or comminuted. Additional exclusion criteria included intracranial hemorrhage, more than 1 skull fracture, or pneumocephalus. RESULTS Three hundred twenty-six patients met inclusion criteria. The median patient age was 19 months (range 2 weeks to 15 years). One hundred ninety-three patients (59%) were male and 133 (41%) were female. One hundred eighty-four patients (56%) were placed under 23-hour observation, 87 (27%) were admitted to the hospital, and 55 patients (17%) were discharged from the emergency department. Two hundred seventy-eight patients (85%) arrived by ambulance, 36(11%) arrived by car, and 12 (4%) were airlifted by helicopter. Two hundred fifty-seven patients (79%) were transferred from another institution. The mean hospital stay for patients admitted to the hospital was 46 hours (range 7-395 hours). The mean hospital stay for patients placed under 23-hour observation status was 18 hours (range 2-43 hours). The reasons for hospitalization longer than 1 day included Child Protective Services involvement in 24 patients and other injuries in 11 patients. Thirteen percent (n = 45) had altered mental status or loss of consciousness by history. No patient had any neurological deficits on examination, and none required neurosurgical intervention. Less than 16% (n = 50) had subsequent outpatient follow-up. These patients were all neurologically intact at the follow-up visit. CONCLUSIONS Hospitalization is not necessary for many children with NDSFs. Patients with mental status changes, additional injuries, or possible nonaccidental injury may require observation.	Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Pediat Surg, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Neurosurg, Houston, TX 77030 USA; Childrens Mem Hermann Hosp, Houston, TX USA		Sandberg, DI (corresponding author), Univ Texas Hlth Ctr Houston, Dept Pediat Neurosurg, 6431 Fannin St,MSB 5-144, Houston, TX 77030 USA.	david.i.sandberg@uth.tmc.edu			University of Texas Health-Science Center Summer Research Program Grant; National Institute of Neurological Diseases and Stroke (NTH) [5 T35 NS 64931-5]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T35NS064931] Funding Source: NIH RePORTER	The participation of Eliel N. Arrey, BS, in this project was supported by the University of Texas Health-Science Center Summer Research Program Grant. This grant is funded by the National Institute of Neurological Diseases and Stroke (NTH Award no. 5 T35 NS 64931-5)	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Ersahin Y, 1996, CHILD NERV SYST, V12, P323, DOI 10.1007/BF00301021; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hassan SF, 2014, J TRAUMA ACUTE CARE, V77, P166, DOI 10.1097/TA.0000000000000256; Hung GR, 2011, TINTINALLIS EMERGENC; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Moran C., 2012, HOUSTON CHRONICLE; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention, 2000, TRAUM BRAIN INJ US A; O'Halloran M, 2010, EXPENSE OUTRAGE COST; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	21	20	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2015	16	6					703	708		10.3171/2015.4.PEDS1545			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CX0FM	WOS:000365372300012	26339955	Bronze			2022-02-06	
J	Broer, S; Loscher, W				Broeer, Sonja; Loescher, Wolfgang			Novel combinations of phenotypic biomarkers predict development of epilepsy in the lithium-pilocarpine model of temporal lobe epilepsy in rats	EPILEPSY & BEHAVIOR			English	Article						Seizures; Epileptogenesis; Seizure threshold; Behavior; Status epilepticus	TRANSCRANIAL MAGNETIC STIMULATION; STATUS EPILEPTICUS; BRAIN-INJURY; BEHAVIORAL ALTERATIONS; SEIZURE MODEL; EPILEPTOGENESIS; BUMETANIDE; DISCOVERY; DISEASE; DAMAGE	The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. Epilepsy is often a consequence of brain insults such as traumatic brain injury or stroke, but as yet no biomarker exists to predict the development of epilepsy in patients at risk. Given the complexity of epilepsy, it is unlikely that a single biomarker is sufficient for this purpose, but a combinatorial approach may be needed to overcome the challenge of individual variability and disease heterogeneity. The goal of the present prospective study in the lithium-pilocarpinemodel of epilepsy in rats was to determine the discriminative utility of combinations of phenotypic biomarkers by examining their ability to predict epilepsy. For this purpose, we used a recent model refinement that allows comparing rats that will or will not develop spontaneous recurrent seizures (SRS) after pilocarpine-induced status epilepticus (SE). Potential biomarkers included in our study were seizure threshold and seizure severity in response to timed i.v. infusion of pentylenetetrazole (PTZ) and behavioral alterations determined by a battery of tests during the three weeks following SE. Three months after SE, video/EEG monitoring was used to determine which rats had developed SRS. To determine whether a biomarker or combination of biomarkers performed better than chance at predicting epilepsy after SE, derived data underwent receiver operating characteristic (ROC) curve analyses. When comparing rats with and without SRS and sham controls, the best intergroup discrimination was obtained by combining all measurements, resulting in a ROC area under curve (AUC) of 0.9592 (P < 0.01), indicating an almost perfect discrimination or accuracy to predict development of SRS. These data indicate that a combinatorial biomarker approach may overcome the challenge of individual variability in the prediction of epilepsy. (C) 2015 Elsevier Inc. All rights reserved.	[Loescher, Wolfgang] Univ Vet Med, Dept Pharmacol Toxicol & Pharm, D-30559 Hannover, Germany; Ctr Syst Neurosci, D-30559 Hannover, Germany		Loscher, W (corresponding author), Univ Vet Med, Dept Pharmacol Toxicol & Pharm, D-30559 Hannover, Germany.	wolfgang.loescher@tiho-hannover.de	Loscher, Wolfgang/G-9824-2016	Loscher, Wolfgang/0000-0002-9648-8973; Broer, Sonja/0000-0002-7969-6586	European UnionEuropean Commission [602102]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony (Germany)	This study was funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602102 (EPITARGET) and the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony (Germany). We thank G. Bougamra, R. Klee, Dr. V. Rankovic, J. Ostermeyer, P. Hampel, E. Kaczmarek, M. Weissing, and D. Moller for skilled technical assistance.	Atluri G, 2013, NEUROIMAGE-CLIN, V3, P123, DOI 10.1016/j.nicl.2013.07.004; Bauer PR, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714300010; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Brandt C, 2015, NEUROBIOL DIS, V75, P78, DOI 10.1016/j.nbd.2014.12.015; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Brima T, 2013, BRAIN RES, V1507, P146, DOI 10.1016/j.brainres.2013.02.037; Broer S, 2013, NEUROSCIENCE, V252, P253, DOI 10.1016/j.neuroscience.2013.07.050; Broer S, 2012, NEUROBIOL DIS, V46, P362, DOI 10.1016/j.nbd.2012.01.017; CHERLOW DG, 1977, ARCH NEUROL-CHICAGO, V34, P527, DOI 10.1001/archneur.1977.00500210029003; Choy M, 2014, J NEUROSCI, V34, P8672, DOI 10.1523/JNEUROSCI.4806-13.2014; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Faure JB, 2013, EPILEPSIA, V54, P1203, DOI 10.1111/epi.12219; FISH DR, 1993, BRAIN, V116, P397, DOI 10.1093/brain/116.2.397; Glien M, 2001, EPILEPSY RES, V46, P111, DOI 10.1016/S0920-1211(01)00272-8; GLOOR P, 1990, BRAIN, V113, P1673, DOI 10.1093/brain/113.6.1673; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; Honndorf S, 2011, EPILEPSY RES, V94, P26, DOI 10.1016/j.eplepsyres.2010.12.012; Hsieh TH, 2012, J NEUROPHYSIOL, V107, P966, DOI 10.1152/jn.00690.2011; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Kanner AM, 2014, NEUROTHERAPEUTICS, V11, P358, DOI 10.1007/s13311-014-0271-4; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kimiskidis VK, 2014, CURR OPIN NEUROL, V27, P236, DOI 10.1097/WCO.0000000000000071; Kucker S, 2010, NEUROBIOL DIS, V37, P661, DOI 10.1016/j.nbd.2009.12.002; Langer M, 2011, EPILEPSY RES, V96, P207, DOI 10.1016/j.eplepsyres.2011.06.005; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loscher W, 2009, EUR J PHARMACOL, V610, P1, DOI 10.1016/j.ejphar.2009.03.025; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Pitkanen A, 2012, JASPERS BASIC MECH E, P1; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; POLLACK GM, 1985, J PHARMACOL METHOD, V13, P135, DOI 10.1016/0160-5402(85)90057-9; Rattka M, 2013, EPILEPSY RES, V103, P135, DOI 10.1016/j.eplepsyres.2012.09.015; Rattka M, 2012, EUR J NEUROSCI, V36, P2505, DOI 10.1111/j.1460-9568.2012.08143.x; Rattka M, 2011, NEUROPHARMACOLOGY, V60, P505, DOI 10.1016/j.neuropharm.2010.11.005; Rice AC, 1998, EPILEPSIA, V39, P1148, DOI 10.1111/j.1528-1157.1998.tb01305.x; Rosen C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-20; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; SO N, 1989, ANN NEUROL, V25, P423, DOI 10.1002/ana.410250502; Soreide K, 2009, J CLIN PATHOL, V62, P1, DOI 10.1136/jcp.2008.061010; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; Valdes PA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646916; White HS, 2014, NEUROTHERAPEUTICS, V11, P373, DOI 10.1007/s13311-013-0250-1	50	20	20	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	DEC	2015	53						98	107		10.1016/j.yebeh.2015.09.028			10	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CY3RS	WOS:000366328200017	26539702				2022-02-06	
J	Kadow, BT; Tyagi, P; Chermansky, CJ				Kadow, Brian T.; Tyagi, Pradeep; Chermansky, Christopher J.			Neurogenic Causes of Detrusor Underactivity	CURRENT BLADDER DYSFUNCTION REPORTS			English	Article						Detrusor underactivity; Underactive bladder; Neurogenic bladder; Urinary retention		Detrusor underactivity (DU) is a poorly understood dysfunction of the lower urinary tract which arises from multiple etiologies. Symptoms of DU are non-specific, and a pressure-flow urodynamic study is necessary to differentiate DU from other conditions such as overactive bladder (OAB) or bladder outlet obstruction (BOO). The prevalence of DU ranges from 10 to 48 %, and DU is most prevalent in elderly males. The pathophysiology underlying DU can be from both neurogenic and non-neurogenic causes. In this article, we review the neurogenic causes of detrusor underactivity, including diabetic bladder dysfunction, spinal cord injury, multiple sclerosis, Parkinson's disease, cerebrovascular accident, traumatic brain injury, and Fowler's syndrome. As knowledge about the underlying causes of DU advances, there have been several potential therapeutic approaches proposed to help those who suffer from this condition.	[Kadow, Brian T.; Tyagi, Pradeep; Chermansky, Christopher J.] Univ Pittsburgh, Dept Urol, Med Ctr, 300 Halket St,Suite 4710, Pittsburgh, PA 15213 USA		Chermansky, CJ (corresponding author), Univ Pittsburgh, Dept Urol, Med Ctr, 300 Halket St,Suite 4710, Pittsburgh, PA 15213 USA.	chermanskycj2@upmc.edu			NIH/NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK093424]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK093424] Funding Source: NIH RePORTER	This study received support provided in part from NIH/NIDDK grant DK093424.	Abarbanel J, 2007, UROLOGY, V69, P436, DOI 10.1016/j.urology.2006.11.019; Abrams P, 1999, BJU INT, V84, P14; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Aizawa N, 2012, NEUROUROL URODYNAM, V31, P148, DOI 10.1002/nau.21212; Araki I, 2000, J UROLOGY, V164, P1640, DOI 10.1016/S0022-5347(05)67048-6; Araki I, 2003, J UROLOGY, V169, P1384, DOI 10.1097/01.ju.0000049644.27713.c8; Arrellano-Valdez F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-549; Badri AV, 2014, CURR UROL REP, V15, DOI 10.1007/s11934-014-0435-0; Blackett H, 2009, PARKINSONISM RELAT D, V15, P81, DOI 10.1016/j.parkreldis.2007.10.016; Bougas Dimitrios A., 2004, International Urology and Nephrology, V36, P507, DOI 10.1007/s11255-004-0847-8; BRINDLEY GS, 1977, J NEUROL NEUROSUR PS, V40, P358, DOI 10.1136/jnnp.40.4.358; BRINDLEY GS, 1982, PARAPLEGIA, V20, P365, DOI 10.1038/sc.1982.65; Burney TL, 1996, J UROLOGY, V156, P1748, DOI 10.1016/S0022-5347(01)65498-3; Campeau Lysanne, 2011, Curr Urol Rep, V12, P396, DOI 10.1007/s11934-011-0219-8; Cardenas DD, 2014, SPINAL CORD, V52, P70, DOI 10.1038/sc.2013.137; Chancellor MB, 2008, UROLOGY, V72, P966, DOI 10.1016/j.urology.2008.04.041; Chapple CR, 2015, EUR UROL, V68, P351, DOI 10.1016/j.eururo.2015.02.030; Cho HJ, 2015, ANN NEUROL, V77, P726, DOI 10.1002/ana.24379; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Corcos J, 2013, CUAJ-CAN UROL ASSOC, V7, pS181, DOI 10.5489/cuaj.1618; Cruz CD, 2015, ADV DRUG DELIVER REV, V82-83, P153, DOI 10.1016/j.addr.2014.11.007; DasGupta R, 2003, DRUGS, V63, P153, DOI 10.2165/00003495-200363020-00003; Dmitrieva N, 2002, J NEUROSCI, V22, P7147; Drake MJ, 2014, NAT REV UROL, V11, P454, DOI 10.1038/nrurol.2014.156; Ersoz M, 2005, CEREBROVASC DIS, V20, P395, DOI 10.1159/000088670; Fedele D, 2005, NAT CLIN PRACT UROL, V2, P282, DOI 10.1038/ncpuro0211; FOWLER CJ, 1985, BRIT J UROL, V57, P67, DOI 10.1111/j.1464-410X.1985.tb08988.x; FOWLER CJ, 1988, BRIT MED J, V297, P1436, DOI 10.1136/bmj.297.6661.1436; Frias B, 2015, J NEUROSCI, V35, P2146, DOI 10.1523/JNEUROSCI.0373-14.2015; FRIMODTMOLLER C, 1978, DAN MED BULL, V25, P49; Giannantoni A, 2011, ARCH PHYS MED REHAB, V92, P1134, DOI 10.1016/j.apmr.2011.02.013; Hinson JL, 1996, UROL CLIN N AM, V23, P475, DOI 10.1016/S0094-0143(05)70326-8; Jeong SJ, 2012, KOREAN J UROL, V53, P342, DOI 10.4111/kju.2012.53.5.342; Kim TG, 2015, ANN REHABIL MED-ARM, V39, P262, DOI 10.5535/arm.2015.39.2.262; Kong KH, 2000, ARCH PHYS MED REHAB, V81, P1464, DOI 10.1053/apmr.2000.9630; Krishnamoorthy S, 2009, INDIAN J UROL, V25, P407, DOI 10.4103/0970-1591.56186; Kulakli F, 2014, BRAIN INJURY, V28, P323, DOI 10.3109/02699052.2013.865268; Kuo Hann-Chorng, 2010, Rev Urol, V12, pe69; LAPIDES J, 1972, Journal of Urology, V107, P458; Levanovich PE, 2015, INT UROL NEPHROL, V47, P465, DOI 10.1007/s11255-015-0924-1; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIM CS, 1995, WORLD J UROL, V13, P34; Litwiller SE, 1999, J UROLOGY, V161, P743, DOI 10.1016/S0022-5347(01)61760-9; Liu CW, 2010, SPINAL CORD, V48, P319, DOI 10.1038/sc.2009.132; Liu Z, 2015, INT UROL NEPHROL, V47, P751, DOI 10.1007/s11255-015-0951-y; MAGGI CA, 1988, BRAIN RES, V449, P61, DOI 10.1016/0006-8993(88)91024-4; Manack A, 2011, NEUROUROL URODYNAM, V30, P395, DOI 10.1002/nau.21003; Miyazato Minoru, 2013, Rev Urol, V15, P11; Moody BJ, 2014, NEUROUROL URODYNAM, V33, P1159, DOI 10.1002/nau.22470; Nirmal J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102644; Oelke M, 2015, NEUROL URODYN; Osman NI, 2014, NAT REV UROL, V11, P639, DOI 10.1038/nrurol.2014.286; Pataky Z, 2013, EXP CLIN ENDOCR DIAB, V121, P20, DOI 10.1055/s-0032-1329957; Pezet S, 2006, ANNU REV NEUROSCI, V29, P507, DOI 10.1146/annurev.neuro.29.051605.112929; Ransmayr GN, 2008, NEUROLOGY, V70, P299, DOI 10.1212/01.wnl.0000296826.61499.26; Ren J, 2015, NEUROUROL URODYN; Roth B, 2009, J UROLOGY, V181, P2209, DOI 10.1016/j.juro.2009.01.049; Sasaki K, 2004, DIABETES, V53, P2723, DOI 10.2337/diabetes.53.10.2723; Sasaki K, 2003, UROL CLIN N AM, V30, P1, DOI 10.1016/S0094-0143(02)00116-7; SCHAFER W, 1995, WORLD J UROL, V13, P47; Sievert KD, 2010, ANN NEUROL, V67, P74, DOI 10.1002/ana.21814; Smith PP, 2014, INT UROL NEPHROL, V46, pS35, DOI 10.1007/s11255-014-0809-8; Smith PP, 2010, NEUROUROL URODYNAM, V29, P408, DOI 10.1002/nau.20765; Song QX, 2014, NAT REV UROL, V11, P579, DOI 10.1038/nrurol.2014.244; STASKIN DS, 1988, J UROLOGY, V140, P117, DOI 10.1016/S0022-5347(17)41501-1; Vizzard MA, 2006, PROG BRAIN RES, V152, P97, DOI 10.1016/S0079-6123(05)52007-7; Witsell DL, 2012, HEAD NECK-J SCI SPEC, V34, P1136, DOI 10.1002/hed.21894; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523; Yoshimura N, 2005, BJU INT, V95, P733, DOI 10.1111/j.1464-410X.2005.05392.x; Yu Z, 2015, UROL INT; Yum KS, 2013, EUR NEUROL, V70, P291, DOI 10.1159/000352040	71	20	20	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7212	1931-7220		CURR BLADDER DYSFUNC	Curr. Bladder Dysfunct. Rep.	DEC	2015	10	4					325	331		10.1007/s11884-015-0331-6			7	Urology & Nephrology	Emerging Sources Citation Index (ESCI)	Urology & Nephrology	V5Z9B	WOS:000420091000003	26715948	Green Accepted			2022-02-06	
J	Ulbrich, F; Kaufmann, K; Roesslein, M; Wellner, F; Auwarter, V; Kempf, J; Loop, T; Buerkle, H; Goebel, U				Ulbrich, Felix; Kaufmann, Kai; Roesslein, Martin; Wellner, Franziska; Auwaerter, Volker; Kempf, Juergen; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich			Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NOBLE-GAS ARGON; NF-KAPPA-B; SH-SY5Y CELLS; DAMAGE; ACTIVATION; XENON; PATHWAYS; ROTENONE; RATS	Purpose Recently, the noble gas argon attracted significant attention due to its neuroprotective properties. However, the underlying molecular mechanism is still poorly understood. There is growing evidence that the extracellular regulated kinase 1/2 (ERK1/2) is involved in Argon's protective effect. We hypothesized that argon mediates its protective effects via the upstream located toll-like receptors (TLRs) 2 and 4. Methods Apoptosis in a human neuroblastoma cell line (SH-SY5Y) was induced using rotenone. Argon treatment was performed after induction of apoptosis with different concentrations (25, 50 and 75 Vol% in oxygen 21 Vol%, carbon dioxide and nitrogen) for 2 or 4 hours respectively. Apoptosis was analyzed using flow cytometry (annexin-V (AV)/propidiumiodide (PI)) staining, caspase-3 activity and caspase cleavage. TLR density on the cells' surface was analyzed using FACS and immunohistochemistry. Inhibition of TLR signaling and extracellular regulated kinase 1/2 (ERK1/2) were assessed by western blot, activity assays and FACS analysis. Results Argon 75 Vol% treatment abolished rotenone-induced apoptosis. This effect was attenuated dose-and time-dependently. Argon treatment was accompanied with a significant reduction of TLR2 and TLR4 receptor density and protein expression. Moreover, argon mediated increase in ERK1/2 phosphorylation was attenuated after inhibition of TLR signaling. ERK1/2 and TLR signaling inhibitors abolished the anti-apoptotic and cytoprotective effects of argon. Immunohistochemistry results strengthened these findings. Conclusion These findings suggest that argon-mediated anti-apoptotic and neuroprotective effects are mediated via inhibition of TLR2 and TLR4.	[Ulbrich, Felix; Kaufmann, Kai; Roesslein, Martin; Wellner, Franziska; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich] Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Auwaerter, Volker; Kempf, Juergen] Univ Freiburg, Inst Forens Med, Forens Toxicol, D-79106 Freiburg, Germany		Ulbrich, F (corresponding author), Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany.	felix.ulbrich@uniklinik-freiburg.de	Gobel, Ulrich/Q-7613-2016; Auwarter, Volker/D-1075-2012	Gobel, Ulrich/0000-0002-9991-3226; Auwarter, Volker/0000-0002-1883-2804	German Research Foundation (DFG)German Research Foundation (DFG); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Alderliesten T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113575; Ali I, 2013, PULM CIRC, V3, P578, DOI 10.1086/674337; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Auwarter V, 2004, FORENSIC SCI INT, V143, P169, DOI 10.1016/j.forsciint.2004.02.043; Ben Mkaddem S, 2010, ONCOTARGET, V1, P741, DOI 10.18632/oncotarget.209; Brucken A, 2014, NEUROCRITICAL CARE; Brucken A, 2014, RESUSCITATION, V85, P826, DOI 10.1016/j.resuscitation.2014.02.014; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Condello S, 2011, J NEUROCHEM, V116, P67, DOI 10.1111/j.1471-4159.2010.07085.x; Cui WY, 2012, AMINO ACIDS, V43, P1157, DOI 10.1007/s00726-011-1171-0; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gan XQ, 2014, BONE, V62, P67, DOI 10.1016/j.bone.2014.01.018; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2013, CURR PROTEIN PEPT SC, V14, P33, DOI 10.2174/1389203711314010006; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Liu ZW, 2013, BIOL TRACE ELEM RES, V156, P262, DOI 10.1007/s12011-013-9857-7; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Monaghan TK, 2008, J MOL NEUROSCI, V36, P45, DOI 10.1007/s12031-008-9082-6; Spaggiari S, 2013, CELL CYCLE, V12, P2636, DOI 10.4161/cc.25650; Tan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102195; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Ulbrich F, 2015, J NEUROCHEMISTRY; Ulbrich F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115984; Vaisid T, 2013, BBA-MOL CELL RES, V1833, P2369, DOI 10.1016/j.bbamcr.2013.06.006; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	33	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143887	10.1371/journal.pone.0143887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	WOS:000365891600067	26624894	Green Published, gold, Green Submitted			2022-02-06	
J	Han, K; Chapman, SB; Krawczyk, DC				Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.			Altered amygdala connectivity in individuals with chronic traumatic brain injury and comorbid depressive symptoms	FRONTIERS IN NEUROLOGY			English	Article						TBI; depression; functional connectivity; fMRI; amygdala; resting-state; BDI; beck depression inventory-II	INTRINSIC FUNCTIONAL CONNECTIVITY; TREATMENT-RESISTANT DEPRESSION; POSTTRAUMATIC-STRESS-DISORDER; GLOBAL SIGNAL REGRESSION; IMPAIRED SELF-AWARENESS; MAJOR DEPRESSION; INVENTORY-II; PSYCHIATRIC-DISORDERS; NETWORK DYSFUNCTION; DEFAULT MODE	Depression is one of the most common psychiatric conditions in individuals with chronic traumatic brain injury (TBI). Though depression has detrimental effects in TBI and network dysfunction is a "hallmark" of TBI and depression, there have not been any prior investigations of connectivity-based neuroimaging biomarkers for comorbid depression in TBI. We utilized resting-state functional magnetic resonance imaging to identify altered amygdala connectivity in individuals with chronic TBI (8 years post injury on average) exhibiting comorbid depressive symptoms (N = 31), relative to chronic TBI individuals having minimal depressive symptoms (N = 23). Connectivity analysis of these participant sub-groups revealed that the TBI-plus-depressive symptoms group showed relative increases in amygdala connectivity primarily in the regions that are part of the salience, somatomotor, dorsal attention, and visual networks (p), < 0.01, Pihiswi < 0.025). Relative increases in amygdala connectivity in the TBI-plus-depressive symptoms group were also observed within areas of the limbic cortical mood regulating circuit (the left dorsomedial and right dorsolateral prefrontal cortices and thalamus) and the brainstem. Further analysis revealed that spatially dissociable patterns of correlation between amygdala connectivity and symptom severity according to subtypes (Cognitive and Affective) of depressive symptoms (p(voxel) < 0.01, p(duster) < 0.025). Taken together, these results suggest that amygdala connectivity may be a potentially effective neuroimaging biomarker for comorbid depressive symptoms in chronic TBI.	[Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Dallas, TX 75230 USA; [Krawczyk, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA		Han, K (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Dallas, TX 75230 USA.	kihwan.han@utdallas.edu	Han, Kihwan/I-1984-2019	Han, Kihwan/0000-0002-4574-7306	Department of Defense CDMRP grantsUnited States Department of Defense [W81XWH-11-2-0194, W81XWH-11-2-0195]; Meadows Foundation	We would like to thank all study participants and their families that supported this study. Our thanks also go to Mr. kVeikei Yu and Mr. Michael Holloway for the acquisition of MRI scans, Ms. Tiffani Jantz, Mr. David Martinez and Ms. Jellena Rakic for the acquisition of neuropsychological test scores and Mr. Barry Rodgers for his assistance with the analysis of neuropsychological test scores. Lastly, we would like to thank Dr. Ian Robertson and Dr. Vas Asha for their helpful suggestions. This work has been supported by Department of Defense CDMRP grants W81XWH-11-2-0194 to DCK and W81XWH-11-2-0195 to SRC and a grant from the Meadows Foundation to DCK and SBC.	Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Alalade E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020035; AMARAL DG, 1992, EXP BRAIN RES, V88, P375, DOI 10.1007/BF02259113; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; APPLEGATE CD, 1983, PHYSIOL BEHAV, V31, P353, DOI 10.1016/0031-9384(83)90201-9; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cao H, 2014, NEUROIMAGE, V84, P888, DOI 10.1016/j.neuroimage.2013.09.013; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chen CH, 2008, NEUROPSYCHOPHARMACOL, V33, P1909, DOI 10.1038/sj.npp.1301593; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; CLARK DC, 1983, J NERV MENT DIS, V171, P705, DOI 10.1097/00005053-198312000-00001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordova-Palomera A, 2015, HUM BRAIN MAPP, V36, P3761, DOI 10.1002/hbm.22876; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Pasquale F, 2013, NEUROIMAGE, V69, P51, DOI 10.1016/j.neuroimage.2012.11.051; Deb S, 1999, AM J PSYCHIAT, V156, P374; Delis D. C., 2001, D KEFS EXECUTIVE FUN; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Dutta A, 2014, PSYCHIAT RES-NEUROIM, V224, P139, DOI 10.1016/j.pscychresns.2014.10.003; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Goldberg D, 2011, WORLD PSYCHIATRY, V10, P226; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Guo WB, 2013, PROG NEURO-PSYCHOPH, V46, P13, DOI 10.1016/j.pnpbp.2013.06.009; Guo WB, 2013, PROG NEURO-PSYCHOPH, V44, P51, DOI 10.1016/j.pnpbp.2013.01.010; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hamilton JP, 2013, NEUROBIOL DIS, V52, P4, DOI 10.1016/j.nbd.2012.01.015; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Han K, 2011, J MAGN RESON IMAGING, V34, P1480, DOI 10.1002/jmri.22823; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Harro J, 2001, BRAIN RES REV, V38, P79, DOI 10.1016/S0165-0173(01)00082-0; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Hu X, 2015, MOVEMENT DISORD, V30, P238, DOI 10.1002/mds.26087; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Maller JJ, 2014, BEHAV BRAIN RES, V271, P147, DOI 10.1016/j.bbr.2014.05.047; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Manoliu A, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00930; Matthews SC, 2008, J AFFECT DISORDERS, V111, P13, DOI 10.1016/j.jad.2008.05.022; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Palmer GA, 2014, MIL MED, V179, P879, DOI 10.7205/MILMED-D-14-00048; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramasubbu R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00017; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Romero K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00158; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Saad ZS, 2013, BRAIN CONNECT, V3, P339, DOI 10.1089/brain.2013.0156; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Sakaki M, 2013, J COGNITIVE NEUROSCI, V25, P1206, DOI 10.1162/jocn_a_00392; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Siegert RJ, 2009, J INT NEUROPSYCH SOC, V15, P142, DOI 10.1017/S1355617708090048; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sripada C, 2014, NEUROIMAGE, V89, P110, DOI 10.1016/j.neuroimage.2013.11.006; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tahmasian M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00639; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Taylor JG, 2005, NEURAL NETWORKS, V18, P353, DOI 10.1016/j.neunet.2005.03.005; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ., 1995, GUIDELINES SURVEILLA; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vanheule S, 2008, ASSESSMENT, V15, P177, DOI 10.1177/1073191107311261; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER MEMORY SCAL; WechslerD, 2001, WECHSLER TEST ADULT; Wei MB, 2015, J AFFECT DISORDERS, V174, P527, DOI 10.1016/j.jad.2014.12.020; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]	159	20	22	2	22	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 4	2015	6								231	10.3389/fneur.2015.00231			22	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CV3LR	WOS:000364161200001	26581959	Green Published, gold			2022-02-06	
J	Ameloot, K; Genbrugge, C; Meex, I; Janssens, S; Boer, W; Mullens, W; Ferdinande, B; Dupont, M; Dens, J; De Deyne, C				Ameloot, K.; Genbrugge, C.; Meex, I.; Janssens, S.; Boer, W.; Mullens, W.; Ferdinande, B.; Dupont, M.; Dens, J.; De Deyne, C.			Low hemoglobin levels are associated with lower cerebral saturations and poor outcome after cardiac arrest	RESUSCITATION			English	Article						Hemoglobin; Post-cardiac arrest; Cerebral saturation	BLOOD-CELL TRANSFUSION; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; RESTRICTIVE TRANSFUSION; CRITICALLY-ILL; CLINICAL-TRIAL; ANEMIA; THRESHOLD; MORTALITY; CORONARY	Purpose: Post-cardiac arrest (CA) patients have a large cerebral penumbra at risk for secondary ischemic damage in case of suboptimal brain oxygenation during ICU stay. The aims of this study were to investigate the association between hemoglobin, cerebral oxygenation (SctO(2)) and outcome in post-CA patients. Methods: Prospective observational study in 82 post-CA patients. Hemoglobin, a corresponding SctO2 measured by NIRS and SVO2 in patients with a pulmonary artery catheter (n = 62) were determined hourly during hypothermia in the first 24 h of ICU stay. Results: We found a strong linear relationship between hemoglobin and mean SctO(2) (SctO2 = 0.70 x hemoglobin + 56 (R-2 0.84, p = 10(-6))). Hemoglobin levels below 10 g/dl generally resulted in lower brain oxygenation. There was a significant association between good neurological outcome (43/82 patients in CPC 1-2 at 180 days post-CA) and admission hemoglobin above 13 g/dl (OR 2.76, 95% CI 1.09: 7.00, p = 0.03) or mean hemoglobin above 12.3 g/dl (OR 2.88, 95% CI 1.02: 8.16, p = 0.04). This association was entirely driven by results obtained in patients with a mean SVO2 below 70% (OR 6.25, 95% CI 1.33: 29.43, p = 0.01) and a mean SctO2 below 62.5% (OR 5.87, 95% CI 1.08: 32.00, p = 0.03). Conclusion: Hemoglobin levels below 10 g/dl generally resulted in lower cerebral oxygenation. Average hemoglobin levels below 12.3 g/dl were associated with worse outcome in patients with suboptimal SVO2 or SctO2. The safety of a universal restrictive transfusion threshold of 7 g/dl can be questioned in post-CA patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ameloot, K.; Mullens, W.; Ferdinande, B.; Dupont, M.; Dens, J.] Ziekenhuis Oost Limburg, Dept Cardiol, B-3600 Schiepse Bos, Genk, Belgium; [Genbrugge, C.; Meex, I.; Boer, W.; De Deyne, C.] Ziekenhuis Oost Limburg, Dept Anesthesiol & Crit Care Med, B-3600 Schiepse Bos, Genk, Belgium; [Genbrugge, C.; Meex, I.; Mullens, W.; Dens, J.; De Deyne, C.] Univ Hasselt, Fac Med & Life Sci, Diepenbeek, Belgium; [Janssens, S.] Univ Hosp Leuven, Dept Cardiol, Leuven, Belgium		Ameloot, K (corresponding author), Ziekenhuis Oost Limburg, B-3600 Schiepse Bos, Genk, Belgium.	Koen.ameloot@zol.be	Boer, Willem/AAL-9731-2021; Genbrugge, Cornelia/AAD-8463-2019				Ameloot K, 2015, RESUSCITATION, V91, P56, DOI 10.1016/j.resuscitation.2015.03.016; Ameloot K, 2014, RESUSCITATION, V85, P1263, DOI 10.1016/j.resuscitation.2014.06.025; BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P505, DOI 10.1111/j.1748-1716.1975.tb05842.x; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; COETZEE A, 1990, SCAND J CLIN LAB INV, V50, P149, DOI 10.3109/00365519009087504; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Griesdale DE, 2014, NEUROCRIT CARE; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 2014, NEW ENGL J MED, V371, P1459, DOI 10.1056/NEJMe1408976; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hedstrom M, 1996, ACTA ORTHOP SCAND, V67, P317, DOI 10.3109/17453679609002322; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; KOROSUE K, 1992, STROKE, V23, P1487, DOI 10.1161/01.STR.23.10.1487; Kwok CS, 2015, JACC-CARDIOVASC INTE, V8, P436, DOI 10.1016/j.jcin.2014.09.026; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Meex I, 2013, RESUSCITATION, V84, P788, DOI 10.1016/j.resuscitation.2013.01.003; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Nagao K, 2012, AM J EMERG MED, V30, P770, DOI 10.1016/j.ajem.2011.03.031; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salisbury AC, 2014, J AM COLL CARDIOL, V64, P811, DOI 10.1016/j.jacc.2014.05.040; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Silvain J, 2014, J AM COLL CARDIOL, V63, P1289, DOI 10.1016/j.jacc.2013.11.029; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	36	20	20	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	NOV	2015	96						280	286		10.1016/j.resuscitation.2015.08.015			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	CY7JM	WOS:000366584500052	26325099				2022-02-06	
J	Jak, AJ; Aupperle, R; Rodgers, CS; Lang, AJ; Schiehser, DM; Norman, SB; Twamley, EW				Jak, Amy J.; Aupperle, Robin; Rodgers, Carie S.; Lang, Ariel J.; Schiehser, Dawn M.; Norman, Sonya B.; Twamley, Elizabeth W.			Evaluation of a hybrid treatment for Veterans with comorbid traumatic brain injury and posttraumatic stress disorder: Study protocol for a randomized controlled trial	CONTEMPORARY CLINICAL TRIALS			English	Article						PTSD; TBI; Cognitive processing therapy; Cognitive rehabilitation; Veterans; Treatment	COGNITIVE-PROCESSING THERAPY; PERSISTENT POSTCONCUSSION SYNDROME; HISTORY; PTSD; REHABILITATION; PERFORMANCE; COMPLAINTS; ADHERENCE; SYMPTOMS; OUTCOMES	Comorbidity of posttraumatic stress disorder (PTSD) and history of traumatic brain injury (TBI) is high among Veterans of Operation Iraqi Freedom/Enduring Freedom/New Dawn (OIF/OEF/OND). Cognitive processing therapy (CPT) is empirically supported for the treatment of PTSD, but it is not specifically designed to accommodate the memory, attention, or problem solving deficits that are experienced by many Veterans with comorbid PTSD and TBI. Compensatory cognitive rehabilitation, including cognitive symptom management and rehabilitation therapy (CogSMART), is effective for cognitive deficits stemming from a variety of etiologies, including TBI. We have integrated components of CogSMART into CPT in order to address the unique challenges faced by Veterans with ongoing cognitive complaints related to PTSD and a history of mild TBI. Here we describe an ongoing randomized controlled trial investigating the efficacy of our novel hybrid treatment, SMART-CPT, as compared to standard CPT, for OIF/OEF/OND Veterans with PTSD and a history of mild to moderate TBI. We describe the development of this hybrid treatment as well as implementation of the randomized controlled trial. Published by Elsevier Inc.	[Jak, Amy J.; Norman, Sonya B.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Jak, Amy J.; Rodgers, Carie S.; Lang, Ariel J.; Schiehser, Dawn M.; Norman, Sonya B.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Schiehser, Dawn M.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Jak, Amy J.; Rodgers, Carie S.; Lang, Ariel J.; Schiehser, Dawn M.; Norman, Sonya B.; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Aupperle, Robin] Univ Tulsa, Laureate Inst Brain Res, Tulsa, OK 74104 USA; [Norman, Sonya B.] Natl Ctr PTSD, White River Jct, VT USA		Jak, AJ (corresponding author), 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA.	ajak@ucsd.edu; raupperle@laureateinstitute.org; cariesodgers@va.gov; ajlang@ucsd.edu; dschiehser@ucsd.edu; snorman@ucsd.edu; etwamley@ucsd.edu	Aupperle, Robin/AAU-8550-2020		U.S. Department of DefenseUnited States Department of Defense [W81XWH-11-1-0641]	Funding was provided by U.S. Department of Defense award W81XWH-11-1-0641.	Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 2012, PTSD TRAUMATIC BRAIN; Bryant RA, 2012, PTSD MILD TRAUMATIC; Budget D.C., 2012, VETERANS HLTH ADM TR; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cook JM, 2015, ADM POLICY MENT HLTH, V42, P147, DOI 10.1007/s10488-014-0555-3; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Foa E.B., 2008, EFFECTIVE TREATMENTS; Forbes D, 2012, J ANXIETY DISORD, V26, P442, DOI 10.1016/j.janxdis.2012.01.006; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; GIBBONS RD, 1988, PSYCHOPHARMACOL BULL, V24, P438; Gupta SK, 2011, J PLANT PATHOL MICRO, V2, P2; Heaton R. K., 2004, REVISED COMPREHENSIV; Hedeker D., 1999, J EDUC BEHAV STAT, V24, P70, DOI DOI 10.3102/10769986024001070]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Keane TM, 1997, ANN NY ACAD SCI, V821, P24, DOI 10.1111/j.1749-6632.1997.tb48266.x; Kennedy C M, 2001, CNS Spectr, V6, P787; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lehman A, 1994, TOOLKIT EVALUATING Q; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; McCrea M., 2008, MILD TRAUMATIC BRAIN; MEYERS J, 1995, MEYERS SCORING SYSTE; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Resick P. A., 2008, COGNITIVE PROCESSING; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Suris A, 2013, J TRAUMA STRESS, V26, P28, DOI 10.1002/jts.21765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley E. W., 2015, J HEAD TRAU IN PRESS; Twamley E. W., 2014, J HEAD TRAUMA REHABI; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; VA/DoD, 2010, VA DOD CLIN PRACT GU; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler, 2008, WAIS 4 ADM SCORING M; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wisco BE, 2014, J CLIN PSYCHIAT, V75, P1338, DOI 10.4088/JCP.14m09328	63	20	20	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	NOV	2015	45		B				210	216		10.1016/j.cct.2015.10.009			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	DA4FJ	WOS:000367755200011	26500169	Bronze			2022-02-06	
J	Narad, ME; Minich, N; Taylor, HG; Kirkwood, MW; Brown, TM; Stancin, T; Wade, SL				Narad, Megan E.; Minich, Nori; Taylor, H. Gerry; Kirkwood, Michael W.; Brown, Tanya M.; Stancin, Terry; Wade, Shari L.			Effects of a Web-Based Intervention on Family Functioning Following Pediatric Traumatic Brain Injury	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						traumatic brain injury; adolescents; family functioning; problem solving	BEHAVIOR PROBLEMS; PARENTAL DISTRESS; ASSESSMENT DEVICE; HEAD-INJURY; CHILDREN; ADOLESCENTS; PREDICTORS; OUTCOMES; ADAPTATION; CHILDHOOD	Objective:Investigate effectiveness of an online Counselor-Assisted Problem-Solving (CAPS) intervention on family functioning after traumatic brain injury.Methods:Participants were randomized to CAPS (n = 65) or Internet resource comparison (IRC; n = 67). CAPS is a counselor-assisted web-based program. IRC was given access to online resources. Outcomes were examined at 6, 12, and 18 months after baseline. Injury severity, age, and socioeconomic status were examined as moderators.Results:A main effect of time was noted for teen-reported conflict and parent-reported problem solving. CAPS had decreased parent-reported conflict and a reduction in parental effective communication. Effects were specific to subsets of the sample.Conclusion:CAPS, a family-based problem-solving intervention designed to address problem behaviors, had modest effects on some aspects of family functioning compared with IRC. Effects were generally limited to subsets of the families and were not evident across all follow-up assessments.	[Narad, Megan E.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil & Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Minich, Nori; Taylor, H. Gerry] Case Western Reserve Univ, Div Dev & Behav Pediat & Pediat, Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Tanya M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Div Pediat Psychol, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil & Pediat, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil & Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Stancin, Terry/L-7993-2019		NIH from the National Institutes of Mental Health [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; National Institute of Disability and Rehabilitation Research, Department of Education [H133G050239]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	Supported in part by (1) NIH grant R01-MH073764 from the National Institutes of Mental Health, (2) a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program, and (3) grant H133G050239 from the National Institute of Disability and Rehabilitation Research, Department of Education. This material does not necessarily represent the policy of these agencies, or is the material necessarily endorsed by the Federal Government.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Lorenz FO, 2001, ANN M NAT COUNC FAM; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Melby JN, 2003, J SOC PERS RELAT, V20, P171, DOI 10.1177/02654075030202003; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; NEZU AM, 1986, J CONSULT CLIN PSYCH, V54, P196, DOI 10.1037/0022-006X.54.2.196; Pericall MTL, 2014, DEV MED CHILD NEUROL, V56, P19, DOI 10.1111/dmcn.12237; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Scaramella L., 1998, IOWA FAMILY INTERACT; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	28	20	20	2	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	NOV-DEC	2015	36	9					700	707		10.1097/DBP.0000000000000208			8	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	CV7YX	WOS:000364494500006	26461100	Green Accepted			2022-02-06	
J	Xu, LY; Ryu, J; Nguyen, JV; Arena, J; Rha, E; Vranis, P; Hitt, D; Marsh-Armstrong, N; Koliatsos, VE				Xu, Leyan; Ryu, Jiwon; Nguyen, Judy V.; Arena, John; Rha, Elizabeth; Vranis, Pamela; Hitt, Devon; Marsh-Armstrong, Nicholas; Koliatsos, Vassilis E.			Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						CTE; Concussion; Diffuse axonal injury; Retina; Tau; Traumatic axonal injury	MOUSE MODEL; NEUROFIBRILLARY TANGLES; UNITED-STATES; AXONAL INJURY; BLAST INJURY; RAT MODEL; CONCUSSION; HEAD; ENCEPHALOPATHY; DEMENTIA	Chronic traumatic encephalopathy (CTE) is associated with repetitive mild traumatic brain injury (mTBI) in the context of contact and collision sports, but not all exposed individuals develop this condition. In addition, experiments in animal models in several laboratories have shown that non-transgenic mice do not develop tauopathy after exposure to repetitive mTBI schedules. It is thus reasonable to assume that genetic factors may play an etiological role in the development of CTE. More than 40 mutations in the tau gene are known to confer proneness to aggregation and are thought to cause neurodegenerative diseases including frontotemporal degeneration (FTD). Transgenic mice harboring these mutations can be used to ask the question whether repetitive mTBI can accelerate onset and course of tauopathy or worsen the outcomes of transgenic disease. In this study, we exposed mice harboring the tau P301S transgene associated with FTD to repetitive mTBI schedules by impact acceleration (IA) that we have previously characterized. We explored the progression of tauopathy in the retina and neocortex based on density of neuronal profiles loaded with tau pS422, a marker of advanced tau hyperphosphorylation. We found that the density of tau pS422 (+) retinal ganglion cells (RGCs) increased twenty fold with one mTBI hit, a little over fifty fold with four mTBI hits and sixty fold with 12 mTBI hits. The severity of mTBI burden (number of hits) was a significant factor in tauopathy outcome. On the other hand, we found no association between repetitive mTBI and density of pS422 ( +) neuronal profiles in neocortex, a region that is not featured by significant TAI in our repetitive mTBI model. We observed similar, but less prominent, trends in tauopathy-prone transgenic mice harboring all 6 isoforms of wild-type human tau without mouse tau. Our findings indicate that repetitive mTBI accelerates tauopathy under diverse genetic conditions predisposing to tau aggregation and suggest a vulnerability-stress model in understanding some cases of acquired neurodegenerative disease after repetitive mTBI. (C) 2015 Elsevier Inc. All rights reserved.	[Xu, Leyan; Ryu, Jiwon; Arena, John; Rha, Elizabeth; Vranis, Pamela; Hitt, Devon; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Nguyen, Judy V.; Marsh-Armstrong, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Marsh-Armstrong, Nicholas] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Xu, LY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, 720 Rutland Ave,Ross Res Bldg 558, Baltimore, MD 21205 USA.	lxu9@jhmi.edu; jryu4@jhmi.edu; judy.v.nguyen@gmail.com; jarena2@jhmi.edu; lizrha@gmail.com; pvranis1@jhu.edu; dhitt@sas.upenn.edu; marsh-armstrong@jhmi.edu; koliat@jhmi.edu		Arena, John/0000-0002-4322-4472; Ryu, Jiwon/0000-0003-0251-7858; Vranis, Pamela/0000-0002-7942-5380; Hitt, Devon/0000-0002-4994-1392	Maryland TEDCO [2011-MSCRF-11 0067-00, 110902]; Spyros N Lemos memorial gift	This work was supported by Maryland TEDCO (2011-MSCRF-11 0067-00; 110902) and funds from the Spyros N Lemos memorial gift to VEK.	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; Allen B, 2002, J NEUROSCI, V22, P9340; Ando K, 2011, AM J PATHOL, V178, P803, DOI 10.1016/j.ajpath.2010.10.034; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Bussiere T, 1999, ACTA NEUROPATHOL, V97, P221, DOI 10.1007/s004010050978; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Collin L, 2014, BRAIN, V137, P2834, DOI 10.1093/brain/awu213; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Dujardin S, 2015, NEUROPATH APPL NEURO, V41, P59, DOI 10.1111/nan.12200; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hasegawa M, 1996, FEBS LETT, V384, P25, DOI 10.1016/0014-5793(96)00271-2; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koliatsos V. E., 2015, BRAIN NEUROTRAUMA MO; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pennanen L, 2005, BIOCHEM BIOPH RES CO, V337, P1097, DOI 10.1016/j.bbrc.2005.09.168; Persky Rebecca W, 2010, Curr Cardiol Rep, V12, P6, DOI 10.1007/s11886-009-0080-2; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sosin DM, 1996, BRAIN INJURY, V10, P47; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Voss K, 2011, AM J PATHOL, V179, P2148, DOI 10.1016/j.ajpath.2011.08.020; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Wszolek ZK, 2003, ADV NEUROL, V91, P153; Xu L, 2014, EXP NEUROL; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	69	20	21	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						168	176		10.1016/j.expneurol.2015.08.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW7BB	WOS:000365151800016	26311071				2022-02-06	
J	Turner, RC; Lucke-Wold, BP; Logsdon, AF; Robson, MJ; Dashnaw, ML; Huang, JH; Smith, KE; Huber, JD; Rosen, CL; Petraglia, AL				Turner, Ryan C.; Lucke-Wold, Brandon P.; Logsdon, Aric F.; Robson, Matthew J.; Dashnaw, Matthew L.; Huang, Jason H.; Smith, Kelly E.; Huber, Jason D.; Rosen, Charles L.; Petraglia, Anthony L.			The quest to model chronic traumatic encephalopathy: a multiple model and injury paradigm experience	FRONTIERS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; tauopathy; animal models; cognitive performance; perivascular pathology	BRAIN-INJURY; MOUSE MODEL; COGNITIVE IMPAIRMENT; DEFICITS; TAU; DIAGNOSIS; PATHOLOGY; DISEASE; STRESS; BETA	Chronic neurodegeneration following a history of neurotrauma is frequently associated with neuropsychiatric and cognitive symptoms. In order to enhance understanding about the underlying pathophysiology linking neurotrauma to neurodegeneration, a multi-model preclinical approach must be established to account for the different injury paradigms and pathophysiologic mechanisms. We investigated the development of tau pathology and behavioral changes using a multi-model and multi-institutional approach, comparing the preclinical results to tauopathy patterns seen in post-mortem human samples from athletes diagnosed with chronic traumatic encephalopathy (GTE). We utilized a scaled and validated blast induced traumatic brain injury model in rats and a modified pneumatic closed-head impact model in mice. Tau hyperphosphorylation was evaluated by western blot and immunohistochemistry. Elevated-plus maze and Morris water maze were employed to measure impulsive like behavior and cognitive deficits respectively. Animals exposed to single blast (similar to 50 PSI reflected peak overpressure) exhibited elevated AT8 immunoreactivity in the contralateral hippocampus at 1 month compared to controls (q = 3.96, p < 0.05). Animals exposed to repeat blast (six blasts over 2 weeks) had increased AT8 (q = 8.12, p < 0.001) and AT270 (q = 4.03, p < 0.05) in the contralateral hippocampus at 1 month post-injury compared to controls. In the modified controlled closed-head impact mouse model, no significant difference in AT8 was seen at 7 days, however a significant elevation was detected at 1 month following injury in the ipsilateral hippocampus compared to control (q = 4.34, p < 0.05). Elevated-plus maze data revealed that rats exposed to single blast (q = 3.53, p < 0.05) and repeat blast (q = 4.21, p <0.05) spent more time in seconds exploring the open arms compared to controls. Morris water maze testing revealed a significant difference between groups in acquisition times on days 22-27. During the probe trial, single blast (t = 6.44, p < 0.05) and repeat blast (t = 8.00, p < 005) rats spent less time in seconds exploring where the platform had been located compared to controls. This study provides a multi-model example of replicating tau and behavioral changes in animals and provides a foundation for future investigation of GTE disease pathophysiology and therapeutic development.	[Turner, Ryan C.; Lucke-Wold, Brandon P.; Rosen, Charles L.] W Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; [Turner, Ryan C.; Lucke-Wold, Brandon P.; Logsdon, Aric F.; Huber, Jason D.; Rosen, Charles L.] W Virginia Univ, Ctr Neurosci, Sch Med, Morgantown, WV 26506 USA; [Logsdon, Aric F.; Smith, Kelly E.; Huber, Jason D.] W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Robson, Matthew J.] Vanderbilt Univ, Sch Med, Dept Pharm, Nashville, TN 37235 USA; [Dashnaw, Matthew L.] Univ Rochester, Sch Med & Dent, Dept Neurosurg, Rochester, NY USA; [Huang, Jason H.] Baylor Scott & White Hlth Syst, Dept Neurosurg, Temple, TX USA; [Petraglia, Anthony L.] Rochester Reg Hlth, Div Neurosurg, Rochester, NY 14621 USA		Petraglia, AL (corresponding author), Rochester Reg Hlth, Div Neurosurg, Rochester, NY 14621 USA.	anthony.petraglia@rochesterregional.org	Robson, Matthew/H-3127-2013; Huang, Jason H/J-4739-2019; Lucke-Wold, Brandon/AAW-1881-2021; Lucke-Wold, Brandon/AAW-3525-2021	Robson, Matthew/0000-0002-3277-3062; Huang, Jason H/0000-0002-4426-0168; Lucke-Wold, Brandon/0000-0001-6577-4080; Turner, Ryan/0000-0001-5523-0645; Fraser, Kelly/0000-0003-1563-050X	West Virginia University Research Funding Development grant; American Foundation of Pharmaceutical Education; American Medical Association Foundation; Neurosurgery Research and Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER	A West Virginia University Research Funding Development grant funded the project. An American Foundation of Pharmaceutical Education Pre-doctoral Fellowship supported Brandon Lucke-Wold and Aric Logsdon. An American Medical Association Foundation Seed Grant and a Neurosurgery Research and Education Foundation Medical Student Summer Research Fellowship supported Brandon Lucke-Wold	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gandy Sam, 2014, F1000Res, V3, P229, DOI 10.12688/f1000research.5372.1; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucke-Wold BP, 2015, TRANSL RES, DOI [10.1016/j. trsl.2015.08.005, DOI 10.1016/J.TRSL.2015.05.005]; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002	46	20	21	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 20	2015	6								222	10.3389/fneur.2015.00222			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CV0JW	WOS:000363938000001	26539159	Green Published, gold			2022-02-06	
J	Ilie, G; Vingilis, ER; Mann, RE; Hamilton, H; Toplak, M; Adlaf, EM; Kolla, N; Ialomiteanu, A; van der Mass, M; Asbridge, M; Vingilis-Jaremko, L; Rehm, J; Cusimano, MD				Ilie, Gabriela; Vingilis, Evelyn R.; Mann, Robert E.; Hamilton, Hayley; Toplak, Maggie; Adlaf, Edward M.; Kolla, Nathan; Ialomiteanu, Anca; van der Mass, Mark; Asbridge, Mark; Vingilis-Jaremko, Larissa; Rehm, Juergen; Cusimano, Michael D.			The association between traumatic brain injury and ADHD in a Canadian adult sample	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Traumatic brain injury; Attention deficit disorders; ADHD; Anxiety; Ontario adults; Population survey	UNITED-STATES; HEAD-INJURY; ATTENTION; DISORDER; SURVEILLANCE; AGGRESSION; PREVALENCE; CHILDREN; RECOVERY; PEOPLE	Objective: This study describes the association between lifetime traumatic brain injury (TBI) and attention deficit and hyperactivity disorder (ADHD) among Canadian adults. Method: A cross-sectional sample of 3993 Ontario adults aged 18 or older were surveyed by Computer Assisted Telephone Interviewing (CATI) throughout 2011 and 2012 as part of the CAMH Monitor, a rolling survey assessing the health, mental health and substance use of Ontario adults. TBI was defined as trauma to the head that ed in loss of consciousness for at least five minutes or overnight hospitalization. ADHD was measured by the 6-item ASRS screener for adult ADHD, and self-reported history of diagnosed ADHD. Results: Among adults with a history of TBI, 6.6% (95% CI: 4.7, 9.4) screened ADHD positive, and 5.9% (95% CI: 3.6, 9.5) reported having been diagnosed with ADHD in their lifetime. Adults with lifetime TBI had significantly greater odds of scoring positive on the ADHD/ASRS screen (OR = 2.49, 95% Cl: 1.54, 4.04), and of reporting a history of diagnosed ADHD (OR = 2.64, 95% Cl: 1.40, 4.98) than without TBI, when holding values of sex, age, and education constant. Conclusion: Significant positive associations between lifetime TBI and both current and past ADHD were observed among adults in this population. More research to understand these associations, and their significance for the etiology and management of TBI and ADHD, is needed. (C) 2015 Elsevier Ltd. All rights reserved.	[Ilie, Gabriela] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Vingilis, Evelyn R.] Univ Western Ontario, Dept Family Med, Populat & Community Hlth Unit, London, ON, Canada; [Mann, Robert E.; Hamilton, Hayley; Adlaf, Edward M.; Kolla, Nathan; Ialomiteanu, Anca; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mann, Robert E.; Hamilton, Hayley; Adlaf, Edward M.; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [van der Mass, Mark] Univ Toronto, Dept Sociol, Toronto, ON M5S 1A1, Canada; [Toplak, Maggie] York Univ, Dept Psychol, LaMarsh Ctr Child & Youth Res, Toronto, ON M3J 2R7, Canada; [Kolla, Nathan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Ilie, Gabriela; Vingilis-Jaremko, Larissa] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada		Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Ilie, Gabriela/AAM-9122-2021; van der Maas, Mark/AAL-5601-2020; Kolla, Nathan/W-4671-2019; Cusimano, Michael/X-4059-2019	van der Maas, Mark/0000-0001-9606-0187; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR103946]; Ontario Neurotrauma Foundation; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 102537]; Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Social Sciences and Humanities Research Council (SSHRC)Social Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario	This work was financially supported by a Team Grant (TIR103946) from Canadian Institutes of Health Research and by funds from the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from the Canadian Institutes for Health Research (CIHR) operating grant (no. MOP 102537). AUTO21, a member of the Networks of Centres of Excellence (NCE) program that is administered and funded by the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Social Sciences and Humanities Research Council (SSHRC), in partnership with Industry Canada. Drs. RM, HH and JR also acknowledge on going funding support from the Ontario Ministry of Health and Long-Term Care.	Able SL, 2007, PSYCHOL MED, V37, P97, DOI 10.1017/S0033291706008713; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Adlaf E. M., 2013, CAMH MONITOR 2012 ME; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barkley R. A., 2006, ATTENTION DEFICIT HY; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Centre for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Eme R, 2012, EXPERT REV NEUROTHER, V12, P475, DOI [10.1586/ERN.12.15, 10.1586/ern.12.15]; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Finkelstein E, 2000, INCIDENCE EC BURDEN; Frances A, 2000, DSM 4 CLASSIFICATION; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heeringa SG, 2010, APPL SURVEY DATA; Hie G., 2015, J NEUROTRAUM, V32, P10; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Hughes A., 2013, IR, V34, P13, DOI [10.1080/03033910.2012.754323, DOI 10.1080/03033910.2012.754323]; Ialomiteanu A., 2011, CAMH RES DOCUMENT SE, V35; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Korn E.L., 1999, ANAL HLTH SURVEYS; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Laird RD, 2005, DEV PSYCHOPATHOL, V17, P127, DOI 10.1017/S0954579405050078; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Okie S, 2006, NEW ENGL J MED, V354, P2637, DOI 10.1056/NEJMp068113; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Silvetti M, 2013, NEURAL NETWORKS, V46, P199, DOI 10.1016/j.neunet.2013.05.008; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vingilis E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/982072; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weyandt Lisa L, 2006, J Atten Disord, V10, P9; Wickens CM, 2015, ACCIDENT ANAL PREV, V78, P87, DOI 10.1016/j.aap.2015.02.013; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Zernicke R. F., 2009, Journal of Intercollegiate Sport, V2, P42; Zwi M, 2008, BMJ-BRIT MED J, V6, P2244	55	20	20	1	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	OCT	2015	69						174	179		10.1016/j.jpsychires.2015.08.004			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CS2UP	WOS:000361927800025	26343610	Green Accepted			2022-02-06	
J	Samal, BB; Waites, CK; Almeida-Suhett, C; Li, Z; Marini, AM; Samal, NR; Elkahloun, A; Braga, MFM; Eiden, LE				Samal, Babru B.; Waites, Cameron K.; Almeida-Suhett, Camila; Li, Zheng; Marini, Ann M.; Samal, Nihar R.; Elkahloun, Abdel; Braga, Maria F. M.; Eiden, Lee E.			Acute Response of the Hippocampal Transcriptome Following Mild Traumatic Brain Injury After Controlled Cortical Impact in the Rat	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Hippocampus; Controlled cortical impact; Inflammation; Mild traumatic brain injury	CYCLASE-ACTIVATING POLYPEPTIDE; LENTIVIRAL INFECTION; EXPRESSION; SEQUELAE; STRESS; CELLS; MODEL	We have previously demonstrated that mild controlled cortical impact (mCCI) injury to rat cortex causes indirect, concussive injury to underlying hippocampus and other brain regions, providing a reproducible model for mild traumatic brain injury (mTBI) and its neurochemical, synaptic, and behavioral sequelae. Here, we extend a preliminary gene expression study of the hippocampus-specific events occurring after mCCI and identify 193 transcripts significantly upregulated, and 21 transcripts significantly downregulated, 24 h after mCCI. Fifty-three percent of genes altered by mCCI within 24 h of injury are predicted to be expressed only in the non-neuronal/glial cellular compartment, with only 13 % predicted to be expressed only in neurons. The set of upregulated genes following mCCI was interrogated using Ingenuity Pathway Analysis (IPA) augmented with manual curation of the literature (190 transcripts accepted for analysis), revealing a core group of 15 first messengers, mostly inflammatory cytokines, predicted to account for > 99 % of the transcript upregulation occurring 24 h after mCCI. Convergent analysis of predicted transcription factors (TFs) regulating the mCCI target genes, carried out in IPA relative to the entire Affymetrix-curated transcriptome, revealed a high concordance with TFs regulated by the cohort of 15 cytokines/cytokine-like messengers independently accounting for upregulation of the mCCI transcript cohort. TFs predicted to regulate transcription of the 193-gene mCCI cohort also displayed a high degree of overlap with TFs predicted to regulate glia-, rather than neuron-specific genes in cortical tissue. We conclude that mCCI predominantly affects transcription of non-neuronal genes within the first 24 h after insult. This finding suggests that early non-neuronal events trigger later permanent neuronal changes after mTBI, and that early intervention after mTBI could potentially affect the neurochemical cascade leading to later reported synaptic and behavioral dysfunction.	[Samal, Babru B.; Waites, Cameron K.; Eiden, Lee E.] NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Almeida-Suhett, Camila; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Li, Zheng] NIMH, Unit Synapse Dev & Plast, Bethesda, MD 20892 USA; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Elkahloun, Abdel] NHGRI, Microarray Core, Bethesda, MD 20892 USA		Eiden, LE (corresponding author), NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bldg 49,Room 5A-38,9000 Rockville Pike, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov	Li, Zheng/I-8016-2014; Samal, Babru/ABE-5931-2020; Almeida-Suhett, Camila/I-8045-2016	Li, Zheng/0000-0002-2978-2531; Almeida-Suhett, Camila/0000-0002-7588-9487; Waites, Cameron/0000-0001-6926-4643	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [Z01 MH002386-22]	We thank Chang-Mei Hsu for expert technical assistance in preparation of RNA for microarray and qRT-PCR analysis. This work was supported by the NIMH Intramural Research Program Project Z01 MH002386-22.	Ait-Ali D, 2010, CELL MOL NEUROBIOL, V30, P1441, DOI 10.1007/s10571-010-9620-y; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; Depboylu C, 2004, EUR J NEUROSCI, V19, P2997, DOI 10.1111/j.0953-816X.2004.03404.x; Depboylu C, 2012, J NEUROPATH EXP NEUR, V71, P15, DOI 10.1097/NEN.0b013e31823cfac5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eiden LE, 2008, ANN NY ACAD SCI, V1144, P6, DOI 10.1196/annals.1418.019; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Kovesdi E, 2008, NEUROTOX RES, V13, P71, DOI 10.1007/BF03033558; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Leker RR, 2002, ACTA NEUROCHIR SUPPL, V83, P49; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; McCabe JT, 2014, ULTRASOUND MED BIOL, V40, P965, DOI 10.1016/j.ultrasmedbio.2013.11.023; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Samal B, 2007, PEPTIDES, V28, P1871, DOI 10.1016/j.peptides.2007.06.013; Samal BB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.131pt4; Serova LI, 2013, NEUROSCIENCE, V236, P298, DOI 10.1016/j.neuroscience.2013.01.040; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WEIHE E, 1993, NEUROREPORT, V4, P263, DOI 10.1097/00001756-199303000-00009	30	20	20	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	OCT	2015	57	2					282	303		10.1007/s12031-015-0626-2			22	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CR7VN	WOS:000361560000016	26319264				2022-02-06	
J	Gregson, BA; Rowan, EN; Francis, R; McNamee, P; Boyers, D; Mitchell, P; McColl, E; Chambers, IR; Unterberg, A; Mendelow, AD				Gregson, Barbara A.; Rowan, Elise N.; Francis, Richard; McNamee, Paul; Boyers, Dwayne; Mitchell, Patrick; McColl, Elaine; Chambers, Iain R.; Unterberg, Andreas; Mendelow, A. David		STITCH TRAUMA Investigators	Surgical Trial In Traumatic intraCerebral Haemorrhage (STITCH): a randomised controlled trial of Early Surgery compared with Initial Conservative Treatment	HEALTH TECHNOLOGY ASSESSMENT			English	Article							COST-EFFECTIVENESS; HEAD-INJURY; HEMATOMAS; DESIGN; SPINE; STICH	Background: While it is accepted practice to remove extradural (EDH) and subdural haematomas (SDH) following traumatic brain injury, the role of surgery in parenchymal traumatic intracerebral haemorrhage (TICH) is controversial. There is no evidence to support Early Surgery in this condition. Objectives: There have been a number of trials investigating surgery for spontaneous intracerebral haemorrhage but none for TICH. This study aimed to establish whether or not a policy of Early Surgery for TICH improves outcome compared with a policy of Initial Conservative Treatment. Design: This was an international multicentre pragmatic parallel group trial. Patients were randomised via an independent telephone/web-based randomisation service. Setting: Neurosurgical units in 59 hospitals in 20 countries registered to take part in the study. Participants: The study planned to recruit 840 adult patients. Patients had to be within 48 hours of head injury with no more than two intracerebral haematomas greater than 10 ml. They did not have a SDH or EDH that required evacuation or any severe comorbidity that would mean they could not achieve a favourable outcome if they made a complete recovery from their head injury. Interventions: Patients were randomised to Early Surgery within 12 hours or to Initial Conservative Treatment with delayed evacuation if it became clinically appropriate. Main outcome measures: The Extended Glasgow Outcome Scale (GOSE) was measured at 6 months via a postal questionnaire. The primary outcome was the traditional dichotomised split into favourable outcome (good recovery or moderate disability) and unfavourable outcome (severe disability, vegetative, dead). Secondary outcomes included mortality and an ordinal assessment of Glasgow Outcome Scale and Rankin Scale. Results: Patient recruitment began in December 2009 but was halted by the funding body because of low UK recruitment in September 2012. In total, 170 patients were randomised from 31 centres in 13 countries: 83 to Early Surgery and 87 to Initial Conservative Treatment. Six-month outcomes were obtained for 99% of 168 eligible patients (82 Early Surgery and 85 Initial Conservative Treatment patients). Patients in the Early Surgery group were 10.5% more likely to have a favourable outcome (absolute benefit), but this difference did not quite reach statistical significance because of the reduced sample size. Fifty-two (63%) had a favourable outcome with Early Surgery, compared with 45 (53%) with Initial Conservative Treatment [odds ratio 0.65; 95% confidence interval (CI) 0.35 to 1.21; p = 0.17]. Mortality was significantly higher in the Initial Conservative Treatment group (33% vs. 15%; absolute difference 18.3%; 95% CI 5.7% to 30.9%; p = 0.006). The Rankin Scale and GOSE were significantly improved with Early Surgery using a trend analysis (p = 0.047 and p = 0.043 respectively). Conclusions: This is the first ever trial of surgery for TICH and indicates that Early Surgery may be a valuable tool in the treatment of TICH, especially if the Glasgow Coma Score is between 9 and 12, as was also found in Surgical Trial In spontaneous intraCerebral Haemorrhage (STICH) and Surgical Trial In spontaneous lobar intraCerebral Haemorrhage (STICH II). Further research is clearly warranted.	[Gregson, Barbara A.; Rowan, Elise N.; Francis, Richard; Mitchell, Patrick; Mendelow, A. David] Newcastle Univ, Inst Neurosci, Neurosurg Trials Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McNamee, Paul; Boyers, Dwayne] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [McColl, Elaine] Newcastle Univ, Newcastle Clin Trials Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Chambers, Iain R.] James Cook Univ Hosp, South Tees Hosp Fdn Trust, Middlesbrough, Cleveland, England; [Unterberg, Andreas] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany		Gregson, BA (corresponding author), Newcastle Univ, Inst Neurosci, Neurosurg Trials Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	barbara.gregson@ncl.ac.uk	Agrawal, Amit/C-1511-2011; Abdullah, J/C-2828-2011; Mendelow, Alexander/AAW-2878-2021; McColl, Elaine/V-9906-2019; Boyers, Dwayne/AAJ-8774-2021	Agrawal, Amit/0000-0002-3287-5448; Abdullah, J/0000-0002-0258-7410; McColl, Elaine/0000-0001-8300-3204; 	Chief Scientist Office [HSRU1, HERU1] Funding Source: Medline		Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons AANS/CNS Joint Section on Neurotrauma and Critical Care, 2008, J NEUROTRAUM, V25, P276; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Briggs AH, 1999, HLTH TECHNOL ASSESS, P3; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; D'Avella D, 2001, J Neurosurg Sci, V45, P29; Department of Health (DH), 2013, NHS PAYMENT BY RESUL; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Francis R, 2014, CHARACTERISTICS OF T; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; Glick H, 2007, ECONOMIC EVALUATION; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Hutchinson P, THE RESCUEICP STUDY; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kenyon GM, 2011, BRIT J NEUROSURG, V25, P352, DOI 10.3109/02688697.2010.551675; Kind P, 1999, CENTRE FOR HEALTH EC; Kind P, 1996, QUALITY LIFE PHARMAC, V2, P191; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Manca A, 2010, PHARMACOECONOMICS, V28, P1079, DOI 10.2165/11537760-000000000-00000; Marion DW, 2006, NEUROSURGERY, V58, P655; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Mendelow AD, 2005, LANCET, V365, P387; Mendelow AD, 2003, ACTA NEUROCHIR, V145, P679, DOI 10.1007/s00701-003-0063-9; MENDELOW AD, 1993, STROKE, V24, pI115; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; National Institute for Health and Care Excellence (NICE), 2003, NICE CLINICAL GUIDEL; National Institute for Health and Care Excellence (NICE), 2007, CLINICAL GUIDELINES; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Prasad K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000200.pub2, 10.1002/14651858.CD002244.pub3]; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Siddique MS, 2002, J NEUROSURG, V96, P86, DOI 10.3171/jns.2002.96.1.0086; Simon J, 2006, BJOG-INT J OBSTET GY, V113, P144, DOI 10.1111/j.1471-0528.2005.00785.x; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; World Bank, GNI PER CAPITA HOW W; World Health Organization, COST EFFECTIVENESS A; ZUMKELLER M, 1992, NEUROSURG REV, V15, P33, DOI 10.1007/BF02352065	44	20	22	0	1	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	SEP	2015	19	70								10.3310/hta19700			162	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	CR0DZ	WOS:000360989800001	26346805	Green Published, Green Submitted, gold			2022-02-06	
J	Grossman, EJ; Kirov, II; Gonen, O; Novikov, DS; Davitz, MS; Lui, YW; Grossman, RI; Inglese, M; Fieremans, E				Grossman, Elan J.; Kirov, Ivan I.; Gonen, Oded; Novikov, Dmitry S.; Davitz, Matthew S.; Lui, Yvonne W.; Grossman, Robert I.; Inglese, Matilde; Fieremans, Els			N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI	NEUROIMAGE			English	Article						Diffusion MRI; Mild traumatic brain injury; Proton magnetic resonance spectroscopy; White matter tract integrity; NAA; Diffusion kurtosis imaging	TRAUMATIC BRAIN-INJURY; GAUSSIAN WATER DIFFUSION; WHITE-MATTER; AXONAL INJURY; TISSUE-MICROSTRUCTURE; RELAXATION-TIMES; KURTOSIS; SPECTROSCOPY; DENSITY; MODELS	Diffusion MRI combined with biophysical modeling allows for the description of a white matter (WM) fiber bundle in terms of compartment specific white matter tract integrity (WMTI) metrics, which include intra-axonal diffusivity (D-axon), extra-axonal axial diffusivity (D-e parallel to), extra-axonal radial diffusivity (D-e perpendicular to), axonal water fraction (AWF), and tortuosity (alpha) of extra-axonal space. Here we derive these parameters from diffusion kurtosis imaging to examine their relationship to concentrations of global WM N-acetyl-aspartate (NAA), creatine (Cr), choline (Cho) and myo-Inositol (mI), as measured with proton MR spectroscopy (H-1-MRS), in a cohort of 25 patients with mild traumatic brain injury (MTBI). We found statistically significant (p < 0.05) positive correlations between NAA and Daxon, AWF, a, and fractional anisotropy; negative correlations between NAA and D-e,D-perpendicular to and the overall radial diffusivity (D-perpendicular to). These correlations were supported by similar findings in regional analysis of the genu and splenium of the corpus callosum. Furthermore, a positive correlation in global WM was noted between Daxon and Cr, as well as a positive correlation between D-e parallel to and Cho, and a positive trend between D-e parallel to and mI. The specific correlations between NAA, an endogenous probe of the neuronal intracellular space, and WMTI metrics related to the intra-axonal space, combined with the specific correlations of D-e parallel to with mI and Cho, both predominantly present extra-axonally, corroborate the overarching assumption of many advanced modeling approaches that diffusion imaging can disentangle between the intra-and extra-axonal compartments in WM fiber bundles. Our findings are also generally consistent with what is known about the pathophysiology of MTBI, which appears to involve both intra-axonal injury (as reflected by a positive trend between NAA and D-axon) as well as axonal shrinkage, demyelination, degeneration, and/or loss (as reflected by correlations between NAA and D-e perpendicular to, AWF, and alpha). (C) 2015 Elsevier Inc. All rights reserved.	[Grossman, Elan J.; Kirov, Ivan I.; Gonen, Oded; Novikov, Dmitry S.; Lui, Yvonne W.; Grossman, Robert I.; Inglese, Matilde; Fieremans, Els] NYU, Dept Radiol, Sch Med, Ctr Biomed Imaging, New York, NY 10016 USA; [Grossman, Elan J.; Gonen, Oded] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY USA; [Davitz, Matthew S.] NYU, Coll Arts & Sci, New York, NY USA; [Inglese, Matilde] Mt Sinai Sch Med, Dept Neurol Radiol & Neurosci, New York, NY USA; [Inglese, Matilde] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy		Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol Radiol & Neurosci, One Gustave L Levy Pl,Box 1137, New York, NY 10029 USA.	ejg279@nyu.edu; Ivan.Kirov@nyumc.org; Oded.Gonen@nyumc.org; Dmitry.Novikov@nyumc.org; md2773@nyu.edu; Yvonne.Lui@nyumc.org; Robert.Grossman@nyumc.org; matilde.inglese@mssm.edu; Els.Fieremans@nyumc.org	Inglese, Matilde/AAH-3189-2020; Kirov, Ivan/I-2792-2019	Inglese, Matilde/0000-0002-9610-0297; Kirov, Ivan/0000-0001-5641-8578; Fieremans, Els/0000-0002-1384-8591; Gonen, Oded/0000-0002-3148-2028; Novikov, Dmitry/0000-0002-4213-3050	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EB01015, NS050520, NS039135, NS051623]; Noto Foundation; Center for Advanced Imaging Innovation and Research; National Institute for Biomedical Imaging and Bioengineering Biomedical Technology Resource Center [P41EB017183]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183, R01EB001015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051623, R56NS051623, R56NS050520, R01NS039135, R01NS088040, R01NS050520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051] Funding Source: NIH RePORTER	The authors thank Jelle Veraart for assistance with image post-processing and James Babb for fruitful discussions on statistical analyses. This research was supported in part by the National Institutes of Health grant numbers EB01015, NS050520, NS039135, and NS051623, the Noto Foundation to M.I., and the Center for Advanced Imaging Innovation and Research, a National Institute for Biomedical Imaging and Bioengineering Biomedical Technology Resource Center, for grant number P41EB017183.	Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Basser P., 2007, MAGN RESON IMAGING, V25, P550; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Burcaw L. M., 2014, P INT SOC MAGN RESON, V22, P4434; Burcaw LM, 2015, NEUROIMAGE, V114, P18, DOI 10.1016/j.neuroimage.2015.03.061; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Ethofer T, 2003, MAGN RESON MED, V50, P1296, DOI 10.1002/mrm.10640; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E., 2012, P 20 SCI M, P3600; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Goelman G, 2007, MAGN RESON MED, V58, P167, DOI 10.1002/mrm.21251; Goelman G, 2006, MAGN RESON MED, V56, P34, DOI 10.1002/mrm.20942; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; HU J, 1995, J MAGN RESON SER B, V108, P213, DOI 10.1006/jmrb.1995.1126; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones D.K., 2010, DIFFUSION MRI THEORY; Kirov II, 2008, MAGN RESON MED, V60, P790, DOI 10.1002/mrm.21715; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kiselev V. G., 2010, DIFFUSION MRI THEORY; Kroenke CD, 2004, MAGN RESON MED, V52, P1052, DOI 10.1002/mrm.20260; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Maier SE, 2004, MAGN RESON MED, V51, P321, DOI 10.1002/mrm.10685; Mori S, 2005, MRI ATLAS HUMAN WHIT; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Novikov D.S., 2015, P INT SOC MAG RESON, V23, P469; Novikov DS, 2014, P NATL ACAD SCI USA, V111, P5088, DOI 10.1073/pnas.1316944111; Ozarslan E, 2013, NEUROIMAGE, V78, P16, DOI 10.1016/j.neuroimage.2013.04.016; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Panagiotaki E, 2009, LECT NOTES COMPUT SC, V5761, P329; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soher BJ, 1998, MAGNET RESON MED, V40, P822, DOI 10.1002/mrm.1910400607; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tal A, 2012, NMR BIOMED, V25, P1392, DOI 10.1002/nbm.2812; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wellcome Trust Centre for Neuroimaging U.C.L., 2010, STAT PAR MAPP SPM8 M; Wijtenburg SA, 2013, NEUROIMAGE, V66, P161, DOI 10.1016/j.neuroimage.2012.10.014; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	71	20	20	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP	2015	118						334	343		10.1016/j.neuroimage.2015.05.061			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CQ5GB	WOS:000360630200032	26037050	Green Accepted			2022-02-06	
J	Jaramillo, CA; Cooper, DB; Wang, CP; Tate, DF; Eapen, BC; York, GE; Pugh, MJ				Jaramillo, Carlos A.; Cooper, Douglas B.; Wang, Chen-Pin; Tate, David F.; Eapen, Blessen C.; York, Gerald E.; Pugh, Mary Jo			Subgroups of US IRAQ and Afghanistan veterans: associations with traumatic brain injury and mental health conditions	BRAIN IMAGING AND BEHAVIOR			English	Article						Veterans; Iraq; Afghanistan; TBI; PTSD; Latent class analysis	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SUBSTANCE USE DISORDERS; ENDURING FREEDOM; PTSD SYMPTOMS; WAR VETERANS; CHRONIC PAIN; LATENT CLASSES; MILITARY; CARE	U. S. veterans of Iraq and Afghanistan are known to have a high prevalence of traumatic brain injury (TBI), posttraumatic stress disorder (PTSD), and depression, which are often comorbid and share many symptoms. Attempts to describe this cohort by single diagnoses have limited our understanding of the complex nature of this population. The objective of this study was to identify subgroups of Iraq and Afghanistan veterans (IAVs) with distinct compositions of symptoms associated with TBI, PTSD, and depression. Our cross-sectional, observational study included 303,716 IAVs who received care in the Veterans Health Administration in 2010-2011. Symptoms and conditions were defined using International Classification of Diseases, Ninth Revision codes and symptom-clusters were identified using latent class analysis. We identified seven classes with distinct symptom compositions. One class had low probability of any condition and low health care utilization (HCU) (48 %). Other classes were characterized by high probabilities of mental health comorbidities (14 %); chronic pain and sleep disturbance (20 %); headaches and memory problems (6 %); and auditory problems (2.5 %). Another class had mental health comorbidities and chronic pain (7 %), and the last had high probabilities of most symptoms examined (3 %). These last two classes had the highest likelihood of TBI, PTSD, and depression and were identified as high healthcare utilizers. There are subgroups of IAVs with distinct clusters of symptom that are meaningfully associated with TBI, PTSD, depression, and HCU. Additional studies examining these veteran subgroups could improve our understanding of this complex comorbid patient population.	[Jaramillo, Carlos A.; Eapen, Blessen C.] South Texas Vet Healthcare Syst ALMD, Polytrauma Rehabil Ctr, San Antonio, TX 78229 USA; [Cooper, Douglas B.; Tate, David F.; York, Gerald E.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Wang, Chen-Pin; Pugh, Mary Jo] South Texas Vet Hlth Care Syst, Res & Dev, San Antonio, TX 78229 USA; [Wang, Chen-Pin; Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA		Jaramillo, CA (corresponding author), South Texas Vet Healthcare Syst ALMD, Polytrauma Rehabil Ctr, 7400 Merton Minter Blvd 11C6, San Antonio, TX 78229 USA.	jaramilloc3@uthscsa.edu; douglas.b.cooper.ctr@mail.mil; wangc3@uthscsa.edu; dftatephd@mac.com; Blessen.Eapen2@va.gov; gerald.e.york4.mil@mail.mil; maryjo.pugh2@va.gov	Pugh, Mary Jo/K-5336-2019; Tate, David F/I-3963-2013	Pugh, Mary Jo/0000-0003-4196-7763; Tate, David F/0000-0003-0213-1920	VA Health Services Research and DevelopmentUS Department of Veterans Affairs [DHI 09-237]; Veterans AffairsUS Department of Veterans Affairs [I01HX000329] Funding Source: NIH RePORTER	The study was funded by VA Health Services Research and Development (DHI 09-237).	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Association A. P, 2000, DIAGN STAT MAN MENT; Bandeen-Roche K, 1997, J AM STAT ASSOC, V92, P1375, DOI 10.2307/2965407; Belanger H. G., 2012, VALIDITY VET HLTH AD; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Elbogen EB, 2013, PSYCHIAT SERV, V64, P134, DOI 10.1176/appi.ps.004792011; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hebenstreit C, 2014, J AFFECT DISORDERS, V166, P132, DOI 10.1016/j.jad.2014.04.061; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holowka DW, 2014, J CONSULT CLIN PSYCH, V82, P569, DOI 10.1037/a0036347; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Landy PJB, 1998, INJURY, V29, P199, DOI 10.1016/S0020-1383(97)00178-2; Lanza S. T., 2012, HDB PSYCHOL RES METH, P691; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maguen S, 2013, J AFFECT DISORDERS, V145, P344, DOI 10.1016/j.jad.2012.08.021; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Romesser J, 2012, J REHABIL RES DEV, V49, P1127, DOI 10.1682/JRRD.2010.12.0238; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Walker W. C., 2012, J HEAD TRAUMA REHAB, V38, P329; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	53	20	20	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					445	455		10.1007/s11682-015-9402-8			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CR8LQ	WOS:000361604300006	25963862				2022-02-06	
J	Ki, HJ; Lee, HJ; Lee, HJ; Yi, JS; Yang, JH; Lee, IW				Ki, Hee Jong; Lee, Hyung-Jin; Lee, Hong-Jae; Yi, Jin-Seok; Yang, Ji-Ho; Lee, Il-Woo			The Risk Factors for Hydrocephalus and Subdural Hygroma after Decompressive Craniectomy in Head Injured Patients	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Decompressive craniectomy; Hydrocephalus; Subdural hygroma	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; COMMUNICATING HYDROCEPHALUS; SURGICAL COMPLICATIONS; EFFUSION	Objective : The present study aims to investigate 1) the risk factors for hydrocephalus and subdural hygroma (SDG) occurring after decompressive craniectomy (DC), and 2) the association between the type of SDG and hydrocephalus. Methods : We retrospectively reviewed the clinical and radiological features of 92 patients who underwent DC procedures after severe head injuries. The risk factors for developing post-traumatic hydrocephalus (PTH) and SDG were analyzed. Types of SDGs were classified according to location and their relationship with hydrocephalus was investigated. Results : Ultimately, 26.09% (24/92) of these patients developed PTH. In the univariate analyses, hydrocephalus was statically associated with large bone flap diameter, large craniectomy area, bilateral craniectomy, intraventricular hemorrhage, contralateral or interhemisheric SDGs, and delayed cranioplasty. However, in the multivariate analysis, only large craniectomy area (adjusted OR=4.66; p=0.0239) and contralateral SDG (adjusted OR=6.62; p=0.0105) were significant independent risk factors for developing hydrocephalus after DC. The incidence of overall SDGs after DC was 55.43% (51/92). Subgroup analysis results were separated by SDG types. Statistically significant associations between hydrocephalus were found in multivariate analysis in the contralateral (adjusted OR=5.58; p=0.0074) and interhemispheric (adjusted OR=17.63; p=0.0113) types. Conclusion : For patients who are subjected to DC following severe head trauma, hydrocephalus is associated with a large craniectomy area and contralateral SDG. For SDGs after DC that occur on the interhemispherical or controlateral side of the craniectomy, careful follow-up monitoring for the potential progression into hydrocephalus is needed.	[Ki, Hee Jong; Lee, Hyung-Jin; Lee, Hong-Jae; Yi, Jin-Seok; Yang, Ji-Ho; Lee, Il-Woo] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Neurosurg, Taejon 34943, South Korea		Lee, HJ (corresponding author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Neurosurg, 64 Daeheung Ro, Taejon 34943, South Korea.	hyungjin@catholic.ac.kr					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Cho BR, 2012, KOREAN J NEUROTRAUMA, V8, P110; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; da Costa DG, 1941, ARCH SURG-CHICAGO, V43, P559, DOI 10.1001/archsurg.1941.01210160020003; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; FOLTZ EL, 1956, J NEUROSURG, V13, P546, DOI 10.3171/jns.1956.13.6.0546; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; OHNO K, 1987, J NEUROL NEUROSUR PS, V50, P1694, DOI 10.1136/jnnp.50.12.1694; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; VANNESTE J, 1992, ARCH NEUROL-CHICAGO, V49, P366, DOI 10.1001/archneur.1992.00530280046021; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	29	20	27	0	4	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2015	58	3					254	261		10.3340/jkns.2015.58.3.254			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CX2BU	WOS:000365500700014	26539270	gold, Green Published			2022-02-06	
J	Kriz, PK; Zurakowski, RD; Almquist, JL; Reynolds, J; Ruggieri, D; Collins, CL; d'Hemecourt, PA; Comstock, RD				Kriz, Peter K.; Zurakowski, R. David; Almquist, Jon L.; Reynolds, John; Ruggieri, Danielle; Collins, Christy L.; d'Hemecourt, Pierre A.; Comstock, R. Dawn			Eye Protection and Risk of Eye Injuries in High School Field Hockey	PEDIATRICS			English	Article							LACROSSE; EYEWEAR; HEAD; FACE	OBJECTIVE: To determine if injury rates among female field hockey players differ before and after implementation of a national mandate for protective eyewear (MPE). METHODS: We analyzed girls' field hockey exposure and injury data collected from national (High School Reporting Information Online [RIO]) and regional (Fairfax County Public Schools) high school sports injury databases in 2 seasons before (2009/10 and 2010/11) and 2 seasons after (2011/12 and 2012/13) a national MPE. RESULTS: The incidence of eye/orbital injuries was significantly higher in states without MPE (0.080 injuries per 1000 athletic exposures [AEs]) than in states with MPE (before the 2011/12 mandate) and the postmandate group (0.025 injuries per 1000 AEs) (odds ratio 3.20, 95% confidence interval 1.47-6.99, P = .003). There was no significant difference in concussion rates for the 2 groups (odds ratio 0.77, 95% confidence interval 0.58-1.02, P = .068). After the 2011/12 MPE, severe eye/orbital injuries (time loss >21 days) were reduced by 67%, and severe/medical disqualification head/face injuries were reduced by 70%. Concussion rates for field hockey (0.335 per 1000 AEs) rank third among girls' sports included in the High School RIO surveillance program. CONCLUSIONS: Among female high school field hockey players, MPE is associated with a reduced incidence of eye/orbital injuries and fewer severe eye/orbital and head/face injuries. Concussion rates did not change as a result of the national MPE. Concussion remains the most common injury involving the head and face among female field hockey players, prompting further inquiry into potential effects of adopting protective headgear/helmets.	[Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Sports Med,Dept Orthoped,Hasbro Childrens Hos, Providence, RI 02903 USA; [Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Sports Med,Dept Pediat,Hasbro Childrens Hosp, Providence, RI 02903 USA; [Zurakowski, R. David] Harvard Univ, Sch Med, Dept Anesthesia, Boston Childrens Hosp, Boston, MA 02115 USA; [Zurakowski, R. David] Harvard Univ, Sch Med, Dept Surg, Boston Childrens Hosp, Boston, MA 02115 USA; [d'Hemecourt, Pierre A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Almquist, Jon L.; Reynolds, John] Fairfax Cty Publ Sch, Falls Church, VA USA; [Ruggieri, Danielle] Providence Coll, Providence, RI 02918 USA; [Collins, Christy L.] OhioHlth Res & Innovat Inst, Columbus, OH USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Aurora, CO USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Aurora, CO USA		Kriz, PK (corresponding author), 2 Dudley St,Ste 200, Providence, RI 02905 USA.	peter_kriz@brown.edu			Prevent Blindness America grant [701-5215]; Centers for Disease Control and Prevention grantUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE001172-01]; National Operating Committee on Standards for Athletic Equipment; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172] Funding Source: NIH RePORTER	Funded in part by Prevent Blindness America grant 701-5215 and Centers for Disease Control and Prevention grant R49/CE001172-01. The authors also acknowledge the generous research funding contributions of the National Operating Committee on Standards for Athletic Equipment.	American Medical Society for Sports Medicine, 2014, SPORTS MED FELL US C; Dick R, 2007, J ATHL TRAINING, V42, P211; Echlin PS, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12286; ELLIOTT AJ, 1984, BRIT MED J, V289, P21, DOI 10.1136/bmj.289.6436.21-a; Field Hockey NCAA, NCAA FIELD HOCK RUL; Field Hockey USA, US WOM NAT TEAM ROST; Hendrickson CD, 2008, CLIN J SPORT MED, V18, P399, DOI 10.1097/JSM.0b013e318188b89d; Kriz PK, 2012, PEDIATRICS, V130, P1069, DOI 10.1542/peds.2012-1492; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Loh S, GOING DEEP OPINIONS; McCullagh P., 1989, GEN LINEAR MODELS, P193, DOI DOI 10.1007/978-1-4899-3242-6; Micieli JA, 2014, CAN J OPHTHALMOL, V49, P243, DOI 10.1016/j.jcjo.2014.03.008; Micieli R, 2014, OPEN ACCESS J SPORTS, V5, P43, DOI 10.2147/OAJSM.S61010; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; National Collegiate Athletic Association, 1981 82 2012 13 NCAA; National Federation of State High School Associations, PART STAT; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091	19	20	20	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2015	136	3					521	527		10.1542/peds.2015-0216			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CQ6IN	WOS:000360708100040	26283783	Bronze			2022-02-06	
J	Schyma, C; Lux, C; Madea, B; Courts, C				Schyma, Christian; Lux, Constantin; Madea, Burkhard; Courts, Cornelius			The 'triple contrast' method in experimental wound ballistics and backspatter analysis	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Gunshot wounds; Wound ballistics; Suicide; Firearms; Forensic medicine; Forensic genetics	BLOOD-SPATTER PATTERNS; CLOSE-RANGE SHOTS; BIOLOGICAL TRACES; GUN BARRELS; HEAD; GUNSHOTS; FIREARM; HAND; RECONSTRUCTION; PERSISTENCE	In practical forensic casework, backspatter recovered from shooters' hands can be an indicator of self-inflicted gunshot wounds to the head. In such cases, backspatter retrieved from inside the barrel indicates that the weapon found at the death scene was involved in causing the injury to the head. However, systematic research on the aspects conditioning presence, amount and specific patterns of backspatter is lacking so far. Herein, a new concept of backspatter investigation is presented, comprising staining technique, weapon and target medium: the 'triple contrast method' was developed, tested and is introduced for experimental backspatter analysis. First, mixtures of various proportions of acrylic paint for optical detection, barium sulphate for radiocontrast imaging in computed tomography and fresh human blood for PCR-based DNA profiling were generated (triple mixture) and tested for DNA quantification and short tandem repeat (STR) typing success. All tested mixtures yielded sufficient DNA that produced full STR profiles suitable for forensic identification. Then, for backspatter analysis, sealed foil bags containing the triple mixture were attached to plastic bottles filled with 10 % ballistic gelatine and covered by a 2-3-mm layer of silicone. To simulate backspatter, close contact shots were fired at these models. Endoscopy of the barrel inside revealed coloured backspatter containing typable DNA and radiographic imaging showed a contrasted bullet path in the gelatine. Cross sections of the gelatine core exhibited cracks and fissures stained by the acrylic paint facilitating wound ballistic analysis.	[Schyma, Christian] Univ Bern, Inst Forens Med, Bern, Switzerland; [Lux, Constantin; Madea, Burkhard; Courts, Cornelius] Univ Bonn, Inst Legal Med, Bonn, Germany		Schyma, C (corresponding author), Univ Bern, Inst Forens Med, Bern, Switzerland.	christian.schyma@irm.unibe.ch			SNF (Swiss National Science Foundation)Swiss National Science Foundation (SNSF); DFG (Deutsche Forschungsgemeinschaft)German Research Foundation (DFG)	This research work was funded by the SNF (Swiss National Science Foundation) and the DFG (Deutsche Forschungsgemeinschaft).	Betz P, 1995, FORENSIC SCI INT, V76, P47, DOI 10.1016/0379-0738(95)01793-3; Courts C, 2014, J FORENSIC SCI, V59, P1129, DOI 10.1111/1556-4029.12434; Courts C, 2012, INT J LEGAL MED, V126, P391, DOI 10.1007/s00414-011-0655-5; FACKLER ML, 1988, AM J FOREN MED PATH, V9, P218, DOI 10.1097/00000433-198809000-00008; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 1997, INT J LEGAL MED, V110, P27; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P253; Kunz SN, 2013, FORENSIC SCI INT, V228, pE54, DOI 10.1016/j.forsciint.2013.02.012; Kunz SN, 2015, J FORENSIC SCI, V60, P166, DOI 10.1111/1556-4029.12572; Lux C, 2014, FORENSIC SCI INT, V237, P62, DOI 10.1016/j.forsciint.2014.01.016; Perdekamp MG, 2011, INT J LEGAL MED, V125, P479, DOI 10.1007/s00414-010-0517-6; Radford GE, 2009, THESIS OTAGO DUNEDIN; Regneri W, 2006, THESIS U SAARLANDES; Schyma C, 2000, J FORENSIC SCI, V45, P1303; Schyma C, 1999, J FORENSIC SCI, V44, P95; Schyma C, 2012, FORENSIC SCI INT, V214, P82, DOI 10.1016/j.forsciint.2011.07.021; Schyma C, 2010, RECHTSMEDIZIN, V20, P123, DOI 10.1007/s00194-009-0650-z; Schyma C, 2013, FORENSIC SCI INT-GEN, V7, P22, DOI 10.1016/j.fsigen.2012.05.008; Schyma C, 2012, INT J LEGAL MED, V126, P37, DOI 10.1007/s00414-010-0546-1; Schyma CWA, 2010, FORENSIC SCI INT, V197, P114, DOI 10.1016/j.forsciint.2010.01.002; Sellier K, 1969, SCHUSSWAFFEN SCHUSSW, P227; STONE IC, 1992, AM J FOREN MED PATH, V13, P275, DOI 10.1097/00000433-199212000-00001; STONE IC, 1987, J FORENSIC SCI, V32, P711; Taylor MC, 2011, INT J LEGAL MED, V125, P617, DOI 10.1007/s00414-010-0462-4; Verhoff MA, 2003, INT J LEGAL MED, V117, P229, DOI 10.1007/s00414-003-0383-6; Visser JM, 2003, THESIS U PRETORIA; Weimann W., 1931, DTSCH Z GERICHTL MED, V17, P92, DOI DOI 10.1007/BF02252047; Wiethold, 1934, DTSCH Z GERICHTL MED, V23, P71, DOI 10.1007/BF01771912; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f	30	20	20	2	52	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1027	1033		10.1007/s00414-015-1151-0			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	CQ0VM	WOS:000360315900014	25616629	Green Submitted			2022-02-06	
J	Tang, HL; Hua, F; Wang, J; Yousuf, S; Atif, F; Sayeed, I; Stein, DG				Tang, Huiling; Hua, Fang; Wang, Jun; Yousuf, Seema; Atif, Fahim; Sayeed, Iqbal; Stein, Donald G.			Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury	BRAIN INJURY			English	Article						Cytokines; frontal cortex; neurosteroids; neuroprotection; toll-like receptors	NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; B SIGNALING PATHWAY; CEREBRAL ISCHEMIA/REPERFUSION; EXPERIMENTAL STROKE; CORTICAL CONTUSION; IMMUNE-RESPONSE; MICE; RAT; ACTIVATION	Objective: Inflammation is an important component of the response to traumatic brain injury (TBI). Progesterone has been shown to inhibit neuroinflammation following (TBI) and may do so through Toll-like receptor (TLR)-mediated pathways. In vitro studies indicate that 1,25-dihydroxyvitamin D(3) (VDH) may also modulate the inflammatory response through the TLR4 pathway. This study tested the hypothesis that PROG and VDH would exert additive and synergistic neuroprotective effects compared with individual treatment by modulating TLR4/NF-kappa B-mediated inflammation pathways after TBI in rats. Research design and methods: Bilateral medial frontal cortical impact injury was induced in young adult Sprague-Dawley rats. Progesterone (i.p., 16 mg kg(-1) body weight) and VDH (1 mu g kg(-1) body weight) were injected separately or combined at 1 and 6 hours after surgery. Rats were killed 24 hours post-surgery and peri-contusional brain tissue harvested for immunostaining and protein measurement. Results: TLR4, phosphorylation of NF-kappa B, neuronal loss and astrocyte activation were significantly reduced with combination treatment after TBI compared to each agent given individually. Conclusions: At 24 hours after TBI, combination therapy shows greater efficacy in reducing neuroinflammation compared to progesterone and VDH given separately, and does so by modulating the TLR4/NF-kappa B signalling pathway.	[Tang, Huiling; Hua, Fang; Wang, Jun; Yousuf, Seema; Atif, Fahim; Sayeed, Iqbal; Stein, Donald G.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Sch Med, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 R01 HD61971]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061971] Funding Source: NIH RePORTER	The research reported in the paper was supported by NIH 5 R01 HD61971 and by gifts from BHR Pharma, The Marcus Foundation, and Allen and Company. The authors report no conflicts of interest.	Alfonso-Loeches S, 2013, TOXICOLOGY, V311, P27, DOI 10.1016/j.tox.2013.03.001; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; De Nicola AF, 2013, CNS NEUROL DISORD-DR, V12, P1205; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; Espinoza TR, 2011, J HEAD TRAUMA REHAB, V26, P497, DOI 10.1097/HTR.0b013e31823088fa; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Hua F, 2015, J CEREBR BLOOD F MET, V35, P536, DOI 10.1038/jcbfm.2014.240; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kong Y, 2011, INT IMMUNOPHARMACOL, V11, P1407, DOI 10.1016/j.intimp.2011.04.025; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McIntosh TK, 1996, LAB INVEST, V74, P315; Michaud JP, 2013, P NATL ACAD SCI USA, V110, P1941, DOI 10.1073/pnas.1215165110; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; SHARMA N, 1994, CELL MOTIL CYTOSKEL, V27, P234, DOI 10.1002/cm.970270305; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Thota C, 2013, REPROD SCI, V20, P463, DOI 10.1177/1933719112459225; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003	55	20	23	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1165	1174		10.3109/02699052.2015.1035330			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400004	26083048	Green Accepted			2022-02-06	
J	Trivedi, RB; Humphreys, K				Trivedi, Ranak B.; Humphreys, Keith			Participant exclusion criteria in treatment research on neurological disorders: Are unrepresentative study samples problematic?	CONTEMPORARY CLINICAL TRIALS			English	Article						Effectiveness; Exclusion criteria; Neurological disorders	CLINICAL-TRIALS; ELIGIBILITY CRITERIA; ALZHEIMERS-DISEASE; IMPACT; RECRUITMENT; DEMENTIA; DESIGN	Objective: Exclusion criteria are an important determinant of the external validity of treatment research findings, yet the prevalence and impact of exclusion criteria have not been studied systematically. Our objective was to describe prevalent exclusion criteria in treatment research on neurological disorders and to analyze their impact on sample representativeness and generalizability of findings. Design: Narrative literature review of studies focusing on treatment for neurological disorders. Studies were identified from PubMed and bibliographies. Results: Eight studies were included in the narrative review:3 studies focused on Alzheimer's disease/dementia, 2 each focused on traumatic brain injury (TBI) and epilepsy, and 1 focused on amyotrophic lateral sclerosis (ALS). The total number of patients screened across all studies was 20,018, of which 14,721 (73.5%) were excluded. An average of 6 exclusion criteria was applied. The criteria that contributed most to exclusion were the presence of comorbid psychiatric conditions, a history of alcohol or other substance misuse, and cognitive impairments. Women and the elderly were underrepresented among included samples. Race/ethnicity proportions were seldom reported. Conclusion: Exclusion criteria are used extensively in neurological treatment research and prevent about 3 in 4 patients from participating in research. This limits the generalizability of current findings. Further, because excluded individuals are disproportionately from vulnerable populations, extensive exclusion also raises ethical concerns. Exclusion criteria should be used only in cases where there is a strong rationale so that neurological treatment research can make a greater impact on clinical care. Published by Elsevier Inc.	VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Palo Alto, CA USA; Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA		Trivedi, RB (corresponding author), Ctr Innovat Implementat, 795 Willow Rd,Bldg 324 MPD-152, Menlo Pk, CA 94025 USA.	Ranak.trivedi@va.gov			VA HSR&D Career Development Award [CDA-09-206]; VA HSR&D Senior Research Career Scientist award	Dr. Trivedi is supported by a VA HSR&D Career Development Award (CDA-09-206). Dr. Humphreys is supported by a VA HSR&D Senior Research Career Scientist award. None of the authors have conflicts of interest. The views expressed in this manuscript are those of the authors and do not represent the views of the Department of Veterans' Affairs.	Alliance Family Caregiver, 2013, INC PREV MAJ CAUS BR; Almici M, 2012, J AM GERIATR SOC, V60, P1596, DOI 10.1111/j.1532-5415.2012.04068.x; Anand R, 2003, AM J GERIAT PSYCHIAT, V11, P160, DOI 10.1176/appi.ajgp.11.2.160; Baquet CR, 2006, CANCER DETECT PREV, V30, P24, DOI 10.1016/j.cdp.2005.12.001; BRAWLEY OW, 1995, CONTROL CLIN TRIALS, V16, P293, DOI 10.1016/0197-2456(95)00131-X; Britton A, 1999, J Health Serv Res Policy, V4, P112; Chio A, 2011, NEUROLOGY, V77, P1432, DOI 10.1212/WNL.0b013e318232ab9b; CONDON JT, 1986, AUST NZ J PSYCHIAT, V20, P87, DOI 10.3109/00048678609158870; Cooper C, 2014, INT J GERIATR PSYCH, V29, P515, DOI 10.1002/gps.4034; da Conceicao PO, 2013, EPILEPSY BEHAV, V27, P310, DOI 10.1016/j.yebeh.2013.02.014; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; FREEDMAN LS, 1995, CONTROL CLIN TRIALS, V16, P277, DOI 10.1016/0197-2456(95)00048-8; Grill JD, 2014, ALZ DIS ASSOC DIS, V28, P1, DOI 10.1097/WAD.0000000000000016; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Humphreys K, 2005, ADDICTION, V100, P1249, DOI 10.1111/j.1360-0443.2005.01175.x; Humphreys K.N., 2015, CLIN SCHIZO IN PRESS; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Lyketsos Constantin G, 2007, Dialogues Clin Neurosci, V9, P111; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, DOI 10.1371/JOURNAL.PMED.1000097]; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Schneider LS, 1997, J AM GERIATR SOC, V45, P923, DOI 10.1111/j.1532-5415.1997.tb02960.x; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d; Taylor JS, 2012, J AM GERIATR SOC, V60, P413, DOI 10.1111/j.1532-5415.2011.03847.x; Tlusta E, 2008, EPILEPSIA, V49, P1479, DOI 10.1111/j.1528-1167.2008.01618_2.x; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Yamal JM, 2014, CLIN TRIALS, V11, P187, DOI 10.1177/1740774514522560; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	32	20	20	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	SEP	2015	44						20	25		10.1016/j.cct.2015.07.009			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	CT2FB	WOS:000362616300003	26188162				2022-02-06	
J	Kim, H; Cam-Etoz, B; Zhai, GH; Hubbard, WJ; Zinn, KR; Chaudry, IH				Kim, Hyunki; Cam-Etoz, Betul; Zhai, Guihua; Hubbard, William J.; Zinn, Kurt R.; Chaudry, Irshad H.			Salutary Effects of Estrogen Sulfate for Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						DTI; estrogen; PET; TBI	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; 17-BETA-ESTRADIOL; HEMORRHAGE; PERFORMANCE; HORMONES; RATS; PET; PROTECTION	Estrogen plays an important role as a neuroprotector in the central nervous system (CNS), directly interacting with neurons and regulating physiological properties of non-neuronal cells. Here we evaluated estrogen sulfate (E-2-SO4) for traumatic brain injury (TBI) using a Sprague-Dawley rat model. TBI was induced via lateral fluid percussion (LFP) at 24h after craniectomy. E-2-SO4 (1mg/kg BW in 1mL/kg BW) or saline (served as control) was intravenously administered at 1h after TBI (n=5/group). Intracranial pressure (ICP), cerebral perfusion pressure (CPP), and partial brain oxygen pressure (pbtO(2)) were measured for 2h (from 23 to 25h after E-2-SO4 injection). Brain edema and diffuse axonal injury (DAI) were assessed by diffusion tensor imaging (DTI), and cerebral glycolysis was measured by F-18-labeled fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging, at 1 and 7 days after E-2-SO4 injection. E-2-SO4 significantly decreased ICP, while increasing CPP and pbtO(2) (p<0.05) as compared with vehicle-treated TBI rats. The edema size in the brains of the E-2-SO4 treated group was also significantly smaller than that of vehicle-treated group at 1 day after E-2-SO4 injection (p=0.04), and cerebral glycolysis of injured region was also increased significantly during the same time period (p=0.04). However, E-2-SO4 treatment did not affect DAI (p>0.05). These findings demonstrated the potential benefits of E-2-SO4 in TBI.	[Kim, Hyunki; Zhai, Guihua; Zinn, Kurt R.] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA; [Cam-Etoz, Betul; Hubbard, William J.; Chaudry, Irshad H.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA		Chaudry, IH (corresponding author), Univ Alabama Birmingham, Dept Surg, Surg Res Ctr, 1670 Univ Blvd,Volker Hall, Birmingham, AL 35294 USA.	IChaudry@uab.edu		Zinn, Kurt/0000-0001-7463-4741	United States Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program in TBI of the Department of Defense [W81XWH-08-20153]	We give special thanks to Dr. Ahmar Ayub for TBI induction in rats, data collection, and analyses. Also, we thank Nicole Day and Tracy Niedzielko for their assistance in animal TBI induction, and Dr. Candace Floyd for letting us use her TBI induction instrument. This study was supported by the United States Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program in TBI W81XWH-08-20153 of the Department of Defense to I.H.C.	Akabori H, 2010, SHOCK, V33, P43, DOI 10.1097/SHK.0b013e3181b0ebcb; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Beyer C, 1999, ANAT EMBRYOL, V199, P379, DOI 10.1007/s004290050236; Bodanapally UK, 2013, NEURORADIOLOGY, V55, P771, DOI 10.1007/s00234-013-1166-5; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Choudhry MA, 2008, J LEUKOCYTE BIOL, V83, P518, DOI 10.1189/jlb.0607369; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dandekar M, 2007, J NUCL MED, V48, P602, DOI 10.2967/jnumed.106.036608; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DeWitt D. S., 1995, NEW HORIZ, V3, P376; Farwell MD, 2014, CANCER-AM CANCER SOC, V120, P3433, DOI 10.1002/cncr.28860; Faul M, 2010, TRAUMATIC BRAIN INJU; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; GARCIASEGURA LM, 1994, PROG NEUROBIOL, V44, P279, DOI 10.1016/0301-0082(94)90042-6; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Kawasaki T, 2012, J ANESTH, V26, P883, DOI 10.1007/s00540-012-1425-3; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Kim H, 2011, MOL IMAGING BIOL, V13, P94, DOI 10.1007/s11307-010-0320-2; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Liu R, 2010, J PHARMACOL EXP THER, V332, P1006, DOI 10.1124/jpet.109.160937; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Neter J., 1996, APPL LINEAR STAT MOD, V4; Ratib O, 2010, J NUCL MED, V51, DOI 10.2967/jnumed.110.076125; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Seif M., 2014, J MAGN RESON IMAGING; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Siriphorn A, 2012, J COMP NEUROL, V520, P2630, DOI 10.1002/cne.23056; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Zuccoli G, 2014, NEURORADIOLOGY, V56, P679, DOI 10.1007/s00234-014-1379-2	44	20	21	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1210	1216		10.1089/neu.2014.3771			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400004	25646701	Green Published			2022-02-06	
J	Chen, S; Yu, SY; Yan, HD; Cai, JY; Ouyang, YM; Ruan, HJ; Fan, CY				Chen, Shuai; Yu, Shi-yang; Yan, Hede; Cai, Jiang-yu; Ouyang, Yuanming; Ruan, Hong-jiang; Fan, Cun-yi			The time point in surgical excision of heterotopic ossification of post-traumatic stiff elbow: recommendation for early excision followed by early exercise	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Post-traumatic heterotopic ossification; elbow stiffness; time point; early excision; surgical excision	TRAUMATIC BRAIN-INJURY; RADIOULNAR SYNOSTOSIS; ANTERIOR CAPSULOTOMY; FLEXION CONTRACTURE; OPERATIVE TREATMENT; RELEASE; FOREARM; MOTION; BONE; ARTHROLYSIS	Background: Post-traumatic heterotopic ossification (HO) around the elbow may severely impair joint function. Although surgical excision is effective at restoring range of motion (ROM), traditional surgical treatment is postponed for at least 1 year to prevent recurrence, which leads to secondary contracture of the elbow. Because the optimal timing of resection is controversial, our study was performed to compare recurrence and elbow function between early and late excision in our patients to determine whether the delay is necessary. Methods: We retrospectively reviewed 164 patients during a 4-year period. In the control group (112 patients), HO was excised at an average of 23.0 months after initial injury (range, 9-204 months); in the early excision group (52 patients), resection was performed at an average of 6.1 months (range, 3-8 months). HO recurrence was assessed by the Hastings classification system. Final ROM and Mayo Elbow Performance Scores were also evaluated. Results: Recurrent HO was observed in 30 of 112 patients (26.8%) in the control group and 15 of 52 (28.9%) in early excision group. No significant difference in HO recurrence was found between the 2 groups (P = .942). Moreover, there were no notable differences regarding ROM, Mayo Elbow Performance Scores, and complications postoperatively. Conclusions: Early excision associated with early exercise is effective for the treatment of HO aiming at a low recurrence rate and satisfactory function. The conventional surgical delay of more than 1 year may be shortened. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Chen, Shuai; Yu, Shi-yang; Cai, Jiang-yu; Ouyang, Yuanming; Ruan, Hong-jiang; Fan, Cun-yi] Shanghai Jiao Tong Univ, Dept Orthopaed, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China; [Yan, Hede] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China		Fan, CY (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	fancunyi888@hotmail.com	fan, cunyi/ABI-7199-2020	fan, cunyi/0000-0002-7854-5233	Project of Advanced and Appropriate Technology of Shanghai Municipal Commission of Health and Family Planning [2013SY043]; Science and Technology Project of Pudong New Area Health Bureau of Shanghai [PW2013D-7]	This article was supported by the Project of Advanced and Appropriate Technology of Shanghai Municipal Commission of Health and Family Planning (2013SY043) and Science and Technology Project of Pudong New Area Health Bureau of Shanghai (PW2013D-7). The authors declare that the funders had no role in data collection, data analysis, or preparation or editing of the manuscript.	ABRAMS RA, 1993, J HAND SURG-AM, V18A, P703, DOI 10.1016/0363-5023(93)90322-T; Aldridge JM, 2004, J BONE JOINT SURG AM, V86A, P1955, DOI 10.2106/00004623-200409000-00014; Bauer AS, 2012, J HAND SURG-AM, V37A, P1422, DOI 10.1016/j.jhsa.2012.03.013; Beingessner DM, 2000, J HAND SURG-AM, V25A, P483, DOI 10.1053/jhsu.2000.6922; Botte MJ, 1997, ORTHOPEDICS, V20, P335; Breborowicz M, 2014, INT ORTHOP, V38, P561, DOI 10.1007/s00264-013-2172-2; Brinsden Mark D, 2008, J Orthop Surg Res, V3, P39, DOI 10.1186/1749-799X-3-39; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charalambous CP, 2012, J BONE JOINT SURG AM, V94A, P1428, DOI 10.2106/JBJS.K.00711; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Darlis NA, 2006, J SHOULDER ELB SURG, V15, P709, DOI 10.1016/j.jse.2006.01.006; Djurickovic S, 1996, J TRAUMA, V41, P825, DOI 10.1097/00005373-199611000-00010; Ellerin BE, 1999, AM J PHYS MED REHAB, V78, P259, DOI 10.1097/00002060-199905000-00016; EVANS EB, 1991, CLIN ORTHOP RELAT R, P94; Evans PJ, 2009, J HAND SURG-AM, V34A, P769, DOI 10.1016/j.jhsa.2009.02.020; Everding NG, 2013, J HAND SURG-AM, V38A, P2496, DOI 10.1016/j.jhsa.2013.06.007; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GATES HS, 1992, J BONE JOINT SURG AM, V74A, P1229, DOI 10.2106/00004623-199274080-00013; HASTINGS H, 1994, HAND CLIN, V10, P417; HOFFER MM, 1978, J TRAUMA, V18, P667, DOI 10.1097/00005373-197809000-00009; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Jupiter JB, 1998, J BONE JOINT SURG AM, V80A, P248, DOI 10.2106/00004623-199802000-00012; Koh KH, 2013, J SHOULDER ELB SURG, V22, P1128, DOI 10.1016/j.jse.2013.04.019; Lacey BW, 2011, PM&R, V3, P982, DOI 10.1016/j.pmrj.2011.06.004; Liu S, 2011, J TRAUMA, V70, P373, DOI 10.1097/TA.0b013e3181e4f5e3; LUNDBORG G, 1992, J HAND SURG-BRIT EUR, V17B, P245, DOI 10.1016/0266-7681(92)90106-C; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Moritomo H, 2001, J SHOULDER ELB SURG, V10, P164, DOI 10.1067/mse.2001.112055; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; PETERSON SL, 1989, J TRAUMA, V29, P365, DOI 10.1097/00005373-198903000-00015; Rhee YG, 2009, CLIN ORTHOP SURG, V1, P27, DOI 10.4055/cios.2009.1.1.27; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Summerfield SL, 1997, J SHOULDER ELB SURG, V6, P321, DOI 10.1016/S1058-2746(97)90025-2; Thompson H C 3rd, 1967, Clin Orthop Relat Res, V50, P129; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480; URBANIAK JR, 1985, J BONE JOINT SURG AM, V67A, P1160, DOI 10.2106/00004623-198567080-00003; VINCE KG, 1987, J BONE JOINT SURG AM, V69A, P640, DOI 10.2106/00004623-198769050-00002; Viola RW, 1999, J HAND SURG-AM, V24A, P370; Williams BG, 2012, J SHOULDER ELB SURG, V21, P1632, DOI 10.1016/j.jse.2012.04.007	45	20	25	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	AUG	2015	24	8					1165	1171		10.1016/j.jse.2015.05.044			7	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	CM9RO	WOS:000358046800006	26189802				2022-02-06	
J	Gardner, EC				Gardner, Elizabeth C.			Head, Face, and Eye Injuries in Collegiate Women's Field Hockey	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head; eye; and face injuries; women's field hockey; collegiate	SURVEILLANCE SYSTEM; LACROSSE; SPORT	Background: While there is concern regarding head, face, and eye injuries in field hockey, prompting some to recommend the use of protective equipment such as goggles and helmets, little has been written about their incidence and mechanism of injury in the modern game of field hockey. The elucidation of this information will better inform the development of maximally effective injury prevention schemes to protect the athlete while maintaining the integrity of the game. Purpose: To determine the incidence and epidemiology of head, face, and eye injuries in United States collegiate women's field hockey players from 2004-2005 to 2008-2009. Study Design: Descriptive epidemiological study. Methods: All head, face, and eye injuries reported to the National Collegiate Athletic Association Injury Surveillance System for collegiate women's field hockey athletes from the 2004-2005 through 2008-2009 seasons were analyzed. Data regarding the event type, injury mechanism, body part injured, type of injury, outcome, and time lost were reviewed. The weighted injury incidence per 1000 athlete-exposures (AEs) was calculated using the exposure data set for the same years; 95% CIs were calculated based on a normal approximation to the Poisson distribution. Results: There were 150 reported traumatic injuries during this time period, with a weighted occurrence of 1587.3 injuries. The overall incidence of head, face, and eye injuries in collegiate women's field hockey was 0.94 per 1000 AEs (95% CI, 0.86-1.19). Injuries to the head or face, other than the mouth, nose, and eye, accounted for 75.3% of these injuries. The incidence of eye injuries was 0.07 per 1000 AEs (95% CI, 0.03-0.12); nose injuries occurred at a rate of 0.10 per 1000 AEs (95% CI, 0.05-0.15). The rate of traumatic dental injuries was 0.06 per 1000 AEs (95% CI, 0.04-0.14). Contact with an apparatus caused 72.9% of all injuries; specifically, contact with an elevated ball accounted for 47.9% of all injuries, and contact with an elevated stick caused 21.7% of all injuries. While the majority of players suffering a head, face, or eye injury were able to return to sport that season (90.0%), the remaining athletes suffered season-ending injuries (10%). Concussions accounted for 42.8% of all head, face, and eye injuries reported (0.40 per 1000 AEs; 95% CI, 0.32-0.53). Conclusion: Head, face, and eye injuries occur regularly in women's field hockey. This description of the injury profile and mechanisms of injury may be used to design appropriate injury prevention schemes for the sport.	Yale Univ, Sch Med, Dept Orthopaed Surg & Rehabil, New Haven, CT 06519 USA		Gardner, EC (corresponding author), Yale Univ, Sch Med, Dept Orthopaed Surg & Rehabil, 800 Howard Ave,1st Floor, New Haven, CT 06519 USA.	elizabeth.gardner@yale.edu			NCAA	The author has declared the following potential conflict of interest or source of funding: The National Collegiate Athletic Association (NCAA) Injury Surveillance System data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance System was funded by the NCAA. The content of this article is solely the responsibility of the author and does not necessarily represent the official view of the Datalys Center or the NCAA.	[Anonymous], 1996, Pediatrics, V98, P311; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Datalys Center Inc, 2012, NCAA 2004 05 2008 09; Dick R, 2007, J ATHL TRAINING, V42, P211; Dick R, 2007, J ATHL TRAINING, V42, P173; Echlin PS, 2005, BRIT J SPORT MED, V39, P254, DOI 10.1136/bjsm.2004.013128; ELLIOTT AJ, 1984, BRIT MED J, V289, P21, DOI 10.1136/bmj.289.6436.21-a; Hendrickson CD, 2008, CLIN J SPORT MED, V18, P399, DOI 10.1097/JSM.0b013e318188b89d; International Hockey Federation, MEMB NAT FED; JONES NP, 1994, BRIT J SPORT MED, V28, P272, DOI 10.1136/bjsm.28.4.272; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; National Center for Catastrophic Sport Injury Research, 24 NAT CTR CAT SPORT; National Collegiate Athletic Association, FIELD HOCK RUL MOD 2; Schwarz A, 2011, NY TIMES, pB13; Smith C, NEW JERSEY SCH DISTR; Stoner LJ, 1993, ASTM STP, V2, P183; Washington RL, 2004, PEDIATRICS, V113, P619; Webster DA, 1999, MED SCI SPORT EXER, V31, P938, DOI 10.1097/00005768-199907000-00004; WILDE GJS, 1986, RISK ANAL, V6, P95, DOI 10.1111/j.1539-6924.1986.tb00197.x; Yard EE, 2006, J ATHL TRAINING, V41, P441	24	20	20	0	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2015	43	8					2027	2034		10.1177/0363546515588175			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	CO1DF	WOS:000358892400031	26093006				2022-02-06	
J	Seel, RT; Barrett, RS; Beaulieu, CL; Ryser, DK; Hammond, FM; Cullen, N; Garmoe, W; Sommerfeld, T; Corrigan, JD; Horn, SD				Seel, Ronald T.; Barrett, Ryan S.; Beaulieu, Cynthia L.; Ryser, David K.; Hammond, Flora M.; Cullen, Nora; Garmoe, William; Sommerfeld, Teri; Corrigan, John D.; Horn, Susan D.			Institutional Variation in Traumatic Brain Injury Acute Rehabilitation Practice	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Craniocerebral trauma; Health services; Health services research; Occupational therapy; Physical therapy specialty; Psychology; Recreation therapy; Rehabilitation; Speech therapy; Therapeutics	FUNCTIONAL INDEPENDENCE MEASURE; SYSTEMS NATIONAL DATABASE; AGITATED BEHAVIOR SCALE; CARE SITE MATTER; REPRESENTATIVENESS; RELIABILITY; RECOVERY; STROKE	Objective: To describe institutional variation in traumatic brain injury (TBI) inpatient rehabilitation program characteristics and evaluate to what extent patient factors and center effects explain how TBI inpatient rehabilitation services are delivered. Design: Secondary analysis of a prospective, multicenter, cohort database. Setting: TBI inpatient rehabilitation programs. Participants: Patients with complicated mild, moderate, or severe TBI (N=2130). Interventions: Not applicable. Main Outcome Measures: Mean minutes; number of treatment activities; use of groups in occupational therapy, physical therapy, speech therapy, therapeutic recreation, and psychology inpatient rehabilitation sessions; and weekly hours of treatment. Results: A wide variation was observed between the 10 TBI programs, including census size, referral flow, payer mix, number of dedicated beds, clinician experience, and patient characteristics. At the centers with the longest weekday therapy sessions, the average session durations were 41.5 to 52.2 minutes. At centers with the shortest weekday sessions, the average session durations were approximately 30 minutes. The centers with the highest mean total weekday hours of occupational, physical, and speech therapies delivered twice as much therapy as the lowest center. Ordinary least-squares regression modeling found that center effects explained substantially more variance than patient factors for duration of therapy sessions, number of activities administered per session, use of group therapy, and amount of psychological services provided. Conclusions: This study provides preliminary evidence that there is significant institutional variation in rehabilitation practice and that center effects play a stronger role than patient factors in determining how TBI inpatient rehabilitation is delivered. (C) 2015 by the American Congress of Rehabilitation Medicine	[Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA 30309 USA; [Barrett, Ryan S.; Horn, Susan D.] Int Sever Informat Syst, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Ryser, David K.] Intermt Med Ctr, Neuro Specialty Rehabil Unit, Salt Lake City, UT USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Cullen, Nora] Toronto Rehabil Inst, Toronto, ON, Canada; [Garmoe, William] Medstar Natl Rehabil Hosp, Washington, DC USA; [Sommerfeld, Teri] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Seel, RT (corresponding author), Shepherd Ctr, Crawford Res Inst, 6th Fl,2020 Peachtree Rd, Atlanta, GA 30309 USA.	ron_seel@shepherd.org		Cullen, Nora/0000-0001-6359-9418	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01) and the National Institute on Disability and Rehabilitation Research (grant no. H133A080023); Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Agency for Healthcare Research and Quality (US), 2007, AHRQ STRAT PLAN; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Chan L, 2013, ARCH PHYS MED REHAB, V94, P622, DOI 10.1016/j.apmr.2012.09.033; Commission of the Accreditation of Rehabilitation Facilities (CARF) International, 2014, MED REH STAND MAN; CORDIS, 7 FRAM PROGR FUND EU; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Deutsch A, 2013, ARCH PHYS MED REHAB, V94, P630, DOI 10.1016/j.apmr.2013.02.011; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P1305, DOI 10.1016/j.apmr.2012.04.030; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Institute of Medicine, 2007, FUTURE DISABILITY AM; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Steyerberg, 2019, CLIN PREDICTION MODE	24	20	20	2	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S197	S208		10.1016/j.apmr.2015.02.034			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100003	26212397				2022-02-06	
J	Yuan, YM; Zhu, F; Pu, YY; Wang, D; Huang, AJ; Hu, X; Qin, SY; Sun, X; Su, ZD; He, C				Yuan, Yimin; Zhu, Feng; Pu, Yingyan; Wang, Dan; Huang, Aijun; Hu, Xin; Qin, Shangyao; Sun, Xiu; Su, Zhida; He, Cheng			Neuroprotective effects of nitidine against traumatic CNS injury via inhibiting microglia activation	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Nitidine; Microglia; Traumatic brain injury; Spinal cord injury; Neuroprotection	SPINAL-CORD-INJURY; OLFACTORY ENSHEATHING CELLS; NF-KAPPA-B; REACTIVE MICROGLIA; K+ CHANNEL; EXPRESSION; RECOVERY; PATHWAY; NEUROTOXICITY; KCNN4/KCA3.1	Glial cell response to injury has been well documented in the pathogenesis after traumatic brain injury (TBI) and spinal cord injury (SCI). Although microglia, the resident macrophages in the central nervous system (CNS), are responsible for clearing debris and toxic substances, excessive activation of these cells will lead to exacerbated secondary damage by releasing a variety of inflammatory and cytotoxic mediators and ultimately influence the subsequent repair after CNS injury. In fact, inhibition of microgliosis represents a therapeutic strategy for CNS trauma. We here showed that nitidine, a benzophenanthridine alkaloid, restricted reactive microgliosis and promoted CNS repair after traumatic injury. Nitidine was shown to prevent cultured microglia from LPS-induced reactive activation by regulation of ERK and NF-kappa B signaling pathway. Furthermore, the nitidine-mediated inhibition of microgliosis was also shown in injured brain and spinal cord, which significantly increased neuronal survival and decreased neural tissue damage after injury. Importantly, behavioral analysis revealed that nitidine-treated mice with SCI had improved functional recovery as assessed by Basso Mouse Scale and swimming test. Together, these findings indicated that nitidine increased CNS tissue sparing and improved functional recovery by attenuating reactive microgliosis, suggestive of the potential therapeutic benefit for CNS injury. (C) 2015 Elsevier Inc. All rights reserved.	[Su, Zhida] Second Mil Med Univ, Minist Educ, Inst Neurosci, Shanghai, Peoples R China; Second Mil Med Univ, Minist Educ, Key Lab Mol Neurobiol, Shanghai, Peoples R China		Su, ZD (corresponding author), Second Mil Med Univ, Minist Educ, Inst Neurosci, Shanghai, Peoples R China.	suzhida@smmu.edu.cn; chenghe@smmu.edu.cn	Su, Zhida/G-6094-2015	Hu, Xin/0000-0002-3253-6024	National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81271352, 31171124, 31130024, 31301210]; National Key Basic Research ProgramNational Basic Research Program of China [2011CB504401]; Foundation for Military Medicine [CWS11J042]	This work was supported by the National Natural Science Foundation (81271352, 31171124, 31130024, 31301210), National Key Basic Research Program (2011CB504401), and Foundation for Military Medicine (CWS11J042).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Cao L, 2013, NEUROSCI BULL, V29, P189, DOI 10.1007/s12264-013-1324-0; Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hu J, 2006, CHEM BIODIVERS, V3, P990, DOI 10.1002/cbdv.200690108; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Iwasaki H, 2010, CANCER CHEMOTH PHARM, V65, P719, DOI 10.1007/s00280-009-1077-7; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lemmon VP, 2014, J NEUROTRAUM, V31, P1354, DOI 10.1089/neu.2014.3400; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Rohl C, 2007, BRAIN RES, V1129, P43, DOI 10.1016/j.brainres.2006.10.057; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Su ZD, 2013, GLIA, V61, P490, DOI 10.1002/glia.22450; Su ZD, 2010, GLIA, V58, P901, DOI 10.1002/glia.20972; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang ZQ, 2012, J ETHNOPHARMACOL, V144, P145, DOI 10.1016/j.jep.2012.08.041; Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang SC, 1999, ACTA NEUROPATHOL, V97, P393, DOI 10.1007/s004010051003	54	20	22	3	29	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	AUG	2015	48						287	300		10.1016/j.bbi.2015.04.008			14	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	CN5HP	WOS:000358460700030	25900440				2022-02-06	
J	Lazarus, C; Soheilypour, M; Mofrad, MRK				Lazarus, Carole; Soheilypour, Mohammad; Mofrad, Mohammad R. K.			Torsional Behavior of Axonal Microtubule Bundles	BIOPHYSICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; FLEXURAL RIGIDITY; TRANSPORT; DENDRITES; MECHANICS; FILAMENTS; NETWORKS; NEURONS; LENGTH; MODEL	Axonal microtubule (MT) bundles crosslinked by microtubule-associated protein (MAP) tau are responsible for vital biological functions such as maintaining mechanical integrity and shape of the axon as well as facilitating axonal transport. Breaking and twisting of MTs have been previously observed in damaged undulated axons. Such breaking and twisting of MTs is suggested to cause axonal swellings that lead to axonal degeneration, which is known as "diffuse axonal injury". In particular, overstretching and torsion of axons can potentially damage the axonal cytoskeleton. Following our previous studies on mechanical response of axonal MT bundles under uniaxial tension and compression, this work seeks to characterize the mechanical behavior of MT bundles under pure torsion as well as a combination of torsional and tensile loads using a coarse-grained computational model. In the case of pure torsion, a competition between MAP tau tensile and MT bending energies is observed. After three turns, a transition occurs in the mechanical behavior of the bundle that is characterized by its diameter shrinkage. Furthermore, crosslink spacing is shown to considerably influence the mechanical response, with larger MAP tau spacing resulting in a higher rate of turns. Therefore, MAP tau crosslinking of MT filaments protects the bundle from excessive deformation. Simultaneous application of torsion and tension on MT bundles is shown to accelerate bundle failure, compared to pure tension experiments. MAP tau proteins fail in clusters of 10-100 elements located at the discontinuities or the ends of MT filaments. This failure occurs in a stepwise fashion, implying gradual accumulation of elastic tensile energy in crosslinks followed by rupture. Failure of large groups of interconnecting MAP tau proteins leads to detachment of MT filaments from the bundle near discontinuities. This study highlights the importance of torsional loading in axonal damage after traumatic brain injury.	[Lazarus, Carole; Soheilypour, Mohammad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Lazarus, Carole; Soheilypour, Mohammad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA		Mofrad, MRK (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859	National Science Foundation through a CAREER awardNational Science Foundation (NSF) [CBET-0955291]	Financial support was provided by the National Science Foundation through a CAREER award (CBET-0955291).	Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Blundell JR, 2009, MACROMOLECULES, V42, P5388, DOI 10.1021/ma9004633; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; BRADY ST, 1984, J CELL BIOL, V99, P1716, DOI 10.1083/jcb.99.5.1716; Cheminiak P, 2010, EUR PHYS J E, V31, P215, DOI 10.1140/epje/i2010-10562-x; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cotter C. J., 2004, COMPUTATIONAL NANOTE; FADIC R, 1985, J COMP NEUROL, V236, P258, DOI 10.1002/cne.902360209; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Huang A, 2009, FUTURE MED CHEM, V1, P467, DOI 10.4155/FMC.09.40; Ivancevic VG, 2009, COGN NEURODYNAMICS, V3, P281, DOI 10.1007/s11571-008-9070-0; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; Kim T, 2009, EXP MECH, V49, P91, DOI 10.1007/s11340-007-9091-3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; Li C, 2006, BIOCHEM BIOPH RES CO, V349, P1145, DOI 10.1016/j.bbrc.2006.08.153; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Mofrad MRK, 2009, ANNU REV FLUID MECH, V41, P433, DOI 10.1146/annurev.fluid.010908.165236; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Paszkowska E, 2010, POL J RADIOL, V75, P13; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Reeves A, 2004, DISORDERS NERVOUS SY; Rodney D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108004; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Soheilypour M, 2015, BIOPHYS J, V108, P1718, DOI 10.1016/j.bpj.2015.01.030; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thibault L. E., 1990, P IRCOBI C BIOM IMP; Vable M., 2009, MECH MAT; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yasuda R, 1996, J MOL BIOL, V263, P227, DOI 10.1006/jmbi.1996.0571; Yi LJ, 2008, J APPL PHYS, V103, DOI 10.1063/1.2930882; YU WQ, 1994, J NEUROSCI, V14, P2818; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	45	20	20	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	JUL 21	2015	109	2					231	239		10.1016/j.bpj.2015.06.029			9	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	CN3GE	WOS:000358312800007	26200859	Bronze, Green Published			2022-02-06	
J	Richard, YF; Swaine, BR; Sylvestre, MP; Lesage, A; Zhang, X; Feldman, DE				Richard, Yvonne F.; Swaine, Bonnie R.; Sylvestre, Marie-Pierre; Lesage, Alain; Zhang, Xun; Feldman, Debbie Ehrmann			The Association Between Traumatic Brain Injury and Suicide: Are Kids at Risk?	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						adults; childhood; mental health; pediatrics; repeated injuries; suicide; traumatic brain injury; youth	PSYCHIATRIC DIAGNOSES; NORTHERN FINLAND; BIRTH COHORT; YOUNG-ADULTS; CHILDREN; POPULATION; CHILDHOOD; BEHAVIOR; OUTCOMES; EPIDEMIOLOGY	Traumatic brain injury (TBI) in late adolescence and adulthood is associated with a higher risk of suicide; however, it is unknown whether this association is also present in people who sustained a TBI during childhood. The purpose of the present study was to determine whether experiencing a TBI during childhood is a risk factor for suicide later in life and to examine whether the risk of suicide differs by sex or injury severity. A cohort of 135,703 children aged 0-17 years was identified from the Quebec population-based physician reimbursement database in 1987, and follow-up was conducted until 2008. Of the children in this cohort, 21,047 had sustained a TBI. Using a survival analysis with time-dependent indicators of TBI, we found a higher risk of suicide for people who sustained a TBI during childhood (hazard ratio (HR) = 1.49, 95% confidence interval (CI): 1.04, 2.14), adolescence (HR = 1.57, 95% CI: 1.09, 2.26), and adulthood (HR = 2.53, 95% CI: 1.79, 3.59). When compared with less severe injuries, such as concussions and cranial fractures, more severe injuries, such as intracranial hemorrhages, were associated with a higher risk of suicide (HR = 2.18 vs. 2.77, respectively). Repeated injuries were associated with higher risks of suicide in all age groups.	[Richard, Yvonne F.; Swaine, Bonnie R.] Univ Montreal, Fac Med, Sch Rehabil, Ctr Interdisciplinary Res Rehabil, Montreal, PQ H3C 3J7, Canada; [Sylvestre, Marie-Pierre] Univ Montreal, Univ Montreal Hosp Res Ctr, Dept Social & Prevent Med, Sch Publ Hlth, Montreal, PQ H3C 3J7, Canada; [Lesage, Alain] Univ Montreal, Dept Psychiat, Inst Univ Sante Mentale, Montreal Res Ctr,Quebec Suicide Res Network, Montreal, PQ H3C 3J7, Canada; [Zhang, Xun] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Feldman, Debbie Ehrmann] Univ Montreal, Ctr Interdisciplinary Res Rehabil, Univ Montreal Publ Hlth Res Inst, Fac Med,Sch Rehabil, Montreal, PQ H3C 3J7, Canada		Swaine, BR (corresponding author), Univ Montreal, Ecole Readaptat, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [84479]; Reseau Quebecois de Recherche sur le Suicide; Fonds de Recherche Quebec-Sante	This work was supported by the Canadian Institutes of Health Research (grant 84479). Y.F.R. received a study grant from the Reseau Quebecois de Recherche sur le Suicide. B.R.S. and D.E.F. received a senior research award from the Fonds de Recherche Quebec-Sante.	ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; April KT, 2013, CHILD CARE HLTH DEV, V39, P442, DOI 10.1111/j.1365-2214.2012.01386.x; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Beales G, 1983, Nurs Times, V79, P50; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1080/j.1440-1614.2000.00691.x; Bergeron L, 1993, ENQUETE QUEBECOISE S; Bertolote JM., 2002, SUICIDOLOGI, V7, P3, DOI [DOI 10.1186/1477-7525-9-13, 10.5617/suicidologi.2330, DOI 10.5617/SUICIDOLOGI.2330]; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gagne M, 2012, EVOLUTION HOSPITALIS; Gagne M, 2010, MORTALITE SUICIDE QU; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Galaif Elisha R, 2007, Int J Adolesc Med Health, V19, P27; Gamache P, 2010, INDICE DEFAVORISATIO; Goldston DB, 2009, J CONSULT CLIN PSYCH, V77, P281, DOI 10.1037/a0014732; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Kostylova A, 2005, INJURY PREV, V11, P186, DOI 10.1136/ip.2004.006585; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lesage A, 2006, PREVALENCE MENTAL IL; LESAGE AD, 1994, AM J PSYCHIAT, V151, P1063; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKeown RE, 2006, AM J PUBLIC HEALTH, V96, P1744, DOI 10.2105/AJPH.2005.066951; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; MOSCICKI EK, 1995, SUICIDE LIFE-THREAT, V25, P22; Nowrangi MA, 2014, PSYCHOSOMATICS, V55, P430, DOI 10.1016/j.psym.2013.11.006; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Osmond MH, 2002, J TRAUMA, V52, P8, DOI 10.1097/00005373-200201000-00004; Pampalon R, 2003, SANTE SOC SOLIDARITE, V2, P191, DOI DOI 10.3406/OSS.2003.932; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Powell J, 2000, BRIT J PSYCHIAT, V176, P266, DOI 10.1192/bjp.176.3.266; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; R Development Core Team, 2013, R LANG ENV STAT COMP; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Rhodes AE, 2012, CAN J PUBLIC HEALTH, V103, P213, DOI 10.1007/BF03403815; SAS Institute, 2013, SAS SYST WIND REL 9; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	66	20	20	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JUL 15	2015	182	2					177	184		10.1093/aje/kwv014			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	CM9UJ	WOS:000358054200011	26121988	Green Published, Bronze			2022-02-06	
J	Brigo, F; Igwe, SC; Nardone, R; Lochner, P; Tezzon, F; Otte, WM				Brigo, Francesco; Igwe, Stanley C.; Nardone, Raffaele; Lochner, Piergiorgio; Tezzon, Frediano; Otte, Willem M.			Wikipedia and neurological disorders	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Epidemiology; Google; Infodemiology; Internet; Neurological disorders; Wikipedia	BREAST-CANCER; GOOGLE; SEARCH; BEHAVIOR; WEB; CELEBRITY; EPILEPSY; IMPACT; MEDIA	Our aim was to evaluate Wikipedia page visits in relation to the most common neurological disorders by determining which factors are related to peaks in Wikipedia searches for these conditions. Millions of people worldwide use the internet daily as a source of health information. Wikipedia is a popular free online encyclopedia used by patients and physicians to search for health-related information. The following Wikipedia articles were considered: Alzheimer's disease; Amyotrophic lateral sclerosis; Dementia; Epilepsy; Epileptic seizure; Migraine; Multiple sclerosis; Parkinson's disease; Stroke; Traumatic brain injury. We analyzed information regarding the total article views for 90 days and the rank of these articles among all those available in Wikipedia. We determined the highest search volume peaks to identify possible relation with online news headlines. No relation between incidence or prevalence of neurological disorders and the search volume for the related articles was found. Seven out of 10 neurological conditions showed relations in search volume peaks and news headlines. Six out of these seven peaks were related to news about famous people suffering from neurological disorders, especially those from showbusiness. Identification of discrepancies between disease burden and health seeking behavior on Wikipedia is useful in the planning of public health campaigns. Celebrities who publicly announce their neurological diagnosis might effectively promote awareness programs, increase public knowledge and reduce stigma related to diagnoses of neurological disorders. (C) 2015 Elsevier Ltd. All rights reserved.	[Brigo, Francesco] Univ Verona, Sect Clin Neurol, Dept Neurol & Movement Sci, I-37134 Verona, Italy; [Brigo, Francesco; Nardone, Raffaele; Lochner, Piergiorgio; Tezzon, Frediano] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Igwe, Stanley C.] Fed Teaching Hosp, Dept Neuropsychiat, Abakaliki, Abakaliki Ebony, Nigeria; [Nardone, Raffaele] Paracelsus Med Univ, Christian Doppler Clin, Dept Neurol, Salzburg, Austria; [Lochner, Piergiorgio] Univ Piemonte Orientale Amedeo Avogadro, Dept Translat Med, Novara, Italy; [Otte, Willem M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Pediat Neurol, Utrecht, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, Image Sci Inst, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands		Brigo, F (corresponding author), Univ Verona, Sect Clin Neurol, Dept Neurol & Movement Sci, Piazzale LA Scuro 10, I-37134 Verona, Italy.	dr.francescobrigo@gmail.com	Otte, Willem M./J-6140-2019; Lochner, Piergiorgio/AAB-6784-2020; Otte, Willem M/I-1228-2013; Brigo, Francesco/H-6513-2013	Otte, Willem M./0000-0003-1511-6834; Lochner, Piergiorgio/0000-0002-2101-6066; Otte, Willem M/0000-0003-1511-6834; Brigo, Francesco/0000-0003-0928-1577; Nardone, Raffaele/0000-0001-5243-6760			BRAGAZZI NL, 2013, MULT SCLER INT, V2013, DOI DOI 10.1155/2013/924029; Brigo F, 2014, MULT SCLER RELAT DIS, V3, P440, DOI 10.1016/j.msard.2014.02.005; Brigo F, 2014, CAN J NEUROL SCI, V41, P542, DOI 10.1017/S0317167100018692; Brigo F, 2014, EPILEPSY BEHAV, V31, P67, DOI 10.1016/j.yebeh.2013.11.020; Brigo F, 2014, SEIZURE-EUR J EPILEP, V23, P86, DOI 10.1016/j.seizure.2013.09.015; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Chataway Jeremy, 2010, Pract Neurol, V10, P271, DOI 10.1136/jnnp.2010.224931; Corley CD, 2010, ADV EXP MED BIOL, V680, P559, DOI 10.1007/978-1-4419-5913-3_61; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; MacArthur GJ, 2011, J MED SCREEN, V18, P204, DOI 10.1258/jms.2011.011092; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Otte WM, 2013, EPILEPSY BEHAV, V29, P571, DOI 10.1016/j.yebeh.2013.10.013; Twine C, 2006, BREAST, V15, P667, DOI 10.1016/j.breast.2006.03.006	17	20	20	1	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2015	22	7					1170	1172		10.1016/j.jocn.2015.02.006			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK9KE	WOS:000356558200019	25890773				2022-02-06	
J	Klimo, P; Ragel, BT; Jones, GM; McCafferty, R				Klimo, Paul, Jr.; Ragel, Brian T.; Jones, G. Morgan; McCafferty, Randall			Severe Pediatric Head Injury During the Iraq and Afghanistan Conflicts	NEUROSURGERY			English	Article						Head injury; Improvised explosive device; Operation enduring freedom; Operation Iraqi freedom; Pediatric; Penetrating	COMBAT SUPPORT HOSPITALS; TRAUMATIC BRAIN-INJURY; SURGICAL-TEAM; MILITARY; CHILDREN; EXPERIENCE; CARE; MORTALITY; BLAST; EPIDEMIOLOGY	BACKGROUND:Much has been written about injuries sustained by US and coalition soldiers during the Global War on Terrorism campaigns. However, injuries to civilians, including children, have been less well documented.OBJECTIVE:To describe the epidemiologic features and outcomes associated with isolated severe head injury in children during Operations Enduring Freedom and Iraqi Freedom (OEF and OIF).METHODS:A retrospective review of children (<18 years old) in the Joint Theater Trauma Registry with isolated head injury (defined as an Abbreviated Injury Score Severity Code >3) and treated at a US combat support hospital in Iraq or Afghanistan (2004-2012). The primary outcome was in-hospital mortality.RESULTS:We identified 647 children with severe isolated head injuries: 337 from OEF, 268 from OIF, and 42 nontheater specific. Most were boys (76%; median age = 8 years). Penetrating injuries were most common (60.6%). Overall, 330 (51%) children underwent a craniotomy/craniectomy; 156 (24.1%) succumbed to their injuries. Admission Glasgow Coma Score was predictive of survival among the entire cohort and each of the individual conflicts. Male sex also significantly increased the odds of survival for the entire group and OEF, but not for OIF. Closed-head injury improved the predictive ability of our model but did not reach statistical significance as an independent factor.CONCLUSION:This is the largest study of combat-related isolated head injuries in children. Admission Glasgow Coma Score and male sex were found to be predictive of survival. Assets to comprehensively care for the pediatric patient should be established early in future conflicts.ABBREVIATIONS:CI, confidence intervalGCS, Glasgow Coma ScoreICP, intracranial pressureIED, improvised explosive deviceJTTR, Joint Theater Trauma RegistryLN, local nationalMTF, military treatment facilityOEF, Operation Enduring FreedomOIF, Operation Iraqi Freedom	[Klimo, Paul, Jr.] Semmes Murphey Neurol & Spine Inst, Memphis, TN 38120 USA; [Klimo, Paul, Jr.; Jones, G. Morgan] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Ragel, Brian T.] Mercy Hosp & Clin, Dept Neurosurg, Springfield, MO USA; [Jones, G. Morgan] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA; [McCafferty, Randall] Wilford Hall USAF Med Ctr, Lackland AFB, TX USA		Klimo, P (corresponding author), Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklimo@semmes-murphey.com					Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; [Anonymous], 1971, JAMA, V215, P277; Arul GS, 2012, ANN ROY COLL SURG, V94, P52, DOI 10.1308/003588412X13171221499027; Beekley AC, 2004, AM J SURG, V187, P652, DOI 10.1016/j.amjsurg.2004.02.001; Beekley AC, 2009, J TRAUMA, V66, pS129, DOI 10.1097/TA.0b013e31819d85e7; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Borgman MA, 2011, PEDIATRICS, V127, pE892, DOI 10.1542/peds.2010-2439; Burnett MW, 2008, PEDIATRICS, V121, P261, DOI 10.1542/peds.2006-3666; Coppola CP, 2006, ARCH PEDIAT ADOL MED, V160, P972, DOI 10.1001/archpedi.160.9.972; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Eastridge BJ, 2009, J TRAUMA, V66, pS48, DOI 10.1097/TA.0b013e31819ce315; Edwards MJ, 2014, J AM COLL SURGEONS, V218, P1018, DOI 10.1016/j.jamcollsurg.2013.12.050; Edwards MJ, 2012, J TRAUMA ACUTE CARE, V73, P1278, DOI 10.1097/TA.0b013e318270d3ee; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fuenfer MM, 2009, MIL MED, V174, P887, DOI 10.7205/MILMED-D-02-2308; Klimo P, 2005, J NEUROSURG, V103, P207, DOI 10.3171/ped.2005.103.3.0207; Klimo P, 2010, J NEUROSURG-PEDIATR, V6, P107, DOI 10.3171/2010.3.PEDS109; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Martin JE, 2010, J NEUROSURG-PEDIATR, V6, P250, DOI 10.3171/2010.6.PEDS1031; Mathew P, 2013, BRIT J NEUROSURG, V27, P489, DOI 10.3109/02688697.2013.767314; Matos RI, 2008, PEDIATRICS, V122, pE959, DOI 10.1542/peds.2008-1244; McGuigan R, 2007, J PEDIATR SURG, V42, P207, DOI 10.1016/j.jpedsurg.2006.09.020; Nessen SC, 2009, J TRAUMA, V66, pS37, DOI 10.1097/TA.0b013e31819ce302; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peoples GE, 2005, MIL MED, V170, P462, DOI 10.7205/MILMED.170.6.462; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wilson KL, 2013, AM SURGEON, V79, P257	36	20	20	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2015	77	1					1	7		10.1227/NEU.0000000000000743			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CL2LS	WOS:000356776100001	25812072				2022-02-06	
J	LaVela, SL; Landers, K; Etingen, B; Karalius, VP; Miskevics, S				LaVela, Sherri L.; Landers, Kelsie; Etingen, Bella; Karalius, Vytas P.; Miskevics, Scott			Factors related to caregiving for individuals with spinal cord injury compared to caregiving for individuals with other neurologic conditions	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Caregiving; Spinal cord injury; Sleep; Coronary heart disease; Obesity	QUALITY-OF-LIFE; CORONARY-HEART-DISEASE; TRAUMATIC BRAIN-INJURY; SHORT-SLEEP DURATION; FAMILY CAREGIVERS; DEMENTIA CAREGIVERS; SPOUSAL CAREGIVERS; HEALTH; DEPRESSION; PEOPLE	Context/objective: To compare outcomes among caregivers of adults with spinal cord injuries (SCIs) to caregivers of adults with other neurological conditions, and determine if caregiving for SCI is associated with poor health status and chronic conditions. Design: Secondary data analysis of 2009/2010 Behavioral Risk Factor Surveillance System survey. Participants: Informal caregivers of adults with neurological conditions. Outcome measures: Sociodemographics, caregiving factors (e.g. role, emotional support, life satisfaction), lifestyle behaviors, chronic conditions, and health status. Results: Demographics and lifestyle behaviors did not differ in caregivers of adults with SCI vs. caregivers of adults with other neurological conditions (except younger age of SCI caregivers). Greater proportions of caregivers of adults with SCI had coronary heart disease (CHD) (12% vs. 6%, P = 0.06) and were obese (43% vs. 28%, P = 0.03). Frequent physical distress was reported by 20% of caregivers of persons with SCI (vs. 12% of other caregivers, P = 0.09), but mental health did not differ between caregiver groups. A greater proportion of caregivers of adults with SCI experienced insufficient sleep (47% vs. 30%, P = 0.008) and more days without enough sleep (13 vs. 9 days, P = 0.008). Odds of being younger, caregiver of a spouse, having CHD, and being obese were associated with being a caregiver of an adult with SCI. Conclusion: Caregivers of adults with SCI report similar mental health status, but more poor sleep, and have increased odds of CHD and obesity. Interventions to address physical distress, improve sleep, and address CHD and obesity are needed in this cohort.	[LaVela, Sherri L.; Landers, Kelsie; Etingen, Bella; Miskevics, Scott] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hlth Serv Res & Dev, Hines, IL 60141 USA; [LaVela, Sherri L.; Etingen, Bella; Karalius, Vytas P.; Miskevics, Scott] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Spinal Cord Injury Qual Enhancement Res Initiat S, Hines, IL 60141 USA; [LaVela, Sherri L.; Landers, Kelsie; Etingen, Bella; Miskevics, Scott] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Ctr Evaluat Practices & Experiences Patient Ctr C, Hines, IL 60141 USA; [LaVela, Sherri L.] Northwestern Univ, Ctr Healthcare Studies, Inst Publ Hlth & Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Karalius, Vytas P.] Loyola Univ, Dept Publ Hlth Sci, Stritch Sch Med, Maywood, IL 60153 USA		Etingen, B (corresponding author), US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hlth Serv Res & Dev, 151-H,Bldg 1,Off D 322,5th Ave & Roosevelt Rd, Hines, IL 60141 USA.	Bella.Etingen@va.gov		LaVela, Sherri/0000-0001-9900-0120	Veterans Health Administration, Health Services Research and Development (HSRD) Service [LIP 42-125]	This work was supported by the Veterans Health Administration, Health Services Research and Development (HSR&D) Service (LIP 42-125).	Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P83, DOI 10.3233/NRE-2010-0583; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Beccuti G, 2011, CURR OPIN CLIN NUTR, V14, P402, DOI 10.1097/MCO.0b013e3283479109; Blanes L, 2007, SPINAL CORD, V45, P399, DOI 10.1038/sj.sc.3102038; Buchanan Robert J, 2011, Int J MS Care, V13, P76, DOI 10.7224/1537-2073-13.2.76; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carter PA, 2000, CANCER NURS, V23, P410, DOI 10.1097/00002820-200012000-00002; Carter PA, 2003, CANCER NURS, V26, P253, DOI 10.1097/00002820-200308000-00001; Castro CM, 2009, BEHAV SLEEP MED, V7, P164, DOI 10.1080/15402000902976713; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chang EWC, 2007, PSYCHO-ONCOLOGY, V16, P950, DOI 10.1002/pon.1167; Chang HY, 2010, ARCH GERONTOL GERIAT, V50, P267, DOI 10.1016/j.archger.2009.04.006; Cho MH, 2006, J CANCER EDUC, V21, pS37, DOI 10.1207/s15430154jce2101s_8; Dreer LE, 2007, REHABIL PSYCHOL, V52, P351, DOI 10.1037/0090-5550.52.3.351; Ebrahimzadeh MH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-48; Eisenberg M.G., 2010, FINAL REPORT INQUIRY; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Faraut B, 2012, J HYPERTENS, V30, P1354, DOI 10.1097/HJH.0b013e32835465e5; GERHART KA, 1993, ARCH PHYS MED REHAB, V74, P1030, DOI 10.1016/0003-9993(93)90057-H; Gibbins J, 2009, J PAIN SYMPTOM MANAG, V38, P860, DOI 10.1016/j.jpainsymman.2009.04.025; Godwin KM, 2013, J NEUROSCI NURS, V45, P147, DOI 10.1097/JNN.0b013e31828a410b; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hung Jen-Wen, 2012, Chang Gung Med J, V35, P392; Kim H, 2012, J ADV NURS, V68, P846, DOI 10.1111/j.1365-2648.2011.05787.x; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; Kotronoulas G, 2013, J PAIN SYMPTOM MANAG, V45, P579, DOI 10.1016/j.jpainsymman.2012.03.013; LaVela SL, 2012, SPINAL CORD, V50, P682, DOI 10.1038/sc.2012.31; Lavela SL, 2010, CHRONIC ILLN, V6, P67, DOI 10.1177/1742395309356943; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Lira FS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-113; Manigandan C, 2000, SPINAL CORD, V38, P559, DOI 10.1038/sj.sc.3101035; McKibbin CL, 2005, SLEEP, V28, P1245, DOI 10.1093/sleep/28.10.1245; National Alliance for Caregiving, 2010, CAR VET SERV HOM REP; National Alliance for Caregiving and AARP, 2009, CAR US EX SUMM; Navaie-Waliser M, 2002, MED CARE, V40, P1249, DOI 10.1097/00005650-200212000-00012; Nogueira PC, 2012, REV LAT-AM ENFERM, V20, P1048, DOI 10.1590/S0104-11692012000600006; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Post MWM, 2005, SPINAL CORD, V43, P311, DOI 10.1038/sj.sc.3101704; Raj JT, 2006, SPINAL CORD, V44, P676, DOI 10.1038/sj.sc.3101899; Rittman M, 2009, J NEUROSCI NURS, V41, P39, DOI 10.1097/JNN.0b013e318193459a; Rowe MA, 2008, J CLIN SLEEP MED, V4, P362; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R, 2009, REHABIL PSYCHOL, V54, P1, DOI 10.1037/a0014932; Shankar A, 2008, AM J EPIDEMIOL, V168, P1367, DOI 10.1093/aje/kwn281; Simpson C, 2013, J CLIN NURS, V22, P3042, DOI 10.1111/jocn.12127; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; von Kanel R, 2008, GERONTOLOGY, V54, P131, DOI 10.1159/000113649; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Weitzenkamp DA, 1997, ARCH PHYS MED REHAB, V78, P822, DOI 10.1016/S0003-9993(97)90194-5; Wheaton AG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-295; Zahran H. S., 2004, Morbidity and Mortality Weekly Report, V53, P963	54	20	21	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2015	38	4					505	514		10.1179/2045772314Y.0000000240			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CL4RS	WOS:000356941800013	24993244	Green Published			2022-02-06	
J	Sabir, M; Gaudreault, PO; Freyburger, M; Massart, R; Blanchet-Cohen, A; Jaber, M; Gosselin, N; Mongrain, V				Sabir, Meriem; Gaudreault, Pierre-Olivier; Freyburger, Marlene; Massart, Renaud; Blanchet-Cohen, Alexis; Jaber, Manar; Gosselin, Nadia; Mongrain, Valerie			Impact of traumatic brain injury on sleep structure, electrocorticographic activity and transcriptome in mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Closed-head injury; Sleep architecture; Recovery sleep; EEG spectral analysis; Transcriptome; Cerebral cortex; Hippocampus; Plasticity genes; Clock genes; Chemokines	CLOSED-HEAD INJURY; DIFFUSE AXONAL INJURY; MICROGLIAL ACTIVATION; OXIDATIVE DAMAGE; MILD; EXPRESSION; DEPRIVATION; MODEL; HOMEOSTASIS; DISTURBANCE	Traumatic brain injury (TBI), including mild TBI (mTBI), is importantly associated with vigilance and sleep complaints. Because sleep is required for learning, plasticity and recovery, we here evaluated the bidirectional relationship between mTBI and sleep with two specific objectives: (1) Test that mTBI rapidly impairs sleep-wake architecture and the dynamics of the electrophysiological marker of sleep homeostasis (i.e., non-rapid eye movement sleep delta (1-4 Hz) activity); (2) evaluate the impact of sleep loss following mTBI on the expression of plasticity markers that have been linked to sleep homeostasis and on genome-wide gene expression. A closed-head injury model was used to perform a 48 h electrocorticographic (ECoG) recording in mice submitted to mTBI or Sham surgery. mTBI was found to immediately decrease the capacity to sustain long bouts of wakefulness as well as the amplitude of the time course of ECoG delta activity during wakefulness. Significant changes in ECoG spectral activity during wakefulness, non-rapid eye movement and rapid eye movement sleep were observed mainly on the second recorded day. A second experiment was performed to measure gene expression in the cerebral cortex and hippocampus after a mTBI followed either by two consecutive days of 6 h sleep deprivation (SD) or of undisturbed behavior (quantitative PCR and next-generation sequencing). mTBI modified the expression of genes involved in immunity, inflammation and glial function (e.g., chemokines, glial markers) and SD changed that of genes linked to circadian rhythms, synaptic activity/neuronal plasticity, neuroprotection and cell death and survival. SD appeared to affect gene expression in the cerebral cortex more importantly after mTBI than Sham surgery including that of the astrocytic marker Gfap, which was proposed as a marker of clinical outcome after TBI. Interestingly, SD impacted the hippocampal expression of the plasticity elements Arc and EfnA3 only after mTBI. Overall, our findings reveal alterations in spectral signature across all vigilance states in the first days after mTBI, and show that sleep loss post-mTBI reprograms the transcriptome in a brain area-specific manner and in a way that could be deleterious to brain recovery. (C) 2015 Elsevier Inc. All rights reserved.	[Sabir, Meriem; Gaudreault, Pierre-Olivier; Freyburger, Marlene; Jaber, Manar; Gosselin, Nadia; Mongrain, Valerie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Sabir, Meriem; Gaudreault, Pierre-Olivier; Freyburger, Marlene; Jaber, Manar; Gosselin, Nadia; Mongrain, Valerie] Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; [Sabir, Meriem] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Gaudreault, Pierre-Olivier; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Freyburger, Marlene; Mongrain, Valerie] Univ Montreal, Dept Neurosci, Montreal, PQ H3C 3J7, Canada; [Massart, Renaud] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Blanchet-Cohen, Alexis] Inst Rech Clin Montreal, Bioinformat, Montreal, PQ H2W 1R7, Canada		Mongrain, V (corresponding author), Hop Sacre Coeur, Res Ctr, Ctr Adv Res Sleep Med, 5400 Gouin West Blvd, Montreal, PQ H4J 1C5, Canada.	valerie.mongrain@umontreal.ca	Mongrain, Valerie/A-3931-2012	Massart, Renaud/0000-0002-1631-1853	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CBI-127051]; Research Center of the Hopital du Sacre-Coeur de Montreal; Fonds de la Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec [22210, 24742]	The authors thank Odile Neyret and Gaetan Tremblay for help with sequencing, Eric Beaumont for help regarding the brain injury, Peter Meerlo for critical discussion of the data, Catherine Duclos and Erika Belanger-Nelson for critical review of the manuscript, and Erika Belanger-Nelson, Michele Houde, Janine El Helou, Adeline Rachalski and Chloe Provost for help with SD and animal handling. This study was supported by a grant from the Canadian Institutes of Health Research (CBI-127051), start-up funds from the Research Center of the Hopital du Sacre-Coeur de Montreal, and salary awards from the Fonds de la Recherche du Quebec - Sante (22210, 24742).	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Amzica F, 2000, ACTA NEUROBIOL EXP, V60, P229; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, BABRAHAM BIOINFORMAT; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borbely A A, 1982, Hum Neurobiol, V1, P195; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Colak T, 2012, INJURY, V43, P1264, DOI 10.1016/j.injury.2012.01.021; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Curie T, 2013, SLEEP, V36, P311, DOI 10.5665/sleep.2440; Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; El Helou J, 2013, P NATL ACAD SCI USA, V110, P9974, DOI 10.1073/pnas.1221381110; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Eroglu B, 2014, J NEUROCHEM, V130, P626, DOI 10.1111/jnc.12781; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hanell A, 2012, J NEUROTRAUM, V29, P2660, DOI 10.1089/neu.2012.2376; Hazra A., 2014, J NEUROSCI RES; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krueger JM, 2011, PROG BRAIN RES, V193, P39, DOI 10.1016/B978-0-444-53839-0.00003-X; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Lerman BJ, 2012, BRAIN BEHAV, V2, P563, DOI 10.1002/brb3.75; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; Massart R, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.120; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mirabelli-Badenier M, 2011, THROMB HAEMOSTASIS, V105, P409, DOI 10.1160/TH10-10-0662; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Mongrain V, 2013, GENETIC BASIS OF SLEEP AND SLEEP DISORDERS, P147; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Murai KK, 2011, GLIA, V59, P1567, DOI 10.1002/glia.21226; Nelson AB, 2010, SLEEP, V33, P1659, DOI 10.1093/sleep/33.12.1659; Ohlmann KK, 2009, AAOHN J, V57, P381, DOI 10.3928/08910162-20090817-02; Oliveros JC, 2007, VENNY INTERACTIVE TO; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pellegrino R, 2014, SLEEP, V37, P1327, DOI 10.5665/sleep.3924; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066955; Schiehser D. M., 2014, J HEAD TRAU IN PRESS; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Ziegler G, 2009, BBA-MOL BASIS DIS, V1792, P1198, DOI 10.1016/j.bbadis.2009.10.003	97	20	22	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JUL	2015	47				SI		118	130		10.1016/j.bbi.2014.12.023			13	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	CL8NM	WOS:000357231400014	25576803				2022-02-06	
J	Tritos, NA; Yuen, KCJ; Kelly, DF				Tritos, Nicholas A.; Yuen, Kevin C. J.; Kelly, Daniel F.		AACE Neuroendocrine Pituitary Sci	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: A NEUROENDOCRINE APPROACH TO PATIENTS WITH TRAUMATIC BRAIN INJURY	ENDOCRINE PRACTICE			English	Article							GROWTH-HORMONE REPLACEMENT; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY DYSFUNCTION; QUALITY-OF-LIFE; DIABETES-INSIPIDUS; UNITED-STATES; HYPOTHALAMOPITUITARY DYSFUNCTION; TESTOSTERONE THERAPY; LONG-TERM; HYPOPITUITARISM	Objective: Traumatic brain injury (TBI) is now recognized as a major public health concern in the United States and is associated with substantial morbidity and mortality in both children and adults. Several lines of evidence indicate that TBI-induced hypopituitarism is not infrequent in TBI survivors and may contribute to the burden of illness in this population. The goal of this article is to review the published data and propose an approach for the neuroendocrine evaluation and management of these patients. Methods: To identify pertinent articles, electronic literature searches were conducted using the following keywords: "traumatic brain injury," "pituitary," "hypopituitarism," "growth hormone deficiency," "hypogonadism," "hypoadrenalism," and "hypothyroidism." Relevant articles were identified and considered for inclusion in the present article. Results: TBI-induced hypopituitarism appears to be more common in patients with severe TBI. However, patients with mild TBI or those with repeated, sports-, or blast-related TBI are also at risk for hypopituitarism. Deficiencies of growth hormone and gonadotropins appear to be most common and have been associated with increased morbidity in this population. A systematic approach is advised in order to establish the presence of pituitary hormone deficiencies and implement appropriate replacement therapies. Conclusion: The presence of traumatic hypopituitarism should be considered during the acute phase as well as during the rehabilitation phase of patients with TBI. All patients with moderate to severe TBI require evaluation of pituitary function. In addition, symptomatic patients with mild TBI and impaired quality of life are at risk for hypopituitarism and should be offered neuroendocrine testing.	[Tritos, Nicholas A.] Massachusetts Gen Hosp, Neuroendocrine Unit, Zero Emerson Pl,Suite 112, Boston, MA 02114 USA; [Tritos, Nicholas A.] Harvard Univ, Sch Med, Boston, MA USA; [Yuen, Kevin C. J.] Swedish Neurosci Inst, Swedish Pituitary Ctr, Seattle, WA USA; [Kelly, Daniel F.] St Johns Brain Tumor Ctr, Santa Monica, CA USA; [Kelly, Daniel F.] Pituitary Disorders Program, Santa Monica, CA USA; [Kelly, Daniel F.] John Wayne Canc Inst, Santa Monica, CA USA		Tritos, NA (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Zero Emerson Pl,Suite 112, Boston, MA 02114 USA.	ntritos@partners.org	Tritos, Nicholas/W-1594-2019	Tritos, Nicholas/0000-0001-8867-607X	IpsenIpsen; PfizerPfizer; Novo NordiskNovo Nordisk	Dr. Tritos has received research support from Ipsen, Pfizer, and Novo Nordisk. The other authors have no multiplicity of interest to disclose.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Cegla J, 2013, CLIN ENDOCRINOL, V78, P738, DOI 10.1111/cen.12043; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cook DM, 2012, PITUITARY, V15, P301, DOI 10.1007/s11102-011-0372-6; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Devin JK, 2012, NEUROSURG CLIN N AM, V23, P679, DOI 10.1016/j.nec.2012.06.001; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Estes Susie M, 2005, Pituitary, V8, P267, DOI 10.1007/s11102-006-6053-1; Farwell AP, 2013, CURR OPIN ENDOCRINOL, V20, P478, DOI 10.1097/01.med.0000433069.09294.e8; Fenske W, 2012, J CLIN ENDOCR METAB, V97, P3426, DOI 10.1210/jc.2012-1981; Fenske W, 2011, J CLIN ENDOCR METAB, V96, P1506, DOI 10.1210/jc.2010-2345; Fenske WK, 2014, J AM SOC NEPHROL, V25, P2376, DOI 10.1681/ASN.2013080895; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Garcia JM, 2013, J CLIN ENDOCR METAB, V98, P2422, DOI 10.1210/jc.2013-1157; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Hannon MJ, 2012, J CLIN ENDOCR METAB, V97, P1423, DOI 10.1210/jc.2011-3201; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marko NF, 2010, PITUITARY, V13, P249, DOI 10.1007/s11102-010-0227-6; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Personnier C, 2014, J CLIN ENDOCR METAB, V99, P2052, DOI 10.1210/jc.2013-4129; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; SNOW K, 1992, MAYO CLIN PROC, V67, P1055, DOI 10.1016/S0025-6196(12)61120-3; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Toogood AA, 2008, ENDOCRIN METAB CLIN, V37, P235, DOI 10.1016/j.ecl.2007.10.004; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	56	20	21	0	6	AMER ASSOC CLINICAL ENDOCRINOLOGISTS	JACKSONVILLE	245 RIVERSIDE AVENUE, STE 200, JACKSONVILLE, FL 32202 USA	1530-891X	1934-2403		ENDOCR PRACT	Endocr. Pract.	JUL	2015	21	7					823	831		10.4158/EP14567.DSCR			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DO7LQ	WOS:000377964500014	26172127				2022-02-06	
J	Mwanga-Amumpaire, J; Carroll, RW; Baudin, E; Kemigisha, E; Nampijja, D; Mworozi, K; Santorino, D; Nyehangane, D; Nathan, DI; De Beaudrap, P; Etard, JF; Feelisch, M; Fernandez, BO; Berssenbrugge, A; Bangsberg, D; Bloch, KD; Boum, Y; Zapol, WM				Mwanga-Amumpaire, Juliet; Carroll, Ryan W.; Baudin, Elisabeth; Kemigisha, Elisabeth; Nampijja, Dorah; Mworozi, Kenneth; Santorino, Data; Nyehangane, Dan; Nathan, Daniel I.; De Beaudrap, Pierre; Etard, Jean-Franois; Feelisch, Martin; Fernandez, Bernadette O.; Berssenbrugge, Annie; Bangsberg, David; Bloch, Kenneth D.; Boum, Yap, II; Zapol, Warren M.			Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial	OPEN FORUM INFECTIOUS DISEASES			English	Article						cerebral malaria; methemoglobin; nitric oxide; Plasmodium falciparum	TRAUMATIC BRAIN-INJURY; SEVERE FALCIPARUM-MALARIA; ENDOTHELIAL DYSFUNCTION; UNCOMPLICATED MALARIA; CEREBROSPINAL-FLUID; AFRICAN CHILDREN; KENYAN CHILDREN; INHALATION; MARKERS; HUMANS	Background. Children with cerebral malaria (CM) have high rates of mortality and neurologic sequelae. Nitric oxide (NO) metabolite levels in plasma and urine are reduced in CM. Methods. This randomized trial assessed the efficacy of inhaled NO versus nitrogen (N-2) as an adjunctive treatment for CM patients receiving intravenous artesunate. We hypothesized that patients treated with NO would have a greater increase of the malaria biomarker, plasma angiopoietin-1 (Ang-1) after 48 hours of treatment. Results. Ninety-two children with CM were randomized to receive either inhaled 80 part per million NO or N-2 for 48 or more hours. Plasma Ang-1 levels increased in both treatment groups, but there was no difference between the groups at 48 hours (P = not significant [NS]). Plasma Ang-2 and cytokine levels (tumor necrosis factor-alpha, interferon-., interleukin [IL]-1 beta, IL-6, IL-10, and monocyte chemoattractant protein-1) decreased between inclusion and 48 hours in both treatment groups, but there was no difference between the groups (P = NS). Nitric oxide metabolite levels-blood methemoglobin and plasma nitrate-increased in patients treated with NO (both P<.05). Seven patients in the N-2 group and 4 patients in the NO group died. Five patients in the N-2 group and 6 in the NO group had neurological sequelae at hospital discharge. Conclusions. Breathing NO as an adjunctive treatment for CM for a minimum of 48 hours was safe, increased blood methemoglobin and plasma nitrate levels, but did not result in a greater increase of plasma Ang-1 levels at 48 hours.	[Mwanga-Amumpaire, Juliet; Kemigisha, Elisabeth; Mworozi, Kenneth; Nyehangane, Dan; Boum, Yap, II] Epictr Mbarara Res Ctr, Mbarara, Uganda; [Mwanga-Amumpaire, Juliet; Nampijja, Dorah; Santorino, Data; Boum, Yap, II] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Carroll, Ryan W.; Nathan, Daniel I.; Bloch, Kenneth D.; Zapol, Warren M.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St,Thier Bldg,Floor 5, Boston, MA 02114 USA; [Carroll, Ryan W.; Bangsberg, David] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Med, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Carroll, Ryan W.] MassGen Hosp Children, Pediat Crit Care Med, Boston, MA USA; [Baudin, Elisabeth; Etard, Jean-Franois] Epictr, Paris, France; [De Beaudrap, Pierre; Etard, Jean-Franois] Univ Montpellier I, Inst Rech Dev, UMI 233, F-34006 Montpellier, France; [Feelisch, Martin; Fernandez, Bernadette O.] Univ Southampton, Southampton SO9 5NH, Hants, England; [Berssenbrugge, Annie] Ikaria, Clinton, NJ USA; [Carroll, Ryan W.; Bangsberg, David; Bloch, Kenneth D.; Zapol, Warren M.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA		Carroll, RW (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St,Thier Bldg,Floor 5, Boston, MA 02114 USA.	rcarroll4@mgh.harvard.edu	Fernandez, Bernadette/AAG-7202-2020; Feelisch, Martin/C-3042-2008; Etard, Jean-Francois/V-4865-2019; Etard, Jean Francois/A-9630-2008; De Beaudrap, Pierre/K-3113-2017	Fernandez, Bernadette/0000-0001-6337-0381; Feelisch, Martin/0000-0003-2320-1158; Etard, Jean-Francois/0000-0002-4873-0788; Etard, Jean Francois/0000-0002-4873-0788; De Beaudrap, Pierre/0000-0002-9037-6057			Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; Gianetti J, 2004, J THORAC CARDIOV SUR, V127, P44, DOI 10.1016/j.jtcvs.2002.08.001; Gladwin MT, 2011, JAMA-J AM MED ASSOC, V305, P893, DOI 10.1001/jama.2011.235; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Gries A, 2000, THROMB HAEMOSTASIS, V83, P309; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Janka JJ, 2010, J INFECT DIS, V202, P791, DOI 10.1086/655225; Kinsella JR, 2006, CURR OPIN PEDIATR, V18, P107, DOI 10.1097/01.mop.0000193291.09894.6c; Kinsella JP, 1997, SEMIN PERINATOL, V21, P418, DOI 10.1016/S0146-0005(97)80007-9; Krishna S, 2012, CURR OPIN INFECT DIS, V25, P484, DOI 10.1097/QCO.0b013e3283567b20; Lang JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086053; Li YS, 2013, BRAIN RES, V1507, P134, DOI 10.1016/j.brainres.2013.02.031; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; Medana IM, 2005, T ROY SOC TROP MED H, V99, P610, DOI 10.1016/j.trstmh.2004.11.017; Medana IM, 2007, J NEUROL SCI, V258, P93, DOI 10.1016/j.jns.2007.03.005; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nagasaka Y, 2008, ANESTHESIOLOGY, V109, P675, DOI 10.1097/ALN.0b013e318186316e; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Postels DG, 2012, NEUROLOGY, V79, P1268, DOI 10.1212/WNL.0b013e31826aacd4; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Serghides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027714; Stammet P, 2013, J AM COLL CARDIOL, V62, P851, DOI 10.1016/j.jacc.2013.04.039; Stork E, 1997, NEW ENGL J MED, V336, P597; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Wraight WM, 2001, BRIT J ANAESTH, V86, P267, DOI 10.1093/bja/86.2.267; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641	38	20	21	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2328-8957			OPEN FORUM INFECT DI	Open Forum Infect. Dis.	SUM	2015	2	3								10.1093/ofid/ofv111			9	Immunology; Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Microbiology	CX6BP	WOS:000365786500027	26309894	Green Published, gold			2022-02-06	
J	Skidmore, ER; Whyte, EM; Butters, MA; Terhorst, L; Reynolds, CF				Skidmore, Elizabeth R.; Whyte, Ellen M.; Butters, Meryl A.; Terhorst, Lauren; Reynolds, Charles F., III			Strategy Training During Inpatient Rehabilitation May Prevent Apathy Symptoms After Acute Stroke	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; BEHAVIORAL ACTIVATION; POSTSTROKE DEPRESSION; FUNCTIONAL RECOVERY; RELIABILITY; IMPAIRMENT; SCALE; INDEPENDENCE; DISORDERS; INTERVIEW	Background: Apathy, or lack of motivation for goal-directed activities, contributes to reduced engagement in and benefit from rehabilitation, impeding recovery from stroke. Objective: To examine the effects of strategy training, a behavioral intervention used to augment usual inpatient rehabilitation, on apathy symptoms over the first 6 months after stroke. Design: Secondary analysis of randomized controlled trial. Setting: Acute inpatient rehabilitation. Participants: Participants with acute stroke who exhibited cognitive impairments (Quick Executive Interview Scores >= 3) and were admitted for inpatient rehabilitation were randomized to receive strategy training (n = 15, 1 session per day, 5 days per week, in addition to usual inpatient rehabilitation) or reflective listening (n = 15, same dose). Methods: Strategy training sessions focused on participant-selected goals and participant-derived strategies to address these goals, using a global strategy training method (Goal-Plan-Do-Check). Reflective listening sessions focused on participant reflections on their rehabilitation goals and experiences, facilitated by open-ended questions and active listening skills (attending, following, and responding). Main Outcome Measures: Trained raters blinded to group assignment administered the Apathy Evaluation Scale at study admission, 3 months, and 6 months. Data were analyzed with repeated-measures fixed-effects models. Results: Participants in both groups had similar subsyndromal levels of apathy symptoms at study admission (strategy training, mean = 25.79, standard deviation = 7.62; reflective listening, mean = 25.18, standard deviation = 4.40). A significant group x time interaction (F-2,F-28 = 3.61, P = .040) indicated that changes in apathy symptom levels differed between groups over time. The magnitude of group differences in change scores was large (d = -0.99, t(28) = -2.64, P = .013) at month 3 and moderate to large (d = -0.70, t(28) = -1.86, P = .073) at month 6. Conclusion: Strategy training shows promise as an adjunct to usual rehabilitation for maintaining low levels of poststroke apathy.	[Skidmore, Elizabeth R.; Terhorst, Lauren] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA 15260 USA; [Skidmore, Elizabeth R.; Whyte, Ellen M.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Whyte, Ellen M.; Butters, Meryl A.; Reynolds, Charles F., III] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Whyte, Ellen M.; Butters, Meryl A.; Reynolds, Charles F., III] Western Psychiat Inst & Clin, Adv Ctr Intervent & Serv Res Late Life Mood Disor, Pittsburgh, PA USA		Skidmore, ER (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, 5012 Forbes Tower, Pittsburgh, PA 15260 USA.	skidmore@pitt.edu	Butters, Meryl/AAR-2863-2021; Terhorst, Lauren/H-7942-2018		University of Pittsburgh Medical Center Rehabilitation Institute, University of Pittsburgh Office of Research Health Sciences, Pittsburgh, PA [P30 MH090333, K12 HD055931, R01 HD074693]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD073770, R21HD071728, R01HD074693, R01HD055525, K12HD055931] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH090333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024827] Funding Source: NIH RePORTER	Support was provided by grants P30 MH090333, K12 HD055931, R01 HD074693, from the University of Pittsburgh Medical Center Rehabilitation Institute, University of Pittsburgh Office of Research Health Sciences, Pittsburgh, PA.	Autret K, 2013, BMJ CASE REP; Brodaty H, 2005, PSYCHOL MED, V35, P1707, DOI 10.1017/S0033291705006173; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Caeiro L, 2012, EUR J NEUROL, V19, P291, DOI 10.1111/j.1468-1331.2011.03508.x; Caeiro L, 2013, CEREBROVASC DIS, V35, P507, DOI 10.1159/000350202; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Delis DC., 2001, DELIS KAPLAN EXECUTI; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Kanter JW, 2010, CLIN PSYCHOL REV, V30, P608, DOI 10.1016/j.cpr.2010.04.001; Kaplan E., 2001, ASSESSMENT APHASIA R; Khan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041778; KRAUS MF, 1995, INT J PSYCHIAT MED, V25, P39, DOI 10.2190/BXRM-3M58-WBC5-A7EL; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Larson EB, 2010, ARCH PHYS MED REHAB, V91, P389, DOI 10.1016/j.apmr.2009.11.015; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARIN RS, 1993, J AFFECT DISORDERS, V28, P7, DOI 10.1016/0165-0327(93)90072-R; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mayo NE, 2009, STROKE, V40, P3299, DOI 10.1161/STROKEAHA.109.554410; Meichenbaum, 1977, COGNITIVE BEHAV MODI; Mikami K, 2013, AM J GERIAT PSYCHIAT, V21, P855, DOI 10.1016/j.jagp.2012.07.003; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Njomboro P, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00073; Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002; Pollock N, 1998, CANADIAN OCCUPATIONA; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robinson RG, 2009, J NEUROPSYCH CLIN N, V21, P144, DOI 10.1176/appi.neuropsych.21.2.144; Rochat L, 2013, NEUROLOGY, V81, P1674, DOI 10.1212/01.wnl.0000435290.49598.1d; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Skidmore ER, 2014, CLIN REHABIL, V28, P378, DOI 10.1177/0269215513502799; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; Skidmore ER, 2014, NEUROREHABIL NEURAL; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Tang WK, 2013, CEREBROVASC DIS, V35, P566, DOI 10.1159/000351152; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van Dalen JW, 2013, STROKE, V44, P851, DOI 10.1161/STROKEAHA.112.674614; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Watanabe A, 2003, J NEUROPSYCH CLIN N, V15, P442, DOI 10.1176/appi.neuropsych.15.4.442; Whyte EM, 2008, CEREBROVASC DIS, V26, P317, DOI 10.1159/000149580; Withall A, 2011, INT PSYCHOGERIATR, V23, P264, DOI 10.1017/S1041610209991116	54	20	20	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2015	7	6					562	570		10.1016/j.pmrj.2014.12.010			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CK2PO	WOS:000356053400002	25595665	Green Accepted			2022-02-06	
J	Carr, D; Lindstrom, AC; Jareborg, A; Champion, S; Waddell, N; Miller, D; Teagle, M; Horsfall, I; Kieser, J				Carr, Debra; Lindstrom, Anne-Christine; Jareborg, Andreas; Champion, Stephen; Waddell, Neil; Miller, David; Teagle, Michael; Horsfall, Ian; Kieser, Jules			Development of a skull/brain model for military wound ballistics studies	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Helmet; High velocity; Bullet; Rifle; Penetrating	EQUESTRIAN INJURIES; HEAD; GUNSHOTS; SKULL	Reports on penetrating ballistic head injuries in the literature are dominated by case studies of suicides; the penetrating ammunition usually being .22 rimfire or shotgun. The dominating cause of injuries in modern warfare is fragmentation and hence, this is the primary threat that military helmets protect the brain from. When helmets are perforated, this is usually by bullets. In combat, 20 % of penetrating injuries occur to the head and its wounding accounts for 50 % of combat deaths. A number of head simulants are described in the academic literature, in ballistic test methods for helmets (including measurement of behind helmet blunt trauma, BHBT) and in the 'open' and 'closed' government literature of several nations. The majority of these models are not anatomically correct and are not assessed with high-velocity rifle ammunition. In this article, an anatomically correct 'skull' (manufactured from polyurethane) and 'brain' (manufactured from 10 %, by mass, gelatine) model for use in military wound ballistic studies is described. Filling the cranium completely with gelatine resulted in a similar 'skull' fracture pattern as an anatomically correct 'brain' combined with a representation of cerebrospinal fluid. In particular, posterior cranial fossa and occipital fractures and brain ejection were observed. This pattern of injury compared favourably to reported case studies of actual incidents in the literature.	[Carr, Debra; Miller, David; Teagle, Michael; Horsfall, Ian] Cranfield Univ, Def Acad United Kingdom, Impact & Armour Grp, Ctr Def Engn Cranfield Def & Secur, Shrivenham SN6 8LA, Wilts, England; [Lindstrom, Anne-Christine; Jareborg, Andreas; Waddell, Neil; Kieser, Jules] Univ Otago, Sir John Walsh Res Inst, Dunedin, New Zealand; [Champion, Stephen] Cranfield Univ, Def Acad United Kingdom, Weap & Vehicle Syst Grp, Ctr Def Engn Cranfield Def & Secur, Shrivenham SN6 8LA, Wilts, England		Carr, D (corresponding author), Cranfield Univ, Def Acad United Kingdom, Impact & Armour Grp, Ctr Def Engn Cranfield Def & Secur, Shrivenham SN6 8LA, Wilts, England.	d.j.carr@cranfield.ac.uk	Champion, Stephen/N-4249-2015; Carr, Debra/K-6845-2013	Champion, Stephen/0000-0002-7818-8096; Waddell, John/0000-0001-8889-4632; Carr, Debra/0000-0002-9476-2166; Horsfall, Ian/0000-0002-2108-1087	Royal Swedish Academy of Sciences; Impact and Armour Group at Cranfield University	A-CL acknowledges an equipment grant from the Royal Swedish Academy of Sciences. Miss E. Girvan (Otago Centre for Electron Microscopy) assisted with the EDS analysis. This work was internally funded by The Impact and Armour Group at Cranfield University.	BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Baxter D, 2012, SURG OXFORD, V30, P116; Betz P, 1997, FORENSIC SCI INT, V86, P155, DOI 10.1016/S0379-0738(97)02121-X; BOND GR, 1995, PEDIATRICS, V95, P487; Breeze J, 2011, J TRAUMA, V71, P108, DOI 10.1097/TA.0b013e318203304a; CAREY ME, 1987, MIL MED, V152, P6; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hejna P, 2011, INT J LEGAL MED, V125, P587, DOI 10.1007/s00414-011-0553-x; Jones SJ, 2004, BRIT J SPORT MED, V38, P159, DOI 10.1136/bjsm.2002.002584; Jussila J, 2004, FORENSIC SCI INT, V141, P91, DOI 10.1016/j.forsciint.2003.11.036; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; Kieser DC, 2013, INT J LEGAL MED, V127, P951, DOI 10.1007/s00414-013-0874-z; Lewis EA, 2006, PERS ARM SYST S 2006, P18; LIESKE K, 1991, INT J LEGAL MED, V104, P235, DOI 10.1007/BF01369813; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; Mabbott A, 2013, INT S BALL FREIB GER; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; Rennick SL, 2005, J FORENSIC SCI, V50, P1016; Schyma C, 2012, INT J LEGAL MED, V126, P607, DOI 10.1007/s00414-012-0704-8; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; SPALDING TJW, 1991, BRIT J SURG, V78, P1102, DOI 10.1002/bjs.1800780921; Sturdivan LM, 1981, MATH MODEL PROBABILI; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; WATKINS FP, 1988, J TRAUMA, V28, pS40, DOI 10.1097/00005373-198801001-00011	27	20	20	1	36	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAY	2015	129	3					505	510		10.1007/s00414-014-1073-2			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	CG4DO	WOS:000353233200015	25194710				2022-02-06	
J	Fahlstedt, M; Depreitere, B; Halldin, P; Sloten, JV; Kleiven, S				Fahlstedt, Madelen; Depreitere, Bart; Halldin, Peter; Sloten, Jos Vander; Kleiven, Svein			Correlation between Injury Pattern and Finite Element Analysis in Biomechanical Reconstructions of Traumatic Brain Injuries	JOURNAL OF BIOMECHANICS			English	Article						Head injuries; Accident reconstructions; Image correlation; Bicycle accidents; FEA	HEMORRHAGE; PROGRESSION; THRESHOLD	At present, Finite Element (FE) analyses are often used as a tool to better understand the mechanisms of head injury. Previously, these models have been compared to cadaver experiments, with the next step under development being accident reconstructions. Thus far, the main focus has been on deriving an injury threshold and little effort has been put into correlating the documented injury location with the response displayed by the FE model. Therefore, the purpose of this study was to introduce a novel image correlation method that compares the response of the FE model with medical images. The injuries shown on the medical images were compared to the strain pattern in the FE model and evaluated by two indices; the Overlap Index (OI) and the Location Index (LI). As the name suggests, OI measures the area which indicates both injury in the medical images and high strain values in the FE images. LI evaluates the difference in center of mass in the medical and FE images. A perfect match would give an OI and LI equal to 1. This method was applied to three bicycle accident reconstructions. The reconstructions gave an average OI between 0.01 and 0.19 for the three cases and between 039 and 0.88 for LI. Performing injury reconstructions are a challenge as the information from the accidents often is uncertain. The suggested method evaluates the response in an objective way which can be used in future injury reconstruction studies. (C) 2015 Elsevier Ltd. All rights reserved.	[Fahlstedt, Madelen; Halldin, Peter; Kleiven, Svein] KTH Royal Inst Technol, Sch Technol & Hlth, Neuron Engn, S-14152 Huddinge, Sweden; [Depreitere, Bart] Katholieke Univ Leuven, Expt Neurosurg & Neuroanat, Leuven, Belgium; [Sloten, Jos Vander] Katholieke Univ Leuven, Biomech, Leuven, Belgium		Fahlstedt, M (corresponding author), KTH Royal Inst Technol, Sch Technol & Hlth, Neuron Engn, Alfred Nobels Alle 10, S-14152 Huddinge, Sweden.	madelen.fahlstedt@sth.kth.se	Depreitere, Bart/AAA-9846-2020	Depreitere, Bart/0000-0002-7458-0648	Lansforsakringarnas Cooperation Research Fund [P1/14]	This study was partly financed by Lansforsakringarnas Cooperation Research Fund (Grant no. P1/14). The authors would also like to thank Katrien Baeck for her assistance in gathering and retrieving the information on the accident data and medical images.	Anderson R.W.G., 1999, P INT RES COUNC BIOM; Baeck K., 2013, THESIS KU LEUVEN LEU; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Derler S, 2012, TRIBOL LETT, V45, P1, DOI 10.1007/s11249-011-9854-y; Dokko Y., 2003, P ENH SAF VEH ESV C; Doorly M.C., 2007, THESIS U COLL DUBLIN; Fahlstedt M., 2012, P INT RES COUNC BIOM; Gennarelli T, 1987, P 31 STAPP CAR CRASH; Hardy W N, 2001, Stapp Car Crash J, V45, P1; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Nahum AM, 1977, P 21 STAPP CAR CRASH; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, P 36 STAPP CAR CRASH; Verschueren P., 2009, THESIS KU LEUVEN LEU; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	26	20	22	1	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAY 1	2015	48	7					1331	1335		10.1016/j.jbiomech.2015.02.057			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CH0ZP	WOS:000353751200014	25817473				2022-02-06	
J	Kerr, ZY; Hayden, R; Dompier, TP; Cohen, R				Kerr, Zachary Y.; Hayden, Ross; Dompier, Thomas P.; Cohen, Randy			Association of Equipment Worn and Concussion Injury Rates in National Collegiate Athletic Association Football Practices 2004-2005 to 2008-2009 Academic Years	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; injury prevention; scrimmages; traumatic brain injury	SURVEILLANCE SYSTEM; RECURRENT CONCUSSION; NCAA CONCUSSION; PLAYERS; EPIDEMIOLOGY; DEPRESSION; STATEMENT; RISK	Background: The epidemiology of football-related concussions has been extensively examined. However, although football players experience more at-risk exposure time during practices than competitions, there is a dearth of literature examining the nature of the activities or equipment worn during practice. In particular, varying levels of equipment worn during practices may place players at varying levels of risk for concussion. Purpose: To describe the epidemiology of NCAA men's football concussions that occurred during practices from the 2004-2005 to 2008-2009 academic years by amount of equipment worn. Study Design: Descriptive epidemiology study. Methods: Men's collegiate football data from the National Collegiate Athletic Association Injury Surveillance System (NCAA ISS) during the 5-year study period were analyzed. Injury rates and injury rate ratios (RRs) were reported with 95% confidence intervals. Results: During the study period, 795 concussions were reported during practices, resulting in an injury rate of 0.39 per 1000 athlete-exposures (AEs) (95% CI, 0.36-0.42). Among NCAA divisions, Division III had the highest concussion rate (0.54/1000 AEs), followed by Division I (0.34/1000 AEs) and Division II (0.24/1000 AEs) (all P values for RRs comparing divisions <.001). Most concussions in practice occurred when players were fully padded (69.9%), followed by wearing shells (23.5%) and helmets only (1.9%). The practice concussion rate was higher in fully padded practices (0.66/1000 AEs) compared with practices when shells were worn (0.33/1000 AEs; RR = 1.99 [95% CI, 1.69-2.35]; P < .001) and practices when only helmets were worn (0.03/1000 AEs; RR = 22.39 [95% CI, 13.41-37.39]; P < .001). The practice concussion rate of the preseason (0.76/1000 AEs) was higher than that of the regular season (0.18/1000 AEs; RR = 4.14 [95% CI, 3.55-4.83]; P < .001) and that of postseason (0.25/1000 AEs; RR = 3.02 [95% CI, 1.95-4.67]; P < .001). The types of practice with the highest concussion rate were scrimmages (1.55/1000 AEs). Although only 3 concussions were sustained during scrimmage practices in which players wore shells, the concussion rate (2.84/1000 AEs) was higher than all other reported rates. Conclusion: Practice concussion rates are highest during fully padded practices, preseason practices, and scrimmages, suggesting that the nature, focus, and intensity of football practices affect concussion risk. In addition, coaching staff should continue to closely monitor player safety during scrimmages. Meanwhile, future surveillance should examine whether removing scrimmages, particularly those that are not fully padded, will meaningfully reduce the incidence and rate of concussions.	[Kerr, Zachary Y.; Hayden, Ross; Dompier, Thomas P.; Cohen, Randy] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA		Kerr, ZY (corresponding author), 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	zkerr@datalyscenter.org		Kerr, Zachary/0000-0003-1423-1259	The National Collegiate Athletic Association (NCAA) Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention; NCAA	One or more of the authors has declared the following potential conflict of interest or source of funding: The National Collegiate Athletic Association (NCAA) Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCAA.	Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Dick RW, 1997, AM SOC TEST MATER, V1305, P9, DOI 10.1520/STP11767S; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; ESPN, 2014, PAC 12 LIM CONT PRAC; ESPN, 2014, IVY LEAG LIM FULL CO; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heck JF, 2004, J ATHL TRAINING, V39, P101; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mueller FO, 2012, ANN SURVEY FOOTBALL; National Collegiate Athletic Association, FOOTB PRACT GUID	23	20	20	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2015	43	5					1134	1141		10.1177/0363546515570622			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	CH4CV	WOS:000353980000019	25931501				2022-02-06	
J	Pastor, PN; Reuben, CA; Kobau, R; Helmers, SL; Lukacs, S				Pastor, Patricia N.; Reuben, Cynthia A.; Kobau, Rosemarie; Helmers, Sandra L.; Lukacs, Susan			Functional difficulties and school limitations of children with epilepsy: Findings from the 2009-2010 National Survey of Children with Special-Health Care Needs	DISABILITY AND HEALTH JOURNAL			English	Article						Epilepsy; Disability; Comorbid conditions	CHILDHOOD EPILEPSY; SEIZURE; PSYCHOPATHOLOGY; PERFORMANCE; PREVALENCE; DISABILITY; DISORDERS; PROGNOSIS; EDUCATION; BEHAVIOR	Background: Epilepsy is a common serious neurologic disorder in children. However, most studies of children's functional difficulties and school limitations have used samples from tertiary care or other clinical settings. Objective: To compare functional difficulties and school limitations of a national sample of US children with special health care needs (CSHCN) with and without epilepsy. Methods: Data from the 2009-2010 National Survey of CSHCN for 31,897 children aged 6-17 years with and without epilepsy were analyzed for CSHCN in two groups: 1) CSHCN with selected comorbid conditions (intellectual disability, cerebral palsy, autism, or traumatic brain injury) and 2) CSHCN without these conditions. Functional difficulties and school limitations, adjusted for the effect of sociodemographic characteristics, were examined by epilepsy and comorbid conditions. Results: Three percent of CSHCN had epilepsy. Among CSHCN with epilepsy 53% had comorbid conditions. Overall CSHCN with epilepsy, both with and without comorbid conditions, had more functional difficulties than CSHCN without epilepsy. For example, after adjustment for sociodemographic characteristics a higher percentage of children with epilepsy, compared to children without epilepsy, had difficulty with communication (with conditions: 53% vs. 37%, without conditions: 13% vs. 5%). Results for school limitations were similar. After adjustment, a higher percentage of children with epilepsy, compared to children without epilepsy, missed 11 + school days in the past year (with conditions: 36% vs. 18%, without conditions: 21% vs. 15%). Conclusion: CSHCN with epilepsy, compared to CSHCN without epilepsy, were more likely to have functional difficulties and limitations in school attendance regardless of comorbid conditions. Published by Elsevier Inc.	[Pastor, Patricia N.; Reuben, Cynthia A.; Lukacs, Susan] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Kobau, Rosemarie] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Helmers, Sandra L.] Emory Univ, Sch Med, Atlanta, GA USA		Pastor, PN (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA.	php3@cdc.gov					Austin JK, 2011, EPILEPSY BEHAV, V21, P373, DOI 10.1016/j.yebeh.2011.05.028; Bailet LL, 2000, EPILEPSIA, V41, P426, DOI 10.1111/j.1528-1157.2000.tb00184.x; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Berg AT, 2011, J CHILD NEUROL, V26, P540, DOI 10.1177/0883073810384869; Berg AT, 2005, DEV MED CHILD NEUROL, V47, P749, DOI 10.1017/S001216220500157X; Berg AT, 2004, PEDIATRICS, V114, P645, DOI 10.1542/peds.2003-1151-L; Besag FMC, 2006, EPILEPSIA, V47, P119, DOI 10.1111/j.1528-1167.2006.00709.x; Bethell CD, 2002, AMBUL PEDIATR, V2, P38, DOI 10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2; BOYLE CA, 1994, PEDIATRICS, V93, P399; Bramlett MD, VITAL HEALTH STAT FO, V1; Centers for Disease Control and Prevention National Center for Health Statistics State and Area Integrated Telephone Survey, 2011, 2009 2010 NATIONAL S; Dunn DW, 2009, DEV MED CHILD NEUROL, V51, P364, DOI 10.1111/j.1469-8749.2008.03172.x; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; ELLENBERG JH, 1984, ANN NEUROL, V15, P127, DOI 10.1002/ana.410150204; Ellis N, 2000, SEIZURE-EUR J EPILEP, V9, P22, DOI 10.1053/seiz.1999.0353; Fastenau PS, 2008, J LEARN DISABIL-US, V41, P195, DOI 10.1177/0022219408317548; Gabis L, 2005, EPILEPSY BEHAV, V7, P652, DOI 10.1016/j.yebeh.2005.08.008; GOULDEN KJ, 1991, EPILEPSIA, V32, P690, DOI 10.1111/j.1528-1157.1991.tb04711.x; Hermann BP, 2008, EPILEPSIA, V49, P1847, DOI 10.1111/j.1528-1167.2008.01735.x; Hesdorffer DC, 2013, EPILEPSIA, V54, P207, DOI 10.1111/epi.12056; IOM (Institute of Medicine), 2012, EPILEPSY ACROSS THE; Jones JE, 2008, PEDIATR REV, V29, pE9, DOI 10.1542/pir.29-2-e9; Matson JL, 1999, J INTELL DISABIL RES, V43, P531, DOI 10.1046/j.1365-2788.1999.00247.x; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; MURPHY CC, 1995, EPILEPSIA, V36, P866, DOI 10.1111/j.1528-1157.1995.tb01629.x; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Piccinelli P, 2008, DEV MED CHILD NEUROL, V50, P353, DOI [10.1111/j.1469-8749.2007.02040.x, 10.1111/j.1469-8749.2008.02040.x]; Reilly C, 2013, CHILD ADOL MENT H-UK, V18, P65, DOI 10.1111/j.1475-3588.2012.00648.x; Research Triangle Institute, 2012, SUDAAN LANGUAGE MANU; Rodenburg R, 2005, J PEDIATR PSYCHOL, V30, P453, DOI 10.1093/jpepsy/jsi071; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Shinnar S, 2002, J CHILD NEUROL, V17, pS4, DOI 10.1177/08830738020170010201; Sogawa Y, 2010, EPILEPSIA, V51, P2432, DOI 10.1111/j.1528-1167.2010.02724.x; Stevanovic D, 2012, EPILEPSY BEHAV, V25, P141, DOI 10.1016/j.yebeh.2012.07.017; Zafeiriou DI, 1999, J CHILD NEUROL, V14, P289, DOI 10.1177/088307389901400504	35	20	20	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	APR	2015	8	2					231	239		10.1016/j.dhjo.2014.09.002			9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	CD7YY	WOS:000351313400011	25312691				2022-02-06	
J	Kenborg, L; Rugbjerg, K; Lee, PC; Ravnskjaer, L; Christensen, J; Ritz, B; Lassen, CF				Kenborg, Line; Rugbjerg, Kathrine; Lee, Pei-Chen; Ravnskjaer, Line; Christensen, Jane; Ritz, Beate; Lassen, Christina F.			Head injury and risk for Parkinson disease Results from a Danish case-control study	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; METAANALYSIS; SMOKING; HUMANS	Objective:To examine the association between head injuries throughout life and the risk for Parkinson disease (PD) in an interview-based case-control study.Methods:We identified 1,705 patients diagnosed with PD at 10 neurologic centers in Denmark in 1996-2009 and verified their diagnoses in medical records. Patients were matched to 1,785 controls randomly selected from the Danish Central Population Register on sex and year of birth. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression.Results:We observed no association between any head injury before first cardinal symptom and PD (OR 1.02; 95% CI 0.88, 1.19). Examination of number of head injuries (1: OR 1.02; 95% CI 0.87, 1.20; 2: OR 1.03; 95% CI 0.72, 1.47) or hospitalization for a head injury (OR 0.89; 95% CI 0.70, 1.12) did not show an association with PD. For 954 study subjects with at least one head injury, there was no evidence of an association between loss of consciousness (OR 0.89; 95% CI 0.67, 1.17), duration of loss of consciousness (1 minute: OR 0.93; 95% CI 0.58, 1.49; 1-5 minutes: OR 0.74; 95% CI 0.51, 1.08; 5 minutes: OR 0.81; 95% CI 0.53, 1.24), or amnesia (OR 1.31; 95% CI 0.88, 1.95) and risk for PD. Application of a lag time of 10 years between head injury and first cardinal symptom resulted in similar risk estimates.Conclusions:The results do not support the hypothesis that head injury increases the risk for PD.	[Kenborg, Line; Rugbjerg, Kathrine; Ravnskjaer, Line; Christensen, Jane; Lassen, Christina F.] Danish Canc Soc, Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Lee, Pei-Chen; Ritz, Beate] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Ritz, Beate] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Lee, Pei-Chen] Natl Taipei Univ Nursing Hlth Sci, Coll Healthcare Adm & Management, Dept Hlth Care Management, Taipei, Taiwan; [Lassen, Christina F.] Bispebjerg Hosp, Dept Occupat & Environm Med, DK-2400 Copenhagen, Denmark		Kenborg, L (corresponding author), Danish Canc Soc, Danish Canc Soc Res Ctr, Copenhagen, Denmark.	kenborg@cancer.dk	Rugbjerg, Kathrine/L-6531-2019; Ritz, Beate R/E-3043-2015; Kenborg, Line/T-4122-2018	Rugbjerg, Kathrine/0000-0001-7854-1075; Kenborg, Line/0000-0002-3584-6570; , Pei-Chen/0000-0001-7813-0823	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01ES013717]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES013717] Funding Source: NIH RePORTER	Supported by grant R01ES013717 from the NIH.	BHARUCHA NE, 1986, NEUROLOGY, V36, P284, DOI 10.1212/WNL.36.2.284; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Dong JQ, 2003, BIOMED ENVIRON SCI, V16, P173; Fang F, 2012, MOVEMENT DISORD, V27, P1632, DOI 10.1002/mds.25143; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Lai BCL, 2002, PARKINSONISM RELAT D, V8, P297, DOI 10.1016/S1353-8020(01)00054-2; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MORANO A, 1994, ACTA NEUROL SCAND, V89, P164; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; *R FDN STAT COMP, 2001, R LANG ENV STAT COMP; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Spangenberg S, 2009, PARKINSONISM RELAT D, V15, P12, DOI 10.1016/j.parkreldis.2008.02.004; Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wright JM, 2005, ARCH ENVIRON HEALTH, V60, P32, DOI 10.3200/AEOH.60.1.32-38	25	20	20	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 17	2015	84	11					1098	1103		10.1212/WNL.0000000000001362			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD9YU	WOS:000351458600011	25681453	Green Published			2022-02-06	
J	Jenson, D; Unnikrishnan, VU				Jenson, Daniel; Unnikrishnan, Vinu U.			Energy dissipation of nanocomposite based helmets for blast-induced traumatic brain injury mitigation	COMPOSITE STRUCTURES			English	Article						Blast-induced traumatic brain injury; Multiscale analysis; Mathematical homogenization; Molecular dynamics		Injuries caused to the head by ballistic shock waves during blast impacts are not well understood. It has been postulated that traumatic brain injury (TBI) can be caused when the blast wave causes the kinetic energy and the pressure in the main blood vessels to oscillate rapidly and travel to the brain thereby damaging the axonal fibers and neurons or with the direct wave transmission to the head. In the direct wave transmission, the severity of blast wave impact can be reduced by ballistic helmets. The ballistic helmets currently used in the military have been designed to provide protection against penetrating ballistic projectiles and their effectiveness against blast shock wave has not been thoroughly understood. This research would focus on developing a multiscale computational model of blast impact response of high-performance nanocomposite materials for the helmet, followed by estimation of blast energy transfer to the tissues in the human head. Such a combined atomistic-computational model of ballistic response of nanocomposites, coupled with a human morphology-specific computational model is necessary to study the mechanics of blast impact on human head. (C) 2014 Elsevier Ltd. All rights reserved.	[Jenson, Daniel; Unnikrishnan, Vinu U.] Univ Alabama, Dept Aerosp Engn & Mech, Tuscaloosa, AL 35487 USA		Unnikrishnan, VU (corresponding author), Univ Alabama, Dept Aerosp Engn & Mech, Tuscaloosa, AL 35487 USA.	vunnikrishnan@ua.edu			University of Alabama	The second author would like to acknowledge the faculty start up funds and the Research Grants Committee 2014-seed Grants from The University of Alabama.	Ackerman MJ, D LIB MAGAZINE, V1; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chandra N, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.094101; Che JW, 1999, NANOTECHNOLOGY, V10, P263, DOI 10.1088/0957-4484/10/3/307; Collins PG, 2000, SCI AM, V283, P62, DOI 10.1038/scientificamerican1200-62; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cullis Ian G, 2010, INT J PRESS VESSELS, V87, P493; Dewey JM, 2010, INT S MIL ASP BLAST; Edmund Baker Wilfred, 1973, EXPLOSIONS AIR; Elias Randjbaran, 2014, SCI WORLD J, V24, P7; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Gilbert RP, 2013, COMPUT MATH APPL, V66, P943, DOI 10.1016/j.camwa.2013.06.022; Griebel M, 2004, COMPUT METHOD APPL M, V193, P1773, DOI 10.1016/j.cma.2003.12.025; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jason AM, 2010, THESIS; Kleiven S, 2002, TRAFFIC INJ PREV, V3, P303, DOI DOI 10.1080/15389580214633; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Mellor Adrian J, 2012, J CRIT CARE, V27; Meo M, 2006, COMPOS SCI TECHNOL, V66, P1597, DOI 10.1016/j.compscitech.2005.11.015; MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3; Mylvaganam K, 2004, J PHYS CHEM B, V108, P15009, DOI 10.1021/jp048061x; Namilae S, 2004, CHEM PHYS LETT, V387, P247, DOI 10.1016/j.cplett.2004.01.104; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ostraich B, 2011, SHOCK WAVES, V21, P101, DOI 10.1007/s00193-011-0300-8; QU JM, 1993, MECH MATER, V14, P269, DOI 10.1016/0167-6636(93)90082-3; Reddy J., 2008, INTRO CONTINUUM MECH; Sainsbury T, 2010, CHEM MATER, V22, P2164, DOI 10.1021/cm902987k; Sears A, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.235406; Stuart SJ, 2000, J CHEM PHYS, V112, P6472, DOI 10.1063/1.481208; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tan KT, 2014, INT J IMPACT ENG, V64, P20, DOI 10.1016/j.ijimpeng.2013.09.003; Taraghi I, 2014, MATER DESIGN, V53, P152, DOI 10.1016/j.matdes.2013.06.051; Unnikrishnan GU, 2007, J BIOMECH ENG-T ASME, V129, P315, DOI 10.1115/1.2720908; Unnikrishnan GU, 2012, INT J NUMER METH BIO, V28, P229, DOI 10.1002/cnm.1462; Vonach M, 2012, PHYSIOL MEAS, V33, P801, DOI 10.1088/0967-3334/33/5/801; Wang X, 2013, J MECH BEHAV BIOMED, V20, P126, DOI 10.1016/j.jmbbm.2013.01.007	39	20	21	2	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-8223	1879-1085		COMPOS STRUCT	Compos. Struct.	MAR	2015	121						211	216		10.1016/j.compstruct.2014.08.028			6	Mechanics; Materials Science, Composites	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics; Materials Science	AZ2TP	WOS:000348085500020					2022-02-06	
J	Li, JY; Li, N; Jiang, Y				Li Junyi; Li Na; Jiang Yan			Mesenchymal Stem Cells Secrete Brain-Derived Neurotrophic Factor and Promote Retinal Ganglion Cell Survival After Traumatic Optic Neuropathy	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Mesenchymal stem cells; brain-derived neurotrophic factor; retinal ganglion cells; traumatic optic neuropathy	OLFACTORY ENSHEATHING CELLS; NEURITE REGENERATION; INJURY; DEATH; BDNF	Objective: The study aimed to investigate whether intravitreal injection of mesenchymal stem cells (MSCs) cultivated in vitro could increase the number of survived retinal ganglion cells (RGCs) after traumatic optic neuropathy and sought to identify potential mechanisms underlying such growth. Methods: The right eye of 24 cats in the MSC transplantation group accepted intravitreal injection of MSCs, and the other 24 cats in the phosphate buffer (PBS) control group received isotonic saline after traumatic optic neuropathy. The RGCs' survival rate in separated retinal and brain-derived neurotrophic factor (BDNF) expression were observed by Dil labeling and Enzyme-Linked Immuno Sorbent Assay (ELISA), respectively, at 3, 7, 14, and 28 days after transplantation. Results: Quantitative analysis showed that RGCs were significantly attenuated at 3, 7, 14, and 28 days after transplantation in both areas of the retina (peripheral, P-7d = 0.0011, P-14d < 0.001, P-28d < 0.001; central, P-3d = 0.0437, P-7d = 0.0067, P-14d < 0.001, P-28d < 0.001). Mean density of RGCs in the MSC transplantation group was significantly higher than that of the PBS control group after 14 days of treatment (P < 0.001). The homogenates BDNF (hBDNF) in the MSC transplantation group was obviously higher than that in the PBS control group at 14 and 28 days (P < 0.05). Conclusions: The MSCs transplanted into the retina of cats can slow down RGC apoptosis and steadily express BDNF. The MSC-mediated neuroprotection after optic nerve injury may be related to BNDF.	[Li Junyi; Li Na; Jiang Yan] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Otolaryngol Head & Neck Surg, Qingdao 266071, Shangdong, Peoples R China		Li, N (corresponding author), 16 South Jiangsu St, Qingdao 266003, Shandong, Peoples R China.	dr_lient@126.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81170895]; Natural Science Foundation of Shandong Province, ChinaNatural Science Foundation of Shandong Province [ZR2009CM053]	Supported by the Natural Science Foundation of China (81170895) and Natural Science Foundation of Shandong Province, China (ZR2009CM053).	Bonnet D, 2004, BRAIN RES, V1007, P142, DOI 10.1016/j.brainres.2004.02.023; Chaudhary P, 1999, MOL BRAIN RES, V67, P36, DOI 10.1016/S0169-328X(99)00032-7; Chong NHV, 1999, BRIT J OPHTHALMOL, V83, P120, DOI 10.1136/bjo.83.1.120; Dezawa Mari, 2002, Anatomical Science International, V77, P12, DOI 10.1046/j.0022-7722.2002.00012.x; Fang MR, 2011, ANAT REC, V294, P24, DOI 10.1002/ar.21281; Gass P, 2010, INT J NEUROPSYCHOPH, V13, P1, DOI 10.1017/S1461145709991039; Gavrilova N, 2010, INVEST OPHTH VIS SCI, V51, P2051; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Iacono E, 2012, VET RES COMMUN, V36, P107, DOI 10.1007/s11259-012-9520-3; Jiang Yan, 2007, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V42, P520; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Koda M, 2005, NEUROREPORT, V16, P1763, DOI 10.1097/01.wnr.0000183329.05994.d7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Li Y, 2003, J NEUROSCI, V23, P7783; Li Y, 2007, GLIA, V55, P312, DOI 10.1002/glia.20458; Lin Jianhua, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P982; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Maysinger D, 1996, EXP NEUROL, V138, P177, DOI 10.1006/exnr.1996.0056; Mead B., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Petruska JC, 2010, EUR J NEUROSCI, V32, P997, DOI 10.1111/j.1460-9568.2010.07392.x; Quimby JM, 2011, J FELINE MED SURG, V13, P418, DOI 10.1016/j.jfms.2011.01.005; Takano M, 2002, EXP EYE RES, V74, P319, DOI 10.1006/exer.2001.1118; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; Wu JJ, 2010, NEUROCHEM RES, V35, P495, DOI 10.1007/s11064-009-0086-6	29	20	23	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2015	26	2					548	552		10.1097/SCS.0000000000001348			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CD2FX	WOS:000350891600102	25723663				2022-02-06	
J	Max, JE; Friedman, K; Wilde, EA; Bigler, ED; Hanten, G; Schachar, RJ; Saunders, AE; Dennis, M; Ewing-Cobbs, L; Chapman, SB; Yang, TT; Levin, HS				Max, Jeffrey E.; Friedman, Keren; Wilde, Elisabeth A.; Bigler, Erin D.; Hanten, Gerri; Schachar, Russell J.; Saunders, Ann E.; Dennis, Maureen; Ewing-Cobbs, Linda; Chapman, Sandra B.; Yang, Tony T.; Levin, Harvey S.			Psychiatric Disorders in Children and Adolescents 24 Months After Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; PERSONALITY-CHANGE; COGNITIVE RESERVE; RELIABILITY; VALIDITY; CHILDHOOD; SCHEDULE	This study aimed to better understand the occurrence of novel psychiatric disorders (NPDs) in children with mild traumatic brain injury (mTBI) in relation to preinjury variables, injury-related variables, and concurrent neurocognitive outcome. Eighty-seven children aged 5-14 years who had experienced mTBI were studied from consecutive hospital admissions with semistructured psychiatric interviews soon after injury (baseline). Fifty-four children were reassessed 24 months postinjury. Standardized instruments were used to evaluate injury severity, lesion characteristics, preinjury variables (lifetime psychiatric disorder, family psychiatric history, family function, socioeconomic status, psychosocial adversity, adaptive function, and academic function), and finally, postinjury neurocognitive and adaptive function. At 24 months postinjury, NPDs had occurred in 17 of 54 (31%) participants. NPD at 24 months was related to frontal white matter lesions and was associated with estimated preinjury reading, preinjury adaptive function, and concurrent deficits in reading, processing speed, and adaptive function. These findings extend earlier reports that the psychiatric morbidity after mTBI in children is more common than previously thought, and moreover, it is linked to preinjury individual variables and injury characteristics and is associated with postinjury adaptive and neurocognitive functioning.	[Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Friedman, Keren] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Provo, UT 84602 USA; [Schachar, Russell J.; Dennis, Maureen] Univ Toronto, Toronto, ON, Canada; [Saunders, Ann E.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Chapman, Sandra B.] Univ Texas Dallas, Dallas, TX 75230 USA; [Yang, Tony T.] Univ Calif San Francisco, San Francisco, CA 94143 USA		Max, JE (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.	jmax@ucsd.edu		Schachar, Russell/0000-0002-2015-4395	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K-08 MH01800]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800, R01MH085734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This study was supported by grants from the National Institute of Mental Health (K-08 MH01800 to Dr. Max) and the National Institute of Neurological Disorders and Stroke (NS-21889 to Dr. Levin).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boyle MH, 1996, J AM ACAD CHILD PSY, V35, P1440, DOI 10.1097/00004583-199611000-00012; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cohen J., 2013, STAT POWER ANAL BEHA; Costello EJ, 1996, ARCH GEN PSYCHIAT, V53, P1137; Delis D.C., 1994, CVLT C CALIFORNIA VE; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 2010, COGNITIVE BEHAV ABNO; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Semel E., 1995, CLIN EVALUATION LANG, VThird; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Woodcock R.W., 1989, WOODCOCK JOHNSON TES; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yeates KO, CLIN PSYCHOL SCI	47	20	20	0	10	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2015	27	2					112	120		10.1176/appi.neuropsych.13080190			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CJ1NM	WOS:000355250300106	25923850	Green Submitted, Green Accepted			2022-02-06	
J	Nelson, NW; Anderson, CR; Thuras, P; Kehle-Forbes, SM; Arbisi, PA; Erbes, CR; Polusny, MA				Nelson, Nathaniel W.; Anderson, Carolyn R.; Thuras, Paul; Kehle-Forbes, Shannon M.; Arbisi, Paul A.; Erbes, Christopher R.; Polusny, Melissa A.			Factors associated with inconsistency in self-reported mild traumatic brain injury over time among military personnel in Iraq	BRITISH JOURNAL OF PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COMBAT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL OUTCOMES; OEF/OIF VETERANS; SYMPTOMS; SOLDIERS; DEPLOYMENT; AFGHANISTAN; CONSISTENCY; CONTEXT	Background Estimates of the prevalence of mild traumatic brain injury (mTBI) among military personnel and combat veterans rely almost exclusively on retrospective self-reports; however, reliability of these reports has received little attention. Aims To examine the consistency of reporting of mTBI over time and identify factors associated with inconsistent reporting. Method A longitudinal cohort of 948 US National Guard Soldiers deployed to Iraq completed self-report questionnaire screening for mTBI and psychological symptoms while in-theatre 1 month before returning home (time 1, T-1) and 1 year later (time 2, T-2). Results Most respondents (n = 811, 85.5%) were consistent in their reporting of mTBI across time. Among those who were inconsistent in their reports (n = 137, 14.5%), the majority denied mTBI at T-1 and affirmed mTBI at T-2 (n = 123, 89.8%). Respondents rarely endorsed mTBI in-theatre and later denied mTBI (n = 1 4, 10.2% of those with inconsistent reports). Post-deployment post-traumatic stress symptoms and non-specific physical complaints were significantly associated with inconsistent report of mTBI. Conclusions Military service members' self-reports of mTBI are generally consistent over time; however, inconsistency in retrospective self-reporting of mTBI status is associated with current posttraumatic stress symptoms and non-specific physical health complaints.	[Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, Minneapolis, MN 55403 USA; [Nelson, Nathaniel W.; Anderson, Carolyn R.; Thuras, Paul; Kehle-Forbes, Shannon M.; Arbisi, Paul A.; Erbes, Christopher R.; Polusny, Melissa A.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Thuras, Paul; Kehle-Forbes, Shannon M.; Arbisi, Paul A.; Erbes, Christopher R.; Polusny, Melissa A.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [Kehle-Forbes, Shannon M.; Polusny, Melissa A.] Ctr Chron Dis Outcomes Res, Minneapolis, MN USA		Nelson, NW (corresponding author), Univ St Thomas, MOH 217,1000 LaSalle Ave, Minneapolis, MN 55403 USA.		Polusny, Melissa/X-8158-2019; Polusny, Melissa Anderson/N-8112-2014	Polusny, Melissa/0000-0002-4932-305X; Polusny, Melissa Anderson/0000-0002-4932-305X	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Quality Enhancement Research Initiative Rapid Response) [08-252]; resources and facilities of the Minneapolis VA Health Care System; VA Health Services Research & Development Career Development Award	This material is based on work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Quality Enhancement Research Initiative Rapid Response Project 08-252) and the resources and facilities of the Minneapolis VA Health Care System The views expressed in this manuscript are those of the authors and do not reflect the official policy or position of the Department of Veterans Affairs, the Department of Defense or the US Government S.M.K -F is supported by a VA Health Services Research & Development Career Development Award.	Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bush S. S., 2013, MILD TRAUMATIC BRAIN, P381; Clauw DJ, 2003, J OCCUP ENVIRON MED, V45, P1040, DOI 10.1097/01.jom.0000091693.43121.2f; David AC, 2010, J TRAUMA STRESS, V23, P599, DOI 10.1002/jts.20566; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Engelhard IM, 2008, MEMORY, V16, P3, DOI 10.1080/09658210701334022; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; General Accounting Office, 2008, GAO08276; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Heir T, 2009, BRIT J PSYCHIAT, V194, P510, DOI 10.1192/bjp.bp.108.056580; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jones N, 2014, BRAIN INJURY, V28, P896, DOI 10.3109/02699052.2014.888479; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Maestas KL, 2011, REHABIL PSYCHOL, V56, P366, DOI 10.1037/a0025447; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314	39	20	20	0	7	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON SW1X 8PG, ENGLAND	0007-1250	1472-1465		BRIT J PSYCHIAT	Br. J. Psychiatry	MAR	2015	206	3					237	244		10.1192/bjp.bp.114.149096			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CE0FC	WOS:000351478900010	25614533	Bronze			2022-02-06	
J	Robertson, CL; Fidan, E; Stanley, RM; Noje, C; Bayir, H				Robertson, Courtney L.; Fidan, Emin; Stanley, Rachel M.; Noje, Corina; Bayir, Huelya			Progesterone for Neuroprotection in Pediatric Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; developmental brain injury; infant; neurosteroid; trauma	SEX STEROID-HORMONES; CORTICAL CONTUSION INJURY; EXTREMELY PRETERM INFANTS; CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; RAT-BRAIN; IMMATURE RATS; CELL-DEATH; INFLAMMATORY RESPONSE; GABA(A) RECEPTORS	Objective: To provide an overview of the preclinical literature on progesterone for neuroprotection after traumatic brain injury and to describe unique features of developmental brain injury that should be considered when evaluating the therapeutic potential for progesterone treatment after pediatric traumatic brain injury. Data Sources: National Library of Medicine PubMed literature review. Study Selection: The mechanisms of neuroprotection by progesterone are reviewed, and the preclinical literature using progesterone treatment in adult animal models of traumatic brain injury is summarized. Unique features of the developing brain that could either enhance or limit the efficacy of neuroprotection by progesterone are discussed, and the limited preclinical literature using progesterone after acute injury to the developing brain is described. Finally, the current status of clinical trials of progesterone for adult traumatic brain injury is reviewed. Data Extraction and Data Synthesis: Progesterone is a pleiotropic agent with beneficial effects on secondary injury cascades that occur after traumatic brain injury, including cerebral edema, 40 studies have used progesterone for treatment after traumatic brain injury in adult animal models, with results summarized in tabular form. However, very few studies have evaluated progesterone in pediatric animal models of brain injury. To date, two human phase II trials of progesterone for adult traumatic brain injury have been published, and two multicenter phase III trials are underway. Conclusions: The unique features of the developing brain from that of a mature adult brain make it necessary to independently study progesterone in clinically relevant, immature animal models of traumatic brain injury. Additional preclinical studies could lead to the development of a novel neuroprotective therapy that could reduce the long-term disability in head-injured children and could potentially provide benefit in other forms of pediatric brain injury (global ischemia, stroke, and statue epilepticus).	[Robertson, Courtney L.; Noje, Corina] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Robertson, Courtney L.; Noje, Corina] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Fidan, Emin; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Stanley, Rachel M.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Stanley, Rachel M.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA		Robertson, CL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	crober48@jhmi.edu; bayihx@upmc.edu			Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [1H34MC193530100]; Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS061817, NS076511]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061817, R01NS076511] Funding Source: NIH RePORTER	Dr. Stanley received support from the Health Resources and Services Administration (1H34MC193530100). Her institution received grant support from the Health Resources and Services Administration (planning grant to plan a trial of progesterone for pediatric traumatic brain injury). Dr. Noje is employed by Johns Hopkins School of Medicine. Dr. Bayir received support for article research from the National Institutes of Health (NS061817 and NS076511). Her institution received grant support from NINDS. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Beyenburg S, 2001, EPILEPSY RES, V44, P141, DOI 10.1016/S0920-1211(01)00194-2; BHR Pharma LLC, SYNAPSE GLOB PHAS 3; Billiards SS, 2006, J COMP NEUROL, V497, P199, DOI 10.1002/cne.20991; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carre JL, 2001, J STEROID BIOCHEM, V78, P89, DOI 10.1016/S0960-0760(01)00079-6; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; DALTON K, 1976, BRIT J PSYCHIAT, V129, P438, DOI 10.1192/bjp.129.5.438; DALTON K, 1979, J ROY SOC MED, V72, P397; Dazert P, 2006, NEUROSCIENCE, V142, P1071, DOI 10.1016/j.neuroscience.2006.07.056; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Ezquer ME, 2008, BRAIN RES, V1214, P73, DOI 10.1016/j.brainres.2008.03.029; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Ferrazzano P, 2013, CNS NEUROL DISORD-DR, V12, P338, DOI 10.2174/1871527311312030007; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Gonzalez-Ramirez M, 2010, PHARMACOL BIOCHEM BE, V97, P267, DOI 10.1016/j.pbb.2010.08.009; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Grosso S, 2003, EPILEPSY RES, V54, P29, DOI 10.1016/S0920-1211(03)00042-1; GUENNOUN R, 1995, MOL BRAIN RES, V30, P287, DOI 10.1016/0169-328X(95)00016-L; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; HOLMES GL, 1984, DEV BRAIN RES, V16, P45, DOI 10.1016/0165-3806(84)90061-0; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; JungTestas I, 1996, CELL MOL NEUROBIOL, V16, P439, DOI 10.1007/BF02088110; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kohchi C, 1998, BRAIN RES, V801, P233, DOI 10.1016/S0006-8993(98)00585-X; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; MCDONALD JW, 1992, BRAIN RES, V583, P54, DOI 10.1016/S0006-8993(10)80009-5; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Mellon SH, 2007, PHARMACOL THERAPEUT, V116, P107, DOI 10.1016/j.pharmthera.2007.04.011; Miller L, 1998, J IMMUNOL, V160, P5098; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moorthy K, 2005, EXP GERONTOL, V40, P295, DOI 10.1016/j.exger.2005.01.004; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nunez JL, 2007, DEV NEUROBIOL, V67, P1879, DOI 10.1002/dneu.20567; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Perrot-Sinal TS, 2003, NEUROSCIENCE, V116, P995, DOI 10.1016/S0306-4522(02)00794-7; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Quadros PS, 2008, ENDOCRINOLOGY, V149, P3054, DOI 10.1210/en.2007-1133; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P320, DOI 10.1016/j.yebeh.2005.02.006; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Trotter A, 2001, J CLIN ENDOCR METAB, V86, P601, DOI 10.1210/jc.86.2.601; Trotter A, 1999, J CLIN ENDOCR METAB, V84, P4531, DOI 10.1210/jc.84.12.4531; Trotter A, 2012, J CLIN ENDOCR METAB, V97, P1041, DOI 10.1210/jc.2011-2612; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wagner CK, 2008, ENDOCRINOLOGY, V149, P2743, DOI 10.1210/en.2008-0049; Wagner CK, 2006, FRONT NEUROENDOCRIN, V27, P340, DOI 10.1016/j.yfrne.2006.07.003; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Wright D, PROGESTERONE TRAUMAT; Wright DW, 2008, BRAIN INJURY, V22, P107, DOI 10.1080/02699050701867399; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	124	20	25	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2015	16	3					236	244		10.1097/PCC.0000000000000323			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	CD1AZ	WOS:000350807300008	25581631	Green Accepted			2022-02-06	
J	Xu, L; Yu, WK; Lin, ZL; Tan, SJ; Bai, XW; Ding, K; Li, N				Xu, Lin; Yu, Wen-Kui; Lin, Zhi-Liang; Tan, Shan-Jun; Bai, Xiao-Wu; Ding, Kai; Li, Ning			Chemical sympathectomy attenuates inflammation, glycocalyx shedding and coagulation disorders in rats with acute traumatic coagulopathy	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						catecholamine; chemical sympathectomy; coagulopathy; heart rate variability; hemorrhage; trauma	HEART-RATE-VARIABILITY; DIMINISHED PHYSIOLOGICAL RESERVE; TISSUE-PLASMINOGEN ACTIVATOR; ENDOTHELIAL GLYCOCALYX; NERVOUS-SYSTEM; BRAIN-INJURY; TNF-ALPHA; FIBRINOLYSIS; HYPERACTIVITY; DEGRADATION	Acute traumatic coagulopathy (ATC) may trigger sympathoadrenal activation associated with endothelial damage and coagulation disturbances. Overexcitation of sympathetic nerve in this state would disrupt sympathetic-vagal balance, leading to autonomic nervous system dysfunction. The aim of this study was to evaluate the autonomic function in ATC and its influence on inflammation, endothelial and coagulation activation. Male Sprague-Dawley rats were randomly assigned to sham, ATC control (ATCC) and ATC with sympathectomy by 6-hydroxydopamine (ATCS) group. Sham animals underwent the same procedure without trauma and bleeding. Following trauma and hemorrhage, rats underwent heart rate variability (HRV) test, which predicts autonomic dysfunction through the analysis of variation in individual R-R intervals. Then, rats were euthanized at baseline, and at 0, 1 and 2 h after shock and blood gas, conventional coagulation test and markers of inflammation, coagulation, fibrinolysis, endothelial damage and catecholamine were measured. HRV showed an attenuation of total power and high frequency, along with a rise of low frequency and low frequency : high frequency ratio in the ATC rats, which both were reversed by sympathectomy in the ATCS group. Additionally, sympathetic denervation significantly suppressed the increase of proinflammatory cytokines, tumor necrosis factor-a and the fibrinolysis markers including tissue-type plasminogen activator and plasmin-antiplasmin complex. Serum catecholamine, soluble thrombomodulin and syndecan-1 were also effectively inhibited by sympathectomy. These data indicated that autonomic dysfunction in ATC involves both sympathetic activation and parasympathetic inhibition. Moreover, sympathectomy yielded anti-inflammatory, antifibrinolysis and endothelial protective effects in rats with ATC. The role of autonomic neuropathy in ATC should be explored further. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Xu, Lin; Yu, Wen-Kui; Lin, Zhi-Liang; Tan, Shan-Jun; Bai, Xiao-Wu; Ding, Kai; Li, Ning] Second Mil Med Univ, Clin Sch Nanjing, Res Inst Gen Surg, Jinling Hosp, Nanjing, Jiangsu, Peoples R China		Li, N (corresponding author), Jinling Hosp, Res Inst Gen Surg, 305 Zhong Shan East Rd, Nanjing 210002, Jiangsu, Peoples R China.	ning_liprof@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270884]; 12th 5-year plan major project of PLA [WS12J001]; Jiangsu Province's Key Medical Talent Program of China [RC2011128]	Source of support: National Natural Science Foundation of China (nos. 81270884), the 12th 5-year plan major project of PLA (nos. WS12J001) and the Jiangsu Province's Key Medical Talent Program of China (nos. RC2011128).	Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Chaswal M, 2011, CAN J PHYSIOL PHARM, V89, P865, DOI [10.1139/Y11-084, 10.1139/y11-084]; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; da Silva VJD, 2012, EXP PHYSIOL, V97, P1143, DOI 10.1113/expphysiol.2011.061473; Darlington DN, 2013, SHOCK, V39, P440, DOI 10.1097/SHK.0b013e31829040e3; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hermann GE, 2008, NEUROSCIENTIST, V14, P53, DOI 10.1177/1073858407305725; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Jiang X, 2002, MICROVASC RES, V64, P438, DOI 10.1006/mvre.2002.2441; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kawada T, 2013, ACTA PHYSIOL, V209, P55, DOI 10.1111/apha.12123; Molina PE, 2005, SHOCK, V24, P3, DOI 10.1097/01.shk.0000167112.18871.5c; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Picklo MJ, 1997, J AUTONOM NERV SYST, V62, P111, DOI 10.1016/S0165-1838(96)00121-X; Pierce A, 2014, CURR OPIN ANESTHESIO, V27, P246, DOI 10.1097/ACO.0000000000000047; Preckel Daniel, 2004, HeartDrug, V4, P123; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Wang Y, 2002, BLOOD COAGUL FIBRIN, V13, P471, DOI 10.1097/00001721-200209000-00001; Winchell RJ, 2006, J TRAUMA, V60, P1173; Yamakawa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056728	34	20	21	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	MAR	2015	26	2					152	160		10.1097/MBC.0000000000000211			9	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	CA6GC	WOS:000349007300006	25325345				2022-02-06	
J	Miller, AP; Shah, AS; Aperi, BV; Budde, MD; Pintar, FA; Tarima, S; Kurpad, SN; Stemper, BD; Glavaski-Joksimovic, A				Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Budde, Matthew D.; Pintar, Frank A.; Tarima, Sergey; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra			Effects of blast overpressure on neurons and glial cells in rat organotypic hippocampal slice cultures	FRONTIERS IN NEUROLOGY			English	Article						blast injury; traumatic brain injury; in vitro model; organotypic slice culture; hippocampus; cell death	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; CENTRAL-NERVOUS-SYSTEM; REACTIVE ASTROCYTES; SELECTIVE VULNERABILITY; MICROGLIA ACTIVATION; MOLECULAR-MECHANISMS; INDUCED NEUROTRAUMA; NEURITE OUTGROWTH; OXIDATIVE STRESS	Due to recent involvement in military conflicts, and an increase in the use of explosives, there has been an escalation in the incidence of blast-induced traumatic brain injury (bTBI) among US military personnel. Having a better understanding of the cellular and molecular cascade of events in bTB I is prerequisite for the development of an effective therapy that currently is unavailable. The present study utilized organotypic hippocampal slice cultures (OHCs) exposed to blast overpressures of 150 kPa (low) and 280 kPa (high) as an in vitro bTBI model. Using this model, we further characterized the cellular effects of the blast injury. Blast-evoked cell death was visualized by a propidium iodide (PI) uptake assay as early as 2 h post-injury. Quantification of PI staining in the cornu Ammonis 1 and 3 (CA1 and CA3) and the dentate gyrus regions of the hippocampus at 2, 24, 48, and 72 h following blast exposure revealed significant time dependent effects. OHCs exposed to 150 kPa demonstrated a slow increase in cell death plateauing between 24 and 48 h, while OHCs from the high-blast group exhibited a rapid increase in cell death already at 2 h, peaking at 24 h post-injury. Measurements of lactate dehydrogenase release into the culture medium also revealed a significant increase in cell lysis in both low- and high-blast groups compared to sham controls. OHCs were fixed at 72 h post-injury and immunostained for markers against neurons, astrocytes, and microglia. Labeling OHCs with PI, neuronal, and glial markers revealed that the blast-evoked extensive neuronal death and to a lesser extent loss of glial cells. Furthermore, our data demonstrated activation of astrocytes and microglial cells in low- and high-blasted OHCs, which reached a statistically significant difference in the high-blast group. These data confirmed that our in vitro bTBI model is a useful tool for studying cellular and molecular changes after blast exposure.	[Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Budde, Matthew D.; Pintar, Frank A.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53295 USA; [Miller, Anna P.; Pintar, Frank A.; Kurpad, Shekar N.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53295 USA; [Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Budde, Matthew D.; Pintar, Frank A.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Tarima, Sergey] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53295 USA		Glavaski-Joksimovic, A (corresponding author), Med Coll Wisconsin, Zablocki VA Med Ctr, Dept Neurosurg, Neurosci Res Labs 151, 5000 West Natl Ave, Milwaukee, WI 53295 USA.	aglavaski@mcw.edu	Kurpad, Shekar/V-2188-2019; Stemper, Brian/AAX-7611-2020	Miller, Anna/0000-0002-6823-0852	Department of Neurosurgery, Medical College of Wisconsin; VA Medical ResearchUS Department of Veterans Affairs	This work was supported by the Department of Neurosurgery, Medical College of Wisconsin and the VA Medical Research. Authors acknowledge Christy Stadig, Natasha Wilkins, Rachel Chiariello, Ronald Chmill, Eric Inglin, Corey Hopp, Richard Pahapill, and Kyle Stehlik for their excellent technical assistance.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Billingham C, 2013, NEUROPATH APPL NEURO, V39, P243, DOI 10.1111/j.1365-2990.2012.01283.x; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cho ES, 2007, J VET SCI, V8, P15, DOI 10.4142/jvs.2007.8.1.15; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Coltman BW, 1996, INT J DEV NEUROSCI, V14, P707, DOI 10.1016/S0736-5748(96)00071-8; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; Dailey ME, 1999, METHODS, V18, P222, DOI 10.1006/meth.1999.0775; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Deweer B, 2001, BEHAV BRAIN RES, V127, P209, DOI 10.1016/S0166-4328(01)00366-7; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Friend DM, 2013, J NEUROCHEM, V125, P566, DOI 10.1111/jnc.12201; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; GIULIAN D, 1995, J NEUROSCI, V15, P7712; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Holopainen IE, 2005, NEUROCHEM RES, V30, P1521, DOI 10.1007/s11064-005-8829-5; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; LEBLOND J, 1989, J NEUROPHYSIOL, V62, P1; Lein PJ, 2011, METHODS MOL BIOL, V758, P115, DOI 10.1007/978-1-61779-170-3_8; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.00216.x; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lucci EB, 2006, SURG CLIN N AM, V86, P579, DOI 10.1016/j.suc.2006.03.001; Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McGeer PL, 1998, J NEURAL TRANSM-SUPP, P159; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mewes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045017; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nakajima K, 2001, NEUROSCI LETT, V307, P171, DOI 10.1016/S0304-3940(01)01943-7; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; RIESKE E, 1989, BRAIN RES, V492, P1, DOI 10.1016/0006-8993(89)90883-4; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sarnowska A, 2009, STEM CELLS DEV, V18, P1191, DOI 10.1089/scd.2008.0096; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shah AS, 2011, ASME 2011 INT MECH E; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Skibo GG, 2000, NEUROSCIENCE, V96, P427, DOI 10.1016/S0306-4522(99)00562-X; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Stuchlik A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00106; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Taylor PA, 2009, LY TIME, V131, DOI [10.1115/1.3118765, DOI 10.1115/1.3118765]; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Pinto MCX, 2012, NEUROCHEM INT, V61, P713, DOI 10.1016/j.neuint.2012.06.018; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Ziemka-Nalecz M, 2013, ACTA NEUROBIOL EXP, V73, P130; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077	149	20	20	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 12	2015	6								20	10.3389/fneur.2015.00020			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU7YM	WOS:000363757800001	25729377	Green Published, gold			2022-02-06	
J	Greco, T; Hovda, DA; Prins, ML				Greco, Tiffany; Hovda, David A.; Prins, Mayumi L.			Adolescent TBI-Induced Hypopituitarism Causes Sexual Dysfunction in Adult Male Rats	DEVELOPMENTAL NEUROBIOLOGY			English	Article						pituitary; adolescent; hormone; traumatic brain injury; sexual dysfunction	TRAUMATIC BRAIN-INJURY; PITUITARY-FUNCTION; BEHAVIOR; CHILDHOOD; PUBERTY; TESTOSTERONE; CHILDREN; AMYGDALA	Adolescents are at greatest risk for traumatic brain injury (TBI) and repeat TBI (RTBI). TBI-induced hypopituitarism has been documented in both adults and juveniles and despite the necessity of pituitary function for normal physical and brain development, it is still unrecognized and untreated in adolescents following TBI. TBI induced hormonal dysfunction during a critical developmental window has the potential to cause long-term cognitive and behavioral deficits and the topic currently remains unaddressed. The purpose of this study was to determine if four mild TBIs delivered to adolescent male rats disrupts testosterone production and adult behavioral outcomes. Plasma testosterone was quantified from 72 hrs preinjury to 3 months postinjury and pubertal onset, reproductive organ growth, erectile function and reproductive behaviors were assessed at 1 and 2 months postinjury. RTBI resulted in both acute and chronic decreases in testosterone production and delayed onset of puberty. Significant deficits were observed in reproductive organ growth, erectile function and reproductive behaviors in adult rats at both 1 and 2 months postinjury. These data suggest adolescent RTBI-induced hypopituitarism underlies abnormal behavioral changes observed during adulthood. The impact of undiagnosed hypopituitarism following RTBI in adolescence has significance not only for growth and puberty, but also for brain development and neurobehavioral function as adults. (c) 2014 Wiley Periodicals, Inc. Develop Neurobiol 75: 193-202, 2015	[Greco, Tiffany; Hovda, David A.; Prins, Mayumi L.] Semel Inst, Dept Neurosurg, Los Angeles, CA 90095 USA; [Greco, Tiffany; Hovda, David A.; Prins, Mayumi L.] Semel Inst, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hovda, David A.; Prins, Mayumi L.] Semel Inst, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Hovda, David A.] Semel Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Greco, T (corresponding author), Semel Inst, Dept Neurosurg, Los Angeles, CA 90095 USA.	tgreco@mednet.ucla.edu	Greco, Tiffany/ABA-3519-2021; Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NFL Charities, UCLA Brain Injury Research Center, Marilyn and Austin Anderson Fellowship	Contract grant sponsor: NFL Charities, UCLA Brain Injury Research Center, Marilyn and Austin Anderson Fellowship.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Becu-Villalobos D, 1997, CELL MOL NEUROBIOL, V17, P699, DOI 10.1023/A:1022542221535; BOBROW NA, 1971, ARCH SEX BEHAV, V1, P329, DOI 10.1007/BF01638061; Cunningham RL, 2007, NEUROSCIENCE, V150, P609, DOI 10.1016/j.neuroscience.2007.09.038; De Lorme KC, 2012, BRAIN RES, V1460, P33, DOI 10.1016/j.brainres.2012.04.035; Dyer K, 2013, DISABIL REHABIL, V29, P29; Edelstein RS, 2011, HORM BEHAV, V60, P248, DOI 10.1016/j.yhbeh.2011.05.007; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giuliano F, 2000, NEUROSCI BIOBEHAV R, V24, P517, DOI 10.1016/S0149-7634(00)00020-8; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HART BL, 1983, HORM BEHAV, V17, P274, DOI 10.1016/0018-506X(83)90026-0; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; HUFFER V, 1964, ANN INTERN MED, V61, P255, DOI 10.7326/0003-4819-61-2-255; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Lauzier F., 2012, CRIT CARE S1, V16, pP299; LEWIS VG, 1977, ADOLESCENCE, V12, P1; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; MORENO J, 2012, INT J PSYCHOL S1, V47, P684; Moreno J, 2012, INT J PSYCHOL, V47, P574; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; NAZIAN SJ, 1980, ARCH ANDROLOGY, V4, P283, DOI 10.3109/01485018008986974; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; PRIMUS RJ, 1989, DEV PSYCHOBIOL, V22, P633, DOI 10.1002/dev.420220608; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Schneider M, 2013, CELL TISSUE RES, V354, P99, DOI 10.1007/s00441-013-1581-2; Schulz KM, 2004, HORM BEHAV, V45, P242, DOI 10.1016/j.yhbeh.2003.12.007; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; SIZONENKO P C, 1987, Pediatrician, V14, P191; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tandon A, 2009, ACTA NEUROCHIR, V151, P1411, DOI 10.1007/s00701-009-0444-9; vansEden CG, 1990, PROG BRAIN RES, V85, P169; Vetter-O'Hagen CS, 2012, DEV PSYCHOBIOL, V54, P523, DOI 10.1002/dev.20610; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786	51	20	21	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	FEB	2015	75	2					193	202		10.1002/dneu.22218			10	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	AY8JC	WOS:000347798900006	25066665				2022-02-06	
J	Griesdale, DEG; Ortenwall, V; Norena, M; Wong, H; Sekhon, MS; Kolmodin, L; Henderson, WR; Dodek, P				Griesdale, Donald E. G.; Ortenwall, Victoria; Norena, Monica; Wong, Hubert; Sekhon, Mypinder S.; Kolmodin, Leif; Henderson, William R.; Dodek, Peter			Adherence to guidelines for management of cerebral perfusion pressure and outcome in patients who have severe traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Brain injuries; Traumatic; Cerebral perfusion pressure; Intracranial pressure; Neurocritical care; Area under curve	SECONDARY INSULTS; PROGNOSTIC VALUE; HEAD-INJURY; AUTOREGULATION; EPIDEMIOLOGY; PREDICTION; REACTIVITY; PROTOCOL	Purpose: The aims of this study are to assess adherence to the Brain Trauma Foundation (BTF) cerebral perfusion pressure (CPP) guidelines and to determine if adherence is associated with mortality in patients who have a severe traumatic brain injury. Materials and methods: Retrospective cohort study of 127 patients admitted to one intensive care unit between 2006 and 2012. Adherence to BTF guidelines was measured as the time that the CPP was within 50 to 70 mm Hg divided by the total time of CPP monitoring (CPP time index). Results: The percentage of time that the CPP was within the recommended range was 31.6% (SD, 22.2); CPP was greater than 70 mm Hg for 63.9% (SD, 26.2) of the time and less than 50 mm Hg for 4.5% of the time (SD, 16.3). After adjustment for covariates, CPP time index (between 50 and 70 mm Hg) was not associated with hospital mortality (odds ratio [OR], 1.2; 95% confidence interval [CI], 0.98-1.6; P=.079). The time indices for CPP >= 70 and <50 mm Hg were associated with decreased (OR, 0.66; 95% CI, 0.52-0.82; P<.0001) and increased (OR, 9.9; 95% CI, 1.4-69.6; P=.021) mortality, respectively. Conclusion: Cerebral perfusion pressure was greater than 70 mm Hg for most of the time. This level of CPP was associated with decreased hospital mortality. (C) 2014 Elsevier Inc. All rights reserved.	[Griesdale, Donald E. G.; Sekhon, Mypinder S.; Kolmodin, Leif; Henderson, William R.; Dodek, Peter] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Ortenwall, Victoria] Lund Univ, Dept Anaesthesiol & Crit Care Med, Lund, Sweden; [Norena, Monica; Wong, Hubert; Dodek, Peter] Providence Hlth Care, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Norena, Monica; Wong, Hubert; Dodek, Peter] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wong, Hubert] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada		Griesdale, DEG (corresponding author), Vancouver Gen Hosp, Room 2438,2nd Floor,855 West 12th Ave, Vancouver, BC V5Z 1M9, Canada.	donald.griesdale@vch.ca	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624	Vancouver Coastal Health Research Institute's "VGH & UBC Hospital Foundation Best of Health Fund"; Department of Anesthesiology, Pharmacology & Therapeutics at the University of British Columbia; Department of Anesthesiology & Perioperative Care at Vancouver General Hospital	Dr Griesdale is supported in part through the Vancouver Coastal Health Research Institute's "VGH & UBC Hospital Foundation Best of Health Fund" and the Department of Anesthesiology, Pharmacology & Therapeutics at the University of British Columbia and The Department of Anesthesiology & Perioperative Care at Vancouver General Hospital.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2007, NEUROL RES, V29, P672, DOI 10.1179/016164107X240053; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; LASSEN NA, 1974, CIRC RES, V34, P749, DOI 10.1161/01.RES.34.6.749; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mackenzie IMJ, 2011, INTENS CARE MED, V37, P435, DOI 10.1007/s00134-010-2103-2; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Statistics Canada, 2011, LEAD CAUS DEATH TOT; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Vespa Paul, 2003, Neurosurg Focus, V15, pE4; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wenner JB, 2009, J CRIT CARE, V24, P401, DOI 10.1016/j.jcrc.2009.03.008	39	20	24	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2015	30	1					111	115		10.1016/j.jcrc.2014.07.026			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW4GJ	WOS:000346238900019	25179411				2022-02-06	
J	Massaro, AM; Doerfler, S; Nawalinski, K; Michel, B; Driscoll, N; Ju, C; Patel, H; Quattrone, F; Frangos, S; Maloney-Wilensky, E; Grady, MS; Stein, SC; Kasner, SE; Kumar, MA				Massaro, Allie M.; Doerfler, Sean; Nawalinski, Kelsey; Michel, Bernard; Driscoll, Nicolette; Ju, Connie; Patel, Hiren; Quattrone, Francis; Frangos, Suzanne; Maloney-Wilensky, Eileen; Grady, Michael Sean; Stein, Sherman C.; Kasner, Scott E.; Kumar, Monisha A.			Thromboelastography Defines Late Hypercoagulability After TBI: A Pilot Study	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Head trauma; Thromboelastography; TEG; Coagulopathy; Hypercoagulability	TRAUMATIC BRAIN-INJURY; ADMISSION RAPID THROMBELASTOGRAPHY; PROTEIN-C PATHWAY; VENOUS THROMBOEMBOLISM; NEUROSURGICAL PATIENTS; HEAD-INJURIES; 1602 EPISODES; DATA-BANK; COAGULOPATHY; COAGULATION	Traumatic brain injury (TBI) is associated with a hypercoagulable state, the mechanism and duration of which remain unclear. We sought to determine whether thromboelastography (TEG) analysis could identify the hypercoagulable state after TBI, as defined by elevations in maximal amplitude (MA), thrombus generation (TG), G value (G), and alpha angle (alpha A). Patients with moderate-severe TBI, defined primarily as a GCS < 12, admitted between 1/2012 and 8/2013 were eligible for enrolment in this prospective cohort study. TEG profiles were obtained between 0-24 h (T1), 24-48 h (T2), 48-72 h (T3), 72-96 h (T4), and 96-120 h (T5) after admission. Early TEG was defined as 0-48 h, and late TEG was defined as > 48 h. Twenty five patients (80 % men) and 7 age- and sex-matched control subjects were studied. Median age was 38 years (range 18-85). Early MA was [63.6 mm (60.5, 67.4)] versus late MA [69.9 mm (65.2,73.9); p = 0.02], early TG was [763.3 mm/min (712.8, 816.2)] versus late TG [835.9 mm/min (791.2,888.3); p = 0.02], and early G was [8.8 d/cm(2) (7.7,10.4)] versus late G [11.6 d/cm(2) (9.4,14.1); p = 0.02]. Study patients had higher MA (p = 0.02), TG (p = 0.03), and G (p = 0.02) values at T5 compared to controls. There was a linear increase per day of MA by 2.6 mm (p = 0.001), TG 31.9 mm/min (p a parts per thousand currency sign 0.001), and G value by 1.3 d/cm(2) (p a parts per thousand currency sign 0.001) when clustered by pairs in regression analysis. Lower MA values trended toward home discharge (p = 0.08). The data suggest a progressive and delayed hypercoagulable state observed days after initial TBI. The hypercoagulable state may reflect excess platelet activity.	[Massaro, Allie M.; Kasner, Scott E.; Kumar, Monisha A.] Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Massaro, Allie M.; Doerfler, Sean; Nawalinski, Kelsey; Michel, Bernard; Driscoll, Nicolette; Ju, Connie; Patel, Hiren; Quattrone, Francis; Frangos, Suzanne; Maloney-Wilensky, Eileen; Grady, Michael Sean; Stein, Sherman C.; Kasner, Scott E.; Kumar, Monisha A.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Doerfler, Sean; Nawalinski, Kelsey; Michel, Bernard; Driscoll, Nicolette; Ju, Connie; Patel, Hiren; Quattrone, Francis; Frangos, Suzanne; Maloney-Wilensky, Eileen; Grady, Michael Sean; Stein, Sherman C.; Kumar, Monisha A.] Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA		Massaro, AM (corresponding author), Perelman Sch Med, Dept Neurol, 3 West Gates Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	allie.massaro@gmail.com	Driscoll, Nicolette/AAR-3699-2021	Driscoll, Nicolette/0000-0001-8364-460X	Haemonetics; WL Gore; AstraZenecaAstraZeneca; GlaxoSmithKlineGlaxoSmithKline; Acorda; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Dr. Kumar has received research support from Haemonetics. Dr. Kasner has received grants from WL Gore, AstraZeneca, GlaxoSmithKline, and Acorda. He acts as a consultant for Merck, Novartis, Medtronic, and Boehringer Ingelheim. Dr. Grady has received Grant funding from the NIH. For the remaining authors, none were declared.	Abrahams JM, 2002, SURG NEUROL, V58, P5, DOI 10.1016/S0090-3019(02)00777-2; [Anonymous], 1971, JAMA, V215, P277; Branco BC, 2014, SHOCK, V41, P200, DOI 10.1097/SHK.0000000000000109; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cotton BA, 2012, J TRAUMA ACUTE CARE, V72, P1470, DOI 10.1097/TA.0b013e31824d56ad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Gonzalez E, 2010, J SURG RES, V163, P96, DOI 10.1016/j.jss.2010.03.058; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Haemonetics TBMC, 2008, BAS CLIN TRAIN; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Kashuk JL, 2012, TRANSFUSION, V52, P23, DOI 10.1111/j.1537-2995.2011.03264.x; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2013, THROMB RES, V131, pE26, DOI 10.1016/j.thromres.2012.11.005; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCrath DJ, 2005, ANESTH ANALG, V100, P1576, DOI 10.1213/01.ANE.0000155290.86795.12; Nielsen VG, 2008, THROMB RES, V122, P145, DOI 10.1016/j.thromres.2007.09.003; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rivard GE, 2005, J THROMB HAEMOST, V3, P2039, DOI 10.1111/j.1538-7836.2005.01513.x; Rogers FB, 2001, SURGERY, V130, P1, DOI 10.1067/msy.2001.114558; Schrieber M, 2007, J TRAUMA, V63, P1261; Shackford SR, 2004, ANN SURG, V240, P496; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wegner J, 2010, SEMIN THROMB HEMOST, V36, P699, DOI 10.1055/s-0030-1265286; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	44	20	21	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					45	51		10.1007/s12028-014-0051-3			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300007	25127903				2022-02-06	
J	Rabinowitz, AR; Merritt, VC; Arnett, PA				Rabinowitz, Amanda R.; Merritt, Victoria C.; Arnett, Peter A.			The Return-to-Play Incentive and the Effect of Motivation on Neuropsychological Test-Performance: Implications for Baseline Concussion Testing	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							SPORT-RELATED CONCUSSION	Athletes may be less engaged in baseline cognitive testing in the absence of a powerful return-to-play incentive. The present study sought to evaluate whether athletes' level of motivation (1) influences baseline test performance and (2) changes across pre- and post-injury assessments. We found a significant relationship between examiners' ratings of athletes motivation toward testing and baseline cognitive test performance. Athletes, but not controls, demonstrated increased motivation between tests. These findings suggest that baseline test performance may underestimate true premorbid abilities for a subset of athletes.	[Rabinowitz, Amanda R.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Merritt, Victoria C.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Rabinowitz, AR (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Goddard Labs 306, 3710 Hamilton Walk, Philadelphia, PA 19104 USA.	rabinowitz.a@gmail.com		Merritt, Victoria/0000-0001-5683-4168	Benton Meier Neuropsychology Scholarship from the American Psychological Foundation	This work was supported in part by the Benton Meier Neuropsychology Scholarship from the American Psychological Foundation to Amanda R. Rabinowitz. The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the American Psychological Foundation.	Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Lovell M, 2000, IMPACT IMMEDIATE POS; Rabinowitz A. R., 2012, NAT AC NEUR NASHV TE; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; The Psychological Corporation, 2001, WECHSLER TEST ADULT	7	20	20	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JAN 2	2015	40	1			SI		29	33		10.1080/87565641.2014.1001066			5	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CA6IR	WOS:000349015800006	25649777				2022-02-06	
J	Vera-Estay, E; Dooley, JJ; Beauchamp, MH				Vera-Estay, E.; Dooley, J. J.; Beauchamp, M. H.			Cognitive underpinnings of moral reasoning in adolescence: The contribution of executive functions	JOURNAL OF MORAL EDUCATION			English	Article						social cognition; adolescence; executive functions; moral reasoning	TRAUMATIC BRAIN-INJURY; JUDGMENT; BEHAVIOR; COMPETENCE; RESILIENCY; SYMPATHY; EMOTION; HOT	Adolescence is a developmental period characterized by intense changes, which impact the interaction between individuals and their environments. Moral reasoning (MR) is an important skill during adolescence because it guides social decisions between right and wrong. Identifying the cognitive underpinnings of MR is essential to understanding the development of this function. The aim of this study was to explore predictors of MR in typically developing adolescents (n = 92, 33 males, M = 16.3 years, SD = 2.2 years) and the specific contribution of higher order cognitive processing using an innovative visual MR assessment tool and measures of executive functioning and intelligence. MR maturity was correlated with four executive functions (cognitive flexibility, feedback utilization, conceptual reasoning, verbal fluency) and was predicted by four variables: age, intelligence, nonverbal flexibility and verbal fluency. Overall, these results contribute to a better understanding of MR during adolescence and highlight the importance of using innovative tools to measure social cognition.	[Vera-Estay, E.; Beauchamp, M. H.] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Vera-Estay, E.; Beauchamp, M. H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Dooley, J. J.] Cuyahoga Cty Court Psychiat Clin Justice Ctr, Cleveland, OH USA		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC); Government of Chile (CONICYT)	This study was funded by the Social Sciences and Humanities Research Council of Canada (Miriam Beauchamp) and a scholarship to Evelyn Vera-Estay from the Government of Chile (CONICYT). The funding body was not involved in the study design, collection, analysis or interpretation of data or in the writing of the manuscript and the decision to submit the article for publication.	Adams G. R., 2006, BLACKWELL HDB ADOLES, DOI [10.1002/9780470756607, DOI 10.1002/9780470756607]; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson PJ, 2010, STUD NEUROPSYCHOL NE, P3; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp M. H., 2012, ADM CODING MANUAL SO; Blakemore SJ, 2008, Q J EXP PSYCHOL, V61, P40, DOI 10.1080/17470210701508715; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cottone J, 2007, J SCI STUD RELIG, V46, P37, DOI 10.1111/j.1468-5906.2007.00339.x; Couper E., 2002, BRAIN IMPAIR, V3, P105, DOI [DOI 10.1375/BRIM.3.2.105, 10.1375/brim.3.2.105]; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Derryberry WP, 2005, J ADV ACAD, V17, P6, DOI 10.4219/jsge-2005-392; Derryberry WP, 2007, J MORAL EDUC, V36, P475, DOI 10.1080/03057240701688036; Derryberry WP, 2008, GIFTED CHILD QUART, V52, P340, DOI 10.1177/0016986208321806; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Eisenberg N, 2004, CHILD DEV, V75, P25, DOI 10.1111/j.1467-8624.2004.00652.x; Eisenberg N, 2002, J PERS SOC PSYCHOL, V82, P993, DOI 10.1037//0022-3514.82.6.993; Eisenberg N, 2001, CHILD DEV, V72, P518, DOI 10.1111/1467-8624.00294; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; GFELLNER BM, 1986, J YOUTH ADOLESCENCE, V15, P147, DOI 10.1007/BF02141735; GIBBS JC, 1982, CHILD DEV, V53, P895, DOI 10.1111/j.1467-8624.1982.tb01351.x; GIBBS JC, 2010, MORAL DEV REALITY TH; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hala S., 2010, SELF SOCIAL REGULATI, P293; Kalinian H, 2003, ARCH CLIN NEUROPSYCH, V18, P760; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Kohlberg, 1987, MEASUREMENT MORAL JU, V1; Kohlberg Lawrence., 1983, MORAL STAGES CURRENT; Labelle-Chiasson V., 2012, J INT NEUROPSYCH SOC, V18, P206; Lahat A, 2013, CHILD DEV, V84, P955, DOI 10.1111/cdev.12001; Lahat A, 2012, HUM DEV, V55, P26, DOI 10.1159/000335525; Langdon PE, 2010, DEV REV, V30, P273, DOI 10.1016/j.dr.2010.01.001; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; Malti T, 2010, NEW DIR CHILD ADOLES, V129, P1, DOI 10.1002/cd.272; Malti T, 2009, CHILD DEV, V80, P442, DOI 10.1111/j.1467-8624.2009.01271.x; Martel MM, 2007, DEV PSYCHOPATHOL, V19, P541, DOI 10.1017/S0954579407070265; Miller M, 2010, J ABNORM CHILD PSYCH, V38, P315, DOI 10.1007/s10802-009-9369-2; Moll H, 2007, PHILOS T R SOC B, V362, P639, DOI 10.1098/rstb.2006.2000; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; NARVAEZ D, 1993, J EDUC GIFTED, V16, P268; Narvaez D, 2010, NEW DIR CHILD ADOLES, V129, P77, DOI 10.1002/cd.276; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Piaget J., 1932, MORAL JUDGEMENT CHIL; Poulshock J. W., 2006, THESIS U EDINBURGH E; Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008; Rest JR., 1979, DEV JUDGING MORAL IS; Richardson CB, 2012, HUM DEV, V55, P4, DOI 10.1159/000335362; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Stams GJ, 2006, J ABNORM CHILD PSYCH, V34, P697, DOI 10.1007/s10802-006-9056-5; Steinberg L, 2009, AM PSYCHOL, V64, P583, DOI 10.1037/a0014763; Swedene JK, 2005, J MORAL EDUC, V34, P43, DOI 10.1080/03057240500049307; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tappan MB, 1997, DEV REV, V17, P78, DOI 10.1006/drev.1996.0422; Travis F, 2011, CONSCIOUS COGN, V20, P1256, DOI 10.1016/j.concog.2011.03.020; Turiel Elliot, 1983, DEV SOCIAL KNOWLEDGE; Van Vugt E, 2011, INT J OFFENDER THER, V55, P1234, DOI 10.1177/0306624X11396441; Wain O, 2007, INT J NEUROSCI, V117, P135, DOI 10.1080/00207450500534068; Wechsler D., 2011, WECHSLER ABBREVIATED	73	20	20	1	37	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0305-7240	1465-3877		J MORAL EDUC	J. Moral Educ.	JAN 2	2015	44	1					17	33		10.1080/03057240.2014.986077			17	Education & Educational Research	Social Science Citation Index (SSCI)	Education & Educational Research	CD5XF	WOS:000351161400002					2022-02-06	
J	Chong, SL; Harjanto, S; Testoni, D; Ng, ZM; Low, CYD; Lee, KP; Lee, JH				Chong, Shu-Ling; Harjanto, Sumitro; Testoni, Daniela; Ng, Zhi Min; Low, Chyi Yeu David; Lee, Khai Pin; Lee, Jan Hau			Early Hyperglycemia in Pediatric Traumatic Brain Injury Predicts for Mortality, Prolonged Duration of Mechanical Ventilation, and Intensive Care Stay	INTERNATIONAL JOURNAL OF ENDOCRINOLOGY			English	Article							RELIABLE OUTCOME PREDICTOR; ADMISSION HYPERGLYCEMIA; CONCOMITANT INJURIES; PROGNOSTIC-FACTORS; BLOOD-GLUCOSE; CHILDREN; HYPOTHERMIA; SEVERITY; INSULIN; MODELS	We aim to study the association between hyperglycemia and in-hospital outcomes among children with moderate and severe traumatic brain injury (TBI). This retrospective cohort study was conducted in a tertiary pediatric hospital between 2003 and 2013. All patients < 16 years old who presented to the Emergency Department within 24 hours of head injury with a Glasgow Coma Scale (GCS) <= 13 were included. Our outcomes of interest were death, 14 ventilation-free, 14 pediatric intensive care unit( PICU-) free, and 28 hospital-free days. Hyperglycemia was defined as glucose > 200mg/dL (11.1 mmol/L). Among the 44 patients analyzed, the median age was 8.6 years (interquartile range (IQR) 5.0-11.0). Median GCS and pediatric trauma scores were 7 (IQR 4-10) and 4 (IQR 3-6), respectively. Initial hyperglycemia was associated with death (37% in the hyperglycemia group versus 8% in the normoglycemia group, p - 0.019), reduced median PICU-free days (6 days versus 11 days, p - 0.006), and reduced median ventilation-free days (8 days versus 12 days, p = 0.008). This association was however not significant in the stratified analysis of patients with GCS <= 8. Conclusion. Our findings demonstrate that early hyperglycemia is associated with increased mortality, prolonged duration of mechanical ventilation, and PICU stay in children with TBI.	[Chong, Shu-Ling; Lee, Khai Pin] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore 229899, Singapore; [Chong, Shu-Ling; Ng, Zhi Min; Lee, Khai Pin; Lee, Jan Hau] SingHealth, Duke NUS Paediat Acad Clin Programme, Singapore 229899, Singapore; [Harjanto, Sumitro] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Testoni, Daniela] Univ Fed Sao Paulo, Escola Paulista Med, Div Neonatal Med, BR-04020060 Sao Paulo, SP, Brazil; [Ng, Zhi Min] KK Womens & Childrens Hosp, Dept Paediat Med, Singapore 229899, Singapore; [Low, Chyi Yeu David] KK Womens & Childrens Hosp, Dept Neurosurg, Singapore 229899, Singapore; [Lee, Jan Hau] KK Womens & Childrens Hosp, Childrens Intens Care Unit, Singapore 229899, Singapore		Chong, SL (corresponding author), KK Womens & Childrens Hosp, Dept Emergency Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.	chong.shu-ling@kkh.com.sg	NOBRE, DANIELA TESTONI COSTA/D-6657-2017	NOBRE, DANIELA TESTONI COSTA/0000-0001-7629-4904; Lee, Jan Hau/0000-0002-8430-4217			Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; [Anonymous], 2014, INJURY PREVENTION CO; Asilioglu N, 2011, J PEDIAT-BRAZIL, V87, P325, DOI [10.1590/S0021-75572011000400009, 10.2223/JPED.2097]; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Elkon B, 2014, PEDIATR CRIT CARE ME, V15, P623, DOI 10.1097/PCC.0000000000000170; Heather NL, 2012, CLIN ENDOCRINOL, V77, P357, DOI 10.1111/j.1365-2265.2012.04376.x; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kan CH, 2009, MALAYS J MED SCI, V16, P25; KING LR, 1971, ANN SURG, V173, P337, DOI 10.1097/00000658-197103000-00003; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; Macrae D, 2014, NEW ENGL J MED, V370, P107, DOI 10.1056/NEJMoa1302564; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Pentelenyi T, 1979, Acta Neurochir Suppl (Wien), V28, P103; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; Rake AJ, 2010, PEDIATR CRIT CARE ME, V11, P707, DOI 10.1097/PCC.0b013e3181e88b1f; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	37	20	22	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-8337	1687-8345		INT J ENDOCRINOL	Int. J. Endocrinol.		2015	2015								719476	10.1155/2015/719476			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CI9XI	WOS:000355123400001	26074963	Green Published, gold, Green Submitted			2022-02-06	
J	Lu, LY; Cao, HL; Wei, XE; Li, YH; Li, WB				Lu, Liyan; Cao, Heli; Wei, Xiaoer; Li, Yuehua; Li, Wenbin			Iron Deposition Is Positively Related to Cognitive Impairment in Patients with Chronic Mild Traumatic Brain Injury: Assessment with Susceptibility Weighted Imaging	BIOMED RESEARCH INTERNATIONAL			English	Article							PARKINSONS-DISEASE; IMMATURE RAT; STRESS; MATTER; PHASE; MRI; ABNORMALITIES; PERFORMANCE; NETWORK	Background. This study aimed to evaluate the usability of SWI in assessment of brain iron to detect cognitive dysfunction in patients with chronic mild traumatic brain injury (mTBI). Methods. 39 patients with mTBI and 37 normal controls were given the Mini-Mental State Examination (MMSE) and underwent SWI scanning at least 6 months after injury. Angle radian values were calculated with phase images. The angle radian values were compared between groups using analysis of covariance, and their association with MMSE scores was analyzed using Spearman correlations. Results. Significantly higher angle radian values (p < 0.05) were found in the head of the caudate nucleus, the lenticular nucleus, the hippocampus, the thalamus, the right substantia nigra, the red nucleus, and the splenium of the corpus callosum (SCC) in the mTBI group, compared to the control group. MMSE scores were negatively correlated with angle radian values in the right substantia nigra (r = -0.685, p < 0.001). Conclusions. Patients with chronic mTBI might have abnormally high accumulations of iron, and their MMSE scores are negatively associated with angle radian values in the right substantia nigra, suggesting a role of SWI in the assessment of cognitive impairments of these patients.	[Lu, Liyan; Wei, Xiaoer; Li, Yuehua; Li, Wenbin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China; [Cao, Heli] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China		Li, WB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sh163.net			National Natural Scientific Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271540, 81301213]; Science and Technology Commission of Shanghai Municipality Grant (STCSM)Science & Technology Commission of Shanghai Municipality (STCSM) [08411951200]	This study is supported by the National Natural Scientific Foundation of China (NSFC; no. 81271540 and no. 81301213) and the Science and Technology Commission of Shanghai Municipality Grant (STCSM; no. 08411951200).	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster ER, 2008, BRAIN COGNITION, V67, P1, DOI 10.1016/j.bandc.2007.10.002; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu J., 2015, J NEUROTRAUMA; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Lu LY, 2014, NEUROL INDIA, V62, P487, DOI 10.4103/0028-3886.144434; Lull N, 2010, NEUROLOGIA, V25, P174; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Rossi M, 2010, INVEST RADIOL, V45, P795, DOI 10.1097/RLI.0b013e3181ec9c96; Rossi ME, 2014, ACAD RADIOL, V21, P64, DOI 10.1016/j.acra.2013.09.018; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shen W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140739; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tuite Paul J, 2013, J Alzheimers Dis Parkinsonism, VSuppl 1, P001; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050706; Wu SF, 2014, EUR REV MED PHARMACO, V18, P2605; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhang ZQ, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0117-3	49	20	21	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								470676	10.1155/2015/470676			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	DA2JZ	WOS:000367622400001	26798636	Green Published, gold, Green Submitted			2022-02-06	
J	Mackenzie, B; Vivier, P; Reinert, S; Machan, J; Kelley, C; Jacobs, E				Mackenzie, Bonnie; Vivier, Patrick; Reinert, Steven; Machan, Jason; Kelley, Caroline; Jacobs, Elizabeth			Impact of a State Concussion Law on Pediatric Emergency Department Visits	PEDIATRIC EMERGENCY CARE			English	Article							TRAUMATIC BRAIN-INJURY; AMERICAN MEDICAL SOCIETY; SPORT-RELATED CONCUSSION; BOOSTER SEAT USE; HELMET-USE LAWS; UNITED-STATES; HEAD-INJURY; HIGH-SCHOOL; CHILDREN	Objective: Many states have passed concussion laws that mandate that players undergo medical clearance before returning to play. Few data have been collected on the impact of such laws on emergency department (ED) visits. This study measures the impact of Rhode Island concussion legislation on sports-related concussion visits to a pediatric ED. Methods: International Classification of Diseases, Ninth Revision, Clinical Modification codes with injury mechanism-associated E-codes were extracted from hospital databases from 2004 to 2011 for both sports-related concussions and sports-related ankle ligamentous injuries (comparison group). Visit rates for sports-related concussions were compared before and after the passage of the state concussion law. Secondary outcome measures included rates of head imaging per ED visit for concussion before and after passage of the law. Times series analysis was used to analyze season-to-season count and rate changes. Results: Overall rate of sports-related concussion visits more than doubled (2.2-fold increase; 95% confidence interval, 1.3-3.6; adjusted P = 0.01) during the fall sports season following the implementation of legislation (2010) relative to the previous year (3.6% vs 1.4%). Rates of sports-related ankle sprain visits tended to increase during the fall sports season but did not achieve statistical significance. Rates of computed tomography scan imaging of the head did not change over time. Conclusions: The data from this study revealed an increase in pediatric ED visits for sports-related concussions, without a corresponding increase in head imaging, suggesting that the passage of a state concussion law has led to increased vigilance in evaluation of sports-related concussions, without an increase in diagnostic computed tomography scans.	[Mackenzie, Bonnie; Vivier, Patrick; Jacobs, Elizabeth] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Vivier, Patrick] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Reinert, Steven] Brown Univ, Lifespan Informat Serv, Providence, RI 02912 USA; [Machan, Jason] Brown Univ, Dept Orthoped & Surg, Providence, RI 02912 USA; [Machan, Jason; Kelley, Caroline] Brown Univ, Providence, RI 02912 USA		Mackenzie, B (corresponding author), Rhode Isl Hosp, Dept Emergency Med, 593 Eddy St,Claverick 2, Providence, RI 02903 USA.	bonnie.mackenzie@mac.com	Machan, Jason T/D-3897-2013	Machan, Jason T/0000-0003-2048-4914; Geiger, Caroline/0000-0001-8616-8450	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104937] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM104937] Funding Source: Medline		Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Aldana PR, 2011, AAP NEWS, pE110620; [Anonymous], 2011, 2011 RHOD ISL KIDS C; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; CHERRY DK, 2002, ADV DATA, V328, P1; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gunn VL, 2007, PEDIATRICS, V119, pE131, DOI 10.1542/peds.2006-1876; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; SOSIN DM, 1992, JAMA-J AM MED ASSOC, V267, P1649, DOI 10.1001/jama.267.12.1649; Sun KN, 2010, PEDIATRICS, V126, P484, DOI 10.1542/peds.2010-0249; Swenson DM, 2013, CLIN J SPORT MED; Wei HG, 2000, ACAD EMERG MED, V7, P710, DOI 10.1111/j.1553-2712.2000.tb02052.x; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; 2000, PEDIATRICS, V106, P154	27	20	20	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2015	31	1					25	30		10.1097/PEC.0000000000000325			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AY2NK	WOS:000347426700006	25526017				2022-02-06	
J	Mansfield, E; Stergiou-Kita, M; Cassidy, JD; Bayley, M; Mantis, S; Kristman, V; Kirsh, B; Gomez, M; Jeschke, MG; Vartanian, O; Moody, J; Colantonio, A				Mansfield, Elizabeth; Stergiou-Kita, Mary; Cassidy, John David; Bayley, Mark; Mantis, Steve; Kristman, Vicki; Kirsh, Bonnie; Gomez, Manuel; Jeschke, Mark G.; Vartanian, Oshin; Moody, Joel; Colantonio, Angela			Return-to-work challenges following a work-related mild TBI: The injured worker perspective	BRAIN INJURY			English	Article						Injured workers; insurance; mild traumatic brain injury; occupational injuries; return-to-work; workers' compensation	TRAUMATIC BRAIN-INJURY; LONG-TERM SYMPTOMS; EXPERIENCE; RECOMMENDATIONS; REHABILITATION; RECOVERY; PATIENT; PEOPLE; HEALTH	Primary objective: To explore how individuals with work-related mild traumatic brain injury (wrMTBI) experience return-to-work (RTW) processes when returning to the workplace where the injury occurred. Design: RTW experiences were explored using in-depth interviews and an inductive analytic approach. Qualitative analysis guided by the research question moved through phases of line-by-line and thematic coding through which categories and the interaction between categories emerged. Participants: Twelve workers diagnosed with a wrMTBI reported on their RTW experiences following wrMTBIs that occurred 3-5 years prior to the time of the interview. Main outcomes and results: Participants perceived employer and workers' compensation factors as profoundly influencing their RTW experiences. Participants consistently reported that employers and workers' compensation representatives had an inadequate understanding of wrMTBI sequelae. Six of 12 participants were re-injured following their wrMTBI, with three of these injuries occurring at work. Conclusion: Employers, co-workers and workers' compensation representatives should be aware of wrMTBI sequelae so injured workers can receive appropriate supports and both stigmatization and re-injury can be mitigated. Greater attention to the structural and social elements of workplace and compensation environments could inform strategies to break down barriers to successful return-to-work following a wrMTBI.	[Mansfield, Elizabeth; Stergiou-Kita, Mary; Bayley, Mark; Kristman, Vicki; Kirsh, Bonnie; Gomez, Manuel; Jeschke, Mark G.; Vartanian, Oshin; Colantonio, Angela] Univ Toronto, Toronto, ON, Canada; [Stergiou-Kita, Mary; Bayley, Mark; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Stergiou-Kita, Mary; Kristman, Vicki] Inst Work & Hlth, Toronto, ON, Canada; [Cassidy, John David] Univ Southern Denmark, Odense, Denmark; [Mantis, Steve] Ontario Network Injured Workers Grp, Kaministiquia, ON, Canada; [Kristman, Vicki] Lakehead Univ, Thunder Bay, ON P7B 5E1, Canada; [Jeschke, Mark G.] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON M4N 3M5, Canada; [Jeschke, Mark G.] Sunnybrook Res Inst, Toronto, ON, Canada; [Moody, Joel] Elect Safety Author, Mississauga, ON, Canada				; Mansfield, Elizabeth/S-3426-2016	Bayley, Mark/0000-0001-7860-9463; Colantonio, Angela/0000-0003-2094-4765; Moody, Joel/0000-0002-6002-0316; Mansfield, Elizabeth/0000-0003-1776-8641	Canadian Institutes of Health Research-Institute for Gender and Health GrantCanadian Institutes of Health Research (CIHR) [OGW-123786]; Toronto Rehabilitation Institute Foundation - UHN; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; CIHR Research Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute	This study was supported by a Canadian Institutes of Health Research-Institute for Gender and Health Grant (#OGW-123786). We also acknowledge the Toronto Rehabilitation Institute Foundation - UHN and the Ontario Ministry of Health and Long Term Care, which provided funding under the Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute, University Health Network. Support for Dr. Colantonio was provided by the CIHR Research Chair in Gender, Work and Health (#CGW-126580) and the Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bernhard D, 2010, INT J SOCIAL SECURIT, V2, P1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown GD, 2007, NEW SOLUT, V17, P311, DOI 10.2190/NS.17.4.g; Cancelliere C, 2013, HDB WORK DISABILITY, P303; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Clayton A, 2002, 5 AUSTR NAT U; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; Eakin JM, 2005, OCCUPATIONAL HLTH SA, P159; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; Galizzi M, 2010, IND RELAT, V49, P22, DOI 10.1111/j.1468-232X.2009.00585.x; Gillespie BM, 2010, INT J NURS STUD, V47, P732, DOI 10.1016/j.ijnurstu.2009.11.001; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Harkins C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-391; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Hopkins A, 1994, J OCCUP HEALTH, V10, P129; Ison T., 1986, OSGOODE HALL LAW J, V24, P723; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lippel K, 2007, INT J LAW PSYCHIAT, V30, P427, DOI 10.1016/j.ijlp.2007.06.013; Lippel Katherine, 2003, POLICY PRACTICE HLTH, V1, P97; Lund T, 2006, INT J REHABIL RES, V29, P229, DOI 10.1097/01.mrr.0000210056.24915.c2; MacEachen E, 2010, J OCCUP REHABIL, V20, P349, DOI 10.1007/s10926-010-9229-5; MacEachen E, 2007, POLICY PRACT HEALTH, V5, P41, DOI 10.1080/14774003.2007.11667693; Mansfield E, 2014, QUAL HEALTH RES, V24, P1183, DOI 10.1177/1049732314545887; Mansfield L, 2012, POLICY PRACT HEALTH, V10, P3, DOI 10.1080/14774003.2012.11667766; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Purse K, 1998, ECON LABOUR RELAT RE, V9, P246; Roberts-Yates C, 2003, DISABIL REHABIL, V25, P898, DOI 10.1080/0963828031000122203; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Stergiou-Kita M, 2014, J OCCUP REHABIL, V24, P173, DOI 10.1007/s10926-013-9463-8; Stewart BJ, 2012, INT J NURS STUD, V49, P560, DOI 10.1016/j.ijnurstu.2011.11.004; Strunin L, 2004, AM J IND MED, V45, P338, DOI 10.1002/ajim.10356; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; TARASUK V, 1995, QUAL HEALTH RES, V5, P204, DOI 10.1177/104973239500500205; Tjulin A, 2011, DISABIL REHABIL, V33, P1979, DOI 10.3109/09638288.2011.553708; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Workplace Safety and Insurance Board (WSIB), 2013, NUMB 2012 WSIB STAT; Young AE, 2010, SCAND J WORK ENV HEA, V36, P473, DOI 10.5271/sjweh.2986	54	20	21	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	11					1362	1369		10.3109/02699052.2015.1053524			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR4MF	WOS:000361306100011	26287754				2022-02-06	
J	Muresanu, DF; Ciurea, AV; Gorgan, RM; Gheorghita, E; Florian, SI; Stan, H; Blaga, A; Ianovici, N; Iencean, SM; Turliuc, D; Davidescu, HB; Mihalache, C; Brehar, FM; Mihaescu, AS; Mardare, DC; Anghelescu, A; Chiparus, C; Lapadat, M; Pruna, V; Mohan, D; Costea, C; Costea, D; Palade, C; Bucur, N; Figueroa, J; Alvarez, A				Muresanu, Dafin F.; Ciurea, Alexandru V.; Gorgan, Radu M.; Gheorghita, Eva; Florian, Stefan I.; Stan, Horatiu; Blaga, Alin; Ianovici, Nicolai; Iencean, Stefan M.; Turliuc, Dana; Davidescu, Horia B.; Mihalache, Cornel; Brehar, Felix M.; Mihaescu, Anca S.; Mardare, Dinu C.; Anghelescu, Aurelian; Chiparus, Carmen; Lapadat, Magdalena; Pruna, Viorel; Mohan, Dumitru; Costea, Constantin; Costea, Daniel; Palade, Claudiu; Bucur, Narcisa; Figueroa, Jesus; Alvarez, Anton			A Retrospective, Multi-Center Cohort Study Evaluating the Severity-Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Cerebrolysin; disability; functional recovery; neuroprotection; clinical outcome; traumatic brain injury	PEPTIDE PREPARATION; CEREBRAL INFARCTION; FUNCTIONAL RECOVERY; NEUROGENESIS; NEURONS; GLUTAMATE; MODERATE; DEATH	Traumatic brain injury (TBI) is a leading cause of death and disability for which there is currently no effective drug therapy available. Because drugs targeting a single TBI pathological pathway have failed to show clinical efficacy to date, pleiotropic agents with effects on multiple mechanisms of secondary brain damage could represent an effective option to improve brain recovery and clinical outcome in TBI patients. In this multicenter retrospective study, we investigated severity-related efficacy and safety of the add-on therapy with two concentrations (20 ml/day or 30 ml/day) of Cerebrolysin (EVER Neuro Pharma, Austria) in TBI patients. Adjunctive treatment with Cerrebrolysin started within 48 hours after TBI and clinical outcomes were ranked according to the Glasgow Outcome Scale and the Modified Rankin Disability Score at 10 and 30 days post-TBI. Analyses of efficacy were performed separately for subgroups of patients with mild, moderate or severe TBI according to Glasgow Coma Scale scores at admission. Compared to standard medical care alone (control group), both doses of Cerebrolysin were associated with improved clinical outcome scores at 10 days post-TBI in mild patients and at 10 and 30 days in moderate and severe cases. A dose-dependent effect of Cerebrolysin on TBI recovery was supported by the dose-related differences and the significant correlations with treatment duration observed for outcome measures. The safety and tolerability of Cerebrolysin in TBI patients was very good. In conclusion, the results of this large retrospective study revealed that early Cerebrolysin treatment is safe and is associated to improved TBI outcome.	[Muresanu, Dafin F.; Palade, Claudiu] Univ Med & Pharm Iuliu Hatieganu, Dept Clin Neurosci, Cluj Napoca 400012, Romania; [Muresanu, Dafin F.] RoNeuro Inst Neurol Res & Diagnost, Cluj Napoca, Romania; [Ciurea, Alexandru V.] Sanador Med Ctr, Dept Neurosurg, Bucharest, Romania; [Gorgan, Radu M.; Brehar, Felix M.] Bagdasar Arseni Emergency Hosp, Dept Neurosurg, Bucharest, Romania; [Gheorghita, Eva; Bucur, Narcisa] Bagdasar Arseni Emergency Hosp, Anesthesiol & Intens Care Dept, Bucharest, Romania; [Florian, Stefan I.; Stan, Horatiu; Blaga, Alin] Univ Med & Pharm Iuliu Hatieganu, Cluj Cty Emergency Hosp, Dept Neurosurg, Cluj Napoca 400012, Romania; [Ianovici, Nicolai; Turliuc, Dana] Prof Dr Nicolae Oblu Emergency Clin Hosp, Dept Neurosurg, Iasi, Romania; [Iencean, Stefan M.] Gr T Popa Univ Med & Pharm, Dept Neurosurg, Iasi, Romania; [Davidescu, Horia B.] Sf Apostol Andrei Emergency Clin Hosp, Dept Neurosurg, Constanta, Romania; [Mihaescu, Anca S.] Sf Apostol Andrei Emergency Clin Hosp, Neurosurg Clin Div, Galati, Romania; [Mihaescu, Anca S.; Mardare, Dinu C.; Anghelescu, Aurelian; Chiparus, Carmen; Lapadat, Magdalena] Bagdasar Arseni Emergency Hosp, Phys Neuralmuscular Rehabil Clin, Bucharest, Romania; [Mohan, Dumitru] Univ Med & Pharm, Dept Neurosurg, Oradea, Romania; [Costea, Constantin; Costea, Daniel] Emergency Clin Hosp, Neurosurg Clin Div, Timisoara, Romania; [Figueroa, Jesus; Alvarez, Anton] Medinova Inst Neurosci, Rehasalud Rehabil Clin, La Coruna, Spain; [Figueroa, Jesus] Hosp Clin Univ, Rehabilitat Dept, Santiago De Compostela, Spain; [Alvarez, Anton] QPS Holdings, Dept Clin Res, La Coruna, Spain		Muresanu, DF (corresponding author), Univ Med & Pharm Iuliu Hatieganu, Dept Clin Neurosci, Victor Babes St 8, Cluj Napoca 400012, Romania.	dafinm@ssnn.ro	Florian, Ioan Stefan I/D-5934-2016; Muresanu, Fior-Dafin/AAI-8120-2021; Pruna, Viorel/AAY-1398-2021; Brehar, Felix M/B-8095-2011	Florian, Ioan Stefan I/0000-0001-7127-0946; Iencean, Stefan Mircea/0000-0002-6230-8540			AKAI F, 1992, HISTOL HISTOPATHOL, V7, P213; Alvarez XA, 2013, FUTUR NEUROL, V8, P175, DOI 10.2217/FNL.12.95; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P281; Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; Alvarez XA, 2008, J NEURAL TRANSM, V115, P683, DOI 10.1007/s00702-008-0024-9; Alvarez XA, 2009, INT J NEUROPSYCHOPH, V12, P867, DOI 10.1017/S1461145709990101; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Fei Z, 1992, CHINESE J NERV MENTA, V18, P6; Georgy GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064847; HutterPaier B, 1996, J NEURAL TRANSM-SUPP, P267; Konig P, 2006, J NEUROL NEUROCHIR P, V7, P12; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1602/neurorx.1.1.46; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Muresanu DF, 2011, CNS NEUROL DISORD-DR, V10, P415; Muresanu DF, 2010, J CELL MOL MED, V14, P455, DOI 10.1111/j.1582-4934.2010.01020.x; Onose G, 2009, J Med Life, V2, P350; Patockova J, 2003, PHYSIOL RES, V52, P455; Popescu BO, 2007, J CELL MOL MED, V11, P1225, DOI 10.1111/j.1582-4934.2007.00149.x; Ren J, 2007, RESTOR NEUROL NEUROS, V25, P25; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; Satou T, 2000, J NEURAL TRANSM, V107, P1253, DOI 10.1007/s007020070015; Schwab M, 1998, J NEURAL TRANSM-SUPP, P299; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Valouskova V, 1998, J NEURAL TRANSM-SUPP, P343; Wong GKC, 2005, ACTA NEUROCHIR SUPPL, V95, P59; Wronski R, 2000, J NEURAL TRANSM-SUPP, P263; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Xiong HG, 1996, BRAIN RES, V737, P188, DOI 10.1016/0006-8993(96)00731-7; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061	38	20	20	0	18	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	5					587	599		10.2174/1871527314666150430162531			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CI8DM	WOS:000354999100005	25924999				2022-02-06	
J	Friesland, A; Weng, ZY; Duenas, M; Massa, SM; Longo, FM; Lu, Q				Friesland, Amy; Weng, Zhiying; Duenas, Maria; Massa, Stephen M.; Longo, Frank M.; Lu, Qun			Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75(NTR)	NEUROTOXICOLOGY			English	Article						Chemotherapeutics; Peripheral neuropathy; Rho GTPases; p75(NTR); Kinases and phosphatases	TRAUMATIC BRAIN-INJURY; RHO-KINASE; INDUCED NEUROTOXICITY; ACTIVATED RHOA; SMALL GTPASES; DOUBLE-BLIND; CHEMOTHERAPY; CANCER; PHOSPHORYLATION; NEUROPROTECTION	Cisplatin is an effective and widely used first-line chemotherapeutic drug for treating cancers. However, many patients sustain cisplatin-induced peripheral neuropathy (CIPN), often leading to a reduction in drug dosages or complete cessation of treatment altogether. Therefore, it is important to understand cisplatin mechanisms in peripheral nerve tissue mediating its toxicity and identify signaling pathways for potential intervention. Rho GTPase activation is increased following trauma in several models of neuronal injury. Thus, we investigated whether components of the Rho signaling pathway represent important neuroprotective targets with the potential to ameliorate CIPN and thereby optimize current chemotherapy treatment regimens. We have developed a novel CIPN model in the mouse. Using this model and primary neuronal culture, we determined whether LM11A-31, a small-molecule, orally bioavailable ligand of the p75 neurotrophin receptor (p75(NTR)), can modulate Rho GTPase signaling and reduce CIPN. Von Frey filament analysis of sural nerve function showed that LM11A-31 treatment prevented decreases in peripheral nerve sensation seen with cisplatin treatment. Morphometric analysis of harvested sural nerves revealed that cisplatin-induced abnormal nerve fiber morphology and the decreases in fiber area were alleviated with concurrent LM11A-31 treatment. Cisplatin treatment increased RhoA activity accompanied by the reduced tyrosine phosphorylation of SHP2, which was reversed by LM11A-31. LM11A-31 also countered the effects of calpeptin, which activated RhoA by inhibiting SHP2 tyrosine phosphatase. Therefore, suppression of RhoA signaling by LM11A-31 that modulates p75(NTR) or activates SHP2 tyrosine phosphatase downstream of the NGF receptor enhances neuroprotection in experimental CIPN in mouse model. (C) 2014 Elsevier Inc. All rights reserved.	[Friesland, Amy; Weng, Zhiying; Duenas, Maria; Lu, Qun] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Friesland, Amy; Lu, Qun] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, Greenville, NC 27834 USA; [Weng, Zhiying] Kunming Med Univ, Sch Pharmaceut Sci, Kunming 650500, Peoples R China; [Weng, Zhiying] Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Kunming 650500, Peoples R China; [Massa, Stephen M.] Vet Adm Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Massa, Stephen M.] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Longo, Frank M.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA		Lu, Q (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA.	luq@ecu.edu			Jean Perkins Foundation;  [NIH/NCI-CA111891];  [CA165202]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R15CA165202, R01CA111891] Funding Source: NIH RePORTER	Dr. Frank Longo is a founder of PharmatrophiX, a company focused on the development of small molecule ligands for neurotrophin receptors. PharmatrophiX Inc has made an unrestricted gift. The authors also wish to acknowledge the grant supports from NIH/NCI-CA111891 (Lu) and CA165202 (Lu) as well as Jean Perkins Foundation (Longo).	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; CASCINU S, 1995, J CLIN ONCOL, V13, P26, DOI 10.1200/JCO.1995.13.1.26; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Dergham P, 2002, J NEUROSCI, V22, P6570; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Feng YZ, 2009, J VASC SURG, V50, P675, DOI 10.1016/j.jvs.2009.05.017; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Gutierrez-Gutierrez G, 2010, CLIN TRANSL ONCOL, V12, P81, DOI 10.1007/S12094-010-0474-z; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019; James SE, 2008, NEUROTOXICOLOGY, V29, P605, DOI 10.1016/j.neuro.2008.04.008; James SE, 2010, NEUROTOXICOLOGY, V31, P188, DOI 10.1016/j.neuro.2009.12.010; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kaley TJ, 2009, BRIT J HAEMATOL, V145, P3, DOI 10.1111/j.1365-2141.2008.07558.x; Koeppen S, 2004, J CANCER RES CLIN, V130, P153, DOI 10.1007/s00432-003-0524-9; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kranenburg O, 1997, J CELL SCI, V110, P2417; Longo FM, 2008, CNS NEUROL DISORD-DR, V7, P63, DOI 10.2174/187152708783885093; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Pace A, 2007, J CLIN ONCOL, V25; Pace A, 2003, J CLIN ONCOL, V21, P927, DOI 10.1200/JCO.2003.05.139; Pace A, 2010, NEUROLOGY, V74, P762, DOI 10.1212/WNL.0b013e3181d5279e; Park SB, 2008, CURR MED CHEM, V15, P3081, DOI 10.2174/092986708786848569; Routhier A, 2010, ONCOL REP, V23, P861, DOI 10.3892/or_00000708; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Smyth JF, 1997, ANN ONCOL, V8, P569, DOI 10.1023/A:1008211226339; Song XY, 2006, J NEUROCHEM, V96, P833, DOI 10.1111/j.1471-4159.2005.03564.x; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Strumberg D, 2002, ANN ONCOL, V13, P229, DOI 10.1093/annonc/mdf058; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; Tatsumi S, 2005, NEUROSCIENCE, V131, P491, DOI 10.1016/j.neuroscience.2004.10.022; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VANDERHOOP RG, 1990, NEW ENGL J MED, V322, P89, DOI 10.1056/NEJM199001113220204; VANDERHOOP RG, 1990, CANCER-AM CANCER SOC, V66, P1697, DOI 10.1002/1097-0142(19901015)66:8<1697::AID-CNCR2820660808>3.0.CO;2-G; Verdu E, 1999, MUSCLE NERVE, V22, P329, DOI 10.1002/(SICI)1097-4598(199903)22:3<329::AID-MUS5>3.0.CO;2-8; Walters CE, 2002, J IMMUNOL, V168, P4087, DOI 10.4049/jimmunol.168.8.4087; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	50	20	20	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	DEC	2014	45						81	90		10.1016/j.neuro.2014.09.005			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	AX5GQ	WOS:000346955100009	25277379	Green Accepted			2022-02-06	
J	Shi, HY; Hwang, SL; Lee, IC; Chen, IT; Lee, KT; Lin, CL				Shi, Hon-Yi; Hwang, Shiuh-Lin; Lee, I-Chen; Chen, I-Te; Lee, King-Teh; Lin, Chih-Lung			Trends and outcome predictors after traumatic brain injury surgery: a nationwide population-based study in Taiwan	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; trends; predictors; hospital resource utilization; mortality rate	UNITED-STATES; MORTALITY; SURVIVAL; CENTERS; IMPACT; COSTS	Object. The authors sought to analyze trends in hospital resource utilization and mortality rates in a population of patients who had received traumatic brain injury (TBI) surgery. Methods. This nationwide population-based cohort study retrospectively analyzed 18,286 patients who had received surgical treatment for TBI between 1998 and 2010. The multiple linear regression model and Cox proportional hazards model were used for multivariate assessment of outcome predictors. Results. The prevalence rate of surgical treatment for patients with TBI gradually but significantly (p < 0.001) increased by 47.6% from 5.0 per 100,000 persons in 1998 to 7.4 per 100,000 persons in 2010. Age, sex, Deyo-Charlson comorbidity index score, hospital volume, and surgeon volume were significantly associated with TBI surgery outcomes (p < 0.05). Over the 12-year period analyzed, the estimated mean hospital treatment cost increased 19.06%, whereas the in-hospital mortality rate decreased 10.9%. The estimated mean time of overall survival after TBI surgery (+/- SD) was 83.0 +/- 4.2 months, and the overall in-hospital and 1-, 3-, and 5-year survival rates were 74.5%, 67.3%, 61.1%, and 57.8%, respectively. Conclusions. These data reveal an increased prevalence of TBI, especially in older patients, and an increased hospital treatment cost but a decreased in-hospital mortality rate. Health care providers and patients should recognize that attributes of the patient and of the hospital may affect hospital resource utilization and the mortality rate. These results are relevant not only to other countries with similar population sizes but also to countries with larger populations.	[Shi, Hon-Yi; Lee, I-Chen; Chen, I-Te; Lee, King-Teh] Kaohsiung Med Univ, Coll Med, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Hwang, Shiuh-Lin; Lin, Chih-Lung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Hwang, Shiuh-Lin; Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 80708, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Div Hepatobiliary Surg, Dept Surg, Kaohsiung 80708, Taiwan		Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, 100 Shih Chun 1st Rd, Kaohsiung 80708, Taiwan.	hshi@kmu.edu.tw					ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finkelstein E., 2006, INCIDENCE EC BURDEN; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Leitgeb J, 2012, J TRAUMA ACUTE CARE, V72, P1263, DOI 10.1097/TA.0b013e318248ed83; Lin JW, 2008, ACT NEUR S, V101, P113; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Soll-Johanning H, 2004, DAN MED BULL, V51, P207; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7	30	20	22	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1323	1330		10.3171/2014.8.JNS131526			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700004	25280095				2022-02-06	
J	Walcott, BP; Khanna, A; Kwon, CS; Phillips, HW; Nahed, BV; Coumans, JV				Walcott, Brian P.; Khanna, Arjun; Kwon, Churl-Su; Phillips, H. Westley; Nahed, Brian V.; Coumans, Jean-Valery			Time interval to surgery and outcomes following the surgical treatment of acute traumatic subdural hematoma	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Aspirin; Craniectomy; Gastrostomy; Subdural; Surgery; Tracheostomy; Trauma	BRAIN-INJURY; PROGNOSTIC-FACTORS; MORTALITY; RISK; MORBIDITY; THERAPY	Although the pre-surgical management of patients with acute traumatic subdural hematoma prioritizes rapid transport to the operating room, there is conflicting evidence regarding the importance of time interval from injury to surgery with regards to outcomes. We sought to determine the association of surgical timing with outcomes for subdural hematoma. A retrospective review was performed of 522 consecutive patients admitted to a single center from 2006-2012 who underwent emergent craniectomy for acute subdural hematoma. After excluding patients with unknown time of injury, penetrating trauma, concurrent cerebrovascular injury, epidural hematoma, or intraparenchymal hemorrhage greater than 30 mL, there remained 45 patients identified for analysis. Using a multiple regression model, we examined the effect of surgical timing, in addition to other variables on in-hospital mortality (primary outcome), as well as the need for tracheostomy or gastrostomy (secondary outcome). We found that increasing injury severity score (odds ratio [OR] 1.146; 95% confidence interval [CI] 1.035-1.270; p = 0.009) and age (OR1.066; 95%CI 1.006-1.129; p = 0.031) were associated with in-hospital mortality in multivariate analysis. In this model, increasing time to surgery was not associated with mortality, and in fact had a significant effect in decreasing mortality (OR 0.984; 95%CI 0.971-0.997; p = 0.018). Premorbid aspirin use was associated with a paradoxical decrease in mortality (OR 0.019; 95%CI 0.001-0.392; p = 0.010). In this patient sample, shorter time interval from injury to surgery was not associated with better outcomes. While there are potential confounding factors, these findings support the evaluation of rigorous preoperative resuscitation as a priority in future study. (C) 2014 Elsevier Ltd. All rights reserved.	[Walcott, Brian P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA		Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St,White Bldg Room 502, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu	Nahed, Brian/E-4239-2014	Nahed, Brian/0000-0001-8537-106X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25 NS065743] Funding Source: Medline		BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Compagnone C, 2007, NEUROSURGERY, V61, P232, DOI [10.1227/01.neu.0000279218.53504.fe, 10.1227/01.NEU.0000186239.10915.09]; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Fang MC, 2012, STROKE, V43, P1795, DOI 10.1161/STROKEAHA.111.630731; Harr JN, 2013, CRIT CARE MED, V41, P399, DOI 10.1097/CCM.0b013e31826ab38b; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	27	20	21	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2014	21	12					2107	2111		10.1016/j.jocn.2014.05.016			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX0DF	WOS:000346622900010	25065950	Green Published, Green Accepted			2022-02-06	
J	Wright, DW; Espinoza, TR; Merck, LH; Ratcliff, JJ; Backster, A; Stein, DG				Wright, David W.; Espinoza, Tamara R.; Merck, Lisa H.; Ratcliff, Jonathan J.; Backster, Anika; Stein, Donald G.			Gender Differences in Neurological Emergencies Part II: A Consensus Summary and Research Agenda on Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; SEX-DIFFERENCES; CONTUSION INJURY; UNITED-STATES; RISK-FACTORS; SYMPTOMS; RECOVERY; EDEMA; EPIDEMIOLOGY; POPULATION	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. There is strong evidence that gender and sex play an important role across the spectrum of TBI, from pathophysiology to clinical care. In May 2014, Academic Emergency Medicine held a consensus conference Gender-Specific Research in Emergency Care: Investigate, Understand, and Translate How Gender Affects Patient Outcomes. A TBI working group was formed to explore what was known about the influence of sex and gender on TBI and to identify gaps for future research. The findings resulted in four major recommendations to guide the TBI research agenda.	[Wright, David W.; Espinoza, Tamara R.; Backster, Anika] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Stein, Donald G.] Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA; [Merck, Lisa H.] Brown Univ, Dept Emergency Med, Neurol Emergencies Res Program, Providence, RI 02912 USA; [Ratcliff, Jonathan J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA		Wright, DW (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	david.wright@emory.edu	Stein, Donald/AAJ-5139-2020		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R13NS087861-01]; Office of Research on Women's Health at the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R13NS087861, T32NS047996] Funding Source: NIH RePORTER	The consensus conference was supported by grant 1R13NS087861-01 from the National Institute of Neurological Disorders and Stroke and the Office of Research on Women's Health at the National Institutes of Health. Additional funding was provided by several organizational, institutional, and individual donors. Non-CME events were supported by Janssen Pharmaceuticals and Besins Critical Care/BH Pharma. See the executive summary elsewhere in this issue for full funding information.	Amara J, 2014, WOMEN HEALTH ISS, V24, pE171, DOI 10.1016/j.whi.2013.12.004; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Farace E, 2000, Neurosurg Focus, V8, pe6; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Institute of Medicine, 2001, EXPLORING BIOL CONTR; Jehle D, 2007, ACAD EMERG MED, V14, P899, DOI 10.1197/j.aem.2007.06.029; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Laker SR, 2011, PM R S2, V3, P8; Langlois J, 2005, TRAUMATIC BRAIN INJU; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee YB, 2009, J KOREAN NEUROSURG S, V46, P451, DOI 10.3340/jkns.2009.46.5.451; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Institute of Mental Health, SEX DIFF BRAIN BEH M; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Raukar NP, 2014, ACAD EMERG MED, V21, P1370, DOI 10.1111/acem.12535; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Safdar B, 2014, ACAD EMERG MED, V21, P1307, DOI 10.1111/acem.12530; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Stein DG, 2007, PROG BRAIN RES, V161, P339, DOI 10.1016/S0079-6123(06)61024-8; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; U.S. Department of Health and Human Services, WOM HLTH US 2012 ILL; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Waljas M, 2013, J HEAD TRAUMA REHAB, V20, P20; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	55	20	21	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2014	21	12					1414	1420		10.1111/acem.12532			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AW9KS	WOS:000346576700016	25420582	Bronze, Green Accepted			2022-02-06	
J	Xue, LP; Wang, JK; Wang, WM; Yang, ZY; Hu, ZL; Hu, M; Ding, P				Xue, Liping; Wang, Jinkun; Wang, Weimin; Yang, Zhiyong; Hu, Zhulin; Hu, Min; Ding, Peng			The Effect of Stromal Cell-Derived Factor 1 in the Migration of Neural Stem Cells	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						Neural stem cells; Stromal cell-derived factor 1 (SDF-1); Migration	DIFFERENTIAL EXPRESSION; CHEMOKINE RECEPTOR; PERIPHERAL-BLOOD; BONE-MARROW; CXCR4; SDF-1; MOBILIZATION; MUSCLE; INJURY; CXCL12	Neural stem cells (NSCs) have widely been used in the treatment of human neurological disorders as cell therapy via intracerebral or intraventricular infusion. However, the migration mechanism required for NSCs homing and recruitment remains to be elucidated. Recently, SDF-1/CXCR4 axis was shown to be responsible for in cell migration and differentiation during the neural development stage and involved in the pathophysiological process of neurological disorders. In this study, we investigated the effect of SDF-1 in migration of NSCs in vitro and in vivo. The expression of CXCR4 receptor was examined by immunocytochemistry and RT-PCR. The migratory ability of NSCs induced by SDF-1 was assessed by transwell chemotaxis assay. The traumatic brain injury rat model was well established, and the recruitment of NSCs and expression of SDF-1 were investigated in vivo. Our findings demonstrated that SDF-1, in vitro, significantly induced the migratory of NSCs in a dose-dependent manner. An overexpression of neural stem cell marker Nestin in the hippocampus was observed after TBI, and the expressions of SDF-1 surrounding the lesion areas were significantly increased. Our results suggested that the migration of NSCs was activated by chemotactic effect of SDF-1. It was also proved the relevance of SDF-1 in the migration of endogenous NSCs after brain injury. Taken together, these results demonstrated that SDF-1/CXCR4 axis may play crucial role in the migration of Nestin-positive cell after brain injury.	[Xue, Liping; Hu, Zhulin; Hu, Min] Yunnan 2 Prov Peoples Hosp, Dept Ophthalmol, Kunming 650021, Peoples R China; [Wang, Jinkun; Wang, Weimin; Yang, Zhiyong; Ding, Peng] Kunming Med Univ, Dept Neurosurg, Affiliated Hosp 1, Kunming 650032, Peoples R China		Ding, P (corresponding author), Kunming Med Univ, Dept Neurosurg, Affiliated Hosp 1, 295 XiChang Rd, Kunming 650032, Peoples R China.	drpengding@126.com			Grant for High-Level Training of Yun Nan [2013FZ280]; Yunnan Provincial Science and Technology Department [2010CD157]; Kunming Medical University [2010CD157]; Yunnan Province [2013FZ280]; Department of technology, Yunnan province [2010CD157]; Yunnan Medical University [2010CD157]	This study was supported by a special Grant for High-Level Training of Yun Nan (2013FZ280) and a special joint grant of Yunnan Provincial Science and Technology Department and Kunming Medical University (2010CD157). This work is supported by special training funding (No. 2013FZ280) for high-level experts of Yunnan Province, and Joint program (No. 2010CD157) of Department of technology, Yunnan province and Yunnan Medical University.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Bellmann-Sickert K, 2011, CHEMMEDCHEM, V6, P193, DOI 10.1002/cmdc.201000403; Comerford I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045095; Durbec Pascale, 2008, V438, P213, DOI 10.1007/978-1-59745-133-8_18; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Gouwy M, 2011, EUR J IMMUNOL, V41, P963, DOI 10.1002/eji.201041178; Heit Bryan, 2003, Sci STKE, V2003, pPL5, DOI 10.1126/stke.2003.170.pl5; Huber BC, 2011, CARDIOVASC RES, V90, P529, DOI 10.1093/cvr/cvr014; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Janssen U, 2002, NEPHRON, V92, P797, DOI 10.1159/000065448; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Li MZ, 2011, GLIA, V59, P108, DOI 10.1002/glia.21080; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; NELSON RD, 1988, METHOD ENZYMOL, V162, P50; Noda M, 2011, BLOOD, V117, P451, DOI 10.1182/blood-2010-04-277897; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Wong K., 2008, J VISUALIZED EXPT, P12; Woznica David, 2006, V346, P311; Yang SZ, 2013, DEVELOPMENT, V140, P4554, DOI 10.1242/dev.098145; Zhang JX, 2013, DISASTER ADV, V6, P1; Zou Li-Ping, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P321	33	20	21	0	18	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	DEC	2014	70	3					1609	1616		10.1007/s12013-014-0103-5			8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AT2LT	WOS:000344767100018	25241080				2022-02-06	
J	Baker, JG; Rieger, BP; McAvoy, K; Leddy, JJ; Master, CL; Lana, SJ; Willer, BS				Baker, J. G.; Rieger, B. P.; McAvoy, K.; Leddy, J. J.; Master, C. L.; Lana, S. J.; Willer, B. S.			Principles for return to learn after concussion	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							HEAD-INJURY; CHILDREN; SPORT; ADOLESCENTS		[Baker, J. G.] SUNY Buffalo, Sch Social Work Nucl Med Orthopaed & Sports Med, Buffalo, NY 14214 USA; [Rieger, B. P.] SUNY Upstate Med Univ, Upstate Concuss Ctr, Syracuse, NY 13210 USA; [McAvoy, K.] Rocky Mt Youth Hosp Children, Ctr Concuss, Denver, CO USA; [Leddy, J. J.] SUNY Buffalo, Buffalo, NY 14214 USA; [Master, C. L.] Childrens Hosp Philadelphia, Dept Surg & Pediat, Philadelphia, PA 19104 USA; [Lana, S. J.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14214 USA; [Willer, B. S.] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14214 USA		Baker, JG (corresponding author), SUNY Buffalo, Sch Social Work, 219 Parker Hall, Buffalo, NY 14214 USA.	jgbaker@buffalo.edu		Master, Christina/0000-0002-6717-4270	Robert Rich Family Foundation; Program for Understanding Childhood Concussion and Stroke; Buffalo Bills Team Physician Fund; Buffalo Sabres Foundation	We thank the following organisations for financial support: The Robert Rich Family Foundation, Program for Understanding Childhood Concussion and Stroke, Buffalo Bills (Ralph Wilson) Team Physician Fund and the Buffalo Sabres Foundation.	Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2009, REAP BENEFITS GOOD C; McAvoy K, 2012, BRAIN INJ PROF, V9, P26; McAvoy K, 2012, COMMUNIQUE, V40; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Oregon Center for Applied Science I, CONC MAN POL RES HDB; Rieger BP, 2012, BRAIN INJ PROF, V9, P22; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107	18	20	20	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	NOV	2014	68	11					1286	1288		10.1111/ijcp.12517			3	Medicine, General & Internal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pharmacology & Pharmacy	AS8BN	WOS:000344475500003	25348379	Bronze			2022-02-06	
J	Bodanapally, UK; Shanmuganathan, K; Boscak, AR; Jaffray, PM; Van der Byl, G; Roy, AK; Dreizin, D; Fleiter, TR; Mirvis, SE; Krejza, J; Aarabi, B				Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Boscak, Alexis R.; Jaffray, Paul M.; Van der Byl, Giulia; Roy, Ashis K.; Dreizin, David; Fleiter, Thorsten R.; Mirvis, Stuart E.; Krejza, Jaroslaw; Aarabi, Bizhan			Vascular complications of penetrating brain injury: comparison of helical CT angiography and conventional angiography	JOURNAL OF NEUROSURGERY			English	Article						intracranial arterial injuries; penetrating traumatic brain injury; traumatic intracranial pseudoaneurysms; CT angiography; digital subtraction angiography; vascular disorders	MISSILE HEAD WOUNDS; TRAUMATIC ANEURYSMS; NECK INJURIES; INITIAL EVALUATION; ARTERIAL INJURIES; GUNSHOT WOUNDS; DIAGNOSIS; MANAGEMENT	Object. The authors conducted a study to compare the sensitivity and specificity of helical CT angiography (CTA) and digital subtraction angiography (DSA) in detecting intracranial arterial injuries after penetrating traumatic brain injury (PTBI). Methods. In a retrospective evaluation of 48 sets of angiograms from 45 consecutive patients with PTBI, 3 readers unaware of the DSA findings reviewed the CTA images to determine the presence or absence of arterial injuries. A fourth reader reviewed all the disagreements and decided among the 3 interpretations. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CTA were calculated on a per-injury basis and in a subpopulation of patients with traumatic intracranial aneurysms (TICAs). Results. Sensitivity of CTA for detecting arterial injuries was 72.7% (95% CI 49.8%-89.3%); specificity, 93.5% (95% CI 78.6%-99.2%); PPV, 88.9% (95% CI 65.3%-98.6%); and NPV, 82.9% (95% CI 66.4%-93.4%). All 7 TICAs were correctly identified by CTA. Sensitivity, specificity, PPV, and NPV of CTA in detecting TICAs were 100%. To compare agreement with DSA, the standard of reference, confidence scores categorized as low, intermediate, and high probability yielded an overall effectiveness of 77.8% (95% CI 71.8%-82.9%). Conclusions. Computed tomography angiography had limited overall sensitivity in detecting arterial injuries in patients with PTBI. However, it was accurate in identifying TICAs, a subgroup of injuries usually managed by either surgical or endovascular approaches, and non-TICA injuries involving the first-order branches of intracranial arteries.	[Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Boscak, Alexis R.; Jaffray, Paul M.; Roy, Ashis K.; Dreizin, David; Fleiter, Thorsten R.; Mirvis, Stuart E.; Krejza, Jaroslaw] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Radiol, Baltimore, MD 21201 USA; [Aarabi, Bizhan] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Neurosurg, Baltimore, MD 21201 USA; [Van der Byl, Giulia] Univ Pavia, San Matteo Med Ctr, IRCCS Fdn, Dept Radiol, I-27100 Pavia, Italy		Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22 S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu	Krejza, Jaroslaw/A-1355-2009				AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Aarabi B, 2001, J TRAUMA S, V51, pS26; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; [Anonymous], 2001, J TRAUMA S, V51, pS7; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Inaba K, 2006, J TRAUMA, V61, P144, DOI 10.1097/01.ta.0000222711.01410.bc; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Munera F, 2002, RADIOLOGY, V224, P366, DOI 10.1148/radiol.2242010973; Munera F, 2000, RADIOLOGY, V216, P356, DOI 10.1148/radiology.216.2.r00jl25356; Sliker CW, 2008, AM J ROENTGENOL, V190, P790, DOI 10.2214/AJR.07.2378; Steenburg SD, 2010, RADIOGRAPHICS, V30, P869, DOI 10.1148/rg.304105022	15	20	23	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2014	121	5					1275	1283		10.3171/2014.7.JNS132688			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AR4AM	WOS:000343530400037	25170662				2022-02-06	
J	Casey-Trott, TM; Millman, ST; Turner, PV; Nykamp, SG; Lawlis, PC; Widowski, TM				Casey-Trott, T. M.; Millman, S. T.; Turner, P. V.; Nykamp, S. G.; Lawlis, P. C.; Widowski, T. M.			Effectiveness of a nonpenetrating captive bolt for euthanasia of 3 kg to 9 kg pigs	JOURNAL OF ANIMAL SCIENCE			English	Article						animal welfare; captive bolt; euthanasia; insensibility; nursery; pig	MATURATION-DEPENDENT RESPONSE; DETERMINING BRAIN-DEATH; CERVICAL DISLOCATION; WELFARE IMPLICATIONS; BLUNT TRAUMA; NEUROPHYSIOLOGY; DEPOPULATION; MOVEMENTS; CESSATION; PIGLETS	The objective of this study was to determine the effectiveness of a nonpenetrating captive bolt, Zephyr-E, for euthanasia of suckling and weaned pigs from 3 to 9 kg (5-49 d of age) using signs of insensibility and death as well as postmortem assessment of traumatic brain injury (TBI). The Zephyr-E was used by 15 stock people to euthanize 150 compromised pigs from 4 farrowing and nursery units from commercial farms and 2 research stations. Brainstem reflexes, convulsions, and heartbeat were used to assess insensibility, time of brain death, and cardiac arrest following Zephyr-E application. Skull fracture displacement (FD) was quantified from computed tomography (CT) scans (n = 24), macroscopic scoring was used to assess brain hemorrhage and skull fracture severity (n = 150), and microscopic scoring was used to assess subdural hemorrhage (SDH) and parenchymal hemorrhage within specific brain regions that are responsible for consciousness and vital function (n = 32). The Zephyr-E caused immediate, sustained insensibility until death in 98.6% of pigs. On average, clonic convulsions (CC) ceased in 82.2 s (+/- 3.4 SE), brain death was achieved in 144.9 s (+/- 5.4 SE), and cardiac arrest occurred in 226.5 s (+/- 8.7 SE). Time of brain death and cardiac arrest differed significantly among stock people (P = 0.0225 and P = 0.0369). Age was positively related to the duration of CC (P = 0.0092), time of brain death (P = 0.0025), and cardiac arrest (P = 0.0068) with shorter durations seen in younger pigs. Average FD was 8.3 mm (+/- 1.0 SE). Macroscopic scores were significantly different among weight classes for subcutaneous (P = 0.0402) and subdural-ventral (P = 0.0037) hemorrhage with the lowest severity hemorrhage found in the 9-kg weight category. Microscopic scores differed among brain sections (P = 0.0070) for SDH with lower scores found in the brainstem compared to the cerebral cortex and midbrain. Parenchymal hemorrhage differed among brain sections (P = 0.0052) and weight categories (P = 0.0128) with the lowest scores in the midbrain and brainstem and the 7-and 9-kg weight categories. The Zephyr-E was highly effective for the euthanasia of pigs up to 9 kg (49 d) based on immediate insensibility sustained until death. Postmortem results confirmed that severe skull fracture and widespread brain hemorrhage were caused by the Zephyr-E nonpenetrating captive bolt.	[Casey-Trott, T. M.; Widowski, T. M.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Millman, S. T.] Iowa State Univ, Ames, IA 50011 USA; [Turner, P. V.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Nykamp, S. G.] Ontario Vet Coll, Primary Healthcare Ctr, Hlth Sci Ctr, Guelph, ON N1G 2W1, Canada; [Lawlis, P. C.] Ontario Minist Agr & Food, Guelph, ON N1G 4Y2, Canada		Widowski, TM (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	twidowsk@uoguelph.ca		Millman, Suzanne/0000-0001-5752-4647	National Pork Board	Funding was provided by the National Pork Board. The authors wish to thank the dedicated stock people from the farms in Ontario and Saskatchewan who were willing to take on this task. We are also grateful to the students and staff from the University of Guelph and University of Saskatchewan; in particular, J. Brown and C. Large, for their contributions to data collection, and to M. Edwards for her statistical advice. The prototype Zephyr-E used in the study reported here was manufactured by the University of Guelph. Since completion of this study, the Zephyr-E has been made commercially available by Bock Industries Inc. (128 North Front St., Phillipsburg, PA 16866)	AKRITAS MG, 1990, J AM STAT ASSOC, V85, P73, DOI 10.2307/2289527; American Association of Swine Veterinarians (AASV) and National Pork Board (NPB), 2009, AASV PUBL; American Veterinary Medical Association (AVMA), 2013, AVMA GUID EUTH AN; ANIL MH, 1991, MEAT SCI, V30, P13, DOI 10.1016/0309-1740(91)90030-T; Aroni F, 2012, J MATERN-FETAL NEO M, V25, P1750, DOI 10.3109/14767058.2012.663823; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; Casey-Trott TM, 2013, J ANIM SCI, V91, P5477, DOI 10.2527/jas.2013-6320; Chevillon P., 2004, P INT SOC AN HYG ST, P45; Conci F, 2001, J NEUROL NEUROSUR PS, V71, P621, DOI 10.1136/jnnp.71.5.621; Dawson MD, 2007, J APPL POULTRY RES, V16, P583, DOI 10.3382/japr.2007-00023; Dawson MD, 2009, J APPL POULTRY RES, V18, P135, DOI 10.3382/japr.2008-00072; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2007, J NEUROTRAUM, V24, P5, DOI 10.1089/neu.2006.0054; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hameister T, 2010, BERL MUNCH TIERARZTL, V123, P11, DOI 10.2376/0005-9366-123-11; HANNA JP, 1995, NEUROLOGY, V45, P985, DOI 10.1212/WNL.45.5.985; Hills Teresa E, 2010, Nursing, V40, P34, DOI 10.1097/01.NURSE.0000390667.52579.8e; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Ibrahim N. G., 2010, BIOCH ENG J, V132, P1; Lee PH, 2005, PARKINSONISM RELAT D, V11, P105, DOI 10.1016/j.parkreldis.2004.09.005; MADSEN FF, 1990, ACTA NEUROCHIR, V105, P150, DOI 10.1007/BF01670000; Matthis J. S., 2004, THESIS N CAROLINA ST; McKinstry JL, 2004, MEAT SCI, V67, P121, DOI 10.1016/j.meatsci.2003.10.002; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Morrow WEM, 2006, J SWINE HEALTH PROD, V14, P25; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; Raj ABM, 1996, ANIM WELFARE, V5, P71; ROPPER AH, 1984, NEUROLOGY, V34, P1089, DOI 10.1212/WNL.34.8.1089; Sadler LJ, 2014, J ANIM SCI, V92, P793, DOI 10.2527/jas.2013-6598; Schinckel A. P., 2004, Professional Animal Scientist, V20, P79; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sutherland M., 2010, 08145 NAT PORK BOARD; Turner PV, 2012, POULTRY SCI, V91, P1558, DOI 10.3382/ps.2012-02139; Whiting TL, 2011, CAN VET J, V52, P753; Widowski T, 2008, ALL D LEM SWIN C P, P107; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Woods J., 2012, THESIS IOWA STATE U; Young RJ, 2002, NEUROIMAG CLIN N AM, V12, P189, DOI 10.1016/S1052-5149(02)00003-5	43	20	20	0	17	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0021-8812	1525-3163		J ANIM SCI	J. Anim. Sci.	NOV	2014	92	11					5166	5174		10.2527/jas.2014-7980			9	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	AT0JM	WOS:000344622600036	25349360				2022-02-06	
J	Gandhi, RR; Overton, TL; Haut, ER; Lau, B; Vallier, HA; Rohs, T; Hasenboehler, E; Lee, JK; Alley, D; Watters, J; Rogers, FB; Shafi, S				Gandhi, Rajesh R.; Overton, Tiffany L.; Haut, Elliott R.; Lau, Brandyn; Vallier, Heather A.; Rohs, Thomas; Hasenboehler, Erik; Lee, Jane Kayle; Alley, Darrell; Watters, Jennifer; Rogers, Frederick B.; Shafi, Shahid			Optimal timing of femur fracture stabilization in polytrauma patients: A practice management guideline from the Eastern Association for the Surgery of Trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Long bone stabilization; fracture fixation; timing fixation; early fixation; delayed fixation	FEMORAL-SHAFT FRACTURE; RESPIRATORY-DISTRESS-SYNDROME; DELAYED INTERNAL-FIXATION; MULTIPLE TRAUMA; THORACIC TRAUMA; HEAD-INJURY; GRADE; MORTALITY; QUALITY; RECOMMENDATIONS	BACKGROUND: Femur fractures are common among trauma patients and are typically seen in patients with multiple injuries resulting from high-energy mechanisms. Internal fixation with intramedullary nailing is the ideal method of treatment; however, there is no consensus regarding the optimal timing for internal fixation. We critically evaluated the literature regarding the benefit of early (<24 hours) versus late (>24 hours) open reduction and internal fixation of open or closed femur fractures on mortality, infection, and venous thromboembolism (VTE) in trauma patients. METHODS: A subcommittee of the Practice Management Guideline Committee of the Eastern Association for the Surgery of Trauma conducted a systematic review and meta-analysis for the earlier question. RevMan software was used to generate forest plots. Grading of Recommendations, Assessment, Development, and Evaluations methodology was used to rate the quality of the evidence, using GRADEpro software to create evidence tables. RESULTS: No significant reduction in mortality was associated with early stabilization, with a risk ratio (RR) of 0.74 (95% confidence interval [CI], 0.50-1.08). The quality of evidence was rated as "low.'' No significant reduction in infection (RR, 0.4; 95% CI, 0.10Y1.6) or VTE (RR, 0.63; 95% CI, 0.37-1.07) was associated with early stabilization. The quality of evidence was rated "low.'' CONCLUSION: In trauma patients with open or closed femur fractures, we suggest early (<24 hours) open reduction and internal fracture fixation. This recommendation is conditional because the strength of the evidence is low. Early stabilization of femur fractures shows a trend (statistically insignificant) toward lower risk of infection, mortality, and VTE. Therefore, the panel concludes the desirable effects of early femur fracture stabilization probably outweigh the undesirable effects in most patients. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Gandhi, Rajesh R.; Overton, Tiffany L.; Shafi, Shahid] JPS Hlth Network, Dept Surg, Ft Worth, TX USA; [Alley, Darrell] East Texas Med Ctr, Dept Surg, Tyler, TX USA; [Haut, Elliott R.; Lau, Brandyn] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Hasenboehler, Erik] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA; [Vallier, Heather A.] MetroHealth, Dept Orthopaed, Cleveland, OH USA; [Rohs, Thomas] Borgess Hlth, Dept Surg, Kalamazoo, MI USA; [Lee, Jane Kayle] Advocate Med Grp, Dept Surg, Chicago, IL USA; [Watters, Jennifer] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Rogers, Frederick B.] Lancaster Gen Hlth, Dept Trauma & Acute Care Surg, Lancaster, PA USA		Overton, TL (corresponding author), JPS Hlth Network, Trauma Serv, 1500 S Main St, Ft Worth, TX 76104 USA.	toverton@jpshealth.org	Haut, Elliott R./J-3948-2019; Lau, Brandyn/H-4825-2018	Lau, Brandyn/0000-0003-3575-2440; Vallier, Heather/0000-0003-3881-6518; Haut, Elliott/0000-0001-7075-771X	Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [CE-12-11-4489]; Synthes; Smith and Nephew; Department of DefenseUnited States Department of Defense; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Orthopaedic Trauma Association; Medical Research FoundationUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	E.R.H. is the primary investigator and supported by a contract (CE-12-11-4489) from the Patient-Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care Via Health Information Technology." E.R.H. receives royalties from Lippincott, Williams, & Wilkins for a book, "Avoiding Common ICU Errors" and has given expert witness testimony in various medical malpractice cases. E.R.H. is a member of the EAST Board of Directors and Chairs the EAST Guidelines Committee. R.R.J. is a speaker for Lifecell. E.H. is supported by grants from Synthes and Smith and Nephew and is a consultant for Synthes. E.H. is also a speaker for AO North America Faculty. B.L. is the co-principal investigator of a contract (CE-12-11-4489) with the Patient-Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care Via Health Information Technology." H.A.V. is a member of the board for the Orthopaedic Trauma Association and Center for Orthopaedic Trauma Advancement. H.A.V. receives support for the METRC research consortium funded by the Department of Defense, the FAITH research study funded by the National Institute of Health, and the sacrum research study funded by the Orthopaedic Trauma Association. J.W. is supported by a grant to study acupuncture in the ICU by the Medical Research Foundation and receives travel expenses for PROPPR trial meetings. S.S., F.B.R., T.R., D.A., J.K.L., and T.L.O. have nothing to disclose.	Baixauli F, 1998, CLIN ORTHOP RELAT R, P67; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; Bosse MJ, 1997, J BONE JOINT SURG AM, V79A, P799, DOI 10.2106/00004623-199706000-00001; Brundage SI, 2002, J TRAUMA, V52, P299, DOI 10.1097/00005373-200202000-00016; Brunetti M, 2012, J CLIN EPIDEMIOL; Cantu RV, 2014, J TRAUMA ACUTE CARE, V76, P1433, DOI 10.1097/TA.0000000000000230; CHARASH WE, 1994, J TRAUMA, V37, P667, DOI 10.1097/00005373-199410000-00023; DAVIS TRC, 1988, INJURY, V19, P244, DOI 10.1016/0020-1383(88)90036-8; Debrauwer S, 2000, Acta Orthop Belg, V66, P484; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunham CM, 2001, J TRAUMA, V50, P958, DOI 10.1097/00005373-200105000-00037; FAKHRY SM, 1994, J TRAUMA, V37, P255, DOI 10.1097/00005373-199408000-00018; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; Giannoudis PV, 2006, J BONE JOINT SURG BR, V88B, P281, DOI 10.1302/0301-620X.88B3.16465; GREGORY P, 1995, CLIN ORTHOP RELAT R, P95; Guyatt G, 2012, J CLIN EPIDEMIOL; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; KALTENECKER G, 1990, J TRAUMA, V30, P474, DOI 10.1097/00005373-199030040-00019; Kerwin AJ, 2012, J TRAUMA ACUTE CARE, V73, pS283, DOI 10.1097/TA.0b013e31827013e9; Labeeu F, 1996, J TRAUMA, V40, P223; Morshed S, 2009, J BONE JOINT SURG AM, V91A, P3, DOI 10.2106/JBJS.H.00338; Nahm NJ, 2011, J TRAUMA, V71, P175, DOI 10.1097/TA.0b013e3181fc93a2; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; PAPE HC, 1993, INJURY, V24, pS82, DOI 10.1016/0020-1383(93)90012-U; POOLE GV, 1992, J TRAUMA, V32, P654, DOI 10.1097/00005373-199205000-00019; REYNOLDS MA, 1995, ANN SURG, V222, P470; ROGERS FB, 1994, J TRAUMA, V36, P774, DOI 10.1097/00005373-199406000-00004; Scalea TM, 1999, J TRAUMA, V46, P839, DOI 10.1097/00005373-199905000-00012; Schunemann HJ, 2008, ANN INTERN MED, V149, DOI 10.7326/0003-4819-149-12-200812160-02002; SEIBEL R, 1985, ANN SURG, V202, P283, DOI 10.1097/00000658-198509000-00003; Starr AJ, 1998, J ORTHOP TRAUMA, V12, P38, DOI 10.1097/00005131-199801000-00007; StataCorp, 2011, STAT STAT SOFTW REL; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; VANNIEKERK JLM, 1987, INJURY, V18, P120, DOI 10.1016/0020-1383(87)90187-2; Weninger P, 2007, J TRAUMA, V62, P692, DOI 10.1097/01.ta.0000243203.38466.e0; WILLIAMS MM, 1995, CLIN ORTHOP RELAT R, P182; Ziran BH, 1997, J TRAUMA, V43, P916, DOI 10.1097/00005373-199712000-00008	49	20	22	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2014	77	5					787	795		10.1097/TA.0000000000000434			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AT1OB	WOS:000344702300025	25494434	Bronze			2022-02-06	
J	Lindquist, BE; Shuttleworth, CW				Lindquist, Britta E.; Shuttleworth, C. William			Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						acute stroke; adenosine; brain slice; electrophysiology; energy metabolism; spreading depression	RAT HIPPOCAMPAL SLICES; CEREBRAL-ARTERY OCCLUSION; BLOOD-FLOW; BRAIN ISCHEMIA; SYNAPTIC-TRANSMISSION; NEURONAL ACTIVATION; GLUTAMATE RELEASE; FOCAL ISCHEMIA; DC SHIFTS; DEPRESSION	Spreading depolarization (SD), a pathologic feature of migraine, stroke and traumatic brain injury, is a propagating depolarization of neurons and glia Causing profound metabolic demand. Adenosine, the low-energy metabolite of ATP, has been shown to be elevated after SD in brain slices and under conditions likely to trigger SD in vivo. The relationship between metabolic status and adenosine accumulation after SD was tested here, in brain slices and in vivo: In brain slides, metabolic impairment(assessed by nicotinamide adenine dinucleotide (phosphate) autofluorescence and O-2 availability) was associated with prolonged extracellular direct current (DC) shifts indicating delayed repolarization, and increased adenosine accumulation. In Vivo, adenosine accumulation was observed after SD even in otherwise healthy mice. As in brain slices, in vivo adenosine accumulation correlated with DC shift duration and increased when DC shifts were prolonged by metabolic impairment (i.e., hypoglycemia or middle cerebral artery occlusion). A striking pattern of adenosine dynamics was observed during focal ischemic stroke, with nearly all the observed adenosine signals in the periinfarct region occurring in association with SDs. These findings suggest that adenosine accumulation could serve as a biomarker of SD incidence and severity; in a range of clinical conditions.	[Lindquist, Britta E.; Shuttleworth, C. William] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA		Shuttleworth, CW (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, 1 Univ New Mexico, Albuquerque, NM 87131 USA.	Bshuttleworth@salud.unm.edu	Lindquist, Britta/AAY-1659-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS078805, NS051288]; UNM Clinical and Translational Science Center [NCATS UL1TR000041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103400] Funding Source: NIH RePORTER	This work was supported by NIH grants NS078805 (BEL) and NS051288 (CWS). Statistical support was provided by UNM Clinical and Translational Science Center (NCATS UL1TR000041).	ASTRUP J, 1976, BRAIN RES, V103, P418, DOI 10.1016/0006-8993(76)90817-9; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Carter RE, 2013, J NEUROCHEM, V125, P673, DOI 10.1111/jnc.12237; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2004, NEUROCRIT CARE, V1, P85, DOI 10.1385/NCC:1:1:85; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; FOWLER JC, 1993, NEUROSCI LETT, V157, P83, DOI 10.1016/0304-3940(93)90648-5; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Galeffi F, 2011, J CEREBR BLOOD F MET, V31, P626, DOI 10.1038/jcbfm.2010.136; GIDO G, 1993, J CEREBR BLOOD F MET, V13, P179, DOI 10.1038/jcbfm.1993.21; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Heinrich A, 2012, BRIT J PHARMACOL, V167, P1003, DOI 10.1111/j.1476-5381.2012.01932.x; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Hoffmann U, 2013, J CEREBR BLOOD F MET, V33, P191, DOI 10.1038/jcbfm.2012.132; Ivanov Anton, 2011, Front Neuroenergetics, V3, P9, DOI 10.3389/fnene.2011.00009; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; KRAIG RP, 1985, PROG BRAIN RES, V63, P155; Kuraoka M, 2009, EXP ANIM TOKYO, V58, P19, DOI 10.1538/expanim.58.19; Latini S, 1999, BRIT J PHARMACOL, V127, P729, DOI 10.1038/sj.bjp.0702591; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lindquist B, 2013, A1R MEDIATED SPREADI; Lindquist BE, 2012, NEUROSCIENCE, V223, P365, DOI 10.1016/j.neuroscience.2012.07.053; Masino S, 2013, ADENOSINE KEY LINK M; Melani A, 1999, STROKE, V30, P2448, DOI 10.1161/01.STR.30.11.2448; Mies G, 1997, NEUROSCI LETT, V221, P165, DOI 10.1016/S0304-3940(96)13317-6; MIES G, 1984, EXP NEUROL, V84, P249, DOI 10.1016/0014-4886(84)90222-X; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NEWMAN GC, 1991, J CEREBR BLOOD F MET, V11, P398, DOI 10.1038/jcbfm.1991.80; Office of Laboratory Animal Welfare, 2002, PUBL HLTH SERV POL H; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Pasini FL, 2000, BRAIN RES BULL, V51, P327, DOI 10.1016/S0361-9230(99)00240-3; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Shuttleworth CW, 2003, J NEUROSCI, V23, P3196; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; Warren RE, 2005, DIABETES OBES METAB, V7, P493, DOI 10.1111/j.1463-1326.2004.00421.x; Yang O, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528610	49	20	20	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2014	34	11					1779	1790		10.1038/jcbfm.2014.146			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AS7HZ	WOS:000344428800006	25160669	Bronze, Green Published			2022-02-06	
J	Wang, HQ; Liao, ZB; Sun, XC; Shi, QH; Huo, G; Xie, YF; Tang, XL; Zhi, XG; Tang, ZH				Wang, Haiquan; Liao, Zhengbu; Sun, Xiaochuan; Shi, Quanhong; Huo, Gang; Xie, Yanfeng; Tang, Xiaolan; Zhi, Xinggang; Tang, Zhaohua			Intravenous administration of Honokiol provides neuroprotection and improves functional recovery after traumatic brain injury through cell cycle inhibition	NEUROPHARMACOLOGY			English	Article						Cell cycle; Honokiol; Neuron; Apoptosis; Neuroprotection; Traumatic brain injury	RETINOBLASTOMA PROTEIN; NEURONAL SURVIVAL; SCAR FORMATION; CDK INHIBITOR; DEATH; APOPTOSIS; ARREST; PROLIFERATION; HIPPOCAMPUS; ACTIVATION	Recently, increasing evidence has shown that cell cycle activation is a key factor of neuronal death and neurological dysfunction after traumatic brain injury (TBI). This study aims to investigate the effects of Honokiol, a cell cycle inhibitor, on attenuating the neuronal damage and facilitating functional recovery after TBI in rats, in an attempt to unveil its underlying molecular mechanisms in TBI. This study suggested that delayed intravenous administration of Honokiol could effectively ameliorate TBI-induced sensorimotor and cognitive dysfunctions. Meanwhile, Honokiol treatment could also reduce the lesion volume and increase the neuronal survival in the cortex and hippocampus. The neuronal degeneration and apoptosis in the cortex and hippocampus were further significantly attenuated by Honokiol treatment. In addition, the expression of cell cycle-related proteins, including cyclin D1, CDK4, pRb and E2F1, was significantly increased and endogenous cell cycle inhibitor p27 was markedly decreased at different time points after TBI. And these changes were significantly reversed by post-injury Honokiol treatment. Furthermore, the expression of some of the key cell cycle proteins such as cyclin D1 and E2F1 and the associated apoptosis in neurons were both remarkably attenuated by Honokiol treatment. These results show that delayed intravenous administration of Honokiol could effectively improve the functional recovery and attenuate the neuronal cell death, which is probably, at least in part, attributed to its role as a cell cycle inhibition This might give clues to developing attractive therapies for future clinical trials. (C) 2014 Elsevier Ltd. All rights reserved.	[Wang, Haiquan; Liao, Zhengbu; Sun, Xiaochuan; Shi, Quanhong; Huo, Gang; Xie, Yanfeng; Zhi, Xinggang; Tang, Zhaohua] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Tang, Xiaolan] Qinghai Univ, Coll Med, Lab Med Mol Biol, Xining 810000, Qinghai Provinc, Peoples R China; [Tang, Xiaolan] Qinghai Univ, Coll Med, Dept Cardiol, Xining 810000, Qinghai Provinc, Peoples R China		Tang, ZH (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing 400016, Peoples R China.	zhaohua_tang@yahoo.com	liao, ZB/ABF-8804-2021	liao, ZB/0000-0003-4591-9689; sun, xiao chuan/0000-0001-6992-332X	National Natural Science Funds of ChinaNational Natural Science Foundation of China (NSFC) [81301630, 30801182]; National key clinical specialist construction Programs of China [[2011]170]	This research was supported by the National Natural Science Funds of China under the award No. 81301630 and 30801182 and the National key clinical specialist construction Programs of China (award no. [2011]170). We would like to thank Xinggang Zhi for his technical assistance.	Akashiba H, 2006, CELL MOL LIFE SCI, V63, P2397, DOI 10.1007/s00018-006-6194-4; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Arora S, 2012, CURR MOL MED, V12, P1244, DOI 10.2174/156652412803833508; Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Boutillier AL, 2000, ONCOGENE, V19, P2171, DOI 10.1038/sj.onc.1203532; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Curzon P., 2009, METHODS BEHAV ANAL N; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI [10.1089/ars.2009.2440, 10.1089/ARS.2009.2440]; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Greene LA, 2004, CELL DEATH DIFFER, V11, P49, DOI 10.1038/sj.cdd.4401341; Hahm ER, 2007, MOL CANCER THER, V6, P2686, DOI 10.1158/1535-7163.MCT-07-0217; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Ino H, 2001, J NEUROSCI, V21, P6086, DOI 10.1523/JNEUROSCI.21-16-06086.2001; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Ishikawa C, 2012, BBA-GEN SUBJECTS, V1820, P879, DOI 10.1016/j.bbagen.2012.03.009; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Liou KT, 2003, PLANTA MED, V69, P130, DOI 10.1055/s-2003-37707; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park EJ, 2009, CANCER LETT, V277, P133, DOI 10.1016/j.canlet.2008.11.029; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018490; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	45	20	23	2	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	NOV	2014	86						9	21		10.1016/j.neuropharm.2014.06.018			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AR8QN	WOS:000343839800002	24973706				2022-02-06	
J	Khajeh, L; Blijdorp, K; Neggers, SJCMM; Ribbers, GM; Dippel, DWJ; van Kooten, F				Khajeh, Ladbon; Blijdorp, Karin; Neggers, Sebastian J. C. M. M.; Ribbers, Gerard M.; Dippel, Diederik W. J.; van Kooten, Fop			Hypopituitarism after subarachnoid haemorrhage, do we know enough?	BMC NEUROLOGY			English	Article						Subarachnoid haemorrhage; Hypopituitarism; Neuroendocrine; Functional outcome	TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY FUNCTION; GOOD NEUROLOGICAL RECOVERY; INSULIN TOLERANCE-TEST; QUALITY-OF-LIFE; NEUROENDOCRINE DYSFUNCTION; ACUTE-PHASE; PSYCHOSOCIAL OUTCOMES; GROWTH-HORMONE; GH DEFICIENCY	Background: Fatigue, slowness, apathy and decrease in level of activity are common long-term complaints after a subarachnoid haemorrhage (SAH). They resemble the symptoms frequently found in patients with endocrine dysfunction. Pituitary dysfunction may be the result of SAH or its complications. We therefore hypothesized that it may explain some of the long-term complaints after SAH. We reviewed the literature to clarify the occurrence, pattern and severity of endocrine abnormalities and we attempted to identify risk factors for hypopituitarism after SAH. We also assessed the effect of hypopituitarism on long-term functional recovery after SAH. Methods: In a MEDLINE search for studies published between 1995 and 2014, we used the term subarachnoid haemorrhage in combination with pituitary, hypopituitarism, growth hormone, gonadotropin, testosterone, cortisol function, thyroid function and diabetes insipidus. We selected all case-series and cohort studies reporting endocrine function at least 3 months after SAH and studied their reported prevalence, pathogenesis, risk factors, clinical course and outcome. Results: We identified 16 studies describing pituitary function in the long term after SAH. The reported prevalence of endocrine dysfunction varied from 0 to 55% and the affected pituitary axes differed between studies. Due to methodological issues no inferences on risk factors, course and outcome could be made. Conclusions: Neuroendocrine dysfunction may be an important and modifiable determinant of poor functional outcome after SAH. There is an urgent need for well-designed prospective studies to more precisely assess its incidence, clinical course and effect on mood, behaviour and quality of life.	[Khajeh, Ladbon; Dippel, Diederik W. J.; van Kooten, Fop] Erasmus MC Univ, Med Ctr, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Blijdorp, Karin; Neggers, Sebastian J. C. M. M.] Erasmus MC Univ, Dept Internal Med, Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Ribbers, Gerard M.] Erasmus MC Univ, Med Ctr, Dept Rehabil Med, NL-3000 CA Rotterdam, Netherlands; [Ribbers, Gerard M.] Rijndam Rehabil Ctr, Rotterdam, Netherlands		Khajeh, L (corresponding author), Erasmus MC Univ, Med Ctr, Dept Neurol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.khajeh@erasmusmc.nl	Ribbers, Gerard M/C-1454-2014; Dippel, Diederik/AAJ-2192-2020; Ribbers, Gerard/N-3623-2019	Ribbers, Gerard M/0000-0002-6114-349X; Dippel, Diederik/0000-0002-9234-3515; 			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Arlt W, 2008, CLIN MED, V8, P211, DOI 10.7861/clinmedicine.8-2-211; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Blijdorp K, 2013, EUR J ENDOCRINOL, V169, P497, DOI 10.1530/EJE-13-0436; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Citerio G, 2007, INTENS CARE MED, V33, P1580, DOI 10.1007/s00134-007-0700-5; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; DOCZI T, 1981, NEUROSURGERY, V9, P394, DOI 10.1227/00006123-198110000-00008; Dutta P, 2012, NEUROL INDIA, V60, P390, DOI 10.4103/0028-3886.100729; Gardner CJ, 2011, BRIT J NEUROSURG, V25, P337, DOI 10.3109/02688697.2010.546900; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Gasco V, 2013, EUR J ENDOCRINOL, V168, P23, DOI 10.1530/EJE-12-0584; Guresir E, 2008, NEUROSURGERY, V63, P1088, DOI 10.1227/01.NEU.0000335170.76722.B9; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Hartoft-Nielsen ML, 2004, HORM RES, V61, P53, DOI 10.1159/000075239; ISOTANI E, 1994, STROKE, V25, P2198, DOI 10.1161/01.STR.25.11.2198; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khursheed N, 2013, INT J ENDOCRINOL MET, V11, P179, DOI 10.5812/ijem.8241; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2008, EXP CLIN ENDOCR DIAB, V116, P276, DOI 10.1055/s-2007-1004552; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; LJUNGGREN B, 1985, J NEUROSURG, V62, P673, DOI 10.3171/jns.1985.62.5.0673; MCKENNA P, 1989, NEUROSURGERY, V24, P361, DOI 10.1227/00006123-198903000-00009; Noble AJ, 2010, NEUROSURGERY, V66, P772, DOI 10.1227/01.NEU.0000367548.63164.B2; Nye EJ, 2001, CLIN ENDOCRINOL, V55, P625, DOI 10.1046/j.1365-2265.2001.01389.x; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Papavasiliou AK, 2001, SURG NEUROL, V55, P138, DOI 10.1016/S0090-3019(01)00364-0; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Pfeifer M, 2001, CLIN ENDOCRINOL, V54, P17, DOI 10.1046/j.1365-2265.2001.01179.x; Poll EM, 2010, J NEUROTRAUM, V27, P189, DOI 10.1089/neu.2009.1014; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P772, DOI 10.1136/jnnp.72.6.772; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; SONESSON B, 1987, NEUROSURGERY, V21, P279, DOI 10.1227/00006123-198709000-00001; SONESSON B, 1989, ACTA NEUROL SCAND, V80, P400, DOI 10.1111/j.1600-0404.1989.tb03901.x; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vestergaard P, 1997, HORM METAB RES, V29, P106, DOI 10.1055/s-2007-979000; WIJDICKS EFM, 1991, STROKE, V22, P1519, DOI 10.1161/01.STR.22.12.1519; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	62	20	21	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	OCT 14	2014	14								205	10.1186/s12883-014-0205-0			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ3UM	WOS:000348152100002	25312299	gold, Green Published			2022-02-06	
J	Barbey, AK; Colom, R; Paul, EJ; Chau, A; Solomon, J; Grafman, JH				Barbey, Aron K.; Colom, Roberto; Paul, Erick J.; Chau, Aileen; Solomon, Jeffrey; Grafman, Jordan H.			Lesion mapping of social problem solving	BRAIN			English	Article						social intelligence; latent variable modelling; voxel-based lesion-symptom mapping	TRAUMATIC BRAIN-INJURY; ANTERIOR TEMPORAL-LOBES; HUMAN WORKING-MEMORY; FRONTAL-LOBE; COGNITIVE NEUROSCIENCE; GENERAL INTELLIGENCE; PREFRONTAL CORTEX; OLDER-ADULTS; ORBITOFRONTAL CONTRIBUTIONS; FUNCTIONAL-ORGANIZATION	Accumulating neuroscience evidence indicates that human intelligence is supported by a distributed network of frontal and parietal regions that enable complex, goal-directed behaviour. However, the contributions of this network to social aspects of intellectual function remain to be well characterized. Here, we report a human lesion study (n = 144) that investigates the neural bases of social problem solving (measured by the Everyday Problem Solving Inventory) and examine the degree to which individual differences in performance are predicted by a broad spectrum of psychological variables, including psychometric intelligence (measured by the Wechsler Adult Intelligence Scale), emotional intelligence (measured by the Mayer, Salovey, Caruso Emotional Intelligence Test), and personality traits (measured by the Neuroticism-Extraversion-Openness Personality Inventory). Scores for each variable were obtained, followed by voxel-based lesion-symptom mapping. Stepwise regression analyses revealed that working memory, processing speed, and emotional intelligence predict individual differences in everyday problem solving. A targeted analysis of specific everyday problem solving domains (involving friends, home management, consumerism, work, information management, and family) revealed psychological variables that selectively contribute to each. Lesion mapping results indicated that social problem solving, psychometric intelligence, and emotional intelligence are supported by a shared network of frontal, temporal, and parietal regions, including white matter association tracts that bind these areas into a coordinated system. The results support an integrative framework for understanding social intelligence and make specific recommendations for the application of the Everyday Problem Solving Inventory to the study of social problem solving in health and disease.	[Barbey, Aron K.; Paul, Erick J.] Univ Illinois, Decis Neurosci Lab, Urbana, IL 61801 USA; [Barbey, Aron K.; Paul, Erick J.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Barbey, Aron K.] Univ Illinois, Dept Internal Med, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Barbey, Aron K.] Univ Illinois, Inst Genom Biol, Champaign, IL 61820 USA; [Colom, Roberto] Univ Autonoma Madrid, Fdn CIEN, Fdn Reina Sofia, Madrid, Spain; [Chau, Aileen; Grafman, Jordan H.] Rehabil Inst Chicago, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA		Barbey, AK (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Decis Neurosci Lab, Urbana, IL 61801 USA.	barbey@illinois.edu; jgrafman@ric.org	Colom, Roberto/F-8779-2010; Barbey, Aron/L-7312-2015	Colom, Roberto/0000-0001-5865-163X; Barbey, Aron/0000-0002-6092-0912	U.S. National Institute of Neurological Disorders and Stroke intramural research programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0675]; Ministerio de Ciencia e Innovacion [Ministry of Science and Innovation, Spain] [PSI2010-20364]; Universidad Autonoma de Madrid [CEMU-2012-004]	This work was supported by funding from the U.S. National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the United States Army Medical Research and Material Command administered by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study, grant number DAMD17-01-1-0675). R. Colom was supported by grant PSI2010-20364 from Ministerio de Ciencia e Innovacion [Ministry of Science and Innovation, Spain] and CEMU-2012-004 [Universidad Autonoma de Madrid].	Abu-Akel A, 2003, BRAIN RES REV, V43, P29, DOI 10.1016/S0165-0173(03)00190-5; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; Adolphs R, 2013, CURR OPIN NEUROBIOL, V23, P291, DOI 10.1016/j.conb.2013.04.011; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Arbuckle JL, 2010, EXP AGING RES, V36, P230; Barbey AK, 2011, OXFORD HDB SOCIAL NE, P349; Barbey AK, 2014, BRAIN STRUCT FUNCT, V219, P485, DOI 10.1007/s00429-013-0512-z; Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312; Barbey AK, 2014, SOC COGN AFFECT NEUR, V9, P265, DOI 10.1093/scan/nss124; Barbey AK, 2013, NEUROIMAGE, V82, P547, DOI 10.1016/j.neuroimage.2013.05.087; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barbey AK, 2009, TRENDS NEUROSCI, V32, P603, DOI 10.1016/j.tins.2009.09.001; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; BlanchardFields F, 1997, PSYCHOL AGING, V12, P684, DOI 10.1037/0882-7974.12.4.684; Burgaleta M, 2014, HUM BRAIN MAPP, V35, P1957, DOI 10.1002/hbm.22305; Burton CL, 2006, CLIN NEUROPSYCHOL, V20, P432, DOI 10.1080/13854040590967063; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; CAREY ME, 1982, ACTA CHIR SCAND, P351; Caveness W F, 1979, Adv Neurol, V22, P1; Channon S, 2004, ACTA PSYCHOL, V115, P235, DOI 10.1016/j.actpsy.2003.12.008; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Colom R, 2009, INTELLIGENCE, V37, P124, DOI 10.1016/j.intell.2008.07.007; CORNELIUS SW, 1987, PSYCHOL AGING, V2, P144, DOI 10.1037/0882-7974.2.2.144; Costa PT, 2000, ASSESSMENT, V7, P325, DOI 10.1177/107319110000700402; DeYoung CG, 2014, J PERS ASSESS, V96, P46, DOI 10.1080/00223891.2013.806327; DIEHL M, 1995, PSYCHOL AGING, V10, P478, DOI 10.1037/0882-7974.10.3.478; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Harlow JM, 1999, J NEUROPSYCH CLIN N, V11, P281, DOI 10.1176/jnp.11.2.281; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Jensen A.R., 1998, G FACTOR SCI MENTAL; Jezzini A, 2012, P NATL ACAD SCI USA, V109, P10077, DOI 10.1073/pnas.1200143109; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kennedy DP, 2011, NATURE, V474, P452, DOI 10.1038/474452a; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; LOEHLIN J. C., 2004, LATENT VARIABLE MODE, V4; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mar RA, 2007, SOC COGN AFFECT NEUR, V2, P199, DOI 10.1093/scan/nsm011; MARSISKE M, 1995, PSYCHOL AGING, V10, P269, DOI 10.1037/0882-7974.10.2.269; Mayer JD, 2004, PSYCHOL INQ, V15, P197, DOI 10.1207/s15327965pli1503_02; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mienaltowski A, 2011, ANN NY ACAD SCI, V1235, P75, DOI 10.1111/j.1749-6632.2011.06207.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Ochsner KN, 2004, CURR OPIN NEUROBIOL, V14, P254, DOI 10.1016/j.conb.2004.03.011; Ochsner KN, 2001, AM PSYCHOL, V56, P717, DOI 10.1037//0003-066X.56.9.717; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; Quilty LC, 2014, J PERS ASSESS, V96, P87, DOI 10.1080/00223891.2013.834440; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Rombouts SARB, 1997, AM J NEURORADIOL, V18, P1317; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Rylander G, 1939, PERSONALITY CHANGES; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Simmons WK, 2013, HUM BRAIN MAPP, V34, P2944, DOI 10.1002/hbm.22113; Simmons WK, 2010, CEREB CORTEX, V20, P813, DOI 10.1093/cercor/bhp149; Simmons WK, 2009, J INT NEUROPSYCH SOC, V15, P645, DOI 10.1017/S1355617709990348; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; SPSS, 2013, IBM SPSS STAT WIND V; Sternberg RJ, 2000, HDB INTELLIGENCE; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Thornton WL, 2007, PSYCHOL AGING, V22, P470, DOI 10.1037/0882-7974.22.3.470; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitfield KE, 2003, EXP AGING RES, V29, P1, DOI 10.1080/03610730303703; Woolgar A, 2010, P NATL ACAD SCI USA, V107, P14899, DOI 10.1073/pnas.1007928107	88	20	20	1	27	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	OCT	2014	137		10				2823	2833		10.1093/brain/awu207			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR2MG	WOS:000343420900026	25070511	Bronze, Green Published			2022-02-06	
J	Con, J; Friese, RS; Long, DM; Zangbar, B; O'Keeffe, T; Joseph, B; Rhee, P; Tang, AL				Con, Jorge; Friese, Randall S.; Long, Dustin M.; Zangbar, Bardiya; O'Keeffe, Terence; Joseph, Bellal; Rhee, Peter; Tang, Andrew L.			Falls from ladders: age matters more than height	JOURNAL OF SURGICAL RESEARCH			English	Article						Fall from ladder; Head injuries; Truncal injuries; Extremity fractures; Geriatric trauma	INJURIES; SEVERITY; PATTERNS	Background: Falls from ladders account for a significant number of hospital visits. However, the epidemiology, injury pattern, and how age affects such falls are poorly described in the literature. Materials and methods: Patients >= 18 y who suffered falls from ladders over a 51/2-y period were identified in our trauma registry. Dividing patients into three age groups (18-45, 46-65, and >66 y), we compared demographic characteristics, clinical data, and outcomes including injury pattern and mortality. The odds ratios (ORs) were calculated with the group 18-45 y as reference; group means were compared with one-way analysis of variance. Results: Of 27,155 trauma patients, 340 (1.3%) had suffered falls from ladders. The average age was 55 y, with a male predominance of 89.3%. Average fall height was 9.8 ft, and mean Injury Severity Score was 10.6. Increasing age was associated with a decrease in the mean fall height (P < 0.001), an increase in the mean Injury Severity Score (P < 0.05), and higher likelihood of admission (>66 y: OR, 5.3; confidence interval [CI], 2.5-11.5). In univariate analysis, patients in the >66-y age group were more likely to sustain traumatic brain injuries (OR, 3.4; CI, 1.5-7.8) and truncal injuries (OR, 3.6; CI, 1.9-7.0) and less likely to sustain hand and/or forearm fractures (OR, 0.3; CI, 0.1-0.9). Conclusions: Older people are particularly vulnerable after falling from ladders. Although they fell from lower heights, the elderly sustained different and more severe injury patterns. Ladder safety education should be particularly tailored at the elderly. (C) 2014 Elsevier Inc. All rights reserved.	[Con, Jorge] W Virginia Univ, Dept Surg, Morgantown, WV 26506 USA; [Friese, Randall S.; Zangbar, Bardiya; O'Keeffe, Terence; Joseph, Bellal; Rhee, Peter; Tang, Andrew L.] Univ Arizona, Dept Surg, Tucson, AZ USA; [Long, Dustin M.] W Virginia Univ, Dept Biostat, Morgantown, WV 26506 USA		Con, J (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Surg, POB 9238, Morgantown, WV 26506 USA.	jocon@hsc.wvu.edu	Long, Dustin/AAA-5006-2019; Zangbar, Bardiya/K-7147-2014	Long, Dustin/0000-0002-5423-4481; Zangbar, Bardiya/0000-0003-1215-1693	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM104942] Funding Source: Medline		American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; Brown A., 2013, GALLUP EC; D'Souza AL, 2007, AM J PREV MED, V32, P413, DOI 10.1016/j.amepre.2007.01.012; Demetriades D, 2005, J TRAUMA, V58, P342, DOI 10.1097/01.TA.0000135161.44100.D8; Diggs BS, 2005, ACAD EMERG MED, V12, P267, DOI 10.1197/j.aem.2004.10.028; Lapostolle F, 2005, CRIT CARE MED, V33, P1239, DOI 10.1097/01.CCM.0000164564.11989.C3; O'Sullivan J, 2004, INJURY, V35, P429, DOI 10.1016/S0020-1383(03)00265-1; Office of Statistics and Programming NCfIPaC CDC, 2010, 10 LEAD CAUS INJ DEA; Partridge RA, 1998, ACAD EMERG MED, V5, P31, DOI 10.1111/j.1553-2712.1998.tb02571.x; Richter D, 1996, INJURY, V27; ROZYCKI GS, 1991, ARCH EMERG MED, V8, P245; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021	12	20	21	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2014	191	2					262	267		10.1016/j.jss.2014.05.072			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AO5CB	WOS:000341358100003	25066188	Green Accepted			2022-02-06	
J	Margetis, K; Korfias, SI; Gatzonis, S; Boutos, N; Stranjalis, G; Boviatsis, E; Sakas, DE				Margetis, Konstantinos; Korfias, Stefanos I.; Gatzonis, Stylianos; Boutos, Nick; Stranjalis, George; Boviatsis, Efstathios; Sakas, Damianos E.			Intrathecal Baclofen Associated With Improvement of Consciousness Disorders in Spasticity Patients	NEUROMODULATION			English	Article						Baclofen; consciousness disorders; GABA-B; infusion pump; intrathecal drug delivery; MeSH; persistent vegetative state; receptors; therapy	THALAMIC RETICULAR NUCLEUS; TRAUMATIC BRAIN-INJURY; GABA(B) RECEPTORS; VEGETATIVE STATE; SELECTIVE LOSS; BASAL GANGLIA; RECOVERY; NEURONS; INHIBITION; HYPOCRETIN	ObjectiveIntrathecal baclofen (ITB) pump is a therapeutic option for persistent vegetative state and minimal conscious state patients that have associated spasticity. We investigated whether this treatment modality can affect their level of consciousness. MethodIn this prospective, open label, observational study, we implanted ITB pumps for the treatment of spasticity in eight patients with disorders of consciousness (vegetative state and minimally conscious state) and we followed them with the Coma Recovery Scale-Revised, the Eastern Cooperative Oncology Group (ECOG) performance scale, and the Modified Ashworth spasticity scale. Baclofen dose and complications also were noted. ResultsThe offending pathologies were traumatic brain injury in six, anoxia due to cardiac arrest in one, acute obstructive hydrocephalus in one. Two of the patients showed a marked, persistent improvement that fulfilled the criteria of emergence from minimally conscious state. Two of patients had their ITB pumps prematurely removed because of complications. The ECOG score was 4 for all patients and did not change during the study. ConclusionITB might be associated with a significant improvement in the disorder of consciousness of two patients from a total of six that had a chronic ITB treatment.	[Margetis, Konstantinos; Korfias, Stefanos I.; Gatzonis, Stylianos; Boutos, Nick; Stranjalis, George; Boviatsis, Efstathios; Sakas, Damianos E.] Univ Athens, Dept Neurosurg 1, Athens 10676, Greece		Margetis, K (corresponding author), Univ Athens, Dept Neurosurg, Evangelismos Hosp, Ipsilantou 45, Athens 10676, Greece.	konstantinmarg@yahoo.com	Margetis, Konstantinos/M-1104-2019				Ambardekar AV, 1999, NEUROSCIENCE, V93, P1339, DOI 10.1016/S0306-4522(99)00282-1; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bowery NG, 2010, ADV PHARMACOL, V58, P1, DOI 10.1016/S1054-3589(10)58001-3; BOWERY NG, 1987, NEUROSCIENCE, V20, P365, DOI 10.1016/0306-4522(87)90098-4; Bowery NG, 1999, NEUROPHARMACOLOGY, V38, P1675, DOI 10.1016/S0028-3908(99)00130-6; BOWERY NG, 1992, ARZNEIMITTELFORSCH, V42-1, P215; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Ferrarelli F, 2011, SCHIZOPHRENIA BULL, V37, P306, DOI 10.1093/schbul/sbq142; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Kawecki Zdzislaw, 2007, Przegl Lek, V64 Suppl 2, P13; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Margetis K, 2014, J CLIN PSYCHOPHARM, V34, P171, DOI 10.1097/JCP.0b013e3182a59232; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; McAlonan K, 2000, J NEUROSCI, V20, P8897; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Montero VM, 1999, NEUROSCIENCE, V91, P805, DOI 10.1016/S0306-4522(98)00632-0; Montero VM, 1997, NEUROSCIENCE, V76, P1069, DOI 10.1016/S0306-4522(96)00417-4; Montero VM, 2000, BRAIN RES, V864, P95, DOI 10.1016/S0006-8993(00)02182-X; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Oyama H, 2010, NEUROL MED-CHIR, V50, P386, DOI 10.2176/nmc.50.386; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pistoia F, 2013, BRAIN INJURY, V27, P1330, DOI 10.3109/02699052.2013.809554; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Posner JB, 2007, PLUM POSNERS DIAGNOS; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stevens DR, 1999, EUR J NEUROSCI, V11, P1148, DOI 10.1046/j.1460-9568.1999.00519.x; Taira T, 2007, ACTA NEUROCHIR SUPPL, V97, P227; Taira T, 2003, ACT NEUR S, V87, P37; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Ulrich D, 1996, P NATL ACAD SCI USA, V93, P13245, DOI 10.1073/pnas.93.23.13245; Ulrich D, 1996, J PHYSIOL-LONDON, V493, P845, DOI 10.1113/jphysiol.1996.sp021427; Ulrich D, 2007, J NEUROPHYSIOL, V98, P3791, DOI 10.1152/jn.00756.2007; Weese GD, 1999, J NEUROSCI, V19, P10135; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Xie XM, 2006, J PHYSIOL-LONDON, V574, P399, DOI 10.1113/jphysiol.2006.108266	50	20	22	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	OCT	2014	17	7					699	704		10.1111/ner.12147			6	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	AU3KT	WOS:000345512700017	24350688				2022-02-06	
J	Xu, ZNS; Yao, AN; Chu, SS; Paun, MK; McClintic, AM; Murphy, SP; Mourad, PD				Xu, Zinnia S.; Yao, Anning; Chu, Stephanie S.; Paun, Marla K.; McClintic, Abbi M.; Murphy, Sean P.; Mourad, Pierre D.			Detection of Wild Traumatic Brain Injury in Rodent Models Using Shear Wave Elastography	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						brain; edema; elastography; traumatic brain injury; ultrasound	CONTROLLED CORTICAL IMPACT; MAGNETIC-RESONANCE ELASTOGRAPHY; VISCOELASTIC PROPERTIES; BLOOD-FLOW; VOLUME; EDEMA	Objectives-Traumatic brain injury (TBI) can cause adverse physiologic changes in fluid content within the brain, which may lead to changes in tissue elasticity (eg, stiffness). This study evaluated the ability of ultrasonic shear wave elastography to observe these changes in the brain after TBI in vivo. Methods-Mice and rats received a mild TBI or sham surgery and were imaged acutely or 24 hours after injury using shear wave elastography, and the hemispheric stiffness values were compared. Results-Stiffness values were consistent across brain hemispheres of sham TBI rodents. By 24 hours after TBI, relative brain tissue stiffness values for mice and rats each decreased ipsilaterally and increased contralaterally, both relative to each other and compared to sham TBI rodents (P < .05). The absolute tissue elasticity value increased for rats (P < .05) but not for mice. Conclusions-Differences between intrahemispheric stiffness values of rodent brains by 24 hours after mild TBI may reflect the observed edema and hemorrhage ipsilateral to TBI and the known reduction of cerebral blood flow in both brain hemispheres. If these hypotheses hold true, ultrasonic shear wave elastography may offer a method for detecting adverse changes in fluid content within the brain after mild TBI.	[Xu, Zinnia S.; Yao, Anning; Chu, Stephanie S.; Mourad, Pierre D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Paun, Marla K.; Mourad, Pierre D.] Univ Washington, Appl Phys Lab, Seattle, WA 98195 USA; [McClintic, Abbi M.; Murphy, Sean P.; Mourad, Pierre D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Mourad, PD (corresponding author), Univ Washington, Dept Neurol Surg, Box 356470, Seattle, WA 98195 USA.	pierre@apl.washington.edu			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-11-2-0109]	This work was supported by the Congressionally Directed Medical Research Program (award W81XWH-11-2-0109).	Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Deffieux T, 2012, IEEE T ULTRASON FERR, V59, P2390, DOI 10.1109/TUFFC.2012.2472; Derieppe M, 2012, EUR RADIOL, V22, P243, DOI 10.1007/s00330-011-2229-9; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Faul M, 2010, TRAUMATIC BRAIN INJU; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Garra BS, 2011, ULTRASOUND Q, V27, P177, DOI 10.1097/RUQ.0b013e31822a2138; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Lee Bruce, 2005, NeuroRx, V2, P372; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Mace E, 2011, IEEE T MED IMAGING, V30, P550, DOI 10.1109/TMI.2010.2079940; McCracken PJ, 2005, MAGN RESON MED, V53, P628, DOI 10.1002/mrm.20388; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; O'Reilly MA, 2012, INT J HYPERTHER, V28, P386, DOI 10.3109/02656736.2012.666709; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Xu ZNS, 2013, J ULTRAS MED, V32, P485, DOI 10.7863/jum.2013.32.3.485	27	20	24	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	OCT	2014	33	10					1763	1771		10.7863/ultra.33.10.1763			9	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AQ0MP	WOS:000342477700006	25253822				2022-02-06	
J	Zhang, H; Han, MQ; Zhang, XN; Sun, XT; Ling, F				Zhang, Hao; Han, Mengqi; Zhang, Xiaonian; Sun, Xinting; Ling, Feng			The Effect and Mechanism of Growth Hormone Replacement on Cognitive Function in Rats with Traumatic Brain Injury	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; GH DEFICIENCY; PERFORMANCE; THERAPY; NEURONS; MEMORY; MODEL; HYPOPITUITARISM; EXPRESSION	Objective: The effects of growth hormone on cognitive dysfunction were observed in a controlled cortical impact (CCI) rat model and the underlying mechanism was explored. Method: Three-month-old male SD rats were randomly divided into sham (n = 10), control (n = 10), and CCI groups (n = 40) The parameters were set as follows: striking speed, 3.5 m/s; impact depth, 1.5 mm; and dwell time, 400 msec. Eight and ten weeks post-injury, the GH levels were measured the water maze test and novel object recognition test were performed. CCI rats were divided into normal and decreased GH groups, and further randomly divided into two sub-groups (rhGH treatment and saline vehicle groups). All rats were tested for SYN, BDNF, and TrkB mRNA in the prefrontal cortex and hippocampus by RT-PCR. Results: CCI rats 8 weeks post-injury had cognitive dysfunction regardless of the GH level (P, 0.05). rhGH treatment improved cognitive function in CCI rats. There was a positive correlation between the expression of prefrontal BDNF and SYN mRNA in CCI rats after rhGH therapy and the water maze test score (r = 0.773 and 0.534, respectively; P<0.05). Furthermore, the expression of BDNF, TrkB, and SYN mRNA in the hippocampus was negatively correlated with the water maze test score (r = 0.602, 0.773, 0.672, and 0.783, respectively; P<0.05). There was a difference in the expression of hippocampal and prefrontal BDNF, TrkB, and SYN mRNA (P<0.05) Conclusion: rhGH treatment had a positive effect on cognitive function, which was more evident in GH-deficient rats. The increased expression of hippocampal and prefrontal BDNF and TrkB mRNA is implicated in rhGH therapy to improve cognitive function. Changes in the expression of hippocampal SYN mRNA following rhGH therapy may also play a role in improving cognitive function.	[Zhang, Hao; Zhang, Xiaonian; Sun, Xinting] Capital Med Univ, China Rehabil Res Ctr, Beijing, Peoples R China; [Han, Mengqi] Beijing Jishuitan Hosp, Beijing, Peoples R China; [Ling, Feng] Capital Med Univ, Beijing Xuanwu Hosp, Beijing, Peoples R China		Ling, F (corresponding author), Capital Med Univ, China Rehabil Res Ctr, Beijing, Peoples R China.	crrck3@sina.com			Chinese central public research institutes [2011CZ-6, 2012CZ-5]	The special basic research fund for Chinese central public research institutes (2011CZ-6,2012CZ-5) http://www.most.gov.cn/ztzl/gjzctx/ptzckjtr/200802/t20080222_59209.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beca SG, 2012, PITUITARY, V15, P10, DOI 10.1007/s11102-008-0133-3; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Brandoli C, 1998, J NEUROSCI, V18, P7953; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creyghton Wouter M, 2004, Semin Vasc Med, V4, P167, DOI 10.1055/s-2004-835375; Crispino M, 1999, EXP NEUROL, V159, P574, DOI 10.1006/exnr.1999.7186; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOU Yi, 2009, Zhonghua Shao Shang Za Zhi, V25, P275; Doulah AH, 2009, NEUROSCI LETT, V466, P47, DOI 10.1016/j.neulet.2009.09.016; Eastwood SL, 2000, BRIT J PSYCHIAT, V176, P236, DOI 10.1192/bjp.176.3.236; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Ferrer I, 1999, DEMENT GERIATR COGN, V10, P55, DOI 10.1159/000051214; GRANON S, 1995, BEHAV NEUROSCI, V109, P474, DOI 10.1037/0735-7044.109.3.474; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hao LY, 2010, NEUROSCIENCE, V166, P763, DOI 10.1016/j.neuroscience.2010.01.006; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1; Kurihara M, 2011, GEN COMP ENDOCR, V170, P156, DOI 10.1016/j.ygcen.2010.09.020; Kwak MJ, 2009, J KOREAN MED SCI, V24, P729, DOI 10.3346/jkms.2009.24.4.729; LAI ZN, 1993, BRAIN RES, V621, P260, DOI 10.1016/0006-8993(93)90114-3; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; Miladi-Gorji H, 2011, NEUROBIOL LEARN MEM, V96, P479, DOI 10.1016/j.nlm.2011.08.001; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Morris GM, 2008, SCHOLARPEDIA US, V3, P6315; Morselli L L, 2008, J Endocrinol Invest, V31, P39; Nieuwpoort IC, 2008, EUR J ENDOCRINOL ENG, V159, pS53; Oertel H, 2004, PSYCHONEUROENDOCRINO, V29, P839, DOI 10.1016/S0306-4530(03)00151-3; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Pathipati P, 2009, BEHAV BRAIN RES, V204, P93, DOI 10.1016/j.bbr.2009.05.023; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Quik EH, 2012, GROWTH HORM IGF RES, V22, P42, DOI 10.1016/j.ghir.2011.12.007; Rocha M, 1999, BRAIN RES, V827, P79, DOI 10.1016/S0006-8993(99)01307-4; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thornton PL, 2000, J GERONTOL A-BIOL, V55, pB106; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Wass JAH, 2010, J ENDOCRINOL, V207, P125, DOI 10.1677/JOE-10-0126; Ying XG, 2004, J CLIN CARDIOVASCU D, V10, P613; Zhou JP, 2007, INFLUENCE GNRH ANALO	54	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108518	10.1371/journal.pone.0108518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6CW	WOS:000343671700105	25268832	Green Published, gold, Green Submitted			2022-02-06	
J	Dekker, SE; Sillesen, M; Bambakidis, T; Jin, G; Liu, BL; Boer, C; Johansson, PI; Halaweish, I; Maxwell, J; Alam, HB				Dekker, Simone E.; Sillesen, Martin; Bambakidis, Ted; Jin, Guang; Liu, Baoling; Boer, Christa; Johansson, Par I.; Halaweish, Ihab; Maxwell, Jake; Alam, Hasan B.			Normal saline influences coagulation and endothelial function after traumatic brain injury and hemorrhagic shock in pigs	SURGERY			English	Article							FRESH-FROZEN PLASMA; LARGE-ANIMAL-MODEL; PREHOSPITAL MANAGEMENT; INTRACRANIAL-PRESSURE; MASSIVE TRANSFUSION; E-SELECTIN; RESUSCITATION; BLOOD; COAGULOPATHY; NEUTROPHILS	Background. Traumatic brain injury (TBI) and hemorrhagic shock (HS) are the leading causes of trauma-related deaths. These insults disrupt coagulation and endothelial systems. This study investigated whether previously reported differences in lesion size and brain swelling during normal saline (NS), colloids (Hextend [HEX]), and fresh frozen plasma (HP) resuscitation are associated with differential effects on coagulation and endothelial systems. Methods. We subjected 15 Yorkshire swine to TBI and HS (40% blood volume), and kept in HS for 2 hours before resuscitation with NS, HEX, or REP Markers of endothelial activation (E-selectin, Intercellular adhesion molecule [ICAM]-1), coagulation activation (prothrombin fragment 1 + 2), and natural anticoagulation (activated protein C (aPC]) were determined in serum and brain whole cell lysates. Results. Serum levels of aPC were greater in the NS group (203 +/- 30 pg/mL) compared with HEX (77 +/- 28 pg/mL; P = .02) and HP (110 +/- 28 pg/mL; P = .09), as was PF 1 + 2 in the brain when compared with FFP (PF 1 + 2, 89 +/- 46 vs 37 +/- 14 ng/mL; P = .035). Brain E-selectin was greater in the NS group compared with FFP (3.36 +/- 0.02 vs 3.31 +/- 0.01 ng/mL; P = .029). Circulating ICAM-1 levels were increased in the NS group (151 +/- 9 ng/mL) compared with the HEX (100 +/- 9 ng/mL; P < .01) and REP (108 +/- 9 ng/mL; P = .01). Conclusion. In this clinically realistic large animal model of TBI + HS, NS resuscitation was associated with an early activation of coagulation, natural anticoagulation, and endothelial systems, compared with HEX and FFP.	[Dekker, Simone E.; Bambakidis, Ted; Jin, Guang; Liu, Baoling; Halaweish, Ihab; Maxwell, Jake; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA; [Dekker, Simone E.; Boer, Christa] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, Amsterdam, Netherlands; [Sillesen, Martin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care,Dept S, Boston, MA USA; [Sillesen, Martin] Copenhagen Univ Hosp, Dept Surg, Hillerod, Denmark; [Johansson, Par I.] Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Houston, Sch Med, Dept Surg, Ctr Translat Injury Res CeTIR, Houston, TX USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Johansson, Par I/P-9283-2015	Johansson, Par I/0000-0001-9778-5964; Boer, Christa/0000-0002-7781-6951; Sillesen, Martin/0000-0001-9494-5475	US Army Medical Research Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [00521959]; Lundbeck FoundationLundbeckfonden [R134-A12630]	Funded by a grant from the US Army Medical Research Material Command GRANTT00521959 (to H.B.A.) and a grant from the Lundbeck Foundation R134-A12630 (to M.S and P.I.J).	Alam HB, 2009, J TRAUMA, V67, P856, DOI 10.1097/TA.0b013e3181b5ae75; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Bernardes-Silva M, 2001, J CEREBR BLOOD F MET, V21, P1115, DOI 10.1097/00004647-200109000-00009; Bolliger D, 2010, BRIT J ANAESTH, V104, P318, DOI 10.1093/bja/aeq001; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; EDWARDS RL, 1992, SEMIN HEMATOL, V29, P202; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Ganter MT, 2010, BEST PRACT RES-CLIN, V24, P15, DOI 10.1016/j.bpa.2009.09.010; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HESS DC, 1994, NEUROSCI LETT, V168, P201, DOI 10.1016/0304-3940(94)90450-2; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; McKeating EG, 1998, ACT NEUR S, V71, P200; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Myburgh J, 2007, NEW ENGL J MED, V357, P874; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Ragaller Max, 2010, J Emerg Trauma Shock, V3, P1, DOI 10.4103/0974-2700.58649; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Stanimirovic DB, 1997, ACT NEUR S, V70, P12; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Velik-Salchner C, 2006, THROMB RES, V117, P597, DOI 10.1016/j.thromres.2005.05.015; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	41	20	20	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	SEP	2014	156	3					556	563		10.1016/j.surg.2014.04.016			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AO3KN	WOS:000341228200009	24953275				2022-02-06	
J	Kreuzer, PM; Landgrebe, M; Vielsmeier, V; Kleinjung, T; De Ridder, D; Langguth, B				Kreuzer, Peter M.; Landgrebe, Michael; Vielsmeier, Veronika; Kleinjung, Tobias; De Ridder, Dirk; Langguth, Berthold			Trauma-Associated Tinnitus	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast; brain injury; chronic tinnitus; noise trauma; trauma; whiplash	OPERATION IRAQI FREEDOM; TEMPORAL BONE-FRACTURES; NOISE-INDUCED TINNITUS; INDUCED HEARING-LOSS; POSTTRAUMATIC-STRESS-DISORDER; PURE-TONE TRAUMA; BRAIN-INJURY; AUDITORY-CORTEX; PERILYMPHATIC FISTULA; WHIPLASH INJURIES	Background: Up to 53% of individuals suffering from traumatic brain injuries develop tinnitus. Objective: To review the current literature on trauma-associated tinnitus in order to provide orientation for the clinical management of patients with trauma-associated tinnitus. Materials: A systematic literature search has been conducted in PubMed database applying the search terms posttraumatic tinnitus and trauma-associated tinnitus. Results have been complemented by related studies, book chapters, and the authors' clinical experience. Results: Not only mechanical, pressure-related, or noise-related head traumata but also neck injuries and emotional trauma can cause tinnitus. Exact diagnosis is essential. Disorders such as ossicular chain disruption, traumatic eardrum perforation, or perilymphatic fistula can be surgically treated. It should also be considered that pulsatile tinnitus can be a sign of life-threatening disorders such as carotid cavernous fistulas, arteriovenous malformations, and carotid dissections. Also, posttraumatic stress disorder should be taken into consideration as a potential contributing factor. Conclusions: There is an evident mismatch between the high incidence of trauma-associated tinnitus and scarce literature on the topic. A consistent and-at best-standardized assessment of tinnitus-and hearing-related sequelae of trauma is recommended both for the improvement of clinical care and for a deeper understanding of the various pathophysiological mechanisms of trauma-associated tinnitus.	[Kreuzer, Peter M.; Landgrebe, Michael; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Vielsmeier, Veronika] Univ Regensburg, Dept Otolaryngol, D-93053 Regensburg, Germany; [Landgrebe, Michael] Social Fdn Bamberg, Dept Psychiat Psychosomat Med & Psychotherapy, Bamberg, Germany; [Kleinjung, Tobias] Univ Zurich, Dept Otolaryngol, Zurich, Switzerland; Brain Res Ctr Antwerp Innovat & Interdisciplinary, Antwerp, Belgium; [De Ridder, Dirk] Univ Otago, Unit Neurosurg, Dept Surg Sci, Dunedin Sch Med, Dunedin, New Zealand		Kreuzer, PM (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Univ Str 84, D-93053 Regensburg, Germany.	peter.kreuzer@medbo.de	Kleinjung, Tobias/AAJ-3141-2020; Langguth, Berthold/AAP-2638-2021	Kleinjung, Tobias/0000-0003-3867-234X; 	European Psychiatric Association; ServierServier; PfizerPfizer; Astra ZenecaAstraZeneca; LundbeckLundbeck Corporation; LillyEli Lilly; Tinnitus Research Initiative; Tinnitus Research Initiative, Antwerp University TOP Project; SJ Medical Neurodivision; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); American Tinnitus Association	Dr Kreuzer received travel grants by the European Psychiatric Association, Servier, Pfizer, and Astra Zeneca; Dr Landgrebe received travel grants, consultancy, and speaker honoraria from Servier, Lundbeck, and Lilly; Dr Vielsmeier is supported by the Tinnitus Research Initiative; Dr Kleinjung is supported by the Tinnitus Research Initiative; Dr De Ridder is supported by the Tinnitus Research Initiative, Antwerp University TOP Project, and has received consultancy fees from SJ Medical Neurodivision; and Dr Langguth is supported by the Deutsche Forschungsgemeinschaft, the American Tinnitus Association, and the Tinnitus Research Initiative, and he received consultancy and speaker honoraria from Autifony, ANM, Astra Zeneca, Merz, Novartis, Pfizer, Lundbeck, and Servier.	Andersson G, 2009, J AM ACAD AUDIOL, V20, P315, DOI 10.3766/jaaa.20.5.5; Ansell M J, 2010, J R Army Med Corps, V156, P106; ARAN JM, 1995, HEARING RES, V82, P179, DOI 10.1016/0378-5955(94)00175-P; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Axelsson Alf, 2000, Noise Health, V2, P47; Basura GJ, 2012, BRAIN RES, V1485, P95, DOI 10.1016/j.brainres.2012.08.037; Bauer CA, 2011, EAR HEARING, V32, P145, DOI 10.1097/AUD.0b013e3181f5374f; Becker GD, 2001, EUR ARCH OTO-RHINO-L, V258, P159, DOI 10.1007/s004050100334; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Rocha CACB, 2007, PROG BRAIN RES, V166, P209, DOI 10.1016/S0079-6123(07)66018-X; Bluvstein I, 2013, J CLIN PSYCHOL MED S, V20, P164, DOI 10.1007/s10880-012-9318-z; Breeze J, 2011, BRIT J ORAL MAX SURG, V49, P607, DOI 10.1016/j.bjoms.2010.10.006; Breeze J, 2011, J LARYNGOL OTOL, V125, P13, DOI 10.1017/S0022215110002215; Brodie HA, 1997, AM J OTOL, V18, P188; BROWN JJ, 1978, ACTA OTO-LARYNGOL, V86, P394, DOI 10.3109/00016487809107518; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; Chae SW, 2001, J LARYNGOL OTOL, V115, P313; Chen J, 2001, Chin J Traumatol, V4, P106; Claussen, 1995, Int Tinnitus J, V1, P105; CLAUSSEN CF, 1995, ACTA OTO-LARYNGOL, P53; COOPER JC, 1976, ARCH OTOLARYNGOL, V102, P148; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; DALISE M, 1997, CEREBROVASC DIS, P1169; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Demeester K, 2007, B-ENT, P37; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Depauw P, 2001, CLIN NEUROL NEUROSUR, V103, P197, DOI 10.1016/S0303-8467(01)00141-X; Dinh CT, 2009, AUDIOL NEURO-OTOL, V14, P383, DOI 10.1159/000241895; Dobie R.A., 2004, TINNITUS THEORY MANA, P266; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); FAUSTI S, 1994, EAR HEARING, V15, P232, DOI 10.1097/00003446-199406000-00004; FAUSTI SA, 1993, ARCH OTOLARYNGOL, V119, P661; FAUSTI SA, 1992, J INFECT DIS, V165, P1026, DOI 10.1093/infdis/165.6.1026; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fechter LD, 2007, TOXICOL SCI, V98, P510, DOI 10.1093/toxsci/kfm101; FITZGERALD DC, 1995, ARCH PHYS MED REHAB, V76, P1017, DOI 10.1016/S0003-9993(95)81041-2; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; FRECKMANN N, 1981, ACTA NEUROCHIR, V55, P273, DOI 10.1007/BF01808443; Friedman JA, 2001, J NEUROSURG, V94, P831, DOI 10.3171/jns.2001.94.5.0831; Fukai J, 2001, SURG NEUROL, V55, P353, DOI 10.1016/S0090-3019(01)00469-4; Geckle L, 2004, SOLDIER PERCEPTIONS; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; George MS, 2009, BRAIN STIMUL, V2, P14, DOI 10.1016/j.brs.2008.06.001; Gilles A, 2012, OTOL NEUROTOL, V33, P899, DOI 10.1097/MAO.0b013e31825d640a; GLASSCOCK ME, 1992, AM J OTOL, V13, P333; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Goto F, 2001, AURIS NASUS LARYNX, V28, P29, DOI 10.1016/S0385-8146(00)00089-4; Granier M, 2006, Rev Stomatol Chir Maxillofac, V107, P253, DOI 10.1016/S0035-1768(06)77047-4; Hagberg M, 2005, INT ARCH OCC ENV HEA, V78, P575, DOI 10.1007/s00420-005-0621-y; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; Helfer TM, 2011, AM J AUDIOL, V20, P33, DOI 10.1044/1059-0889(2011/10-0033); Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Jacobson G P, 2001, J Am Acad Audiol, V12, P493; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Khedr EM, 2010, NEUROEPIDEMIOLOGY, V35, P45, DOI 10.1159/000306630; Komiya H, 2000, ACTA OTO-LARYNGOL, V120, P750; Kreuzer PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045599; Kreuzer PM, 2013, J HEAD TRAUMA REHAB, V28, P386, DOI 10.1097/HTR.0b013e318254736e; KRONENBERG J, 1993, AM J OTOL, V14, P92; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2012, EXPERT OPIN PHARMACO, V13, P2495, DOI 10.1517/14656566.2012.739608; Langguth Berthold, 2011, MMW Fortschr Med, V153, P40; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Leske M C, 1981, ASHA, V23, P229; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lewis J E, 2002, J Am Acad Audiol, V13, P339; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; Liang Wen, 2007, J Trauma, V63, P1014; Lin CY, 2010, HEARING RES, V269, P42, DOI 10.1016/j.heares.2010.07.005; Lollis SS, 2006, J NEUROSURG, V105, P1, DOI 10.3171/jns.2006.105.1.1; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Malouff JM, 2011, CURR PSYCHIAT REP, V13, P31, DOI 10.1007/s11920-010-0163-1; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Marciano E, 2003, INT J AUDIOL, V42, P4, DOI 10.3109/14992020309056079; McVeigh K, 2010, J R Army Med Corps, V156, P110; Meenen N M, 1994, Unfallchirurgie, V20, P138, DOI 10.1007/BF02588158; Meenen NM, 1994, UNFALLCHIRURGIE, V20, P149; Mirza S, 2005, J LARYNGOL OTOL, V119, P366, DOI 10.1258/0022215053945723; Mittal MK, 2007, ACCIDENT ANAL PREV, V39, P624, DOI 10.1016/j.aap.2006.10.005; MIZOBUCHI M, 1991, Neurological Surgery, V19, P83; Moller AR, 2011, TEXTBOOK OF TINNITUS, P1; Mrena R, 2004, ACTA OTO-LARYNGOL, V124, P946, DOI 10.1080/00016480310017045; Mrena R, 2004, INT J AUDIOL, V43, P177, DOI 10.1080/14992020400050025; Mrena R, 2002, AUDIOL NEURO-OTOL, V7, P122, DOI 10.1159/000057660; Mrena R, 2009, INT J AUDIOL, V48, P394, DOI 10.1080/14992020902777225; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Nicolas-Puel Cecile, 2006, Int Tinnitus J, V12, P64; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2006, NEUROREPORT, V17, P559, DOI 10.1097/00001756-200604240-00001; OOSTERVELD WJ, 1991, ACTA OTO-LARYNGOL, V111, P201, DOI 10.3109/00016489109137375; Ortmann M, 2011, EUR J NEUROSCI, V33, P568, DOI 10.1111/j.1460-9568.2010.07542.x; Persaud R, 2003, CLIN OTOLARYNGOL, V28, P203, DOI 10.1046/j.1365-2273.2003.00688.x; PHOON WH, 1993, OCCUP MED-OXFORD, V43, P35, DOI 10.1093/occmed/43.1.35; Potier M, 2009, EAR HEARING, V30, P291, DOI 10.1097/AUD.0b013e31819769fc; PYYKKO I, 1992, AM J OTOL, V13, P339; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Redekop GJ, 2008, CAN J NEUROL SCI, V35, P146, DOI 10.1017/S0317167100008556; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rocha CACB, 2008, AUDIOL NEURO-OTOL, V13, P153, DOI 10.1159/000112423; Rosanowski F, 1996, LARYNGO RHINO OTOL, V75, P514, DOI 10.1055/s-2007-997624; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Rowlands RG, 2009, J LARYNGOL OTOL, V123, P182, DOI 10.1017/S0022215108002569; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schecklmann M, 2013, BRAIN STRUCT FUNCT, V218, P1061, DOI 10.1007/s00429-013-0520-z; Scholten-Peeters GGM, 2002, SPINE, V27, P412, DOI 10.1097/00007632-200202150-00018; SCHUKNECHT H F, 1951, Trans Am Acad Ophthalmol Otolaryngol, V55, P407; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Sindhusake Doungkamol, 2004, J Am Acad Audiol, V15, P269; Snow J, 2004, TINNITUS THEORY MANA, P16; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Taranda J, 2009, PLOS BIOL, V7, P71, DOI 10.1371/journal.pbio.1000018; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tranter RMD, 2009, J FORENSIC LEG MED, V16, P53, DOI 10.1016/j.jflm.2008.09.001; Tungsinmunkong Sunee, 2007, Journal of the Medical Association of Thailand, V90, P2662; Turner Oliver, 2007, Ann Gen Psychiatry, V6, P26, DOI 10.1186/1744-859X-6-26; Ulug T, 2006, J OTOLARYNGOL, V35, P380, DOI 10.2310/7070.2006.0069; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vibert D, 2003, ANN OTO RHINOL LARYN, V112, P246, DOI 10.1177/000348940311200310; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichbold V, 2003, INT J AUDIOL, V42, P489, DOI 10.3109/14992020309081519; Weichbold V, 2007, INT J AUDIOL, V46, P128, DOI 10.1080/14992020601126849; Weider Dudley J, 2005, Int Tinnitus J, V11, P137; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; WILLIAMS JD, 1980, ANN OTO RHINOL LARYN, V89, P239, DOI 10.1177/000348948008900310; Wysocki J, 2005, SKULL BASE-INTERD AP, V15, P99, DOI 10.1055/s-2005-870593; Wysocki J, 2005, SKULL BASE, V15, P106; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Yetiser S, 2008, AM J OTOLARYNG, V29, P31, DOI 10.1016/j.amjoto.2007.01.001; Yoganandan N, 2002, ACCIDENT ANAL PREV, V34, P663, DOI 10.1016/S0001-4575(01)00066-5; [No title captured]	154	20	22	4	35	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					432	442		10.1097/HTR.0b013e31829d3129			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700012	23982788				2022-02-06	
J	Krishnamoorthy, V; Prathep, S; Sharma, D; Gibbons, E; Vavilala, MS				Krishnamoorthy, Vijay; Prathep, Sumidtra; Sharma, Deepak; Gibbons, Edward; Vavilala, Monica S.			Association between electrocardiographic findings and cardiac dysfunction in adult isolated traumatic brain injury	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Cardiac function; electrocardiography; traumatic brain injury		Introduction: Abnormal electrocardiographic (ECG) findings can be seen in traumatic brain injury (TBI) patients. ECG may be an inexpensive tool to identify patients at high risk for developing cardiac dysfunction after TBI. The aim of this study was to examine abnormal ECG findings after isolated TBI and their association with true cardiac dysfunction, based on echocardiogram. Methods: Data from adult patients with isolated TBI between 2003 and 2010 was retrospectively examined. Inclusion criteria included the presence of a 12-lead ECG within 24 h of admission and a formal echocardiographic examination within 72 h of admission after TBI. Patients with preexisting cardiac disease were excluded. Baseline clinical characteristics, 12-lead ECG, and echocardiogram report were abstracted. Logistic regression was used to identify the relationship of specific ECG abnormalities with cardiac dysfunction. Results: We examined data from 59 patients with isolated TBI who underwent 12-lead ECG and echocardiographic evaluation. In this cohort, 13 (22%) patients had tachycardia (heart rate >100 bpm), 25 (42.4%) patients had a prolonged QTc, and 6 (10.2%) patients had morphologic end-repolarization abnormalities (MERA), with each having an association with abnormal echocardiographic findings: Odds ratios (and 95% confidence intervals) were 4.14 (1.02-17.05), 9.0 (1.74-46.65), and 5.63 (1.96-32.94), respectively. Ischemic-like ECG changes were not associated with echocardiographic abnormalities. Conclusions: Repolarization abnormalities (prolonged QTc and MERA), but not ischemic-like ECG changes, are associated with cardiac dysfunction after isolated TBI. 12-lead ECG may be an inexpensive screening tool to evaluate isolated TBI patients for cardiac dysfunction prior to more expensive or invasive studies.	[Krishnamoorthy, Vijay; Prathep, Sumidtra; Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Gibbons, Edward] Univ Washington, Dept Cardiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA		Krishnamoorthy, V (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Harborview Med Ctr, 325 Ninth Ave,POB 359724, Seattle, WA 98104 USA.	vkrish@uw.edu			FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R25 TW009345] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM086270] Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R25TW009345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086270] Funding Source: NIH RePORTER		Ako J, 2006, AM J MED, V119, P10, DOI 10.1016/j.amjmed.2005.08.022; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Berman M, 2010, J HEART LUNG TRANSPL, V29, P957, DOI 10.1016/j.healun.2010.04.008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coghlan LA, 2009, STROKE, V40, P412, DOI 10.1161/STROKEAHA.108.528778; Collier BR, 2004, J NEUROSURG ANESTH, V16, P196, DOI 10.1097/00008506-200407000-00003; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Fan X, 2012, CHINESE MED J-PEKING, V125, P3430, DOI 10.3760/cma.j.issn.0366-6999.2012.19.013; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Hravnak M, 2009, STROKE, V40, P3478, DOI 10.1161/STROKEAHA.109.556753; James P, 2000, BRIT MED J, V320, P1502, DOI 10.1136/bmj.320.7248.1502; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Junttila E, 2013, ANESTH ANALG, V116, P190, DOI 10.1213/ANE.0b013e318270034a; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; LOWENSOHN RI, 1977, LANCET, V1, P626; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Richard C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-39; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Sharma D, 2012, J NEUROSURG ANESTH, V24, P178, DOI 10.1097/ANA.0b013e318254fb70; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	26	20	20	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	SEP	2014	18	9					570	574		10.4103/0972-5229.140144			5	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3F5D	WOS:000218208800006	25249741	Bronze, Green Published			2022-02-06	
J	Merzagora, ACR; Izzetoglu, M; Onaral, B; Schultheis, MT				Merzagora, Anna C. Rodriguez; Izzetoglu, Meltem; Onaral, Banu; Schultheis, Maria T.			Verbal working memory impairments following traumatic brain injury: an fNIRS investigation	BRAIN IMAGING AND BEHAVIOR			English	Article						Near-infrared specroscopy; Brain injuries; Working memory; Hemodynamics	NEAR-INFRARED SPECTROSCOPY; FRONTAL ACTIVATION; HEMOGLOBIN OXYGENATION; PREFRONTAL CORTEX; COGNITIVE-CONTROL; FUNCTIONAL MRI; FLUENCY TASK; PERFORMANCE; LOAD; FMRI	The construct of working memory and its reliance on dorsolateral prefrontal cortex (DLPFC) have been the focus of many studies in healthy subjects and in clinical populations. However, transfer of knowledge gained from cognitive science studies to clinical applications can be a challenging goal. This scarce cross-dissemination may be partially due to the use of 'tools' that are limited in their ability to generate meaningful information about impairments in clinical groups. To this end, this paper investigates the use of functional near-infrared spectroscopy (fNIRS), which offers unique opportunities for recording neuroactivation. Specifically, we examine measures of the DLPFC hemodynamic response during a working memory task in adults with traumatic brain injury (TBI) and healthy controls. Analysis of hemodynamic measures showed significant differences between the two groups, even without differences in behavioral performance. Additional subtle disparities were linked to levels of performance in TBI and healthy subjects. fNIRS hemodynamic measures may therefore provide novel information to existing theories and knowledge of the working memory construct. Future studies may further define these subtle differences captured by fNIRS to help identify which components affect inter-individual variations in performance and could play a contributing role in the choice and planning of neurorehabilitation interventions targeting working memory.	[Merzagora, Anna C. Rodriguez; Izzetoglu, Meltem; Onaral, Banu; Schultheis, Maria T.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Schultheis, Maria T.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA		Merzagora, ACR (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, 3141 Chestnut St, Philadelphia, PA 19104 USA.	a.merzagora@drexel.edu		Schultheis, Maria/0000-0002-6558-548X			Allain P, 2001, BRAIN COGNITION, V45, P21, DOI 10.1006/brcg.2000.1249; Andreasen NC, 1995, NEUROIMAGE, V2, P284, DOI 10.1006/nimg.1995.1036; Arenth PM, 2007, CLIN NEUROPSYCHOL, V21, P38, DOI 10.1080/13854040600878785; Azechi M, 2010, SCHIZOPHR RES, V117, P52, DOI 10.1016/j.schres.2009.10.003; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bakvis P, 2010, EPILEPSY BEHAV, V19, P448, DOI 10.1016/j.yebeh.2010.08.026; Beauchamp MH, 2003, NEUROIMAGE, V20, P1649, DOI 10.1016/j.neuroimage.2003.07.003; Beneventi H, 2010, SCAND J PSYCHOL, V51, P192, DOI 10.1111/j.1467-9450.2010.00808.x; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Bozkurt A, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-29; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chan RCK, 2010, PSYCHIAT RES, V179, P259, DOI 10.1016/j.psychres.2009.07.014; Chance B, 1998, OPT EXPRESS, V2, P411, DOI 10.1364/OE.2.000411; CHANCE B, 1993, P NATL ACAD SCI USA, V90, P3770, DOI 10.1073/pnas.90.8.3770; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Ciaramelli E, 2006, BRAIN COGNITION, V60, P198; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Conners C, 1999, ADHD ADULTS CHILDREN; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Cutini S, 2008, NEUROIMAGE, V42, P945, DOI 10.1016/j.neuroimage.2008.05.013; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dumas JA, 2010, HORM BEHAV, V58, P929, DOI 10.1016/j.yhbeh.2010.09.003; Ehlis AC, 2007, PSYCHIAT RES-NEUROIM, V156, P1, DOI 10.1016/j.pscychresns.2006.11.007; Fallgatter AJ, 1997, NEUROSCI LETT, V223, P89, DOI 10.1016/S0304-3940(97)13416-4; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; Genova HM, 2009, FRONT BIOSCI-LANDMRK, V14, P1730, DOI 10.2741/3336; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; Hale JB, 2002, J PSYCHOEDUC ASSESS, V20, P128, DOI 10.1177/073428290202000202; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Herrmann MJ, 2003, BRAIN RES BULL, V61, P51, DOI 10.1016/S0361-9230(03)00066-2; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hitch GJ, 2005, MEMORY, V13, P247, DOI 10.1080/09658210344000314; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hoffmann S, 2007, CURR OPIN NEUROL, V20, P275, DOI 10.1097/WCO.0b013e32810c8e87; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Horovitz SG, 2004, HUM BRAIN MAPP, V22, P110, DOI 10.1002/hbm.20018; Hoshi Y, 2011, PHILOS T R SOC A, V369, P4425, DOI 10.1098/rsta.2011.0262; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Izzetoglu K, 2011, J INNOV OPT HEAL SCI, V4, P239, DOI 10.1142/S1793545811001587; Izzetoglu M, 2005, IEEE T NEUR SYS REH, V13, P153, DOI 10.1109/TNSRE.2005.847377; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Kennan RP, 2002, NEUROIMAGE, V16, P587, DOI 10.1006/nimg.2002.1060; Krainik A, 2005, STROKE, V36, P1146, DOI 10.1161/01.STR.0000166178.40973.a7; Kubota Y, 2006, NEUROIMAGE, V31, P1783, DOI 10.1016/j.neuroimage.2006.02.003; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Leon-Carrion J, 2006, NEUROSCI LETT, V403, P90, DOI 10.1016/j.neulet.2006.04.050; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Lindauer Ute, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00025; Logie R. H., 1995, VISUOSPATIAL WORKING; Lovell M. R., 2007, NEUROSURGERY, V61, P359, DOI [10.1227/ 01. NEU. 0000279985.94168.7F, DOI 10.1227/01.NEU.0000279985.94168.7F.359-360]; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Matsuo K, 2000, J NEUROPSYCH CLIN N, V12, P465, DOI 10.1176/appi.neuropsych.12.4.465; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Mehta MA, 2000, J NEUROSCI, V20; Miyai I, 2003, STROKE, V34, P2866, DOI 10.1161/01.STR.0000100166.81077.8A; Negoro H, 2010, CHILD PSYCHIAT HUM D, V41, P193, DOI 10.1007/s10578-009-0160-y; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Pfurtscheller G, 2010, INT J PSYCHOPHYSIOL, V76, P186, DOI 10.1016/j.ijpsycho.2010.03.013; Philipose LE, 2007, BEHAV NEUROL, V18, P37, DOI 10.1155/2007/396946; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; Prat CS, 2007, J COGNITIVE NEUROSCI, V19, P1950, DOI 10.1162/jocn.2007.19.12.1950; Reichle ED, 2000, COGNITIVE PSYCHOL, V40, P261, DOI 10.1006/cogp.2000.0733; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Roussotte FF, 2011, NEUROIMAGE, V54, P3067, DOI 10.1016/j.neuroimage.2010.10.072; Ruocco AC, 2010, PSYCHIAT RES-NEUROIM, V182, P117, DOI 10.1016/j.pscychresns.2010.01.011; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schecklmann M, 2008, J PSYCHIATR RES, V43, P98, DOI 10.1016/j.jpsychires.2008.02.005; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Schreppel T, 2008, NEUROPSYCHOBIOLOGY, V57, P188, DOI 10.1159/000147473; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tian FH, 2009, BRAIN RES, V1303, P120, DOI 10.1016/j.brainres.2009.09.085; Townsend J, 2010, PSYCHIAT RES-NEUROIM, V182, P22, DOI 10.1016/j.pscychresns.2009.11.010; Tuchin V, 2002, HDB OPTICAL BIOMEDIC; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Van Snellenberg JX, 2009, PSYCHIAT RES-NEUROIM, V174, P89, DOI 10.1016/j.pscychresns.2009.04.001; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weissman DH, 2002, COGNITIVE BRAIN RES, V15, P47, DOI 10.1016/S0926-6410(02)00215-X; Wright HH, 2005, AM J SPEECH-LANG PAT, V14, P107, DOI 10.1044/1058-0360(2005/012)	110	20	22	1	11	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		446	459		10.1007/s11682-013-9258-8			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP9ZR	WOS:000342441400013	24085609				2022-02-06	
J	Borkar, SA; Garg, K; Garg, M; Sharma, BS				Borkar, Sachin Anil; Garg, Kanwaljeet; Garg, Mayank; Sharma, Bhawani Shankar			Transorbital penetrating cerebral injury caused by a wooden stick: surgical nuances for removal of a foreign body lodged in cavernous sinus	CHILDS NERVOUS SYSTEM			English	Article						Transorbital injury; Penetrating injury; Cavernous sinus	INTRAORBITAL WOODEN; INTRACRANIAL WOOD; BRAIN-ABSCESS; CT	Penetrating head injury (PHI) is rare in civilian population and is mostly caused by low-velocity modes. A transorbital penetrating intracranial injury is very rare and more severe than traumatic brain injury. We report a rare case of transorbital penetrating cranial injury caused by a wooden stick. The surgical strategy was planned as the wooden stick was lodged in the right cavernous sinus. The wooden stick was successfully removed. Patient made an uneventful recovery. Transorbital penetrating injuries are uncommon form of injury and require a multidisciplinary approach. No attempt should be made to remove the foreign body without the backup of an operating room because of the possibility that the object may be tamponading an injured vessel. A careful planning and a strict adherence to basic perioperative principles can lead to a satisfactory outcome.	[Borkar, Sachin Anil; Garg, Kanwaljeet; Garg, Mayank; Sharma, Bhawani Shankar] All India Inst Med Sci, Dept Neurosurg, New Delhi, India		Borkar, SA (corresponding author), All India Inst Med Sci, Dept Neurosurg, New Delhi, India.	sachin.aiims@gmail.com; kanwaljeet84@gmail.com	Garg, Kanwaljeet/AAS-7965-2021				AMANO K, 1982, J COMPUT ASSIST TOMO, V6, P1163, DOI 10.1097/00004728-198212000-00018; BERT F, 1995, J CLIN MICROBIOL, V33, P1950, DOI 10.1128/JCM.33.7.1950-1953.1995; BRAUN J, 1987, J COMPUT ASSIST TOMO, V11, P525, DOI 10.1097/00004728-198705000-00030; Domenicucci M, 1999, J Neurosurg Sci, V43, P229; Faraji M, 2005, NEUROSURG QUART, V15, P160, DOI 10.1097/01.wnq.0000176390.07352.4d; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; Ho VT, 1996, AM J NEURORADIOL, V17, P134; Jacob JT, 2005, J NEUROSURG, V102, P350, DOI 10.3171/ped.2005.102.3.0350; Kitakami A, 1999, NEUROL MED-CHIR, V39, P150, DOI 10.2176/nmc.39.150; Lasky JB, 1997, J TRAUMA, V42, P555, DOI 10.1097/00005373-199703000-00030; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; Maruya J, 2002, NEUROL MED-CHIR, V42, P143, DOI 10.2176/nmc.42.143; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; Matsuyama T, 1997, J NEUROSURG, V86, P619, DOI 10.3171/jns.1997.86.4.0619; MILLER CF, 1977, SURG NEUROL, V7, P95; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Satyarthee GD, 2009, NEUROL INDIA, V57, P331, DOI 10.4103/0028-3886.53285; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; Uchino A, 1997, NEURORADIOLOGY, V39, P213, DOI 10.1007/s002340050396	21	20	26	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2014	30	8					1441	1444		10.1007/s00381-014-2364-0			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AM3CY	WOS:000339730800016	24493367				2022-02-06	
J	Casella, EM; Thomas, TC; Vanino, DL; Fellows-Mayle, W; Lifshitz, J; Card, JP; Adelson, PD				Casella, Eric M.; Thomas, Theresa Currier; Vanino, Dana L.; Fellows-Mayle, Wendy; Lifshitz, Jonathan; Card, J. Patrick; Adelson, P. David			Traumatic brain injury alters long-term hippocampal neuron morphology in juvenile, but not immature, rats	CHILDS NERVOUS SYSTEM			English	Article						Golgi; Juvenile traumatic brain injury (TBI); Controlledcorticalimpact injury(CCI); Rats; Hippocampus; Dendritic length; Branching points; Soma area	CONTROLLED CORTICAL IMPACT; TEMPORAL-LOBE EPILEPSY; METHYL-D-ASPARTATE; HEAD-INJURY; UNITED-STATES; BEHAVIORAL DEFICITS; EXPERIMENTAL-MODELS; CHILDREN; MICE; NEUROTOXICITY	Pediatric traumatic brain injury (TBI) represents a prominent yet understudied medical condition that can profoundly impact brain development. As the juvenile injured brain matures in the wake of neuropathological cascades during potentially critical periods, circuit alterations may explain neurological consequences, including cognitive deficits. We hypothesize that experimental brain injury in juvenile rats, with behavioral deficits that resolve, will lead to quantifiable structural changes in hippocampal neurons at chronic time points post-injury. Controlled cortical impact (CCI), a model of focal TBI with contusion, was used to induce brain injury on post-natal day (PND) 17 juvenile rats. The histological consequence of TBI was quantified in regions of the hippocampus at post-injury day 28 (PID28) on sections stained using a variation of the Golgi-Cox staining method. Individual neuronal morphologies were digitized from the dentate gyrus (DG), CA3, and CA1 regions. Soma area in the ipsilateral injured DG and CA3 regions of the hippocampus increased significantly at PID28 in comparison to controls. In CA1, dendritic length and dendritic branching decreased significantly in comparison to controls and the contralateral hemisphere, without change in soma area. To extend the study, we examined neuronal morphology in rats with CCI at PND7. On PID28 after CCI on PND7 rats, CA1 neurons showed no injury-induced change in morphology, potentially indicating an age-dependent morphological response to injury. Long-lasting structural alterations in hippocampal neurons of brain-injured PND17 juvenile animals, but not PND7 immature animals, suggest differential plasticity depending on age-at-injury, with potential consequences for later function.	[Casella, Eric M.; Thomas, Theresa Currier; Lifshitz, Jonathan; Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Casella, Eric M.; Thomas, Theresa Currier; Lifshitz, Jonathan; Adelson, P. David] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Thomas, Theresa Currier; Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ 85012 USA; [Lifshitz, Jonathan; Adelson, P. David] Arizona State Univ, Neurosci Program, Tempe, AZ 85287 USA; [Adelson, P. David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Card, J. Patrick] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Fellows-Mayle, Wendy] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Vanino, Dana L.] Med Univ S Carolina, Charleston, SC 29412 USA		Adelson, PD (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Ambulatory Bldg B,4th Floor,1919 East Thomas Rd, Phoenix, AZ 85016 USA.	dadelson@phoenixchildrens.com	Adelson, David/W-2083-2019; Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Card, John/0000-0002-6148-7364	Walter L. Copeland Fund of the Pittsburgh Foundation; Phoenix Children's Hospital	The authors would like to sincerely thank the contributions of Dan Santone for the preliminary studies that made this research possible. Also, Rachel K. Rowe, PhD, Jordan L. Harrison, Jenna M. Ziebell, PhD, and the rest of the Translational Neurotrauma Research Team-Phoenix, AZ, provided thoughtful feedback on early drafts of the manuscript. These experiments were carried out at the University of Pittsburgh and analyzed and prepared for publication at the University of Arizona College of Medicine-Phoenix. This work was supported by the Walter L. Copeland Fund of the Pittsburgh Foundation Funding for Cranial Research and Phoenix Children's Hospital Mission Support Funds.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Biagas K. V., 1992, Society for Neuroscience Abstracts, V18, P1088; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bothwell S, 2001, J NEUROSCI, V21, P4789, DOI 10.1523/JNEUROSCI.21-13-04789.2001; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Card JP, 2005, J NEUROTRAUM, V22, P1209; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fletcher J, 1995, VARIABILITY OUTCOMES; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Iacono D, 2008, J NEUROPATH EXP NEUR, V67, P578, DOI 10.1097/NEN.0b013e3181772794; IKONOMIDOU C, 1989, J NEUROSCI, V9, P2809; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; KRAUS JF, 1987, PEDIATRICS, V79, P501; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 1985, OUTCOME HEAD INJURY; Levin HS, 1995, NEUROBEHAVIORAL OUTC; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mao H., 2013, J NEUROTRAUMA; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SCHEIBEL ME, 1974, EPILEPSIA, V15, P55, DOI 10.1111/j.1528-1157.1974.tb03997.x; Scheibel ME, 1978, METHODS GOLGI, P89; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Stevenson KL, 2000, J NEUROTRAUM, V17, P997; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497	45	20	21	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2014	30	8					1333	1342		10.1007/s00381-014-2446-z			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AM3CY	WOS:000339730800002	24881033				2022-02-06	
J	Hamden, K; Agresti, D; Jeanmonod, R; Woods, D; Reiter, M; Jeanmonod, D				Hamden, Khalief; Agresti, Darin; Jeanmonod, Rebecca; Woods, Dexter; Reiter, Mark; Jeanmonod, Donald			Characteristics of elderly fall patients with baseline mental status: high-risk features for intracranial injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 16, 2013	Atlanta, GA	Soc Acad Emergency Med			TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; OLDER PATIENTS; WARFARIN USE; EMERGENCY; ANTICOAGULATION; HEMORRHAGE; INTERVENTION; MORTALITY	Background: Falls are a major cause of morbidity in the elderly. Objectives: We describe the low-acuity elderly fall population and study which historical and clinical features predict traumatic intracranial injuries (ICIs). Methods: This is a prospective observational study of patients at least 65 years old presenting with fall to a tertiary care facility. Patients were eligible if they were at baseline mental status and were not triaged to the trauma bay. At presentation, a data form was completed by treating physicians regarding mechanism and position of fall, history of head strike, headache, loss of consciousness (LOC), and signs of head trauma. Radiographic imaging was obtained at the discretion of treating physicians. Medical records were subsequently reviewed to determine imaging results. All patients were called in follow-up at 30 days to determine outcome in those not imaged. The study was institutional review board approved. Results: A total of 799 patients were enrolled; 79.5% of patients underwent imaging. Twenty-seven had ICIs (3.4%). Fourteen had subdural hematoma, 7 had subarachnoid hemorrhage, 3 had cerebral contusion, and 3 had a combination of injuries. Logistic regression demonstrated 2 study variables that were associated with ICIs: LOC (odds ratio, 2.8; confidence interval, 1.2-6.3) and signs of head trauma (odds ratio, 13.2; confidence interval, 2.7-64.1). History of head strike, mechanism and position, headache, and anticoagulant and antiplatelet use were not associated with ICIs. Conclusion: Elderly fall patients who are at their baseline mental status have a low incidence of ICIs. The best predictors of ICIs are physical findings of trauma to the head and history of LOC. (C) 2014 Elsevier Inc. All rights reserved.	[Hamden, Khalief] Caril Clin, Dept Emergency Med, Blacksburg, VA USA; [Agresti, Darin; Jeanmonod, Rebecca; Jeanmonod, Donald] St Lukes Univ Hosp & Hlth Network, Dept Emergency, Bethlehem, PA USA; [Woods, Dexter; Reiter, Mark] Univ Tennessee, Sch Med, Dept Emergency Med, Nashville, TN USA		Jeanmonod, R (corresponding author), St Lukes Hosp & Hlth Network, Dept Emergency Med, 801 Ostrum St, Bethlehem, PA 18015 USA.	rebeccajeanmonod@yahoo.com					Birnbaumer DM, 2010, ROSENS EMERGENCY MED, P286; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62, P347; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Foo CL, 2012, AUSTRALAS J AGEING, V31, P40, DOI 10.1111/j.1741-6612.2010.00499.x; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Fuller GF, 2000, AM FAM PHYSICIAN, V61, P2159; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Government Accountability Office (GAO), 2008, MED B; Gray LC, 2013, ANN EMERG MED, V62, P467, DOI 10.1016/j.annemergmed.2013.05.008; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nagurney J T, 1998, J Emerg Med, V16, P709, DOI 10.1016/S0736-4679(98)00083-3; Paniagua MA, 2006, AM J EMERG MED, V24, P413, DOI 10.1016/j.ajem.2005.12.005; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Schiller J. S., 2007, FALL INJURY EPISODES; SCOTT JC, 1990, RHEUM DIS CLIN N AM, V16, P717; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tiedemann A, 2013, EMERG MED J, V30, P918, DOI 10.1136/emermed-2012-201783; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806	34	20	20	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2014	32	8					890	894		10.1016/j.ajem.2014.04.051			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	AR1AK	WOS:000343311000011	24929771				2022-02-06	
J	Jin, G; Liu, BL; You, ZR; Bambakidis, T; Dekker, SE; Maxwell, J; Halaweish, I; Linzel, D; Alam, HB				Jin, Guang; Liu, Baoling; You, Zerong; Bambakidis, Ted; Dekker, Simone E.; Maxwell, Jake; Halaweish, Ihab; Linzel, Durk; Alam, Hasan B.			Development of a novel neuroprotective strategy: Combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells	SURGERY			English	Article							HISTONE DEACETYLASE INHIBITION; INDUCED NEURONAL APOPTOSIS; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; HEMORRHAGIC-SHOCK; ISCHEMIC DAMAGE; CARDIAC-ARREST; PROTEIN; STROKE; DEATH	Background. Therapeutic hypothermia and histone deacetylase inhibitors, such as valproic acid (VPA),.independently have been shown to have neuroprotective properties in models of cerebral ischemic and traumatic brain injury. However, the depth of hypothermia and the dose of VPA needed to achieve the desired result are logistically challenging. It remains unknown whether these two promising strategies can be combined to yield synergistic results. We designed an experiment to answer this question by subjecting hippocampal-derived HT22 cells to severe hypoxia in vitro. Methods. Mouse hippocampal HT22 cells were exposed to 200 AM cobalt chloride (CoCl2), which created hypoxic conditions in vitro. Cells were incubated for 6 or 30 hours under the following conditions: (1) Dulbecco's Modified Eagle Medium; (2) 200 mu M CoCl2; (3) 200 mu M CoCl2 plus 1 mmol/L VPA; (4) 200 AM CoCl2 plus 32 degrees C hypothermia; and (5) 200 mu M CoCl2 plus both 1 mmol/L VPA and 32 C hypothermia. Cellular viability was evaluated by (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) and lactate dehydrogenase release assays at 30 hours after treatment. Levels of acetylated histone H3, hypoxia-inducible factor-1 alpha, phospho-GSK-3 beta, beta-catenin, and high-mobility group box-1 were measured by Western blotting. Results. High levels of acetylated histone H3 were detected in the VPA-treated cells. The release of lactate dehydrogenase was greatly suppressed after the combined hypothermia + VPA treatment (0.269 +/- 0.003) versus VPA (0.836 +/- 0.026) or hypothermia (0.451 +/- 0.005) treatments alone (n = 3, P = .0001). (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay showed that the number of viable cells was increased by 17.6 % when VPA and hypothermia were used in combination (n = 5, P = .0001). Hypoxia-inducible factor-la and phospho-GSK-3 beta expression were synergistically affected by the combination treatment, whereas high-mobility group box-1 was increased by VPA treatment, and inhibited by the hypothermia. Conclusion. This is the first study to demonstrate that the neuroprotective effects of VPA and hypothermia are synergistic. This novel approach can be used to develop more effective therapies for the prevention of neuronal death.	[Jin, Guang; Liu, Baoling; Bambakidis, Ted; Dekker, Simone E.; Maxwell, Jake; Halaweish, Ihab; Linzel, Durk; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [You, Zerong] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Charlestown, MA USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 GM084127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM084127] Funding Source: NIH RePORTER	Supported in part by a grant from the National Institutes of Health (RO1 GM084127) to H.B.A.	Alam HB, 2012, BRIT J SURG, V99, P29, DOI 10.1002/bjs.7756; Alam HB, 2012, J TRAUMA ACUTE CARE, V73, P809, DOI 10.1097/TA.0b013e318265d1b8; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Alam HB, 2005, J SURG RES, V126, P172, DOI 10.1016/j.jss.2005.01.019; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Caltana L, 2009, NEUROTOX RES, V15, P348, DOI 10.1007/s12640-009-9038-9; Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129; Chen WQ, 2008, ACTA NEUROCHIR SUPPL, V102, P395, DOI 10.1007/978-3-211-85578-2_77; Chhunchha B, 2013, AM J PHYSIOL-CELL PH, V304, pC636, DOI 10.1152/ajpcell.00345.2012; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Kallmunzer B, 2011, CEREBROVASC DIS, V31, P532, DOI 10.1159/000324621; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim SH, 2007, ONCOL REP, V17, P647; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Li YQ, 2008, J TRAUMA, V64, P863, DOI 10.1097/TA.0b013e318166b822; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Lyden PD, 2006, INT J STROKE, V1, P9, DOI 10.1111/j.1747-4949.2005.00011.x; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; Song ZC, 2012, CELL PROLIFERAT, V45, P239, DOI 10.1111/j.1365-2184.2012.00810.x; Sugiura S, 2011, SHOCK, V36, P494, DOI 10.1097/SHK.0b013e31822f7e58; Tanaka T, 2010, AM J PHYSIOL-REG I, V298, pR661, DOI 10.1152/ajpregu.00732.2009; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; West MA, 2008, J TRAUMA, V64, P870; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhang SQ, 2011, MOL CELL BIOCHEM, V354, P161, DOI 10.1007/s11010-011-0815-4; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	39	20	21	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2014	156	2					221	228		10.1016/j.surg.2014.03.038			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AL9LV	WOS:000339463700003	24950983	Green Accepted			2022-02-06	
J	Van Gent, JM; Bandle, J; Calvo, RY; Zander, AL; Olson, EJ; Shackford, SR; Peck, KA; Sise, CB; Sise, MJ				Van Gent, Jan-Michael; Bandle, Jesse; Calvo, Richard Y.; Zander, Ashley L.; Olson, Erik J.; Shackford, Steven R.; Peck, Kimberly A.; Sise, C. Beth; Sise, Michael J.			Isolated traumatic brain injury and venous thromboembolism	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; isolated traumatic brain injury; venous thromboembolism	INTRACRANIAL HEMORRHAGIC INJURIES; ENOXAPARIN PROPHYLAXIS; PLATELET DYSFUNCTION; TISSUE FACTOR; COAGULOPATHY; HYPOPERFUSION; HEMOSTASIS; SAFETY	BACKGROUND: Traumatic brain injury (TBI) is considered an independent risk factor of venous thromboembolism (VTE). However, the role of TBI severity in VTE risk has not been determined. We hypothesized that increased severity of brain injury in patients with isolated TBI (iTBI) is associated with an increased incidence of VTE. METHODS: The records of patients admitted from June 2006 to December 2011 were reviewed for injury data, VTE risk factors, results of lower extremity surveillance ultrasound, and severity of TBI. Patients were identified by DRG International Classification of Diseases-9th Rev. codes for TBI, and only those with a nonhead Abbreviated Injury Scale (AIS) score of 1 or lower, indicating minimal associated injury, were included. The association of iTBI and VTE was determined using a case-control design. Among iTBI patients, those diagnosed with VTE (cases) were matched for age, sex, and admission year to those without VTE (controls). Data were analyzed using conditional logistic regression. RESULTS: There were 345 iTBI patients: 41 cases (12%) and 304 controls (88%). A total of 151 controls could not be matched to an appropriate case and were excluded. Of the remaining 153 controls, 1 to 16 controls were matched to each of the 41 VTE cases. Compared with the controls, the cases had a higher mean head-AIS score (4.4 vs. 3.9, p = 0.001) and overall Injury Severity Score (20.4 vs. 16.8, p = 0.001). Following adjustment for all factors found to be associated with VTE (ventilator days, central line placement, operative time > 2 hours, chemoprophylaxis, history of VTE, and history of cancer), the cases were significantly more likely to have a greater head injury severity (head-AIS score >= 5; odds ratio, 5.25; 95% confidence interval, 1.59-17.30; p = 0.006). CONCLUSION: The incidence of VTE in iTBI patients was significantly associated with the severity of TBI. VTE surveillance protocols may be warranted in these high-risk patients, as early detection of VTE could guide subsequent therapy. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Van Gent, Jan-Michael; Bandle, Jesse; Calvo, Richard Y.; Zander, Ashley L.; Olson, Erik J.; Shackford, Steven R.; Peck, Kimberly A.; Sise, C. Beth; Sise, Michael J.] Scripps Mercy Hosp, Trauma Serv, San Diego, CA 92103 USA		Van Gent, JM (corresponding author), Scripps Mercy Hosp, Trauma Serv MER62, 4077 Fifth Ave, San Diego, CA 92103 USA.	vangent.jan-michael@scrippshealth.org		Calvo, Richard/0000-0001-9147-2668; Van Gent, Jan-Michael/0000-0002-4655-2527			Brandt MM, 2007, AM J SURG, V193, P383; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Faul M, 2010, TRAUMATIC BRAIN INJU; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Mackman N, 2008, J THROMB HAEMOST, V6, P303, DOI 10.1111/j.1538-7836.2007.02873.x; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Schrieber M, 2007, J TRAUMA, V63, P1261; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210	18	20	20	4	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2014	77	2					238	242		10.1097/TA.0000000000000294			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AN0EJ	WOS:000340255700010	25058248				2022-02-06	
J	Luo, BE; Huang, JH; Lu, L; Hu, XY; Luo, ZJ; Li, M				Luo, Beier; Huang, Jinghui; Lu, Lei; Hu, Xueyu; Luo, Zhuojing; Li, Ming			Electrically induced brain-derived neurotrophic factor release from schwann cells	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						calcium; brain-derived neurotrophic factor; mitogen-activated protein kinase; electrical stimulation; calcium-calmodulin dependent protein kinase	CONDUCTIVE POLYPYRROLE/CHITOSAN POLYMERS; OLFACTORY ENSHEATHING CELLS; PERIPHERAL-NERVE; SPINAL-CORD; HIPPOCAMPAL-NEURONS; DEPENDENT RELEASE; REGENERATION; BDNF; FIELDS; NGF	Regulating the production of brain-derived neurotrophic factor (BDNF) in Schwann cells (SCs) is critical for their application in traumatic nerve injury, neurodegenerative disorders, and demyelination disease in both central and peripheral nervous systems. The present study investigated the possibility of using electrical stimulation (ES) to activate SCs to release BDNF. We found that short-term ES was capable of promoting BDNF production from SCs, and the maximal BDNF release was achieved by ES at 6 V (3 Hz, 30 min). We further examined the involvement of intracellular calcium ions ([Ca2+](i)) in the ES-induced BDNF production in SCs by pharmacological studies. We found that the ES-induced BDNF release required calcium influx through T-type voltage-gated calcium channel (VGCC) and calcium mobilization from internal calcium stores, including inositol triphosphate-sensitive stores and caffeine/ryanodine-sensitive stores. In addition, calcium-calmodulin dependent protein kinase IV (CaMK IV), mitogen-activated protein kinase (MAPK), and cAMP response element-binding protein (CREB) were found to play important roles in the ES-induced BDNF release from SCs. In conclusion, ES is capable of activating SCs to secrete BDNF, which requires the involvement of calcium influx through T-type VGCC and calcium mobilization from internal calcium stores. In addition, activation of CaMK IV, MAPK, and CREB were also involved in the ES-induced BDNF release. The findings indicate that ES can improve the neurotrophic ability in SCs and raise the possibility of developing electrically stimulated SCs as a source of cell therapy for nerve injury in both peripheral and central nervous systems. (c) 2014 Wiley Periodicals, Inc.	[Luo, Beier; Li, Ming] Second Mil Med Univ, Inst Orthopaed, Changhai Hosp, Shanghai, Peoples R China; [Huang, Jinghui; Hu, Xueyu; Luo, Zhuojing] Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Peoples R China; [Lu, Lei] Fourth Mil Med Univ, Dept Oral Anat & Physiol, Sch Stomatol, Xian 710032, Peoples R China		Luo, ZJ (corresponding author), Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Peoples R China.	zhuojingl@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201389, 30973052, 30872870]; National Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB542206]; Program for Changjiang Scholar and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT1053]	Contract grant sponsor: National Natural Science Foundation of China; Contract grant numbers: 81201389; 30973052; 30872870; Contract grant sponsor: National Basic Research Program of China (973 Program); Contract grant number: 2014CB542206; Contract grant sponsor: Program for Changjiang Scholar and Innovative Research Team in University; Contract grant number: IRT1053.	Balkowiec A, 2002, J NEUROSCI, V22, P10399; Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Brighton CT, 2008, J BONE JOINT SURG AM, V90A, P833, DOI 10.2106/JBJS.F.01437; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; Canossa M, 2001, EMBO J, V20, P1640, DOI 10.1093/emboj/20.7.1640; Cho MR, 2002, FRONT BIOSCI, V7, pA1, DOI 10.2741/cho; COLLIER TJ, 1993, EXP NEUROL, V124, P129, DOI 10.1006/exnr.1993.1183; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fang YA, 2010, J TISSUE ENG REGEN M, V4, P581, DOI 10.1002/term.264; Geremia NM, 2010, EXP NEUROL, V223, P128, DOI 10.1016/j.expneurol.2009.07.022; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; He J, 2009, CHEM-BIOL INTERACT, V177, P34, DOI 10.1016/j.cbi.2008.08.012; Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511; Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951; Kobayashi M, 2012, J NEUROPATH EXP NEUR, V71, P511, DOI 10.1097/NEN.0b013e318257fe7b; Kwon YW, 1996, J NEUROBIOL, V29, P503; Liang W, 2010, BRAIN RES, V1357, P19, DOI 10.1016/j.brainres.2010.07.091; McGrath AM, 2010, BRAIN RES BULL, V83, P207, DOI 10.1016/j.brainresbull.2010.07.001; McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; MONTEROMENEI CN, 1992, BRAIN RES, V570, P198, DOI 10.1016/0006-8993(92)90582-T; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; OZAWA H, 1989, J CELL PHYSIOL, V138, P477, DOI 10.1002/jcp.1041380306; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Penna V, 2012, CELLS TISSUES ORGANS, V196, P534, DOI 10.1159/000338059; Qi FY, 2013, BIOMATERIALS, V34, P1799, DOI 10.1016/j.biomaterials.2012.11.042; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010; Song GB, 2008, ANTICANCER RES, V28, P2245; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tep C, 2012, J BIOL CHEM, V287, P1600, DOI 10.1074/jbc.M111.312736; Wang T, 2011, CELL MOL NEUROBIOL, V31, P357, DOI 10.1007/s10571-010-9626-5; Ward NL, 2000, EXP NEUROL, V162, P297, DOI 10.1006/exnr.1999.7346; ZHANG WC, 1994, CHINESE MED J-PEKING, V107, P583; Zhao ZQ, 2012, STEM CELL RES, V8, P38, DOI 10.1016/j.scr.2011.08.001	38	20	21	2	22	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2014	92	7					893	903		10.1002/jnr.23365			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG8YL	WOS:000335704400008	24753179				2022-02-06	
J	Galvagno, SM; Dubose, JJ; Grissom, TE; Fang, R; Smith, R; Bebarta, VS; Shackelford, S; Scalea, TM				Galvagno, Samuel M.; Dubose, Joseph J.; Grissom, Thomas E.; Fang, Raymond; Smith, Richard; Bebarta, Vikhyat S.; Shackelford, Stacy; Scalea, Thomas M.			The Epidemiology of Critical Care Air Transport Team Operations in Contemporary Warfare	MILITARY MEDICINE			English	Article							SEVERE LUNG INJURY; RESCUE TEAM; MILITARY; FORCE; US	Critical Care Air Transport Teams (CCATTs) have evolved as a vital component of the U.S. Air Force's aeromedical evacuation system. Previous epidemiological research in this area is limited. The objective of this commentary is to highlight the importance of obtaining robust epidemiological data regarding patients transported by CCATTs. A limited epidemiological analysis was performed to describe CCATT patients transported during Operation Enduring Freedom and the waning months of Operation Iraqi Freedom. CCATT transports for the calendar year 2011 were examined as recorded in the U.S. Transportation Command Regulating and Command and Control (C2) Evacuation System database. As many as 290 CCATT primary patient transport records were reviewed. Of these, 58.6% of patients had multiple injuries, 15.9% of patients had traumatic brain injury, 7% had acute coronary syndromes, and 24.8% of all transports were for nonbattle-related injuries. The most common International Classification of Disease, 9th Edition, Clinical Modification coded injury was bilateral lower extremity amputation (40%). Explosive blasts were the top mechanism of injury for patients requiring CCAT. The distribution of injuries and illnesses requiring CCAT appear to have changed compared to previous conventional conflicts. Understanding the epidemiology of casualties evacuated by CCATT during modern warfare is a prerequisite for the development of effective predeployment training to ensure optimal outcomes for critically ill and injured warriors.	[Galvagno, Samuel M.; Grissom, Thomas E.] Univ Maryland, Sch Med, Ctr Shock Trauma, Dept Anesthesiol,Div Trauma Anesthesiol,Program T, Baltimore, MD 21201 USA; [Galvagno, Samuel M.; Grissom, Thomas E.] Univ Maryland, Sch Med, Ctr Shock Trauma, Dept Anesthesiol,Div Crit Care Med,Program Trauma, Baltimore, MD 21201 USA; [Dubose, Joseph J.; Shackelford, Stacy] Univ Maryland, Sch Med, Ctr Shock Trauma, Program Trauma, Baltimore, MD 21201 USA; [Dubose, Joseph J.; Fang, Raymond; Shackelford, Stacy] US Air Force, CSTARS, Baltimore, MD 21201 USA; [Smith, Richard] Air Univ, Maxwell Air Force Base, Montgomery, AL 36112 USA; [Bebarta, Vikhyat S.] US Army, Inst Surg Res, Route Care Res Ctr, Ft Sam Houston, TX 78234 USA		Galvagno, SM (corresponding author), Univ Maryland, Sch Med, Ctr Shock Trauma, Dept Anesthesiol,Div Trauma Anesthesiol,Program T, T1R83,22 South Greene St, Baltimore, MD 21201 USA.		Bebarta, Vikhyat S/L-9537-2015; Bebarta, Vikhyat S/M-1513-2015; Grissom, Thomas E./AAH-5749-2019	Galvagno, Samuel/0000-0001-5563-4092			Barnes SL, 2008, J TRAUMA, V64, pS144; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS378, DOI 10.1097/TA.0b013e3182754900; Bridges E, 2009, MIL MED, V174, P370, DOI 10.7205/MILMED-D-03-9607; Chung KK, 2009, J TRAUMA, V67, P231, DOI 10.1097/TA.0b013e3181ac68cf; Dorlac GR, 2009, J TRAUMA, V66, pS164, DOI 10.1097/TA.0b013e31819cdf72; DuBose J, 2012, J TRAUMA ACUTE CARE, V73, pS423, DOI 10.1097/TA.0b013e3182754636; Fang R, 2011, J TRAUMA, V71, pS91, DOI 10.1097/TA.0b013e3182218f97; Ficke JR, 2012, J TRAUMA ACUTE CARE, V73, pS520, DOI 10.1097/TA.0b013e31827559da; Galvagno Samuel M Jr, 2011, Air Med J, V30, P258, DOI 10.1016/j.amj.2011.04.006; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Lairet J, 2013, PREHOSP EMERG CARE, V17, P486, DOI 10.3109/10903127.2013.811564; Leland A, 2010, 75700 C RES SERV, P1; Mason PE, 2011, J EMERG MED, V41, P8, DOI 10.1016/j.jemermed.2008.06.032; Maureen M, 2011, MIL MED, V176, P769, DOI 10.7205/MILMED-D-10-00349; Pierce Penny F, 2003, Crit Care Nurs Clin North Am, V15, P221, DOI 10.1016/S0899-5885(02)00082-5; Rice DH, 2008, CRIT CARE, V12, DOI 10.1186/cc6782; Sariego Jack, 2010, Am Surg, V76, pE37; Thorson CM, 2012, J TRAUMA ACUTE CARE, V73, pS483, DOI 10.1097/TA.0b013e31827546fb; United States Air Force, AIR FORC TACT TECHN, P1	21	20	20	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUN	2014	179	6					612	618		10.7205/MILMED-D-13-00474			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7UM	WOS:000340806500005	24902127	Bronze			2022-02-06	
J	Lawson, J; Reynolds, F; Bryant, W; Wilson, L				Lawson, Jackie; Reynolds, Frances; Bryant, Wendy; Wilson, Lesley			'It's like having a day of freedom, a day off from being ill': Exploring the experiences of people living with mental health problems who attend a community-based arts project, using interpretative phenomenological analysis	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						activity; art; creativity; depression; interpretative phenomenological analysis; mental illness; well-being	TRAUMATIC BRAIN-INJURY; RECOVERY; PSYCHOLOGY; SERVICES	To explore the psychosocial benefits of participating in a 2-year community arts project, eight people living with long-term mental health problems were interviewed. The project involved participants in selecting items of professional artwork, creating personal responses and curating a public exhibition. Interviews were analysed using interpretative phenomenological analysis. Participants experienced the arts project as improving self-worth, emancipating self from illness labels, offering a sense of belonging, enabling acquisition of valued skills and offering meaningful occupation and routines. Some regarded their developing creative skills as improving their self-management of mental health. However, some anticipated the project's ending with anxiety.	[Lawson, Jackie] Dorset HealthCare Univ NHS Fdn Trust, Dorset, England; [Reynolds, Frances; Bryant, Wendy; Wilson, Lesley] Brunel Univ, Uxbridge UB8 3PH, Middx, England		Reynolds, F (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Seacole Bldg,Uxbridge Campus, Uxbridge UB8 3PH, Middx, England.	frances.reynolds@brunel.ac.uk		Reynolds, Frances/0000-0001-7228-6931			Camic PM, 2008, J HEALTH PSYCHOL, V13, P287, DOI 10.1177/1359105307086698; CATTANACH A, 1999, PROCESS ARTS THERAPI; Csikszentmihalyi M., 1996, CREATIVITY FLOW PSYC; Finlay L., 2008, J PHENOMENOL PSYCHOL, V39, P1, DOI [10.1163/156916208X311601, DOI 10.1163/156916208X311601]; Gale E, 2005, WATER TOWERS, P103; Gleadell C., 2012, TELEGRAPH; Griffiths S, 2008, J MENT HEALTH, V17, P49, DOI 10.1080/09638230701506242; Hacking S, 2008, HEALTH SOC CARE COMM, V16, P638, DOI 10.1111/j.1365-2524.2008.00789.x; Heenan D, 2006, DISABIL SOC, V21, P179, DOI 10.1080/09687590500498143; Jacobson N, 2001, PSYCHIATR SERV, V52, P482, DOI 10.1176/appi.ps.52.4.482; JOHNSON V, 2007, INT J MENTAL HLTH PR, V0009, P00028, DOI DOI 10.1080/14623730.2007.9721836; Jones DFW, 2004, ELECTRON WORLD, V110, P55; Lloyd C., 2007, BRIT J OCCUP THER, V70, P207, DOI [DOI 10.1177/030802260707000505, 10.1177/030802260707000505]; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Murray M, 2008, J HEALTH PSYCHOL, V13, P147, DOI 10.1177/1359105307086704; Office of the Deputy Prime Minister, 2004, MENT HLTH SOC EXCL; Parr H, 2006, T I BRIT GEOGR, V31, P150, DOI 10.1111/j.1475-5661.2006.00207.x; Repper J., 2003, SOCIAL INCLUSION REC; Reynolds F, 2011, J AGING STUD, V25, P328, DOI 10.1016/j.jaging.2010.12.001; Secker J, 2007, MENTAL HLTH SOCIAL I; Secker J, 2007, J PUBLIC MENT HEALTH, V6, P14, DOI 10.1108/17465729200700024; Slade M, 2009, J MENT HEALTH, V18, P367, DOI 10.3109/09638230903191256; Smith J.A., 2009, INTERPRETATIVE PHENO; Spandler H, 2007, J PSYCHIATR MENT HLT, V14, P791, DOI 10.1111/j.1365-2850.2007.01174.x; Stacey G, 2010, PERSPECT PUBLIC HEAL, V130, P70, DOI 10.1177/1466424008094811; Stickley T., 2010, ARTS HEALTH, V2, P23, DOI DOI 10.1080/17533010903031614; Teall W, 2010, STAYING AHEAD HELD P; Van Lith T, 2011, DISABIL REHABIL, V33, P652, DOI 10.3109/09638288.2010.505998; VanLith T, 2009, AUSTR E J ADVANCEMEN, V8, P1; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]	31	20	20	1	26	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	JUN	2014	19	6					765	777		10.1177/1359105313479627			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AJ3WJ	WOS:000337598300007	23520347	Green Accepted			2022-02-06	
J	Morton, RP; Hanak, BW; Levitt, MR; Fink, KR; Peterson, EC; Vilela, MD; Kim, LJ; Chesnut, RM				Morton, Ryan P.; Hanak, Brian W.; Levitt, Michael R.; Fink, Kathleen R.; Peterson, Eric C.; Vilela, Marcelo D.; Kim, Louis J.; Chesnut, Randall M.			Blunt traumatic occlusion of the internal carotid and vertebral arteries Clinical article	JOURNAL OF NEUROSURGERY			English	Article						blunt cerebrovascular injury; Biffl grade; stroke; trauma; TCD; emboli; internal carotid artery; vertebral artery; vascular disorders; traumatic brain injury	CEREBROVASCULAR INJURIES; EARLY-DIAGNOSIS; FOLLOW-UP; THERAPY	Object. The stroke rate, management, and outcome after blunt cerebrovascular occlusion (Biffl Grade IV injury) is not well defined, given the rarity of the disease. Both hemodynamic failure and embolic mechanisms have been implicated in the pathophysiology of subsequent stroke after blunt cerebrovascular occlusion. In this study, the authors evaluated their center's experience with Biffl Grade IV injuries, focusing on elucidating the mechanisms of stroke and their optimal management. Methods. A retrospective review identified all internal carotid artery (ICA) or vertebral artery (VA) Biffl Grade IV injuries over a 7-year period at a single institution. Results. Fifty-nine Biffl Grade IV injuries were diagnosed affecting 11 ICAs, 44 unilateral VAs, and 2 bilateral VAs. The stroke rates were 64%, 9%, and 50%, respectively. Of the 11 Biffl Grade IV ICA injuries, 5 presented with stroke while 2 developed delayed stroke. An ipsilateral posterior communicating artery greater than 1 mm on CT angiography was protective against stroke due to hemodynamic failure (p = 0.015). All patients with Biffl Grade IV injuries affecting the ICA who had at least 8 emboli per hour on transcranial Doppler (TCD) ultrasonography developed an embolic pattern of stroke (p = 0.006). Treatment with aspirin versus dual antiplatelet therapy had a similar effect on stroke rate in the ICA group (p = 0.5) and all patients who suffered stroke either died (n = 3) or required a decompressive hemicraniectomy with subsequent poor outcome (n = 4). All 10 strokes associated with Biffl Grade IV VA injuries were embolic and clinically asymptomatic. In VA Biffl Grade IV injury, neither the presence of emboli nor treatment with antiplatelet agents affected stroke rates. Conclusions. At the authors' institution, traumatic ICA occlusion is rare but associated with a high stroke rate. Robust collateral circulation may mitigate its severity. Embolic monitoring with TCD ultrasonography and prophylactic antiplatelet therapy should be used in all ICA Biffl Grade IV injuries. Unilateral VA Biffl Grade IV injury is the most common type of traumatic occlusion and is associated with significantly less morbidity. Embolic monitoring using TCD and prophylactic antiplatelet therapy do not appear to be beneficial in patients with traumatic VA occlusion.	[Morton, Ryan P.; Hanak, Brian W.; Levitt, Michael R.; Kim, Louis J.; Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Fink, Kathleen R.] Univ Washington, Harborview Med Ctr, Dept Radiol, Seattle, WA 98104 USA; [Peterson, Eric C.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Vilela, Marcelo D.] Hosp Mater Dei, Dept Neurol Surg, Belo Horizonte, MG, Brazil		Morton, RP (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Box 359766,325 9th Ave, Seattle, WA 98104 USA.	rymorton@uw.edu		Hanak, Brian/0000-0002-3155-7413	Volcano, Inc.	Dr. Kim has ownership in, and is a patent holder for, SPI Surgical, Inc.; serves as a consultant to Aesculap and MicroVention; and has received clinical or research support for this study from Volcano, Inc.	Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Cothren CC, 2004, ARCH SURG-CHICAGO, V139, P540, DOI 10.1001/archsurg.139.5.540; Eachempati SR, 1998, J TRAUMA, V45, P997, DOI 10.1097/00005373-199812000-00004; Edwards NM, 2007, J AM COLL SURGEONS, V204, P1007, DOI 10.1016/j.jamcollsurg.2006.12.041; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; SCHOMER DF, 1994, NEW ENGL J MED, V330, P1565, DOI 10.1056/NEJM199406023302204; SPENCER MP, 1990, STROKE, V21, P415, DOI 10.1161/01.STR.21.3.415; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; STEINBERG GK, 1993, J NEUROSURG, V79, P161, DOI 10.3171/jns.1993.79.2.0161; STURZENEGGER M, 1995, J NEUROL, V242, P231, DOI 10.1007/BF00919596; Wahl WL, 2002, J TRAUMA, V52, P896, DOI 10.1097/00005373-200205000-00012	15	20	22	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2014	120	6					1446	1450		10.3171/2014.2.JNS131658			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AH7ZA	WOS:000336352700021	24678781				2022-02-06	
J	Personnier, C; Crosnier, H; Meyer, P; Chevignard, M; Flechtner, I; Boddaert, N; Breton, S; Mignot, C; Dassa, Y; Souberbielle, JC; Piketty, M; Laborde, K; Jais, JP; Viaud, M; Puget, S; Sainte-Rose, C; Polak, M				Personnier, Claire; Crosnier, Helene; Meyer, Philippe; Chevignard, Mathilde; Flechtner, Isabelle; Boddaert, Nathalie; Breton, Sylvain; Mignot, Caroline; Dassa, Yamina; Souberbielle, Jean-Claude; Piketty, Marie; Laborde, Kathleen; Jais, Jean-Philipe; Viaud, Magali; Puget, Stephanie; Sainte-Rose, Christian; Polak, Michel			Prevalence of Pituitary Dysfunction After Severe Traumatic Brain Injury in Children and Adolescents: A Large Prospective Study	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							GROWTH-HORMONE DEFICIENCY; QUALITY-OF-LIFE; GH REPLACEMENT; HYPOPITUITARISM; EPIDEMIOLOGY; PREDICTORS; BIRTH	Context: Traumatic brain injury (TBI) in childhood is a major public health issue. Objective: We sought to determine the prevalence of pituitary dysfunction in children and adolescents after severe TBI and to identify any potential predictive factors. Design: This was a prospective longitudinal study. Setting: The study was conducted at a university hospital. Patients: Patients, hospitalized for severe accidental or inflicted TBI, were included. The endocrine assessment was performed between 6 and 18 months after the injury. Main Outcome Measures: Basal and dynamic tests of pituitary function were performed in all patients and GH dynamic testing was repeated in patients with low stimulated GH peak (<7 ng/mL). The diagnosis of proven severe GH deficiency (GHD) was based on the association of two GH peaks less than 5 ng/mL on both occasions of testing and IGF-I levels below -2 SD score. Initial cranial tomography or magnetic resonance imaging was analyzed retrospectively. Results: We studied 87 children and adolescents [60 males, median age 6.7 y (range 0.8-15.2)] 9.5 +/- 3.4 months after the TBI (73 accidental, 14 inflicted). The second GH peak, assessed 4.9 +/- 0.1 months after the first evaluation, remained low in 27 children and adolescents. Fifteen patients had a GH peak less than 5 ng/mL (mean IGF-ISD score -1.3 +/- 1.5) and five (5.7%) strict criteria for severe GHD. Two children had mild central hypothyroidism and one had ACTH deficiency. We did not find any predictive factors associated with existence of GHD (demographic characteristics, growth velocity, trauma severity, and radiological parameters). Conclusion: At 1 year after the severe TBI, pituitary dysfunction was found in 8% of our study sample. We recommend systematic hormonal assessment in children and adolescents 12 months after a severe TBI and prolonged clinical endocrine follow-up.	[Personnier, Claire; Crosnier, Helene; Dassa, Yamina; Viaud, Magali; Polak, Michel] Hop Univ Necker Enfants Malades, AP HP, Pediat Endocrinol Gynecol & Diabetol Unit, F-75015 Paris, France; [Meyer, Philippe] Hop Univ Necker Enfants Malades, AP HP, Pediat Anesthesiol Unit, F-75015 Paris, France; [Boddaert, Nathalie; Breton, Sylvain] Hop Univ Necker Enfants Malades, AP HP, Radiol Unit, F-75015 Paris, France; [Mignot, Caroline; Puget, Stephanie; Sainte-Rose, Christian] Hop Univ Necker Enfants Malades, AP HP, Pediat Neurosurg Unit, F-75015 Paris, France; [Souberbielle, Jean-Claude; Piketty, Marie; Laborde, Kathleen] Hop Univ Necker Enfants Malades, AP HP, Funct Explorat Unit, F-75015 Paris, France; [Jais, Jean-Philipe] Hop Univ Necker Enfants Malades, AP HP, Dept Biostat, F-75015 Paris, France; [Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Neurol Injury, F-94410 St Maurice, France; [Boddaert, Nathalie; Breton, Sylvain; Puget, Stephanie; Sainte-Rose, Christian; Polak, Michel] Univ Paris 05, F-75014 Paris, France; [Chevignard, Mathilde] Univ Paris 06, ER6, F-75252 Paris, France; [Boddaert, Nathalie; Polak, Michel] IMAGINE Affiliate, F-75015 Paris, France		Crosnier, H (corresponding author), Hop Univ Necker Enfants Malades, Serv Endocrinol Gynecol & Diabetol Pediatr, 149 Rue Sevres, F-75015 Paris, France.	h.savajol-crosnier@orange.fr; michel.polak@nck.aphp.fr	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; boddaert, nathalie/0000-0003-0991-7774	Pfizer SAS	This work was supported by through an educational grant from Pfizer SAS. The sponsor was not involved in the data collection, manuscript preparation, or publishing decisions.	Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; ALBERTSSONWIKLAND K, 1994, J CLIN ENDOCR METAB, V78, P1195, DOI 10.1210/jc.78.5.1195; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Cansu A, 2006, EPILEPSIA, V47, P1855, DOI 10.1111/j.1528-1167.2006.00821.x; Carel JC, 1997, J CLIN ENDOCR METAB, V82, P2117, DOI 10.1210/jc.82.7.2117; Casano-Sancho P, 2013, CLIN ENDOCRINOL OXF; Czernichow P, 2011, DIAGNOSIS ENDOCRINE; Devesa J, 2011, THER CLIN RISK MANAG, V7, P199, DOI 10.2147/TCRM.S21403; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLEY TP, 1972, J CLIN INVEST, V51, P431, DOI 10.1172/JCI106829; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; LOCHE S, 1987, CLIN ENDOCRINOL, V27, P145, DOI 10.1111/j.1365-2265.1987.tb01139.x; Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Polak M, 2013, J CLIN ENDOCR METAB, V98, P2682, DOI 10.1210/jc.2013-2236; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Ranke MB, 2011, DIAGNOSTICS OF ENDOCRINE FUNCTION IN CHILDREN AND ADOLESCENTS, 4TH EDITION, P102; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Sempe M., 1979, AUXOLOGIE METHODES S; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; TEASDALE G, 1974, LANCET, V2, P81; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786	45	20	21	0	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	JUN	2014	99	6					2052	2060		10.1210/jc.2013-4129			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	AP8PI	WOS:000342340500046	24635130	Bronze			2022-02-06	
J	Probst, MA; Kanzaria, HK; Schriger, DL				Probst, Marc A.; Kanzaria, Hemal K.; Schriger, David L.			A conceptual model of emergency physician decision making for head computed tomography in mild head injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-CARE; RADIATION-EXPOSURE; CLINICAL PREDICTORS; DEFENSIVE MEDICINE; RISK TOLERANCE; UNITED-STATES; CT SCANS; DEPARTMENTS; RULE	The use of computed tomographic scanning in blunt head trauma has increased dramatically in recent years without an accompanying rise in the prevalence of injury or hospital admission for serious conditions. Because computed tomography is neither harmless nor inexpensive, researchers have attempted to optimize utilization, largely through research that describes which clinical variables predict intracranial injury, and use this information to develop clinical decision instruments. Although such techniques may be useful when the benefits and harms of each strategy (neuroimaging vs observation) are quantifiable and amenable to comparison, the exact magnitude of these benefits and harms remains unknown in this clinical scenario. We believe that most clinical decision instrument development efforts are misguided insofar as they ignore critical, nonclinical factors influencing the decision to image. In this article, we propose a conceptual model to illustrate how clinical and nonclinical factors influence emergency physicians making this decision. We posit that elements unrelated to standard clinical factors, such as personality of the physician, fear of litigation and of missed diagnoses, patient expectations, and compensation method, may have equal or greater impact on actual decision making than traditional clinical factors. We believe that 3 particular factors deserve special consideration for further research: fear of error/malpractice, financial incentives, and patient engagement. Acknowledgement and study of these factors will be essential if we are to understand how emergency physicians truly make these decisions and how test-ordering behavior can be modified. (C) 2014 Elsevier Inc. All rights reserved.	[Probst, Marc A.; Schriger, David L.] Univ Calif Los Angeles, Sch Med, Ctr Emergency Med, Los Angeles, CA 90024 USA; [Kanzaria, Hemal K.] Univ Calif Los Angeles, Sch Med, Ctr Emergency Med, Robert Wood Johnson Fdn Clin Scholars Program, Los Angeles, CA 90024 USA		Probst, MA (corresponding author), Univ Calif Los Angeles, Sch Med, Ctr Emergency Med, Los Angeles, CA 90024 USA.	mprobst@gmail.com			Robert Wood Johnson Foundation Clinical Scholars ProgramRobert Wood Johnson Foundation (RWJF); National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL120466]	This work was supported by the Robert Wood Johnson Foundation Clinical Scholars Program (Dr Kanzaria) and by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number F32HL120466 (Dr Probst). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Robert Wood Johnson Foundation. There are no other conflicts of interest.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andruchow JE, 2012, ARCH INTERN MED, V172, P660, DOI 10.1001/archinternmed.2011.2243; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Baskerville JR, 2012, AM J EMERG MED, V30, P367, DOI 10.1016/j.ajem.2010.12.008; Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brook RH, 2010, JAMA-J AM MED ASSOC, V304, P795, DOI 10.1001/jama.2010.1174; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Flynn D, 2012, ACAD EMERG MED, V19, P959, DOI 10.1111/j.1553-2712.2012.01414.x; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Gordon JA, 2001, ACAD EMERG MED, V8, P54, DOI 10.1111/j.1553-2712.2001.tb00552.x; Gupta M, 2011, ANN EMERG MED, V58, P407, DOI 10.1016/j.annemergmed.2011.06.003; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; Heyer CM, 2007, ROFO-FORTSCHR RONTG, V179, P261, DOI 10.1055/s-2006-927366; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Jones JGA, 2012, WEST J EMERG MED, V13, P202, DOI 10.5811/westjem.2011.11.6804; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Kovacs G, 1999, ACAD EMERG MED, V6, P947, DOI 10.1111/j.1553-2712.1999.tb01246.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2007, AM J ROENTGENOL, V189, P271, DOI 10.2214/AJR.07.2248; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Liu SW, 2011, ACAD EMERG MED, V18, P430, DOI 10.1111/j.1553-2712.2011.01033.x; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mitchell JM, 2008, MED CARE, V46, P460, DOI 10.1097/MLR.0b013e31815dc5ae; Mitchell JM, 2012, HEALTH AFFAIR, V31, P741, DOI 10.1377/hlthaff.2011.1372; Mitchell JM, 2010, ARCH SURG-CHICAGO, V145, P732, DOI 10.1001/archsurg.2010.149; Mitchell JM, 2000, INQUIRY-J HEALTH CAR, V37, P134; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Nahed BV, 2012, PLOS ONE US; PEARSON SD, 1995, J GEN INTERN MED, V10, P557, DOI 10.1007/BF02640365; Pines JM, 2010, AM J EMERG MED, V28, P771, DOI 10.1016/j.ajem.2009.03.019; Pines JM, 2009, AM J EMERG MED, V27, P552, DOI 10.1016/j.ajem.2008.04.031; Pitts SR, 2012, NEW ENGL J MED, V367, P2465, DOI 10.1056/NEJMp1211315; Prevedello LM, 2012, AM J MED, V125, P356, DOI 10.1016/j.amjmed.2011.06.023; Raja AS, 2011, ARCH INTERN MED, V171, P260, DOI 10.1001/archinternmed.2010.520; Ratnapalan S, 2004, AM J ROENTGENOL, V182, P1107, DOI 10.2214/ajr.182.5.1821107; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P42, DOI 10.1017/S0317167100006296; Sandhu H, 2006, ANN EMERG MED, V48, P713, DOI 10.1016/j.annemergmed.2006.03.011; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Takakuwa KM, 2010, AM J ROENTGENOL, V195, P1151, DOI 10.2214/AJR.09.3847; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wears RL, 2011, ANN EMERG MED, V58, P9, DOI 10.1016/j.annemergmed.2011.02.026; Wennberg JE, 1999, QUALITY MED CARE US; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7	65	20	20	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2014	32	6					645	650		10.1016/j.ajem.2014.01.003			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	AI1AK	WOS:000336581800031	24560384	Green Accepted			2022-02-06	
J	Kraitsy, K; Uecal, M; Grossauer, S; Bruckmann, L; Pfleger, F; Ropele, S; Fazekas, F; Gruenbacher, G; Patz, S; Absenger, M; Porubsky, C; Smolle-Juettner, F; Tezer, I; Molcanyi, M; Fasching, U; Schaefer, U				Kraitsy, Klaus; Uecal, Muammer; Grossauer, Stefan; Bruckmann, Lukas; Pfleger, Florentina; Ropele, Stefan; Fazekas, Franz; Gruenbacher, Gerda; Patz, Silke; Absenger, Markus; Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem; Molcanyi, Marek; Fasching, Ulrike; Schaefer, Ute			Repetitive Long-Term Hyperbaric Oxygen Treatment (HBOT) Administered after Experimental Traumatic Brain Injury in Rats Induces Significant Remyelination and a Recovery of Sensorimotor Function	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SOMATOSENSORY-EVOKED POTENTIALS; ISCHEMIA-REPERFUSION INJURY; FLUID-PERCUSSION INJURY; MITOCHONDRIAL-FUNCTION; CEREBRAL-ISCHEMIA; HEAD-INJURY; THERAPY; MODEL	Cells in the central nervous system rely almost exclusively on aerobic metabolism. Oxygen deprivation, such as injury-associated ischemia, results in detrimental apoptotic and necrotic cell loss. There is evidence that repetitive hyperbaric oxygen therapy (HBOT) improves outcomes in traumatic brain-injured patients. However, there are no experimental studies investigating the mechanism of repetitive long-term HBOT treatment-associated protective effects. We have therefore analysed the effect of long-term repetitive HBOT treatment on brain trauma-associated cerebral modulations using the lateral fluid percussion model for rats. Trauma-associated neurological impairment regressed significantly in the group of HBO-treated animals within three weeks post trauma. Evaluation of somatosensory-evoked potentials indicated a possible remyelination of neurons in the injured hemisphere following HBOT. This presumption was confirmed by a pronounced increase in myelin basic protein isoforms, PLP expression as well as an increase in myelin following three weeks of repetitive HBO treatment. Our results indicate that protective long-term HBOT effects following brain injury is mediated by a pronounced remyelination in the ipsilateral injured cortex as substantiated by the associated recovery of sensorimotor function.	[Kraitsy, Klaus; Uecal, Muammer; Pfleger, Florentina; Gruenbacher, Gerda; Patz, Silke; Fasching, Ulrike; Schaefer, Ute] Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria; [Grossauer, Stefan; Bruckmann, Lukas] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Ropele, Stefan; Fazekas, Franz] Med Univ Graz, Clin Div Gen Neurol, Graz, Austria; [Absenger, Markus] Med Univ Graz, Med Res Ctr, Core Facil Microscopy, Graz, Austria; [Porubsky, Christian; Smolle-Juettner, Freyja; Tezer, Irem] Med Univ Graz, Dept Surg, Div Thorac & Hyperbar Surg, Graz, Austria; [Molcanyi, Marek] Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; [Molcanyi, Marek] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany		Schaefer, U (corresponding author), Med Univ Graz, Res Unit Expt Neurotraumatol, Graz, Austria.	ute.schaefer@medunigraz.at					Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Asou Hiroaki, 1995, Keio Journal of Medicine, V44, P47; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Brkic P, 2012, BRAIN INJ; Butt AM, 1997, J NEUROSCI RES, V48, P588; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Campbell J.N., 2011, J NEUROTRAUMA; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Chang CF, 2000, EXP NEUROL, V166, P298, DOI 10.1006/exnr.2000.7506; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; Crawford AH, 2013, J COMP PATHOL, V149, P242, DOI 10.1016/j.jcpa.2013.05.004; Cummins FJ, 2010, J CARDIOVASC TRANSL, V3, P683, DOI 10.1007/s12265-010-9221-7; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; DeBruin LS, 2006, BIOCHEM CELL BIOL, V84, P993, DOI 10.1139/O06-180; Dell'Acqua ML, 2012, NEUROPATH APPL NEURO, V38, P454, DOI 10.1111/j.1365-2990.2011.01228.x; DEROSBO NK, 1991, DEV NEUROSCI-BASEL, V13, P34; Eovaldi B, 2010, NEUROPSYCH DIS TREAT, V6, P785, DOI 10.2147/NDT.S16071; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Furlonger A J, 2000, Crit Care Resusc, V2, P246; Gambi D, 1996, ITAL J NEUROL SCI, V17, P23, DOI 10.1007/BF01995706; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Huchzermeyer C, 2013, J CEREBR BLOOD F MET, V33, P263, DOI 10.1038/jcbfm.2012.165; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; IULIANO BA, 1994, J NEUROL SCI, V123, P186, DOI 10.1016/0022-510X(94)90222-4; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lee LC, 2012, AM J PHYS MED REHAB, V91, P528, DOI 10.1097/PHM.0b013e31824ad556; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Michalski D, 2009, BRAIN RES, V1303, P161, DOI 10.1016/j.brainres.2009.09.038; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; MINK RB, 1995, STROKE, V26, P2307, DOI 10.1161/01.STR.26.12.2307; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; MONDELLI M, 1989, ITAL J NEUROL SCI, V10, P433, DOI 10.1007/BF02334949; Morelli A, 2011, CELL BIOCHEM BIOPHYS, V61, P179, DOI 10.1007/s12013-011-9174-8; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; NEUBAUER RA, 1993, J NEUROSURG, V78, P687; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Ohguri T, 2007, INT J RADIAT ONCOL, V67, P248, DOI 10.1016/j.ijrobp.2006.08.009; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Prakash A, 2012, J PEDIATR NEUROSCI, V7, P4, DOI 10.4103/1817-1745.97610; Puri V, 2005, MUSCLE NERVE, V32, P230, DOI 10.1002/mus.20316; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Ren HJ, 2001, CHINESE MED J-PEKING, V114, P387; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; ROBERTSON A, 1993, ACTA NEUROPATHOL, V86, P163, DOI 10.1007/BF00334883; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; SHIBASAKI H, 1982, ANN NEUROL, V12, P355, DOI 10.1002/ana.410120407; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Smith G, 2012, BALLET REV, V40, P18; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; STANLEY GP, 1991, BRAIN, V114, P1827, DOI 10.1093/brain/114.4.1827; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yi JH, 2007, BRAIN RES, V1154, P200, DOI 10.1016/j.brainres.2007.04.011; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	89	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2014	9	5							e97750	10.1371/journal.pone.0097750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3AL	WOS:000336730600054	24848795	Green Published, Green Submitted, gold			2022-02-06	
J	Flynn, JR; te Nijenhuis, J; Metzen, D				Flynn, James R.; te Nijenhuis, Jan; Metzen, Daniel			The g beyond Spearman's g: Flynn's paradoxes resolved using four exploratory meta-analyses	INTELLIGENCE			English	Article						Flynn effect; Jensen effect; Method of correlated vectors; Significance of IQ gains over time; Significance of black IQ gains on whites	TRAUMATIC BRAIN-INJURY; PRENATAL COCAINE EXPOSURE; PRESCHOOL-CHILDREN; IQ; OUTCOMES; PERFORMANCE; ABILITIES; LITIGANTS; GAINS	When IQ tests are ranked by the magnitude of their score gains over time, this hierarchy lacks a positive correlation with the same tests ranked by their g loadings. Therefore, Jensen declared IQ gains "hollow" and, by implication, extended this judgment to score gains that indicated that blacks had made IQ gains on whites. We offer four exploratory meta-analyses that apply Jensen's method to the subtest score differences between normal subjects and those suffering from certain afflictions; iodine deficiency (K = 6, N = 196), prenatal cocaine exposure (K = 2, N = 215), fetal alcohol syndrome and degree of fetal alcohol syndrome (respectively, K = 1, N = 110; and K = 3, N = 125), and traumatic brain injury (K = 14, N = 629). All of these create a substantial cognitive deficit in those afflicted. However, the correlations between subtest score differences and g loadings run from -0.23 to +0.12, with an unweighted average of 0.00. (C) 2014 Elsevier Inc. All rights reserved.	[Flynn, James R.] Univ Otago, Dept Polit Studies, Dunedin, New Zealand; [Flynn, James R.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [te Nijenhuis, Jan; Metzen, Daniel] Univ Amsterdam, Amsterdam, Netherlands		Flynn, JR (corresponding author), Univ Otago, Dept Polit Studies, POB 56, Dunedin, New Zealand.		Nijenhuis, Jan te/D-1015-2013	Nijenhuis, Jan te/0000-0002-1268-6121			Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Arendt RE, 2004, J DEV BEHAV PEDIATR, V25, P83, DOI 10.1097/00004703-200404000-00002; Armstrong EL, 2014, LEARN INDIVID DIFFER, V29, P41, DOI 10.1016/j.lindif.2013.10.009; Asanbe CB, 2006, J HEALTH CARE POOR U, V17, P400, DOI 10.1353/hpu.2006.0054; Bandstra ES, 2001, NEUROTOXICOL TERATOL, V23, P545, DOI 10.1016/S0892-0362(01)00181-7; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; Blake TM, 2009, CLIN NEUROPSYCHOL, V23, P373, DOI 10.1080/13854040802279691; BLEICHRODT N, 1994, DAMAGED BRAIN OF IODINE DEFICIENCY, P195; BLEICHRODT N, 1980, AM J PHYS ANTHROPOL, V53, P55, DOI 10.1002/ajpa.1330530110; BLEICHRODT N, 1987, PREVENTION CONTROL I, P65; Borenstein M., 2009, INTRO META ANAL; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Coyle TR, 2008, INTELLIGENCE, V36, P719, DOI 10.1016/j.intell.2008.05.001; Dehaene P, 1995, GROSSESSE ALCOOL PRE; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Flynn J., 2009, WHAT IS INTELLIGENCE; Flynn J. R., 2014, HDB INTELLIGENCE EVO; Flynn JR, 2013, INTELLIGENCE, V41, P851, DOI 10.1016/j.intell.2013.06.014; Flynn James R., 2008, HAVE ALL LIBERALS GO; Flynn JR, 2013, INTELLIGENCE AND HUMAN PROGRESS: THE STORY OF WHAT WAS HIDDEN IN OUR GENES, P1; Genovese JEC, 2002, J EDUC RES, V96, P101, DOI 10.1080/00220670209598797; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Hunter J.E., 2004, METHODS META ANAL CO, V2nd ed.; Hunter J. E., 1990, METHODS METAANALYSIS; Jensen A.R., 1998, G FACTOR SCI MENTAL; Juretko K., 2006, MUSTER KOGNITUVER FU; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; Lewis BA, 2004, NEUROTOXICOL TERATOL, V26, P617, DOI 10.1016/j.ntt.2004.06.007; Loser H, 1995, ALKOHOLEMBRYPATHIE A; Morrow CE, 2004, J PEDIATR PSYCHOL, V29, P543, DOI 10.1093/jpepsy/jsh056; Rindermann H, 2013, INTELLIGENCE, V41, P821, DOI 10.1016/j.intell.2013.06.016; Ritchie S. J., 2014, PSYCHOL AGI IN PRESS; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rushton JP, 2007, INTELLIGENCE, V35, P1, DOI 10.1016/j.intell.2006.09.002; Rushton JP, 2006, PSYCHOL SCI, V17, P921, DOI 10.1111/j.1467-9280.2006.01803.x; Schmidt F.L., 2004, SOFTWARE HUNTER SCHM; Singer LT, 2004, JAMA-J AM MED ASSOC, V291, P2448, DOI 10.1001/jama.291.20.2448; te Nijenhuis J., 2013, INTELLIGENCE; te Nijenhuis J, 2007, INTELLIGENCE, V35, P283, DOI 10.1016/j.intell.2006.07.006; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; van den Briel T, 2000, AM J CLIN NUTR, V72, P1179; Wechsler D., 1958, MEASUREMENT APPRAISA; Woodley MA, 2013, INTELLIGENCE, V41, P832, DOI 10.1016/j.intell.2013.02.002; Woodley MA, 2012, INTELLIGENCE, V40, P189, DOI 10.1016/j.intell.2011.12.002; Woodley MA, 2012, PERS INDIV DIFFER, V53, P152, DOI 10.1016/j.paid.2011.03.028	48	20	20	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0160-2896	1873-7935		INTELLIGENCE	Intelligence	MAY-JUN	2014	44						1	10		10.1016/j.intell.2014.01.009			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AJ6DN	WOS:000337780000001					2022-02-06	
J	Greenberg, JK; Stoev, IT; Park, TS; Smyth, MD; Leonard, JR; Leonard, JC; Pineda, JA; Limbrick, DD				Greenberg, Jacob K.; Stoev, Ivan T.; Park, Tae Sung; Smyth, Matthew D.; Leonard, Jeffrey R.; Leonard, Julie C.; Pineda, Jose A.; Limbrick, David D.			Management of children with mild traumatic brain injury and intracranial hemorrhage	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Mild traumatic brain injury; pediatrics; intracranial hemorrhage	HEAD COMPUTED-TOMOGRAPHY; PEDIATRIC-PATIENTS; PROGRESSION; MODERATE; ADMISSION; UTILITY; SCAN	BACKGROUND Traumatic brain injury (TBI) is a significant public health problem affecting tens of thousands of children each year, and an important subset of these patients sustains intracranial hemorrhage (ICH). The purpose of this study was to test the hypothesis that we could identify a subset of children with traumatic ICH who could be monitored on a general neurosurgery ward with a low risk of clinical deterioration. METHODS We performed a retrospective review of pediatric patients 18 years or younger with mild TBI (Glasgow Coma Scale [GCS] score 14-15) and traumatic ICH admitted to Saint Louis Children's Hospital between 2006 and 2011. We excluded patients with injuries unrelated to the TBI that would require intensive care unit (ICU) admission and those with penetrating intracranial injuries. RESULTS We identified 118 patients meeting inclusion criteria. Repeat neuroimaging was obtained in 69 (58%) of 118 patients. Radiologic progression was noted in 6 (8.7%) of 69 patients, with a trend toward more frequent progression in patients with epidural hematoma (EDH) versus other ICH (3 [20%] of 15 vs. 3 [5.6%] of 54; p = 0.11). Of 118 patients, 8 (6.8%) experienced clinically important neurologic decline (CIND) and 6 (5.1%) required neurosurgical intervention. Both CIND and the need for neurosurgical intervention were significantly higher in patients with EDH (21% each) compared with those with other types of ICH (4% and 2%, respectively) (p = 0.02, p < 0.01). Based on these results, we developed a preliminary management framework to assist in determining which patients can be safely observed on a neurosurgery ward without an ICU admission. Specifically, those patients without EDH, intraventricular hemorrhage, coagulopathy, or concern for a high-risk neurosurgical lesion (e.g., arteriovenous malformation) may be safely observed on the ward. CONCLUSIONS These results demonstrate that few children with mild TBI and ICH experience CIND and the preliminary framework we developed assists in identifying which patients can safely avoid ICU admission. This framework should be validated prospectively and externally. LEVEL OF EVIDENCE Therapeutic/care management, level IV.	[Greenberg, Jacob K.; Stoev, Ivan T.; Park, Tae Sung; Smyth, Matthew D.; Leonard, Jeffrey R.; Limbrick, David D.] Washington Univ, Dept Neurol Surg, St Louis, MO USA; [Park, Tae Sung; Smyth, Matthew D.; Leonard, Jeffrey R.; Leonard, Julie C.; Pineda, Jose A.; Limbrick, David D.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA		Greenberg, JK (corresponding author), St Louis Childrens Hosp, 1 ChildrensWay,4S20, St Louis, MO 63110 USA.	greenbergj@wusm.wustl.edu	Pineda, Jose/W-2806-2019	Leonard, Julie/0000-0003-3670-1944	Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000448, TL1 TR000449]; Intellectual and Developmental Disabilities Research Center at Washington University [NIH/NICHD P30 HD062171]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER	This work was supported by the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) under Award Numbers UL1 TR000448 and TL1 TR000449 and by the Intellectual and Developmental Disabilities Research Center at Washington University (NIH/NICHD P30 HD062171).	Agency for Healthcare Research and Quality (AHRQ), 2005, HCUP STAT INP DAT SI; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], CONS PRIC IND INFL C; Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Dawson EC, 2012, PEDIATR NEUROSURG, V48, P221, DOI 10.1159/000346697; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Healthcare Cost and Utilization Project (HCUP), 2005, COST TO CHARG RAT FI; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167	29	20	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2014	76	4					1089	1095		10.1097/TA.0000000000000155			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AE7FF	WOS:000334161500035	24662876	Green Accepted			2022-02-06	
J	Metting, Z; Spikman, JM; Rodiger, LA; van der Naalt, J				Metting, Zwany; Spikman, Jacoba M.; Rodiger, Lars A.; van der Naalt, Joukje			Cerebral perfusion and neuropsychological follow up in mild traumatic brain injury: Acute versus chronic disturbances?	BRAIN AND COGNITION			English	Article						Mild traumatic brain injury; Perfusion CT; Neuropsychological testing; Emotion recognition; Executive function	MINOR HEAD-INJURY; DIFFUSE AXONAL INJURY; SOCIAL COGNITION; EMOTION RECOGNITION; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; FUNCTIONAL MRI; FRONTAL LOBES; DYSFUNCTION; DEFICITS	In a subgroup of patients with mild traumatic brain injury (TBI) residual symptoms, interfering with outcome and return to work, are found. With neuropsychological assessment cognitive deficits can be demonstrated although the pathological underpinnings of these cognitive deficits are not fully understood. As the admission computed tomography (CT) often is normal, perfusion CT imaging may be a useful indicator of brain dysfunction in the acute phase after injury in these patients. In the present study, directly after admission perfusion CT imaging was performed in mild TBI patients with follow-up neuropsychological assessment in those with complaints and a normal non-contrast CT. Neuropsychological tests comprised the 15 Words test Immediate Recall, Trailmaking test part B, Zoo Map test and the FEEST, which were dichotomized into normal and abnormal. Perfusion CT results of patients with normal neuropsychological test scores were compared to those with abnormal test scores. In total eighteen patients were included. Those with an abnormal score on the Zoo Map test had a significant lower CBV in the right frontal and the bilateral parieto-temporal white matter. Patients with an abnormal score on the FEEST had a significant higher MTT in the bilateral frontal white matter and a significant decreased CBF in the left parieto-temporal grey matter. No significant relation between the perfusion CT parameters and the 15 Words test and the Trailmaking test part B was present. In conclusion, impairments in executive functioning and emotion perception assessed with neuropsychological tests during follow up were related to differences in cerebral perfusion at admission in mild TBI. The pathophysiological concept of these findings is discussed. (C) 2014 Elsevier Inc. All rights reserved.	[Metting, Zwany; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Rodiger, Lars A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands		Metting, Z (corresponding author), Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	z.meetting@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	ZonMw, Den Haag, The NetherlandsNetherlands Organization for Health Research and DevelopmentNetherlands Government [39200002]	This study was funded by ZonMw, Den Haag, The Netherlands (Grant number 39200002).	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Audenaert K., 2003, MED SCI MONITOR, V9, P112; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Deelman B. G., 1980, FUNCTIESTOORNISSEN T; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Mehrazin M, 2011, HELL J NUCL MED, V14, P243; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Young A., 2002, FACIAL EXPRESSIONS E; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	82	20	20	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	APR	2014	86						24	31		10.1016/j.bandc.2014.01.012			8	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AF2VP	WOS:000334570900004	24556319				2022-02-06	
J	Rajandram, RK; Omar, SNS; Rashdi, MFN; Jabar, MNA				Rajandram, Rama Krsna; Omar, Syed Nabil Syed; Rashdi, Muhd Fazly Nizam; Jabar, Mohd Nazimi Abdul			Maxillofacial injuries and traumatic brain injury - a pilot study	DENTAL TRAUMATOLOGY			English	Article						facial trauma; traumatic brain injury; facial bone fracture; maxillofacial trauma; motor vehicle accident	CLOSED-HEAD INJURIES; FACIAL FRACTURES; MALAYSIA; IMPACT	Background Maxillofacial injuries comprising hard tissue as well as soft tissue injuries can be associated with traumatic brain injuries due to the impact of forces transmitted through the head and neck. To date, the role of maxillofacial injury on brain injury has not been properly documented with some saying it has a protective function on the brain while others opposing this idea. Aim This cross-sectional retrospective study evaluated all patients with maxillofacial injuries. The aim of the study was to analyze the occurrence and relationship of maxillofacial injuries with traumatic brain injuries. Material and Methods We retrospectively studied the hospital charts of all trauma patients seen at the accident and emergency department of UKM Medical Centre from November 2010 until November 2011. A detail analysis was then carried out on all patients who satisfied the inclusion and exclusion criteria. Results A total of 11294 patients were classified as trauma patients in which 176 patients had facial fractures and 292 did not have facial fractures. Middle face fractures was the most common pattern of facial fracture seen. Traumatic brain injury was present in 36.7% of maxillofacial cases. A significant association was found between facial fractures and traumatic brain injury (P<0.05). Patient with facial fractures had a 1.5 increased risk of having a traumatic brain injury (95% CI 1.197-1.909). Conclusion Patients with maxillofacial injuries with or without facial fractures are at risk of acute or delayed traumatic brain injury. All patients should always have proper radiological investigations together with a proper observation and follow-up schedule.	[Rajandram, Rama Krsna; Omar, Syed Nabil Syed; Rashdi, Muhd Fazly Nizam; Jabar, Mohd Nazimi Abdul] Natl Univ Malaysia, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia		Rajandram, RK (corresponding author), Natl Univ Malaysia, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia.	decruze79@yahoo.com	Rajandram, Rama/C-6674-2017; Jabar, Nazimi Abdul/M-6175-2014; Nabil, Syed/S-6602-2019	Rajandram, Rama/0000-0001-7343-0800; Jabar, Nazimi Abdul/0000-0003-3761-1342; Nabil, Syed/0000-0001-6709-357X	National University of Malaysia Young Reseachers Grant [UKM-GGPM-TKP-023-2011]	This paper is supported by the National University of Malaysia Young Reseachers Grant (UKM-GGPM-TKP-023-2011).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Allareddy V, 2011, J ORAL MAXIL SURG, V69, P2613, DOI 10.1016/j.joms.2011.02.057; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Grant AL, 2012, J CRANIOFAC SURG, V23, P1324, DOI 10.1097/SCS.0b013e31825e60ae; Hashim H, 2011, DENT TRAUMATOL, V27, P19, DOI 10.1111/j.1600-9657.2010.00958.x; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Langlois JA, 1996, J HEAD TRAUMA REHAB, V2005, P196; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Naveen Shankar A, 2011, J CRANIOMAXILLOFAC S, V40, P675; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Ramli R, 2011, DENT TRAUMATOL, V27, P122, DOI 10.1111/j.1600-9657.2010.00968.x; Simoni Payman, 2003, Arch Facial Plast Surg, V5, P113; Thoren H, 2010, J ORAL MAXIL SURG, V68, P805, DOI 10.1016/j.joms.2009.09.057; Tsang KK, 2011, BR J ORAL MAXILLOFAC, V50, P298	18	20	22	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2014	30	2					128	132		10.1111/edt.12052			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AC0KO	WOS:000332183400008	23782407				2022-02-06	
J	Sharma, B; Bradbury, C; Mikulis, D; Green, R				Sharma, Bhanu; Bradbury, Cheryl; Mikulis, David; Green, Robin			MISSED DIAGNOSIS OF TRAUMATIC BRAIN INJURY IN PATIENTS WITH TRAUMATIC SPINAL CORD INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; traumatic spinal cord injury; diagnosis	HEAD-INJURY	Objective: To determine the frequency of missed acute care traumatic brain injury diagnoses in patients with traumatic spinal cord injury, and to examine risk factors for missed traumatic brain injury diagnosis. Design: Prospective magnetic resonance imaging and neuropsychological assessment plus retrospective medical record review, including computed tomography. Subjects: Ninety-two adults with traumatic spinal cord injury recruited from a large, tertiary spinal cord injury program, initially referred from urban teaching hospitals with neurotrauma facilities. Methods: Diagnosis of traumatic brain injury made with clinical neurological indices (i.e., Glasgow Coma Scale, post-traumatic amnesia, and loss of consciousness), neuroimaging (computed tomography and structural magnetic resonance imaging), and neuropsychological tests of attention and speed of processing, memory, and executive function; all measures were validated on a case-by-case basis to rule out confounds. Missed traumatic brain injury diagnoses were made via acute care medical record review and were corroborated by patient/family report where possible. Results: The frequency of missed traumatic brain injury diagnoses in our sample was 58.5%. Missed traumatic brain injury diagnoses were more frequent in injuries sustained outside of a motor vehicle collision (MVC), with 75.0% of acute care traumatic brain injury diagnoses missed in non-MVC patients vs. 42.9% missed in MVC patients. Among patients with non-MVC injuries, a comparable percentage of missed traumatic brain injury diagnoses were observed in patients with cervical (79%) and sub-cervical injuries (80%). Conclusion: In more than half of the traumatic spinal cord injury patients referred for in-patient rehabilitation, acute care diagnoses of traumatic brain injury were missed. A risk factor for missed diagnosis was an injury caused by a mechanism other than an MVC (e.g., falls, assaults), perhaps due to reduced expectations of traumatic brain injury in non-MVC patients. In our research study, we employed multiple assessments to aid diagnosis, which is particularly important for detecting the milder traumatic brain injuries often associated with spinal cord injury; unfortunately, limited resources may preclude a comprehensive diagnostic approach in clinical settings. Our findings point to the need to examine current acute care diagnostic protocols, and to increase vigilance in patients with traumatic injuries sustained outside of an MVC setting.	[Sharma, Bhanu; Green, Robin] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Sharma, Bhanu; Green, Robin] Toronto Western Hosp, Toronto Rehabil Inst, Toronto, ON M5T 2S8, Canada; [Bradbury, Cheryl] Toronto Western Hosp, Toronto Rehabil Inst, Spinal Cord Rehabil Program, Toronto, ON M5T 2S8, Canada; [Mikulis, David] Toronto Western Hosp, Joint Dept Med Imaging, Div Neuroradiol, Toronto, ON M5T 2S8, Canada		Green, R (corresponding author), Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada.	Robin.Green@uhn.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; Green, Robin/0000-0001-9451-3963	Ontario Neurotrauma Foundation; Canada Research Chairs ProgramCanada Research Chairs	The study was supported by funding from the Ontario Neurotrauma Foundation and the Canada Research Chairs Program. The authors have no competing interests to declare.	Arzaga Deborah, 2003, SCI Nurs, V20, P86; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Lu D, 2012, ESSENTIALS SPINAL CO, P98; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; Smith A., 1982, SYMBOL DIGIT MODALIT; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Wechsler D, 2001, WECHLER TEST ADULT R; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	17	20	22	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2014	46	4					370	373		10.2340/16501977-1261			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AE7CR	WOS:000334154800012	24549169	gold, Green Submitted			2022-02-06	
J	Singh, D; Cronin, DS; Haladuick, TN				Singh, Dilaver; Cronin, Duane S.; Haladuick, Tyler N.			Head and brain response to blast using sagittal and transverse finite element models	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						head and brain modeling; finite element modeling; mild traumatic brain injury; blast	INTRACRANIAL-PRESSURE; INJURY; DEFORMATION; THRESHOLD; IMPULSE	Mild traumatic brain injury caused by blast exposure from Improvised Explosive Devices has become increasingly prevalent in modern conflicts. To investigate head kinematics and brain tissue response in blast scenarios, two solid hexahedral blast-head models were developed in the sagittal and transverse planes. The models were coupled to an Arbitrary Lagrangian-Eulerian model of the surrounding air to model blast-head interaction, for three blast load cases (5 kg C4 at 3, 3.5 and 4 m). The models were validated using experimental kinematic data, where predicted accelerations were in good agreement with experimental tests, and intracranial pressure traces at four locations in the brain, where the models provided good predictions for frontal, temporal and parietal, but underpredicted pressures at the occipital location. Brain tissue response was investigated for the wide range of constitutive properties available. The models predicted relatively low peak principal brain tissue strains from 0.035 to 0.087; however, strain rates ranged from 225 to 571 s-1. Importantly, these models have allowed us to quantify expected strains and strain rates experienced in brain tissue, which can be used to guide future material characterization. These computationally efficient and predictive models can be used to evaluate protection and mitigation strategies in future analysis. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Singh, Dilaver; Cronin, Duane S.; Haladuick, Tyler N.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada		Singh, D (corresponding author), Univ Waterloo, Dept Mech Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	d3singh@uwaterloo.ca	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Cronin, Duane/0000-0001-7538-0560	Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Defence Research and Development Canada - Valcartier; Med-Eng Corporation	The authors would like to acknowledge the support of the Natural Sciences and Engineering Research Council, Defence Research and Development Canada - Valcartier, and Med-Eng Corporation.	Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; [Anonymous], VIS HUM PROJ; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Belytschko T., 2000, NONLINEAR FINITE ELE; Bir C, 2011, W81XWH0910498 US ARM; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bulmash G., 1984, ARBRLTR02555; BULSON PS, 1997, EXPLOSIVE LOADING EN; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; COLEMAN AJ, 1995, ULTRASOUND MED BIOL, V21, P405, DOI 10.1016/0301-5629(94)00116-U; Cronin D. S., 2008, P PERS ARM SYST S, P84; Danelson KA, 2008, STAPP CAR C, V52, P59; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Dionne JP, 2002, REDUCTION BLAST INDU; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; DuBois P, 2003, 4 EUR LS DYNA US C U, P31; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gehre C., 2009, ENHANCED SAFETY VEHI; Gennarelli TA, 2003, ANN P ASS ADV AUTOMO, V4, P624; Greer A D., 2006, THESIS U WATERLOO WA; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Haladuick TN, 2011, MODELLING GLOBAL HEA; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Ipek H., 2009, 21 INT TECH C ENH SA; Kleinberger M, 1993, 37 STAPP CAR CRASH C, V37, P261; Kleiven S., 2008, MTBI PREC S IBIA C L; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lockhart P. A., 2012, P PASS NUR GERM; Lockhart PA, 2010, THESIS U WATERLOO WA; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Makris A, 2000, REDUCTION BLAST INDU; Mao H., 2009, THESIS WAYNE STATE U; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Namani R, 2009, J BIOMECH, V42, P2047, DOI 10.1016/j.jbiomech.2009.06.007; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Newman J A, 2000, Stapp Car Crash J, V44, P215; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Puso MA, 2006, INT J NUMER METH ENG, V67, P841, DOI 10.1002/nme.1651; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Roberts JC, 2012, J BIOMECH, V45, P2899, DOI 10.1016/j.jbiomech.2012.07.027; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shafieian M, 2011, 37 ANN IEEE BIOENG C; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Singh D, 2012, P PASS NUR GERM; Singh D, 2011, COMP DETAILED SAGITT; Sista B, 2011, OH STAT U INJ BIOM S; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tan P, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P1657; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Thunert C, 2013, CORA RELEASE 3 6 USE; Tsaklis P, 2010, HUMAN MOV SCI, V11, P91, DOI [10.2478/v10038-009-0025-z, DOI 10.2478/V10038-009-0025-Z]; Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015; Ward C., 1980, 801304 SAE, DOI [10.4271/801304, DOI 10.4271/801304]; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518; Zhu Feng, 2010, Stapp Car Crash J, V54, P211; Zhu F, 2010, MATER DESIGN, V31, P4704, DOI 10.1016/j.matdes.2010.05.023	70	20	20	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	APR	2014	30	4					470	489		10.1002/cnm.2612			20	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	AE0UB	WOS:000333680600002	24293124				2022-02-06	
J	Ustinova, KI; Perkins, J; Leonard, WA; Hausbeck, CJ				Ustinova, K. I.; Perkins, J.; Leonard, W. A.; Hausbeck, C. J.			Virtual reality game-based therapy for treatment of postural and co-ordination abnormalities secondary to TBI: A pilot study	BRAIN INJURY			English	Article						Brain injury; clinical trial; motor recovery; postural control; rehabilitation; virtual reality	TRAUMATIC BRAIN-INJURY; EXERCISE PROGRAMS; CHRONIC STROKE; REHABILITATION; BALANCE; TELEREHABILITATION; ENVIRONMENTS; RELIABILITY; RECOVERY; BENEFITS	Primary objective: The study objective was to test the efficacy of game-based virtual reality (VR) therapy as a mean of correcting postural and co-ordination abnormalities in individuals with traumatic brain injury (TBI). Therapy was done with interactive customized VR games and scenarios, utilizing an Xbox Kinect sensor. Research design: The study was a pilot project using the structure of a phase II clinical trial. Methods and procedures: Fifteen participants with mild-to-moderate chronic TBI-related balance and motor co-ordination impairments participated in 15 sessions, each lasting similar to 50-55 minutes, scheduled 2-3 times a week over 5-6 consecutive weeks. Participants were evaluated at baseline, immediately after the final session and in a 1-month follow-up with a battery of clinical tests (measuring postural stability, gait and co-ordination) and movement performance parameters. Movement parameters included arm-leg co-ordination, dynamic stability and arm precision, calculated from kinematic data recorded with Xbox Kinect sensor. Results: Following therapy, most participants improved their static and dynamic postural stability, gait and arm movements. These effects persisted over the retention interval. Conclusions: Results will be used to improve the VR program, with the goal of producing a cost-effective, accessible and easy to individualize therapeutic approach. The pilot data will be used for designing a larger scale clinical trial.	[Ustinova, K. I.; Perkins, J.; Leonard, W. A.] Cent Michigan Univ, Herbert H & Grace A Dow Coll Hlth Profess, Mt Pleasant, MI 48858 USA; [Hausbeck, C. J.] Hope Network Rehabil Serv, Phys Therapy Dept, Mt Pleasant, MI USA		Ustinova, KI (corresponding author), Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48858 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591	Blue Cross Blue Shield Foundation of Michigan; Association of Schools of Allied Health Professions; US Department of DefenseUnited States Department of Defense	The authors report no conflicts of interest. Supported by Blue Cross Blue Shield Foundation of Michigan and Association of Schools of Allied Health Professions. The VR therapy development was sponsored by the US Department of Defense.	Arce FI, 2004, HUM MOVEMENT SCI, V22, P749, DOI 10.1016/j.humov.2003.12.002; BERG K, 1989, Physiotherapy Canada, V41, P304; Bickerstaff ER, 1989, NEUROLOGICAL EXAMINA; Bobath K, 1972, PHYS THERAPY SERVICE, P37; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carr JH, 1987, MOTOR RELEARNING STR; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Danek A, 2004, NERVENARZT, V75, P411, DOI 10.1007/s00115-004-1717-4; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; Demiris G, 2005, J MED SYST, V29, P595, DOI 10.1007/s10916-005-6127-z; Deutsch JE, 2011, TOP STROKE REHABIL, V18, P701, DOI 10.1310/tsr1806-701; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Fulk GD, 2007, PHYS REHABILITATION, P895; Gil-Gomez JA, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-30; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Holden MK, 2002, J NEUROL PHYS THER, V26, P62, DOI DOI 10.1097/01253086-200226020-00003; Katz-Leurer M, 2009, DISABIL REHABIL, V31, P243, DOI 10.1080/09638280801927830; Keshner Emily A, 2004, J Neuroeng Rehabil, V1, P8, DOI 10.1186/1743-0003-1-8; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Knott M., 1968, PROPRIOCEPTIVE NEURO; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Lange B, 2009, EUR J PHYS REHAB MED, V45, P143; Levin MF, 2009, STUD HEALTH TECHNOL, V145, P94, DOI 10.3233/978-1-60750-018-6-94; Lin JH, 2010, STROKE, V41, P2021, DOI 10.1161/STROKEAHA.110.589739; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Mumford N, 2012, BRAIN INJURY, V26, P166, DOI 10.3109/02699052.2011.648706; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; O'Neil RL, 2013, NEUROREHABILITATION, V33, P667, DOI 10.3233/NRE-130985; Paavola JM, 2013, J NOV PHYSIOTHER, V3, P129, DOI 10.4172/2165-7025.1000129; Perkins J, 2013, J NOVEL PHYSIOTHERAP, V177, P112, DOI [10.4172/2165-7025.1000177, DOI 10.4172/2165-7025.1000177]; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rogante M, 2010, NEUROREHABILITATION, V27, P287, DOI 10.3233/NRE-2010-0612; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Schafer AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-76; Siegelbaum SA, 2013, PRINCIPLES NEURAL SC, P1487; Subramanian SK, 2013, NEUROREHAB NEURAL RE, V27, P13, DOI 10.1177/1545968312449695; Subramony SH, 2012, BRADLEYS NEUROLOGY C, P285; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ustinova K. I., 2013, 2013 International Conference on Virtual Rehabilitation (ICVR), P87, DOI 10.1109/ICVR.2013.6662109; Ustinova KI, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-61; van der Steen MC, 2011, EXP BRAIN RES, V208, P411, DOI 10.1007/s00221-010-2493-y; Weiss Patrice L, 2004, J Neuroeng Rehabil, V1, P12, DOI 10.1186/1743-0003-1-12; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Yavuzer G, 2008, EUR J PHYS REHAB MED, V44, P237	54	20	22	1	56	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					486	495		10.3109/02699052.2014.888593			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900013	24702281				2022-02-06	
J	Patel, TP; Ventre, SC; Geddes-Klein, D; Singh, PK; Meaney, DF				Patel, Tapan P.; Ventre, Scott C.; Geddes-Klein, Donna; Singh, Pallab K.; Meaney, David F.			Single-Neuron NMDA Receptor Phenotype Influences Neuronal Rewiring and Reintegration following Traumatic Injury	JOURNAL OF NEUROSCIENCE			English	Article						functional connectivity; GluN2B; mechanical injury; network activity; synchrony	LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; D-ASPARTATE RECEPTORS; RAT CORTICAL-NEURONS; BRAIN-INJURY; IN-VITRO; AXONAL INJURY; SYNAPTIC-TRANSMISSION; MECHANICAL STRETCH; NR2B SUBUNIT	Alterations in the activity of neural circuits are a common consequence of traumatic brain injury (TBI), but the relationship between single-neuron properties and the aggregate network behavior is not well understood. We recently reported that the GluN2B-containing NMDA receptors (NMDARs) are key in mediating mechanical forces during TBI, and that TBI produces a complex change in the functional connectivity of neuronal networks. Here, we evaluated whether cell-to-cell heterogeneity in the connectivity and aggregate contribution of GluN2B receptors to [Ca2+](i) before injury influenced the functional rewiring, spontaneous activity, and network plasticity following injury using primary rat cortical dissociated neurons. We found that the functional connectivity of a neuron to its neighbors, combined with the relative influx of calcium through distinct NMDAR subtypes, together contributed to the individual neuronal response to trauma. Specifically, individual neurons whose [Ca2+](i) oscillations were largely due to GluN2B NMDAR activation lost many of their functional targets 1 h following injury. In comparison, neurons with large GluN2A contribution or neurons with high functional connectivity both independently protected against injury-induced loss in connectivity. Mechanistically, we found that traumatic injury resulted in increased uncorrelated network activity, an effect linked to reduction of the voltage-sensitive Mg2+ block of GluN2B-containing NMDARs. This uncorrelated activation of GluN2B subtypes after injury significantly limited the potential for network remodeling in response to a plasticity stimulus. Together, our data suggest that two single-cell characteristics, the aggregate contribution of NMDAR subtypes and the number of functional connections, influence network structure following traumatic injury.	[Patel, Tapan P.; Ventre, Scott C.; Geddes-Klein, Donna; Singh, Pallab K.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Meaney, David/0000-0002-0954-4122; Patel, Tapan/0000-0001-8959-6645	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS35712, HD41699, P01 NS056202]; Department of DefenseUnited States Department of Defense [W911NF-10-1-0526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176, P01NS056202, R01NS035712] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health Grants R01 NS35712, HD41699, and P01 NS056202; and Department of Defense Grant W911NF-10-1-0526.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Arrondo G, 2009, MULT SCLER J, V15, P509, DOI 10.1177/1352458508101321; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Babiloni C, 2004, EUR J NEUROSCI, V19, P2583, DOI 10.1111/j.0953-816X.2004.03333.x; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Fetcho JR, 1998, HISTOCHEM J, V30, P153, DOI 10.1023/A:1003243302777; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Frizelle PA, 2006, MOL PHARMACOL, V70, P1022, DOI 10.1124/mol.106.024042; Furukawa Y, 2000, NEUROSCIENCE, V96, P385, DOI 10.1016/S0306-4522(99)00553-9; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Kew JNC, 1998, J NEUROSCI, V18, P1935; Kloda A, 2007, P NATL ACAD SCI USA, V104, P1540, DOI 10.1073/pnas.0609649104; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muldoon SF, 2013, P NATL ACAD SCI USA, V110, P3567, DOI 10.1073/pnas.1216958110; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; REEVES TM, 1995, EXP BRAIN RES, V106, P248; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tovar KR, 1999, J NEUROSCI, V19, P4180; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; von Engelhardt J, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.019.2009; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	75	20	20	0	8	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 19	2014	34	12					4200	4213		10.1523/JNEUROSCI.4172-13.2014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD4WX	WOS:000333253300009	24647941	Bronze, Green Published			2022-02-06	
J	Maier, D; Njoku, I; Schmutzhard, E; Dharsee, J; Doppler, M; Hartl, R; Winkler, AS				Maier, Daniel; Njoku, Innocent, Jr.; Schmutzhard, Erich; Dharsee, Jaffer; Doppler, Magdalena; Haertl, Roger; Winkler, Andrea Sylvia			Traumatic Brain Injury in a Rural and an Urban Tanzanian Hospital-A Comparative, Retrospective Analysis Based on Computed Tomography	WORLD NEUROSURGERY			English	Article						Africa; Brain; Computed tomography; Epidemiology; Radiography; Rural population; Tanzania; Traumatic brain injury	CONSECUTIVE SERIES; NEUROLOGIC DISEASE; PATTERN; DISORDERS; AFRICA	BACKGROUND: In a resource-poor environment such as rural East Africa, expensive medical devices such as computed tomographic (CT) scanners are rare. The CT scanner at the rural Haydom Lutheran Hospital (HLH) in Tanzania therefore offers a unique chance to observe possible differences with urban medical centers in the disease pattern of trauma-related cranial pathologies. The purpose of this study was to compare traumatic brain injuries (TBIs) between a rural and an urban area of Tanzania. METHODS: HLH has 350 beds and one CT scanner. The urban Aga Khan Hospital is a private hospital with 80 beds and one CT scanner. This was a retrospective study. Data of 248 patients at HLH and of 432 patients at Aga Khan Hospital with TBI could be collected. RESULTS: The prevalence of TBI was significantly higher in the rural area compared to the urban area (34.2% vs. 21.9%, P < 0.0001). TBI due to violence was noted to occur more frequently at HLH, whereas road traffic accidents were more frequent at the Aga Khan Hospital. The number of patients showing a normal CT result was significantly higher in the urban area (53.0% vs. 35.9%, P < 0.0001). Bone fractures (35.9% vs. 15.7%, P < 0.0001) and pneumocephalus (6.9% vs. 0.9%, P < 0.0001) were diagnosed significantly more frequently in the rural survey. Soft tissue swelling (11.6% vs. 1.2%, P < 0.0001) and frontal sinus injuries (7.4% vs. 0.4%, P < 0.0001) were observed significantly more often in the urban setting. CONCLUSIONS: This study documents the burden of TBI and the differences in TBI-related CT diagnoses and their incidence between urban and rural areas in Eastern Africa. These results are important as they demonstrate that patients with severe TBI are not a primarily urban concern. Management of TBI should be included in the training curricula for health personnel alike irrespective of whether their workplace is primarily urban or rural.	[Maier, Daniel; Schmutzhard, Erich; Doppler, Magdalena] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Njoku, Innocent, Jr.; Haertl, Roger] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10032 USA; [Dharsee, Jaffer] Aga Khan Hosp, Dept Radiol, Dar Es Salaam, Tanzania; [Winkler, Andrea Sylvia] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany		Hartl, R (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10032 USA.	roh9005@med.cornell.edu		Schmutzhard, Erich/0000-0003-3295-7491			Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Attebery JE, 2010, WORLD NEUROSURG, V73, P290, DOI 10.1016/j.wneu.2010.02.008; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; Birbeck GL, 2001, TROP DOCT, V31, P82, DOI 10.1177/004947550103100209; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Bower JH, 2007, NEUROLOGY, V68, P338, DOI 10.1212/01.wnl.0000252801.61190.e8; Haydom Lutheran Hospital, ANN REP 2007; Hulme P, 2010, PAN AFR MED J, V7; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Maas AIR, 2007, WIEN KLIN WOCHENSCHR, V119, P20, DOI 10.1007/s00508-006-0759-y; Maier D, 2010, WIEN KLIN WOCHENSCHR, V122, P40, DOI 10.1007/s00508-010-1436-8; Moshiro C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-11; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muyembe VM, 1998, E AFR MED J, V75, P364; Ogunseyinde A O, 1999, West Afr J Med, V18, P33; Ohaegbulam Samuel C, 2011, Surg Neurol Int, V2, P182, DOI 10.4103/2152-7806.91137; Otieno T, 2004, INJURY, V35, P1228, DOI 10.1016/j.injury.2004.03.013; Owolabi MO, 2007, ARCH NEUROL-CHICAGO, V64, P1696, DOI 10.1001/archneur.64.12.1696; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x; Winkler AS, 2009, TROP DOCT, V39, P102, DOI 10.1258/td.2008.080144; World Health Organization, 2004, ATL COUNTR RES NEUR, P26; Zellner H, 2010, WIEN KLIN WOCHENSCHR, V122, P47, DOI 10.1007/s00508-010-1437-7	23	20	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR-APR	2014	81	3-4					478	482		10.1016/j.wneu.2013.08.014			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AG7EP	WOS:000335581200020	23954733				2022-02-06	
J	Goh, CP; Putz, U; Howitt, J; Low, LH; Gunnersen, J; Bye, N; Morganti-Kossmann, C; Tan, SS				Goh, Choo-Peng; Putz, Ulrich; Howitt, Jason; Low, Ley-Hian; Gunnersen, Jenny; Bye, Nicole; Morganti-Kossmann, Cristina; Tan, Seong-Seng			Nuclear trafficking of Pten after brain injury leads to neuron survival not death	EXPERIMENTAL NEUROLOGY			English	Article						Nclfip1; Neuroprotection; Nedd4; Pten; Traumatic brain injury; Ubiquitination	CEREBRAL-ISCHEMIA; UBIQUITIN LIGASE; COGNITIVE DEFICITS; TUMOR SUPPRESSION; NEDD4 FAMILY; IN-VIVO; PROTEIN; NDFIP1; STROKE; PHOSPHORYLATION	There is controversy whether accumulation of the tumor suppressor PTEN protein in the cell nucleus under stress conditions such as trauma and stroke causes cell death. A number of in vitro studies have reported enhanced apoptosis in neurons possessing nuclear PTEN, with the interpretation that its nuclear phosphatase activity leads to reduction of the survival protein phospho-Akt. However, there have been no in vivo studies to show that nuclear PTEN in neurons under stress is detrimental. Using a mouse model of injury, we demonstrate here that brain trauma altered the nucleo-cytoplasmic distribution of Pten, resulting in increased nuclear Pten but only in surviving neurons near the lesion. This event was driven by Ndfip1, an adaptor and activator of protein ubiquitination by Nedd4 E3 ligases. Neurons next to the lesion with nuclear PTEN were invariably negative for TUNEL, a marker for cell death. These neurons also showed increased Ndfip1 which we previously showed to be associated with neuron survival. Biochemical assays revealed that overall levels of Pten in the affected cortex were unchanged after trauma, suggesting that Pten abundance globally had not increased but rather Pten subcellular location in affected neurons had changed. Following experimental injury, the number of neurons with nuclear Pten was reduced in heterozygous mice (Ndfip1(+/-)) although lesion volumes were increased. We conclude that nuclear trafficking of Pten following injury leads to neuron survival not death. (C) 2013 Elsevier Inc. All rights reserved.	[Goh, Choo-Peng; Putz, Ulrich; Howitt, Jason; Low, Ley-Hian; Gunnersen, Jenny; Tan, Seong-Seng] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Brain Dev & Regenerat Lab, Parkville, Vic 3010, Australia; [Bye, Nicole; Morganti-Kossmann, Cristina] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Clayton, Vic 3800, Australia		Tan, SS (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Brain Dev & Regenerat Lab, Parkville, Vic 3010, Australia.	stan@florey.edu.au		Howitt, Jason/0000-0001-9922-7931; Morganti-Kossmann, Cristina/0000-0002-0807-2063; Gunnersen, Jenny/0000-0002-6310-7724	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; Victorian Government through the Operational Infrastructure Scheme	This work was supported by the National Health and Medical Research Council (NH&MRC) and the Victorian Government through the Operational Infrastructure Scheme.	Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Chang N, 2007, TRENDS NEUROSCI, V30, P581, DOI 10.1016/j.tins.2007.08.006; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Ehrnhoefer DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027680; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Howitt J, 2012, J CELL BIOL, V196, P29, DOI 10.1083/jcb.201105009; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; Lackovic J, 2012, EXP NEUROL, V235, P326, DOI 10.1016/j.expneurol.2012.02.014; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Namura S, 1998, J NEUROSCI, V18, P3659; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Omori N, 2002, BRAIN RES, V954, P317, DOI 10.1016/S0006-8993(02)03366-8; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stadler K, 2008, AM J PHYSIOL-ENDOC M, V295, pE456, DOI 10.1152/ajpendo.00015.2008; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zheng M, 2012, J CELL SCI, V125, P1556, DOI 10.1242/jcs.095729; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	40	20	21	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2014	252						37	46		10.1016/j.expneurol.2013.11.017			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299TW	WOS:000330419600005	24275527				2022-02-06	
J	Olson, DM; Batjer, HH; Abdulkadir, K; Hall, CE				Olson, DaiWai M.; Batjer, Hunt H.; Abdulkadir, Kamal; Hall, Christiana E.			Measuring and Monitoring ICP in Neurocritical Care: Results from a National Practice Survey	NEUROCRITICAL CARE			English	Article						Intracranial pressure monitoring; ICP; Documentation; Critical care; Standard practice	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; HEAD-INJURY; INFORMATION-TECHNOLOGY; CLINICAL-PRACTICE; HEALTH-CARE; UNCERTAINTY; HEMORRHAGE; COSTS	The use of intracranial pressure (ICP) monitors is nearly synonymous with Neurocritical Care. Recent studies in nursing literature have report high levels of practice variance associated with ICP monitoring and treatment. There are no recent practice surveys to describe how critical care physicians and nurses who are familiar with ICP management provide care to their patients. A short survey was developed and disseminated electronically to the members of the Neurocritical Care Society. The summary from 241 professionals provides evidence that there is significant practice variation associated with ICP monitoring and management. The results highlight the need to develop standardized approaches to measuring, monitoring, recording, and treating ICP.	[Olson, DaiWai M.; Hall, Christiana E.] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Olson, DaiWai M.; Batjer, Hunt H.; Hall, Christiana E.] Univ Texas Southwestern, Dept Neurosurg, Dallas, TX 75390 USA; [Abdulkadir, Kamal] Univ Texas Southwestern, Dept Nursing, Dallas, TX 75390 USA		Olson, DM (corresponding author), Univ Texas Southwestern, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	DaiWai.Olson@UTsouthwestern.edu; Hunt.Batjer@UTsouthwestern.edu; Kamal.Abdulkadir@UTsouthwestern.edu; Christiana.Hall@UTsouthwestern.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X			AANN, 2004, AANN COR CURR NEUR N; Abou-Assi S, 2001, POSTGRAD MED, V109, P52, DOI 10.3810/pgm.2001.02.850; ALLAN D, 1989, J ADV NURS, V14, P127, DOI 10.1111/j.1365-2648.1989.tb00910.x; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dykema J, 2011, EVAL HEALTH PROF, V34, P434, DOI 10.1177/0163278711406113; Greenberg M, 2006, HDB NEUROSURGERY; Greenberg MS, 2001, HDB NEUROSURGERY; Hunter KM, 2002, HLTH CARE INFORM INT, P209; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kim GS, 2011, NEUROCRIT CARE, V14, P68, DOI 10.1007/s12028-010-9401-y; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Logan RL, 1996, LANCET, V347, P595, DOI 10.1016/S0140-6736(96)91284-2; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; March K, 2000, Crit Care Nurs Clin North Am, V12, P429; March K, 2009, AACN AANN PROTOCOLS; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Marmarou A, 1992, J NEUROSURG, V75, pS21; Miriovsky BJ, 2012, J CLIN ONCOL, V30, P4243, DOI 10.1200/JCO.2012.42.8011; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Olson DM, 2013, J NEUROSCI NURS, V45, P186, DOI 10.1097/JNN.0b013e3182986400; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Parashos P, 2005, COMMUNITY DENT ORAL, V33, P9, DOI 10.1111/j.1600-0528.2004.00181.x; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rehman T, 2012, CLIN NEUROL NEUROSUR, V114, P651, DOI 10.1016/j.clineuro.2011.12.040; Shaw M, 2008, ACTA NEUROCHIR SUPPL, V102, P217, DOI 10.1007/978-3-211-85578-2_42; Sinkowitz-Cochran RL, 2013, CLIN INFECT DIS, V56, P1159, DOI 10.1093/cid/cit005; Vaismoradi M, 2011, J ADV NURS, V67, P991, DOI 10.1111/j.1365-2648.2010.05547.x; Watkins P, 2005, CLIN MED, V5, P197, DOI 10.7861/clinmedicine.5-3-197; Wells DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11678	31	20	21	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2014	20	1					15	20		10.1007/s12028-013-9847-9			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB2RI	WOS:000331639400003	23839709				2022-02-06	
J	Shu, IW; Onton, JA; Prabhakar, N; O'Connell, RM; Simmons, AN; Matthews, SC				Shu, I-Wei; Onton, Julie A.; Prabhakar, Nitin; O'Connell, Ryan M.; Simmons, Alan N.; Matthews, Scott C.			Combat veterans with PTSD after mild TBI exhibit greater ERPs from posterior-medial cortical areas while appraising facial features	JOURNAL OF AFFECTIVE DISORDERS			English	Article						PTSD; Mild TBI; N300; Posterior cingulate cortex; Precuneus; Biomarker	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; CONCUSSED INDIVIDUALS; NEURAL MECHANISMS; COGNITIVE CONTROL; TIME-COURSE; DEPRESSION; EMOTION	Posttraumatic stress disorder (PTSD) worsens prognosis following mild traumatic brain injury (mTBI). Combat personnel with histories of mTBI exhibit abnormal activation of distributed brain networks including emotion processing and default mode networks. How developing PTSD further affects these abnormalities has not been directly examined. We recorded electroencephalography in combat veterans with histories of mTBI, but without active PTSD (mTBI only, n=16) and combat veterans who developed PTSD after mTBI (mTBI + PTSD, n = 16) during the Reading the Mind in the Eyes Test (RMET), a validated test of empathy requiring emotional appraisal of facial features. Task-related event related potentials (ERPs) were identified, decomposed using independent component analysis (ICA) and localized anatomically using dipole modeling. We observed larger emotional face processing ERPs in veterans with mTBI + PTSD, including greater N300 negativity. Furthermore, greater N300 negativity correlated with greater PTSD severity, especially avoidance/numbing and hyperarousal symptom clusters. This correlation was dependent on contributions from the precuneus and posterior cingulate cortex (PCC). Our results support a model where, in combat veterans with histories of mTBI, larger ERPs from overactive posterior-medial cortical areas may be specific to PTSD, and is likely related to negative selfreferential activits. Published by Elsevier B.V.	[Shu, I-Wei; Matthews, Scott C.] VISN 22 Mental Illness, Res Educ & Clin Ctr, San Diego, CA 92161 USA; [Shu, I-Wei; O'Connell, Ryan M.; Simmons, Alan N.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Prabhakar, Nitin; O'Connell, Ryan M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; [Simmons, Alan N.; Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, La Jolla, CA 92161 USA; [Onton, Julie A.] Naval Hlth Res Ctr, San Diego, CA 92106 USA		Shu, IW (corresponding author), VISN 22 Mental Illness, Res Educ & Clin Ctr, 3350 La Jolla Village Dr,116A, San Diego, CA 92161 USA.	ishu@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112	BUMED under Work Unit 61032; VA Mental Illness Research, Education and Clinical Center; VA Office of Academic AffiliationsUS Department of Veterans Affairs; VA Advanced Fellowship Program in Mental Illness Research Treatment; VA Center of Excellence for Stress and Mental Health; University of California San Diego Academic Senate, Department of Veterans Affairs; Congressionally Directed Medical Research ProgramUnited States Department of Defense; CDA-2 from the VA CSRD	This work represents Report No. 12-xx and was supported by BUMED under Work Unit 61032. The views expressed in this article arc those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government Approved for public release; distribution is unlimited. This research has been conducted in compliance with all applicable federal regulations governing the protection of Inunan subjects in research (Protocols NHRC.2010.0022 and NHRC.2010.0023).; This research was also supported by the VA Mental Illness Research, Education and Clinical Center, VA Office of Academic Affiliations, VA Advanced Fellowship Program in Mental Illness Research Treatment, and the VA Center of Excellence for Stress and Mental Health, and by grants from the University of California San Diego Academic Senate, Department of Veterans Affairs, and the Congressionally Directed Medical Research Program. Dr. Matthews is supported by a CDA-2 from the VA CSR&D.	Albert J, 2012, HUM BRAIN MAPP, V33, P2147, DOI 10.1002/hbm.21347; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Attias J, 1996, BRIT J PSYCHIAT, V168, P110, DOI 10.1192/bjp.168.1.110; Bae KY, 2011, PROG NEURO-PSYCHOPH, V35, P1908, DOI 10.1016/j.pnpbp.2011.08.002; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Campanella S., 2013, NEUROIMAGE; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Ehlers CL, 2006, ANN NY ACAD SCI, V1071, P125, DOI 10.1196/annals.1364.011; Farrow TFD, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00349; Felmingham KL, 2003, NEUROREPORT, V14, P777, DOI 10.1097/00001756-200304150-00024; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Hayes JP, 2009, PSYCHIAT RES-NEUROIM, V172, P7, DOI 10.1016/j.pscychresns.2008.05.005; Hermans R. M., 2012, PSYCHOL MED, P1; Javanbakht A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-5; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson J.D., 2013, CLIN EEG NEUROSCI; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lanius RA, 2007, PSYCHIAT RES-NEUROIM, V155, P45, DOI 10.1016/j.pscychresns.2006.11.006; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mazza M., 2012, PSYCHIAT RES; Mechias ML, 2010, NEUROIMAGE, V49, P1760, DOI 10.1016/j.neuroimage.2009.09.040; Morey R.A., 2012, HUM BRAIN MAPP; Nardo D, 2011, PSYCHOL MED, V15, P1; Nietlisbach G, 2010, PSYCHOL REP, V106, P832, DOI 10.2466/PR0.106.3.832-844; Pantazatos SP, 2012, NEUROIMAGE, V61, P1355, DOI 10.1016/j.neuroimage.2012.03.051; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Ramage A.E., 2012, HUM BRAIN MAPP; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Simmons AN, 2013, J AFFECT DISORDERS, V146, P426, DOI 10.1016/j.jad.2012.08.006; Simmons AN, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-6; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stanford MS, 2001, PSYCHIAT RES, V102, P125, DOI 10.1016/S0165-1781(01)00236-0; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Tanelian T., 2008, INIVISIBLE WOUNDS WA; Tanev Kaloyan, 2003, Curr Psychiatry Rep, V5, P369; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Whalley MG, 2009, BRAIN COGNITION, V69, P98, DOI 10.1016/j.bandc.2008.05.008; Wood KH, 2012, NEUROIMAGE, V60, P787, DOI 10.1016/j.neuroimage.2011.12.048; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016; Yun XY, 2011, NEUROSCI LETT, V498, P10, DOI 10.1016/j.neulet.2011.04.040; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhang WH, 2012, BIOL PSYCHOL, V89, P444, DOI 10.1016/j.biopsycho.2011.12.011; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	72	20	20	1	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB	2014	155						234	240		10.1016/j.jad.2013.06.057			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	287XB	WOS:000329574500033	24342149				2022-02-06	
J	Wei, L; Zhang, YF; Yang, C; Wang, Q; Zhuang, ZW; Sun, ZY				Wei, Liang; Zhang, Yanfei; Yang, Cheng; Wang, Qi; Zhuang, Zhongwei; Sun, Zhiyang			Neuroprotective effects of ebselen in traumatic brain injury model: involvement of nitric oxide and p38 mitogen-activated protein kinase signalling pathway	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						ebselen; inflammation; neuroprotection; traumatic brain injury	LPS-INDUCED INFLAMMATION; CEREBRAL-BLOOD-FLOW; NF-KAPPA-B; HEMORRHAGIC-SHOCK; MAPK; EXPRESSION; ISCHEMIA; DAMAGE; EDEMA; CELLS	1. Previous investigations have found that ebselen is able to treat neurodegenerative diseases caused by radical and acute total cerebral ischaemia. The aim of the present study was to investigate the neuroprotective effects of ebselen in a traumatic brain injury (TBI) model. 2. Ninety Sprague-Dawley rats were randomly divided into five groups (n = 18 in each): (i) sham operation; (ii) an injury model group; (iii) low-dose (3 mg/kg) ebselen-treated group; (iv) a moderate-dose (10 mg/kg) ebselen-treated group; and (v) a high-dose (30 mg/kg) ebselen-treated group. The TBI model was created according using a modified weight-drop model. Neurological severity score (NSS), brain water content and histopathological deficits were assessed as parameters of injury severity. Expression of nitric oxide (NO), inducible NO synthase (iNOS) mRNA, Toll-like receptor (TLR) and phosphorylated (p-) p38 mitogen-activated protein kinase (MAPK) were examined by chemical colorimetry, quantitative polymerase chain reaction and western blotting 24 h after intragastric ebselen administration. 3. Rats in the TBI model group exhibited markedly more severe neurological injury (higher NSS, more brain water content and more histopathological deficits) than those in the sham-operated group. Ebselen treatment significantly ameliorated the neurological injury of TBI rats in a dose-dependent manner. Moreover, ebselen significantly reduced the NO and iNOS mRNA levels and inhibited TLR4 and p-p38 MAPK expression, indicating the involvement of NO and p38 MAPK signalling pathways in the neuroprotection afforded by ebselen. 4. In conclusion, ebselen ameliorated neurological injury, possibly by reducing NO levels and modulating the TLR4-mediated p38 MAPK signalling pathway. Therefore, ebselen may have potential to treat secondary injuries of TBI.	[Wei, Liang; Zhang, Yanfei; Yang, Cheng; Wang, Qi; Zhuang, Zhongwei; Sun, Zhiyang] Tongji Univ, East Hosp, Sch Med, Dept Neurosurg, Shanghai 200120, Peoples R China		Sun, ZY (corresponding author), Tongji Univ, East Hosp, Sch Med, Dept Neurosurg, 150 Jimo Rd,Pudong New Area, Shanghai 200120, Peoples R China.	sunzhiyangtj@hotmail.com					Bowie AG, 2005, MOL IMMUNOL, V42, P859, DOI 10.1016/j.molimm.2004.11.007; Burggraaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014561; Byun EB, 2013, INT IMMUNOPHARMACOL, V15, P450, DOI 10.1016/j.intimp.2012.11.021; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Fu YH, 2013, J ETHNOPHARMACOL, V145, P193, DOI 10.1016/j.jep.2012.10.051; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kim JP, 2012, ACTA NEUROCHIR, V154, P823, DOI 10.1007/s00701-012-1306-4; Koizumi H, 2011, NEUROL MED-CHIR, V51, P337, DOI 10.2176/nmc.51.337; Kwak HJ, 2005, J PHARMACOL EXP THER, V315, P1188, DOI 10.1124/jpet.105.092056; Lee YJ, 2003, BIOCHEM PHARMACOL, V66, P2281, DOI 10.1016/j.bcp.2003.07.014; Li YB, 2002, NEUROSCI LETT, V330, P69, DOI 10.1016/S0304-3940(02)00444-5; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Mozer AB, 2010, CURR NEUROVASC RES, V7, P238; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Nogueira CW, 2011, ARCH TOXICOL, V85, P1313, DOI 10.1007/s00204-011-0720-3; Nozawa R, 1996, J PHARM PHARMACOL, V48, P64, DOI 10.1111/j.2042-7158.1996.tb05879.x; Nurnberger S, 2012, AM J PHYSIOL-GASTR L, V303, pG1373, DOI 10.1152/ajpgi.00056.2012; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Ozgur T, 2012, RENAL FAILURE, V34, P991, DOI 10.3109/0886022X.2012.706880; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Schallert T, 1997, ADV NEUROL, V73, P229; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Wang YX, 2010, J SURG RES, V161, P119, DOI 10.1016/j.jss.2008.10.030; Wu JF, 2012, INT IMMUNOPHARMACOL, V12, P74, DOI 10.1016/j.intimp.2011.10.015; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xu JH, 2006, NEUROSCI LETT, V399, P210, DOI 10.1016/j.neulet.2006.02.024	36	20	21	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1870	1440-1681		CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	FEB	2014	41	2					134	138		10.1111/1440-1681.12186			5	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	AR9ON	WOS:000343904500005	24131109				2022-02-06	
J	Espinosa-Garcia, C; Aguilar-Hernandez, A; Ceruantes, M; Morali, G				Espinosa-Garcia, Claudia; Aguilar-Hernandez, Alejandra; Ceruantes, Miguel; Morali, Gabriela			Effects of progesterone on neurite growth inhibitors in the hippocampus following global cerebral ischemia	BRAIN RESEARCH			English	Article						Global cerebral ischemia; Progesterone; Neuroprotection; Nogo-A; Neurite growth inhibitors	TRAUMATIC BRAIN-INJURY; CA1 PYRAMIDAL NEURONS; SPINAL-CORD-INJURY; TRANSIENT FOREBRAIN ISCHEMIA; NOGO-A EXPRESSION; FUNCTIONAL RECOVERY; ADULT-RAT; CELL-DEATH; NEUROPROTECTIVE FACTOR; DENDRITIC PLASTICITY	In this study, the effects of progesterone (P-4) on the immunoreactivity to the neurite growth inhibitor Nogo-A, its receptor (Ng-R), and its effector Rho-A in the rat hippocampus, in association with parameters of spatial learning and memory following global cerebral ischemia, were assessed. Adult male rats were subjected to global cerebral ischemia (15 min), and treated with P-4 or its vehicle at 15 min, 2, 6, 24,48 and 72 h of reperfusion. Immunoreactivity to Nogo-A, Ng-R, and Rho-A was evaluated at 24 h, 72 h or 7 d, or at 14 d of reperfusion after rats were tested in the Morris Water Maze (MWM). Global cerebral ischemia induced an increase in Nogo-A, Ng-R, and Rho-A immunoreactivities in the cell bodies of CA1 pyramidal neurons at 24 h after global cerebral ischemia, peaking at 72 h, and persisting 14 d later. In addition, at 72 h, a strong immunoreactivity was observed in the hippocampal layers where dendritic arborizations of C.A1 pyramidal neurons are located. Treatment with P-4 reduced Nogo-A, Ng-R, and Rho-A immunoreactivities in CA1, particularly at 72 h of reperfusion. These effects of P-4 were consistent with the parameters of a more efficient spatial learning and memory in the MWM, as compared to vehicle-treated rats. Overall results suggest the reduction of neurite growth inhibitory molecules Nogo-A, Ng-R, and Rho-A, as a part of the restorative effects of progesterone possibly allowing the plastic phenomena to occur, able to support the functional preservation of the hippocampus following global cerebral ischemia. (C) 2013 Elsevier B.V. All rights reserved.	[Espinosa-Garcia, Claudia; Aguilar-Hernandez, Alejandra; Morali, Gabriela] UMAE Hosp Especialidades, CMN Siglo XXI, IMSS, Unidad Invest Med Farmacol, Mexico City 03100, DF, Mexico; [Ceruantes, Miguel] Univ Michoacana SNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico		Morali, G (corresponding author), UMAE Hosp Especialidades, CMN Siglo XXI, IMSS, Unidad Invest Med Farmacol, Eugenia 626 Girasol 302, Mexico City 03100, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Espinosa-Garcia, Claudia/0000-0002-9909-9092	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/G10/827, 2010020]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2009-01/134199, 229241]	This paper constitutes a partial fulfillment of the requirements for the Ph.D. of CEG at the Programa de Doctorado en Ciencias Biomedicas, UNAM. This study was partially supported by Instituto Mexicano del Seguro Social (Grant no. FIS/IMSS/PROT/G10/827; CEG fellowship 2010020), and CONACYT (Grant no. CB-2009-01/134199; CEG fellowship 229241). The authors thank Ms. Maria del Carmen Baltazar for her skillful technical assistance.	Aggarwal R, 2008, J PHARM PHARMACOL, V60, P731, DOI 10.1211/jpp.60.6.0008; Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barone FC, 2006, CLIN NEUROSCI RES, V6, P329, DOI 10.1016/j.cnr.2006.09.010; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Cervantes M, 2012, ADV PRECLINICAL STUD; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Cheatwood JL, 2008, TOP STROKE REHABIL, V15, P42, DOI 10.1310/tsr1501-42; Chen SY, 2009, NEUROSCI LETT, V465, P171, DOI 10.1016/j.neulet.2009.09.011; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Espinosa-Garcia C, 2013, NEUROSCI LETT, V550, P98, DOI 10.1016/j.neulet.2013.06.023; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hamill Cecily E, 2005, Clin Neurosurg, V52, P29; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Himeda T, 2007, CELL MOL NEUROBIOL, V27, P229, DOI 10.1007/s10571-006-9104-2; Huber AB, 2002, J NEUROSCI, V22, P3553; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jiang C, 2011, INT IMMUNOPHARMACOL, V11, P1925, DOI 10.1016/j.intimp.2011.08.001; Jiang W, 2009, TRANSL RES, V154, P40, DOI 10.1016/j.trsl.2009.04.005; Karanjia N, 2011, CURR TREAT OPTION NE, V13, P191, DOI 10.1007/s11940-011-0112-2; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kovalenko T, 2006, HIPPOCAMPUS, V16, P814, DOI 10.1002/hipo.20211; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Morali G, 2012, RESTOR NEUROL NEUROS, V30, P1, DOI 10.3233/RNN-2011-0605; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUDRICK LA, 1989, BRAIN RES, V493, P179, DOI 10.1016/0006-8993(89)91014-7; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; ONODERA H, 1990, NEUROSCIENCE, V38, P125, DOI 10.1016/0306-4522(90)90379-I; Orzylowska O, 1999, NEUROSCI LETT, V263, P72, DOI 10.1016/S0304-3940(99)00043-9; Overman JJ, 2014, NEUROSCIENTIST, V20, P15, DOI 10.1177/1073858413491146; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; PULSINELLI WA, 1988, STROKE, V19, P913, DOI 10.1161/01.STR.19.7.913; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Roine R.O., 1997, CURRENT REV CEREBROV, P159; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Ruan YW, 2006, NEUROSCIENCE, V140, P191, DOI 10.1016/j.neuroscience.2006.01.039; Ruan YW, 2012, NEUROSCIENCE, V218, P268, DOI 10.1016/j.neuroscience.2012.05.035; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; Sairanen TR, 1997, J CEREBR BLOOD F MET, V17, P1107, DOI 10.1097/00004647-199710000-00013; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schneider A, 2009, ANESTH ANALG, V108, P971, DOI 10.1213/ane.0b013e318193ca99; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Skibo GG, 2010, VITAM HORM, V82, P107, DOI 10.1016/S0083-6729(10)82006-0; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; VanGuilder HD, 2012, J NEUROCHEM, V121, P77, DOI 10.1111/j.1471-4159.2012.07671.x; Wang TZ, 2010, BRAIN RES, V1360, P147, DOI 10.1016/j.brainres.2010.08.101; Wang XX, 2002, J NEUROSCI, V22, P5505; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yang JF, 2013, J SURG RES, V182, pE69, DOI 10.1016/j.jss.2012.11.010; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yasuda Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-70; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zhang Z, 2010, HIPPOCAMPUS, V20, P402, DOI 10.1002/hipo.20642; Zhao YZ, 2011, SYNAPSE, V65, P880, DOI 10.1002/syn.20915; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	91	20	23	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 30	2014	1545						23	34		10.1016/j.brainres.2013.11.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA3XC	WOS:000331027500003	24316245				2022-02-06	
J	Parsons, TD; Courtney, CG				Parsons, Thomas D.; Courtney, Christopher G.			An initial validation of the Virtual Reality Paced Auditory Serial Addition Test in a college sample	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Neuropsychological assessment; Ecological validity; Paced Auditory Serial Addition Test; Virtual environment	TRAUMATIC BRAIN-INJURY; INFORMATION-PROCESSING CAPACITY; CLOSED-HEAD-INJURY; RADIAL-ARM MAZE; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL ASSESSMENT; EXECUTIVE FUNCTION; TEST PASAT; COGNITIVE IMPAIRMENT; CONSTRUCT-VALIDITY	Background: Numerous studies have demonstrated that the Paced Auditory Serial Addition Test (PASAT) has utility for the detection of cognitive processing deficits. While the PASAT has demonstrated high levels of internal consistency and test-retest reliability, administration of the PASAT has been known to create undue anxiety and frustration in participants. As a result, degradation of performance may be found on the PASAT. The difficult nature of the PASAT may subsequently decrease the probability of their return for follow up testing. New method: This study is a preliminary attempt at assessing the potential of a PASAT embedded in a virtual reality environment. The Virtual Reality PASAT (VR-PASAT) was compared with a paper-and-pencil version of the PASAT as well as other standardized neuropsychological measures. The two modalities of the PASAT were conducted with a sample of 50 healthy university students, between the ages of 19 and 34 years. Equivalent distributions were found for age, gender, education, and computer familiarity. Results: Moderate relationships were found between VR-PASAT and other putative attentional processing measures. The VR-PASAT was unrelated to indices of learning, memory, or visuospatial processing. Comparison with existing method(s): Comparison of the VR-PASAT with the traditional paper-and-pencil PASAT indicated that both versions require the examinee to sustain attention at an increasingly demanding, externally determined rate. Conclusions: Results offer preliminary support for the construct validity (in a college sample) of the VR-PASAT as an attentional processing measure and suggest that this task may provide some unique information not tapped by traditional attentional processing tasks. (C) 2013 Elsevier B.V. All rights reserved.	[Parsons, Thomas D.] Univ N Texas, Dept Psychol, Denton, TX 76203 USA; [Courtney, Christopher G.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA		Parsons, TD (corresponding author), Univ N Texas, Dept Psychol, Clin Neuropsychol & Simulat CNS Lab, 1155 Union Circle 311280, Denton, TX 76203 USA.	Thomas.Parsons@unt.edu		Parsons, Thomas/0000-0003-0331-5019			An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; [Anonymous], 2007, AUT NEUR ASS METR VE; Armstrong CM, 2013, J CLIN EXP NEUROPSYC, V35, P113, DOI 10.1080/13803395.2012.740002; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Beck L, 2010, CYBERPSYCH BEH SOC N, V13, P211, DOI 10.1089/cyber.2008.0343; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Broadbent D.E., 1958, PERCEPTION COMMUNICA, DOI [10.1037/10037-000, DOI 10.1037/10037-000]; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chronicle EP, 1998, NEUROPSYCHOL REHABIL, V8, P273; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Dandeneau SD, 2007, J PERS SOC PSYCHOL, V93, P651, DOI 10.1037/0022-3514.93.4.651; DEARY IJ, 1994, BIOL PSYCHOL, V38, P1, DOI 10.1016/0301-0511(94)90046-9; Delis DC, 1997, DELIS KAPLAN EXECUTI; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dujardin K, 2007, CORTEX, V43, P601, DOI 10.1016/S0010-9452(08)70490-8; Goodrich-Hunsaker NJ, 2010, BEHAV NEUROSCI, V124, P405, DOI 10.1037/a0019193; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; Hiscock M, 1998, J CLIN EXP NEUROPSYC, V20, P463, DOI 10.1076/jcen.20.4.463.1466; Holdwick DJ, 1999, ARCH CLIN NEUROPSYCH, V14, P273, DOI 10.1016/S0887-6177(98)00021-3; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; Johnson S K, 1997, Appl Neuropsychol, V4, P145, DOI 10.1207/s15324826an0403_1; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P171, DOI 10.1080/09084282.2011.643955; KENNEDY RS, 1992, AVIAT SPACE ENVIR MD, V63, P588; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; KUJALA P, 1995, J NEUROL NEUROSUR PS, V59, P77, DOI 10.1136/jnnp.59.1.77; Law AS, 2006, ACTA PSYCHOL, V122, P27, DOI 10.1016/j.actpsy.2005.09.002; Lejuez C.W., 2003, BEHAV THERAPIST; Levin HS, 1982, LANCET, V2, P605; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Parsons Thomas D, 2012, Stud Health Technol Inform, V173, P331; Patton J.H., 1991, CLIN NEUROPSYCHOL, V5, P33, DOI [10.1080/13854049108401840, DOI 10.1080/13854049108401840]; Plancher G, 2012, NEUROPSYCHOLOGIA, V50, P592, DOI 10.1016/j.neuropsychologia.2011.12.013; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prevey ML, 1998, EPILEPSY RES, V30, P1, DOI 10.1016/S0920-1211(97)00091-0; Prins PJM, 2011, CYBERPSYCH BEH SOC N, V14, P115, DOI 10.1089/cyber.2009.0206; Rao S., 1990, MANUAL BRIEF REPEATA; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; SAMPSON H, 1960, AUST J PSYCHOL, V12, P70, DOI 10.1080/00049536008255188; SAMPSON H, 1958, CAN J PSYCHOLOGY, V12, P179, DOI 10.1037/h0083750; Scarpetta F., 2008, J CYBERTHERAPY REHAB, V1, P127; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; Shucard JL, 2004, J INT NEUROPSYCH SOC, V10, P35, DOI 10.1017/S1355617704101057; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tombaugh TN, 2004, J CLIN EXP NEUROPSYC, V26, P257, DOI 10.1076/jcen.26.2.257.28080; Tombaugh TN, 1999, ADM MANUAL ADJUSTING; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wiens AN, 1997, J CLIN EXP NEUROPSYC, V19, P473, DOI 10.1080/01688639708403737; Wingenfeld SA, 1999, CLIN NEUROPSYCHOL, V13, P268, DOI 10.1076/clin.13.3.268.1736; Wu DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056624; Wu DR, 2010, IEEE T AFFECT COMPUT, V1, P109, DOI 10.1109/T-AFFC.2010.12	74	20	20	1	34	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 30	2014	222						15	23		10.1016/j.jneumeth.2013.10.006			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AB3DR	WOS:000331672000002	24184058				2022-02-06	
J	Curtis, K; Lam, M; Mitchell, R; Black, D; Taylor, C; Dickson, C; Jan, S; Palmer, CS; Langcake, M; Myburgh, J				Curtis, Kate; Lam, Mary; Mitchell, Rebecca; Black, Deborah; Taylor, Colman; Dickson, Cara; Jan, Stephen; Palmer, Cameron S.; Langcake, Mary; Myburgh, John			Acute costs and predictors of higher treatment costs of trauma in New South Wales, Australia	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Health economics; Cost; Outcomes; Injury	HOSPITAL COSTS; INJURY; SYSTEM; MORTALITY; VICTORIA	Background: Accurate economic data are fundamental for improving current funding models and ultimately in promoting the efficient delivery of services. The financial burden of a high trauma casemix to designated trauma centres in Australia has not been previously determined, and there is some evidence that the episode funding model used in Australia results in the underfunding of trauma. Aim: To describe the costs of acute trauma admissions in trauma centres, identify predictors of higher treatment costs and cost variance in New South Wales (NSW), Australia. Materials and methods: Data linkage of admitted trauma patient and financial data provided by 12 Level 1 NSW trauma centres for the 08/09 financial year was performed. Demographic, injury details and injury scores were obtained from trauma registries. Individual patient general ledger costs (actual trauma patient costs), Australian Refined Diagnostic Related Groups (AR-DRG) and state-wide average costs (which form the basis of funding) were obtained. The actual costs incurred by the hospital were then compared with the state-wide AR-DRG average costs. Multivariable multiple linear regression was used for identifying predictors of costs. Results: There were 17,522 patients, the average per patient cost was $10,603 and the median was $4628 (interquartile range: $2179-10,148). The actual costs incurred by trauma centres were on average $134 per bed day above AR-DRG costs-determined costs. Falls, road trauma and violence were the highest causes of total cost. Motor cyclists and pedestrians had higher median costs than motor vehicle occupants. As a result of greater numbers, patients with minor injury had comparable total costs with those generated by patients with severe injury. However the median cost of severely injured patients was nearly four times greater. The count of body regions injured, sex, length of stay, serious traumatic brain injury and admission to the Intensive Care Unit were significantly associated with increased costs (p < 0.001). Conclusion: This multicentre trauma costing study demonstrated the feasibility of trauma registry and financial data linkage. Discrepancies between the observed costs of care in these 12 trauma centres and the NSW average AR-DRG costs suggest that trauma care is currently underfunded in NSW. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.	[Curtis, Kate] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [Curtis, Kate; Dickson, Cara; Langcake, Mary; Myburgh, John] St George Hosp, Sydney, NSW, Australia; [Mitchell, Rebecca] Univ New S Wales, Sydney, NSW 2052, Australia; [Curtis, Kate; Myburgh, John] Univ NSW, Fac Med, St George Clin Sch, Sydney, NSW, Australia; [Lam, Mary; Black, Deborah] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Taylor, Colman] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Palmer, Cameron S.] Royal Childrens Hosp, Trauma Serv, Melbourne, Vic, Australia; [Palmer, Cameron S.] Monash Univ, Dept Epidemiol & Preventat Med, Clayton, Vic 3800, Australia		Curtis, K (corresponding author), St George Publ Hosp, Trauma Serv, Gray St, Kogarah, NSW 2217, Australia.	Kate.Curtis@sesiahs.health.nsw.gov.au	Mitchell, Rebecca/Z-5476-2019; Jan, Stephen/AAG-3333-2021; black, deborah/C-2829-2017	Mitchell, Rebecca/0000-0003-1939-1761; black, deborah/0000-0001-9174-1565; Jan, Stephen/0000-0003-2839-1405	Sydney Nursing School/Sydney University Post-doctoral Fellowship; ARC-linkage Post-doctoral FellowshipAustralian Research Council [LP0990057]; NHMRC Senior Research FellowshipNational Health and Medical Research Council of Australia [1020430]; NSW Institute of Injury and Trauma Management; The St George, Sutherland Medical Research Foundation	K. Curtis was supported by a Sydney Nursing School/Sydney University Post-doctoral Fellowship. R. Mitchell was supported by an ARC-linkage Post-doctoral Fellowship (LP0990057). Stephen Jan is a recipient of an NHMRC Senior Research Fellowship (1020430). Funding support was provided by the NSW Institute of Injury and Trauma Management and The St George, Sutherland Medical Research Foundation. The study sponsors had no involvement in the study design, collection, analysis and interpretation of data or the writing of the manuscript.	Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL 1998 R; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 2; Australian Institute of Health and Welfare, 2010, AUSTR HLTH 2010; Australian Institute of Health and Welfare (AIHW), 2010, AUSTR I HLTH WELF AI, V17; Australian Institute of Health and Welfare (AIHW), 2010, AUSTR I HLTH WELF AI, V42; Australian Tax Office, 2010, FIN YEAR END 30 JUN; Branch I-GFS, 2008, EPISODE FUNDING POLI, P1; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Christensen MC, 2008, INJURY, V39, P1013, DOI 10.1016/j.injury.2008.01.012; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Curtis Kate, 2002, Aust Health Rev, V25, P73; Curtis K, 2011, HEALTH INF MANAG J, V40, P7, DOI 10.1177/183335831104000102; Curtis K, 2009, AUST HEALTH REV, V33, P84, DOI 10.1071/AH090084; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Grotz M, 2004, UNFALLCHIRURG, V107, P68, DOI 10.1007/s00113-003-0715-5; Health NSW, 2009, SEL SPEC STAT SERV P; International Business Machines Corporation (IBM), 2008, STAT PACK SOC SCI SP; Ivers R, 2006, INJURY PREV, V12, P351, DOI 10.1136/ip.2006.013813; Krug, 2002, INJURY LEADING CAUSE; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Lyons RA, 2010, INT J INJ CONTROL SA, V17, P145, DOI 10.1080/17457300903453104; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; Mitchell RJ, 2008, MED J AUSTRALIA, V188, P405, DOI 10.5694/j.1326-5377.2008.tb01685.x; NSW Health Department, 2006, 2006 2007 NSW PROGR; NSW Health Department, 2010, NSW HLTH EP FUND POL; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-1; Pape HC, 2009, EUR J TRAUMA EMERG S, V35, P61, DOI 10.1007/s00068-008-8013-0; PowerHealth Solutions, 2006, POWERPERFORMANCE MAN; Probst C, 2009, UNFALLCHIRURG, V112, P975, DOI 10.1007/s00113-009-1684-0; Rotondo MF, 2009, J TRAUMA, V67, P915, DOI 10.1097/TA.0b013e3181b848e7; Rowell D, 2011, J TRAUMA, V70, P1086, DOI 10.1097/TA.0b013e3181ed4d29; Twijnstra MJ, 2010, ANN SURG, V251, P339, DOI 10.1097/SLA.0b013e3181c0e910; Willensberg L, 2011, ROADS REC SUCC SYST; World Health Organization, 2012, INT CLASS DIS ICD; World Health Organization, 2009, GLOB STAT REP ROAD S	37	20	20	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2014	45	1					279	284		10.1016/j.injury.2012.10.002			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	264OJ	WOS:000327887800051	23092784				2022-02-06	
J	Decloe, MD; Meeuwisse, WH; Hagel, BE; Emery, CA				Decloe, Melissa D.; Meeuwisse, Willem H.; Hagel, Brent E.; Emery, Carolyn A.			Injury rates, types, mechanisms and risk factors in female youth ice hockey	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Ice hockey; Children's injuries; Epidemiology; Injury Prevention; Concussion	OF-THE-LITERATURE; BODY CHECKING; PLAYERS; EPIDEMIOLOGY; SPORT	Background The objectives of this cohort study were to examine the rate, types, mechanisms and risk factors for injury in female youth (ages 9-17) ice hockey players in the Girls Hockey Calgary Association. Methods The main outcome was ice hockey injury, defined as any injury occurring during the 2008/2009 season that required medical attention, and/or removal from a session and/or missing a subsequent session. Potential risk factors included age group, level of play, previous injury, ice hockey experience, physical activity level, weight, height, position of play and menarche. Incidence rate ratios (IRR) were estimated with Poisson Regression adjusted for cluster (team). Exposure data were collected for every session for each participating player. Results Twenty-eight teams (n=324) from Atom (ages 9-10), PeeWee (11-12), Bantam (13-14) and Midget (15-17) participated with 53 reported injuries. The overall injury rate was 1.9 injuries/1000 player-hours (95% CI 1.4 to 2.7). Previous injury (IRR=2.7, 95% CI 1.7 to 4.3), games (IRR=2.1, 95% CI 1.1 to 4.2), menarche (PeeWee) (IRR=4.1, 95% CI 1.0 to 16.8) were significant risk factors. In Midget, the more elite divisions were associated with a lower injury risk (A-IRR=0.2, 95% CI 0.1 to 0.5) (AAA-IRR=0.5, 95% CI 0.2 to 0.9). Conclusions Injury rates were lower in this study than previously found in male youth and women's ice hockey populations. Previous injury and game play as risk factors are consistent with the literature. Menarche as a risk factor is a new finding in this study. This research will inform future studies of the development of injury prevention strategies in this population.	[Decloe, Melissa D.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Alberta Childrens Prov Gen Hosp, Dept Pediat, Fac Med, Calgary, AB, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada		Emery, CA (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca	Hagel, Brent/AAK-3319-2020; Emery, Carolyn/AAI-2761-2020		Alberta Centre for Child, Family and Community Research [08SM-EMERY]	This research project was funded through an Investigator-driven grant from the Alberta Centre for Child, Family and Community Research (grant number 08SM-EMERY).	Agel J, 2007, J ATHL TRAINING, V42, P249; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; BERNARD D, 1993, ASTM STP, V1212, P44; Bracko MR, 2001, PEDIATR EXERC SCI, V13, P26, DOI 10.1123/pes.13.1.26; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Dryden D M, 2000, J Sci Med Sport, V3, P140, DOI 10.1016/S1440-2440(00)80076-6; Dryden DM, 2000, MED SCI SPORT EXER, V32, P1378, DOI 10.1097/00005768-200008000-00004; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; EMERY CA, 2008, BRIT J SPORT MED, V42, P491; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; FINKE R C, 1988, Journal of Orthopaedic and Sports Physical Therapy, V10, P54; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hanson SL, 1999, SOCIOL SPORT J, V16, P92, DOI 10.1123/ssj.16.2.92; Hewett TE, 2007, AM J SPORT MED, V35, P659, DOI 10.1177/0363546506295699; *HOCK CAN, HOCK CAN ANN REP 200; LYSENS RJ, 1991, SPORTS MED, V12, P281, DOI 10.2165/00007256-199112050-00001; Molsa J, 2003, AM J SPORT MED, V31, P751; Montelpare WJ, 2004, ASTM INT, V1, P70; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; ROY MA, 1989, PHYSICIAN SPORTSMED, V17, P119, DOI 10.1080/00913847.1989.11709735; Roy MA, 1989, PHYS SP MED, V17, P125; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Smith AM, 1997, AM J SPORT MED, V25, P500, DOI 10.1177/036354659702500413; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Theberge N, 2003, YOUTH SOC, V34, P497, DOI 10.1177/0044118X03034004005; Voaklander DC, 1998, SPORTS MED TRAINING, V8, P239, DOI 10.1080/15438629809512530; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	33	20	20	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	1					51	+		10.1136/bjsports-2012-091653			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	272YX	WOS:000328500500011	23446642				2022-02-06	
J	Joseph, B; Aziz, H; Pandit, V; Kulvatunyou, N; O'Keeffe, T; Tang, A; Wynne, J; Hashmi, A; Vercruysse, G; Friese, RS; Rhee, P				Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Kulvatunyou, Narong; O'Keeffe, Terence; Tang, Andrew; Wynne, Julie; Hashmi, Ammar; Vercruysse, Gary; Friese, Randall S.; Rhee, Peter			Low-dose aspirin therapy is not a reason for repeating head computed tomographic scans in traumatic brain injury: a prospective study	JOURNAL OF SURGICAL RESEARCH			English	Article							INTRACRANIAL HEMORRHAGE; ELDERLY-PATIENTS; OUTCOMES; ANTIPLATELET	Background: Most studies have categorized all antiplatelet drugs into one category. The aim of our study was to evaluate the utility of repeat head computed tomography (RHCT) and outcomes in patients on low-dose aspirin (acetylsalicylic acid; ASA) therapy. Methods: Patients with traumatic brain injury with intracranial hemorrhage on initial head computed tomography (CT) were prospectively enrolled. Patients on prehospital low-dose (81 mg) aspirin therapy were matched with patients exclusive of antiplatelet and anticoagulation therapy using propensity score matching in a 1:1 ratio for age, Glasgow Coma Scale, head Abbreviated Injury Scale score, Injury Severity Score, and neurological examination. Outcome measures were progression on RHCT and subsequent neurosurgical intervention. Results: A total of 144 patients who had intracranial hemorrhage on initial CT scan (ASA group: 72; No-ASA group: 72) were enrolled. The mean age was 72.8 +/- 11.7 years, 59.7% were male, and median head Abbreviated Injury Scale was 3 (2-3). There was no difference in progression on RHCT (25% in ASA versus 16.6% in no-ASA), change in management as a result of RHCT (1.4% versus 1.4%), RHCT as a result of neurological decline (0 versus 1.4%), discharge Glasgow Coma Scale (15 [14-15] versus 15 [14-15]), and mortality (0 versus 1.4%) between the two groups. Conclusions: Low-dose aspirin therapy is not associated with progression of initial insult on RHCT or clinical deterioration. Prehospital low-dose aspirin therapy as a sole criterion should not warrant a routine repeat head CT in traumatic brain injury. Published by Elsevier Inc.	[Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Kulvatunyou, Narong; O'Keeffe, Terence; Tang, Andrew; Wynne, Julie; Hashmi, Ammar; Vercruysse, Gary; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Aziz, Hassan/ABA-5681-2021	Aziz, Hassan/0000-0003-0406-1946			Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; DOUTREMEPUICH C, 1990, HAEMOSTASIS, V20, P99; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; HIRSH J, 1995, CHEST, V108, pS231, DOI 10.1378/chest.108.4_Supplement.231S; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2013, AM SURG IN PRESS; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Mattox K, 2012, TRAUMA; MERRIMAN E, 1979, J NEUROSURG, V50, P682, DOI 10.3171/jns.1979.50.5.0682; MINAR E, 1995, CIRCULATION, V91, P2167, DOI 10.1161/01.CIR.91.8.2167; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; REYMOND MA, 1992, NEUROSURG REV, V15, P21, DOI 10.1007/BF02352062; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; SPEKTOR S, 1995, ACTA NEUROCHIR, V134, P51, DOI 10.1007/BF01428502; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Yu J, 2012, JACC-CARDIOVASC INTE, V5, P1231, DOI 10.1016/j.jcin.2012.07.016	17	20	21	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2014	186	1					287	291		10.1016/j.jss.2013.08.009			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	274TJ	WOS:000328628800051	24011918				2022-02-06	
J	Maller, JJ; Thomson, RHS; Pannek, K; Rose, SE; Bailey, N; Lewis, PM; Fitzgerald, PB				Maller, Jerome J.; Thomson, Richard H. S.; Pannek, Kerstin; Rose, Stephen E.; Bailey, Neil; Lewis, Philip M.; Fitzgerald, Paul B.			The (Eigen)Value of Diffusion Tensor Imaging to Investigate Depression After Traumatic Brain Injury	HUMAN BRAIN MAPPING			English	Article						depression; magnetic resonance imaging; diffusion; dorsolateral prefrontal cortex; longitudinal fasciculus; white matter	WHITE-MATTER ABNORMALITIES; HIPPOCAMPAL VOLUMETRICS; ANATOMICAL MRI; MILD; DISORDER; ADULTS; EEG; PHARMACOTHERAPY; STIMULATION; 1ST-EPISODE	Background: Many people with a traumatic brain injury (TBI), even mild to moderate, will develop major depression (MD). Recent studies of patients with MD suggest reduced fractional anisotropy (FA) in dorsolateral prefrontal cortex (DLPFC), temporal lobe tracts, midline, and capsule regions. Some of these pathways have also been found to have reduced FA in patients with TBI. It is unknown whether the pathways implicated in MD after TBI are similar to those with MD without TBI. This study sought to investigate whether there were specific pathways unique to TBI patients who develop MD. Methods: A sample of TBI-MD subjects (N = 14), TBI-no-MD subjects (N = 12), MD-no-TBI (N = 26), and control subjects (no TBI or MD, N = 23), using a strict measurement protocol underwent psychiatric assessments and diffusion tensor brain Magnetic Resonance Imaging (MRI). Results: The findings of this study indicate that (1) TBI patients who develop MD have reduced axial diffusivity in DLPFC, corpus callosum (CC), and nucleus accumbens white matter tracts compared to TBI patients who do not develop MD and (2) MD patients without a history of TBI have reduced FA along the CC. We also found that more severe MD relates to altered radial diffusivity. Conclusions: These findings suggest that compromise to specific white matter pathways, including both axonal and myelination aspects, after a mild TBI underlie the susceptibility of these patients developing MD. Hum Brain Mapp 35:227-237, 2014. (c) 2012 Wiley Periodicals, Inc.	[Maller, Jerome J.; Thomson, Richard H. S.; Bailey, Neil; Fitzgerald, Paul B.] Alfred & Monash Univ, Sch Psychol & Psychiat, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3181, Australia; [Pannek, Kerstin] Univ Queensland, Clin Res Ctr, Ctr Adv Imaging, Sch Med, Brisbane, Qld, Australia; [Rose, Stephen E.] Univ Queensland, Ctr Med Diagnost Technol Queensland, Clin Res Ctr, Ctr Magnet Resonance, Brisbane, Qld, Australia; [Lewis, Philip M.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia		Maller, JJ (corresponding author), Alfred & Monash Univ, Sch Psychol & Psychiat, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3181, Australia.	j.maller@alfred.org.au	Rose, Stephen/C-8044-2009; Maller, Jerome J/H-4963-2014; Pannek, Kerstin/C-8059-2011; Fitzgerald, Paul B/A-1225-2008; Bailey, Neil/AAB-2741-2021	Maller, Jerome J/0000-0003-4685-1508; Pannek, Kerstin/0000-0002-6512-7630; Fitzgerald, Paul B/0000-0003-4217-8096; Rose, Stephen/0000-0003-1558-6297; Bailey, Neil/0000-0002-8483-1068			Ahdidan J, 2011, ACTA PSYCHIAT SCAND, V123, P211, DOI 10.1111/j.1600-0447.2010.01644.x; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Bennett MR, 2010, AUST NZ J PSYCHIAT, V44, P301, DOI 10.3109/00048670903555146; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bruder GE, 2012, HUM BRAIN MAPP, V33, P1325, DOI 10.1002/hbm.21284; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Drevets WC, 2000, NUCL MED BIOL, V27, P499, DOI 10.1016/S0969-8051(00)00119-0; First MB, 2001, STRUCTURED CLIN INTE; Foster JK, 1999, MEMORY, V7, P715, DOI 10.1080/096582199387823; Garrett A, 2011, AM J PSYCHIAT, V168, P173, DOI 10.1176/appi.ajp.2010.09121718; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Heller W, 1993, NEUROPSYCHOLOGY, V7, P746; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kato N, 2000, NEUROPHARMACOLOGY, V39, P1107, DOI 10.1016/S0028-3908(99)00234-8; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mori S, 2005, MRI ATLAS HUMAN WHIT; Muller N, 2011, NEUROTOX RES, V19, P308, DOI 10.1007/s12640-010-9210-2; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saletu B, 2010, CLIN EEG NEUROSCI, V41, P203, DOI 10.1177/155005941004100407; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Shankman SA, 2011, INT J PSYCHOPHYSIOL, V79, P287, DOI 10.1016/j.ijpsycho.2010.11.004; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sheline YI, 2010, ARCH GEN PSYCHIAT, V67, P277, DOI 10.1001/archgenpsychiatry.2009.204; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Tanis Keith Q., 2007, CNS & Neurological Disorders-Drug Targets, V6, P151, DOI 10.2174/187152707780363276; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; von Gunten A, 2000, J NEUROPSYCH CLIN N, V12, P493, DOI 10.1176/appi.neuropsych.12.4.493; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Wagner G, 2010, J PSYCHIATR NEUROSCI, V35, P247, DOI 10.1503/jpn.090081; Yuan YG, 2007, NEUROREPORT, V18, P1845, DOI 10.1097/WNR.0b013e3282f1939f; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	71	20	20	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JAN	2014	35	1					227	237		10.1002/hbm.22171			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	264EN	WOS:000327859900018	23008175	Green Published			2022-02-06	
J	Ness, BM; Vroman, K				Ness, Bryan M.; Vroman, Kerryellen			Preliminary Examination of the Impact of Traumatic Brain Injury and Posttraumatic Stress Disorder on Self-Regulated Learning and Academic Achievement Among Military Service Members Enrolled in Postsecondary Education	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						posttraumatic stress disorder; service member; self-regulated learning; military; academic achievement; traumatic brain injury	PERFORMANCE-APPROACH; COLLEGE-STUDENTS; VETERANS; EFFICACY; IRAQ; AFGHANISTAN; MOTIVATION; COMMUNITY; GOALS; PTSD	Objective: Delineate the effects of self-reported traumatic brain injury (TBI) or posttraumatic stress disorder (PTSD) on self-regulated learning and academic achievement for university-enrolled military Service members. Participants: Students (N = 192) from 8 regionally diverse universities, representing an estimated 6% of Service members enrolled across schools. Setting: Public universities that are members of the Servicemember Opportunity College consortium. Design: Cross-sectional study evaluating the relationships between self-reported TBI, PTSD, and self-regulated learning variables and their contribution to academic achievement. Main Measures: Self-report of military service; symptoms of TBI and PTSD; self-regulation strategies including effort, time/environment regulation, and academic self-efficacy; and grade point average (GPA). Results: There was no effect of self-reported TBI or PTSD on GPA, effort regulation, or time/environment regulation strategies; however, participants with TBI or PTSD reported significantly lower academic self-efficacy. Multiple regression analysis revealed self-efficacy was the strongest predictor of GPA among all participants, followed by military rank. Conclusion: The sample consisted of high achieving students responsive to a university administrator, which raises the possibility of sampling bias. Because of the low recruitment rate for this study and lack of published research on this subject, replicating the results is necessary before drawing generalizable conclusions about the population.	[Ness, Bryan M.] Univ New Hampshire, Dept Commun Sci & Disorders, Durham, NH 03824 USA; [Vroman, Kerryellen] Univ New Hampshire, Dept Occupat Therapy, Durham, NH 03824 USA		Ness, BM (corresponding author), Univ New Hampshire, Dept Commun Sci & Disorders, 4 Lib Way,151 Hewitt Hall, Durham, NH 03824 USA.	Bryan.Ness@unh.edu					Bandura A, 1996, CHILD DEV, V67, P1206, DOI 10.2307/1131888; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bragin M, 2010, CLIN SOC WORK J, V38, P316, DOI 10.1007/s10615-010-0267-4; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Britton PC, 2012, AM J PUBLIC HEALTH, V102, pS125, DOI 10.2105/AJPH.2011.300415; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cleary TJ, 2004, PSYCHOL SCHOOLS, V41, P537, DOI 10.1002/pits.10177; Crede M, 2011, LEARN INDIVID DIFFER, V21, P337, DOI 10.1016/j.lindif.2011.03.002; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Ellison ML, 2012, PSYCHIATR REHABIL J, V35, P209, DOI 10.2975/35.3.2012.209.217; Field Kelly., 2008, CHRON HIGHER EDUC, V54, pA1; Galor S, 2012, J LOSS TRAUMA, V17, P522, DOI 10.1080/15325024.2012.674440; Gore PA, 2006, J CAREER ASSESSMENT, V14, P92, DOI 10.1177/1069072705281367; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jarvis, 2011, ASHE HIGHER ED REPOR, V37, P1, DOI [10.1353/rhe.2012.0055, DOI 10.1002/AEHE.3703]; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kitsantas A, 2008, J ADV ACAD, V20, P42, DOI 10.4219/jaa-2008-867; Linnenbrink EA, 2002, SCHOOL PSYCHOL REV, V31, P313; Linnenbrink EA, 2005, J EDUC PSYCHOL, V97, P197, DOI 10.1037/0022-0663.97.2.197; Livingston WG, 2011, J STUD AFF RES PRACT, V48, P315, DOI 10.2202/1949-6605.6292; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Nandagopal K, 2012, LEARN INDIVID DIFFER, V22, P597, DOI 10.1016/j.lindif.2011.11.018; National Center for PTSD, US PTSD CHECKL; O'Herrin E., 2011, PEER REV, V13, P15; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Patrick H, 1997, J EARLY ADOLESCENCE, V17, P109, DOI 10.1177/0272431697017002001; Persky KR, 2010, COMMUNITY COLL J RES, V35, P111, DOI 10.1080/10668926.2011.525184; Pintrich P., 1991, MANUAL MOTIVATED STR; PINTRICH PR, 1990, J EDUC PSYCHOL, V82, P33, DOI 10.1037/0022-0663.82.1.33; Pintrich PR, 2004, EDUC PSYCHOL REV, V16, P385, DOI 10.1007/s10648-004-0006-x; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rotgans J, 2009, EDUC STUD-UK, V35, P239, DOI 10.1080/03055690802648051; Ruban LM, 2003, J LEARN DISABIL-US, V36, P270, DOI 10.1177/002221940303600306; Rumann CB, 2010, J HIGH EDUC, V81, P431, DOI 10.1353/jhe.0.0103; Ryan AM, 2006, PERS SOC PSYCHOL B, V32, P1246, DOI 10.1177/0146167206289345; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schunk DH, 1997, EDUC PSYCHOL-US, V32, P195, DOI 10.1207/s15326985ep3204_1; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Service Opportunity College Consortium, PROV ED OPP SERV MEM; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Steele J. L., 2010, MILITARY VETERANS EX; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Trainin G, 2005, LEARN DISABILITY Q, V28, P261, DOI 10.2307/4126965; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; U.S. Department of Education, 2003 04 2007 08 NAT; US Census Bureau, 2011, AM FACT FIND VET STA; US Department of Veterans Affairs, 2011, ED ATT VET 2000 2009; Vance ML, 2009, J POSTSECOND EDUC DI, V22, P18; Vollmeyer R, 2006, EDUC PSYCHOL REV, V18, P239, DOI 10.1007/s10648-006-9017-0; Weathers F, PTSD CHECKLIST MILIT; Widome R, 2011, AM J HEALTH BEHAV, V35, P387, DOI 10.5993/AJHB.35.4.1; Zimmerman BJ, 2008, AM EDUC RES J, V45, P166, DOI 10.3102/0002831207312909; Zimmerman BJ, 1990, EDUC PSYCHOL REV, V2, P173, DOI 10.1007/BF01322178	62	20	20	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					33	43		10.1097/HTR.0b013e3182a1cd4e			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400008	23982790				2022-02-06	
J	Norris, JN; Sams, R; Lundblad, P; Frantz, E; Harris, E				Norris, Jacob N.; Sams, Richard; Lundblad, Peter; Frantz, Earl; Harris, Erica			Blast-related mild traumatic brain injury in the acute phase: Acute stress reactions partially mediate the relationship between loss of consciousness and symptoms	BRAIN INJURY			English	Article						Acute stress; blast-injury; combat; loss of consciousness; mild traumatic brain injury	SPORT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; PERSISTENT POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; SERVICE MEMBERS; DISORDER; MILITARY; SOLDIERS; IRAQ; VETERANS	Primary objective: The objective was to compare symptoms in service members diagnosed with a blast-related mTBI (mild traumatic brain injury) with a loss of consciousness (LOC) to those without LOC. Research design: Clinicians saw US military personnel within 72 hours of sustaining a blast-related mTBI and at a follow-up visit 48-72 hours later (n = 210). Methods and procedures: Demographics, post-concussive symptoms, diagnosis of acute stress reaction (ASR) and simple reaction time data from the Automated Neuropsychological Assessment Metric (ANAM) were collected. Main outcomes and results: ASRs were significantly more likely in patients reporting LOC versus patients reporting no LOC. At the first post-injury visit, LOC was associated with difficulty sleeping, hearing loss, memory problems and reporting more symptoms. A follow-up analysis explored if symptomatic differences were influenced by ASR. Adjusting for ASR, the statistical relationships between LOC and symptoms were weaker (i.e. reduced Odds Ratios). At the follow-up visit, difficulty sleeping was associated with LOC before and after adjusting for ASR. Patients with both ASR and LOC had the slowest simple reaction times. Conclusions: Results suggest ASR may partially mediate symptom presentation and cognitive dysfunction in the acute phase following blast-related mTBI. Future research is warranted.	[Norris, Jacob N.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20910 USA; [Sams, Richard] Branch Hlth Clin Kings Bay, Kings Bay, GA USA; [Lundblad, Peter] Naval Hosp Bremerton, Bremerton, WA USA; [Frantz, Earl] Naval Hosp Camp Lejeune, Camp Lejeune, NC USA; [Harris, Erica] Naval Hlth Res Ctr, San Diego, CA USA		Norris, JN (corresponding author), Naval Med Res Ctr, Silver Spring, MD 20910 USA.	jacob.norris@med.navy.mil		Sams, Richard/0000-0003-3264-9616	Navy Bureau of Medicine and Surgery [N24LB]	This report was supported by Navy Bureau of Medicine and Surgery, under Work Unit No. N24LB. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government. Approved for public release; distribution is unlimited. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (USAMRMC IRB Number M-10166 and NMRC.2013.0003).	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Associated Press, 2007, CARS STUD CARS STUD; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conaton E., 2012, 649011 DODI; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Defense and Veterans Brain Injury Center, 2013, MIL AC CONC EV MACE; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Gosselin N, 2010, J NEUROL NEUROSUR PS, V81, P1297, DOI 10.1136/jnnp.2010.222471; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmes S, 2011, BIOL RES NURS, V13, P97, DOI 10.1177/1099800410382290; Isserlin L, 2008, AM J ORTHOPSYCHIAT, V78, P423, DOI 10.1037/a0014304; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sams R, 2012, MIL MED, V177, P48, DOI 10.7205/MILMED-D-11-00214; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Torg JS, 1982, ATHLETIC INJURIES HE; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Zhang Jiangyue, 2009, Biomed Sci Instrum, V45, P119; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	63	20	21	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1052	1062		10.3109/02699052.2014.891761			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200005	24655334				2022-02-06	
J	Pfortmueller, CA; Kunz, M; Lindner, G; Zisakis, A; Puig, S; Exadaktylos, AK				Pfortmueller, Carmen A.; Kunz, Mirco; Lindner, Gregor; Zisakis, Athanasios; Puig, Stefan; Exadaktylos, Aristomenis K.			Fall-Related Emergency Department Admission: Fall Environment and Settings and Related Injury Patterns in 6357 Patients with Special Emphasis on the Elderly	SCIENTIFIC WORLD JOURNAL			English	Article							PREVENTION; HOSPITALIZATIONS; FRACTURES; ADULTS; COST; HOME; AGE	Principals. Throughout the world, falls are a major public health problem and a socioeconomic burden. Nevertheless there is little knowledge about how the injury types may be related to the aetiology and setting of the fall, especially in the elderly. We have therefore analysed all patients presenting with a fall to our Emergency Department (ED) over the past five years. Methods. Our retrospective data analysis comprised adult patients admitted to our Emergency Department between January 1, 2006, and December 31, 2010, in relation to a fall. Results. Of a total of 6357 patients 78% (n = 4957) patients were younger than 75 years. The main setting for falls was patients home (n = 2239, 35.3%). In contrast to the younger patients, the older population was predominantly female (56.3% versus 38.6%; P < 0.0001). Older patients were more likely to fall at home and suffer from medical conditions (all P < 0.0001). Injuries to the head (P < 0.0001) and to the lower extremity (P < 0.019) occurred predominantly in the older population. Age was the sole predictor for recurrent falls (OR 1.2, P < 0.0001). Conclusion. Falls at home are the main class of falls for all age groups, particularly in the elderly. Fall prevention strategies must therefore target activities of daily living. Even though falls related to sports mostly take place in the younger cohort, a significant percentage of elderly patients present with falls related to sporting activity. Falls due to medical conditions were most likely to result in mild traumatic brain injury.	[Pfortmueller, Carmen A.; Lindner, Gregor] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Lindner, Gregor; Zisakis, Athanasios; Puig, Stefan; Exadaktylos, Aristomenis K.] Univ Bern, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Lindner, Gregor; Zisakis, Athanasios; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Kunz, Mirco] Cantonal Hosp Winterthur, Div Anesthesiol, CH-8400 Winterthur, Switzerland; [Puig, Stefan] Univ Hosp Bern, Univ Inst Diagnost Intervent & Pediat Radiol, CH-3010 Bern, Switzerland		Pfortmueller, CA (corresponding author), Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland.	cpfortmueller@gmail.com	Lindner, Gregor/AAR-6761-2020	Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Annweiler C, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-50; [Anonymous], 2011, PROVIDER S SAI; Barnett A, 2003, AGE AGEING, V32, P407, DOI 10.1093/ageing/32.4.407; Caterino JM, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-19; Demetriades D, 2005, J TRAUMA, V58, P342, DOI 10.1097/01.TA.0000135161.44100.D8; Frick KD, 2010, J AM GERIATR SOC, V58, P136, DOI 10.1111/j.1532-5415.2009.02575.x; Heinrich S, 2010, OSTEOPOROSIS INT, V21, P891, DOI 10.1007/s00198-009-1100-1; KALLINEN M, 1995, SPORTS MED, V20, P41, DOI 10.2165/00007256-199520010-00004; Kool B, 2007, INJURY, V38, P570, DOI 10.1016/j.injury.2006.10.014; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; Mitchell R, 2010, AUSTRALAS J AGEING, V29, P117, DOI 10.1111/j.1741-6612.2010.00413.x; Moore M, 2010, J AM GERIATR SOC, V58, P357, DOI 10.1111/j.1532-5415.2009.02683.x; O'Connor Patricia, 2006, Healthc Q, V9 Spec No, P43; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Sartini M, 2010, EUR J PUBLIC HEALTH, V20, P604, DOI 10.1093/eurpub/ckp165; Sherrington C, 2004, J Sci Med Sport, V7, P43, DOI 10.1016/S1440-2440(04)80277-9; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Thomas S, 2010, AGE AGEING, V39, P681, DOI 10.1093/ageing/afq102; Ullah S, 2010, OSTEOPOROSIS INT, V21, P2125, DOI 10.1007/s00198-010-1189-2; Wareham K, 2003, INJURY, V34, P219, DOI 10.1016/S0020-1383(02)00212-7; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Zelle BA, 2005, INJURY, V36, P169, DOI 10.1016/j.injury.2004.06.004	24	20	20	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1537-744X			SCI WORLD J	Sci. World J.		2014									256519	10.1155/2014/256519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9QJ	WOS:000332869000001	24723797	Green Published, gold, Green Submitted			2022-02-06	
J	Piras, F; Piras, F; Ciullo, V; Danese, E; Caltagirone, C; Spalletta, G				Piras, Federica; Piras, Fabrizio; Ciullo, Valentina; Danese, Emanuela; Caltagirone, Carlo; Spalletta, Gianfranco			Time dysperception perspective for acquired brain injury	FRONTIERS IN NEUROLOGY			English	Article						interval timing; cognitive dysfunction; time distortions; brain damage; information processing	MEDIAL-TEMPORAL-LOBE; WORKING-MEMORY; INTERNAL CLOCK; PARKINSONS-DISEASE; TIMING DEFICITS; SUBJECTIVE TIME; SMOOTH-PURSUIT; PERCEPTION; ATTENTION; DURATION	Distortions of time perception are presented by a number of neuropsychiatric illnesses. Here we survey timing abilities in clinical populations with focal lesions in key brain structures recently implicated in human studies of timing. We also review timing performance in amnesic and traumatic brain injured patients in order to identify the nature of specific timing disorders in different brain damaged populations. We purposely analyzed the complex relationship between both cognitive and contextual factors involved in time estimation, as to characterize the correlation between timed and other cognitive behaviors in each group. We assume that interval timing is a solid construct to study cognitive dysfunctions following brain injury, as timing performance is a sensitive metric of information processing, while temporal cognition has the potential of influencing a wide range of cognitive processes. Moreover, temporal performance is a sensitive assay of damage to the underlying neural substrate after a brain insult. Further research in neurological and psychiatric patients will clarify whether time distortions are a manifestation of, or a mechanism for, cognitive and behavioral symptoms of neuropsychiatric disorders.	[Piras, Federica; Piras, Fabrizio; Ciullo, Valentina; Caltagirone, Carlo; Spalletta, Gianfranco] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Neuropsychiat Lab, Via Ardeatina 306, I-00179 Rome, Italy; [Danese, Emanuela] Univ Roma La Sapienza, Fac Med 2, St Andrea Hosp, NESMOS Dept, Rome, Italy		Spalletta, G (corresponding author), IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Neuropsychiat Lab, Via Ardeatina 306, I-00179 Rome, Italy.	g.spalletta@hsantalucia.it	Spalletta, Gianfranco/K-3828-2018; Ciullo, Valentina/AAC-5246-2022; Piras, Federica/AAC-4768-2022; Piras, Fabrizio/M-7902-2016	Spalletta, Gianfranco/0000-0002-7432-4249; Ciullo, Valentina/0000-0002-6870-6259; Piras, Federica/0000-0002-9546-7038; Piras, Fabrizio/0000-0003-3566-5494			Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Anderson JW, 2011, NEUROPSYCHOLOGY, V25, P36, DOI 10.1037/a0020333; Aparicio P, 2005, BRAIN COGNITION, V58, P62, DOI 10.1016/j.bandc.2004.09.009; BADLER J, 2008, J VIS, V8, P672, DOI DOI 10.1167/8.6.672; Balci Fuat, 2009, P161, DOI 10.1007/978-1-59745-422-3_8; Bares M, 2010, CEREBELLUM, V9, P124, DOI 10.1007/s12311-009-0133-5; Basso G, 1996, NEUROREPORT, V7, P2111, DOI 10.1097/00001756-199609020-00009; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Beste C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001263; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Bidwell LC, 2010, CURR PSYCHIAT REP, V12, P366, DOI 10.1007/s11920-010-0136-4; Blanchard MM, 2011, PSYCHOL MED, V41, P611, DOI 10.1017/S003329171000098X; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Buhusi CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006268; Buhusi CV, 2009, PHILOS T R SOC B, V364, P1875, DOI 10.1098/rstb.2009.0022; Buhusi CV, 2002, BEHAV NEUROSCI, V116, P291, DOI 10.1037//0735-7044.116.2.291; Carroll CA, 2009, BRAIN COGNITION, V70, P181, DOI 10.1016/j.bandc.2009.02.001; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Claassen DO, 2013, NEUROPSYCHOLOGIA, V51, P267, DOI 10.1016/j.neuropsychologia.2012.09.018; Coslett HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010324; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2012, J NEUROSCI, V32, P16704, DOI 10.1523/JNEUROSCI.1258-12.2012; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000166; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Danckert J, 2007, J COGNITIVE NEUROSCI, V19, P1706, DOI 10.1162/jocn.2007.19.10.1706; Foster SM, 2013, NEUROPSYCHOLOGIA, V51, P211, DOI 10.1016/j.neuropsychologia.2012.09.017; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Gallistel C.R., 1990, ORG LEARNING LEARNIN; Gibbon J, 1984, AN COGN P HF GUGGENH; Gilden DL, 2009, NEUROPSYCHOLOGY, V23, P265, DOI 10.1037/a0014553; Harrington DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017461; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 2004, BRAIN, V127, P561, DOI 10.1093/brain/awh065; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Head D, 2008, NEUROPSYCHOLOGY, V22, P491, DOI 10.1037/0894-4105.22.4.491; Henry MJ, 2015, CEREB CORTEX, V25, P450, DOI 10.1093/cercor/bht240; Huang J, 2012, RES DEV DISABIL, V33, P538, DOI 10.1016/j.ridd.2011.10.021; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jones CRG, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00081; Jones LA, 2004, Q J EXP PSYCHOL-B, V57, P55, DOI 10.1080/02724990344000088; Kagerer FA, 2002, NEUROPSYCHOLOGIA, V40, P357, DOI 10.1016/S0028-3932(01)00111-7; Kinsbourne M, 2002, NEUROBEHAVIOR LANGUA, P315; Kinsbourne M., 1990, NEUROPSYCHOLOGICAL I, P319, DOI DOI 10.1017/CBO9780511665547.017; Koch G, 2003, NEUROLOGY, V60, P1844, DOI 10.1212/WNL.60.11.1844; Koch G, 2002, NEUROLOGY, V59, P1658, DOI 10.1212/01.WNL.0000032504.45792.8F; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2012, PSYCHOLOGIST, V25, P594; Lustig C, 2005, BRAIN COGNITION, V58, P9, DOI 10.1016/j.bandc.2004.09.005; MACAR F, 2003, METH NE FRO NEUROSCI, P533; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Marx I, 2010, J NEURAL TRANSM, V117, P403, DOI 10.1007/s00702-009-0345-3; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; MECK WH, 1984, ANN NY ACAD SCI, V423, P528, DOI 10.1111/j.1749-6632.1984.tb23457.x; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Meck WH, 2002, LEARN MOTIV, V33, P88, DOI 10.1006/lmot.2001.1101; Melgire M, 2005, BRAIN COGNITION, V58, P119, DOI 10.1016/j.bandc.2004.09.013; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Mimura M, 2000, J INT NEUROPSYCH SOC, V6, P517, DOI 10.1017/S1355617700655017; Mioni G, 2013, BRAIN COGNITION, V81, P305, DOI 10.1016/j.bandc.2012.12.005; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; N'Diaye K, 2004, COGNITIVE BRAIN RES, V21, P250, DOI 10.1016/j.cogbrainres.2004.04.006; Nichelli P, 1995, ANN NY ACAD SCI, V769, P183, DOI 10.1111/j.1749-6632.1995.tb38139.x; Noulhiane M, 2007, NEUROREPORT, V18, P1035, DOI 10.1097/WNR.0b013e3281668be1; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Papageorgiou C, 2013, PROG NEURO-PSYCHOPH, V40, P173, DOI 10.1016/j.pnpbp.2012.07.017; Paulsen JS, 2004, AM J NEURORADIOL, V25, P1715; Penhune VB, 1999, NEUROPSYCHOLOGIA, V37, P315, DOI 10.1016/S0028-3932(98)00075-X; Penney TB, 2005, BRAIN COGNITION, V58, P109, DOI 10.1016/j.bandc.2004.09.012; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Perbal S, 2001, NEUROREPORT, V12, P939, DOI 10.1097/00001756-200104170-00015; Perbal S, 2000, NEUROCASE, V6, P347, DOI 10.1093/neucas/6.4.347; Perbal-Hatif Severine, 2012, Dialogues Clin Neurosci, V14, P425; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Piras F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018203; Pouthas V, 2004, ACTA NEUROBIOL EXP, V64, P367; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rammsayer TH, 1997, NEUROPSYCHOBIOLOGY, V35, P36, DOI 10.1159/000119328; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rammsayer TH, 2001, Q J EXP PSYCHOL-B, V54, P247, DOI 10.1080/02724990143000036; Rammsayer TH, 2001, EUR J COGN PSYCHOL, V13, P549, DOI 10.1080/09541440042000322; Roy M, 2012, PSYCHIAT RES, V200, P159, DOI 10.1016/j.psychres.2012.06.008; Rubia K, 1997, NEUROREPORT, V8, P1273, DOI 10.1097/00001756-199703240-00043; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; SHAW C, 1994, NEUROPSYCHOLOGIA, V32, P857, DOI 10.1016/0028-3932(94)90023-X; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith A, 2002, J CHILD PSYCHOL PSYC, V43, P529, DOI 10.1111/1469-7610.00043; Smith JG, 2007, BRAIN COGNITION, V64, P130, DOI 10.1016/j.bandc.2007.01.005; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Teixeira S, 2013, CNS NEUROL DISORD-DR, V12, P567; Toplak ME, 2005, PERCEPT MOTOR SKILL, V100, P659, DOI 10.2466/PMS.100.3.659-675; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Trivino M, 2010, BRAIN, V133, P1173, DOI 10.1093/brain/awp346; TYSK L, 1983, PERCEPT MOTOR SKILL, V56, P983, DOI 10.2466/pms.1983.56.3.983; Vallesi A, 2007, NEUROPSYCHOLOGIA, V45, P2755, DOI 10.1016/j.neuropsychologia.2007.04.017; Vidalaki VN, 1999, NEUROPSYCHOLOGIA, V37, P1061, DOI 10.1016/S0028-3932(98)00155-9; VONSTEINBUCHEL N, 1993, BEHAV BRAIN RES, V56, P1, DOI 10.1016/0166-4328(93)90017-K; WAHL OF, 1980, PERCEPT MOTOR SKILL, V50, P535, DOI 10.2466/pms.1980.50.2.535; Wearden JH, 2008, BRAIN COGNITION, V67, P264, DOI 10.1016/j.bandc.2008.01.010; Wearden JH, 1997, J EXP PSYCHOL HUMAN, V23, P962; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P129; Wearden JH, 1999, BEHAV PROCESS, V46, P25, DOI 10.1016/S0376-6357(98)00059-X; Wearden JH, 2001, Q J EXP PSYCHOL-B, V54, P289, DOI 10.1080/02724990042000173; Wiener M, 2008, NEUROPSYCHOLOGIA, V46, P1927, DOI 10.1016/j.neuropsychologia.2008.01.021; Wiener M, 2011, J COGNITIVE NEUROSCI, V23, P2811, DOI 10.1162/jocn.2011.21626; WILLIAMS JM, 1989, J CLIN EXP NEUROPSYC, V11, P713, DOI 10.1080/01688638908400927; Yin B, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00036; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zelaznik HN, 2012, HUM MOVEMENT SCI, V31, P255, DOI 10.1016/j.humov.2011.05.003	126	20	20	2	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	4								217	10.3389/fneur.2013.00217			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QV	WOS:000209629200006	24454304	Green Published, gold			2022-02-06	
J	Vanderploeg, RD; Donnell, AJ; Belanger, HG; Curtiss, G				Vanderploeg, Rodney D.; Donnell, Alison J.; Belanger, Heather G.; Curtiss, Glenn			Consolidation deficits in traumatic brain injury: The core and residual verbal memory defect	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Memory; Neuropsychological tests; Closed head injury; Longitudinal studies; Veterans health	CLOSED-HEAD-INJURY; LEARNING TEST; COGNITIVE SEQUELAE; FOLLOW-UP; RECOVERY; MODERATE; PERFORMANCE; RETRIEVAL; TBI; ORGANIZATION	While memory deficits are consistently found to be a salient problem in individuals with moderate to severe traumatic brain injury (TBI), the specific memory processes (i.e., encoding, consolidation, and retrieval) underlying the verbal memory deficit are disputed in the literature. The current study evaluated the recovery of these verbal memory processes over time. A TBI patient group evaluated acutely after the injury (baseline) and again at 6 months and 1 year post injury was compared to a demographically similar control group evaluated only once. The current results replicated previous findings in support of an impaired consolidation hypothesis as the primary deficit underlying memory impairment in TBI. These deficits are reflected in relatively more rapid forgetting through 1 year post injury and relatively less proactive interference up to 6 months post injury.	[Vanderploeg, Rodney D.; Donnell, Alison J.; Belanger, Heather G.; Curtiss, Glenn] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley Vet Hosp, HSR&D RR&D Ctr Excellence Maximizing Rehabil Outc, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Curtiss, Glenn] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.; Donnell, Alison J.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp Psychol Serv 116B, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Rodney.vanderploeg@va.gov	Curtiss, Glenn/ABB-5566-2020		Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Health Administration (VHA)US Department of Veterans Affairs; Defense and Veterans Brain Injury Center (DVBIC) through the U.S. Army Medical Research and Materiel Command [W81XWH-09-C-0026]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration (VHA), and the Defense and Veterans Brain Injury Center (DVBIC) through the U.S. Army Medical Research and Materiel Command under Contract No. W81XWH-09-C-0026. Further support was provided by the James A. Haley Veterans' Hospital.	Baddeley A., 2000, OXFORD HDB MEMORY, P77; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Broadbent D.E., 1958, PERCEPTION COMMUNICA, DOI [10.1037/10037-000, DOI 10.1037/10037-000]; Brown S.C., 2000, OXFORD HDB MEMORY, P93, DOI DOI 10.1016/J.ADOLESCENCE.2017.05.018; BUTTERS N, 1995, ANNU REV PSYCHOL, V46, P493; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Centers for Disease Control Vietnam Experience Study, 1988, JAMA-J AM MED ASSOC, V18, P2701; Centers for Disease Control Vietnam Experience Study, 1988, JAMA-J AM MED ASSOC, V18, P2708; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deluca J., 2004, COMPREHENSIVE HDB PS, P217; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; Hart R. P., 1994, NEUROPSYCHOLOGY, V8, P325, DOI [10.1037/0894-4105.8.3.325, DOI 10.1037/0894-4105.8.3.325]; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; JOHNSON MK, 1992, J COGNITIVE NEUROSCI, V4, P268, DOI 10.1162/jocn.1992.4.3.268; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2000, BRAIN INJURY, V14, P987; NOVACK TA, 1995, CLIN NEUROPSYCHOL, V9, P38; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Paolo AM, 1997, NEUROPSYCHOLOGY, V11, P613, DOI 10.1037/0894-4105.11.4.613; Postman L., 1971, EXPT PSYCHOL, P1019; Ruff R. M., 1991, J NEUROSURG, V75, P550; Spence K., 1968, PSYCHOL LEARNING MOT; Squire L. R., 1983, MEMORY CONSOLIDATION, P185; Squire LR., 1987, MEMORY BRAIN; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wills P, 2000, BRAIN INJURY, V14, P693; Wilson B. A., 1994, MEMORY, V2, P149; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Wright MJ, 2009, J CLIN EXP NEUROPSYC, V31, P790, DOI 10.1080/13803390802508918	56	20	20	2	10	TAYLOR & FRANCIS INC	PHILADELPHIA	520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2014	36	1					58	73		10.1080/13803395.2013.864600			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AI4KT	WOS:000336834800005	24303929				2022-02-06	
J	Vermetten, E; Greenberg, N; Boeschoten, MA; Delahaije, R; Jetly, R; Castro, CA; McFarlane, AC				Vermetten, Eric; Greenberg, Neil; Boeschoten, Manon A.; Delahaije, Roos; Jetly, Rakesh; Castro, Carl A.; McFarlane, Alexander C.			Deployment-related mental health support: comparative analysis of NATO and allied ISAF partners	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Military; deployment; mental health; NATO; review	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; NATIONAL-GUARD SOLDIERS; UK ARMED-FORCES; RANDOMIZED CONTROLLED-TRIAL; MILITARY PERSONNEL; PEACEKEEPING OPERATIONS; IRAQ RANDOMIZATION; RISK-MANAGEMENT; COMBAT STRESS	Background: For years there has been a tremendous gap in our understanding of the mental health effects of deployment and the efforts by military forces at trying to minimize or mitigate these. Many military forces have recently systematized the mental support that is provided to support operational deployments. However, the rationale for doing so and the consequential allocation of resources are felt to vary considerably across North Atlantic Treaty Organisation (NATO) International Security Assistance (ISAF) partners. This review aims to compare the organization and practice of mental support by five partnering countries in the recent deployment in Afghanistan in order to identify and compare the key methods and structures for delivering mental health support, describe bottlenecks and illustrate new developments. Method: Information was collected through document analysis and semi-structured interviews with key military mental healthcare stakeholders. The review resulted from close collaboration between key military mental healthcare professionals within the Australian Defense Forces (ADF), Canadian Armed Forces (CAF), United Kingdom Armed Forces (UK), Netherlands Armed Forces (NLD), and the United States Army (US). Key stakeholders were interviewed about the mental health support provided during a serviceperson's military career. The main items discussed were training, prevention, early identification, intervention, and aftercare in the field of mental health. Results: All forces reported that much attention was paid to mental health during the individual's military career, including deployment. In doing so there was much overlap between the rationale and applied methods. The main method of providing support was through training and education. The educative focus was to strengthen the mental resilience of individual soldiers while providing a range of mental healthcare services. All forces had abandoned standard psychological debriefing after critical incidents. Instead, by default, mental healthcare professionals acted to support the leader and peer led "after action'' reviews. All countries provided professional mental support close to the front line, aimed at early detection and early return to normal activities within the unit. All countries deployed a mental health support team that consisted of a range of mental health staff including psychiatrists, psychologists, social workers, mental health nurses, and chaplains. There was no overall consensus in the allocation of mental health disciplines in theatre. All countries (except the US) provided troops with a third location decompression (TLD) stop after deployment, which aimed to recognize what the deployed units had been through and to prepare them for transition home. The US conducted in-garrison 'decompression', or 'reintegration training' in the US, with a similiar focus to TLD. All had a reasonably comparable infrastructure in the field of mental healthcare. Shared bottlenecks across countries included perceived stigma and barriers to care around mental health problems as well as the need for improving the awareness and recognition of mental health problems among service members. Conclusion: This analysis demonstrated that in all five partners state-of-the-art preventative mental healthcare was included in the last deployment in Afghanistan, including a positive approach towards strengthening the mental resilience, a focus on self-regulatory skills and self-empowerment, and several initiatives that were well-integrated in a military context. These initiatives were partly/completely implemented by the military/colleagues/supervisors and applicable during several phases of the deployment cycle. Important new developments in operational mental health support are recognition of the role of social leadership and enhancement of operational peer support. This requires awareness of mental problems that will contribute to reduction of the barriers to care in case of problems. Finally, comparing mental health support services across countries can contribute to optimal preparation for the challenges of military deployment.	[Vermetten, Eric] Mil Mental Hlth Res, Dept Def, NL-3500 EZ Utrecht, Netherlands; [Vermetten, Eric] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Vermetten, Eric; Boeschoten, Manon A.] Arq Psychotrauma Res Grp, Diemen, Netherlands; [Greenberg, Neil] Kings Coll London, Weston Educ Ctr, Acad Ctr Def Mental Hlth, London, England; [Delahaije, Roos] Netherlands Org Appl Sci Res TNO, Def Safety & Secur, Soesterberg, Netherlands; [Jetly, Rakesh] Natl Def, Hlth Serv Grp, Directorate Mental Hlth, Ottawa, ON, Canada; [Castro, Carl A.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA; [McFarlane, Alexander C.] Univ Adelaide, Ctr Traumat Stress Studies, Adelaide, SA, Australia		Vermetten, E (corresponding author), Mil Mental Hlth Res, Lundlaan 1, NL-3500 EZ Utrecht, Netherlands.	hgjm.vermetten@mindef.nl	Vermetten, Eric/B-1335-2008	Vermetten, Eric/0000-0003-0579-4404; greenberg, neil/0000-0003-4550-2971; Boeschoten, Manon/0000-0001-5722-0731			Adler AB, 2008, MIL MED, V173, P10, DOI 10.7205/MILMED.173.1.10; Adler AB, 2013, MIL MED, V178, P760, DOI 10.7205/MILMED-D-12-00549; Adler AB, 2009, MIL MED, V174, P21, DOI 10.7205/MILMED-D-00-2208; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Bartone PT, 1998, MIL MED, V163, P587, DOI 10.1093/milmed/163.9.587; Britt T W, 2001, J Occup Health Psychol, V6, P53, DOI 10.1037/1076-8998.6.1.53; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Britt TW, 2012, PSYCHOL SERV, V9, P26, DOI 10.1037/a0026412; Britt TW, 2004, MIL MED, V169, P541, DOI 10.7205/MILMED.169.7.541; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Castro CA, 2012, J TRAUMA STRESS, V25, P376, DOI 10.1002/jts.21721; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Davidovitz R, 2007, J PERS SOC PSYCHOL, V93, P632, DOI 10.1037/0022-3514.93.4.632; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Engelhard IM, 2007, BRIT J PSYCHIAT, V191, P140, DOI 10.1192/bjp.bp.106.034884; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Goodwin L, 2012, J NERV MENT DIS, V200, P429, DOI 10.1097/NMD.0b013e31825322fe; Gould M, 2010, J ROY SOC MED, V103, P148, DOI 10.1258/jrsm.2010.090426; Greenberg N, 2011, OCCUP MED-OXFORD, V61, P184, DOI 10.1093/occmed/kqr022; Greenberg N, 2008, J R Army Med Corps, V154, P124; Greenberg N, 2010, J TRAUMA STRESS, V23, P430, DOI 10.1002/jts.20538; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horesh D, 2011, SOC PSYCH PSYCH EPID, V46, P863, DOI 10.1007/s00127-010-0255-6; Hunt E, 2013, OCCUP MED-OXFORD, V63, P549, DOI 10.1093/occmed/kqt113; Hyams KC, 2006, BMJ-BRIT MED J, V333, P979, DOI 10.1136/bmj.39023.648970.80; Institute of Medicine (IOM), 2014, PREV PSYCH DIS SERV; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Johnson WB, 2010, MIL MED, V175, P548, DOI 10.7205/MILMED-D-09-00119; Jones E, 2003, J TRAUMA STRESS, V16, P411, DOI 10.1023/A:1024426321072; Jones N, 2013, OCCUP ENVIRON MED, V70, P439, DOI 10.1136/oemed-2012-101229; Jones N, 2012, PSYCHIATRY, V75, P49, DOI 10.1521/psyc.2012.75.1.49; Jones N, 2010, PSYCHIATRY, V73, P352, DOI 10.1521/psyc.2010.73.4.352; Keller RT, 2005, MIL MED, V170, P355, DOI 10.7205/MILMED.170.5.355; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Mulligan K, 2011, PSYCHOL MED, V41, P673, DOI 10.1017/S003329171000125X; Mulligan K, 2012, J CONSULT CLIN PSYCH, V80, P331, DOI 10.1037/a0027664; Peterson C, 2011, AM PSYCHOL, V66, P10, DOI 10.1037/a0021658; Pfeiffer PN, 2012, MIL MED, V177, P1471, DOI 10.7205/MILMED-D-12-00115; Pietrzak Robert H, 2009, J Spec Oper Med, V9, P74; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Ruff Robert L, 2010, F1000 Med Rep, V2, P64, DOI 10.3410/M2-64; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Seligman MEP, 2011, AM PSYCHOL, V66, P82, DOI 10.1037/a0021898; Smid GE, 2013, SOC PSYCH PSYCH EPID, V48, P1743, DOI 10.1007/s00127-013-0709-8; Smid GE, 2009, J CLIN PSYCHIAT, V70, P1572, DOI 10.4088/JCP.08r04484; Smith TC, 2009, PUBLIC HEALTH REP, V124, P90, DOI 10.1177/003335490912400112; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Solomon Z, 2005, AM J PSYCHIAT, V162, P2309, DOI 10.1176/appi.ajp.162.12.2309; SOLOMON Z, 1991, SOC PSYCH PSYCH EPID, V26, P8, DOI 10.1007/BF00783574; SOLOMON Z, 1991, SOC PSYCH PSYCH EPID, V26, P1, DOI 10.1007/BF00783573; Solomon Z, 2006, J NERV MENT DIS, V194, P935, DOI 10.1097/01.nmd.0000249060.48248.ba; Steenkamp MM, 2013, AM J PREV MED, V44, P507, DOI 10.1016/j.amepre.2013.01.013; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; van Emmerik AAP, 2002, LANCET, V360, P766, DOI 10.1016/S0140-6736(02)09897-5; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wittchen HU, 2012, INT J METH PSYCH RES, V21, P98, DOI 10.1002/mpr.1356	70	20	20	0	42	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8066			EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2014	5								23732	10.3402/ejpt.v5.23732			19	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	AO2HD	WOS:000341138300001	25206953	gold, Green Published			2022-02-06	
J	Zhang, XP; Yan, XW; Gorman, J; Hoffman, SN; Zhang, L; Boscarino, JA				Zhang, Xiaopeng; Yan, Xiaowei; Gorman, Jennifer; Hoffman, Stuart N.; Zhang, Li; Boscarino, Joseph A.			Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						insulin resistance; neurocognitive disorders; intensive care; gender	CORONARY-ARTERY-BYPASS; TRAUMATIC BRAIN-INJURY; VENOUS OXYGEN-SATURATION; COGNITIVE DYSFUNCTION; INSULIN-RESISTANCE; CARDIOPULMONARY BYPASS; BLOOD-TRANSFUSION; DIABETES-MELLITUS; RANDOMIZED-TRIAL; GLUCOSE CONTROL	Objective: Neurocognitive disorders commonly occur following cardiac surgery. However, the underlying etiology of these disorders is not well understood. The current study examined the association between perioperative glucose levels and other risk factors and the onset of neurocognitive disorders in adult patients following coronary artery bypass and/or valvular surgery. Methods: Adult patients who underwent their first cardiac surgery at a large tertiary care medical center were identified and those with neurocognitive disorders prior to surgery were excluded. Demographic, perioperative, and postoperative neurocognitive outcome data were extracted from the Society for Thoracic Surgery database, and from electronic medical records, between January 2004 and June 2009. Multiple clinical risk factors and measures associated with insulin resistance, such as hyperglycemia, were assessed. Multivariable Cox competing risk survival models were used to assess hyperglycemia and postoperative neurocognitive disorders at follow up, adjusting for other risk factors and confounding variables. Results: Of the 855 patients included in the study, 271 (31.7%) had new onset neurocognitive disorders at follow-up. Age, sex, New York Heart Failure (NYHF) Class, length of postoperative intensive care unit stay, perioperative blood product transfusion, and other key factors were identified and assessed as potential risk factors (or confounders) for neurocognitive disorders at follow-up. Bivariate analyses suggested that new onset neurocognitive disorders were associated with NYHF Class, cardiopulmonary bypass, history of diabetes, intraoperative blood product use, and number of diseased coronary vessels, which are commonly-accepted risk factors in cardiac surgery. In addition, higher first glucose level (median=116 mg/dL) and higher peak glucose >169 mg/dL were identified as risk factors. Male sex and nonuse of intra-operative blood products appeared to be protective. Controlling for potential risk factors and confounders, multivariable Cox survival models suggested that increased perioperative first glucose measured in 20 unit increments, was significantly associated with the onset of postoperative neurocognitive disorders at follow-up (hazard ratio [HR]=1.16, P<0.001) and that women had an elevated risk for this outcome (HR=4.18, P=0.01). Conclusion: Our study suggests that perioperative hyperglycemia was associated with new onset of postoperative neurocognitive disorders in adult patients after cardiac surgery, and that men tended to be protected from these outcomes. These findings may suggest a need for the revision of clinical protocols for perioperative insulin therapy to prevent long-term neurocognitive complications.	[Zhang, Xiaopeng; Zhang, Li] Geisinger Med Ctr, Dept Anesthesiol, Danville, PA 17822 USA; [Yan, Xiaowei; Gorman, Jennifer; Boscarino, Joseph A.] Weis Ctr Res, Geisinger Clin, Ctr Hlth Res, Danville, PA 17822 USA; [Hoffman, Stuart N.] Geisinger Med Ctr, Dept Neurol, Danville, PA 17822 USA		Zhang, XP (corresponding author), Geisinger Med Ctr, Dept Anesthesiol, 100 North Acad Ave, Danville, PA 17822 USA.	xzhang1@geisinger.edu			Geisinger Clinic Research Fund	This work was funded by the Geisinger Clinic Research Fund. We would like to thank Ms Amanda Bengier and Ms Mary Ann Blosky, RN, for their assistance in data collection and project management, and Drs Alfred S Casale, Joel J Berberich, Xianren Wu and Thomas M Schieble for making this project possible.	Anastasiadis K, 2011, HEART, V97, P1082, DOI 10.1136/hrt.2010.218610; Anderson RE, 2005, EUR J CARDIO-THORAC, V28, P425, DOI 10.1016/j.ejcts.2005.05.025; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Boodhwani M, 2007, J THORAC CARDIOV SUR, V134, P1453, DOI 10.1016/j.jtcvs.2007.08.025; Boodhwani M, 2007, J THORAC CARDIOV SUR, V134, P1443, DOI 10.1016/j.jtcvs.2007.08.016; Boodhwani M, 2006, CIRCULATION, V114, pI461, DOI 10.1161/CIRCULATIONAHA.105.001354; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Bucciarelli-Ducci C, 2006, AM J CARDIOL, V98, P1349, DOI 10.1016/j.amjcard.2006.06.025; Charlson ME, 2007, J CARDIAC SURG, V22, P465, DOI 10.1111/j.1540-8191.2007.00471.x; Cheng DCH, 1996, J THORAC CARDIOV SUR, V112, P755, DOI 10.1016/S0022-5223(96)70062-4; de la Monte SM, 2010, J ALZHEIMERS DIS, V21, P967, DOI 10.3233/JAD-2010-091726; Degroot A, 2003, BRAIN RES, V979, P71, DOI 10.1016/S0006-8993(03)02868-3; Dennis SH, 2011, J NEUROSCI, V31, P11941, DOI 10.1523/JNEUROSCI.1183-11.2011; Dungan K, 2011, DIABETES OBES METAB, V13, P1130, DOI 10.1111/j.1463-1326.2011.01474.x; Faivre E, 2011, J NEUROPHYSIOL, V105, P1574, DOI 10.1152/jn.00866.2010; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gerriets T, 2010, EUR HEART J, V31, P360, DOI 10.1093/eurheartj/ehp178; Gold JP, 2004, ANN THORAC SURG, V78, P1579, DOI 10.1016/j.athoracsur.2004.05.051; Gore DC, 2001, J TRAUMA, V51, P540, DOI 10.1097/00005373-200109000-00021; Grigore AM, 2002, ANESTH ANALG, V94, P4, DOI 10.1097/00000539-200201000-00002; Haljan G, 2009, STROKE, V40, P2769, DOI 10.1161/STROKEAHA.109.549436; Hammon JW, 2006, J THORAC CARDIOV SUR, V131, P114, DOI 10.1016/j.jtcvs.2005.08.057; Hannerz H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000180; Heo K, 2003, CEREBROVASC DIS, V15, P230, DOI 10.1159/000068825; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Hogue CW, 2003, ANN THORAC SURG, V76, P1119, DOI 10.1016/S0003-4975(03)00817-8; Holinski S, 2011, ANN THORAC CARDIOVAS, V17, P137, DOI 10.5761/atcs.oa.10.01545; Howell NJ, 2011, CIRCULATION, V123, P170, DOI 10.1161/CIRCULATIONAHA.110.945170; Hudetz JA, 2009, ACTA ANAESTH SCAND, V53, P864, DOI 10.1111/j.1399-6576.2009.01978.x; Hui L, 2005, BRAIN RES, V1052, P1, DOI 10.1016/j.brainres.2005.05.043; Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kadoi Y, 2005, J THORAC CARDIOV SUR, V129, P576, DOI 10.1016/j.jtcvs.2004.07.012; Kawahara F, 2003, ACTA ANAESTH SCAND, V47, P419, DOI 10.1034/j.1399-6576.2003.00063.x; Kozora E, 2010, ANN THORAC SURG, V90, P1134, DOI 10.1016/j.athoracsur.2010.05.076; Krebs-Kraft DL, 2008, NEUROBIOL LEARN MEM, V89, P142, DOI 10.1016/j.nlm.2007.07.008; Lang BT, 2009, BRAIN RES, V1258, P25, DOI 10.1016/j.brainres.2008.12.026; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Lennmyr F, 2010, CRIT CARE MED, V38, P1726, DOI 10.1097/CCM.0b013e3181e7982e; Martin ED, 2012, CEREB CORTEX, V22, P1717, DOI 10.1093/cercor/bhr216; Mathew JP, 2009, STROKE, V40, P880, DOI 10.1161/STROKEAHA.108.531236; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Moreira T, 2007, NEUROSCIENCE, V144, P1169, DOI 10.1016/j.neuroscience.2006.10.054; Nagasawa H, 2005, J NEUROL, V252, P1541, DOI 10.1007/s00415-005-0878-9; Notzold A, 2006, THORAC CARDIOV SURG, V54, P307, DOI 10.1055/s-2006-924089; Nuttall GA, 1998, CRIT CARE MED, V26, P1351, DOI 10.1097/00003246-199808000-00019; Pei D, 2003, J ENDOCRINOL INVEST, V26, P397, DOI 10.1007/BF03345193; Porizka M, 2011, EUR J CARDIO-THORAC, V39, P442, DOI 10.1016/j.ejcts.2010.11.054; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Saczynski JS, 2008, AM J EPIDEMIOL, V168, P1132, DOI 10.1093/aje/kwn228; Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449; Siepe M, 2011, EUR J CARDIO-THORAC, V40, P200, DOI 10.1016/j.ejcts.2010.11.024; Silbert BS, 2006, ANESTHESIOLOGY, V104, P1137, DOI 10.1097/00000542-200606000-00007; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Stanley TO, 2002, ANESTH ANALG, V94, P290, DOI 10.1097/00000539-200202000-00011; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Szalma I, 2006, ANN THORAC SURG, V82, P1430, DOI 10.1016/j.athoracsur.2006.05.005; Tong M, 2009, J ALZHEIMERS DIS, V17, P827, DOI 10.3233/JAD-2009-1115; van Dijk D, 2007, JAMA-J AM MED ASSOC, V297, P701, DOI 10.1001/jama.297.7.701; VENN GE, 1995, ANN THORAC SURG, V59, P1331, DOI 10.1016/0003-4975(95)00096-4; Verhoeven JJ, 2011, PEDIATR CARDIOL, V32, P131, DOI 10.1007/s00246-010-9829-z; VOLL CL, 1991, J CEREBR BLOOD F MET, V11, P1006, DOI 10.1038/jcbfm.1991.168; Williamson JD, 2007, AM J CARDIOL, V99, p112I, DOI 10.1016/j.amjcard.2007.03.029; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Yamada S, 2005, CEREBROVASC DIS, V20, P164, DOI 10.1159/000087200; Yoshitani K, 2001, ANESTH ANALG, V92, P1370; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhong J, 2009, NEUROL RES, V31, P483, DOI 10.1179/174313208X338133	71	20	22	0	6	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2014	10						361	369		10.2147/NDT.S57761			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	AB5ZD	WOS:000331866300001	24570589	Green Published, Green Submitted, gold			2022-02-06	
J	Robertson, CL; Saraswati, M; Scafidi, S; Fiskum, G; Casey, P; McKenna, MC				Robertson, Courtney L.; Saraswati, Manda; Scafidi, Susanna; Fiskum, Gary; Casey, Paula; McKenna, Mary C.			Cerebral Glucose Metabolism in an Immature Rat Model of Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						developmental brain injury; metabolism; mitochondria; NMR spectroscopy; trauma	MAGNETIC-RESONANCE-SPECTROSCOPY; CONTROLLED CORTICAL IMPACT; C-13 NMR; GLIAL METABOLISM; GLUTAMINE CYCLE; AMINO-ACIDS; IN-VIVO; ASTROCYTES; DYSFUNCTION; TRAFFICKING	Altered cerebral metabolism and mitochondrial function have been identified in experimental and clinical studies of pediatric traumatic brain injury (TBI). Metabolic changes detected using H-1 (proton) magnetic resonance spectroscopy correlate with long-term outcomes in children after severe TBI. We previously identified early (4-h) and sustained (24-h and 7-day) abnormalities in brain metabolites after controlled cortical impact (CCI) in immature rats. The current study aimed to identify specific alterations of cerebral glucose metabolism at 24h after TBI in immature rats. Rats (postnatal days 16-18) underwent CCI to the left parietal cortex. Sham rats underwent craniotomy only. Twenty-four hours after CCI, rats were injected (intraperitoneally) with [1,6-C-13]glucose. Brains were removed, separated into hemispheres, and frozen. Metabolites were extracted with perchloric acid and analyzed using H-1 and C-13-nuclear magnetic resonance spectroscopy. TBI resulted in decreases in N-acetylaspartate in both hemispheres, compared to sham contralateral. At 24h after TBI, there was significant decrease in the incorporation of C-13 label into [3-C-13]glutamate and [2-C-13]glutamate in the injured brain. There were no differences in percent enrichment of [3-C-13]glutamate, [4-C-13]glutamate, [3-C-13]glutamine, or [4-C-13]glutamine. There was significantly lower percent enrichment of [2-C-13]glutamate in both TBI sides and the sham craniotomy side, compared to sham contralateral. No differences were detected in enrichment of C-13 glucose label in [2-C-13]glutamine, [2-C-13]GABA (gamma-aminobutyric acid), [3-C-13]GABA, or [4-C-13]GABA, [3-C-13]lactate, or [3-C-13]alanine between groups. Results suggest that overall oxidative glucose metabolism in the immature brain recovers at 24h after TBI. Specific reductions in [2-C-13]glutamate could be the result of impairments in either neuronal or astrocytic metabolism. Future studies should aim to identify pathways leading to decreased metabolism and develop cell-selective metabolic rescue.	[Robertson, Courtney L.; Saraswati, Manda; Scafidi, Susanna] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Robertson, Courtney L.; Scafidi, Susanna] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21287 USA; [Casey, Paula; McKenna, Mary C.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [McKenna, Mary C.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA		Robertson, CL (corresponding author), Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, 1800 Orleans St,Bloomberg Childrens Room 6321, Baltimore, MD 21287 USA.	crober48@jhmi.edu		Scafidi, Susanna/0000-0002-1229-8778	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 NS42805, 5P01 HD016596, K08 NS069815]; University of Maryland Department of Pediatrics (SRIS grant); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS069815, K08NS042805] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (grants K08 NS42805, 5P01 HD016596, and K08 NS069815) and the the University of Maryland Department of Pediatrics (SRIS grant).	Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cremer J E, 1974, Biochem J, V142, P527; DEVIVO DC, 1975, J NEUROCHEM, V25, P161, DOI 10.1111/j.1471-4159.1975.tb12244.x; Eid T, 2012, NEUROCHEM RES, V37, P2339, DOI 10.1007/s11064-012-0766-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Haberg A, 1998, J CEREBR BLOOD F MET, V18, P1223, DOI 10.1097/00004647-199811000-00008; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N; HOLTZMAN D, 1975, J NEUROCHEM, V24, P1011, DOI 10.1111/j.1471-4159.1975.tb03670.x; HOLTZMAN D, 1973, BIOL NEONATE, V22, P230; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marin-Valencia I, 2012, NEUROCHEM INT, V61, P1036, DOI 10.1016/j.neuint.2012.07.020; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; McKenna MC, 1996, J NEUROCHEM, V66, P386; Melo TM, 2005, J CEREBR BLOOD F MET, V25, P1254, DOI 10.1038/sj.jcbfm.9600128; Melo TM, 2006, J CEREBR BLOOD F MET, V26, P1496, DOI 10.1038/sj.jcbfm.9600300; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Qu H, 2003, NEUROCHEM INT, V42, P101, DOI 10.1016/S0197-0186(02)00051-7; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Richards EM, 2007, STROKE, V38, P1578, DOI 10.1161/STROKEAHA.106.473967; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; SONNEWALD U, 1993, NEUROCHEM INT, V22, P19, DOI 10.1016/0197-0186(93)90064-C; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; Walls AB, 2011, J CEREBR BLOOD F MET, V31, P494, DOI 10.1038/jcbfm.2010.115; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zwingmann C, 2003, NMR BIOMED, V16, P370, DOI 10.1002/nbm.850	51	20	20	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2013	30	24					2066	2072		10.1089/neu.2013.3007			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	271QK	WOS:000328406500008	24032394	Green Published			2022-02-06	
J	Di Ieva, A; Schmitz, EM; Cusimano, MD				Di Ieva, Antonio; Schmitz, Erika M.; Cusimano, Michael D.			Analysis of Intracranial Pressure: Past, Present, and Future	NEUROSCIENTIST			English	Article						fractal analysis; intracranial pressure; neuromonitoring; nonlinear analysis; time series; traumatic brain injury	ARTIFICIAL NEURAL-NETWORKS; DETRENDED FLUCTUATION ANALYSIS; HEART-RATE-VARIABILITY; LEMPEL-ZIV COMPLEXITY; WAVE-FORM; FRACTAL CHARACTERIZATION; STATISTICAL PHYSICS; APPROXIMATE ENTROPY; TIME-SERIES; HYPERTENSION	The monitoring of intracranial pressure (ICP) is an important tool in medicine for its ability to portray the brain's compliance status. The bedside monitor displays the ICP waveform and intermittent mean values to guide physicians in the management of patients, particularly those having sustained a traumatic brain injury. Researchers in the fields of engineering and physics have investigated various mathematical analysis techniques applicable to the waveform in order to extract additional diagnostic and prognostic information, although they largely remain limited to research applications. The purpose of this review is to present the current techniques used to monitor and interpret ICP and explore the potential of using advanced mathematical techniques to provide information about system perturbations from states of homeostasis. We discuss the limits of each proposed technique and we propose that nonlinear analysis could be a reliable approach to describe ICP signals over time, with the fractal dimension as a potential predictive clinically meaningful biomarker. Our goal is to stimulate translational research that can move modern analysis of ICP using these techniques into widespread practical use, and to investigate to the clinical utility of a tool capable of simplifying multiple variables obtained from various sensors.	[Di Ieva, Antonio; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Di Ieva, Antonio; Schmitz, Erika M.; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada		Di Ieva, A (corresponding author), St Michaels Hosp, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	diieva@hotmail.com	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650; Di Ieva, Antonio/0000-0002-5341-5416			Aboy M, 2001, P ANN INT IEEE EMBS, V23, P2231, DOI 10.1109/IEMBS.2001.1017216; Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Anderson JL, 1997, J AM COLL CARDIOL, V30, P226, DOI 10.1016/S0735-1097(97)00108-3; Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; Ang B.T., 2010, P 10 IEEE INT C INF, P1; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Bellotti A, 2001, CLIN NEUROL NEUROSUR, V103, P223, DOI 10.1016/S0303-8467(01)00154-8; Bravi A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-90; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Caccia DC, 1997, PHYSICA A, V246, P609, DOI 10.1016/S0378-4371(97)00363-4; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Di Ieva A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00429; DILEVA A, 2012, NEURORADIOLOGY; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; Eide PK, 2010, ACTA NEUROL SCAND, V122, P262, DOI 10.1111/j.1600-0404.2009.01304.x; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Eide PK, 2012, J NEUROSURG, V116, P961, DOI 10.3171/2012.1.JNS111313; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Fan JY, 2010, BIOL RES NURS, V11, P317, DOI 10.1177/1099800409349164; Fausett L., 1994, FUNDAMENTALS NEURAL; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GREENBERG MS, 2006, HDB NEUROSURGERY, P866; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; Havlin S, 1999, PHYSICA A, V274, P99, DOI 10.1016/S0378-4371(99)00333-7; Heissler Hans E, 2012, Acta Neurochir Suppl, V114, P87, DOI 10.1007/978-3-7091-0956-4_15; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Holm S, 2008, MED ENG PHYS, V30, P164, DOI 10.1016/j.medengphy.2007.03.003; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hornero R, 2007, MED BIOL ENG COMPUT, V45, P617, DOI 10.1007/s11517-007-0194-x; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; IYENGAR N, 1996, AM J PHYSL 2, V271, pR1028; Jospin M, 2007, IEEE T BIO-MED ENG, V54, P840, DOI 10.1109/TBME.2007.893453; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kenkel NC., 1996, COENOSES, V11, P77, DOI DOI 10.1002/PBC; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8; Mandelbrot BB., 1982, FRACTAL GEOMETRY NAT; Mariak Z, 2000, ACTA NEUROCHIR, V142, P407, DOI 10.1007/s007010050450; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; Morgalla MH, 1999, J NEUROL SCI, V168, P90, DOI 10.1016/S0022-510X(99)00137-9; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Perkiomaki JS, 2001, AM J CARDIOL, V88, P17, DOI 10.1016/S0002-9149(01)01578-8; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Santamarta D, 2010, CHILD NERV SYST, V26, P1683, DOI 10.1007/s00381-010-1244-5; Scalzo F, 2012, IEEE PULSE, V3, P49, DOI 10.1109/MPUL.2011.2181024; SCHEPERS HE, 1992, IEEE ENG MED BIOL, V11, P57, DOI 10.1109/51.139038; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Shaw M, 2008, ACT NEUR S, V102, P229, DOI 10.1007/978-3-211-85578-2_44; Shieh JS, 2004, NEUROCOMPUTING, V57, P239, DOI 10.1016/j.neucom.2003.10.006; SHIELDS CB, 1984, NEUROSURGERY, V14, P592, DOI 10.1227/00006123-198405000-00014; Stadnitski T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00127; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; STANLEY HE, 1988, NATURE, V335, P405, DOI 10.1038/335405a0; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; SZEWCZYKOWSKI J, 1977, J NEUROSURG, V47, P19, DOI 10.3171/jns.1977.47.1.0019; SZEWCZYKOWSKI J, 1976, J NEUROSURG, V45, P155, DOI 10.3171/jns.1976.45.2.0155; Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8; Varela M, 2003, EUR J APPL PHYSIOL, V89, P230, DOI 10.1007/s00421-002-0790-2; Weiss B, 2009, J NEUROSCI METH, V185, P116, DOI 10.1016/j.jneumeth.2009.07.027; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; West BJ, 2010, FRONT PHYSIOL, V1, DOI [10.3389/fphys.2010.00012, 10.3389/fphys.2010.00001]; Westhout FD, 2008, SURG NEUROL, V70, P70, DOI 10.1016/j.surneu.2007.04.020; Zhang F, 2011, IEEE ENG MED BIO, P7111, DOI 10.1109/IEMBS.2011.6091797; Zhang XS, 1999, IEEE T BIO-MED ENG, V46, P548, DOI 10.1109/10.759055; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	89	20	21	0	32	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	DEC	2013	19	6					592	603		10.1177/1073858412474845			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247WG	WOS:000326653000010	23389057				2022-02-06	
J	Hawley, C; Wilson, J; Hickson, C; Mills, S; Ekeocha, S; Sakr, M				Hawley, Carol; Wilson, James; Hickson, Craig; Mills, Sara; Ekeocha, Samila; Sakr, Magdy			Epidemiology of paediatric minor head injury: Comparison of injury characteristics with Indices of Multiple Deprivation	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injury; Trauma; Paediatric; Information; Emergency department; Epidemiology; Deprivation; Population	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENTS; UNINTENTIONAL INJURY; CHILDREN; CHILDHOOD; RISK; HOME; AGE; ETHNICITY; ACCIDENT	Background: Head injury (HI) is a common presentation to Child Emergency Departments (CEDs), but the actual number of children attending with minor HI is unclear. Most research has focussed on admitted patients, often relying on hospital-coded admission data. We studied the incidence of minor HI presenting to the CED of a major teaching hospital in Coventry and Warwickshire. HI attendances were compared with population data to identify injury patterns relating to deprivation. Methods: All CED admissions were screened by the research team, and data on minor head injuries (GCS 13-15) collected prospectively from 1st January until 31st August 2011. Information was collected on demographics, ethnicity, cause and severity of injury, injury location (in or outside the home), other injuries and mode of arrival. Deprivation data were obtained by cross-referencing postcodes with English Indices of Multiple Deprivation (IMD 2010). For comparison, the hospital audit department provided figures for coded head injuries during the same period. Results: During the 8 month period, hand-searching identified 1747 children with minor HI, aged between 0 and 16 years. Of these 99% had minimal HI (GCS 15 or 'alert'). In the same period, hospitalcoded minor HIs numbered only 1081. HIs formed 9% of all CED attendances. Thirteen children returned to the CED with worrying symptoms after discharge home. Approximately 3.4% of the local paediatric population attend the CED with HI per year (3419/ 100,000 population). Falls accounted for 62% of HIs overall, rising to 77% in children aged 0-5. Most in-home head injuries (81%) were the result of falls (p < 0.0001). Significantly more injuries took place inside the home for 0-5 year olds (58%) than for older children (20%) (p < 0.0001). Children living in the most deprived areas were more likely to attend the CED with HI (RR: 1.19; CI: 1.06-1.35, p = 0.004), and arrive using emergency services (OR: 1.77; CI: 1.302.40, p < 0.001). There were no significant differences between the deprived and non-deprived groups for location or cause of injury. Conclusions: Young children are particularly at risk of HI and parents should be offered information on injury prevention. More children from deprived areas attended with HI and these families may benefit most from targeted interventions. (C) 2013 Elsevier Ltd. All rights reserved.	[Hawley, Carol; Wilson, James; Mills, Sara; Ekeocha, Samila] Univ Warwick, Sch Med, Coventry CV4 7AL, W Midlands, England; [Hickson, Craig; Sakr, Magdy] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England		Hawley, C (corresponding author), Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England.	c.a.hawley@warwick.ac.uk	Hawley, Carol/AAG-3830-2019		University Research Scholarship Scheme	Drs Hickson, JW, SM and SE shared a small bursary provided by the University Research Scholarship Scheme.	Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; Beattie TF, 2001, EMERG MED J, V18, P110, DOI 10.1136/emj.18.2.110; Beattie TF, 1997, ARCH DIS CHILD, V77, P82, DOI 10.1136/adc.77.1.82; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 S; Department of Health, 2010, HOSP EP STAT ACC EM; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; GARLING A, 1993, J PEDIATR PSYCHOL, V18, P105, DOI 10.1093/jpepsy/18.1.105; GLIK DC, 1993, J PEDIATR PSYCHOL, V18, P115, DOI 10.1093/jpepsy/18.1.115; Green SA, 2013, J PUBLIC HEALTH-UK, V35, P286, DOI 10.1093/pubmed/fds071; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kendrick D, 2009, INJURY PREV, V15, P197, DOI 10.1136/ip.2008.020677; Kendrick D., 2007, COCHRANE DB SYST REV, V24; Khambalia A, 2006, INJURY PREV, V12, P378, DOI 10.1136/ip.2006.012161; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laflamme L, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/819687; Laing GJ, 1999, PUBLIC HEALTH, V113, P291, DOI 10.1016/S0033-3506(99)00182-1; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; NERSESIAN WS, 1985, PEDIATRICS, V75, P41; NICE, 2007, HEAD INJ TRIAG ASS I; Office for National Statistics, 2012, POP HOUS EST ENGL WA; Office for National Statistics, 2011, CENS; Pearson M, 2011, HEALTH PROMOT INT, V26, P376, DOI 10.1093/heapro/daq074; RIVARA FP, 1987, J SOC ISSUES, V43, P13, DOI 10.1111/j.1540-4560.1987.tb01292.x; Roberts I, 1996, BRIT MED J, V312, P29, DOI 10.1136/bmj.312.7022.29; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Strong Mark, 2006, Int J Health Geogr, V5, P29, DOI 10.1186/1476-072X-5-29; TEASDALE G, 1974, LANCET, V2, P81; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	41	20	20	0	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2013	44	12					1855	1861		10.1016/j.injury.2013.07.021			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	244GV	WOS:000326376500030	23958554				2022-02-06	
J	Peleg, RK; Fishlev, G; Bechor, Y; Bergan, J; Friedman, M; Koren, S; Tirosh, A; Efrati, S				Peleg, Ronit Koren; Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony; Koren, Shlomit; Tirosh, Amit; Efrati, Shai			Effects of hyperbaric oxygen on blood glucose levels in patients with diabetes mellitus, stroke or traumatic brain injury and healthy volunteers: a prospective, crossover, controlled trial	DIVING AND HYPERBARIC MEDICINE			English	Article						Hyperbaric oxygen; blood glucose; prospective controlled trial; blood pressure; heart rate	THERAPY	Introduction: A decrease in blood glucose levels (BGL) during hyperbaric oxygen treatment (HBOT) is a well-recognised phenomenon, but studies of this are limited and inconclusive. This study evaluated the effect of HBOT on BGL in patients with diabetes mellitus (DM), traumatic brain injury (TBI) or stroke and healthy volunteers in a prospective, open, controlled trial. Methods: Thirty-nine participants were enrolled and evaluated twice: once during HBOT (90 minutes at 203 kPa), and once during a control session on normobaric air. Sessions were held up to two weeks apart and participants were instructed to eat the same diet. BGI was measured before, during and at the completion of each session. Results: For the whole study group, there was a small but statistically significant decrease in BGL in both the HBOT (7.27 +/- 3.66 mmol L-1 before to 6.71 +/- 3.88 mmol L-1 after, P = 0.037) and control (air) sessions (7.43 +/- 3.49 mmol L-1 before to 6.71 +/- 3.77 mmol L-1 after, P = 0.004). This fall did not differ between the two conditions (P = 0.59). Examining the three groups separately, BGL fell in all three subgroups, but this fall was only statistically significant for the air session in the diabetic group. There were no statistically significant differences in the BGL reduction when HBOT was compared to normobaric air in any of the three subgroups. Conclusions: BGL may decrease during HBOT and accordingly it should be monitored before entering the chamber. However, this decrease in BGL should probably not be attributed to the hyperbaric environment per se.	[Peleg, Ronit Koren; Koren, Shlomit; Tirosh, Amit; Efrati, Shai] Assaf Harofeh Med Ctr, Dept Internal Med A, IL-70300 Zerifin, Israel; [Peleg, Ronit Koren; Koren, Shlomit; Tirosh, Amit; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Fishlev, Gregori; Bechor, Yair; Bergan, Jacob; Friedman, Mony] Assaf Harofeh Med Ctr, Inst Hyperbar Med, IL-70300 Zerifin, Israel; [Koren, Shlomit; Tirosh, Amit; Efrati, Shai] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Peleg, RK (corresponding author), Assaf Harofeh Med Ctr, Dept Internal Med A, IL-70300 Zerifin, Israel.	ronitkoren@gmail.com		Tirosh, Amit/0000-0003-3794-9634			Al-Waili NS, 2006, ARCH MED RES, V37, P991, DOI 10.1016/j.arcmed.2006.05.009; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; DEDOV I I, 1987, Problemy Endokria, V33, P10; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Ekanayake L., 2001, S PAC UNDERW MED SOC, V31, P16; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Jungehulsing GJ, 2013, ACTA NEUROL SCAND, V127, P427, DOI 10.1111/ane.12070; Leach RM, 1998, BRIT MED J, V317, P1140; Neuman TS., 2008, PHYSL MED HYPERBARIC; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; TORBATI D, 1985, NEUROSCI LETT, V55, P109, DOI 10.1016/0304-3940(85)90003-5; Trytko B., 2003, S PAC UNDERW MED SOC, V33, P62; Wilkinson D, 2012, DIABETIC MED, V29, P986, DOI 10.1111/j.1464-5491.2012.03587.x	13	20	24	0	3	SOUTH PACIFIC UNDERWATER MED SOC	MELBOURNE	C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE, VIC 3004, AUSTRALIA	1833-3516			DIVING HYPERB MED	Diving Hyperb. Med.	DEC	2013	43	4					218	221					4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	281CG	WOS:000329076500003	24510327				2022-02-06	
J	Leng, DD; Han, WJ; Rui, Y; Dai, Y; Xia, YF				Leng, Dan-dan; Han, Wen-jing; Rui, Yao; Dai, Yue; Xia, Yu-feng			In vivo disposition and metabolism of madecassoside, a major bioactive constituent in Centella asiatica (L.) Urb.	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Madecassoside; Tissue distribution; Excretion; Metabolism; Enterohepatic circulation; Hepatobiliary transporter	COLLAGEN-INDUCED ARTHRITIS; TISSUE DISTRIBUTION; RAT; PHARMACOKINETICS; EXCRETION	Ethnopharmacological relevance: Centella asiatica (L.) Urb. herb is frequently used in traditional Chinese medicine for many indications, such as traumatic injuries, keloid and scar. Madecassoside is the main active ingredient of this herb drug with higher content than other triterpenoid constituents. Understandings of pharmacokinetic profiles of madecassoside should be beneficial for its development as a therapeutic agent. Materials and methods: Sprague-Dawley rats were intravenously and orally administered madecassoside (100 mg/kg), respectively. Plasma, heart, liver, spleen, lung, kidney, brain, bile, urine and feces were collected at the designed time points. Madecassoside concentrations in biological samples were determined by a sensitive and well-validated liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) method. A liquid chromatography coupled with time-of-flight mass spectrometry (LC-TOF-MS) method was established to identify its major metabolites in feces. To further pursue the disposition characteristics of madecassoside in rats, the involvement of the hepatobiliary efflux transporters in biliary elimination were studied by combination with digoxin (P-glycoprotein inhibitor) or probenecid (multidrug resistance-associated protein inhibitor). A linked-rat model was also used to assess the role of enterohepatic circulation in the pharmacokinetics of madecassoside. Results: After a single oral dosing, madecassoside was widely distributed in heart, liver, spleen, lung and kidney of rats, and the levels of madecassoside in liver and kidney were relatively higher than other organs. The excretions of madecassoside in bile, urine and feces were 7.16% (0-12 h), 0.25% (0-72 h) and 24.68% (0-72 h), respectively. The findings suggested that madecassoside might excrete mainly by metabolites. The combination with either digoxin or probenecid significantly attenuated the excretion of madecassoside as parent from bile, indicating that P-glycoprotein and multidrug resistance-associated protein might contribute to the hepatobiliary elimination of madecassoside. The presence of enterohepatic circulation, as implied by double-humped profiles in plasma and tissue concentration-time curves, was confirmed by a linked-rat model. Furthermore, three metabolities of madecassoside were indentified in rat feces and the possible metabolic pathways were proposed. Conclusions: These findings provide valuable information regarding in vivo process of madecassoside, and help us to recognize the efficacy and safety of madecassoside itself, the relevant herbs or herbal preparations. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Leng, Dan-dan; Han, Wen-jing; Dai, Yue; Xia, Yu-feng] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China; [Leng, Dan-dan; Han, Wen-jing; Rui, Yao; Xia, Yu-feng] China Pharmaceut Univ, Dept Chinese Mat Med Anal, Nanjing 210009, Peoples R China; [Dai, Yue] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Nanjing 210009, Peoples R China		Xia, YF (corresponding author), China Pharmaceut Univ, Dept Chinese Mat Med Anal, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.	yfxiacpu@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81173631]; National Innovative Research Plan for Undergraduate Students of China [J0630858]; Qing lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	The research was financially supported by the National Natural Science Foundation of China (No. 81173631), National Innovative Research Plan for Undergraduate Students of China (No. J0630858), Qing lan Project of Jiangsu Province, and partially funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	BOITEAU P, 1956, Therapie, V11, P125; Cao W, 2010, INT IMMUNOPHARMACOL, V10, P723, DOI 10.1016/j.intimp.2010.03.015; Chen LH, 2013, J ETHNOPHARMACOL, V145, P77, DOI 10.1016/j.jep.2012.09.054; Fardel O, 2001, TOXICOLOGY, V167, P37, DOI 10.1016/S0300-483X(01)00456-5; Han WJ, 2012, BIOMED CHROMATOGR, V26, P26, DOI 10.1002/bmc.1620; Li Gui-gui, 2007, Yaoxue Xuebao, V42, P475; Li HZ, 2009, PHYTOMEDICINE, V16, P538, DOI 10.1016/j.phymed.2008.11.002; Liu M, 2008, INT IMMUNOPHARMACOL, V8, P1561, DOI 10.1016/j.intimp.2008.06.011; Liu M, 2008, PLANTA MED, V74, P809, DOI 10.1055/s-2008-1074533; Liu Mu-Rong, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P440; Marier JF, 2002, J PHARMACOL EXP THER, V302, P369, DOI 10.1124/jpet.102.033340; Song J, 2012, BURNS, V38, P677, DOI 10.1016/j.burns.2011.12.017; Sun XH, 2009, J PHARMACEUT BIOMED, V50, P27, DOI 10.1016/j.jpba.2009.03.011; Thomas MT, 2010, IND CROP PROD, V32, P545, DOI 10.1016/j.indcrop.2010.07.003; Wang R, 2008, J PHOTOCH PHOTOBIO B, V90, P179, DOI 10.1016/j.jphotobiol.2008.01.003; 张蕾磊, 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P455	16	20	24	1	37	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741	1872-7573		J ETHNOPHARMACOL	J. Ethnopharmacol.	NOV 25	2013	150	2					601	608		10.1016/j.jep.2013.09.004			8	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	260AR	WOS:000327567900024	24091240				2022-02-06	
J	Zhang, J; Xiong, Y; Lu, LX; Wang, H; Zhang, YF; Fang, F; Song, YL; Jiang, H				Zhang, J.; Xiong, Y.; Lu, L. X.; Wang, H.; Zhang, Y. F.; Fang, F.; Song, Y. L.; Jiang, H.			AQP1 EXPRESSION ALTERATIONS AFFECT MORPHOLOGY AND WATER TRANSPORT IN SCHWANN CELLS AND HYPDXIA-INDUCED UP-REGULATION OF AQP1 OCCURS IN A HIF-1 alpha-DEPENDENT MANNER	NEUROSCIENCE			English	Article						AQP1; Schwann cells; peripheral nerve system; nerve edema; water transport; HIF-1 alpha	PERIPHERAL NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; RAT ASTROCYTES; HYPOXIA; AQUAPORIN-1; MICE; HOMEOSTASIS; INDUCTION; ISCHEMIA; LESSONS	Aquaporin-1 (AQP1) is the principle water channel in the peripheral nervous system (PNS) and is specifically localized to Schwann cells in the PNS. However, the pathophysiological role of AQP1 in peripheral nerves is poorly understood. Here, we utilized RNA interference by lentiviral transduction to specifically down-regulate AQP1 expression and a lentiviral overexpression protocol to up-regulate AQP1 expression, in primary Schwann cell cultures. AQP1 gene silencing resulted in a cell shrinkage phenotype, while AQP1 gene overexpression caused a cell swelling phenotype, as validated by cell volume determinations. Secondly, we utilized an in vitro hypoxia model in Schwann cells to mimic in vivo facial nerve injury. We demonstrated that AQP1 expression was induced within 8 h following hypoxia injury in vitro, and that AQP1 knockdown (KD) caused the cells to resist edema following hypoxia. Finally, we investigated the hypoxic regulation of the AQP1 gene, as well as the involvement of Hypoxia-inducible factor-1 alpha (HIF-1 alpha) in AQP1 modulation and we found that KD of HIF-1 alpha decreased hypoxia-dependent induction of endogenous AQP1 expression at both the mRNA and protein levels. Taken together, these results indicate that (1) AQP1 is an important factor responsible for the fast water transport of cultured Schwann cells and is involved in cell plasticity; (2) AQP1 alterations may be a primary factor in hypoxia-induced peripheral nerve edema; (3) HIF-1 alpha participates in the hypoxic induction of the AQP1 gene; (4) AQP1 inhibition might provide a new therapeutic alternative for the treatment of some forms of peripheral nerve edema. Crown Copyright (C) 2013 Published by Elsevier Ltd. on behalf of IBRO. All rights reserved.	[Zhang, J.; Lu, L. X.; Wang, H.; Zhang, Y. F.; Fang, F.; Song, Y. L.; Jiang, H.] Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai 200003, Peoples R China; [Zhang, J.] Nanchang Univ, Affiliated Hosp 1, Dept Plast Surg, Nanchang 330006, Jiangxi, Peoples R China; [Xiong, Y.] Nanchang Univ, Affiliated Hosp 2, Dept Gastroenterol, Nanchang 330006, Jiangxi, Peoples R China		Jiang, H (corresponding author), Changzheng Hosp, Dept Plast Surg, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	dosjh@126.com					Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Bender AS, 1998, J NEUROSCI RES, V54, P673, DOI 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.0.CO;2-P; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Gao HW, 2006, GLIA, V53, P783, DOI 10.1002/glia.20336; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Kaneko K, 2008, MICROVASC RES, V75, P297, DOI 10.1016/j.mvr.2007.12.003; King LS, 2002, TRENDS ENDOCRIN MET, V13, P355, DOI 10.1016/S1043-2760(02)00665-3; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Ma TH, 2011, ACTA PHARMACOL SIN, V32, P711, DOI 10.1038/aps.2011.63; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mou KJ, 2010, J NEURO-ONCOL, V100, P375, DOI 10.1007/s11060-010-0205-x; Nandasena BGTL, 2007, BRAIN RES, V1157, P32, DOI 10.1016/j.brainres.2007.04.033; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Oshio K, 2006, BIOCHEM BIOPH RES CO, V341, P1022, DOI 10.1016/j.bbrc.2006.01.062; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Semenza G L, 2000, Respir Res, V1, P159, DOI 10.1186/rr27; Semenza G. L., 2007, SCI STKE, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Shields SD, 2007, PAIN, V131, P8, DOI 10.1016/j.pain.2006.11.018; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Verkman AS, 2000, CURR OPIN NEPHROL HY, V9, P517, DOI 10.1097/00041552-200009000-00010; Wang H, 2012, EXP BIOL MED, V237, P1249, DOI 10.1258/ebm.2012.012134; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yang M, 2013, J CELL BIOCHEM, V114, P111, DOI 10.1002/jcb.24308; Zhang H, 2010, J BIOL CHEM, V285, P5896, DOI 10.1074/jbc.M109.090233	30	20	20	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 12	2013	252						68	79		10.1016/j.neuroscience.2013.08.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236YS	WOS:000325836000007	23948641				2022-02-06	
J	Greer, J; Riby, DM; Hamiliton, C; Riby, LM				Greer, Joanna; Riby, Deborah M.; Hamiliton, Colin; Riby, Leigh M.			Attentional lapse and inhibition control in adults with Williams Syndrome	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Williams Syndrome; Ageing; Cognition; Inhibition; Executive function; Attentional lapse; Concentration	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; EXECUTIVE FUNCTION; DEFICIT/HYPERACTIVITY DISORDER; AGE; FAILURES; DISSOCIATION; PERFORMANCE; COGNITION; ACCURACY	Research exploring cognitive processing associated with Williams Syndrome (WS) has suggested that executive functioning deficits exist across the developmental spectrum. Such executive functions include problem solving, planning, dividing attention and inhibiting responses. Within a framework of executive functions, the aim of the current study was to explore attentional lapse and inhibition skills in older adults with WS (n = 20; aged 36-61 yr) and consider the implications of deficits within this group. Participants with WS were compared to typical adults of the same chronological age and typical older adults (aged 65+ yr) to consider attentional changes seen in the ageing process. The study employed a sustained attention to response task known to assess inhibition and attentional lapse but which had not previously been used with this population. Compared to both groups of typical matches, the results indicated atypicalities of attention and inhibition in adults with WS. Specifically, compared to the typical matches, adults with WS failed to withhold a response (showing inhibition deficits), had problems re-engaging attentional control processes after making an error and showed a generalised deficit of concentration and task engagement. We conclude that further attention should be paid to the cognitive capacity of older individuals with WS in order to consider the everyday challenges faced by this group and to provide adequate intervention and support for daily living. (C) 2013 Elsevier Ltd. All rights reserved.	[Greer, Joanna; Hamiliton, Colin; Riby, Leigh M.] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Riby, Deborah M.] Univ Durham, Dept Psychol, Durham DH1 3HP, England		Riby, LM (corresponding author), Northumbria Univ, Dept Psychol, Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	leigh.riby@northumbria.ac.uk	Riby, Deborah/G-8474-2013	Riby, Deborah/0000-0001-5747-8441			Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; Crosbie J, 2001, AM J PSYCHIAT, V158, P1884, DOI 10.1176/appi.ajp.158.11.1884; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Dykens EM, 2007, MENT RETARD DEV D R, V13, P272, DOI 10.1002/mrdd.20159; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Hasher L, 1988, PSYCHOL LEARNING MOT, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Hocking DR, 2013, DEVELOPMENTAL SCI, V16, P428, DOI 10.1111/desc.12042; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Jones W, 2000, J COGNITIVE NEUROSCI, V12, P30, DOI 10.1162/089892900561968; Krinsky-McHale SJ, 2005, AM J MENT RETARD, V110, P482, DOI 10.1352/0895-8017(2005)110[482:RPIAWW]2.0.CO;2; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Little K, 2013, RES DEV DISABIL, V34, P959, DOI 10.1016/j.ridd.2012.11.020; McVay JC, 2013, ACTA PSYCHOL, V142, P136, DOI 10.1016/j.actpsy.2012.11.006; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P991, DOI 10.1038/nn1494; Mills DL, 2000, J COGNITIVE NEUROSCI, V12, P47, DOI 10.1162/089892900561977; Mobbs D, 2007, BIOL PSYCHIAT, V62, P256, DOI 10.1016/j.biopsych.2006.05.041; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Osborne Lucy R., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700035X; Osorio A, 2012, RES DEV DISABIL, V33, P1169, DOI 10.1016/j.ridd.2012.02.003; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Rhodes SM, 2011, J CLIN EXP NEUROPSYC, V33, P147, DOI 10.1080/13803395.2010.495057; Rhodes SM, 2010, NEUROPSYCHOLOGIA, V48, P1216, DOI 10.1016/j.neuropsychologia.2009.12.021; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Searcy YM, 2004, AM J MENT RETARD, V109, P231, DOI 10.1352/0895-8017(2004)109<231:TRBAAI>2.0.CO;2; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Smallwood J, 2006, CONSCIOUS COGN, V15, P218, DOI 10.1016/j.concog.2005.03.003; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Smith AD, 2009, PERCEPTION, V38, P694, DOI 10.1068/p6050; Starns JJ, 2010, PSYCHOL AGING, V25, P377, DOI 10.1037/a0018022; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Wang YK, 1997, HUM MOL GENET, V6, P465, DOI 10.1093/hmg/6.3.465; West R, 2010, CORTEX, V46, P550, DOI 10.1016/j.cortex.2009.08.001; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Williams LM, 2010, PEDIATR NEUROL, V42, P118, DOI 10.1016/j.pediatrneurol.2009.08.010	39	20	21	0	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	NOV	2013	34	11					4170	4177		10.1016/j.ridd.2013.08.041			8	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	251BD	WOS:000326901900056	24076981	Green Accepted			2022-02-06	
J	Icer, M; Guloglu, C; Orak, M; Ustundag, M				Icer, Mustafa; Guloglu, Cahfer; Orak, Murat; Ustundag, Mehmet			Factors affecting mortality caused by falls from height	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Fall from height; height of fall; hemopneumothorax; mortality; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; PROGNOSTIC-FACTORS; FATAL FALLS; CHILDREN; PATTERN	BACKGROUND: Falls from height are among the most common trauma cases presenting to emergency departments and often cause mortality and morbidity. In the present study, we aimed to determine the factors that effectively reduce mortality caused by falls from height. METHODS: Data from 2252 trauma patients who presented to Dicle University Emergency Service between January 2005 and December 2008 due to falling from height in the Southeastern Anatolia region were retrospectively analyzed. We analyzed the parameters that are considered to have a positive effect on mortality, which included the following: month of fall; age; gender; etiology; place of fall; type of ground on which the patient fell; height of fall; intubation; hypotension; tachycardia; neck, head, thoracal, abdominal, pelvic, and extremity injuries; Glasgow Coma Score (GCS); Injury Severity Score (ISS); and Revised Trauma Score (RTS). RESULTS: There were 1435 males (63.7%) and 817 females (36.3%) included in the study. Two thousand thirty-one (94.6%) patients survived the fall while 121(5.4%) died. The mean age of the surviving patients was 15.55 +/- 18.60 years, while the patients who died had a mean age of 29.59 +/- 28.93 years. The mean height of the fall of the survivors' was 3.09 meters, and the mean height of the fall for those that died was 6.61 +/- 5.73 meters (p<0.001). CONCLUSION: The mean fatal height of the fall in falls from height is 6.61 m. Age, attempted suicide, height of fall, type of ground on which the patient fell, place of fall, and head, thoracic, and abdominal trauma are the primary factors affecting mortality caused by falls from height.	[Icer, Mustafa; Guloglu, Cahfer; Orak, Murat; Ustundag, Mehmet] Dicle Univ, Tip Fak, Acil Tip Anabilim Dali, TR-21280 Diyarbakir, Turkey		Icer, M (corresponding author), Dicle Univ, Tip Fak, Acil Tip Anabilim Dali, TR-21280 Diyarbakir, Turkey.	drmicer@mynet.com					Agalar F, 1999, INT SURG, V84, P271; Al B, 2009, ULUS TRAVMA ACIL CER, V15, P141; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Aufmkolk M, 1999, UNFALLCHIRURG, V102, P525, DOI 10.1007/s001130050445; CEYLAN S, 2002, TURK KLIN TIP BILIM, V22, P156; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Driscoll TR, 2003, INJ PREV, V9, P15, DOI 10.1136/ip.9.1.15; Goodacre S, 1999, J TRAUMA, V46, P1055, DOI 10.1097/00005373-199906000-00014; Goren S, 2003, FORENSIC SCI INT, V137, P37, DOI 10.1016/S0379-0738(03)00285-8; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Lapostolle F, 2005, CRIT CARE MED, V33, P1239, DOI 10.1097/01.CCM.0000164564.11989.C3; LEHMAN D, 1993, PEDIATRICS, V92, P121; Liu CC, 2009, INJURY, V40, P595, DOI 10.1016/j.injury.2008.11.014; LOWENSTEIN SR, 1989, ANN EMERG MED, V18, P161, DOI 10.1016/S0196-0644(89)80107-6; MATHIS RD, 1993, J TRAUMA, V34, P123, DOI 10.1097/00005373-199301000-00023; McSwaim NE, 2000, TRAUMA, P127; McSwain NE, 1990, POSTGRAD SURG, V2, P140; MELLER JL, 1987, AM J DIS CHILD, V141, P1271, DOI 10.1001/archpedi.1987.04460120033027; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; SCALEA T, 1986, J TRAUMA, V26, P706, DOI 10.1097/00005373-198608000-00005; SIEBEN RL, 1971, PEDIATRICS, V47, P886; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; SPIEGEL CN, 1977, AM J PUBLIC HEALTH, V67, P1143, DOI 10.2105/AJPH.67.12.1143; Taviloglu K, 2001, Ulus Travma Derg, V7, P146; Turk EE, 2004, J TRAUMA, V57, P301, DOI 10.1097/01.TA.0000074554.86172.0E; Venkatesh VT, 2007, MED SCI LAW, V47, P330, DOI 10.1258/rsmmsl.47.4.330; WARNER KG, 1986, ANN EMERG MED, V15, P1088, DOI 10.1016/S0196-0644(86)80134-2; Yagmur Y, 2004, INJURY, V35, P425, DOI 10.1016/S0020-1383(03)00198-0	30	20	22	0	8	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	NOV	2013	19	6					529	535		10.5505/tjtes.2013.77535			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	278IO	WOS:000328883200006	24347212	Bronze			2022-02-06	
J	Larsen, BT; Edwards, WD; Jensen, MH; Johnson, CH; McBane, RD; Harmsen, WS; Maleszewski, JJ				Larsen, Brandon T.; Edwards, William D.; Jensen, Mark H.; Johnson, Craig H.; McBane, Robert D.; Harmsen, William S.; Maleszewski, Joseph J.			Surgical Pathology of Hypothenar Hammer Syndrome With New Pathogenetic Insights A 25-Year Institutional Experience With Clinical and Pathologic Review of 67 Cases	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						hypothenar hammer syndrome; ulnar artery; fibromuscular dysplasia; vascular pathology	FIBROMUSCULAR DYSPLASIA; RENOVASCULAR HYPERTENSION; DISEASE; ARTERY; BRAIN	Hypothenar hammer syndrome (HHS) is characterized by digital ischemia after repetitive traumatic injury to the ulnar artery. Some hypothesize that susceptible patients have an intrinsic vasculopathy such as fibromuscular dysplasia (FMD). To investigate this hypothesis, we reviewed our institutional experience with this syndrome over 25 years. Clinical records were reviewed from all patients who underwent surgical treatment for HHS (1987 to 2011), and histologic features of excised ulnar arteries were characterized. A total of 67 patients (mean age 45 y; range, 21 to 75 y; 65 men) were treated for unilateral or bilateral disease. Common symptoms included digital pain (96% of cases), cold intolerance (79%), cyanosis (70%), numbness (54%), tingling (51%), and ulceration (40%). Angiography showed ulnar artery occlusion (89%), irregularity (56%), tortuosity (46%), and digital emboli (89%). Common pathologic features (from 75 specimens) included: luminal thrombosis (87%); intimal thickening (60%) and fibrosis (57%); internal elastic membrane disruption (95%); medial fibrosis (96%), hypertrophy (43%), neovascularization (49%), dilatation (29%), and disruption (25%); and adventitial neovascularization (53%). Specific features of dysplasia were present in 10 cases (15%), including smooth muscle disorganization and additional smooth muscle bundles outside the external elastic membrane, but typical FMD was not identified. Histologic features in HHS most often represent secondary changes consistent with repetitive trauma. Dysplastic features can be found in occasional cases, but FMD does not appear to contribute to HHS in most patients. Angiography should be interpreted with caution in superficial locations, as a string-of-beads appearance may simply reflect a posttraumatic corkscrew deformity of the ulnar artery.	[Larsen, Brandon T.; Edwards, William D.; Maleszewski, Joseph J.] Mayo Clin, Div Anat Pathol, Rochester, MN 55905 USA; [McBane, Robert D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Harmsen, William S.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Jensen, Mark H.; Johnson, Craig H.] Mayo Clin, Dept Plast & Reconstruct Surg, Rochester, MN 55905 USA		Maleszewski, JJ (corresponding author), Mayo Clin, Div Anat Pathol, 200 First St SW, Rochester, MN 55905 USA.	maleszewski.joseph@mayo.edu		McBane, Robert/0000-0001-8727-8029			Begelman SM, 2000, CURR OPIN RHEUMATOL, V12, P41, DOI 10.1097/00002281-200001000-00007; Dethmers RSM, 2005, J HAND SURG-BRIT EUR, V30B, P419, DOI 10.1016/j.jhsb.2005.02.013; Ferris BL, 2000, J VASC SURG, V31, P104, DOI 10.1016/S0741-5214(00)70072-3; HARRISON EG, 1971, MAYO CLIN PROC, V46, P161; HARRISON EG, 1967, AM J MED, V43, P97, DOI 10.1016/0002-9343(67)90151-9; Karimi Kamran M H, 2005, W V Med J, V101, P250; LITTLE JM, 1972, ARCH SURG-CHICAGO, V105, P684; Marie I, 2007, MEDICINE, V86, P334, DOI 10.1097/MD.0b013e31815c95d3; METTINGER KL, 1982, STROKE, V13, P53, DOI 10.1161/01.STR.13.1.53; METTINGER KL, 1982, STROKE, V13, P46, DOI 10.1161/01.STR.13.1.46; Nitecki S, 2008, VASCULAR, V16, P279, DOI 10.2310/6670.2008.00002; Olin JW, 2012, CIRCULATION, V125, P3182, DOI 10.1161/CIRCULATIONAHA.112.091223; Olin JW, 2011, J VASC SURG, V53, P826, DOI 10.1016/j.jvs.2010.10.066; Slovut DP, 2004, NEW ENGL J MED, V350, P1862, DOI 10.1056/NEJMra032393; Stone JR, 2004, CARDIOVASC PATHOL, V13, P20, DOI 10.1016/S1054-8807(03)00110-8; Stroud S D, 1985, Occup Health Nurs, V33, P31; Taylor LM, 2003, J VASC SURG, V37, P697, DOI 10.1067/mva.2003.218	17	20	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	NOV	2013	37	11					1700	1708		10.1097/PAS.0b013e318297fa37			9	Pathology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Surgery	299YF	WOS:000330430900009	23887165				2022-02-06	
J	Chai, RC; Jiang, JH; Wong, AYK; Jiang, F; Gao, K; Vatcher, G; Yu, ACH				Chai, Rui Chao; Jiang, Jiao Hua; Wong, Ann Yuen Kwan; Jiang, Feng; Gao, Kai; Vatcher, Greg; Yu, Albert Cheung Hoi			AQP5 is differentially regulated in astrocytes during metabolic and traumatic injuries	GLIA			English	Article						aquaporin; ischemia; MCAO; scratch-wound; stab-wound	AQUAPORIN WATER CHANNELS; INNER MITOCHONDRIAL-MEMBRANE; CENTRAL-NERVOUS-SYSTEM; BRAIN EDEMA; RAT ASTROCYTES; REACTIVE ASTROCYTES; ISCHEMIC-STROKE; GENE-EXPRESSION; CELL-MIGRATION; PROTEIN	Water movement plays vital roles in both physiological and pathological conditions in the brain. Astrocytes are responsible for regulating this water movement and are the major contributors to brain edema in pathological conditions. Aquaporins (AQPs) in astrocytes play critical roles in the regulation of water movement in the brain. AQP1, 3, 4, 5, 8, and 9 have been reported in the brain. Compared with AQP1, 4, and 9, AQP3, 5, and 8 are less studied. Among the lesser known AQPs, AQP5, which has multiple functions identified outside the central nervous system, is also indicated to be involved in hypoxia injury in astrocytes. In our study, AQP5 expression could be detected both in primary cultures of astrocytes and neurons, and AQP5 expression in astrocytes was confirmed in 1- to 4-week old primary cultures of astrocytes. AQP5 was localized on the cytoplasmic membrane and in the cytoplasm of astrocytes. AQP5 expression was downregulated during ischemia treatment and upregulated after scratch-wound injury, which was also confirmed in a middle cerebral artery occlusion model and a stab-wound injury model in vivo. The AQP5 increased after scratch injury was polarized to the migrating processes and cytoplasmic membrane of astrocytes in the leading edge of the scratch-wound, and AQP5 over-expression facilitated astrocyte process elongation after scratch injury. Taken together, these results indicate that AQP5 might be an important water channel in astrocytes that is differentially expressed during various brain injuries. GLIA 2013;61:1748-1765	[Chai, Rui Chao; Jiang, Jiao Hua; Wong, Ann Yuen Kwan; Jiang, Feng; Gao, Kai; Vatcher, Greg; Yu, Albert Cheung Hoi] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Chai, Rui Chao; Jiang, Jiao Hua; Wong, Ann Yuen Kwan; Jiang, Feng; Gao, Kai; Vatcher, Greg; Yu, Albert Cheung Hoi] Peking Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Chai, Rui Chao; Jiang, Jiao Hua; Wong, Ann Yuen Kwan; Jiang, Feng; Gao, Kai; Vatcher, Greg; Yu, Albert Cheung Hoi] Peking Univ, Natl Hlth & Family Planning Commiss, Key Lab Neurosci, Minist Educ, Beijing 100191, Peoples R China; [Yu, Albert Cheung Hoi] Peking Univ, Inst Syst Biomed, Lab Translat Med, Beijing 100191, Peoples R China		Yu, ACH (corresponding author), Peking Univ, Neurosci Res Inst, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	achy@hsc.pku.edu.cn	Chai, Ruichao/AAF-3361-2020		Beijing Natural Science FoundationBeijing Natural Science Foundation [7091004]; National Basic Research Program of China (973 program)National Basic Research Program of China [2011CB504400]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870818, 31070974, 31171009]; Foundation for Innovative Research Groups of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81221002]	Grant sponsor: Beijing Natural Science Foundation; Grant number: 7091004; Grant sponsor: National Basic Research Program of China (973 program); Grant number: 2011CB504400; Grant sponsor: National Natural Science Foundation of China; Grant numbers: 30870818, 31070974, and 31171009; Grant sponsor: Foundation for Innovative Research Groups of the National Natural Science Foundation of China; Grant number: 81221002.	Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Amiry-Moghaddam M, 2005, FASEB J, V19, P1459, DOI 10.1096/fj.04-3515com; Anderova M, 2004, GLIA, V48, P311, DOI 10.1002/glia.20076; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; BONDY C, 1993, P NATL ACAD SCI USA, V90, P4500, DOI 10.1073/pnas.90.10.4500; Butler TL, 2006, AM J PHYSIOL-HEART C, V291, pH705, DOI 10.1152/ajpheart.00090.2006; Calamita G, 2005, J BIOL CHEM, V280, P17149, DOI 10.1074/jbc.C400595200; Chen HH, 2013, ARCH MED RES, V44, P93, DOI 10.1016/j.arcmed.2013.01.004; Chen XQ, 2005, GLIA, V50, P182, DOI 10.1002/glia.20147; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; Dong Y, 2009, J NEUROCHEM, V109, P182, DOI 10.1111/j.1471-4159.2009.05974.x; Finnie JW, 2011, J CLIN NEUROSCI, V18, P947, DOI 10.1016/j.jocn.2010.11.010; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Fu XM, 2007, GLIA, V55, P935, DOI 10.1002/glia.20515; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Guo JJ, 2012, NEUROSCI BULL, V28, P669, DOI 10.1007/s12264-012-1288-5; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kawedia JD, 2007, P NATL ACAD SCI USA, V104, P3621, DOI 10.1073/pnas.0608384104; Kawedia JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057541; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Liu HS, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-18; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mccoy E, 2007, GLIA, V55, P1034, DOI 10.1002/glia.20524; Mccoy E, 2010, GLIA, V58, P209, DOI 10.1002/glia.20916; Meng SZ, 2004, EUR J NEUROSCI, V19, P2261, DOI 10.1111/j.0953-816X.2004.03315.x; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Roberta A, 2010, CURR NEUROPHARMACOL, V8, P84, DOI 10.2174/157015910791233178; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Serrano-Perez MC, 2011, GLIA, V59, P94, DOI 10.1002/glia.21079; Shi WZ, 2012, NEUROSCI BULL, V28, P680, DOI 10.1007/s12264-012-1281-z; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Sidhaye VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038717; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tang Zhaohua, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P141; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Wang W, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-242; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yang CZ, 2011, J NEUROSCI RES, V89, P2041, DOI 10.1002/jnr.22657; Yang CZ, 2012, P NATL ACAD SCI USA, V109, P6963, DOI 10.1073/pnas.1118754109; Yool AJ, 2007, NEUROSCIENTIST, V13, P470, DOI 10.1177/1073858407303081; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yu ACH, 1995, PROG BRAIN RES, V105, P245; Yu ACH, 2001, GLIA, V35, P121, DOI 10.1002/glia.1077; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang QY, 2008, P NATL ACAD SCI USA, V105, P7612, DOI 10.1073/pnas.0802467105; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702; Zhou Y, 2010, NEUROCHEM RES, V35, P2124, DOI 10.1007/s11064-010-0325-x	76	20	20	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	OCT	2013	61	10					1748	1765		10.1002/glia.22555			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205NU	WOS:000323451900015	23922257				2022-02-06	
J	Kunz, M; Nussberger, J; Holtmannspotter, M; Bitterling, H; Plesnila, N; Zausinger, S				Kunz, Mathias; Nussberger, Juerg; Holtmannspoetter, Markus; Bitterling, Harro; Plesnila, Nikolaus; Zausinger, Stefan			Bradykinin in Blood and Cerebrospinal Fluid after Acute Cerebral Lesions: Correlations with Cerebral Edema and Intracranial Pressure	JOURNAL OF NEUROTRAUMA			English	Article						acute cerebral lesions; bradykinin; cerebral edema; CSF; intracranial pressure	TRAUMATIC BRAIN-INJURY; KALLIKREIN-KININ SYSTEM; B-2 RECEPTOR ANTAGONIST; PLACEBO-CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TISSUE KALLIKREIN; PLASMA; RATS; INHIBITION; ISCHEMIA	Bradykinin (BK) was shown to stimulate the production of physiologically active metabolites, blood-brain barrier disruption, and brain edema. The aim of this prospective study was to measure BK concentrations in blood and cerebrospinal fluid (CSF) of patients with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke and to correlate BK levels with the extent of cerebral edema and intracranial pressure (ICP). Blood and CSF samples of 29 patients suffering from acute cerebral lesions (TBI, 7; SAH,: 10; ICH, 8; ischemic stroke, 4) were collected for up to 8 days after insult. Seven patients with lumbar drainage were used as controls. Edema (5-point scale), ICP, and the GCS (Glasgow Coma Score) at the time of sample withdrawal were correlated with BK concentrations. Though all plasma-BK samples were not significantly elevated, CSF-BK levels of all patients were significantly elevated in overall (n=73) and early (72h) measurements (n=55; 4.3 +/- 6.9 and 5.6 +/- 8.9 fmol/mL), compared to 1.2 +/- 0.7 fmol/mL of controls (p=0.05 and 0.006). Within 72h after ictus, patients suffering from TBI (p=0.01), ICH (p=0.001), and ischemic stroke (p=0.02) showed significant increases. CSF-BK concentrations correlated with extent of edema formation (r=0.53; p<0.001) and with ICP (r=0.49; p<0.001). Our results demonstrate that acute cerebral lesions are associated with increased CSF-BK levels. Especially after TBI, subarachnoid and intracerebral hemorrhage CSF-BK levels correlate with extent of edema evolution and ICP. BK-blocking agents may turn out to be effective remedies in brain injuries.	[Kunz, Mathias; Zausinger, Stefan] Univ Munich, Dept Neurosurg, D-81377 Munich, Germany; [Holtmannspoetter, Markus; Bitterling, Harro] Univ Munich, Dept Neuroradiol, D-81377 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Inst Surg Res, Klinikum Grosshadern, D-81377 Munich, Germany; [Nussberger, Juerg] CHU Vaudois, Serv Angiol, CH-1011 Lausanne, Switzerland		Kunz, M (corresponding author), Univ Munich, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany.	Mathias.Kunz@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019	Kunz MD, Mathias/0000-0003-1641-450X	Laboratoires Fournier S.A. (Dijon, France)	This study was partly supported by a donation from Laboratoires Fournier S.A. (Dijon, France). The authors thank Mrs. Catherine Amstutz (Lausanne) for her excellent technical support in BK measurements.	BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Cugno M, 2001, CHEST, V120, P1776, DOI 10.1378/chest.120.6.1776; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; FRANCEL PC, 1992, J NEUROTRAUMA S1, V9, P27; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Gorlach C, 1996, PEPTIDES, V17, P1373, DOI 10.1016/S0196-9781(96)00223-9; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; Kaplan AP, 2010, CHEM IMMUNOL ALLERGY, V95, P67, DOI 10.1159/000315938; KASUYA H, 1988, ACTA NEUROCHIR, V91, P120, DOI 10.1007/BF01424566; Lehmberg J, 2003, J CEREBR BLOOD F MET, V23, P441, DOI 10.1097/01.WCB.0000052280.23292.35; Marmarou A, 2005, J NEUROTRAUM, V22, P1444, DOI 10.1089/neu.2005.22.1444; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; PELLACANI A, 1994, CLIN SCI, V87, P567, DOI 10.1042/cs0870567; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Raidoo DM, 1996, IMMUNOPHARMACOLOGY, V33, P104, DOI 10.1016/0162-3109(96)00021-5; Raidoo DM, 1996, IMMUNOPHARMACOLOGY, V32, P39, DOI 10.1016/0162-3109(96)00007-0; Regoli D, 1996, IMMUNOPHARMACOLOGY, V33, P24, DOI 10.1016/0162-3109(96)00077-X; Shakur H, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-109; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Thal SC, 2009, CRIT CARE MED, V37, P2228, DOI 10.1097/CCM.0b013e3181a068fc; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; Wagner S, 2002, J NEUROL SCI, V202, P75, DOI 10.1016/S0022-510X(02)00208-3; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6	33	20	20	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1638	1644		10.1089/neu.2012.2774			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800004	23638655				2022-02-06	
J	Luo, J; Lee, S; Wu, D; Yeh, J; Ellamushi, H; Wheeler, AP; Warnes, G; Zhang, Y; Bo, X				Luo, J.; Lee, S.; Wu, D.; Yeh, J.; Ellamushi, H.; Wheeler, A. P.; Warnes, G.; Zhang, Y.; Bo, X.			P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord	CELL DEATH & DISEASE			English	Article						purinoceptor; ATP receptor; Schwann cell; cell death; cell transplantation; spinal cord injury	P2X(7) RECEPTOR EXPRESSION; EXTRACELLULAR ATP; PURINERGIC RECEPTORS; IMPROVES RECOVERY; HUMAN ASTROCYTES; P-2Z RECEPTOR; OXIDIZED ATP; STRATEGIES; SURVIVAL; CALCIUM	The potential to use Schwann cells (SCs) in neural repair for patients suffering from neurotrauma and neurodegenerative diseases is well recognized. However, significant cell death after transplantation hinders the clinical translation of SC-based therapies. Various factors may contribute to the death of transplanted cells. It is known that prolonged activation of P2X7 purinoceptors (P2X7R) can lead to death of certain types of cells. In this study, we show that rat SCs express P2X7R and exposure of cultured SCs to high concentrations of ATP (3-5mM) or a P2X7R agonist, 2'(3')-O-(4-benzoylbenzoyl)ATP (BzATP) induced significant cell death rapidly. High concentrations of ATP and BzATP increased ethidium uptake by SCs, indicating increased membrane permeability to large molecules, a typical feature of prolonged P2X7R activation. SC death, as well as ethidium uptake, induced by ATP was blocked by an irreversible P2X7R antagonist oxidized ATP (oxATP) or a reversible P2X7R antagonist A438079. oxATP also significantly inhibits the increase of intracellular free calcium induced by minimolar ATP concentrations. Furthermore, ATP did not cause death of SCs isolated from P2X7R-knockout mice. All these results suggest that P2X7R is responsible for ATP-induced SC death in vitro. When rat SCs were treated with oxATP before transplantation into uninjured rat spinal cord, 35% more SCs survived than untreated SCs 1 week after transplantation. Moreover, 58% more SCs isolated from P2X7R-knockout mice survived after being transplanted into rat spinal cord than SCs from wild-type mice. This further confirms that P2X7R is involved in the death of transplanted SCs. These results indicate that targeting P2X7R on SCs could be a potential strategy to improve the survival of transplanted cells. As many other types of cells, including neural stem cells, also express P2X7R, deactivating P2X7R may improve the survival of other types of transplanted cells.	[Luo, J.; Lee, S.; Wu, D.; Yeh, J.; Ellamushi, H.; Zhang, Y.; Bo, X.] Queen Mary Univ London, Blizard Inst, Ctr Neurosci & Trauma, London E1 2AT, England; [Luo, J.] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Wuhan 430030, Peoples R China; [Lee, S.] Semyung Univ, Coll Korean Med, Jechon 390711, South Korea; [Yeh, J.; Ellamushi, H.] Dept Neurosurg, London E1 2AT, England; [Wheeler, A. P.] Blizard Adv Light Microscopy Core Facil, London E1 2AT, England; [Warnes, G.] Queen Mary Univ London, Flow Cytometry Core Facil, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England		Bo, X (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Neurosci & Trauma, 4 Newark St, London E1 2AT, England.	x.bo@qmul.ac.uk	Bo, Xuenong/E-9845-2012; Warnes, Gary/I-1110-2019	Bo, Xuenong/0000-0002-9202-3562; Warnes, Gary/0000-0001-7614-6266; Wheeler, Ann/0000-0001-8617-827X	International Spinal Research Trust [NRB094]; Wellcome TrustWellcome TrustEuropean Commission [084688/Z/08/Z]; Medtronic UKMedtronic; Semyung University	We are very grateful to GlaxoSmithKline UK for providing the P2X7R KO mice. We thank JV Priestley, G Burnstock, and G Knight for critical reading of the manuscript. This work was supported by a Nathalie Rose Barr PhD Studentship from International Spinal Research Trust (NRB094) (to YZ and XB) and a Wellcome Trust grant (084688/Z/08/Z) to XB and YZ). YZ was supported by a grant from Medtronic UK (to JY and HE). SL was supported by studentship from Semyung University (to XB and JY).	Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Colomar A, 2001, EUR J NEUROSCI, V14, P927, DOI 10.1046/j.0953-816x.2001.01714.x; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Craighead MW, 2001, NEUROSCI LETT, V311, P77, DOI 10.1016/S0304-3940(01)02110-3; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2003, BRIT J PHARMACOL, V140, P441, DOI 10.1038/sj.bjp.0705469; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; EASTERBROOKSMITH SB, 1976, EUR J BIOCHEM, V62, P125, DOI 10.1111/j.1432-1033.1976.tb10105.x; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Grafe P, 1999, J PHYSIOL-LONDON, V515, P377, DOI 10.1111/j.1469-7793.1999.377ac.x; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Luo JA, 2011, GLIA, V59, P424, DOI 10.1002/glia.21111; LYONS SA, 1994, J NEUROCHEM, V63, P552; Matute C, 2008, MOL NEUROBIOL, V38, P123, DOI 10.1007/s12035-008-8028-x; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Schneider EM, 2006, ANN NY ACAD SCI, V1090, P245, DOI 10.1196/annals.1378.027; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.2007.05311.x	44	20	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	OCT	2013	4								e829	10.1038/cddis.2013.343			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	251XK	WOS:000326967100015	24091672	Green Published, gold			2022-02-06	
J	Lyttle, MD; Cheek, JA; Blackburn, C; Oakley, E; Ward, B; Fry, A; Jachno, K; Babl, FE				Lyttle, Mark D.; Cheek, John A.; Blackburn, Carol; Oakley, Ed; Ward, Brenton; Fry, Amanda; Jachno, Kim; Babl, Franz E.			Applicability of the CATCH, CHALICE and PECARN paediatric head injury clinical decision rules: pilot data from a single Australian centre	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; PREDICTION RULES; REFERRAL CENTER; CHILDREN; CT; ADOLESCENTS; VICTORIA; RISK	Background Clinical decision rules (CDRs) for paediatric head injury (HI) exist to identify children at risk of traumatic brain injury. Those of the highest quality are the Canadian assessment of tomography for childhood head injury (CATCH), Children's head injury algorithm for the prediction of important clinical events (CHALICE) and Pediatric Emergency Care Applied Research Network (PECARN) CDRs. They target different cohorts of children with HI and have not been compared in the same setting. We set out to quantify the proportion of children with HI to which each CDR was applicable. Methods Consecutive children presenting to an Australian paediatric Emergency Department with HIs were enrolled. Published inclusion/exclusion criteria and predictor variables from the CDRs were collected prospectively. Using these we determined the frequency with which each CDR was applicable. Results 1012 patients (69.9%) were enrolled with 949 available for analysis. Mean age was 6.8 years (21% < 2 years). 95% had initial Glasgow Coma Scale 15. CT rate was 12.8% and neurosurgery rate was 0.7%. No CDR was applicable to all patients. CHALICE was applicable to the most (97%, 95% CI 96% to 98%) and CATCH to the fewest (26%, 95% CI 24% to 29%). PECARN was applicable to 76% (95% CI 70% to 82%) aged < 2 years, and 74% (95% CI 71% to 77%) aged 2-< 18 years. Conclusions Each CDR is applicable to a different proportion of children with HI. This makes a direct comparison of the CDRs difficult. Prior to selection of any for implementation they should undergo validation outside the derivation setting coupled with an analysis of their performance accuracy, usability and cost effectiveness.	[Lyttle, Mark D.; Cheek, John A.; Blackburn, Carol; Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Oakley, Ed; Ward, Brenton; Fry, Amanda; Jachno, Kim; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Oakley, Ed] Monash Med Ctr, Emergency Dept, Clayton, Vic 3168, Australia; [Oakley, Ed] Monash Univ, Clayton, Vic, Australia; [Babl, Franz E.] Univ Melbourne, Melbourne, Vic, Australia		Babl, FE (corresponding author), Univ Melbourne, Royal Childrens Hosp, Emergency Dept, Parkville, Vic 3055, Australia.	franz.babl@rch.org.au		Jachno, Kim/0000-0003-2550-9674; Lyttle, Mark/0000-0002-8634-7210	Murdoch Children's Research Institute (MCRI), Melbourne, Australia	The study was supported in part by grant funding from the Murdoch Children's Research Institute (MCRI), Melbourne, Australia. MCRI is a non-governmental paediatric research institute. There was no influence from the part funder on design or conduct of the study.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DI, 2002, PEDIATR RADIOL, V32, P42; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Canadian Institute for Health Information, HEAD INJ CAN DEC CHA; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; FAULKNER K, 1987, ACTA RADIOL, V28, P483; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lockie F, INT NEUR SOC M 10 IN; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Osmond MH, 2006, ACAD EMERG MED, P13; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Peden M, 2008, WORLD REPORT CHILD I; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Royal Children's Hospital, CLIN PRACT GUID HEAD; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; VADE A, 1995, AM J ROENTGENOL, V165, P905, DOI 10.2214/ajr.165.4.7676990	28	20	23	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	OCT	2013	30	10					790	794		10.1136/emermed-2012-201887			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	267XI	WOS:000328131300004	23015114				2022-02-06	
J	Cai, JY; Lu, C; Chen, MH; Ba, HJ; Chen, XD; Lin, JH; Sun, J				Cai, Jian-Yong; Lu, Chuan; Chen, Mao-Hua; Ba, Hua-Jun; Chen, Xian-Dong; Lin, Jian-Hu; Sun, Jun			Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage	CLINICA CHIMICA ACTA			English	Article						Early neurological deterioration; Intracerebral hemorrhage; Outcome; Neurofilament; Stroke	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; NF-H; CEREBROSPINAL-FLUID; SERUM BIOMARKER; SPINAL-CORD; PNF-H; PROTEOLYSIS; PROTEINS; CALPAIN	Background: Phosphorylated axonal neurofilament subunit H (pNF-H) is a biomarker of axonal injury. We investigated whether plasma pNF-H concentrations were associated with 6-month clinical outcomes and early neurological deterioration (END) of patients with acute intracerebral hemorrhage. Methods: Plasma pNF-H concentrations of 112 patients and 112 healthy individuals were quantified by ELISA. Unfavorable outcome was defined as modified Rankin Scale score >2. Associations of plasma pNF-H concentrations with END, 6-month mortality and unfavorable outcome were evaluated. Results: Plasma pNF-H concentrations were increased in patients than in healthy individuals [700.2 (430.8) pg/ml vs. 25.5 (32.4) pg/ml, P < 0.001]. A logistic regression analysis selected plasma pNF-H concentration as an independent predictor for 6-month mortality [OR: 1.287, 95% CI: 1.140-1.524, P < 0.001], 6-month unfavorable outcome (OR 1.265, 95% CI 1.121-1.517, P < 0.001) and END (OR 1.246, 95% CI 1.109-1.498, P < 0.001). A receiver operating characteristic curve analysis showed that plasma pNF-H concentration predicted 6-month clinical outcomes and END with high area under curves (all P < 0.001). The predictive value of pNF-H was similar to that of the National Institutes of Health Stroke Scale score (all P > 0.05). In a combined logistic-regression model, pNF-H did not improve the predictive value of National Institutes of Health Stroke Scale score (all P > 0.05). Conclusions: Increased plasma pNF-H concentration was highly associated with 6-month clinical outcomes and END of patients with intracerebral hemorrhage. (c) 2013 Elsevier B.V. All rights reserved.	[Cai, Jian-Yong; Lu, Chuan; Chen, Mao-Hua; Ba, Hua-Jun; Chen, Xian-Dong; Lin, Jian-Hu; Sun, Jun] Cent Hosp Wenzhou City, Dept Neurosurg, Wenzhou 325000, Peoples R China		Sun, J (corresponding author), Cent Hosp Wenzhou City, Dept Neurosurg, 32 Dajian Lane, Wenzhou 325000, Peoples R China.	junsunmd@163.com			Zhejiang Medical and Health Science and Technology Plan Project [2010SSA004]; Zhejiang Province Public Technology Applied Research Projects [2010C33015]	The authors thank all staffs in the Department of Neurosurgery, The Central Hospital of Wenzhou City (Wenzhou, China) for their technical support. This work was financially supported by Zhejiang Medical and Health Science and Technology Plan Project (2010SSA004) and Zhejiang Province Public Technology Applied Research Projects (2010C33015).	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Aronowski J, 1999, J CEREBR BLOOD F MET, V19, P652, DOI 10.1097/00004647-199906000-00008; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; Huh JW, 2002, EXP NEUROL, V175, P198, DOI 10.1006/exnr.2002.7880; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Matsushige T, 2012, J NEUROL SCI, V321, P39, DOI 10.1016/j.jns.2012.07.043; Matsushige T, 2009, J NEUROL SCI, V280, P59, DOI 10.1016/j.jns.2009.01.021; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Rosen H, 2004, J NEUROL SCI, V221, P19, DOI 10.1016/j.jns.2004.03.003; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shaw G, 2004, BIOCHEM BIOPH RES CO, V325, P619, DOI 10.1016/j.bbrc.2004.09.223; Singh P, 2011, J NEUROL SCI, V304, P117, DOI 10.1016/j.jns.2011.01.025; Strong MJ, 2001, J NEUROCHEM, V76, P1315, DOI 10.1046/j.1471-4159.2001.00094.x; Vajtr D, 2012, Soud Lek, V57, P7; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	30	20	21	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	SEP 23	2013	424						182	186		10.1016/j.cca.2013.06.019			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	226NH	WOS:000325042600035	23810564				2022-02-06	
J	Huang, YH; Lee, TC; Liao, CC; Deng, YH; Kwan, AL				Huang, Yu-Hua; Lee, Tao-Chen; Liao, Chen-Chieh; Deng, Yu-Han; Kwan, Aij-Lie			Tracheostomy in craniectomised survivors after traumatic brain injury: A cross-sectional analytical study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Decompressive craniectomy; Traumatic brain injury; Tracheostomy; Glasgow coma scale; Age	DECOMPRESSIVE CRANIECTOMY	Background: Decompressive craniectomy (DC) is a life-saving measure for traumatic brain injury (TBI). However, survivors may remain in a vegetative or minimally conscious state and require tracheostomy to facilitate airway management. In this cross-sectional analytical study, we investigated the predictors for tracheostomy requirement and influence of tracheostomy timing on outcomes in craniectomised survivors after TBI. Methods: We enrolled 160 patients undergoing DC and surviving >7 days after TBI in this 3-year retrospective study. The patients were subdivided into 2 groups based on whether tracheostomy was (N = 38) or was not (N = 122) performed. We identified intergroup differences in early clinical parameters. Multivariable logistic regression was used to adjust for independent predictors of the need for tracheostomy. Early tracheostomy was defined as the performance of the procedure within the first 10 days after DC. Intensive care unit (ICU) stay, hospital stay, mortality, and Glasgow outcome scale (GOS) were analysed according to the timing of the tracheostomy procedure. Results: After TBI, 24% of craniectomised survivors required tracheostomy. In the multivariate logistic regression mode, the significant factors related to the need for tracheostomy were age (odds ratio = 1.041; p = 0.002), the Glasgow coma score (GCS) at admission (odds ratio = 0.733; p = 0.005), and normal status of basal cisterns (odds ratio = 0.000; p = 0.008). The ICU stay was shorter for patients with early tracheostomy than for those undergoing late tracheostomy (p = 0.004). The timing of tracheostomy had no influence on the hospital stay, mortality, or GOS. Conclusion: Age and admission GCS were independent predictors of the need for tracheostomy in craniectomised survivors after TBI. If tracheostomy is necessary, an earlier procedure may assist in patient care. (C) 2013 Elsevier Ltd. All rights reserved.	[Huang, Yu-Hua; Lee, Tao-Chen; Liao, Chen-Chieh; Deng, Yu-Han] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Huang, Yu-Hua; Lee, Tao-Chen; Liao, Chen-Chieh; Deng, Yu-Han] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Huang, Yu-Hua; Deng, Yu-Han] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Dept Surg, Coll Med, Kaohsiung, Taiwan		Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Kaohsiung, Taiwan.	newlupin2001@yahoo.com.tw					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Chan ED, 1998, CHEST, V114, P1704, DOI 10.1378/chest.114.6.1704; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Gurkin MA, 2002, AM SURGEON, V68, P324; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Horn EM, 1998, RESP PHYSIOL, V114, P201, DOI 10.1016/S0034-5687(98)00087-5; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Koh WY, 1997, ANAESTH INTENS CARE, V25, P365, DOI 10.1177/0310057X9702500407; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Scales DC, 2008, CRIT CARE MED, V36, P2547, DOI 10.1097/CCM.0b013e31818444a5; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	26	20	20	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1226	1231		10.1016/j.injury.2012.12.029			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600016	23347766				2022-02-06	
J	Kouloulas, EJ; Papadeas, AG; Michail, X; Sakas, DE; Boviatsis, EJ				Kouloulas, Efthimios J.; Papadeas, Alexandros G.; Michail, Xanthi; Sakas, Damianos E.; Boviatsis, Efstathios J.			Prognostic value of time-related Glasgow Coma Scale components in severe traumatic brain injury: a prospective evaluation with respect to 1-year survival and functional outcome	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injury; functional independence measure; functional outcome; Glasgow Coma Scale; rehabilitation; survival	INTERNATIONAL CLASSIFICATION; HEAD-INJURY; DISABILITY; LINKING; HEALTH	The severity of traumatic brain injury (TBI) is determined by many variables, the complexity of which has made prediction of functional outcome an elusive target. To evaluate whether the three components of the Glasgow Coma Scale (GCS) and their alterations over time can serve as predictors of functional outcome after a severe TBI at 12 months after the TBI insult, we carried out a prospective study of patients with severe TBI. Seventy patients were initially enrolled. Data were retrieved from the emergency department records and the patients' intensive care unit, neurosurgical, and rehabilitation unit records. All patients underwent follow-up at 3, 6, and 12 months after injury. GCS components were evaluated on the day of injury and 2 weeks after injury. Functional outcome was estimated using the Glasgow Outcome Scale and the Functional Independence Measure motor scale. It was evaluated during rehabilitation and at 12 months after injury. Fifty-one patients were alive and followed up until 12 months. Logistic regression and receiver-operator characteristic curve analyses were carried out. In terms of functional outcome at 12 months, only GCS on day 15 was found to be a prognostic factor, with all its subscales being related to outcome 12 months later, whereas a higher GCS score on day 15 was also related to survival. A higher motor and verbal response on day 15 was strongly associated with a patient's functional independence, whereby the motor response was a better predictor. The GCS motor score 2 weeks after injury was statistically significantly associated with the 12-month functional outcome in TBI survivors. Motor response was the most useful predictor among the GCS components with respect to the long-term functional outcome in patients with severe TBI. (c) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Kouloulas, Efthimios J.; Boviatsis, Efstathios J.] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Neurosurg 2, GR-11527 Athens, Greece; [Papadeas, Alexandros G.] Univ Athens, Sch Med, Epiphany Phys Med & Rehabil Unit, GR-11527 Athens, Greece; [Michail, Xanthi] Univ Athens, Sch Med, Technol Educ Inst Athens, Dept Phys Therapy, GR-11527 Athens, Greece; [Sakas, Damianos E.] Univ Athens, Sch Med, Evangelismos Gen Hosp, Dept Neurosurg 1, GR-11527 Athens, Greece; [Kouloulas, Efthimios J.] Apolloneio Phys Med & Rehabil Ctr, Larisa, Greece		Kouloulas, EJ (corresponding author), 15th,23rd October St, Larisa 21221, Greece.	kouloulas@yahoo.com	Kouloulas, Efthimios/AAT-2299-2021				Boake C, 2000, PHYS MED REHABILITAT, P1073; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Choi SC, 1996, NEUROTRAUMA, P593; Chua KSG, 1999, INT J REHABIL RES, V22, P189, DOI 10.1097/00004356-199909000-00005; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Hall K, 1977, J REHABIL OUTCOMES M, V1, P63; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanscom DA, 1987, J HEAD TRAUMA REHAB, V2, P1; Harrell FE Jr, 2017, REGRESSION MODELING; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jennett B, 1981, MANAGEMENT HEAD INJU; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Katz DI, 1998, PROGNOSIS NEUROLOGY, P31; Koskinen S, 2009, INT J REHABIL RES, V32, pS47, DOI 10.1097/00004356-200908001-00064; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MALKMUS D, 1983, PHYS THER, V63, P1952, DOI 10.1093/ptj/63.12.1952; Marion D, 1999, TRAUMATIC BRAIN INJU, P119; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ptyushkin P, 2012, AM J PHYS MED REHAB, V91, pS48, DOI 10.1097/PHM.0b013e31823d4e99; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Stineman MG, 1997, ARCH PHYS MED REHAB, V78, P636, DOI 10.1016/S0003-9993(97)90430-5; TEASDALE G, 1974, LANCET, V2, P81; Timmons M, 1987, J HEAD TRAUMA REHAB, V2, P64; WHITLOCK J A JR, 1992, Brain Injury, V6, P447, DOI 10.3109/02699059209008140; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	33	20	20	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2013	36	3					260	267		10.1097/MRR.0b013e32835fd99a			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	202LZ	WOS:000323219400010	23470551				2022-02-06	
J	Merkley, TL; Larson, MJ; Bigler, ED; Good, DA; Perlstein, WM				Merkley, Tricia L.; Larson, Michael J.; Bigler, Erin D.; Good, Daniel A.; Perlstein, William M.			Structural and Functional Changes of the Cingulate Gyrus following Traumatic Brain Injury: Relation to Attention and Executive Skills	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						MRI; TBI; Cortical volume; Cognitive flexibility; Working memory; Anterior cingulate; ACC	CLOSED-HEAD INJURY; OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE CONTROL; DIFFUSION-TENSOR; WORKING-MEMORY; STROOP TASK; POSTTRAUMATIC AMNESIA; CORTICAL SURFACE; COUNTING STROOP; ERROR-DETECTION	Impairments of attention and executive functions are common sequelae of traumatic brain injury (TBI). The anterior cingulate is implicated in conflict-related task performance, such as the Stroop, and is susceptible to TBI-related injury due to its frontal location and proximity to the rough surface of the falx cerebri. We investigated the relationship between cingulate cortex volume and performance on tasks of selective attention and cognitive flexibility (single-trial Stroop and Auditory Consonant Trigrams [ACT]). Participants consisted of 12 adults with severe TBI and 18 controls. T1-weighted volumetric MRI data were analyzed using automated cortical reconstruction, segmentation, parcellation, and volume measurement. Cortical volume reductions were prominent bilaterally in frontal, temporal, and inferior parietal regions. Specific regional reduction of the cingulate cortex was observed only for cortical volume of right caudal anterior cingulate (cACC). The TBI group performed significantly worse than control participants on the Stroop and ACT tasks. Findings suggest that atrophy of the right cACC may contribute to reduced performance on executive function tasks, such as the Stroop and ACT, although this is likely but one node of an extensive brain network involved in these cognitive processes.	[Merkley, Tricia L.; Larson, Michael J.; Bigler, Erin D.; Good, Daniel A.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Merkley, Tricia L.] Baylor Coll Med, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [Merkley, Tricia L.] Univ Texas Houston, Sch Med, Houston, TX USA; [Merkley, Tricia L.] Inst Rehabil & Res TIRR Mem Hermann, Houston, TX USA; [Larson, Michael J.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Perlstein, William M.] Malcom Randall VA, VA RR&D Brain Rehabil & Res Ctr Excellence, Gainesville, FL USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Merkley, Tricia L./AAN-2989-2020; Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065; Merkley, Tricia/0000-0002-0897-8391	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS053335, R21 MH073076]; Ira Fulton Foundation at Brigham Young University; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH073076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS053335] Funding Source: NIH RePORTER	This research was supported by grants NIH F31 NS053335 toMJL and NIH R21 MH073076 to WMP, and by the Ira Fulton Foundation at Brigham Young University. Dr. Erin Bigler notes that he sees forensic neuropsychology cases. No other conflicts of interest are reported.	Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler E.D., 2006, BRAIN INJURY MED PRI, P201; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Boone KB, 1998, ARCH CLIN NEUROPSYCH, V13, P585, DOI 10.1016/S0887-6177(97)00074-7; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.3.CO;2-H; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; COHEN, 1988, STAT POWER ANAL BEHA; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; Damasio A. R., 2011, CLIN NEUROPSYCHOLOGY, P417; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, AM J PSYCHIAT, V168, P968, DOI 10.1176/appi.ajp.2011.10091290; Fassbender C, 2006, CLIN PSYCHOL REV, V26, P445, DOI 10.1016/j.cpr.2006.01.003; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Heflin LH, 2011, NEUROPSYCHOLOGY, V25, P655, DOI 10.1037/a0023863; Hillary FG, 2014, BRAIN IMAGING BEHAV, V8, P435, DOI 10.1007/s11682-012-9205-0; Hinnant D.W., 1999, TRAUMATIC BRAIN INJU, P187; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kondo H, 2004, NEUROIMAGE, V21, P2, DOI 10.1016/j.neuroimage.2003.09.046; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meador KJ, 2011, EPILEPSY BEHAV, V21, P147, DOI 10.1016/j.yebeh.2011.03.020; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mertens VB, 2006, ARCH CLIN NEUROPSYCH, V21, P733, DOI 10.1016/j.acn.2006.08.005; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Perlstein WM, 1998, NEUROPSYCHOLOGY, V12, P414, DOI 10.1037/0894-4105.12.3.414; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sattler J. M., 2008, ASSESSMENT CHILDREN; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shafritz KM, 2005, NEUROIMAGE, V25, P600, DOI 10.1016/j.neuroimage.2004.12.054; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stamatakis EA, 2002, J NUCL MED, V43, P476; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEASDALE G, 1974, LANCET, V2, P81; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van der Wee NJA, 2003, NEUROIMAGE, V20, P2271, DOI 10.1016/j.neuroimage.2003.05.001; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; VOGT BA, 1995, J COMP NEUROL, V359, P490, DOI 10.1002/cne.903590310; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Weible AP, 2013, BEHAV BRAIN RES, V245, P63, DOI 10.1016/j.bbr.2013.02.010; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	82	20	21	0	24	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2013	19	8					899	910		10.1017/S135561771300074X			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	209AQ	WOS:000323725800007	23845701				2022-02-06	
J	Peterson, RL; Kirkwood, MW; Taylor, HG; Stancin, T; Brown, TM; Wade, SL				Peterson, Robin L.; Kirkwood, Michael W.; Taylor, H. Gerry; Stancin, Terry; Brown, Tanya M.; Wade, Shari L.			Adolescents' Internalizing Problems Following Traumatic Brain Injury Are Related to Parents' Psychiatric Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; closed head injury; depression; neurobehavioral outcomes; pediatrics	CLOSED-HEAD-INJURY; FAMILY ASSESSMENT DEVICE; NEUROBEHAVIORAL SYMPTOMS; ANXIETY DISORDERS; BEHAVIOR PROBLEMS; CHILDREN; VALIDITY; PREVALENCE; OUTCOMES; SYMPTOMATOLOGY	Background: A small body of previous research has demonstrated that pediatric traumatic brain injury (TBI) increases risk for internalizing problems, but findings have varied regarding their predictors and correlates. Methods: We examined the level and correlates of internalizing symptoms in 130 teens who had sustained a complicated mild to severe TBI within the past 1 to 6 months. Internalizing problems were measured via both maternal-and paternal-report Child Behavior Checklist. We also measured family functioning, parent psychiatric symptoms, and postinjury teen neurocognitive function. Results: Mean parental ratings of internalizing problems were within the normal range. Depending on informant, 22% to 26% of the sample demonstrated clinically elevated internalizing problems. In multiple and binary logistic regression models, only parent psychiatric symptoms consistently provided unique prediction of teen internalizing symptoms. For maternal but not paternal report, female gender was associated with greater internalizing problems. Conclusion: Parent and teen emotional problems are associated following adolescent TBI. Possible reasons for this relationship, including the effects of TBI on the family unit, are discussed.	[Peterson, Robin L.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Psychiat, Cleveland, OH 44109 USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Brown, Tanya M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Peterson, RL (corresponding author), Univ Denver, Dept Psychol, 2155 South Race St, Denver, CO 80208 USA.	robin.peterson@du.edu	Stancin, Terry/L-7993-2019		NIH from the National Institute of Mental Health [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (1) NIH grant R01-MH073764 from the National Institute of Mental Health and (2) a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; ANGOLD A, 1992, DEV PSYCHOPATHOL, V4, P5, DOI 10.1017/S0954579400005538; [Anonymous], 1999, WECHSL ABR SCAL INT; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis D.C., 1994, CVLT C CALIFORNIA VE; Derogatis L. R., 1994, USE PSYCHOL TESTING, P217; Donders J, 1996, J HEAD TRAUMA REHAB, V11, P67, DOI 10.1097/00001199-199606000-00010; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Duhig AM, 2000, CLIN PSYCHOL-SCI PR, V7, P435, DOI 10.1093/clipsy/7.4.435; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; Hammen Constance, 1996, P153; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mottram L, 2005, PSYCHOL ASSESSMENT, V17, P212, DOI 10.1037/1040-3590.17.2.212; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P110, DOI 10.1080/09084281003708977; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Psychological Corporation, 2003, WECHSLER INTELLIGENC; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; The Psychological Corporation, 2008, WECHSLER ADULT INTEL; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	52	20	20	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					E1	E12		10.1097/HTR.0b013e318263f5ba			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600001	22935574	Green Accepted			2022-02-06	
J	Tollefsen, WW; Brown, CA; Cox, KL; Walls, RM				Tollefsen, William Wallace; Brown, Calvin A., III; Cox, Kelly L.; Walls, Ron M.			Two Hundred Sixty Pediatric Emergency Airway Encounters by Air Transport Personnel A Report of the Air Transport Emergency Airway Management (NEAR VI: "A-TEAM") Project	PEDIATRIC EMERGENCY CARE			English	Article						prehospital; helicopter; intubation	TRAUMATIC BRAIN-INJURY; HOSPITAL ENDOTRACHEAL INTUBATION; RAPID-SEQUENCE INTUBATION; CENTRAL LINE SIMULATION; SEVERE HEAD-INJURY; TRAINING ALGORITHM; SUCCESS RATES; URBAN; FIELD; EXPERIENCE	Background: Effective airway management is the cornerstone of resuscitative efforts for any critically ill or injured patient. The role and safety of pediatric prehospital intubation is controversial, particularly after prior research has shown varying degrees of intubation success. We report a series of consecutive prehospital pediatric intubations performed by air-transport providers. Methods: We retrospectively reviewed intubation flight records from an 89-rotorcraft, multistate emergency flight service during the time period from January 1, 2007, to December 31, 2009. All patients younger than 15 years were included in our analysis. We characterized patient, flight, and operator demographics; intubation methods; success rates; rescue techniques; and adverse events with descriptive statistics. We report proportions with 95% confidence intervals and differences between groups with Fisher exact and chi(2) tests; P < 0.05 was considered significant. Results: Two hundred sixty pediatric intubations were performed consisting of 88 medical (33.8%) and 172 trauma (66.2%) cases; 98.8% (n = 257) underwent an orotracheal intubation attempt as the first method. First-pass intubation success was 78.6% (n = 202), and intubation was ultimately successful in 95.7% (n = 246) of cases. Medical and trauma intubations had similar success rates (98% vs 95%, Fisher exact test P = 0.3412). There was no difference in intubation success between age groups (chi(2) = 0.26, P = 0.88). Three patients were managed primarily with an extraglottic device. Rescue techniques were used in 11 encounters (4.2%), all of which were successful. Cricothyrotomy was performed twice, both successful. Conclusions: Prehospital pediatric intubation performed by air-transport providers, using rapid sequence intubation protocols, is highly successful. This effect on patient outcome requires further study.	[Tollefsen, William Wallace; Brown, Calvin A., III; Walls, Ron M.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Tollefsen, William Wallace] Harvard Affiliated Emergency Med Residency, Boston, MA USA; [Tollefsen, William Wallace] Univ Massachusetts, Dept Emergency Med, Worcester, MA 01605 USA; [Brown, Calvin A., III; Walls, Ron M.] Harvard Univ, Sch Med, Div Emergency Med, Boston, MA USA; [Cox, Kelly L.] Univ Illinois, Dept Emergency Med, Peoria, IL USA		Tollefsen, WW (corresponding author), 75 Francis St,NH-236A, Boston, MA 02115 USA.	wtollefsen@partners.org			Air-Evac EMS, Inc.	This study was supported by a research grant from Air-Evac EMS, Inc.	Barsuk JH, 2009, J HOSP MED, V4, P397, DOI 10.1002/jhm.468; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Britt RC, 2007, AM SURGEON, V73, P680; Britt RC, 2009, AM J SURG, V197, P533, DOI 10.1016/j.amjsurg.2008.11.016; Burton John H, 2003, Prehosp Emerg Care, V7, P352, DOI 10.1080/10903120390936554; Colwell CB, 2005, ACAD EMERG MED, V12, P417, DOI 10.1197/j.aem.2004.11.024; Cook BS, 2006, J TRAUMA NURS, V13, P146; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Germann C, 2009, PREHOSP EMERG CARE, V13, P44, DOI 10.1080/10903120802474505; Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Kovacs G, 2000, ANN EMERG MED, V36, P301, DOI 10.1067/mem.2000.109339; Lowe L, 1998, Air Med J, V17, P101, DOI 10.1016/S1067-991X(98)90103-1; Ma OJ, 1998, AM J EMERG MED, V16, P125, DOI 10.1016/S0735-6757(98)90027-4; MURPHYMACABOBBY M, 1992, ANN EMERG MED, V21, P664, DOI 10.1016/S0196-0644(05)82776-3; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Reed MJ, 2005, EMERG MED J, V22, P99, DOI 10.1136/emj.2003.008771; Rose W D, 1994, Air Med J, V13, P475, DOI 10.1016/S1067-991X(05)80289-5; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; STEWART RD, 1984, ANN EMERG MED, V13, P1032, DOI 10.1016/S0196-0644(84)80064-5; STRATTON SJ, 1991, ANN EMERG MED, V20, P1314, DOI 10.1016/S0196-0644(05)81073-X; Walls RM, 2008, MANUAL EMERGENCY AIR, P81; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	34	20	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2013	29	9					963	968					6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	300NP	WOS:000330470900002	23974713				2022-02-06	
J	Unal, A; Bulbul, F; Alpak, G; Virit, O; Copoglu, US; Savas, HA				Unal, Ahmet; Bulbul, Feridun; Alpak, Gokay; Virit, Osman; Copoglu, U. Sertan; Savas, Haluk A.			Effective Treatment of Catatonia by Combination of Benzodiazepine and Electroconvulsive Therapy	JOURNAL OF ECT			English	Article						catatonia; ECT; benzodiazepine	LORAZEPAM; ECT	Objective: Catatonia, a motor dysregulation syndrome, can emerge in numerous psychiatric disorders, mainly in schizophrenia and mood disorders, and metabolic and endocrine disorders such as infections, toxic states, epilepsy, and traumatic brain injury. In our study, we aimed to investigate demographic, clinical, and treatment-related characteristics of catatonic patients managed in our inpatient clinic. Methods: The medical records of 57 patients diagnosed to have catatonia according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, criteria who were admitted to the inpatient psychiatry clinic of the Gaziantep University School of Medicine between 1 January, 2003, and 31 December, 2011, were retrospectively reviewed. Results: In patients with catatonia, mood disorders (63.2%) were found to be the most common underlying or primary disease, whereas mutism (47.4%) was found to be the most common catatonic symptom. There was a comorbid medical condition in 9 patients (15.8%). Patients underwent an average of 9.00 electroconvulsive therapy (ECT) sessions. Among 57 patients with catatonia, catatonic symptoms were resolved in 57 patients (100%) by benzodiazepine and ECT. Conclusions: In our study, full recovery was achieved in catatonia by benzodiazepine plus ECT combination. As a result, we recommend combined ECT and benzodiazepine for catatonia.	[Unal, Ahmet; Bulbul, Feridun; Alpak, Gokay; Virit, Osman; Savas, Haluk A.] Gaziantep Univ, Fac Med, Dept Psychiat, TR-27310 Sahinbey, Gaziantep, Turkey; [Copoglu, U. Sertan] Sanliurfa Ceylanpinar State Hosp, Dept Psychiat, Sanliurfa, Turkey		Unal, A (corresponding author), Gaziantep Univ, Fac Med, Dept Psychiat, TR-27310 Sahinbey, Gaziantep, Turkey.	drahmetunal@hotmail.com	Unal, Ahmet/ABH-9455-2020	Unal, Ahmet/0000-0002-8612-528X			American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Bush G, 1996, ACTA PSYCHIAT SCAND, V93, P137, DOI 10.1111/j.1600-0447.1996.tb09815.x; Cabo-Rodriguez B, 2011, EUR PSYCHIAT, V26, P1211; Chalasani P, 2005, PSYCHOL MED, V35, P1667, DOI 10.1017/S0033291705005453; Chalasani Padmaja, 2011, Indian J Psychiatry, V53, P49, DOI 10.4103/0019-5545.75564; Clark T, 1999, HOSP MED, V60, P740, DOI 10.12968/hosp.1999.60.10.1219; DEVANAND DP, 1995, CONVULSIVE THER, V11, P3; Dutt Alakananda, 2011, Indian J Psychiatry, V53, P36, DOI 10.4103/0019-5545.75559; Fink M, 2012, ACTA PSYCHIAT SCAND, V125, P11, DOI 10.1111/j.1600-0447.2011.01771.x; FRANCIS A, 1992, AM J PSYCHIAT, V149, P581; Francis A, 1997, COMPR PSYCHIAT, V38, P56, DOI 10.1016/S0010-440X(97)90054-7; Francis A, 2010, CURR PSYCHIAT REP, V12, P180, DOI 10.1007/s11920-010-0113-y; Hatta K, 2007, J ECT, V23, P233, DOI 10.1097/yct.0b013e3181587949; Huang TL, 2005, PSYCHIAT CLIN NEUROS, V59, P52, DOI 10.1111/j.1440-1819.2005.01331.x; Hung YY, 2006, CLIN NEUROPHARMACOL, V29, P144, DOI 10.1097/01.WNF.0000221908.56361.C7; Makhinson M, 2012, J ECT, V28, pE35, DOI 10.1097/YCT.0b013e318254c2ea; McKeown NJ, 2010, WEST J EMERG MED, V11, P186; Penland H. R., 2006, ANN GEN PSYCHIATR, V5, P1; Pfuhlmann B, 2001, EUR ARCH PSY CLIN N, V2511, P14; PHILBRICK KL, 1994, J NEUROPSYCH CLIN N, V6, P1; Raveendranathan D, 2012, EUR ARCH PSY CLIN N, V262, P425, DOI 10.1007/s00406-011-0285-4; Reisner AD, 2003, NEUROPSYCHOL REV, V13, P199, DOI 10.1023/B:NERV.0000009484.76564.58; ROHLAND BM, 1993, J AFFECT DISORDERS, V29, P255, DOI 10.1016/0165-0327(93)90015-C; ROSEBUSH PI, 1991, J CLIN PSYCHIAT, V52, P187; Seethalakshmi R, 2008, ANN CLIN PSYCHIATRY, V20, P5, DOI 10.1080/10401230701844786; Sienaert P, 2011, J AFFECT DISORDERS, V135, P1, DOI 10.1016/j.jad.2011.02.012; Taylor MA, 2003, AM J PSYCHIAT, V160, P1233, DOI 10.1176/appi.ajp.160.7.1233; Tibrewal P, 2010, PROG NEURO-PSYCHOPH, V34, P1520, DOI 10.1016/j.pnpbp.2010.08.017; Tuerlings JHAM, 2010, GEN HOSP PSYCHIAT, V32, P631, DOI 10.1016/j.genhosppsych.2010.08.007; Van Den Eede F, 2005, EUR PSYCHIAT, V20, P422, DOI 10.1016/j.eurpsy.2005.03.012; van Waarde JA, 2010, J ECT, V26, P248, DOI 10.1097/YCT.0b013e3181c18a13; Virit O, 2009, KLIN PSIKIYATRI, V12, P51; Weder ND, 2008, ANN CLIN PSYCHIATRY, V20, P97, DOI 10.1080/10401230802017092	33	20	20	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1095-0680	1533-4112		J ECT	J. ECT	SEP	2013	29	3					206	209		10.1097/YCT.0b013e3182887a1a			4	Behavioral Sciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychiatry	298YX	WOS:000330362100020	23965606				2022-02-06	
J	Covassin, T; Elbin, RJ; Crutcher, B; Burkhart, S				Covassin, Tracey; Elbin, R. J.; Crutcher, Bryan; Burkhart, Scott			The Management of Sport-Related Concussion: Considerations for Male and Female Athletes	TRANSLATIONAL STROKE RESEARCH			English	Article						Concussions; Sex differences; Neurocognitive function; Clinical assessment	SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; SEX-DIFFERENCES; GENDER-DIFFERENCES; HEAD-INJURY; COLLEGIATE; IMPACT; EPIDEMIOLOGY; SPECIFICITY	Sport-related concussion continues to be a centerpiece of attention in the field of sports medicine. The benefit to using neurocognitive testing when managing concussion will be documented in this review. In addition to providing critical objective information on the neurocognitive status of the concussed athlete, research data will be provided on the pre- and post-concussion neurocognitive profiles of concussed male and female athletes. Specifically, an overview of research will be presented on the epidemiology of male and female concussion rates, as well as concussion outcomes including symptoms and cognitive function post-injury. Finally, a clinician's perspective on managing sports-related concussion will be presented focusing on three factors regarding sex differences: risk factors, clinical presentation, and management.	[Covassin, Tracey; Crutcher, Bryan] Michigan State Univ, E Lansing, MI 48824 USA; [Elbin, R. J.; Burkhart, Scott] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15203 USA		Covassin, T (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	covassin@msu.edu					Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barth JT, 1989, MILD HEAD INJURY, P257; Bernhardt DT, 2000, PEDIATR ANN, V29, P172, DOI 10.3928/0090-4481-20000301-11; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T., 2012, CLIN J SPORT MED; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; DeHaas DM, 2009, 1981 82 2007 08 NCAA; Ebell MH, 2006, AM FAM PHYSICIAN, V74, P2087; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Esposito G, 1996, J NUCL MED, V37, P559; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halpern D, 2000, SEX DIFFERENCES COGN; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Kimura D, 2002, PSYCHOL REP, V91, P1137, DOI 10.2466/PR0.91.7.1137-1142; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; LEWIS RS, 1987, BRAIN COGNITION, V6, P142, DOI 10.1016/0278-2626(87)90115-1; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan W., PEDIATR, V129, P38; National Federation of State High School Associations, PART HIGH SCH SPORTS; NCAA, 2012, NCAA PART RAT GOING; NFHSA, 2008, PART HIGH SCH SPORTS; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; SCHNEIDER K, 1988, INT J SPORT BIOMECH, V4, P358, DOI 10.1123/ijsb.4.4.358; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X	41	20	20	0	30	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483			TRANSL STROKE RES	Transl. Stroke Res.	AUG	2013	4	4					420	424		10.1007/s12975-012-0228-z			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	176GD	WOS:000321290900006	24323339				2022-02-06	
J	Hemley, SJ; Bilston, LE; Cheng, S; Chan, JN; Stoodley, MA				Hemley, Sarah J.; Bilston, Lynne E.; Cheng, Shaokoon; Chan, Jing Ning; Stoodley, Marcus A.			Aquaporin-4 Expression in Post-Traumatic Syringomyelia	JOURNAL OF NEUROTRAUMA			English	Article						aquaporin-4; post-traumatic syringomyelia; spinal cord injury	SPINAL-CORD-INJURY; CEREBROSPINAL-FLUID FLOW; SUBARACHNOID SPACE; WATER CHANNEL; BRAIN EDEMA; ANIMAL-MODEL; MICE; RAT; ARACHNOIDITIS; ISOFORMS	Aquaporin-4 (AQP4) is an astroglial water channel protein that plays an important role in the transmembrane movement of water within the central nervous system. AQP4 has been implicated in numerous pathological conditions involving abnormal fluid accumulation, including spinal cord edema following traumatic injury. AQP4 has not been studied in post-traumatic syringomyelia, a condition that cannot be completely explained by current theories of cerebrospinal fluid dynamics. Alterations of AQP4 expression or function may contribute to the fluid imbalance leading to syrinx formation or enlargement. The aim of this study was to examine AQP4 expression levels and distribution in an animal model of posttraumatic syringomyelia. Immunofluorescence and western blotting were used to assess AQP4 and glial fibrillary acidic protein (GFAP) expression in an excitotoxic amino acid/arachnoiditis model of post-traumatic syringomyelia in Sprague-Dawley rats. At all time-points, GFAP-positive astrocytes were observed in tissue surrounding syrinx cavities, although western blot analysis demonstrated an overall decrease in GFAP expression, except at the latest stage investigated. AQP4 expression was significantly higher at the level of syrinx at three and six weeks following the initial syrinx induction surgery. Significant increases in AQP4 expression also were observed in the upper cervical cord, rostral to the syrinx except in the acute stage of the condition at the three-day time-point. Immunostaining showed that AQP4 was expressed around all syrinx cavities, most notably adjacent to a mature syrinx (six- and 12-week time-point). This suggests a relationship between AQP4 and fluid accumulation in post-traumatic syringomyelia. However, whether this is a causal relationship or occurs in response to an increase in fluid needs to be established.	[Hemley, Sarah J.; Stoodley, Marcus A.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Bilston, Lynne E.] Neurosci Res Australia, Sydney, NSW, Australia; [Bilston, Lynne E.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Cheng, Shaokoon] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Chan, Jing Ning] Gosford Hosp, Sydney, NSW, Australia		Hemley, SJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, Level 1,2 Technol Pl, Sydney, NSW 2109, Australia.	sarah.hemley@mq.edu.au	Bilston, Lynne E/C-9665-2011	Bilston, Lynne E/0000-0001-8250-9019; Cheng, Shaokoon/0000-0002-2057-4605; Stoodley, Marcus/0000-0002-4207-8493; hemley, sarah/0000-0003-3064-861X	Column of Hope Research Grant; National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia [604008]; Brain Foundation of Australia; NHMRC of AustraliaNational Health and Medical Research Council of Australia; NHMRCNational Health and Medical Research Council of Australia	This work was funded by a Column of Hope Research Grant, the National Health and Medical Research Council (NHMRC) of Australia (Project No. 604008) and the Brain Foundation of Australia.; Dr Hemley was supported by a scholarship from the NHMRC of Australia.; Professor Bilston is supported by an NHMRC senior research fellowship.	Attenello FJ, 2008, NEUROSURGERY, V62, P1307, DOI 10.1227/01.neu.0000333302.72307.3b; Batzdorf U, 1998, J NEUROSURG, V89, P382, DOI 10.3171/jns.1998.89.3.0382; Bilston LE, 2010, J NEUROSURG, V112, P808, DOI 10.3171/2009.5.JNS08945; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Brodbelt AR, 2003, SPINE, V28, pE413, DOI 10.1097/01.BRS.0000092346.83686.B9; Brodbelt AR, 2003, EUR SPINE J, V12, P300, DOI 10.1007/s00586-002-0492-9; Calamita G, 2001, BIOL REPROD, V64, P1660, DOI 10.1095/biolreprod64.6.1660; Cheng S, 2012, J BIOMECH, V45, P1186, DOI 10.1016/j.jbiomech.2012.01.050; CURTIS KA, 1995, PARAPLEGIA, V33, P290, DOI 10.1038/sc.1995.65; Cutler CP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00021; Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5; HALL P, 1980, J NEUROSURG, V52, P812, DOI 10.3171/jns.1980.52.6.0812; Hemley SJ, 2009, J NEUROSURG-SPINE, V11, P696, DOI 10.3171/2009.6.SPINE08564; Hirt B, 2011, NEUROSCIENCE, V189, P79, DOI 10.1016/j.neuroscience.2011.05.037; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Klekamp J, 2002, J NEUROSURG, V97, P317, DOI 10.3171/spi.2002.97.3.0317; Klekamp J, 1997, J NEUROSURG, V86, P233, DOI 10.3171/jns.1997.86.2.0233; Klekamp J, 2002, ACTA NEUROCHIR, V144, P649, DOI 10.1007/s00701-002-0944-3; Klekamp J, 2001, NEUROSURGERY, V48, P174, DOI 10.1097/00006123-200101000-00031; Koyanagi I, 2005, SURG NEUROL, V63, P350, DOI 10.1016/j.surneu.2004.05.038; LASFARGUES JE, 1995, PARAPLEGIA, V33, P62, DOI 10.1038/sc.1995.16; Lignot JH, 2002, J EXP BIOL, V205, P2653; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mao L, 2011, BRAIN INJURY, V25, P300, DOI 10.3109/02699052.2010.542432; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rossi A, 2011, GLIA, V59, P1056, DOI 10.1002/glia.21177; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saito F, 2008, J TRAUMA, V64, P53, DOI 10.1097/TA.0b013e31815b847d; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Solenov EI, 2002, J NEUROSCI METH, V113, P85, DOI 10.1016/S0165-0270(01)00481-2; Sorbo JG, 2012, J NEUROSCI METH, V211, P31, DOI 10.1016/j.jneumeth.2012.07.021; Stoodley MA, 1997, J NEUROSURG, V86, P686, DOI 10.3171/jns.1997.86.4.0686; Stoodley MA, 1996, BRAIN RES, V707, P155, DOI 10.1016/0006-8993(95)01228-1; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Terris J, 1995, AM J PHYSIOL-RENAL, V269, pF775, DOI 10.1152/ajprenal.1995.269.6.F775; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Yang LQ, 2001, SPINE, V26, P1842, DOI 10.1097/00007632-200109010-00004; Yeo SI, 2011, ANAT CELL BIOL, V44, P50, DOI 10.5115/acb.2011.44.1.50; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	48	20	21	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1457	1467		10.1089/neu.2012.2614			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500010	23441695	Green Published			2022-02-06	
J	Kutsogiannis, DJ; Asthana, S; Townsend, DR; Singh, G; Karvellas, CJ				Kutsogiannis, Demetrios J.; Asthana, Sonal; Townsend, Derek R.; Singh, Gurmeet; Karvellas, Constantine J.			The incidence of potential missed organ donors in intensive care units and emergency rooms: a retrospective cohort	INTENSIVE CARE MEDICINE			English	Article						Organ donation; Donation after circulatory death; Brain death; Collaborative requesting	TRAUMATIC BRAIN-INJURY; CARDIAC DEATH; LUNG TRANSPLANTATION; LIFE-SUPPORT; DONATION; WITHDRAWAL; HEMORRHAGE; MORTALITY; DECISION; CRITERIA	There is a shortage of organ donors in Canada. The number of potential organ donors that are not referred to organ procurement organizations in Canada is unknown. We conducted a retrospective cohort study of all deaths in ICUs and emergency rooms not referred to the Human Organ Procurement and Exchange Program in four hospitals between 1 January 2008 and 31 December 2010. The primary outcome was the number of normal and expanded criteria heart-beating donors and circulatory death (DCD) donors. Of 2,931 deaths, 64 patients were identified as having a high probability for progression to heart-beating donation (Glasgow Coma Score of 3 and three or more absent brainstem reflexes) and 130 patients were assessed for possible DCD donation. The number of potential abdominal and lung heart-beating donors ranged from 3.2 to 7.5 and 0.5 to 2.7 per million population. The number of potential DCD abdominal and lung donors ranged from 3.9 to 6.5 and 2.7 to 4.3 per million population. Potential heart-beating abdominal (p = 0.04) and lung (p = 0.06) donors increased after legislation mandating donation discussion. Non-pupillary brainstem reflexes were documented in fewer than 60 % of records. Life-sustaining treatment was withdrawn in 19 of 46 (41.3 %) cardiac arrest patients not requiring high doses of vasoactive drugs within 24 h. The number of heart-beating or DCD organ donors represented by missed referrals may represent up to 7.5 donors per million population. Improved documentation of brainstem reflexes and encouraging referral of patients suffering cardiac arrest to ICU specialists may improve donor numbers.	[Kutsogiannis, Demetrios J.; Townsend, Derek R.; Singh, Gurmeet; Karvellas, Constantine J.] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Asthana, Sonal] BGS Global Hosp, Div Transplantat, Bangalore, Karnataka, India; [Kutsogiannis, Demetrios J.] Royal Alexandra Hosp, Edmonton, AB T5H 3V9, Canada		Kutsogiannis, DJ (corresponding author), Royal Alexandra Hosp, 616 CSC,10240 Kingsway Ave, Edmonton, AB T5H 3V9, Canada.	jim.kutsogiannis@ualberta.ca		Karvellas, Constantine/0000-0002-1555-1089			Abadie A, 2006, J HEALTH ECON, V25, P599, DOI 10.1016/j.jhealeco.2006.01.003; Antonelli M, 2012, INTENS CARE MED, V38, P192, DOI 10.1007/s00134-011-2447-2; Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Botha P, 2009, CURR OPIN ORGAN TRAN, V14, P206, DOI 10.1097/MOT.0b013e328326c834; Canadian Institute for Health Information, 2010, E STAT REP TRANSPL W; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; de Groot YJ, 2012, CRIT CARE MED, V40, P233, DOI 10.1097/CCM.0b013e31822f0633; de Groot YJ, 2011, INTENS CARE MED, V37, P665, DOI 10.1007/s00134-011-2131-6; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Kohn R, 2011, INTENS CARE MED, V37, P1210, DOI 10.1007/s00134-011-2257-6; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; Morgan SE, 2008, J HEALTH PSYCHOL, V13, P644, DOI 10.1177/1359105308090936; Ojo AO, 2005, SEMIN DIALYSIS, V18, P463, DOI 10.1111/j.1525-139X.2005.00090.x; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Oto T, 2008, GEN THORAC CARDIOVAS, V56, P533, DOI 10.1007/s11748-008-0315-y; Oz MC, 2003, J HEART LUNG TRANSPL, V22, P389, DOI 10.1016/S1053-2498(03)00074-3; Rabinstein AA, 2012, LANCET NEUROL, V11, P414, DOI 10.1016/S1474-4422(12)70060-1; Rosner B., 1995, FUNDAMENTALS BIOSTAT; Rull R, 2003, LIVER TRANSPLANT, V9, P389, DOI 10.1053/jlts.2003.50050; Salim A, 2010, J TRAUMA, V69, P451, DOI 10.1097/TA.0b013e3181e7847a; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Snell GI, 2008, AM J TRANSPLANT, V8, P1282, DOI 10.1111/j.1600-6143.2008.02231.x; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Weng L, 2011, INTENS CARE MED, V37, P655, DOI 10.1007/s00134-010-2124-x; Yee AH, 2010, NEUROLOGY, V74, P1380, DOI 10.1212/WNL.0b013e3181dad5f0; Yeung Jonathan C, 2009, Thorac Surg Clin, V19, P261, DOI 10.1016/j.thorsurg.2009.02.006; Young D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3911; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72	33	20	22	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	AUG	2013	39	8					1452	1459		10.1007/s00134-013-2952-6			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182UC	WOS:000321769100013	23702637				2022-02-06	
J	Lo Pizzo, M; Schiera, G; Di Liegro, I; Di Liegro, CM; Pal, J; Czeiter, E; Sulyok, E; Doczi, T				Lo Pizzo, Marianna; Schiera, Gabriella; Di Liegro, Italia; Di Liegro, Carlo Maria; Pal, Jozsef; Czeiter, Endre; Sulyok, Endre; Doczi, Tamas			Aquaporin-4 distribution in control and stressed astrocytes in culture and in the cerebrospinal fluid of patients with traumatic brain injuries	NEUROLOGICAL SCIENCES			English	Article						Cultured astrocytes; Cerebrospinal fluid; Aquaporin-4; Traumatic brain injury	URINARY-EXCRETION; ARGININE-VASOPRESSIN; RAT-BRAIN; EXPRESSION; PROTEIN; EDEMA; MODEL	Distribution of aquaporin-4 (AQP4) was studied by western analysis and immunofluorescence in rat astrocytes exposed to either hypothermic (30 A degrees C) or hyperosmolar (0.45 M sucrose) stress, and in the cerebrospinal fluid (CSF) of patients who suffered traumatic brain injury (TBI). CSF was obtained from 5 healthy subjects and from 20 patients suffering from severe TBI. CSF samples were taken at admission and on days 3 and 5-7. Here we report that, in response to both hypothermia and hyperosmolar stress, AQP4 was markedly reduced in cultured astrocytes. We also found that AQP4 significantly increased in patients with severe brain injury in respect to healthy subjects (P < 0.002). AQP4 in CSF remained unchanged in patients with elevated intracranial pressure (ICP), whereas there was a clear tendency to further increase in those patients whose ICP could be controlled within the normal range. We conclude that AQP4 levels in CSF are elevated after TBI and it might serve as a useful biochemical marker to assess brain water metabolism in clinical settings.	[Lo Pizzo, Marianna; Di Liegro, Italia] Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, I-90127 Palermo, Italy; [Schiera, Gabriella; Di Liegro, Carlo Maria] Univ Palermo, Dept Mol & Biomol Technol Sci STEMBIO, I-90128 Palermo, Italy; [Pal, Jozsef; Doczi, Tamas] Univ Pecs, Fac Med, Dept Neurosurg, H-7624 Pecs, Hungary; [Pal, Jozsef; Doczi, Tamas] MTA PTE Clin Neurosci MR Res Grp, H-7624 Pecs, Hungary; [Czeiter, Endre] Univ Pecs, Dept Anat, Fac Med, H-7624 Pecs, Hungary; [Sulyok, Endre] Univ Pecs, Fac Hlth Sci, Inst Hlth Promot & Family Care, H-7621 Pecs, Hungary		Di Liegro, I (corresponding author), Univ Palermo, Dept Expt Biomed & Clin Neurosci BIONEC, I-90127 Palermo, Italy.	italia.diliegro@unipa.it	Czeiter, Endre/B-1404-2009; Doczi, Tamas/C-5750-2009	Di Liegro, Italia/0000-0002-0546-1274; Di Liegro, Carlo Maria/0000-0001-7362-7814; Schiera, Gabriella/0000-0002-8638-6455; Pal, Jozsef/0000-0001-6468-6409	University of Palermo (Italy)	The experimental work was supported by the University of Palermo (Italy). The studies were carried out with the written permission and under the control of the Institutional Review Board of the University of Pecs (IRB 00003108).	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cole R., 1989, DISSECTION TISSUE CU, P121; Deen PMT, 1996, J AM SOC NEPHROL, V7, P836; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Fujita Y, 2003, NEUROSCI RES, V47, P437, DOI 10.1016/j.neures.2003.08.006; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Ishikawa SE, 2001, J CLIN ENDOCR METAB, V86, P1665, DOI 10.1210/jc.86.4.1665; KANNO K, 1995, NEW ENGL J MED, V332, P1540, DOI 10.1056/NEJM199506083322303; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kroksveen AC, 2011, J PROTEOMICS, V74, P371, DOI 10.1016/j.jprot.2010.11.010; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nielsen S, 1997, J NEUROSCI, V17, P171; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2001, BRIT J NEUROSURG, V15, P101; Rai T, 1997, J AM SOC NEPHROL, V8, P1357; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Sarfaraz D, 1999, AM J PHYSIOL-ENDOC M, V276, pE596, DOI 10.1152/ajpendo.1999.276.3.E596; Schiera G, 2005, J CELL MOL MED, V9, P373, DOI 10.1111/j.1582-4934.2005.tb00362.x; Starklint J, 2006, SCAND J CLIN LAB INV, V66, P55, DOI 10.1080/00365510500452955; Sulyok E, 2004, ACTA NEUROCHIR, V146, P955, DOI 10.1007/s00701-004-0319-z; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246	27	20	20	0	6	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2013	34	8					1309	1314		10.1007/s10072-012-1233-4			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	204RU	WOS:000323387100006	23143012				2022-02-06	
J	Rauen, K; Trabold, R; Brem, C; Terpolilli, NA; Plesnila, N				Rauen, Katrin; Trabold, Raimund; Brem, Christian; Terpolilli, Nicole A.; Plesnila, Nikolaus			Arginine Vasopressin V-1a Receptor- Deficient Mice Have Reduced Brain Edema and Secondary Brain Damage following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Antidiuretic hormone; arginine vasopressin; brain edema; traumatic brain injury; V-1a receptor	CONTROLLED CORTICAL IMPACT; ANTAGONIST SR49059; VOLUME REGULATION; CHOROID-PLEXUS; V-2 RECEPTORS; BLOOD-VOLUME; RAT; AQUAPORIN-4; EXPRESSION; SYSTEM	The formation of brain edema and subsequent intracranial hypertension are major predictors of unfavorable outcome following traumatic brain injury (TBI). Previously, we reported that arginine vasopressin (AVP) receptor antagonists reduce post-traumatic and post-ischemic brain edema in mice. The aim of the current study was to investigate further the contribution of arginine vasopressin V-1a receptors to TBI-induced secondary brain damage in V-1a receptor knock-out mice. V-1a receptor knock-out (V-1a -/-) and wild-type mice were subjected to controlled cortical impact (CCI), and edema (brain water content measured before and 24 h after CCI), primary and secondary contusion volume (15 min and 24 h after CCI), neurological function (one day before and seven days after CCI), body weight (before and seven days after CCI) and mortality were measured. Twenty-four h after CCI, V1a receptor knock-out mice had significantly less brain water content than wild-type mice (mean +/- standard error of the mean: 79.8% +/- 0.3 vs. 80.6% +/- 0.2, respectively), and secondary contusion volume was significantly smaller (38.2 +/- 1.7 mm(3) vs. 45.1 +/- 1.5 mm(3) in wild-type mice). Furthermore, the V1a receptor knock-out mice had less neurological dysfunction (3.2 +/- 0.8 vs. 7.0 +/- 1.4 in wild-type mice) and weight loss (1.0 +/- 1.0% vs. 4.9 +/- 1.8% in wild-type mice) seven days after CCI. Our data show that mice lacking V1a receptors have less secondary brain damage following experimental traumatic brain injury. We therefore conclude that V-1a receptors may represent a novel drug target for preventing post-traumatic brain edema.	[Rauen, Katrin; Trabold, Raimund; Brem, Christian; Terpolilli, Nicole A.; Plesnila, Nikolaus] Univ Munich, Med Ctr, Dept Neurosurg, Munich, Germany; [Rauen, Katrin; Trabold, Raimund; Brem, Christian; Terpolilli, Nicole A.; Plesnila, Nikolaus] Univ Munich, Inst Surg Res, Med Ctr, D-80539 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res, Med Ctr, Munich, Germany		Plesnila, N (corresponding author), Inst Stroke & Dementia Res, Max Lebsche Pl 30, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Terpolilli, Nicole/AAG-3598-2021; Plesnila, Nikolaus/T-7522-2019	Rauen, Katrin/0000-0003-4555-6697			Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; BARGMANN WOLFGANG, 1951, AMER SCI, V39, P255; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; BUIJS RM, 1978, CELL TISSUE RES, V192, P423, DOI 10.1007/bf00224932; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Cintra ED, 2004, ARQ NEURO-PSIQUIAT, V62, P226, DOI 10.1590/S0004-282X2004000200007; CSERR HF, 1992, PROG BRAIN RES, V91, P3; DELBIGIO MR, 1990, ACT NEUR S, V51, P14; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059, DOI 10.1152/ajprenal.1989.256.6.F1059; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; DOCZI T, 1993, ACTA NEUROCHIR, V121, P1, DOI 10.1007/BF01405174; FARACI FM, 1988, CIRC RES, V63, P373, DOI 10.1161/01.RES.63.2.373; Hockel K, 2012, STROKE, V43, P227, DOI 10.1161/STROKEAHA.111.626168; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; Lam TI, 2009, AM J PHYSIOL-CELL PH, V297, pC278, DOI 10.1152/ajpcell.00093.2009; LATZKOVITS L, 1993, AM J PHYSIOL, V264, pC603, DOI 10.1152/ajpcell.1993.264.3.C603; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marmarou A, 2005, ACT NEUR S, V95, P277; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; Maybauer MO, 2008, BEST PRACT RES-CLIN, V22, P253, DOI 10.1016/j.bpa.2008.03.003; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nielsen S, 1997, J NEUROSCI, V17, P171; O'Donnell ME, 2005, AM J PHYSIOL-CELL PH, V289, pC283, DOI 10.1152/ajpcell.00001.2005; Okuno K, 2008, ACTA NEUROCHIR SUPPL, V102, P431, DOI 10.1007/978-3-211-85578-2_84; Oliver G, 1895, J Physiol, V18, P277; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Raggenbass M, 2008, EUR J PHARMACOL, V583, P243, DOI 10.1016/j.ejphar.2007.11.074; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Rap Z M, 1978, Adv Neurol, V20, P381; Rosenberg G A, 1990, Adv Neurol, V52, P149; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Stroop R, 1998, ACT NEUR S, V71, P303; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2011, J CEREBR BLOOD F MET, V31, P47, DOI 10.1038/jcbfm.2010.188; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thibonnier M, 1998, PROG BRAIN RES, V119, P147; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Tribollet E, 1998, PROG BRAIN RES, V119, P45; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Xu Miao, 2007, Chin J Traumatol, V10, P90; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Yukutake Y, 2010, NEUROSCIENCE, V168, P885, DOI 10.1016/j.neuroscience.2009.10.029; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	61	20	21	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1442	1448		10.1089/neu.2012.2807			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500008	23441636				2022-02-06	
J	Zhu, JM; Zhang, JF; Ji, M; Gu, HW; Xu, Y; Chen, C; Hu, N				Zhu, Juming; Zhang, Junfang; Ji, Min; Gu, Hongwei; Xu, Yue; Chen, Chen; Hu, Nan			The Role of Peroxisome Proliferator-Activated Receptor and Effects of Its Agonist, Pioglitazone, on a Rat Model of Optic Nerve Crush: PPAR gamma in Retinal Neuroprotection	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GANGLION-CELL DAMAGE; MOUSE MODEL; ROSIGLITAZONE; GLAUCOMA; INHIBITION; MECHANISMS; EXPRESSION; PROTECTION; NEUROPATHY	It has been shown that peroxisome proliferators-activated receptor gamma (PPAR gamma) is beneficial for central nervous system injury. However its role on optic nerve injury remains unknown. In the present study, we examined the change of PPAR gamma expression in rat retina following optic nerve injury and investigated the effect of pioglitazone (Pio), a PPAR gamma agonist, on retinal ganglion cells (RGCs) neuroprotection using a rat optic nerve crush (ONC) model. Our results showed that PPAR gamma mRNA and protein levels were increased after ONC, and most of PPAR gamma-immunoreactive cells colocalized with Muller cells. Pio treatment significantly enhanced the number of surviving RGCs and inhibited RGCs apoptosis induced by ONC. However, when PPAR gamma antagonist GW9662 was used, these neuroprotective effects were abolished. In addition, pio attenuated Muller cell activation after ONC. These results indicate that PPAR gamma appears to protect RGCs from ONC possibly via the reduction of Muller glial activation. It provides evidence that activation of PPAR gamma may be a potential alternative treatment for RGCs neuroprotection.	[Zhu, Juming; Zhang, Junfang; Ji, Min; Gu, Hongwei; Xu, Yue; Chen, Chen; Hu, Nan] Nantong Univ, Inst Eye, Nantong, Peoples R China		Hu, N (corresponding author), Nantong Univ, Inst Eye, Nantong, Peoples R China.	hunaneye@hotmail.com			science and technology project of Nantong, China [BK2012070]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81200680]	This work was supported by a grant from the science and technology project of Nantong, China (No. BK2012070), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the National Natural Science Foundation of China (No: 81200680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoun P, 2003, INVEST OPHTH VIS SCI, V44, P2999, DOI 10.1167/iovs.02-1060; Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046/j.1460-9568.2000.00110.x; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Carta AR, 2011, NEUROSCIENCE, V194, P250, DOI 10.1016/j.neuroscience.2011.07.046; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Esposito E, 2011, EXPERT OPIN THER TAR, V15, P943, DOI 10.1517/14728222.2011.581231; Fu QL, 2009, NEUROSCIENCE, V162, P375, DOI 10.1016/j.neuroscience.2009.04.075; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; Herzlich Alexandra A, 2009, Open Biol J, V2, P141; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kisiswa L, 2010, OPHTHALMIC RES, V43, P61, DOI 10.1159/000247591; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Lee CH, 2011, J NEUROL SCI, V300, P120, DOI 10.1016/j.jns.2010.09.005; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4898, DOI 10.1167/iovs.07-1447; Mabuchi F, 2004, INVEST OPHTH VIS SCI, V45, P4352, DOI 10.1167/iovs.04-0355; Mackenzie P, 2008, SURV OPHTHALMOL, V53, pS39, DOI 10.1016/j.survophthal.2008.08.008; Michalik L, 2002, INT J DEV BIOL, V46, P105; Nakazawa T, 2006, MOL VIS, V12, P867; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Pershadsingh HA, 2008, PPAR RES, V2008, DOI 10.1155/2008/164273; Qi L, 2010, INT J CLIN EXP MED, V3, P283; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sarayba MA, 2005, EXP EYE RES, V80, P435, DOI 10.1016/j.exer.2004.10.009; Schmidt KG, 2008, CURR NEUROPHARMACOL, V6, P164, DOI 10.2174/157015908784533851; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Vidal-Sanz M, 2000, NEUROTOX RES, V2, P215, DOI 10.1007/BF03033795; Vigneswara V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053473; Wilhelm B, 2006, GRAEF ARCH CLIN EXP, V244, P551, DOI 10.1007/s00417-005-0102-8; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	39	20	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68935	10.1371/journal.pone.0068935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	WOS:000324146200040	23874818	Green Submitted, Green Published, gold			2022-02-06	
J	Tian, Y; Wang, ZG; Jia, Y; Li, SJ; Wang, B; Wang, SZ; Sun, L; Zhang, JN; Chen, JL; Jiang, RC				Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Chen, Jieli; Jiang, Rongcai			Intracranial pressure variability predicts short-term outcome after intracerebral hemorrhage: A retrospective study	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Intracranial pressure; Successive variation; Short-term outcome; Intracerebral hemorrhage; Mannitol; Cerebral perfusion pressure	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; STROKE; MANAGEMENT; MULTICENTER; CHINA	Introduction: Elevated intracranial pressure (ICP) is generally observed in brain injury and intracerebral hemorrhage (ICH) patients and is consistently associated with poor neurological outcome. Intracranial pressure variability (IPV) is a better predictor of long-term neurological outcome than mean ICP in traumatic brain injury patients. However, whether IPV regulates functional outcome in ICH patients has not been investigated. In the present study, we investigated the relationship between IPV and functional outcome in ICH patients and determined whether IPV is a valid predictor of neurological outcome in ICH patients. Methods: A consecutive series of 56 patients with ICH were enrolled in this study. These patients underwent surgical treatments and were planted with an ICP monitor. The ICP was continuously recorded for 7 days at one-hour intervals. The mean arterial blood pressure (MAP) and cerebral perfusion pressure (CPP) were also calculated. We used successive variation (SV) to represent IPV, which was calculated by averaging the difference in ICP between successive parameters. The short-term outcome was dichotomized into improved and deteriorated groups based on the changes in their Glasgow Coma Scale (GCS) score between admission and 30 days after admission. The long-term outcome was evaluated by Glasgow Outcome Scale (GOS) at 12 months after discharge from the hospital, and the patients were dichotomized into independent and dependent groups. Results: The results showed that IPV was lower in the improved patient group and higher in patients with poorer outcome at 30 days after ICH. There was a significant positive correlation between SV and short-term neurological outcome. We also found the in-patient mortality was significantly increased in the high IPV patient group (P = 0.02), which was divided by the cutoff point using receiver operating characteristic (ROC) curve analysis. The univariate correlation analysis demonstrated that the IPV levels were positively correlated with mean ICP (R-2 = 0.652, P = 0.000), while were negatively correlated with CPP (R-2 = 0.426, P = 0.000). Increases in SV of ICP were a predictor of 30-day poor short-term outcome, but not for 12-month long-term outcome after adjusting for the potential confounders in a multivariable logistic regression model. Conclusions: The results suggest that high IPV is correlated with poorer outcome in ICH patients. Managing the ICP at an appropriate level during the early phase after ICH may improve functional outcome in ICH patients. (C) 2013 Elsevier B.V. All rights reserved.	[Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	yetian1986@gmail.com; wzgforrest@sina.com; jynlgz@sina.com; lishengjie870707@sina.com; tianjinwangb@163.com; wsz1987315@163.com; tjsl2010@163.com; jianningzhang@hotmail.com; jieli@neuro.hfh.edu; jianghope@gmail.com					Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Fan JY, 2010, BIOL RES NURS, V11, P317, DOI 10.1177/1099800409349164; Herrington WG, 2011, NEUROLOGY, V77, P2073, DOI 10.1212/WNL.0b013e318239be24; JENNETT B, 1975, LANCET, V1, P480; Kalita J, 2009, ACTA NEUROL SCAND, V119, P254, DOI 10.1111/j.1600-0404.2008.01095.x; Kirkness CJ, 2008, ACTA NEUROCHIR SUPPL, V102, P105, DOI 10.1007/978-3-211-85578-2_21; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Ko Y, 2010, STROKE, V41, P2512, DOI 10.1161/STROKEAHA.110.595561; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Messe S, 2009, NEUROCRIT CARE, V11, P38, DOI 10.1007/s12028-009-9207-y; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SCHACHINGER H, 1989, J HYPERTENS, V7, pS81; Spruit-van Eijk M, 2012, AGE AGEING, V41, P746, DOI 10.1093/ageing/afs105; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wagle J, 2011, DEMENT GERIATR COGN, V31, P379, DOI 10.1159/000328970; Wei JW, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-16; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	23	20	22	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	JUL 15	2013	330	1-2					38	44		10.1016/j.jns.2013.04.001			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	170GA	WOS:000320837200009	23628469				2022-02-06	
J	De Beaumont, L; Beauchemin, M; Beaulieu, C; Jolicoeur, P				De Beaumont, Louis; Beauchemin, Maude; Beaulieu, Christelle; Jolicoeur, Pierre			Long-term attenuated electrophysiological response to errors following multiple sports concussions	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Sports concussion; Event-related potentials; Error-related negativity; Cognitive control	FOOTBALL PLAYERS; ABNORMALITIES; HISTORY; SYSTEM; CORTEX	This study extracted the error-related negativity (ERN) waveform component recorded from a visual-spatial attention and a visual short-term memory task to assess rigorously the long-term and cumulative effects of concussions on evaluative processes of cognitive control related to performance monitoring. This study demonstrates that, relative to control athletes, multiply concussed athletes show significant ERN amplitude reduction elicited by error generation. These cumulative effects of concussions on ERN amplitude were found in two distinct experimental paradigms designed to solicit concussion-sensitive cognitive abilities such as attention and short-term memory. This suggests that the mechanisms that contribute to the evaluation of cognitive performance may be significantly affected following multiple concussions even in low-conflict situations.	[De Beaumont, Louis; Beaulieu, Christelle] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ G9A 5H7, Canada; [De Beaumont, Louis; Beauchemin, Maude] Montreal Sacred Heart Hosp, Res Ctr, Montreal, PQ, Canada; [Jolicoeur, Pierre] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada		De Beaumont, L (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, CP 5000, Trois Rivieres, PQ G9A 5H7, Canada.	Louis.Debeaumont@uqtr.ca			Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	We wish to thank the Canadian Institute of Health Research (CIHR) for funding this work through grants awarded to P.J. and L.D.B. We also want to recognize the important technical assistance of Pia Amping to this work. Authors' statement: This manuscript has not been published elsewhere, and it has not been submitted simultaneously for publication elsewhere. Statement of authorship: All authors listed have contributed to the original work. Disclosure: The authors have reported no conflicts of interest. Ethical adherence: This study has been approved by the ethics committee of the University of Montreal.	Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hewig J, 2011, PSYCHOPHYSIOLOGY, V48, P1390, DOI 10.1111/j.1469-8986.2011.01209.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1997, NEUROLOGY, V48, P581; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2009, NEUROREPORT, V20, P1486, DOI 10.1097/WNR.0b013e32833283fe; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LEZAK MD, 1995, NEUROPSYCHYOLOGICAL; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory PR, 1999, BRIT J SPORT MED, V33, P297; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Olvet DM, 2009, BRAIN RES, V1284, P89, DOI 10.1016/j.brainres.2009.05.079; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	39	20	20	1	30	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL 1	2013	35	6					596	607		10.1080/13803395.2013.800023			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	238BH	WOS:000325914900004	23701388				2022-02-06	
J	Kalanuria, A; Nyquist, PA; Armonda, RA; Razumovsky, A				Kalanuria, Atul; Nyquist, Paul A.; Armonda, Rocco A.; Razumovsky, Alexander			Use of Transcranial Doppler (TCD) Ultrasound in the Neurocritical Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Transcranial Doppler; Neurocritical care unit; Vasospasm; Stroke; Intracranial hypertension	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL-BLOOD-FLOW; ACUTE ISCHEMIC-STROKE; PATENT FORAMEN OVALE; CAROTID-ENDARTERECTOMY; HEMODYNAMIC-CHANGES; BRAIN-DEATH; PULSATILITY INDEX; ASYMPTOMATIC EMBOLIZATION; VERTEBROBASILAR VASOSPASM	Transcranial Doppler (TCD) is a portable device that uses a handheld 2-MHz transducer. It is most commonly used in subarachnoid hemorrhage where cerebral blood flow velocities in major intracranial blood vessels are measured to detect vasospasm in the first 2 to 3 weeks. TCD is used to detect vasospasm in traumatic brain injury and post-tumor resection, measurement of cerebral autoregulation and cerebrovascular reactivity, diagnosis of acute arterial occlusions in stroke, screening for patent foramen ovale and monitoring of emboli. It can be used to detect abnormally high intracranial pressure and for confirmation of total cerebral circulatory arrest in brain death.	[Kalanuria, Atul; Nyquist, Paul A.] Johns Hopkins Univ Hosp, Div Neurocrit Care, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Armonda, Rocco A.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Razumovsky, Alexander] Sentient NeuroCare Serv, Hunt Valley, MD 21031 USA		Razumovsky, A (corresponding author), Sentient NeuroCare Serv, 11011 McCormick Rd,Suite 200, Hunt Valley, MD 21031 USA.	arazumovsky@sentientmedical.com					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1986, NEURORADIOLOGY, V28, P11, DOI 10.1007/BF00341759; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid Rune, 2002, Eur J Ultrasound, V16, P3, DOI 10.1016/S0929-8266(02)00045-9; Ackerstaff RGA, 2000, STROKE, V31, P1817, DOI 10.1161/01.STR.31.8.1817; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Akopov S, 2002, STROKE, V33, P1274, DOI 10.1161/01.STR.0000013740.62456.A0; Albert A, 1997, J NEUROIMAGING, V7, P159, DOI 10.1111/jon199773159; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Alexandrov AV, 2000, J NEUROIMAGING, V10, P27, DOI 10.1111/jon200010127; Alotaibi NM, 2012, J NEUROINTERV SURG, P1; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Babikian VL, 2000, J NEUROIMAGING, V10, P101, DOI 10.1111/jon2000102101; Baracchini C, 2000, STROKE, V31, P2942, DOI 10.1161/01.STR.31.12.2942; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bejjani GK, 1999, SURG NEUROL, V52, P577, DOI 10.1016/S0090-3019(99)00108-1; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Belvis R, 2006, J NEUROIMAGING, V16, P133, DOI 10.1111/j.1552-6569.2006.00021.x; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; BRASS LM, 1988, STROKE, V19, P1466, DOI 10.1161/01.STR.19.12.1466; Burch CM, 1996, J NEUROIMAGING, V6, P8, DOI 10.1111/jon1996618; Burgin WS, 2000, STROKE, V31, P1128, DOI 10.1161/01.STR.31.5.1128; Camerlingo M, 1996, ITAL J NEUROL SCI, V17, P215, DOI 10.1007/BF01995686; Cardiol RE, 2011, REV ESP CARDIOL, V64, P12; Carrera E, 2009, NEUROSURGERY, V65, P316, DOI 10.1227/01.NEU.0000349209.69973.88; Cervoni L, 1996, ITAL J NEUROL SCI, V17, P291, DOI 10.1007/BF01997789; CHAN KH, 1992, SURG NEUROL, V38, P433, DOI 10.1016/0090-3019(92)90111-Y; Conti A, 2009, NEUROCRIT CARE, V10, P326, DOI 10.1007/s12028-009-9199-7; Czosnyka M, 1996, CEREBROVAS BRAIN MET, V8, P273; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Demchuk AM, 2000, J NEUROIMAGING, V10, P1; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1; Dorsch N, 2011, ACTA NEUROCHIR SUPPL, V110, P5, DOI 10.1007/978-3-7091-0353-1_1; Droste DW, 2002, STROKE, V33, P2211, DOI 10.1161/01.STR.0000027884.03365.AC; DROSTE DW, 1989, STROKE, V20, P1005, DOI 10.1161/01.STR.20.8.1005; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; FERI M, 1994, CRIT CARE MED, V22, P1120, DOI 10.1097/00003246-199407000-00012; GAUNT ME, 1994, BRIT J SURG, V81, P1435, DOI 10.1002/bjs.1800811009; Goertler M, 2002, J NEUROL NEUROSUR PS, V72, P338, DOI 10.1136/jnnp.72.3.338; Gonzalez NR, 2007, J NEUROSURG, V107, P1101, DOI 10.3171/JNS-07/12/1101; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; GROLIMUND P, 1987, STROKE, V18, P1018, DOI 10.1161/01.STR.18.6.1018; GROSSET DG, 1992, STROKE, V23, P674, DOI 10.1161/01.STR.23.5.674; Hadani M, 1999, INTENS CARE MED, V25, P822, DOI 10.1007/s001340050958; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; HARDERS AG, 1987, J NEUROSURG, V66, P718, DOI 10.3171/jns.1987.66.5.0718; HASSLER W, 1988, J NEUROSURG, V68, P745; HASSLER W, 1989, J NEUROSURG, V71, P195, DOI 10.3171/jns.1989.71.2.0195; HOLLERHAGE HG, 1988, J NEUROSURG, V69, P803; Ionita CC, 2008, NEUROCRIT CARE, V9, P8, DOI 10.1007/s12028-007-9029-8; JANSEN C, 1993, STROKE, V24, P665, DOI 10.1161/01.STR.24.5.665; JANSEN C, 1994, STROKE, V25, P992, DOI 10.1161/01.STR.25.5.992; Jo KI, 2012, WORLD NEUROSURG, V77, P316, DOI 10.1016/j.wneu.2011.06.061; JOB FP, 1994, AM J CARDIOL, V74, P381, DOI 10.1016/0002-9149(94)90407-3; Keyrouz SG, 2007, CRIT CARE, V11, DOI 10.1186/cc5958; King A, 2009, STROKE, V40, P3711, DOI 10.1161/STROKEAHA.109.563056; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; KUSHNER MJ, 1991, NEUROLOGY, V41, P109, DOI 10.1212/WNL.41.1.109; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; LANGLOIS O, 1992, NEUROCHIRURGIE, V38, P138; Lee MT, 2006, BLOOD, V108, P847, DOI 10.1182/blood-2005-10-009506; Lennard N, 1997, J VASC SURG, V26, P579, DOI 10.1016/S0741-5214(97)70055-7; LENNIHAN L, 1993, J NEUROL NEUROSUR PS, V56, P906, DOI 10.1136/jnnp.56.8.906; Levi CR, 1997, BRAIN, V120, P621, DOI 10.1093/brain/120.4.621; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Lysakowski C, 2001, STROKE, V32, P2292, DOI 10.1161/hs1001.097108; MAEDA H, 1993, STROKE, V24, P670, DOI 10.1161/01.STR.24.5.670; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Marshall SA, 2010, NEUROSURG CLIN N AM, V21, P291, DOI 10.1016/j.nec.2009.10.010; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN PJ, 1994, STROKE, V25, P390, DOI 10.1161/01.STR.25.2.390; Mascia L, 2003, INTENS CARE MED, V29, P1088, DOI 10.1007/s00134-003-1780-5; MATTLE H, 1988, ARCH NEUROL-CHICAGO, V45, P289, DOI 10.1001/archneur.1988.00520270067022; McGirt Matthew J, 2003, J Stroke Cerebrovasc Dis, V12, P88, DOI 10.1053/jscd.2003.10; Moehring MA, 2002, ULTRASOUND MED BIOL, V28, P49, DOI 10.1016/S0301-5629(01)00486-0; Molina CA, 2001, STROKE, V32, P1079, DOI 10.1161/01.STR.32.5.1079; Molloy J, 1999, STROKE, V30, P1440, DOI 10.1161/01.STR.30.7.1440; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Nakae R, 2011, NEUROSURGERY, V69, P876, DOI 10.1227/NEU.0b013e318222dc4c; Otten ML, 2008, NEUROL RES, V30, P444, DOI 10.1179/174313208X284089; Patel PM, CEREBRAL PHYSL EFFEC, P305; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; Rajajee V, 2012, NEUROSURGERY, V70, P1195, DOI 10.1227/NEU.0b013e3182417dca; Rasulo EA, 2008, EUR J ANAESTH, V25, P167, DOI 10.1017/S0265021507003341; Razumovsky A, 2013, ACTA NEUROCHIR SUPPL, V115, P87, DOI 10.1007/978-3-7091-1192-5_19; Razumovsky AY, 1999, ACTA NEUROL SCAND, V99, P65; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; Ringelstein EB, 1998, STROKE, V29, P725; Rowland MJ, 2012, BRIT J ANAESTH; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Schwarze JJ, 1999, STROKE, V30, P1234, DOI 10.1161/01.STR.30.6.1234; Serena J, 1998, STROKE, V29, P1322, DOI 10.1161/01.STR.29.7.1322; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; SLOAN MA, 1994, STROKE, V25, P2187, DOI 10.1161/01.STR.25.11.2187; Smith M, 2007, CURR OPIN ANESTHESIO, V20, P400, DOI 10.1097/ACO.0b013e3282efa686; Soustiel JF, 2002, STROKE, V33, P72, DOI 10.1161/hs0102.100484; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Spencer MP, 1997, STROKE, V28, P685, DOI 10.1161/01.STR.28.4.685; Stork JL, 2002, STROKE, V33, P2014, DOI 10.1161/01.STR.0000021002.17394.7F; Sviri GE, 2004, STROKE, V35, P1867, DOI 10.1161/01.STR.0000133397.44528.f8; Sviri GE, 2006, NEUROSURGERY, V59, P360, DOI 10.1227/01.NEU.0000223502.93013.6E; Tegeler CH, 2012, J NEUROIMAGING, P1; Toni D, 1998, STROKE, V29, P1144, DOI 10.1161/01.STR.29.6.1144; Tsivgoulis G, 2007, STROKE, V38, P1245, DOI 10.1161/01.STR.0000259712.64772.85; Ursino M, 1998, J NEUROSURG, V89, P255, DOI 10.3171/jns.1998.89.2.0255; Velat GJ, 2011, WORLD NEUROSURG, V76, P446, DOI 10.1016/j.wneu.2011.02.030; Vora YY, 1999, NEUROSURGERY, V44, P1237, DOI 10.1097/00006123-199906000-00039; Wardlaw JM, 1998, J NEUROSURG, V88, P272, DOI 10.3171/jns.1998.88.2.0272; Washington CW, 2011, NEUROCRIT CARE, V15, P312, DOI 10.1007/s12028-011-9594-8; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Wijman CAC, 2001, CEREBROVASC DIS, V11, P317, DOI 10.1159/000047660; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wozniak MA, 1996, J NEUROIMAGING, V6, P87, DOI 10.1111/jon19966287; YONEDA S, 1974, STROKE, V5, P707, DOI 10.1161/01.STR.5.6.707; ZANETTE EM, 1989, STROKE, V20, P899, DOI 10.1161/01.STR.20.7.899; Zubkov AY, 2009, NEUROL RES, V31, P626, DOI 10.1179/174313209X382331; ZURYNSKI Y, 1991, Neurological Research, V13, P248; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	125	20	22	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					441	+		10.1016/j.nec.2013.02.005			17	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100012	23809037				2022-02-06	
J	Leung, LY; Wei, G; Shear, DA; Tortella, FC				Leung, Lai Yee; Wei, Guo; Shear, Deborah A.; Tortella, Frank C.			The Acute Effects of Hemorrhagic Shock on Cerebral Blood Flow, Brain Tissue Oxygen Tension, and Spreading Depolarization following Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain tissue oxygen tension; cerebral blood flow; cortical spreading depolarization; hemorrhagic shock; traumatic brain injury	SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; SECONDARY INSULTS; NITRIC-OXIDE; DEPRESSION; MODEL; HYPOTENSION; DAMAGE	Traumatic brain injury (TBI) often occurs in conjunction with additional trauma, resulting in secondary complications, such as hypotension as a result of blood loss. This study investigated the combined effects of penetrating ballistic-like brain injury (PBBI) and hemorrhagic shock (HS) on physiological parameters, including acute changes in regional cerebral blood flow (rCBF), brain tissue oxygen tension (PbtO2), and cortical spreading depolarizations (CSDs). All recordings were initiated before injury (PBBI/HS/both) and maintained for 2.5 h. Results showed that PBBI alone and combined PBBI and HS produced a sustained impairment of ipsilateral rCBF that decreased by 70% from baseline (p < 0.05). Significant and sustained reductions in PbtO2 (50% baseline; p < 0.05) were also observed in the injured hemisphere of the animals subjected to both PBBI and HS (PBBI + HS). In contrast, PBBI alone produced smaller, more transient reductions in PbtO2 levels. The lower limit of cerebral autoregulation was significantly higher in the PBBI + HS group (p < 0.05, compared to HS alone). Critically, combined injury resulted in twice the number of spontaneous CSDs as in PBBI alone (p < 0.05). It also lowered the propagation speed of CSD and the threshold of CSD occurrence [induced CSD at higher mean arterial pressure (MAP)]. However, rCBF and PbtO2 were not responsive to the depolarizations. Our data suggest that PBBI together with HS causes persistent impairment of CBF and brain tissue oxygen tension, increasing the probability of CSDs that likely contribute to secondary neuropathology and compromise neurological recovery.	[Leung, Lai Yee; Wei, Guo; Shear, Deborah A.; Tortella, Frank C.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Leung, LY (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave,2W12, Silver Spring, MD 20910 USA.	laiyee.leung@us.army.mil	Leung, Lai Yee/H-8204-2013		Combat Casualty Care Research ProgramUnited States Department of Defense; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); National Research Council Research Associateship Program (National Academy of Sciences, Washington, DC)	The views of the authors do not purport or reflect the position of the Department of the Army or the Department of Defense (para 4-3, AR 360-5). This research is funded by the Combat Casualty Care Research Program, U.S. Army Medical Research and Materiel Command. The primary author is sponsored by the National Research Council Research Associateship Program (National Academy of Sciences, Washington, DC). The authors thank Dr. Jed A. Hartings (University of Cincinnati, Cincinnati, OH) for his valuable advice on cortical spreading depolarization and SPC Shawn McLoughlin and Ms. Xiaofang Yang for their technical support.	Ayata C, 2000, NEUROSCIENCE, V95, P639; BARRIOT P, 1987, INTENS CARE MED, V13, P203; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Hartings JA, 2006, J CEREBR BLOOD F MET, V26, P696, DOI 10.1038/sj.jcbfm.9600223; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kawase M, 2000, CAN J ANAESTH, V47, P807, DOI 10.1007/BF03019486; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Liebetanz D, 2006, NEUROSCI LETT, V398, P85, DOI 10.1016/j.neulet.2005.12.058; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; Merkler D, 2009, ANN NEUROL, V66, P355, DOI 10.1002/ana.21746; MURR R, 1993, ANESTH ANALG, V77, P898; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Petzold GC, 2008, STROKE, V39, P1292, DOI 10.1161/STROKEAHA.107.500710; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sukhotinsky I, 2010, J CEREBR BLOOD F MET, V30, P1168, DOI 10.1038/jcbfm.2009.285; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Trabold R, 2006, BRAIN RES, V1071, P237, DOI 10.1016/j.brainres.2005.11.095; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; Zaharchuk G, 1999, STROKE, V30, P2197, DOI 10.1161/01.STR.30.10.2197; Zauner A., 1997, HEAD INJURY	44	20	20	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	14					1288	1298		10.1089/neu.2012.2715			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	183MV	WOS:000321821100009	23461630				2022-02-06	
J	Lou, MQ; Chen, XZ; Wang, K; Xue, YJ; Cui, DM; Xue, F				Lou, Meiqing; Chen, XianZhen; Wang, Ke; Xue, Yajun; Cui, Daming; Xue, Fei			Increased intracranial pressure is associated with the development of acute lung injury following severe traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; Acute lung injury; Systemic inflammatory response syndrome; Intracranial pressure	INFLAMMATORY RESPONSE SYNDROME; SEVERE HEAD-INJURY; MIDLINE SHIFT; HEMORRHAGE	Objective: This study investigated the relationship among intracranial pressure (ICP), the development of acute lung injury (ALI) and systemic inflammatory response syndrome (SIRS) following a severe traumatic brain injury (TBI). Methods: Post-traumatic ICP was continuously monitored for the first week following injury in a series of consecutive patients with isolated severe TBI. The initial ICP and the duration of intracranial hypertension (ICH) were calculated. The risk factors associated with the development of ALI and SIRS were evaluated. Results: Of the 86 patients enrolled, 22 patients developed ALI and 52 patients developed SIRS during the observation period. The patients with ALI presented with a significantly higher initial ICP (31.3 +/- 7.8 mmHgvs. 23.0 +/- 8.8 mmHg,p <0.001) and a longer duration of ICH (16.8 +/- 6.5 h vs. 11.9 +/- 6.0 h, p = 0.002) than those without ALI. The incidence of both ALI and SIRS increased with increasing initial ICI), and the presence of SIRS was associated with a fourfold increase in the risk of developing ALI (odds ratio [OR], 4.0; 95% confidence interval [CI], 1.2-13.0). Conclusions: Increased ICP is associated with increased risks of developing ALI and SIRS following severe TB!. Future studies designed to verify the causative relationship between increased ICP and the systemic responses are warranted. (C) 2012 Elsevier B.V. All rights reserved.	[Lou, Meiqing; Chen, XianZhen; Wang, Ke; Xue, Yajun; Cui, Daming; Xue, Fei] Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Shanghai 200072, Peoples R China		Wang, K (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	trizzt@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81101909, 81201708]	This work is supported by the National Natural Science Foundation of China (No. 81101909 and No. 81201708).	ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Atkinson JLD, 1997, NEUROSURGERY, V41, P1214, DOI 10.1097/00006123-199711000-00052; Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brown LM, 2011, AM J SURG, V201, P486, DOI 10.1016/j.amjsurg.2010.02.003; Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; Ciurea AV, 2005, ACT NEUR S, V93, P209; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Fujishima S, 2008, BIOMED PHARMACOTHER, V62, P333, DOI 10.1016/j.biopha.2007.07.003; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hukkanen RR, 2009, TOXICOL PATHOL, V37, P799, DOI 10.1177/0192623309343778; Kitamura Y, 2010, NEUROL MED-CHIR, V50, P456, DOI 10.2176/nmc.50.456; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Matuschak George M, 2010, Mo Med, V107, P252; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001	21	20	22	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2013	115	7					904	908		10.1016/j.clineuro.2012.09.001			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	177VH	WOS:000321403000012	23010612				2022-02-06	
J	Olivecrona, M; Olivecrona, Z				Olivecrona, Magnus; Olivecrona, Zandra			Use of the CRASH study prognosis calculator in patients with severe traumatic brain injury treated with an intracranial pressure-targeted therapy	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						CRASH calculator; Intracranial pressure targeted therapy; Lund concept; Prognosis; Severe traumatic brain injury	PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; VOLUME REGULATION; MRC CRASH; PROSTACYCLIN; PRINCIPLES; ADULTS; SCALE; EDEMA	Based on the Corticosteroid Randomisation after Significant Head Injury (CRASH) trial database, a prognosis calculator has been developed for the prediction of outcome in an individual patient with a head injury. In 47 patients with severe traumatic brain injury (sTBI) prospectively treated using an intracranial pressure (ICP) targeted therapy, the individual prognosis for mortality at 14 days and unfavourable outcome at 6 months was calculated and compared with the actual outcome. An overestimation of the risk of mortality and unfavourable outcome was found. The mean risk for mortality and unfavourable outcome were estimated to be 44.6 +/- 32.5% (95% confidence interval [CI], 35.1-54.2%) and 69.3 +/- 23.7% (95% CI, 62.3-76.2%). The actual outcome was 4.3% and 42.6% respectively. The absolute risk reduction (ARR) for mortality was 33.1% and for unfavourable outcome 29.8%. A logistic fit for outcome at 6 months shows a statistically significant difference (p < 0.01). A receiver operating characteristic (ROC) curve analysis shows an area under the curve (AUC) of 0.691. The CRASH prognosis calculator overestimates the risk of mortality and unfavourable outcome in patients with sTBI treated with an ICP-targeted therapy based on the Lund concept. We do not advocate the use of the calculator for treatment decisions in individual patients. We further conclude that patients with blunt sTBI admitted within 8 hours of trauma should be treated regardless of their clinical status as long as the initial cerebral perfusion pressure is > 10 mmHg. (C) 2012 Elsevier Ltd. All rights reserved.	[Olivecrona, Magnus; Olivecrona, Zandra] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden		Olivecrona, M (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden.	Magnus.olivecrona@neuro.umu.se		Olivecrona, Magnus/0000-0001-8457-4711	Foundation for Clinical Neurosciences at Umea University; Umea University Hospital; Tore Nilsson Fund; Kempe Fund; Capio Research Fund	This study was financially supported by the Foundation for Clinical Neurosciences at Umea University, Umea University Hospital, the Tore Nilsson Fund, the Kempe Fund, and the Capio Research Fund.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; Edwards P, 2005, LANCET, V365, P1957; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; JENNETT B, 1975, LANCET, V1, P480; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; SCHERER W, 2008, EUROPEAN J ANAES S43, V25, P7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	22	20	20	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2013	20	7					996	1001		10.1016/j.jocn.2012.09.015			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	178QX	WOS:000321463600017	23702375				2022-02-06	
J	Tallus, J; Lioumis, P; Hamalainen, H; Kahkonen, S; Tenovuo, O				Tallus, Jussi; Lioumis, Pantelis; Hamalainen, Heikki; Kahkonen, Seppo; Tenovuo, Olli			Transcranial Magnetic Stimulation-Electroencephalography Responses in Recovered and Symptomatic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; electroencephalography; transcranial magnetic stimulation	PRIMARY MOTOR CORTEX; HEAD-INJURY; LONG-TERM; FUNCTIONAL CONNECTIVITY; CORTICAL EXCITABILITY; SPORTS CONCUSSION; NEURONAL-ACTIVITY; CORPUS-CALLOSUM; EEG RESPONSES; COMBINED TMS	Mild traumatic brain injury (mTBI) may cause diffuse damage to the brain, especially to the frontal areas, that may lead to persistent symptoms. We studied participants with past mTBI by means of navigated transcranial magnetic stimulation (nTMS) combined with electroencephalography (EEG). Eleven symptomatic and 8 recovered participants with a history of single mTBI and 9 healthy controls participated. Average time from injury to testing was 5 years. The participants did not have abnormalities or signs of injury on brain magnetic resonance imaging, and they did not use any centrally acting medication. Left primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) were stimulated with nTMS and evoked potentials measured from the corresponding areas of both hemispheres. Delayed ipsilateral P30 and contralateral N45 peak latencies to left DLPFC nTMS were found in the symptomatic group, along with higher DLPFC N100 amplitudes compared with the control or recovered group. The recovered group had shorter P200 latencies in left DLPFC nTMS compared with the other groups. Both mTBI groups had higher motor thresholds compared with the control group. In left M1 nTMS, the mTBI groups showed less P30 amplitude increase, and the symptomatic group showed longer P60 interhemispheric latency difference with higher stimulation intensities. The results suggest altered brain reactivity and connectivity in mTBI. Some of the observed differences may be related to compensatory mechanisms of recovery. nTMS-EEG is a potentially useful tool for studying the effects of mTBI.	[Tallus, Jussi; Hamalainen, Heikki] Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Turku 20014, Finland; [Lioumis, Pantelis; Kahkonen, Seppo] Univ Helsinki, Cent Hosp, HUSLAB, BioMag Lab, Helsinki, Finland; [Tenovuo, Olli] Univ Turku, Turku Univ Hosp, Dept Neurol, Turku 20014, Finland		Tallus, J (corresponding author), Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Assistentinkatu 7, Turku 20014, Finland.	jptall@utu.fi	Lioumis, Pantelis/A-3801-2019	Lioumis, Pantelis/0000-0003-2016-9199	Helsinki University Central Hospital (EVO-funding); SalWe Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation) [1104/10]; University of Turku; Tekes - the Finnish Funding Agency for Technology and InnovationFinnish Funding Agency for Technology & Innovation (TEKES)	Pantelis Lioumis was supported by Helsinki University Central Hospital (EVO-funding) and the SalWe Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation grant 1104/10).; Heikki Hamalainen was supported by the University of Turku (professorship) and Tekes - the Finnish Funding Agency for Technology and Innovation.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BARKER AT, 1985, LANCET, V1, P1106; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Bikmullina R, 2009, EXP BRAIN RES, V194, P517, DOI 10.1007/s00221-009-1723-7; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Bonnard M, 2009, EUR J NEUROSCI, V30, P913, DOI 10.1111/j.1460-9568.2009.06864.x; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Bruckmann S, 2012, BRAIN, V135, P2215, DOI 10.1093/brain/aws071; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Del Felice A, 2011, EPILEPSY RES, V96, P123, DOI 10.1016/j.eplepsyres.2011.05.015; Edgley SA, 1997, BRAIN, V120, P839, DOI 10.1093/brain/120.5.839; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Ferreri F, 2011, NEUROIMAGE, V54, P90, DOI 10.1016/j.neuroimage.2010.07.056; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Julkunen P, 2008, J NEUROSCI METH, V172, P270, DOI 10.1016/j.jneumeth.2008.04.021; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; Kahkonen S, 2003, NEUROPSYCHOPHARMACOL, V28, P747, DOI 10.1038/sj.npp.1300099; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2002, CLIN NEUROPHYSIOL, V113, P175, DOI 10.1016/S1388-2457(01)00721-0; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lioumis P, 2009, HUM BRAIN MAPP, V30, P1387, DOI 10.1002/hbm.20608; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Nikulin VV, 2003, EUR J NEUROSCI, V18, P1206, DOI 10.1046/j.1460-9568.2003.02858.x; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; ROSENTHAL J, 1967, J NEUROPHYSIOL, V30, P844, DOI 10.1152/jn.1967.30.4.844; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Saisanen L, 2008, J CLIN NEUROPHYSIOL, V25, P367, DOI 10.1097/WNP.0b013e31818e7944; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Van Der Werf YD, 2006, EXP BRAIN RES, V175, P246, DOI 10.1007/s00221-006-0548-x; Van der Werf YD, 2006, EXP BRAIN RES, V175, P231, DOI 10.1007/s00221-006-0551-2; Virtanen J, 1999, MED BIOL ENG COMPUT, V37, P322, DOI 10.1007/BF02513307; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333	52	20	21	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	14					1270	1277		10.1089/neu.2012.2760			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	183MV	WOS:000321821100007	23384582	Green Published			2022-02-06	
J	Tam, AKH; Kapadia, A; Ilodigwe, D; Li, ZY; Schweizer, TA; Macdonald, RL				Tam, Alan K. H.; Kapadia, Anish; Ilodigwe, Don; Li, Zeyu; Schweizer, Tom A.; Macdonald, R. Loch			Impact of global cerebral atrophy on clinical outcome after subarachnoid hemorrhage Clinical article	JOURNAL OF NEUROSURGERY			English	Article						subarachnoid hemorrhage; vasospasm; cerebral infarction; cerebral atrophy; vascular disorders	INFLAMMATORY RESPONSE SYNDROME; FUNCTIONAL STATUS EXAMINATION; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; INFARCTION; VASOSPASM; VOLUME; SCALE; POPULATION	Object. Atrophy in specific brain areas correlates with poor neuropsychological outcome after subarachnoid hemorrhage (SAH). Few studies have compared global atrophy in SAH with outcome. The authors examined the relationship between global brain atrophy, clinical factors, and outcome after SAH. Methods. This study was a post hoc exploratory analysis of the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) trial, a randomized, double-blind, placebo-controlled trial of 413 patients with aneurysmal SAH. Patients with infarctions or areas of encephalomalacia on CT, and those with large clip/coil artifacts, were excluded. The 97 remaining patients underwent CT at baseline and 6 weeks, which was analyzed using voxel-based volumetric measurements. The percentage difference in volume between time points was compared against clinical variables. The relationship with clinical outcome was modeled using univariate and multivariate analysis. Results. Older age, male sex, and systemic inflammatory response syndrome (SIRS) during intensive care stay were significantly associated with brain atrophy. Greater brain atrophy was significantly associated with poor outcome on the modified Rankin scale (mRS), severity of deficits on the National Institutes of Health Stroke Scale (NIHSS), worse executive functioning, and lower EuroQol Group-5D (EQ-5D) score. Adjusted for confounders, brain atrophy was not significantly associated with Mini-Mental State Examination and Functional Status Examination scores. Brain atrophy was not associated with angiographic vasospasm or delayed ischemic neurological deficit. Conclusions. Worse mRS score, NIHSS score, executive functioning, and EQ-5D scores were associated with greater brain atrophy and older age, male sex, and SIRS burden. These data suggest outcome is associated with factors that cause global brain injury independent of focal brain injury.	[Tam, Alan K. H.; Kapadia, Anish; Ilodigwe, Don; Li, Zeyu; Schweizer, Tom A.; Macdonald, R. Loch] St Michaels Hosp, Li Ka Shing Knowledge Inst, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr,Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada		Macdonald, RL (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	macdonaldlo@smh.ca	adsa, sdfadf/ABD-7369-2020	Tam, Alan/0000-0001-7155-6768	Physicians Services Incorporated Foundation; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Actelion Pharmaceuticals	R. Loch Macdonald is chief scientific officer of Edge Therapeutics, Inc., and receives grant support from the Physicians Services Incorporated Foundation, the Heart and Stroke Foundation of Canada, and the Canadian Institutes of Health Research. R. Loch Macdonald is a consultant for Actelion Pharmaceuticals, Ltd. Actelion Pharmaceuticals was the sponsor of the CONSCIOUS-1 trial and they provided financial support for the exploratory analysis described in this article. The data analysis and writing are the work of the authors.	BELL BA, 1985, NEUROSURGERY, V16, P498, DOI 10.1227/00006123-198504000-00011; Bendel P, 2006, NEUROLOGY, V67, P575, DOI 10.1212/01.wnl.0000230221.95670.bf; Bendel P, 2010, AM J NEURORADIOL, V31, P370, DOI 10.3174/ajnr.A1804; Bendel P, 2009, NEURORADIOLOGY, V51, P711, DOI 10.1007/s00234-009-0552-5; Biessels GJ, 2006, J NEUROL, V253, P477, DOI 10.1007/s00415-005-0036-4; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; de Bresser J, 2012, STROKE, V43, P2782, DOI 10.1161/STROKEAHA.112.669184; Dhar R, 2008, NEUROCRIT CARE, V8, P404, DOI 10.1007/s12028-008-9054-2; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Firbank MJ, 2007, J NEUROL, V254, P713, DOI 10.1007/s00415-006-0238-4; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Hadjivassiliou M, 2001, NEUROLOGY, V56, P1672, DOI 10.1212/WNL.56.12.1672; HALE PM, 1992, NEUROSURGERY, V31, P1085, DOI 10.1227/00006123-199212000-00015; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; Lin X, 2001, J NEUROL SCI, V189, P99, DOI 10.1016/S0022-510X(01)00576-7; Lindegaard K F, 1993, Adv Tech Stand Neurosurg, V20, P39; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Miklossy J, 2008, J ALZHEIMERS DIS, V13, P381; OHMAN J, 1991, J NEUROSURG, V74, P14, DOI 10.3171/jns.1991.74.1.0014; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Risselada R, 2010, EUR J EPIDEMIOL, V25, P261, DOI 10.1007/s10654-010-9432-x; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; SALERNO JA, 1992, HYPERTENSION, V20, P340, DOI 10.1161/01.HYP.20.3.340; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; SOININEN H, 1992, NEUROBIOL AGING, V13, P717, DOI 10.1016/0197-4580(92)90095-F; Staff RT, 2010, J AM GERIATR SOC, V58, P688, DOI 10.1111/j.1532-5415.2010.02765.x; Tam AKH, 2010, NEUROCRIT CARE, V13, P182, DOI 10.1007/s12028-010-9402-x; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van der Zanden BP, 2006, DRUG ALCOHOL DEPEN, V82, P111, DOI 10.1016/j.drugalcdep.2005.08.012; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zivadinov R, 2009, NEUROLOGY, V73, P504, DOI 10.1212/WNL.0b013e3181b2a706	37	20	22	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUL	2013	119	1					198	206		10.3171/2013.3.JNS121950			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	168WT	WOS:000320739300038	23662822				2022-02-06	
J	Bertens, D; Fasotti, L; Boelen, DHE; Kessels, RPC				Bertens, Dirk; Fasotti, Luciano; Boelen, Danielle H. E.; Kessels, Roy P. C.			A randomized controlled trial on errorless learning in goal management training: study rationale and protocol	BMC NEUROLOGY			English	Article						Goal management training; Errorless learning; Executive deficits; Acquired brain injury	TRAUMATIC BRAIN-INJURY; EXECUTIVE DYSFUNCTION; PRACTICAL GUIDE; FRONTAL-LOBE; OLDER-ADULTS; REHABILITATION; MEMORY; DEMENTIA; IMPLICIT; INDIVIDUALS	Background: Many brain-injured patients referred for outpatient rehabilitation have executive deficits, notably difficulties with planning, problem-solving and goal directed behaviour. Goal Management Training (GMT) has proven to be an efficacious cognitive treatment for these problems. GMT entails learning and applying an algorithm, in which daily tasks are subdivided into multiple steps. Main aim of the present study is to examine whether using an errorless learning approach (preventing the occurrence of errors during the acquisition phase of learning) contributes to the efficacy of Goal Management Training in the performance of complex daily tasks. Methods/Design: The study is a double blind randomized controlled trial, in which the efficacy of Goal Management Training with an errorless learning approach will be compared with conventional Goal Management Training, based on trial and error learning. In both conditions 32 patients with acquired brain injury of mixed etiology will be examined. Main outcome measure will be the performance on two individually chosen everyday-tasks before and after treatment, using a standardized observation scale and goal attainment scaling. Discussion: This is the first study that introduces errorless learning in Goal Management Training. It is expected that the GMT-errorless learning approach will improve the execution of complex daily tasks in brain-injured patients with executive deficits. The study can contribute to a better treatment of executive deficits in cognitive rehabilitation.	[Bertens, Dirk; Fasotti, Luciano; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Fasotti, Luciano] Rehabil Med Ctr Groot Klimmendaal SIZA Support &, Arnhem, Netherlands; [Boelen, Danielle H. E.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands		Bertens, D (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	d.bertens@donders.ru.nl	Kessels, Roy P.C./D-1902-2010; Bertens, Dirk/X-4633-2018	Kessels, Roy P.C./0000-0001-9500-9793; 	National Initiative Brain and Cognition (NIHC) [056-11-011]	The study is funded by the National Initiative Brain and Cognition (NIHC, grant # 056-11-011). This quick-result project is embedded in the pillar "The Healthy Brain, Program Cognitive Rehabilitation".	Baddeley A, 1988, Psychopharmacol Ser, V6, P12; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Bettcher BM, 2008, J INT NEUROPSYCH SOC, V14, P199, DOI 10.1017/S1355617708080193; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess Kenneth L, 2002, Provider, V28, P43; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess P. W., 1996, BADS BEHAV ASSESSMEN; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Damasio AR, 1995, ANN NY ACAD SCI, V769, P241, DOI 10.1111/j.1749-6632.1995.tb38142.x; Dechamps A, 2011, AM J ALZHEIMERS DIS, V26, P273, DOI 10.1177/1533317511404394; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Fillingham JK, 2005, INT J LANG COMM DIS, V40, P505, DOI 10.1080/13682820500138572; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Haslam C, 2011, J CLIN EXP NEUROPSYC, V33, P432, DOI 10.1080/13803395.2010.533155; Hebb D. O., 1961, BRAIN MECH LEARNING, P37, DOI DOI 10.5962/BHL.TITLE.7220; Hunkin NM, 1998, NEUROPSYCHOLOGIA, V36, P25, DOI 10.1016/S0028-3932(97)00106-1; Kern RS, 2009, SCHIZOPHRENIA BULL, V35, P807, DOI 10.1093/schbul/sbn010; Kessels RPC, 2009, NEUROREHABILITATION, V25, P307, DOI 10.3233/NRE-2009-0529; Kessels RPC, 2005, J INT NEUROPSYCH SOC, V11, P144; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Kuzis G, 1999, NEUROPSY NEUROPSY BE, V12, P265; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; McClelland J L, 1999, Prog Brain Res, V121, P75; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Mount J, 2007, NEUROREHABILITATION, V22, P123; POLLENS RD, 1988, J COGNITIVE REHABILI, V6, P26; Robertson I., 1996, GOAL MANAGEMENT TRAI; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spinella M, 2005, INT J NEUROSCI, V115, P649, DOI 10.1080/00207450590524304; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Voigt-Radloff S, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-44; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669; Zimmermann P, 2007, TEST ATTENTIONAL PER; [No title captured]	54	20	21	0	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	JUN 20	2013	13								64	10.1186/1471-2377-13-64			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	171OS	WOS:000320939400001	23786651	Green Published, gold			2022-02-06	
J	Shakeril, M; Mandkhah, A; Panahi, F				Shakeril, Moslem; Mandkhah, Atta; Panahi, Farid			S100B Protein as a Post-traumatic Biomarker for Prediction of Brain Death in Association With Patient Outcomes	ARCHIVES OF TRAUMA RESEARCH			English	Article						Posttraumatic Brain Death; Predictor; Biomarkers; S100B Protein; Outcome		Background: S100B is a calcium-binding protein, belonging to the S100 family proteins which are characterized by their high solubility and, currently, comprises 21 members which are expressed in a cell-specific manner. If we can predict the possibility of definite brain death after brain injury, we will rescue some organs of body to transplant proposes. Objectives: In this regard our study focused on the S100B protein value in predicting brain death after head trauma. In this study, the use of serum level of protein S100, 24 hours after trauma has been considered as a reliable index for predicting brain death. Patients and Methods: 72 patients (50 male and 22 female) aged 5 - 80 years old (median 40 +/- 17.72 years) with severe head traumas (GCS=8) were recruited in this cross-sectional study. Glasgow Coma Scale (GCS) and computed tomography (CT) scan findings were recorded for all patients, and then a single 5mL blood sample was obtained from each patient on admission, after 48 hours and a week later or after brain death to determine the level of S100B protein. Results: Primary and the last GCS of patients had a predictive value in determining brain death (P < 0.0005), also there was a significant correlation between GCS and level of S100B protein. There was a significant correlation between CT scan findings and S100B protein only after 48 hours of trauma. Conclusions: Changes in S100B protein, especially the levels of this dimer 48 hours after trauma can be used as marker to predict brain death. Alongside other known prognostic factors such as age, GCS and diameters of the pupils, however, this factor individually can not conclusive predict the patient's clinical course and incidence of brain death. However, it is suitable to use GCS, CT scan, clinical symptoms and biomarkers together for a perfect prediction of brain death.	[Shakeril, Moslem; Mandkhah, Atta] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Panahi, Farid] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran		Shakeril, M (corresponding author), Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran.	lemshakeri@yahoo.com	Panahi, Farid/K-3021-2012	Panahi, Farid/0000-0002-8237-6989	Research Deputy of Tabriz University of Medical Sciences	Research Deputy of Tabriz University of Medical Sciences.	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Diehl LA, 2007, BRAIN RES, V1144, P107, DOI 10.1016/j.brainres.2007.01.084; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Els T, 2001, STROKE, V32, P43, DOI 10.1161/01.STR.32.1.43; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Green AJE, 2001, J NEUROL NEUROSUR PS, V70, P744, DOI 10.1136/jnnp.70.6.744; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Janigro D, 2004, ANAESTHESIA, V59, P1149, DOI 10.1111/j.1365-2044.2004.04003.x; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Lima JE, 2004, BRAZ J MED BIOL RES, V37, P19, DOI 10.1590/S0100-879X2004000100003; Lomas JP, 2005, EMERG MED J, V22, P889, DOI 10.1136/emj.2005.031732; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Missler U, 2002, CLIN CHIM ACTA, V321, P29, DOI 10.1016/S0009-8981(02)00061-X; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Oh EJ, 2007, J CLIN LAB ANAL, V21, P387, DOI 10.1002/jcla.20201; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Studahl M, 2000, J NEUROL, V247, P636, DOI 10.1007/s004150070134; Sumas ME, 1999, PRINCIPLES NEUROSURG, P117; TEASDALE G, 1974, LANCET, V2, P81; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2007, NEUROCRIT CARE, V6, P94, DOI 10.1007/s12028-007-0005-0; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Winn HR, 2004, YOUMANS NEUROLOGICAL, V5; Wunderlich MT, 2003, J NEUROL NEUROSUR PS, V74, P827, DOI 10.1136/jnnp.74.6.827-a; Youl Jang Woo, 2006, J KOREAN NEUROSURG S, V39, P271	35	20	22	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	SUM	2013	2	2					76	80		10.5812/atr.8549			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	V24BV	WOS:000215133400004	24396798	Green Submitted, Green Published			2022-02-06	
J	Metting, Z; Cerliani, L; Rodiger, LA; van der Naalt, J				Metting, Zwany; Cerliani, Leonardo; Rodiger, Lars A.; van der Naalt, Joukje			Pathophysiological Concepts in Mild Traumatic Brain Injury: Diffusion Tensor Imaging Related to Acute Perfusion CT Imaging	PLOS ONE			English	Article							HEAD-INJURY; DAMAGE; DYSFUNCTION; IMPAIRMENT	Background: A subgroup of patients with mild traumatic brain injury (TBI) experiences residual symptoms interfering with their return to work. The pathophysiological substrate of the suboptimal outcome in these patients is a source of debate. Objective: To provide greater insight into the pathophysiological mechanisms of mild TBI. Methods: Diffusion tensor imaging (DTI) was performed during follow-up of 18 patients with mild TBI and compared with healthy control subjects. DTI data of the patient group were also compared with perfusion CT imaging in the acute phase of injury. Results: In patients with mild TBI, a trend was observed for a decreased fractional anisotropy (FA) in widespread bilateral frontal white matter areas with increased mean diffusivity (MD) in the parieto-temporal regions, compared to healthy control subjects. Cerebral blood volume (CBV) correlated significantly with FA in several white matter tracts including the corpus callosum, the internal capsule, the inferior fronto-occipital fascicle, the corticospinal tract, the superior and the inferior longitudinal fascicle. Conclusion: In mild TBI with normal conventional imaging significant associations between cerebral perfusion in the acute phase of injury and DTI analyses in the chronic phase of injury were discerned. The pathophysiological concept of these findings is being outlined.	[Metting, Zwany; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Cerliani, Leonardo] Univ Groningen, NeuroImaging Ctr, Groningen, Netherlands; [Cerliani, Leonardo] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Rodiger, Lars A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands		Metting, Z (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands.	z.metting@umcg.nl		cerliani, leonardo/0000-0002-2655-6133; van der Naalt, Joukje/0000-0001-9873-2418	ZonMw, Den Haag, The NetherlandsNetherlands Organization for Health Research and DevelopmentNetherlands Government [39200002]; NWO MaGW Open competition grant [400-08-089]; NIHC grant [056-13-017]	This study was funded by ZonMw, Den Haag, The Netherlands (grant number 39200002). In addition, L. Cerliani is supported by an NWO MaGW Open competition grant (grant number 400-08-089) and by an NIHC grant (grant number 056-13-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	20	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64461	10.1371/journal.pone.0064461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	WOS:000319330200139	23704986	Green Published, Green Submitted, gold			2022-02-06	
J	Hanks, RA; Sander, AM; Millis, SR; Hammond, FM; Maestas, KL				Hanks, Robin A.; Sander, Angelle M.; Millis, Scott R.; Hammond, Flora M.; Maestas, Kacey L.			Changes in Sexual Functioning From 6 to 12 Months Following Traumatic Brain Injury: A Prospective TBI Model System Multicenter Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						rehabilitation; sexual dysfunction; traumatic brain injury	HEAD-INJURY; ADENOCARCINOMA; PRETREATMENT; DYSFUNCTION; BEHAVIOR	Objective: To investigate longitudinal changes in sexual functioning during the first year following moderate to severe traumatic brain injury (TBI). Design: Prospective cohort study. Setting: Community. Participants: 182 persons (53 women and 129 men) with moderate to severe TBI who were admitted to 1 of 6 participating TBI Model System centers and followed in the community at 6 and 12 months after injury. Main Measures: Derogatis Interview for Sexual Functioning-Self-Report (DISF-SR); Global Sexual Satisfaction Index (GSSI). Results: Mean T-scores on the DISF-SR Arousal subscale demonstrated marginal improvement over time, with a 2.59-point increase (P = .05) from 6 to 12 months after injury. There were no significant differences over this 6-month period on the remaining DISF-SR subscales, including sexual cognition/fantasy, sexual behavior/experience, and orgasm. There was no significant change in satisfaction with sexual functioning on the GSSI from 6 months (72% satisfied) to 12 months (71% satisfied). Conclusions and Implications: Sexual function and satisfaction appears to be stable in those with moderate to severe TBI from 6 to 12 months after injury, with the exception of minimal improvement in arousal. These findings, to our knowledge, reflect the first evidence regarding prospective changes in sexual functioning in this population. Future research can go far to assist clinicians in treatment planning and managing patient expectations of recovery of sexual functioning after TBI.	[Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI 48201 USA; [Sander, Angelle M.; Maestas, Kacey L.] Harris Hlth Syst, Dept Phys Med & Rehabil, Baylor Coll Med, Houston, TX USA; [Sander, Angelle M.; Maestas, Kacey L.] TIRR Mem Hermann Dallas, Brain Injury Res Ctr, Dallas, TX USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Carolinas Rehabil, Carolinas HealthCare Syst, Charlotte, NC USA		Hanks, RA (corresponding author), Wayne State Univ, Sch Med, 261 Mack Ave,Ste 555, Detroit, MI 48201 USA.	rhanks@med.wayne.edu			National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A080044, H133A070042, H133A070043, H133B031117]	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grant nos. H133A080044, H133A070042, H133A070043, and H133B031117)	Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Derogatis L, 1987, DEROGATIS INTERVIEW; Derogatis L. R., 1975, DEROGATIS SEXUAL FUN; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; Evans C, 1998, EVID BAS MENT HLTH, V1, P70, DOI DOI 10.1136/EBMH.1.3.70; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gervasio AH, 1999, SEXUALITY SEXUAL DYS; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Nicolosi A, 2006, J SEX MARITAL THER, V32, P331, DOI 10.1080/00926230600666469; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sandel ME, 2007, SEXUALITY REPROD NEU; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Strauss D, 1991, SEX DISABIL, V9, P49; TEASDALE G, 1974, LANCET, V2, P81; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P729, DOI 10.1016/0360-3016(90)90503-C; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P1001, DOI 10.1016/0360-3016(90)90025-F	27	20	20	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					179	185		10.1097/HTR.0b013e31828b4fae			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000004	23661069				2022-02-06	
J	Keller, D; Kulp, H; Maher, Z; Santora, TA; Goldberg, AJ; Seamon, MJ				Keller, Deborah; Kulp, Heather; Maher, Zoe; Santora, Thomas A.; Goldberg, Amy J.; Seamon, Mark J.			Life after near death: Long-term outcomes of emergency department thoracotomy survivors	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Emergency department thoracotomy; long-term outcomes; quality of life	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; MAJOR TRAUMA; FUNCTIONAL CONSEQUENCES; ROOM THORACOTOMY; RECOVERY; DETERMINANTS; ADOLESCENTS; POPULATION	BACKGROUND: Predictors of hospital survival after emergency department thoracotomy (EDT) are well established, but little is known of long-term outcomes after hospital survival. Our primary study objective was to analyze the long-term social, cognitive, functional, and psychological outcomes in EDT survivors. METHODS: Review of our Level I trauma center registry (2000-2010) revealed that 37 of 448 patients survived hospitalization after EDT. Demographics and clinical characteristics were analyzed. After attempts to contact survivors, 21 patients or caretakers were invited to an outpatient study evaluation; 16 were unreachable (none of whom were present in the Social Security Death Index). Study evaluation included demographic and social data and an outpatient multidisciplinary assessment with validated scoring instruments (Mini-Mental Status Exam, Glasgow Outcome Scores, Timed Get-Up and Go Test, Functional Independence Measure Scoring, SF-36 Health Survey, and civilian posttraumatic stress disorder checklist). RESULTS: After extended hospitalization (43 +/- 41 days), disposition varied ( home, 62%; rehabilitation, 32%; skilled nursing facility, 6%), but readmission was common (33%) in the 37 EDT hospital survivors. Of the 21 contacted, 16 completed the study evaluation, 2 had died, 1 remained in a comatose state, and 2 were available by telephone only. While unemployment (75%), daily alcohol (50%), and drug use (38%) were common, of the 16 patients who underwent the comprehensive, multidisciplinary outpatient assessment after a median of 59 months following EDT, 75% had normal cognition and returned to normal activities, 81% were freely mobile and functional, and 75% had no evidence of posttraumatic stress disorder upon outpatient screening. CONCLUSION: Despite the common belief that EDT survivors often live with severe neurologic or functional impairment, we have found that most of our sampled EDT survivors had no evidence of long-term impairment. It is our hope that these results are considered by physicians making life or death decisions regarding the "futility'' of EDT in our most severely injured patients. Copyright (c) 2013 by Lippincott Williams & Wilkins	[Keller, Deborah] Univ Hosp Case Med Ctr, Dept Surg, Cleveland, OH USA; [Kulp, Heather] Alfred I duPont Childrens Hosp, Wilmington, DE USA; [Santora, Thomas A.; Goldberg, Amy J.] Temple Univ, Sch Med, Div Trauma & Surg Crit Care, Philadelphia, PA 19122 USA; [Maher, Zoe] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19122 USA; [Seamon, Mark J.] Cooper Univ Hosp, Div Trauma & Surg Crit Care, Dept Surg, Camden, NJ 08103 USA		Seamon, MJ (corresponding author), Cooper Univ Hosp, Div Trauma & Surg Crit Care, Dept Surg, 3 Cooper Plaza,Suite 411, Camden, NJ 08103 USA.	seamon-mark@CooperHealth.edu	Keller, Deborah Susan/B-2043-2014; Seamon, Mark/AAM-4713-2021	Keller, Deborah Susan/0000-0002-8645-6206; 			Asensio JA, 2001, J AM COLL SURGEONS, V193, P303; Baker CC, 1980, AM J SURG, V39, P677; BOYD M, 1992, J TRAUMA, V33, P714, DOI 10.1097/00005373-199211000-00021; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; ESPOSITO TJ, 1991, J TRAUMA, V31, P881, DOI 10.1097/00005373-199107000-00001; Gabbe BJ, 2008, ANN SURG, V247, P854, DOI 10.1097/SLA.0b013e3181656d1e; Han PP, 2011, J TRAUMA, V70, P923, DOI 10.1097/TA.0b013e31820cf03e; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; LORENZ HP, 1992, J TRAUMA, V32, P780, DOI 10.1097/00005373-199206000-00020; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; MILLHAM FH, 1993, J TRAUMA, V34, P332, DOI 10.1097/00005373-199303000-00004; Mollberg NM, 2011, ANN THORAC SURG, V92, P455, DOI 10.1016/j.athoracsur.2011.04.042; Moore EE, 2011, J TRAUMA, V70, P334, DOI 10.1097/TA.0b013e3182077c35; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Passos EM, 2012, J AM COLL SURGEONS, V214, P18, DOI 10.1016/j.jamcollsurg.2011.09.020; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Seamon MJ, 2008, WORLD J SURG, V32, P604, DOI 10.1007/s00268-007-9392-9; Seamon MJ, 2007, J TRAUMA, V63, P113, DOI 10.1097/TA.0b013e31806842a1; Seamon MJ, 2011, J TRAUMA, V71, P306, DOI 10.1097/TA.0b013e31822178bd; SLOAN EP, 1995, J TRAUMA, V38, P736, DOI 10.1097/00005373-199505000-00010; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Timmers TK, 2011, ARCH SURG-CHICAGO, V146, P412, DOI 10.1001/archsurg.2010.279; Weninger P, 2008, J TRAUMA, V65, P799, DOI 10.1097/TA.0b013e3181820dae	27	20	20	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2013	74	5					1315	1320		10.1097/TA.0b013e31828c3db4			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	149JZ	WOS:000319316600027	23609284				2022-02-06	
J	Wang, JY; Liou, AKF; Ren, ZH; Zhang, L; Brown, BN; Cui, XT; Badylak, SF; Cai, YN; Guan, YQ; Leak, RK; Chen, J; Ji, X; Chen, L				Wang, J. Y.; Liou, A. K. F.; Ren, Z. H.; Zhang, L.; Brown, B. N.; Cui, X. T.; Badylak, S. F.; Cai, Y. N.; Guan, Y. Q.; Leak, Rehana K.; Chen, J.; Ji, X.; Chen, L.			Neurorestorative Effect of Urinary Bladder Matrix-Mediated Neural Stem Cell Transplantation Following Traumatic Brain Injury in Rats	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						TBI; UBM; stem cell transplantation; protection; neurodegeneration; neurobehavioral function	EXTRACELLULAR-MATRIX; SUBVENTRICULAR ZONE; COGNITIVE DEFICITS; COLLAGEN MATRIX; CHEMOKINES; SCAFFOLD; DAMAGE; MODEL; MOTOR; SITE	Traumatic brain injury (TBI) is a leading cause of cell death and disability among young adults and lacks a successful therapeutic strategy. The multiphasic injuries of TBI severely limit the success of conventional pharmacological approaches. Recent successes with transplantation of stem cells in bioactive scaffolds in other injury paradigms provide new hope for the treatment of TBI. In this study, we transplanted neural stem cells (0.5x10(5) cells/mu l) cultured in a bioactive scaffold derived from porcine urinary bladder matrix (UBM; 4 injection sites, 2.5 mu l each) into the rat brain following controlled cortical impact (CCI, velocity, 4.0 m/sec; duration, 0.5 sec; depth, 3.2mm). We evaluated the effectiveness of this strategy to combat the loss of motor, memory and cognitive faculties. Before transplantation, compatibility experiments showed that UBM was able to support extended proliferation and differentiation of neural stem cells. Together with its reported anti-inflammatory properties and rapid degradation characteristics in vivo, UBM emerged to be an ideal scaffold. The transplants reduced neuron/tissue loss and white matter injury, and also significantly ameliorated motor, memory, and cognitive impairments. Furthermore, exposure to UBM alone was sufficient to decrease the loss of sensorimotor skills from TBI (examined 3-28 days post-CCI). However, only UBMs that contained proliferating neural stem cells helped attenuate memory and cognitive impairments (examined 26-28 days post-CCI). In summary, these results demonstrate the therapeutic efficacy of stem cells in bioactive scaffolds against TBI and show promise for translation into future clinical use.	[Wang, J. Y.; Ren, Z. H.; Cai, Y. N.; Guan, Y. Q.; Chen, J.; Ji, X.; Chen, L.] Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, Beijing 100053, Peoples R China; [Wang, J. Y.; Ren, Z. H.; Cai, Y. N.; Guan, Y. Q.; Chen, J.; Ji, X.; Chen, L.] Capital Med Univ, China Int Neurosci Inst, Xuanwu Hosp, Beijing 100053, Peoples R China; [Liou, A. K. F.; Chen, J.] Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15213 USA; [Zhang, L.; Cui, X. T.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Brown, B. N.; Cui, X. T.; Badylak, S. F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA; [Brown, B. N.; Badylak, S. F.] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15261 USA; [Leak, Rehana K.] Duquesne Univ, Mylan Sch Pharm, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA; [Cui, X. T.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA		Chen, L (corresponding author), Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.	jixm@ccmu.edu.cn; chlyz34@163.com	Leak, Rehana K/I-2607-2019; Ji, Xunming/AAN-3370-2021	Leak, Rehana K/0000-0003-2817-7417; Cui, Xinyan/0000-0002-0470-2005; Badylak, Stephen/0000-0003-3555-0689	Department of Defense Concept grant; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS36736, NS43802, NS45048]; National Science FoundationNational Science Foundation (NSF) [DMR-0748001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272804, 30970939, 30870854, 81171241]; Key Project of Chinese Ministry of EducationMinistry of Education, China [210003]; National Basic Research Program of China (973 Program)National Basic Research Program of China [2011CB707804];  [2011-3-093]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036736, R01NS043802, R01NS045048] Funding Source: NIH RePORTER	J.Y. Wang and A.K.F. Liou contributed equally to this work. This work was supported by the Department of Defense Concept grant (to J.C. and X.T.C,), the National Institutes of Health Grants (NS36736, NS43802, and NS45048 to J.C), and National Science Foundation (DMR-0748001 to X.T.C.). L.C. was supported by grants from the National Natural Science Foundation of China (Grant # 81272804 and 30970939), the Key Project of Chinese Ministry of Education (Grant # 210003), and the High Level Talent Fund from the Beijing Healthcare System (Grant # 2011-3-093). X.J. was supported by grants from the National Natural Science Foundation of China (Grant # 30870854 and 81171241) and the National Basic Research Program of China (973 Program) (Grant # 2011CB707804).	Badylak S, 2003, HEART SURG FORUM, V6, pE20; Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2; Davis NF, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.11.036; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Gilbert TW, 2008, J SURG RES, V147, P61, DOI 10.1016/j.jss.2007.04.035; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hodgetts S.I., 2012, CELL TRANSPLANT; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Kohen NT, 2009, BIOINTERPHASES, V4, P69, DOI 10.1116/1.3274061; Kouris NA, 2011, REGEN MED, V6, P569, DOI [10.2217/RME.11.48, 10.2217/rme.11.48]; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Larijani Bagher, 2012, Acta Med Iran, V50, P79; Lewis M., 2012, AM J EMERG MED; Liew A, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt119; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Liu LB, 2012, INT UROGYNECOL J, V23, P1271, DOI 10.1007/s00192-012-1745-8; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Martino G, 2004, LANCET NEUROL, V3, P372, DOI 10.1016/S1474-4422(04)00771-9; Martino G, 2002, LANCET NEUROL, V1, P499, DOI 10.1016/S1474-4422(02)00223-5; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Mauney J, 2010, MATRIX BIOL, V29, P657, DOI 10.1016/j.matbio.2010.08.008; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Penolazzi L, 2012, J CELL PHYSIOL, V227, P857, DOI 10.1002/jcp.22983; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Shah U, 2010, ACTA BIOMATER, V6, P3029, DOI 10.1016/j.actbio.2010.02.041; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Snyder EY, 2012, NEW ENGL J MED, V366, P1940, DOI 10.1056/NEJMcibr1200138; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang G., 2012, NEUROTHERAPEUTICS; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Zhao YH, 2012, J TRADIT CHIN MED, V32, P289, DOI 10.1016/S0254-6272(13)60027-8; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	56	20	20	2	16	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	MAY	2013	12	3					413	425		10.2174/1871527311312030014			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	145CE	WOS:000318990800014	23469853	Green Accepted			2022-02-06	
J	Tayra, JT; Kameda, M; Yasuhara, T; Agari, T; Kadota, T; Wang, FF; Kikuchi, Y; Liang, HB; Shinko, A; Wakamori, T; Vcelar, B; Weik, R; Date, I				Tayra, Judith Thomas; Kameda, Masahiro; Yasuhara, Takao; Agari, Takashi; Kadota, Tomohito; Wang, Feifei; Kikuchi, Yoichiro; Liang, Hanbai; Shinko, Aiko; Wakamori, Takaaki; Vcelar, Brigitta; Weik, Robert; Date, Isao			The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease	BRAIN RESEARCH			English	Article						Carbamylated erythropoietin; Dopamine; Neuroprotection; Neurorescue; Parkinson's disease	TRAUMATIC BRAIN-INJURY; MEAN PLATELET VOLUME; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; ACUTE STROKE; ACTIVATION; DIFFERENTIATION; NEURONS; EDEMA; DEATH	Parkinson's disease is characterized by progressive degeneration of dopaminergic neurons. Thus the development of therapeutic neuroprotection and neurorescue strategies to mitigate disease progression is important. In this study we evaluated the neuroprotective/rescue effects of erythropoietin Fc fusion protein (EPO-Fc) and carbamylated erythropoietin Fe fusion protein (CEPO-Fc) in a rat model of Parkinson's disease. Adult female Sprague-Dawley rats received intraperitoneal injection of EPO-Fc, CEPO-Fc or PBS. Behavioral evaluations consisted of rota-rod, cylinder and amphetamine-induced rotation tests. In the neuroprotection experiment, the CEPO-Fc group demonstrated significant improvement compared with the EPO-Fc group on the amphetamine-induced rotation test throughout the four-week follow-up period. Histologically, significantly more tyrosine hydroxylase (TH)-positive neurons were recognized in the substantia nigra (SN) pars compacta in the CEPO-Fc group than in the PBS and EPO-Fc groups. In the neurorescue experiment, rats receiving CEPO-Fc showed significantly better behavioural scores than those receiving PBS. The histological data concerning striatum also showed that the CEPO-Fc group had significantly better preservation of TH-positive fibers compared to the PBS and EPO-Fc groups. Importantly, there were no increases in hematocrit or hemoglobin levels in the CEPO-Fc group in either the neuroprotection or the neurorescue experiments. In conclusion, the newly developed CEPO-Fc might confer neuroprotective and neurorescue benefits in a rat model of Parkinson's disease without the side effects associated with polycythemia. CEPO-Fc might be a therapeutic tool for patients with Parkinson's disease. (C) 2013 Elsevier B.V. All rights reserved.	[Tayra, Judith Thomas; Kameda, Masahiro; Yasuhara, Takao; Agari, Takashi; Kadota, Tomohito; Wang, Feifei; Kikuchi, Yoichiro; Liang, Hanbai; Shinko, Aiko; Wakamori, Takaaki; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Okayama 7008558, Japan; [Vcelar, Brigitta; Weik, Robert] Polymun Sci GmbH, Vienna, Austria		Kameda, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	mrkameda@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Health Science Research Grants for Research on Brain Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors thank Ms. Masako Arao and Ms. Natsuki Uemori for their assistance. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by Health Science Research Grants for Research on Brain Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Aluf Y, 2010, FREE RADICAL RES, V44, P635, DOI 10.3109/10715761003692529; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Andre P, 2000, P NATL ACAD SCI USA, V97, P13835, DOI 10.1073/pnas.250475997; Bar-Or D, 2011, CRIT CARE MED, V39, P2191, DOI 10.1097/CCM.0b013e3182204a9c; Bath P, 2004, STROKE, V35, P622, DOI 10.1161/01.STR.0000116105.26237.EC; BECK G, 1986, J IMMUNOL, V136, P3025; Blann AD, 1997, BLOOD COAGUL FIBRIN, V8, P383, DOI 10.1097/00001721-199710000-00002; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Cerami A, 2011, J INTERN MED, V269, P8, DOI 10.1111/j.1365-2796.2010.02319.x; Cerami A, 2001, SEMIN ONCOL, V28, P66, DOI 10.1053/sonc.2001.25401; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Ehrenreich H, 2005, P NATL ACAD SCI USA, V102, P862, DOI 10.1073/pnas.0406008102; Ehrenreich H, 2004, SCIENCE, V305, P184, DOI 10.1126/science.1100891; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2006, MOL MED, V12, P74, DOI 10.2119/2006-00042.Erbayraktar; Erbayraktar Z, 2009, MOL MED, V15, P235, DOI 10.2119/molmed.2009.00051; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Ferruci L., 2007, BRIT J HAEMATOL, V136, P549; Fu ZQ, 2010, J NEUROIMMUNOL, V221, P15, DOI 10.1016/j.jneuroim.2010.01.016; Greisenegger S, 2004, STROKE, V35, P1688, DOI 10.1161/01.STR.0000130512.81212.a2; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, pS60, DOI 10.1016/0090-1229(92)90042-M; HORNYKIEWICZ O, 1988, MT SINAI J MED, V55, P11; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jubinsky PT, 1997, BLOOD, V90, P1867, DOI 10.1182/blood.V90.5.1867; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Kennedy J, 2005, CEREBROVASC DIS, V19, P272, DOI 10.1159/000084140; Kikuchi Y, 2011, J CELL PHYSIOL, V226, P1390, DOI 10.1002/jcp.22467; Kirkeby A, 2008, THROMB HAEMOSTASIS, V99, P720, DOI 10.1160/TH07-03-0208; Leconte C, 2011, NEUROPHARMACOLOGY, V60, P354, DOI 10.1016/j.neuropharm.2010.09.025; Lee SM, 2004, BIOCHEM BIOPH RES CO, V320, P1087, DOI 10.1016/j.bbrc.2004.06.060; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Liu W, 2011, EXP NEUROL, V230, P227, DOI 10.1016/j.expneurol.2011.04.021; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; Motero M., 2007, EXP NEUROL, V204, P106; Nijboer WN, 2010, CRIT CARE MED, V38, P1155, DOI 10.1097/CCM.0b013e3181cf6e78; Ogunshola OO, 2006, AM J PHYSIOL-REG I, V290, pR678, DOI 10.1152/ajpregu.00246.2005; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Piloto N, 2009, CARDIOVASC TOXICOL, V9, P201, DOI 10.1007/s12012-009-9054-2; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schmidt RE, 2008, EXP NEUROL, V209, P161, DOI 10.1016/j.expneurol.2007.09.018; Schriebl K, 2006, PROTEIN EXPRES PURIF, V49, P265, DOI 10.1016/j.pep.2006.05.018; Sethi KD, 2002, CURR OPIN NEUROL, V15, P457, DOI 10.1097/00019052-200208000-00009; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Sifringer M, 2010, BRAIN BEHAV IMMUN, V24, P792, DOI 10.1016/j.bbi.2009.08.010; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Sturm B, 2010, EUR J CLIN INVEST, V40, P561, DOI 10.1111/j.1365-2362.2010.02292.x; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wei L, 2006, J PHARMACOL EXP THER, V317, P109, DOI 10.1124/jpet.105.094391; Wu CL, 2010, NEUROBIOL DIS, V40, P146, DOI 10.1016/j.nbd.2010.05.019; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Yasuhara T, 2006, FRONT BIOSCI-LANDMRK, V11, P760, DOI 10.2741/1834; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816; Zhou QH, 2011, BRAIN RES, V1382, P315, DOI 10.1016/j.brainres.2011.01.061	77	20	20	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 28	2013	1502						55	70		10.1016/j.brainres.2013.01.042			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	126SG	WOS:000317640900006	23380533	Green Submitted			2022-02-06	
J	Eriksson, G; Tham, K; Kottorp, A				Eriksson, Gunilla; Tham, Kerstin; Kottorp, Anders			A cross-diagnostic validation of an instrument measuring participation in everyday occupations: The Occupational Gaps Questionnaire (OGQ)	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						assessment; construct validity; occupational therapy; Rasch analysis; rehabilitation	LIFE; MODEL	The aim of this study was to validate the Occupational Gaps Questionnaire (OGQ) when used in samples of people with acquired brain injuries (ABI), stroke, stress-related disorders, concussion, and persons receiving rehabilitation after ABI to investigate whether the OGQ could be used as a generic scale. A total of 601 individuals answered the OGQ at various time points after illness/injury. A Rasch analysis was performed on the data to evaluate evidence of internal scale validity and person response validity, and the capability of the OGQ to separate people into different levels of participation in everyday occupations. The results provided evidence that the OGQ is a valid measure across different diagnostic groups. A generic version of the OGQ can separate at least two levels of perceived occupational gaps and is therefore recommended as a screening tool to be used by occupational therapists working with different diagnostic groups.	[Eriksson, Gunilla; Tham, Kerstin; Kottorp, Anders] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Occupat Therapy, S-14183 Stockholm, Sweden; [Eriksson, Gunilla] Akad Sjukhuset, Univ Hosp, Dept Speech Pathol Physiotherapy & Occupat Therap, Uppsala, Sweden; [Eriksson, Gunilla] Uppsala Univ, Dept Publ Hlth & Care Sci, Uppsala, Sweden; [Kottorp, Anders] Zurich Univ Appl Sci, Winterthur, Switzerland		Eriksson, G (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Occupat Therapy, Alfred Nobels Alle 23, S-14183 Stockholm, Sweden.	gunilla.eriksson@ki.se	Tham, Kerstin/T-3964-2018	Tham, Kerstin/0000-0001-7025-5226; Kottorp, Anders/0000-0002-8976-2612	Health Care Sciences Postgraduate School at Karolinska Institutet, Stockholm, Sweden; Swedish Brain Foundation; Swedish Stroke Association; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Council for Working Life and Social WelfareSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte); Stockholm County CouncilStockholm County Council; Karolinska Institutet, Stockholm, Sweden; Uppsala County Council; Uppsala University, Uppsala, Sweden; Swedish Association of Occupational Therapists	The authors would like to thank the researchers who collected the data in the subsamples. Financial support was provided by the Health Care Sciences Postgraduate School at Karolinska Institutet, Stockholm, Sweden, the Swedish Brain Foundation, the Swedish Stroke Association, the Swedish Research Council, the Swedish Council for Working Life and Social Welfare, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, Stockholm, Sweden and between Uppsala County Council and Uppsala University, Uppsala, Sweden, and the Swedish Association of Occupational Therapists.	Baum C. M., 2001, ACTIVITY CARD SORT T; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Eriksson G, 2010, OTJR-OCCUP PART HEAL, V30, P184, DOI 10.3928/15394492-20091123-01; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Fallahpour M, 2011, OTJR-OCCUP PART HEAL, V31, P200, DOI 10.3928/15394492-20110513-01; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V1; Fisher W., 1992, RASCH MEAS T, V6, P238; FSA, 2012, GAP VARD AKT INSR SO; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS72, DOI 10.1016/j.apmr.2009.11.031; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Linacre J. M., 2007, WINSTEPS RASCH MEASU; Linacre J.M., 2002, RASCH MEAS T, V16; Linacre JM., 2011, USERS GUIDE WINSTEPS; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Mayo NE, 1999, DISABIL REHABIL, V21, P258; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Townsend E. A., 2007, ENABLING OCCUPATION; Wright B, 1994, MEASUREMENT T, V8, P370	23	20	21	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.	MAR	2013	20	2					152	160		10.3109/11038128.2012.749944			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	095TN	WOS:000315357700010	23216376				2022-02-06	
J	Rust, DA; Gilmore, CJ; Treme, G				Rust, David A.; Gilmore, C. Jan; Treme, Gehron			Injury Patterns at a Large Western United States Ski Resort With and Without Snowboarders The Taos Experience	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						ski; snowboard; ACL; knee sprain; wrist sprain; distal radius fracture; closed head injuries; AC separation; wrist guard; helmet	RISK; 10-YEAR	Background: Differences in injury patterns among alpine skiers and snowboarders have previously been recognized, and controversy remains about the safety implications that snowboarding may pose to a ski resort. A change of policy at Taos Ski Valley provides a unique and modern perspective on the effect that snowboarders have on ski resort injuries. Hypothesis: The addition of snowboarders to a large ski resort may result in a significant change in both the rate and pattern of injuries treated. Study Design: Descriptive epidemiology study. Methods: Patient records from the Mogul Medical Clinic at Taos Ski Valley were reviewed from the 2006-2007 ski season through the 2009-2010 season (approximately 2 years before and after snowboarding was allowed) and recorded for age, sex, diagnosis, body region, anatomic location, injury type, and sport (skiing, snowboarding). The total numbers of mountain visits for the time periods with and without snowboarding were used to determine injury rates. Results: The overall rate of persons injured increased from 206.7 per 100,000 mountain visits without snowboarders to 233.8 with snowboarders. The relative risk ratio was 1.131, also represented as a 13.1% increased risk of injury (IRI) (statistically significant; 95% CI, 3.5%-23.6%). Increases were seen in the rate of upper extremity injuries (IRI, 39.1%; 95% CI, 14.3-69.4) and head/neck injuries (IRI 30.8%; not significant), while lower extremity and trunk/pelvis injuries remained relatively constant. Distal radius fractures, closed head injuries, and acromioclavicular separations showed statistically significant increases with the addition of snowboarding. The most frequent injuries among snowboarders were distal radius fractures, wrist sprains, closed head injuries, and acromioclavicular separations. The most frequent injuries among skiers were anterior cruciate ligament tears, knee sprains, closed head injuries, and gastrocnemius tears. The median age of injured persons decreased from 39 years (range, 4-100 years) without snowboarders to 31 years (range, 4-99 years) with snowboarders, and this was significant. Approximately 45% of injured persons were female, and this did not change with the addition of snowboarders. Conclusion: In this study, there was a small but statistically significant increase in the likelihood of injury with the addition of snowboarding to a large ski resort. It is likely that factors such as younger demographic, elevated risk-taking behavior, or increased mountain crowding are involved. The difference in injuries is largely because of a significant increase in distal radius fractures, closed head injuries, and acromioclavicular separations. On mountain safety precautions such as widening of runs and streamlining of high traffic areas, training medical providers to recognize and treat sport-specific injuries, and promoting the use of wrist guards and helmets may be useful in reducing the effect that snowboarders have on ski resort injuries.	[Rust, David A.; Gilmore, C. Jan; Treme, Gehron] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA		Rust, DA (corresponding author), 1 Univ New Mexico, Dept Orthopaed & Rehabil, MSC10 5600, Albuquerque, NM 87131 USA.	rustdave@hotmail.com					ABULABAN RB, 1991, CAN MED ASSOC J, V145, P1097; Aschauer E, 2007, UNFALLCHIRURG, V110, P301, DOI 10.1007/s00113-007-1263-1; Bergstrom KA, 1999, SCAND J MED SCI SPOR, V9, P110; BLADIN C, 1993, AM J SPORT MED, V21, P701, DOI 10.1177/036354659302100511; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Hasler RM, 2010, BRIT J SPORT MED, V44, P816, DOI 10.1136/bjsm.2010.071357; Hayes JR, 2008, J PEDIATR SURG, V43, P928, DOI 10.1016/j.jpedsurg.2007.12.041; Idzikowski JR, 2000, AM J SPORT MED, V28, P825, DOI 10.1177/03635465000280061001; Kim S, 2012, AM J SPORT MED, V40, P770, DOI 10.1177/0363546511433279; Kroneke EL, 2008, CLIN J SPORT MED, V18, P38, DOI 10.1097/JSM.0b013e318160c044; Made C, 2004, SCAND J MED SCI SPOR, V14, P128, DOI 10.1111/j.1600-0838.2003.00342.x; Matsunaga T, 2004, BRIT J SPORT MED, V38, P80, DOI 10.1136/bjsm.2002.001578; Moffat C, 2009, WEST J EMERG MED, V10, P257; O'Neill DF, 1999, AM J SPORT MED, V27, P94; Olsson H, 2009, NY TIMES, pD6; PINO EC, 1989, AM J SPORT MED, V17, P778, DOI 10.1177/036354658901700610; Russell K, 2007, CLIN J SPORT MED, V17, P145, DOI 10.1097/JSM.0b013e31803f901b; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Schoffl V, 2011, WILD ENVIRON MED, V22, P46, DOI 10.1016/j.wem.2010.11.008; Schoffl V, 2010, SPORTS MED, V40, P657, DOI 10.2165/11533690-000000000-00000; SnowSports Industries America, 2012, 2012 SNOW SPORTS PAR; Wakahara K, 2006, AM J SPORT MED, V34, P1670, DOI 10.1177/0363546506288113; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559	24	20	20	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2013	41	3					652	656		10.1177/0363546512472045			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	098QG	WOS:000315563200024	23324432				2022-02-06	
J	Safain, M; Roguski, M; Antoniou, A; Schirmer, CS; Malek, AM; Riesenburger, R				Safain, Mina; Roguski, Marie; Antoniou, Alexander; Schirmer, Clemens S.; Malek, Adel M.; Riesenburger, Ron			A single center's experience with the bedside subdural evacuating port system: a useful alternative to traditional methods for chronic subdural hematoma evacuation	JOURNAL OF NEUROSURGERY			English	Article						chronic subdural hematoma; subdural evacuating port system; bur hole; craniotomy; subdural drain; traumatic brain injury	TWIST-DRILL CRANIOSTOMY; BURR-HOLE; DRAINAGE; MANAGEMENT; HYGROMA	Object. The traditional methods for managing symptomatic chronic subdural hematoma (SDH) include evacuation via a bur hole or craniotomy, both with or without drain placement. Because chronic SDH frequently occurs in elderly patients with multiple comorbidities, the bedside approach afforded by the subdural evacuating port system (SEPS) is an attractive alternative method that is performed under local anesthesia and conscious sedation. The goal of this study was to evaluate the radiographic and clinical outcomes of SEPS as compared with traditional methods. Methods. A prospectively maintained database of 23 chronic SDHs treated by bur hole or craniotomy and of 23 chronic SDHs treated by SEPS drainage at Tufts Medical Center was compiled, and a retrospective chart review was performed. Information regarding demographics, comorbidities, presenting symptoms, and outcome was collected. The volume of SDH before and after treatment was semiautomatically measured using imaging software. Results. There was no significant difference in initial SDH volume (94.5 cm(3) vs 112.6 cm(3), respectively; p = 0.25) or final SDH volume (31.9 cm(3) vs 28.2 cm(3), respectively; p = 0.65) between SEPS drainage and traditional methods. In addition, there was no difference in mortality (4.3% vs 9.1%, respectively; p = 0.61), length of stay (11 days vs 9.1 days, respectively; p = 0.48), or stability of subdural evacuation (94.1% vs 83.3%, respectively; p = 0.60) for the SEPS and traditional groups at an average follow-up of 12 and 15 weeks, respectively. Only 2 of 23 SDHs treated by SEPS required further treatment by bur hole or craniotomy due to inadequate evacuation of subdural blood. Conclusions. The SEPS is a safe and effective alternative to traditional methods of evacuation of chronic SDHs and should be considered in patients presenting with a symptomatic chronic SDH. (http://thejns.org/doi/abs/10.3171/2012.11.JNS12689)	[Safain, Mina; Roguski, Marie; Antoniou, Alexander; Malek, Adel M.; Riesenburger, Ron] Tufts Med Ctr, Dept Neurosurg, Boston, MA USA; [Schirmer, Clemens S.] Baystate Med Ctr, Div Neurosurg, Springfield, MA 01199 USA; [Safain, Mina; Roguski, Marie; Antoniou, Alexander; Malek, Adel M.; Riesenburger, Ron] Tufts Univ, Sch Med, Dept Neurosurg, Boston, MA 02111 USA		Riesenburger, R (corresponding author), Dept Neurosurg, Proger 7,800 Washington St, Boston, MA 02110 USA.	rriesenburger@tuftsmedicalcenter.org		Schirmer, Clemens/0000-0003-1743-8781; Safain, Mina/0000-0003-1077-8062			Asfora WT, 2003, SURG NEUROL, V59, P329, DOI 10.1016/S0090-3019(03)00039-9; Aydin MD, 2004, NEUROL INDIA, V52, P121; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; Gazzeri R, 2007, ACTA NEUROCHIR, V149, P487, DOI 10.1007/s00701-007-1139-8; Gokmen M, 2008, ZBL NEUROCHIR, V69, P129, DOI 10.1055/s-2007-1004587; Gurelik M, 2007, CAN J NEUROL SCI, V34, P84, DOI 10.1017/S0317167100005849; HASEGAWA M, 1992, NEUROSURGERY, V31, P580, DOI 10.1227/00006123-199209000-00024; KAUFMAN HH, 1984, ACTA NEUROCHIR, V72, P197, DOI 10.1007/BF01406870; Tyler JK, 2010, J NEUROSURG, V113, P1004, DOI 10.3171/2010.5.JNS1083; Lee JK, 2009, J KOREAN NEUROSURG S, V46, P210, DOI 10.3340/jkns.2009.46.3.210; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Lee KS, 1998, BRAIN INJURY, V12, P901; Lee KS, 2004, BRAIN INJURY, V18, P351, DOI 10.1080/02699050310001645801; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee Kyeong-Seok, 1996, Journal of Korean Medical Science, V11, P55; Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; Muzii V F, 2005, J Neurosurg Sci, V49, P41; Okada Y, 2002, SURG NEUROL, V57, P405, DOI 10.1016/S0090-3019(02)00720-6; Rughani AI, 2010, J NEUROSURG, V113, P609, DOI 10.3171/2009.11.JNS091244; Santos-Ditto RA, 2007, GAC MED MEX, V143, P203; SATO S, 1975, J NEUROSURG, V43, P569, DOI 10.3171/jns.1975.43.5.0569; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; Takeda N, 2006, ACTA NEUROCHIR, V148, P541, DOI 10.1007/s00701-005-0689-x; van Eck ATCJ, 2002, J CLIN NEUROSCI, V9, P573, DOI 10.1054/jocn.2001.1061	26	20	21	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2013	118	3					694	700		10.3171/2012.11.JNS12689			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	094DW	WOS:000315244200034	23259822				2022-02-06	
J	Smania, N; Avesani, R; Roncari, L; Ianes, P; Girardi, P; Varalta, V; Gambini, MG; Fiaschi, A; Gandolfi, M				Smania, Nicola; Avesani, Renato; Roncari, Laura; Ianes, Patrizia; Girardi, Paolo; Varalta, Valentina; Gambini, Maria Grazia; Fiaschi, Antonio; Gandolfi, Marialuisa			Factors Predicting Functional and Cognitive Recovery Following Severe Traumatic, Anoxic, and Cerebrovascular Brain Damage	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Disability Rating Scale; discharge destination; outcome assessment; predictive factors; prognosis; rehabilitation	DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; INDEPENDENCE MEASURE; INPATIENT REHABILITATION; DISCHARGE DESTINATION; STROKE; MODERATE; RELIABILITY; POPULATION	Objectives: To compare demographic data, clinical data, and rate of functional and cognitive recovery in patients with severe traumatic, cerebrovascular, or anoxic acquired brain injury (ABI) and to identify factors predicting discharge home. Participants: Three hundred twenty-nine patients with severe ABI (192 with traumatic, 104 with cerebrovascular, and 33 with anoxic brain injury). Design: Longitudinal prospective study of inpatients attending the intensive Rehabilitation Department of the "Sacro Cuore" Don Calabria Hospital (Negrar, Verona, Italy). Main measures: Etiology, sex, age, rehabilitation admission interval, rehabilitation length of stay, discharge destination, Glasgow Coma Scale, Disability Rating Scale (DRS), Glasgow Outcome Scale, Levels of Cognitive Functioning, and Functional Independence Measure. Results: Predominant etiology was traumatic; male gender was prevalent in all the etiologic groups; patients with traumatic brain injury were younger than the patients in the other groups and had shorter rehabilitation admission interval, greater functional and cognitive outcomes on all considered scales, and a higher frequency of returning home. Patients with anoxic brain injury achieved the lowest grade of functional and cognitive recovery. Age, etiology, and admission DRS score predicted return home. Conclusions: Patients with traumatic brain injury achieved greater functional and cognitive improvements than patients with cerebrovascular and anoxic ABI. Age, etiology, and admission DRS score can assist in predicting discharge destination.	[Smania, Nicola; Roncari, Laura; Ianes, Patrizia; Varalta, Valentina; Fiaschi, Antonio; Gandolfi, Marialuisa] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Venice, Italy; [Roncari, Laura] Univ Verona, Sch Specializat Phys Med & Rehabil, Venice, Italy; [Girardi, Paolo] Univ Verona, Dept Med & Publ Hlth, Unit Epidemiol & Med Stat, Venice, Italy; [Smania, Nicola; Ianes, Patrizia; Varalta, Valentina; Gandolfi, Marialuisa] Sacro Cuore Don Calabria, Neuromotor & Cognit Rehabil Res Ctr CRRNC, Verona, Italy; [Avesani, Renato; Gambini, Maria Grazia] Sacro Cuore Don Calabria, Rehabil Dept, Verona, Italy; [Fiaschi, Antonio] IRCCS Osped San Camillo Venezia Lido, Venice, Italy		Smania, N (corresponding author), Azienda Osped Univ Integrata Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, S Riabilitaz Neurol, GB Rossi Univ Hosp, Via LA Scuro 10, I-37134 Verona, Italy.	nicola.smania@univr.it	Gandolfi, Marialuisa/J-7033-2018; Varalta, Valentina/AAB-2055-2019; Gambini, Maria grazia/ABA-3969-2021	Gandolfi, Marialuisa/0000-0002-0877-4807; Gambini, Maria Grazia/0000-0002-6211-2169; girardi, Paolo/0000-0001-8330-9414	Cari Verona Foundation (Mosaico), Verona, Italy	A grant from the Cari Verona Foundation (Mosaico), Verona, Italy, supported this study.	ALEXANDER MP, 1994, STROKE, V25, P128, DOI 10.1161/01.STR.25.1.128; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boake C, 2000, PHYS MED REHABILITAT, P1073; Burke DT, 2005, BRAIN INJURY, V19, P675, DOI 10.1080/02699050400024953; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Flanagan SR, 2008, ARCH PHYS MED REHAB, V89, pS9, DOI 10.1016/j.apmr.2007.12.010; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Formisano R, 2005, ACT NEUR S, V93, P201; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Hagen C, 1979, REHABILITATION HEAD, P87; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hillen T, 2000, STROKE, V31, P469, DOI 10.1161/01.STR.31.2.469; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kothari S, 2008, ARCH PHYS MED REHAB, V89, pS27, DOI 10.1016/j.apmr.2007.12.014; Kwasnica C, 2008, ARCH PHYS MED REHAB, V89, pS15, DOI 10.1016/j.apmr.2007.12.006; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; OCZKOWSKI WJ, 1993, ARCH PHYS MED REHAB, V74, P1291, DOI 10.1016/0003-9993(93)90081-K; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Paolucci S, 2003, STROKE, V34, P2861, DOI 10.1161/01.STR.0000102902.39759.D3; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Riachy M, 2008, BMC NEUROL, V26, P8; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Sandstrom R, 1998, ARCH PHYS MED REHAB, V79, P762, DOI 10.1016/S0003-9993(98)90353-7; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Stucki G, 2005, DISABIL REHABIL, V27, P353, DOI 10.1080/09638280400014105; Taricco M, 2006, Eura Medicophys, V42, P73; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; ZAMPOLINI M, 2003, ITAL J REHABIL MED M, V17, P15	50	20	20	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2013	28	2					131	140		10.1097/HTR.0b013e31823c0127			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	105HU	WOS:000316058300007	22333677				2022-02-06	
J	Alharfi, IM; Stewart, TC; Foster, J; Morrison, GC; Fraser, DD				Alharfi, Ibrahim M.; Stewart, Tanya Charyk; Foster, Jennifer; Morrison, Gavin C.; Fraser, Douglas D.			Central Diabetes Insipidus in Pediatric Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; diabetes insipidus; mortality; traumatic brain injury	SEVERE HEAD-INJURY; PREDICTIVE FACTORS; CHILDREN; DEATH; DYSFUNCTION; MORTALITY; OUTCOMES	Objectives: To determine the occurrence rate of central diabetes insipidus in pediatric patients with severe traumatic brain injury and to describe the clinical, injury, biochemical, imaging, and intervention variables associated with mortality. Design: Retrospective chart and imaging review. Setting: Children's Hospital, level 1 trauma center. Patients: Severely injured (Injury Severity Score >= 12) pediatric trauma patients (>1 month and <18 yr) with severe traumatic brain injury (presedation Glasgow Coma Scale <= 8 and head Maximum Abbreviated Injury Scale >= 4) that developed acute central diabetes insipidus between January 2000 and December 2011. Measurements and Main Results: Of 818 severely injured trauma patients, 180 had severe traumatic brain injury with an overall mortality rate of 27.2%. Thirty-two of the severe traumatic brain injury patients developed acute central diabetes insipidus that responded to desamino-8-D-arginine vasopressin and/or vasopressin infusion, providing an occurrence rate of 18%. At the time of central diabetes insipidus diagnosis, median urine output and serum sodium were 6.8 ml/kg/hr (interquartile range = 5-11) and 154 mmol/L (interquartile range = 149-159), respectively. The mortality rate of central diabetes insipidus patients was 87.5%, with 71.4% declared brain dead after central diabetes insipidus diagnosis. Early central diabetes insipidus onset, within the first 2 days of severe traumatic brain injury, was strongly associated with mortality (p < 0.001), as were a lower presedation Glasgow Coma Scale (p = 0.03), a lower motor Glasgow Coma Scale (p = 0.01), an occurrence of fixed pupils (p = 0.04), and a prolonged partial thromboplastin time (p = 0.04). Cerebral edema on the initial computed tomography, obtained in the first 24 hrs after injury, was the only imaging finding associated with death (p = 0.002). Survivors of central diabetes insipidus were more likely to have intracranial pressure monitoring (p = 0.03), have thiopental administered to induce coma (p = 0.04) and have received a decompressive craniectomy for elevated intracranial pressure (p = 0.04). Conclusions: The incidence of central diabetes insipidus in pediatric patients with severe traumatic brain injury is 18%. Mortality was associated with early central diabetes insipidus onset and cerebral edema on head computed tomography. Central diabetes insipidus nonsurvivors were less likely to have received intracranial pressure monitoring, thiopental coma and decompressive craniectomy. (Pediatr Crit Care Med 2013; 14:203-209)	[Alharfi, Ibrahim M.; Foster, Jennifer; Morrison, Gavin C.; Fraser, Douglas D.] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Dept Pediat Crit Care, Childrens Hosp, Riyadh, Saudi Arabia; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Foster, Jennifer; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Fraser, Douglas D.] Ctr Crit Illness Res, London, ON, Canada		Fraser, DD (corresponding author), Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada.	douglas.fraser@lhsc.on.ca		Foster, Jennifer/0000-0001-8919-9383			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alharfi IM, 2012, J NEUROTRAUMA; [Anonymous], 1987, PEDIATR NEUROL, V3, P242; Bajpai A, 2008, INDIAN PEDIATR, V45, P463; BARZILAY Z, 1988, J MED, V19, P47; Boughey JC, 2004, AM SURGEON, V70, P500; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chou YC, 2009, BRAIN INJURY, V23, P1095, DOI 10.3109/02699050903379396; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1987, CRIT CARE MED, V15, P551, DOI 10.1097/00003246-198706000-00002; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kouvarellis AJ, 2011, CHILD NERV SYST, V27, P1139, DOI 10.1007/s00381-011-1464-3; KAHLER O M, 1948, Med Klin, V43, P58; Lekmanov A. U., 2010, Anesteziologiya i Reanimatologiya, P41; MAZUREK A, 1994, INT ANESTHESIOL CLIN, V32, P11; Mishra Garima, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS180, DOI 10.4103/2230-8210.84858; Nakagawa TA, 2011, CRIT CARE MED, V39, P2139, DOI 10.1097/CCM.0b013e31821f0d4f; NEVTONOVA G A, 1950, Khirurgiia (Mosk), V6, P68; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; OUTWATER KM, 1984, NEUROLOGY, V34, P1243, DOI 10.1212/WNL.34.9.1243; PORTER RJ, 1948, J NEUROL NEUROSUR PS, V11, P258, DOI 10.1136/jnnp.11.4.258; Report of Special Task Force. Guidelines for the determination of brain death in children, 1987, PEDIATRICS, V80, P298; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; STAWORN D, 1994, CRIT CARE MED, V22, P1301, DOI 10.1097/00003246-199408000-00014; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; WANG LC, 1994, PEDIATR NEUROL, V11, P273, DOI 10.1016/0887-8994(94)90001-9; Wise-Faberowski L, 2004, J NEUROSURG ANESTH, V16, P220, DOI 10.1097/00008506-200407000-00006; Yang YH, 2011, PEDIATR NEUROL, V45, P377, DOI 10.1016/j.pediatrneurol.2011.09.002	38	20	23	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2013	14	2					203	209		10.1097/PCC.0b013e31827127b5			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	088GC	WOS:000314820800018	23314181				2022-02-06	
J	Chen, MF; Huang, TY; Kuo, YM; Yu, L; Chen, HI; Jen, CYJ				Chen, Mei-Feng; Huang, Tung-Yi; Kuo, Yu-Min; Yu, Lung; Chen, Hsiun-ing; Jen, Chauying J.			Early postinjury exercise reverses memory deficits and retards the progression of closed-head injury in mice	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; COGNITIVE DEFICITS; TREADMILL EXERCISE; MOUSE MODEL; RAT HIPPOCAMPUS; DYNAMIC CHANGES; UP-REGULATION; CELLS; INFLAMMATION	Closed-head injury (CHI) usually involves both physical damage of neurons and neuroinflammation. Although exercise promotes neuronal repair and suppresses neuroinflammation, CHI patients currently often remain resting during the post-traumatic period. This study aimed to investigate whether and how postinjury exercise benefited the brain structure and function in mice after CHI. Closed-head injury immediately caused an elevated neurological severity score, with rapid loss of object recognition memory, followed by progressive location-dependent brain damage (neuronal loss and activation of microglia in the cortex and hippocampus). An early exercise protocol at moderate intensity (starting 2 days postimpact and lasting for 7 or 14 days) effectively restored the object recognition memory and prevented the progressive neuronal loss and activation of microglia. However, if the exercise started 9 days postimpact, it was unable to recover recognition memory deficits. In parallel, early exercise intervention drastically promoted neurite regeneration, while late exercise intervention was much less effective. We also tested the possible involvement of brain-derived neurotrophic factor (BDNF) and mitogen-activated protein kinase phosphatase-1 (MKP-1) in the exercise-induced beneficial effects. Exercise gradually restored the impact-abolished hippocampal expression of BDNF and MPK-1, while oral administration of triptolide (a synthesis inhibitor of MKP-1 and an antagonist of nuclear factor-B) before each bout of exercise blocked the restorative effects of exercise on MKP-1 and recognition memory, as well as the exercise-induced retardation of neuronal loss. Although triptolide treatment alone inhibited activation of microglia and maintained neuronal numbers, it did not recover the injury-hampered recognition memory. Overall, moderate exercise shortly after CHI reversed the deficits in recognition memory and prevented the progression of brain injury.	[Chen, Mei-Feng; Kuo, Yu-Min; Yu, Lung; Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Huang, Tung-Yi; Chen, Hsiun-ing; Jen, Chauying J.] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Kuo, Yu-Min] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Yu, Lung] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan 70101, Taiwan		Jen, CYJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan.	jen@mail.ncku.edu.tw	Chen, Mei Feng/I-2763-2016; Huang, Troy/I-6395-2019; Kuo, Yu-Min/A-9050-2013	Chen, Mei Feng/0000-0002-7170-0843; Kuo, Yu-Min/0000-0003-4867-2482	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2320-B-006-019-MY3, NSC 98-2320-B-006-028-MY3]	We thank Mr Ju-San Chen in the Department of Mechanical Engineering for constructing the closed-head injury set-up and Dr Paul R. Saunders for critically reading the manuscript. This study was supported by grants from the National Science Council, Taiwan (NSC 98-2320-B-006-019-MY3 and NSC 98-2320-B-006-028-MY3).	Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Chen MF, 2010, MED SCI SPORT EXER, V42, P2173, DOI 10.1249/MSS.0b013e3181e2158d; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Feliciano DV, 2008, TRAUMA; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leem YH, 2011, BIOCHEM BIOPH RES CO, V406, P359, DOI 10.1016/j.bbrc.2011.02.046; Lin N, 2007, BIOCHEM PHARMACOL, V73, P136, DOI 10.1016/j.bcp.2006.08.027; Liu YF, 2008, NEUROBIOL LEARN MEM, V90, P81, DOI 10.1016/j.nlm.2008.02.005; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; Pace CJ, 2002, J NEUROSCI METH, V119, P23, DOI 10.1016/S0165-0270(02)00152-8; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Seo TB, 2010, NEUROSCI LETT, V481, P178, DOI 10.1016/j.neulet.2010.06.087; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Su ZD, 2010, GLIA, V58, P901, DOI 10.1002/glia.20972; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Vasilevskis EE, 2010, CRIT CARE MED, V38, pS683, DOI 10.1097/CCM.0b013e3181f245d3; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Wu CW, 2007, J NEUROCHEM, V103, P2471, DOI 10.1111/j.1471-4159.2007.04987.x; Wu SY, 2011, BRAIN BEHAV IMMUN, V25, P135, DOI 10.1016/j.bbi.2010.09.006; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	50	20	20	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	FEB	2013	591	4					985	1000		10.1113/jphysiol.2012.241125			16	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	092VB	WOS:000315150000020	23184513	Green Published			2022-02-06	
J	Lin, C; Dong, Y; Lv, LQ; Yu, MK; Hou, LJ				Lin, Chao; Dong, Yan; Lv, Liquan; Yu, Mingkun; Hou, Lijun			Clinical features and functional recovery of traumatic isolated oculomotor nerve palsy in mild head injury with sphenoid fracture	JOURNAL OF NEUROSURGERY			English	Article						mild head trauma; oculomotor nerve palsy; sphenoid fracture; surgical treatment; outcome measure; traumatic brain injury	SUPERIOR ORBITAL FISSURE	Object. The aim of this study was to provide information about long-term functional outcome in patients with isolated oculomotor nerve palsy following minor head injury and to discuss surgical treatment of these patients, especially those with accompanying sphenoid fracture. Methods. A retrospective analysis was made of 26 patients with traumatic isolated oculomotor nerve palsy. The severity of oculomotor nerve palsy and the functional recovery were evaluated based on extraocular muscle movement, eyelid movement, and pupil size. On average, patients were evaluated 3.6 days after the initial,injury, and the average follow-up period was 14.2 months (range 3 months-2 years). Results. Twenty men and six women were enrolled in this study. The most common cause of trauma was motor vehicle accident in 17 (65.4%) of 26. Among all the recorded symptoms, internal ophthalmoplegia was most frequently seen. The recovery rates of ptosis, external ophthalmoplegia, and internal ophthalmoplegia were 95% (19 of 20 patients), 83.3% (15 of 18 patients), and 50% (13 of 26 patients), respectively. The 6 patients with sphenoid fracture underwent surgical decompression of the superior orbital fissure, after which all patients experienced recovery from ptosis and external ophthalmoplegia and 66.7% (4 of 6 patients) recovered from internal ophthalmoplegia. Conclusions. Limited eye movement may be a major factor that negatively affects functional recovery after mild head injury. Sphenoid fracture might be one of the potential mechanisms involved in traumatic isolated oculomotor nerve palsy after mild head injury. Surgical decompression should be considered when there is evidence of bone compression of the superior orbital fissure. (http://thejns.org/doi/abs/10.3171/2012.9.JNS12702)	[Lin, Chao; Dong, Yan; Lv, Liquan; Yu, Mingkun; Hou, Lijun] Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai Neurosurg Inst, Shanghai 200003, Peoples R China		Hou, LJ (corresponding author), Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai Neurosurg Inst, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	lijunhou@smmu.edu.cn					Acarturk S, 2004, ANN PLAS SURG, V53, P60, DOI 10.1097/01.sap.0000106424.54415.dc; Bagheri A, 2006, J AAPOS, V10, P385, DOI 10.1016/j.jaapos.2006.06.014; Chen CC, 2005, BJ SPORT MED, V39, P34; Chen CT, 2010, PLAST RECONSTR SURG, V126, P205, DOI 10.1097/PRS.0b013e3181dab658; Cheng YS, 2008, CHINESE MED J-PEKING, V121, P276, DOI 10.1097/00029330-200802010-00020; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Kaido T, 2006, J CLIN NEUROSCI, V13, P852, DOI 10.1016/j.jocn.2005.08.020; Kuo LT, 2010, J NEUROTRAUM, V27, P1959, DOI 10.1089/neu.2010.1407; Levy RL, 2005, NEUROLOGY, V65, P169, DOI 10.1212/01.wnl.0000167288.10702.03; Liu Yo-Tsen, 2004, J Chin Med Assoc, V67, P149; McCulley TJ, 2002, AM J OPHTHALMOL, V134, P626, DOI 10.1016/S0002-9394(02)01625-2; Miller NR, 1996, CURR OPIN NEUROL, V9, P21, DOI 10.1097/00019052-199602000-00005; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Ng YSP, 2005, CAN J OPHTHALMOL, V40, P645, DOI 10.1016/S0008-4182(05)80062-6; Park UC, 2008, EYE, V22, P691, DOI 10.1038/sj.eye.6702720; POSTMA MP, 1990, J ORAL MAXIL SURG, V48, P503, DOI 10.1016/0278-2391(90)90241-S; Takeuchi Satoru, 2008, Brain and Nerve (Tokyo), V60, P555; TOKUNO T, 1995, NEUROL SURG TOKYO, V23, P497	21	20	23	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2013	118	2					364	369		10.3171/2012.9.JNS12702			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	076DY	WOS:000313937900021	23121431				2022-02-06	
J	Lockie, FD; Dalton, S; Oakley, E; Babl, FE				Lockie, Francis D.; Dalton, Sarah; Oakley, Ed; Babl, Franz E.		Paediat Res Emergency Dept Int	Triggers for head computed tomography following paediatric head injury: Comparison of physicians' reported practice and clinical decision rules	EMERGENCY MEDICINE AUSTRALASIA			English	Article						clinical decision rule; clinical practice guideline; computed tomography; emergency department; paediatric head injury; research network	TRAUMATIC BRAIN-INJURY; DELAYED DIAGNOSIS; CHILDREN; PREDICTION; RADIATION; ADOLESCENTS	Objective To compare head computed tomography (CT) triggers for paediatric head injury as reported by senior paediatric emergency physicians in Australia and New Zealand with triggers in published evidence-based clinical decision rules (CDRs). Methods A survey of CT triggers after head injury was distributed to senior emergency physicians at PREDICT (Paediatric Research in Emergency Departments International Collaborative) sites in Australia and New Zealand. Results were compared with recommendations for CT scans in CATCH, CHALICE and PECARN CDRs. Clinical practice guidelines (CPGs) from each site were also reviewed. Results The response rate was 93% (130/140). No published trigger for head CT was identified by 100% of survey participants and each CDR included several triggers not identified by many respondents. Abnormal examination findings, including depressed skull fracture and base of skull fracture, were most likely to prompt respondents to order a head CT (>90%). A concerning mechanism of injury, such as a fall greater than 3 feet or five stairs, triggered a CT response only in approximately 10% of respondents. Eight different head injury CPGs were used across the 13 PREDICT sites. These were highly variable between sites and CPGs were not explicitly based on published CDRs. Conclusion High-quality, published CDRs exist for head CT use after paediatric head injury. Physician-reported CT triggers differ from CDR-recommended triggers. The major published head injury CDRs should be prospectively validated in the Australasian setting before incorporating them into local practice and CPGs.	[Lockie, Francis D.; Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Oakley, Ed; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Oakley, Ed] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Lockie, FD (corresponding author), Womens & Childrens Hosp, Emergency Dept, Adelaide, SA 5006, Australia.	franlockie@gmail.com					Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Connors JM, 2001, PEDIATR EMERG CARE, V17, P1, DOI 10.1097/00006565-200102000-00001; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; National Center for Health Statistics Centers for Disease Control and Prevention, 2005, PUBL US DAT FIL EM D; National Center for Health Statistics Centers for Disease Control and Prevention, 1995, PUBL US DAT FIL EM D; National Collaborating Centre for Acute Care, 2003, HEAD INJ TRIAG ASS I; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond M. H., 2006, ACAD EMERG MED, V13, pS11, DOI DOI 10.1197/j.aem.2006.03.008; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	27	20	22	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	FEB	2013	25	1					75	82		10.1111/1742-6723.12019			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	087GD	WOS:000314748400012	23379456				2022-02-06	
J	Ulfarsson, T; Gudnason, GA; Rosen, T; Blomstrand, C; Sunnerhagen, KS; Lundgren-Nilsson, A; Nilsson, M				Ulfarsson, Trandur; Gudnason, Gudni Arnar; Rosen, Thord; Blomstrand, Christian; Sunnerhagen, Katharina Stibrant; Lundgren-Nilsson, Asa; Nilsson, Michael			Pituitary Function and Functional Outcome in Adults after Severe Traumatic Brain Injury: The Long-Term Perspective	JOURNAL OF NEUROTRAUMA			English	Article						functioning; hypopituitarism; long-term outcome; quality of life; TBI	GROWTH-HORMONE DEFICIENCY; QUALITY-OF-LIFE; REACTION LEVEL SCALE; GLASGOW COMA SCALE; PREMATURE MORTALITY; POSTTRAUMATIC HYPOPITUITARISM; NATURAL-HISTORY; HEAD-INJURY; FOLLOW-UP; PREVALENCE	Post-traumatic hypopituitarism (PTHP) has been linked to disability and decreased quality of life. However, no studies have addressed the long-term consequences of PTHP in adults with severe traumatic brain injury (TBI) only. In this study, we evaluated the relationship between pituitary function, quality of life, and functioning in 51 patients (16-65 years of age) with severe TBI who were admitted to Sahlgrenska University Hospital, Gothenburg from 1999 to 2002. The patients were assessed once, 2-10 years after trauma. Data from the time of injury were collected retrospectively to adjust for injury severity. Outcome measures included hormonal testing, the Short Form-36 Health Survey, the Glasgow Outcome Scale-Extended, and a self-report questionnaire specifically designed for this study and based on the International Classification of Functioning, Disability and Health. Of 51 patients, 14 (27.5%) presented with PTHP, and 11 (21.6%) had isolated growth hormone deficiency. Patients with PTHP were more often overweight at follow-up (p = 0.01); the higher body mass index was partially explained by PTHP (R 2 change = 0.07, p = 0.001). Otherwise no significant correlation was found among PTHP, functioning, or patient-reported quality of life. This study-which is unique in the homogeneity of the patients, the long follow-up time, and the use of injury severity as an outcome predictor-did not confirm results from previous studies linking PTHP to a worse outcome. Therefore, screening for PTHP might be restricted to specific subgroups such as overweight patients, indicating growth hormone deficiency.	[Ulfarsson, Trandur; Blomstrand, Christian; Nilsson, Michael] Univ Gothenburg, Ctr Brain Repair & Rehabil CBR, Gothenburg, Sweden; [Sunnerhagen, Katharina Stibrant; Lundgren-Nilsson, Asa] Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Ulfarsson, Trandur; Blomstrand, Christian; Sunnerhagen, Katharina Stibrant; Lundgren-Nilsson, Asa] Sahlgrens Univ Hosp, Dept Rehabil Med, SE-40043 Gothenburg, Sweden; [Gudnason, Gudni Arnar; Rosen, Thord] Sahlgrens Univ Hosp, Dept Endocrinol, SE-40043 Gothenburg, Sweden		Ulfarsson, T (corresponding author), Sahlgrens Univ Hosp, Dept Rehabil Med, Box 30110, SE-40043 Gothenburg, Sweden.	trandur.ulfarsson@vgregion.se	NILSSON, MICHAEL/ABE-7821-2020; Sunnerhagen, Katharina Stibrant/AAE-2405-2020	NILSSON, MICHAEL/0000-0002-8826-1621; Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Blomstrand, Christian/0000-0003-3503-860X	ALF Goteborg; AFA Insurance; Sten A Olsson Foundation; Swedish Cancer & Traffic Injury Society Fund; Lansforsakringar Alliance; PfizerPfizer; insurance company Lansforsakringar Alliance	This study was based on data from the Sahlgrenska University Hospital. The authors acknowledge research support from ALF Goteborg, AFA Insurance, Sten A Olsson Foundation for Research and Culture, the Swedish Cancer & Traffic Injury Society Fund, and the Lansforsakringar Alliance. The authors gratefully acknowledge the participants and their next of kin for their participation in the study. They also thank Ingrid Morberg at the Rehabilitation Medicine, Olof Ehn and Olof Strandberg at the Department of Endocrinology, and Helene Seeman-Lodding at the NICU, the Sahlgrenska University Hospital, for their support and practical assistance, as well as Anna Ekmans for statistical advice.; Thord Rosen has received honoraria for lecturing for the pharmaceutical companies Pfizer, Novo Nordisk, and Bayer Schering Pharma. He has received a grant from Pfizer and the insurance company Lansforsakringar Alliance. No competing financial interests exist for Trandur Ulfarsson, Gudni Arnar Gudnason, Christian Blomstrand, Katharina Stibrant Sunnerhagen, A sa Lundgren-Nilsson, and Michael Nilsson.	Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bengtsson BA, 1998, GROWTH HORM IGF RES, V8, P77, DOI 10.1016/S1096-6374(98)80014-2; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Blair JC, 2010, BRIT J NEUROSURG, V24, P10, DOI 10.3109/02688690903536637; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Feldt-Rasmussen U, 2004, GROWTH HORM IGF RES, V14, pS51, DOI 10.1016/j.ghir.2004.03.013; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Moock J, 2009, EUR J ENDOCRINOL, V160, P17, DOI 10.1530/EJE-08-0738; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Olczyk J, 2010, NEUROENDOCRINOL LETT, V31, P700; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; ROSEN T, 1993, CLIN ENDOCRINOL, V38, P63, DOI 10.1111/j.1365-2265.1993.tb00974.x; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sullivan M., 2002, SWEDISH MANUAL INTER; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; Wallymahmed ME, 1999, CLIN ENDOCRINOL, V51, P333; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	52	20	20	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					271	280		10.1089/neu.2012.2494			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300004	23121499				2022-02-06	
J	Grin'kina, NM; Abdel-Baki, SG; Bergold, PJ				Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.			Reversible Behavioral Deficits in Rats during a Cycle of Demyelination-Remyelination of the Fimbria	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; MORRIS WATER MAZE; COGNITIVE FUNCTION; HIPPOCAMPUS; MEMORY; NAVIGATION; PLACE; SEGREGATION; AVOIDANCE	Traumatic brain injury (TBI) selectively damages white matter. White matter damage does not produce deficits in many behavioral tests used to analyze experimental TBI. Rats were impaired on an active place avoidance task following inactivation of one hippocampal injection of tetrodotoxin. The need for both hippocampi suggests that acquisition of the active place avoidance task may require interhippocampal communication. The controlled cortical impact model of TBI demyelinates midline white matter and impairs rats on the active place avoidance task. One white matter region that is demyelinated is the fimbria that contains hippocampal commissural fibers. We therefore tested whether demyelination of the fimbria produces deficits in active place avoidance. Lysophosphatidylcholine (LPC) was injected stereotaxically to produce a cycle of demyelination-remyelination of the fimbria. At 4 days, myelin loss was observed in the fimbria of LPC-, but not saline-injected rats. Fourteen days after injection, myelin content increased in LPC-, but not saline-injected rats. Three days after injection, both saline- and LPC-injected rats had similar performance on an open field and passive place avoidance task in which the rat avoided a stationary shock zone on a stationary arena. The following day, on the active place avoidance task, LPC-injected rats had a significantly higher number of shock zone entrances suggesting learning was impaired. At 14 days after injection, saline- and LPC-injected rats had similar performance on open field and passive place avoidance. On active place avoidance, however, saline-and LPC-injected rats had a similar number of total entrances suggesting that the impairment seen at 4 days was no longer present at 14 days. These data suggest that active place avoidance is highly sensitive to white matter injury.	[Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol Pharmacol & Neurol, Brooklyn, NY 11203 USA		Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380	United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-2-0171]	This work was supported by contract W81XWH-10-2-0171 from the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P., 2007, HIPPOCAMPUS BOOK; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Duarte FS, 2010, PSYCHOPHARMACOLOGY, V212, P653, DOI 10.1007/s00213-010-1985-6; Easton A, 2010, BEHAV BRAIN RES, V215, P310, DOI 10.1016/j.bbr.2009.10.019; FENTON AA, 1993, BEHAV NEUROSCI, V107, P552, DOI 10.1037/0735-7044.107.4.552; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Jean I, 2003, BRAIN RES, V972, P110, DOI 10.1016/S0006-8993(03)02510-1; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; OLTON DS, 1982, BRAIN RES, V233, P241, DOI 10.1016/0006-8993(82)91200-8; Olypher AV, 2006, J NEUROSCI, V26, P158, DOI 10.1523/JNEUROSCI.2064-05.2006; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	27	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53775	10.1371/journal.pone.0053775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	WOS:000314019100031	23349742	gold, Green Published, Green Submitted			2022-02-06	
J	Wang, JW; Wang, HD; Cong, ZX; Zhang, XS; Zhou, XM; Zhang, DD				Wang, Jia-Wei; Wang, Han-Dong; Cong, Zi-Xiang; Zhang, Xiang-Sheng; Zhou, Xiao-Ming; Zhang, Ding-Ding			Activation of metabotropic glutamate receptor 5 reduces the secondary brain injury after traumatic brain injury in rats	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury; Metabotropic glutamate receptor 5; Inflammation	CEREBRAL-ISCHEMIA; CELL-DEATH; PATHOPHYSIOLOGY; NEUROPROTECTION; NEUROTOXICITY; STRATEGIES; MICROGLIA; APOPTOSIS	A wealth of evidence has shown that microglia-associated neuro-inflammation is involved in the secondary brain injury contributed to the poor outcome after traumatic brain injury (TBI). In vitro studies were reported that activation of metabotropic glutamate receptor 5 (mGluR5) could inhibit the microglia-associated inflammation in response to lipopolysaccharide and our previous study indicated that mGluR5 was expressed in activated microglia following TBI. However, there is little known about whether mGluR5 activation can provide neuro-protection and reduce microglia-associated neuro-inflammation in rats after TBI. The goal of the present study was to investigate the effects of mGluR5 activation with selective agonist CHPG, on cerebral edema, neuronal degeneration, microglia activation and the releasing of pro-inflammatory cytokines, in a rat model of TBI. Rats were randomly distributed into various subgroups undergoing the sham surgery or TBI procedures, and 250 nmol of CHPG or equal volume vehicle was given through intracerebroventricular injection at 30 mm post-TBI. All rats were sacrificed at 24 h after TBI for the further measurements. Our data indicated that post-TBI treatment with CHPG could significantly reduce the secondary brain injury characterized by the cerebral edema and neuronal degeneration, lead to the inhibition of microglia activation and decrease the expression of pro-inflammatory cytokines in both mRNA transcription and protein synthesis. These results provide the substantial evidence that activation of mGluR5 reduces the secondary brain injury after TBI, in part, through modulating microglia-associated neuro-inflammation. (C) 2012 Elsevier Inc. All rights reserved.	[Wang, Jia-Wei; Wang, Han-Dong; Cong, Zi-Xiang; Zhang, Ding-Ding] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Xiang-Sheng; Zhou, Xiao-Ming] Second Mil Med Univ, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hdwang_nj@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070974]; Key Subject of Jiangsu Province [X4200722]	This work was supported by grants from National Natural Science Foundation of China (No. 81070974), and the Key Subject of Jiangsu Province (X4200722).	Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Byrnes KR, 2009, ANN NEUROL, V66, P63, DOI 10.1002/ana.21673; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hunter AJ, 1998, TRENDS PHARMACOL SCI, V19, P59, DOI 10.1016/S0165-6147(97)01157-7; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	24	20	20	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 18	2013	430	3					1016	1021		10.1016/j.bbrc.2012.12.046			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	082EW	WOS:000314376100025	23261470				2022-02-06	
J	Bonova, P; Burda, J; Danielisova, V; Nemethova, M; Gottlieb, M				Bonova, Petra; Burda, Jozef; Danielisova, Viera; Nemethova, Miroslava; Gottlieb, Miroslav			Development of a pattern in biochemical parameters in the core and penumbra during infarct evolution after transient MCAO in rats	NEUROCHEMISTRY INTERNATIONAL			English	Article						MCAO; Ischaemia; Reperfusion; SOD; Glutamate; Translation activity	MANGANESE-SUPEROXIDE-DISMUTASE; FOCAL CEREBRAL-ISCHEMIA; UNFOLDED PROTEIN RESPONSE; GLOBAL FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; AMINO-ACIDS; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT ENZYMES	The period from stroke initiation to the cessation of penumbra damage spread represents a therapeutic window when expansion can be alleviated. In the present work, we studied some biochemical parameters helpful for the estimation of infarct progression and thus for the application of interventions. We designed four groups: the control group and three groups of animals after middle cerebral artery occlusion with reperfusion periods of 2 h, 1 day or 3 days. In the ischaemic core and penumbra, fluorimetric and spectrophotometric methods for investigating total MnSOD and MAO-A/B activity as well as level of the glutamate were used. Protein synthesis was assessed by in vitro measurements of C-14-leucine incorporation. Noticeable differences between core and penumbra biochemical parameters were shown. In the core, protein synthesis was transiently inhibited two hours and three days after ischaemia (36%). Glutamate and total SOD activity peaked on the first day, but on the third day after MCAO, rapidly decreased by about 44% and 33.6%, respectively. In the penumbra, ischaemia led to higher protein synthesis (78%), elevations in glutamate and rapid activation of MnSOD (by about 884%) one day after insult. On the third day, protein synthesis and MnSOD were still significantly elevated (36% and 388%, respectively), while glutamate levels returned to baseline. In addition, the impact of ischaemia on MAO-A/B activity in the penumbra was confirmed. In conclusion, biochemical parameter screening could be helpful to assess cell damage progress and the possibility of rescue. These regions reflect different biochemical patterns that seem to be clearly established on the first day after transient MCAO. Moreover, the first day of post-ischaemic reperfusion in the present model of stroke seems to be the breakpoint, i.e. the time at which expanding cell death from the infarct core to the penumbra can be at least partially eliminated. (C) 2012 Elsevier Ltd. All rights reserved.	[Bonova, Petra; Burda, Jozef; Danielisova, Viera; Nemethova, Miroslava; Gottlieb, Miroslav] Slovak Acad Sci, Inst Neurobiol, SK-04001 Kosice, Slovakia		Bonova, P (corresponding author), Slovak Acad Sci, Inst Neurobiol, Soltesovej 4-6, SK-04001 Kosice, Slovakia.	kravcukova@saske.sk	Nemethova, Miroslava/AAD-9106-2020; Jozef, Burda/F-6058-2011; Bonova, Petra/F-2887-2018; Nemethova, Miroslava/F-1506-2018	Nemethova, Miroslava/0000-0002-2841-8009; Bonova, Petra/0000-0002-5427-8126; Nemethova, Miroslava/0000-0002-2841-8009	Slovak Grant Agencies [VEGA 2/0092/12, VEGA 2/0148/12, VEGA 2/0066/12]	The authors gratefully acknowledge the excellent technical assistance of Dana Jurusova. This study was supported by the Slovak Grant Agencies VEGA 2/0092/12, VEGA 2/0148/12 and VEGA 2/0066/12.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Adachi N, 2005, BRAIN RES REV, V50, P275, DOI 10.1016/j.brainresrev.2005.08.002; Aggoun-Zouaoui D, 1998, APOPTOSIS, V3, P133, DOI 10.1023/A:1009653126347; ANDINE P, 1991, J NEUROCHEM, V57, P222, DOI 10.1111/j.1471-4159.1991.tb02119.x; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashafaq M, 2012, NUTR RES, V32, P133, DOI 10.1016/j.nutres.2011.12.014; Ashwal S, 1998, STROKE, V29, P1037, DOI 10.1161/01.STR.29.5.1037; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Back T, 1998, CELL MOL NEUROBIOL, V18, P621, DOI 10.1023/A:1020265701407; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bidmon HJ, 1998, STROKE, V29, P203, DOI 10.1161/01.STR.29.1.203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burda J, 2006, CELL MOL NEUROBIOL, V26, P1141, DOI 10.1007/s10571-006-9036-x; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; CLEMENS JA, 1988, LIFE SCI, V42, P707, DOI 10.1016/0024-3205(88)90463-8; COOPER HK, 1977, ACTA NEUROL SCAND, V56, P130; Danielisova V, 2005, NEUROCHEM RES, V30, P559, DOI 10.1007/s11064-005-2690-4; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Garcia L, 2004, J NEUROSCI RES, V77, P292, DOI 10.1002/jnr.20140; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hossmann KA, 2012, J CEREBR BLOOD F MET, V32, P1310, DOI 10.1038/jcbfm.2011.186; Huang HF, 2012, CNS NEUROSCI THER, V18, P811, DOI 10.1111/j.1755-5949.2012.00380.x; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; KATO H, 1995, BRAIN RES BULL, V36, P205, DOI 10.1016/0361-9230(94)00191-3; Kawase M, 1999, STROKE, V30, P1962, DOI 10.1161/01.STR.30.9.1962; Keller JN, 1998, J NEUROSCI, V18, P687; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; KLEIHUES P, 1975, BRAIN RES, V95, P61, DOI 10.1016/0006-8993(75)90207-3; Kokubo Y, 2003, NEUROSURGERY, V53, P186, DOI 10.1227/01.NEU.0000069023.01440.D6; Kravcukova P, 2009, CELL MOL NEUROBIOL, V29, P887, DOI 10.1007/s10571-009-9371-9; Lang D, 2011, BRAIN RES, V1425, P155, DOI 10.1016/j.brainres.2011.10.005; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Li YB, 1998, BRAIN RES, V814, P164, DOI 10.1016/S0006-8993(98)01082-8; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x; MANS RJ, 1961, ARCH BIOCHEM BIOPHYS, V94, P48, DOI 10.1016/0003-9861(61)90009-1; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Molchanova S, 2004, NEUROCHEM RES, V29, P1519, DOI 10.1023/B:NERE.0000029564.98905.5c; Mrsic-Pelcic J., 2012, CELL BIOCH FUNCT; Murakami K, 1998, J NEUROSCI, V18, P205; Negovskii V.A., 1962, RESUSCITATION ARTIFI, P290; PHEBUS LA, 1989, LIFE SCI, V44, P1335, DOI 10.1016/0024-3205(89)90390-1; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Sun M, 2009, NEUROCHEM INT, V54, P339, DOI 10.1016/j.neuint.2008.12.017; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; SUN Y, 1988, CLIN CHEM, V34, P497; Tipton KF, 2004, CURR MED CHEM, V11, P1965, DOI 10.2174/0929867043364810; Uchida H, 2010, CELL MOL NEUROBIOL, V30, P1125, DOI 10.1007/s10571-010-9545-5; Yang Y, 2001, NEUROPATHOLOGY, V21, P181, DOI 10.1046/j.1440-1789.2001.00397.x; Yao H, 2001, MOL BRAIN RES, V91, P112, DOI 10.1016/S0169-328X(01)00135-8; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zhao H, 2012, CURR DRUG TARGETS, V13, P173, DOI 10.2174/138945012799201621; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13	63	20	20	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2013	62	1					8	14		10.1016/j.neuint.2012.10.015			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	083EJ	WOS:000314445200002	23142152				2022-02-06	
J	Choi, CI; Lee, YD; Kim, H; Kim, SH; Suh-Kim, H; Kim, SS				Choi, Chan-Il; Lee, Young-Don; Kim, Heejaung; Kim, Seung Hyun; Suh-Kim, Haeyoung; Kim, Sung-Soo			Neural Induction With Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an Amyotrophic Lateral Sclerosis Mouse Model	CELL TRANSPLANTATION			English	Article						Mesenchymal stem cells (MSCs); Amyotrophic lateral sclerosis (ALS); Ce2+/Zn2+ superoxide dismutase; Superoxide dismutase-1 (SOD1); Neurogenin 1 (Ngn1)	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; IN-VITRO DIFFERENTIATION; BONE-MARROW; SPINAL-CORD; TRANSGENIC MICE; CEREBROSPINAL-FLUID; HNT NEURONS; DISEASE PROGRESSION; FUNCTIONAL RECOVERY	Amyotrophic lateral sclerosis (ALS) is characterized by progressive dysfunction and degeneration of motor neurons in the central nervous system (CNS). In the absence of effective drug treatments for ALS, stem cell treatment has emerged as a candidate therapy for this disease. To date, however, there is no consensus protocol that stipulates stem cell types, transplantation timing, or frequency. Using an ALS mouse model carrying a high copy number of a mutant human superoxide dismutase-1 (SOD1)(G93A) transgene, we investigated the effect of neural induction on the innate therapeutic potential of mesenchymal stem cells (MSCs) in relation to preclinical transplantation parameters. In our study, the expression of monocyte chemoattractant protein-1 (MCP-1) was elevated in the ALS mouse spinal cord. Neural induction of MSCs with neurogenin 1 (Ngn1) upregulated the expression level of the MCP-1 receptor, CCR2, and enhanced the migration activity toward MCP-1 in vitro. Ngn1-expressing MSCs (MSCs-Ngn1) showed a corresponding increase in tropism to the CNS after systemic transplantation in ALS mice. Notably, MSCs-Ngn1 delayed disease onset if transplanted during preonset ages, whereas unprocessed MSCs failed to do so. If transplanted near the onset ages, a single treatment with MSCs-Ngn1 was sufficient to enhance motor functions during the symptomatic period (15-17 weeks), whereas unprocessed MSCs required repeated transplantation to achieve similar levels of motor function improvement. Our data indicate that systemically transplanted MSCs-Ngn1 can migrate to the CNS and exert beneficial effects on host neural cells for an extended period of time through paracrine functions, suggesting a potential benefit of neural induction of transplanted MSCs in long-term treatment of ALS.	[Choi, Chan-Il; Lee, Young-Don; Suh-Kim, Haeyoung; Kim, Sung-Soo] Ajou Univ, Sch Med, Dept Anat, Suwon 443749, South Korea; [Choi, Chan-Il; Suh-Kim, Haeyoung] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 443749, South Korea; [Choi, Chan-Il; Suh-Kim, Haeyoung] Ajou Univ, Sch Med, Div Cell Transformat & Restorat BK21, Suwon 443749, South Korea; [Lee, Young-Don] Ajou Univ, Sch Med, Ctr Cell Death Regulating Biodrug, Suwon 443749, South Korea; [Lee, Young-Don] Ajou Univ, Sch Med, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Kim, Heejaung; Kim, Seung Hyun] Hanyang Univ, Coll Med, Inst Biomed Sci, Dept Neurol, Seoul 133791, South Korea		Kim, SS (corresponding author), Ajou Univ, Sch Med, Dept Anat, San 5, Suwon 443749, South Korea.	hysuh@ajou.ac.kr; kimdmg@ajou.ac.kr	Kim, Seung Hyun/T-5133-2017	Kim, Seung Hyun/0000-0001-9644-9598; Kim, Heejaung/0000-0002-0755-1740; Suh-Kim, Haeyoung/0000-0001-8175-1209; Kim, Sung-Soo/0000-0003-3591-5932	Brain Research Center of the 21st Century Frontier Research ProgramMinistry of Education, Science and Technology, Republic of Korea [2011K000262]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010-0020406, 2010-0023676]; Basic Science Research Program through NRF	This work was partly supported by Brain Research Center of the 21st Century Frontier Research Program (2011K000262) and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (2010-0020406) to HSK and by Basic Science Research Program through NRF funded by the Ministry of Education, Science and Technology (2010-0023676) to SSK. Conflicts of Interest: The authors declare no financial or other competing interests.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; APPEL SH, 1995, ADV NEUROL, V68, P47; Bakshi A, 2006, J NEUROTRAUM, V23, P55, DOI 10.1089/neu.2006.23.55; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20; Bradley WG, 1996, CLIN NEUROSCI, V3, P323; Brown RH, 2001, SEMIN NEUROL, V21, P131; Chen LC, 2004, AMYOTROPH LATERAL SC, V5, P164, DOI 10.1080/14660820410017091; Cho KJ, 1999, NEUROREPORT, V10, P3939, DOI 10.1097/00001756-199912160-00039; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Ferrero I, 2008, CELL TRANSPLANT, V17, P255, DOI 10.3727/096368908784153940; Garbuzova-Davis S, 2001, AMYOTROPH LATERAL SC, V2, P175, DOI 10.1080/14660820152882179; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Garbuzova-Davis S, 2006, AMYOTROPH LATERAL SC, V7, P221, DOI 10.1080/17482960600864470; Garbuzova-Davis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002494; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Habisch HJ, 2007, J NEURAL TRANSM, V114, P1395, DOI 10.1007/s00702-007-0748-y; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hou Ling-Ling, 2003, Shengli Xuebao, V55, P153; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Kim SS, 2005, NEUROREPORT, V16, P1357, DOI 10.1097/01.wnr.0000175243.12966.f5; Kim SS, 2008, STEM CELLS, V26, P2217, DOI 10.1634/stemcells.2008-0108; Ko Il-Kwon, 2008, Int J Stem Cells, V1, P49; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; Mazo M, 2010, CELL TRANSPLANT, V19, P313, DOI 10.3727/096368909X480323; Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5; Miana-Mena FJ, 2005, AMYOTROPH LATERAL SC, V6, P55, DOI 10.1080/14660820510026162; Migheli A, 1999, NEUROSCI LETT, V261, P25, DOI 10.1016/S0304-3940(98)01001-5; Mitrecic D, 2010, CELL TRANSPLANT, V19, P537, DOI 10.3727/096368910X498269; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/ten.2004.10.1093; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Przedborski Serge, 2003, Curr Neurol Neurosci Rep, V3, P70, DOI 10.1007/s11910-003-0041-x; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rothstein JD, 2003, ANN NEUROL, V53, P423, DOI 10.1002/ana.10561; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Shaw PJ, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160574; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Tohill M, 2004, BIOTECHNOL APPL BIOC, V40, P17, DOI 10.1042/BA20030173; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Wang Lei, 2002, Hematology, V7, P113; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; Willing AE, 2001, BRAIN RES BULL, V56, P525, DOI 10.1016/S0361-9230(01)00625-6; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Zhang C, 2009, CYTOTHERAPY, V11, P299, DOI 10.1080/14653240902806986; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	74	20	22	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2013	22	5					855	870		10.3727/096368912X637019			16	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	139LX	WOS:000318585300008	22472631				2022-02-06	
J	Eastvold, AD; Walker, WC; Curtiss, G; Schwab, K; Vanderploeg, RD				Eastvold, Angela D.; Walker, William C.; Curtiss, Glenn; Schwab, Karen; Vanderploeg, Rodney D.			The Differential Contributions of Posttraumatic Amnesia Duration and Time Since Injury in Prediction of Functional Outcomes Following Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute hospitalization; independence; outcome prediction; PTA; rehabilitation; return-to-work; TBI	HEAD-INJURY; COMMUNITY INTEGRATION; RETURN; MULTICENTER; EMPLOYMENT; WORK; REHABILITATION; PRODUCTIVITY; UTILITY; STATE	Objective: To examine the relative contributions of preinjury, injury severity, and acute postinjury variables in predicting outcomes at 1 year following moderate-severe traumatic brain injury (TBI). Design: Secondary analysis of a prospective longitudinal cohort study. Setting: Four Veterans Affairs Medical Center acute inpatient rehabilitation programs. Participants: Active duty military or veterans with a nonpenetrating moderate-to-severe TBI. Main outcome measures: Independent living status (N = 280) and work status (N = 248) at one year postinjury. Results: Preinjury characteristics as a group accounted for the largest amount of variance in independent living status at 1 year; however, posttraumatic amnesia (PTA) uniquely explained the largest amount of variance (8.8%). Those with less than 60 days PTA were 9 times more likely to be independent; those with less than 30 days PTA were 3 times more likely to be independent. In contrast, acute postinjury characteristics accounted for the largest amount of variance in work status, with time to rehabilitation explaining the most unique variance (10.4%). Those with less than 48 days time to rehabilitation were 2.4 times more likely to be productive. Conclusions: This study highlights the differential contribution of variables in the prediction of 2 specific functional outcomes in a military sample, adding to our current body of knowledge to assist clinicians, patients and their families following TBI.	[Eastvold, Angela D.; Curtiss, Glenn; Vanderploeg, Rodney D.] James A Haley Vet Affairs Med Ctr, Tampa, FL USA; [Walker, William C.] Hunter H McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, William C.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Walker, William C.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA USA; [Schwab, Karen] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Schwab, Karen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Curtiss, Glenn; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Curtiss, Glenn] Univ S Florida, Dept Aging & Mental Hlth Dispar, Tampa, FL USA; [Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA		Eastvold, AD (corresponding author), Univ Utah, Sch Med, Dept Neurol, 650 Komas Ave,106A, Salt Lake City, UT 84108 USA.	angela.eastvold@hsc.utah.edu	Walker, William C/N-3162-2014; Curtiss, Glenn/ABB-5566-2020		Department of Defense through the Henry Jackson Foundation [MDA 905-03-2-0003]; Department of Veterans Affairs, Veterans Health Administration (VHA), Defense and Veterans Brain Injury Center, Uniformed Services University of the Health Sciences, Bethesda, MD	The research reported here was originally supported by the Department of Veterans Affairs, Veterans Health Administration (VHA), Defense and Veterans Brain Injury Center, Uniformed Services University of the Health Sciences, Bethesda, MD, and a Department of Defense award administered through the Henry Jackson Foundation (grant MDA 905-03-2-0003). Further support was provided by the VHA Medical Center in Tampa, Florida.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Centers for Disease Contol and Prevention, TBI BRAIN INJ; Chandler SK, 1993, VOCATIONAL EVALUATIO, P161; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DeMaris A, 2002, SOCIOL METHOD RES, V31, P27, DOI 10.1177/0049124102031001002; Fleming J, 1999, BRAIN INJURY, V13, P417; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hoofien D, 2001, BRAIN INJURY, V15, P189; JENNETT B, 1975, LANCET, V1, P480; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	41	20	20	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2013	28	1					48	58		10.1097/HTR.0b013e31823c9317			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	070ZW	WOS:000313555400006	22333678				2022-02-06	
J	El-Matbouly, M; El-Menyar, A; Al-Thani, H; Tuma, M; El-Hennawy, H; AbdulRahman, H; Parchani, A; Peralta, R; Asim, M; El-Faramawy, A; Zarour, A; Latifi, R				El-Matbouly, Moamena; El-Menyar, Ayman; Al-Thani, Hassan; Tuma, Mazin; El-Hennawy, Hany; AbdulRahman, Husham; Parchani, Ashok; Peralta, Ruben; Asim, Mohammad; El-Faramawy, Ahmed; Zarour, Ahmad; Latifi, Rifat			Traumatic Brain Injury in Qatar: Age Matters-Insights from a 4-Year Observational Study	SCIENTIFIC WORLD JOURNAL			English	Article							UNITED-STATES; EPIDEMIOLOGY	Background. Overall traumatic brain injury (TBI) incidence and related death rates vary across different age groups. Objectives. To evaluate the incidence, causes, and outcome of TBI in adolescents and young adult population in Qatar. Method. This was a retrospective review of all TBIs admitted to the trauma center between January 2008 and December 2011. Demographics, mechanism of injury, morbidity, and mortality were analyzed in different age groups. Results. A total of 1665 patients with TBI were admitted; the majority were males (92%) with a mean age of 28 +/- 16 years. The common mechanism of injury was motor vehicle crashes and falls from height (51% and 35%, resp.). TBI was incidentally higher in young adults (34%) and middle age group (21%). The most frequent injuries were contusion (40%), subarachnoid (25%), subdural (24%), and epidural hemorrhage (18%). The mortality rate was 11% among TBI patients. Mortality rates were 8% and 12% among adolescents and young adults, respectively. The highest mortality rate was observed in elderly patients (35%). Head AIS, ISS, and age were independent predictors for mortality. Conclusion. Adolescents and adults sustain significant portions of TBI, whereas mortality is much higher in the older group. Public awareness and injury prevention campaigns should target young population.	[El-Matbouly, Moamena] Weill Cornell Med Coll, Doha 24144, Qatar; [El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Clin Res, Trauma Surg Sect, Doha 3050, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Med Clin, Doha 24144, Qatar; [Al-Thani, Hassan; Tuma, Mazin; El-Hennawy, Hany; AbdulRahman, Husham; Parchani, Ashok; Peralta, Ruben; El-Faramawy, Ahmed; Zarour, Ahmad; Latifi, Rifat] Hamad Gen Hosp, Trauma Surg Sect, Doha 3050, Qatar; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA		El-Menyar, A (corresponding author), Hamad Gen Hosp, Clin Res, Trauma Surg Sect, Doha 3050, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; El-Matbouly, Moamena/0000-0003-1313-6612; Latifi, Rifat/0000-0003-1091-3682			Alves O. L., 2001, BRAIN INJURY; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Carli P, 2004, LANCET, V363, P584, DOI 10.1016/S0140-6736(04)15626-2; CDC, 2006, MMWR-MORBID MORTAL W, V59, P303; CDC, 2006, MORT DAT MULT CAUS O; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2007, TRAUMATIC BRAIN INJU; Chesnutt R. M., 1999, INTRO BACKGROUND REH; Collins C., 2002, OCCUPATIONAL THERAPY, P395; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Granacher R. P., 2008, TRAUMATIC BRAIN INJU, VSecond; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hannay HJ, 2004, NEUROPHYSIOLOGICAL A, P158; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P457; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Valadka A. B., 2004, TRAUMA, P385; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zitnay GA, 2005, ACT NEUR S, V93, P131	28	20	21	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1537-744X			SCI WORLD J	Sci. World J.		2013									354920	10.1155/2013/354920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195KC	WOS:000322700000001	23983630	Green Published, Green Submitted, gold			2022-02-06	
J	Itoh, T; Imano, M; Nishida, S; Tsubaki, M; Mizuguchi, N; Hashimoto, S; Ito, A; Satou, T				Itoh, Tatsuki; Imano, Motohiro; Nishida, Shozo; Tsubaki, Masahiro; Mizuguchi, Nobuyuki; Hashimoto, Shigeo; Ito, Akihiko; Satou, Takao			Increased apoptotic neuronal cell death and cognitive impairment at early phase after traumatic brain injury in aged rats	BRAIN STRUCTURE & FUNCTION			English	Article						Cell death; Traumatic brain injury; Cerebral dysfunction; Apoptosis; Oxidative stress	CENTRAL-NERVOUS-SYSTEM; MITOCHONDRIAL DYSFUNCTION; CEREBRAL-CORTEX; OXYGEN RADICALS; HEAD-INJURY; ISCHEMIA; HIPPOCAMPUS; ACTIVATION; PROTECTS; DAMAGE	Progressive age-associated increases in cerebral dysfunction have been shown to occur following traumatic brain injury (TBI). Moreover, levels of neuronal mitochondrial antioxidant enzymes in the aged brain are reduced, resulting in free radical-induced cell death. It was hypothesized that cognitive impairment after TBI in the aged progresses to a greater degree than in younger individuals, and that damage involves neuronal degeneration and death by free radicals. In this study, we investigated the effects of free radicals on neuronal degeneration, cell death, and cognitive impairment in 10-week-old (young group) and 24-month-old rats (aged group) subjected to TBI. Young and aged rats received TBI with a pneumatic controlled injury device. At 1, 3 and 7 days after TBI, immunohistochemistry, lipid peroxidation and behavioral studies were performed. At 1, 3 and 7 days post-TBI, the number of 8-hydroxy-2'-deoxyguanosine-, 4-hydroxy-2-nonenal- and single-stranded DNA (ssDNA)-positive cells, and the levels of malondialdehyde around the damaged area after TBI significantly increased in the aged group when compared with the young group (P < 0.05). In addition, the majority of ssDNA-positive cells in both groups co-localized with neuronal cells around the damaged area. There was a significant decrease in the number of surviving neurons and an increase in cognitive impairment after TBI in the aged group when compared with the young group (P < 0.05). These results indicate that following TBI, high levels of free radicals are produced in the aged rat brain, which induces neuronal degeneration and apoptotic cell death around the damaged area, resulting in cognitive impairment.	[Itoh, Tatsuki; Ito, Akihiko; Satou, Takao] Kinki Univ, Dept Pathol, Fac Med, Osaka 5898511, Japan; [Imano, Motohiro] Kinki Univ, Dept Surg, Fac Med, Osaka 5898511, Japan; [Nishida, Shozo; Tsubaki, Masahiro] Kinki Univ, Fac Pharmaceut Sci, Higashiosaka, Osaka 577, Japan; [Mizuguchi, Nobuyuki] Kinki Univ, Life Sci Res Inst, Osaka 5898511, Japan; [Hashimoto, Shigeo] PL Hosp, Dept Pathol, Osaka, Japan; [Satou, Takao] Kinki Univ Hosp, Fac Med, Div Hosp Pathol, Osaka, Japan		Itoh, T (corresponding author), Kinki Univ, Dept Pathol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	tatsuki@med.kindai.ac.jp			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24501009] Funding Source: KAKEN		Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Buga AM, 2008, ROM J MORPHOL EMBRYO, V49, P279; CHAN PH, 1985, PROG BRAIN RES, V63, P227; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; DAS S, 2008, CURR AGING SCI, P1; Dorszewska J, 2004, RESP PHYSIOL NEUROBI, V139, P145, DOI 10.1016/j.resp.2003.10.009; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Jin Y, 2008, ACTA PHARMACOL SIN, V29, P1399, DOI 10.1111/j.1745-7254.2008.00848.x; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; Lee EJ, 2005, J PINEAL RES, V38, P42, DOI 10.1111/j.1600-079X.2004.00173.x; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Lynch AM, 2002, EUR J NEUROSCI, V15, P1779, DOI 10.1046/j.1460-9568.2002.02012.x; Martinez-Lara E, 2005, BRAIN RES, V1054, P88, DOI 10.1016/j.brainres.2005.06.060; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith DR, 2001, NEUROBIOL AGING, V22, P773, DOI 10.1016/S0197-4580(01)00240-8; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xu K, 2008, ADV EXP MED BIOL, V614, P379, DOI 10.1007/978-0-387-74911-2_42	40	20	22	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653			BRAIN STRUCT FUNCT	Brain Struct. Funct.	JAN	2013	218	1					209	220		10.1007/s00429-012-0394-5			12	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	063SB	WOS:000313019200016	22374222				2022-02-06	
J	Majdan, M; Mauritz, W; Wilbacher, I; Brazinova, A; Rusnak, M; Leitgeb, J				Majdan, Marek; Mauritz, Walter; Wilbacher, Ingrid; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes			Barbiturates Use and Its Effects in Patients with Severe Traumatic Brain Injury in Five European Countries	JOURNAL OF NEUROTRAUMA			English	Article						barbiturates; guidelines; intracranial pressure; medication; traumatic brain injury	REFRACTORY INTRACRANIAL HYPERTENSION; PENTOBARBITAL COMA; MANAGEMENT; EPIDEMIOLOGY; MODERATE; DESIGN	The guidelines for management of traumatic brain injury (TBI) recommend that high-dose barbiturate therapy may be considered to lower intracranial pressure (ICP) that is refractory to other therapeutic options. Lower doses of barbiturates may be used for sedation of patients with TBI, although there is no mention of this in the published guidelines. The goal of this study was to analyze the use of barbiturates in patients with severe TBI in the European centers where the International Neurotrauma Research Organization introduced guideline-based TBI management and to analyze the effects of barbiturates on ICP, use of vasopressors, and short- and long-term outcome of these patients. Data on 1172 patients with severe TBI were collected in 13 centers located in five European countries. Patients were categorized into three groups based on doses of barbiturates administered during treatment. Univariate and multivariate statistical methods were used to analyze the effects of barbiturates on the outcome of patients. Fewer than 20% of all patients with severe TBI were given barbiturates overall, and only 6% was given high doses. High-dose barbiturate treatment caused a decrease in ICP in 69% of patients but also caused hemodynamic instability leading to longer periods of mean arterial pressure <70mm Hg despite increased use of high doses of vasopressors. The adjusted analysis showed no significant effect on outcome on any stage after injury. Thiopental and methohexital were equally effective. Low doses of thiopental and methohexital were used for sedation of patients without side effects. Phenobarbital was probably used for prophylaxis of post-traumatic seizures.	[Majdan, Marek; Brazinova, Alexandra; Rusnak, Martin] Trnava Univ, Dept Publ Hlth, Fac Hlth Care & Social Work, Trnava 91843, Slovakia; [Majdan, Marek; Mauritz, Walter; Wilbacher, Ingrid; Brazinova, Alexandra; Rusnak, Martin] INRO, Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Dept Publ Hlth, Fac Hlth Care & Social Work, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Rusnak, Martin/K-9349-2016; Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Rusnak, Martin/0000-0003-3321-1042; Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712	European Union grant (Project "Research - Treat - TBI"; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries) [ICA2-CT-2002-100]; Austrian Worker's Compensation Board (AUVA) [FK 33/2003]; "Jubilee Fund" of the Austrian National Bank [8987]	The data used for this study were collected for a project funded by an European Union grant (Project "Research - Treat - TBI"; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; Contract number: ICA2-CT-2002-100), and for another project funded by the Austrian Worker's Compensation Board (AUVA; Contract number FK 33/2003), and by the "Jubilee Fund" of the Austrian National Bank (Project number 8987). INRO is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham, and by donations from various sources.	[Anonymous], 2000, J Neurotrauma, V17, P527; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; Blissitt PA, 2012, AACN ADV CRIT CARE, V23, P186, DOI 10.1097/NCI.0b013e31824db4f3; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 1996, J NEUROTRAUM, V13, P711; Bullock MR, 2007, J NEUROTRAUMA SUPPL, V24, P1; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kirchberger K, 1998, EPILEPSIA, V39, P1104, DOI 10.1111/j.1528-1157.1998.tb01297.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; Rangel-Castillo L, 2006, CRIT CARE CLIN, V22, P713, DOI 10.1016/j.ccc.2006.06.003; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WorldBank, 2011, WE CLASS COUNTR	26	20	21	1	21	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	1					23	29		10.1089/neu.2012.2554			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	061GU	WOS:000312837300005	22950895	Green Published			2022-02-06	
J	Roka, A; Beko, G; Halasz, J; Toldi, G; Lakatos, P; Azzopardi, D; Tulassay, T; Szabo, M				Roka, Aniko; Beko, Gabriella; Halasz, Jozsef; Toldi, Gergely; Lakatos, Petra; Azzopardi, Denis; Tulassay, Tivadar; Szabo, Miklos			Changes in serum cytokine and cortisol levels in normothermic and hypothermic term neonates after perinatal asphyxia	INFLAMMATION RESEARCH			English	Article						Asphyxia; Cytokine; Cortisol; Hypothermia; Neonate	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; MODERATE HYPOTHERMIA; INFLAMMATORY MEDIATORS; ADRENAL INSUFFICIENCY; MILD HYPOTHERMIA; EXPRESSION; INFECTION; NEWBORN	Perinatal asphyxia is characterized by an inflammatory response that contributes to cerebral injury. Therapeutic hypothermia improves neurological outcome in asphyxiated term neonates, but its clear effect on the inflammatory response is unknown. A range of cytokines and cortisol levels were measured at the 6th, 12th and 24th postnatal hours in neonates with hypoxic-ischemic encephalopathy treated with standard intensive care on hypothermia (n = 10) or normothermia (n = 8). The influence of postnatal age and hypothermia on serum cytokine and cortisol levels was evaluated. Interleukin (IL)-6 levels (at 6 h of age) and IL-4 levels (at all time points) were significantly lower in asphyxiated neonates treated with hypothermia compared to normothermic neonates. Vascular endothelial growth factor levels were higher in the hypothermia than in the normothermia group at the 6th and 12th postnatal hours. IL-10 levels decreased significantly between 6 and 24 h of age in both groups. However, no difference of IL-10 levels was observed between the study groups. The duration of hypothermia before 6 hours of age correlated with lower levels of IL-6, interferon-gamma and tumor necrosis factor-alpha measured at 6 h of age and IL-10 levels at 12 h of age. Cortisol levels did not differ between the study groups, but did gradually decrease in both groups during the study period. At 6 and 24 h of age, a positive correlation was observed between cortisol and IL-10 levels. Therapeutic hypothermia may rapidly suppress and modify the immediate cytokine response to asphyxia. The correlation between cytokine levels and duration of hypothermia suggests that the earlier hypothermia is introduced, the more pronounced its beneficial immunomodulatory effect.	[Roka, Aniko; Toldi, Gergely; Lakatos, Petra; Tulassay, Tivadar; Szabo, Miklos] Semmelweis Univ, Dept Pediat 1, H-1083 Budapest, Hungary; [Beko, Gabriella] Semmelweis Univ, Dept Lab Med, H-1083 Budapest, Hungary; [Halasz, Jozsef] Vadaskert Child Psychiat Hosp, H-1021 Budapest, Hungary; [Azzopardi, Denis] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, London W12 0NN, England		Toldi, G (corresponding author), Semmelweis Univ, Dept Pediat 1, Bokay U 53, H-1083 Budapest, Hungary.	toldigergely@yahoo.com		Halasz, Jozsef/0000-0002-3040-495X; Toldi, Gergely/0000-0003-0178-1243	Hungarian Scientific Research Foundation (OTKA)Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K76316]; United Kingdom Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Department of HealthEuropean Commission; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0100126, G0200270] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0100126, G0200270] Funding Source: researchfish	This study was supported by the Hungarian Scientific Research Foundation (OTKA Grant no. K76316). The TOBY trial was supported by the United Kingdom Medical Research Council and the Department of Health.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Aly H, 2009, BRAIN DEV-JPN, V31, P600, DOI 10.1016/j.braindev.2008.09.004; Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Azzopardi D, 2007, SEMIN FETAL NEONAT M, V12, P303, DOI 10.1016/j.siny.2007.01.022; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Fernandez EF, 2009, J PERINATOL, V29, pS44, DOI 10.1038/jp.2009.24; Fotopoulos S, 2001, BIOL NEONATE, V79, P213; Groschl M, 2003, CLIN CHEM, V49, P1688, DOI 10.1373/49.10.1688; Grow J, 2002, CLIN PERINATOL, V29, P585, DOI 10.1016/S0095-5108(02)00059-3; Jacobs S, 2007, COCHRANE DB SYST REV, P4, DOI DOI 10.1002/14651858.CD003311.PUB2; Kamath BD, 2010, J PEDIATR-US, V156, P495, DOI 10.1016/j.jpeds.2009.10.044; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Mastorakos G, 2006, ANN NY ACAD SCI, V1088, P373, DOI 10.1196/annals.1366.021; Matsui T, 2006, J NEUROSURG ANESTH, V18, P32; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Morita Y, 2009, CYTOKINE, V47, P48, DOI 10.1016/j.cyto.2009.04.004; Okazaki K, 2006, BIOL NEONATE, V89, P183, DOI 10.1159/000089180; PROCIANOY RS, 1988, ACTA PAEDIATR SCAND, V77, P671, DOI 10.1111/j.1651-2227.1988.tb10728.x; Protonotariou E, 1999, EARLY HUM DEV, V56, P31, DOI 10.1016/S0378-3782(99)00029-8; Qing M, 2006, CRIT CARE, V10, DOI 10.1186/cc4886; Quintos JB, 2010, CURR OPIN ENDOCRINOL, V17, P8, DOI 10.1097/MED.0b013e32833363cc; Roka A, 2008, PEDIATRICS, V121, pE844, DOI 10.1542/peds.2007-1987; Russwurm S, 2002, J INTERF CYTOK RES, V22, P215, DOI 10.1089/107999002753536185; Saliba E, 2001, BIOL NEONATE, V79, P224; Sarandakou A, 1998, MEDIAT INFLAMM, V7, P309, DOI 10.1080/09629359890811; Scher M, 2001, Curr Neurol Neurosci Rep, V1, P175, DOI 10.1007/s11910-001-0014-x; Seron-Ferre M, 2001, AM J OBSTET GYNECOL, V184, P1278, DOI 10.1067/mob.2001.113322; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Sipos W, 2010, RESUSCITATION, V81, P603, DOI 10.1016/j.resuscitation.2010.01.014; SZAFLARSKI J, 1995, STROKE, V26, P1093, DOI 10.1161/01.STR.26.6.1093; Xanthou M, 2002, ACTA PAEDIATR, V91, P92, DOI 10.1080/080352502320764256; Yanagawa Y, 2002, RESUSCITATION, V53, P93, DOI 10.1016/S0300-9572(01)00499-3; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	39	20	20	0	3	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	JAN	2013	62	1					81	87		10.1007/s00011-012-0554-3			7	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	063NC	WOS:000313005500011	22986466				2022-02-06	
J	Mao, ZQ; Wang, N; Hussain, M; Li, M; Zhang, HQ; Zhang, QH; Zhang, P; Zhi, XL; Ling, F				Mao, Zhiqi; Wang, Ning; Hussain, Mohammed; Li, Meng; Zhang, Hongqi; Zhang, Qiuhang; Zhang, Peng; Zhi, Xinglong; Ling, Feng			Traumatic intracranial aneurysms due to blunt brain injury-a single center experience	ACTA NEUROCHIRURGICA			English	Article						Cerebrovascular trauma; Intracranial aneurysm; Brain injuries	INTERNAL CAROTID-ARTERY; CEREBELLAR ARTERY; VERTEBRAL ARTERY; MANAGEMENT; CHILDHOOD; INFANCY; WOUNDS	Traumatic intracranial aneurysms (TICAs) have previously been described in literature. However, the evidence of TICAs secondary to blunt brain injury have not been elucidated well, with most of the conclusions coming from isolated case reports. We have attempted to examine the epidemiology, classification, clinical presentation, therapeutic modalities, and outcomes of TICAs with our series of patients at the neurosurgery department of Xuanwu Hospital, China. We reviewed our aneurysm database from January 1, 2005 to December 31, 2011. In particular, patients with TICAs secondary to blunt brain injury were reviewed. Variables assessed included age, sex, causes of blunt brain injury, skull fracture, location, classification, clinical presentation, time elapsed to arrive at diagnoses, treatment, and eventual outcome. Based on our assessment, we arrived at a modified classification scheme to categorize these aneurysms. We reviewed 2335 patients with cerebral aneurysm from January 1, 2005 to December 31, 2011. Of these, 15 patients (0.64 %) with traumatic aneurysms secondary to blunt brain injury were identified.Motor vehicle accidents (MVA) were observed to be the most common cause of injury (10 patients, 66.7 %), followed by TICAs sustained after falling down (5 patients, 33.3 %). The most common symptom at presentation was epistaxis (6 patients, 40 %), followed by ophthalmic problems (6 patients, 40 %), with both presentations seen in 1 patient. The most common diagnostic modality used was DSA in 12 patients (80 %) followed by CTA in 2 patients (13.3 %). Infraclinoid TICAs were seen in 9 patients (60 %), whereas supraclinoid TICAs were seen in 5 patients (33.3 %), with perifalx TICAs seen in 1 patient. Endovascular intervention therapies were performed in 11 patients (73.3 %), bypass surgery and trapping in 2 (13.3 %), transnasal endoscopic approach in combination with balloon assisted in 2 patients. At discharge, 2 patients had poor clinical outcomes (13.3 %), 5 had fair (33.3 %),and 8 resulted with good outcomes (53.3 %). TICAs arising secondary to blunt brain injury account for 0.64 % of all cerebral aneurysms. Infraclinoid, supraclinoid ICA and perifalx TICAs are the most common aneurysms arising from blunt brain injury. Our study further shows that traumatic patients presenting with recurrent epistaxis, oculomotor nerve palsy, and delayed intracranial hemorrhage should receive cerebroangiography as soon as possible. An early diagnosis and proper treatment could prove to be helpful in terms of improving final clinical outcome.	[Mao, Zhiqi; Wang, Ning; Li, Meng; Zhang, Hongqi; Zhang, Qiuhang; Zhang, Peng; Zhi, Xinglong; Ling, Feng] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China; [Hussain, Mohammed] Wayne State Univ, Dept Neurosurg, Detroit, MI USA		Ling, F (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, 45 Changchun St, Beijing 100053, Peoples R China.	dr.lingfeng@gmail.com	Zhiqi, Mao/V-5983-2017	Zhiqi, Mao/0000-0002-8535-4531			Allison JW, 1998, PEDIATR RADIOL, V28, P223, DOI 10.1007/s002470050336; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Bhatia S, 2011, ACTA NEUROCHIR, V153, P905, DOI 10.1007/s00701-010-0846-8; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Dario A, 1997, J Neurosurg Sci, V41, P195; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; ENDO S, 1980, CHILD BRAIN, V6, P131; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; GEORGE B, 1987, NEUROSURGERY, V20, P821; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lath R, 2002, J CLIN NEUROSCI, V9, P466, DOI 10.1054/jocn.2001.1050; Martin E M, 1986, J Neurosci Nurs, V18, P89; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; PARKINSON D, 1985, SURG NEUROL, V23, P453, DOI 10.1016/0090-3019(85)90236-8; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; Sakamoto S, 2009, ACTA NEUROCHIR, V151, P1531, DOI 10.1007/s00701-009-0285-6; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Tan TC, 2001, BRIT J NEUROSURG, V15, P137; Tureyen K, 2001, BRIT J NEUROSURG, V15, P429, DOI 10.1080/02688690120082440; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; WANG AN, 1986, SURG NEUROL, V25, P77, DOI 10.1016/0090-3019(86)90120-5; Wang X, 2008, NEUROL INDIA, V56, P47, DOI 10.4103/0028-3886.39312; WIENER I, 1984, J TRAUMA, V24, P346, DOI 10.1097/00005373-198404000-00012; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294; Zhang C, 2011, NEUROPEDIATRICS, V42, P204, DOI 10.1055/s-0031-1291221	38	20	24	0	12	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	DEC	2012	154	12					2187	2193		10.1007/s00701-012-1487-x			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	040XJ	WOS:000311359500008	22975866				2022-02-06	
J	O'Callaghan, A; McAllister, L; Wilson, L				O'Callaghan, Anna; McAllister, Lindy; Wilson, Linda			Insight vs readiness: Factors affecting engagement in therapy from the perspectives of adults with TBI and their significant others	BRAIN INJURY			English	Article						Readiness for therapy; acceptance of impairments; engagement with therapy	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; WORKING ALLIANCE; PATIENT COMPLIANCE; SELF-AWARENESS; REHABILITATION; PARTICIPATION; RECOVERY; SEVERITY; MODEL	Introduction: Adults sustain significant, often irreversible impairments following brain injury. The process they go through coming to terms with these impairments can seriously interfere with their readiness to engage in rehabilitation. Aim: This study aimed to look beyond the development of self-awareness and insight in order to explore the concept of readiness as it relates to clients' experiences of engaging with therapy. Method: Sixteen in-depth interviews were conducted with 14 adults with a moderate-severe traumatic brain injury (TBI) and nine of their significant others. These participants were asked to speak about the continuum of care they experienced and the factors that effected their engagement with care. Results: The results of this study indicated that participants believed their ability to engage in therapy was related to the degree to which they were aware of and accepted their impairments and motivated to engage in rehabilitation. Participants reported that the rate and degree to which they developed awareness varied according to the type of impairments they experienced (i.e. physical vs cognitive). Participants also stated that one way to augment their awareness was to compare their new vs old selves and to compare their recovery to those of others with a similar impairment. Finally, participants reported that it was important to be able to access services when they had accepted their impairment and were ready to engage in therapy. Conclusion: The clinical implications for considering the degree of awareness of impairments and readiness for engagement in care of an adult with a moderate-severe TBI are discussed in relation to future services planning.	[O'Callaghan, Anna] Univ Queensland, Brisbane, Qld, Australia; [McAllister, Lindy] Univ Sydney, Sydney, NSW 2006, Australia; [Wilson, Linda] Charles Sturt Univ, Albury, NSW, Australia		O'Callaghan, A (corresponding author), Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	annamocallaghan@gmail.com	Wilson, Linda/P-8523-2015	Wilson, Linda/0000-0003-4175-7125	Speech Pathology Australia Postgraduate Student Research Grant	This research was partially funded through a Speech Pathology Australia Postgraduate Student Research Grant. The authors report no conflicts of interest. The authors alone were responsible for the content and writing of the paper.	Attride-Stirling J., 2001, QUALITATIVE RES, V1, P385, DOI [10.1177/146879410100100307, DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; BOWLING A., 2002, RES METHODS HLTH INV; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Charmaz K, 1995, SOCIOL QUART, V36, P657, DOI 10.1111/j.1533-8525.1995.tb00459.x; Charmaz K., 1997, GOOD DAYS BAD DAYS S, Vsecond; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Commonwealth Department of Health and Aged Care National Key Centre for Social Applications of Geographical Information Systems, 2001, MEAS REM ACC REM IND, Vrevised; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Durgin CJ, 2000, J HEAD TRAUMA REHAB, V15, P1195, DOI 10.1097/00001199-200012000-00002; Fearnside MR, 1997, MED J AUSTRALIA, V167, P293, DOI 10.5694/j.1326-5377.1997.tb125070.x; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Gentleman D, 2001, TRAUMA, V3, P193; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Grbich C, 1999, HDB RES METHODS HLTH; Greenwood, 1999, HDB RES METHODS HLTH; Hughes P, 2003, DOING EARLY CHILDHOO; Isaki E, 2000, BRAIN INJURY, V14, P441; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Llewellyn G, 1999, HDB RES METHODS HLTH, P174; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Minichiello V., 1999, HDB RES METHODS HLTH, P35; Morse JM, 1995, QUALITATIVE RES METH; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Newberry L, 2001, NEW DIRECTION FOLLW; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Schwandt T. A., 2000, HDB QUALITATIVE RES, P189; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Tuel SM, 1992, BRAIN INJURY, V6, P337; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	50	20	20	1	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1599	1610		10.3109/02699052.2012.698788			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700006	22738228				2022-02-06	
J	Bukur, M; Lustenberger, T; Cotton, B; Arbabi, S; Talving, P; Salim, A; Ley, EJ; Inaba, K				Bukur, Marko; Lustenberger, Thomas; Cotton, Bryan; Arbabi, Saman; Talving, Peep; Salim, Ali; Ley, Eric J.; Inaba, Kenji			Beta-blocker exposure in the absence of significant head injuries is associated with reduced mortality in critically ill patients	AMERICAN JOURNAL OF SURGERY			English	Article						Trauma; Critically ill; Beta-blocker; Inflammation; Mortality	TRAUMATIC BRAIN-INJURY; NONCARDIAC SURGERY; ADRENERGIC-BLOCKADE; SYSTEMIC INFLAMMATION; IMPROVED OUTCOMES; RISK PATIENTS; PROPRANOLOL; SEPSIS; CATECHOLAMINES; SURVIVAL	BACKGROUND: The effect of beta-blockade in trauma patients without significant head injuries is unknown. The purpose of this investigation was to determine the impact of beta-blocker exposure on mortality in critically injured trauma patients who did not sustain significant head injuries. METHODS: Critically ill trauma patients (Injury Severity Score >= 25) admitted to the surgical intensive care unit from January 2000 to December 2008 without severe traumatic brain injuries (head Abbreviated Injury Score >= 3) were included in this retrospective review. Patients who received beta-blockers within 30 days of intensive care unit admission were compared with those who did not. The primary outcome measure evaluated was in-hospital mortality. RESULTS: During the 9-year study period, 663 critically injured patients (Injury Severity Score >= 25) were admitted to the intensive care unit. Of these, 98 patients (14.8%) received beta-blockers. Patients exposed to beta-blockers had significantly lower in-hospital mortality (11.2% vs 19.3%, P = .006). Stepwise logistic regression identified beta-blocker use as an independent protective factor for mortality (adjusted odds ratio, .37; P = .007) in critically injured patients. CONCLUSIONS: Beta-blocker exposure was associated with reduced mortality in critically injured patients without head injuries. Prospective validation of this finding is warranted. (C) 2012 Elsevier Inc. All rights reserved.	[Bukur, Marko; Salim, Ali; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90048 USA; [Lustenberger, Thomas; Talving, Peep; Inaba, Kenji] Los Angeles Cty Univ So Calif Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA USA; [Cotton, Bryan] Univ Texas Med Sch Houston, Dept Surg, Div Acute Care Surg, Houston, TX USA; [Arbabi, Saman] Univ Washington, Harborview Med Ctr, Dept Surg, Div Trauma & Crit Care, Seattle, WA 98104 USA		Bukur, M (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90048 USA.	marko.bukur@cshs.org	INABA, KENJI/AAC-8532-2020; Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015	Talving, Peep/0000-0002-9741-2073; Bukur, Marko/0000-0002-1850-7147			Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Barrow RE, 2006, ANN SURG, V243, P115, DOI 10.1097/01.sla.0000193834.07413.91; Benschop RJ, 1997, BRAIN BEHAV IMMUN, V11, P321, DOI 10.1006/brbi.1997.0499; Benschop RJ, 1996, FASEB J, V10, P517, DOI 10.1096/fasebj.10.4.8647351; Cioca DP, 2000, JPN HEART J, V41, P385; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; DOUGLAS RG, 1989, BRIT J SURG, V76, P115, DOI 10.1002/bjs.1800760205; FRAYN KN, 1985, CIRC SHOCK, V16, P229; Friese RS, 2008, J TRAUMA, V64, P1061, DOI 10.1097/TA.0b013e3181684cf0; Herndon DN, 2003, AM J PHYSIOL-ENDOC M, V285, pE783, DOI 10.1152/ajpendo.00508.2002; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; HERNDON DN, 1988, ANN SURG, V208, P484, DOI 10.1097/00000658-198810000-00010; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jacobs AK, 2009, J AM COLL CARDIOL, V54, P2102, DOI 10.1016/j.jacc.2009.07.004; Kohm AP, 2000, IMMUNOL TODAY, V21, P539, DOI 10.1016/S0167-5699(00)01747-3; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Martin M, 2005, J TRAUMA, V59, P1086, DOI 10.1097/01.ta.0000190249.19668.37; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; Norbury WB, 2007, CRIT CARE MED, V35, pS616, DOI 10.1097/01.CCM.0000278599.30298.80; Oberbeck R, 2009, CURR MED CHEM, V16, P1082, DOI 10.2174/092986709787581770; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Rough J, 2009, SURGERY, V145, P235, DOI 10.1016/j.surg.2008.09.013; Sametz W, 1999, EUR J CLIN INVEST, V29, P582; Schmitz D, 2007, RESUSCITATION, V72, P286, DOI 10.1016/j.resuscitation.2006.07.001; SHAW JHF, 1988, SURGERY, V103, P520; Shojania K, 2001, AHRQ PUBLICATION, V01-e058; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; WILMORE DW, 1974, ANN SURG, V180, P653, DOI 10.1097/00000658-197410000-00031; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899	38	20	20	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610			AM J SURG	Am. J. Surg.	NOV	2012	204	5					697	703		10.1016/j.amjsurg.2012.02.007			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	045YZ	WOS:000311734000031	22578406				2022-02-06	
J	Bukur, M; Hadjibashi, AA; Ley, EJ; Malinoski, D; Singer, M; Barmparas, G; Margulies, D; Salim, A				Bukur, Marko; Hadjibashi, Anoushiravan Amini; Ley, Eric J.; Malinoski, Darren; Singer, Matthew; Barmparas, Galinos; Margulies, Daniel; Salim, Ali			Impact of prehospital hypothermia on transfusion requirements and outcomes	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; hypothermia; blood transfusions; complications	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; EARLY COAGULOPATHY; BLOOD-TRANSFUSION; OXYGEN DELIVERY; POTENTIAL ROLE; DAMAGE CONTROL; RESUSCITATION; COAGULATION; MORTALITY	BACKGROUND: Prehospital hypothermia (PH) is known to increase mortality following traumatic injury. PH relationship with transfusion requirements has not been documented. The purpose of this investigation was to analyze the impact of PH on blood product requirements and subsequent outcomes. METHODS: The Los Angeles County Trauma System Database was queried for all patients admitted between 2005 and 2009. Demographics, physiologic parameters, and transfusion requirements were obtained and dichotomized by admission temperatures with a core temperature of less than 36.5 degrees C considered hypothermic. Multivariate analysis was performed to determine factors contributing to transfusion requirements and to derive adjusted odds ratios (AORs) for mortality and rates of adult respiratory distress syndrome and pneumonia. RESULTS: A total of 21,023 patients were analyzed in our study with 44.6% presenting with PH. Hypothermic patients required 26% more fluid resuscitation (p < 0.001) in the emergency department and 17% more total blood products (p < 0.001) than those who were admitted with a normal temperature. There was a trend toward an increase in emergency department transfusion (8%, p = 0.06). PH was independently associated with the need for a transfusion (AOR, 1.1; p = 0.047), increased mortality (AOR, 2.0; p < 0.01), as well as incidence of adult respiratory distress syndrome (AOR, 1.8; p < 0.05) and pneumonia (AOR, 2.6; p < 0.01). CONCLUSION: PH is associated with increased transfusion and fluid requirements and subsequently worse outcomes. Interventions that correct hypothermia may decrease transfusion requirements and improve outcomes. Prospective studies investigating correction of hypothermia in trauma patients are warranted. (J Trauma Acute Care Surg. 2012;73: 1195-1201. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Bukur, Marko] Cedars Sinai Med Ctr, Div Trauma & Crit Care, Dept Surg, Los Angeles, CA 90048 USA		Bukur, M (corresponding author), Cedars Sinai Med Ctr, Div Trauma & Crit Care, Dept Surg, 8635 W 3rd St,Suite 650, Los Angeles, CA 90048 USA.	bukurm@cshs.org	Barmparas, Galinos/L-6530-2019	Bukur, Marko/0000-0002-1850-7147			BUSH HL, 1995, J VASC SURG, V21, P392, DOI 10.1016/S0741-5214(95)70281-4; COHEN JR, 1995, J VASC SURG, V21, P400; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; DANZL DF, 1987, ANN EMERG MED, V16, P1042, DOI 10.1016/S0196-0644(87)80757-6; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Fukudome EY, 2009, CRIT CARE MED, V37, pS265, DOI 10.1097/CCM.0b013e3181aa60ac; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; GUNNING KA, 1995, AUST NZ J SURG, V65, P80, DOI 10.1111/j.1445-2197.1995.tb07265.x; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; HESSEL EA, 1980, J SURG RES, V28, P23, DOI 10.1016/0022-4804(80)90078-5; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Inaba K, 2009, WORLD J SURG, V33, P864, DOI 10.1007/s00268-009-9936-2; Ireland S, 2011, RESUSCITATION, V82, P300, DOI 10.1016/j.resuscitation.2010.10.016; JOHNSTON TD, 1994, J TRAUMA, V37, P413, DOI 10.1097/00005373-199409000-00014; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Leben J, 1996, Acta Anaesthesiol Scand Suppl, V109, P39; Lewis FR, 1997, ANN SURG, V226, P447; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; MICHELSON AD, 1994, THROMB HAEMOSTASIS, V71, P633; Plurad D, 2007, J TRAUMA, V63, P1, DOI 10.1097/TA.0b013e318068b1ed; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; SHIBUTANI K, 1983, CRIT CARE MED, V11, P640, DOI 10.1097/00003246-198308000-00010; Silverboard H, 2005, J TRAUMA, V59, P717, DOI 10.1097/01.ta.0000174919.35240.21; Spahn DR, 2005, BRIT J ANAESTH, V95, P130, DOI 10.1093/bja/aei169; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; VILLALOBOS TJ, 1955, P SOC EXP BIOL MED, V89, P192; WEG JG, 1991, CRIT CARE MED, V19, P650, DOI 10.1097/00003246-199105000-00011; YENARI MA, 1995, THROMB RES, V77, P475, DOI 10.1016/0049-3848(95)93883-2; YOSHIHARA H, 1985, THROMB RES, V37, P503, DOI 10.1016/0049-3848(85)90096-9	38	20	20	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2012	73	5					1195	1201		10.1097/TA.0b013e31826fc7d9			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	043VF	WOS:000311577100029	23117380				2022-02-06	
J	Chung, EM; Biko, DM; Schroeder, JW; Cube, R; Conran, RM				Chung, Ellen M.; Biko, David M.; Schroeder, Jason W.; Cube, Regino; Conran, Richard M.			From the Radiologic Pathology Archives Precocious Puberty: Radiologic-Pathologic Correlation	RADIOGRAPHICS			English	Article							SERTOLI-CELL TUMOR; CONGENITAL ADRENAL-HYPERPLASIA; PRIMARY ADRENOCORTICAL CARCINOMA; HYPOTHALAMIC-PITUITARY FUNCTION; MCCUNE-ALBRIGHT-SYNDROME; TRAUMATIC BRAIN-INJURY; NEUROFIBROMATOSIS TYPE-1; SONOGRAPHIC APPEARANCE; CLINICAL PRESENTATION; IMAGING FINDINGS	Precocious puberty represents a unique diagnostic problem in which imaging plays an important role. Development of secondary sex characteristics may result from inappropriate activation of the hypothalamic-pituitary axis with release of gonadotropin, or from gonadotropin-independent secretion of sex steroids by the adrenal glands or gonads. A variety of lesions can manifest with precocious puberty, including various central nervous system (CNS) lesions, adrenal lesions, and sex cord-stromal tumors of the testis or ovary. CNS lesions causing precocious puberty are much more common in boys than in girls and are well evaluated with brain magnetic resonance imaging. Neoplastic (hypothalamic-chiasmatic astrocytoma, suprasellar germinoma) and nonneoplastic (hypothalamic hamartoma, hydrocephalus, trauma, empty sella, infection, congenital midline anomalies) conditions may affect the function of the hypothalamic-pituitary axis. The adrenal cortex may produce sex hormones. Some adrenal cortical neoplasms (ACNs) in patients under 5 years of age are related to a mutation of the tumor suppressor gene p53 and represent a disease that is distinct from ACNs in older children and adults. Adrenal cortical hyperplasia secondary to an enzymatic defect in steroid biosynthesis causes virilization and salt wasting, which usually manifest in the neonatal period; however, milder forms of the disease may manifest in childhood. Female precocious puberty may be caused by an autonomously functioning ovarian cyst or a juvenile granulosa cell tumor of the ovary. Male precocious puberty may be caused by a sex steroid-producing Leydig or Sertoli cell tumor of the testis. Ultrasonography is the primary modality for evaluating the sex organs and may also be used to evaluate for adrenal abnormalities.	[Chung, Ellen M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA; [Conran, Richard M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Pathol, Bethesda, MD 20814 USA; [Chung, Ellen M.] Amer Inst Radiol Pathol, Pediat Radiol Sect, Silver Spring, MD USA; [Biko, David M.; Schroeder, Jason W.] Walter Reed Natl Mil Med Ctr, Dept Radiol, Bethesda, MD USA; [Cube, Regino] Madigan Army Med Ctr, Dept Radiol, Tacoma, WA 98431 USA		Chung, EM (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiol & Radiol Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	ellen.chung@usuhs.edu			American Institute for Radiologic Pathology (AIRP); Joint Pathology Center (JPC); Uniformed Services University of the Health Sciences (USU)	Supported by the American Institute for Radiologic Pathology (AIRP), the Joint Pathology Center (JPC), and Uniformed Services University of the Health Sciences (USU).	Abdolvahabi RM, 2000, NEUROL RES, V22, P123; Acar C, 2009, UROLOGY, V73, P1165, DOI 10.1016/j.urology.2008.10.036; Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Adan L, 2000, EUR J PEDIATR, V159, P348, DOI 10.1007/s004310051285; Al-Agha OM, 2007, ARCH PATHOL LAB MED, V131, P311; Al-Alwan I, 1999, J PEDIATR-US, V135, P71, DOI 10.1016/S0022-3476(99)70330-6; Antonini SRR, 2002, J PEDIATR ENDOCR MET, V15, P1525; AVERY GR, 1991, CLIN RADIOL, V43, P260, DOI 10.1016/S0009-9260(05)80251-X; Avila NA, 1999, AM J ROENTGENOL, V172, P1003, DOI 10.2214/ajr.172.4.10587136; AVNI EF, 1993, PEDIATR RADIOL, V23, P88, DOI 10.1007/BF02012391; Bharwani N, 2011, AM J ROENTGENOL, V196, pW706, DOI 10.2214/AJR.10.5540; Binning Mandy J, 2007, Neurosurg Focus, V23, pE2; Boland GWL, 2009, AM J ROENTGENOL, V192, P956, DOI 10.2214/AJR.08.1431; Borer JG, 2000, UROL CLIN N AM, V27, P529, DOI 10.1016/S0094-0143(05)70100-2; Boyce AM, 2012, J CLIN ENDOCR METAB, V97, pE1782, DOI 10.1210/jc.2012-1791; Brauner R, 1999, CHILD NERV SYST, V15, P662, DOI 10.1007/s003810050455; Burger P. C., 2007, TUMORS CENTRAL NERVO; Buzi F, 1998, ACTA PAEDIATR, V87, P1138; CACCIARI E, 1994, J CLIN ENDOCR METAB, V78, P767, DOI 10.1210/jc.78.3.767; Caoili EM, 2007, ACAD RADIOL, V14, P468, DOI 10.1016/j.acra.2007.01.009; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Cassidy FH, 2010, RADIOGRAPHICS, V30, P665, DOI 10.1148/rg.303095049; Chalumeau M, 2002, PEDIATRICS, V109, P61, DOI 10.1542/peds.109.1.61; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; COHEN HL, 1993, AM J ROENTGENOL, V160, P583, DOI 10.2214/ajr.160.3.8430559; COHEN HL, 1992, AM J ROENTGENOL, V159, P89, DOI 10.2214/ajr.159.1.1609728; Cohen HL, 2007, CAFFEYS PEDIAT DIAGN, P2456; Conkey DS, 2005, CLIN ONCOL-UK, V17, P322, DOI 10.1016/j.clon.2005.04.009; Conran RM, 2010, STOCKER DEHNERS PEDI, P911; Cronje H S, 1998, Obstet Gynecol Surv, V53, P240, DOI 10.1097/00006254-199804000-00022; DANEMAN A, 1983, PEDIATR RADIOL, V13, P11, DOI 10.1007/BF00975660; De Sanctis V, 2000, J PEDIATR ENDOCR MET, V13, P687; de Sousa G, 2008, HORM-INT J ENDOCRINO, V7, P170, DOI 10.1007/BF03401509; Debeneix C, 2001, HORM RES, V56, P12, DOI 10.1159/000048084; Defilippi C, 2006, J PEDIATR ENDOCR MET, V19, P561; Drevelangas A, 1999, EUR RADIOL, V9, P1934, DOI 10.1007/s003300050954; DUNNICK NR, 1994, RADIOL CLIN N AM, V32, P99; DUNNICK NR, 1982, J COMPUT ASSIST TOMO, V6, P978, DOI 10.1097/00004728-198210000-00020; Echevarria ME, 2008, ONCOLOGIST, V13, P690, DOI 10.1634/theoncologist.2008-0037; Falhammar H, 2012, ENDOCRINE, V41, P355, DOI 10.1007/s12020-011-9591-x; Fernandez GC, 2004, BRIT J RADIOL, V77, P521, DOI 10.1259/bjr/31653779; FISHMAN EK, 1987, AM J ROENTGENOL, V148, P531, DOI 10.2214/ajr.148.3.531; GABRILOVE JL, 1980, J UROLOGY, V124, P757, DOI 10.1016/S0022-5347(17)55652-9; Garel L, 2001, RADIOGRAPHICS, V21, P1393, DOI 10.1148/radiographics.21.6.g01nv041393; GIERKE CL, 1994, AM J ROENTGENOL, V163, P373, DOI 10.2214/ajr.163.2.8037034; Giglio M, 2003, UROL INT, V70, P205, DOI 10.1159/000068770; Gittleman AM, 2003, CLIN IMAG, V27, P221, DOI 10.1016/S0899-7071(02)00586-7; Groussin L, 2009, J CLIN ENDOCR METAB, V94, P1713, DOI 10.1210/jc.2008-2302; Grunt JA, 2004, J PEDIATR ENDOCR MET, V17, P775; Guillamo JS, 2003, BRAIN, V126, P152, DOI 10.1093/brain/awg016; HAMPER UM, 1987, AM J ROENTGENOL, V148, P915, DOI 10.2214/ajr.148.5.915; Hanson JA, 1996, PEDIATR RADIOL, V26, P794, DOI 10.1007/BF01396204; HEDLUND GL, 1994, SEMIN ULTRASOUND CT, V15, P49, DOI 10.1016/S0887-2171(05)80029-0; Herman-Giddens ME, 2004, PEDIATRICS, V113, P911, DOI 10.1542/peds.113.4.911; Hernanz-Schulman M, 2002, PEDIATR RADIOL, V32, P130, DOI 10.1007/s00247-001-0592-4; Herter LD, 2002, J ULTRAS MED, V21, P1237, DOI 10.7863/jum.2002.21.11.1237; HRICAK H, 1985, RADIOLOGY, V156, P415, DOI 10.1148/radiology.156.2.4011904; HUSEMAN CA, 1978, J PEDIATR-US, V92, P748, DOI 10.1016/S0022-3476(78)80142-5; JABRA AA, 1993, CLIN IMAG, V17, P199, DOI 10.1016/0899-7071(93)90110-9; Jou P, 2009, J UROLOGY, V181, P2299, DOI 10.1016/j.juro.2009.02.051; Kaplowitz P, 2002, PEDIATRICS, V109, P139, DOI 10.1542/peds.109.1.139; Kaplowitz PB, 1999, PEDIATRICS, V104, P936, DOI 10.1542/peds.104.4.936; KING LR, 1993, J ULTRAS MED, V12, P577, DOI 10.7863/jum.1993.12.10.577; KORNREICH L, 1995, PEDIATR RADIOL, V25, P7, DOI 10.1007/BF02020830; Kornreich L, 2001, AM J NEURORADIOL, V22, P1963; Krebs TL, 1998, RADIOGRAPHICS, V18, P1425, DOI 10.1148/radiographics.18.6.9821192; Lack EE, 2007, TUMORS ADRENAL GLAND, P161; Lack EE, 2007, TUMORS ADRENAL GLAND; Leyva-Carmona M, 2009, J PEDIAT HEMATOL ONC, V31, P304, DOI 10.1097/MPH.0b013e318196a70e; Liang L, 2002, NEURORADIOLOGY, V44, P382, DOI 10.1007/s00234-001-0752-0; LISTERNICK R, 1995, J PEDIATR-US, V127, P718, DOI 10.1016/S0022-3476(95)70159-1; Listernick R, 2007, ANN NEUROL, V61, P189, DOI 10.1002/ana.21107; LIU P, 1993, PEDIATR RADIOL, V23, P127, DOI 10.1007/BF02012404; Love S., 2008, GREENFIELDS NEUROPAT; Maixner W, 2006, CHILD NERV SYST, V22, P867, DOI 10.1007/s00381-006-0129-0; Maizlin ZV, 2004, J ULTRAS MED, V23, P959, DOI 10.7863/jum.2004.23.7.959; MASSA G, 1989, EUR J PEDIATR, V148, P742, DOI 10.1007/BF00443099; McDonnell CM, 2003, J PAEDIATR CHILD H, V39, P682, DOI 10.1046/j.1440-1754.2003.00268.x; Merke DP, 1996, ARCH DIS CHILD, V75, P269, DOI 10.1136/adc.75.4.269; Mohn A, 1999, PEDIATR NEUROSURG, V31, P316, DOI 10.1159/000028882; Naing Soe, 2007, Pediatr Endocrinol Rev, V4, P335; Ng SM, 2003, ARCH DIS CHILD, V88, P414, DOI 10.1136/adc.88.5.414; NUSSBAUM AR, 1986, RADIOLOGY, V160, P641, DOI 10.1148/radiology.160.3.3526401; Oltmann SC, 2010, J PEDIATR SURG, V45, P135, DOI 10.1016/j.jpedsurg.2009.10.021; ORSINI LF, 1984, RADIOLOGY, V153, P113, DOI 10.1148/radiology.153.1.6473771; Osborn AG, 1994, DIAGNOSTIC NEURORADI; Outwater EK, 2000, ULTRASOUND OBST GYN, V15, P365, DOI 10.1046/j.1469-0705.2000.00123.x; Outwater EK, 1998, RADIOGRAPHICS, V18, P1523, DOI 10.1148/radiographics.18.6.9821198; Paterson A, 2002, EUR RADIOL, V12, P2491, DOI 10.1007/s00330-002-1311-8; Perlman EJ, 2010, STOCKER DEHNERS PEDI, P837; PESCOVITZ OH, 1986, J PEDIATR-US, V108, P47, DOI 10.1016/S0022-3476(86)80767-3; PRANDO A, 1990, PEDIATR RADIOL, V20, P163, DOI 10.1007/BF02012962; Premkumar A, 1997, J CLIN ULTRASOUND, V25, P211, DOI 10.1002/(SICI)1097-0096(199705)25:4<211::AID-JCU10>3.0.CO;2-N; REINGES MHT, 1994, UROLOGY, V44, P540, DOI 10.1016/S0090-4295(94)80054-5; Ribeiro J, 2000, PEDIATR RADIOL, V30, P45, DOI 10.1007/s002470050013; Ricci ZJ, 2004, PEDIATR RADIOL, V34, P177, DOI 10.1007/s00247-003-1035-1; RIETH KG, 1987, AM J ROENTGENOL, V148, P1231, DOI 10.2214/ajr.148.6.1231; Rivarola MA, 2001, ACTA PAEDIATR, V90, P751, DOI 10.1080/080352501750315654; ROBBEN SGF, 1995, BRIT J RADIOL, V68, P34, DOI 10.1259/0007-1285-68-805-34; Rodriguez-Macias KA, 1999, ARCH DIS CHILD, V81, P53, DOI 10.1136/adc.81.1.53; SCHLUND JF, 1995, JMRI-J MAGN RESON IM, V5, P171, DOI 10.1002/jmri.1880050211; Scully RE, 1996, TUMORS OVARY MALDEVE; Setian N, 2002, J PEDIATR ENDOCR MET, V15, P1487; Shenoy SN, 2004, PEDIATR NEUROSURG, V40, P249, DOI 10.1159/000082302; Shin SL, 2007, AM J ROENTGENOL, V189, pW65, DOI 10.2214/AJR.07.2089; Sivasankaran Sujatha, 2009, J Pediatr Adolesc Gynecol, V22, pe114, DOI 10.1016/j.jpag.2008.08.001; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Starzyk J, 2003, J PEDIATR ENDOCR MET, V16, P447; Stikkelbroeck NMML, 2003, EUR RADIOL, V13, P1597, DOI 10.1007/s00330-002-1786-3; SURRATT JT, 1991, RADIOGRAPHICS, V11, P533, DOI 10.1148/radiographics.11.4.1887110; Taffel M, 2012, RADIOL CLIN N AM, V50, P219, DOI 10.1016/j.rcl.2012.02.009; Tanaka YO, 2004, RADIOGRAPHICS, V24, pS147, DOI 10.1148/rg.24si045501; Thomas JC, 2001, J UROLOGY, V166, P2338, DOI 10.1016/S0022-5347(05)65583-8; Trivin C, 2006, CLIN ENDOCRINOL, V65, P239, DOI 10.1111/j.1365-2265.2006.02582.x; Ulbright TM, 1999, SEX CORD STROMAL TUM, P193; VANZULLI A, 1992, RADIOLOGY, V183, P425, DOI 10.1148/radiology.183.2.1561344; Vieira TC, 2007, J PEDIATR ENDOCR MET, V20, P1141; Virdis R, 2000, J PEDIATR ENDOCR MET, V13, P841; Wasniewska M, 2006, J PEDIATR ENDOCR MET, V19, P619; Wasniewska M, 2004, J PEDIATR-US, V145, P670, DOI 10.1016/j.jpeds.2004.06.083; Wieneke JA, 2003, AM J SURG PATHOL, V27, P867, DOI 10.1097/00000478-200307000-00001; WILSON CB, 1980, PEDIATRICS, V66, P767; Woodward PJ, 2002, RADIOGRAPHICS, V22, P189, DOI 10.1148/radiographics.22.1.g02ja14189	124	20	23	0	9	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0271-5333			RADIOGRAPHICS	Radiographics	NOV-DEC	2012	32	7					2071	2099		10.1148/rg.327125146			29	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	036MT	WOS:000311031100023	23150859	Bronze			2022-02-06	
J	Turkstra, LS; Quinn-Padron, M; Johnson, JE; Workinger, MS; Antoniotti, N				Turkstra, Lyn S.; Quinn-Padron, Maura; Johnson, Jacqueline E.; Workinger, Marilyn S.; Antoniotti, Nina			In-Person Versus Telehealth Assessment of Discourse Ability in Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain injury; communication; language; rehabilitation; telehealth; telerehabilitation	SOCIAL COMMUNICATION-SKILLS; NARRATIVE DISCOURSE; PRACTICE GUIDELINES; LANGUAGE THERAPY; TELEREHABILITATION; REHABILITATION; DISORDERS; PEOPLE; INDIVIDUALS; DIAGNOSIS	Objectives: To compare in-person versus telehealth (TH) assessment of discourse ability in adults with chronic traumatic brain injury (TBI). Design: Repeated-measures design with random order of conditions. Participants: Twenty adults withmoderate-to-severe TBI. Method: Participants completed conversation, picture description, story-generation, and procedural description tasks. Sessions were video-recorded and transcribed. Measures: Measures of productivity and quality of discourse. Results: Significant differences between conditions were not detected in this sample, and feedback from participants was positive. Conclusions: These preliminary results support the use of TH for the assessment of discourse ability in adults with TBI, at least for individuals with sufficient cognitive skills to follow TH procedures.	[Turkstra, Lyn S.; Johnson, Jacqueline E.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA; [Quinn-Padron, Maura; Workinger, Marilyn S.; Antoniotti, Nina] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025011] Funding Source: NIH RePORTER	This work was supported by Grant 1UL1RR025011 from the Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health.	American Speech-Language-Hearing Association, 2010, PROF ISS TEL SPEECH; American Speech-Language-Hearing Association, 2005, SPEECH LANG PATH PRO; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brennan DM, 2004, TELEMED J E-HEALTH, V10, P147, DOI 10.1089/1530562041641237; Brown J, 2006, ASHA LEADER; Bureau of Labor Statistics, 2011, OCC OUTL HDB 2010 20; Cherney L. R., 1998, ANAL DISCOURSE COMMU; Cherney LR, 2008, J SPEECH LANG HEAR R, V51, P1282, DOI 10.1044/1092-4388(2008/07-0206); Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Cullum CM, 2006, ASSESSMENT, V13, P385, DOI 10.1177/1073191106289065; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Darkins A, 2008, ARCH PHYS MED REHAB, V89, P182, DOI 10.1016/j.apmr.2007.07.027; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Duffy JR, 1997, MAYO CLIN PROC, V72, P1116, DOI 10.4065/72.12.1116; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Georgeadis AC, 2004, APHASIOLOGY, V18, P639, DOI 10.1080/02687030444000075; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hagan C, 1978, RANCHO LOS AMIGOS LE; Hengst JA, 2007, TOP LANG DISORD, V27, P37, DOI 10.1097/00011363-200701000-00005; JENNETT B, 1975, LANCET, V1, P480; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Loban W., 1976, 18 NAT COUNC TEACH E; Loh PK, 2007, J TELEMED TELECARE, V13, P90, DOI 10.1258/135763307780096159; MacWhinney B., 2000, CHILDES PROJECT; Mashima Pauline A, 2008, Telemed J E Health, V14, P1101, DOI 10.1089/tmj.2008.0080; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Nelson EL, 2006, EVAL PROGRAM PLANN, V29, P419, DOI 10.1016/j.evalprogplan.2006.02.001; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Prensky M., 2001, HORIZON, V9, P1, DOI [DOI 10.1108/10748120110424816, 10.1108/10748120110424816]; Randolph C., 2001, REPEATABLE BATTERY A; Ricker JH, 2003, NEUROREHABILITATION, V18, P179; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Torsney K, 2003, NEUROREHABILITATION, V18, P183; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Wade J, 2003, APHASIOLOGY, V17, P1031, DOI 10.1080/02687030344000373; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Wellek S., 2010, TESTING STAT HYPOTHE; WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657; Workinger MS, 1995, PERSPECTIVES NEUROPH, V5, P2; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	49	20	20	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					424	432		10.1097/HTR.0b013e31823346fc			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200013	22190010	Green Accepted			2022-02-06	
J	Waldron-Perrine, B; McGuire, AP; Spencer, RJ; Drag, LL; Pangilinan, PH; Bieliauskas, LA				Waldron-Perrine, Brigid; McGuire, Adam P.; Spencer, Robert J.; Drag, Lauren L.; Pangilinan, Percival H.; Bieliauskas, Linas A.			The Influence of Sleep and Mood on Cognitive Functioning Among Veterans Being Evaluated for Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							POSTCONCUSSION SYNDROME; TEST-PERFORMANCE; SYMPTOMS; INSOMNIA; ADULTS	Objective: Veterans undergoing evaluation for mild traumatic brain injury commonly report insomnia, psychiatric symptoms, and cognitive dysfunction. This study examines the effects of self-reported amount of sleep and subjective sleep quality on neuropsychological test performance. Method: 262 veterans were seen for neuropsychological assessment in a Veterans Affairs traumatic brain injury clinic. All participants completed measures of depression, anxiety, and sleep satisfaction, and also estimated the number of hours they slept the night before the assessment. Factor scores of attention/concentration and memory were created using factor analyses. Data were analyzed with linear regression. Results: Depression and anxiety were significantly correlated with sleep satisfaction and predictive of cognitive ability. Both sleep satisfaction and hours slept were significantly correlated with memory, but not attention. After controlling for the effects of depression and anxiety, hours slept but not sleep satisfaction was predictive of memory test performance. Conclusions: Perceived sleep quality is heavily influenced by psychiatric symptoms; therefore, veterans' report of sleep satisfaction may merely reflect their overall level of distress. Sleep quantity, however, appears to uniquely contribute to memory performance. Thus, assessment of sleep is important and provides clinicians with useful information, especially among individuals with psychiatric comorbidities.	[Waldron-Perrine, Brigid; McGuire, Adam P.; Spencer, Robert J.; Pangilinan, Percival H.; Bieliauskas, Linas A.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA; [Drag, Lauren L.; Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48109 USA; [Pangilinan, Percival H.] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Waldron-Perrine, B (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.			McGuire, Adam/0000-0002-4512-1207			Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bower B, 2010, J SLEEP RES, V19, P323, DOI 10.1111/j.1365-2869.2009.00816.x; Castaneda AE, 2008, J AFFECT DISORDERS, V110, P36, DOI 10.1016/j.jad.2007.12.239; Chiu Hsiao-Yean, 2010, Hu Li Za Zhi, V57, P106; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Douglas KM, 2009, AUST NZ J PSYCHIAT, V43, P1105, DOI 10.3109/00048670903279887; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Franzen PL, 2010, PSYCHIAT RES, V177, P240, DOI 10.1016/j.psychres.2009.02.011; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kronholm E, 2011, J SLEEP RES, V20, P288, DOI 10.1111/j.1365-2869.2010.00899.x; Kronholm E, 2009, J SLEEP RES, V18, P436, DOI 10.1111/j.1365-2869.2009.00765.x; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lee EK, 2010, CAN J PSYCHIAT, V55, P403, DOI 10.1177/070674371005500703; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Meyers JE., 1995, REY COMPLEX FIGURE T; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Neu D, 2011, PSYCHIAT RES, V189, P128, DOI 10.1016/j.psychres.2010.12.005; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reitan RM, 1992, TRAIL MAKING TEST MA; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 2008, WAIS 4 ADM SCOR MAN; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Zachary, 2000, SHIPLEY I LIVING SCA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	20	20	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2012	177	11					1293	1301		10.7205/MILMED-D-12-00169			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33OF	WOS:000209027400010	23198504	Bronze			2022-02-06	
J	Martens, KM; Vonder Haar, C; Hutsell, BA; Hoane, MR				Martens, Kris M.; Vonder Haar, Cole; Hutsell, Blake A.; Hoane, Michael R.			A Discrimination Task Used as a Novel Method of Testing Decision-Making Behavior following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal modeling; behavioral testing; cognitive assessment; traumatic brain injury	RATS; LESIONS; RECOVERY; PERFORMANCE; STIMULI; CORTEX	Traumatic brain injury (TBI) results in a multitude of deficits following injury. Some of the most pervasive in humans are the changes that affect frontally-mediated cognitive functioning, such as decision making. The assessment of decision-making behavior in rodents has been extensively tested in the field of the experimental analysis of behavior. However, due to the narrow therapeutic window following TBI, time-intensive operant paradigms are rarely incorporated into the battery of tests traditionally used, the majority of which assess motor and sensory functioning. The cognitive measures that are used are frequently limited to memory and do not account for changes in decision-making behavior. The purpose of the present study was to develop a simplified discrimination task that can assess deficits in decision-making behavior in rodents. For the task, rats were required to dig in cocoa-scented sand (versus unscented sand) for a reinforcer. Rats were given 12 sessions per day until a criterion level of 80% accuracy for 3 days straight was reached. Once the criterion was achieved, cortical contusion injuries were induced (frontal, parietal, or sham). Following a recovery period, the rats were re-tested on cocoa versus unscented sand. Upon reaching criterion, a reversal discrimination was evaluated in which the reinforcer was placed in unscented sand. Finally, a novel scent discrimination (basil versus coffee with basil reinforced), and a reversal (coffee) were evaluated. The results indicated that the Dig task is a simple experimental preparation that can be used to assess deficits in decision-making behavior following TBI.	[Martens, Kris M.; Vonder Haar, Cole; Hutsell, Blake A.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrat Res Cognit & Neural Sci, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrat Res Cognit & Neural Sci, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu	Hutsell, Blake/ABD-8248-2020	Vonder Haar, Cole/0000-0001-7949-2068; Hoane, Michael/0000-0001-7779-2657			*CDC, 2011, INJ PREV CONTR TRAUM; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; EICHENBAUM H, 1986, J NEUROSCI, V6, P1876; Fantino E, 1998, J EXP ANAL BEHAV, V69, P355, DOI 10.1901/jeab.1998.69-355; FINGER S, 1971, J COMP PHYSIOL PSYCH, V77, P221, DOI 10.1037/h0031648; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Iversen IH, 2008, J EXP ANAL BEHAV, V90, P113, DOI 10.1901/jeab.2008.90-113; Kaiser DH, 2006, BEHAV PROCESS, V73, P164, DOI 10.1016/j.beproc.2006.05.003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li HB, 1999, BRAIN RES BULL, V48, P113, DOI 10.1016/S0361-9230(98)00157-9; Lu XCM, 1998, NEUROSCIENCE, V84, P849, DOI 10.1016/S0306-4522(97)00520-4; NEAFSEY EJ, 1990, CEREBRAL CORTEX RAT, P197; PORTER D, 1984, J EXP PSYCHOL ANIM B, V10, P138; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Slotnick BM, 1997, BRAIN RES, V762, P89, DOI 10.1016/S0006-8993(97)00357-0; SPEAR PD, 1975, BRAIN RES, V94, P337, DOI 10.1016/0006-8993(75)90066-9; SULLIVAN RM, 1991, DEV BRAIN RES, V60, P219, DOI 10.1016/0165-3806(91)90050-S; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WILLIAMS BA, 1994, ANIMAL LEARNING COGN, P81	26	20	20	0	12	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2012	29	15					2505	2512		10.1089/neu.2012.2388			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	022NY	WOS:000309967300008	22924664				2022-02-06	
J	Silva, MA; Nakase-Richardson, R; Sherer, M; Barnett, SD; Evans, CC; Yablon, SA				Silva, Marc A.; Nakase-Richardson, Risa; Sherer, Mark; Barnett, Scott D.; Evans, Clea C.; Yablon, Stuart A.			Posttraumatic Confusion Predicts Patient Cooperation During Traumatic Brain Injury Rehabilitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Confusion; Neurobehavioral Manifestations; Patient Compliance; Rehabilitation	WORKING ALLIANCE; AWARENESS; SEVERITY; RECOVERY; AMNESIA	Silva MA, Nakase-Richardson R, Sherer M, Barnett SD, Evans CC, Yablon SA: Posttraumatic confusion predicts patient cooperation during traumatic brain injury rehabilitation. Am J Phys Med Rehabil 2012; 91: 890-893. Scant research has examined the relationship between posttraumatic confusion (PTC) and cooperation during rehabilitation from moderate to severe traumatic brain injury. In this study, PTC and cooperation were examined in a prospective cohort of 74 inpatients with traumatic brain injury. Confusion was measured using the Confusion Assessment Protocol. Cooperation was rated on a 0-100 scale by rehabilitation therapists. Using multiple regression analysis, PTC significantly predicted cooperation (R-2 = 0.33, P < 0.001). Age at injury, education, days since injury, and Glasgow Come Scale scores were not significant predictors. Bivariate analyses indicated that four PTC symptoms significantly predicted poorer cooperation: daytime hypersomnolence (rho = -0.42, P < 0.001), agitation (rho = -0.39, P = 0.001), psychosis (rho = -0.39, P = 0.001), and cognitive impairment (rho = -0.24, P = 0.04). Results provide empirical support that PTC is associated with poorer cooperation and empirical justification for interventions to manage confusion during early recovery from traumatic brain injury.	[Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Barnett, Scott D.] Res Ctr Excellence Maximizing Rehabil Outcomes, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Evans, Clea C.] Methodist Rehabil Ctr, Jackson, MS USA; [Evans, Clea C.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Yablon, Stuart A.] Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Yablon, Stuart A.] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, 13000 Bruce B Downs Blvd,116B, Tampa, FL 33612 USA.		Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	National Institute on Disability and Rehabilitation Research, Department of Education [H133A060038, H133A070043, H133A070027]	Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article. Supported by grants from the National Institute on Disability and Rehabilitation Research, Department of Education (H133A060038, [TBI Model System National Data and Statistical Center], H133A070043 [Texas TBI Model System of TIRR], H133A070027, [North Texas TBI Model System]). However, the contents of this article do not necessarily represent the policy of the National Institute on Disability and Rehabilitation Research, Department of Education, and endorsement by the Federal Government should not be assumed. Statistical support was provided by the HSR&D/RR&D Center of Excellence for Maximizing Rehabilitation Outcomes (COE-HFP 09-156). Presented, in part, in poster format at the annual meeting of the American Psychological Association, Washington, DC, August 2011.	Horn TS, 2010, ARCH PHYS MED REHAB, V91, P30, DOI 10.1016/j.apmr.2009.08.148; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; SHERER M, 2004, CONFUSION ASSESSMENT; Sherer M, 2003, ARCH PHYS MED REHAB, V84, pA1; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635	12	20	21	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	2012	91	10					890	893		10.1097/PHM.0b013e31825a1648			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	012FU	WOS:000309222100009	22660372				2022-02-06	
J	Egea-Guerrero, JJ; Gordillo-Escobar, E; Revuelto-Rey, J; Enamorado-Enamorado, J; Vilches-Arenas, A; Pacheco-Sanchez, M; Dominguez-Roldan, JM; Murillo-Cabezas, F				Egea-Guerrero, J. J.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Enamorado-Enamorado, J.; Vilches-Arenas, A.; Pacheco-Sanchez, M.; Dominguez-Roldan, J. M.; Murillo-Cabezas, F.			Clinical Variables and Neuromonitoring Information (Intracranial Pressure and Brain Tissue Oxygenation) as Predictors of Brain-Death Development After Severe Traumatic Brain Injury	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	35th Annual Congress of the Italian-Society-of-Organ-Transplantation (SITO)	OCT 27-29, 2011	Rome, ITALY	Italian Soc Organ Transplantat, Cathol Univ Sch Med Policlinico A. Gemelli, Div Organ Transplantat				Background and purpose. The aim of this study was to ascertain the role of clinical variables and neuromonitoring data as predictors of brain death (BD) after severe traumatic brain injury (TBI). Patients and methods. This prospective observational study involved severe TBI patients admitted to the intensive care unit between October 2009 and May 2011. The following variables were recorded: gender, age, reference Glasgow Coma Scale after resuscitation, pupillary reactivity, prehospital hypotension and desaturation, injury severity score, computed tomography (CT) findings, intracranial hypertension, and low brain tissue oxygenation (Pti02) levels (<16 mm Hg), as well as the final result of BD. Results. Among 61 patients (86.9% males) who met the inclusion criteria, the average age was 37.69 +/- 16.44 years. Traffic accidents were the main cause of TBI (62.3%). The patients at risk of progressing to BD (14.8% of the entire cohort) were those with a mass lesion on CT (odds ratio [OR] 33.6; 95% confidence interval [CI]: 3.75-300.30; P = .002), altered pupillary reaction at admission (OR 25.5; 95% CI: 2.27-285.65; P = .009), as well low Pti02 levels on admission (OR 20.41; 95% CI: 3.52-118.33; P < .001) and during the first 24 hours of neuromonitoring (OR 20; 95% CI: 2.90-137.83; P < .001). Multivariate logistic regression showed that a low Pti02 level on admission was the best independent predictor for BD (OR 20.41; 95% CI: 3.53-118.33; P = .001). Conclusions. Clinical variables and neuromonitoring information may identify TBI patients at risk of deterioration to BD.	[Egea-Guerrero, J. J.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Enamorado-Enamorado, J.; Pacheco-Sanchez, M.; Dominguez-Roldan, J. M.; Murillo-Cabezas, F.] Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Seville 41013, Spain; [Vilches-Arenas, A.] Univ Seville, Dept Prevent Med & Publ Hlth, Seville, Spain		Egea-Guerrero, JJ (corresponding author), Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.	juanjoegea@hotmail.com	Murillo-Cabezas, Francisco/AAO-3348-2021; Egea-Guerrero, Juan Jose JJ/P-5080-2014; Dominguez-Roldan, Jose-Maria/M-1728-2016; IBIS, NEUROCRITICOS/C-1805-2016; Vilches-Arenas, Angel/C-1167-2015	Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; Vilches-Arenas, Angel/0000-0003-2197-3760; Revuelto-Rey, Jaume/0000-0001-8350-9555			Figaji AA, 2010, NEUROCRIT CARE, V12, P56, DOI 10.1007/s12028-009-9298-5; Egea-Guerrero JJ, 2011, NEUROLOGY, V76, P489, DOI 10.1212/WNL.0b013e3181fe77fa; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; Revuelto-Rey J, 2012, MED INTENSIVA, V36, P213, DOI 10.1016/j.medin.2011.08.002; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	6	20	20	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345			TRANSPL P	Transplant. Proc.	SEP	2012	44	7					2050	2052		10.1016/j.transproceed.2012.07.070			3	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	011ET	WOS:000309148300065	22974906				2022-02-06	
J	Gaetani, P; Revay, M; Sciacca, S; Pessina, F; Aimar, E; Levi, D; Morenghi, E				Gaetani, P.; Revay, M.; Sciacca, S.; Pessina, F.; Aimar, E.; Levi, D.; Morenghi, E.			Traumatic brain injury in the elderly: considerations in a series of 103 patients older than 70	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Aged; Anticoagulants; Sub-arachnoid hemorrhage	PREINJURY WARFARIN USE; CLOSED-HEAD INJURIES; INTRACRANIAL HEMORRHAGE; MORTALITY; AGE; ANTICOAGULATION; IMPACT; ANTIPLATELET; OUTCOMES	Aim. Mortality and morbidity due to brain injury in the elderly population is a growing clinical problem: among older patients, those >70 years have a considerably higher risk both in terms of mortality and morbidity. Thereafter, the reasons influencing outcome have not been clearly examined: in the present study we addressed these questions considering the main clinical characteristics exerting a significant impact on the outcome of patients aged > 70, with emphasis for the severity of brain injury and anticoagulant (CAW) treatments. Methods. We performed a retrospective analysis of 103 consecutive isolated head injury patients older than 70, admitted at our Department in the period November 2004-November 2009. The clinical variables considered were as follow: age, sex, type of TBI, GCS, pre-TBI use of anti-coagulants (aspirin, warfarin, clopidogrel), INR at admission (INR values were subdivided in values >1.25 as at risk for hemorrhagic events and <1.25 as normal), initial CT scan classification looking at the presence of subarachnoid hemorrhage (t-SAH) or mass lesions; the main outcome measure was the Glasgow Outcome Scale. Results. The most frequent cause of TBI was accidental fall (65%): 39 were in CAW therapies and in 36 cases the cause of falling down injury was recorded due to a sincopal event (arterial hypotension, atrial fibrillation); in the older patients an accidental fall is significantly related to the TBI, while in the patients aged 70-75 years, TBI is related to a traffic accident (P=0.002). Moreover the cause of TBI correlates with the CAW treatment, the accidental fall being significantly more frequent in patients in CAW treatment (P=0.003). Overall mortality rate is significantly related to an elevated INR class, to presence of t-SAH (16/50 patients) and subdural hematoma (26/46). Conclusion. The results of the present study show that in a population of patients aged > 70, TBI is a high risk event if patient has concurrent treatment with CAW therapies and if an accidental fall is the cause of TBI. In these cases the finding of t-SAH represents a high-risk parameter for mortality but not for morbidity.	[Gaetani, P.; Revay, M.; Sciacca, S.; Pessina, F.; Aimar, E.] IRCCS Ist Clin Humanitas, Dept Neurosurg, I-20089 Milan, Italy; [Levi, D.] Univ LU de S, Lugano, Switzerland; [Morenghi, E.] IRCCS Ist Clin Humanitas, Biostat Unit, I-20089 Milan, Italy		Gaetani, P (corresponding author), IRCCS Ist Clin Humanitas, Dept Neurosurg, Via Manzoni 56, I-20089 Milan, Italy.	neuro.gaetani@gmail.com	; Pessina, Federico/K-7198-2016	Gaetani, Paolo/0000-0003-0662-5872; Pessina, Federico/0000-0002-8717-4999; Revay, Martina/0000-0003-2270-5733			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; AMACHER AL, 1987, NEUROSURGERY, V20, P954; Faul M, 2010, TRAUMATIC BRAIN INJU; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; Karni A, 2001, AM SURGEON, V67, P1098; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	18	20	20	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616			J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2012	56	3					231	237					7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	157JP	WOS:000319892700007	22854591				2022-02-06	
J	Post, A; Hoshizaki, TB; Gilchrist, M; Brien, S				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael; Brien, Susan			Analysis of the influence of independent variables used for reconstruction of a traumatic brain injury incident	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Finite element modelling; traumatic brain injury; reconstruction; injury biomechanics; subdural hematoma	MULTIBODY DYNAMICS; HEAD; FALLS; MILD; BIOMECHANICS; MODELS	Traumatic brain injuries contribute to a high degree of morbidity and mortality in society. To study traumatic brain injuries researchers reconstruct the event using both physical and FE models. The purpose of these reconstructions is to correlate the brain deformation metric to the type of injury as a measure for prediction. These reconstructions are guided by a series of independent variables which all have influence upon the outcome variables. This research uses a combination of physical and FE modelling to quantify how independent variables such as velocity and impact vector (angle) contribute to the resulting variance in brain deformation metrics. The results indicated that using a Hybrid III neck controls the rotational acceleration response from an impact. Also, it was found that strain rate and product of strain and strain rate were more sensitive to changes in impact angle. Linear acceleration decreased with increasing impact angle, while brain deformations did not follow this trend, which suggests that peak linear acceleration may not be the only factor in the production of larger brain deformations.	[Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON K1S 5S9, Canada; [Gilchrist, Michael] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, 200 Lees Ave,A-106, Ottawa, ON K1S 5S9, Canada.	apost@uottawa.ca	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X; Post, Andrew/0000-0002-5960-5552			Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan T, 2005, THESIS U COLL DUBLIN; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Miller RT, 1998, P 42 STAPP CAR CRASH; Nahum AM, 1977, P 21 STAPP CAR CRASH; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Oeur A, 2011, 23 INT SOC BIOM C BR; Ommaya A, 1967, 11 P STAPP CAR CRASH, P47; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A., 2010, 8 C INT SPORTS ENG A; Post A, 2011, J BIOMECH IN PRESS; Post A, 2011, COMPUT METH IN PRESS; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P89, DOI 10.1243/17543371JSET34; Rousseau P, 2009, J ASTM INT, V6, P159; Ruan J. S., 1994, THESIS WAYNE STATE U; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Sosin DM, 1996, BRAIN INJURY, V10, P47; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, P 39 STAPP CAR CRASH, P121; [No title captured]	32	20	20	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371			P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		290	298		10.1177/1754337112436629			9	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000018		Green Submitted			2022-02-06	
J	Feng, JF; Gurkoff, GG; Van, KC; Song, M; Lowe, DA; Zhou, J; Lyeth, BG				Feng, Jun-feng; Gurkoff, Gene G.; Van, Ken C.; Song, Minsoo; Lowe, David A.; Zhou, Jia; Lyeth, Bruce G.			NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Hypoxia; Hippocampus; Neuronal degeneration; Glutamate; N-acetylaspartylglutamate (NAAG); Astrocyte	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; METABOTROPIC GLUTAMATE RECEPTORS; N-ACETYLASPARTYLGLUTAMATE NAAG; AMINO-ACID RELEASE; HUMAN HEAD-INJURY; NEURONAL DEGENERATION; CARBOXYPEPTIDASE-II; FLUORO-JADE; RAT	Traumatic brain injury (TBI) leads to a rapid and excessive glutamate elevation in the extracellular milieu, resulting in neuronal degeneration and astrocyte damage. Posttraumatic hypoxia is a clinically relevant secondary insult that increases the magnitude and duration of glutamate release following TBI. N-acetyl-aspartyl glutamate (NAAG), a prevalent neuropeptide in the CNS, suppresses presynaptic glutamate release by its action at the mGluR3 (a group II metabotropic glutamate receptor). However, extracellular NAAG is rapidly converted into NAA and glutamate by the catalytic enzyme glutamate carboxypeptidase U (GCPII) reducing presynaptic inhibition. We previously reported that the GCPII inhibitor ZJ-43 and its prodrug di-ester PGI-02776 reduce the deleterious effects of excessive extracellular glutamate when injected systemically within the first 30 min following injury. We now report that PGI-02776 (10 mg/kg) is neuroprotective when administered 30 min post-injury in a model of TB! plus 30 min of hypoada (FiO(2)=11%). 24 h following TBI with hypoxia, significant increases in neuronal cell death in the CA1, CA2/3, CA3c, hilus and dentate gyrus were observed in the ipsilateral hippocampus. Additionally, there was a significant reduction in the number of astrocytes in the ipsilateral CA1, CA2/3 and in the CA3c/hilus/dentate gyrus. Administration of PGI-02776 immediately following the cessation of hypoxia significantly reduced neuronal and astrocytic cell death across all regions of the hippocampus. These findings indicate that NAAG peptidase inhibitors administered post-injury can significantly reduce the deleterious effects of TBI combined with a secondary hypmdc insult. (C) 2012 Elsevier B.V. All rights reserved.	[Feng, Jun-feng; Gurkoff, Gene G.; Van, Ken C.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Feng, Jun-feng] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200027, Peoples R China; [Song, Minsoo; Lowe, David A.] PsychoGenics Inc, Tarrytown, NY 10591 USA; [Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophon & Sci Technol, Sacramento, CA 95817 USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS61352, NS29995]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, R43NS061352] Funding Source: NIH RePORTER	This research was supported by NIH NS61352 (JZ) and NIH NS29995 (BGL).	Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Koura SS, 1998, ACT NEUR S, V71, P244; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Luthi-Carter R, 1998, BRAIN RES, V795, P341, DOI 10.1016/S0006-8993(98)00244-3; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schweitzer C, 2000, NEUROPHARMACOLOGY, V39, P1700, DOI 10.1016/S0028-3908(99)00265-8; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 2006, ADV EXP MED BIOL, V576, P317; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	50	20	21	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 21	2012	1469						144	152		10.1016/j.brainres.2012.06.021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998UE	WOS:000308265100015	22750589	Green Accepted			2022-02-06	
J	Binder, LM; Spector, J; Youngjohn, JR				Binder, Laurence M.; Spector, Jack; Youngjohn, James R.			Psychogenic Stuttering and Other Acquired Nonorganic Speech and Language Abnormalities	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Forensic neuropsychology; Head injury; Traumatic brain injury; Malingering; symptom validity testing; Aphasia	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; VALIDITY; SCALE; TESTS	Three cases are presented of peculiar speech and language abnormalities that were evaluated in the context of personal injury lawsuit or workers compensation claims of brain dysfunction after mild traumatic brain injuries. Neuropsychological measures of effort and motivation showed evidence of suboptimal motivation or outright malingering. The speech and language abnormalities of these cases probably were not consistent with neurogenic features of dysfluent speech including stuttering or aphasia. We propose that severe dysfluency or language abnormalities persisting after a single, uncomplicated, mild traumatic brain injury are unusual and should elicit suspicion of a psychogenic origin.	[Binder, Laurence M.] Oregon Hlth & Sci Univ, Dept Neurol, Beaverton, OR 97005 USA		Binder, LM (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 4900 SW Griffith Dr,Ste 244, Beaverton, OR 97005 USA.	pdxlarry@aol.com					Albers J. W., 2007, ASSESSMENT MALINGERE, P312; Arnold G., 2007, ASSESSMENT FEIGNED C, P178; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Baumgartner JM, 1999, STUTTERING RELATED D, P269; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; Boone K., 2003, DOT COUNTING TEST MA; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Cottingham ME, 2010, CLIN NEUROPSYCHOL, V24, P1006, DOI 10.1080/13854046.2010.481636; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duffy J. R., 2001, PSYCHOGENIC SPEECH D; FESTA JR, 2008, TXB CLIN NEUROPSYCHO, P363; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; GREIFFENSTEIN MF, 2007, ASSESSMENT MALINGERE, P100; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Helm-Estabrooks Nancy, 1998, Seminars in Speech and Language, V19, P23, DOI 10.1055/s-2008-1064032; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mohr J. P., 1976, STUDIES NEUROLINGUIS, P201; Moore DP, 2001, TXB CLIN NEUROPSYCHI; Morgan J. J., 2009, NEUROPSYCHOLOGY MALI, P180; National Center for Injury Prevention, 2003, MILD TRAUM BRAIN INJ; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Seery CH, 2005, AM J SPEECH-LANG PAT, V14, P284, DOI 10.1044/1058-0360(2005/028); Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Vossler DG, 2004, NEUROLOGY, V63, P516, DOI 10.1212/01.WNL.0000133208.57562.CB; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	39	20	21	0	31	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2012	27	5					557	568		10.1093/arclin/acs051			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	976UN	WOS:000306611300008	22789718	Bronze			2022-02-06	
J	Rapp, PE; Curley, KC				Rapp, Paul E.; Curley, Kenneth C.			Is a diagnosis of "mild traumatic brain injury" a category mistake?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Advanced Technology Applications for Combat Casualty Care Conference (ATACCC)	AUG 15-18, 2011	Fort Lauderdale, FL			Diagnosis; mild TBI; nosology	TEST-RETEST RELIABILITY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; EYE-TARGET SYNCHRONIZATION; EVENT-RELATED POTENTIALS; COMPLAINT BASE RATES; HEAD-INJURY; QUANTITATIVE EEG; AMERICAN ACADEMY; POSTCONCUSSIONAL SYMPTOMS	BACKGROUND: Efforts to produce definitions and diagnostic standards for mild traumatic brain injury (TBI) have a long and complex history. The diagnosis of TBI must be considered in the larger context of neuropsychiatric diagnosis. A major reconceptualization of diagnosis is now underway in which the classical syndrome conceptualization is being discarded. We address the question, what are the implications of this revision of thinking in the specific context of TBI? METHODS: A recent literature on logical structures for neuropsychiatric disorders was reviewed. The symptom pattern of TBI was identified, and a literature survey determined the frequency of these symptom patterns in other disorders and in healthy control populations. RESULTS: The frequency of symptom endorsement in populations without a history of TBI can be equal to endorsement frequencies in populations with a history of mild TBI. In some studies, the frequency of symptom endorsement in healthy controls having no history of head injury actually exceeded the endorsement rates in a comparison group with a history mild TBI. CONCLUSION: The heterogeneity of this clinical population and their clinical presentations, the absence of a unitary etiology of postinjury deficits, and the complex idiosyncratic time course of the appearance of these deficits argue against the valid implementation of the classical model of diagnosis. In addition, the accepted criteria of diagnostic utility are not satisfied. TBI is not a disease; it is an event. More precisely, TBI is an event or a sequence of events that can, in some instances, lead to a diagnosable neurological or psychiatric disorder. (J Trauma Acute Care Surg. 2012;73:S13-S23. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Rapp, Paul E.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, Bethesda, MD 20814 USA; [Curley, Kenneth C.] USA, Med Res & Mat Command, Combat Casualty Care Directorate, Ft Detrick, MD USA		Rapp, PE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Traumat Injury Res Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	prapp@usuhs.mil					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Andrich D., 1988, RASCH MODELS MEASURE; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arlinghaus KA, 2004, TXB TRAUMATIC BRAIN, P59; Bardel A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-37; Barr WB, BRAIN INJ, V26, P58; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Catani C., 2003, THESIS U KONSTANZ KO; Chakraborty K, 2012, INT J SOC PSYCHIATR, V58, P87, DOI 10.1177/0020764010387065; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; Contreras R, 2008, J BIOL PHYS, V34, P381, DOI 10.1007/s10867-008-9092-1; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Department of Veterans Affairs, 2007, VET HLTH ADM DIR VHA; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Grouvier WD, 1988, ARCH CLIN NEUROPSYCH, V3, P273; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Head H., 1926, APHASIA KINDRED DISO; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hoffman DA, 1999, J NEUROPSYCH CLIN N, V11, P401, DOI 10.1176/jnp.11.3.401; Hughlings-Jackson J., 1882, SELECTED WRITINGS J, V2, P29; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P10; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kupfer DJ, 2002, RESEARCH AGENDA FOR DSM-V, pXV; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P430, DOI 10.1097/00001199-200609000-00050; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mullins-Sweatt SN, 2009, PSYCHOL ASSESSMENT, V21, P302, DOI 10.1037/a0016607; Naunheim RS, 2011, AM J EMERG MED, V29, P845, DOI 10.1016/j.ajem.2010.03.010; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Naunheim RS, 2010, AM J EMERG MED, V28, p386e1; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; PERSONS JB, 1986, AM PSYCHOL, V41, P1252, DOI 10.1037/0003-066X.41.11.1252; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapp PE, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-119; Rentzsch J, 2008, INT J PSYCHOPHYSIOL, V67, P81, DOI 10.1016/j.ijpsycho.2007.10.006; Rizzo PA, 1983, NEUROPSYCHOBIOLOGY, V9, P72; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Ruff Robert L, 2010, F1000 Med Rep, V2, P64, DOI 10.3410/M2-64; Ryle G., 1949, CONCEPT MIND; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; SINHA R, 1992, BIOL PSYCHIAT, V32, P992; Smith DH, 2006, PSYCHOSOMATICS, V47, P271, DOI 10.1176/appi.psy.47.3.271; Smith GT, 2009, PSYCHOL ASSESSMENT, V21, P272, DOI 10.1037/a0016699; Smith GT, 2009, PSYCHOL ASSESSMENT, V21, P241, DOI 10.1037/a0016919; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher RW, 2003, CLIN ELECTROENCEPHAL, V34, P39, DOI 10.1177/155005940303400203; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; TUKEY JW, 1979, J AM STAT ASSOC, V74, P786, DOI 10.2307/2286400; US Government Accountability Office, 2008, VA HLTH CAR MILD TRA; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Viera AJ, 2005, FAM MED, V37, P360; Vila M, 2009, J PEDIATR PSYCHOL, V34, P989, DOI 10.1093/jpepsy/jsp005; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P1420, DOI 10.1111/j.1469-8986.2011.01206.x; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; World Health Organization, 2004, ICD 10 INT STAT CLAS; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P1844, DOI 10.1016/j.neuropsychologia.2009.02.025; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P145, DOI 10.1016/j.neuropsychologia.2008.08.001; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zolog TC, 2011, J COGN BEHAV PSYCHOT, V11, P191	119	20	20	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73			1			S13	S23		10.1097/TA.0b013e318260604b			11	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	992VP	WOS:000307808500004	22847083	Green Published			2022-02-06	
J	Cai, WK; Carlson, SW; Brelsfoard, JM; Mannon, CE; Moncman, CL; Saatman, KE; Andres, DA				Cai, Weikang; Carlson, Shaun W.; Brelsfoard, Jennifer M.; Mannon, Catherine E.; Moncman, Carole L.; Saatman, Kathryn E.; Andres, Douglas A.			Rit GTPase Signaling Promotes Immature Hippocampal Neuronal Survival	JOURNAL OF NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; PROGRAMMED CELL-DEATH; DENTATE GYRUS; ADULT NEUROGENESIS; OXIDATIVE STRESS; GRANULE NEURONS; MOUSE-BRAIN; P38 MAPK; MICE	The molecular mechanisms governing the spontaneous recovery seen following brain injury remain elusive, but recent studies indicate that injury-induced stimulation of hippocampal neurogenesis contributes to the repair process. The therapeutic potential of endogenous neurogenesis is tempered by the demonstration that traumatic brain injury (TBI) results in the selective death of adult-born immature neurons, compromising the cell population poised to compensate for trauma-induced neuronal loss. Here, we identify the Ras-related GTPase, Rit, as a critical player in the survival of immature hippocampal neurons following brain injury. While Rit knock-out (Rit(-/-)) did not alter hippocampal development, hippocampal neural cultures derived from Rit(-/-) mice display increased cell death and blunted MAPK cascade activation in response to oxidative stress, without affecting BDNF-dependent signaling. When compared with wild-type hippocampal cultures, Rit loss rendered immature (Dcx(+)) neurons susceptible to oxidative damage, without altering the survival of neural progenitor (Nestin(+)) cells. Oxidative stress is a major contributor to neuronal cell death following brain injury. Consistent with the enhanced vulnerability of cultured Rit(-/-) immature neurons, Rit(-/-) mice exhibited a significantly greater loss of adult-born immature neurons within the dentate gyrus after TBI. In addition, post-TBI neuronal remodeling was blunted. Together, these data identify a new and unexpected role for Rit in injury-induced neurogenesis, functioning as a selective survival mechanism for immature hippocampal neurons within the subgranular zone of the dentate gyrus following TBI.	[Cai, Weikang; Mannon, Catherine E.; Moncman, Carole L.; Andres, Douglas A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Carlson, Shaun W.; Brelsfoard, Jennifer M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA; [Carlson, Shaun W.; Brelsfoard, Jennifer M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Andres, DA (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, 741 S Limestone St, Lexington, KY 40536 USA.	dandres@uky.edu	Cai, Weikang/K-2394-2019	Cai, Weikang/0000-0001-5638-0805; Carlson, Shaun/0000-0002-1413-5075	Public Health Service from the National Institute of Neurological Disorders and Stroke [NS045103, NS058484, NS072302]; Kentucky Spinal Cord and Head Injury Research Trust [7-20]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [2P20 RR020171]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058484, R01NS072302, R56NS045103, R01NS045103] Funding Source: NIH RePORTER	This work was supported by Public Health Service Grants NS045103 (D. A. A.), NS058484 (K. E. S.), and NS072302 (K. E. S.) from the National Institute of Neurological Disorders and Stroke, Kentucky Spinal Cord and Head Injury Research Trust Grant 7-20 (K. E. S.), and National Center for Research Resources Grant 2P20 RR020171 (D. A. A.). We thank Drs. G.-X. Shi, M. Gentry, and P. Lein for helpful discussions. This manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the NCRR.	Amiri A, 2012, J NEUROSCI, V32, P5880, DOI 10.1523/JNEUROSCI.5462-11.2012; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 1997, J NEUROSCI, V17, P2492; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rudolph JL, 2007, BBA-MOL CELL RES, V1773, P1793, DOI 10.1016/j.bbamcr.2007.09.008; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; SHOLL DA, 1953, J ANAT, V87, P387; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Spencer ML, 2002, J BIOL CHEM, V277, P20160, DOI 10.1074/jbc.M201092200; Spencer ML, 2002, J BIOL CHEM, V277, P17605, DOI 10.1074/jbc.M111400200; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weinstein DE, 1996, BRAIN RES, V743, P11, DOI 10.1016/S0006-8993(96)00979-1; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	55	20	20	0	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 18	2012	32	29					9887	9897		10.1523/JNEUROSCI.0375-12.2012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	975RI	WOS:000306528200014	22815504	Green Accepted, Bronze, Green Published			2022-02-06	
J	Bagnato, S; Minafra, L; Bravata, V; Boccagni, C; Sant'Angelo, A; Castiglione, A; Andriolo, M; Lucca, LF; De Tanti, A; Pistarini, C; Formisano, R; Dolce, G; Gelfi, C; Galardi, G				Bagnato, Sergio; Minafra, Luigi; Bravata, Valentina; Boccagni, Cristina; Sant'Angelo, Antonino; Castiglione, Alberto; Andriolo, Maria; Lucca, Lucia Francesca; De Tanti, Antonio; Pistarini, Caterina; Formisano, Rita; Dolce, Giuliano; Gelfi, Cecilia; Galardi, Giuseppe			Brain-Derived Neurotrophic Factor (Val66Met) Polymorphism Does Not Influence Recovery from a Post-Traumatic Vegetative State: A Blinded Retrospective Multi-Centric Study	JOURNAL OF NEUROTRAUMA			English	Article						disorders of consciousness; genetic factors; levels of cognitive functioning; traumatic brain injury; vegetative state	MET ALLELE; BDNF; PLASTICITY; ALTERS; MATURATION; SURVIVORS; VOLUME	Brain-derived neurotrophic factor (BDNF) is a neurotrophin that influences neuronal plasticity throughout life. Emergence from a vegetative state (VS) after a traumatic brain injury (TBI) implies that the brain undergoes plastic changes. A common polymorphism in the BDNF gene-BDNF Val66Met (referred to herein as BDNFMet)-impairs cognitive function in healthy subjects. The aim of this study was to determine whether the BDNFMet polymorphism plays a role in the recovery of consciousness and cognitive functions in patients in a VS after a TBI. Fifty-three patients in a VS 1 month after a TBI were included in the study and genotyped for the BDNFMet polymorphism. Scores of levels of cognitive functioning (LCF) at 1, 3, 6, and 12 months post-TBI were retrospectively compared in patients without (Val group), and with (Met group), the BDNFMet polymorphism. The BDNFMet polymorphism was detected in 20 out of the 53 patients. The mean LCF scores in the Val and Met groups were 1.6 +/- 0.5 and 1.4 +/- 0.5 at 1 month, 2.3 +/- 0.7 and 2.5 +/- 1.2 at 3 months, 3.3 +/- 1.7 and 3.5 +/- 1.7 at 6 months, and 4 +/- 1.9 and 3.9 +/- 1.8 at 12 months, respectively (p > 0.05). The percentages of patients in the Val and Met groups who emerged from the VS were 36.4% and 30% at 3 months, 66.3% and 70% at 6 months, and 70% and 87.5% at 12 months (p > 0.05), respectively. These findings provide evidence that the BDNFMet polymorphism is not involved in cognitive improvement in patients with a VS following TBI. Future studies should focus on the role of other BDNF polymorphisms in the recovery from a VS.	[Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Castiglione, Alberto; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Neurophysiol Unit, I-90015 Cefalu, PA, Italy; [Andriolo, Maria] Fdn Ist San Raffaele G Giglio, Clin Pathol & Microbiol Lab, I-90015 Cefalu, PA, Italy; [Minafra, Luigi; Bravata, Valentina] HSR Giglio, Lab Tecnol Oncol LATO, Cefalu, Italy; [Minafra, Luigi; Bravata, Valentina; Gelfi, Cecilia] Natl Council Res CNR, Inst Mol Bioimaging & Physiol IBFM, Cefalu Segrate, Italy; [Lucca, Lucia Francesca; Dolce, Giuliano] St Anna Inst, Crotone, Italy; [De Tanti, Antonio] Cardinal Ferrari Ctr, Fontanellato, Italy; [Pistarini, Caterina] Sci Inst Pavia, IRCCS S Maugeri Fdn, Neurorehabil Unit, Pavia, Italy; [Formisano, Rita] IRCCS Fdn Santa Lucia Roma, Postcoma Unit, Rome, Italy; [Formisano, Rita] IRCCS Fdn Santa Lucia Roma, Headache Ctr, Rome, Italy; [Gelfi, Cecilia] UNIMI, Dept Sci & Biomed Technol, Milan, Italy		Bagnato, S (corresponding author), Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Bagnato, Sergio/H-6842-2013; Lucca, Lucia Francesca/AAB-8558-2022; Pistarini, CATERINA/K-5234-2018; Gelfi, Cecilia/L-1490-2016	Bagnato, Sergio/0000-0002-6289-1887; Pistarini, CATERINA/0000-0001-8925-0484; Gelfi, Cecilia/0000-0002-2996-6912; Boccagni, Cristina/0000-0002-6317-015X; Minafra, Luigi/0000-0003-3112-4519; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711			Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Bates D, 2005, NEUROPSYCHOL REHABIL, V15, P175, DOI 10.1080/09602010443000399; Birkenhager TK, 2012, J PSYCHIATR RES, V46, P285, DOI 10.1016/j.jpsychires.2011.12.006; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Boccagni C, 2011, J CLIN NEUROPHYSIOL, V28, P489, DOI 10.1097/WNP.0b013e318231c8c8; Braakman R., 1998, ACTA NEUROCHIR, V95, P49; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fingelkurts A. A., CLIN NEUROPHYSIOLO S, V62; Fingelkurts AA, 2012, CONSCIOUS COGN, V21, P149, DOI 10.1016/j.concog.2011.10.004; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Hagen C., 1972, LEVELS COGNITIVE FUN; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nemoto K, 2006, NEUROSCI LETT, V397, P25, DOI 10.1016/j.neulet.2005.11.067; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Royal College of Physicians, 2003, PERM VEG STAT GUID D; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Tang S, 2010, BRAIN RES, V1354, P1, DOI 10.1016/j.brainres.2010.07.051; TSUKAHARA T, 1995, NEUROSURGERY, V37, P733, DOI 10.1227/00006123-199510000-00018; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang XY, 2012, PSYCHOPHARMACOLOGY, V222, P277, DOI 10.1007/s00213-012-2643-y	47	20	22	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	11					2050	2059		10.1089/neu.2011.2184			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	983CX	WOS:000307095800006	22708958	Green Submitted			2022-02-06	
J	Conneeley, AL				Conneeley, Anne Louise			Transitions and Brain Injury: A Qualitative Study Exploring the Journey of People with Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury; transitions; occupation; identity; rehabilitation; qualitative research	COMMUNITY INTEGRATION; SELF-AWARENESS; PERSPECTIVES; EXPERIENCE; OUTCOMES	This qualitative study aimed to explore transitions from hospital to the home over a period of one year. Methods and procedures: A longitudinal, phenomenological approach was employed and 18 individuals with severe traumatic brain injury, their family members and rehabilitation professionals were interviewed using semistructured interviews, when the person with brain injury was discharged from the ward, after 6 months and again after one year. Results: Themes identified within the data included returning home, getting back to normal, moving forward and the role of rehabilitation in the transitional period. Further subthemes were also identified including issues of life-course disruption, self-identity, status and reconstruction. Conclusions: Data suggested that access to rehabilitation programs employing individualised, contextual interventions following discharge to the home were integral in enabling the transition through to autonomy and independence. Consideration of issues of identity and status can enable a different and potentially important perspective on the experience of transitions for those with brain injury. Reclaiming personal autonomy and control appeared to be central to the reconstruction of a coherent sense of self, enabling a meaningful life after brain injury.	Coventry Univ, Fac Hlth & Life Sci, Coventry CV1 5FB, W Midlands, England		Conneeley, AL (corresponding author), Coventry Univ, Fac Hlth & Life Sci, Priory St, Coventry CV1 5FB, W Midlands, England.	l.conneeley@coventry.ac.uk					Agnihotri S, 2010, DEV NEUROREHABIL, V13, P369, DOI 10.3109/17518423.2010.499409; Arber A, 2006, J RES NURS, V11, P147, DOI 10.1177/1744987106056956; Arber S, 1999, GENDER INEQUALITIES IN HEALTH, P123; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Banja J., 1994, J HEAD TRAUMA REHAB, V9, P70; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CAPLAN AL, 1988, ARCH PHYS MED REHAB, V69, P312; Carpenter C, 2008, QUALITATIVE RES OCCU; Chew-Graham C.A., 2002, FAM PRACT, V19, P185; Conneeley A. L., 2004, BR J OCCUP THER, V67, P248, DOI DOI 10.1177/030802260406700603; Conneeley AL., 2002, BRIT J OCCUPATIONAL, V65, P185, DOI 10.1177/030802260206500406; Conneeley AL., 2003, BRIT J OCCUP THER, V66, P440; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Exley C, 2001, HEALTH, V5, P112, DOI 10.1177/136345930100500106; Finlay L., 2003, REFLEXIVITY; Fleming J., 2006, BRAIN IMPAIR, V7, P83, DOI [https://doi.org/10.1375/brim.7.2.83, DOI 10.1375/BRIM.7.2.83, 10.1375/brim.7.2.83]; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Giddens Anthony, 1991, MODERNITY SELF IDENT; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Hoogerdijk B, 2011, SCAND J OCCUP THER, V18, P122, DOI 10.3109/11038121003645985; Hwan K., 2010, AM J OCCUPATIONAL TH, V64, P709; JOHANSEN RK, 2002, LISTENING SILENCE SE; Kirsh B, 2009, WORK, V32, P391, DOI 10.3233/WOR-2009-0851; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lefebvre H., 2006, ILLNESS CRISIS LOSS, V14, P337, DOI DOI 10.1177/105413730601400403; Letherby G, 1999, WOMEN STUD INT FORUM, V22, P359, DOI 10.1016/S0277-5395(99)00028-X; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 2000, ARCH PHYS MED REHAB, V81, P817, DOI 10.1016/S0003-9993(00)90117-5; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Playford E.D., 2000, CLIN REHABIL, V4, P49; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Shaw LR, 1997, BRAIN INJURY, V11, P219; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; Taylor M. C., 2007, EVIDENCE BASED PRACT; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; World Health Organization, 2007, INT CLASS FUNCT DIS	47	20	20	1	23	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	JUL	2012	13	1			SI		72	84		10.1017/BrImp.2012.3			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	964VQ	WOS:000305725200007					2022-02-06	
J	Hofbauer, M; Jaindl, M; Hochtl, LL; Ostermann, RC; Kdolsky, R; Aldrian, S				Hofbauer, Marcus; Jaindl, Manuela; Hoechtl, Leonard Lee; Ostermann, Roman C.; Kdolsky, R.; Aldrian, Silke			Spine injuries in polytraumatized pediatric patients: Characteristics and experience from a Level I trauma center over two decades	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Spine injuries; polytrauma; pediatric; outcome	CERVICAL-SPINE; BLUNT TRAUMA; CHILDREN; SEVERITY	BACKGROUND: Spine injuries, a common component in polytrauma, are relatively rare in pediatric patients. Previous studies mainly described injuries to the cervical region, whereas information of injury patterns to the thoracic and lumbosacral region lack in the current literature. The aim of this study was to determine the incidence and characteristics of polytraumatized children and associated spine injuries in different pediatric development ages. METHODS: A cohort review of all pediatric patients with the diagnosis of polytrauma and associated spine injury, admitted to a urban Level I trauma center, was conducted over an 18-year period from January 1992 to December 2010. Patients were stratified into four developmental age groups: infants/toddlers (age 0-4 years), preschool/young children (age 5-9 years), preadolescents (age 10-14 years), and adolescents (age 15-17 years). Demographics, clinical injury data, patterns of spine injuries, associated injuries, treatment, and outcome were abstracted and analyzed. RESULTS: From a database of 897 severely (Injury Severity Score >= 16) injured pediatric patients, 28 children met the inclusion criteria. The mean age was 12.7 years (range, 1.3-16.7 years), and there were 18 males and 10 females. Younger children (age 0-9 years) sustained more injuries to the upper spine region, whereas injuries to the lumbar region were only seen in adolescents. Nine (32%) patients received surgical treatment for spine fracture or subluxation, and 15 (54%) were treated by nonoperative means. Four patients (14%) received only palliative treatment due to medical futility. Overall, the most commonly associated injury was thoracic injury (89%) followed by traumatic brain injury (64%). CONCLUSION: The age-related anatomy and physiology predispose younger children to upper spine injuries in contrast to lower spine injuries seen in adolescents. Predictors of mortality include pathologic pupillary light reflex, high Injury Severity Score and Abbreviated Injury Scale score, and a low Glasgow Coma Scale score at admission. Thoracic injuries were the most common associated injuries followed by traumatic brain injury. (J Trauma Acute Care Surg. 2012; 73: 156-161. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Hofbauer, Marcus; Jaindl, Manuela; Hoechtl, Leonard Lee; Ostermann, Roman C.; Kdolsky, R.; Aldrian, Silke] Med Univ Vienna, Dept Trauma Surg, A-1090 Vienna, Austria		Hofbauer, M (corresponding author), Med Univ Vienna, Dept Trauma Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	marcus.hofbauer@medunwien.ac.at					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bederman SS, 2011, J TRAUMA, V71, pE71, DOI 10.1097/TA.0b013e3182092eac; Bliss D, 2002, CRIT CARE MED, V30, pS409, DOI 10.1097/00003246-200211001-00005; Broder J, 2007, EMERG RADIOL, V14, P227, DOI 10.1007/s10140-007-0618-9; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Frankel H L, 1969, Paraplegia, V7, P179; Garcia RA, 2002, AM J PHYS MED REHAB, V81, P458, DOI 10.1097/00002060-200206000-00011; Halpern CH, 2010, SPINE, V35, P1721, DOI 10.1097/BRS.0b013e3181e9acb2; Hebert JS, 2000, SPINE, V25, P55, DOI 10.1097/00007632-200001010-00011; Houshian S, 2002, J TRAUMA, V52, P715, DOI 10.1097/00005373-200204000-00018; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Leonard JC, 2011, ANN EMERG MED, V58, P145, DOI 10.1016/j.annemergmed.2010.08.038; MACKENZIE EJ, 1988, JAMA-J AM MED ASSOC, V260, P3290, DOI 10.1001/jama.260.22.3290; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Mahan ST, 2009, J TRAUMA, V67, P537, DOI 10.1097/TA.0b013e3181ad8fc9; Markel TA, 2009, J TRAUMA, V67, P23, DOI 10.1097/TA.0b013e318184ba9a; Mohseni S, 2011, J PEDIATR SURG, V46, P1771, DOI 10.1016/j.jpedsurg.2011.03.007; Mortazavi M, 2011, CHILD NERV SYST, V27, P705, DOI 10.1007/s00381-010-1342-4; Mueller DL, 2011, J TRAUMA, V70, P724, DOI 10.1097/TA.0b013e3182092ff8; NAKAYAMA DK, 1989, ANN SURG, V210, P770, DOI 10.1097/00000658-198912000-00013; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Reamy Rebecca R, 2004, J S C Med Assoc, V100, P317; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; SCHWEIBERER L, 1987, UNFALLCHIRURG, V90, P529; Vogel LC, 2011, J SPINAL CORD MED, V34, P60, DOI 10.1179/107902610X12883422813787	27	20	20	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2012	73	1					156	161		10.1097/TA.0b013e31824e32b5			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	979JU	WOS:000306814100023	22743385				2022-02-06	
J	Pearson, WS; Ovalle, F; Faul, M; Sasser, SM				Pearson, William S.; Ovalle, Fernando, Jr.; Faul, Mark; Sasser, Scott M.			A REVIEW OF TRAUMATIC BRAIN INJURY TRAUMA CENTER VISITS MEETING PHYSIOLOGIC CRITERIA FROM THE AMERICAN COLLEGE OF SURGEONS COMMITTEE ON TRAUMA/CENTERS FOR DISEASE CONTROL AND PREVENTION FIELD TRIAGE GUIDELINES	PREHOSPITAL EMERGENCY CARE			English	Article						traumatic brain injury; trauma centers; triage; criteria	PREHOSPITAL MANAGEMENT; TEAM ACTIVATION; UNITED-STATES; VALIDATION	Background. Traumatic brain injury (TBI) represents a serious subset of injuries among persons in the United States, and prehospital care of these injuries can mitigate both the morbidity and the mortality in patients who suffer from these injuries. Guidelines for triage of injured patients have been set forth by the American College of Surgeons Committee on Trauma (ACS-COT) in cooperation with the Centers for Disease Control and Prevention (CDC). These guidelines include physiologic criteria, such as the Glasgow Coma Scale (GCS) score, systolic blood pressure, and respiratory rate, which should be used in determining triage of an injured patient. Objectives. This study examined the numbers of visits at level I and II trauma centers by patients with a diagnosed TBI to determine the prevalence of those meeting physiologic criteria from the ACS-COT/CDC guidelines and to determine the extent of mortality among this patient population. Methods. The data for this study were taken from the 2007 National Trauma Data Bank (NTDB) National Sample Program (NSP). This data set is a nationally representative sample of visits to level I and II trauma centers across the United States and is funded by the American College of Surgeons. Estimates of demographic characteristics, physiologic measures, and death were made for this study population using both chi-square analyses and adjusted logistic regression modeling. Results. The analyses demonstrated that although many people who sustain a TBI and were taken to a level I or II trauma center did not meet the physiologic criteria, those who did meet the physiologic criteria had significantly higher odds of death than those who did not meet the criteria. After controlling for age, gender, race, Injury Severity Score (ISS), and length of stay in the hospital, persons who had a GCS score <= 13 were 17 times more likely to die than TBI patients who had a higher GCS score (odds ratio [OR] 17.4; 95% confidence interval [CI] 10.7-28.3). Other physiologic criteria also demonstrated significant odds of death. Conclusions. These findings support the validity of the ACS-COT/CDC physiologic criteria in this population and stress the importance of prehospital triage of patients with TBI in the hopes of reducing both the morbidity and the mortality resulting from this injury.	[Pearson, William S.; Ovalle, Fernando, Jr.; Faul, Mark; Sasser, Scott M.] Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Ovalle, Fernando, Jr.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Sasser, Scott M.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA		Pearson, WS (corresponding author), Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop F-62, Atlanta, GA 30341 USA.	wpearson@cdc.gov		Faul, Mark/0000-0002-7683-0348	Intramural CDC HHS [CC999999] Funding Source: Medline		[Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brown JB, 2011, J TRAUMA, V70, P38, DOI 10.1097/TA.0b013e3182077ea8; CDC, 2010, MMWR-MORBID MORTAL W, V59, P303; Cook CH, 2001, ARCH SURG-CHICAGO, V136, P752, DOI 10.1001/archsurg.136.7.752; Coronado V., 2012, BRAIN INJURY MED; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; ESPOSITO TJ, 1995, ARCH SURG-CHICAGO, V130, P171; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Henry MC, 1996, AM J EMERG MED, V14, P124, DOI 10.1016/S0735-6757(96)90117-5; Henry MC, 1996, ACAD EMERG MED, V3, P992, DOI 10.1111/j.1553-2712.1996.tb03340.x; Lehmann RK, 2007, AM J SURG, V193, P630, DOI 10.1016/j.amjsurg.2007.01.017; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mackersie RC, 2006, PREHOSP EMERG CARE, V10, P287, DOI 10.1080/10903120600721636; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; PHILLIPS JA, 1993, J TRAUMA, V34, P127, DOI 10.1097/00005373-199301000-00024; Purtill MA, 2008, J TRAUMA, V65, P1253, DOI 10.1097/TA.0b013e31818bbfc2; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Tinkoff GH, 2002, J TRAUMA, V52, P1153, DOI 10.1097/00005373-200206000-00022; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	24	20	20	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JUL-SEP	2012	16	3					323	328		10.3109/10903127.2012.682701			6	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	946QD	WOS:000304367100002	22548387	Green Accepted			2022-02-06	
J	Rodgers, KM; Bercum, FM; McCallum, DL; Rudy, JW; Frey, LC; Johnson, KW; Watkins, LR; Barth, DS				Rodgers, Krista M.; Bercum, Florencia M.; McCallum, Danielle L.; Rudy, Jerry W.; Frey, Lauren C.; Johnson, Kirk W.; Watkins, Linda R.; Barth, Daniel S.			Acute Neuroimmune Modulation Attenuates the Development of Anxiety-Like Freezing Behavior in an Animal Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						lateral fluid percussion injury; neuroinflammation; post-traumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; FLUID PERCUSSION INJURY; CHRONIC MILD STRESS; PREFRONTAL CORTEX; OXIDATIVE STRESS; NERVOUS-SYSTEM; NITRIC-OXIDE; CELL-DEATH; RAT-BRAIN	Chronic anxiety is a common and debilitating result of traumatic brain injury (TBI) in humans. While little is known about the neural mechanisms of this disorder, inflammation resulting from activation of the brain's immune response to insult has been implicated in both human post-traumatic anxiety and in recently developed animal models. In this study, we used a lateral fluid percussion injury (LFPI) model of TBI in the rat and examined freezing behavior as a measure of post-traumatic anxiety. We found that LFPI produced anxiety-like freezing behavior accompanied by increased reactive gliosis (reflecting neuroimmune inflammatory responses) in key brain structures associated with anxiety: the amygdala, insula, and hippocampus. Acute peri-injury administration of ibudilast (MN166), a glial cell activation inhibitor, suppressed both reactive gliosis and freezing behavior, and continued neuroprotective effects were apparent several months post-injury. These results support the conclusion that inflammation produced by neuroimmune responses to TBI play a role in post-traumatic anxiety, and that acute suppression of injury-induced glial cell activation may have promise for the prevention of post-traumatic anxiety in humans.	[Rodgers, Krista M.; Bercum, Florencia M.; McCallum, Danielle L.; Rudy, Jerry W.; Watkins, Linda R.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Frey, Lauren C.] Univ Colorado, Dept Neurol, Denver, CO 80202 USA; [Frey, Lauren C.] Colorado Injury Control Res Ctr, Denver, CO USA; [Johnson, Kirk W.] MediciNova Inc, San Diego, CA USA		Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, UCB 345, Boulder, CO 80309 USA.	dbarth@psych.colorado.edu	Rodgers, Krista/AAC-5063-2020	RODGERS, KRISTA/0000-0003-4393-6389	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040]; Craig Hospital Gift Fund; University of Colorado Innovative Seed Grant; Autism Speaks Pilot Study grant [7153]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS36981, DA024044, DA01767]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K05DA024044] Funding Source: NIH RePORTER	This work was supported by U.S. Army Medical Research and Material Command grant PR100040, the Craig Hospital Gift Fund, a University of Colorado Innovative Seed Grant, Autism Speaks Pilot Study grant 7153, National Institutes of Health grant NS36981 to D.S.B., and National Institutes of Health grants DA024044, DA01767 to L.R.W.	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; Dellu F, 1996, PSYCHONEUROENDOCRINO, V21, P441, DOI 10.1016/0306-4530(96)00017-0; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; GEHRMANN J, 1991, ACTA NEUROPATHOL, V82, P442, DOI 10.1007/BF00293378; Gibson LCD, 2006, EUR J PHARMACOL, V538, P39, DOI 10.1016/j.ejphar.2006.02.053; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAEBER MB, 1988, J NEUROCYTOL, V17, P209, DOI 10.1007/BF01674208; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Ikeda K, 2003, J NEUROSCI, V23, P4667; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kung JC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-29; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Lee J.Y., 2011, BRAIN RES; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liberatore GT, 1999, NAT MED, V5, P1403; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Loram LC, 2009, J NEUROSCI, V29, P14015, DOI 10.1523/JNEUROSCI.3447-09.2009; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; McCann MJ, 1996, NEUROSCIENCE, V72, P273, DOI 10.1016/0306-4522(95)00526-9; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; MORRISSEY TK, 1989, BEHAV BRAIN RES, V35, P195, DOI 10.1016/S0166-4328(89)80141-X; NITZ AJ, 1986, EXP NEUROL, V94, P264, DOI 10.1016/0014-4886(86)90101-9; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; PELLIS SM, 1991, BEHAV BRAIN RES, V46, P151, DOI 10.1016/S0166-4328(05)80108-1; PELLIS SM, 1991, BEHAV BRAIN RES, V45, P185, DOI 10.1016/S0166-4328(05)80084-1; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SANBERG PR, 1988, BEHAV NEUROSCI, V102, P748, DOI 10.1037/0735-7044.102.5.748; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; SCHALLERT T, 1979, EXP NEUROL, V64, P33, DOI 10.1016/0014-4886(79)90003-7; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Sternberg EM, 1997, J CLIN INVEST, V100, P2641, DOI 10.1172/JCI119807; Sullivan RM, 2004, STRESS, V7, P131, DOI 10.1080/102538900410001679310; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Tucker P, 2004, BIOL PSYCHIAT, V56, P121, DOI 10.1016/j.biopsych.2004.03.009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wang FZ, 2011, ANESTHESIOLOGY, V114, P643, DOI 10.1097/ALN.0b013e31820a4bf3; Wheaton P., 2011, J PSYCHOPHARMACOL; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Yagi K, 2010, NEUROSURGERY, V66, P551, DOI 10.1227/01.NEU.0000365771.89576.77; Yan Fang, 2002, Zhonghua Yi Xue Za Zhi, V82, P1025; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131; Yanase H, 1996, CLIN EXP PHARMACOL P, V23, P317, DOI 10.1111/j.1440-1681.1996.tb02830.x; Yoshioka M, 2002, PHARMACOL RES, V45, P305, DOI 10.1006/phrs.2002.0949; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang D, 2009, TOXICOL APPL PHARM, V238, P64, DOI 10.1016/j.taap.2009.04.015	123	20	20	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	10					1886	1897		10.1089/neu.2011.2273			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	971YV	WOS:000306244400393	22435644	Green Published			2022-02-06	
J	Wang, JW; Wang, HD; Zhong, WZ; Li, N; Cong, ZX				Wang, Jia-Wei; Wang, Han-Dong; Zhong, Wu-Zhao; Li, Ning; Cong, Zi-Xiang			Expression and cell distribution of metabotropic glutamate receptor 5 in the rat cortex following traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Metabotropic glutamate receptor 5; Rat cortex; Expression; Fluoro-Jade C	GROUP-I; ENDOGENOUS ACTIVATION; SYNAPTIC-TRANSMISSION; MESSENGER-RNAS; AMINO-ACIDS; MGLUR5; GENE; NMDA; LOCALIZATION; INVOLVEMENT	Traumatic brain injury (TBI)-released excessive glutamate resulted in the activation of glutamate receptors including the metabotropic glutamate receptor 5 (mGluR5). To investigate the expression and cell distribution of mGluR5 in the rat cortex following TBI, western blot and quantitative real-time PCR were used to study the protein and mRNA level of mGluR5 respectively while immunohistochemistry analysis and double immunofluorescence with neural cell marker were used to define the cell distribution of mGluR5. Furthermore, we examined the effects of post-TBI administration of (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG), a selective mGluR5 agonist, on the neuronal degeneration in the cortex. In the present study, we found that the protein level of mGluR5 was up-regulated by traumatic brain injury, while TBI-induced mGluR5 mRNA expression displayed biphasic changes with up-regulation in the early time and down-regulation in the late time after TBI. And neuron, astrocyte and microglia in the cortex after TBI all expressed mGluR5. Moreover, CHPG treatment significantly reduced the number of degenerating neurons detected by Fluoro-Jade C staining. These findings demonstrate that expression of mGluR5 differentially changes both spatially and temporally after TBI and may be related to the neuroprotection after TBI. Therefore, understanding the expression and cell distribution of mGluR5 after TBI may give insight into pathophysiology after TBI and provide a new target for the therapy of TBI. (c) 2012 Elsevier B.V. All rights reserved.	[Wang, Jia-Wei; Wang, Han-Dong; Cong, Zi-Xiang] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hdwang_nj@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070974]; Key Subject of Jiangsu Province [X4200722]	This work was supported by grants from National Natural Science Foundation of China (no. 81070974), and the Key Subject of Jiangsu Province (X4200722).	Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Aronica E, 2001, NEUROSCIENCE, V105, P509, DOI 10.1016/S0306-4522(01)00181-6; Backstrom P, 2007, PSYCHOPHARMACOLOGY, V192, P571, DOI 10.1007/s00213-007-0753-8; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Catania MV, 2001, J NEUROSCI, V21, P7664, DOI 10.1523/JNEUROSCI.21-19-07664.2001; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chu ZG, 2005, J NEUROSCI, V25, P5740, DOI 10.1523/JNEUROSCI.0913-05.2005; Ciccarelli R, 1997, GLIA, V21, P390, DOI 10.1002/(SICI)1098-1136(199712)21:4<390::AID-GLIA6>3.0.CO;2-7; Corti C, 2003, J BIOL CHEM, V278, P33105, DOI 10.1074/jbc.M212380200; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; Harney SC, 2006, J NEUROSCI, V26, P1128, DOI 10.1523/JNEUROSCI.2753-05.2006; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hubert GW, 2001, J NEUROSCI, V21, P1838, DOI 10.1523/JNEUROSCI.21-06-01838.2001; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Lea PM, 2002, PHARMACOL BIOCHEM BE, V73, P287, DOI 10.1016/S0091-3057(02)00825-0; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Mudo G, 2007, BRAIN RES, V1149, P1, DOI 10.1016/j.brainres.2007.02.041; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Simonyi A, 2010, EUR J PHARMACOL, V639, P17, DOI 10.1016/j.ejphar.2009.12.039; Spillson AB, 2003, EXP NEUROL, V184, pS97, DOI 10.1016/j.expneurol.2003.08.001; Szekeres PG, 1998, J NEUROCHEM, V70, P1694; Wang X, 2012, ADDICT BIOL; Xu X, 2012, NEUROSCIENCE, V202, P474, DOI 10.1016/j.neuroscience.2011.12.008; Yamaguchi S, 1998, J NEUROCHEM, V71, P60; Yanamala N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S16; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	43	20	22	0	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 29	2012	1464						73	81		10.1016/j.brainres.2012.05.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	976XI	WOS:000306620300009	22587887				2022-02-06	
J	Jiang, PF; Sun, Y; Zhu, T; Zhan, CY; Gu, WZ; Yuan, TM; Yu, HM				Jiang, Peifang; Sun, Yi; Zhu, Tao; Zhan, Canyang; Gu, Weizhong; Yuan, Tianming; Yu, Huimin			Endogenous neurogenesis in the hippocampus of developing rat after intrauterine infection	BRAIN RESEARCH			English	Article						Neurogenesis; Bromodeoxyuridine; Hippocampus; Intrauterine infection; PI3K/Akt	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; ADULT NEUROGENESIS; WHITE-MATTER; OLIGODENDROCYTE PROGENITORS; ENHANCES NEUROGENESIS; SUBVENTRICULAR ZONE; PERINATAL HYPOXIA; DENTATE GYRUS	Perinatal infection is a major cause of neonatal neurologic morbidity. The goal of this study is to examine the effects of intrauterine infection on hippocampal neurogenesis and self-repair during early developmental stages. The animals were randomly divided into two groups: E. coli infected group and control group. Neurogenesis was examined by incorporation of BrdU, a marker of proliferating cells and their progeny. Rats were sacrificed on P3, P7, P14 and P28, and their brains were prepared for histological analysis of cell proliferation. To evaluate hippocampus neurogenesis, rats were sacrificed on P7 and P28, and their brains were prepared for evaluation of newly generated neural stem cells using double labeling of BrdU and Nestin, newly formed neurons using double labeling of BrdU and NeuN, and newly formed astrocytes using double labeling of BrdU and GFAP. In intrauterine E. coli infected group, there was significant increase in numbers of BrdU-labeled cells (about 2-fold at P7) than that of the control group (P < 0.05). Confocal microscopy showed that there was a significant difference in BrdU/Nestin coexpression between the control and E. coli infected groups (P < 0.01). Evaluation of the phenotype of the surviving cells showed that E. coli infected and control groups had a similar proportion of neuronal and glial differentiation. No significant difference was found in the percentage of newborn cells expressing neuronal and glial phenotype in the control and E. coli infected groups (P > 0.05). Real-time RT-PCR and Western blot analysis showed that there was a significant increase of BDNF, TrkB, p-Akt and Survivin mRNA and protein expression during postnatal 7 days in the E. coli infected group (P < 0.05). Our results suggest that endogenous neurogenesis may occur in hippocampus in early postnatal period and may be enhanced by neonatal inflammation reactive syndrome. The PI3K/Akt signaling pathway may be involved in regulation of BDNF and is important in the potential activation of neuroprotective and repair pathways during critical time windows of hippocampal development. (C) 2012 Elsevier B.V. All rights reserved.	[Sun, Yi; Zhan, Canyang; Yuan, Tianming; Yu, Huimin] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Neonatol, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Peifang] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Tao] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Crit Care Med, Hangzhou 310016, Zhejiang, Peoples R China; [Gu, Weizhong] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China		Yu, HM (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, Dept Neonatol, Zhugan Xiang 57, Hangzhou 310003, Zhejiang, Peoples R China.	yuhuimin@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973222]; Health Bureau of Zhejiang Province [2010KYB064]; Key Science and Technology Innovation Team of Zhejiang Province [2010R50045]	The work of the authors is supported by Grants from National Natural Science Foundation of China (30973222), Health Bureau of Zhejiang Province (2010KYB064) and Key Science and Technology Innovation Team of Zhejiang Province for early screening and intervention of birth defects (2010R50045). We are also grateful to Kewen Jiang for advice during the first part of this study. We sincerely thank Guifeng Xiao for assistance with the confocal imaging. We also thank the members of the Central Laboratory for helpful discussions.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Bartley J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-15; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; Boehme F, 2011, EUR J NEUROSCI, V33, P1799, DOI 10.1111/j.1460-9568.2011.07676.x; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chavali PL, 2011, J BIOL CHEM, V286, P9393, DOI 10.1074/jbc.M110.167445; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fatemi SH, 1999, MOL PSYCHIATR, V4, P145, DOI 10.1038/sj.mp.4000520; Fatemi SH, 2002, MOL PSYCHIATR, V7, P633, DOI 10.1038/sj.mp.4001046; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gualco E, 2010, CELL DEATH DIFFER, V17, P439, DOI 10.1038/cdd.2009.146; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Joannides AJ, 2007, BRAIN, V130, P1263, DOI 10.1093/brain/awm070; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Parent JM, 2007, ANN NEUROL, V61, P185, DOI 10.1002/ana.21088; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Shen Y, 2009, NEUROPATHOLOGY, V29, P528, DOI 10.1111/j.1440-1789.2009.01005.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Song WY, 2010, J NEUROSCI, V30, P15608, DOI 10.1523/JNEUROSCI.2581-10.2010; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villapol S, 2008, NEUROSCIENCE, V153, P108, DOI 10.1016/j.neuroscience.2008.01.054; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Yuan TM, 2005, J PERINAT MED, V33, P415, DOI 10.1515/JPM.2005.074; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006	48	20	21	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 12	2012	1459						1	14		10.1016/j.brainres.2012.03.058			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	961XW	WOS:000305503800001	22569202				2022-02-06	
J	Arango-Lasprilla, JC; Ketchum, JM; Drew, A; Hammond, F; Powell, JM; Kreutzer, J; Lim, PC; Carr, C				Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Drew, Allison; Hammond, Flora; Powell, Janet M.; Kreutzer, Jeffrey; Lim, P. Chuwn; Carr, Caroline			Neurobehavioural symptoms 1 year after traumatic brain injury: A preliminary study of the relationship between race/ethnicity and symptoms	BRAIN INJURY			English	Article						Brain injuries; minority health; depression; memory; attention; communication; neurobehavioural manifestations	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; RACIAL/ETHNIC DIFFERENCES; FUNCTIONING INVENTORY; MINORITY STATUS; DEPRESSION; OUTCOMES; REHABILITATION; DISPARITIES; ADULTS; RATES	Objective: To investigate whether White, African American and Hispanic individuals with a traumatic brain injury (TBI) express differences in neurobehavioural symptoms at 1 year post-injury after adjusting for demographic and injury characteristics. Design: Retrospective study. Participants: One thousand, three hundred and thirty-nine individuals from the TBI Model Systems National Database with primarily moderate-to-severe TBI (978 White, 288 African American and 73 Hispanic) hospitalized between 1996 and 2001. Main outcome measures: Neurobehavioural Functioning Inventory (NFI) at 1 year post-injury. Results: There were significant differences in NFI scores among the races/ethnicities for the depression, somatic, memory/attention, communication and motor subscales, after adjusting for demographic and injury characteristics; there were not significant differences in the aggression sub-scale. Hispanics had higher levels of symptom reporting than African Americans and Whites, while differences between African Americans and Whites were not significant. Conclusions: Hispanics scored significantly higher than Whites and African Americans on the sub-scales of the NFI, indicating more problems in these areas. Future research should focus on identifying factors that may contribute to the difference between the groups and treatment interventions should be implemented accordingly.	[Arango-Lasprilla, Juan Carlos; Drew, Allison; Kreutzer, Jeffrey] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, Jessica M.; Carr, Caroline] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Ketchum, Jessica M.; Carr, Caroline] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Hammond, Flora] Indiana Univ Sch Med, Indianapolis, IN USA; [Hammond, Flora] Carolinas Rehabil, Charlotte, NC USA; [Powell, Janet M.] Univ Washington, Dept Rehabil Med, Div Occupat Therapy, Seattle, WA 98195 USA		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, VCU W Hosp, Dept Phys Med & Rehabil, 3rd Floor,Room 3-102,1200 E Broad St, Richmond, VA 23298 USA.	jcarangolasp@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A070036, H133A21943-16, H133A070032]	This research was supported by grants H133A070036, H133A21943-16 and H133A070032 from the National Institute on Disability and Rehabilitation Research, United States Department of Education.	Aguilar-Gaxiola SA, 2008, ISSUES CHILD FAM LIV, P3, DOI 10.1007/978-0-387-78512-7_1; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Dunlop DD, 2003, AM J PUBLIC HEALTH, V93, P1945, DOI 10.2105/AJPH.93.11.1945; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Gureje O, 1997, AM J PSYCHIAT, V154, P989; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Perez JE, 2008, ISSUES CHILD FAM LIV, P117, DOI 10.1007/978-0-387-78512-7_6; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4	25	20	20	0	14	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					814	824		10.3109/02699052.2012.655360			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500003	22583172				2022-02-06	
J	Finkel, AG; Yerry, J; Scher, A; Choi, YS				Finkel, Alan G.; Yerry, Juanita; Scher, Ann; Choi, Young S.			Headaches in Soldiers With Mild Traumatic Brain Injury: Findings and Phenomenologic Descriptions	HEADACHE			English	Article						headache diagnosis; post-traumatic headache; traumatic brain injury; blast; continuous headache; migraine	TEMPOROMANDIBULAR DISORDER; CUTANEOUS ALLODYNIA; CHRONIC PAIN; MIGRAINE; EPIDEMIOLOGY; FIBROMYALGIA; COMORBIDITY; MECHANISMS; ASSOCIATION; PREVALENCE	Objective.-The primary goal of this study was to use headache criteria-based classification for headache types described by service members. Background.-Headache is common in soldiers returning from the wars in Afghanistan and Iraq. To date, few papers have provided detailed descriptions of these headaches. Methods.-The first 25 patients seen by a certified headache specialist at the Traumatic Brain Injury Center at Womack Army Medical Center, Fort Bragg, NC, between August 2008 and December 2009 are reported. Results.-Service members described a total of 55 headaches. Most, but not all, headaches began within 1 week after injury. Migraine type was most common. Aura occurred in 5 soldiers. Continuous headaches were described in 88%. Uncommon headache types including cluster type were diagnosed. Additional symptoms and service outcomes are described. Conclusions.-We conclude that headaches occurring after various types of head injury, including explosions, can be assigned primary and secondary headache diagnoses using standard classifications not necessarily available to larger survey-based studies.	[Finkel, Alan G.] Carolina Headache Inst, Chapel Hill, NC 27516 USA; [Finkel, Alan G.; Yerry, Juanita; Choi, Young S.] Womack Army Med Ctr, Ft Bragg, NC USA; [Scher, Ann] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Finkel, Alan G.] Def & Vet Brain Injury Ctr, Rockville, MD USA		Finkel, AG (corresponding author), Carolina Headache Inst, 103 Market St, Chapel Hill, NC 27516 USA.	finkela@carolinaheadacheinstitute.com		Scher, Ann/0000-0003-4599-9834			Anderson GC, 2011, PAIN, V152, P765, DOI 10.1016/j.pain.2010.11.007; Ashkenazi A, 2007, CEPHALALGIA, V27, P325, DOI 10.1111/j.1468-2982.2007.01291.x; Ayesh EE, 2007, J DENT RES, V86, P1187, DOI 10.1177/154405910708601209; Bahra A, 2003, HEADACHE, V43, P179, DOI 10.1046/j.1526-4610.2003.03041.x; Baranauskas G, 1998, PROG NEUROBIOL, V54, P349, DOI 10.1016/S0301-0082(97)00067-1; Bevilaqua-Grossi D, 2010, CEPHALALGIA, V30, P425, DOI 10.1111/j.1468-2982.2009.01928.x; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Calhoun AH, 2010, HEADACHE, V50, P1273, DOI 10.1111/j.1526-4610.2009.01608.x; Centonze V, 2004, NEUROL SCI, V25, pS291, DOI 10.1007/s10072-004-0314-4; Crystal SC, 2010, CURR PAIN HEADACHE R, V14, P449, DOI 10.1007/s11916-010-0146-2; de Tommaso M, 2009, CEPHALALGIA, V29, P453, DOI 10.1111/j.1468-2982.2008.01754.x; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Geppetti P, 2010, INTERN EMERG MED, V5, pS7, DOI 10.1007/s11739-010-0461-y; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.x; Jonsson P, 2011, CEPHALALGIA, V31, P1015, DOI 10.1177/0333102411410082; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lidbeck Jan, 2002, Pain Res Manag, V7, P81; Lim PF, 2010, CLIN J PAIN, V26, P116, DOI 10.1097/AJP.0b013e3181c507ef; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Mathew NT, 2004, NEUROLOGY, V63, P848, DOI 10.1212/01.WNL.0000137107.27585.F7; National Center for Health Statistics, 2005, DAT FIL DOC NAT HLTH; Nilsson IM, 2006, J OROFAC PAIN, V20, P138; Plesh O, 2002, PAIN, V99, P515, DOI 10.1016/S0304-3959(02)00262-2; Plesh O, 2011, J OROFAC PAIN, V25, P25; Research Triangle Institute, 2004, SUDAAN MAN REL 9 0; Rhee Hyekyun, 2005, J Pediatr Nurs, V20, P153, DOI 10.1016/j.pedn.2005.01.003; Robbins MS, 2010, SEMIN NEUROL, V30, P107, DOI 10.1055/s-0030-1249220; Scher AI, 2005, CURR OPIN NEUROL, V18, P305, DOI 10.1097/01.wco.0000169750.52406.a2; Scher AI, 2008, HEADACHE, V48, P16, DOI 10.1111/j.1526-4610.2007.00970.x; Scher AI, 2006, HEADACHE, V46, P1416, DOI 10.1111/j.1526-4610.2006.00584.x; Schiffman EL, 2010, J OROFAC PAIN, V24, P7; Sessle Barry J., 2005, Reviews in Analgesia, V8, P85, DOI 10.3727/000000005783992881; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57, DOI 10.1177/10454411000110010401; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Stewart WF, 1996, NEUROLOGY, V47, P52, DOI 10.1212/WNL.47.1.52; Tietjen GE, 2009, HEADACHE, V49, P1333, DOI 10.1111/j.1526-4610.2009.01521.x; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; VONKORFF M, 1988, PAIN, V32, P173, DOI 10.1016/0304-3959(88)90066-8	40	20	20	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2012	52	6					957	965		10.1111/j.1526-4610.2012.02167.x			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	952OA	WOS:000304800600004	22568576				2022-02-06	
J	Griesbach, GS; Vincelli, J; Tio, DL; Hovda, DA				Griesbach, G. S.; Vincelli, J.; Tio, D. L.; Hovda, D. A.			EFFECTS OF ACUTE RESTRAINT-INDUCED STRESS ON GLUCOCORTICOID RECEPTORS AND BRAIN-DERIVED NEUROTROPHIC FACTOR AFTER MILD TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						traumatic brain injury; stress; brain-derived neurotrophic factor; glucocorticoid receptor	PITUITARY-ADRENAL AXIS; PRIMED BURST POTENTIATION; MESSENGER-RNA EXPRESSION; LATERAL FLUID PERCUSSION; RAT HIPPOCAMPUS; GENE-EXPRESSION; DENTATE GYRUS; ADRENOCORTICAL AXIS; CORTICOSTERONE; BDNF	We have previously reported that experimental mild traumatic brain injury results in increased sensitivity to stressful events during the first post-injury weeks, as determined by analyzing the hypothalamic-pituitary-adrenal (HPA) axis regulation following restraint-induced stress. This is the same time period when rehabilitative exercise has proven to be ineffective after a mild fluid-percussion injury (FPI). Here we evaluated effects of stress on neuroplasticity. Adult male rats underwent either an FPI or sham injury. Additional rats were only exposed to anesthesia. Rats were exposed to 30 min of restraint stress, followed by tail vein blood collection at post-injury days (PID) 1, 7, and 14. The response to dexamethasone (DEX) was also evaluated. Hippocampal tissue was collected 120 min after stress onset. Brain-derived neurotrophic factor (BDNF) along with glucocorticoid (GR) and mineralocorticoid (MR) receptors was determined by Western blot analysis. Results indicated injury-dependent changes in glucocorticoid and mineralocorticoid receptors that were influenced by the presence of dexamethasone. Control and FPI rats responded differentially to DEX in that GR increases after receiving the lower dose of DEX were longer lasting in the FPI group. A suppression of MR was found at PID 1 in vehicle-treated FPI and Sham groups. Decreases in the precursor form of BDNF were observed in different FPI groups at PIDs 7 and 14. These findings suggest that the increased sensitivity to stressful events during the first post-injury weeks, after a mild FPI, has an impact on hippocampal neuroplasticity. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Griesbach, G. S.; Vincelli, J.; Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Tio, D. L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Hovda, D. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacolp, Los Angeles, CA 90095 USA		Griesbach, GS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.	ggriesbach@mednet.ucla.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS6190]; UCLA Brain Injury Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061960] Funding Source: NIH RePORTER	This study was supported by NINDS award NS6190 (G.S.G.) and the UCLA Brain Injury Research Center. We thank David Garfinkel for his excellent technical help.	Ashman TA, 2006, MT SINAI J MED, V73, P999; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; DALLMAN MF, 1987, ANN NY ACAD SCI, V512, P402, DOI 10.1111/j.1749-6632.1987.tb24976.x; de Kloet ER, 2000, EUR J PHARMACOL, V405, P187, DOI 10.1016/S0014-2999(00)00552-5; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; DeKeyser FG, 2000, NEUROIMMUNOMODULAT, V7, P182, DOI 10.1159/000026437; DIAMOND DM, 1994, BEHAV BRAIN RES, V62, P1, DOI 10.1016/0166-4328(94)90032-9; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Fujikawa T, 2000, BRAIN RES, V874, P186, DOI 10.1016/S0006-8993(00)02576-2; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han JS, 2002, EUR J NEUROSCI, V16, P1399, DOI 10.1046/j.1460-9568.2002.02191.x; Hansson AC, 2000, EUR J NEUROSCI, V12, P2918, DOI 10.1046/j.1460-9568.2000.00185.x; Hansson AC, 2006, J NEUROENDOCRINOL, V18, P104, DOI 10.1111/j.1365-2826.2005.01390.x; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; Herman JP, 1998, J NEUROSCI, V18, P7462; Hirasawa K, 2000, J NEUROSURG, V93, P581, DOI 10.3171/jns.2000.93.4.0581; Houshyar H, 2001, J NEUROENDOCRINOL, V13, P875, DOI 10.1046/j.1365-2826.2001.00714.x; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Jeanneteau FD, 2012, P NATL ACAD SCI USA, V109, P1305, DOI 10.1073/pnas.1114122109; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; JOELS M, 1994, PROG NEUROBIOL, V43, P1, DOI 10.1016/0301-0082(94)90014-0; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Meyer A, 1996, BRAIN RES, V732, P121, DOI 10.1016/0006-8993(96)00502-1; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Neigh GN, 2009, J CEREBR BLOOD F MET, V29, P1673, DOI 10.1038/jcbfm.2009.85; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Paskitti ME, 2000, MOL BRAIN RES, V80, P142, DOI 10.1016/S0169-328X(00)00121-2; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SAPOLSKY RM, 1984, ENDOCRINOLOGY, V114, P287, DOI 10.1210/endo-114-1-287; Sapolsky RM, 1999, EXP GERONTOL, V34, P721, DOI 10.1016/S0531-5565(99)00047-9; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.3.CO;2-F; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; SHENKIN HA, 1971, J NEUROSURG, V34, P657, DOI 10.3171/jns.1971.34.5.0657; Spyrka J, 2010, BRAIN RES, V1320, P28, DOI 10.1016/j.brainres.2010.01.031; STEINBOK P, 1979, NEUROSURGERY, V5, P559, DOI 10.1227/00006123-197911000-00003; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204	70	20	21	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 17	2012	210						393	402		10.1016/j.neuroscience.2012.03.005			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	951ON	WOS:000304730000037	22445725	Green Accepted			2022-02-06	
J	Chen, YH; Keller, JJ; Kang, JH; Lin, HC				Chen, Yi-Hua; Keller, Joseph J.; Kang, Jiunn-Horng; Lin, Herng-Ching			Association between Traumatic Brain Injury and the Subsequent Risk of Brain Cancer	JOURNAL OF NEUROTRAUMA			English	Article						epidemiology; malignant brain tumors; TBI	OF-THE-LITERATURE; HEAD TRAUMA; POSTTRAUMATIC GLIOMA; TUMORS; ADULTS; EPIDEMIOLOGY; POPULATION; CHINA	This population-based study in Taiwan aimed to investigate the risk of having a diagnosis of malignant brain tumors within 3 years after a traumatic brain injury (TBI). This study used data from the Traumatic Brain Injury Registry and the National Health Insurance Research Database. The study cohort comprised 5007 patients who had visited ambulatory care centers or had been hospitalized with a diagnosis of TBI between 2001 and 2002. The comparison cohort was 25,035 randomly selected enrollees. Each patient's brain cancer status was individually tracked for a 3-year period following their index date. Stratified Cox proportional hazards regressions were performed for analyses. During the 3 years of follow-up, nine patients in each cohort, both the TBI and the non-TBI cohort, were diagnosed with brain cancer. As compared to those patients without TBI, patients with TBI were more likely to receive a diagnosis of malignant brain tumors within the 3-year period following their index date: the incidence rate of malignant brain tumors was 6.28 (95% CI: 3.06-11.53) per 10,000 person-years in patients with TBI and 1.25 (95% CI: 0.61-2.29) per 10,000 person-years in patients without TBI. After adjusting for sociodemographic characteristics, the hazard of being diagnosed with malignant brain tumors during the 3-year follow-up period was 4.67 (95% CI: 1.84-11.83) times greater for those who sustained a TBI than for patients in the comparison cohort. In addition, we found an association between TBI severity and malignant brain tumor among patients with TBI (p = 0.033). Our findings suggest a positive correlation between TBI and the relatively short-term development of malignant neoplasms of the brain.	[Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Keller, Joseph J.] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei 110, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Dept Phys Med & Rehabil, Taipei 110, Taiwan		Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Coll Publ Hlth & Nutr, 250 Wu Hsing St, Taipei 110, Taiwan.	henry11111@tmu.edu.tw					ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; Anselmi E, 2006, TUMORI J, V92, P175, DOI 10.1177/030089160609200215; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; BURCH JD, 1987, J NATL CANCER I, V78, P601; CARPENTER AV, 1987, AM J PUBLIC HEALTH, V77, P1180, DOI 10.2105/AJPH.77.9.1180; Davis Faith S, 2007, Expert Rev Anticancer Ther, V7, pS3, DOI 10.1586/14737140.7.12s.S3; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; Hu JF, 1998, CANCER DETECT PREV, V22, P100, DOI 10.1046/j.1525-1500.1998.CDOA22.x; Hwang Shiuh-Lin, 1992, Kaohsiung Journal of Medical Sciences, V8, P656; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; KEPES JJ, 1984, SURG NEUROL, V22, P149, DOI 10.1016/0090-3019(84)90043-0; LAWS ER, 1993, CA-CANCER J CLIN, V43, P263, DOI 10.3322/canjclin.43.5.263; Magnavita N, 2003, NEUROL SCI, V24, P31, DOI 10.1007/s100720300018; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; SCHLEHOFER B, 1992, CANCER, V69, P2541, DOI 10.1002/1097-0142(19920515)69:10<2541::AID-CNCR2820691025>3.0.CO;2-H; Wrensch M, 2000, NEUROEPIDEMIOLOGY, V19, P234, DOI 10.1159/000026261; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; ZAMPIERI P, 1994, J NEURO-ONCOL, V19, P61, DOI 10.1007/BF01051049; Zhou B, 2010, INT J MED SCI, V7, P248; Zulch KJ, 1965, BRAIN TUMORS THEIR B	26	20	21	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1328	1333		10.1089/neu.2011.2235			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600006	22320191				2022-02-06	
J	Fleming, JC; Bailey, CS; Hundt, H; Gurr, KR; Bailey, SI; Cepinskas, G; Lawendy, AR; Badhwar, A				Fleming, Jennifer C.; Bailey, Christopher S.; Hundt, Hans; Gurr, Kevin R.; Bailey, Stewart I.; Cepinskas, Gediminas; Lawendy, Abdel-Rahman; Badhwar, Amit			Remote inflammatory response in liver is dependent on the segmental level of spinal cord injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Meeting of the Society-for-Neuroscience	OCT, 2009	Chicago, IL	Soc Neurosci		Leukocyte; liver; spinal cord injury; inflammation; intravital microscopy	SYMPATHETIC-NERVOUS-SYSTEM; TRAUMA PATIENTS; LEUKOCYTE MOBILIZATION; ISOFLURANE ANESTHESIA; COMPRESSION INJURY; INTEGRIN BLOCKADE; IMMUNE-SYSTEM; BRAIN; NEUTROPHILS; COMPLICATIONS	BACKGROUND: Traumatic spinal cord injury (SCI) triggers a systemic inflammatory response (SIR) that contributes to a high incidence of secondary organ complications, particularly after a cervical or high-level thoracic injury. Because liver plays a key role in initiating and propagating the SIR, the aim of this study was to assess the effects that SCI at differing segmental levels has on the intensity of the inflammatory response in the liver. METHODS: Using male Wistar rats, clip compression SCI was performed at the 4th thoracic (T4 SCI; high-level SCI) or the 12th thoracic (T12 SCI; low-level SCI) spinal cord segment. Sham-injured rats had a partial laminectomy, but no SCI. Leukocyte recruitment to the liver, hepatic blood flow, and hepatocellular injury/death were assessed using intravital microscopy and histology. Chemokine and cytokine concentrations were assessed in the liver. Outcomes were measured at 1.5 hours, 12 hours, and 24 hours after SCI. RESULTS: At 12 hours after injury, T4 SCI caused a threefold increase in hepatic leukocyte recruitment compared with T12 SCI (p < 0.05). T4 SCI induced 50% more hepatocyte injury than T12 SCI at 12 hours (p < 0.05). Hepatic blood flow decreased after SCI, but not after sham injury, and stayed decreased only after T4 SCI at 24 hours after injury. The T4 SCI-induced changes were accompanied by increases in the hepatic concentrations of interleukin-1 beta, leptin, interleukin 10, and cytokine-induced neutrophil chemoattractant-1 at 1.5 hours. CONCLUSIONS: Our findings indicate that traumatic SCI triggers an acute SIR that contributes to hepatocellular injury. SCI-induced remote injury/dysfunction to the liver appears to be transient and is more robust after an upper thoracic SCI compared with a lower thoracic SCI. (J Trauma. 2012; 72: 1194-1202. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Fleming, Jennifer C.; Bailey, Christopher S.; Hundt, Hans; Gurr, Kevin R.; Bailey, Stewart I.; Lawendy, Abdel-Rahman] Univ Western Ontario, Div Orthopaed, Dept Surg, London, ON N6A 4G5, Canada; [Fleming, Jennifer C.; Bailey, Christopher S.; Cepinskas, Gediminas; Lawendy, Abdel-Rahman; Badhwar, Amit] Victoria Hosp, Lawson Hlth Res Inst, Ctr Crit Care Illness Res, Victoria Res Labs,London Hlth Sci Ctr, London, ON N6A 4G5, Canada		Fleming, JC (corresponding author), Univ Western Ontario, Div Orthopaed, Dept Surg, Victoria Hosp,London Hlth Sci Ctr, E4-126A,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	Jennifer.Fleming@lhsc.on.ca	Bailey, Chris S/L-7522-2015; Cepinskas, Gediminas/V-3810-2019; Urquhart, Jennifer/Q-7604-2016	Bailey, Chris S/0000-0001-5508-8415; Urquhart, Jennifer/0000-0002-9393-814X; Cepinskas, Gediminas/0000-0002-0267-6659			Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Bedirli N, 2008, ANESTH ANALG, V106, P830, DOI 10.1213/ane.0b013e3181616fc9; Bloom K K, 1989, J Am Paraplegia Soc, V12, P11; Brock RW, 2001, AM J PHYSIOL-GASTR L, V280, pG279, DOI 10.1152/ajpgi.2001.280.2.G279; Campagnolo DI, 2008, SPINAL CORD, V46, P477, DOI 10.1038/sc.2008.4; CAMPAGNOLO DI, 1994, AM J PHYS MED REHAB, V73, P387, DOI 10.1097/00002060-199411000-00003; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Deitch EA, 1999, J TRAUMA, V46, P781; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; FLETCHER DJ, 1995, SPINE, V20, P1136, DOI 10.1097/00007632-199505150-00005; Furlan JC, 2006, SPINE, V31, P2674, DOI 10.1097/01.brs.0000244569.91204.01; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Hundt H, 2011, INJURY, V42, P691, DOI 10.1016/j.injury.2010.12.013; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Mayorov DN, 2001, J NEUROTRAUM, V18, P727, DOI 10.1089/089771501750357663; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McKinley W, 2007, J SPINAL CORD MED, V30, P215, DOI 10.1080/10790268.2007.11753929; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ogura H, 1999, J TRAUMA, V46, P774, DOI 10.1097/00005373-199905000-00004; Pfeifer R, 2011, J ORTHOP RES, V29, P270, DOI 10.1002/jor.21214; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Stein DM, 2010, NEUROCRIT CARE, V13, P29, DOI 10.1007/s12028-010-9359-9; TANAKA H, 1991, ANN SURG, V214, P187, DOI 10.1097/00000658-199108000-00014; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; Tiegs G, 1999, J NEUROIMMUNOL, V96, P131, DOI 10.1016/S0165-5728(99)00014-4; Weaver LC, 2001, J NEUROTRAUM, V18, P1107, DOI 10.1089/08977150152693782; Wunder C, 2004, MICROVASC RES, V68, P20, DOI 10.1016/j.mvr.2004.03.003; YANO H, 1994, CAN J ANAESTH, V41, P149, DOI 10.1007/BF03009810; Zimmer MB, 2007, J SPINAL CORD MED, V30, P319, DOI 10.1080/10790268.2007.11753947	41	20	21	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1194	1201		10.1097/TA.0b013e31824d68bd			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	944JD	WOS:000304195100017	22673245				2022-02-06	
J	Mustard, CA; Chambers, A; McLeod, C; Bielecky, A; Smith, PM				Mustard, Cameron A.; Chambers, Andrea; McLeod, Christopher; Bielecky, Amber; Smith, Peter M.			Comparison of data sources for the surveillance of work injury	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							CUMULATIVE TRAUMA DISORDERS; UPPER EXTREMITIES; WASHINGTON-STATE; JOB TENURE; COMPENSATION; WORKPLACE; ILLNESS; CLAIMS; MULTIVARIATE; POPULATION	Objective The objective of this study was to compare the incidence of work-related injury and illness presenting to Ontario emergency departments to the incidence of worker's compensation claims reported to the Ontario Workplace Safety & Insurance Board over the period 2004-2008. Methods Records of work-related injury were obtained from two administrative data sources in Ontario for the period 2004-2008: workers' compensation lost-time claims (N = 435 336) and records of non-scheduled emergency department visits where the main problem was attributed to a work-related exposure (N 707 963). Denominator information required to compute the risk of work injury per 2 000 000 work hours, stratified by age and gender was estimated from labour force surveys conducted by Statistics Canada. Results The frequency of emergency department visits for all work-related conditions was approximately 60% greater than the incidence of accepted lost-time compensation claims. When restricted to injuries resulting in fracture or concussion, gender-specific age differences in injury incidence were similar in the two data sources. Between 2004 and 2008, there was a 14.5% reduction in emergency department visits attributed to work-related causes and a 17.8% reduction in lost-time compensation claims. There was evidence that younger workers were more likely than older workers to seek treatment in an emergency department for work-related injury. Conclusions In this setting, emergency department records available for the complete population of Ontario residents are a valid source of surveillance information on the incidence of work-related disorders. Occupational health and safety authorities should give priority to incorporating emergency department records in the routine surveillance of the health of workers.	[Mustard, Cameron A.; Chambers, Andrea; Bielecky, Amber; Smith, Peter M.] Inst Work & Hlth, Toronto, ON M5G 2E9, Canada; [Mustard, Cameron A.; Smith, Peter M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McLeod, Christopher] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada		Mustard, CA (corresponding author), Inst Work & Hlth, 481 Univ Ave,Suite 800, Toronto, ON M5G 2E9, Canada.	cmustard@iwh.on.ca	McLeod, Christopher B/D-7767-2012; Smith, Peter/AAE-4293-2021	Smith, Peter/0000-0001-8286-4563; McLeod, Christopher/0000-0001-9268-3694			[Anonymous], 1999, MMWR, V48, P241; Biddle J, 2001, EVIDENCE LEVEL DETER; Boden L, 2010, WORKERS COMPENSATION; Boden LI, 2008, ANN EPIDEMIOL, V18, P500, DOI 10.1016/j.annepidem.2007.11.003; Breslin FC, 2008, ACCIDENT ANAL PREV, V40, P368, DOI 10.1016/j.aap.2007.07.007; Breslin FC, 2006, OCCUP ENVIRON MED, V63, P27, DOI 10.1136/oem.2005.021006; Breslin FC, 2005, AM J IND MED, V48, P50, DOI 10.1002/ajim.20185; Canadian Institute for Health Information, 2008, NAT AMB CAR REP SYST; Canadian Institute for Health Information, 2001, CAN ENH ICD 10; Canadian Standards Association, 1996, Z 795 96 COD WORK IN; EISENBERG WM, 1988, MON LABOR REV, V111, P58; FINE LJ, 1986, J OCCUP ENVIRON MED, V28, P674, DOI 10.1097/00043764-198608000-00027; Fortuna RJ, 2010, J GEN INTERN MED, V25, P663, DOI 10.1007/s11606-010-1313-1; FRANKLIN GM, 1991, AM J PUBLIC HEALTH, V81, P741, DOI 10.2105/AJPH.81.6.741; Hanrahan LP, 1987, COMPARISON BLS ANN S, P155; Lakdawalla DN, 2007, ECON INQ, V45, P286, DOI 10.1111/j.1465-7295.2006.00011.x; Lippel K, 2003, INT J HEALTH SERV, V33, P253, DOI 10.2190/JPQD-RT1G-QKTK-JF2R; MCCURDY SA, 1991, AM J PUBLIC HEALTH, V81, P85, DOI 10.2105/AJPH.81.1.85; Morse T F, 1998, Int J Occup Environ Health, V4, P209; Mustard C, 2003, AM J PUBLIC HEALTH, V93, P1283, DOI 10.2105/AJPH.93.8.1283; Rosenman KD, 2006, J OCCUP ENVIRON MED, V48, P357, DOI 10.1097/01.jom.0000205864.81970.63; SELIGMAN PJ, 1988, AM J PUBLIC HEALTH, V78, P1218, DOI 10.2105/AJPH.78.9.1218; Shannon HS, 2002, AM J IND MED, V42, P467, DOI 10.1002/ajim.10142; Silverstein B, 1998, AM J PUBLIC HEALTH, V88, P1827, DOI 10.2105/AJPH.88.12.1827; Smith GS, 2005, AM J PUBLIC HEALTH, V95, P1213, DOI 10.2105/AJPH.2004.049338; Smith P, 2011, CAN J PUBLIC HEALTH, V102, P127, DOI 10.1007/BF03404161; Smith Peter M, 2004, Chronic Dis Can, V25, P127; Smith PM, AM J IND MED, DOI [10.1002/ajim.21000, DOI 10.1002/AJIM.21000]; Teutsch S, 2000, PRINCIPLES PRACTICE; Utterback D.F., 2010, USE WORKERS COMPENSA; Zakaria D, 2003, AM J IND MED, V43, P507, DOI 10.1002/ajim.10217	31	20	20	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	MAY	2012	69	5					317	324		10.1136/oemed-2011-100222			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	926YO	WOS:000302869600003	22267447	Green Published, hybrid			2022-02-06	
J	Pignolo, L; Rogano, S; Quintieri, M; Leto, E; Dolce, G				Pignolo, Loris; Rogano, Stefania; Quintieri, Maria; Leto, Elio; Dolce, Giuliano			DECREASING INCIDENCE OF PAROXYSMAL SYMPATHETIC HYPERACTIVITY SYNDROME IN THE VEGETATIVE STATE	JOURNAL OF REHABILITATION MEDICINE			English	Article; Proceedings Paper	Workshop on Consciousness and the Vegetative State - Today/2nd Conference on Consciousness and Coma	JUL 06, 2010	Salerno, ITALY			paroxysmal sympathetic hyperactivity; dysautonomia; incidence; vegetative state; outcome	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; DYSAUTONOMIA; DAMAGE; COMA; MANAGEMENT; DISABILITY; DISORDERS	Objective: To update knowledge of the incidence of paroxysmal sympathetic hyperactivity (PSH, also referred to as dysautonomia), an emergency condition tentatively attributed to sympathetic paroxysms or diencephalic-hypothalamic disarrangement associated with severe diffuse brain axonal damage or hypoxia. This condition is reportedly common in the vegetative state, threatens survival and affects outcome. Methods: The results of a retrospective study on 333 subjects in a vegetative state admitted to a dedicated unit in 1998-2005 are compared with a survey on patients admitted to the same unit in 2006-2010. Results and comment: In the 1998-2005 period, the incidence of PSH was 32% and 16% in post-traumatic and non-traumatic patients, respectively. It decreased to 18% and 7% in the 2006-2010 period. The PSH duration and the time spent in emergency units before admission and in the dedicated unit for the vegetative state after admission also decreased significantly. Incidence was greater among post-traumatic patients; its effect on outcome does not appear to have changed.	[Pignolo, Loris] S Anna Inst, Crotone, Italy; [Pignolo, Loris] RAN, Crotone, Italy		Pignolo, L (corresponding author), S Anna Inst, Crotone, Italy.	l.pignolo@istitutosantanna.it					ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2005, BRAIN INJURY, V19, P545, DOI 10.1080/02699050400025075; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Baguley IJ, 1999, MAYO CLIN PROC, V74, P105, DOI 10.4065/74.1.105; Borer-Alafi N, 2002, BRAIN INJURY, V16, P593, DOI 10.1080/02699050110119484; Dolce G., 2002, POSTTRAUMATIC VEGETA; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hagen C., 1972, LEVELS COGNITIVE FUN; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kang YM, 2004, INT J NEUROSCI, V114, P299, DOI 10.1080/00207450490264115; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Luther MS, 2007, BRAIN INJURY, V21, P763, DOI 10.1080/02699050701481639; Metz SA, 1978, ANNS INT MED, V88, P89; O'Brien PB, 2006, CRIT CARE RESUSC, V8, P200; Ong J, 2005, CNS DRUG REV, V11, P317; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pignolo L, 2009, BRAIN INJURY, V23, P1, DOI 10.1080/02699050802595873; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TALMAN WT, 1988, ARCH NEUROL-CHICAGO, V45, P1037, DOI 10.1001/archneur.1988.00520330129022; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Young GB, 2004, J CLIN NEUROPHYSIOL, V21, P379; Zandbergen EGJ, 2001, INTENS CARE MED, V27, P1661, DOI 10.1007/s001340101076	36	20	21	0	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	MAY	2012	44	6			SI		502	504		10.2340/16501977-0981			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	956TW	WOS:000305113000005	22661000	Green Submitted, gold			2022-02-06	
J	Sinopoli, KJ; Dennis, M				Sinopoli, Katia J.; Dennis, Maureen			Inhibitory control after traumatic brain injury in children	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						TBI; Inhibitory control; Effortful inhibition; Effortless inhibition	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; DEFICIT HYPERACTIVITY DISORDER; EVENT-RELATED FMRI; GO/NOGO RESPONSE-INHIBITION; COLOR-OBJECT INTERFERENCE; STOP-SIGNAL PARADIGM; COGNITIVE CONTROL; EXECUTIVE FUNCTIONS; ANTERIOR CINGULATE	Inhibitory control describes a number of distinct processes. Effortless inhibition refers to acts of control that are automatic and reflexive. Effortful inhibition refers to voluntary, goal-directed acts of control such as response flexibility, interference control, cancellation inhibition, and restraint inhibition. Disruptions to a number of inhibitory control processes occur as a consequence of childhood traumatic brain injury (TBI). This paper reviews the current knowledge of inhibition deficits following childhood TB!, and includes an overview of the inhibition construct and a discussion of the specific deficits shown by children and adolescents with TBI and the factors that mediate the expression of these deficits, including injury-related variables and the expression of pre- and post-injury attention-deficit/hyperactivity disorder. The review illustrates that inhibitory control processes differ in terms of measurement, assessment, and neurological underpinnings, and also that childhood TBI may selectively disrupt particular forms of inhibition. (C) 2011 ISDN. Published by Elsevier Ltd. All rights reserved.	[Sinopoli, Katia J.; Dennis, Maureen] Univ Toronto, BrainFit Lab, Fac Med, Toronto, ON M5G 1V7, Canada; [Sinopoli, Katia J.] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON M5G 1V7, Canada		Sinopoli, KJ (corresponding author), Univ Toronto, BrainFit Lab, Fac Med, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	katia.sinopoli@sickkids.ca	Sinopoli, Katia/AAO-7803-2020		Ontario Neurotrauma Foundation [2007-ABI-PHD-565]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD04946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	Funding to Katia J. Sinopoli was provided by the Ontario Neurotrauma Foundation to (2007-ABI-PHD-565, The Regulation of Thoughts and Actions in Children Following Traumatic Brain Injury). This research was also supported by an NIH 1RO1 grant to Keith O. Yeates and Maureen Dennis (HD04946, Social Outcomes in Pediatric Traumatic Brain Injury).	Adams ZW, 2008, DEV DISABIL RES REV, V14, P268, DOI 10.1002/ddrr.37; Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bedard AC, 2003, J ABNORM CHILD PSYCH, V31, P315, DOI 10.1023/A:1023285614844; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bissett PG, 2011, J EXP PSYCHOL LEARN, V37, P392, DOI 10.1037/a0021800; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bujoreanu IS, 2008, DEV NEUROPSYCHOL, V33, P584, DOI 10.1080/87565640802254364; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Clohessy AB, 2001, ACTA PSYCHOL, V106, P51, DOI 10.1016/S0001-6918(00)00026-3; Crosbie J, 2008, NEUROSCI BIOBEHAV R, V32, P40, DOI 10.1016/j.neubiorev.2007.05.002; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Desman C, 2008, CHILD NEUROPSYCHOL, V14, P483, DOI 10.1080/09297040701625831; Diamond A, 2005, DEV PSYCHOPATHOL, V17, P807, DOI 10.1017/S0954579405050388; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Geier C, 2009, PHARMACOL BIOCHEM BE, V93, P212, DOI 10.1016/j.pbb.2009.01.021; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gordon M, 1983, GORDON DIAGNOSTIC SY; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Huang-Pollock CL, 2007, J CLIN CHILD ADOLESC, V36, P127, DOI 10.1080/15374410701274124; JOHNSON MH, 1995, DEV PSYCHOBIOL, V28, P281, DOI 10.1002/dev.420280504; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Kaufmann L, 2005, NEUROIMAGE, V25, P888, DOI 10.1016/j.neuroimage.2004.12.041; Kelly AMC, 2004, EUR J NEUROSCI, V19, P3105, DOI 10.1111/j.0953-816X.2004.03429.x; Klein C, 2001, PSYCHOPHYSIOLOGY, V38, P179; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; La Heij W, 2011, J EXP CHILD PSYCHOL, V108, P156, DOI 10.1016/j.jecp.2010.08.007; Larsson H, 2011, J CHILD PSYCHOL PSYC, V52, P954, DOI 10.1111/j.1469-7610.2011.02379.x; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, BRAIN INJURY, V12, P41; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mincic AM, 2010, ACTA NEUROBIOL EXP, V70, P406; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Padmala S, 2010, NEUROPSYCHOLOGIA, V48, P558, DOI 10.1016/j.neuropsychologia.2009.10.017; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Prevor MB, 2005, COGNITIVE DEV, V20, P256, DOI 10.1016/j.cogdev.2005.04.001; Rhodes SM, 2005, PSYCHOL MED, V35, P1109, DOI 10.1017/S0033291705004599; Ridderinkhof KR, 1997, J EXP CHILD PSYCHOL, V65, P315, DOI 10.1006/jecp.1997.2367; Rieger M, 2003, NEUROPSYCHOLOGY, V17, P272, DOI 10.1037/0894-4105.17.2.272; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rueda MR, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-39; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Schatz J, 2001, J INT NEUROPSYCH SOC, V7, P275, DOI 10.1017/S1355617701733012; Scheres A, 2001, CHILD NEUROPSYCHOL, V7, P172, DOI 10.1076/chin.7.3.172.8746; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Sinopoli KJ, 2011, DEV PSYCHOL, V47, P1479, DOI 10.1037/a0024440; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Somsen RJM, 2007, DEVELOPMENTAL SCI, V10, P664, DOI 10.1111/j.1467-7687.2007.00613.x; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Zelazo PD, 2006, NAT PROTOC, V1, P297, DOI 10.1038/nprot.2006.46; [No title captured]	103	20	20	2	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2012	30	3			SI		207	215		10.1016/j.ijdevneu.2011.08.006			9	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	936XH	WOS:000303622800006	22100363	Green Accepted			2022-02-06	
J	Yan, XX; Cai, Y; Zhang, XM; Luo, XG; Cai, HB; Rose, GM; Patrylo, PR				Yan, Xiao-Xin; Cai, Yan; Zhang, Xue-Mei; Luo, Xue-Gang; Cai, Huaibin; Rose, Gregory M.; Patrylo, Peter R.			BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice	EXPERIMENTAL NEUROLOGY			English	Article						Aberrant neuroplasticity; Temporal lobe epilepsy; Mossy fiber sprouting; Dystrophic neurites; Beta-secretase; Alzheimer's disease	AMYLOID PRECURSOR PROTEIN; TEMPORAL-LOBE EPILEPSY; GATED SODIUM-CHANNELS; ALZHEIMERS-DISEASE PATHOGENESIS; TRAUMATIC BRAIN-INJURY; PILOCARPINE MODEL; BETA-SECRETASE; SYNAPTIC PLASTICITY; MOSSY FIBER; NEURONAL-ACTIVITY	The brain is capable of remarkable synaptic reorganization following stress and injury, often using the same molecular machinery that governs neurodevelopment. This form of plasticity is crucial for restoring and maintaining network function. However, neurodegeneration and subsequent reorganization can also play a role in disease pathogenesis, as is seen in temporal lobe epilepsy and Alzheimer's disease. beta-Secretase-1 (BACE1) is a protease known for cleaving beta-amyloid precursor protein into beta-amyloid (A beta), a major constituent in amyloid plaques. Emerging evidence suggests that BACE1 is also involved with synaptic plasticity and nerve regeneration. Here we examined whether BACE1 immunoreactivity (IR) was altered in pilocarpine-induced epileptic CD1 mice in a manner consistent with the synaptic reorganization seen during epileptogenesis. BACE1-IR increased in the CA3 mossy fiber field and dentate inner molecular layer in pilocarpine-induced epileptic mice, relative to controls (saline-treated mice and mice 24-48 h after pilocarpine-status), and paralleled aberrant expression of neuropeptide Y. Regionally increased BACE1-IR also occurred in neuropil in hippocampal area CA1 and in subregions of the amygdala and temporal cortex in epileptic mice, colocalizing with increased IR for growth associated protein 43 (GAP43) and polysialylated-neural cell adhesion molecule (PSA-NCAM), but reduced IR for microtubule-associated protein 2 (MAP2). These findings suggest that BACE1 is involved in aberrant limbic axonal sprouting in a model of temporal lobe epilepsy, warranting further investigation into the role of BACE1 in physiological vs. pathological neuronal plasticity. Published by Elsevier Inc.	[Yan, Xiao-Xin; Cai, Yan; Luo, Xue-Gang] Cent S Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Changsha 410013, Hunan, Peoples R China; [Cai, Yan; Rose, Gregory M.; Patrylo, Peter R.] So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA; [Yan, Xiao-Xin; Rose, Gregory M.; Patrylo, Peter R.] So Illinois Univ, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA; [Zhang, Xue-Mei; Rose, Gregory M.; Patrylo, Peter R.] So Illinois Univ, Dept Anat, Carbondale, IL 62901 USA; [Zhang, Xue-Mei] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin 150086, Peoples R China; [Cai, Huaibin] NIA, Neurogenet Lab, Bethesda, MD 20892 USA		Yan, XX (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Changsha 410013, Hunan, Peoples R China.	yanxiaoxin@csu.edu.cn; ppatrylo@siumed.edu	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS056371]; Illinois Department of Public Health; Southern Illinois University Center for Alzheimer's disease and related disorders; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Central South University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS056371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000928, ZIAAG000959] Funding Source: NIH RePORTER	This study was supported by the National Institute of Health (1R21NS056371 to P.R.P., X.-X.Y.), the Illinois Department of Public Health (X.-X.Y.), the Southern Illinois University Center for Alzheimer's disease and related disorders (P.R.P., G.M.R, X.-X.Y.), the intramural program of the National Institute on Aging (H.C) and the Central South University (X.-X.Y.).	Akman CI, 2010, EPILEPSY BEHAV, V17, P373, DOI 10.1016/j.yebeh.2009.12.007; Akram A, 2008, NEUROBIOL AGING, V29, P1296, DOI 10.1016/j.neurobiolaging.2007.03.007; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Ben-Ari Yehezkel, 2008, Dialogues Clin Neurosci, V10, P17; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Cai Y, 2010, EUR J NEUROSCI, V32, P1223, DOI 10.1111/j.1460-9568.2010.07376.x; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chi ZH, 2008, NEUROCHEM INT, V52, P1305, DOI 10.1016/j.neuint.2008.02.008; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Dube C, 2001, EXP NEUROL, V167, P227, DOI 10.1006/exnr.2000.7561; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Fabene PF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001105; Farah MH, 2011, J NEUROSCI, V31, P5744, DOI 10.1523/JNEUROSCI.6810-10.2011; GEDDES JW, 1991, NEUROBIOL AGING, V12, P330, DOI 10.1016/0197-4580(91)90011-8; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hashimoto M, 2003, NEUROCHEM RES, V28, P1743, DOI 10.1023/A:1026073324672; HENRY TR, 1993, ARCH NEUROL-CHICAGO, V50, P582, DOI 10.1001/archneur.1993.00540060022011; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Howell OW, 2007, NEUROBIOL DIS, V26, P174, DOI 10.1016/j.nbd.2006.12.014; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Huth T, 2011, PFLUG ARCH EUR J PHY, V461, P355, DOI 10.1007/s00424-010-0913-2; Iijima T, 1998, J NEUROTRAUM, V15, P277, DOI 10.1089/neu.1998.15.277; Isokawa M, 2000, EPILEPSIA, V41, pS14, DOI 10.1111/j.1528-1157.2000.tb01550.x; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Jacobs KM, 2000, EPILEPSIA, V41, pS153, DOI 10.1111/j.1528-1157.2000.tb01574.x; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2011, J BIOL CHEM, V286, P8106, DOI 10.1074/jbc.M110.134692; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; KUHL DE, 1980, ANN NEUROL, V8, P348, DOI 10.1002/ana.410080403; Kurz JE, 2008, EPILEPSIA, V49, P1696, DOI 10.1111/j.1528-1167.2008.01616.x; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Li GL, 2000, APMIS, V108, P98; Li SL, 2006, NEUROBIOL DIS, V23, P362, DOI 10.1016/j.nbd.2006.03.011; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Longo T, 2005, EPILEPSIA, V46, P125, DOI 10.1111/j.1528-1167.2005.01019.x; Luan Tian-zhu, 2005, Zhonghua Yi Xue Za Zhi, V85, P1770; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Luo XY, 2010, INT J CLIN EXP PATHO, V3, P618; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Magloczky Z, 2010, EPILEPSY RES, V89, P52, DOI 10.1016/j.eplepsyres.2010.01.002; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Miyazaki H, 2007, BIOCHEM BIOPH RES CO, V361, P43, DOI 10.1016/j.bbrc.2007.06.170; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Nadler JV, 2007, PEPTIDES, V28, P357, DOI 10.1016/j.peptides.2006.07.026; NUKINA N, 1992, GERONTOLOGY, V38, P10; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Patrylo PR, 1998, J NEUROPHYSIOL, V79, P418, DOI 10.1152/jn.1998.79.1.418; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Pereno GI, 2010, BRAIN RES, V1328, P130, DOI 10.1016/j.brainres.2010.01.087; POLLARD H, 1994, NEUROSCIENCE, V61, P773, DOI 10.1016/0306-4522(94)90401-4; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Seeger G, 2009, NEUROBIOL DIS, V35, P258, DOI 10.1016/j.nbd.2009.05.003; SHENG JG, 1994, J NEUROCHEM, V63, P1872; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Shrimpton AE, 2007, NEUROPATHOLOGY, V27, P228, DOI 10.1111/j.1440-1789.2007.00766.x; Smith BN, 2001, J NEUROPHYSIOL, V85, P1, DOI 10.1152/jn.2001.85.1.1; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Tang FR, 2010, EPILEPSY RES, V89, P43, DOI 10.1016/j.eplepsyres.2009.10.015; Tolner EA, 2003, EUR J NEUROSCI, V17, P2369, DOI 10.1046/j.1460-9568.2003.02687.x; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Uebachs M, 2010, J NEUROSCI, V30, P8489, DOI 10.1523/JNEUROSCI.1534-10.2010; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xiong K, 2007, EXP BRAIN RES, V181, P435, DOI 10.1007/s00221-007-0943-y; Yan XX, 2007, J COMP NEUROL, V501, P52, DOI 10.1002/cne.21239; Yan XX, 2004, J NEUROSCI, V24, P2942, DOI 10.1523/JNEUROSCI.0092-04.2004; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang XH, 2010, SCI CHINA LIFE SCI, V53, P322, DOI 10.1007/s11427-010-0062-z; Zhang XM, 2010, EUR J NEUROSCI, V31, P710, DOI 10.1111/j.1460-9568.2010.07103.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	95	20	21	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2012	235	1					228	237		10.1016/j.expneurol.2012.01.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	934FZ	WOS:000303430400024	22265658	Green Accepted			2022-02-06	
J	Arun, P; Oguntayo, S; Alamneh, Y; Honnold, C; Wang, Y; Valiyaveettil, M; Long, JB; Nambiar, MP				Arun, Peethambaran; Oguntayo, Samuel; Alamneh, Yonas; Honnold, Cary; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.			Rapid Release of Tissue Enzymes into Blood after Blast Exposure: Potential Use as Biological Dosimeters	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LITHOTRIPTER SHOCK-WAVES; EXPLOSIVE BLAST; RATS; DAMAGE; PERMEABILIZATION; OVERPRESSURE; AFGHANISTAN; MEMBRANE; PROTEINS	Explosive blast results in multiple organ injury and polytrauma, the intensity of which varies with the nature of the exposure, orientation, environment and individual resilience. Blast overpressure alone may not precisely indicate the level of body or brain injury after blast exposure. Assessment of the extent of body injury after blast exposure is important, since polytrauma and systemic factors significantly contribute to blast-induced traumatic brain injury. We evaluated the activity of plasma enzymes including aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and creatine kinase (CK) at different time points after blast exposure using a mouse model of single and repeated blast exposures to assess the severity of injury. Our data show that activities of all the enzymes in the plasma were significantly increased as early as 1 h after blast exposure. The elevated enzyme activity remained up to 6 h in an overpressure dose-dependent manner and returned close to normal levels at 24 h. Head-only blast exposure with body protection showed no increase in the enzyme activities suggesting that brain injury alone does not contribute to the systemic increase. In contrast to plasma increase, AST, ALT and LDH activity in the liver and CK in the skeletal muscle showed drastic decrease at 6 h after blast exposures. Histopathology showed mild necrosis at 6 h and severe necrosis at 24 h after blast exposures in liver and no changes in the skeletal muscle suggesting that the enzyme release from the tissue to plasma is probably triggered by transient cell membrane disruption from shockwave and not due to necrosis. Overpressure dependent transient release of tissue enzymes and elevation in the plasma after blast exposure suggest that elevated enzyme activities in the blood can be potentially used as a biological dosimeter to assess the severity of blast injury.	[Arun, Peethambaran; Oguntayo, Samuel; Alamneh, Yonas; Wang, Ying; Valiyaveettil, Manojkumar; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Honnold, Cary] Walter Reed Army Inst Res, Vet Serv Program, Div Pathol, Silver Spring, MD USA		Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA.	madhusoodana.nambiar@amedd.army.mil			Congressionally Directed Medical Research Programs grant [W81XWH-08-2-0017]	The study was supported by Congressionally Directed Medical Research Programs grant (Award Number W81XWH-08-2-0017) to JBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bassit RA, 2010, EUR J APPL PHYSIOL, V108, P945, DOI 10.1007/s00421-009-1305-1; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Cullen DK, 2011, NEUROIMAGE, V54, pS37, DOI 10.1016/j.neuroimage.2010.10.076; Delius M, 1999, CANCER RES, V59, P5227; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; DOUKAS AG, 1993, ULTRASOUND MED BIOL, V19, P137, DOI 10.1016/0301-5629(93)90006-A; Elsayed NM, 2000, TOXICOLOGY, V155, P91, DOI 10.1016/S0300-483X(00)00281-X; GAMBIHLER S, 1994, J MEMBRANE BIOL, V141, P267; GAMBIHLER S, 1992, NATURWISSENSCHAFTEN, V79, P328, DOI 10.1007/BF01138714; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Gorbunov NV, 2006, EXP MOL PATHOL, V80, P11, DOI 10.1016/j.yexmp.2005.06.007; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Reagan WJ, 2010, TOXICOL PATHOL, V38, P1134, DOI 10.1177/0192623310382438; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Shahshahani MM, 2011, J DERMATOL, V38, P1153, DOI 10.1111/j.1346-8138.2011.01278.x; Singab ANB, 2005, ARCH PHARM RES, V28, P791, DOI 10.1007/BF02977344; Sorichter S, 1999, EXERC IMMUNOL REV, V5, P5; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	42	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2012	7	4							e33798	10.1371/journal.pone.0033798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955JA	WOS:000305012700016	22493674	Green Submitted, Green Published, gold			2022-02-06	
J	Johnson, LSM				Johnson, L. Syd M.			Return to Play Guidelines Cannot Solve the Football-Related Concussion Problem	JOURNAL OF SCHOOL HEALTH			English	Article						injury prevention; physical fitness & sport; health policy	SPORT-RELATED CONCUSSION; 2ND IMPACT SYNDROME; YOUTH ICE HOCKEY; CONTACT SPORTS; BRAIN-INJURIES; HEAD; MANAGEMENT; CHILDREN; TIME	BACKGROUND: High school football players are the single largest cohort of athletes playing tackle football, and account for the majority of sport-related concussions. Return to play guidelines (RTPs) have emerged as the preferred approach for addressing the problem of sport-related concussion in youth athletes. METHODS: This article reviews evidence of the risks and effects of football-related concussion and subconcussive brain trauma, as well as the effectiveness of RTPs as a preventative measure. Literature review utilized PubMed and Google Scholar, using combinations of the search terms "football,'' "sports,'' "concussion, ''Chronic Traumatic Encephalopathy,'' "athlete,'' "youth,'' and "pediatric.'' Literature review emphasized medical journals and primary neuroscientific research on sport-related concussion and concussion recovery, particularly in youth athletes. RESULTS: Sport-related concussion is a significant problem among student athletes. Student athletes are more vulnerable to concussion, and at risk of neurocognitive deficits lasting a year or more, with serious effects on academic and athletic performance. RTPs do little to address the problem of sport-related concussion or the chronic damage caused by subconcussive brain trauma. CONCLUSIONS: Emphasizing RTPs as the solution to the concussion problem in tackle football risks neglecting genuine reforms that would prevent concussions. More effective concussion prevention is needed. Eliminating tackling from school football for youth under 16 is recommended to reduce concussions. Additional modifications to football are recommended to enhance safety and reduce brain trauma at all levels of play.	Michigan Technol Univ, Humanities Dept, Houghton, MI 49931 USA		Johnson, LSM (corresponding author), Michigan Technol Univ, Humanities Dept, 1400 Townsend Dr, Houghton, MI 49931 USA.	lsjohnso@mtu.edu		Johnson, L. Syd/0000-0002-9486-4613	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [NNF 80045]; States of Mind: Emerging Issues in Neuroethics	Research funded by Canadian Institutes of Health Research, NNF 80045, States of Mind: Emerging Issues in Neuroethics.	Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Bey T, 2009, WEST J EMERG MED, V10, P6; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Center for the Study of Traumatic Encephalopathy, 2009, 18 YEAR OLD HIGH SCH; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Finn J.D., 1993, SCH ENGAGEMENT STUDE; Gilbert F., 2011, AJOB NEUROSCIENCE, V2, P48, DOI [DOI 10.1080/21507740.2011.611125, https://doi.org/10.1080/21507740.2011.611125]; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heck JF, 2004, J ATHL TRAINING, V39, P101; Johnson LSM, 2011, CAN MED ASSOC J, V183, P921, DOI 10.1503/cmaj.110282; Kissick J, 2007, CANADIAN ACAD SPORT; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lamborn S. D., 1992, STUDENT ENGAGEMENT A, P153; Maloney JL, 2000, CHILD DEV, V71, P502, DOI 10.1111/1467-8624.00160; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Newlin C., 2010, ESTIMATED PROBABILIT; Nowinski C, 2010, NY TIMES; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Schwarz A, 2010, NY TIMES; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	37	20	20	1	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	APR	2012	82	4					180	185		10.1111/j.1746-1561.2011.00684.x			6	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	901RC	WOS:000300983500005	22385091				2022-02-06	
J	Murtha, L; McLeod, D; Spratt, N				Murtha, Lucy; McLeod, Damian; Spratt, Neil			Epidural Intracranial Pressure Measurement in Rats Using a Fiber-optic Pressure Transducer	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 62; Neuroscience; brain; rat; intracranial pressure; epidural; fibre-optic transducer; ischemic injury		Elevated intracranial pressure (ICP) is a significant problem in several forms of ischemic brain injury including stroke, traumatic brain injury and cardiac arrest. This elevation may result in further neurological injury, in the form of transtentorial herniation(1,2,3,4), midbrain compression, neurological deficit or increased cerebral infarct(2,4). Current therapies are often inadequate to control elevated ICP in the clinical setting(5,6,7). Thus there is a need for accurate methods of ICP measurement in animal models to further our understanding of the basic mechanisms and to develop new treatments for elevated ICP. In both the clinical and experimental setting ICP cannot be estimated without direct measurement. Several methods of ICP catheter insertion currently exist. Of these the intraventricular catheter has become the clinical 'gold standard' of ICP measurement in humans(8). This method involves the partial removal of skull and the instrumentation of the catheter through brain tissue. Consequently, intraventricular catheters have an infection rate of 6-11% (9). For this reason, subdural and epidural cannulations have become the preferred methods in animal models of ischemic injury. Various ICP measurement techniques have been adapted for animal models, and of these, fluid-filled telemetry catheters(10) and solid state catheters are the most frequently used(11,12,13,14,15). The fluid-filled systems are prone to developing air bubbles in the line, resulting in false ICP readings. Solid state probes avoid this problem (Figure 1). An additional problem is fitting catheters under the skull or into the ventricles without causing any brain injury that might alter the experimental outcomes. Therefore, we have developed a method that places an ICP catheter contiguous with the epidural space, but avoids the need to insert it between skull and brain. An optic fibre pressure catheter (420LP, SAMBA Sensors, Sweden) was used to measure ICP at the epidural location because the location of the pressure sensor (at the very tip of the catheter) was found to produce a high fidelity ICP signal in this model. There are other manufacturers of similar optic fibre technologies(13) that may be used with our methodology. Alternative solid state catheters, which have the pressure sensor located at the side of the catheter tip, would not be appropriate for this model as the signal would be dampened by the presence of the monitoring screw. Here, we present a relatively simple and accurate method to measure ICP. This method can be used across a wide range of ICP related animal models.	[Murtha, Lucy; McLeod, Damian; Spratt, Neil] Univ Newcastle, Callaghan, NSW 2308, Australia		Spratt, N (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Neil.Spratt@newcastle.edu.au	Spratt, Neil J/K-4208-2012; MCLEOD, DAMIAN/G-7704-2013	Spratt, Neil J/0000-0002-9023-6177; MCLEOD, DAMIAN/0000-0002-1297-8984	National Stroke Foundation; Hunter Medical Research Institute (HMRI); National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia	This project was funded by the National Stroke Foundation, Hunter Medical Research Institute (HMRI) and National Health and Medical Research Council (NH&MRC), Australia. Special thanks to the Faculty of Health Workshop staff at The University of Newcastle for their technical expertise.	Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; Geraci E B, 1996, J Neurosci Nurs, V28, P381; Hg LKY, 1970, STROKE, V1, P158, DOI 10.1161/01.STR.1.3.158; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Plum F, 1966, Res Publ Assoc Res Nerv Ment Dis, V41, P318; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Silasi G, 2009, CURR NEUROVASC RES, V6, P62, DOI 10.2174/156720209787466046; SILVER FL, 1984, STROKE, V15, P492, DOI 10.1161/01.STR.15.3.492; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	15	20	20	2	16	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2012		62							e3689	10.3791/3689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36PG	WOS:000209222900026	22565931	Green Published			2022-02-06	
J	Pacher, P; Mackie, K				Pacher, Pal; Mackie, Ken			Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article								Remote neuronal degeneration and death/injury, which often occur in regions remote but functionally connected to the primary lesion site, may play a pivotal role in extending neuronal damage/dysfunction following traumatic brain injury, stroke, or peripheral nerve injury, as well as in chronic neurodegenerative diseases such as multiple sclerosis and amyotrophic lateral sclerosis. Even though the precise mechanisms of remote neuronal injury are poorly understood and no efficacious treatment options are available, it involves glial activation, inflammation, oxidative/nitrative stress, and apoptotic cell death. The newly discovered endocannabinoid signaling system consisting of endocannabinoids (endogenous bioactive lipid mediators), their synthetic and metabolizing enzymes, and their primary G protein-coupled cannabinoid 1 and 2 (CB1 and CB2) receptors has been implicated in the regulation of numerous physiological and pathological processes/functions, including those associated with neurodegeneration. Using a well-characterized rodent model of remote neuronal degeneration, Oddi et al. (J Mol Med 2012, in press, DOI 10.1007/s00109-012-0884-1) have demonstrated that targeting CB2 cannabinoid receptors may represent a promising novel approach to attenuate this pathological process. This editorial discusses the clinical significance of these interesting observations and the mechanisms of the possible interplay of CB2 receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration.	[Pacher, Pal] NIAAA, Sect Oxidat Stress Tissue Injury, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA; [Mackie, Ken] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA		Pacher, P (corresponding author), NIAAA, Sect Oxidat Stress Tissue Injury, Lab Physiol Studies, NIH, 5625 Fishers Lane,MSC-9413, Bethesda, MD 20892 USA.	pacher@mail.nih.gov	Pacher, Pal/B-6378-2008; Mackie, Ken/E-3715-2013	Pacher, Pal/0000-0001-7036-8108; Mackie, Ken/0000-0001-8501-6199	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000375] Funding Source: NIH RePORTER; Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z99 AA999999, ZIA AA000375-05, ZIA AA000375-06, Z01 AA000375-02, ZIA AA000375-04, Z01 AA000375-03] Funding Source: Medline		Atwood BK, 2012, PROG NEURO-PSYCHOPH, V38, P16, DOI 10.1016/j.pnpbp.2011.12.001; Atwood BK, 2012, MOL PHARMACOL, V81, P250, DOI 10.1124/mol.111.074013; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Oddi S, 2012, J MOL MED, V90, P371, DOI 10.1007/s00109-011-0846-z; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Viscomi MT, 2009, CEREBELLUM, V8, P184, DOI 10.1007/s12311-009-0107-7; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874	16	20	21	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	APR	2012	90	4					347	351		10.1007/s00109-012-0884-1			5	Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Research & Experimental Medicine	916XM	WOS:000302136500001	22371074				2022-02-06	
J	Sala-Rabanal, M; Wang, SZ; Nichols, CG				Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.			On Potential Interactions between Non-selective Cation Channel TRPM4 and Sulfonylurea Receptor SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; REACTIVE ASTROCYTES; TRAFFICKING; STOICHIOMETRY; SENSITIVITY; ACTIVATION; EXPRESSION; MUTATIONS; PROTEIN; STROKE	The sulfonylurea receptor SUR1 associates with Kir6.2 or Kir6.1 to form K-ATP channels, which link metabolism to excitability in multiple cell types. The strong physical coupling of SUR1 with Kir6 subunits appears exclusive, but recent studies argue that SUR1 also modulates TRPM4, a member of the transient receptor potential family of non-selective cation channels. It has been reported that, following stroke, brain, or spinal cord injury, SUR1 is increased in neurovascular cells at the site of injury. This is accompanied by up-regulation of a non-selective cation conductance with TRPM4-like properties and apparently sensitive to sulfonylureas, leading to the postulation that post-traumatic non-selective cation currents are determined by TRPM4/SUR1 channels. To investigate the mechanistic hypothesis for the coupling between TRPM4 and SUR1, we performed electrophysiological and FRET studies in COSm6 cells expressing TRPM4 channels with or without SUR1. TRPM4-mediated currents were Ca2+-activated, voltage-dependent, underwent desensitization, and were inhibited by ATP but were insensitive to glibenclamide and tolbutamide. These properties were not affected by cotransfection with SUR1. When the same SUR1 was cotransfected with Kir6.2, functional K-ATP channels were formed. In cells cotransfected with Kir6.2, SUR1, and TRPM4, we measured K-ATP-mediated K+ currents and Ca2+-activated, sulfonylurea-insensitive Na+ currents in the same patch, further showing that SUR1 controls K-ATP channel activity but not TRPM4 channels. FRET signal between fluorophore-tagged TRPM4 subunits was similar to that between Kir6.2 and SUR1, whereas there was no detectable FRET efficiency between TRPM4 and SUR1. Our data suggest that functional or structural association of TRPM4 and SUR1 is unlikely.	[Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Wang, Shizhen] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63110 USA		Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 425 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Wang, Shizhen/N-6577-2017; Sala-Rabanal, Monica/AAU-2383-2021; Nichols, Colin/D-6336-2012	Wang, Shizhen/0000-0003-1065-4756; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL95010]; American Heart AssociationAmerican Heart Association [10POST4280056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL095010] Funding Source: NIH RePORTER	This work was supported, in whole or in part, by National Institutes of Health Grant HL95010 (to C. G. N.). This work was also supported by Postdoctoral Fellowship 10POST4280056 from the American Heart Association (to S. W.).	Akrouh A, 2009, IUBMB LIFE, V61, P971, DOI 10.1002/iub.246; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Favilla CG, 2011, STROKE, V42, P710, DOI 10.1161/STROKEAHA.110.599274; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hille B., 2001, ION CHANNELS EXCITAB, P237; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Kuhner P, 2012, N-S ARCH PHARMACOL, V385, P299, DOI 10.1007/s00210-011-0709-8; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Makhina EN, 2001, METHOD PHARMACOL TOX, P261; Makhina EN, 1998, J BIOL CHEM, V273, P3369, DOI 10.1074/jbc.273.6.3369; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Morita H, 2007, J PHARMACOL SCI, V103, P417, DOI 10.1254/jphs.FP0061332; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Popovich P. G., 2010, EXP NEUROL, V232, P615; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Reading SA, 2007, STROKE, V38, P2322, DOI 10.1161/STROKEAHA.107.483404; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2007, BBA-MOL BASIS DIS, V1772, P947, DOI 10.1016/j.bbadis.2007.03.004; Simard JM, 2011, STROKE, V42, pE409, DOI 10.1161/STROKEAHA.111.620666; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simard JM, 2004, J NEUROSURG ANESTH, V16, P98, DOI 10.1097/00008506-200401000-00021; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R., 2007, V179, P269; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5	57	20	20	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8746	8756		10.1074/jbc.M111.336131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	WOS:000301797800008	22291026	hybrid, Green Published			2022-02-06	
J	Sauerbeck, A; Hunter, R; Bing, GY; Sullivan, PG				Sauerbeck, Andrew; Hunter, Randy; Bing, Guoying; Sullivan, Patrick G.			Traumatic brain injury and trichloroethylene exposure interact and produce functional, histological, and mitochondrial deficits	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Trichloroethylene; Parkinson's disease; Mitochondria; Dual injury; Synergy; Multifactorial	ENVIRONMENTAL RISK-FACTORS; PARKINSONS-DISEASE; HEAD TRAUMA; ENHANCED VULNERABILITY; COMBINED PARAQUAT; COMPLEX I; TOXICITY; NEURONS; DAMAGE; NEUROTOXICITY	Mitochondria play a pivotal role in the development of pathology associated with Parkinson's disease (PD), traumatic brain injury (TBI), and following exposure to the environmental toxin trichloroethylene (TCE). Evidence from humans indicates that both TBI and TCE can play a role in the development of PD and that each of these insults result in significant mitochondrial dysfunction. In the current studies we hypothesized that exposure to both TCE and TBI would result in increased pathology associated with PD. To test this hypothesis, 16 week old male Fischer 344 rats were administered ICE for either one or two weeks by oral gavage. Following exposure to ICE, rats were subjected to either a sham, mild (1.0 mm), or moderate (2.0 mm) controlled cortical impact TBI. Given the strong connection between mitochondrial function and PD, TBI, and TCE, tissue from the striatum and substantia nigra were analyzed 6 h after the TBI. Neither ICE exposure, TBI, nor the combination of the two insults resulted in mitochondrial deficits at 6 h post-TBI in the substantia nigra. Unlike the substantia nigra, the striatum exhibited significant mitochondrial dysfunction. Exposure to TCE alone for two weeks resulted in approximately a 75% reduction in mitochondrial function (p<0.05) in the striatum whereas TBI alone resulted in approximately a 30% reduction in striatal mitochondrial function. Following 1 week exposure to ICE followed by TBI, there was a significant reduction (50%) in mitochondrial function (p<0.05) which required the presence of both insults. Beginning 12 days after the injury significant motor impairment was observed with Rotarod testing. Animals exposed to ICE and a moderate TBI exhibited performance which was approximately 50% of controls (p<0.01). Cylinder testing revealed that at 30 days post-injury animals exposed to ICE and a moderate TBI also had about a 34% reduction in the usage of the contralateral fore paw and this impairment was significantly worse than both control animals and animals exposed to TCE and a mild 181 (p<0.05). At 30 days post-injury there was a 13-17% reduction in the number of tyrosine hydroxylase (TH) positive neurons in the substantia nigra (p<0.05), which was the result of protein loss and not cell death. Loss of TH positive neurons did not result in changes in striatal TH fiber density or levels of the dopamine transporter or type-2 dopamine receptor. Additionally, exposure to TCE prior to the TBI did not increase the loss of cortical tissue, indicating regional specificity for TCE induced deficits. These studies provide further evidence for the connection between ICE, TBI, and PD and lend support to the concept that PD develops from a multifactorial injury scenario. (C) 2012 Elsevier Inc. All rights reserved.	[Sauerbeck, Andrew; Hunter, Randy; Bing, Guoying; Sullivan, Patrick G.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Sauerbeck, Andrew; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Sullivan, PG (corresponding author), 741 S Limestone St,BBSRB Room 475, Lexington, KY 40536 USA.	Adsaue2@uky.edu; Randy.Hunter@Covance.com; guoying.bing@uky.edu; patsull@uky.edu		Bing, Guoying/0000-0003-0609-8152	National Institutes of Health, U.S. Public Health ServiceUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [R01 N548191, R01 NS062993, P30 NS051220, T32 AG000242]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062993, P30NS051220, R01NS048191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000242] Funding Source: NIH RePORTER	The authors would like to thank Dr. Jignesh Pandya and Andrea Sebastian for excellent technical assistance during this project. The authors would also like to thank Dr. Don Gash for assistance throughout the experiments and review of the final manuscript. This research was supported by grants from the National Institutes of Health, U.S. Public Health Service grants R01 N548191, R01 NS062993 (P.G.S.), P30 NS051220, T32 AG000242.	Afonso-Oramas D, 2009, NEUROBIOL DIS, V36, P494, DOI 10.1016/j.nbd.2009.09.002; Akundi RS, 2004, J NEUROCHEM, V91, P263, DOI 10.1111/j.1471-4159.2004.02710.x; [Anonymous], 1998, EOHS ENC OCC HLTH SA; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; *ATSDR, 1997, TOX PROF TRICHL; Bakke B, 2007, J OCCUP ENVIRON HYG, V4, P375, DOI 10.1080/15459620701301763; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bringmann G, 1995, J NEURAL TRANSM-SUPP, P235; Bringmann G, 1995, J NEURAL TRANSM-SUPP, P245; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Doder M, 1999, J NEUROL NEUROSUR PS, V66, P380, DOI 10.1136/jnnp.66.3.380; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; FACTOR SA, 1988, MOVEMENT DISORD, V3, P30, DOI 10.1002/mds.870030105; Fei QY, 2008, J NEUROCHEM, V105, P2091, DOI 10.1111/j.1471-4159.2008.05293.x; Ferrante RJ, 1997, BRAIN RES, V753, P157, DOI 10.1016/S0006-8993(97)00008-5; Gash DM, 2008, ANN NEUROL, V63, P184, DOI 10.1002/ana.21288; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Janetzky B, 1995, J NEURAL TRANSM-SUPP, P265; Kilburn KH, 2002, ARCH ENVIRON HEALTH, V57, P113, DOI 10.1080/00039890209602925; Kochen W, 2003, ADV EXP MED BIOL, V527, P253; KOUTOUZIS TK, 1994, BRAIN RES, V646, P242, DOI 10.1016/0006-8993(94)90085-X; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Ling ZD, 2006, EXP NEUROL, V199, P499, DOI 10.1016/j.expneurol.2006.01.010; Ling ZD, 2004, NEUROSCIENCE, V124, P619, DOI 10.1016/j.neuroscience.2003.12.017; Liu M, 2008, J NEUROSCI RES, V86, P2792, DOI 10.1002/jnr.21725; Liu M, 2010, J NEUROCHEM, V112, P773, DOI 10.1111/j.1471-4159.2009.06497.x; Mouton P. R., 2002, PRINCIPLES PRACTICES; Nakamura K, 2000, MOL PHARMACOL, V58, P271, DOI 10.1124/mol.58.2.271; Naoi M, 1999, MECH AGEING DEV, V111, P175, DOI 10.1016/S0047-6374(99)00064-0; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; Nilsson GE, 2001, NEWS PHYSIOL SCI, V16, P217; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2004, RAT NERVOUS SYSTEM; RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V134, P743, DOI 10.1016/S0006-291X(86)80483-1; Riederer P, 2002, EUR J PHARMACOL, V442, P1, DOI 10.1016/S0014-2999(02)01308-0; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SEMCHUK KM, 1993, NEUROLOGY, V43, P1173, DOI 10.1212/WNL.43.6.1173; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; Thiruchelvam M, 2000, BRAIN RES, V873, P225, DOI 10.1016/S0006-8993(00)02496-3; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Veldman BAJ, 1998, CLIN NEUROL NEUROSUR, V100, P15, DOI 10.1016/S0303-8467(98)00009-2; VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x	62	20	20	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2012	234	1					85	94		10.1016/j.expneurol.2011.12.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	910DN	WOS:000301617500010	22201550	Green Accepted			2022-02-06	
J	Yang, TY; Wang, TC; Tsai, YH; Huang, KC				Yang, T-Y.; Wang, T-C.; Tsai, Y-H.; Huang, K-C.			The effects of an injury to the brain on bone healing and callus formation in young adults with fractures of the femoral shaft	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							HEAD-INJURY; SERUM	In patients with traumatic brain injury and fractures of long bones, it is often clinically observed that the rate of bone healing and extent of callus formation are increased. However, the evidence has been unconvincing and an association between such an injury and enhanced fracture healing remains unclear. We performed a retrospective cohort study of 74 young adult patients with a mean age of 24.2 years (16 to 40) who sustained a femoral shaft fracture (AO/OTA type 32A or 32B) with or without a brain injury. All the fractures were treated with closed intramedullary nailing. The main outcome measures included the time required for bridging callus formation (BCF) and the mean callus thickness (MCT) at the final follow-up. Comparative analyses were made between the 20 patients with a brain injury and the 54 without brain injury. Subgroup comparisons were performed among the patients with a brain injury in terms of the severity of head injury, the types of intracranial haemorrhage and gender. Patients with a brain injury had an earlier appearance of BCF (p < 0.001) and a greater final MCT value (p < 0.001) than those without. There were no significant differences with respect to the time required for BCF and final MCT values in terms of the severity of head injury (p = 0.521 and p = 0.153, respectively), the types of intracranial haemorrhage (p = 0.308 and p = 0.189, respectively) and gender (p = 0.383 and p = 0.662, respectively). These results confirm that an injury to the brain may be associated with accelerated fracture healing and enhanced callus formation. However, the severity of the injury to the brain, the type of intracranial haemorrhage and gender were not statistically significant factors in predicting the rate of bone healing and extent of final callus formation.	[Yang, T-Y.; Tsai, Y-H.; Huang, K-C.] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Orthopaed, Pu Tz City 613, Chia Yi, Taiwan; [Wang, T-C.] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Pu Tz City 613, Chia Yi, Taiwan		Huang, KC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Chiayi, Dept Orthopaed, 6 West Sec,Chia Pu Rd, Pu Tz City 613, Chia Yi, Taiwan.	kc2672@adm.cgmh.org.tw	HUANG, Kuo-Chin/S-7371-2019	HUANG, Kuo-Chin/0000-0002-3225-1504			Babhulkar S, 2005, CLIN ORTHOP RELAT R, P50, DOI 10.1097/01.blo.0000152369.99312.c5; Beil FT, 2010, J TRAUMA, V69, P1259, DOI 10.1097/TA.0b013e3181c4544d; BRUMBACK RJ, 1988, J BONE JOINT SURG AM, V70A, P1453, DOI 10.2106/00004623-198870100-00003; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; GARLAND DE, 1983, CLIN ORTHOP RELAT R, P190; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P219; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1980, CLIN ORTHOP RELAT R, P198; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Little DG, 2007, J BONE JOINT SURG BR, V89B, P425, DOI 10.1302/0301-620X.89B4.18301; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Rigaux P, 2005, JOINT BONE SPINE, V72, P146, DOI 10.1016/j.jbspin.2004.05.012; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SMITH R, 1987, J BONE JOINT SURG BR, V69, P518, DOI 10.1302/0301-620X.69B4.3611149; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550	22	20	25	0	6	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X	2044-5377		J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	FEB	2012	94B	2					227	230		10.1302/0301-620X.94B2.28193			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	893WF	WOS:000300387700016	22323691				2022-02-06	
J	Wang, EY; Gao, JL; Yang, Q; Parsley, MO; Dunn, TJ; Zhang, L; DeWitt, DS; Denner, L; Prough, DS; Wu, P				Wang, Enyin; Gao, Junling; Yang, Qin; Parsley, Margaret O.; Dunn, Tiffany J.; Zhang, Lin; DeWitt, Douglas S.; Denner, Larry; Prough, Donald S.; Wu, Ping			Molecular Mechanisms Underlying Effects of Neural Stem Cells against Traumatic Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						alpha-SMA; calcineurin; GDNF; human NSC; Rho; TBI; traumatic axonal injury	AMYLOID PRECURSOR PROTEIN; MARROW STROMAL CELLS; BRAIN-INJURY; NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; COGNITIVE FUNCTION; THERAPEUTIC STRATEGY; CALCINEURIN SUBUNIT; ISOFORM EXPRESSION; PROGENITOR CELLS	Transplantation of neural stem cells (NSCs) improves functional outcomes following traumatic brain injury (TBI). Previously we demonstrated that human NSCs (hNSCs) via releasing glial cell line-derived neurotrophic factor (GDNF), preserved cognitive function in rats following parasagittal fluid percussion. However, the underlying mechanisms remain elusive. In this study, we report that NSC grafts significantly reduce TBI-induced axonal injury in the fimbria and other brain regions by blocking abnormal accumulation of amyloid precursor protein (APP). A preliminary mass spectrometry proteomics study revealed the opposite effects of TBI and NSCs on many of the cytoskeletal proteins in the CA3 region of the hippocampus, including alpha-smooth muscle actin (alpha-SMA), the main stress fiber component. Further, Western blot and immunostaining studies confirmed that TBI significantly increased the expression of alpha-SMA in hippocampal neurons, whereas NSC grafts counteracted the effect of TBI. In an in vitro model, rapid stretch injury significantly shortened lengths of axons and dendrites, increased the expression of both APP and alpha-SMA, and induced actin aggregation, effects offset by GDNF treatment. These GDNF protective effects were reversed by a GDNF-neutralizing antibody or a specific calcineurin inhibitor, and were mimicked by a specific Rho inhibitor. In summary, we demonstrate for the first time that hNSC grafts and treatment with GDNF acutely reduce traumatic axonal injury and promote neurite outgrowth. Possible mechanisms underlying GDNF-mediated neurite protection include balancing the activity of calcineurin, whereas GDNF-induced neurite outgrowth may result from the reduction of the abnormal alpha-SMA expression and actin aggregation via blocking Rho signals. Our study also suggests the necessity of further exploring the roles of alpha-SMA in the central nervous system (CNS), which may lead to a new avenue to facilitate recovery after TBI and other injuries.	[Wang, Enyin; Gao, Junling; Dunn, Tiffany J.; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Parsley, Margaret O.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Denner, Larry] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Wang, Enyin; Zhang, Lin] Sichuan Univ, W China Sch Preclin & Forens Med, Dept Forens Biol, Chengdu 610064, Peoples R China; [Yang, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurol, Wuhan 430074, Peoples R China		Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	piwu@utmb.edu	Prough, Donald S/G-5793-2013; wu, Ping/G-8958-2011	Prough, Donald S/0000-0001-7994-532X; 	Department of the Army via the United States Army [W81XWH-08-2-0137]; Coalition for Brain Injury Research; Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect; TIRR Foundation; China Scholarship CouncilChina Scholarship Council; John S. Dunn Research Foundation; Cullen Foundation	We thank Sigmund J. Haidacher, Yaping Zeng, Wenru Zhang, and Jason R. Thonhoff for technical support. This work was supported by the Department of the Army (W81XWH-08-2-0137 to P.W.) via the United States Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014. The content of this work does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred. Other support for this study came from the Coalition for Brain Injury Research (P.W.), the Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect (P.W.), the TIRR Foundation (P.W.), the China Scholarship Council (E.W.), the John S. Dunn Research Foundation (P.W.), and the Cullen Foundation (P.W.).	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Akerud P, 1999, J NEUROCHEM, V73, P70, DOI 10.1046/j.1471-4159.1999.0730070.x; Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Chaponnier C, 2004, J PATHOL, V204, P386, DOI 10.1002/path.1635; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Consales C, 2007, BRAIN RES, V1159, P28, DOI 10.1016/j.brainres.2007.04.071; Coulpier M, 2004, MOL CELL NEUROSCI, V27, P132, DOI 10.1016/j.mcn.2004.06.001; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ERB DE, 1991, EXP BRAIN RES, V83, P253; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kitagawa H, 1999, J CEREBR BLOOD F MET, V19, P1336, DOI 10.1097/00004647-199912000-00007; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lee JI, 2004, MOL CELLS, V17, P390; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; MACKAY DJG, 1995, TRENDS NEUROSCI, V18, P496, DOI 10.1016/0166-2236(95)92773-J; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pertusa A, 2008, NEUROBIOL AGING, V29, P1366, DOI 10.1016/j.neurobiolaging.2007.02.026; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Pierce JES, 1996, J NEUROSCI, V16, P1083; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Riedel G, 1999, CELL MOL LIFE SCI, V55, P549, DOI 10.1007/s000180050313; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; SCHAAR DG, 1993, EXP NEUROL, V124, P368, DOI 10.1006/exnr.1993.1207; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Tate MC, 2002, CELL TRANSPLANT, V11, P283; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wang Y, 1997, J NEUROSCI, V17, P4341; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yoong LF, 2009, MOL CELL NEUROSCI, V41, P464, DOI 10.1016/j.mcn.2009.05.002	91	20	22	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					295	312		10.1089/neu.2011.2043			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300009	22077363				2022-02-06	
J	Gorman, S; Barnes, MA; Swank, PR; Prasad, M; Ewing-Cobbs, L				Gorman, Stephanie; Barnes, Marcia A.; Swank, Paul R.; Prasad, Mary; Ewing-Cobbs, Linda			The Effects of Pediatric Traumatic Brain Injury on Verbal and Visual-Spatial Working Memory	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Pediatric; Working memory; Inhibitory control; Dual-task; Outcome	CLOSED-HEAD-INJURY; POOR COMPREHENDERS; INTRUSION ERRORS; SELECTIVE METAANALYSIS; READING-COMPREHENSION; COGNITIVE-DEVELOPMENT; INHIBITORY CONTROL; SHORT-TERM; CHILDREN; CHILDHOOD	The purpose of this study was to investigate the effects of pediatric traumatic brain injury (TBI) on verbal and visual-spatial working memory (WM). WM tasks examined memory span through recall of the last item of a series of stimuli. Additionally, both verbal and visual-spatial tests had a dual-task condition assessing the effect of increasing demands on the central executive (CE). Inhibitory control processes in verbal WM were examined through intrusion errors. The TBI group (n = 73) performed more poorly on verbal and visual-spatial WM tasks than orthopedic-injured children (n = 30) and non-injured children (n = 40). All groups performed more poorly on the dual-task conditions, reflecting an effect of increasing CE load. This effect was not greater for the TBI group. There were no group differences in intrusion errors on the verbal WM task, suggesting that problems in WM experienced by children with TBI were not primarily due to difficulties in inhibitory control. Finally, injury-related characteristics, namely days to follow commands, accounted for significant variance in WM performance, after controlling for relevant demographic variables. Findings suggest that WM impairments in TBI are general rather than modality-specific and that severity indices measured over time are better predictors of WM performance than those taken at a single time point. (JINS, 2012, 18, 29-38)	[Ewing-Cobbs, Linda] Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Childrens Learning Inst, Houston, TX 77030 USA; [Gorman, Stephanie] Univ Houston, Dept Psychol, Houston, TX USA		Ewing-Cobbs, L (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Childrens Learning Inst, 7000 Fannin UCT 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			National Institutes of Health-National Institute for Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded by the National Institutes of Health-National Institute for Neurological Diseases and Stroke grant, R01-NS046308. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the study.	Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Barnes M. A., 2010, PEDIAT NEUROPSYCHOLO, P297; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BELL MA, 1992, CHILD DEV, V63, P1142, DOI 10.1111/j.1467-8624.1992.tb01685.x; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Carretti B, 2005, J EXP CHILD PSYCHOL, V91, P45, DOI 10.1016/j.jecp.2005.01.005; CLAYTON CE, 2006, HDB FUNCTIONAL NEURO, P269; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cornoldi C, 2006, MEMORY, V14, P176, DOI 10.1080/09658210544000033; Cornoldi C, 2001, CHILD NEUROPSYCHOL, V7, P230, DOI 10.1076/chin.7.4.230.8735; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; De Beni R, 1998, Q J EXP PSYCHOL-A, V51, P305, DOI 10.1080/713755761; De Beni R, 2000, LEARN INDIVID DIFFER, V12, P131, DOI 10.1016/S1041-6080(01)00033-4; Dempster FN, 1993, EMERGING THEMES COGN, V1, P3; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P89; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DIAMOND A, 1991, BRAIN MATURATION COG; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Fuster J., 1989, PREFRONTAL CORTEX AN; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GOLDMAN PS, 1977, NATURE, V267, P613, DOI 10.1038/267613a0; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KONRAD K, 2000, CHILD NEUROPSYCHOL, V7, P377; Konrad KN, 2000, BRAIN INJURY, V14, P859; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Loose R, 2003, HUM BRAIN MAPP, V18, P249, DOI 10.1002/hbm.10082; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luria A.R., 1973, WORKING BRAIN; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Milner B., 1964, FRONTAL GRANULAR COR; Miyake A., 1999, MODELS WORKING MEMOR; MRZLIJAK L, 1990, PREFRONTAL CORTEX IT, V85, P185; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Nichelli F, 2001, NEUROL SCI, V22, P377, DOI 10.1007/s100720100068; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Palladino P, 2001, MEM COGNITION, V29, P344, DOI 10.3758/BF03194929; Pimperton H, 2010, J MEM LANG, V62, P380, DOI 10.1016/j.jml.2010.02.005; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Shah, 1999, MODELS WORKING MEMOR, DOI DOI 10.1017/CBO9781139174909.005; Swanson HL, 2006, REV EDUC RES, V76, P249, DOI 10.3102/00346543076002249; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940	70	20	20	0	19	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2012	18	1					29	38		10.1017/S1355617711001251			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	874LL	WOS:000298958800003	22014162	Green Accepted			2022-02-06	
S	Larson, AN; McIntosh, AL		Heggie, TW; Caine, DJ		Larson, A. Noelle; McIntosh, Amy L.			The Epidemiology of Injury in ATV and Motocross Sports	EPIDEMIOLOGY OF INJURY IN ADVENTURE AND EXTREME SPORTS	Medicine and Sport Science		English	Article; Book Chapter							ALL-TERRAIN-VEHICLE; TRAUMA CENTERS; CHILDREN; ADOLESCENTS; CONCUSSION; PREVENTION; SEVERITY; CRASHES; HELMETS; RIDERS	Off-road motorsports are popular in rural and suburban areas, and allow for racing, recreation, and easy access to backcountry destinations. This chapter will review the incidence and types of injuries sustained in off-road motorsports. We completed a structured review of motocross and all-terrain vehicle (ATV) injuries, assessing for injury rates, risk factors, and mortality figures. Information for this study was obtained from a PubMed search under the terms 'motocross', 'motorcross', 'all-terrain vehicies', 'injury', 'motorcycle', 'ATV'. Abstracts and articles in the English language from 1980 onward were reviewed. Further statistics were obtained from the US Consumer Product Safety Commission publications. Operating vehicles off-road requires coordination, experience, and training. Motocross is an organized sport with national associations governing the competition of highly trained athletes. ATVs are used both recreationally and commercially, typically for farming and ranching. ATV use appears more dangerous that motocross, with a higher mortality rate, disproportionately for children. Both sports continue to have high rates of head, spinal cord, and extremity injury. Future prospective studies in off-road motorsports should evaluate the risk factors for injury and target specific areas for injury prevention. Improved training programs, use and improvement of safety helmets, and for ATV use, limiting access to minors, may improve the overall safety of off-road motorsports. Copyright (C) 2012 S. Karger AG, Basel	[Larson, A. Noelle; McIntosh, Amy L.] Mayo Clin, Div Pediat Orthoped Surg, Rochester, MN 55905 USA		Larson, AN (corresponding author), Mayo Clin, Div Pediat Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.	larson.noelle@mayo.edu	Larson, A. Noelle/AAC-7158-2019	Larson, A. Noelle/0000-0001-6542-6975; McIntosh, Amy/0000-0002-3660-4901			Alawi Khalid, 2006, CJEM, V8, P277; American Academy of Orthopaedic Surgeons, POS STAT ALL TERR VE; [Anonymous], 2007, CONSUMER PRODUCT SAF, V11, P2; [Anonymous], 2000, PEDIATRICS, V105, P1352; Ascensao A, 2008, J SPORT MED PHYS FIT, V48, P311; Barnett TM, 2008, FOOT ANKLE INT, V29, P245, DOI 10.3113/FAI.2008.0245; Bizzarri F, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-23; Bougard C, 2008, ACCIDENT ANAL PREV, V40, P635, DOI 10.1016/j.aap.2007.09.002; Bougard C, 2012, EUR J APPL PHYSIOL, V112, P59, DOI 10.1007/s00421-011-1948-6; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Brandenburg MA, 2007, J TRAUMA, V63, P994, DOI 10.1097/TA.0b013e31814b91fe; Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Burns BJ, 2011, PREHOSP EMERG CARE, V15, P414, DOI 10.3109/10903127.2011.561416; Colburn NT, 2003, INJURY, V34, P207, DOI 10.1016/S0020-1383(02)00039-6; Commission, 2007, COM2007725 COMM EUR, P5; Cvijanovich NZ, 2001, PEDIATRICS, V108, P631, DOI 10.1542/peds.108.3.631; Garland Sara, 2010, 2009 ANN REPORT ATV; Gielen JL, 2009, SKELETAL RADIOL, V38, P1153, DOI 10.1007/s00256-009-0746-2; Gittelman MA, 2006, PEDIATRICS, V117, P2190, DOI 10.1542/peds.2005-2603; Gobbi A, 2004, KNEE SURG SPORT TR A, V12, P574, DOI 10.1007/s00167-004-0510-z; Gorski TF, 2003, AM SURGEON, V69, P895; Grange JT, 2009, CURR SPORT MED REP, V8, P125, DOI 10.1249/JSR.0b013e3181a61e95; Hall AJ, 2009, AM J PREV MED, V36, P311, DOI 10.1016/j.amepre.2008.11.019; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Helmkamp JC, 2007, INJURY PREV, V13, P426, DOI 10.1136/ip.2007.016030; Kirkpatrick R, 2007, J PEDIATR ORTHOPED, V27, P725, DOI 10.1097/BPO.0b013e3181558856; Konttinen T, 2008, J STRENGTH COND RES, V22, P202, DOI 10.1519/JSC.0b013e31815f5831; Konttinen T, 2007, J SPORT SCI, V25, P995, DOI 10.1080/02640410600944584; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; Lister DG, 1998, J PEDIATR SURG, V33, P1081, DOI 10.1016/S0022-3468(98)90535-8; Lynch JM, 1998, J PEDIATR SURG, V33, P329, DOI 10.1016/S0022-3468(98)90456-0; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McIntosh AL, 2011, CONCUSSIVE INJURIES; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mullins RJ, 2007, J AM COLL SURGEONS, V204, P216, DOI 10.1016/j.jamcollsurg.2006.10.025; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; RODGERS GB, 1993, ACCIDENT ANAL PREV, V25, P335, DOI 10.1016/0001-4575(93)90027-T; Sawyer JR, 2011, J PEDIATR ORTHOPED, V31, P623, DOI 10.1097/BPO.0b013e31822a2f0f; Scutchfield SB, 2003, CLIN ORTHOP RELAT R, P61, DOI 10.1097/01.blo.0000060441.40507.3e; Smith LM, 2005, J TRAUMA, V58, P783, DOI 10.1097/01.TA.0000158252.11002.6E; STREETER R, 2008, ANN REPORT ATV RELAT; Tomida Y, 2005, BRIT J SPORT MED, V39, P508, DOI 10.1136/bjsm.2004.013722; White S L, 1999, J Foot Ankle Surg, V38, P214	43	20	21	0	9	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0254-5020		978-3-318-02164-6	MED SPORT SCI	Med.Sport Sci.		2012	58						158	172					15	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Social Sciences - Other Topics; Sport Sciences	BCI64	WOS:000310249000010	22824845				2022-02-06	
J	Pardini, M; Krueger, F; Koenigs, M; Raymont, V; Hodgkinson, C; Zoubak, S; Goldman, D; Grafman, J				Pardini, M.; Krueger, F.; Koenigs, M.; Raymont, V.; Hodgkinson, C.; Zoubak, S.; Goldman, D.; Grafman, J.			Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury	TRANSLATIONAL PSYCHIATRY			English	Article						endocannabinoids; post-traumatic stress disorder; single-nucleotide polymorphisms	ENDOCANNABINOID SYSTEM; PREFRONTAL CORTEX; COMBAT VETERANS; INVENTORY; LESIONS; TRAUMA; PTSD	The past few years have seen an increase in the clinical awareness of post-traumatic stress disorder (PTSD), one of the most disabling and least understood behavioral disorders. Although the biological bases of PTSD are poorly understood, fatty-acid amide hydrolase (FAAH) activity has been linked with arousability and aversive-memories extinction, that is, two key features of PTSD. In this study, we investigated the association between the FAAH genetic polymorphisms and PTSD development and maintenance. We assessed PTSD frequency in a group of male Vietnam war veterans who suffered combat-related penetrating traumatic brain injury, that is, a relatively homogeneous population regarding the nature of the events that led to PTSD. We showed that rs2295633, a single-nucleotide polymorphism of FAAH, was significantly associated with PTSD diagnosis in subjects without lesions in the ventromedial prefrontal cortex. Moreover, the presence of the C allele was associated with more severe re-experiencing of trauma and more negative reported childhood experiences. In conclusion, our data suggest that FAAH has an important role in PTSD through modulation of aversive memories and point to both a novel therapeutic target and a possible risk marker for this condition. Translational Psychiatry (2012) 2, e75; doi:10.1038/tp.2012.1; published online 31 January 2012	[Grafman, J.] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ 07052 USA; [Pardini, M.; Grafman, J.] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, NIH, Bethesda, MD USA; [Pardini, M.] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Pardini, M.] Univ Genoa, Magnet Resonance Res Ctr Nervous Syst Dis, Genoa, Italy; [Krueger, F.] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, F.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Koenigs, M.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Raymont, V.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Raymont, V.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Hodgkinson, C.; Zoubak, S.; Goldman, D.] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA		Grafman, J (corresponding author), Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	FKruger@gmu.edu; jgrafman@kesslerfoundation.org	Majid, Salma/AAT-2616-2020; Pardini, Matteo/F-8414-2010; Goldman, David/F-9772-2010	Majid, Salma/0000-0002-1724-5405; Pardini, Matteo/0000-0002-4740-1982; Goldman, David/0000-0002-1724-5405; Grafman, Jordan H./0000-0001-8645-4457; Hodgkinson, Colin/0000-0002-5365-8119; Koenigs, Michael/0000-0002-5799-4881	US National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000301] Funding Source: NIH RePORTER	The work was supported by the US National Institute of Neurological Disorders and Stroke intramural research program and a project grant from the US Army Medical Research and Material Command administrated by the Henry M Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Caruso D.R., 2002, MAYER SALOVEY CARUSO; Dlugos AM, 2010, NEUROPSYCHOPHARMACOL, V35, P613, DOI 10.1038/npp.2009.166; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Hill MN, 2009, CNS NEUROL DISORD-DR, V8, P451, DOI 10.2174/187152709789824624; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Lutz B, 2007, MOL NEUROBIOL, V36, P92, DOI 10.1007/s12035-007-8004-x; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Taylor S., 2006, CLIN GUIDE PTSD COGN; Varvel SA, 2007, NEUROPSYCHOPHARMACOL, V32, P1032, DOI 10.1038/sj.npp.1301224; Wechsler D, 1997, WMS 3 ADM SCORING MA	22	20	21	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	JAN	2012	2								e75	10.1038/tp.2012.1			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	971PZ	WOS:000306217600011	22832737	Green Published, gold			2022-02-06	
J	Wilde, EA; Hunter, JV; Bigler, ED				Wilde, Elisabeth A.; Hunter, Jill V.; Bigler, Erin D.			Pediatric traumatic brain injury: Neuroimaging and neurorehabilitation outcome	NEUROREHABILITATION			English	Article						Neuroimaging; neurorehabilitation; diffusion tensor imaging (DTI); magnetic resonance imaging (MRI); computed tomography (CT); children	DIFFUSE AXONAL INJURY; WORKING-MEMORY; CORTICAL THICKNESS; HEAD-INJURY; CHILDREN; MODERATE; ADOLESCENTS; ACTIVATION; CHILDHOOD; LESIONS	Brain injury in the pediatric patient not only occurs in an immature brain, but potentially influences all subsequent brain and neurodevelopmental maturation. This presents unique challenges in neuroimaging the developing central nervous system, which is reviewed herein. The most significant neuroimaging advances in assessing pediatric traumatic brain injury (TBI) have occurred with magnetic resonance imaging (MRI), particularly diffusion tensor imaging and the multiple emerging techniques using functional MRI (fMRI). Pediatric neuroimaging findings of TBI are discussed in terms of techniques that can assess underlying neural networks and provide information about neuroplasticity of recovery. Neuroimaging methods also provide insights into the complexities of brain injury, cognitive and neurobehavioral recovery, and how multimodality contemporary neuroimaging methods best demonstrate underlying neuropathology that affects outcome.	[Wilde, Elisabeth A.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA		Wilde, EA (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	ewilde@bcm.edu			National Institute Neurological Disorders and Stroke grant [R01-NS21889, 1 RO1-HD-04946]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by the National Institute Neurological Disorders and Stroke grant R01-NS21889 ("Neurobehavioral outcome of head injury in children") and 1 RO1-HD-04946 (Social Outcomes in Pediatric Traumatic Brain Injury). We gratefully acknowledge the contribution of Tracy Abildskov in manuscript preparation. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V., 2010, PEDIAT TRAUMATIC BRA; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Dennis M, 2010, CORTEX, V46, P1043, DOI 10.1016/j.cortex.2009.10.008; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Faul M, 2010, TRAUMATIC BRAIN INJU; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gorman S., 2011, J INT NEUROPSYCH SOC, V17, P1; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jernigan TL, 2011, PROG BRAIN RES, V189, P77, DOI 10.1016/B978-0-444-53884-0.00019-1; Johnson CP, 2011, J INT NEUROPSYCH SOC, P1; Karunanayaka PR, 2007, NEUROREHABILITATION, V22, P355; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lajiness-O'Neill R, 2011, APPL NEUROPSYCHOL, V18, P298, DOI 10.1080/09084282.2011.595457; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Scheibel RS, 2011, SOC NEUROSCI-UK, V6, P582, DOI 10.1080/17470919.2011.588844; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Essen D., 2012, NEUROIMAGE; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Wilde E. A., 2012, BRAIN IMAGING BEHAV; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	58	20	20	0	30	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	3					245	260		10.3233/NRE-2012-0794			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	028QC	WOS:000310436200003	23093453				2022-02-06	
J	Zlotnik, A; Leibowitz, A; Gurevich, B; Ohayon, S; Boyko, M; Klein, M; Knyazer, B; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Leibowitz, Akiva; Gurevich, Boris; Ohayon, Sharon; Boyko, Matthew; Klein, Moti; Knyazer, Boris; Shapira, Yoram; Teichberg, Vivian I.			Effect of estrogens on blood glutamate levels in relation to neurological outcome after TBI in male rats	INTENSIVE CARE MEDICINE			English	Article						Traumatic brain injury; Estrogen; Blood glutamate; Neuroprotection	CLOSED-HEAD-INJURY; TRAUMATIC BRAIN-INJURY; CONJUGATED EQUINE ESTROGENS; SCAVENGING ACTIVITY; RECEPTOR; MECHANISMS; ESTRADIOL; WOMEN; NEUROPROTECTION; PROGESTERONE	Estrogen has been shown to possess neuroprotective properties both in vitro and in vivo. Traumatic brain injury (TBI) in ovulating females results in favorable neurological outcomes when compared to males with similar insults. The brain-to-blood glutamate gradient removes excess glutamate from brain extracellular fluids (ECF). Enhancing this gradient leads to improved neurological outcomes following TBI. In this study we investigate the effect of female gonadal steroids on blood glutamate levels and neurological outcomes. Forty male Sprague-Dawley rats were assigned to one of five groups: (1) sham, (2) Premarin treatment, (3) TBI, (4) TBI + Premarin treatment, and (5) TBI + Premarin pretreatment. TBI was induced, and estrogen and glutamate levels were determined at 0, 60, 120, 135, and 150 min. Neurological recovery was evaluated using the Neurological Severity Score (NSS) at 1 h and reassessed at 24 h post TBI. Premarin treatment groups demonstrated a decline in blood glutamate levels by 60 min. This decline was found to be more pronounced in the TBI + Premarin group, which maintained the decline throughout the experiment. At 120 min, the difference between groups was most pronounced (TBI + Premarin 99 +/- A 36 mu M/l vs. control 200 +/- A 46 mu M/l, p < 0.01). Neurological recovery was significantly better in the Premarin treatment group (NSS at 24 h 6 +/- A 1 vs. control 11 +/- A 1). Premarin injected into male rats significantly decreases blood glutamate levels in rats suffering TBI. This decrease is associated with improved neurological outcomes, thus implicating the role of estrogen in neuroprotection.	[Zlotnik, Alexander; Leibowitz, Akiva; Gurevich, Boris; Ohayon, Sharon; Boyko, Matthew; Klein, Moti; Shapira, Yoram] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel; [Knyazer, Boris] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Ophthalmol, IL-84105 Beer Sheva, Israel; [Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel		Leibowitz, A (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel.	akival@bgu.ac.il	Knyazer., Boris/D-8969-2014; klein, moti/AAR-6552-2021; Leibowitz, Akiva/F-1397-2012; Knyazer, Boris/AAM-6854-2020	Knyazer., Boris/0000-0002-9246-3226; Knyazer, Boris/0000-0002-9246-3226; Boyko, Matthew/0000-0003-3116-1643; Leibowitz, Akiva/0000-0003-4244-1915			Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Behl C, 2000, J NEUROCYTOL, V29, P351, DOI 10.1023/A:1007109222673; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Cimarosti H, 2005, NEUROSCI LETT, V385, P52, DOI 10.1016/j.neulet.2005.05.006; Cimarosti H, 2006, NEUROCHEM RES, V31, P483, DOI 10.1007/s11064-006-9043-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Duckles SP, 2007, CLIN EXP PHARMACOL P, V34, P801, DOI 10.1111/j.1440-1681.2007.04683.x; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Klin Y, 2010, BIOCHEM BIOPH RES CO, V399, P694, DOI 10.1016/j.bbrc.2010.07.144; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Mitrovic AD, 1999, NEUROCHEM INT, V34, P101, DOI 10.1016/S0197-0186(98)00066-7; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Patkar S, 2011, NEUROSCI RES, V71, P78, DOI 10.1016/j.neures.2011.05.006; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shen KH, 2008, SHOCK, V30, P668, DOI 10.1097/SHK.0b013e31817538cb; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Wang Q, 1999, STROKE, V30, P630, DOI 10.1161/01.STR.30.3.630; Warren MP, 2004, AM J OBSTET GYNECOL, V190, P1141, DOI 10.1016/j.ajog.2003.09.033; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Zauner A, 1996, ACT NEUR S, V67, P40; Zhao LQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-24; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120; Zlotnik A, 2011, NEUROCHEM RES, V36, P732, DOI 10.1007/s11064-010-0388-8; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	40	20	20	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	JAN	2012	38	1					137	144		10.1007/s00134-011-2401-3			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858YM	WOS:000297839600020	22124768				2022-02-06	
J	Bottari, C; Gosselin, N; Guillemette, M; Lamoureux, J; Ptito, A				Bottari, Carolina; Gosselin, Nadia; Guillemette, M.; Lamoureux, J.; Ptito, Alain			Independence in managing one's finances after traumatic brain injury	BRAIN INJURY			English	Article						Problem-solving; planning; cognition; brain injuries; independent living; rehabilitation; executive functions	MILD COGNITIVE IMPAIRMENT; PATIENTS PERFORMING ACTIVITIES; FRONTAL-LOBE DAMAGE; EXECUTIVE DEFICITS; DYSFUNCTION; ABILITIES; AWARENESS; CAPACITY; VALIDITY; PROFILE	Primary objective: To establish whether the budgeting task of the Instrumental Activities of Daily Living (IADL) Profile discriminates individuals with a traumatic brain injury (TBI) from healthy controls and to identify the nature of the observed difficulties. Method: This study tested 27 adults with moderate or severe TBI and 27 controls matched for age, sex and education on the budgeting task of the IADL Profile. The budgeting task is a complex real-world problem involving the preparation of a yearly budget for an individual living on a fixed income with the goal of saving money to purchase a car. Main results: The results showed that TBI subjects, the majority of whom had documented frontal lesions and/or diffuse axonal injury based on CT scan reports, were more likely than control subjects to experience difficulties on all task-related operations (planning, carrying out and verifying attainment of goal), with planning being particularly affected. These deficits were shown to impact on financial abilities, an issue of particular concern for TBI individuals reporting full responsibility of their finances. Conclusions: The budgeting task of the IADL Profile discriminates TBI subjects from controls. Planning was shown to be the most significant difficulty underlying reduced independence in the task.	[Ptito, Alain] McGill Univ, Ctr Hlth, Dept Psychol, Montreal, PQ H3A 1A1, Canada; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Occupat Therapy Program, Montreal, PQ, Canada; [Bottari, Carolina; Gosselin, Nadia; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Bottari, Carolina; Gosselin, Nadia; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A1, Canada; [Bottari, Carolina; Lamoureux, J.] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Guillemette, M.] Hop Anna Laberge, Montreal, PQ, Canada		Ptito, A (corresponding author), McGill Univ, Ctr Hlth, Dept Psychol, 1025 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	alain.ptito@mcgill.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Quebec Rehabilitation Research network; Fonds de la recherche en sante du QuebecFonds de la Recherche en Sante du Quebec [6623]; Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal	This study was supported by the Canadian Institutes of Health Research (fellowships to Nadia Gosselin and Carolina Bottari), the Quebec Rehabilitation Research network (studentship to Melanie Guillemette), the Fonds de la recherche en sante du Quebec (grant to Elisabeth Dutil, Carolina Bottari and collaborators; Grant number 6623) and the Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal.	Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Crowe K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56, http://dx.doi.org/10.1375/pplt.2005.12.1.56]; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Grafman J, 1999, LANCET, V354, P1921, DOI 10.1016/S0140-6736(99)90438-5; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; Hoskin KM, 2005, REHABIL PSYCHOL, V50, P355, DOI 10.1037/0090-5550.50.4.355; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1973, WORKING BRAIN INTRO; MARSON DC, 2000, ARCH CLIN NEUROPSYCH, V15, P638; Moye J, 2007, J GERONTOL B-PSYCHOL, V62, pP3, DOI 10.1093/geronb/62.1.P3; Okonkwo OC, 2008, AM J GERIAT PSYCHIAT, V16, P650, DOI 10.1097/JGP.0b013e31817e8a9d; SEARIGHT R, 1991, J MENT HEALTH ADMIN, V18, P128; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Wechsler D., 1997, WECHSLER MEMORY SCAL	32	20	20	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2011	25	13-14					1306	1317		10.3109/02699052.2011.624570			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	847MI	WOS:000296976600006	22077536				2022-02-06	
J	Iverson, GL; Hakulinen, U; Waljas, M; Dastidar, P; Lange, RT; Soimakallio, S; Ohman, J				Iverson, Grant L.; Hakulinen, Ullamari; Waljas, Minna; Dastidar, Prasun; Lange, Rael T.; Soimakallio, Seppo; Ohman, Juha			To exclude or not to exclude: White matter hyperintensities in diffusion tensor imaging research	BRAIN INJURY			English	Article						Diffusion tensor imaging; methodology; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; CORPUS-CALLOSUM; MILD; PREVALENCE; CHILDREN; ABNORMALITIES; MODERATE; BIPOLAR; REPRODUCIBILITY	Objective: A practical methodological issue for diffusion tensor imaging (DTI) researchers is determining what to do about incidental findings, such as white matter hyperintensities (WMHI). The purpose of this study was to compare healthy control subjects with or without WMHIs on whole brain DTI. Method: Participants were 30 subjects (age=37.7, SD=11.3, Range=18-60; 70% female) who had no known developmental, general medical, neurological or psychiatric condition that could have had an adverse affect on brain morphology. Results: MRI (3 Tesla) revealed, at minimum, a WMHI in eight subjects (26.7%). Fractional anisotropy (FA) was calculated for 19 regions of interest (ROI). Frequency distributions of FA scores for the 19 ROIs were calculated. The 10th percentile for each ROI was selected as a cut-off score. Having four or more low FA scores occurred in 16.7%. More subjects with incidental findings met criterion for low FA scores (37.5%), compared to 9.1% of subjects with no findings. When subjects with minor WMHIs were retained and only those with multiple incidental findings were excluded, 8.3% of the retained subjects met criterion for low FA scores compared to 50.0% of the excluded subjects. Conclusions: The decision to include or exclude subjects who have incidental findings can influence the results of a study.	[Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada; [Hakulinen, Ullamari; Dastidar, Prasun; Soimakallio, Seppo] Pirkanmaa Hosp Dist, Med Imaging Ctr, Tampere, Finland; [Waljas, Minna; Ohman, Juha] Tampere Univ Hosp, Tampere, Finland; [Dastidar, Prasun; Soimakallio, Seppo; Ohman, Juha] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Lange, Rael T.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Ohman, Juha/0000-0002-6592-1367; Iverson, Grant/0000-0001-7348-9570	Pirkanmaa Hospital District, Tampere University Hospital	This study was supported by Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital. Grant Iverson, PhD has been reimbursed by the government, professional scientific bodies and commercial organizations for discussing or presenting research relating to MTBI and sport-related concussion at meetings, scientific conferences and symposiums. He is a co-investigator, collaborator or consultant on grants relating to TBI funded by several organizations. Dr Lange notes that the views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or US Government.	Agid R, 2003, INT J NEUROPSYCHOPH, V6, P215, DOI 10.1017/S146114570300347X; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Cao QJ, 2010, BRAIN RES, V1310, P172, DOI 10.1016/j.brainres.2009.10.031; Carter JC, 2009, PSYCHIAT RES-NEUROIM, V172, P215, DOI 10.1016/j.pscychresns.2008.09.005; Cooney BS, 1996, HEADACHE, V36, P616, DOI 10.1046/j.1526-4610.1996.3610616.x; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Ehrlich S, 2005, J AFFECT DISORDERS, V86, P281, DOI 10.1016/j.jad.2005.01.007; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; Greenwald BS, 2001, J AM GERIATR SOC, V49, P1218, DOI 10.1046/j.1532-5415.2001.49240.x; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jacobus J, 2009, NEUROTOXICOL TERATOL, V31, P349, DOI 10.1016/j.ntt.2009.07.006; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Lyoo IK, 2002, COMPR PSYCHIAT, V43, P361, DOI 10.1053/comp.2002.34636; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Moore PB, 2001, BRIT J PSYCHIAT, V178, P172, DOI 10.1192/bjp.178.2.172; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Pillai JJ, 2002, PSYCHIAT RES-NEUROIM, V114, P51, DOI 10.1016/S0925-4927(01)00129-9; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sassi RB, 2003, J AFFECT DISORDERS, V77, P237, DOI 10.1016/S0165-0327(02)00170-2; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soderlund H, 2003, CORTEX, V39, P1093, DOI 10.1016/S0010-9452(08)70879-7; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Widjaja E, 2010, EPILEPSY RES, V89, P246, DOI 10.1016/j.eplepsyres.2010.01.008; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Zhou B, 2010, J NEUROL, V257, P405, DOI 10.1007/s00415-009-5334-9	48	20	20	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2011	25	13-14					1325	1332		10.3109/02699052.2011.608409			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	847MI	WOS:000296976600008	22077537				2022-02-06	
J	Nacci, A; Ferrazzi, M; Berrettini, S; Panicucci, E; Matteucci, J; Bruschini, L; Ursino, F; Fattori, B				Nacci, A.; Ferrazzi, M.; Berrettini, S.; Panicucci, E.; Matteucci, J.; Bruschini, L.; Ursino, F.; Fattori, B.			Vestibular and stabilometric findings in whiplash injury and minor head trauma	ACTA OTORHINOLARYNGOLOGICA ITALICA			English	Article						Whiplash injury; Minor head trauma; Vestibular pathology; Stabilometry; Vestibular-spinal reflex	CERVICAL WHIPLASH; BRAIN-INJURY; NECK; SYMPTOMS; AFFERENTS; EXTENSION; VERTIGO	Vertigo and postural instability following whiplash and/or minor head injuries is very frequent. According to some authors, post-whiplash vertigo cannot be caused by real injury to vestibular structures; other authors maintain that vestibular damage is possible even in the case of isolated whiplash, with vascular or post-traumatic involvement. Furthermore, many of the balance disorders reported after trauma can be justified by post-traumatic modification to the cervical proprioceptive input, with consequent damage to the vestibular spinal reflex. The aim of this study was to evaluate the vestibular condition and postural status in a group of patients (Group A, n = 90) affected with balance disorders following whiplash, and in a second group (Group B, n = 20) with balance disorders after minor head injury associated with whiplash. Both groups were submitted to videonystagmography (VNG) and stabilometric investigation (open eyes - OE, closed eyes - CE, closed eyes with head retroflexed - CER) within 15 days of their injuries and repeated within 10 days after conclusion of cervical physiotherapy treatment. The VNG tests revealed vestibulopathy in 19% of cases in Group A (11% peripheral, 5% central, 3% in an undefined site) and in 60% of subjects in Group B (50% peripheral, 10% central). At the follow-up examination, all cases of non-compensated labyrinth deficit showed signs of compensation, while there were two cases (2%) in Group A and one case (5%) in Group B of PPV. As far as the altered posturographic recordings are concerned, while there was no specific pattern in the two groups, they were clearly pathologic, especially during CER. Both in OE and in CE there was an increase in the surface values and in those pertaining to shifting of the gravity centre on the sagittal plane, which was even more evident during CER. In Group A, the pre-post-physiotherapy comparison of CER results showed that there was a statistically significant improvement in the majority of the parameters after treatment. Moreover, in Group B there was frequent lateral shifting of the centre of gravity that was probably linked with the high percentage of labyrinth deficits. The comparison between the first and second stabilometric examinations was statistically significant only in those parameters referring to gravity centre shifting on the frontal plane, which was probably due to the progressive improvement in the associated vestibulopathy rather than to the physiotherapy treatment performed for the cervical damage. Hence, our study confirms that only in a minority of cases can whiplash cause central or peripheral vestibulopathy, and that this is more probable after minor head injury associated with whiplash. In addition, our data confirm that static stabilometry is fundamental for assessing postural deficits following a cervical proprioceptive disorder. In these cases, in fact, analysis of the different parameters and the indices referring to cervical interference not only permits evaluation of altered postural performance, but also detects and quantifies destabilisation activity within the cervical proprioceptive component.	[Nacci, A.; Ferrazzi, M.; Berrettini, S.; Matteucci, J.; Bruschini, L.; Ursino, F.; Fattori, B.] Univ Pisa, ENT Audiol & Phoniatr Unit, Dept Neurosci, I-56124 Pisa, Italy; [Panicucci, E.] Univ Pisa, Dept Expt Pathol, I-56124 Pisa, Italy		Nacci, A (corresponding author), Univ Pisa, ENT Audiol & Phoniatr Unit, Dept Neurosci, Via Paradisa 2, I-56124 Pisa, Italy.	a.nacci@med.unipi.it	Nacci, Andrea/AAF-7207-2019; Bruschini, Luca/AAM-8656-2020	Bruschini, Luca/0000-0002-6900-1306			ABRAHAMS VC, 1975, J NEUROPHYSIOL, V38, P10, DOI 10.1152/jn.1975.38.1.10; Agostini V, 2011, GAIT POSTURE, V34, P248, DOI 10.1016/j.gaitpost.2011.05.008; Armato E, 2002, CONTROLE POSTURAL PA, P105; BAKER J, 1982, BRAIN RES, V252, P151, DOI 10.1016/0006-8993(82)90989-1; BALLA J, 1988, HEADACHE PROBLEMS DI, P249; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Baloh RW, 2001, CLIN NEUROPHYSIOL, P322; Boniver Raymond, 2002, Int Tinnitus J, V8, P129; Bono G, 1995, 12 GIORN IT OT COLP, P21; BOYLE R, 1981, J NEUROPHYSIOL, V45, P852, DOI 10.1152/jn.1981.45.5.852; BRANDT T, 1981, ANN NY ACAD SCI, V374, P636, DOI 10.1111/j.1749-6632.1981.tb30907.x; Burdo S, 2000, SINDROMI OTONEUROLOG, P41; Casani A, 2000, 17 GIORN IT OT 20 GI, P95; Ciancaglini R, 2000, SINDROMI OTONEUROLOG, P31; CLAUSSEN CF, 1995, ACTA OTO-LARYNGOL, P53; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; DICHGANS J, 1974, BRAIN RES, V71, P225, DOI 10.1016/0006-8993(74)90964-0; DIERINGER N, 1984, EXP BRAIN RES, V55, P574; Endo K, 2008, SPINE, V33, pE539, DOI 10.1097/BRS.0b013e31817c55fe; Fattori B, 1992, 4 GIORN VEST PRAT DA, P39; Ferrari Robert, 2006, Aust Fam Physician, V35, P367; Fischer AJEM, 1997, CLIN OTOLARYNGOL, V22, P192, DOI 10.1046/j.1365-2273.1997.00031.x; FISCHER AJEM, 1995, ACTA OTO-LARYNGOL, P49; FRIEDMAN D, 1995, AM J ROENTGENOL, V164, P443, DOI 10.2214/ajr.164.2.7839986; Gagey PM, 1986, HUIT LECONS POSTUROL; Garcia R, 1996, CRANIO, V14, P233, DOI 10.1080/08869634.1996.11745973; GAY JR, 1953, JAMA-J AM MED ASSOC, V152, P1698, DOI 10.1001/jama.1953.03690180020006; Ghilardi PL, 2003, VESTIBOLOMETRIA CLIN, P135; Ghilardi PL, 1995, 12 GIORN IT OT COLP, P85; Ghilardi PL, 1989, ATT 76 C NAZ SIO RIE, P383; Giordano C, 2003, AUDIOMETRIA CLIN APP; Giordano C, 1995, 12 GIORN IT OT COLP, P103; GUIDETTI G, 1989, VESTIBULAR COMPENSATION, P145; GUIDETTI G, 1988, Agressologie, V29, P653; Guidetti G, 1996, DIAGNOSI TERAPIA DIS, P381; Guidetti G, 1996, DIAGNOSI TERAPIA DIS, P615; Guidetti G, 1990, DIAGNOSI TRATTAMENTO, P129; Honrubia V, 2001, CLIN NEUROPHYSIOL, P152; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; Klobas L, 2004, SWED DENT J, V28, P29; MacNab I, 2002, J BONE JOINT SURG BR, V84, P807; MAGNUSSON T, 1994, CEPHALALGIA, V14, P223, DOI 10.1046/j.1468-2982.1994.014003223.x; Manfrin M, 2008, TRATTATO VESTIBOLOGI, V3, P331; Mira E, 1995, 12 GIORN IT OT COLP, P9; Nomura Y, 1998, EQUILIB RES, V57, P608; NORRE M E, 1987, Acta Oto-Rhino-Laryngologica Belgica, V41, P574; Nuti D, 1992, 12 GIORN IT NIST CLI, P25; OOSTERVELD WJ, 1991, ACTA OTO-LARYNGOL, V111, P201, DOI 10.3109/00016489109137375; Palmgren Per J, 2009, Chiropr Osteopat, V17, P6, DOI 10.1186/1746-1340-17-6; PEARCE JMS, 1993, J NEUROL NEUROSUR PS, V56, P1328, DOI 10.1136/jnnp.56.12.1328-a; PEARCE JMS, 1989, J NEUROL NEUROSUR PS, V52, P1329, DOI 10.1136/jnnp.52.12.1329; PETERSON BW, 1988, PROG BRAIN RES, V76, P163; Pignataro O, 2000, SINDROMI OTONEUROLOG, P23; RADANOV BP, 1991, LANCET, V338, P712, DOI 10.1016/0140-6736(91)91441-V; Richmond F J, 1979, Prog Brain Res, V50, P245; Rowlands RG, 2009, J LARYNGOL OTOL, V123, P182, DOI 10.1017/S0022215108002569; Schuknecht HF, 1969, ARCH OTOLARYNGOL, V90, P113; SINFORIANI E, 1993, CONFIN CEPHALALGICA, V2, P71; Skovron ML, 1998, WHIPLASH INJURIES CU, P61; SPITZER WO, 1995, SPINE, V20, pS1; TEASDALE G, 1974, LANCET, V2, P81; TOGLIA JU, 1976, NEUROLOGY, V26, P808, DOI 10.1212/WNL.26.9.808; Tranter RMD, 2009, J FORENSIC LEG MED, V16, P53, DOI 10.1016/j.jflm.2008.09.001; Yoganandan N, 1999, SPINE, V24, P83, DOI 10.1097/00007632-199901010-00021; Zappal G, 1988, RIABILITAZIONE APPRE, V8, P337	66	20	20	1	16	PACINI EDITORE	PISA	VIA DELLA GHERARDESCA-ZONA INDUSTRIALE OSPEDALETTO, 56121 PISA, ITALY	0392-100X	1827-675X		ACTA OTORHINOLARYNGO	Acta Otorhinolaryngol. Ital.	DEC	2011	31	6					378	389					12	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	884GB	WOS:000299691800005	22323849				2022-02-06	
J	Saboori, P; Sadegh, A				Saboori, P.; Sadegh, A.			Material modeling of the head's subarachnoid space	SCIENTIA IRANICA			English	Article						Subarachnoid; Material modeling; Finite element; Head; Brain; Impact		The goal of this study is to investigate the mechanotransduction of an external load to the brain and the causation of concussion and Traumatic Brain Injury (TBI). However, as one step toward this goal, in this paper, the investigation of the material model selection and material properties of the subarachnoid space (SAS) are presented. As the interface between the skull and the brain, the material modeling of SAS plays an important role in the analysis of damping and movement of the brain within the skull, leading to TBI. Based on the histology and morphology of the SAS region, three material types, namely, soft solid, viscous fluid and porous media were proposed. To validate these material models, the relative displacement between the skull and the brain was compared with the experimental study. It was concluded that the optimum material properties of the three material models are for soft solid material, E = 1000 Pa, for viscous fluid, mu = 0.25 Pa.s, and for porous media, the permeability of 3.125 x 10(-10) m(2). The results indicated that the properties determined in this study for the three material models are appropriate and reliable for future investigations. That is, if one decides to use any of these materials to model the SAS, in local or global FE analyses, these values are suitable. (C) 2012 Sharif University of Technology. Production and hosting by Elsevier B.V. All rights reserved.	[Sadegh, A.] CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA; [Saboori, P.] Manhattan Coll, Dept Mech Engn, Riverdale, NY USA; [Sadegh, A.] CUNY City Coll, Ctr Adv Engn Design & Dev, New York, NY USA		Sadegh, A (corresponding author), CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA.	sadegh@ccny.cuny.edu					Al-Bsharat A., 1999, J STAPP CAR CRASH C, V43; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Jin X., 2006, J STAPP CAR CRASH, V50, P637; Kierszenbaum, 2007, HISTOLOGY CELL BIOL; Killer HE, 2006, BRAIN, V129, P1027, DOI 10.1093/brain/awl045; Kleiven S., 2002, J STAPP CAR CRASH, V46; Kleiven S, 2007, J STAPP CAR CRASH, V21, P81; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Ruan J.S., 1993, STAPP CAR CRASH C, P37; Saboori P., 2011, THESIS CITY U NEW YO; Saboori P., 2010, 16 US NAT C THEOR AP; Saboori P., 2010, JUN SCI C JSC VIENN; Saboori P., 2009, P INT MECH ENG C EXP; Saboori P., 2010, 26 SO BIOM ENG C SBE; Saboori P., 2010, P INT MECH ENG C EXP; Saboori P., 2011, SOC BIOM C FARM PENN; Saboori P., 2010, SUMM BIOENG C SBS; Saboori P., 2011, ARCHITECTURE HISTOLO; Saboori P., 2011, P INT MECH ENG C EXP; Saboori Parisa, 2011, MECHANOTRANSDUCTION; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, STAPP CAR CRASH C, V36; Van Der Rest M., 1991, 412 CNRSUPR U C BERN; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zoghi M., 2009, INT J COMPUT METHODS, V12, P1; Zoghi-Moghadam M, 2008, COMPUT METHOD BIOMEC, V11, P397, DOI 10.1080/10255840701848806; Zoghi-Moghadam M, 2010, INT J BIOMED ENG TEC, V4, P195, DOI 10.1504/IJBET.2010.034939	33	20	20	0	1	SHARIF UNIV TECHNOLOGY	TEHRAN	PO BOX 11155-8639, TEHRAN, 00000, IRAN	1026-3098			SCI IRAN	Sci. Iran.	DEC	2011	18	6					1492	1499		10.1016/j.scient.2011.11.032			8	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	890VR	WOS:000300174500045		gold			2022-02-06	
J	Blume, HK; Lucas, S; Bell, KR				Blume, Heidi K.; Lucas, Sylvia; Bell, Kathleen R.			Subacute Concussion-Related Symptoms in Youth	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Child; Subacute symptoms; Postconcussive symptoms; Post-traumatic headache; Post-concussive syndrome	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC HEADACHE; UNITED-STATES; SLEEP; CHILDREN; RECOVERY	Most athletes who experience a sports-related concussion recover from the acute effects within a few weeks. However, some children and adolescents with concussion experience symptoms for many weeks, or even months after the injury. Subacute and chronic symptoms related to concussion are particularly concerning in children, because cognitive deficits, headache or neck pain, sleep dysfunction, and emotional dysregulation can affect school performance and social function at a critical period of development and maturation. This article reviews the epidemiology of subacute symptoms after pediatric concussion and the current recommendations for the assessment and management cif these symptoms in children and adolescents.	[Blume, Heidi K.; Lucas, Sylvia; Bell, Kathleen R.] Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98105 USA		Blume, HK (corresponding author), Seattle Childrens Hosp, Div Pediat Neurol, B-5552 Sand Point Way NE, Seattle, WA 98105 USA.	heidi.blume@seattlechildrens.org		Bell, Kathleen/0000-0002-0928-2046	Department of Education, National Institute on Disability and Rehabilitation Research, TBI Model Systems: University of Washington Traumatic Brain Injury Model System [H133A070032]	This paper was supported in part by the Department of Education, National Institute on Disability and Rehabilitation Research, TBI Model Systems: University of Washington Traumatic Brain Injury Model System H133A070032.	Abend NS, 2008, J CHILD NEUROL, V23, P438, DOI 10.1177/0883073807309772; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, LANCET NEUROL, V4, P673, DOI 10.1016/S1474-4422(05)70196-4; Baumann Robert J, 2002, Paediatr Drugs, V4, P555; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hermann C, 2002, APPL PSYCHOPHYS BIOF, V27, P143, DOI 10.1023/A:1016295727345; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; O'Bryant SE, 2006, HEADACHE, V46, P1364, DOI 10.1111/j.1526-4610.2006.00579.x; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; RUBIN AM, 1995, AM J OTOL, V16, P216; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	67	20	20	1	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					665	+		10.1016/j.pmr.2011.08.007			19	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	858SI	WOS:000297822600008	22050942				2022-02-06	
J	Boffano, P; Boffano, M; Gallesio, C; Roccia, F; Cignetti, R; Piana, R				Boffano, Paolo; Boffano, Michele; Gallesio, Cesare; Roccia, Fabio; Cignetti, Riccardo; Piana, Raimondo			Rugby Players' Awareness of Concussion	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Rugby; concussion; sport injuries	MANAGEMENT; SPORTS; FOOTBALL; UNION	Purpose: Concussion is a common issue in most contact sports, such as rugby, being one of the most troublesome injuries facing the sports medicine physician. The aim of this article was to survey the knowledge and beliefs concerning concussion in a sample of young rugby athletes in the northwest of Italy. Methods: The athletes of 4 amateur rugby teams completed a questionnaire about their knowledge about the signs and symptoms of concussion and of return-to-play strategies and protocols. Results: Twenty-five athletes reported that they had not been informed by anyone about symptoms of concussion and its consequences. Among these, 7 players thought they could return to play immediately after a concussion during the very same match. Conclusions: The surveyed group in this study presented a general lack of knowledge of concussion. Rugby athletes and coaches must be made aware about signs and symptoms of concussion to suspect this injury. It would be desirable that rugby players are educated regarding the potential risks of playing while symptomatic.	[Boffano, Paolo] Univ Turin, San Giovanni Battista Hosp, Head & Neck Dept, Div Maxillofacial Surg,Maxillofacial Surg Unit, I-10126 Turin, Italy; [Boffano, Michele] CTO Hosp, Turin, Italy; [Cignetti, Riccardo; Piana, Raimondo] Univ Turin, Univ Sch Sports Sci, I-10126 Turin, Italy; [Piana, Raimondo] AO CTO M, Turin, Italy		Boffano, P (corresponding author), Univ Turin, San Giovanni Battista Hosp, Head & Neck Dept, Div Maxillofacial Surg,Maxillofacial Surg Unit, Corso Dogliotti 14, I-10126 Turin, Italy.	paolo.boffano@gmail.com	Boffano, Paolo/J-1094-2016	Boffano, Paolo/0000-0002-0782-9933; Roccia, Fabio/0000-0002-4765-6395; GALLESIO, CESARE/0000-0003-3863-3009			Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Goldberg LD, 2006, SPORTS MED ARTHROSC, V14, P199, DOI 10.1097/01.jsa.0000212326.23560.09; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; *INT RUGB BOARD, LAWS GAM; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910	13	20	21	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2011	22	6					2053	2056		10.1097/SCS.0b013e318231988d			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	857TE	WOS:000297741900040	22067860				2022-02-06	
J	Dengler, J; Frenzel, C; Vajkoczy, P; Wolf, S; Horn, P				Dengler, Julius; Frenzel, Christin; Vajkoczy, Peter; Wolf, Stefan; Horn, Peter			Cerebral tissue oxygenation measured by two different probes: challenges and interpretation	INTENSIVE CARE MEDICINE			English	Article						Licox; Raumedic; Cerebral tissue oxygenation; PbrO(2); Cerebral autoregulation	TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR AUTOREGULATION; SUBARACHNOID HEMORRHAGE; PRESSURE REACTIVITY; AGREEMENT; METAANALYSIS; THERAPY; MODEL; PO2	Purpose: Cerebral tissue oxygenation (PbrO(2)) is most frequently monitored using a Licox CC1.SB system (LX, Integra Neuroscience, France) but recently a new probe-the Neurovent-PTO (NV)-was introduced by a different manufacturer (Raumedic, Germany). There are no prospective data on how these probes compare in clinical routine. We therefore compared both probes in comatose patients suffering from traumatic brain injury (TBI) or subarachnoid haemorrhage (SAH) during dynamic changes of inspirational oxygen fraction (FiO(2)) and mean arterial pressure (MAP). Methods: PbrO(2) in 11 patients was recorded continuously using an LX and NV probe placed side by side into the same cerebrovascular region. Once a steady baseline value was reached FiO(2) was increased by 20% for 10 min. Once the baseline values were re-established MAP was increased by 20 mmHg for 10 min. Evaluation was performed using a four-parameter logistic function and Bland-Altman analyses. Results: PbrO(2) values of both probes differed significantly at all times. The LX probe reacted significantly faster to changes in FiO(2) and MAP. Limits of agreement ranged between -32.1 and 20.0 mmHg. Mean LX values were 6.1 mmHg lower than NV values. Conclusions: Since the examined patient cohort was rather small, this study's results are preliminary. However, they suggest that LX and NV probes measure different PbrO(2) values in routine monitoring as well as during phases of dynamic changes in FiO(2) and MAP. These data therefore do not support the view that both probes can be used interchangeably.	[Dengler, Julius; Frenzel, Christin; Vajkoczy, Peter; Wolf, Stefan; Horn, Peter] Charite, Dept Neurosurg, CVK, D-13553 Berlin, Germany		Dengler, J (corresponding author), Charite, Dept Neurosurg, CVK, Augustenburger Pl 1, D-13553 Berlin, Germany.	julius.dengler@charite.de			Department of Neurosurgery of the Charite, Berlin	The study was exclusively funded by the Department of Neurosurgery of the Charite, Berlin.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Dings J, 1996, ZBL NEUROCHIR, V57, P177; Huschak G, 2009, J NEUROSURG ANESTH, V21, P155, DOI 10.1097/ANA.0b013e31818f2eac; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2010, NEUROCRIT CARE, V13, P163, DOI 10.1007/s12028-010-9348-z; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; Pinheiro J. C., 2009, MIXED EFFECTS MODELS; Purins K, 2005, ACTA NEUROCHIR WIEN, V152, P681; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; The R Project for Statistical Computing, 2010, R PROJ STAT COMP R 2; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6	22	20	21	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	NOV	2011	37	11					1809	1815		10.1007/s00134-011-2316-z			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849WU	WOS:000297156900013	21809108				2022-02-06	
J	Sundberg, J; Estrada, C; Jenkins, C; Ray, J; Abramo, T				Sundberg, Jennifer; Estrada, Cristina; Jenkins, Cathy; Ray, Jacqueline; Abramo, Thomas			Hypothermia is associated with poor outcome in pediatric trauma patients	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							ADMISSION HYPOTHERMIA; VITAL-STATISTICS; MORTALITY; SEVERITY; MODELS	Objective: The objective of the study was to determine if hypothermia in pediatric trauma patients is associated with increased mortality. Methods: We reviewed the charts of level 1 trauma patients aged 3 months to 17 years who presented between September 2006 and March 2008. We analyzed data for patients with temperatures recorded within 30 minutes of arrival to the pediatric emergency department. Logistic regression models were used to test for associations of hypothermia with death while adjusting for mode of transport, season of year, and presence of intracranial pathology as documented by an abnormal head computed tomographic scan. Results: Of the 226 level 1 trauma patients presenting during the study period, 190 met inclusion criteria. Twenty-one patients (11%) died. The odds ratio (OR) of a hypothermic patient dying was 9.2 times that of a normothermic patient when adjusting for seasonal variation (95% confidence interval [CI], 3.2-26.2; P < 0.0001). The OR of a hypothermic patient dying was 8.7 times that of a normothermic patient when adjusting for mode of transport (ground vs air) (95% CI, 3.1-24.6; P < 0.0001). Although it did not reach statistical significance, there was a trend toward an association between hypothermia and the presence of traumatic brain injury as evidenced by an abnormal head computed tomographic scan (OR = 2.4; 95% CI, 0.9-6.0; P = .07). Conclusions: Hypothermia is a risk factor for increased mortality in pediatric trauma patients. This pilot study warrants a more detailed, multicenter analysis to assess the impact of hypothermia in the pediatric trauma patient. (C) 2011 Elsevier Inc. All rights reserved.	[Sundberg, Jennifer; Estrada, Cristina; Ray, Jacqueline; Abramo, Thomas] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA; [Jenkins, Cathy] Vanderbilt Univ, Dept Biostat, Nashville, TN USA		Sundberg, J (corresponding author), Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA.	sundbergj@ema.net		Abramo MD, Thomas/0000-0003-2331-4582			Aitken LM, 2009, RESUSCITATION, V80, P217, DOI 10.1016/j.resuscitation.2008.10.021; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; Bernardo L M, 1999, Int J Trauma Nurs, V5, P101, DOI 10.1016/S1075-4210(99)90057-3; CORNELI HM, 1992, J PEDIATR-US, V120, P671, DOI 10.1016/S0022-3476(05)80226-4; Coule LWW, 2007, PEDIAT CRITICAL CARE, P1805; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; Dilley Anthony WD, 2006, PEDIAT TRAUMA PATHOP, P419; Dowd MD, 2002, CRIT CARE MED, V30, pS385, DOI 10.1097/00003246-200211001-00002; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Ewald MBC, 2006, TXB PEDIAT EMERGENCY; Fukudome EY, 2009, CRIT CARE MED, V37, pS265, DOI 10.1097/CCM.0b013e3181aa60ac; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; R Core Team, 2017, R LANG ENV STAT COMP; Rotondo MF, 1997, SURG CLIN N AM, V77, P761, DOI 10.1016/S0039-6109(05)70582-X; Sambasivan CN, 2009, CURR OPIN CRIT CARE, V15, P560, DOI 10.1097/MCC.0b013e328331f57c; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Shaz BH, 2009, ANESTH ANALG, V108, P1760, DOI 10.1213/ane.0b013e3181a0b6c6; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; Waibel BH, PEDIAT CRIT CARE MED, V11, P199; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Wetzel RC, 2002, CRIT CARE MED, V30, pS468, DOI 10.1097/00003246-200211001-00012; Willis RB, 2008, PEDIATRICS, V121, P849, DOI 10.1542/peds.2008-0094	28	20	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2011	29	9					1019	1022		10.1016/j.ajem.2010.06.002			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	851OP	WOS:000297280800009	20708896				2022-02-06	
J	Gabrielian, L; Willshire, LW; Helps, SC; van den Heuvel, C; Mathias, J; Vink, R				Gabrielian, Levon; Willshire, Luke W.; Helps, Stephen C.; van den Heuvel, Corinna; Mathias, Jane; Vink, Robert			Intracranial Pressure Changes following Traumatic Brain Injury in Rats: Lack of Significant Change in the Absence of Mass Lesions or Hypoxia	JOURNAL OF NEUROTRAUMA			English	Article						brain swelling; fluid percussion; hemorrhage; impact-acceleration; neurotrauma	CEREBRAL PERFUSION-PRESSURE; CORTICAL IMPACT INJURY; SEVERE HEAD-INJURY; FLUID-PERCUSSION; TIME-COURSE; EDEMA; ICP; HYPERTENSION; HYPOTENSION; ANESTHESIA	Traumatic brain injury (TBI) often causes raised intracranial pressure (ICP), with > 50% of all TBI-related deaths being associated with this increase in ICP. To date, there is no effective pharmacological treatment for TBI, partly because widely used animal models of TBI may not replicate many of the pathophysiological responses observed in humans, and particularly the ICP response. Generally, rodents are the animal of choice in neurotrauma research, and edema formation has been demonstrated in rat models; however, few studies in rats have specifically explored the effects of TBI on ICP. The aim of the current study was to investigate the ICP response of rats in two different, focal and diffuse, injury models of TBI. Adult male Sprague-Dawley rats were subjected to brain trauma by either lateral fluid percussion or impact-acceleration induced injury, in the presence or absence of secondary hypoxia. ICP, mean arterial blood pressure (MABP), and cerebral perfusion pressure (CPP) were monitored for 4 h after TBI. TBI alone or coupled with hypoxia did not result in any significant increase of ICP in rats unless there was an intracranial hemorrhage. At all other times, changes in CPP were the result of changes in MABP and not ICP. Our results suggest that rats may be able to compensate for the intracranial expansion associated with cerebral edema after TBI, and that they only develop a consistent post-traumatic increase in ICP in the presence of a mass lesion. Therefore, they are an inappropriate model for the investigation of ICP changes after TBI, and for the development of therapies targeting ICP.	[Gabrielian, Levon; Willshire, Luke W.; Helps, Stephen C.; van den Heuvel, Corinna; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurol Dis, Adelaide, SA 5005, Australia; [Mathias, Jane] Univ Adelaide, Sch Psychol, Adelaide Ctr Neurol Dis, Adelaide, SA 5005, Australia		Vink, R (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurol Dis, Adelaide, SA 5005, Australia.	Robert.Vink@adelaide.edu.au	Mathias, J L/L-6295-2013; Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; , Corinna/0000-0003-0664-8935; Mathias, Jane/0000-0001-8957-8594	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	We would thank Dr. Emma Thornton for her helpful comments during the preparation of this manuscript. This research was funded, in part, by a grant from the National Health and Medical Research Council of Australia.	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BULL JWD, 1969, P ROY SOC MED, V62, P1301, DOI 10.1177/003591576906201242; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fish R, 1997, ANESTHESIA ANALGESIA, P6; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLINTWORTH GK, 1968, ANAT RECORD, V160, P635, DOI 10.1002/ar.1091600312; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; MAGGI CA, 1986, EXPERIENTIA, V42, P109, DOI 10.1007/BF01952426; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NIDA TY, 1995, J NEUROTRAUM, V12, P77, DOI 10.1089/neu.1995.12.77; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Papadopoulos M.C., 2004, FASEB J, V10, P1; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rolett EL, 2000, AM J PHYSIOL-REG I, V279, pR9, DOI 10.1152/ajpregu.2000.279.1.R9; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soustiel JF, 2010, NEUROTHERAPEUTICS, V7, P13, DOI 10.1016/j.nurt.2009.11.001; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thomas S, 1998, ACT NEUR S, V71, P135; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Zweckberger K, 2009, NEUROSCI LETT, V454, P115, DOI 10.1016/j.neulet.2009.02.014	59	20	21	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2011	28	10					2103	2111		10.1089/neu.2011.1785			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	839OX	WOS:000296378500011	21657835				2022-02-06	
J	Bukur, M; Kurtovic, S; Berry, C; Tanios, M; Margulies, DR; Ley, EJ; Salim, A				Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Margulies, Daniel R.; Ley, Eric J.; Salim, Ali			Pre-Hospital Intubation is Associated with Increased Mortality After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Surgery (AAS)/6th Annual Academic-Surgical Congress	FEB 01-03, 2011	Huntington Beach, CA	Assoc Acad Surg (AAS), Acad Surg		traumatic brain injury; pre-hospital intubation; mortality; outcomes	ENDOTRACHEAL INTUBATION; EARLY VENTILATION; HYPOTENSION; MODERATE; HYPOXIA; FIELD	Background. Early endotracheal intubation in patients sustaining moderate to severe traumatic brain injury (TBI) is considered the standard of care. Yet the benefit of pre-hospital intubation (PHI) in patients with TBI is questionable. The purpose of this study was to investigate the relationship between pre-hospital endotracheal intubation and mortality in patients with isolated moderate to severe TBI. Methods. The Los Angeles County Trauma System Database was queried for all patients > 14 y of age with isolated moderate to severe TBI admitted between 2005 and 2009. The study population was then stratified into two groups: those patients requiring intubation in the field (PHI group) and those patients with delayed airway management (No-PHI group). Demographic characteristics and outcomes were compared between groups. Multivariate analysis was used to determine the relationship between pre-hospital endotracheal intubation and mortality. Results. A total of 2549 patients were analyzed and then stratified into the two groups: PHI and No-PHI. There was a significant difference noted in overall mortality (90.2% versus 12.4%), with the PHI group being more likely to succumb to their injuries. After adjusting for possible confounding factors, multivariable logistic regression analysis demonstrated that PHI was independently associated with increased mortality (AOR 5, 95% CI: 1.7-13.7, P = 0.004). Conclusions. Pre-hospital endotracheal intubation in isolated, moderate to severe TBI patients is associated with a nearly 5-fold increase in mortality. Further prospective studies are required to establish guidelines for optimal pre-hospital management of this critically injured patient population. (C) 2011 Elsevier Inc. All rights reserved.	[Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Margulies, Daniel R.; Ley, Eric J.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020	Bukur, Marko/0000-0002-1850-7147			Barnes SL, 2008, J TRAUMA, V64, pS129, DOI 10.1097/TA.0b013e318160a5b4; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Brain Trauma Foundation Guidelines, MAN PROGN SEV TRAUM; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS7, DOI DOI 10.1089/NEU.2007.9995; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Combes X, 2011, ANESTHESIOLOGY, V114, P105, DOI 10.1097/ALN.0b013e318201c42e; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; GRAHAM DI, 1971, LANCET, V1, P265; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	20	20	22	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2011	170	1					E117	E121		10.1016/j.jss.2011.04.005			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	804BD	WOS:000293627800015	21601884				2022-02-06	
J	Silva, J; Ownsworth, T; Shields, C; Fleming, J				Silva, Jennifer; Ownsworth, Tamara; Shields, Cassandra; Fleming, Jennifer			Enhanced Appreciation of Life Following Acquired Brain Injury: Posttraumatic Growth at 6 Months Postdischarge	BRAIN IMPAIRMENT			English	Article						brain injury; posttraumatic growth; subjective impairment; depressive symptoms	PSYCHOMETRIC EVALUATION; POSITIVE CONSEQUENCES; 2-COMPONENT MODEL; TUMOR PATIENTS; BREAST-CANCER; BENEFIT; DEPRESSION; ADVERSITY; STROKE; SENSE	preliminary research supports that acquired brain injury (ABI) can act as a catalyst for positive psychological changes, and that such posttraumatic growth (PIG) increases with time since injury. In this study, posttraumatic growth refers to positive psychological changes in domains including interpersonal relationships, new possibilities, personal strength, spirituality and appreciation for life. This study aimed to identify associations between levels of subjective impairment and depressive symptoms at discharge, and PTG at 6-months postdischarge following ABI. Sixty participants (73% male) with ABI (Mean days of hospitalisation = 32.92, SD = 40.74) were consecutively recruited from an inpatient rehabilitation unit at discharge and were administered measures of subjective impairment (Mayo-Portland Adaptability Index-4; MPAI-4) and depression (Depression, Anxiety Stress Scales; DASS). Participants were followed up at 6-months postdischarge and administered the Post-Traumatic Growth Inventory, DASS and MPAI-4. The results indicated that levels of PIG reported at six months postdischarge were relatively modest and ranged between no to very small degree of change ('spirituality') and a small to moderate degree of change ('a greater appreciation of life'). Level of subjective impairment at discharge significantly predicted overall level of PIG at 6-months follow-up (beta=.40, p<.05, sr(2)=.28). Further, at 6-months postdischarge, individuals with a greater appreciation for life reported significantly higher levels of subjective impairment (r=.35; p<.01) and depressive symptoms (r=.34, p<.01) at that time point These findings indicate that individuals who perceive greater functional consequences of their ABI are more likely to experience PIG. Further, the process of reevaluating priorities and values in life after ABI may be associated with emotional distress during the early stages of community reintegration.	[Silva, Jennifer; Ownsworth, Tamara; Shields, Cassandra] Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia; [Silva, Jennifer; Ownsworth, Tamara; Shields, Cassandra] Griffith Inst Hlth, Nathan, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Metro S Hlth Serv Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094	Department of Communities (Disability Services); Acquired Brain Injury Outreach Services; Australian Research CouncilAustralian Research Council [LP0776294]	We would like to acknowledge the funding and support for this project from the Department of Communities (Disability Services), Acquired Brain Injury Outreach Services and the Australian Research Council (LP0776294). We are grateful to the occupational therapists and medical directors of the Brain Injury Rehabilitation Unit and Acute Neurosciences Ward at the Princess Alexandra Hospital. We would also like to thank Emily Nalder, Petrea Cornwell, Terrence Haines, Melissa Kendall, Professor Linda Worrall and Professor Lesley Chenoweth for their involvement in the broader project.	Adelbratt S, 2000, PALLIATIVE MED, V14, P499, DOI 10.1191/026921600701536426; ALDWIN CM, 1987, J PERS SOC PSYCHOL, V53, P337, DOI 10.1037/0022-3514.53.2.337; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Caplan G., 1964, PRINCIPLES PREVENTIV; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; Folkman S., 1984, STRESS; Frankl V.E., 1963, MANS SEARCH MEANING; Frazier P, 2001, J CONSULT CLIN PSYCH, V69, P1048, DOI 10.1037//0022-006X.69.6.1048; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gillen G, 2005, AM J OCCUP THER, V59, P346, DOI 10.5014/ajot.59.3.346; Harrington S, 2008, J PSYCHOSOC ONCOL, V26, P43, DOI 10.1080/07347330802115848; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hayes AM, 2007, CLIN PSYCHOL REV, V27, P715, DOI 10.1016/j.cpr.2007.01.008; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joseph S, 2005, PSYCHOL ASSESSMENT, V17, P70, DOI 10.1037/1040-3590.17.1.70; Joseph S, 2006, CLIN PSYCHOL REV, V26, P1041, DOI 10.1016/j.cpr.2005.12.006; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kim Y, 2007, PSYCHOSOM MED, V69, P283, DOI 10.1097/PSY.0b013e3180417cf4; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Maercker A, 2004, PSYCHOL INQ, V15, P41; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; MCGRATH JC, 2008, TRAUMA RECOVERY GROW, P259; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Mols F, 2009, PSYCHOL HEALTH, V24, P583, DOI 10.1080/08870440701671362; Nietzsche Friedrich, 1955, BEYOND GOOD EVIL; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Park CL, 1996, J PERS, V64, P71, DOI 10.1111/j.1467-6494.1996.tb00815.x; PARK CL, 1997, REV GEN PSYCHOL, V0002, P00115, DOI DOI 10.1037/1089-2680.1.2.115; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Sears SR, 2003, HEALTH PSYCHOL, V22, P487, DOI 10.1037/0278-6133.22.5.487; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Strang S, 2001, PALLIATIVE MED, V15, P127, DOI 10.1191/026921601670322085; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; THOMPSON SC, 1991, BASIC APPL SOC PSYCH, V12, P81, DOI 10.1207/s15324834basp1201_6; THOMPSON SC, 1988, J SOC CLIN PSYCHOL, V7, P260, DOI 10.1521/jscp.1988.7.2-3.260; TOMICH PL, 2004, ANN M SOC BEH MED BA; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Warren D., 2008, THESIS U ROCKIES; Yalom I., 1980, EXISTENTIAL PSYCHOTH; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	54	20	21	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2011	12	2			SI		93	104		10.1375/brim.12.2.93			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	837BH	WOS:000296165600003		Green Published			2022-02-06	
J	Yu, CH; Yhee, JY; Kim, JH; Im, KS; Kim, NH; Jung, DI; Lee, HC; Chon, SK; Sur, JH				Yu, Chi-Ho; Yhee, Ji-Young; Kim, Jong-Hyuk; Im, Keum-Soon; Kim, Na-Hyun; Jung, Dong-In; Lee, Hee-Chun; Chon, Seung-Ki; Sur, Jung-Hyang			Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury	JOURNAL OF VETERINARY SCIENCE			English	Article						interleukin-1; interleukin-6; transforming growth factor-beta; traumatic brain injury; tumor necrosis factor-alpha	DOG; HYPOTHERMIA; RAT	We analyzed the expression level and cellular localization of pro- and anti-inflammatory cytokines and histopathologically characterized canine traumatic brain injury (TBI). Canine TBI brains revealed subarachnoid and cerebral cortical hemorrhage, neutrophilic infiltration, neuronal necrosis, astrocytosis, and vasogenic edema. Immunohistochemical evaluations suggested that both pro-inflammatory cytokines [interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha] and anti-inflammatory cytokines [IL-10 and transforming growth factor-beta (TGF-beta)] were highly expressed in neurons and neutrophils. In particular, the highest magnitude of expression was identified for IL-1 beta and TGF-beta. This data helps describe the pathologic characteristics of canine TBI, and may help in the design of potential therapeutic approaches to control secondary damage by inflammatory cytokines.	[Yu, Chi-Ho; Yhee, Ji-Young; Kim, Jong-Hyuk; Im, Keum-Soon; Kim, Na-Hyun; Sur, Jung-Hyang] Konkuk Univ, Dept Pathobiol, Small Anim Tumor Diagnost Ctr, Coll Vet Med, Seoul 143701, South Korea; [Jung, Dong-In] Gyeongsang Natl Univ, Dept Internal Med, Coll Vet Med, Jinju 660701, South Korea; [Lee, Hee-Chun] Gyeongsang Natl Univ, Dept Med Imaging, Coll Vet Med, Jinju 660701, South Korea; [Chon, Seung-Ki] Hyu Anim Clin, Iksan 570973, South Korea		Sur, JH (corresponding author), Konkuk Univ, Dept Pathobiol, Small Anim Tumor Diagnost Ctr, Coll Vet Med, Seoul 143701, South Korea.	jsur@konkuk.ac.kr	KIM, JONG HYUK/AAC-7433-2020	KIM, JONG HYUK/0000-0002-1645-0036; Sur, Jung-Hyang/0000-0003-4496-7582	Konkuk University	We thank to Ms. R. H Jang for excellent technical assistance. This paper was supported by Konkuk University Research Fund in 2009. This report represents part of the thesis submitted by Dr. C. H Yu to fulfill the requirements of a Ph.D.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Foley C, 2009, J VET EMERG CRIT CAR, V19, P269, DOI 10.1111/j.1476-4431.2009.00409.x; FOSSUM T, 2007, SMALL ANIMAL SURG, P1379; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Kitagawa M, 2005, J VET MED SCI, V67, P843, DOI 10.1292/jvms.67.843; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Laurent S, 2010, J COMP PATHOL, V143, P75, DOI 10.1016/j.jcpa.2009.12.008; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MCGAVIN MD, 2006, PATHOLOGIC BASIS VET, P938; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101	13	20	22	3	7	KOREAN SOC VETERINARY SCIENCE	SEOUL	SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 151-742, SOUTH KOREA	1229-845X	1976-555X		J VET SCI	J. Vet. Sci.	SEP	2011	12	3					299	301		10.4142/jvs.2011.12.3.299			3	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	822BA	WOS:000295017500016	21897106	Green Published, gold			2022-02-06	
J	Clune-Ryberg, M; Blanco-Campal, A; Carton, S; Pender, N; O'Brien, D; Phillips, J; Delargy, M; Burke, T				Clune-Ryberg, Melanie; Blanco-Campal, Alberto; Carton, Simone; Pender, Niall; O'Brien, Donncha; Phillips, Jack; Delargy, Mark; Burke, Teresa			The contribution of retrospective memory, attention and executive functions to the prospective and retrospective components of prospective memory following TBI	BRAIN INJURY			English	Article						Memory disorders; neuropsychological test; process approach; cognitive rehabilitation; delayed intentions; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERFORMANCE; REALIZATION; INTENTIONS	Primary objective: Despite the prevalence of prospective memory (PM) problems, relatively little is known about the processes underlying impairment following TBI. This study sought to examine PM performance, using a multiple-task, multiple-response video-based paradigm in which initial encoding of the cue-action associations was ensured (Video-Assessment of Prospective Memory; VAPM). Research design: VAPM was designed to allow easy identification of reasons for failure (i.e. cue detection and/or specific action retrieval). Patients with moderate/severe TBI (n == 32) and matched controls (n == 16) also completed standardized neuropsychological assessment including evaluation of episodic retrospective memory (RM), attention, information processing, executive functions and mood. Main outcomes and results: As a group, those with TBI were impaired on PM tasks with 50%% failing to complete at least 2/6 required tasks despite near perfect performance by controls. Individual profile analyses revealed different reasons for impairment, with RM contributing significantly to both the prospective and retrospective components. This was supported by correlational analyses illustrating a significant relationship between cue detection and RM measures, in addition to measures of executive functions and attention. Conclusions: The contribution of RM to both components of PM, along with the finding of heterogeneity in performance among participants have important implications for theoretical understanding and clinical practice.	[Clune-Ryberg, Melanie; Blanco-Campal, Alberto; Burke, Teresa] Univ Coll Dublin, Sch Psychol, Dublin 4, Ireland; [Carton, Simone] DunLaoghaire Co, Natl Rehabil Hosp, Dept Clin Psychol, Dublin, Ireland; [Pender, Niall] Beaumont Hosp, Dept Clin Psychol, Dublin 9, Ireland; [O'Brien, Donncha] Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland; [Phillips, Jack] Beaumont Private Clin, Dublin, Ireland; [Delargy, Mark] DunLaoghaire Co, Natl Rehabil Hosp, Rehabil Med, Dublin, Ireland		Burke, T (corresponding author), Univ Coll Dublin, Sch Psychol, Dublin 4, Ireland.	evelyn.burke@ucd.ie		Burke, Teresa/0000-0001-8093-9912; Pender, Niall/0000-0002-4172-0704	Irish Research Council for the Humanities and Social Sciences (IRCHSS)Irish Research Council for Science, Engineering and Technology	Funding for this research was provided by the Irish Research Council for the Humanities and Social Sciences (IRCHSS), a postgraduate research scholarship to the first author. The authors report no conflicts of interest.	Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; Baddeley A, 1994, DOORS PEOPLE TEST TE; Baddeley A., 1992, SPEED CAPACITY LANGU; Bravin JH, 2000, J CLIN EXP NEUROPSYC, V22, P418, DOI 10.1076/1380-3395(200006)22:3;1-V;FT418; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; BURKE T, 2010, P 3 INT C PROSP MEM; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; CLUNE M, 2008, VIDEO ASSESSMENT PRO; CLUNE M, 2008, THESIS U COLL DUBLIN; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Delis D.C., 2001, DELIS KAPLAN D KEFS; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; Einstein G.O., 2007, PROSPECTIVE MEMORY O, V1, DOI DOI 10.4135/9781452225913; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Kinch J., 2001, BRAIN IMPAIR, V2, P119, DOI [10.1375/brim.2.2.119, DOI 10.1375/BRIM.2.2.119]; Kinsella GJ, 2009, BRAIN IMPAIR, V10, P45, DOI 10.1375/brim.10.1.45; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2007, INT J PSYCHOPHYSIOL, V64, P226, DOI 10.1016/j.ijpsycho.2006.09.007; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Palmer HM, 2000, BRAIN COGNITION, V44, P103; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; RASKIN S, 1998, P COGN NEUR SOC ANN; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Rey A., 1964, EXAMEN CLIN PSYCHOL; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schmidt M., 1996, REY AUDITORY VERBAL; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Titov N, 2000, BRAIN INJURY, V14, P877; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; West R, 2002, NEUROSCI BIOBEHAV R, V26, P827, DOI 10.1016/S0149-7634(02)00069-6; West R, 2000, APPL COGNITIVE PSYCH, V14, pS115, DOI 10.1002/acp.774; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; WILSON BA, 2005, PROSPECTIVE MEMORY T; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	20	23	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					819	831		10.3109/02699052.2011.589790			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300003	21721845				2022-02-06	
J	Holfelder, K; Schittenhelm, J; Trautmann, K; Haybaeck, J; Meyermann, R; Beschorner, R				Holfelder, K.; Schittenhelm, J.; Trautmann, K.; Haybaeck, J.; Meyermann, R.; Beschorner, R.			De novo expression of the hemoglobin scavenger receptor CD163 by activated microglia is not associated with hemorrhages in human brain lesions	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Microglia; Ischemia; Hypoxia; Trauma; Hemorrhage	CENTRAL-NERVOUS-SYSTEM; PERIVASCULAR MACROPHAGES; REACTIVE ASTROCYTES; CEREBRAL-ISCHEMIA; HUMAN MONOCYTES; HEME UPTAKE; IDENTIFICATION; PROTEIN; INJURY; CELLS	The main function of CD163 (hemoglobin scavenger receptor) is to bind the hemoglobin-haptoglobin complex, thereby mediating extravasal hemolysis. However, CD163 also has an antiinflammatory function. After CD163-mediated endocytosis, hemoglobin is catabolized further by hemeoxygenase 1 (HO-1). Previously, we found expression of HO-1 to be restricted to microglia/macrophages at sites of hemorrhages in human traumatic and ischemic brain lesions. We now investigated if CD163 expression is also correlated with hemorrhages in brain lesions. Methods. Autopsy brain tissue from 44 cases with hemorrhagic brain lesions (32 traumatic brain injuries/TBI, 12 intracerebral bleedings/ICB), 56 non-hemorrhagic brain lesions (30 ischemias, 26 hypoxias) and 6 control brains were investigated. The post injury survival times ranged from a few minutes to 60 months. Results. In controls, single perivascular monocytes expressed CD163, but only single CD163+ microglia were found in 3/6 cases. CD163+ cells in the parenchyma (activated microglia/macrophages) increased significantly within 24 hours after trauma and ischemia and within 1-7 days following ICB or hypoxia. Overall, significantly lower and higher levels of parenchymal CD163+ cells occurred in hypoxia and ischemia, respectively. Perivascular CD163+ cells also increased significantly in all pathological conditions. In areas remote from circumscribed brain lesions (TBI, ICB, ischemia), significant changes were only found in ICB and ischemia. Conclusions. De novo expression of CD163 by activated microglia/macrophages and CD163+ infiltrating monocytes are neither restricted to nor predominant in hemorrhagic brain lesions. Thus, the antiinflammatory function of CD163 probably predominates, both in hemorrhagic and non-hemorrhagic brain lesions and points to possible immunomodulatory treatment strategies targeting CD163	[Holfelder, K.; Schittenhelm, J.; Trautmann, K.; Meyermann, R.; Beschorner, R.] Univ Tubingen, Dept Neuropathol, Inst Pathol & Neuropathol, D-72074 Tubingen, Germany; [Haybaeck, J.] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Haybaeck, J.] Med Univ Graz, Inst Pathol, Graz, Austria		Beschorner, R (corresponding author), Univ Tubingen, Inst Brain Res, Calwerstr 3, D-72076 Tubingen, Germany.	rudi.beschorner@med.uni-tuebingen.de	Beschorner, Rudi/M-6397-2014	Beschorner, Rudi/0000-0003-1109-915X			Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Beschorner R, 2007, HISTOPATHOLOGY, V50, P897, DOI 10.1111/j.1365-2559.2007.02703.x; Beschorner R, 2007, HISTOL HISTOPATHOL, V22, P515, DOI 10.14670/HH-22.515; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Fabriek BO, 2007, J NEUROIMMUNOL, V187, P179, DOI 10.1016/j.jneuroim.2007.04.016; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Ferrer I, 2008, GREENFIELDS NEUROPAT, P121; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hogger P, 1998, J IMMUNOL, V161, P1883; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; MAINES MD, 1993, J PHARMACOL EXP THER, V264, P457; Mittelbronn M, 2001, ACTA NEUROPATHOL, V101, P249; Onofre G., 2009, ACTA MED, V52, P57, DOI [DOI 10.14712/18059694.2016.105, 10.14712/18059694.2016.105]; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Schaer DJ, 2007, ANTIOXID REDOX SIGN, V9, P991, DOI 10.1089/ars.2007.1576; Sulahian TH, 2001, J IMMUNOL METHODS, V252, P25, DOI 10.1016/S0022-1759(01)00328-3; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Wenzel I, 1996, EUR J IMMUNOL, V26, P2758, DOI 10.1002/eji.1830261131; Yepes M, 2005, AM J PATHOL, V166, P511, DOI 10.1016/S0002-9440(10)62273-0; Yepes M, 2007, MOL NEUROBIOL, V35, P255, DOI 10.1007/s12035-007-0024-z; Zhang XH, 2007, J CEREBR BLOOD F MET, V27, P534, DOI 10.1038/sj.jcbfm.9600368	34	20	21	0	2	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911			HISTOL HISTOPATHOL	Histol. Histopath.	AUG	2011	26	8					1007	1017					11	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	780WP	WOS:000291890500005	21692033				2022-02-06	
J	Zakzanis, KK; Yeung, E				Zakzanis, Konstantine K.; Yeung, Emily			Base Rates of Post-concussive Symptoms in a Nonconcussed Multicultural Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Post-concussive syndrome; Base rates; Cross cultural/minority	POSTCONCUSSION-LIKE SYMPTOMS; TRAUMATIC BRAIN-INJURY; HEALTH	The purpose of this preliminary study was to investigate differences in base rates of post-concussion syndrome (PCS) symptomatology in healthy individuals separated by cultural identity and language. In this study, we sought to determine if differences exist in terms of base-rate endorsement of PCS symptomatology in healthy individuals and whether culture and language-based specific clusters of PCS symptomatology exist in healthy individuals. A total of 151 participants, consisting of 33 Caucasians, 49 Chinese, Filipinos, and Southeast Asians, 43 Arabs, West Asians, and South Asians, and 26 participants of African descent completed four questionnaires and two subtests of a test of verbal ability. We found that the occurrence of PCS symptoms did not differ by culture and language-based groups in general, but that there were differences between groups in the base rates of individual symptom endorsement. Our preliminary findings illustrate that cultural and linguistic background may play a moderating role in the endorsement of PCS symptomatology and that false-positive conclusions may be reached disproportionally between groups. Our results underscore the importance of considering the influence of culture and language, in conjunction with a growing list of factors that can influence, maintain, and/or mimic persistent PCS.	[Zakzanis, Konstantine K.; Yeung, Emily] Univ Toronto Scarborough, Dept Psychol, Toronto, ON M1C 1A4, Canada		Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1993, DEPRESSION ANXIETY I; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Grandner MA, 2010, SLEEP MED, V11, P470, DOI 10.1016/j.sleep.2009.10.006; Hayes JS, 1998, ARCH CLIN NEUROPSYCH, V13, P27; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange R. T., 2010, J CLIN EXPT NEUROPSY, V30, P1; LEEHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203; Manzoni Gian Camillo, 2010, Handb Clin Neurol, V97, P3, DOI 10.1016/S0072-9752(10)97001-2; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Rabow MW, 2005, PAIN MED, V6, P235, DOI 10.1111/j.1526-4637.2005.05037.x; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Szanton SL, 2010, SOC SCI MED, V71, P259, DOI 10.1016/j.socscimed.2010.04.001; Treiber FA, 2002, PSYCHOSOM MED, V64, P707, DOI 10.1097/01.PSY.0000021952.59258.1C; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	25	20	20	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2011	26	5					461	465		10.1093/arclin/acr021			5	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	799QC	WOS:000293300200010	21642664	Bronze			2022-02-06	
J	Coste, C; Agar, N; Petitfour, E; Quinette, P; Guillery-Girard, B; Azouvi, P; Piolino, P				Coste, Cecile; Agar, Nathalie; Petitfour, Elise; Quinette, Peggy; Guillery-Girard, Berengere; Azouvi, Philippe; Piolino, Pascale			Exploring the roles of the executive and short-term feature-binding functions in retrieval of retrograde autobiographical memories in severe traumatic brain injury	CORTEX			English	Article						Traumatic brain injury; Autobiographical memory; Executive functions; Short-term binding; Verbal fluency	WORKING-MEMORY; EPISODIC MEMORY; AUTONOETIC CONSCIOUSNESS; FRONTAL VARIANT; AGE; SELF; RECOVERY; BUFFER; DISSOCIATION; INFORMATION	Conway's autobiographical memory (AM) model postulates that memories are not stored in a crystallised form in long-term memory but are reconstructed at time of retrieval via executive and binding processes, to create a temporary multimodal representation from different AM knowledge. Traumatic brain injury (TB!) impairs AM recollection. However, no study has yet considered the distinct roles of executive and short-term feature-binding functions in the retrieval deficits of retrograde AMs after TBI. Examining a group of 33 TBI patients and 33 controls, our study addresses these roles through a first-ever exploration of the links between performance on an AM verbal fluency evaluation that distinguishes four levels of representation, from semantic to episodic (lifetime periods, general events, specific events, specific details of a specific event), and three executive functions (shifting, inhibition and updating) and two short-term feature-binding functions (short-term formation and maintenance of multimodal representations). The results showed that TBI patients were impaired compared to controls in the retrieval of both semantic and episodic retrograde AM representations, but especially for the most episodic level of AM, in the three executive functions and the short-term maintenance of multimodal representations. Regression analyses indicated that the executive predictors (mainly updating) mediated a large proportion (over 70%) of TBI-related deficit on the retrieval of lifetime periods, general events and specific events, in contrast with the main impairment on generation of specific details which were only mildly (just 12%) predicted by the short-term maintenance of multimodal representations. Additional analyses in a subgroup of patients point to episodic memory abilities and time since injury in predicting the retrieval of specific events and details. In summary, the present study mainly emphasizes that the executive deficits in TBI are involved in the disruption of the first levels of AM generative processes that give access to the multiple episodic details recollection. (C) 2010 Elsevier Srl. All rights reserved.	[Coste, Cecile; Piolino, Pascale] CNRS, FRE 3292, Memory & Learning Grp, Cognit Psychol & Neuropsychol Lab, F-92774 Boulogne, France; [Coste, Cecile; Petitfour, Elise; Piolino, Pascale] Paris Descartes Univ, Paris, France; [Agar, Nathalie; Azouvi, Philippe] Hop Raymond Poincare, Phys Med & Rehabil Serv, Garches, France; [Quinette, Peggy; Guillery-Girard, Berengere; Piolino, Pascale] Univ Caen, EPHE, INSERM, U923, F-14032 Caen, France		Piolino, P (corresponding author), CNRS, FRE 3292, Memory & Learning Grp, Cognit Psychol & Neuropsychol Lab, 71 Ave Edouard Vaillant, F-92774 Boulogne, France.	pascale.piolino@parisdescartes.fr	Piolino, pascale/F-8075-2014; Quinette, Peggy/L-8780-2015	Piolino, pascale/0000-0002-7787-924X; Guillery-Girard, Berengere/0000-0002-2316-4716; Quinette, Peggy/0000-0002-7520-7159	French Research MinistryMinistry of Research, France	We wish to thank all patients and controls for their participation and Susan Biggin for grammar/style corrections. This study was funding by a thesis grant awarded to Cecile Coste by the French Research Ministry.	Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1986, WORKING MEMORY; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Baddeley A, 2010, NEUROPSYCHOLOGIA, V48, P1089, DOI 10.1016/j.neuropsychologia.2009.12.009; Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Brickenkamp R., 1998, D2 TEST ATTENTION CO; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Collinson SL, 2009, BRAIN INJURY, V23, P71, DOI 10.1080/02699050802649647; Colzato LS, 2006, J EXP PSYCHOL HUMAN, V32, P705, DOI 10.1037/0096-1523.32.3.705; Conway M, 2004, MEMORY, V12, P525, DOI 10.1080/09658210444000151; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2003, MEMORY, V11, P217, DOI 10.1080/741938205; Conway MA, 2001, PHILOS T R SOC B, V356, P1375, DOI 10.1098/rstb.2001.0940; CONWAY MA, 2000, HDB NEUROPSYCHOLOGY, V2, P281; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Dalgleish T, 2007, MEMORY, V15, P225, DOI 10.1080/09658210701256399; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Dritschel BH, 1998, BRAIN INJURY, V12, P875; DRITSCHEL BH, 1992, MEM COGNITION, V20, P133, DOI 10.3758/BF03197162; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Greene JDW, 1995, NEUROPSYCHOLOGIA, V33, P1647, DOI 10.1016/0028-3932(95)00046-1; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Kopelman MD, 2001, PHILOS T R SOC B, V356, P1409, DOI 10.1098/rstb.2001.0942; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Matuszewski V, 2006, NEUROPSYCHOLOGIA, V44, P2386, DOI 10.1016/j.neuropsychologia.2006.04.031; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MORRIS N, 1990, PERCEPT PSYCHOPHYS, V47, P291, DOI 10.3758/BF03205003; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; Moscovitch M, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P331; Nadel L, 2001, TRENDS COGN SCI, V5, P228, DOI 10.1016/S1364-6613(00)01664-8; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Pak R, 2008, COMPUT HUM BEHAV, V24, P3045, DOI 10.1016/j.chb.2008.05.010; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Picard L, 2009, CONSCIOUS COGN, V18, P864, DOI 10.1016/j.concog.2009.07.008; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; Plancher G, 2009, NEUROPSYCHOLOGIA, V47, P2527, DOI 10.1016/j.neuropsychologia.2009.04.026; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Quinette P, 2003, BRAIN, V126, P1917, DOI 10.1093/brain/awg201; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rosenbaum RS, 2004, NEUROPSYCHOLOGIA, V42, P1619, DOI 10.1016/j.neuropsychologia.2004.04.010; Rudner M, 2008, COGN PROCESS, V9, P19, DOI 10.1007/s10339-007-0183-x; Rudner M, 2007, NEUROPSYCHOLOGIA, V45, P2258, DOI 10.1016/j.neuropsychologia.2007.02.017; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Souchay C, 2004, BRAIN COGNITION, V56, P89, DOI 10.1016/j.bandc.2004.06.002; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Treisman A, 2006, VIS COGN, V14, P411, DOI 10.1080/13506280500195250; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Wechsler D., 2000, ECHELLE INTELLIGENCE; [No title captured], DOI DOI 10.1016/S0079-7421(08)60452-1	91	20	22	0	22	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	JUL-AUG	2011	47	7					771	786		10.1016/j.cortex.2010.07.004			16	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	785ID	WOS:000292221800002	20817159				2022-02-06	
J	Fujita, M; Oda, Y; Wei, EP; Povlishock, JT				Fujita, Motoki; Oda, Yasutaka; Wei, Enoch P.; Povlishock, John T.			The Combination of Either Tempol or FK506 with Delayed Hypothermia: Implications for Traumatically Induced Microvascular and Axonal Protection	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; pial vessels; vascular reactivity; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; STABLE NITROXIDE TEMPOL; FREE-RADICAL PRODUCTION; BRAIN-INJURY; POSTTRAUMATIC HYPOTHERMIA; ANTIOXIDANT TEMPOL; MODEL; RATS; DAMAGE; CONSEQUENCES	Following traumatic brain injury (TBI), inhibition of reactive oxygen species and/or calcineurin can exert axonal and vascular protection. This protection proves optimal when these strategies are used early post-injury. Recent work has shown that the combination of delayed drug administration and delayed hypothermia extends this protection. Here we revisit this issue in TBI using the nitroxide antioxidant Tempol, or the immunophilin ligand FK506, together with delayed hypothermia, to determine their effects upon cerebral vascular reactivity and axonal damage. Animals were subjected to TBI and treated with Tempol at 30 or 90 min post-injury, or 90 min post-injury with concomitant mild hypothermia (33 degrees C). Another group of animals were treated in the same fashion with the exception that they received FK506. Cranial windows were placed to assess vascular reactivity over 6 h post-injury, when the animals were assessed for traumatically induced axonal damage. Vasoreactivity was preserved by early Tempol administration; however, this benefit declined with time. The coupling of hypothermia and delayed Tempol, however, exerted significant vascular protection. The use of early and delayed FK506 provided significant vascular protection which was not augmented by hypothermia. The early administration of Tempol provided dramatic axonal protection that was not enhanced with hypothermia. Early and delayed FK506 provided significant axonal protection, although this protection was not enhanced by delayed hypothermia. The current investigation supports the premise that Tempol coupled with hypothermia extends its benefits. While FK506 proved efficacious with early and delayed administration, it did not provide either increased vascular or axonal benefit with hypothermia. These studies illustrate the potential benefits of Tempol coupled to delayed hypothermia. However, these findings do not transfer to the use of FK506, which in previous studies proved beneficial when coupled with hypothermia. These divergent results may be a reflection of the different animal models used and/or their associated injury severity.	[Fujita, Motoki; Oda, Yasutaka; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Fujita, Motoki; Oda, Yasutaka] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055813, NS047463, NS 057175]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R21NS057175] Funding Source: NIH RePORTER	We thank Susan Walker and Lynn Davis for their excellent technical assistance. This study is supported by National Institutes of Health (NIH) grants HD055813, NS047463, and NS 057175.	Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Behringer W, 2002, J CEREBR BLOOD F MET, V22, P105, DOI 10.1097/00004647-200201000-00013; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; ELLIS EF, 1983, PROSTAGLANDINS, V26, P917, DOI 10.1016/0090-6980(83)90154-5; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kato N, 2003, BRAIN RES, V979, P188, DOI 10.1016/S0006-8993(03)02918-4; Koda Y, 2010, BRAIN RES, V1311, P197, DOI 10.1016/j.brainres.2009.11.028; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1983, ADV EXP MED BIOL, V161, P365; KONTOS HA, 1988, AM J PHYSIOL, V255, pH1259, DOI 10.1152/ajpheart.1988.255.5.H1259; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Kwon TH, 2003, J NEUROTRAUM, V20, P337, DOI 10.1089/089771503765172291; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Rak R, 2000, J NEUROSURG, V92, P646, DOI 10.3171/jns.2000.92.4.0646; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1992, STROKE, V23, P1623, DOI 10.1161/01.STR.23.11.1623	40	20	21	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1209	1218		10.1089/neu.2011.1852			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600009	21521034	Green Published			2022-02-06	
J	Kouvarellis, AJ; Rohlwink, UK; Sood, V; Van Breda, D; Gowen, MJ; Figaji, AA				Kouvarellis, Alison J.; Rohlwink, Ursula K.; Sood, Vishesh; Van Breda, Devon; Gowen, Michael J.; Figaji, Anthony A.			The relationship between basal cisterns on CT and time-linked intracranial pressure in paediatric head injury	CHILDS NERVOUS SYSTEM			English	Article						Basal cisterns; Traumatic brain injury; Children; Computed tomography; Head injury; Intracranial pressure monitoring	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; CHILDREN; HYPERTENSION; CARE	Although intracranial pressure (ICP) monitoring is a cornerstone of care for severe traumatic brain injury (TBI), the indications for ICP monitoring in children are unclear. Often, decisions are based on head computed tomography (CT) scan characteristics. Arguably, the patency of the basal cisterns is the most commonly used of these signs. Although raised ICP is more likely with obliterated basal cisterns, the implications of open cisterns are less clear. We examined the association between the status of perimesencephalic cisterns and time-linked ICP values in paediatric severe TBI. ICP data linked to individual head CT scans were reviewed. Basal cisterns were classified as open or closed by blinded reviewers. For the initial CT scan, we examined ICP values for the first 6 h after monitor insertion. For follow-up scans, we examined ICP values 3 h before and after scanning. Mean ICP and any episode of ICP a parts per thousand yenaEuro parts per thousand 20 mmHg during this period were recorded. Data from 104 patients were examined. Basal cisterns were patent in 51.72% of scans, effaced in 34.48% and obliterated in 13.79%. Even when cisterns were open, more than 40% of scans had at least one episode of ICP a parts per thousand yenaEuro parts per thousand 20 mmHg, and 14% of scans had a mean ICP a parts per thousand yenaEuro parts per thousand 20 mmHg. The specificity of open cisterns in predicting ICP < 20 mmHg was poor (57.9%). Age-related data were worse. Children with severe TBI frequently may have open basal cisterns on head CT despite increased ICP. Open cisterns should not discourage ICP monitoring.	[Kouvarellis, Alison J.; Rohlwink, Ursula K.; Sood, Vishesh; Van Breda, Devon; Gowen, Michael J.; Figaji, Anthony A.] Univ Cape Town, Div Neurosurg, Sch Child & Adolescent Hlth, Red Cross War Mem Childrens Hosp, ZA-7925 Cape Town, South Africa		Figaji, AA (corresponding author), Univ Cape Town, Div Neurosurg, Sch Child & Adolescent Hlth, Red Cross War Mem Childrens Hosp, ZA-7925 Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Rohlwink, Ursula/AAE-2513-2020; Rohlwink, Ursula Karin/U-8917-2019	Rohlwink, Ursula Karin/0000-0002-4469-4935; Sood, Vishesh/0000-0003-1566-5681; Figaji, Anthony/0000-0002-3357-6490			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut R M, 1995, New Horiz, V3, P366; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hirsch W, 2000, PEDIATR RADIOL, V30, P439, DOI 10.1007/s002470000255; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; SADHU VK, 1979, RADIOLOGY, V133, P507, DOI 10.1148/133.2.507; Salim A, 2008, AM SURGEON, V74, P1088; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003	30	20	21	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2011	27	7					1139	1144		10.1007/s00381-011-1464-3			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	775RH	WOS:000291480300016	21538131				2022-02-06	
J	van Noordt, S; Good, D				van Noordt, Stefon; Good, Dawn			Mild head injury and sympathetic arousal: Investigating relationships with decision-making and neuropsychological performance in university students	BRAIN INJURY			English	Article						Head trauma; emotion; cognition; physiological arousal	TRAUMATIC BRAIN-INJURY; CEREBRAL GLUCOSE-METABOLISM; ORBITOFRONTAL CORTEX; FACIAL EXPRESSION; EMOTION; CONCUSSION; DEFICITS; RECOGNITION; MECHANISMS; PROGNOSIS	A: The purpose of this study was to examine the relationships between neuropsychological performance, physiological arousal and decision-making in university students who have or have not reported a history of mild head injury (MHI). Methods: Forty-four students, 18 (41%) reporting a history of MHI, performed a design fluency task and the Iowa Gambling Task (IGT) while electrodermal activity (EDA) was recorded. Results: General cognitive ability and overall choice outcomes did not differ between groups. However, self-reported MHI severity predicted decision-making performance such that the greater the neural indices of trauma, the more disadvantageous the choices made by participants. As expected, both groups exhibited similar base levels of autonomic arousal and physiological responses to reward and punishment outcomes; however, those reporting MHI produced significantly lower levels of EDA during the anticipatory stages of decision-making. Conclusions: Overall, these findings encourage the acceptance of head injury as being on a continuum of brain injury severity, as MHI can emulate neurophysiological and neuropsychological features of more traumatic cases and may be impacting mechanisms which sustain adaptive social decision-making.	[van Noordt, Stefon; Good, Dawn] Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, St Catharines, ON L2S 3A1, Canada		van Noordt, S (corresponding author), Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	sv05lz@brocku.ca			Ontario Neurotrauma Foundation (ONF) [2008-ABI-SR-603]	This research was supported by grant 2008-ABI-SR-603, afforded to Dr Dawn Good from the Ontario Neurotrauma Foundation (ONF). S. van Noordt reports no conflicts of interest. The authors declare that abstracts related to this work have been published as supplementary materials to conference proceedings [74].	BARBAS H, 2003, BIOMED CENTRAL NEURO, V4, P1471; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 2007, IOWA GAMBLING TASK; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Colombetti G, 2008, BRIT J PHILOS SCI, V59, P51, DOI 10.1093/bjps/axm045; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2000, J NEUROSCI, V20, P3033; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DEBONO A, 2008, THESIS BROCK U ST CA; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Denburg NL, 2007, ANN NY ACAD SCI, V1121, P480, DOI 10.1196/annals.1401.031; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jansari A, 1999, J COGNITIVE NEUROSCI, P18; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; LYKKEN DT, 1961, AM J PSYCHOL, V74, P293, DOI 10.2307/1419417; Matis GK, 2009, MED SCI MONITOR, V15, pCR62; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MORALES D, BRAIN CONTUSION IMAG; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Northoff G, 2006, HUM BRAIN MAPP, V27, P572, DOI 10.1002/hbm.20202; Oya H, 2005, P NATL ACAD SCI USA, V102, P8351, DOI 10.1073/pnas.0500899102; POOL JL, 1949, J NEUROPHYSIOL, V12, P385, DOI 10.1152/jn.1949.12.6.385; Roberts AC, 2006, TRENDS COGN SCI, V10, P83, DOI 10.1016/j.tics.2005.12.002; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; SPSS, 2009, STAT PACK SOC SCI; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tellier A, 1999, BRAIN INJURY, V13, P463; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VANNOORDT S, 2010, FRONTIERS HUMAN NEUR; VANNOORDT SJR, 2010, BRAIN INJURY, V24, P219; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; Yechiam E, 2008, PSYCHON B REV, V15, P44, DOI 10.3758/PBR.15.1.44	73	20	21	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					707	716		10.3109/02699052.2011.580312			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600007	21619460				2022-02-06	
J	Lin, YW; Hsieh, CL				Lin, Yi-Wen; Hsieh, Ching-Liang			Oral Uncaria rhynchophylla (UR) reduces kainic acid-induced epileptic seizures and neuronal death accompanied by attenuating glial cell proliferation and S100B proteins in rats	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Epileptic seizures; Hippocampus; GFAP; S100B; Traditional Chinese Medicine; Uncaria rhynchophylla	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; TREATED RATS; HIPPOCAMPAL SLICES; GABA(A) RECEPTORS; S-100 PROTEIN; ANIMAL-MODEL; S100-BETA; EXPRESSION; EPILEPTOGENESIS	Aim of the study: Epilepsy is a common clinical syndrome with recurrent neuronal discharges in cerebral cortex and hippocampus. Here we aim to determine the protective role of Uncaria rhynchophylla (UR), an herbal drug belong to Traditional Chinese Medicine (TCM), on epileptic rats. Materials and methods: To address this issue, we tested the effect of UR on kainic acid (KA)-induced epileptic seizures and further investigate the underlying mechanisms. Results: Oral UR successfully decreased neuronal death and discharges in hippocampal CA1 pyramidal neurons. The population spikes (PSs) were decreased from 4.1 +/- 0.4 mV to 2.1 +/- 0.3 mV in MA-induced epileptic seizures and UR-treated groups, respectively. Oral UR protected animals from neuronal death induced by MA treatment (from 34 +/- 4.6 to 191.7 +/- 48.6 neurons/field) through attenuating glial cell proliferation and S100B protein expression but not GABAA and TRPV1 receptors. Conclusions: The above results provide detail mechanisms underlying the neuroprotective action of UR on MA-induced epileptic seizure in hippocampal CA1 neurons. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.	[Lin, Yi-Wen; Hsieh, Ching-Liang] China Med Univ, Grad Inst Acupuncture Sci, Taichung 40402, Taiwan; [Lin, Yi-Wen; Hsieh, Ching-Liang] China Med Univ, Acupuncture Res Ctr, Taichung 40402, Taiwan; [Hsieh, Ching-Liang] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan		Hsieh, CL (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.	clhsieh@mail.cmuh.org.tw	Lin, Yi-Wen/O-3541-2015	Lin, Yi-Wen/0000-0001-7204-8837	National Science Council, Taiwan, R. O. C.Ministry of Science and Technology, Taiwan [NSC 97-2320-B-039-011-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]	This study was supported by grant NSC 97-2320-B-039-011-MY3 from the National Science Council, Taiwan, R. O. C. and was also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004).	Antonucci F, 2009, EPILEPSIA, V50, P963, DOI 10.1111/j.1528-1167.2008.01983.x; BARGER SW, 1992, J BIOL CHEM, V267, P9689; BARNES JM, 1992, PROG NEUROBIOL, V39, P113, DOI 10.1016/0301-0082(92)90007-2; Bhaskaran MD, 2010, EXP NEUROL, V223, P529, DOI 10.1016/j.expneurol.2010.01.021; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Brenner RP, 2004, J CLIN NEUROPHYSIOL, V21, P319; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Cohen AS, 2003, EUR J NEUROSCI, V17, P1607, DOI 10.1046/j.1460-9568.2003.02597.x; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; de Oliveira DL, 2008, EPILEPSIA, V49, P842, DOI 10.1111/j.1528-1167.2007.01484.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Dudek FE, 2010, EPILEPSIA, V51, P126, DOI 10.1111/j.1528-1167.2010.02626.x; Fu M, 2009, MED HYPOTHESES, V73, P100, DOI 10.1016/j.mehy.2009.01.005; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Hsieh CL, 2009, AM J CHINESE MED, V37, P351, DOI 10.1142/S0192415X09006898; Hsieh CL, 1999, AM J CHINESE MED, V27, P257, DOI 10.1142/S0192415X9900029X; Hughes PE, 1996, NEUROSCIENCE, V74, P1143, DOI 10.1016/0306-4522(96)00174-1; Ichikawa H, 1997, BRAIN RES, V748, P253, DOI 10.1016/S0006-8993(96)01364-9; ISOBE T, 1981, J NEUROCHEM, V37, P522, DOI 10.1111/j.1471-4159.1981.tb00488.x; Kang JQ, 2009, TRENDS MOL MED, V15, P430, DOI 10.1016/j.molmed.2009.07.003; Kang N, 2004, J NEUROPHYSIOL, V92, P873, DOI 10.1152/jn.01231.2003; Kang TH, 2002, EUR J PHARMACOL, V455, P27, DOI 10.1016/S0014-2999(02)02581-5; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; KAPUR N, 1994, NEUROPSYCHOLOGIA, V32, P23, DOI 10.1016/0028-3932(94)90066-3; Kim YB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-42; Kohling R, 2000, J NEUROSCI, V20, P6820, DOI 10.1523/JNEUROSCI.20-18-06820.2000; Lee J, 2003, NEUROSCI LETT, V348, P51, DOI 10.1016/S0304-3940(03)00613-X; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Nadkarni Suhita, 2005, Journal of Integrative Neuroscience, V4, P207, DOI 10.1142/S0219635205000811; Qi JS, 2006, J PHYSIOL-LONDON, V577, P579, DOI 10.1113/jphysiol.2006.113134; Raedt R, 2009, ACTA NEUROL SCAND, V119, P293, DOI 10.1111/j.1600-0404.2008.01108.x; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Rathore C, 2009, EPILEPSIA, V50, P2249, DOI 10.1111/j.1528-1167.2009.02300.x; RICKMANN M, 1995, NEUROSCIENCE, V67, P977, DOI 10.1016/0306-4522(94)00615-C; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sakatani S, 2007, EUR J NEUROSCI, V25, P1144, DOI 10.1111/j.1460-9568.2007.05337.x; Schramm J, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297106.65002.1F, 10.1227/01.neu.0000316250.69898.23]; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shan Y, 1997, EXP NEUROL, V144, P406, DOI 10.1006/exnr.1997.6427; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Shimada Y, 1999, J PHARM PHARMACOL, V51, P715, DOI 10.1211/0022357991772853; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Talathi SS, 2009, NEUROSCI LETT, V455, P145, DOI 10.1016/j.neulet.2009.03.057; Tang NY, 2010, AM J CHINESE MED, V38, P251, DOI 10.1142/S0192415X10007828; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WILLIAMS S, 1993, NEUROSCIENCE, V52, P541, DOI 10.1016/0306-4522(93)90404-4; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063	54	20	21	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	MAY 17	2011	135	2					313	320		10.1016/j.jep.2011.03.018			8	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	778PG	WOS:000291716000013	21402140				2022-02-06	
